data source	chemical name	gene symbol	variant	ddg	disease name	label	uniprot id	chemical_type	pubchem id	smile	chromosome	position	ref allele	alt allele
aimms	dasatinib	ABL1	M244V	0.29			P00519							
aimms	dasatinib	ABL1	G250E	0.48			P00519							
aimms	dasatinib	ABL1	Q252H	0.86			P00519							
aimms	dasatinib	ABL1	Y253F	0.33			P00519							
aimms	dasatinib	ABL1	Y253H	0.29			P00519							
aimms	dasatinib	ABL1	E255K	1.16			P00519							
aimms	dasatinib	ABL1	E255V	1.56			P00519							
aimms	dasatinib	ABL1	V299L	1.86			P00519							
aimms	dasatinib	ABL1	F311L	0.29			P00519							
aimms	dasatinib	ABL1	T315A	3.01			P00519							
aimms	dasatinib	ABL1	T315I	3.29			P00519							
aimms	dasatinib	ABL1	F317L	1.33			P00519							
aimms	dasatinib	ABL1	F317V	2.5			P00519							
aimms	dasatinib	ABL1	M351T	0.19			P00519							
aimms	dasatinib	ABL1	E355G	0.48			P00519							
aimms	dasatinib	ABL1	F359V	0.6			P00519							
aimms	dasatinib	ABL1	V379I	0.0			P00519							
aimms	dasatinib	ABL1	L387M	0.55			P00519							
aimms	dasatinib	ABL1	H396P	-0.17			P00519							
aimms	dasatinib	ABL1	H396R	0.29			P00519							
aimms	nilotinib	ABL1	M244V	0.64			P00519							
aimms	nilotinib	ABL1	G250E	0.78			P00519							
aimms	nilotinib	ABL1	Q252H	1.0			P00519							
aimms	nilotinib	ABL1	Y253F	1.35			P00519							
aimms	nilotinib	ABL1	Y253H	2.11			P00519							
aimms	nilotinib	ABL1	E255K	1.63			P00519							
aimms	nilotinib	ABL1	E255V	2.09			P00519							
aimms	nilotinib	ABL1	F311L	0.34			P00519							
aimms	nilotinib	ABL1	T315A	0.92			P00519							
aimms	nilotinib	ABL1	T315I	3.0			P00519							
aimms	nilotinib	ABL1	F317L	0.8			P00519							
aimms	nilotinib	ABL1	M351T	0.09			P00519							
aimms	nilotinib	ABL1	F359V	1.55			P00519							
aimms	nilotinib	ABL1	V379I	0.81			P00519							
aimms	nilotinib	ABL1	L387M	0.79			P00519							
aimms	nilotinib	ABL1	H396P	0.68			P00519							
aimms	nilotinib	ABL1	H396R	0.68			P00519							
aimms	gefitinib	EGFR	G719S	0.48			P00533							
aimms	gefitinib	EGFR	G719S/T790M	-0.56			P00533							
aimms	gefitinib	EGFR	T790M	-1.21			P00533							
aimms	gefitinib	EGFR	L858R	-1.6			P00533							
aimms	gefitinib	EGFR	L858R/T790M	-0.7			P00533							
aimms	fidarestat	AKR1B1	C303D	1.04			P15121							
aimms	fidarestat	AKR1B1	F121P	0.29			P15121							
aimms	fidarestat	AKR1B1	L300A	0.46			P15121							
aimms	fidarestat	AKR1B1	L300P	1.88			P15121							
aimms	fidarestat	AKR1B1	L301M	0.7			P15121							
aimms	fidarestat	AKR1B1	S302R/C303D	1.91			P15121							
aimms	fidarestat	AKR1B1	T113Y	2.08			P15121							
aimms	fidarestat	AKR1B1	V47I	0.14			P15121							
civic	Daunorubicin	DNMT3A	R882		Acute Myeloid Leukemia	Resistance	Q9Y6K1							
civic	Selumetinib	MAP2K1	P124S		Melanoma	Resistance	Q02750							
civic	Selumetinib	MAP2K1	Q56P		Melanoma	Resistance	Q02750							
civic	Vemurafenib	NRAS	Q61		Melanoma	Resistance	P01111							
civic	Imatinib	PDGFRA	D842V		Gastrointestinal Stromal Tumor	Resistance	P16234							
civic	Imatinib	PDGFRA	D842V		Gastrointestinal Stromal Tumor	Resistance	P16234							
civic	Sorafenib	ARAF	S214C		Lung Non-small Cell Carcinoma	Sensitivity/Response	P10398							
civic	Idarubicin	DNMT3A	R882		Acute Myeloid Leukemia	Sensitivity/Response	Q9Y6K1							
civic	Peginterferon Alfa-2b	JAK2	V617F		Polycythemia Vera	Sensitivity/Response	O60674							
civic	Fedratinib	JAK2	V617F		Polycythemia Vera	Sensitivity/Response	O60674							
civic	Tanespimycin	NRAS	G13D		Melanoma	Sensitivity/Response	P01111							
civic	Temozolomide	NRAS	Q61L		Melanoma	Sensitivity/Response	P01111							
civic	Temozolomide	NRAS	Q61R		Melanoma	Sensitivity/Response	P01111							
civic	Crizotinib	ALK	F1174L		Inflammatory Myofibroblastic Tumor	Resistance	Q9UM73							
civic	Crizotinib	ALK	F1174L		Lung Non-small Cell Carcinoma	Resistance	Q9UM73							
civic	Sorafenib,Imatinib,Nilotinib	KIT	L576P		Melanoma	Resistance	P10721							
civic	Erlotinib,Gefitinib	KRAS	G12/G13		Lung Non-small Cell Carcinoma	Resistance	P01116							
civic	Chemotherapy,Cetuximab	NRAS	Q61		Colorectal Cancer	Resistance	P01111							
civic	Alectinib	ALK	F1174L		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	F1174L		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	TAE684	ALK	R1275Q		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Sorafenib	ARAF	S214C		Lung Non-small Cell Carcinoma	Sensitivity/Response	P10398							
civic	Trametinib	ARAF	S214C		Lung Non-small Cell Carcinoma	Sensitivity/Response	P10398							
civic	Dasatinib	KIT	L576P		Melanoma	Sensitivity/Response	P10721							
civic	Crenolanib	PDGFRA	D842I		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Crenolanib	PDGFRA	D842V		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Crenolanib	PDGFRA	D842Y		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Crenolanib	PDGFRA	I843DEL		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Crenolanib	PDGFRA	D842_I843delinsVM		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	TAE684	ALK	R1275Q		Neuroblastoma	Resistance	Q9UM73							
civic	Imatinib	KIT	Exon 11 Mutation		Melanoma	Sensitivity/Response	P10721							
civic	Motesanib	RET	C634W		Thyroid Gland Medullary Carcinoma	Resistance	P07949							
civic	Motesanib	RET	M918T		Thyroid Gland Medullary Carcinoma	Resistance	P07949							
civic	JAK2 Inhibitor AZD1480	RET	M918T		Thyroid Gland Medullary Carcinoma	Sensitivity/Response	P07949							
civic	Regorafenib	PIK3CA	E542K		Colorectal Cancer	Resistance	P42336							
civic	Trametinib,Mirdametinib	BRAF	V600E		Melanoma	Resistance	P15056							
civic	Regorafenib	KRAS	Exon 2 Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Panitumumab	BRAF	V600		Colorectal Cancer	Resistance	P15056							
civic	Panitumumab,Sorafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Melanoma	Resistance	P15056							
civic	Dabrafenib	BRAF	V600E		Lung Non-small Cell Carcinoma	Resistance	P15056							
civic	Dabrafenib,Trametinib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Dabrafenib	BRAF	V600D		Melanoma	Sensitivity/Response	P15056							
civic	Dabrafenib,Trametinib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	PLX4720,Pictilisib Bismesylate	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Nutlin-3,PLX4720	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Bevacizumab,Vemurafenib,Capecitabine	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Tretinoin	CEBPA	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	P49715							
civic	Chemotherapy,Cetuximab	PIK3CA	Exon 10 Mutation		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab	NRAS	Q61		Colorectal Cancer	Resistance	P01111							
civic	Crizotinib	ALK	F1174L		Neuroblastoma	Resistance	Q9UM73							
civic	Cetuximab	BRAF	V600E		Colorectal Cancer	Resistance	P15056							
civic	Tretinoin	FLT3	ITD		Acute Myeloid Leukemia	Resistance	P36888							
civic	Daunorubicin	FLT3	ITD		Acute Myeloid Leukemia	Resistance	P36888							
civic	SU5614	FLT3	ITD		Acute Myeloid Leukemia	Resistance	P36888							
civic	Chemotherapy,Cetuximab	KRAS	G12/G13		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G12/G13		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G12V		Colorectal Cancer	Resistance	P01116							
civic	Tretinoin	NPM1	EXON 12 MUTATION		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	Chemotherapy,Cetuximab	PIK3CA	Exon 21 Mutation		Colorectal Cancer	Resistance	P42336							
civic	Daunorubicin,Cytarabine	WT1	Exon 7 Mutation		Acute Myeloid Leukemia	Resistance	P19544							
civic	TAE684	ALK	F1174L		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	R1275Q		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	PD173074	FGFR3	FGFR3::BAIAP2L1		Bladder Carcinoma	Sensitivity/Response	P22607							
civic	Cetuximab	KRAS	G13D		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Tretinoin	NPM1	EXON 12 MUTATION		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	Daunorubicin	NPM1	EXON 12 MUTATION		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	Valproic Acid	NPM1	EXON 12 MUTATION		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	Tretinoin,NSC348884	NPM1	EXON 12 MUTATION		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	Anti-CD123,Anti-CD33	NPM1	EXON 12 MUTATION		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	Anti-CD33	NPM1	EXON 12 MUTATION		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	NSC348884	NPM1	W288FS		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	Daunorubicin,Cytarabine,Etoposide	NPM1	W288FS		Acute Myeloid Leukemia	Sensitivity/Response	P06748							
civic	Sirolimus	TSC1	Frameshift Truncation		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q92574							
civic	Everolimus	TSC1	Loss-of-function		Bladder Carcinoma	Sensitivity/Response	Q92574							
civic	Olaparib	BRCA1	Loss-of-function		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Loss-of-function		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Gefitinib,Erlotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Akt Inhibitor MK2206	AKT1	E17K		Breast Cancer	Sensitivity/Response	P31749							
civic	Imatinib	ABL1	BCR::ABL		Acute Myeloid Leukemia	Resistance	P00519							
civic	Erlotinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Gefitinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Dacomitinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Lapatinib	ERBB2	L755S		Breast Cancer	Resistance	P04626							
civic	Hormone Therapy	ESR1	L536Q		Breast Cancer	Resistance	P03372							
civic	Hormone Therapy	ESR1	D538G		Breast Cancer	Resistance	P03372							
civic	Hormone Therapy	ESR1	Y537C		Breast Cancer	Resistance	P03372							
civic	Hormone Therapy	ESR1	Y537N		Breast Cancer	Resistance	P03372							
civic	Hormone Therapy	ESR1	Y537S		Breast Cancer	Resistance	P03372							
civic	Sorafenib	FLT3	TKD MUTATION		Acute Myeloid Leukemia	Resistance	P36888							
civic	Imatinib	KIT	V654A		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Cetuximab	KRAS	Exon 2 Mutation		Colorectal Cancer	Resistance	P01116							
civic	Erlotinib,Gefitinib	KRAS	G12A		Lung Adenocarcinoma	Resistance	P01116							
civic	Cetuximab,Panitumumab	PIK3CA	H1047R		Colorectal Cancer	Resistance	P42336							
civic	Imatinib	ABL1	BCR::ABL		Acute Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Imatinib	ABL1	BCR::ABL		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Dasatinib,Nilotinib	ABL1	BCR::ABL		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Crizotinib	ALK	EML4::ALK		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Palbociclib	CCND3	Loss		T-cell Lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P30281							
civic	Alpelisib	CDK4	EXPRESSION		Estrogen-receptor Positive Breast Cancer	Sensitivity/Response	P11802							
civic	Dasatinib	DDR2	G253C		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q16832							
civic	Dasatinib	DDR2	G505S		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q16832							
civic	Dasatinib	DDR2	G774V		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q16832							
civic	Dasatinib	DDR2	I638F		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q16832							
civic	Dasatinib	DDR2	L239R		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q16832							
civic	Dasatinib	DDR2	L63V		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q16832							
civic	Dasatinib,Erlotinib	DDR2	S768R		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q16832							
civic	Gefitinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	G719S		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib,Erlotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Pemetrexed,Erlotinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Staurosporine	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Neratinib,Lapatinib	ERBB2	D769H		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	D769Y		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	L755_T759del		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	G309A		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	L755S		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	L755W		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	P780INS		Breast Cancer	Sensitivity/Response	P04626							
civic	Lapatinib,Neratinib	ERBB2	R678Q		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	R896C		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	V777L		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	V842I		Breast Cancer	Sensitivity/Response	P04626							
civic	Tamoxifen,Fulvestrant	ESR1	L536Q		Breast Cancer	Sensitivity/Response	P03372							
civic	Fulvestrant,Tamoxifen	ESR1	D538G		Breast Cancer	Sensitivity/Response	P03372							
civic	Tamoxifen,Fulvestrant	ESR1	Y537C		Breast Cancer	Sensitivity/Response	P03372							
civic	Fulvestrant,Tamoxifen	ESR1	Y537N		Breast Cancer	Sensitivity/Response	P03372							
civic	Tamoxifen,Fulvestrant	ESR1	Y537S		Breast Cancer	Sensitivity/Response	P03372							
civic	Ponatinib	FGFR2	FGFR2::MGEA5		Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	Ponatinib,Pazopanib	FGFR2	FGFR2::TACC3		Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	Lestaurtinib	FLT3	ITD		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Sorafenib	FLT3	ITD		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Tyrphostin AG 1296	FLT3	ITD		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Bortezomib,Fasudil	GATA2	EXPRESSION		Lung Adenocarcinoma	Sensitivity/Response	P23769							
civic	Imatinib	KIT	Internal Duplication		Malignant Anus Melanoma	Sensitivity/Response	P10721							
civic	Nilotinib,Imatinib,Dasatinib	KIT	L576P		Lung Non-small Cell Carcinoma	Sensitivity/Response	P10721							
civic	Sunitinib	KIT	V654A		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Selumetinib,Dactolisib	KRAS	G12D		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Cetuximab	KRAS	G13D		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Temozolomide	MGMT	Promoter Methylation		Glioblastoma	Sensitivity/Response	P16455							
civic	Carmustine	MGMT	Promoter Methylation		Glioblastoma	Sensitivity/Response	P16455							
civic	O6-Benzylguanine	MGMT	Promoter Methylation		Glioblastoma	Sensitivity/Response	P16455							
civic	PI3K-alpha Inhibitor MEN1611	PIK3CA	E542K		Breast Cancer	Sensitivity/Response	P42336							
civic	Sirolimus	PIK3CA	E542K		Breast Cancer	Sensitivity/Response	P42336							
civic	PI3K-alpha Inhibitor MEN1611	PIK3CA	H1047R		Breast Cancer	Sensitivity/Response	P42336							
civic	Tretinoin	PML	PML::RARA		Acute Promyelocytic Leukemia	Sensitivity/Response	P29590							
civic	MTOR Inhibitor	PTEN	R233*		Breast Cancer	Sensitivity/Response	P60484							
civic	Doxorubicin	TP53	R175H		Breast Cancer	Sensitivity/Response	Q12888							
civic	Everolimus	TSC1	Frameshift Truncation		Invasive Bladder Transitional Cell Carcinoma	Sensitivity/Response	Q92574							
civic	Imatinib	ABL1	BCR::ABL		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Panitumumab,Cetuximab	PIK3CA	E545K		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab,Panitumumab	PIK3CA	H1047R		Colorectal Cancer	Resistance	P42336							
civic	Doxorubicin	TP53	R249		Breast Cancer	Sensitivity/Response	Q12888							
civic	Imatinib,GW-2580	CSF1R	MEF2D::CSF1R		Acute Lymphoblastic Leukemia	Sensitivity/Response	P07333							
civic	Cytarabine	RUNX1	Mutation		Acute Myeloid Leukemia	Resistance	Q01196							
civic	Linsitinib	IGF2	Overexpression		Prostate Cancer	Sensitivity/Response	P01344							
civic	Gefitinib,Erlotinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Cabazitaxel,Linsitinib,Docetaxel	IGF2	Overexpression		Prostate Cancer	Sensitivity/Response	P01344							
civic	Ibrutinib	BTK	C481S		Chronic Lymphocytic Leukemia	Resistance	Q06187							
civic	Vemurafenib	AKT1	Q79K		Melanoma	Resistance	P31749							
civic	JW55	APC	Mutation		Colon Carcinoma	Sensitivity/Response	P25054							
civic	G007-LK	APC	Mutation		Colorectal Cancer	Sensitivity/Response	P25054							
civic	Enzalutamide,Apalutamide	AR	F877L		Prostate Cancer	Resistance	O95154							
civic	Bicalutamide	AR	W742		Prostate Carcinoma	Resistance	O95154							
civic	Temozolomide	ATM	Mutation		Glioblastoma	Sensitivity/Response	Q13315							
civic	Temozolomide	ATM	Mutation		Melanoma	Sensitivity/Response	Q13315							
civic	NU7441,KU-0060648	ATM	Underexpression		Cancer	Sensitivity/Response	Q13315							
civic	Olaparib	ATM	Mutation		Hematologic Cancer	Sensitivity/Response	Q13315							
civic	Cisplatin,Alisertib	AURKA	Amplification		Esophagus Adenocarcinoma	Sensitivity/Response	O14965							
civic	Paclitaxel	AURKA	Overexpression		Cervical Adenocarcinoma	Resistance	O14965							
civic	Imatinib	KIT	V560DEL		Thymic Carcinoma	Sensitivity/Response	P10721							
civic	Tamoxifen	PGR	Expression		Breast Cancer	Sensitivity/Response	P06401							
civic	Exemestane,Tamoxifen	PGR	Expression		Breast Cancer	Sensitivity/Response	P06401							
civic	Cetuximab	PTEN	Loss		Colorectal Cancer	Resistance	P60484							
civic	Temsirolimus	PTEN	Loss		Prostate Cancer	Sensitivity/Response	P60484							
civic	Trastuzumab	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Gemcitabine,Trametinib	KRAS	G12/G13		Pancreatic Adenocarcinoma	Resistance	P01116							
civic	Olaparib	CDK12	Loss-of-function		Ovarian Serous Carcinoma	Sensitivity/Response	Q9NYV4							
civic	Mercaptopurine,Thioguanine	NT5C2	R367Q		T-cell Acute Lymphoblastic Leukemia	Resistance	P49902							
civic	Thioguanine,Mercaptopurine	NT5C2	K359Q		T-cell Acute Lymphoblastic Leukemia	Resistance	P49902							
civic	Mercaptopurine,Thioguanine	NT5C2	D407A		T-cell Acute Lymphoblastic Leukemia	Resistance	P49902							
civic	Arabinosylguanine,Nelarabine	NT5C2	R367Q		T-cell Acute Lymphoblastic Leukemia	Resistance	P49902							
civic	Nelarabine,Arabinosylguanine	NT5C2	D407A		T-cell Acute Lymphoblastic Leukemia	Resistance	P49902							
civic	Arabinosylguanine,Nelarabine	NT5C2	K359Q		T-cell Acute Lymphoblastic Leukemia	Resistance	P49902							
civic	Multikinase Inhibitor AEE788,Gefitinib	EGFR	T790M		Lung Cancer	Resistance	P00533							
civic	Everolimus	PTEN	Loss		Bladder Carcinoma	Resistance	P60484							
civic	Trastuzumab	PTEN	Loss		Breast Cancer	Resistance	P60484							
civic	Rociletinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Olaparib	ATM	S2289*		Prostate Cancer	Sensitivity/Response	Q13315							
civic	Olaparib	ATM	N2875H		Prostate Cancer	Sensitivity/Response	Q13315							
civic	Cisplatin,Carboplatin	NF2	Y177fs		Peritoneal Mesothelioma	Resistance	Q8NCF5							
civic	Olaparib	BRCA2	Loss-of-function		Prostate Cancer	Sensitivity/Response	P51587							
civic	Imatinib	PDGFRA	D842V		Gastrointestinal Stromal Tumor	Resistance	P16234							
civic	Imatinib	PDGFRA	V561A		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Imatinib	KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Docetaxel,Vinorelbine,Gemcitabine	XRCC1	R194W		Lung Non-small Cell Carcinoma	Sensitivity/Response	P18887							
civic	Carboplatin,Paclitaxel,Cisplatin	GSTP1	Deletion		Ovarian Carcinoma	Sensitivity/Response	P09211							
civic	Cisplatin	BIRC7	Amplification		Colon Cancer	Resistance	Q96CA5							
civic	Cisplatin	EGFR	Exon 4 Deletion		Epithelial Ovarian Cancer	Resistance	P00533							
civic	Carboplatin,Paclitaxel	KRAS	RS61764370		Epithelial Ovarian Cancer	Resistance	P01116							
civic	Fluorouracil	MTHFR	A222V		Stomach Cancer	Sensitivity/Response	P42898							
civic	FOLFOX Regimen	GSTP1	I105V		Colorectal Cancer	Sensitivity/Response	P09211							
civic	Carboplatin,Cisplatin	XRCC1	Q399R		Cervical Cancer	Sensitivity/Response	P18887							
civic	Paclitaxel	ABCB1	S893T		Ovarian Cancer	Sensitivity/Response	P08183							
civic	Cisplatin,Carboplatin	ABCB1	I1145I		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08183							
civic	Cisplatin	ERCC2	K751Q		Osteosarcoma	Resistance	P18074							
civic	Carboplatin,Paclitaxel	ERCC2	K751Q		Lung Non-small Cell Carcinoma	Sensitivity/Response	P18074							
civic	Irinotecan,Fluorouracil	TYMS	5' TANDEM REPEAT		Colorectal Cancer	Resistance	P04818							
civic	Doxorubicin	LRP1B	EXON 12-22 DELETION		Ovarian Cancer	Resistance	Q9NZR2							
civic	PD173074	FGFR1	Amplification		Lung Squamous Cell Carcinoma	Sensitivity/Response	P11362							
civic	Ponatinib	FGFR1	Expression		Lung Cancer	Sensitivity/Response	P11362							
civic	PD173074	FGFR1	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P11362							
civic	Crizotinib	ROS1	Rearrangement		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Onartuzumab	MET	Amplification		Gastric Adenocarcinoma	Sensitivity/Response	P08581							
civic	Platinum Compound,Cetuximab,Fluorouracil	EGFR	Amplification		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P00533							
civic	Cetuximab	EGFR	Overexpression		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P00533							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	EGFR	Overexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	Resistance	Q9NXV6							
civic	Panitumumab	CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	Resistance	Q9NXV6							
civic	Cetuximab	CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	Resistance	Q9NXV6							
civic	Vandetanib	RET	KIF5B::RET		Lung Adenocarcinoma	Sensitivity/Response	P07949							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	HRAS	G13D		Colorectal Cancer	Resistance	Q9HDD0							
civic	MTOR Kinase Inhibitor AZD8055,Mirdametinib,Everolimus,Binimetinib,Selumetinib	HRAS	Mutation		Cancer	Sensitivity/Response	Q9HDD0							
civic	Nivolumab,Pembrolizumab	CD274	Expression		Melanoma	Sensitivity/Response	Q9NZQ7							
civic	Everolimus,Pazopanib	MTOR	Mutation		Bladder Carcinoma	Sensitivity/Response	P42345							
civic	Trastuzumab	AKT2	EXPRESSION		Breast Cancer	Sensitivity/Response	P31751							
civic	Uprosertib	AKT1	E17K		Melanoma	Sensitivity/Response	P31749							
civic	Uprosertib	PTEN	Loss		Melanoma	Sensitivity/Response	P60484							
civic	Capivasertib	AKT1	E17K		Breast Cancer	Sensitivity/Response	P31749							
civic	Pictilisib,Akt Inhibitor MK2206	PIK3CA	E545K		Breast Cancer	Sensitivity/Response	P42336							
civic	PI3Kbeta Inhibitor AZD8186	PTEN	Loss		Breast Cancer	Sensitivity/Response	P60484							
civic	PI3K/BET Inhibitor LY294002,Capivasertib	MTOR	H1968Y		Melanoma	Sensitivity/Response	P42345							
civic	Paclitaxel,Carboplatin,Buparlisib	PTEN	Loss		Cancer	Sensitivity/Response	P60484							
civic	Temsirolimus	NF2	K159fs		Breast Cancer	Sensitivity/Response	Q8NCF5							
civic	Alpelisib	PTEN	Loss		Breast Cancer	Resistance	P60484							
civic	Cetuximab	EGFR	S492R		Colorectal Cancer	Resistance	P00533							
civic	Panitumumab,Cetuximab	FBXW7	Mutation		Colorectal Cancer	Resistance	Q969H0							
civic	Cetuximab,Panitumumab	SMAD4	Mutation		Colorectal Cancer	Resistance	Q13485							
civic	Cetuximab	SMAD4	Underexpression		Head And Neck Squamous Cell Carcinoma	Resistance	Q13485							
civic	PI3K/BET Inhibitor LY294002,Capivasertib	MTOR	P2213S		Melanoma	Sensitivity/Response	P42345							
civic	Sorafenib	BRAF	AGK::BRAF		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	AGK::BRAF		Melanoma	Resistance	P15056							
civic	Vemurafenib	BRAF	PAPSS1::BRAF		Melanoma	Resistance	P15056							
civic	Trametinib	BRAF	PAPSS1::BRAF		Melanoma	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	TRIM24::BRAF		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	L597R		Melanoma	Sensitivity/Response	P15056							
civic	Cetuximab	ERBB3	Overexpression		Colorectal Cancer	Resistance	P21860							
civic	Cetuximab	NT5E	Overexpression		Colorectal Cancer	Sensitivity/Response	P21589							
civic	GSK321	IDH1	R132C		Acute Myeloid Leukemia	Sensitivity/Response	O75874							
civic	Gefitinib	MET	Amplification		Lung Non-small Cell Carcinoma	Resistance	P08581							
civic	Paclitaxel	MYD88	Overexpression		Breast Cancer	Resistance	Q99836							
civic	Crizotinib	MET	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Crizotinib	MET	Exon 14 Skipping Mutation		Cancer	Sensitivity/Response	P08581							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	EGFR	Overexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Imatinib	PDGFRA	D842V		Gastrointestinal Stromal Tumor	Resistance	P16234							
civic	Idelalisib	PIK3CA	P471L		Merkel Cell Carcinoma	Sensitivity/Response	P42336							
civic	Vandetanib	RET	Overexpression		Breast Cancer	Sensitivity/Response	P07949							
civic	Pictilisib,Selumetinib	RIT1	Mutation		Lung Adenocarcinoma	Sensitivity/Response	Q92963							
civic	Pembrolizumab,Nivolumab	CD274	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9NZQ7							
civic	FACT Complex-targeting Curaxin CBL0137	MYCN	Amplification		Neuroblastoma	Sensitivity/Response	P04198							
civic	Vismodegib	SMO	D473H		Medulloblastoma	Resistance	Q99835							
civic	Vismodegib	SMO	Mutation		Basal Cell Carcinoma	Resistance	Q99835							
civic	Arsenic Trioxide,PSI	SMO	Mutation		Basal Cell Carcinoma	Sensitivity/Response	Q99835							
civic	Sonidegib	PTCH1	Mutation		Medulloblastoma	Sensitivity/Response	Q13635							
civic	Vismodegib	PTCH1	LOH		Medulloblastoma	Sensitivity/Response	Q13635							
civic	SB202190	STK11	Underexpression		Prostate Cancer	Sensitivity/Response	Q15831							
civic	Paclitaxel	SYK	OVEREXPRESSION		Ovarian Cancer	Resistance	P43405							
civic	Panitumumab	CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	Q9NXV6							
civic	Vismodegib	SMO	D473H		Basal Cell Carcinoma	Resistance	Q99835							
civic	Pictilisib	PIK3CA	Amplification		Epithelial Ovarian Cancer	Sensitivity/Response	P42336							
civic	Pictilisib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Cetuximab	CDKN2A	p16 Expression		Oropharynx Cancer	Resistance	Q9NXV6							
civic	AKTi-1/2	ERBB2	Amplification		Breast Cancer	Sensitivity/Response	P04626							
civic	Neratinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Rociletinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Lapatinib	ERBB4	Mutation		Melanoma	Sensitivity/Response	Q15303							
civic	Cabozantinib	PIK3CA	Mutation		Colorectal Cancer	Sensitivity/Response	P42336							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	EGFR	VIII		Glioblastoma	Sensitivity/Response	P00533							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	PTEN	Expression		Glioblastoma	Sensitivity/Response	P60484							
civic	Dacomitinib	PTEN	Expression		Glioblastoma	Sensitivity/Response	P60484							
civic	Lapatinib	NRG1	Expression		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	Q02297							
civic	Cetuximab	NRG1	Expression		Colorectal Cancer	Resistance	Q02297							
civic	Seribantumab	NRG1	Expression		Ovarian Cancer	Sensitivity/Response	Q02297							
civic	Gemcitabine,Paclitaxel,Cisplatin,Carboplatin	NRG1	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q02297							
civic	Crizotinib	AREG	Expression		Lung Non-small Cell Carcinoma	Resistance	P15514							
civic	Crizotinib	AREG	Expression		Lung Non-small Cell Carcinoma	Resistance	P15514							
civic	Nimotuzumab	EGFR	Overexpression		Esophagus Squamous Cell Carcinoma	Sensitivity/Response	P00533							
civic	Cetuximab	EGFR	G724S		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Cetuximab	EGFR	G719S		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Cetuximab	AREG	Expression		Colorectal Cancer	Sensitivity/Response	P15514							
civic	Cetuximab	EREG	EXPRESSION		Colorectal Cancer	Sensitivity/Response	O14944							
civic	Erlotinib	MAPK1	E322K		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	Q9H706							
civic	WZ4002	MAPK1	Amplification		Lung Non-small Cell Carcinoma	Resistance	Q9H706							
civic	Abemaciclib	KRAS	A146V		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Palbociclib	KRAS	G12V		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Foretinib	MET	Mutation		Papillary Renal Cell Carcinoma	Sensitivity/Response	P08581							
civic	Crizotinib	MET	Exon 14 Skipping Mutation		Lung Adenocarcinoma	Sensitivity/Response	P08581							
civic	Infigratinib	FGFR1	Expression		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P11362							
civic	Infigratinib	FGFR1	Expression		Gastric Adenocarcinoma	Sensitivity/Response	P11362							
civic	PD173074,Dovitinib	FGFR1	Expression		Bladder Carcinoma	Sensitivity/Response	P11362							
civic	Tyrosine Kinase Inhibitor SU5402,PD173074,Dovitinib	FGFR3	Overexpression		Bladder Carcinoma	Sensitivity/Response	P22607							
civic	Olaparib	CBLC	EXPRESSION		Cancer	Resistance	Q9ULV8							
civic	Cetuximab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	JSI-124	PTPRD	Mutation		Head And Neck Carcinoma	Sensitivity/Response	P23468							
civic	Docetaxel	DEFA1	EXPRESSION		Prostate Cancer	Sensitivity/Response	P59665							
civic	Cisplatin	ERCC1	Expression		Bladder Carcinoma	Sensitivity/Response	P07992							
civic	NOTCH1 Antibody (PF-06293622)	NOTCH1	Amplification		Colorectal Cancer	Sensitivity/Response	P46531							
civic	Patritumab	NRG1	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q02297							
civic	Platinum Compound,Gemcitabine	WEE1	RS3910384		Lung Non-small Cell Carcinoma	Sensitivity/Response	P30291							
civic	Lonafarnib	FNTB	RS11623866		Ovarian Cancer	Resistance	P49356							
civic	Panitumumab,Cetuximab	BRAF	V600E		Colorectal Cancer	Resistance	P15056							
civic	Stattic,JSI-124	PTPRT	Promoter Hypermethylation		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	O14522							
civic	Irinotecan,Levoleucovorin,Fluorouracil,Bevacizumab	VEGFA	Decreased Peri-therapeutic Expression		Colorectal Cancer	Sensitivity/Response	P15692							
civic	Decitabine	DNMT1	EXPRESSION		Ovarian Cancer	Sensitivity/Response	P26358							
civic	Decitabine	KRAS	Mutation		Ovarian Cancer	Sensitivity/Response	P01116							
civic	Paclitaxel	PDCD4	EXPRESSION		Lung Cancer	Sensitivity/Response	Q53EL6							
civic	Temozolomide	MGMT	RS16906252		Glioblastoma	Sensitivity/Response	P16455							
civic	Tamoxifen,Aminoglutethimide	TFF3	EXPRESSION		Breast Cancer	Sensitivity/Response	Q07654							
civic	Irinotecan,Levoleucovorin,Oxaliplatin,Fluorouracil	DKK1	NUCLEAR EXPRESSION		Colorectal Cancer	Resistance	O94907							
civic	RG7356	CD44	CD44s Expression		Cancer	Sensitivity/Response	P16070							
civic	Cetuximab	EGF	EXPRESSION		Head And Neck Squamous Cell Carcinoma	Resistance	P01133							
civic	Cisplatin,Pemetrexed	MDM2	EXPRESSION		Malignant Pleural Mesothelioma	Resistance	Q00987							
civic	Sunitinib,Sorafenib	HMOX1	EXPRESSION		Renal Cell Carcinoma	Resistance	P09601							
civic	Conatumumab	CASP8	Overexpression		Ewing Sarcoma Of Bone	Sensitivity/Response	Q14790							
civic	Pemetrexed	TYMS	Overexpression		Lung Non-small Cell Carcinoma	Resistance	P04818							
civic	Gefitinib	PBK	OVEREXPRESSION		Lung Non-small Cell Carcinoma	Resistance	Q96KB5							
civic	Crizotinib	MET	Amplification		Lung Adenocarcinoma	Sensitivity/Response	P08581							
civic	Vinorelbine,Cisplatin	SMARCA4	Underexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	P51532							
civic	Olaparib	BRCA1	Loss-of-function		Prostate Cancer	Sensitivity/Response	P38398							
civic	Docetaxel,Cetuximab	AREG	Expression		Head And Neck Squamous Cell Carcinoma	Resistance	P15514							
civic	Cetuximab,Docetaxel	EGFR	VIII		Head And Neck Squamous Cell Carcinoma	Resistance	P00533							
civic	Cetuximab,Docetaxel	EGFR	Overexpression		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P00533							
civic	Chemotherapy	TP53	Mutation		Gastric Adenocarcinoma	Sensitivity/Response	Q12888							
civic	Doxorubicin	TP53	Mutation		Breast Cancer	Sensitivity/Response	Q12888							
civic	Fluorouracil	CDKN1A	EXPRESSION		Colorectal Cancer	Resistance	Q9P287							
civic	Fluorouracil	ALCAM	EXPRESSION		Colorectal Cancer	Resistance	Q13740							
civic	Panitumumab,Cetuximab	EGFR	Amplification		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Paclitaxel	STMN1	EXPRESSION		Endometrial Carcinoma	Resistance	P16949							
civic	Tamoxifen	CCND1	Overexpression		Estrogen-receptor Positive Breast Cancer	Resistance	P24385							
civic	Tamoxifen	RSF1	Amplification		Breast Cancer	Resistance	Q96T23							
civic	Tamoxifen	CCND1	Amplification		Breast Cancer	Resistance	P24385							
civic	Dactolisib	AR	OVEREXPRESSION		Breast Cancer	Sensitivity/Response	O95154							
civic	Lapatinib	CDKN1B	CYTOPLASMIC MISLOCALIZATION		Breast Cancer	Resistance	P46527							
civic	Anti-ErbB3 Monoclonal Antibody AV-203	NRG1	Expression		Cancer	Sensitivity/Response	Q02297							
civic	Anti-ErbB3 Monoclonal Antibody AV-203	ERBB3	EXPRESSION		Cancer	Sensitivity/Response	P21860							
civic	Abiraterone,Enzalutamide	AR	V7 EXPRESSION		Prostate Cancer	Resistance	O95154							
civic	Lapatinib,Trastuzumab	PTEN	Loss		Gastric Adenocarcinoma	Resistance	P60484							
civic	9F7-F11,Pertuzumab	ERBB3	EXPRESSION		Pancreatic Ductal Adenocarcinoma	Sensitivity/Response	P21860							
civic	Ganetespib	UGT1A	EXPRESSION		Colorectal Cancer	Resistance	Q9HAW7							
civic	Trastuzumab	ERBB4	NUCLEAR TRANSLOCATION		Breast Cancer	Resistance	Q15303							
civic	Trastuzumab	ERBB4	EXPRESSION		Breast Cancer	Resistance	Q15303							
civic	Lapatinib	ERBB4	EXPRESSION		Breast Cancer	Resistance	Q15303							
civic	7-Ethyl-10-Hydroxycamptothecin	SLFN11	EXPRESSION		Colorectal Cancer	Sensitivity/Response	Q7Z7L1							
civic	Cisplatin	AURKA	Overexpression		Lung Non-small Cell Carcinoma	Resistance	O14965							
civic	Cisplatin	KRAS	RS61764370		Head And Neck Squamous Cell Carcinoma	Resistance	P01116							
civic	Vemurafenib,Dabrafenib	RAC1	P29S		Melanoma	Resistance	P63000							
civic	Platinum Compound,Taxane Compound	BIRC5	NUCLEAR EXPRESSION		Lung Non-small Cell Carcinoma	Sensitivity/Response	O15392							
civic	Cetuximab,Oxaliplatin,Capecitabine	TP53	Wildtype		Colorectal Cancer	Sensitivity/Response	Q12888							
civic	Talazoparib	MRE11	Loss		Endometrial Cancer	Sensitivity/Response	P49959							
civic	Olaparib	ATM	Underexpression		Gastric Adenocarcinoma	Sensitivity/Response	Q13315							
civic	Afatinib	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	Exon 19 Deletion		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	Exon 19 Deletion		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	ERBB2	Amplification		Uterine Corpus Endometrial Carcinoma	Sensitivity/Response	P04626							
civic	Trastuzumab,Lapatinib,Afatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Irinotecan	TOP1	Amplification		Colorectal Cancer	Sensitivity/Response	P11387							
civic	Fluorouracil,Cisplatin	CDKN1B	EXPRESSION		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P46527							
civic	Crizotinib	MET	Amplification		Lung Squamous Cell Carcinoma	Sensitivity/Response	P08581							
civic	Tamoxifen	AGR2	EXPRESSION		Breast Cancer	Resistance	O95994							
civic	Temsirolimus,Ridaforolimus	PIK3CA	Mutation		Endometrial Cancer	Sensitivity/Response	P42336							
civic	Temsirolimus,Ridaforolimus	PTEN	Loss		Endometrial Cancer	Resistance	P60484							
civic	Temsirolimus,Ridaforolimus	KRAS	Mutation		Endometrial Cancer	Sensitivity/Response	P01116							
civic	Cetuximab,Oxaliplatin,Capecitabine	ERBB2	Amplification		Colorectal Cancer	Resistance	P04626							
civic	Infigratinib	FGFR1	Expression		Colorectal Cancer	Sensitivity/Response	P11362							
civic	GNE-617	NAPRT	Promoter Hypermethylation		Cancer	Sensitivity/Response	Q6XQN6							
civic	Bevacizumab,Erlotinib	EGFR	Exon 18 Overexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gemcitabine,Cytarabine,Doxorubicin	ZEB1	Expression		Mantle Cell Lymphoma	Resistance	P37275							
civic	Doxorubicin,Salinomycin	ZEB1	Expression		Mantle Cell Lymphoma	Sensitivity/Response	P37275							
civic	Fulvestrant	TIMP1	Overexpression		Breast Cancer	Resistance	P01033							
civic	Cetuximab	PTP4A3	OVEREXPRESSION		Colorectal Cancer	Sensitivity/Response	O75365							
civic	Pemetrexed	TYMS	Amplification		Lung Adenocarcinoma	Resistance	P04818							
civic	Gefitinib	IGF1R	EXPRESSION		Lung Non-small Cell Carcinoma	Resistance	P08069							
civic	Bevacizumab	EPHB4	EXPRESSION		Colorectal Cancer	Resistance	P54760							
civic	Chemotherapy	TP53	Wildtype		Esophageal Carcinoma	Sensitivity/Response	Q12888							
civic	Pemetrexed	TYMS	Underexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04818							
civic	Pemetrexed	TYMS	Underexpression		Prostate Cancer	Sensitivity/Response	P04818							
civic	Doxorubicin	TOP2A	EXPRESSION		Breast Cancer	Sensitivity/Response	P11388							
civic	Topotecan,Carboplatin,Cyclophosphamide	TOP1	EXPRESSION		Ovarian Cancer	Sensitivity/Response	P11387							
civic	Cetuximab	EGFR	Amplification		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Irinotecan	TOP1	EXPRESSION		Colorectal Cancer	Sensitivity/Response	P11387							
civic	ACLY SiRNA	PRKAA2	T172 PHOSPHORYLATION		Cancer	Sensitivity/Response	P54646							
civic	Fluorouracil	HSPA5	EXPRESSION		Colorectal Cancer	Sensitivity/Response	Q24JP5							
civic	Anti-EGFR Monoclonal Antibody	PIK3CA	Mutation		Colorectal Cancer	Resistance	P42336							
civic	Erlotinib	KRAS	Exon 2 Mutation		Pancreatic Carcinoma	Resistance	P01116							
civic	Everolimus	EIF4EBP1	PHOSPHORYLATION		Gastric Adenocarcinoma	Sensitivity/Response	P06730							
civic	Imatinib,Pictilisib	KIT	Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Paclitaxel	TUBB3	EXPRESSION		Cancer	Resistance	Q13509							
civic	Taxane Compound	TUBB3	EXPRESSION		Breast Cancer	Sensitivity/Response	Q13509							
civic	Pemetrexed	TYMS	Overexpression		Lung Non-small Cell Carcinoma	Resistance	P04818							
civic	Gefitinib,Erlotinib	EGFR	Y1092 PHOSPHORYLATION		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	IGF1R Monoclonal Antibody	IGF1R	NUCLEAR EXPRESSION		Sarcoma	Sensitivity/Response	P08069							
civic	Bicalutamide	CFLAR	EXPRESSION		Prostate Cancer	Resistance	O15519							
civic	Sorafenib	PROM1	EXPRESSION		Hepatocellular Carcinoma	Resistance	O43490							
civic	Paclitaxel	TIMP1	Overexpression		Breast Cancer	Resistance	P01033							
civic	Epirubicin	FOXP3	EXPRESSION		Breast Cancer	Sensitivity/Response	Q9BZS1							
civic	Raltitrexed	TYMS	Overexpression		Gastric Adenocarcinoma	Resistance	P04818							
civic	Everolimus	RPS6	PHOSPHORYLATION		Gastric Adenocarcinoma	Sensitivity/Response	P62753							
civic	Enzastaurin	JAK1	OVEREXPRESSION		Lung Non-small Cell Carcinoma	Sensitivity/Response	P23458							
civic	WYE354,Dactolisib,MTOR Kinase Inhibitor PP242	EIF4EBP1	PHOSPHORYLATION		Colorectal Cancer	Resistance	P06730							
civic	Vinorelbine	BRCA1	Expression		Malignant Mesothelioma	Sensitivity/Response	P38398							
civic	Trametinib	DUSP6	EXPRESSION		Cancer	Sensitivity/Response	Q16828							
civic	Trametinib	KRAS	Mutation		Cancer	Sensitivity/Response	P01116							
civic	Trametinib	BRAF	Mutation		Cancer	Sensitivity/Response	P15056							
civic	Akt Inhibitor MK2206	KRAS	G12D		Pancreatic Carcinoma	Sensitivity/Response	P01116							
civic	Akt Inhibitor MK2206	PTEN	Loss		Pancreatic Carcinoma	Sensitivity/Response	P60484							
civic	Gemcitabine	HSPB1	EXPRESSION		Pancreatic Ductal Adenocarcinoma	Sensitivity/Response	P04792							
civic	Amrubicin	NQO1	EXPRESSION		Lung Cancer	Resistance	P15559							
civic	Amrubicin	NQO1	P187S		Lung Cancer	Sensitivity/Response	P15559							
civic	Platinum Compound,Taxane Compound	BRCA1	Underexpression		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Immunomodulatory Oligonucleotide,Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Paclitaxel	ABCB1	Overexpression		Lung Non-small Cell Carcinoma	Resistance	P08183							
civic	Pemetrexed	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Cisplatin	DNMT1	EXPRESSION		Gastric Adenocarcinoma	Resistance	P26358							
civic	Dasatinib,Cetuximab	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	EGFR	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Docetaxel	CXCR4	EXPRESSION		Gastric Adenocarcinoma	Resistance	P61073							
civic	Gemcitabine	MAGEH1	EXPRESSION		Bile Duct Adenocarcinoma	Resistance	Q9H213							
civic	Paclitaxel,Monomethyl Auristatin E	ABCC3	Amplification		Breast Cancer	Resistance	O15438							
civic	Paclitaxel	ABCC10	Overexpression		Lung Non-small Cell Carcinoma	Resistance	Q5T3U5							
civic	Asparaginase	ASNS	Amplification		Ovarian Cancer	Resistance	P08243							
civic	Gefitinib	EGFR	Overexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Trastuzumab	PTEN	Expression		Breast Cancer	Sensitivity/Response	P60484							
civic	Oxaliplatin	POU5F1	EXPRESSION		Colon Cancer	Resistance	Q01860							
civic	Afatinib	ERBB2	Kinase Domain Mutation		Lung Adenocarcinoma	Sensitivity/Response	P04626							
civic	Sirolimus,Afatinib	ERBB2	Y772_A775DUP		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Afatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Afatinib	ERBB2	Amplification		Pancreatic Adenocarcinoma	Sensitivity/Response	P04626							
civic	Osimertinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	C797S		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Osimertinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib,Rociletinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Rindopepimut	EGFR	VIII		Glioblastoma	Sensitivity/Response	P00533							
civic	Lapatinib	ERBB2	SERUM LEVELS		Breast Cancer	Sensitivity/Response	P04626							
civic	Erlotinib,Gefitinib	EGFR	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Larotrectinib	NTRK1	Fusion		Colorectal Cancer	Sensitivity/Response	P04629							
civic	AGI-5198	IDH1	R132H		Oligodendroglioma	Sensitivity/Response	O75874							
civic	Afatinib	EGFR	Exon 19 Deletion		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	Exon 19 Deletion		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Atezolizumab,Pembrolizumab,Nivolumab	HLA-DRA	EXPRESSION		Skin Melanoma	Sensitivity/Response	P01903							
civic	Ibrutinib	MYD88	L265P		Lymphoplasmacytic Lymphoma	Sensitivity/Response	Q99836							
civic	B-Raf/VEGFR-2 Inhibitor RAF265,Selumetinib	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Selumetinib,B-Raf/VEGFR-2 Inhibitor RAF265	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Trametinib	KRAS	G12/G13		Pancreatic Adenocarcinoma	Sensitivity/Response	P01116							
civic	Afatinib,Trametinib	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Trametinib,Afatinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Cetuximab	KRAS	Exon 2 Mutation		Colorectal Cancer	Resistance	P01116							
civic	MEK Inhibitor RO4987655	BRAF	V600E		Melanoma	Resistance	P15056							
civic	MEK Inhibitor RO4987655	BRAF	WILD TYPE		Melanoma	Resistance	P15056							
civic	MEK Inhibitor RO4987655	NRAS	Mutation		Melanoma	Resistance	P01111							
civic	MEK Inhibitor RO4987655	KRAS	Mutation		Lung Non-small Cell Carcinoma	Resistance	P01116							
civic	MEK Inhibitor RO4987655	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Selumetinib,Docetaxel	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Refametinib	BRAF	V600		Melanoma	Resistance	P15056							
civic	Refametinib	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Binimetinib,Everolimus	NRAS	Q61K		Neuroblastoma	Sensitivity/Response	P01111							
civic	PI3Kbeta Inhibitor AZD8186,SCH772984	KRAS	Mutation		Pancreatic Adenocarcinoma	Sensitivity/Response	P01116							
civic	Teprotumumab,Selumetinib	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Dactolisib,Selumetinib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Trastuzumab,Lapatinib	ERBB2	Amplification		Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Lapatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Lapatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Lapatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Afatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Afatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Afatinib,Trastuzumab	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Olaparib	MRE11	Frameshift		Prostate Cancer	Sensitivity/Response	P49959							
civic	Nimotuzumab	EGFR	VIII		Brain Glioma	Sensitivity/Response	P00533							
civic	Crizotinib,Larotrectinib,Lestaurtinib	NTRK1	Fusion		Lung Adenocarcinoma	Sensitivity/Response	P04629							
civic	Panitumumab	AREG	Expression		Colorectal Cancer	Sensitivity/Response	P15514							
civic	Panitumumab	EREG	EXPRESSION		Colorectal Cancer	Sensitivity/Response	O14944							
civic	Trastuzumab	ERBB2	Amplification		Gastric Adenocarcinoma	Sensitivity/Response	P04626							
civic	Lapatinib	ERBB2	Amplification		Gastric Adenocarcinoma	Sensitivity/Response	P04626							
civic	Imatinib	KIT	EXPRESSION		Endometrial Cancer	Sensitivity/Response	P10721							
civic	Imatinib	KIT	EXPRESSION		Endometrial Cancer	Sensitivity/Response	P10721							
civic	Crizotinib	ROS1	Rearrangement		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Temsirolimus	VHL	Loss		Renal Carcinoma	Sensitivity/Response	P40337							
civic	Quizartinib,Ponatinib	FLT3	D835		Acute Myeloid Leukemia	Resistance	P36888							
civic	SU5614	FLT3	D835		Acute Myeloid Leukemia	Resistance	P36888							
civic	Sorafenib,Quizartinib	FLT3	D835		Acute Myeloid Leukemia	Resistance	P36888							
civic	Sorafenib	FLT3	D835		Acute Myeloid Leukemia	Resistance	P36888							
civic	Sorafenib	FLT3	ITD		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Trastuzumab	ERBB2	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Trastuzumab	ERBB2	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Trastuzumab	ERBB2	Kinase Domain Mutation		Lung Adenocarcinoma	Sensitivity/Response	P04626							
civic	Irinotecan,Trastuzumab	ERBB2	Amplification		Lung Small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Afatinib	ERBB2	Y772_A775DUP		Lung Adenocarcinoma	Sensitivity/Response	P04626							
civic	Afatinib	ERBB2	Y772_A775DUP		Lung Carcinoma	Sensitivity/Response	P04626							
civic	Dacomitinib	ERBB2	P780INS		Lung Adenocarcinoma	Sensitivity/Response	P04626							
civic	Trastuzumab Emtansine	ERBB2	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Futuximab/Modotuximab Mixture	EGFR	G465R		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Panitumumab,Cetuximab	EGFR	G465R		Colorectal Cancer	Resistance	P00533							
civic	Cisplatin,Paclitaxel	ETS2	RS461155		Lung Non-small Cell Carcinoma	Sensitivity/Response	P15036							
civic	Pertuzumab,Trastuzumab,Docetaxel	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Panitumumab	EGFR	S492R		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Panitumumab,Futuximab/Modotuximab Mixture	EGFR	S492R		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Cetuximab	EGFR	S492R		Colorectal Cancer	Resistance	P00533							
civic	Cetuximab,Futuximab/Modotuximab Mixture,Panitumumab	EGFR	R451C		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Futuximab/Modotuximab Mixture,Panitumumab	EGFR	K467T		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Cetuximab	EGFR	K467T		Colorectal Cancer	Resistance	P00533							
civic	Trastuzumab	FCGR3A	F212V		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P20963							
civic	Trastuzumab	FCGR2A	H167R		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P08631							
civic	Cetuximab,Sirolimus	EGFR	P753S		Skin Squamous Cell Carcinoma	Sensitivity/Response	P00533							
civic	Arsenic Trioxide,Tretinoin	PML	PML::RARA		Acute Promyelocytic Leukemia	Sensitivity/Response	P29590							
civic	Tretinoin	PML	B2 DOMAIN MUTATION		Acute Promyelocytic Leukemia	Resistance	P29590							
civic	Tretinoin	PML	PML::RARA A216V		Acute Promyelocytic Leukemia	Resistance	P29590							
civic	Tretinoin	PML	PML::RARA L218P		Acute Promyelocytic Leukemia	Resistance	P29590							
civic	Trastuzumab	ERBB2	Amplification		Endometrial Serous Adenocarcinoma	Sensitivity/Response	P04626							
civic	Trastuzumab	ERBB2	Amplification		Endometrial Cancer	Sensitivity/Response	P04626							
civic	Patidegib	SMO	D473H		Medulloblastoma	Sensitivity/Response	Q99835							
civic	Crizotinib	ROS1	CD74::ROS1 G2032R		Lung Adenocarcinoma	Resistance	P08922							
civic	Cabozantinib	ROS1	CD74::ROS1 G2032R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	OICR-9429	CEBPA	N-TERMINAL FRAME SHIFT		Acute Myeloid Leukemia	Sensitivity/Response	P49715							
civic	Midostaurin	FGFR1	ZNF198::FGFR1		Myeloproliferative Neoplasm	Sensitivity/Response	P11362							
civic	Afimoxifene	FGFR1	Amplification		Breast Cancer	Resistance	P11362							
civic	Sorafenib,Sunitinib	KDR	A1065T		Angiosarcoma	Sensitivity/Response	P35968							
civic	Sunitinib,Sorafenib	KDR	D717V		Angiosarcoma	Sensitivity/Response	P35968							
civic	Everolimus	TSC2	Q1178*		Thyroid Gland Carcinoma	Sensitivity/Response	P49815							
civic	Everolimus	MTOR	F2108L		Thyroid Gland Carcinoma	Resistance	P42345							
civic	Tretinoin,Anthracycline Antineoplastic Antibiotic	FLT3	ITD		Acute Promyelocytic Leukemia	Resistance	P36888							
civic	Neratinib,Trastuzumab	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Tretinoin	ALDH1A2	Underexpression		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	O94788							
civic	Gemcitabine	CIP2A	Underexpression		Pancreatic Ductal Adenocarcinoma	Sensitivity/Response	Q8TCG1							
civic	Erlotinib	ALK	EML4::ALK		Lung Acinar Adenocarcinoma	Resistance	Q9UM73							
civic	Trastuzumab	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab Emtansine	ERBB2	Y772_A775DUP		Lung Adenocarcinoma	Sensitivity/Response	P04626							
civic	Erlotinib,Gefitinib	EGFR	VIII		Glioblastoma	Sensitivity/Response	P00533							
civic	Erlotinib,Gefitinib	PTEN	Expression		Glioblastoma	Sensitivity/Response	P60484							
civic	Panitumumab	KRAS	Q22*		Colon Mucinous Adenocarcinoma	Resistance	P01116							
civic	Capecitabine,Lapatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Capecitabine	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Selumetinib,Trametinib,Mirdametinib	DDX43	Overexpression		Uveal Melanoma	Resistance	Q9NXZ2							
civic	Selumetinib	KIT	RS3733542		Acute Myeloid Leukemia	Sensitivity/Response	P10721							
civic	Selumetinib	FLT3	ITD		Acute Myeloid Leukemia	Resistance	P36888							
civic	Selumetinib,AZ909	TBK1	Overexpression		Melanoma	Sensitivity/Response	Q9UHD2							
civic	Chemotherapy,Bevacizumab	KRAS	Mutation		Colorectal Cancer	Resistance	P01116							
civic	MEK Inhibitor GDC-0623,G-573	KRAS	Mutation		Cancer	Sensitivity/Response	P01116							
civic	Cobimetinib	BRAF	V600E		Cancer	Sensitivity/Response	P15056							
civic	Docetaxel,Selumetinib	KRAS	G12C		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Selumetinib,Docetaxel	KRAS	G12V		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Docetaxel,Selumetinib	STK11	Loss		Lung Non-small Cell Carcinoma	Resistance	Q15831							
civic	Selumetinib,Docetaxel	TP53	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q12888							
civic	Docetaxel	TP53	Loss		Lung Non-small Cell Carcinoma	Resistance	Q12888							
civic	Adjuvant Chemotherapy	TP53	Deleterious Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q12888							
civic	Adjuvant Chemotherapy	TP53	Wildtype		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q12888							
civic	PD1 Inhibitor	HAVCR2	Overexpression		Lung Non-small Cell Carcinoma	Resistance	Q8TDQ0							
civic	PD1 Inhibitor,Anti-TIM-3 Monoclonal Antibody	HAVCR2	Overexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q8TDQ0							
civic	Afatinib,Selumetinib	ERBB3	Overexpression		Cancer	Sensitivity/Response	P21860							
civic	Gefitinib,HER2 Inhibitor CP-724,714,Selumetinib	ERBB3	Overexpression		Cancer	Resistance	P21860							
civic	Afatinib	CDKN2A	p16 Expression		Head And Neck Squamous Cell Carcinoma	Resistance	Q9NXV6							
civic	Bevacizumab	MMP2	SERUM LEVELS		Inflammatory Breast Carcinoma	Sensitivity/Response	P08253							
civic	Bevacizumab	MMP9	SERUM LEVELS		Inflammatory Breast Carcinoma	Resistance	P14780							
civic	Bevacizumab	MMP2	SERUM LEVELS		Brain Glioma	Sensitivity/Response	P08253							
civic	Trastuzumab Emtansine	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab Emtansine	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Cisplatin,Fluorouracil	HSPH1	NUCLEAR EXPRESSION		Gastric Adenocarcinoma	Sensitivity/Response	Q92598							
civic	Fluorouracil,Oxaliplatin	HSPH1	T17 DELETION		Colorectal Cancer	Sensitivity/Response	Q92598							
civic	Angiogenesis Inhibitor	ECSCR	EXPRESSION		Cancer	Sensitivity/Response	Q19T08							
civic	Angiogenesis Inhibitor	ROBO4	EXPRESSION		Cancer	Sensitivity/Response	Q8WZ75							
civic	Atezolizumab,Avelumab,Pembrolizumab,Nivolumab	CD274	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9NZQ7							
civic	Pazopanib	TP53	Deleterious Mutation		Sarcoma	Sensitivity/Response	Q12888							
civic	Gefitinib	PIK3CA	E545K		Lung Adenocarcinoma	Resistance	P42336							
civic	Atezolizumab	CD274	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9NZQ7							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor,ARS-853	KRAS	G12C		Cancer	Sensitivity/Response	P01116							
civic	Trastuzumab,Neratinib,Lapatinib	ERBB2	V842I		Colon Cancer	Sensitivity/Response	P04626							
civic	Ceritinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Neratinib,Lapatinib,Trastuzumab	ERBB2	L755S		Colon Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Neratinib,Lapatinib	ERBB2	V777L		Colon Cancer	Sensitivity/Response	P04626							
civic	Lapatinib,Trastuzumab,Neratinib	ERBB2	L866M		Colon Cancer	Sensitivity/Response	P04626							
civic	Lapatinib,Trastuzumab,Neratinib	ERBB2	S310F/Y		Colon Cancer	Sensitivity/Response	P04626							
civic	Cetuximab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Ixazomib	KRAS	Mutation		Colorectal Cancer	Resistance	P01116							
civic	AZD5438	KRAS	Mutation		Cancer	Sensitivity/Response	P01116							
civic	Crizotinib	MET	Exon 14 Skipping Mutation		Lung Adenocarcinoma	Sensitivity/Response	P08581							
civic	Capmatinib	MET	Exon 14 Skipping Mutation		Lung Adenocarcinoma	Sensitivity/Response	P08581							
civic	Crizotinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	WHI-P154	ALK	EML4::ALK		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	EML4::ALK e20-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	EML4::ALK e2-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Regorafenib	KDR	R961W		Colorectal Adenocarcinoma	Sensitivity/Response	P35968							
civic	2,4-pyrimidinediamine	ALK	EML4::ALK e6-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	EML4::ALK e6-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	TAE684	ALK	EML4::ALK e6-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	TAE684	ALK	EML4::ALK e6-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	EML4::ALK e20-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	EML4::ALK e6-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Retaspimycin Hydrochloride	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Retaspimycin Hydrochloride,Crizotinib	ALK	EML4::ALK		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib,Alvespimycin	ALK	EML4::ALK e20-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Alvespimycin	ALK	EML4::ALK e6-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib,Alvespimycin	ALK	EML4::ALK		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	EML4::ALK		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	KRAS	Exon 2 Mutation		Colorectal Cancer	Resistance	P01116							
civic	Cisplatin	TP53	P47S		Cancer	Resistance	Q12888							
civic	JQ1	GNAQ	Mutation		Uveal Melanoma	Sensitivity/Response	P50148							
civic	JQ1	GNA11	Mutation		Uveal Melanoma	Sensitivity/Response	P29992							
civic	Selumetinib	GNA11	Q209		Uveal Melanoma	Sensitivity/Response	P29992							
civic	Selumetinib	GNAQ	Q209		Uveal Melanoma	Sensitivity/Response	P50148							
civic	Nivolumab	PMS2	K706FS*19		Glioblastoma	Sensitivity/Response	P54278							
civic	Gefitinib,Erlotinib	KRAS	G12C		Colorectal Cancer	Resistance	P01116							
civic	Salirasib	KRAS	Mutation		Lung Adenocarcinoma	Sensitivity/Response	P01116							
civic	Gemcitabine,Erlotinib	KRAS	Exon 2 Mutation		Pancreatic Cancer	Resistance	P01116							
civic	Trametinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Imatinib	KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib	KIT	Mutation		Melanoma	Sensitivity/Response	P10721							
civic	Sunitinib	KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib	KIT	Exon 11 Mutation		Melanoma	Sensitivity/Response	P10721							
civic	Docetaxel,Trametinib	NRAS	Mutation		Skin Melanoma	Sensitivity/Response	P01111							
civic	Binimetinib	NRAS	Q61		Skin Melanoma	Sensitivity/Response	P01111							
civic	Trametinib	NRAS	Mutation		Melanoma	Sensitivity/Response	P01111							
civic	Trametinib	GNA11	Mutation		Uveal Melanoma	Sensitivity/Response	P29992							
civic	Trametinib	GNAQ	Mutation		Uveal Melanoma	Sensitivity/Response	P50148							
civic	Trametinib,Metformin	NRAS	Mutation		Cancer	Sensitivity/Response	P01111							
civic	Everolimus	PTEN	Deletion		Prostate Cancer	Sensitivity/Response	P60484							
civic	Everolimus	PTEN	Mutation		Endometrial Carcinoma	Sensitivity/Response	P60484							
civic	Refametinib	GNAQ	Q209		Uveal Melanoma	Sensitivity/Response	P50148							
civic	Trichostatin A,Vorinostat,Panobinostat,Valproic Acid	BAP1	Mutation		Uveal Melanoma	Sensitivity/Response	Q92560							
civic	MC1568,Vorinostat,Mocetinostat	BAP1	Mutation		Malignant Mesothelioma	Sensitivity/Response	Q92560							
civic	Ponatinib	FGFR2	Mutation		Endometrial Cancer	Sensitivity/Response	P21802							
civic	Ceritinib	ALK	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	NPM::ALK		Anaplastic Large Cell Lymphoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Anaplastic Large Cell Lymphoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	NPM::ALK		Anaplastic Large Cell Lymphoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Inflammatory Myofibroblastic Tumor	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	RANBP2::ALK		Inflammatory Myofibroblastic Tumor	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	EML4::ALK e6-e20		Cancer	Sensitivity/Response	Q9UM73							
civic	Ponatinib	FGFR1	N546K		Ewing Sarcoma Of Bone	Sensitivity/Response	P11362							
civic	Ponatinib	FGFR1	Amplification		Ewing Sarcoma Of Bone	Sensitivity/Response	P11362							
civic	Ceritinib	ROS1	Rearrangement		Lung Adenocarcinoma	Sensitivity/Response	P08922							
civic	Cabozantinib,Foretinib	ROS1	CD74::ROS1 G2032R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Brigatinib,AZD3463,Ceritinib,Crizotinib	ROS1	CD74::ROS1 G2032R		Lung Non-small Cell Carcinoma	Resistance	P08922							
civic	Lorlatinib	ROS1	CD74::ROS1 G2032R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Crizotinib	ROS1	CD74::ROS1 L2026M		Lung Non-small Cell Carcinoma	Resistance	P08922							
civic	Lorlatinib	ROS1	CD74::ROS1 L2026M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Crizotinib	ROS1	CD74::ROS1 G2032R		Lung Non-small Cell Carcinoma	Resistance	P08922							
civic	Foretinib	ROS1	CD74::ROS1 G2032R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Crizotinib,Foretinib,ALK Inhibitor TAE684	ROS1	CD74::ROS1 L2155S		Lung Non-small Cell Carcinoma	Resistance	P08922							
civic	Crizotinib	ROS1	CD74::ROS1 L2026M		Lung Non-small Cell Carcinoma	Resistance	P08922							
civic	Foretinib	ROS1	CD74::ROS1 L2026M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Crizotinib	ROS1	CD74::ROS1 G2101A		Lung Non-small Cell Carcinoma	Resistance	P08922							
civic	Foretinib	ROS1	CD74::ROS1 G2101A		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	TAE684	ALK	CLTC::ALK		Diffuse Large B-cell Lymphoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Diffuse Large B-cell Lymphoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	CLTC::ALK		Diffuse Large B-cell Lymphoma	Sensitivity/Response	Q9UM73							
civic	Pan-RAF Inhibitor LY3009120	BRAF	DEL 485-490		Cancer	Sensitivity/Response	P15056							
civic	Crizotinib	ALK	R1275Q		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	R1275Q		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	F1174L		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Alectinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Alectinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Alectinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Imatinib	BCL2L11	Deletion Polymorphism		Chronic Myeloid Leukemia	Resistance	O43521							
civic	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor	BCL2L11	Deletion Polymorphism		Lung Non-small Cell Carcinoma	Resistance	O43521							
civic	Alectinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Alectinib	ALK	I1171		Lung Non-small Cell Carcinoma	Resistance	Q9UM73							
civic	Ceritinib	ALK	I1171		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	TAE684	ALK	I1171		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	I1171		Lung Non-small Cell Carcinoma	Resistance	Q9UM73							
civic	Niacinamide	SIRT1	Overexpression		Pancreatic Cancer	Resistance	Q96EB6							
civic	Midostaurin	FLT3	TKD MUTATION		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Everolimus	PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Everolimus	PTEN	Loss		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P60484							
civic	Crizotinib	ROS1	Rearrangement		Colorectal Adenocarcinoma	Sensitivity/Response	P08922							
civic	Mitomycin	PALB2	Biallelic Inactivation		Pancreatic Cancer	Sensitivity/Response	Q86YC2							
civic	Mitomycin,Melphalan,Chlorambucil,Cisplatin,Gemcitabine	FANCC	Loss-of-function		Pancreatic Cancer	Sensitivity/Response	Q00597							
civic	Mitomycin	BRCA2	Loss-of-function		Pancreatic Cancer	Sensitivity/Response	P51587							
civic	Imatinib	PDGFRA	I843DEL		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Imatinib	PDGFRB	EBF1::PDGFRB		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P09619							
civic	Oxaliplatin	MLH1	METHYLATION		Stomach Carcinoma	Resistance	P40692							
civic	Sunitinib	FLT3	T227M		Renal Cell Carcinoma	Adverse Response	P36888							
civic	Sirolimus	MTOR	S2215Y		Endometrial Adenocarcinoma	Sensitivity/Response	P42345							
civic	Sirolimus	MTOR	C1483Y		T-cell Acute Lymphoblastic Leukemia	Sensitivity/Response	P42345							
civic	Sirolimus	MTOR	E1799K		Clear Cell Renal Cell Carcinoma	Sensitivity/Response	P42345							
civic	PD173074	FGFR2	N550K		Endometrial Cancer	Sensitivity/Response	P21802							
civic	Gemcitabine,Mitomycin,Doxorubicin,Fluorouracil	RB1	Overexpression		Pancreatic Adenocarcinoma	Resistance	P06400							
civic	Bevacizumab,FOLFIRI Regimen	PPP1R15A	RS557806		Colorectal Cancer	Sensitivity/Response	O75807							
civic	Selumetinib,Irinotecan	KRAS	Exon 2 Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	AZD3463	ALK	F1174L		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Lorlatinib	ALK	F1174L		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Lorlatinib	ALK	F1245C		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Lorlatinib	ALK	R1275Q		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Lorlatinib	ALK	EML4::ALK		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	F1245C		Neuroblastoma	Resistance	Q9UM73							
civic	Crizotinib	ALK	Fusion		Colorectal Adenocarcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Breast Cancer	Sensitivity/Response	Q9UM73							
civic	Brigatinib	ALK	Exon 4-11 Deletion		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Ceritinib	ALK	EML4::ALK e6-e20		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Ceritinib	ALK	I1171		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	NPM::ALK		Cancer	Sensitivity/Response	Q9UM73							
civic	Pictilisib,Tanespimycin	PIK3CA	Mutation		Cancer	Sensitivity/Response	P42336							
civic	Pictilisib,Tanespimycin	PTEN	Mutation		Head And Neck Cancer	Sensitivity/Response	P60484							
civic	Dactolisib	PIK3CA	Mutation		Head And Neck Cancer	Sensitivity/Response	P42336							
civic	Dactolisib	PIK3CA	H1047R		Head And Neck Cancer	Sensitivity/Response	P42336							
civic	Dactolisib	PIK3CA	H1047R		Head And Neck Cancer	Sensitivity/Response	P42336							
civic	Dactolisib,Cetuximab	PIK3CA	H1047R		Head And Neck Cancer	Sensitivity/Response	P42336							
civic	Tanespimycin,Pictilisib,Trametinib	PIK3CA	Mutation		Head And Neck Cancer	Sensitivity/Response	P42336							
civic	Sorafenib	RET	M918T		Thyroid Gland Medullary Carcinoma	Sensitivity/Response	P07949							
civic	Palbociclib	CDK4	Amplification		Liposarcoma	Sensitivity/Response	P11802							
civic	Alectinib	ALK	I1171		Lung Non-small Cell Carcinoma	Resistance	Q9UM73							
civic	Ceritinib	ALK	I1171		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Olaparib	BRCA1	Mutation		Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Mutation		Cancer	Sensitivity/Response	P51587							
civic	Alvocidib	CDKN2A	Loss		Skin Melanoma	Sensitivity/Response	Q9NXV6							
civic	Palbociclib	CDKN2A	Loss		Renal Cell Carcinoma	Sensitivity/Response	Q9NXV6							
civic	Palbociclib	CDKN2B	Loss		Renal Cell Carcinoma	Sensitivity/Response	P42772							
civic	Palbociclib	CDKN2A	Loss		Skin Melanoma	Sensitivity/Response	Q9NXV6							
civic	Palbociclib	CDK4	R24C		Skin Melanoma	Sensitivity/Response	P11802							
civic	Palbociclib	CDKN2A	Loss		Ovarian Cancer	Sensitivity/Response	Q9NXV6							
civic	Pictilisib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	A66	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Tgx 221	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Trastuzumab	PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Trastuzumab	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Trastuzumab	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Gefitinib,Erlotinib	EGFR	T790M		Lung Adenocarcinoma	Resistance	P00533							
civic	Gefitinib,Erlotinib	MET	Amplification		Lung Adenocarcinoma	Resistance	P08581							
civic	Erlotinib,Gefitinib	ERBB2	Amplification		Lung Adenocarcinoma	Resistance	P04626							
civic	Erlotinib	EGFR	S768I		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	S768I		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	C797S		Lung Adenocarcinoma	Resistance	P00533							
civic	Osimertinib	EGFR	T790M		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Vemurafenib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600K		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600K		Melanoma	Sensitivity/Response	P15056							
civic	Alpelisib	PIK3CA	H1047R		Head And Neck Cancer	Sensitivity/Response	P42336							
civic	Alpelisib	PIK3CA	Mutation		Cancer	Sensitivity/Response	P42336							
civic	Alpelisib	PIK3CA	Amplification		Stomach Carcinoma	Sensitivity/Response	P42336							
civic	Cetuximab,Panitumumab	BRAF	Mutation		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Dabrafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Dabrafenib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Gefitinib,Cetuximab,Vemurafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Skin Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Skin Melanoma	Sensitivity/Response	P15056							
civic	Dabrafenib,Trametinib	BRAF	V600		Skin Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib,Panitumumab	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Thyroid Gland Papillary Carcinoma	Sensitivity/Response	P15056							
civic	Trametinib,Dabrafenib	BRAF	V600		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	TRIM24::BRAF		Skin Melanoma	Resistance	P15056							
civic	Spliceostatin A	SF3B1	K700E		Breast Cancer	Sensitivity/Response	O75533							
civic	Spliceostatin A	SF3B1	K666N		Breast Cancer	Sensitivity/Response	O75533							
civic	Crizotinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Cobimetinib,Vemurafenib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Cobimetinib,Vemurafenib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Imatinib	KIT	M541L		Chronic Leukemia	Sensitivity/Response	P10721							
civic	Sunitinib	KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Dactolisib,GDC-0879	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Trametinib,Omipalisib	NRAS	Mutation		Melanoma	Sensitivity/Response	P01111							
civic	Dabrafenib,Trametinib,Vemurafenib	BRAF	V600E		Gastrointestinal Neuroendocrine Tumor	Sensitivity/Response	P15056							
civic	Trastuzumab Emtansine	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Docetaxel,Trastuzumab,Pertuzumab	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Lapatinib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Onatasertib,Sapanisertib	RICTOR	Amplification		Lung Adenocarcinoma	Sensitivity/Response	P85299							
civic	Imatinib	PDGFRA	FIP1L1::PDGFRA		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	Sensitivity/Response	P16234							
civic	Crizotinib	ROS1	Rearrangement		Bronchiolo-alveolar Adenocarcinoma	Sensitivity/Response	P08922							
civic	Crizotinib	ROS1	TFG::ROS1		Inflammatory Myofibroblastic Tumor	Sensitivity/Response	P08922							
civic	Imatinib	PDGFRA	FIP1L1::PDGFRA		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	Sensitivity/Response	P16234							
civic	Imatinib	PDGFRA	FIP1L1::PDGFRA T674I		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	Resistance	P16234							
civic	Dactolisib	PIK3CA	H1047R		Lung Adenocarcinoma	Sensitivity/Response	P42336							
civic	Trastuzumab,Pilaralisib	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab	BIRC5	Overexpression		Her2-receptor Positive Breast Cancer	Resistance	O15392							
civic	Trastuzumab	PIK3CA	E545K		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Sorafenib,Mitogen-Activated Protein Kinase Kinase Inhibitor	BRAF	D594A		Skin Melanoma	Sensitivity/Response	P15056							
civic	PI3K/BET Inhibitor LY294002,Trastuzumab	PTEN	Loss		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P60484							
civic	Trametinib,Sorafenib	BRAF	D594V		Skin Melanoma	Sensitivity/Response	P15056							
civic	Sorafenib,Mitogen-Activated Protein Kinase Kinase Inhibitor	BRAF	K483M		Skin Melanoma	Sensitivity/Response	P15056							
civic	Trametinib,Vemurafenib	BRAF	L597R		Skin Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib,Trametinib	BRAF	L597S		Skin Melanoma	Sensitivity/Response	P15056							
civic	MEK Inhibitor TAK-733	BRAF	L597S		Skin Melanoma	Sensitivity/Response	P15056							
civic	Trametinib,Vemurafenib	BRAF	L597Q		Skin Melanoma	Sensitivity/Response	P15056							
civic	Trametinib,Vemurafenib	BRAF	K601E		Skin Melanoma	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	L597V		Skin Melanoma	Sensitivity/Response	P15056							
civic	Taselisib	PIK3CA	Amplification		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P42336							
civic	Taselisib	PIK3CA	H1047R		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P42336							
civic	Imatinib	KIT	Amplification		Mucosal Melanoma	Resistance	P10721							
civic	Taselisib	PTEN	Mutation		Head And Neck Squamous Cell Carcinoma	Resistance	P60484							
civic	Vemurafenib	NF1	Mutation		Skin Melanoma	Resistance	P21359							
civic	Mirdametinib,Sirolimus	NF1	Mutation		Skin Melanoma	Sensitivity/Response	P21359							
civic	Vemurafenib	NF1	Mutation		Skin Melanoma	Resistance	P21359							
civic	VTX-11e,AZ628	NF1	Mutation		Skin Melanoma	Sensitivity/Response	P21359							
civic	Binimetinib	NRAS	Mutation		Skin Melanoma	Sensitivity/Response	P01111							
civic	Selumetinib	NRAS	Q61		Skin Melanoma	Sensitivity/Response	P01111							
civic	Vemurafenib	NRAS	Q61K		Skin Melanoma	Resistance	P01111							
civic	Selumetinib	NRAS	Q61K		Skin Melanoma	Sensitivity/Response	P01111							
civic	Amuvatinib	NRAS	Mutation		Skin Melanoma	Sensitivity/Response	P01111							
civic	Vismodegib,Sonidegib	SMO	Mutation		Basal Cell Carcinoma	Resistance	Q99835							
civic	Alemtuzumab	TP53	Mutation		Chronic Lymphocytic Leukemia	Sensitivity/Response	Q12888							
civic	Peginterferon Alfa-2a	CALR	EXON 9 FRAMESHIFT		Essential Thrombocythemia	Sensitivity/Response	P27797							
civic	Radiation Therapy,Taselisib	PIK3CA	Mutation		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P42336							
civic	Ipatasertib	PTEN	Mutation		Cancer	Sensitivity/Response	P60484							
civic	Cisplatin	PTEN	Loss		Ovarian Cancer	Resistance	P60484							
civic	Chemotherapy	PTEN	Loss		Stomach Carcinoma	Resistance	P60484							
civic	GSK126	EZH2	Y646		Skin Melanoma	Sensitivity/Response	Q15910							
civic	Carboplatin,Paclitaxel,Sorafenib	CCND1	Amplification		Skin Melanoma	Sensitivity/Response	P24385							
civic	Carboplatin,Sorafenib,Paclitaxel	RAF1	Amplification		Skin Melanoma	Sensitivity/Response	P04049							
civic	Carboplatin,Docetaxel,Sorafenib	KRAS	Amplification		Skin Melanoma	Sensitivity/Response	P01116							
civic	Imatinib	PDGFRB	Fusion		Myeloproliferative Neoplasm	Sensitivity/Response	P09619							
civic	Trastuzumab	ERBB2	Amplification		Gastric Adenocarcinoma	Sensitivity/Response	P04626							
civic	Docetaxel,Capivasertib	PTEN	Loss		Stomach Cancer	Sensitivity/Response	P60484							
civic	Capivasertib	PIK3CA	Mutation		Stomach Cancer	Sensitivity/Response	P42336							
civic	Capivasertib	PTEN	Loss		Cancer	Sensitivity/Response	P60484							
civic	Capivasertib	PIK3CA	Mutation		Cancer	Sensitivity/Response	P42336							
civic	Capivasertib	PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Trastuzumab,Capivasertib	PIK3CA	H1047R		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Capivasertib,Lapatinib	PIK3CA	H1047R		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Binimetinib	NRAS	Mutation		Melanoma	Sensitivity/Response	P01111							
civic	Nivolumab	CD274	Expression		Cancer	Sensitivity/Response	Q9NZQ7							
civic	Sunitinib	RET	Overexpression		Papillary Adenocarcinoma	Sensitivity/Response	P07949							
civic	Tretinoin	PML	PML::RARA		Acute Promyelocytic Leukemia	Sensitivity/Response	P29590							
civic	Ipilimumab	CTLA4	CTLA4::CD28		Sezary's Disease	Sensitivity/Response	P16410							
civic	Cyproterone Acetate,Flutamide,Bicalutamide,Nilutamide	AR	Mutation		Prostate Cancer	Resistance	O95154							
civic	Alpelisib,Enzalutamide,PI3Kbeta Inhibitor AZD8186	PTEN	Mutation		Prostate Cancer	Sensitivity/Response	P60484							
civic	Porcupine Inhibitor WNT974	NOTCH1	Loss-of-function		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P46531							
civic	Fulvestrant	CDK6	Overexpression		Estrogen-receptor Positive Breast Cancer	Resistance	Q00534							
civic	Fulvestrant,Palbociclib	CDK6	Overexpression		Estrogen-receptor Positive Breast Cancer	Sensitivity/Response	Q00534							
civic	Sunitinib	FLT3	Overexpression		B-cell Adult Acute Lymphocytic Leukemia	Sensitivity/Response	P36888							
civic	Platinum Compound	BRCA1	Mutation		Ovarian Carcinoma	Sensitivity/Response	P38398							
civic	Platinum Compound	BRCA2	Mutation		Ovarian Carcinoma	Sensitivity/Response	P51587							
civic	Platinum Compound	BRCA1	Mutation		Ovarian Carcinoma	Sensitivity/Response	P38398							
civic	Platinum Compound	BRCA2	Mutation		Ovarian Carcinoma	Sensitivity/Response	P51587							
civic	Vemurafenib	GNAQ	Q209P		Skin Melanoma	Resistance	P50148							
civic	MEK Inhibitor CI-1040,Akt Inhibitor MK2206	PTEN	V317FS		Skin Melanoma	Sensitivity/Response	P60484							
civic	Palbociclib	RB1	Loss-of-function		Breast Cancer	Resistance	P06400							
civic	Palbociclib	CCND1	Overexpression		Mantle Cell Lymphoma	Sensitivity/Response	P24385							
civic	PLX4720	GNAQ	Q209P		Skin Melanoma	Resistance	P50148							
civic	Palbociclib,Letrozole	ESR1	Overexpression		Breast Cancer	Sensitivity/Response	P03372							
civic	Sirolimus	MTOR	F2108L		Breast Cancer	Resistance	P42345							
civic	MTOR Kinase Inhibitor AZD8055	MTOR	M2327I		Breast Cancer	Resistance	P42345							
civic	RapaLink-1,Sirolimus	MTOR	M2327I		Breast Cancer	Resistance	P42345							
civic	Sirolimus	MTOR	A2034V		Breast Cancer	Resistance	P42345							
civic	RapaLink-1,MTOR Kinase Inhibitor AZD8055	MTOR	A2034V		Breast Cancer	Resistance	P42345							
civic	Apitolisib	PIK3CA	E542K		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P42336							
civic	Apitolisib	PIK3CA	E545K		Cancer	Sensitivity/Response	P42336							
civic	Cetuximab,Panitumumab	BRAF	D594G		Colorectal Cancer	Resistance	P15056							
civic	Sorafenib	FLT3	ITD		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Sorafenib	FLT3	D835H		Acute Myeloid Leukemia	Resistance	P36888							
civic	Sorafenib	FLT3	D835H/Y		Acute Myeloid Leukemia	Resistance	P36888							
civic	Palbociclib	CCND1	Amplification		Renal Cell Carcinoma	Sensitivity/Response	P24385							
civic	Palbociclib,Trastuzumab	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Palbociclib	CCND1	Amplification		Breast Cancer	Sensitivity/Response	P24385							
civic	Palbociclib	CCND1	Overexpression		Mantle Cell Lymphoma	Sensitivity/Response	P24385							
civic	Crizotinib	MET	Amplification		Glioblastoma	Sensitivity/Response	P08581							
civic	Crizotinib	MET	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Pembrolizumab	JAK1	Q503*		Skin Melanoma	Resistance	P23458							
civic	Pembrolizumab	JAK2	c.1641+1dup		Skin Melanoma	Resistance	O60674							
civic	Pembrolizumab	B2M	S14FS		Skin Melanoma	Resistance	Q9Y2E5							
civic	Trametinib	BRAF	PPFIBP2::BRAF		Skin Melanoma	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	KIAA1549::BRAF		Skin Melanoma	Sensitivity/Response	P15056							
civic	Cetuximab	EGFR	Expression		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Vemurafenib	BRAF	V600		Lung Non-small Cell Carcinoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600		Langerhans-cell Histiocytosis	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600		Colorectal Cancer	Resistance	P15056							
civic	Crizotinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Pembrolizumab	CD274	Expression		Merkel Cell Carcinoma	Sensitivity/Response	Q9NZQ7							
civic	Vemurafenib	BRAF	V600E		Hairy Cell Leukemia	Sensitivity/Response	P15056							
civic	Vemurafenib	KRAS	G12D		Hairy Cell Leukemia	Resistance	P01116							
civic	Vemurafenib	MET	Overexpression		Skin Melanoma	Resistance	P08581							
civic	Crizotinib	MET	Overexpression		Uveal Melanoma	Sensitivity/Response	P08581							
civic	Vemurafenib	MET	Overexpression		Skin Melanoma	Resistance	P08581							
civic	Decitabine	DNMT3A	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	Q9Y6K1							
civic	Crizotinib,Vemurafenib	MET	Amplification		Colorectal Cancer	Sensitivity/Response	P08581							
civic	Panitumumab,Vemurafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Thyroid Gland Papillary Carcinoma	Sensitivity/Response	P15056							
civic	Osimertinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Palbociclib	RB1	Loss-of-function		Glioblastoma	Resistance	P06400							
civic	Vorinostat	RAD23B	EXPRESSION		Sarcoma	Sensitivity/Response	P54727							
civic	Vemurafenib,Cetuximab	BRAF	V600		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Palbociclib	CCND1	Amplification		Ovarian Cancer	Sensitivity/Response	P24385							
civic	Phosphatidylinositide 3-Kinase Inhibitor,Ribociclib	PIK3CA	Mutation		Breast Cancer	Sensitivity/Response	P42336							
civic	Nintedanib	RET	CCDC6::RET		Lung Non-small Cell Carcinoma	Sensitivity/Response	P07949							
civic	Vemurafenib	MAP2K1	C121S		Melanoma	Resistance	Q02750							
civic	Pazopanib	FGFR3	S249C		Transitional Cell Carcinoma	Sensitivity/Response	P22607							
civic	Dovitinib	FGFR1	Amplification		Breast Cancer	Sensitivity/Response	P11362							
civic	Dovitinib	FGFR2	Amplification		Breast Cancer	Sensitivity/Response	P21802							
civic	Dovitinib	FGF3	Amplification		Breast Cancer	Sensitivity/Response	P11487							
civic	Palbociclib,Phosphatidylinositide 3-Kinase Inhibitor	PIK3CA	Mutation		Breast Cancer	Sensitivity/Response	P42336							
civic	Ruxolitinib	VHL	R200W (c.598C>T)		Chuvash Polycythemia	Sensitivity/Response	P40337							
civic	Alpelisib	RB1	PHOSPHORYLATION		Breast Cancer	Resistance	P06400							
civic	MTOR Kinase Inhibitor PP242,Everolimus	PIK3CA	Mutation		Breast Cancer	Sensitivity/Response	P42336							
civic	MTOR Kinase Inhibitor PP242,Everolimus	PTEN	Loss		Breast Cancer	Sensitivity/Response	P60484							
civic	MTOR Kinase Inhibitor PP242	PIK3R1	Mutation		Breast Cancer	Sensitivity/Response	Q15303							
civic	MTOR Kinase Inhibitor PP242	ERBB2	Amplification		Breast Cancer	Sensitivity/Response	P04626							
civic	Temsirolimus	PTEN	Loss		Endometrial Cancer	Sensitivity/Response	P60484							
civic	Ipilimumab,Nivolumab	CD274	Expression		Melanoma	Sensitivity/Response	Q9NZQ7							
civic	Pictilisib	PIK3CA	Mutation		Endometrial Cancer	Sensitivity/Response	P42336							
civic	Everolimus	STK11	D194E		Pancreatic Cancer	Sensitivity/Response	Q15831							
civic	Sirolimus	STK11	Loss		Peutz-Jeghers Syndrome	Sensitivity/Response	Q15831							
civic	Sirolimus	STK11	Loss		Peutz-Jeghers Syndrome	Sensitivity/Response	Q15831							
civic	Everolimus,Sirolimus	STK11	Loss		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q15831							
civic	Vandetanib,Everolimus	AKT2	Amplification		Lung Adenocarcinoma	Sensitivity/Response	P31751							
civic	Vandetanib,Everolimus	RET	KIF5B::RET		Lung Adenocarcinoma	Sensitivity/Response	P07949							
civic	Fulvestrant,Everolimus	PIK3CA	H1047R		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Fulvestrant,Everolimus	PTEN	Expression		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Temsirolimus,Perifosine	PIK3CA	H1047R		Thyroid Gland Cancer	Sensitivity/Response	P42336							
civic	Temsirolimus,Perifosine	PIK3CA	E542K		Thyroid Gland Cancer	Sensitivity/Response	P42336							
civic	Perifosine,Temsirolimus	PTEN	R130*		Thyroid Gland Cancer	Sensitivity/Response	P60484							
civic	Everolimus	FBXW7	Loss-of-function		Renal Cell Carcinoma	Sensitivity/Response	Q969H0							
civic	Palbociclib	CCNE1	Amplification		Estrogen-receptor Positive Breast Cancer	Resistance	P24864							
civic	Palbociclib	RB1	M695FS*26		Estrogen-receptor Positive Breast Cancer	Resistance	P06400							
civic	MTOR Inhibitor	FBXW7	Mutation		Cancer	Sensitivity/Response	Q969H0							
civic	Sirolimus	FBXW7	Loss-of-function		Cancer	Sensitivity/Response	Q969H0							
civic	Irbesartan	JUN	Overexpression		Colorectal Adenocarcinoma	Sensitivity/Response	P05412							
civic	Irbesartan	FOS	Overexpression		Colon Adenocarcinoma	Sensitivity/Response	P01100							
civic	IRAK-1/4 Inhibitor,IMG-2005-5	MYD88	L265P		Lymphoplasmacytic Lymphoma	Sensitivity/Response	Q99836							
civic	Refametinib,Sorafenib	KRAS	Mutation		Hepatocellular Carcinoma	Sensitivity/Response	P01116							
civic	Fluorouracil	SMAD4	Deletion		Colorectal Cancer	Resistance	Q13485							
civic	PCV Regimen,Temozolomide	ATRX	Underexpression		Malignant Astrocytoma	Sensitivity/Response	P46100							
civic	Platinum Compound	AURKA	Overexpression		Ovarian Serous Carcinoma	Resistance	O14965							
civic	Crizotinib	MET	Exon 14 Skipping Mutation		Lung Adenocarcinoma	Sensitivity/Response	P08581							
civic	Crizotinib	MET	D1228N		Lung Non-small Cell Carcinoma	Resistance	P08581							
civic	Radiation Therapy,Cisplatin,Fluorouracil	AURKA	EXPRESSION		Esophagus Squamous Cell Carcinoma	Sensitivity/Response	O14965							
civic	Docetaxel	GAS6	EXPRESSION		Prostate Cancer	Resistance	Q14393							
civic	Vemurafenib	STAG2	Underexpression		Melanoma	Resistance	Q8N3U4							
civic	Vemurafenib	STAG3	Underexpression		Melanoma	Resistance	Q9UJ98							
civic	Selumetinib	MAP2K1	Q56_V60del		Ovarian Serous Carcinoma	Sensitivity/Response	Q02750							
civic	Mitogen-Activated Protein Kinase Kinase Inhibitor	BRAF	BRAF::CUL1		Ovarian Serous Carcinoma	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	ZKSCAN1::BRAF		Melanoma	Sensitivity/Response	P15056							
civic	Sorafenib,Bevacizumab,Temsirolimus	BRAF	KIAA1549::BRAF		Spindle Cell Sarcoma	Sensitivity/Response	P15056							
civic	Gefitinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib,Gefitinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Vemurafenib	BRAF	L505H		Melanoma	Resistance	P15056							
civic	Vemurafenib	BRAF	L505H		Melanoma	Resistance	P15056							
civic	Erlotinib,Gefitinib	PIK3CA	E545K		Lung Adenocarcinoma	Resistance	P42336							
civic	Pazopanib	VHL	Mutation		Renal Cell Carcinoma	Sensitivity/Response	P40337							
civic	Pazopanib	EPAS1	Overexpression		Renal Cell Carcinoma	Sensitivity/Response	Q99814							
civic	Pazopanib	HIF1A	EXPRESSION		Renal Cell Carcinoma	Sensitivity/Response	Q16665							
civic	Cediranib,Olaparib	BRCA1	Mutation		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Olaparib,Cediranib	BRCA2	Mutation		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Carboplatin,Cisplatin	BRCA1	Mutation		Triple-receptor Negative Breast Cancer	Sensitivity/Response	P38398							
civic	Cisplatin,Carboplatin	BRCA2	Mutation		Triple-receptor Negative Breast Cancer	Sensitivity/Response	P51587							
civic	Cetuximab	ERBB2	Amplification		Colorectal Cancer	Resistance	P04626							
civic	Cetuximab	ERBB2	Amplification		Colorectal Cancer	Resistance	P04626							
civic	Cetuximab,Panitumumab	ERBB2	Amplification		Colorectal Cancer	Resistance	P04626							
civic	Lapatinib,Trastuzumab	ERBB2	Amplification		Colorectal Cancer	Sensitivity/Response	P04626							
civic	Crizotinib	ROS1	Rearrangement		Lung Adenocarcinoma	Sensitivity/Response	P08922							
civic	Crizotinib	ALK	Fusion		Lung Adenocarcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	MET	Amplification		Lung Adenocarcinoma	Sensitivity/Response	P08581							
civic	Trastuzumab	ERBB2	Amplification		Scrotum Paget's Disease	Sensitivity/Response	P04626							
civic	Platinum Compound	ERBB2	Mutation		Bladder Carcinoma	Sensitivity/Response	P04626							
civic	Vemurafenib	BRAF	V600E		Multiple Myeloma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Multiple Myeloma	Sensitivity/Response	P15056							
civic	Cetuximab	KRAS	Mutation		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	NRAS	Mutation		Colorectal Cancer	Resistance	P01111							
civic	Cetuximab	BRAF	Mutation		Colorectal Cancer	Resistance	P15056							
civic	Cetuximab	PIK3CA	Mutation		Colorectal Cancer	Resistance	P42336							
civic	JQ1,I-BET151	MYCL	EXPRESSION		Multiple Myeloma	Sensitivity/Response	P12524							
civic	MET Tyrosine Kinase Inhibitor SGX523	HGF	EXPRESSION		Glioblastoma	Sensitivity/Response	P14210							
civic	Panitumumab	EGFR	Expression		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Cetuximab	EGFR	Expression		Colorectal Cancer	Sensitivity/Response	P00533							
civic	Vemurafenib	SOX10	Loss		Melanoma	Resistance	P56693							
civic	Quizartinib	FGF2	EXPRESSION		Acute Myeloid Leukemia	Resistance	P09038							
civic	Crizotinib	MET	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Crizotinib	MET	Amplification		Cancer	Sensitivity/Response	P08581							
civic	Crizotinib	KRAS	G12V		Cancer	Resistance	P01116							
civic	Erlotinib	ERRFI1	E384*		Cholangiocarcinoma	Sensitivity/Response	Q9UJM3							
civic	Midostaurin	KIT	D816V		Systemic Mastocytosis	Sensitivity/Response	P10721							
civic	Aromatase Inhibitor	ESR1	S463P		Estrogen-receptor Positive Breast Cancer	Resistance	P03372							
civic	Afatinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Alpelisib	SGK1	Overexpression		Breast Cancer	Resistance	O00141							
civic	Alpelisib	SGK1	Overexpression		Breast Cancer	Resistance	O00141							
civic	SGK1-Inh,Alpelisib	SGK1	Overexpression		Breast Cancer	Sensitivity/Response	O00141							
civic	Pembrolizumab	CD274	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9NZQ7							
civic	CDK Inhibitor SNS-032	CCNE1	Overexpression		Ovarian Cancer	Sensitivity/Response	P24864							
civic	Dinaciclib,Akt Inhibitor MK2206	CCNE1	Amplification		Ovarian Serous Cystadenocarcinoma	Sensitivity/Response	P24864							
civic	Gefitinib,Erlotinib	EGFR	G719S		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Trametinib,Dabrafenib	BRAF	G596C		Lung Non-small Cell Carcinoma	Sensitivity/Response	P15056							
civic	Tazemetostat	SMARCB1	Underexpression		Synovial Sarcoma	Sensitivity/Response	Q92785							
civic	Tazemetostat	SMARCB1	Deletion		Rhabdoid Cancer	Sensitivity/Response	Q92785							
civic	Selumetinib	NF2	Loss		Thyroid Gland Carcinoma	Sensitivity/Response	Q8NCF5							
civic	JQ1 Compound	NF1	Loss		Malignant Peripheral Nerve Sheath Tumor	Sensitivity/Response	P21359							
civic	Afatinib	ERBB3	V104M		Transitional Cell Carcinoma	Sensitivity/Response	P21860							
civic	Afatinib	ERBB3	R103G		Transitional Cell Carcinoma	Sensitivity/Response	P21860							
civic	Afatinib	ERBB3	G284R		Transitional Cell Carcinoma	Sensitivity/Response	P21860							
civic	Vemurafenib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Fluorouracil	MTHFR	A222V		Rectum Cancer	Sensitivity/Response	P42898							
civic	Erlotinib,Gefitinib	EGFR	D761Y		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Trastuzumab Emtansine	ERBB2	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Letrozole,Palbociclib	CDKN2A	Loss		Her2-receptor Negative Breast Cancer	Sensitivity/Response	Q9NXV6							
civic	Lenalidomide,Pomalidomide	CRBN	Mutation		Multiple Myeloma	Resistance	Q96SW2							
civic	Ponatinib	FGFR1	Amplification		Estrogen-receptor Positive Breast Cancer	Sensitivity/Response	P11362							
civic	Ibrutinib	BTK	C481S		Chronic Lymphocytic Leukemia	Resistance	Q06187							
civic	Sunitinib	PDGFRA	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P16234							
civic	Olaparib	BRCA1	Mutation		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Mutation		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Imatinib	PDGFRA	FIP1L1::PDGFRA		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	Sensitivity/Response	P16234							
civic	Olaparib	BRCA1	Mutation		Triple-receptor Negative Breast Cancer	Resistance	P38398							
civic	Olaparib	BRCA2	Mutation		Triple-receptor Negative Breast Cancer	Sensitivity/Response	P51587							
civic	Ponatinib	PDGFRA	FIP1L1::PDGFRA		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	Sensitivity/Response	P16234							
civic	Ponatinib	PDGFRA	FIP1L1::PDGFRA T674I		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	Sensitivity/Response	P16234							
civic	Erlotinib	EGFR	G719		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	JQ1	BRD4	BRD4::NUTM1		NUT Midline Carcinoma	Sensitivity/Response	O60885							
civic	Erlotinib	EGFR	S720		Lung Adenocarcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	K757R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	E746G		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Belinostat	UGT1A1	UGT1A1*28		Cancer	Adverse Response	P22309							
civic	Belinostat	UGT1A1	UGT1A1*60		Cancer	Adverse Response	P22309							
civic	Erlotinib	EGFR	V769_D770insASV		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Fluorouracil,Capecitabine,Tegafur	DPYD	DPYD*2A HOMOZYGOSITY		Cancer	Adverse Response	Q12882							
civic	Tegafur,Fluorouracil,Capecitabine	DPYD	DPYD*13 HOMOZYGOSITY		Cancer	Adverse Response	Q12882							
civic	Capecitabine,Tegafur,Fluorouracil	DPYD	RS67376798 HOMOZYGOSITY		Cancer	Adverse Response	Q12882							
civic	Afatinib	EGFR	Exon 20 Insertion		Lung Adenocarcinoma	Resistance	P00533							
civic	Imatinib	PDGFRA	TNKS2::PDGFRA		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	Sensitivity/Response	P16234							
civic	Methotrexate	SLCO1B1	RS4149056		Cancer	Adverse Response	Q9Y6L6							
civic	Methotrexate	SLCO1B1	N130D		Cancer	Adverse Response	Q9Y6L6							
civic	Methotrexate	TYMS	RS34743033		Cancer	Adverse Response	P04818							
civic	Afatinib,Pertuzumab	ERBB3	V855A		Lung Non-small Cell Carcinoma	Sensitivity/Response	P21860							
civic	Infigratinib,PD173074	FGFR2	FGFR2::BICC1		Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	PD173074,Infigratinib	FGFR2	FGFR2::AHCYL1		Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	Teprotumumab,Cixutumumab	PTPRD	V253I		Ewing Sarcoma Of Bone	Sensitivity/Response	P23468							
civic	Gemcitabine	RRM1	Overexpression		Pancreatic Cancer	Resistance	Q9UET6							
civic	Gemcitabine	RRM2	OVEREXPRESSION		Pancreatic Cancer	Resistance	Q9UI43							
civic	Pembrolizumab	POLE	Mutation		Glioblastoma	Sensitivity/Response	Q1MSJ5							
civic	Pembrolizumab	POLE	Mutation		Endometrial Cancer	Sensitivity/Response	Q1MSJ5							
civic	Afatinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Cabozantinib	MET	D1228V		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Savolitinib	MET	D1228V		Lung Non-small Cell Carcinoma	Resistance	P08581							
civic	Chemotherapy	RB1	Mutation		Lung Small Cell Carcinoma	Sensitivity/Response	P06400							
civic	Osimertinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Entrectinib	NTRK1	SQSTM1::NTRK1		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK3	ETV6::NTRK3		Mammary Analogue Secretory Carcinoma	Sensitivity/Response	Q16288							
civic	Crizotinib	NTRK3	ETV6::NTRK3		Mammary Analogue Secretory Carcinoma	Sensitivity/Response	Q16288							
civic	Entrectinib	NTRK3	ETV6::NTRK3 G623R		Mammary Analogue Secretory Carcinoma	Resistance	Q16288							
civic	Anti-PD-1 Monoclonal Antibody MEDI0680,Durvalumab	MSH2	Loss		Transitional Cell Carcinoma	Sensitivity/Response	P43246							
civic	Anti-PD-1 Monoclonal Antibody MEDI0680,Durvalumab	MSH6	LOSS		Transitional Cell Carcinoma	Sensitivity/Response	P52701							
civic	Palbociclib,Linsitinib	CDKN2A	Loss		Ewing Sarcoma	Sensitivity/Response	Q9NXV6							
civic	Palbociclib,Linsitinib	CDKN2B	Loss		Ewing Sarcoma	Sensitivity/Response	P42772							
civic	Palbociclib	CDKN2A	Loss		Dermatofibrosarcoma Protuberans	Sensitivity/Response	Q9NXV6							
civic	Afatinib	ERBB2	Y772_A775DUP		Lung Adenocarcinoma	Sensitivity/Response	P04626							
civic	Afatinib	ERBB2	G776L		Lung Adenocarcinoma	Sensitivity/Response	P04626							
civic	Afatinib	ERBB2	G778_P780DUP		Lung Adenocarcinoma	Sensitivity/Response	P04626							
civic	Dacomitinib	ERBB2	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Dacomitinib	ERBB2	G778_P780DUP		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Dacomitinib	ERBB2	Y772_A775DUP		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Dacomitinib	ERBB2	M774DELINSWLV		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Vatalanib,Sunitinib	PTPRB	Loss-of-function		Angiosarcoma	Sensitivity/Response	P23467							
civic	Rucaparib	BRCA1	Mutation		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Therapeutic Tumor Infiltrating Lymphocytes	KRAS	G12D		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Therapeutic Tumor Infiltrating Lymphocytes	HLA-C	COPY-NEUTRAL LOSS OF HETEROZYGOSITY		Colorectal Cancer	Resistance	P10321							
civic	Ruxolitinib	JAK1	S703I		Hepatocellular Carcinoma	Sensitivity/Response	P23458							
civic	Vemurafenib,Irinotecan,Cetuximab	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Irinotecan,Vemurafenib,Cetuximab	ARAF	S490T		Colorectal Cancer	Resistance	P10398							
civic	Vemurafenib,Irinotecan,Cetuximab	GNAS	R201C		Colorectal Cancer	Resistance	O95467							
civic	Olaparib	ATM	Mutation		Mantle Cell Lymphoma	Sensitivity/Response	Q13315							
civic	Infigratinib	FGFR1	Amplification		Lung Squamous Cell Carcinoma	Sensitivity/Response	P11362							
civic	Infigratinib	FGFR1	Amplification		Breast Cancer	Resistance	P11362							
civic	Infigratinib	FGFR3	Mutation		Bladder Carcinoma	Sensitivity/Response	P22607							
civic	Infigratinib	FGFR1	Amplification		Bladder Carcinoma	Sensitivity/Response	P11362							
civic	Infigratinib	FGFR2	Mutation		Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	Infigratinib	FGFR2	Fusion		Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	Erdafitinib	FGFR2	FGFR2::BICC1		Transitional Cell Carcinoma	Sensitivity/Response	P21802							
civic	Erdafitinib	FGFR2	Fusion		Cancer	Sensitivity/Response	P21802							
civic	Erdafitinib	FGFR3	FGFR3::TACC3		Cancer	Sensitivity/Response	P22607							
civic	Erdafitinib	FGFR2	FGFR2::BICC1		Endometrial Cancer	Sensitivity/Response	P21802							
civic	Akt Inhibitor MK2206	AKT3	Overexpression		Breast Cancer	Resistance	Q9Y243							
civic	Pan-AKT Kinase Inhibitor GSK690693	AKT3	Overexpression		Triple-receptor Negative Breast Cancer	Sensitivity/Response	Q9Y243							
civic	Quarfloxin,Pidnarulex	BRCA1	Loss-of-function		Breast Cancer	Sensitivity/Response	P38398							
civic	Pidnarulex,Quarfloxin	BRCA2	Loss-of-function		Breast Cancer	Sensitivity/Response	P51587							
civic	Crizotinib	ALK	Alternative Transcript (ATI)		Skin Melanoma	Sensitivity/Response	Q9UM73							
civic	Gefitinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Mirdametinib,Sotrastaurin Acetate	GNA11	Mutation		Uveal Melanoma	Sensitivity/Response	P29992							
civic	Sotrastaurin Acetate,Mirdametinib	GNAQ	Mutation		Uveal Melanoma	Sensitivity/Response	P50148							
civic	Selumetinib	NF1	Mutation		Plexiform Neurofibroma	Sensitivity/Response	P21359							
civic	Olaparib	ATM	Mutation		Prostate Cancer	Sensitivity/Response	Q13315							
civic	Olaparib	PALB2	Biallelic Inactivation		Prostate Cancer	Sensitivity/Response	Q86YC2							
civic	Anti-EGFR Monoclonal Antibody	MET	Amplification		Colorectal Cancer	Resistance	P08581							
civic	Crenolanib,Imatinib	PDGFRA	P577S		Melanoma	Sensitivity/Response	P16234							
civic	Imatinib,Crenolanib	PDGFRA	R841K		Melanoma	Sensitivity/Response	P16234							
civic	Imatinib,Crenolanib	PDGFRA	H845Y		Melanoma	Sensitivity/Response	P16234							
civic	Imatinib,Crenolanib	PDGFRA	G853D		Melanoma	Sensitivity/Response	P16234							
civic	Cetuximab,Crizotinib	MET	Amplification		Colorectal Cancer	Sensitivity/Response	P08581							
civic	Pyrimidine Antagonist	MTAP	Underexpression		Breast Cancer	Sensitivity/Response	Q13126							
civic	Cetuximab	VPS37A	Underexpression		Ovarian Cancer	Resistance	Q8NEZ2							
civic	Lapatinib	EGFR	Expression		Chordoma	Sensitivity/Response	P00533							
civic	Ibrutinib	BTK	T316A		Chronic Lymphocytic Leukemia	Resistance	Q06187							
civic	Lapatinib	ERBB2	T862A		Cancer	Sensitivity/Response	P04626							
civic	Lapatinib	ERBB2	V773A		Cancer	Sensitivity/Response	P04626							
civic	Lapatinib	ERBB2	N857S		Cancer	Sensitivity/Response	P04626							
civic	Lapatinib	ERBB2	H878Y		Cancer	Sensitivity/Response	P04626							
civic	FGFR Inhibitor AZD4547	FGFR2	Amplification		Stomach Carcinoma	Sensitivity/Response	P21802							
civic	FGFR Inhibitor AZD4547	FGFR1	Amplification		Breast Cancer	Sensitivity/Response	P11362							
civic	Lapatinib	ERBB2	Overexpression		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P04626							
civic	Cetuximab	ERBB2	Amplification		Colorectal Cancer	Resistance	P04626							
civic	Erlotinib,Gefitinib	GNAS	c.393T>C		Lung Non-small Cell Carcinoma	Resistance	O95467							
civic	Cetuximab	PIK3CA	C420R		Colorectal Cancer	Resistance	P42336							
civic	Selumetinib,Dactolisib	KRAS	G12V		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Irinotecan,Cetuximab	NRAS	G12D		Colorectal Cancer	Resistance	P01111							
civic	Panitumumab	KRAS	G12/G13		Colorectal Cancer	Resistance	P01116							
civic	Gefitinib	KRAS	G12A		Lung Cancer	Resistance	P01116							
civic	Melphalan	KRAS	G12A		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12A		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12A		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12A		Multiple Myeloma	Resistance	P01116							
civic	Bevacizumab,Sunitinib	IDH1	R132		High Grade Glioma	Sensitivity/Response	O75874							
civic	Pictilisib	PIK3CA	E542K		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Pictilisib	PIK3CA	E542K		Breast Cancer	Sensitivity/Response	P42336							
civic	Pictilisib	PIK3CA	E545K		Breast Cancer	Sensitivity/Response	P42336							
civic	Trastuzumab	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Trastuzumab Emtansine	PIK3CA	E545K		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Cetuximab,Panitumumab	PIK3CA	E545K		Colorectal Cancer	Resistance	P42336							
civic	Aspirin	PIK3CA	Wildtype		Colorectal Cancer	Sensitivity/Response	P42336							
civic	PI103	PIK3CA	E545K		Lung Non-small Cell Carcinoma	Sensitivity/Response	P42336							
civic	Pictilisib	KRAS	G13D		Breast Cancer	Resistance	P01116							
civic	Trastuzumab	PTEN	Loss		Breast Cancer	Resistance	P60484							
civic	Pictilisib	PTEN	Loss		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P60484							
civic	Erlotinib,Gefitinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	PI-103	PIK3CA	E542K		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Pictilisib	PIK3CA	E545K		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Pictilisib	ERBB2	Amplification		Breast Cancer	Sensitivity/Response	P04626							
civic	Pictilisib	PTEN	Loss		Breast Cancer	Sensitivity/Response	P60484							
civic	Pictilisib	PIK3CA	C420R		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Pictilisib	PIK3CA	K111N		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Trastuzumab	PIK3CA	Mutation		Breast Cancer	Resistance	P42336							
civic	Pictilisib	PIK3CA	H1047L		Breast Cancer	Sensitivity/Response	P42336							
civic	Pictilisib	PIK3CA	H1047R		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Trastuzumab	PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Pictilisib	PIK3CA	H1047R		Breast Cancer	Sensitivity/Response	P42336							
civic	Trastuzumab Emtansine	PIK3CA	H1047R		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Cetuximab,Panitumumab	BRAF	V600E		Colorectal Cancer	Resistance	P15056							
civic	Oxaliplatin	BRAF	V600E		Colorectal Cancer	Resistance	P15056							
civic	Irinotecan	BRAF	V600E		Colorectal Cancer	Resistance	P15056							
civic	Capecitabine,Bevacizumab,Oxaliplatin	BRAF	V600E		Colorectal Cancer	Resistance	P15056							
civic	Trametinib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Gefitinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	Ex19 del L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	T790M		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib,Erlotinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Gefitinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Lapatinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Dacomitinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Neratinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Canertinib	EGFR	T790M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Imatinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Panitumumab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Irinotecan,Cetuximab	NRAS	Q61L		Colorectal Cancer	Resistance	P01111							
civic	Selumetinib,Dactolisib	KRAS	G13D		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Cetuximab	NRAS	Q61R		Colorectal Cancer	Resistance	P01111							
civic	Chemotherapy,Cetuximab	BRAF	Mutation		Colorectal Cancer	Resistance	P15056							
civic	Chemotherapy,Cetuximab	NRAS	Q61K		Colorectal Cancer	Resistance	P01111							
civic	Dactolisib,Selumetinib	NRAS	Q61K		Colorectal Cancer	Sensitivity/Response	P01111							
civic	Panitumumab	KRAS	G12D		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab,Irinotecan	PIK3CA	Q546K		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab,Irinotecan	BRAF	D594G		Colorectal Cancer	Resistance	P15056							
civic	Irinotecan,Cetuximab	NRAS	G13R		Colorectal Cancer	Resistance	P01111							
civic	Selumetinib,Dactolisib	KRAS	A146T		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Cetuximab	KRAS	G12D		Colorectal Cancer	Resistance	P01116							
civic	Selumetinib,Dactolisib	KRAS	A146V		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Cetuximab,Chemotherapy	NRAS	Mutation		Colorectal Cancer	Resistance	P01111							
civic	Selumetinib,Dactolisib	KRAS	G12C		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Cetuximab,Irinotecan	PIK3CA	E545Q		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab	PIK3CA	E545K		Colorectal Cancer	Resistance	P42336							
civic	Dactolisib,Selumetinib	KRAS	G12D		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Cetuximab	KRAS	G12V		Colorectal Cancer	Resistance	P01116							
civic	Doxorubicin	ATM	T2666A		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	Mutation		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	R3008C		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	c.902-1G>T		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Irinotecan,Cetuximab	KRAS	A146P		Colorectal Cancer	Resistance	P01116							
civic	Panitumumab	KRAS	G12V		Colorectal Cancer	Resistance	P01116							
civic	Panitumumab	KRAS	G12D		Colorectal Cancer	Resistance	P01116							
civic	Gefitinib	KRAS	G12D		Lung Cancer	Resistance	P01116							
civic	Erlotinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Resistance	P01116							
civic	Melphalan	KRAS	G12D		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12D		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12D		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12D		Multiple Myeloma	Resistance	P01116							
civic	Panitumumab	KRAS	G12C		Colorectal Cancer	Resistance	P01116							
civic	Gefitinib	KRAS	G12C		Lung Cancer	Resistance	P01116							
civic	Melphalan	KRAS	G12C		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12C		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12C		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12C		Multiple Myeloma	Resistance	P01116							
civic	Panitumumab	KRAS	G12R		Colorectal Cancer	Resistance	P01116							
civic	Gefitinib	KRAS	G12V		Lung Cancer	Resistance	P01116							
civic	Panitumumab	KRAS	G12S		Colorectal Cancer	Resistance	P01116							
civic	Gefitinib	KRAS	G12S		Lung Cancer	Resistance	P01116							
civic	Melphalan	KRAS	G12S		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12S		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12S		Multiple Myeloma	Resistance	P01116							
civic	Melphalan	KRAS	G12S		Multiple Myeloma	Resistance	P01116							
civic	Cisplatin,Carboplatin	TP53	R273L		Ovarian Cancer	Resistance	Q12888							
civic	Mitomycin,Cisplatin,Etoposide	TP53	R273C		Stomach Carcinoma	Sensitivity/Response	Q12888							
civic	Mitomycin,Cisplatin,Etoposide	TP53	Y220C		Stomach Carcinoma	Sensitivity/Response	Q12888							
civic	EAP Protocol	TP53	R175H		Stomach Carcinoma	Sensitivity/Response	Q12888							
civic	Temozolomide	IDH1	R132C		Brain Glioma	Sensitivity/Response	O75874							
civic	AGI-5198	IDH1	R132C		High Grade Glioma	Sensitivity/Response	O75874							
civic	Ivosidenib	IDH1	R132C		Acute Myeloid Leukemia	Sensitivity/Response	O75874							
civic	BPTES	IDH1	R132C		Acute Myeloid Leukemia	Sensitivity/Response	O75874							
civic	Trastuzumab Emtansine	PIK3CA	C420R		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Gefitinib,Erlotinib	PIK3CA	Mutation		Lung Non-small Cell Carcinoma	Resistance	P42336							
civic	Erlotinib,Gefitinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Resistance	P01116							
civic	Imatinib	KIT	T417_D419delinsY		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib	KIT	F506_F508DUP		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib	KIT	N822H		Cancer	Resistance	P10721							
civic	Imatinib	KIT	N822K		Cancer	Sensitivity/Response	P10721							
civic	Imatinib	KIT	D816V		Cancer	Resistance	P10721							
civic	Imatinib	PDGFRA	V561D		Cancer	Resistance	P16234							
civic	Imatinib	PDGFRA	D842_H845DELDIMH		Cancer	Resistance	P16234							
civic	Imatinib	PDGFRA	D842V		Cancer	Resistance	P16234							
civic	Imatinib	KIT	K484_G487DEL		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib	KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib	KIT	V560G		Cancer	Resistance	P10721							
civic	Imatinib	KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib	KIT	K642E		Cancer	Resistance	P10721							
civic	Imatinib	PDGFRA	V561D		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Imatinib	KIT	Exon 13 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib	KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	Reduced Sensitivity	P10721							
civic	Imatinib	PDGFRA	D842V		Gastrointestinal Stromal Tumor	Resistance	P16234							
civic	Imatinib	KIT	EXPRESSION		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib	KIT	W557_K558del		Cancer	Resistance	P10721							
civic	Imatinib	KIT	Y503_F504insAY		Cancer	Resistance	P10721							
civic	Imatinib	PDGFRA	Exon 18 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Imatinib	PDGFRA	Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P16234							
civic	Dabrafenib	BRAF	V600K		Melanoma	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	V600K		Melanoma	Sensitivity/Response	P15056							
civic	Gefitinib	EGFR	G719A		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	Wildtype		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	E746_A750del		Bronchiolo-alveolar Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	Exon 19 Deletion		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	E746_A750del		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Lapatinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Dacomitinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Neratinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Canertinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Imatinib	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL M244V		Cancer	Sensitivity/Response	P00519							
civic	Nilotinib,Dasatinib	ABL1	BCR::ABL M244V		Cancer	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate,Nilotinib,Dasatinib	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL Q252H		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Imatinib	ABL1	BCR::ABL Q252H		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib,Dasatinib	ABL1	BCR::ABL Q252H		Cancer	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL Y253F		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL Y253F		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bafetinib,Dasatinib,Nilotinib	ABL1	BCR::ABL Y253F		Cancer	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL E355G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL S417Y		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bafetinib,Dasatinib	ABCB1	Overexpression		Chronic Myeloid Leukemia	Resistance	P08183							
civic	Imatinib	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Cisplatin,Carboplatin	TP53	Y234C		Ovarian Cancer	Resistance	Q12888							
civic	Cisplatin,Carboplatin	TP53	ALTERATION		Ovarian Cancer	Resistance	Q12888							
civic	Tamoxifen	TP53	DNA Binding Domain Mutation		Breast Cancer	Resistance	Q12888							
civic	Tamoxifen	TP53	Mutation		Breast Cancer	Resistance	Q12888							
civic	Etoposide,Mitomycin,Cisplatin	TP53	Overexpression		Stomach Cancer	Sensitivity/Response	Q12888							
civic	EAP Protocol	TP53	R282L		Stomach Carcinoma	Sensitivity/Response	Q12888							
civic	EAP Protocol	TP53	R213P		Stomach Carcinoma	Sensitivity/Response	Q12888							
civic	Etoposide,Doxorubicin,Cisplatin	TP53	Mutation		Stomach Carcinoma	Sensitivity/Response	Q12888							
civic	Nilotinib	ABL1	BCR::ABL F486S		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Doxorubicin	ATM	c.7089+1del		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	c.7515+1_2del		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	K293*		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	F1025L		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	D1930V		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	E2187*		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	L2427P		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	F2732V		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	K468FS		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	D1682H		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	A2062V		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Doxorubicin	ATM	C2488Y		Chronic Lymphocytic Leukemia	Resistance	Q13315							
civic	Nilotinib	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib,Imatinib Mesylate	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib	ABL1	BCR::ABL E292V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib,Imatinib Mesylate	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate,Nilotinib	ABL1	BCR::ABL L384M		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib	ABL1	BCR::ABL V299L		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Nilotinib	ABL1	BCR::ABL L387F		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib	ABL1	BCR::ABL G398R		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Trastuzumab Emtansine	PIK3CA	K111N		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Trastuzumab Emtansine	PIK3CA	I391M		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Rucaparib	BRCA2	Mutation		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Rucaparib	BRCA1	Q1467*		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Rucaparib	BRCA2	M1R		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Rucaparib	BRCA2	M1I		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Rucaparib	BRCA2	V159M		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Rucaparib	BRCA2	V211L		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Rucaparib	BRCA2	V211I		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Rucaparib	BRCA2	R2336P		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Imatinib	KIT	D820Y		Melanoma	Resistance	P10721							
civic	Sunitinib	KIT	D820Y		Melanoma	Sensitivity/Response	P10721							
civic	Imatinib	KIT	K642E		Mucosal Melanoma	Sensitivity/Response	P10721							
civic	Fluorouracil,Cisplatin	GNAS	c.393T>C		Esophageal Cancer	Resistance	O95467							
civic	Temozolomide	MGMT	Underexpression		Glioblastoma	Sensitivity/Response	P16455							
civic	Temozolomide	MGMT	Underexpression		High Grade Glioma	Sensitivity/Response	P16455							
civic	Temozolomide	MGMT	Underexpression		Oligodendroglioma	Sensitivity/Response	P16455							
civic	Temozolomide	MGMT	Underexpression		Glioblastoma	Sensitivity/Response	P16455							
civic	Temozolomide	MGMT	Underexpression		Neuroendocrine Tumor	Sensitivity/Response	P16455							
civic	Gemcitabine,Cisplatin	RRM1	Underexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UET6							
civic	Erlotinib	EGFR	S768I		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Trametinib,Selumetinib	NRAS	Q61K		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01111							
civic	FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074,Infigratinib,FGFR Inhibitor AZD4547	FGFR1	Expression		Sarcoma	Sensitivity/Response	P11362							
civic	Imatinib	KIT	N822K		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Imatinib	KIT	Y823D		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Imatinib	KIT	C809G		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Imatinib	KIT	D820A		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Imatinib	KIT	D820G		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Imatinib	KIT	D816H		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Imatinib	KIT	T670I		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Pembrolizumab,Nivolumab,Atezolizumab	DNMT3A	Mutation		Cancer	Resistance	Q9Y6K1							
civic	Dabrafenib,Panitumumab	BRAF	Amplification		Colorectal Cancer	Resistance	P15056							
civic	Binimetinib,Ribociclib	NRAS	Mutation		Skin Melanoma	Sensitivity/Response	P01111							
civic	Olaparib	IDH1	Mutation		Brain Glioma	Sensitivity/Response	O75874							
civic	Crizotinib	ROS1	G2032R		Lung Adenocarcinoma	Resistance	P08922							
civic	Selumetinib	MAP2K1	K57N		Lung Adenocarcinoma	Sensitivity/Response	Q02750							
civic	Binimetinib	NRAS	Mutation		Skin Melanoma	Sensitivity/Response	P01111							
civic	Gefitinib	EGFR	Mutation		Lung Cancer	Sensitivity/Response	P00533							
civic	Letetresgene Autoleucel	CTAG1B	Overexpression		Multiple Myeloma	Sensitivity/Response	P78358							
civic	Letetresgene Autoleucel	CTAG2	Overexpression		Multiple Myeloma	Sensitivity/Response	O75638							
civic	Cetuximab	KRAS	A146T		Colorectal Cancer	Resistance	P01116							
civic	Entrectinib	NTRK1	Fusion		Cancer	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK3	Fusion		Cancer	Sensitivity/Response	Q16288							
civic	Entrectinib	NTRK1	SQSTM1::NTRK1		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04629							
civic	Entrectinib	ROS1	Rearrangement		Cancer	Sensitivity/Response	P08922							
civic	Entrectinib	ALK	Fusion		Cancer	Sensitivity/Response	Q9UM73							
civic	Larotrectinib	NTRK1	Fusion		Cancer	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK1	LMNA::NTRK1		Sarcoma	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK1	Amplification		Cancer	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK3	Amplification		Cancer	Sensitivity/Response	Q16288							
civic	Entrectinib	NTRK1	LMNA::NTRK1		Colorectal Adenocarcinoma	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK1	LMNA::NTRK1 G595R and G667C		Colorectal Adenocarcinoma	Resistance	P04629							
civic	Rebemadlin	TP53	Wildtype		Cancer	Sensitivity/Response	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	Wildtype		Cancer	Sensitivity/Response	Q12888							
civic	RG7112	TP53	Wildtype		Leukemia	Sensitivity/Response	Q12888							
civic	RG7112	TP53	Deleterious Mutation		Leukemia	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	Deleterious Mutation		Cancer	Resistance	Q12888							
civic	Rebemadlin	TP53	Deleterious Mutation		Cancer	Resistance	Q12888							
civic	Dasatinib	ARID1A	Loss		Ovarian Clear Cell Carcinoma	Sensitivity/Response	O14497							
civic	GSK126	ARID1A	Loss		Ovarian Clear Cell Carcinoma	Sensitivity/Response	O14497							
civic	Cisplatin,Pictilisib	PIK3CA	E545K		Cervix Carcinoma	Sensitivity/Response	P42336							
civic	Cisplatin	PIK3CA	E545K		Cervical Cancer	Resistance	P42336							
civic	Entrectinib	ALK	F1245V		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Anti-CTLA-4 Monoclonal Antibody,Anti-PD-L1 Monoclonal Antibody	CTNNB1	Activating Mutation		Melanoma	Resistance	P35222							
civic	UNC1062	MERTK	OVEREXPRESSION		Melanoma	Sensitivity/Response	Q12866							
civic	Erlotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Docetaxel,Selumetinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Resistance	P01116							
civic	Radiation Therapy	CD274	Expression		Head And Neck Squamous Cell Carcinoma	Resistance	Q9NZQ7							
civic	Cisplatin,Olaparib,Prexasertib	MYC	Overexpression		Lung Small Cell Carcinoma	Sensitivity/Response	P01106							
civic	Lapatinib	ERBB2	L755S		Cancer	Resistance	P04626							
civic	Lapatinib	ERBB2	L755P		Cancer	Resistance	P04626							
civic	Lapatinib	ERBB2	T798M		Cancer	Resistance	P04626							
civic	Tandutinib	FLT3	D835V		Acute Myeloid Leukemia	Resistance	P36888							
civic	Sunitinib	FLT3	D835V		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Sunitinib,Cytarabine	FLT3	D835V		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Daunorubicin,Sunitinib	FLT3	D835V		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Quizartinib	FLT3	D835V		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Carboplatin,Cisplatin	TP53	Overexpression		Ovarian Cancer	Resistance	Q12888							
civic	Osimertinib,Rociletinib	EGFR	Amplification		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Gefitinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Dabrafenib,Trametinib	BRAF	V600E		Lung Non-small Cell Carcinoma	Sensitivity/Response	P15056							
civic	Dovitinib	FGFR1	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P11362							
civic	Imatinib	KIT	V559D		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib,Dasatinib,Tandutinib,PD-180970,Imatinib	KIT	V559D		Cancer	Sensitivity/Response	P10721							
civic	Tyrphostin AG 1296,AS602868	FLT3	D835V		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Trametinib,Selumetinib	MET	Overexpression		Uveal Melanoma	Resistance	P08581							
civic	Capivasertib	AKT1	E17K		Cancer	Sensitivity/Response	P31749							
civic	Capivasertib	PIK3CA	Mutation		Cancer	Sensitivity/Response	P42336							
civic	MDM2 Inhibitor AMGMDS3	TP53	R248Q		Cancer	Resistance	Q12888							
civic	Radioactive Iodine	GNAS	R201H		Thyroid Gland Follicular Carcinoma	Sensitivity/Response	O95467							
civic	Cabozantinib	GNA11	Mutation		Uveal Melanoma	Sensitivity/Response	P29992							
civic	Irinotecan,Cetuximab	NRAS	Q61H		Colorectal Cancer	Resistance	P01111							
civic	Cetuximab	NRAS	G12D		Colorectal Cancer	Resistance	P01111							
civic	Cetuximab,Chemotherapy	KRAS	Mutation		Colorectal Cancer	Resistance	P01116							
civic	Regorafenib	KRAS	G12A		Colorectal Cancer	Resistance	P01116							
civic	Erlotinib,Teprotumumab	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Vemurafenib	PIK3CA	E545K		Melanoma	Resistance	P42336							
civic	Vemurafenib	PIK3CA	E545G		Melanoma	Resistance	P42336							
civic	Chemotherapy,Cetuximab	PIK3CA	Mutation		Colorectal Cancer	Resistance	P42336							
civic	Vemurafenib	PIK3CA	H1047R		Colorectal Cancer	Resistance	P42336							
civic	FOLFOX-4 Regimen,Cetuximab	BRAF	V600E		Colorectal Cancer	Resistance	P15056							
civic	Vemurafenib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Trametinib,Dabrafenib	BRAF	V600E		Skin Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Childhood Pilocytic Astrocytoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Ovarian Serous Carcinoma	Sensitivity/Response	P15056							
civic	Erlotinib	EGFR	Ex19 del L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	L861Q		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Multikinase Inhibitor AEE788,Erlotinib,Gefitinib	EGFR	T790M		Cancer	Resistance	P00533							
civic	Multikinase Inhibitor AEE788,Erlotinib,Gefitinib	EGFR	L858R		Cancer	Sensitivity/Response	P00533							
civic	Bosutinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Reduced Sensitivity	P00519							
civic	Dasatinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Panitumumab	KRAS	G12V		Colorectal Cancer	Resistance	P01116							
civic	Panitumumab	BRAF	V600E		Colorectal Cancer	Resistance	P15056							
civic	Irinotecan,Cetuximab	PIK3CA	R88Q		Colorectal Cancer	Resistance	P42336							
civic	Irinotecan,Cetuximab	PIK3CA	H1047R		Colorectal Cancer	Resistance	P42336							
civic	Panitumumab	NRAS	G13R		Colorectal Cancer	Resistance	P01111							
civic	Chemotherapy,Cetuximab	NRAS	G12C		Colorectal Cancer	Resistance	P01111							
civic	Cetuximab	PIK3CA	G1049R		Colorectal Cancer	Resistance	P42336							
civic	Vemurafenib	HRAS	G13D		Skin Squamous Cell Carcinoma	Resistance	Q9HDD0							
civic	Cetuximab	HRAS	G13D		Colorectal Cancer	Resistance	Q9HDD0							
civic	Cetuximab,FOLFOX-4 Regimen	KRAS	A146T		Colorectal Cancer	Resistance	P01116							
civic	Chemotherapy,Cetuximab	KRAS	Q61H		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	Q61H		Colorectal Cancer	Resistance	P01116							
civic	Erlotinib	EGFR	Mutation		Lung Cancer	Sensitivity/Response	P00533							
civic	Cetuximab,Chemotherapy	KRAS	Q61L		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab,Irinotecan	KRAS	Q61R		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab,Chemotherapy	KRAS	Q61K		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Regorafenib	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Erlotinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Resistance	P01116							
civic	Chemotherapy,Cetuximab	KRAS	Q61		Colorectal Cancer	Resistance	P01116							
civic	Regorafenib	KRAS	G12V		Colorectal Cancer	Resistance	P01116							
civic	Chemotherapy,Cetuximab	KRAS	A146		Colorectal Cancer	Resistance	P01116							
civic	Regorafenib	KRAS	G12D		Colorectal Cancer	Resistance	P01116							
civic	Vemurafenib	KRAS	G12D		Melanoma	Resistance	P01116							
civic	Cetuximab	KRAS	G12D		Ovarian Cancer	Resistance	P01116							
civic	Cetuximab,Chemotherapy	KRAS	G12C		Colorectal Cancer	Resistance	P01116							
civic	Regorafenib	KRAS	G12C		Colorectal Cancer	Resistance	P01116							
civic	Chemotherapy,Cetuximab	KRAS	G12R		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G12R		Colorectal Cancer	Resistance	P01116							
civic	Regorafenib	KRAS	G12R		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G12S		Colorectal Cancer	Resistance	P01116							
civic	Regorafenib	KRAS	G12S		Colorectal Cancer	Resistance	P01116							
civic	Sunitinib	FLT3	D835V		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Vemurafenib	AKT1	E17K		Melanoma	Resistance	P31749							
civic	Cetuximab	PIK3CA	N345K		Colorectal Cancer	Resistance	P42336							
civic	Sunitinib	PDGFRA	V561D		Cancer	Resistance	P16234							
civic	Sunitinib	PDGFRA	D842V		Cancer	Resistance	P16234							
civic	Regorafenib	KIT	V560_L576DEL		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib	KIT	K550_K558del		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Sunitinib	KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Sunitinib	KIT	V560D		Cancer	Resistance	P10721							
civic	Sunitinib	KIT	W557_K558del		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Ponatinib,Imatinib	KIT	W557_K558del		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib,Regorafenib	KIT	W557_K558del		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib	KIT	K558_V559del		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Sunitinib	KIT	A502_Y503insAY		Cancer	Resistance	P10721							
civic	Regorafenib	KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	Reduced Sensitivity	P10721							
civic	Regorafenib	BRAF	Exon 15 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P15056							
civic	Sunitinib	KIT	V560D		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Ponatinib	KIT	P551_E554delPMYE		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib,Sunitinib,Regorafenib,Ponatinib	KIT	V560D		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib	KIT	L576P		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Regorafenib	KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	Reduced Sensitivity	P10721							
civic	Imatinib,Dasatinib	KIT	L576P		Cancer	Sensitivity/Response	P10721							
civic	Sunitinib	KIT	D579del		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Regorafenib	KIT	WILDTYPE		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Dasatinib	KIT	K642E		Melanoma	Sensitivity/Response	P10721							
civic	Ponatinib	KIT	N822K		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Regorafenib	KIT	N822K		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Vemurafenib	BRAF	V600K		Melanoma	Sensitivity/Response	P15056							
civic	Dabrafenib,Trametinib	BRAF	V600K		Skin Melanoma	Sensitivity/Response	P15056							
civic	Erlotinib	EGFR	R108K		High Grade Glioma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	T263P		High Grade Glioma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	A289V		High Grade Glioma	Sensitivity/Response	P00533							
civic	Gefitinib,Erlotinib	EGFR	G719		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	G719S		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	V742A		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	E746_A750del		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	E746_T751>I		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib,Erlotinib	EGFR	G719D		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib,Erlotinib	EGFR	L747P		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	V774A		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	V774M		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	K806E		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	N826Y		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	V834I		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	L838P		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	N842S		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	T847I		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	V851I		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L747_P753delinsS		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	S768I		Lung Adenocarcinoma	Resistance	P00533							
civic	Erlotinib,Gefitinib	EGFR	S768I		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	D770_N771insSVD		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	H773_V774insH		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	R831H		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib,Gefitinib	EGFR	L838V		Cancer	Resistance	P00533							
civic	Erlotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Crizotinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Cetuximab	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		Lung Small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L858R		High Grade Glioma	Sensitivity/Response	P00533							
civic	Erlotinib,Gefitinib	EGFR	L861		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	L861Q		High Grade Glioma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	E868G		Cancer	Sensitivity/Response	P00533							
civic	Dasatinib	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL Q252H		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL Q252H		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL Y253F		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL Y253F		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL E355G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL E355G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL E355G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL E355G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL L387M		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL L387M		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Cetuximab	PIK3CA	E542K		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab	KRAS	G12A		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab,Irinotecan	PIK3CA	H1047L		Colorectal Cancer	Resistance	P42336							
civic	Dasatinib	ABL1	BCR::ABL L364I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL		Acute Lymphoblastic Leukemia	Sensitivity/Response	P00519							
civic	Axitinib	ABL1	BCR::ABL F486S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL F486S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Reduced Sensitivity	P00519							
civic	Dasatinib	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib,Sunitinib,Regorafenib	KIT	P551_E554delPMYE		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Imatinib,Ponatinib,Regorafenib	KIT	V559D		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Cetuximab,Irinotecan	PIK3CA	S158L		Colorectal Cancer	Resistance	P42336							
civic	Fluorouracil,Cetuximab,Oxaliplatin	PIK3CA	E81K		Colorectal Cancer	Resistance	P42336							
civic	Fluorouracil,Oxaliplatin,Cetuximab	PIK3CA	R93W		Colorectal Cancer	Resistance	P42336							
civic	Erlotinib	EGFR	R776C		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Cetuximab,Irinotecan	BRAF	D594G		Colorectal Cancer	Resistance	P15056							
civic	Bosutinib	ABL1	L298V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL E453Q		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ARID1A	Q456*		Ovarian Clear Cell Carcinoma	Sensitivity/Response	O14497							
civic	Vemurafenib	BRAF	V600D		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600D		Melanoma	Sensitivity/Response	P15056							
civic	Erlotinib	EGFR	H773_V774insNPH		Lung Adenocarcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	D770_N771insGL		Lung Adenocarcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	A864T		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	N826S		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	A763_Y764insFQEA		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Vemurafenib	AKT1	Q79K		Melanoma	Resistance	P31749							
civic	Erlotinib	EGFR	VIII		High Grade Glioma	Sensitivity/Response	P00533							
civic	Regorafenib	KIT	T670I		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Vemurafenib	AKT3	E17K		Melanoma	Resistance	Q9Y243							
civic	Axitinib	ABL1	BCR::ABL L384M		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL L384M		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL F359I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL F359I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL F359I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F359I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F359I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL M343T		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL V299L		Chronic Myeloid Leukemia	Reduced Sensitivity	P00519							
civic	Dasatinib	ABL1	BCR::ABL V299L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL E279K		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL Q300R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL F311L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL N331S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL L364P		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL L387F		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL H396P		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL D421G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL G398R		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Bosutinib	ABL1	BCR::ABL E450V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL E453K		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL E453A		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL P480A		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F486S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Sunitinib,Imatinib,Ponatinib,Regorafenib	KIT	K550_W557del		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Regorafenib	KIT	D820Y		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Ponatinib,Sunitinib,Imatinib,Regorafenib	KIT	K558delinsNP		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Regorafenib	KIT	N822K		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib	PDGFRA	D842V		Gastrointestinal Stromal Tumor	Resistance	P16234							
civic	Regorafenib	KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Regorafenib	BRAF	Exon 15 Mutation		Gastrointestinal Stromal Tumor	Resistance	P15056							
civic	Olaparib	BRCA1	W1815X		Endometrioid Ovary Carcinoma	Sensitivity/Response	P38398							
civic	Regorafenib	KIT	Exon 9 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Regorafenib	KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Regorafenib,Imatinib,Ponatinib	KIT	A502_Y503insAY		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib,Imatinib	KIT	D816E		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Erlotinib	EGFR	D770_N771insGT		Lung Adenocarcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	Exon 20 Insertion		Lung Adenocarcinoma	Resistance	P00533							
civic	Vismodegib	SMO	L412F		Basal Cell Carcinoma	Resistance	Q99835							
civic	Vismodegib	SMO	L412F		Basal Cell Carcinoma	Resistance	Q99835							
civic	Erlotinib	EGFR	W731L		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	E734Q		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	T785A		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	C797Y		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	Y801H		Cancer	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	A767_V769dupASV		Lung Adenocarcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	L747_S752delinsQ		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	L861R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Dasatinib	ABL1	BCR::ABL D363G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL V379I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL V379I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Dasatinib	ABL1	BCR::ABL A397P		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL E98G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Vemurafenib	BRAF	G596R		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Erlotinib,Gefitinib	EGFR	Rare Exon 18-21 Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib,Erlotinib	EGFR	Ex19 del L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib,Erlotinib	EGFR	Rare Exon 18-21 Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib	EGFR	Exon 19 Deletion		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Bosutinib	ABL1	C475V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	BCR::ABL N336S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Pembrolizumab	POLD1	C284Y		Lung Adenocarcinoma	Sensitivity/Response	P28340							
civic	Pembrolizumab	POLD1	E374K		Lung Non-small Cell Carcinoma	Sensitivity/Response	P28340							
civic	Vemurafenib	PIK3R2	N561D		Melanoma	Resistance	P30530							
civic	Vemurafenib	PIK3CA	D350G		Melanoma	Resistance	P42336							
civic	Cetuximab	NRAS	Q179X		Colorectal Cancer	Resistance	P01111							
civic	Crizotinib	MET	Exon 14 Skipping Mutation		Lung Adenocarcinoma	Sensitivity/Response	P08581							
civic	Dasatinib	ABL1	R351W		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00519							
civic	Dasatinib,Imatinib Mesylate	ABL1	G340L		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00519							
civic	Dasatinib,Imatinib	KIT	S628N		Cancer	Sensitivity/Response	P10721							
civic	Erlotinib	EGFR	M766_A767insAI		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	Y764_V765insHH		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	D770delinsGY		Lung Adenocarcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	P772_H773insYNP		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Erlotinib	EGFR	P772_V774insPHV		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Palbociclib,Letrozole	ESR1	D538G		Breast Cancer	Sensitivity/Response	P03372							
civic	Pembrolizumab	JAK2	Splice Site (c.1641+2T>G)		Melanoma	Resistance	O60674							
civic	Dasatinib	ARID1A	P1175FS*5		Ovarian Clear Cell Carcinoma	Sensitivity/Response	O14497							
civic	Anti-VEGF Monoclonal Antibody	VHL	Mutation		Renal Cell Carcinoma	Sensitivity/Response	P40337							
civic	Enasidenib	IDH2	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	P48735							
civic	Brigatinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Talazoparib	BRCA1	Loss-of-function		Breast Cancer	Sensitivity/Response	P38398							
civic	Talazoparib	BRCA2	Loss-of-function		Breast Cancer	Sensitivity/Response	P51587							
civic	Trastuzumab Emtansine	ERBB2	Overexpression		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P04626							
civic	Palbociclib	CDK4	Amplification		Liposarcoma	Sensitivity/Response	P11802							
civic	Abemaciclib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Cabozantinib	RET	Fusion		Lung Adenocarcinoma	Sensitivity/Response	P07949							
civic	Vandetanib	RET	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P07949							
civic	Vandetanib	RET	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P07949							
civic	Alectinib	RET	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P07949							
civic	Pembrolizumab,Durvalumab,Nivolumab,Avelumab,Atezolizumab	CD274	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9NZQ7							
civic	Crizotinib,Alectinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Dacomitinib,Erlotinib	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Dacomitinib	EGFR	L858R		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erdafitinib	FGFR3	Fusion		Adrenal Carcinoma	Sensitivity/Response	P22607							
civic	Pemetrexed,Docetaxel,Trametinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Atezolizumab,Nivolumab	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Immune Checkpoint Inhibitor	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Selumetinib,Cetuximab	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Trametinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Selumetinib,Erlotinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Palbociclib,Binimetinib	KRAS	Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Palbociclib	CDK4	EXPRESSION		Sarcoma	Sensitivity/Response	P11802							
civic	Prexasertib,Cisplatin,Olaparib	CHEK1	Overexpression		Lung Small Cell Carcinoma	Sensitivity/Response	O14757							
civic	Talazoparib	BRCA2	Loss-of-function		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Talazoparib	BRCA1	Loss-of-function		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Gefitinib	EGFR	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	MDM2 Inhibitor AMGMDS3	TP53	R248W		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	R175H		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	R273C		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	R273H		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	G245S		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	Y220C		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	M237I		Glioblastoma	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	R158H		Vulva Squamous Cell Carcinoma	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	V157F		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	R249S		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	R280K		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	R280T		Cancer	Resistance	Q12888							
civic	MDM2 Inhibitor AMGMDS3	TP53	R158L		Cancer	Resistance	Q12888							
civic	Trametinib	BRAF	L597Q		Skin Melanoma	Sensitivity/Response	P15056							
civic	Gefitinib	EGFR	Gain-of-function		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Trastuzumab,Fluorouracil,Leucovorin	ERBB2	L755S		Colorectal Adenocarcinoma	Sensitivity/Response	P04626							
civic	Docetaxel,Erlotinib	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Docetaxel	KRAS	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Cabozantinib	GNAQ	Mutation		Uveal Melanoma	Sensitivity/Response	P50148							
civic	Enasidenib	IDH2	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	P48735							
civic	Olaparib,Paclitaxel	ATM	Underexpression		Stomach Cancer	Sensitivity/Response	Q13315							
civic	Midostaurin	FLT3	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Everolimus	VHL	Mutation		Renal Cell Carcinoma	Sensitivity/Response	P40337							
civic	Neratinib	ERBB2	Mutation		Breast Cancer	Sensitivity/Response	P04626							
civic	Sunitinib,Everolimus	BAP1	Mutation		Renal Cell Carcinoma	Resistance	Q92560							
civic	Cetuximab,Panitumumab	NRAS	Mutation		Colorectal Cancer	Resistance	P01111							
civic	Panitumumab,Cetuximab	KRAS	Mutation		Colorectal Cancer	Resistance	P01116							
civic	Imatinib Mesylate	PDGFRA	D842V		Cancer	Resistance	P16234							
civic	Imatinib Mesylate	PDGFRA	V561D		Cancer	Resistance	P16234							
civic	Imatinib Mesylate	KIT	V560D		Cancer	Sensitivity/Response	P10721							
civic	JQ-1	MYC	Overexpression		Multiple Myeloma	Sensitivity/Response	P01106							
civic	Gemcitabine	RRM1	Underexpression		Pancreatic Cancer	Sensitivity/Response	Q9UET6							
civic	Gemcitabine	RRM1	Underexpression		Pancreatic Cancer	Sensitivity/Response	Q9UET6							
civic	Gemcitabine	RRM1	Underexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UET6							
civic	Vinorelbine,Gemcitabine,Paclitaxel	RRM1	Underexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UET6							
civic	Pembrolizumab	CD274	Expression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9NZQ7							
civic	Olaparib	BRCA1	Loss-of-function		Her2-receptor Negative Breast Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Loss-of-function		Her2-receptor Negative Breast Cancer	Sensitivity/Response	P51587							
civic	Checkpoint Kinase Inhibitor AZD7762,Irinotecan	RAD50	L1237F		Ureter Small Cell Carcinoma	Sensitivity/Response	Q92878							
civic	Olaparib	BRCA1	Mutation		Her2-receptor Negative Breast Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Mutation		Breast Cancer	Sensitivity/Response	P51587							
civic	Rilotumumab	MET	Overexpression		Stomach Carcinoma	Sensitivity/Response	P08581							
civic	Everolimus	PTEN	Loss		Cancer	Sensitivity/Response	P60484							
civic	Afatinib	NRG1	ATP1B1::NRG1		Cholangiocarcinoma	Sensitivity/Response	Q02297							
civic	Afatinib	NRG1	SDC4::NRG1		Lung Adenocarcinoma	Sensitivity/Response	Q02297							
civic	Trametinib,Dabrafenib	BRAF	V600E		Cholangiocarcinoma	Sensitivity/Response	P15056							
civic	Dabrafenib,Trametinib	BRAF	V600E		Intrahepatic Cholangiocarcinoma	Sensitivity/Response	P15056							
civic	Trametinib,Dabrafenib	BRAF	V600E		Intrahepatic Cholangiocarcinoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600		Cholangiocarcinoma	Sensitivity/Response	P15056							
civic	Irinotecan,Panitumumab,Vemurafenib	BRAF	V600E		Cholangiocarcinoma	Sensitivity/Response	P15056							
civic	Infigratinib	FGFR2	Fusion		Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	Erlotinib	EGFR	EGFR::RAD51		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Infigratinib	FGFR2	Mutation		Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	Olaparib	BRCA2	Mutation		Pancreatic Cancer	Sensitivity/Response	P51587							
civic	Olaparib	BRCA1	Mutation		Pancreatic Cancer	Sensitivity/Response	P38398							
civic	Oxaliplatin,Cisplatin	BRCA1	Mutation		Pancreatic Cancer	Sensitivity/Response	P38398							
civic	Platinum Compound	BRCA2	Mutation		Pancreatic Cancer	Sensitivity/Response	P51587							
civic	Erlotinib	EGFR	L858R		Cancer	Sensitivity/Response	P00533							
civic	Cytoreductive Surgery,Hyperthermic Intraperitoneal Chemotherapy	EGFR	Mutation		Peritoneal Mesothelioma	Sensitivity/Response	P00533							
civic	Gefitinib,Erlotinib	EGFR	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib,Gefitinib	EGFR	Amplification		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Olaparib,Apitolisib	BAP1	ALTERNATIVE TRANSCRIPT (ATI)		Malignant Mesothelioma	Sensitivity/Response	Q92560							
civic	Veliparib,Cisplatin,Gemcitabine	BRCA1	Mutation		Pancreatic Cancer	Sensitivity/Response	P38398							
civic	Cisplatin,Veliparib,Gemcitabine	BRCA2	Mutation		Pancreatic Cancer	Sensitivity/Response	P51587							
civic	Veliparib	BRCA1	Mutation		Pancreatic Cancer	Sensitivity/Response	P38398							
civic	Veliparib	BRCA2	Mutation		Pancreatic Cancer	Sensitivity/Response	P51587							
civic	Iniparib	BRCA2	Mutation		Pancreatic Cancer	Sensitivity/Response	P51587							
civic	Erlotinib	EGFR	M766_A767insASV		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Afatinib,Gefitinib	EGFR	D770_N771insNPG		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Ceritinib	ALK	STRN::ALK		Colon Adenocarcinoma	Sensitivity/Response	Q9UM73							
civic	Olaparib	BARD1	Loss-of-function		Colorectal Cancer	Sensitivity/Response	Q99728							
civic	Crizotinib	ALK	Fusion		Thyroid Gland Anaplastic Carcinoma	Sensitivity/Response	Q9UM73							
civic	Trastuzumab,Capecitabine	ERBB2	Overexpression		Pancreatic Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Gemcitabine	ERBB2	Overexpression		Pancreatic Cancer	Sensitivity/Response	P04626							
civic	Carboplatin,Buparlisib,Paclitaxel	PTEN	Loss		Solid Tumor	Sensitivity/Response	P60484							
civic	Vemurafenib	BRAF	V600E		Lung Non-small Cell Carcinoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Ovarian Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib,Pertuzumab	BRAF	V600E		Thyroid Gland Anaplastic Carcinoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Laryngeal Squamous Cell Carcinoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	G464V		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	G469A		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	G496A		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	N581S		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	G466V		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	G596R		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	G606E		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	L597Q		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	P731T		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	intron 9 rearrangement		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	intron 10 rearrangement		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	MACF1::BRAF		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	WASFL::BRAF		Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	CUX1::BRAF		Pancreatic Cancer	Sensitivity/Response	P15056							
civic	Vismodegib	PTCH1	Mutation		Cancer	Sensitivity/Response	Q13635							
civic	Vismodegib	SMO	Mutation		Cancer	Sensitivity/Response	Q99835							
civic	Trastuzumab,Pertuzumab	ERBB2	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Pertuzumab,Trastuzumab	ERBB2	Amplification		Colorectal Cancer	Sensitivity/Response	P04626							
civic	Pertuzumab,Trastuzumab	ERBB2	Amplification		Bladder Carcinoma	Sensitivity/Response	P04626							
civic	Trastuzumab,Pertuzumab	ERBB2	Amplification		Biliary Tract Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Pertuzumab	ERBB2	Amplification		Salivary Gland Carcinoma	Sensitivity/Response	P04626							
civic	Trastuzumab,Pertuzumab	ERBB2	Amplification		Pancreatic Cancer	Sensitivity/Response	P04626							
civic	Pertuzumab,Trastuzumab	ERBB2	Amplification		Uterine Cancer	Sensitivity/Response	P04626							
civic	Ivosidenib	IDH1	R132H		Pancreatic Ductal Adenocarcinoma	Sensitivity/Response	O75874							
civic	Pegargiminase,Chloroquine	ASS1	Loss		Sarcoma	Sensitivity/Response	P00966							
civic	Taxol,Cisplatin,Carboplatin	ASS1	Loss		Ovarian Cancer	Resistance	P00966							
civic	Trametinib	RASA1	Loss-of-function		Lung Non-small Cell Carcinoma	Sensitivity/Response	P20936							
civic	GF109203X,Go6983	TLK2	Amplification		Breast Cancer	Sensitivity/Response	Q86UE8							
civic	Sorafenib	BRAF	D594G		Skin Melanoma	Sensitivity/Response	P15056							
civic	U0126	BRAF	D594G		Skin Melanoma	Resistance	P15056							
civic	Sorafenib	BRAF	G469E		Skin Melanoma	Sensitivity/Response	P15056							
civic	U0126	BRAF	G469E		Skin Melanoma	Resistance	P15056							
civic	Erlotinib	EGFR	L747_P753delinsS		Pancreatic Adenocarcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	T790M		Pancreatic Adenocarcinoma	Sensitivity/Response	P00533							
civic	JQ1,Panobinostat	MYCN	Amplification		Neuroblastoma	Sensitivity/Response	P04198							
civic	Crizotinib	ALK	Fusion		Vagina Sarcoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Epithelioid Inflammatory Myofibroblastic Sarcoma	Sensitivity/Response	Q9UM73							
civic	Vemurafenib,Cobimetinib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Thyroid Gland Anaplastic Carcinoma	Sensitivity/Response	P15056							
civic	Cetuximab,Encorafenib	BRAF	V600		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Encorafenib,Cetuximab,Alpelisib	BRAF	V600		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Meloxicam	CTNNB1	S45F		Desmoid Tumor	Sensitivity/Response	P35222							
civic	Afatinib	NRG1	Fusion		Mucinous Adenocarcinoma	Sensitivity/Response	Q02297							
civic	Larotrectinib	NTRK2	STRN::NTRK2		Sarcoma	Sensitivity/Response	Q16620							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		Congenital Fibrosarcoma	Sensitivity/Response	Q16288							
civic	Larotrectinib	NTRK1	LMNA::NTRK1		Sarcoma	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK1	TPM3::NTRK1		Sarcoma	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK1	PDE4DIP::NTRK1		Sarcoma	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK1	SQSTM1::NTRK1		Congenital Fibrosarcoma	Sensitivity/Response	P04629							
civic	Panitumumab,Trametinib,Dabrafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Trametinib,Panitumumab	BRAF	V600E		Colorectal Adenocarcinoma	Sensitivity/Response	P15056							
civic	Trastuzumab,Paclitaxel	ERBB2	Overexpression		Salivary Gland Cancer	Sensitivity/Response	P04626							
civic	Trastuzumab,Capecitabine,Zoledronic Acid	ERBB2	Overexpression		Salivary Gland Cancer	Sensitivity/Response	P04626							
civic	Osimertinib	ERBB2	T798I		Breast Cancer	Sensitivity/Response	P04626							
civic	Dabrafenib,Trametinib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Dabrafenib,Trametinib	BRAF	V600K		Melanoma	Sensitivity/Response	P15056							
civic	Trametinib,Dabrafenib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Gefitinib,Erlotinib	EGFR	G719A		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Erlotinib,Gefitinib	EGFR	R705K		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	L858R		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	Exon 19 Deletion		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Gefitinib	EGFR	Rare Mutation		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Tamoxifen	PIK3CA	Mutation		Estrogen-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Dasatinib	ABL1	BCR::ABL T315A		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Fluorouracil,Cyclophosphamide,Epirubicin,Doxorubicin,Paclitaxel	PIK3CA	Mutation		Breast Cancer	Resistance	P42336							
civic	Lapatinib,Trastuzumab	PIK3CA	H1047R		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Dactolisib	PIK3CA	H1047R		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Imatinib Mesylate,Dasatinib	ABL1	BCR::ABL L248R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Lapatinib,Trastuzumab	PIK3CA	E545K		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Dactolisib	PIK3CA	E545K		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Dasatinib	ABL1	BCR::ABL V299L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F317I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F317S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL Q252H		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate,Nilotinib	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate,Nilotinib	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate,Nilotinib	ABL1	BCR::ABL F311L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate,Nilotinib	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib,Imatinib Mesylate	ABL1	BCR::ABL H396P		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib,Imatinib Mesylate	ABL1	BCR::ABL V299L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL L248R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL Q252H		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL V299L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F317C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL F317I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL E355G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL V379I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Vemurafenib	AKT1	Overexpression		Melanoma	Resistance	P31749							
civic	Dabrafenib	AKT1	Q79K		Melanoma	Resistance	P31749							
civic	Vemurafenib	AKT3	Overexpression		Melanoma	Resistance	Q9Y243							
civic	Dabrafenib,Vemurafenib	NRAS	Mutation		Melanoma	Resistance	P01111							
civic	Vemurafenib,Dabrafenib	KRAS	Mutation		Melanoma	Resistance	P01116							
civic	Vemurafenib	PIK3R2	Overexpression		Melanoma	Resistance	P30530							
civic	Vemurafenib	PREX2	R172I		Melanoma	Resistance	Q70Z35							
civic	Vemurafenib	PTEN	Loss		Melanoma	Resistance	P60484							
civic	Afatinib	NRG1	Fusion		Pancreatic Adenocarcinoma	Sensitivity/Response	Q02297							
civic	Dasatinib	ABL1	BCR::ABL Q252H		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Vemurafenib	PIK3CA	Amplification		Melanoma	Resistance	P42336							
civic	Oxaliplatin	KRAS	G12/G13		Colorectal Cancer	Resistance	P01116							
civic	Irinotecan	KRAS	G12/G13		Colorectal Cancer	Resistance	P01116							
civic	Bevacizumab	KRAS	G12/G13		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab	KRAS	G12/G13		Colorectal Cancer	Resistance	P01116							
civic	Oxaliplatin	PIK3CA	Mutation		Colorectal Cancer	Resistance	P42336							
civic	Irinotecan	PIK3CA	Mutation		Colorectal Cancer	Resistance	P42336							
civic	Bevacizumab	PIK3CA	Mutation		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab	PIK3CA	Mutation		Colorectal Cancer	Resistance	P42336							
civic	Oxaliplatin	BRAF	Mutation		Colorectal Cancer	Resistance	P15056							
civic	Irinotecan	BRAF	Mutation		Colorectal Cancer	Resistance	P15056							
civic	Bevacizumab	BRAF	Mutation		Colorectal Cancer	Resistance	P15056							
civic	Cetuximab	BRAF	Mutation		Colorectal Cancer	Resistance	P15056							
civic	Dasatinib	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL E459K		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	TKD MUTATION		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Cetuximab,Panitumumab	KRAS	G13V		Colorectal Cancer	Resistance	P01116							
civic	Panitumumab,Cetuximab	KRAS	G12S		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab,Panitumumab	PTEN	Loss		Colorectal Cancer	Resistance	P60484							
civic	Cetuximab,Panitumumab	KRAS	G12D		Colorectal Cancer	Resistance	P01116							
civic	Vemurafenib	KRAS	Amplification		Melanoma	Resistance	P01116							
civic	Cetuximab,Panitumumab	KRAS	G12A		Colorectal Cancer	Resistance	P01116							
civic	Panitumumab,Cetuximab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Panitumumab,Cetuximab	KRAS	G13D		Colorectal Cancer	Resistance	P01116							
civic	Cetuximab,Panitumumab	KRAS	G12V		Colorectal Cancer	Resistance	P01116							
civic	Bosutinib	ABL1	TKD MUTATION		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	P-Loop Mutation		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	Non-P-Loop Mutation		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Rucaparib	BRCA1	Mutation		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Nilotinib	ABL1	TKD MUTATION		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Rucaparib	BRCA2	Mutation		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Cetuximab,Panitumumab	PIK3CA	Mutation		Colorectal Cancer	Resistance	P42336							
civic	Panitumumab,Cetuximab	KRAS	G12/G13		Colorectal Cancer	Resistance	P01116							
civic	Aspirin	PIK3CA	Mutation		Colorectal Cancer	Sensitivity/Response	P42336							
civic	Imatinib	ABL1	R351W		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00519							
civic	Regorafenib	KIT	Exon 11 Mutation		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Ruxolitinib	CSF3R	T618I		Chronic Neutrophilic Leukemia	Sensitivity/Response	Q99062							
civic	Ruxolitinib	CSF3R	T618I		Chronic Neutrophilic Leukemia	Sensitivity/Response	Q99062							
civic	Larotrectinib	NTRK1	TRIM63::NTRK1		Melanoma	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK1	DDR2::NTRK1		Melanoma	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK1	GON4L::NTRK1		Melanoma	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK2	ETV6::NTRK2		Acute Myeloid Leukemia	Sensitivity/Response	Q16620							
civic	Dabrafenib,Vemurafenib	BRAF	intron 10 rearrangement		Melanoma	Resistance	P15056							
civic	Vemurafenib,Dabrafenib	BRAF	intron 9 rearrangement		Melanoma	Resistance	P15056							
civic	Irinotecan	BRAF	D594K		Colorectal Cancer	Resistance	P15056							
civic	Oxaliplatin	BRAF	D594K		Colorectal Cancer	Resistance	P15056							
civic	PD173074,AZ12908010,FGFR Inhibitor AZD4547	FGFR3	V555M		Myeloid Neoplasm	Resistance	P22607							
civic	Infigratinib	FGFR3	FGFR3::TACC3		Transitional Cell Carcinoma	Sensitivity/Response	P22607							
civic	Dasatinib	IDH1	R132		Intrahepatic Cholangiocarcinoma	Sensitivity/Response	O75874							
civic	Atezolizumab,Pembrolizumab,Nivolumab	STK11	Mutation		Lung Adenocarcinoma	Resistance	Q15831							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		Congenital Fibrosarcoma	Sensitivity/Response	Q16288							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		Breast Secretory Carcinoma	Sensitivity/Response	Q16288							
civic	Aromatase Inhibitor	KMT2C	Loss		Breast Cancer	Resistance	Q8NEZ4							
civic	Larotrectinib	NTRK1	Fusion		Solid Tumor	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK3	Fusion		Solid Tumor	Sensitivity/Response	Q16288							
civic	Larotrectinib	NTRK1	Fusion		Sarcoma	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	Q16288							
civic	Trametinib,Dabrafenib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Trametinib,Dabrafenib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Trametinib,Dabrafenib	BRAF	V600E		Melanoma	Sensitivity/Response	P15056							
civic	Dabrafenib,Trametinib	BRAF	V600K		Melanoma	Sensitivity/Response	P15056							
civic	Vemurafenib,Cobimetinib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Dasatinib	ABL1	ETV6::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Nilotinib,Imatinib Mesylate	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Nilotinib,Imatinib Mesylate	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dabrafenib,Trametinib	BRAF	V600E		Thyroid Gland Anaplastic Carcinoma	Sensitivity/Response	P15056							
civic	Imatinib	PDGFRB	EBF1::PDGFRB		Childhood B-cell Acute Lymphoblastic Leukemia	Sensitivity/Response	P09619							
civic	Imatinib Mesylate	ABL1	C475V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL N336S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL E453A		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL L387F		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL V299L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL Q300R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL F359I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL E255V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL F486S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	TKD MUTATION		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	P-Loop Mutation		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bosutinib	ABL1	Non-P-Loop Mutation		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Ruxolitinib	JAK2	GOLGA5::JAK2		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	O60674							
civic	BET Inhibitor	FOXO1	PAX3::FOXO1		Alveolar Rhabdomyosarcoma	Sensitivity/Response	Q12778							
civic	Olaparib	PARP1	OVEREXPRESSION		Malignant Peripheral Nerve Sheath Tumor	Sensitivity/Response	P09874							
civic	Birabresib	BRD4	BRD4::NUTM1		NUT Midline Carcinoma	Sensitivity/Response	O60885							
civic	Imatinib	PDGFRA	FIP1L1::PDGFRA T674I		Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1	Resistance	P16234							
civic	Ruxolitinib	JAK2	F694L		Childhood B-cell Acute Lymphoblastic Leukemia	Sensitivity/Response	O60674							
civic	Erlotinib	EGFR	Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Imatinib	PDGFRB	EBF1::PDGFRB		Childhood B-cell Acute Lymphoblastic Leukemia	Sensitivity/Response	P09619							
civic	Dasatinib	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL E459K		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL V379I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL A397P		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL F359C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL E355G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL L248V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib Mesylate	ABL1	BCR::ABL E459K		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Selpercatinib	RET	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P07949							
civic	Selpercatinib	RET	V804M		Thyroid Gland Medullary Carcinoma	Sensitivity/Response	P07949							
civic	Selpercatinib	RET	Fusion		Thyroid Gland Papillary Carcinoma	Sensitivity/Response	P07949							
civic	Cetuximab,Panitumumab	EGFR	V441F		Colorectal Cancer	Resistance	P00533							
civic	Imatinib,Dasatinib	PDGFRB	EBF1::PDGFRB		Childhood B-cell Acute Lymphoblastic Leukemia	Sensitivity/Response	P09619							
civic	Palbociclib,Abemaciclib	SMARCA4	Loss		Lung Non-small Cell Carcinoma	Sensitivity/Response	P51532							
civic	Celecoxib,Sulindac,Aspirin	PIK3CA	Mutation		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P42336							
civic	Ibuprofen,Aspirin,Sulindac	PIK3CA	Amplification		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P42336							
civic	Trametinib,Everolimus	BRAF	KIAA1549::BRAF		Childhood Low-grade Glioma	Sensitivity/Response	P15056							
civic	Vincristine,Dexamethasone,Dasatinib	ABL1	NUP214::ABL1		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P00519							
civic	Dasatinib	ABL1	SNX2::ABL1		B-lymphoblastic Leukemia/lymphoma	Resistance	P00519							
civic	Pazopanib	FGFR1	Amplification		Breast Cancer	Sensitivity/Response	P11362							
civic	Imatinib	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P00519							
civic	Dasatinib	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P00519							
civic	Dasatinib	ABL2	Fusion		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P42684							
civic	Imatinib	ABL1	SNX2::ABL1		B-lymphoblastic Leukemia/lymphoma	Reduced Sensitivity	P00519							
civic	Ruxolitinib	JAK2	SSBP2::JAK2		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	O60674							
civic	Encorafenib,Binimetinib,Cetuximab	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Trametinib,Dabrafenib	BRAF	V600E		Biliary Tract Cancer	Sensitivity/Response	P15056							
civic	Tepotinib	MET	Exon 14 Skipping Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Olaparib	BRCA1	Mutation		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA1	Mutation		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Mutation		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Ivosidenib	IDH1	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	O75874							
civic	Crizotinib	ROS1	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Gilteritinib	FLT3	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Alectinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Ceritinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Lorlatinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Encorafenib,Binimetinib	BRAF	V600		Melanoma	Sensitivity/Response	P15056							
civic	Sunitinib	KIT	V555_V559DEL		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Sunitinib	KIT	K550_K559DEL		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Dasatinib	ABL1	FOXP1::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Palbociclib	CDKN2A	Mutation		Pancreatic Cancer	Sensitivity/Response	Q9NXV6							
civic	Palbociclib	CDKN2A	Mutation		Cholangiocarcinoma	Sensitivity/Response	Q9NXV6							
civic	Pertuzumab,Trastuzumab	ERBB2	Amplification		Colorectal Cancer	Sensitivity/Response	P04626							
civic	Sorafenib,Temsirolimus,Bevacizumab	BRAF	KIAA1549::BRAF		Spindle Cell Sarcoma	Sensitivity/Response	P15056							
civic	Fulvestrant,Alpelisib	PIK3CA	Mutation		Breast Cancer	Sensitivity/Response	P42336							
civic	Icotinib	EGFR	EGFR::RAD51		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Alpelisib,Fulvestrant	PIK3CA	E542K		Breast Cancer	Sensitivity/Response	P42336							
civic	Fulvestrant,Alpelisib	PIK3CA	H1047X		Breast Cancer	Sensitivity/Response	P42336							
civic	Derazantinib	FGFR2	Fusion		Intrahepatic Cholangiocarcinoma	Sensitivity/Response	P21802							
civic	Cetuximab,Irinotecan,Vemurafenib	BRAF	V600		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Crizotinib	ALK	Fusion		Anaplastic Large Cell Lymphoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Inflammatory Myofibroblastic Tumor	Sensitivity/Response	Q9UM73							
civic	Fludarabine,Daunorubicin,Cytarabine,Methotrexate,Imatinib	IKZF1	Deletion		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	Q13422							
civic	Ponatinib	FLT3	ITD		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Sorafenib,Sunitinib	KIT	N822K		Acute Myeloid Leukemia	Sensitivity/Response	P10721							
civic	Sorafenib,Sunitinib	FGFR1	Fusion		Acute Myeloid Leukemia	Sensitivity/Response	P11362							
civic	Sorafenib,Sunitinib	PDGFRA	FIP1L1::PDGFRA		Acute Myeloid Leukemia	Sensitivity/Response	P16234							
civic	Ponatinib	KIT	N822K		Acute Myeloid Leukemia	Sensitivity/Response	P10721							
civic	Ponatinib	FGFR1	FGFR1OP2::FGFR1		Acute Myeloid Leukemia	Sensitivity/Response	P11362							
civic	Sorafenib,Sunitinib	FLT3	ITD		Leukemia	Sensitivity/Response	P36888							
civic	Olaparib	BRCA1	Loss-of-function		Pancreatic Adenocarcinoma	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Loss-of-function		Pancreatic Adenocarcinoma	Sensitivity/Response	P51587							
civic	Sunitinib	KIT	A502_Y503insAY		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Ponatinib,Imatinib	KIT	V560_L576DEL		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Regorafenib,Ponatinib,Imatinib	KIT	V560G		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Sunitinib,Ponatinib	KIT	K642E		Gastrointestinal Stromal Tumor	Sensitivity/Response	P10721							
civic	Ponatinib	KIT	D816E		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Vemurafenib,Sorafenib	BRAF	KIAA1549::BRAF		Childhood Pilocytic Astrocytoma	Resistance	P15056							
civic	Ponatinib	KIT	A829P		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Imatinib,Sunitinib	KIT	N822K		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Sunitinib,Imatinib	KIT	A829P		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Imatinib	KIT	T670I		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Sunitinib,Ponatinib	KIT	T670I		Gastrointestinal Stromal Tumor	Resistance	P10721							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		Congenital Fibrosarcoma	Sensitivity/Response	Q16288							
civic	Larotrectinib	NTRK1	TPM3::NTRK1		Spindle Cell Sarcoma	Sensitivity/Response	P04629							
civic	Larotrectinib	NTRK1	PDE4DIP::NTRK1		Sarcoma	Sensitivity/Response	P04629							
civic	Entrectinib	ALK	Alternative Transcript (ATI)		Mucosal Melanoma	Sensitivity/Response	Q9UM73							
civic	Erdafitinib	FGFR3	Mutation		Transitional Cell Carcinoma	Sensitivity/Response	P22607							
civic	Doxorubicin,Methotrexate	TP53	R273H		Osteosarcoma	Resistance	Q12888							
civic	Palbociclib	CDKN2A	Loss		Lung Non-small Cell Carcinoma	Resistance	Q9NXV6							
civic	Sapanisertib	NFE2L2	Mutation		Lung Squamous Cell Carcinoma	Sensitivity/Response	Q16236							
civic	Ivosidenib	IDH1	Mutation		Cholangiocarcinoma	Sensitivity/Response	O75874							
civic	Vistusertib	RICTOR	Amplification		Lung Small Cell Carcinoma	Sensitivity/Response	P85299							
civic	Imatinib	KIT	S628N		Melanoma	Sensitivity/Response	P10721							
civic	Dasatinib,Imatinib	KIT	D816V		Cancer	Resistance	P10721							
civic	Alpelisib,Fulvestrant	PIK3CA	E545		Breast Cancer	Sensitivity/Response	P42336							
civic	Agerafenib	RET	CCDC6::RET		Colorectal Cancer	Sensitivity/Response	P07949							
civic	Entrectinib	ALK	CAD::ALK		Colorectal Cancer	Sensitivity/Response	Q9UM73							
civic	Lorlatinib	ROS1	GOPC::ROS1		Glioblastoma	Sensitivity/Response	P08922							
civic	Selumetinib	NF1	Mutation		Childhood Low-grade Glioma	Sensitivity/Response	P21359							
civic	Lucitanib	FGFR1	Amplification		Breast Cancer	Sensitivity/Response	P11362							
civic	Afatinib	NRG1	ATP1B1::NRG1		Pancreatic Ductal Adenocarcinoma	Sensitivity/Response	Q02297							
civic	Afatinib	NRG1	APP::NRG1		Pancreatic Ductal Adenocarcinoma	Sensitivity/Response	Q02297							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		Solid Tumor	Sensitivity/Response	Q16288							
civic	Crizotinib	MET	R1004G		Head And Neck Cancer	Sensitivity/Response	P08581							
civic	Irinotecan,Panitumumab	BRAF	G466V		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	G466V		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	G466V		Solid Tumor	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	D594G		Cancer	Sensitivity/Response	P15056							
civic	Cisplatin,Gemcitabine	FGFR3	Mutation		Urinary Bladder Cancer	Sensitivity/Response	P22607							
civic	Vemurafenib	BRAF	V600E		Langerhans Cell Sarcoma	Sensitivity/Response	P15056							
civic	Anti-PD1 Monoclonal Antibody	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Anti-PD-L1 Monoclonal Antibody	EGFR	Exon 19 Deletion		Lung Non-small Cell Carcinoma	Resistance	P00533							
civic	Akt/ERK Inhibitor ONC201	H3-3A	K28M		Glioma	Sensitivity/Response	Q7L7L0							
civic	Osimertinib	EGFR	Exon 20 Insertion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Binimetinib,Cetuximab,Encorafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	BRAF Inhibitor	BRAF	V600D		Melanoma	Sensitivity/Response	P15056							
civic	BRAF Inhibitor,Mitogen-Activated Protein Kinase Kinase Inhibitor	BRAF	V600D		Melanoma	Sensitivity/Response	P15056							
civic	BRAF Inhibitor,Mitogen-Activated Protein Kinase Kinase Inhibitor	BRAF	V600_K601>E		Melanoma	Sensitivity/Response	P15056							
civic	Mitogen-Activated Protein Kinase Kinase Inhibitor,BRAF Inhibitor	BRAF	G469		Melanoma	Sensitivity/Response	P15056							
civic	BRAF Inhibitor,Mitogen-Activated Protein Kinase Kinase Inhibitor	BRAF	A598V		Melanoma	Sensitivity/Response	P15056							
civic	Fisogatinib	FGF19	Overexpression		Hepatocellular Carcinoma	Sensitivity/Response	O95750							
civic	Trastuzumab,Pertuzumab	ERBB2	Amplification		Cholangiocarcinoma	Sensitivity/Response	P04626							
civic	Crizotinib	MET	Exon 14 Skipping Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Crizotinib	MET	Exon 14 Skipping Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Trastuzumab Deruxtecan	ERBB2	Amplification		Stomach Cancer	Sensitivity/Response	P04626							
civic	Dasatinib,Imatinib	ABL1	SNX2::ABL1		B-lymphoblastic Leukemia/lymphoma	Resistance	P00519							
civic	Dabrafenib,Trametinib	BRAF	Amplification		Melanoma	Resistance	P15056							
civic	Cabozantinib	RET	M918T		Thyroid Gland Medullary Carcinoma	Sensitivity/Response	P07949							
civic	Temozolomide,Olaparib	BRCA2	K3326*		Glioblastoma	Sensitivity/Response	P51587							
civic	Gilteritinib	FLT3	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Trametinib	BRAF	N486_P490del		Pancreatic Cancer	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	D594G		Cancer	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	NRF1::BRAF		Transitional Cell Carcinoma	Sensitivity/Response	P15056							
civic	Axitinib	ABL1	BCR::ABL T315V		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Axitinib	ABL1	BCR::ABL V299L		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Axitinib	ABL1	BCR::ABL T315A		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Axitinib	ABL1	BCR::ABL H396P		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL E279K		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Axitinib	ABL1	BCR::ABL E292L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL F317R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL L248R and F359I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Axitinib	ABL1	BCR::ABL L248R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Ponatinib,Dasatinib	ABL1	BCR::ABL E255K V299L		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Imatinib	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Leucovorin,Fluorouracil	DPYD	EXON 11-19 DELETION		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	Q12882							
civic	Crizotinib	MET	MET::ATXN7L1		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Crizotinib	MET	Exon 14 Skipping Mutation		Histiocytic And Dendritic Cell Cancer	Sensitivity/Response	P08581							
civic	Capmatinib	MET	Exon 14 Skipping Mutation		Cancer	Sensitivity/Response	P08581							
civic	Ribociclib,Dexamethasone	CDK4	EXPRESSION		Childhood B-cell Acute Lymphoblastic Leukemia	Sensitivity/Response	P11802							
civic	Palbociclib	CDK6	Overexpression		Glioblastoma Proneural Subtype	Sensitivity/Response	Q00534							
civic	Ribociclib,Dexamethasone	CDK6	EXPRESSION		Childhood B-cell Acute Lymphoblastic Leukemia	Sensitivity/Response	Q00534							
civic	Afatinib	ERBB2	Amplification		Colorectal Cancer	Sensitivity/Response	P04626							
civic	Pazopanib	FGFR1	Amplification		Adenosquamous Lung Carcinoma	Sensitivity/Response	P11362							
civic	Thioguanine,Mercaptopurine	NT5C2	R367Q		Childhood Acute Lymphocytic Leukemia	Resistance	P49902							
civic	Thioguanine,Mercaptopurine	NT5C2	R238W		Childhood Acute Lymphocytic Leukemia	Resistance	P49902							
civic	Mercaptopurine,Thioguanine	NT5C2	S445F		Childhood Acute Lymphocytic Leukemia	Resistance	P49902							
civic	Doxorubicin,Cytarabine,Prednisolone,Gemcitabine	NT5C2	R367Q		Childhood Acute Lymphocytic Leukemia	Resistance	P49902							
civic	Prednisolone,Doxorubicin,Cytarabine,Gemcitabine	NT5C2	R238W		Childhood Acute Lymphocytic Leukemia	Resistance	P49902							
civic	Prednisolone,Cytarabine,Doxorubicin,Gemcitabine	NT5C2	S445F		Childhood Acute Lymphocytic Leukemia	Resistance	P49902							
civic	Imatinib	ABL1	BCR::ABL D363G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL E98G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL H396R		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL M244V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL L364I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Pazopanib	FGFR2	P253R		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	P21802							
civic	Nilotinib,Dasatinib,Bafetinib	ABL1	BCR::ABL		Chronic Myeloid Leukemia	Sensitivity/Response	P00519							
civic	Nilotinib,Bafetinib	ABL1	BCR::ABL T315A		Cancer	Resistance	P00519							
civic	Imatinib,Dasatinib	ABL1	BCR::ABL T315A		Cancer	Resistance	P00519							
civic	Nilotinib,Bafetinib	ABL1	BCR::ABL H396P		Cancer	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL H396P		Cancer	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL Y253F		Cancer	Resistance	P00519							
civic	Imatinib,Bafetinib	ABL1	BCR::ABL Q252H		Cancer	Resistance	P00519							
civic	Bafetinib,Imatinib	ABL1	BCR::ABL M244V		Cancer	Resistance	P00519							
civic	Ruxolitinib	JAK1	OVEREXPRESSION		Sarcoma	Sensitivity/Response	P23458							
civic	Trametinib	BRAF	Non-V600		Solid Tumor	Sensitivity/Response	P15056							
civic	Mercaptopurine,Thioguanine	NT5C2	R367Q		Childhood Acute Lymphocytic Leukemia	Resistance	P49902							
civic	Dasatinib,Bafetinib	LYN	OVEREXPRESSION		Chronic Myeloid Leukemia	Resistance	P07948							
civic	Nilotinib	LYN	OVEREXPRESSION		Chronic Myeloid Leukemia	Resistance	P07948							
civic	Mercaptopurine,Thioguanine	PRPS1	T303S		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Mercaptopurine,Thioguanine	PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Mercaptopurine,Thioguanine	PRPS1	D183E		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	K176N		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	S103I		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	S103N		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	S103T		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Cytarabine	PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P60891							
civic	Cytarabine	PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P60891							
civic	Mercaptopurine,Lometrexol	PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	D139G		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	C77S		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Mercaptopurine,Thioguanine	PRPS1	I72V		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Mercaptopurine,Thioguanine	PRPS1	V53A		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Mercaptopurine,Thioguanine	PRPS1	A87T		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Thioguanine,Mercaptopurine	PRPS1	M115T		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Methotrexate,Asparaginase,Daunorubicin	PRPS1	L191F		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Daunorubicin,Methotrexate,Asparaginase,Cytarabine	PRPS1	S103T		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Asparaginase,Methotrexate,Cytarabine,Daunorubicin	PRPS1	S103N		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Asparaginase,Cytarabine,Methotrexate,Daunorubicin	PRPS1	K176N		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Methotrexate,Asparaginase,Daunorubicin,Cytarabine	PRPS1	D183E		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Methotrexate,Daunorubicin,Cytarabine,Asparaginase	PRPS1	A190T		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Asparaginase,Cytarabine,Methotrexate,Daunorubicin	PRPS1	T303S		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Daunorubicin,Methotrexate,Asparaginase	PRPS1	N144S		B-lymphoblastic Leukemia/lymphoma	Resistance	P60891							
civic	Crizotinib	ROS1	Rearrangement		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Dasatinib	ABL1	BCR::ABL E450Q		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL M244V and L364I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL N146S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL V298I		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL S438C		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Dasatinib	ABL1	BCR::ABL M388L		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Bazedoxifene	IL6	Overexpression		Rhabdomyosarcoma	Resistance	P05231							
civic	Sunitinib	PDGFRA	Overexpression		Rhabdomyosarcoma	Sensitivity/Response	P16234							
civic	Imatinib	PDGFRA	BCR::PDGFRA		B-cell Acute Lymphoblastic Leukemia	Sensitivity/Response	P16234							
civic	Sunitinib	PDGFB	COL1A1::PDGFB		Dermatofibrosarcoma Protuberans	Sensitivity/Response	P01127							
civic	Sunitinib	PDGFRB	Overexpression		Dermatofibrosarcoma Protuberans	Sensitivity/Response	P09619							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	Q16288							
civic	Entrectinib	NTRK3	ETV6::NTRK3		Acute Myeloid Leukemia	Sensitivity/Response	Q16288							
civic	Dasatinib	ABL1	BCR::ABL F359V		Chronic Myeloid Leukemia	Resistance	P00519							
civic	PI-103	PIK3CA	E542K		Breast Cancer	Resistance	P42336							
civic	PI-103	PIK3CA	E545K		Breast Cancer	Resistance	P42336							
civic	PI-103	PIK3CA	H1047L		Breast Cancer	Sensitivity/Response	P42336							
civic	PI-103	PIK3CA	K111N		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	PI-103	PTEN	Loss		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P60484							
civic	PI3Ka/Di	PIK3CA	E542K		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	PI3Ka/Di	PIK3CA	E542K		Breast Cancer	Sensitivity/Response	P42336							
civic	PI3Ka/Di	PIK3CA	E545K		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	PI3Ka/Di	PIK3CA	E545K		Breast Cancer	Sensitivity/Response	P42336							
civic	PI3Ka/Di	PIK3CA	H1047L		Breast Cancer	Sensitivity/Response	P42336							
civic	PI3Ka/Di	PIK3CA	K111N		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	PI3Ka/Di	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Cetuximab	PIK3CA	V955I		Colorectal Cancer	Resistance	P42336							
civic	Imatinib	ABL1	BCR::ABL E355G		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL F486S		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	BCR::ABL E459K		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	Double Ph		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Imatinib	ABL1	P-Loop Mutation		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Gilteritinib	FLT3	D835Y		Cancer	Sensitivity/Response	P36888							
civic	Gilteritinib	FLT3	D835Y		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Cisplatin,Radiation Ionizing Radiotherapy	PIK3CA	E545K		Cervical Cancer	Resistance	P42336							
civic	Arsenic Trioxide	PML	PML::RARA A216V		Acute Promyelocytic Leukemia	Resistance	P29590							
civic	Lapatinib,Trastuzumab,Dactolisib	PIK3CA	K111N		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Venetoclax	BCL2	G101V		Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma	Resistance	P10415							
civic	Imatinib,Chemotherapy	PDGFRB	EBF1::PDGFRB		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P09619							
civic	Trastuzumab	PIK3CA	Amplification		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Dactolisib,Lapatinib	PIK3CA	Amplification		Her2-receptor Positive Breast Cancer	Sensitivity/Response	P42336							
civic	Trastuzumab	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Lapatinib	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Dactolisib	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Dactolisib,Lapatinib	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Trastuzumab,Dactolisib	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	R3Mab	FGFR3	R248C		Cancer	Resistance	P22607							
civic	FLT3/ABL/Aurora Kinase Inhibitor KW-2449	FLT3	Y842C		Acute Myeloid Leukemia	Resistance	P36888							
civic	Sorafenib	FLT3	Y842C		Acute Myeloid Leukemia	Resistance	P36888							
civic	Sunitinib	FLT3	Y842C		Acute Myeloid Leukemia	Resistance	P36888							
civic	Lestaurtinib	FLT3	Y842C		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Midostaurin	FLT3	Y842C		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Lestaurtinib	FLT3	F691L		Acute Myeloid Leukemia	Resistance	P36888							
civic	Midostaurin	FLT3	F691L		Acute Myeloid Leukemia	Resistance	P36888							
civic	Gilteritinib	FLT3	D835I		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Vemurafenib,Akt Inhibitor MK2206	PIK3CA	H1047R		Colorectal Cancer	Sensitivity/Response	P42336							
civic	Vemurafenib	KRAS	Exon 2 Mutation		Colorectal Cancer	Sensitivity/Response	P01116							
civic	Venetoclax	BCL2	F104I		Follicular Lymphoma	Resistance	P10415							
civic	Venetoclax	BCL2	F104I		Follicular Lymphoma	Resistance	P10415							
civic	Olaparib	PALB2	Mutation		Prostate Carcinoma	Sensitivity/Response	Q86YC2							
civic	Olaparib	ATM	Mutation		Prostate Carcinoma	Sensitivity/Response	Q13315							
civic	Irinotecan,Vemurafenib,Cetuximab	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Erlotinib,Vemurafenib	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Imatinib	ABL1	BCR::ABL Y253F		Chronic Myeloid Leukemia	Resistance	P00519							
civic	Gilteritinib	FLT3	D835H		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Gilteritinib	FLT3	D835V		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Trastuzumab Emtansine	PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Trastuzumab	PIK3CA	E545K		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Trastuzumab	PIK3CA	H1047R		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Trastuzumab	PIK3CA	C420R		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Cisplatin	FGFR3	S249C		Transitional Cell Carcinoma	Resistance	P22607							
civic	Quizartinib	FLT3	Y842C		Acute Myeloid Leukemia	Resistance	P36888							
civic	Alectinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Trastuzumab	PIK3CA	K111N		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Trastuzumab	PIK3CA	I391M		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Lapatinib,Capecitabine	PIK3CA	Mutation		Her2-receptor Positive Breast Cancer	Resistance	P42336							
civic	Trastuzumab Emtansine	PTEN	Loss		Her2-receptor Positive Breast Cancer	Resistance	P60484							
civic	Trastuzumab Emtansine	ERBB3	Overexpression		Her2-receptor Positive Breast Cancer	Resistance	P21860							
civic	Binimetinib	KRAS	Mutation		Ovary Serous Adenocarcinoma	Sensitivity/Response	P01116							
civic	Regorafenib	KRAS	Wildtype		Colorectal Cancer	Resistance	P01116							
civic	Venetoclax	BCL2	G101V		Chronic Lymphocytic Leukemia	Resistance	P10415							
civic	Olaparib	BRCA2	Mutation		Prostate Cancer	Sensitivity/Response	P51587							
civic	Capmatinib	MET	Exon 14 Skipping Mutation		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08581							
civic	Selpercatinib	RET	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P07949							
civic	Selpercatinib	RET	Mutation		Thyroid Gland Medullary Carcinoma	Sensitivity/Response	P07949							
civic	Selpercatinib	RET	Fusion		Thyroid Gland Cancer	Sensitivity/Response	P07949							
civic	Venetoclax	IDH1	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	O75874							
civic	Venetoclax	IDH2	Mutation		Acute Myeloid Leukemia	Sensitivity/Response	P48735							
civic	Larotrectinib	NTRK1	SQSTM1::NTRK1		Congenital Fibrosarcoma	Sensitivity/Response	P04629							
civic	Crizotinib	NTRK1	LMNA::NTRK1		Congenital Fibrosarcoma	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK1	LMNA::NTRK1		Colorectal Cancer	Sensitivity/Response	P04629							
civic	Etoposide,Larotrectinib,Methotrexate	NTRK3	ETV6::NTRK3		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	Q16288							
civic	Gilteritinib	FLT3	ITD		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Gilteritinib	FLT3	ITD		Acute Myeloid Leukemia	Sensitivity/Response	P36888							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	Q16288							
civic	Trametinib	NRAS	Q61K		Ovary Serous Adenocarcinoma	Sensitivity/Response	P01111							
civic	Selumetinib	BRAF	KIAA1549::BRAF		Childhood Pilocytic Astrocytoma	Sensitivity/Response	P15056							
civic	Trametinib	BRAF	KIAA1549::BRAF		Childhood Pilocytic Astrocytoma	Sensitivity/Response	P15056							
civic	Vemurafenib	BRAF	V600E		Thyroid Gland Papillary Carcinoma	Sensitivity/Response	P15056							
civic	Dasatinib	ABL1	BCR::ABL H396P		Cancer	Sensitivity/Response	P00519							
civic	Ponatinib,Imatinib,Nilotinib,Dasatinib	ABL1	NUP214::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Imatinib,Dasatinib	ABL1	SFPQ::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Dasatinib	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Dasatinib	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Dasatinib	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma	Reduced Sensitivity	P00519							
civic	Dasatinib	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Tyrosine Kinase Inhibitor	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P00519							
civic	Imatinib	ABL1	ETV6::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Dasatinib	ABL1	RANBP2::ABL1		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P00519							
civic	Ponatinib	ABL1	RCSD1::ABL1		B-lymphoblastic Leukemia/lymphoma	Sensitivity/Response	P00519							
civic	Osimertinib	EGFR	A767_V769dupASV		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	N771_P772insL		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	D770_N771insG		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	S768_D770dup		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	A763_Y764insFQEA		Lung Non-small Cell Carcinoma	Sensitivity/Response	P00533							
civic	Alectinib	ALK	EML4::ALK		Malignant Pleural Mesothelioma	Sensitivity/Response	Q9UM73							
civic	Fluorouracil,Cisplatin	ATRX	Deletion		Cancer	Sensitivity/Response	P46100							
civic	Axitinib,Dovitinib,Lenvatinib,Cabozantinib	KDR	R1032Q		Colorectal Cancer	Sensitivity/Response	P35968							
civic	Imatinib	CSF1R	MEF2D::CSF1R		B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like	Sensitivity/Response	P07333							
civic	Tazemetostat	EZH2	Y646H		Diffuse Large B-cell Lymphoma	Sensitivity/Response	Q15910							
civic	Ceritinib	ALK	I1171T		Neuroblastoma	Sensitivity/Response	Q9UM73							
civic	Sotorasib	KRAS	G12C		Lung Non-small Cell Carcinoma	Sensitivity/Response	P01116							
civic	Larotrectinib	NTRK3	F617L		Gastrointestinal Stromal Tumor	Resistance	Q16288							
civic	Tipifarnib	HRAS	Mutation		Bladder Urothelial Carcinoma	Sensitivity/Response	Q9HDD0							
civic	Tipifarnib	HRAS	Mutation		Head And Neck Squamous Cell Carcinoma	Sensitivity/Response	Q9HDD0							
civic	Lapatinib	ERBB2	V777L		Cancer	Sensitivity/Response	P04626							
civic	Tazemetostat	EZH2	Activating Mutation		Follicular Lymphoma	Sensitivity/Response	Q15910							
civic	Lapatinib	ERBB2	Amplification		Childhood Ependymoma	Sensitivity/Response	P04626							
civic	Encorafenib,Cetuximab	BRAF	V600E		Colorectal Cancer	Sensitivity/Response	P15056							
civic	Ibrutinib	PIM1	L2V		Diffuse Large B-cell Lymphoma Activated B-cell Type	Resistance	P11309							
civic	Ibrutinib	PIM1	P81S		Diffuse Large B-cell Lymphoma Activated B-cell Type	Resistance	P11309							
civic	Ibrutinib	PIM1	S97N		Diffuse Large B-cell Lymphoma Activated B-cell Type	Resistance	P11309							
civic	Lorlatinib,Alectinib	ABCB1	Overexpression		Lung Non-small Cell Carcinoma	Resistance	P08183							
civic	Cetuximab	PIK3CA	K944N		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab	PIK3CA	F930S		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab	PIK3CA	V955G		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab	PIK3CA	K966E		Colorectal Cancer	Resistance	P42336							
civic	Cetuximab	PIK3CA	L938*		Colorectal Cancer	Resistance	P42336							
civic	Erlotinib	EGFR	G598V		Cancer	Sensitivity/Response	P00533							
civic	Entrectinib	NTRK1	TPM3::NTRK1		Cancer	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK1	LMNA::NTRK1		Cancer	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK1	ETV6::NTRK1		Cancer	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK2	VCL::NTRK2		Cancer	Sensitivity/Response	Q16620							
civic	Entrectinib	NTRK2	AFAP1::NTRK2		Cancer	Sensitivity/Response	Q16620							
civic	Entrectinib	NTRK2	ETV6::NTRK2		Cancer	Sensitivity/Response	Q16620							
civic	Everolimus	FLCN	c.1285dupC		Renal Cell Carcinoma	Sensitivity/Response	Q8NFG4							
civic	Exemestane,Metformin	IGF1R	Overexpression		Breast Cancer	Sensitivity/Response	P08069							
civic	Etoposide,Olaparib	SF3B1	K700E		Leukemia	Sensitivity/Response	O75533							
civic	Trastuzumab Deruxtecan	ERBB2	Exon 20 Insertion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P04626							
civic	Gemcitabine,Carboplatin	ERCC1	Underexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	P07992							
civic	Gemcitabine,Carboplatin	RRM1	Underexpression		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UET6							
civic	Olaparib	IDH1	R132C		Cancer	Sensitivity/Response	O75874							
civic	Gemcitabine	SLC29A1	Overexpression		Pancreatic Adenocarcinoma	Sensitivity/Response	Q99808							
civic	Platinum Compound	ERCC1	Underexpression		Ovary Epithelial Cancer	Sensitivity/Response	P07992							
civic	Larotrectinib	NTRK1	Amplification		Solid Tumor	Sensitivity/Response	P04629							
civic	Sunitinib	KIT	EXPRESSION		Glioblastoma	Sensitivity/Response	P10721							
civic	Pasireotide	SSTR5	expression		Neuroendocrine Tumor	Sensitivity/Response	P35346							
civic	Pemigatinib	FGFR1	N546K		Pilocytic Astrocytoma	Sensitivity/Response	P11362							
civic	Trametinib	RAF1	QKI-RAF1		Spindle Cell Sarcoma	Sensitivity/Response	P04049							
civic	Alectinib	ALK	KANK4::ALK		Pancreatic Acinar Cell Adenocarcinoma	Sensitivity/Response	Q9UM73							
civic	R3Mab	FGFR3	Overexpression		Cancer	Sensitivity/Response	P22607							
civic	R3Mab	FGFR3	G370C		Cancer	Resistance	P22607							
civic	R3Mab	FGFR3	Y373C		Cancer	Resistance	P22607							
civic	R3Mab	FGFR3	K650E		Cancer	Resistance	P22607							
civic	Larotrectinib	NTRK2	KANK1::NTRK2		Anaplastic Ependymoma	Sensitivity/Response	Q16620							
civic	Larotrectinib	NTRK2	KANK1::NTRK2		Glioblastoma	Sensitivity/Response	Q16620							
civic	R-CHOP Regimen	MS4A1	Mutation		Diffuse Large B-cell Lymphoma	Resistance	P11836							
civic	Larotrectinib	NTRK2	Fusion		Solid Tumor	Sensitivity/Response	Q16620							
civic	Entrectinib	NTRK3	EML4::NTRK3		Thyroid Gland Papillary Carcinoma	Sensitivity/Response	Q16288							
civic	Entrectinib	NTRK3	EML4::NTRK3		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q16288							
civic	Larotrectinib	NTRK3	ETV6::NTRK3		Congenital Mesoblastic Nephroma	Sensitivity/Response	Q16288							
civic	Ivosidenib	IDH1	R132		Cholangiocarcinoma	Sensitivity/Response	O75874							
civic	Erlotinib	EGFR	EGFR::RAD51		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Osimertinib	EGFR	EGFR::RAD51		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	Afatinib	EGFR	KIF5B::EGFR		Lung Adenocarcinoma	Sensitivity/Response	P00533							
civic	CTX-712	SRSF2	P95L		Myeloid Neoplasm	Sensitivity/Response	Q01130							
civic	CTX-712	SRSF2	P95H		Myeloid Neoplasm	Sensitivity/Response	Q01130							
civic	Entrectinib	NTRK3	EML4::NTRK3		Lung Adenocarcinoma	Sensitivity/Response	Q16288							
civic	Larotrectinib	NTRK3	EML4::NTRK3		High Grade Glioma	Sensitivity/Response	Q16288							
civic	Tazemetostat	EZH2	Activating Mutation		Follicular Lymphoma	Sensitivity/Response	Q15910							
civic	Tazemetostat	EZH2	expression		Diffuse Large B-cell Lymphoma Germinal Center B-cell Type	Sensitivity/Response	Q15910							
civic	Brigatinib	ALK	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	Q9UM73							
civic	Crizotinib	ALK	Fusion		Inflammatory Myofibroblastic Tumor	Sensitivity/Response	Q9UM73							
civic	Entrectinib	ROS1	FUSIONS		Lung Non-small Cell Carcinoma	Sensitivity/Response	P08922							
civic	Entrectinib	NTRK1	Fusion		Solid Tumor	Sensitivity/Response	P04629							
civic	Entrectinib	NTRK3	Fusion		Solid Tumor	Sensitivity/Response	Q16288							
civic	Rucaparib	BRCA1	Mutation		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Rucaparib	BRCA2	Mutation		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Rucaparib	BRCA1	Mutation		Ovarian Cancer	Sensitivity/Response	P38398							
civic	Rucaparib	BRCA2	Mutation		Ovarian Cancer	Sensitivity/Response	P51587							
civic	Imatinib Mesylate	KIT	D816V		Systemic Mastocytosis	Sensitivity/Response	P10721							
civic	Olaparib	BRCA1	Loss-of-function		Her2-receptor Negative Breast Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Loss-of-function		Her2-receptor Negative Breast Cancer	Sensitivity/Response	P51587							
civic	Olaparib	BRCA1	Mutation		Prostate Carcinoma	Sensitivity/Response	P38398							
civic	Olaparib	CDK12	Mutation		Prostate Carcinoma	Sensitivity/Response	Q9NYV4							
civic	Olaparib	CHEK2	mutation		Prostate Carcinoma	Sensitivity/Response	O96017							
civic	Olaparib	PPP2R2A	Mutation		Prostate Carcinoma	Sensitivity/Response	Q96E09							
civic	Olaparib	RAD54L	Mutation		Prostate Carcinoma	Sensitivity/Response	Q92698							
civic	Olaparib	BRIP1	Mutation		Prostate Carcinoma	Sensitivity/Response	Q9BX63							
civic	Olaparib	BARD1	Mutation		Prostate Carcinoma	Sensitivity/Response	Q99728							
civic	Olaparib	CHEK1	Mutation		Prostate Carcinoma	Sensitivity/Response	O14757							
civic	Olaparib	RAD51B	Mutation		Prostate Carcinoma	Sensitivity/Response	O15315							
civic	Olaparib	RAD51D	Mutation		Prostate Carcinoma	Sensitivity/Response	O75771							
civic	Olaparib	BRCA1	Loss-of-function		Triple-receptor Negative Breast Cancer	Sensitivity/Response	P38398							
civic	Olaparib	BRCA2	Loss-of-function		Triple-receptor Negative Breast Cancer	Sensitivity/Response	P51587							
civic	Crizotinib	ALK	Fusion		Anaplastic Large Cell Lymphoma	Sensitivity/Response	Q9UM73							
civic	Entrectinib	NTRK2	Fusion		Solid Tumor	Sensitivity/Response	Q16620							
civic	Pralsetinib	RET	Fusion		Lung Non-small Cell Carcinoma	Sensitivity/Response	P07949							
dbmcs	Nilotinib	ABL1	c.944C>T			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.944C>T			Resistant	P00519							
dbmcs	Bosutinib	ABL1	c.944C>T			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.895G>C			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.943A>G			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.949T>C			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.949T>G			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.949T>A			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.950T>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.725T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.740A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.742C>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.749G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.748G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.755A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.756G>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.758A>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.757T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.763G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.764A>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.709A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.774G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.782G>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.817T>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.823G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.823G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.827A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.829A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.835G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.839T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.866T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.865G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.875A>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.874G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.877A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.892C>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.895G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.931T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.931T>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.944C>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.949T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.949T>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.949T>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.950T>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.959A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.971T>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1024T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1028T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1031C>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1049C>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1065G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1064A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1064A>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1075T>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1075T>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1076T>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1075T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1087G>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1090C>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1094C>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1097C>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1109T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1112T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1117G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1135G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1138G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1144T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1150C>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1159T>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1161G>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1159T>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1162A>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1178A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1187A>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1187A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1186_1187delCAinsGC			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1189G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1250C>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1250C>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1253T>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1252A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1297G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1313C>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1348G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1349A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1349A>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1349A>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1357G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1358A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1358A>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1358A>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1375G>A			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1376A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1376A>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1376A>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1416G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1439C>T			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1457T>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1520A>G			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.763G>A			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.764A>T			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.757T>C			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.1075T>G			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.1076T>G			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.1075T>A			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.742C>G			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.742C>G			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.749G>A			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.875A>T			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.1150C>A			Resistant	P00519							
dbmcs	Nilotinib	ABL1	c.1161G>C			Resistant	P00519							
dbmcs	Bosutinib	ABL1	c.749G>A			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.749G>A			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.944C>T			Resistant	P00519							
dbmcs	Bosutinib	ABL1	c.1052T>C			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.1064A>G			Resistant	P00519							
dbmcs	Bosutinib	ABL1	c.1187A>G			Resistant	P00519							
dbmcs	Bosutinib	ABL1	c.1457T>C			Resistant	P00519							
dbmcs	Imatinib Mesylate + Dasatinib	ABL1	c.944C>T			Resistant	P00519							
dbmcs	Imatinib Mesylate + Dasatinib	ABL1	c.763G>A			Resistant	P00519							
dbmcs	Imatinib Mesylate + Nilotinib	ABL1	c.944C>T			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.743T>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.743T>G			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.950T>C			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.756G>C			Resistant	P00519							
dbmcs	Dasatinib + Nilotinib	ABL1	c.944C>T			Resistant	P00519							
dbmcs	Imatinib Mesylate + Nilotinib	ABL1	c.742C>G			Resistant	P00519							
dbmcs	Imatinib Mesylate + Nilotinib	ABL1	c.757T>C			Resistant	P00519							
dbmcs	Imatinib Mesylate + Nilotinib	ABL1	c.931T>C			Resistant	P00519							
dbmcs	Imatinib Mesylate + Nilotinib	ABL1	c.1076T>G			Resistant	P00519							
dbmcs	Imatinib Mesylate + Nilotinib	ABL1	c.1187A>C			Resistant	P00519							
dbmcs	Imatinib Mesylate + Dasatinib	ABL1	c.895G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1423_1424delTGinsGT			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1007A>G			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.1161G>C			Resistant	P00519							
dbmcs	Imatinib	ABL1	c.899A>G			Resistant	P00519							
dbmcs	Dasatinib	ABL1	c.1375G>A			Resistant	P00519							
dbmcs	Vemurafenib	AKT1	c.235C>A			Resistant	P31749							
dbmcs	Vemurafenib	AKT1	c.49G>A			Resistant	P31749							
dbmcs	Dabrafenib	AKT1	c.235C>A			Resistant	P31749							
dbmcs	BRAF inhibitors	AKT1	c.235C>A			Resistant	P31749							
dbmcs	MK2206	AKT1	c.238_239delTGinsGC			Resistant	P31749							
dbmcs	Vemurafenib	AKT3	c.49G>A			Resistant	Q9Y243							
dbmcs	Alectinib	ALK	c.3512T>C			Resistant	Q9UM73							
dbmcs	Ceritinib	ALK	c.3367G>A			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3467G>A			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3586C>A			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3520T>C			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3455T>G			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3520T>C			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3604G>A			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3617C>A			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3806G>C			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3512T>C			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3522C>A			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3604G>A			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3617C>A			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3453_3454			Resistant	Q9UM73							
dbmcs	AUY922	ALK	c.3467G>A			Resistant	Q9UM73							
dbmcs	Ceritinib	ALK	c.3467G>A			Resistant	Q9UM73							
dbmcs	Alectinib	ALK	c.3538G>C			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3512T>C			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3538G>C			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3734T>G			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3734T>G			Resistant	Q9UM73							
dbmcs	Ceritinib	ALK	c.3604G>A			Resistant	Q9UM73							
dbmcs	Alectinib	ALK	c.3453_3454			Resistant	Q9UM73							
dbmcs	TAE684	ALK	c.3453_3454			Resistant	Q9UM73							
dbmcs	Alectinib	ALK	c.3604G>A			Resistant	Q9UM73							
dbmcs	Brigatinib	ALK	c.3604G>A			Resistant	Q9UM73							
dbmcs	Alectinib	ALK	c.3806G>C			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3512T>A			Resistant	Q9UM73							
dbmcs	Alectinib	ALK	c.3512T>A			Resistant	Q9UM73							
dbmcs	Alectinib	ALK	c.3512T>G			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3512T>G			Resistant	Q9UM73							
dbmcs	Crizotinib	ALK	c.3383G>C			Resistant	Q9UM73							
dbmcs	Lorlatinib	ALK	c.3592C>T			Resistant	Q9UM73							
dbmcs	Alectinib	ALK	c.3604G>A			Resistant	Q9UM73							
dbmcs	G007-LK	APC	c.2555T>A			Resistant	P25054							
dbmcs	IWR-1	APC	c.5455_5456insC			Resistant	P25054							
dbmcs	XAV939	APC	c.2656C>T			Resistant	P25054							
dbmcs	NVP-TNKS656	APC	c.2656C>T			Resistant	P25054							
dbmcs	G007-LK	APC	c.2656C>T			Resistant	P25054							
dbmcs	Abiraterone	AR	c.2105T>A			Resistant	O95154							
dbmcs	Abiraterone	AR	c.2632A>G			Resistant	O95154							
dbmcs	Apalutamide	AR	c.2629T>C			Resistant	O95154							
dbmcs	Enzalutamide	AR	c.2629T>C			Resistant	O95154							
dbmcs	Flutamide	AR	c.2632A>G			Resistant	O95154							
dbmcs	Enzalutamide	AR	c.2629T>C			Resistant	O95154							
dbmcs	Apalutamide	AR	c.2629T>C			Resistant	O95154							
dbmcs	Bicalutamide	AR	c.2226G>T			Resistant	O95154							
dbmcs	Bicalutamide	AR	c.2225G>T			Resistant	O95154							
dbmcs	Vemurafenib + Cetuximab + Irinotecan	ARAF	c.1468T>A			Resistant	P10398							
dbmcs	Pembrolizumab	B2M	c.42_45			Resistant	Q9Y2E5							
dbmcs	Venetoclax	BCL2	c.302G>T			Resistant	P10415							
dbmcs	Venetoclax	BCL2	c.310T>A			Resistant	P10415							
dbmcs	Cetuximab	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Panitumumab	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Panitumumab	BRAF	c.1798_1799			Resistant	P15056							
dbmcs	Refametinib	BRAF	c.1798_1799			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1798_1799			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1514T>A			Resistant	P15056							
dbmcs	Oxaliplatin	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Irinotecan	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Bevacizumab	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Irinotecan + Cetuximab	BRAF	c.1781A>G			Resistant	P15056							
dbmcs	U0126	BRAF	c.1781A>G			Resistant	P15056							
dbmcs	U0126	BRAF	c.1406G>A			Resistant	P15056							
dbmcs	Irinotecan	BRAF	c.1780_1782delGATinsAAG			Resistant	P15056							
dbmcs	Oxaliplatin	BRAF	c.1780_1782delGATinsAAG			Resistant	P15056							
dbmcs	EGFR TKIs	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Cetuximab	BRAF	c.1798_1800			Resistant	P15056							
dbmcs	Panitumumab	BRAF	c.1798_1800			Resistant	P15056							
dbmcs	EGFR TKIs	BRAF	c.1406G>C			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1406G>T			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1802A>C			Resistant	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.141_1140+2del55905			Resistant	P15056							
dbmcs	Trametinib	BRAF	c.1510_1518			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1510_1518			Resistant	P15056							
dbmcs	Sorafenib	BRAF	c.1510_1518			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1790T>A			Resistant	P15056							
dbmcs	GDC0879	BRAF	c.1741A>T			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1390G>A			Resistant	P15056							
dbmcs	Dabrafenib	BRAF	c.1540C>G			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1391G>T			Resistant	P15056							
dbmcs	Trametinib	BRAF	c.1801A>G			Resistant	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1801A>G			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1789C>G			Resistant	P15056							
dbmcs	GDC0879	BRAF	c.1454_1455delTGinsAT			Resistant	P15056							
dbmcs	Dabrafenib	BRAF	c.1457_1471del15			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1457_1471del15			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1406G>C			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1406G>C			Resistant	P15056							
dbmcs	RMC-4550	BRAF	c.1406G>C			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1460_1474del15			Resistant	P15056							
dbmcs	Dabrafenib	BRAF	c.1460_1474del15			Resistant	P15056							
dbmcs	Dabrafenib	BRAF	c.1397G>A			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1397G>A			Resistant	P15056							
dbmcs	PLX7904	BRAF	c.1397G>A			Resistant	P15056							
dbmcs	Nivolumab	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Dabrafenib + Trametinib + SCH772984	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Pembrolizumab	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	PD-0325901	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	PLX4720	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Dasatinib	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	SHP099	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	RMC-4550	BRAF	c.1799T>A			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1803A>C			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1783T>C			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1397G>T			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1786G>C			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1780G>A			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1453_1470delinsTAT			Resistant	P15056							
dbmcs	Vemurafenib	BRAF	c.1391G>A			Resistant	P15056							
dbmcs	Ibrutinib	BTK	c.1441T>A			Resistant	Q06187							
dbmcs	Ibrutinib	BTK	c.946A>G			Resistant	Q06187							
dbmcs	Ibrutinib	BTK	c.1441_1443			Resistant	Q06187							
dbmcs	Lenalidomide	CRBN	c.298C>T			Resistant	Q96SW2							
dbmcs	Lenalidomide	CRBN	c.848G>A			Resistant	Q96SW2							
dbmcs	Pomalidomide	CRBN	c.298C>T			Resistant	Q96SW2							
dbmcs	Pomalidomide	CRBN	c.848G>A			Resistant	Q96SW2							
dbmcs	G007-LK	CTNNB1	c.98C>T			Resistant	P35222							
dbmcs	Cetuximab	EGFR	c.1391C>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1393G>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1473A>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1476C>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1351C>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1400A>C			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2527G>A			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2389T>A			Resistant	P00533							
dbmcs	Panitumumab	EGFR	c.1393G>A			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2392C>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	AEE-788	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Cisplatin	EGFR	c.425_559			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1476C>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1393G>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1400A>C			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2281G>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2281G>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2158_2159delTCinsAT			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2289_2320			Resistant	P00533							
dbmcs	Lapatinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2311_2312insGCGTAGACA			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2319_2320insCAT			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2512C>G			Resistant	P00533							
dbmcs	Crizotinib	EGFR	c.2573T>G			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2310_2311insGGTACA			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2289_2320			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2299_2307			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2300_2301insAATCGC			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2292_2293insCATCAT			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2310_2311insGGTTAT			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2316_2317insTATAACCCT			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2317_2318insCTCATGTAC			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2158_2160			Resistant	P00533							
dbmcs	EGFR TKIs	EGFR	c.88_1008			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2240_2257del18			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2374_2376			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2152_2154			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2239_2253delinsCCT			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2236_2237insTACCTGTAGCAATCAAGG			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2292_2293insCATCAT			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2292_2293insCATCAT			Resistant	P00533							
dbmcs	Naquotinib	EGFR	c.2292_2293insCATCAT			Resistant	P00533							
dbmcs	Dacomitinib	EGFR	c.2292_2293insCATCAT			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2299_2307			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2299_2307			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2299_2307			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2299_2307			Resistant	P00533							
dbmcs	Dacomitinib	EGFR	c.2299_2307			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2153T>A			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2153T>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2302_2310			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2302_2310			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2302_2310			Resistant	P00533							
dbmcs	Dacomitinib	EGFR	c.2302_2310			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2302_2310			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2302_2310			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2302_2310			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2293G>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2551G>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2551G>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2551G>A			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2611G>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2611G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2257C>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2316_2317insGGTAACCCT			Resistant	P00533							
dbmcs	OBX1-012	EGFR	c.2316_2317insGGTAACCCT			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2609A>G			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.1793G>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2096C>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2155G>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2582T>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2582T>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2582T>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2290_2291insTTCAAGAGGCAT			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2290_2291insTTCAAGAGGCAT			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2593G>A			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2593G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2500G>A			Resistant	P00533							
dbmcs	Etoposide	EGFR	c.102_869del11834			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.102_869del11834			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2302_2307delinsATCCTT			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2239_2240delTTinsCC			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2239_2240delTTinsCC			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2239_2240delTTinsCC			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2232C>G			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2156G>C			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2156G>C			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2156G>C			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2156G>C			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2156G>C			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2497T>G			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2497T>G			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2326C>T			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2104G>A			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2618G>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2618G>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2618G>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2310_2311insGTAGACAGCGTAGACAACCCT			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2311_2319			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2311_2319			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2222C>T			Resistant	P00533							
dbmcs	unspecified PD-L1 antibody	EGFR	c.2573T>G			Resistant	P00533							
dbmcs	unspecified CTLA4 antibody + unspecified PD-1 antibody	EGFR	c.2573T>G			Resistant	P00533							
dbmcs	unspecified PD-1 antibody	EGFR	c.2573T>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2240_2254del15			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2236_2250delinsATCCCT			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2389T>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2389T>A			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2389T>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2251_2277delinsAAC			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2288C>T			Resistant	P00533							
dbmcs	JBJ-04-125-02	EGFR	c.2236_2250del15			Resistant	P00533							
dbmcs	Lapatinib	EGFR	c.2236_2250del15			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.3352G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.866C>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2254_2277del24			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2492G>T			Resistant	P00533							
dbmcs	Panitumumab	EGFR	c.1391C>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2560A>G			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2560A>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2560A>G			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2560A>G			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2584C>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2239_2259delinsCAA			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2236_2253delinsGTA			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2203G>A			Resistant	P00533							
dbmcs	Selumetinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Icotinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2369C>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2236_2256delinsGTA			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2317C>T			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2317C>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2317C>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2239_2250del12			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2527G>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2527G>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2527G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2527G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2500G>C			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2500G>C			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2239_2250delinsCCT			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2239_2250delinsCCT			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2239_2250delinsCCT			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2239_2250delinsCCT			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2351C>T			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2300C>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2587G>A			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2127_2129delAAC			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2127_2129delAAC			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2127_2129delAAC			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2127_2129delAAC			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2127_2129delAAC			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2240T>C			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2512C>G			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2126A>G			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2126A>G			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2126A>G			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2305G>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2245G>C			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2245G>C			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2543C>T			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2543C>T			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2159C>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2236_2259delinsGTAAGC			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2125G>A			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2125G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2125G>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2125G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.1476C>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2283+1_2283+2insAGGCATTTCAAG			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2107C>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2107C>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2318A>T			Resistant	P00533							
dbmcs	EKI-285	EGFR	c.2318A>T			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2318A>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2240_2257del18			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2590G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2590G>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2575G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2575G>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2320G>A			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2320G>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2105C>T			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2126A>C			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2126A>C			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2126A>C			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2155G>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2582T>G			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2582T>G			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2155_2157			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2612C>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2612C>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2326C>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2404G>A			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2404G>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2317_2319			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2317_2319			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2317_2319			Resistant	P00533							
dbmcs	Afatinib	EGFR	c.2317_2319			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2317_2319			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.917C>T			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2108T>C			Resistant	P00533							
dbmcs	Panitumumab	EGFR	c.1394G>A			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.1394G>A			Resistant	P00533							
dbmcs	Panitumumab	EGFR	c.1473A>G			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2311_2313			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2311_2313			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2311_2313			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2311_2313			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2240_2251del12			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2305G>C			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2305G>C			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2305G>C			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2305G>C			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2317_2322delinsCTTATG			Resistant	P00533							
dbmcs	Neratinib	EGFR	c.2308_2310delinsGGTTAT			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2327G>A			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2303G>T			Resistant	P00533							
dbmcs	Cetuximab	EGFR	c.2303G>T			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2303G>T			Resistant	P00533							
dbmcs	Icotinib	EGFR	c.2303G>T			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2303G>T			Resistant	P00533							
dbmcs	AEE-788	EGFR	c.2477A>G			Resistant	P00533							
dbmcs	Gefitinib	EGFR	c.2477A>G			Resistant	P00533							
dbmcs	Erlotinib	EGFR	c.2477A>G			Resistant	P00533							
dbmcs	Rociletinib	EGFR	c.2126A>T			Resistant	P00533							
dbmcs	Osimertinib	EGFR	c.2389T>G			Resistant	P00533							
dbmcs	Lapatinib	ERBB2	c.2257A>G			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2393C>T			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2264T>C			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.1988T>C			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2281_2283delACA			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.1976_1977delTTinsAG			Resistant	P04626							
dbmcs	Gefitinib	ERBB2	c.1976_1977delTTinsAG			Resistant	P04626							
dbmcs	Pertuzumab	ERBB2	c.1976_1977delTTinsAG			Resistant	P04626							
dbmcs	Pertuzumab	ERBB2	c.1979G>A			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.1979G>A			Resistant	P04626							
dbmcs	Panitumumab	ERBB2	c.929C>T			Resistant	P04626							
dbmcs	Selumetinib	ERBB2	c.929C>T			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.929C>T			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.929C>T			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2089G>C			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2334_2335insCTTCCTAGC			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2334_2335insCTTCCTAGC			Resistant	P04626							
dbmcs	Gefitinib	ERBB2	c.2176C>A			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2305G>C			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2305G>C			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2305G>C			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2330_2331insAGGTTGTGT			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2339C>T			Resistant	P04626							
dbmcs	AZ5104	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Erlotinib	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Tucatinib	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Dacomitinib	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Osimertinib	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Afatinib	ERBB2	c.2314_2325			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2521C>G			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2326_2328delinsGTAGTA			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2326_2328delinsGTAGTA			Resistant	P04626							
dbmcs	AEE-788	ERBB2	c.2393_2394delCAinsTG			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2393_2394delCAinsTG			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.2393_2394delCAinsTG			Resistant	P04626							
dbmcs	CI-1040	ERBB2	c.2393_2394delCAinsTG			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2329G>C			Resistant	P04626							
dbmcs	Trastuzumab	ERBB2	c.2329G>C			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2329G>C			Resistant	P04626							
dbmcs	Panitumumab	ERBB2	c.2329G>C			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.2329G>C			Resistant	P04626							
dbmcs	AEE-788	ERBB2	c.2264T>C			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2264T>C			Resistant	P04626							
dbmcs	Trastuzumab	ERBB2	c.2257A>G			Resistant	P04626							
dbmcs	Panitumumab	ERBB2	c.2596C>A			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.2596C>A			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2332_2340			Resistant	P04626							
dbmcs	Tucatinib	ERBB2	c.2332_2340			Resistant	P04626							
dbmcs	Trastuzumab	ERBB2	c.2332_2340			Resistant	P04626							
dbmcs	Afatinib	ERBB2	c.2332_2340			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2332_2340			Resistant	P04626							
dbmcs	Erlotinib	ERBB2	c.2332_2340			Resistant	P04626							
dbmcs	AZ5104	ERBB2	c.2332_2340			Resistant	P04626							
dbmcs	Osimertinib	ERBB2	c.2332_2340			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2326_2328delinsCTTTGT			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2326_2328delinsCTTTGT			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2356C>G			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2356C>G			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.2126A>T			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2176C>T			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2584A>G			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.2033G>A			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2033G>A			Resistant	P04626							
dbmcs	Selumetinib	ERBB2	c.1958C>G			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2305G>T			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2305G>T			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2305G>T			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2606T>G			Resistant	P04626							
dbmcs	Lapatinib + Trastuzumab	ERBB2	c.2606T>G			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2606T>G			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2606T>G			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2149G>A			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2493G>C			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2198C>T			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2305G>A			Resistant	P04626							
dbmcs	Erlotinib	ERBB2	c.2326_2328delinsGTATGT			Resistant	P04626							
dbmcs	Tucatinib	ERBB2	c.2326_2328delinsGTATGT			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2326_2328delinsGTATGT			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2326_2328delinsGTATGT			Resistant	P04626							
dbmcs	Gefitinib	ERBB2	c.2326_2328delinsGTATGT			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.2350C>G			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2347T>C			Resistant	P04626							
dbmcs	Pertuzumab	ERBB2	c.1978G>C			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.1978G>C			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2353C>T			Resistant	P04626							
dbmcs	Panitumumab	ERBB2	c.2263_2264delCTinsAG			Resistant	P04626							
dbmcs	AEE-788	ERBB2	c.2263_2264delCTinsAG			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.2263_2264delCTinsAG			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2263_2264delCTinsAG			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2263_2264delCTinsAG			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2318T>C			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2570A>G			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2156A>G			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2524G>A			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2524G>A			Resistant	P04626							
dbmcs	Panitumumab	ERBB2	c.2524G>A			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.2524G>A			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2524G>A			Resistant	P04626							
dbmcs	Trastuzumab	ERBB2	c.2524G>A			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2434G>A			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2407T>A			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2317G>A			Resistant	P04626							
dbmcs	Sapitinib	ERBB2	c.2317G>A			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2265_2279del15			Resistant	P04626							
dbmcs	Lapatinib	ERBB2	c.2393C>T			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.2333G>C			Resistant	P04626							
dbmcs	Cetuximab	ERBB2	c.929C>A			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.929C>A			Resistant	P04626							
dbmcs	Neratinib	ERBB2	c.874G>C			Resistant	P04626							
dbmcs	Lapatinib	ERBB4	c.2425_2426delCAinsGG			Resistant	Q15303							
dbmcs	Cisplatin	ERCC2	c.2251A>C			Resistant	P18074							
dbmcs	Fulvestrant	ESR1	c.1610A>C			Resistant	P03372							
dbmcs	Hormone Therapy	ESR1	c.1607_1608delTCinsAA			Resistant	P03372							
dbmcs	Hormone Therapy	ESR1	c.1613A>G			Resistant	P03372							
dbmcs	Hormone Therapy	ESR1	c.1610A>G			Resistant	P03372							
dbmcs	Hormone Therapy	ESR1	c.1609T>A			Resistant	P03372							
dbmcs	Hormone Therapy	ESR1	c.1610A>C			Resistant	P03372							
dbmcs	Aromatase inhibitors	ESR1	c.1387T>C			Resistant	P03372							
dbmcs	anti-estrogens	ESR1	c.1138G>C			Resistant	P03372							
dbmcs	anti-estrogens	ESR1	c.1606_1608			Resistant	P03372							
dbmcs	anti-estrogens	ESR1	c.1604C>A			Resistant	P03372							
dbmcs	Tazemetostat	EZH2	c.331T>G			Resistant	Q15910							
dbmcs	GSK126	EZH2	c.331T>G			Resistant	Q15910							
dbmcs	DZNeP	EZH2	c.1922A>C			Resistant	Q15910							
dbmcs	GSK126	EZH2	c.1922A>C			Resistant	Q15910							
dbmcs	Tazemetostat	EZH2	c.2032_2037delinsAAGAAG			Resistant	Q15910							
dbmcs	MRK-003	FBXW7	c.1393C>T			Resistant	Q969H0							
dbmcs	MRK-003	FBXW7	c.1394G>A			Resistant	Q969H0							
dbmcs	Regorafenib	FBXW7	c.1513C>T			Resistant	Q969H0							
dbmcs	MRK-003	FBXW7	c.1513C>T			Resistant	Q969H0							
dbmcs	MRK-003	FBXW7	c.1436G>A			Resistant	Q969H0							
dbmcs	MRK-003	FBXW7	c.1514G>T			Resistant	Q969H0							
dbmcs	AZD-4547	FGFR1	c.1681G>A			Resistant	P11362							
dbmcs	Dovitinib	FGFR2	c.1693G>A			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1608G>C			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1614G>C			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1642A>G			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1650T>G			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1697A>G			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1852T>A			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1978A>G.			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1642A>G			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1650T>G			Resistant	P21802							
dbmcs	AZD-4547	FGFR2	c.1650T>G			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1852T>A			Resistant	P21802							
dbmcs	Ponatinib	FGFR2	c.1614G>C			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1614G>C			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1647T>G			Resistant	P21802							
dbmcs	Nintedanib	FGFR2	c.1647T>G			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1649A>G			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1649A>G			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1697A>G			Resistant	P21802							
dbmcs	DEBIO-1347	FGFR2	c.1690G>A			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1693G>A			Resistant	P21802							
dbmcs	Ponatinib	FGFR2	c.1693G>A			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1608G>C			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.755C>G			Resistant	P21802							
dbmcs	AZD-4547	FGFR2	c.755C>G			Resistant	P21802							
dbmcs	RO4987655	FGFR2	c.755C>G			Resistant	P21802							
dbmcs	Selumetinib	FGFR2	c.755C>G			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1648A>C			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1648A>C			Resistant	P21802							
dbmcs	AZD-4547	FGFR2	c.1690G>T			Resistant	P21802							
dbmcs	Infigratinib	FGFR2	c.1690G>T			Resistant	P21802							
dbmcs	DEBIO-1347	FGFR2	c.1690G>C			Resistant	P21802							
dbmcs	PD173074	FGFR2	c.1978A>G			Resistant	P21802							
dbmcs	Dovitinib	FGFR2	c.1978A>G			Resistant	P21802							
dbmcs	Bortezomib	FGFR3	c.1118A>G			Resistant	P22607							
dbmcs	Cisplatin	FGFR3	c.746C>G			Resistant	P22607							
dbmcs	FGFR inhibitors	FGFR3	c.1663G>A			Resistant	P22607							
dbmcs	Cediranib	FGFR3	c.1124A>G			Resistant	P22607							
dbmcs	Nintedanib	FGFR3	c.1124A>G			Resistant	P22607							
dbmcs	Infigratinib	FGFR3	c.1822T>G			Resistant	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1822T>G			Resistant	P22607							
dbmcs	AZD-4547	FGFR3	c.1822T>G			Resistant	P22607							
dbmcs	Infigratinib	FGFR3	c.1663G>C			Resistant	P22607							
dbmcs	Infigratinib	FGFR3	c.1663G>C			Resistant	P22607							
dbmcs	Infigratinib	FGFR3	c.392C>T			Resistant	P22607							
dbmcs	LY-2874455	FGFR3	c.1620C>G			Resistant	P22607							
dbmcs	FIIN-2	FGFR3	c.1620C>G			Resistant	P22607							
dbmcs	AZD-4547	FGFR3	c.1620C>G			Resistant	P22607							
dbmcs	Infigratinib	FGFR3	c.1620C>G			Resistant	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1620C>G			Resistant	P22607							
dbmcs	Infigratinib	FGFR3	c.1948A>G			Resistant	P22607							
dbmcs	AZD-4547	FGFR3	c.1948A>G			Resistant	P22607							
dbmcs	AZD-4547	FGFR3	c.1663G>A			Resistant	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1663G>A			Resistant	P22607							
dbmcs	Infigratinib	FGFR3	c.1663G>A			Resistant	P22607							
dbmcs	Infigratinib	FGFR3	c.1663G>A			Resistant	P22607							
dbmcs	FIIN-2	FGFR3	c.1663G>A			Resistant	P22607							
dbmcs	Nintedanib	FGFR3	c.746C>G			Resistant	P22607							
dbmcs	Tretinoin	FLT3	c.1705_1837			Resistant	P36888							
dbmcs	Daunorubicin	FLT3	c.1705_1837			Resistant	P36888							
dbmcs	SU5614	FLT3	c.1705_1837			Resistant	P36888							
dbmcs	Sorafenib	FLT3	c.2503G>T			Resistant	P36888							
dbmcs	Ponatinib	FLT3	c.2503G>T			Resistant	P36888							
dbmcs	Quizartinib	FLT3	c.2503G>T			Resistant	P36888							
dbmcs	SU5614	FLT3	c.2503G>T			Resistant	P36888							
dbmcs	All-trans Retinoic Acid + Anthracycline	FLT3	c.1705_1837			Resistant	P36888							
dbmcs	Selumetinib	FLT3	c.1705_1837			Resistant	P36888							
dbmcs	Sorafenib	FLT3	c.2503G>C			Resistant	P36888							
dbmcs	Tandutinib	FLT3	c.2504A>T			Resistant	P36888							
dbmcs	Quizartinib	FLT3	c.2071T>C			Resistant	P36888							
dbmcs	Quizartinib	FLT3	c.2503_2504delGAinsTT			Resistant	P36888							
dbmcs	Quizartinib	FLT3	c.2026_2028			Resistant	P36888							
dbmcs	Quizartinib	FLT3	c.2524_2526			Resistant	P36888							
dbmcs	Pexidartinib	FLT3	c.2504A>T			Resistant	P36888							
dbmcs	Pexidartinib	FLT3	c.2503G>T			Resistant	P36888							
dbmcs	Sorafenib	FLT3	c.2503G>T			Resistant	P36888							
dbmcs	Avapritinib	FLT3	c.2503G>T			Resistant	P36888							
dbmcs	Tretinoin	FLT3	c.2503G>T			Resistant	P36888							
dbmcs	Midostaurin	FLT3	c.1352C>T			Resistant	P36888							
dbmcs	Imatinib	FLT3	c.2525A>G			Resistant	P36888							
dbmcs	Crenolanib	FLT3	c.1285A>G			Resistant	P36888							
dbmcs	Lonafarnib	FNTB	c.7-17904G>C			Resistant	P49356							
dbmcs	Vemurafenib	GNAQ	c.626A>C			Resistant	P50148							
dbmcs	PLX4720	GNAQ	c.626A>C			Resistant	P50148							
dbmcs	Vemurafenib + Cetuximab + Irinotecan	GNAS	c.601C>T			Resistant	O95467							
dbmcs	Erlotinib	GNAS	c.393T>C			Resistant	O95467							
dbmcs	Gefitinib	GNAS	c.393T>C			Resistant	O95467							
dbmcs	Cisplatin + Fluorouracil	GNAS	c.393T>C			Resistant	O95467							
dbmcs	EGFR inhibitors	HRAS	c.38G>A			Resistant	Q9HDD0							
dbmcs	Vemurafenib	HRAS	c.38G>A			Resistant	Q9HDD0							
dbmcs	Cetuximab	HRAS	c.38G>A			Resistant	Q9HDD0							
dbmcs	Panitumumab	HRAS	c.35G>T			Resistant	Q9HDD0							
dbmcs	Cetuximab	HRAS	c.35G>T			Resistant	Q9HDD0							
dbmcs	AGI-5198 + Talazoparib	IDH1	c.395G>A			Resistant	O75874							
dbmcs	AGI-5198 + Metformin	IDH1	c.395G>A			Resistant	O75874							
dbmcs	AGI-5198 + Radiotherapy	IDH1	c.395G>A			Resistant	O75874							
dbmcs	AGI-5198 + Olaparib	IDH1	c.394C>T			Resistant	O75874							
dbmcs	AGI-5198 + Talazoparib	IDH1	c.394C>T			Resistant	O75874							
dbmcs	Pembrolizumab	JAK1	c.1507C>T			Resistant	P23458							
dbmcs	Ruxolitinib	JAK2	c.2813G>A			Resistant	O60674							
dbmcs	AZ960	JAK2	c.2600G>A			Resistant	O60674							
dbmcs	AUY922	JAK2	c.2600G>A			Resistant	O60674							
dbmcs	Ruxolitinib	JAK2	c.2600G>A			Resistant	O60674							
dbmcs	Momelotinib	JAK2	c.2600G>A			Resistant	O60674							
dbmcs	Fedratinib	JAK2	c.2600G>A			Resistant	O60674							
dbmcs	Ruxolitinib	JAK2	c.2792A>G			Resistant	O60674							
dbmcs	AZD1208	JAK2	c.1849G>T			Resistant	O60674							
dbmcs	SGI-1776	JAK2	c.1849G>T			Resistant	O60674							
dbmcs	Imatinib	JAK2	c.1849G>T			Resistant	O60674							
dbmcs	NS-018	JAK3	c.1715C>T			Resistant	P52333							
dbmcs	NIBR3049	JAK3	c.2021T>C			Resistant	P52333							
dbmcs	Ruxolitinib	JAK3	c.2570T>C			Resistant	P52333							
dbmcs	Regorafenib	KDR	c.2518C>T			Resistant	P35968							
dbmcs	Sorafenib	KDR	c.2518C>T			Resistant	P35968							
dbmcs	Sorafenib	KIT	c.1727T>C			Resistant	P10721							
dbmcs	Imatinib	KIT	c.1727T>C			Resistant	P10721							
dbmcs	Imatinib	KIT	c.1961T>C			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2466T>A			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2467T>G			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2425T>G			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2459A>C			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2459A>G			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2446G>C			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.1648_1674del27			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.1648_1774			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.1727T>C			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.1735_1737delGAT			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2448C>G			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.2448C>G			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.1665_1679del15			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.2466T>A			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2485G>C			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.2485G>C			Resistant	P10721							
dbmcs	Imatinib	KIT	c.1675G>A			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2466T>G			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2362_2484			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2485_2580			Resistant	P10721							
dbmcs	Imatinib	KIT	c.1895C>T			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2089C>T			Resistant	P10721							
dbmcs	Avapritinib	KIT	c.2009C>T			Resistant	P10721							
dbmcs	Dasatinib	KIT	c.2009C>T			Resistant	P10721							
dbmcs	Nilotinib	KIT	c.2009C>T			Resistant	P10721							
dbmcs	Imatinib	KIT	c.1676T>C			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2458G>A			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2446_2447delGAinsTT			Resistant	P10721							
dbmcs	Regorafenib	KIT	c.2446G>C			Resistant	P10721							
dbmcs	Quizartinib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Cabozantinib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Sorafenib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Flumatinib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Regorafenib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Nilotinib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Ponatinib	KIT	c.2447A>T			Resistant	P10721							
dbmcs	Ponatinib	KIT	c.1654_1674del21			Resistant	P10721							
dbmcs	Avapritinib	KIT	c.1961T>C			Resistant	P10721							
dbmcs	Imatinib	KIT	c.1504_1509			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2465A>T			Resistant	P10721							
dbmcs	Imatinib	KIT	c.1651_1662del12			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.1651_1662del12			Resistant	P10721							
dbmcs	Regorafenib	KIT	c.1651_1662del12			Resistant	P10721							
dbmcs	Imatinib	KIT	c.2446G>T			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.2446G>T			Resistant	P10721							
dbmcs	Flumatinib	KIT	c.2446G>T			Resistant	P10721							
dbmcs	Regorafenib	KIT	c.2446G>T			Resistant	P10721							
dbmcs	Imatinib	KIT	c.1711_1737			Resistant	P10721							
dbmcs	Flumatinib	KIT	c.1711_1737			Resistant	P10721							
dbmcs	Sunitinib	KIT	c.1711_1737			Resistant	P10721							
dbmcs	Cetuximab	KRAS	c.38G>A			Resistant	P01116							
dbmcs	Gefitinib	KRAS	c.34G>T			Resistant	P01116							
dbmcs	Gefitinib	KRAS	c.37G>T			Resistant	P01116							
dbmcs	Gefitinib	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Gefitinib	KRAS	c.34G>A			Resistant	P01116							
dbmcs	Erlotinib	KRAS	c.34G>T			Resistant	P01116							
dbmcs	Erlotinib	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Erlotinib	KRAS	c.35G>T			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.35G>T + c.34G>A			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.35G>T			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.1-11_111			Resistant	P01116							
dbmcs	Gefitinib	KRAS	c.35G>C			Resistant	P01116							
dbmcs	Erlotinib	KRAS	c.35G>C			Resistant	P01116							
dbmcs	Gemcitabine + Trametinib	KRAS	c.34_39			Resistant	P01116							
dbmcs	Carboplatin	KRAS	c.564+2508T>G			Resistant	P01116							
dbmcs	Paclitaxel	KRAS	c.564+2508T>G			Resistant	P01116							
dbmcs	Cisplatin	KRAS	c.564+2508T>G			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.64C>T			Resistant	P01116							
dbmcs	EGFR inhibitors	KRAS	c.1-11_111			Resistant	P01116							
dbmcs	Gemcitabine + Erlotinib	KRAS	c.1-11_111			Resistant	P01116							
dbmcs	Vemurafenib	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.35G>C			Resistant	P01116							
dbmcs	Melphalan	KRAS	c.35G>C			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.436G>C			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.38G>A			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.35G>T			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Melphalan	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.34G>T			Resistant	P01116							
dbmcs	Melphalan	KRAS	c.34G>T			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.34G>C			Resistant	P01116							
dbmcs	Gefitinib	KRAS	c.35G>T			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.34G>A			Resistant	P01116							
dbmcs	Melphalan	KRAS	c.34G>A			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.436G>A			Resistant	P01116							
dbmcs	Regorafenib	KRAS	c.35G>C			Resistant	P01116							
dbmcs	Cetuximab + FOLFOX4	KRAS	c.436G>A			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.183A>C			Resistant	P01116							
dbmcs	Regorafenib	KRAS	c.35G>T			Resistant	P01116							
dbmcs	Regorafenib	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Vemurafenib	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Regorafenib	KRAS	c.34G>T			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.34G>C			Resistant	P01116							
dbmcs	Regorafenib	KRAS	c.34G>C			Resistant	P01116							
dbmcs	Regorafenib	KRAS	c.34G>A			Resistant	P01116							
dbmcs	Panitumumab	KRAS	c.38G>T			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.38G>T			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.34G>A			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.35G>A			Resistant	P01116							
dbmcs	Cetuximab	KRAS	c.35G>C			Resistant	P01116							
dbmcs	Imatinib	KRAS	c.34G>C			Resistant	P01116							
dbmcs	Vemurafenib	MAP2K1	c.607G>A			Resistant	Q02750							
dbmcs	Vemurafenib	MAP2K1	c.167A>C			Resistant	Q02750							
dbmcs	Vemurafenib	MAP2K1	c.169A>G			Resistant	Q02750							
dbmcs	Selumetinib	MAP2K1	c.370C>T			Resistant	Q02750							
dbmcs	Selumetinib	MAP2K1	c.167A>C			Resistant	Q02750							
dbmcs	Vemurafenib	MAP2K1	c.362G>C			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.296T>C			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.344T>C			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.383G>A			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.385T>C			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.632T>A			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.644T>C			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.308T>A			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.312A>C			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.332T>A			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.356A>C			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.360G>C			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.397T>C			Resistant	Q02750							
dbmcs	PLX4720	MAP2K1	c.167A>C			Resistant	Q02750							
dbmcs	Selumetinib	MAP2K1	c.371C>T			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.199G>A			Resistant	Q02750							
dbmcs	BRAF inhibitors	MAP2K1	c.371C>T			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.371C>T			Resistant	Q02750							
dbmcs	Dabrafenib	MAP2K1	c.371C>A			Resistant	Q02750							
dbmcs	Dabrafenib	MAP2K1	c.370C>T			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.171G>C			Resistant	Q02750							
dbmcs	BRAF inhibitors	MAP2K1	c.361T>A			Resistant	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.361T>A			Resistant	Q02750							
dbmcs	Selumetinib	MAP2K1	c.344T>C			Resistant	Q02750							
dbmcs	CI-1040	MAP2K1	c.344T>C			Resistant	Q02750							
dbmcs	AZD-8330	MAP2K1	c.361T>A			Resistant	Q02750							
dbmcs	Regorafenib	MAP2K1	c.361T>A			Resistant	Q02750							
dbmcs	Cetuximab	MAP2K1	c.361T>A			Resistant	Q02750							
dbmcs	PD98059	MAP2K1	c.361T>A			Resistant	Q02750							
dbmcs	GDC0879	MAP2K1	c.361T>A			Resistant	Q02750							
dbmcs	Panitumumab	MAP2K1	c.170A>C			Resistant	Q02750							
dbmcs	Cetuximab	MAP2K1	c.170A>C			Resistant	Q02750							
dbmcs	AZD-8330	MAP2K1	c.167A>C			Resistant	Q02750							
dbmcs	PD98059	MAP2K1	c.167A>C			Resistant	Q02750							
dbmcs	GDC0879	MAP2K1	c.167A>C			Resistant	Q02750							
dbmcs	Regorafenib	MAP2K1	c.167A>C			Resistant	Q02750							
dbmcs	CI-1040	MAP2K1	c.343_344delCTinsGC			Resistant	Q02750							
dbmcs	Trametinib	MAP2K1	c.179T>A			Resistant	Q02750							
dbmcs	Dabrafenib	MAP2K1	c.179T>A			Resistant	Q02750							
dbmcs	GDC0879	MAP2K1	c.171G>C			Resistant	Q02750							
dbmcs	PD98059	MAP2K1	c.171G>C			Resistant	Q02750							
dbmcs	AZD-8330	MAP2K1	c.171G>C			Resistant	Q02750							
dbmcs	Cetuximab	MAP2K1	c.171G>C			Resistant	Q02750							
dbmcs	Regorafenib	MAP2K1	c.171G>C			Resistant	Q02750							
dbmcs	Panitumumab	MAP2K1	c.171G>C			Resistant	Q02750							
dbmcs	PD98059	MAP2K1	c.332T>G			Resistant	Q02750							
dbmcs	Regorafenib	MAP2K1	c.332T>G			Resistant	Q02750							
dbmcs	AZD-8330	MAP2K1	c.332T>G			Resistant	Q02750							
dbmcs	GDC0879	MAP2K1	c.332T>G			Resistant	Q02750							
dbmcs	CI-1040	MAP2K1	c.308T>A			Resistant	Q02750							
dbmcs	Selumetinib	MAP2K1	c.308T>A			Resistant	Q02750							
dbmcs	Cobimetinib	MAP2K1	c.632T>A			Resistant	Q02750							
dbmcs	Regorafenib	MAP2K1	c.632T>A			Resistant	Q02750							
dbmcs	Binimetinib	MAP2K1	c.632T>A			Resistant	Q02750							
dbmcs	AZD-8330	MAP2K1	c.632T>A			Resistant	Q02750							
dbmcs	Selumetinib	MAP2K1	c.632T>A			Resistant	Q02750							
dbmcs	PD98059	MAP2K1	c.632T>A			Resistant	Q02750							
dbmcs	GDC0879	MAP2K1	c.632T>A			Resistant	Q02750							
dbmcs	Dabrafenib	MAP2K1	c.169A>G			Resistant	Q02750							
dbmcs	Regorafenib	MAP2K1	c.385T>C			Resistant	Q02750							
dbmcs	PD98059	MAP2K1	c.385T>C			Resistant	Q02750							
dbmcs	GDC0879	MAP2K1	c.385T>C			Resistant	Q02750							
dbmcs	AZD-8330	MAP2K1	c.385T>C			Resistant	Q02750							
dbmcs	Cetuximab	MAP2K1	c.157T>C			Resistant	Q02750							
dbmcs	Regorafenib	MAP2K1	c.157T>C			Resistant	Q02750							
dbmcs	GDC0879	MAP2K1	c.157T>C			Resistant	Q02750							
dbmcs	AZD-8330	MAP2K1	c.157T>C			Resistant	Q02750							
dbmcs	PD98059	MAP2K1	c.157T>C			Resistant	Q02750							
dbmcs	BRAF + MEK inhibitors	MAP2K2	c.179A>C			Resistant	P36507							
dbmcs	BRAF inhibitors	MAP2K2	c.103G>A			Resistant	P36507							
dbmcs	BRAF inhibitors	MAP2K2	c.136C>T			Resistant	P36507							
dbmcs	BRAF inhibitors	MAP2K2	c.376A>G			Resistant	P36507							
dbmcs	BRAF inhibitors	MAP2K2	c.373T>A			Resistant	P36507							
dbmcs	MEK inhibitors	MAP2K2	c.103G>A			Resistant	P36507							
dbmcs	MEK inhibitors	MAP2K2	c.136C>T			Resistant	P36507							
dbmcs	MEK inhibitors	MAP2K2	c.376A>G			Resistant	P36507							
dbmcs	MEK inhibitors	MAP2K2	c.373T>A			Resistant	P36507							
dbmcs	Crizotinib	MET	c.3682G>A			Resistant	P08581							
dbmcs	Savolitinib	MET	c.3683A>T			Resistant	P08581							
dbmcs	Crizotinib	MET	c.3689A>G			Resistant	P08581							
dbmcs	Crizotinib	MET	c.3703T>G			Resistant	P08581							
dbmcs	MET inhibitors	MET	c.3683A>T			Resistant	P08581							
dbmcs	SU11274	MET	c.1124A>G			Resistant	P08581							
dbmcs	Tivantinib	MET	c.3028G>T			Resistant	P08581							
dbmcs	Capmatinib	MET	c.3683A>T			Resistant	P08581							
dbmcs	Savolitinib	MET	c.3683A>T			Resistant	P08581							
dbmcs	Crizotinib	MET	c.3683A>T			Resistant	P08581							
dbmcs	SU11274	MET	c.3637C>G			Resistant	P08581							
dbmcs	SU11274	MET	c.3742T>C			Resistant	P08581							
dbmcs	Savolitinib	MET	c.3682G>A			Resistant	P08581							
dbmcs	Crizotinib	MET	c.3682G>A			Resistant	P08581							
dbmcs	Capmatinib	MET	c.3682G>A			Resistant	P08581							
dbmcs	Tivantinib	MET	c.3008A>T			Resistant	P08581							
dbmcs	Crizotinib	MET	c.3688T>C			Resistant	P08581							
dbmcs	Savolitinib	MET	c.3688T>C			Resistant	P08581							
dbmcs	Capmatinib	MET	c.3688T>C			Resistant	P08581							
dbmcs	Capmatinib	MET	c.3689A>G			Resistant	P08581							
dbmcs	Cabozantinib	MET	c.3682G>A			Resistant	P08581							
dbmcs	Capmatinib	MET	c.3682G>A			Resistant	P08581							
dbmcs	Crizotinib	MET	c.3688T>C			Resistant	P08581							
dbmcs	Capmatinib	MET	c.3688T>C			Resistant	P08581							
dbmcs	Temozolomide	MSH6	c.3656C>T			Resistant	P52701							
dbmcs	Everolimus	MTOR	c.6322T>C			Resistant	P42345							
dbmcs	Everolimus	MTOR	c.6324C>A			Resistant	P42345							
dbmcs	Sirolimus	MTOR	c.6324C>A			Resistant	P42345							
dbmcs	AZD-8055	MTOR	c.6981G>T			Resistant	P42345							
dbmcs	Sirolimus	MTOR	c.6101C>T			Resistant	P42345							
dbmcs	Carboplatin	NF2	c.528_529			Resistant	Q8NCF5							
dbmcs	Cisplatin	NF2	c.528_529			Resistant	Q8NCF5							
dbmcs	Vemurafenib	NRAS	c.182A>T			Resistant	P01111							
dbmcs	Vemurafenib	NRAS	c.182A>G			Resistant	P01111							
dbmcs	Vemurafenib	NRAS	c.181C>A			Resistant	P01111							
dbmcs	Cetuximab	NRAS	c.35G>A			Resistant	P01111							
dbmcs	Cetuximab	NRAS	c.535C>T			Resistant	P01111							
dbmcs	Cetuximab	NRAS	c.35G>T			Resistant	P01111							
dbmcs	Gedatolisib	NRAS	c.181C>A			Resistant	P01111							
dbmcs	Vemurafenib	NRAS	c.38G>A			Resistant	P01111							
dbmcs	Selumetinib	NRAS	c.182A>T			Resistant	P01111							
dbmcs	LY3009120	NRAS	c.182A>T			Resistant	P01111							
dbmcs	PLX4720	NRAS	c.182A>T			Resistant	P01111							
dbmcs	Tioguanine	NT5C2	c.1100G>A			Resistant	P49902							
dbmcs	Mercaptopurine	NT5C2	c.1100G>A			Resistant	P49902							
dbmcs	Mercaptopurine	NT5C2	c.1075A>C			Resistant	P49902							
dbmcs	Tioguanine	NT5C2	c.1075A>C			Resistant	P49902							
dbmcs	Mercaptopurine	NT5C2	c.1220A>C			Resistant	P49902							
dbmcs	Tioguanine	NT5C2	c.1220A>C			Resistant	P49902							
dbmcs	Entrectinib	NTRK1	c.1783G>A			Resistant	P04629							
dbmcs	Entrectinib	NTRK1	c.1999G>T			Resistant	P04629							
dbmcs	Larotrectinib	NTRK1	c.1783G>A			Resistant	P04629							
dbmcs	Larotrectinib	NTRK1	c.1999G>T			Resistant	P04629							
dbmcs	Pan-TRK inhibitors	NTRK1	c.1783G>A			Resistant	P04629							
dbmcs	Pan-TRK inhibitors	NTRK1	c.1999G>T			Resistant	P04629							
dbmcs	Larotrectinib	NTRK3	c.1867G>A			Resistant	Q16288							
dbmcs	Entrectinib	NTRK3	c.1867G>A			Resistant	Q16288							
dbmcs	Imatinib	PDGFRA	c.2525A>T			Resistant	P16234							
dbmcs	Imatinib	PDGFRA	c.2021C>T			Resistant	P16234							
dbmcs	Sunitinib	PDGFRA	c.2525A>T			Resistant	P16234							
dbmcs	Imatinib	PDGFRA	c.2525A>T			Resistant	P16234							
dbmcs	Sunitinib	PDGFRA	c.2525A>T			Resistant	P16234							
dbmcs	Imatinib	PDGFRA	c.2524_2529delinsATCATG			Resistant	P16234							
dbmcs	Regorafenib	PDGFRA	c.2525A>T			Resistant	P16234							
dbmcs	Nilotinib	PDGFRA	c.2525A>T			Resistant	P16234							
dbmcs	Crenolanib	PDGFRA	c.863A>G			Resistant	P16234							
dbmcs	Sunitinib	PDGFRA	c.863A>G			Resistant	P16234							
dbmcs	Nilotinib	PDGFRA	c.863A>G			Resistant	P16234							
dbmcs	Imatinib	PDGFRA	c.863A>G			Resistant	P16234							
dbmcs	Imatinib	PDGFRA	c.2521_2526delinsAAGATC			Resistant	P16234							
dbmcs	Imatinib	PDGFRA	c.1976A>G			Resistant	P16234							
dbmcs	Imatinib	PDGFRA	c.2537A>T			Resistant	P16234							
dbmcs	Cetuximab	PIK3CA	c.2937_3204+346			Resistant	P42336							
dbmcs	Cetuximab	PIK3CA	c.1624G>A			Resistant	P42336							
dbmcs	Panitumumab	PIK3CA	c.1624G>A			Resistant	P42336							
dbmcs	Cetuximab	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Panitumumab	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Panitumumab	PIK3CA	c.3140A>G			Resistant	P42336							
dbmcs	Gefitinib	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Trastuzumab	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Erlotinib	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Afatinib	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Trastuzumab	PIK3CA	c.3140A>G			Resistant	P42336							
dbmcs	Vemurafenib	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Vemurafenib	PIK3CA	c.1634A>G			Resistant	P42336							
dbmcs	Vemurafenib	PIK3CA	c.1049A>G			Resistant	P42336							
dbmcs	Buparlisib	PIK3CA	c.1357G>A			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.2864T>G			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.2863G>A			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.2832A>C			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.1624G>A			Resistant	P42336							
dbmcs	Buparlisib	PIK3CA	c.1624G>A			Resistant	P42336							
dbmcs	Buparlisib	PIK3CA	c.3145G>C			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.2789T>C			Resistant	P42336							
dbmcs	Bevacizumab + Temsirolimus	PIK3CA	c.3139_3141			Resistant	P42336							
dbmcs	Bortezomib + Temsirolimus + Topotecan	PIK3CA	c.3139_3141			Resistant	P42336							
dbmcs	Buparlisib	PIK3CA	c.1034A>T			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.2896A>G			Resistant	P42336							
dbmcs	Cetuximab	PIK3CA	c.3140A>G			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.3140A>G			Resistant	P42336							
dbmcs	Pictilisib	PIK3CA	c.1645G>T			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.2855T>C			Resistant	P42336							
dbmcs	Buparlisib	PIK3CA	c.115G>A			Resistant	P42336							
dbmcs	A66	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Cetuximab + Fluorouracil	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	Buparlisib	PIK3CA	c.1633G>A			Resistant	P42336							
dbmcs	PI3K pathway inhibitors	PIK3CB	c.3199G>T			Resistant	P42338							
dbmcs	Vemurafenib	PIK3R2	c.1681A>G			Resistant	P30530							
dbmcs	Ibrutinib	PLCG2	c.1993C>T			Resistant	P16885							
dbmcs	Ibrutinib	PLCG2	c.2535A>T			Resistant	P16885							
dbmcs	Tretinoin	PML	c.647C>T			Resistant	P29590							
dbmcs	Tretinoin	PML	c.653T>C			Resistant	P29590							
dbmcs	Vemurafenib	PREX2	c.515G>T			Resistant	Q70Z35							
dbmcs	Pictilisib	PTEN	c.143A>T			Resistant	P60484							
dbmcs	Tirbanibulin	PTEN	c.385G>A			Resistant	P60484							
dbmcs	Alpelisib	PTEN	c.407G>A			Resistant	P60484							
dbmcs	SHP099	PTPN11	c.181G>T			Resistant	Q9UIB8							
dbmcs	SHP099	PTPN11	c.215C>T			Resistant	Q9UIB8							
dbmcs	SHP099	PTPN11	c.226G>A			Resistant	Q9UIB8							
dbmcs	Dabrafenib	RAC1	c.85C>T			Resistant	P63000							
dbmcs	Vemurafenib	RAC1	c.85C>T			Resistant	P63000							
dbmcs	BRAF inhibitors	RAC1	c.85C>T			Resistant	P63000							
dbmcs	BRAF inhibitors	RAF1	c.769T>C			Resistant	P04049							
dbmcs	BRAF inhibitors	RAF1	c.783T>G			Resistant	P04049							
dbmcs	BRAF inhibitors	RAF1	c.1082G>C			Resistant	P04049							
dbmcs	Palbociclib	RB1	c.2083_2084insC			Resistant	P06400							
dbmcs	Letrozole + Ribociclib	RB1	c.1447C>T			Resistant	P06400							
dbmcs	Ponatinib	RET	c.2363T>A			Resistant	P07949							
dbmcs	Motesanib	RET	c.1902C>G			Resistant	P07949							
dbmcs	Motesanib	RET	c.2753T>C			Resistant	P07949							
dbmcs	Vandetanib	RET	c.2410G>C			Resistant	P07949							
dbmcs	Vandetanib	RET	c.2410G>A			Resistant	P07949							
dbmcs	Ceritinib	ROS1	c.5957C>A			Resistant	P08922							
dbmcs	Ceritinib	ROS1	c.5957C>T			Resistant	P08922							
dbmcs	Crizotinib	ROS1	c.6094G>A			Resistant	P08922							
dbmcs	Crizotinib	ROS1	c.5957C>A			Resistant	P08922							
dbmcs	Crizotinib	ROS1	c.5957C>T			Resistant	P08922							
dbmcs	Brigatinib	ROS1	c.6094G>A			Resistant	P08922							
dbmcs	Ceritinib	ROS1	c.6094G>A			Resistant	P08922							
dbmcs	AZD3463	ROS1	c.6094G>A			Resistant	P08922							
dbmcs	Crizotinib	ROS1	c.6076C>A			Resistant	P08922							
dbmcs	Crizotinib	ROS1	c.6464T>C			Resistant	P08922							
dbmcs	Foretinib	ROS1	c.6464T>C			Resistant	P08922							
dbmcs	TAE684	ROS1	c.6464T>C			Resistant	P08922							
dbmcs	Crizotinib	ROS1	c.6302G>C			Resistant	P08922							
dbmcs	Vismodegib	SMO	c.1417G>C			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1418A>G			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1604G>T			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1234C>T			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.843G>T			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1429C>G			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1489G>T			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1417G>T			Resistant	Q99835							
dbmcs	Taladegib	SMO	c.1376C>T			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1376C>T			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1376C>T			Resistant	Q99835							
dbmcs	MRT-92	SMO	c.973_975delCTGinsTTT			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1378T>C			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1234C>T			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.722C>T			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.722C>T			Resistant	Q99835							
dbmcs	Taladegib	SMO	c.722C>T			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1222A>G			Resistant	Q99835							
dbmcs	Taladegib	SMO	c.1222A>G			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1222A>G			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.692A>G			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1417G>C			Resistant	Q99835							
dbmcs	MRT-92	SMO	c.1151A>C			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.961G>A			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.961G>A			Resistant	Q99835							
dbmcs	Taladegib	SMO	c.961G>A			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.961G>A			Resistant	Q99835							
dbmcs	MRT-92	SMO	c.1180_1181delTAinsGC			Resistant	Q99835							
dbmcs	MRT-92	SMO	c.985_987delGTGinsTTT			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1160G>A			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1160G>A			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.842G>T			Resistant	Q99835							
dbmcs	MRT-92	SMO	c.1573_1574delATinsGG			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1598G>A			Resistant	Q99835							
dbmcs	MRT-92	SMO	c.1396_1397delACinsTT			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.843G>T			Resistant	Q99835							
dbmcs	Taladegib	SMO	c.843G>T			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1406G>A			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1406G>A			Resistant	Q99835							
dbmcs	Taladegib	SMO	c.1406G>A			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1552G>A			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1552G>A			Resistant	Q99835							
dbmcs	MRT-92	SMO	c.1552G>A			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1604G>T			Resistant	Q99835							
dbmcs	Posaconazole	SMO	c.1604G>T			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.655A>G			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.655A>G			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1418A>G			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1418A>G			Resistant	Q99835							
dbmcs	Sonidegib	SMO	c.1150G>A			Resistant	Q99835							
dbmcs	Vismodegib	SMO	c.1150G>A			Resistant	Q99835							
dbmcs	Cisplatin	TP53	c.139C>T			Resistant	Q12888							
dbmcs	Cisplatin	TP53	c.818G>T			Resistant	Q12888							
dbmcs	Carboplatin	TP53	c.818G>T			Resistant	Q12888							
dbmcs	Cisplatin	TP53	c.701A>G			Resistant	Q12888							
dbmcs	Carboplatin	TP53	c.701A>G			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.743G>A			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.742C>T			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.524G>A			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.817C>T			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.818G>A			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.733G>A			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.659A>G			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.711G>T			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.473G>A			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.469G>T			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.747G>C			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.839G>A			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.839G>C			Resistant	Q12888							
dbmcs	AMGMDS3	TP53	c.473G>T			Resistant	Q12888							
dbmcs	Nutlin-3	TP53	c.772G>C			Resistant	Q12888							
dbmcs	Nutlin-3	TP53	c.529C>A			Resistant	Q12888							
dbmcs	ALRN-6924	TP53	c.743G>A			Resistant	Q12888							
dbmcs	DS-7423	TP53	c.524G>A			Resistant	Q12888							
dbmcs	Seliciclib	TP53	c.524G>A			Resistant	Q12888							
dbmcs	Seliciclib	TP53	c.476C>T			Resistant	Q12888							
dbmcs	Seliciclib	TP53	c.643A>G			Resistant	Q12888							
dbmcs	Seliciclib	TP53	c.701A>G			Resistant	Q12888							
dbmcs	Seliciclib	TP53	c.659A>G			Resistant	Q12888							
dbmcs	NSC319726	TP53	c.817_819delCGTinsTGG			Resistant	Q12888							
dbmcs	Seliciclib	TP53	c.292C>G			Resistant	Q12888							
dbmcs	DS-7423	TP53	c.722C>T			Resistant	Q12888							
dbmcs	Nutlin-3	TP53	c.695T>G			Resistant	Q12888							
dbmcs	Nutlin-3	TP53	c.839_840delGAinsTG			Resistant	Q12888							
dbmcs	Daunorubicin + Cytarabine	WT1	c.1099_1249			Resistant	P19544							
dbmcs	Paclitaxel	ABCB1	c.2677T>A			Sensitive	P08183							
dbmcs	Cisplatin	ABCB1	c.3435T>C			Sensitive	P08183							
dbmcs	Carboplatin	ABCB1	c.3435T>C			Sensitive	P08183							
dbmcs	Axitinib	ABL1	c.944C>T			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.943A>G			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.949T>G			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.949T>A			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.950T>G			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.757T>C			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.1075T>G			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.1076T>G			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.1075T>A			Sensitive	P00519							
dbmcs	Cabozantinib	ABL1	c.895G>C			Sensitive	P00519							
dbmcs	Crizotinib	ABL1	c.895G>C			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.1076T>G			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.1075T>A			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.757T>C			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.764A>T			Sensitive	P00519							
dbmcs	Foretinib	ABL1	c.895G>C			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.943A>G			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.949T>C			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.949T>G			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.949T>A			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.950T>G			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.895G>C			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.944C>T			Sensitive	P00519							
dbmcs	Vandetanib	ABL1	c.895G>C			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.949T>C			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.827A>G			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.1052T>C			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.1457T>C			Sensitive	P00519							
dbmcs	Nilotinib	ABL1	c.1192G>C			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.1051C>T			Sensitive	P00519							
dbmcs	Imatinib	ABL1	c.1018_1019delGGinsCT			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.1018_1019delGGinsCT			Sensitive	P00519							
dbmcs	Imatinib	ABL1	c.1051C>T			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.943A>G			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.949T>C			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.949T>G			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.949T>A			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.950T>G			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.1075T>G			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.1075T>G			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.1076T>G			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.1075T>A			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.757T>C			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.763G>A			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.763G>A			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.764A>T			Sensitive	P00519							
dbmcs	Ponatinib	ABL1	c.895G>C			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.994C>T			Sensitive	P00519							
dbmcs	Imatinib	ABL1	c.994C>T			Sensitive	P00519							
dbmcs	Dasatinib	ABL1	c.961_962delGGinsCT			Sensitive	P00519							
dbmcs	Imatinib	ABL1	c.961_962delGGinsCT			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.763G>A			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.764A>T			Sensitive	P00519							
dbmcs	Bosutinib	ABL1	c.949T>C			Sensitive	P00519							
dbmcs	Everolimus	AKT1	c.712C>T			Sensitive	P31749							
dbmcs	Temsirolimus	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	Uprosertib	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	Capivasertib	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	allosteric AKT inhibitors	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	non-allosteric AKT inhibitors	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	allosteric AKT inhibitors	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	AKT inhibitors	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	PI3K pathway inhibitors	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	Capivasertib	AKT1	c.202_231			Sensitive	P31749							
dbmcs	ARQ 751	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	BAY1125976	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	Ipatasertib	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	Miransertib	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	Miransertib	AKT1	c.49G>A			Sensitive	P31749							
dbmcs	Capivasertib	AKT1	c.235C>A			Sensitive	P31749							
dbmcs	Brigatinib	ALK	c.4223A>T			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3586C>A			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3586C>A			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3617C>A			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3806G>C			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3512T>C			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.2567T>C			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.1043C>A			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.3592C>T			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.3824G>A			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.3383G>C			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.3512T>A			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.3575G>C			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.3734T>G			Sensitive	Q9UM73							
dbmcs	Lorlatinib	ALK	c.3467G>A			Sensitive	Q9UM73							
dbmcs	Alectinib	ALK	c.3522C>A			Sensitive	Q9UM73							
dbmcs	Alectinib	ALK	c.3586C>A			Sensitive	Q9UM73							
dbmcs	TAE684	ALK	c.3522C>A			Sensitive	Q9UM73							
dbmcs	Crizotinib	ALK	c.3824G>A			Sensitive	Q9UM73							
dbmcs	Lorlatinib	ALK	c.3467G>A			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3512T>C			Sensitive	Q9UM73							
dbmcs	TAE684	ALK	c.3512T>C			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3538G>C			Sensitive	Q9UM73							
dbmcs	TAE684	ALK	c.3538G>C			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3538G>C			Sensitive	Q9UM73							
dbmcs	AZD3463	ALK	c.3522C>A			Sensitive	Q9UM73							
dbmcs	Lorlatinib	ALK	c.3522C>A			Sensitive	Q9UM73							
dbmcs	Lorlatinib	ALK	c.3734T>G			Sensitive	Q9UM73							
dbmcs	Lorlatinib	ALK	c.3824G>A			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3734T>G			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3586C>A			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3806G>C			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3617C>A			Sensitive	Q9UM73							
dbmcs	Tanespimycin	ALK	c.3453_3454			Sensitive	Q9UM73							
dbmcs	Tanespimycin	ALK	c.3604G>A			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3806G>C			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3734T>G			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3383G>C			Sensitive	Q9UM73							
dbmcs	Alectinib + Doxorubicin	ALK	c.3271G>A			Sensitive	Q9UM73							
dbmcs	AZD3463 + Doxorubicin	ALK	c.3271G>A			Sensitive	Q9UM73							
dbmcs	AZD3463	ALK	c.3271G>A			Sensitive	Q9UM73							
dbmcs	Alectinib	ALK	c.3271G>A			Sensitive	Q9UM73							
dbmcs	Alectinib	ALK	c.3467G>A			Sensitive	Q9UM73							
dbmcs	Crizotinib + Cyclophosphamide + Topotecan	ALK	c.3824G>A			Sensitive	Q9UM73							
dbmcs	CEP-28122	ALK	c.3824G>A			Sensitive	Q9UM73							
dbmcs	Ceritinib	ALK	c.3824G>A			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3824G>A			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3520T>G			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3512T>A			Sensitive	Q9UM73							
dbmcs	Lorlatinib	ALK	c.3520T>C			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3520T>C			Sensitive	Q9UM73							
dbmcs	CEP-28122	ALK	c.3520T>C			Sensitive	Q9UM73							
dbmcs	AZD3463	ALK	c.3520T>C			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3575G>C			Sensitive	Q9UM73							
dbmcs	Brigatinib	ALK	c.3833A>C			Sensitive	Q9UM73							
dbmcs	Entrectinib	ALK	c.3733T>G			Sensitive	Q9UM73							
dbmcs	G007-LK	APC	c.2432C>A			Sensitive	P25054							
dbmcs	IWR-1	APC	c.2432C>A			Sensitive	P25054							
dbmcs	XAV939	APC	c.2432C>A			Sensitive	P25054							
dbmcs	NVP-TNKS656	APC	c.4216C>T			Sensitive	P25054							
dbmcs	XAV939	APC	c.4216C>T			Sensitive	P25054							
dbmcs	G007-LK	APC	c.4216C>T			Sensitive	P25054							
dbmcs	IWR-1	APC	c.1658G>A			Sensitive	P25054							
dbmcs	G007-LK	APC	c.1658G>A			Sensitive	P25054							
dbmcs	TASIN-1	APC	c.4012C>T			Sensitive	P25054							
dbmcs	JW67	APC	c.4012C>T			Sensitive	P25054							
dbmcs	JW74	APC	c.4012C>T			Sensitive	P25054							
dbmcs	TASIN-1	APC	c.3925G>T			Sensitive	P25054							
dbmcs	TASIN-1	APC	c.4463T>A			Sensitive	P25054							
dbmcs	IWR-1	APC	c.646C>T			Sensitive	P25054							
dbmcs	G007-LK	APC	c.646C>T			Sensitive	P25054							
dbmcs	TASIN-1	APC	c.4246_4248delGGCinsTGA			Sensitive	P25054							
dbmcs	Enzalutamide	AR	c.2629T>C + c.2632A>G			Sensitive	O95154							
dbmcs	Sorafenib	ARAF	c.641C>G			Sensitive	P10398							
dbmcs	Trametinib	ARAF	c.641C>G			Sensitive	P10398							
dbmcs	Dasatinib	ARID1A	c.3524delC			Sensitive	O14497							
dbmcs	Talazoparib	ARID1A	c.1366C>T			Sensitive	O14497							
dbmcs	Dasatinib	ARID1A	c.1366C>T			Sensitive	O14497							
dbmcs	Olaparib	ARID1A	c.1366C>T			Sensitive	O14497							
dbmcs	VE-821	ARID1A	c.1366C>T			Sensitive	O14497							
dbmcs	Berzosertib	ARID1A	c.1366C>T			Sensitive	O14497							
dbmcs	Rucaparib	ARID1A	c.1366C>T			Sensitive	O14497							
dbmcs	JQ1	ARID1A	c.3442C>T			Sensitive	O14497							
dbmcs	Olaparib	ATM	c.6860_6861insGT			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.8623A>C			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.1810C>T			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.4346T>A			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.6112C>T			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.1555G>A			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.175G>T			Sensitive	Q13315							
dbmcs	Temozolomide + Veliparib	ATM	c.1229T>C			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.8246A>T			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.2471C>T			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.5620C>T			Sensitive	Q13315							
dbmcs	Temozolomide + Veliparib	ATM	c.998C>T			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.2879C>A			Sensitive	Q13315							
dbmcs	Temozolomide + Veliparib	ATM	c.8174A>G			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.4365T>G			Sensitive	Q13315							
dbmcs	Olaparib	ATM	c.5521G>A			Sensitive	Q13315							
dbmcs	Trametinib	BRAF	c.1802A>G			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1790T>G			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1798_1799delGTinsAG			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1798_1799delGTinsAG			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Dasatinib	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	Dasatinib	BRAF	c.1415A>G			Sensitive	P15056							
dbmcs	Panitumumab + Dabrafenib + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Selumetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Sorafenib	BRAF	c.1781A>G			Sensitive	P15056							
dbmcs	Sorafenib	BRAF	c.1406G>A			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1798G>A			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1799T>G			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1798_1799delGTinsAG			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib + Cobimetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib + Cobimetinib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1799T>A + c.1798G>A			Sensitive	P15056							
dbmcs	Sorafenib + Panitumumab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	PLX4720 + Pictilisib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PLX4720 + Nutlin-3	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib + Capecitabine + Bevacizumab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1790T>G			Sensitive	P15056							
dbmcs	Pictilisib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	RO4987655	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Selumetinib + Dactolisib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cobimetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	LY3009120	BRAF	c.1453_1470del18			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Vemurafenib + Gefitinib + Cetuximab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Trametinib + Dabrafenib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Vemurafenib + Cobimetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib + Cobimetinib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Dactolisib + GDC-0879	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	MEK inhibitors	BRAF	c.1781A>C			Sensitive	P15056							
dbmcs	Sorafenib	BRAF	c.1781A>C			Sensitive	P15056							
dbmcs	Sorafenib	BRAF	c.1781A>T			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1781A>T			Sensitive	P15056							
dbmcs	MEK inhibitors	BRAF	c.1448_1449delAAinsTG			Sensitive	P15056							
dbmcs	Sorafenib	BRAF	c.1448_1449delAAinsTG			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1790T>G			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	TAK-733	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1790T>A			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1790T>A			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1801A>G			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1801A>G			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1789C>G			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Vemurafenib + Panitumumab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1786G>T			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Vemurafenib + Irinotecan + Cetuximab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Trametinib + Dabrafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Trametinib + Dabrafenib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib DMSO	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib + Panitumumab + Irinotecan	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib + Pertuzumab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Encorafenib + Cetuximab	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Alpelisib + Cetuximab + Encorafenib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Trametinib + Dabrafenib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Binimetinib + Encorafenib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	Cetuximab + Irinotecan + Vemurafenib	BRAF	c.1798_1799			Sensitive	P15056							
dbmcs	BRAF inhibitors	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	Mitogen-Activated Protein Kinase Kinase inhibitor + BRAF inhibitor	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	Mitogen-Activated Protein Kinase Kinase inhibitor + BRAF inhibitor	BRAF	c.1799_1801delTGA			Sensitive	P15056							
dbmcs	Mitogen-Activated Protein Kinase Kinase inhibitor + BRAF inhibitor	BRAF	c.1405_1407			Sensitive	P15056							
dbmcs	BRAF inhibitors	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BRAF inhibitors	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1406G>C			Sensitive	P15056							
dbmcs	ERK inhibitors	BRAF	c.1454T>G			Sensitive	P15056							
dbmcs	ERK inhibitors	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BRAF inhibitors	BRAF	c.1798_1799delGTinsAG			Sensitive	P15056							
dbmcs	MEK inhibitors	BRAF	c.1802A>G			Sensitive	P15056							
dbmcs	MEK inhibitors	BRAF	c.1790T>G			Sensitive	P15056							
dbmcs	CCT196969	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	TAK-632	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	AZ628	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	CCT241161	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	PLX7904	BRAF	c.1799_1800delTGinsAC			Sensitive	P15056							
dbmcs	Sorafenib	BRAF	c.1406G>T			Sensitive	P15056							
dbmcs	Cobimetinib	BRAF	c.1458_1472del15			Sensitive	P15056							
dbmcs	Cobimetinib	BRAF	c.1458_1472del15			Sensitive	P15056							
dbmcs	Buparlisib + Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	MK2206 + Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Cobimetinib + Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Atezolizumab + Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Selumetinib + Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Binimetinib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Trametinib + Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Cetuximab + Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	MK2206 + Trametinib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Atezolizumab + Cobimetinib + Vemurafenib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Buparlisib + Trametinib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Buparlisib + Selumetinib	BRAF	c.1798_1800			Sensitive	P15056							
dbmcs	Ulixertinib	BRAF	c.1790T>A			Sensitive	P15056							
dbmcs	Binimetinib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	Cobimetinib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	Binimetinib + Encorafenib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	Encorafenib + Trametinib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	Encorafenib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	LY3009120	BRAF	c.1789_1790delCTinsTC			Sensitive	P15056							
dbmcs	RMC-4550	BRAF	c.1741A>G			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1801A>G			Sensitive	P15056							
dbmcs	Dasatinib	BRAF	c.1415A>G			Sensitive	P15056							
dbmcs	Pembrolizumab	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Omipalisib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Binimetinib + Encorafenib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Nivolumab	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1457_1471del15			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1457_1471del15			Sensitive	P15056							
dbmcs	LY3009120	BRAF	c.1457_1471del15			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1457_1471del15			Sensitive	P15056							
dbmcs	TAE226	BRAF	c.1406G>C			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1406G>C			Sensitive	P15056							
dbmcs	Ulixertinib	BRAF	c.1406G>C			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1406G>C			Sensitive	P15056							
dbmcs	Encorafenib + Trametinib	BRAF	c.1406G>C			Sensitive	P15056							
dbmcs	PLX8394	BRAF	c.1406G>C			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1406G>C			Sensitive	P15056							
dbmcs	LY3009120	BRAF	c.1460_1474del15			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1460_1474del15			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.739T>C			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.739T>C			Sensitive	P15056							
dbmcs	AZ628	BRAF	c.1397G>A			Sensitive	P15056							
dbmcs	TAK-632	BRAF	c.1397G>A			Sensitive	P15056							
dbmcs	Ulixertinib	BRAF	c.1454T>G			Sensitive	P15056							
dbmcs	Panitumumab + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Lifirafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Everolimus + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BI-847325	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	INU-152	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Erlotinib + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	SCH772984	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Panitumumab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	SBI-0640756	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dasatinib + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	TW-37 + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	E6201	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	CI-1040	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PAC-1 + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + Selumetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Ulixertinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Pimasertib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Imatinib + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Binimetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Gefitinib + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	CCT196969	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Omipalisib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + SCH772984	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + Dabrafenib + SCH772984	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Afatinib + BI-882370	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Binimetinib + Encorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Navitoclax + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PD-0325901	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Ganetespib + TAK-733	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	SBI-755199	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Navitoclax + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dasatinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Everolimus + Selumetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PLX8394	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Pimasertib + Regorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Selumetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	GDC0879	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BI-882370 + Cetuximab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	RO-5126766 free base	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Trametinib + TW-37	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cediranib + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Pimasertib + Sorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	SB590885	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Agerafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cobimetinib + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dasatinib + SCH772984	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Alpelisib + Cetuximab + Encorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Alpelisib + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Trametinib + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	SBI-0640726	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cobimetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Palbociclib + PD-0325901	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Everolimus + Pimasertib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	EBI-907	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PAC-1 + Trametinib + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PLX4720 + Selumetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Refametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	RO4987655	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	DETD-35	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Lapatinib + Panobinostat	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cobimetinib + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	DETD-35 + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PLX4720 + Tivozanib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Navitoclax + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PF-00477736 + PF3644022	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	TAK-632	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dasatinib + Selumetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Saracatinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + SCH772984	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PLX7904	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Regorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BI-69A11	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + Dabrafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Lapatinib + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	CLM3	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Sorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	RAF-265	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	RAF-265	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	RAF709	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	CCT241161	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BGB-283 + Cetuximab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Encorafenib + Ribociclib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + Sorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cediranib + PLX4720 + Selumetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Erlotinib + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	DEL-22379	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Ganetespib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BI-882370 + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Omipalisib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	LSN3074753	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Binimetinib + Cetuximab + Encorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BI2536	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Ulixertinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	DT01 + Fluorouracil + Oxaliplatin	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	PLX4720 + Vorinostat	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Omipalisib + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	S3I-201	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + Dabrafenib + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Gefitinib + Vemurafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	AZ628	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	LY3009120	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib + Panitumumab + Trametinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Doxorubicin + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	BI2536 + PLX4720	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Cetuximab + Encorafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Gedatolisib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Dabrafenib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	LY3009120	BRAF	c.1803A>C			Sensitive	P15056							
dbmcs	PLX8394	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	Irinotecan + Panitumumab	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	Cetuximab	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	RMC-4550	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	TAK-632	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	TAE226	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1397G>T			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1786G>C			Sensitive	P15056							
dbmcs	RMC-4550	BRAF	c.1786G>C			Sensitive	P15056							
dbmcs	Dabrafenib + Trametinib	BRAF	c.1786G>C			Sensitive	P15056							
dbmcs	PF-00477736 + PF3644022	BRAF	c.1742A>G			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1781A>G			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1790T>G			Sensitive	P15056							
dbmcs	RMC-4550	BRAF	c.1780G>A			Sensitive	P15056							
dbmcs	TAK-632	BRAF	c.1798_1799delGTinsAG			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1798_1799delGTinsAG			Sensitive	P15056							
dbmcs	AZ628	BRAF	c.1798_1799delGTinsAG			Sensitive	P15056							
dbmcs	PLX7904	BRAF	c.1798_1799delGTinsAG			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1453_1470delinsTAT			Sensitive	P15056							
dbmcs	LY3009120	BRAF	c.1453_1470delinsTAT			Sensitive	P15056							
dbmcs	Vemurafenib	BRAF	c.1800G>A			Sensitive	P15056							
dbmcs	Encorafenib + Binimetinib	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Encorafenib + Binimetinib	BRAF	c.1798_1799delGTinsAA			Sensitive	P15056							
dbmcs	Encorafenib + Binimetinib + Cetuximab	BRAF	c.1799T>A			Sensitive	P15056							
dbmcs	Vemurafenib + Panitumumab	BRAF	c.1800G>A			Sensitive	P15056							
dbmcs	Panitumumab + Dabrafenib + Trametinib	BRAF	c.1800G>A			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1803A>G			Sensitive	P15056							
dbmcs	Trametinib	BRAF	c.1791A>T			Sensitive	P15056							
dbmcs	PLX8394	BRAF	c.1392A>T			Sensitive	P15056							
dbmcs	PLX8394	BRAF	c.1405G>A			Sensitive	P15056							
dbmcs	PLX8394	BRAF	c.1406G>T			Sensitive	P15056							
dbmcs	PLX8394	BRAF	c.1803A>G			Sensitive	P15056							
dbmcs	PLX8394	BRAF	c.1791A>T			Sensitive	P15056							
dbmcs	Rucaparib	BRCA1	c.1A>G			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.3G>T			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.181T>G			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.191G>A			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.211A>G			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.212G>A			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.4484G>T			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.4675G>A			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.5074G>A			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.4327C>T			Sensitive	P38398							
dbmcs	Rucaparib	BRCA1	c.4399C>T			Sensitive	P38398							
dbmcs	Olaparib	BRCA1	c.5445G>A			Sensitive	P38398							
dbmcs	Rucaparib	BRCA2	c.2T>G			Sensitive	P51587							
dbmcs	Rucaparib	BRCA2	c.3G>T			Sensitive	P51587							
dbmcs	Rucaparib	BRCA2	c.475G>A			Sensitive	P51587							
dbmcs	Rucaparib	BRCA2	c.631G>C			Sensitive	P51587							
dbmcs	Rucaparib	BRCA2	c.631G>A			Sensitive	P51587							
dbmcs	Rucaparib	BRCA2	c.7007G>C			Sensitive	P51587							
dbmcs	Rucaparib	BRCA2	c.7007G>A			Sensitive	P51587							
dbmcs	Ruxolitinib	CALR	c.1153_1154insTAATT			Sensitive	P27797							
dbmcs	Dasatinib	CBL	c.1111T>C			Sensitive	P22681							
dbmcs	Dasatinib	CBL	c.1150T>C			Sensitive	P22681							
dbmcs	JAK inhibitors	CBL	c.1111T>C			Sensitive	P22681							
dbmcs	JAK inhibitors	CBL	c.1150T>C			Sensitive	P22681							
dbmcs	Palbociclib	CDK4	c.70C>T			Sensitive	P11802							
dbmcs	Palbociclib	CDKN2A	c.238C>T			Sensitive	Q9NXV6							
dbmcs	Imatinib	CSF1R	c.1711T>G			Sensitive	P07333							
dbmcs	Ruxolitinib	CSF3R	c.1853C>T			Sensitive	Q99062							
dbmcs	Ruxolitinib	CSF3R	c.1843A>G			Sensitive	Q99062							
dbmcs	Dasatinib	CSF3R	c.2221_2223			Sensitive	Q99062							
dbmcs	Dasatinib	CSF3R	c.2254_2256			Sensitive	Q99062							
dbmcs	Dasatinib	CSF3R	c.2371_2373			Sensitive	Q99062							
dbmcs	Dasatinib	CSF3R	c.2311_2310			Sensitive	Q99062							
dbmcs	Dasatinib	CSF3R	c.2347_2346			Sensitive	Q99062							
dbmcs	Ibrutinib + Ruxolitinib	CSF3R	c.2221C>T			Sensitive	Q99062							
dbmcs	Ruxolitinib	CSF3R	c.2221C>T			Sensitive	Q99062							
dbmcs	Ibrutinib	CSF3R	c.2221C>T			Sensitive	Q99062							
dbmcs	Ibrutinib	CSF3R	c.1853C>T			Sensitive	Q99062							
dbmcs	Ibrutinib + Ruxolitinib	CSF3R	c.1853C>T			Sensitive	Q99062							
dbmcs	Ruxolitinib	CSF3R	c.1853C>T			Sensitive	Q99062							
dbmcs	Ruxolitinib	CSF3R	c.1919C>A			Sensitive	Q99062							
dbmcs	Trametinib	CSF3R	c.1828A>C			Sensitive	Q99062							
dbmcs	Ruxolitinib	CSF3R	c.1828A>C			Sensitive	Q99062							
dbmcs	Ruxolitinib	CSF3R	c.1829A>G			Sensitive	Q99062							
dbmcs	Trametinib	CSF3R	c.1829A>G			Sensitive	Q99062							
dbmcs	Everolimus + Letrozole	CTNNB1	c.106C>T			Sensitive	P35222							
dbmcs	Everolimus + Letrozole	CTNNB1	c.110C>G			Sensitive	P35222							
dbmcs	Everolimus + Letrozole	CTNNB1	c.110C>A			Sensitive	P35222							
dbmcs	Everolimus + Letrozole	CTNNB1	c.95A>T			Sensitive	P35222							
dbmcs	NTRC 0066-0	CTNNB1	c.133_135delTCT			Sensitive	P35222							
dbmcs	NMS-P715	CTNNB1	c.133_135delTCT			Sensitive	P35222							
dbmcs	BAY1217389	CTNNB1	c.133_135delTCT			Sensitive	P35222							
dbmcs	MPI-0479605	CTNNB1	c.133_135delTCT			Sensitive	P35222							
dbmcs	Mps1-IN-1	CTNNB1	c.133_135delTCT			Sensitive	P35222							
dbmcs	BAY1161909	CTNNB1	c.133_135delTCT			Sensitive	P35222							
dbmcs	Mps-BAY2b	CTNNB1	c.133_135delTCT			Sensitive	P35222							
dbmcs	NMS-P715	CTNNB1	c.121A>G			Sensitive	P35222							
dbmcs	BAY1217389	CTNNB1	c.121A>G			Sensitive	P35222							
dbmcs	BAY1161909	CTNNB1	c.121A>G			Sensitive	P35222							
dbmcs	Mps-BAY2b	CTNNB1	c.121A>G			Sensitive	P35222							
dbmcs	MPI-0479605	CTNNB1	c.121A>G			Sensitive	P35222							
dbmcs	Imatinib	CTNNB1	c.121A>G			Sensitive	P35222							
dbmcs	NTRC 0066-0	CTNNB1	c.121A>G			Sensitive	P35222							
dbmcs	Mps1-IN-1	CTNNB1	c.121A>G			Sensitive	P35222							
dbmcs	NMS-P715	CTNNB1	c.98C>A			Sensitive	P35222							
dbmcs	Mps-BAY2b	CTNNB1	c.98C>A			Sensitive	P35222							
dbmcs	Mps1-IN-1	CTNNB1	c.98C>A			Sensitive	P35222							
dbmcs	NTRC 0066-0	CTNNB1	c.98C>A			Sensitive	P35222							
dbmcs	MPI-0479605	CTNNB1	c.98C>A			Sensitive	P35222							
dbmcs	BAY1217389	CTNNB1	c.98C>A			Sensitive	P35222							
dbmcs	BAY1161909	CTNNB1	c.98C>A			Sensitive	P35222							
dbmcs	BAY1217389	CTNNB1	c.134C>T			Sensitive	P35222							
dbmcs	NTRC 0066-0	CTNNB1	c.134C>T			Sensitive	P35222							
dbmcs	Imatinib	CTNNB1	c.134C>T			Sensitive	P35222							
dbmcs	MPI-0479605	CTNNB1	c.134C>T			Sensitive	P35222							
dbmcs	Mps-BAY2b	CTNNB1	c.134C>T			Sensitive	P35222							
dbmcs	NMS-P715	CTNNB1	c.134C>T			Sensitive	P35222							
dbmcs	Mps1-IN-1	CTNNB1	c.134C>T			Sensitive	P35222							
dbmcs	Dasatinib	DDR2	c.1912A>T			Sensitive	Q16832							
dbmcs	Dasatinib	DDR2	c.716T>G			Sensitive	Q16832							
dbmcs	Dasatinib	DDR2	c.757G>T			Sensitive	Q16832							
dbmcs	Dasatinib	DDR2	c.2321G>T			Sensitive	Q16832							
dbmcs	Dasatinib	DDR2	c.187C>G			Sensitive	Q16832							
dbmcs	Dasatinib	DDR2	c.1513G>A			Sensitive	Q16832							
dbmcs	Dasatinib	DDR2	c.2304T>G			Sensitive	Q16832							
dbmcs	Erlotinib	DDR2	c.2304T>G			Sensitive	Q16832							
dbmcs	Dasatinib + Erlotinib	DDR2	c.2304T>A			Sensitive	Q16832							
dbmcs	Dasatinib + Erlotinib	DDR2	c.2304T>G			Sensitive	Q16832							
dbmcs	Nilotinib + Saracatinib	DDR2	c.757G>T			Sensitive	Q16832							
dbmcs	Ponatinib	DDR2	c.757G>T			Sensitive	Q16832							
dbmcs	Ponatinib	DDR2	c.716T>G			Sensitive	Q16832							
dbmcs	Nilotinib + Saracatinib	DDR2	c.716T>G			Sensitive	Q16832							
dbmcs	Ponatinib	DDR2	c.1912A>T			Sensitive	Q16832							
dbmcs	Nilotinib + Saracatinib	DDR2	c.1912A>T			Sensitive	Q16832							
dbmcs	Nilotinib + Saracatinib	DDR2	c.2321G>T			Sensitive	Q16832							
dbmcs	Ponatinib	DDR2	c.2321G>T			Sensitive	Q16832							
dbmcs	Nilotinib + Saracatinib	DDR2	c.187C>G			Sensitive	Q16832							
dbmcs	Ponatinib	DDR2	c.187C>G			Sensitive	Q16832							
dbmcs	Nilotinib + Saracatinib	DDR2	c.1513G>A			Sensitive	Q16832							
dbmcs	Ponatinib	DDR2	c.1513G>A			Sensitive	Q16832							
dbmcs	Idarubicin	DNMT3A	c.2645G>A			Sensitive	Q9Y6K1							
dbmcs	Capecitabine	DPYD	c.1679T>G			Sensitive	Q12882							
dbmcs	Capecitabine	DPYD	c.2846A>T			Sensitive	Q12882							
dbmcs	Fluorouracil	DPYD	c.1679T>G			Sensitive	Q12882							
dbmcs	Fluorouracil	DPYD	c.2846A>T			Sensitive	Q12882							
dbmcs	Tegafur	DPYD	c.1679T>G			Sensitive	Q12882							
dbmcs	Tegafur	DPYD	c.2846A>T			Sensitive	Q12882							
dbmcs	Rociletinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Olmutinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2155G>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2156G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2240T>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2303G>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2582T>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2582T>G			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2155G>T			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2156G>A			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2240T>C			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2303G>T			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2582T>C			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2582T>G			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Afatinib + Nimotuzumab	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.1636C>T			Sensitive	P00533							
dbmcs	Cetuximab + Sirolimus	EGFR	c.2257C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.866C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.323G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.1793G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.787A>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2270A>G			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2237A>G			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2155G>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2156G>A			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2240T>C			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2582T>C			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2582T>G			Sensitive	P00533							
dbmcs	Lapatinib	EGFR	c.2068G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Panitumumab	EGFR	c.1476C>G			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2185_2283			Sensitive	P00533							
dbmcs	Pemetrexed + Erlotinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Staurosporine	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2185_2283			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2170G>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2185_2283			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2185_2283			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.3274_3276			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.3274_3276			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2186_2283+1del99			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2186_2283+1del99			Sensitive	P00533							
dbmcs	Futuximab	EGFR	c.1393G>A			Sensitive	P00533							
dbmcs	Panitumumab	EGFR	c.1476C>A			Sensitive	P00533							
dbmcs	Futuximab	EGFR	c.1476C>A			Sensitive	P00533							
dbmcs	Panitumumab	EGFR	c.1351C>T			Sensitive	P00533							
dbmcs	Futuximab	EGFR	c.1351C>T			Sensitive	P00533							
dbmcs	Futuximab	EGFR	c.1400A>C			Sensitive	P00533							
dbmcs	Panitumumab	EGFR	c.1400A>C			Sensitive	P00533							
dbmcs	Sirolimus + Cetuximab	EGFR	c.2257C>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2303G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2155_2156			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2308_2309insCAAGCGTAG			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Canertinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Lapatinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Canertinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	AEE-788	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2155_2157			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2155_2157			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2225T>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2156G>A			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2321T>C			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2500_2502delGTGinsATC			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2513T>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2551G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2240_2257del18			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2492G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2581_2583			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2581_2583			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2603A>G			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2326C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2192G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2200G>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2353A>G			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2390G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2401T>C			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2185_2283			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2155G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2156G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2240T>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2303G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2582T>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2582T>G			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2185_2283			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2185_2283			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2310_2311insGGT			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2310_2311insGGT			Sensitive	P00533							
dbmcs	TAS6417	EGFR	c.2310_2311insGGT			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2311_2313delinsTTTCAT			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2239_2253delinsCCT			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2239_2253delinsCCT			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2239_2253delinsCCT			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2239_2253delinsCCT			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2239_2253delinsCCT			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2236_2237insTACCTGTAGCAATCAAGG			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2236_2237insTACCTGTAGCAATCAAGG			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2292_2293insCATCAT			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2299_2307			Sensitive	P00533							
dbmcs	TAS6417	EGFR	c.2299_2307			Sensitive	P00533							
dbmcs	Naquotinib	EGFR	c.2299_2307			Sensitive	P00533							
dbmcs	Nazartinib	EGFR	c.2299_2307			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2299_2307			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2299_2307			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2299_2307			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.664C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.664C>T			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2308_2309insCAAGCGTAG			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2153T>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2153T>A			Sensitive	P00533							
dbmcs	EKI-285	EGFR	c.2153T>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2153T>A			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	Nazartinib	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	TAS6417	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2302_2310			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2293G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2293G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2293G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2504A>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2504A>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2504A>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2504A>T			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2504A>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2551G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.3458G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.3458G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.3458G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2611G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2611G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2257C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2257C>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.185T>G			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.185T>G			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.185T>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.185T>G			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2316_2317insGGTAACCCT			Sensitive	P00533							
dbmcs	Naquotinib	EGFR	c.2316_2317insGGTAACCCT			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2316_2317insGGTAACCCT			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2316_2317insGGTAACCCT			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2316_2317insGGTAACCCT			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.1793G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.1793G>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.1793G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2155G>T			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2155G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2155G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	Lazertinib	EGFR	c.2582T>A			Sensitive	P00533							
dbmcs	MM-151	EGFR	c.1393G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	Naquotinib	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	TAS6417	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2290_2291insTTCAAGAGGCAT			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.323G>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.323G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.323G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2593G>A			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2530C>G			Sensitive	P00533							
dbmcs	EKI-285	EGFR	c.2530C>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2530C>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2579A>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2579A>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2500G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2500G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.102_869del11834			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2621G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2620G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2620G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2620G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2239_2240delTTinsCC			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2235_2236insACACCTGTAGCAATCAAG			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2252C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2125_2127			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2232C>G			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2314_2319			Sensitive	P00533							
dbmcs	TAS6417	EGFR	c.2314_2319			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2156G>C			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2497T>G			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2497T>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2497T>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2141A>G			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2141A>G			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2326C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2326C>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2618G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.865G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.865G>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.865G>A			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2310_2311insGGTGTA			Sensitive	P00533							
dbmcs	TAS6417	EGFR	c.2311_2319			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2311_2319			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2311_2319			Sensitive	P00533							
dbmcs	Nazartinib	EGFR	c.2311_2319			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2311_2319			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2311_2319			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2311_2319			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2086_3099			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2086_3099			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2086_3099			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2086_3099			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2222C>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2222C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2499G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2499G>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2499G>T			Sensitive	P00533							
dbmcs	EAI045	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	TAE226	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	EKI-285	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Naquotinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Lazertinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Bevacizumab + Erlotinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Lifirafenib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Brigatinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	TAS-121	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Buparlisib + Osimertinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Icotinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Osimertinib + Selumetinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Dasatinib + Selumetinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Ibrutinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Afatinib + Cetuximab	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Gefitinib + Pemetrexed	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	AV-412	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Cabozantinib + Erlotinib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	AZD-3759	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Vandetanib	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	JBJ-04-125-02	EGFR	c.2573T>G			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2335G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2240_2254del15			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2240_2254del15			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2240_2254del15			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2240_2254del15			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2236_2250delinsATCCCT			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2236_2250delinsATCCCT			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2236_2250delinsATCCCT			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2236_2250delinsATCCCT			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2236_2250delinsATCCCT			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2389T>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2251_2277delinsAAC			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2251_2277delinsAAC			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2251_2277delinsAAC			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2251_2277delinsAAC			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2251_2277delinsAAC			Sensitive	P00533							
dbmcs	hEGFRvIII-CD3 bi-scFv	EGFR	c.89_889del11867			Sensitive	P00533							
dbmcs	ER2	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Erlotinib + Ganetespib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Vandetanib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Naquotinib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Cisplatin + ER2	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Trametinib + WZ4002	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Gedatolisib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Lifirafenib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Brigatinib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Abivertinib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	TAS6417	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2236_2250del15			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.754C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2215_2232			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2215_2232			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.3352G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.3352G>A			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.3352G>A			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.3352G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.3352G>A			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2239_2256del18			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.866C>T			Sensitive	P00533							
dbmcs	Icotinib	EGFR	c.866C>T			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.866C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.866C>T			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2254_2277del24			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2254_2277del24			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2254_2277del24			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2254_2277del24			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2254_2277del24			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2492G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2492G>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2492G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2492G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.874G>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.874G>C			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.874G>C			Sensitive	P00533							
dbmcs	MM-151	EGFR	c.1391C>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2560A>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2492G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2492G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.910C>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.910C>T			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.910C>T			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2310_2311insGGTTTT			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2239_2259delinsCAA			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2239_2259delinsCAA			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2239_2259delinsCAA			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2239_2259delinsCAA			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2239_2259delinsCAA			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2236_2253delinsGTA			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2236_2253delinsGTA			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2236_2253delinsGTA			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2236_2253delinsGTA			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2203G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2203G>A			Sensitive	P00533							
dbmcs	Cabozantinib + Erlotinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	AV-412	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	CUDC-101	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Abivertinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	BEZ235 + Selumetinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Amlexanox + Selumetinib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Dactolisib	EGFR	c.2369C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2236_2256delinsGTA			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2236_2256delinsGTA			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2236_2256delinsGTA			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2236_2256delinsGTA			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2317C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2317C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2239_2250del12			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2239_2250del12			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2239_2250del12			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2239_2250del12			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2239_2250del12			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2527G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2500G>C			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2500G>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2239_2250delinsCCT			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2239_2250delinsCCT			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2239_2250delinsCCT			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2239_2250delinsCCT			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.866C>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.866C>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2300C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2300C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2127_2129delAAC			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2127_2129delAAC			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2127_2129delAAC			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2127_2129delAAC			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2218_2235			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2218_2235			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2240T>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2240T>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2512C>G			Sensitive	P00533							
dbmcs	MM-151	EGFR	c.1400A>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2126A>G			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.646G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.646G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.646G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.646G>A			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.646G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2305G>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2305G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2305G>A			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2308_2316			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2308_2316			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2543C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2543C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2543C>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2159C>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2159C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2159C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2159C>T			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2159C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2236_2259delinsGTAAGC			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2236_2259delinsGTAAGC			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2236_2259delinsGTAAGC			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2236_2259delinsGTAAGC			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2236_2259delinsGTAAGC			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2315_2316insTTATAACCC			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2125G>A			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2125G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2125G>A			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2125G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.1476C>G			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.1476C>G			Sensitive	P00533							
dbmcs	Panitumumab	EGFR	c.1476C>G			Sensitive	P00533							
dbmcs	Necitumumab	EGFR	c.1476C>G			Sensitive	P00533							
dbmcs	Futuximab	EGFR	c.1476C>G			Sensitive	P00533							
dbmcs	MM-151	EGFR	c.1476C>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2317_2318insCTAACCCTC			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2317_2318insCTAACCCTC			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.1787C>T			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.1787C>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.1787C>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2283+1_2283+2insAGGCATTTCAAG			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2283+1_2283+2insAGGCATTTCAAG			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2107C>A			Sensitive	P00533							
dbmcs	MM-151	EGFR	c.1351C>T			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2318A>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2318A>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2240_2257del18			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2240_2257del18			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2240_2257del18			Sensitive	P00533							
dbmcs	Naquotinib	EGFR	c.2240_2257del18			Sensitive	P00533							
dbmcs	AEE-788	EGFR	c.2240_2257del18			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2240_2257del18			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2590G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2590G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2590G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2572C>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2575G>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2320G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2320G>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2105C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2105C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2126A>C			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2126A>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	TAS-121	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	TAS-121	EGFR	c.2155G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2582T>G			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2356G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2356G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2155_2157			Sensitive	P00533							
dbmcs	Neratinib	EGFR	c.2155_2157			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2612C>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2612C>G			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2612C>G			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2612C>G			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2320_2321insCACATG			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2326C>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2326C>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2404G>A			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2404G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2404G>A			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2311_2312insGCGTAGACA			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2317_2319			Sensitive	P00533							
dbmcs	AUY922	EGFR	c.2317_2319			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.917C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.917C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.917C>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.917C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.829_830delATinsGA			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2108T>C			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2108T>C			Sensitive	P00533							
dbmcs	MM-151	EGFR	c.1394G>A			Sensitive	P00533							
dbmcs	MM-151	EGFR	c.1473A>G			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2311_2313			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2240_2251del12			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2240_2251del12			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2240_2251del12			Sensitive	P00533							
dbmcs	Rociletinib	EGFR	c.2240_2251del12			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2240_2251del12			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2305G>C			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2305G>C			Sensitive	P00533							
dbmcs	Bevacizumab + Gefitinib	EGFR	c.2317_2322delinsCTTATG			Sensitive	P00533							
dbmcs	Bevacizumab + Osimertinib	EGFR	c.2317_2322delinsCTTATG			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2308_2310delinsGGTTAT			Sensitive	P00533							
dbmcs	Dacomitinib	EGFR	c.2308_2310delinsGGTTAT			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2327G>A			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2327G>A			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2327G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2327G>A			Sensitive	P00533							
dbmcs	Poziotinib	EGFR	c.2303G>T			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2314_2315insTTC			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2126A>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2126A>T			Sensitive	P00533							
dbmcs	Cetuximab	EGFR	c.2126A>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2248G>C			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2248G>C			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2248G>C			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2125G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2125G>A			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2125G>A			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2157C>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2157C>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2157C>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2239_2240delTTinsCC			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2239_2240delTTinsCC			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2497T>G			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2497T>G			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2497T>G			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2583G>T			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.2583G>T			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2583G>T			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.829_830delATinsGA			Sensitive	P00533							
dbmcs	Erlotinib	EGFR	c.829_830delATinsGA			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.829_830delATinsGA			Sensitive	P00533							
dbmcs	Afatinib	EGFR	c.2127_2129delAAC			Sensitive	P00533							
dbmcs	Gefitinib	EGFR	c.2127_2129delAAC			Sensitive	P00533							
dbmcs	Lapatinib	EGFR	c.866C>T			Sensitive	P00533							
dbmcs	Lapatinib	EGFR	c.323G>A			Sensitive	P00533							
dbmcs	Lapatinib	EGFR	c.787A>C			Sensitive	P00533							
dbmcs	Osimertinib	EGFR	c.2281G>T			Sensitive	P00533							
dbmcs	Dasatinib	EPHA2	c.1171G>A			Sensitive	P29317							
dbmcs	MTOR inhibitors	EPHA2	c.1171G>A			Sensitive	P29317							
dbmcs	Trastuzumab emtansine	ERBB2	c.1976_1977delTTinsAG			Sensitive	P04626							
dbmcs	Trastuzumab emtansine	ERBB2	c.929C>T			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2393C>T			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2305G>T			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2305G>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2686C>T			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2329G>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2524G>A			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.926G>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.1976_1977delTTinsAG			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2257A>G			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2264T>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.926G>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2305G>T			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2305G>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2686C>T			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2329G>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2524G>A			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2606T>G			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2305G>T			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2305G>C			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2686C>T			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.926G>A			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.929C>T			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.929C>A			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.931T>C			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.962A>G			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.1000T>A			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2326_2327delGGinsCT			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2264_2278del15			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2264_2278del15			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2264T>G			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2340_2341			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2033G>A			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2033G>A			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2329G>T			Sensitive	P04626							
dbmcs	Afatinib + Sirolimus	ERBB2	c.2325_2326			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2325_2326			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2325_2326			Sensitive	P04626							
dbmcs	Dacomitinib	ERBB2	c.2340_2341			Sensitive	P04626							
dbmcs	Trastuzumab emtansine	ERBB2	c.2325_2326			Sensitive	P04626							
dbmcs	Trastuzumab + Neratinib + Lapatinib	ERBB2	c.2524G>A			Sensitive	P04626							
dbmcs	Trastuzumab + Neratinib + Lapatinib	ERBB2	c.2264T>C			Sensitive	P04626							
dbmcs	Trastuzumab + Neratinib + Lapatinib	ERBB2	c.2329G>T			Sensitive	P04626							
dbmcs	Trastuzumab + Neratinib + Lapatinib	ERBB2	c.2596C>A			Sensitive	P04626							
dbmcs	Trastuzumab + Neratinib + Lapatinib	ERBB2	c.929C>T			Sensitive	P04626							
dbmcs	Trastuzumab + Neratinib + Lapatinib	ERBB2	c.929C>A			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2326_2327delGGinsCT			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2340_2341			Sensitive	P04626							
dbmcs	Dacomitinib	ERBB2	c.2320delinsTGGCTGG			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2584A>G			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2318T>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2570A>G			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2632C>T			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2263_2264delCTinsAG			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2265_2279del15			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2340_2341insGGTAGCCCT			Sensitive	P04626							
dbmcs	ERBB2 TKIs	ERBB2	c.926G>A			Sensitive	P04626							
dbmcs	ERBB2 TKIs	ERBB2	c.929C>T			Sensitive	P04626							
dbmcs	ERBB2 TKIs	ERBB2	c.929C>A			Sensitive	P04626							
dbmcs	ERBB2 TKIs	ERBB2	c.931T>C			Sensitive	P04626							
dbmcs	ERBB2 TKIs	ERBB2	c.962A>G			Sensitive	P04626							
dbmcs	ERBB2 TKIs	ERBB2	c.1000T>A			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.930C>T			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2265T>G			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2331G>A			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2340_2341insGGTAGCCCT			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2325_2326insTATGTAATGGCA			Sensitive	P04626							
dbmcs	Trastuzumab emtansine	ERBB2	c.2325_2326insTATGTAATGGCA			Sensitive	P04626							
dbmcs	Trastuzumab emtansine	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Trastuzumab-based chemotherapy	ERBB2	c.2326_2327delGGinsCT			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.1988T>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.1988T>C			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.1988T>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.1988T>C			Sensitive	P04626							
dbmcs	Pertuzumab	ERBB2	c.1988T>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.1976_1977delTTinsAG			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.1976_1977delTTinsAG			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.1976_1977delTTinsAG			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.1976_1977delTTinsAG			Sensitive	P04626							
dbmcs	Compound 23814 + Tivozanib	ERBB2	c.1976_1977delTTinsAG			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2743C>A			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.1979G>A			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.1979G>A			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.1979G>A			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.1979G>A			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.929C>T			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.929C>T			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.929C>T			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.929C>T			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2089G>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2303T>C			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2303T>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2303T>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2317G>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2317G>C			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2317G>C			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2339C>T			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	Poziotinib	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	Pyrotinib	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	Ganetespib	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	AUY922	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	Poziotinib	ERBB2	c.2314_2325			Sensitive	P04626							
dbmcs	Poziotinib	ERBB2	c.2326_2328delinsGTAGTA			Sensitive	P04626							
dbmcs	EKI-285	ERBB2	c.2393_2394delCAinsTG			Sensitive	P04626							
dbmcs	Pilaralisib	ERBB2	c.2393_2394delCAinsTG			Sensitive	P04626							
dbmcs	Buparlisib	ERBB2	c.2393_2394delCAinsTG			Sensitive	P04626							
dbmcs	Lapatinib + Trastuzumab	ERBB2	c.2393_2394delCAinsTG			Sensitive	P04626							
dbmcs	Trastuzumab + XL147	ERBB2	c.2393_2394delCAinsTG			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2393_2394delCAinsTG			Sensitive	P04626							
dbmcs	Cetuximab + Lapatinib	ERBB2	c.2393_2394delCAinsTG			Sensitive	P04626							
dbmcs	WZ4002	ERBB2	c.2393_2394delCAinsTG			Sensitive	P04626							
dbmcs	AEE-788	ERBB2	c.2329G>C			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2329G>C			Sensitive	P04626							
dbmcs	Neratinib + Trastuzumab	ERBB2	c.2329G>C			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2329G>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2329G>C			Sensitive	P04626							
dbmcs	EKI-285	ERBB2	c.2264T>C			Sensitive	P04626							
dbmcs	WZ4002	ERBB2	c.2264T>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2596C>A			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2596C>A			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2596C>A			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2332_2340			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2332_2340			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2332_2340			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2332_2340			Sensitive	P04626							
dbmcs	Dacomitinib	ERBB2	c.2332_2340			Sensitive	P04626							
dbmcs	Poziotinib	ERBB2	c.2332_2340			Sensitive	P04626							
dbmcs	Trastuzumab emtansine	ERBB2	c.2332_2340			Sensitive	P04626							
dbmcs	Dacomitinib	ERBB2	c.2332_2340			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2326_2328delinsCTTTGT			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2126A>T			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2126A>T			Sensitive	P04626							
dbmcs	Pertuzumab	ERBB2	c.2126A>T			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2126A>T			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2176C>T			Sensitive	P04626							
dbmcs	AEE-788	ERBB2	c.2584A>G			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2263_2271delinsAGC			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2033G>A			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2033G>A			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.1958C>G			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.1958C>G			Sensitive	P04626							
dbmcs	JQ1 + Osimertinib	ERBB2	c.2325_2326insTATGTAATGGCA			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2437A>G			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2606T>G			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2149G>A			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2198C>T			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.2305G>A			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2516T>G			Sensitive	P04626							
dbmcs	AZ5104	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Poziotinib	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	AUY922	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Dacomitinib	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Ganetespib	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Poziotinib	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Pyrotinib	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Osimertinib	ERBB2	c.2326_2328delinsGTATGT			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2461G>A			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2347T>C			Sensitive	P04626							
dbmcs	Canertinib	ERBB2	c.2328_2329insTATGTAATGGCA			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.1978G>C			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.1978G>C			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.1978G>C			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.1978G>C			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2353C>T			Sensitive	P04626							
dbmcs	WZ4002	ERBB2	c.2263_2264delCTinsAG			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.2263_2264delCTinsAG			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2263_2264delCTinsAG			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2263_2264delCTinsAG			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2263_2264delCTinsAG			Sensitive	P04626							
dbmcs	EKI-285	ERBB2	c.2263_2264delCTinsAG			Sensitive	P04626							
dbmcs	AEE-788	ERBB2	c.2318T>C			Sensitive	P04626							
dbmcs	AEE-788	ERBB2	c.2632C>T			Sensitive	P04626							
dbmcs	Dacomitinib	ERBB2	c.2335_2336insGTCCTGGTT			Sensitive	P04626							
dbmcs	AEE-788	ERBB2	c.2570A>G			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2156A>G			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.2524G>A			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.2524G>A			Sensitive	P04626							
dbmcs	Trastuzumab	ERBB2	c.926G>C			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2434G>A			Sensitive	P04626							
dbmcs	Poziotinib	ERBB2	c.2434G>A			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2407T>A			Sensitive	P04626							
dbmcs	Gefitinib	ERBB2	c.2265_2279del15			Sensitive	P04626							
dbmcs	Tesevatinib	ERBB2	c.2393C>T			Sensitive	P04626							
dbmcs	Neratinib	ERBB2	c.929C>A			Sensitive	P04626							
dbmcs	Afatinib	ERBB2	c.929C>A			Sensitive	P04626							
dbmcs	Neratinib + Trastuzumab	ERBB2	c.929C>A			Sensitive	P04626							
dbmcs	Lapatinib	ERBB2	c.929C>A			Sensitive	P04626							
dbmcs	Lapatinib + Trastuzumab	ERBB2	c.929C>A			Sensitive	P04626							
dbmcs	Dacomitinib	ERBB2	c.2320_2322delinsTGGCTTGTA			Sensitive	P04626							
dbmcs	Dacomitinib	ERBB2	c.2320_2322delinsTGGCTTGTA			Sensitive	P04626							
dbmcs	Afatinib	ERBB3	c.850G>A			Sensitive	P21860							
dbmcs	Afatinib	ERBB3	c.307C>G			Sensitive	P21860							
dbmcs	Afatinib	ERBB3	c.310G>A			Sensitive	P21860							
dbmcs	Lapatinib	ERBB3	c.785C>A			Sensitive	P21860							
dbmcs	Lapatinib	ERBB3	c.850G>A			Sensitive	P21860							
dbmcs	Lapatinib	ERBB3	c.2426A>G			Sensitive	P21860							
dbmcs	Pertuzumab	ERBB3	c.785C>A			Sensitive	P21860							
dbmcs	Pertuzumab	ERBB3	c.850G>A			Sensitive	P21860							
dbmcs	Trastuzumab	ERBB3	c.785C>A			Sensitive	P21860							
dbmcs	Trastuzumab	ERBB3	c.850G>A			Sensitive	P21860							
dbmcs	Trastuzumab	ERBB3	c.2426A>G			Sensitive	P21860							
dbmcs	Afatinib	ERBB3	c.2564T>C			Sensitive	P21860							
dbmcs	Pertuzumab	ERBB3	c.2564T>C			Sensitive	P21860							
dbmcs	anti-HER3 mAbs	ERBB3	c.785C>A			Sensitive	P21860							
dbmcs	PI3K pathway inhibitors + MEK inhibitors	ERBB3	c.785C>A			Sensitive	P21860							
dbmcs	anti-HER3 mAbs	ERBB3	c.850G>A			Sensitive	P21860							
dbmcs	PI3K pathway inhibitors + MEK inhibitors	ERBB3	c.850G>A			Sensitive	P21860							
dbmcs	PI3K pathway inhibitors + MEK inhibitors	ERBB3	c.2426A>G			Sensitive	P21860							
dbmcs	Lapatinib	ERBB4	c.949G>A			Sensitive	Q15303							
dbmcs	Lapatinib	ERBB4	c.1354G>A			Sensitive	Q15303							
dbmcs	Lapatinib	ERBB4	c.1630C>T			Sensitive	Q15303							
dbmcs	Lapatinib	ERBB4	c.1177C>T			Sensitive	Q15303							
dbmcs	Lapatinib	ERBB4	c.2614G>A			Sensitive	Q15303							
dbmcs	Lapatinib	ERBB4	c.1624G>A			Sensitive	Q15303							
dbmcs	Afatinib	ERBB4	c.3325G>T			Sensitive	Q15303							
dbmcs	Lapatinib	ERBB4	c.1687G>A			Sensitive	Q15303							
dbmcs	Paclitaxel + Carboplatin	ERCC2	c.2251A>C			Sensitive	P18074							
dbmcs	Erlotinib	ERRFI1	c.1150G>T			Sensitive	Q9UJM3							
dbmcs	Tamoxifen	ESR1	c.1607_1608delTCinsAA			Sensitive	P03372							
dbmcs	Fulvestrant	ESR1	c.1607_1608delTCinsAA			Sensitive	P03372							
dbmcs	Tamoxifen	ESR1	c.1613A>G			Sensitive	P03372							
dbmcs	Fulvestrant	ESR1	c.1613A>G			Sensitive	P03372							
dbmcs	Tamoxifen	ESR1	c.1610A>G			Sensitive	P03372							
dbmcs	Fulvestrant	ESR1	c.1610A>G			Sensitive	P03372							
dbmcs	Tamoxifen	ESR1	c.1609T>A			Sensitive	P03372							
dbmcs	Fulvestrant	ESR1	c.1609T>A			Sensitive	P03372							
dbmcs	Tamoxifen	ESR1	c.1610A>C			Sensitive	P03372							
dbmcs	Paclitaxel + Cisplatin	ETS2	c.1023A>G			Sensitive	P15036							
dbmcs	GSK126	EZH2	c.1936T>A			Sensitive	Q15910							
dbmcs	EZH2 inhibitors	EZH2	c.1922A>T			Sensitive	Q15910							
dbmcs	EZH2 inhibitors	EZH2	c.2030C>G			Sensitive	Q15910							
dbmcs	DZNeP	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	Vorinostat	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	GSK126	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	ACY-957 + GSK126	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	ACY-957	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	ACY-957 + DZNeP	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	EED226	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	UNC1999	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	ACY-957 + Doxorubicin	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	EED226 + EI1	EZH2	c.1921T>A			Sensitive	Q15910							
dbmcs	EPZ005687	EZH2	c.1922A>T			Sensitive	Q15910							
dbmcs	Vorinostat	EZH2	c.1922A>C			Sensitive	Q15910							
dbmcs	GSK126	EZH2	c.1922A>C			Sensitive	Q15910							
dbmcs	ACY-957 + DZNeP	EZH2	c.1922A>C			Sensitive	Q15910							
dbmcs	ACY-957 + GSK126	EZH2	c.1922A>C			Sensitive	Q15910							
dbmcs	ACY-957	EZH2	c.1922A>C			Sensitive	Q15910							
dbmcs	EED226	EZH2	c.1937A>T			Sensitive	Q15910							
dbmcs	Tazemetostat	EZH2	c.1937A>T			Sensitive	Q15910							
dbmcs	EED226	EZH2	c.1936T>A			Sensitive	Q15910							
dbmcs	GSK126	EZH2	c.1921T>C			Sensitive	Q15910							
dbmcs	EED226	EZH2	c.1937A>C			Sensitive	Q15910							
dbmcs	Temsirolimus	FBXW7	c.1394G>A			Sensitive	Q969H0							
dbmcs	Vorinostat	FBXW7	c.1513C>T			Sensitive	Q969H0							
dbmcs	Sirolimus	FBXW7	c.575A>C			Sensitive	Q969H0							
dbmcs	Ponatinib	FGFR1	c.1638C>A			Sensitive	P11362							
dbmcs	FIIN-1	FGFR1	c.1681G>A			Sensitive	P11362							
dbmcs	PRN1371	FGFR1	c.1681G>A			Sensitive	P11362							
dbmcs	PD173074	FGFR2	c.1650T>A			Sensitive	P21802							
dbmcs	FGFR inhibitors	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	FGFR inhibitors	FGFR2	c.1647T>G			Sensitive	P21802							
dbmcs	Pazopanib	FGFR2	c.758C>G			Sensitive	P21802							
dbmcs	FGFR inhibitors	FGFR2	c.870G>T			Sensitive	P21802							
dbmcs	FGFR inhibitors	FGFR2	c.959C>G			Sensitive	P21802							
dbmcs	FGFR inhibitors	FGFR2	c.1980G>C			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1642A>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.870G>T			Sensitive	P21802							
dbmcs	Lenvatinib	FGFR2	c.870G>T			Sensitive	P21802							
dbmcs	AZD-4547	FGFR2	c.870G>T			Sensitive	P21802							
dbmcs	Infigratinib	FGFR2	c.870G>T			Sensitive	P21802							
dbmcs	Cediranib	FGFR2	c.870G>T			Sensitive	P21802							
dbmcs	Pazopanib	FGFR2	c.870G>T			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1650T>G			Sensitive	P21802							
dbmcs	PRN1371	FGFR2	c.1650T>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1852T>A			Sensitive	P21802							
dbmcs	Cediranib	FGFR2	c.1647T>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1647T>G			Sensitive	P21802							
dbmcs	FIIN-1	FGFR2	c.1647T>G			Sensitive	P21802							
dbmcs	Derazantinib	FGFR2	c.1647T>G			Sensitive	P21802							
dbmcs	DEBIO-1347	FGFR2	c.1647T>G			Sensitive	P21802							
dbmcs	PRN1371	FGFR2	c.1647T>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1649A>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1697A>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.870_872delGAT			Sensitive	P21802							
dbmcs	Infigratinib	FGFR2	c.870_872delGAT			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1608G>C			Sensitive	P21802							
dbmcs	Nintedanib	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	Cediranib	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	Derazantinib	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	Dovitinib	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	GSK3052230	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	E7090	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	Brivanib	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	DEBIO-1347	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	RO-5126766 free base	FGFR2	c.755C>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1648A>C			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1980G>C			Sensitive	P21802							
dbmcs	Pazopanib	FGFR2	c.1980G>C			Sensitive	P21802							
dbmcs	PRN1371	FGFR2	c.1980G>C			Sensitive	P21802							
dbmcs	Infigratinib	FGFR2	c.1980G>C			Sensitive	P21802							
dbmcs	Lenvatinib	FGFR2	c.1980G>C			Sensitive	P21802							
dbmcs	AZD-4547	FGFR2	c.1980G>C			Sensitive	P21802							
dbmcs	Cediranib	FGFR2	c.1980G>C			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.799_819			Sensitive	P21802							
dbmcs	Infigratinib	FGFR2	c.799_819			Sensitive	P21802							
dbmcs	DEBIO-1347	FGFR2	c.1690G>T			Sensitive	P21802							
dbmcs	Infigratinib	FGFR2	c.1978A>G			Sensitive	P21802							
dbmcs	Cediranib	FGFR2	c.1978A>G			Sensitive	P21802							
dbmcs	AZD-4547	FGFR2	c.1978A>G			Sensitive	P21802							
dbmcs	PRN1371	FGFR2	c.1978A>G			Sensitive	P21802							
dbmcs	Lenvatinib	FGFR2	c.1978A>G			Sensitive	P21802							
dbmcs	Pazopanib	FGFR2	c.1978A>G			Sensitive	P21802							
dbmcs	Ponatinib	FGFR2	c.1978A>G			Sensitive	P21802							
dbmcs	Pazopanib	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	Bortezomib	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	FGFR inhibitors	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	FGFR inhibitors	FGFR3	c.2071G>A			Sensitive	P22607							
dbmcs	R3Mab	FGFR3	c.1114G>T			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.1108G>T			Sensitive	P22607							
dbmcs	R3Mab	FGFR3	c.1124A>G			Sensitive	P22607							
dbmcs	Dovitinib	FGFR3	c.1124A>G			Sensitive	P22607							
dbmcs	Ponatinib	FGFR3	c.1124A>G			Sensitive	P22607							
dbmcs	R3Mab	FGFR3	c.1954A>G			Sensitive	P22607							
dbmcs	Derazantinib	FGFR3	c.1954A>G			Sensitive	P22607							
dbmcs	Ponatinib	FGFR3	c.1822T>G			Sensitive	P22607							
dbmcs	LY-2874455	FGFR3	c.1822T>G			Sensitive	P22607							
dbmcs	FIIN-2	FGFR3	c.1822T>G			Sensitive	P22607							
dbmcs	Dovitinib	FGFR3	c.1822T>G			Sensitive	P22607							
dbmcs	Dovitinib	FGFR3	c.742C>T			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.742C>T			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.742C>T			Sensitive	P22607							
dbmcs	R3Mab	FGFR3	c.742C>T			Sensitive	P22607							
dbmcs	Pazopanib	FGFR3	c.742C>T			Sensitive	P22607							
dbmcs	Dovitinib	FGFR3	c.1620C>G			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.1620C>G			Sensitive	P22607							
dbmcs	Ponatinib	FGFR3	c.1620C>G			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	PD98059	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	Dovitinib	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	Ponatinib	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	SU5402	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	FIIN-2	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	LY-2874455	FGFR3	c.1948A>G			Sensitive	P22607							
dbmcs	PRN1371	FGFR3	c.1949A>T			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1156T>C			Sensitive	P22607							
dbmcs	LY-2874455	FGFR3	c.1663G>A			Sensitive	P22607							
dbmcs	Dovitinib	FGFR3	c.1663G>A			Sensitive	P22607							
dbmcs	Ponatinib	FGFR3	c.1663G>A			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.1118A>G			Sensitive	P22607							
dbmcs	E7090	FGFR3	c.1118A>G			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1118A>G			Sensitive	P22607							
dbmcs	Dovitinib	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	Ponatinib	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	R3Mab	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	Dovitinib	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	AZD-4547	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	Cediranib	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	AZD-4547	FGFR3	c.1108G>T			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.1108G>T			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1108G>T			Sensitive	P22607							
dbmcs	AZD-4547	FGFR3	c.1138G>A			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.1138G>A			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.1138G>A			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1138G>A			Sensitive	P22607							
dbmcs	AZD-4547	FGFR3	c.1950G>A			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.1950G>A			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.1950G>A			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1950G>A			Sensitive	P22607							
dbmcs	AZD-4547	FGFR3	c.742C>T			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.742C>T			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.742C>T			Sensitive	P22607							
dbmcs	AZD-4547	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.746C>G			Sensitive	P22607							
dbmcs	AZD-4547	FGFR3	c.1111A>T			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.1111A>T			Sensitive	P22607							
dbmcs	Erdafitinib	FGFR3	c.1111A>T			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1111A>T			Sensitive	P22607							
dbmcs	AZD-4547	FGFR3	c.1118A>G			Sensitive	P22607							
dbmcs	Infigratinib	FGFR3	c.1118A>G			Sensitive	P22607							
dbmcs	DEBIO-1347	FGFR3	c.1118A>G			Sensitive	P22607							
dbmcs	PD173074	FGFR4	c.1605C>G			Sensitive	P22455							
dbmcs	FGFR inhibitors	FGFR4	c.1649T>A			Sensitive	P22455							
dbmcs	Lestaurtinib	FLT3	c.1705_1837			Sensitive	P36888							
dbmcs	Sorafenib	FLT3	c.1705_1837			Sensitive	P36888							
dbmcs	AG1296	FLT3	c.1705_1837			Sensitive	P36888							
dbmcs	Midostaurin	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	SU11248 + Cytarabine	FLT3	c.2504A>T			Sensitive	P36888							
dbmcs	SU11248 + Daunorubicin	FLT3	c.2504A>T			Sensitive	P36888							
dbmcs	AS602868	FLT3	c.2504A>T			Sensitive	P36888							
dbmcs	AG1296	FLT3	c.2504A>T			Sensitive	P36888							
dbmcs	Sunitinib	FLT3	c.2504A>T			Sensitive	P36888							
dbmcs	Ponatinib	FLT3	c.1705_1837			Sensitive	P36888							
dbmcs	Sunitinib	FLT3	c.1705_1837			Sensitive	P36888							
dbmcs	Sorafenib	FLT3	c.1705_1837			Sensitive	P36888							
dbmcs	Tandutinib	FLT3	c.1798_1799insGTCTTTATGTAGACTTTAGGGAGTATGAGTATG			Sensitive	P36888							
dbmcs	MRX-2843	FLT3	c.2504A>T			Sensitive	P36888							
dbmcs	Tandutinib	FLT3	c.1783_1803			Sensitive	P36888							
dbmcs	Cytarabine + Daunorubicin + Midostaurin	FLT3	c.2503_2505			Sensitive	P36888							
dbmcs	E6201	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	Crenolanib	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	Midostaurin	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	Quizartinib	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	Arsenic trioxide + Cytarabine + Methotrexate + Tretinoin	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	MRX-2843	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	Gilteritinib	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	Crenolanib + Trametinib	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	G-749	FLT3	c.2503G>T			Sensitive	P36888							
dbmcs	Tandutinib	FLT3	c.1794_1795insGGTCTTGTACAAGTAACAGGTAGCAGCGACAACGAGTATTTTTATGTAGACTTTAGGGAGTATGAG			Sensitive	P36888							
dbmcs	Midostaurin	FLT3	c.1715A>G			Sensitive	P36888							
dbmcs	Crenolanib	FLT3	c.1715A>G			Sensitive	P36888							
dbmcs	Azacitidine + Sorafenib	FLT3	c.1797_1798insAGCACAGACAACGAGTATTTTTATGTAGACTTTAGGGAGTATGAGTAT			Sensitive	P36888							
dbmcs	Quizartinib	FLT3	c.1797_1798insAGCACAGACAACGAGTATTTTTATGTAGACTTTAGGGAGTATGAGTAT			Sensitive	P36888							
dbmcs	PD98059	FLT3	c.2501G>A			Sensitive	P36888							
dbmcs	Midostaurin	FLT3	c.2501G>A			Sensitive	P36888							
dbmcs	Cytarabine + Daunorubicin + Midostaurin	FLT3	c.2506_2508			Sensitive	P36888							
dbmcs	Crenolanib	FLT3	c.2503G>C			Sensitive	P36888							
dbmcs	E6201	FLT3	c.2504A>G			Sensitive	P36888							
dbmcs	Midostaurin	FLT3	c.2525A>G			Sensitive	P36888							
dbmcs	Midostaurin	FLT3	c.2508_2510delCAT			Sensitive	P36888							
dbmcs	Tandutinib	FLT3	c.2508_2510delCAT			Sensitive	P36888							
dbmcs	Midostaurin	FLT3	c.1775T>G			Sensitive	P36888							
dbmcs	Dabrafenib	G6PD	c.653C>T			Sensitive	P11413							
dbmcs	Selumetinib	GNA11	c.626A>T			Sensitive	P29992							
dbmcs	Selumetinib	GNA11	c.626A>C			Sensitive	P29992							
dbmcs	Vorinostat	GNA11	c.626A>T			Sensitive	P29992							
dbmcs	Vorinostat	GNA11	c.626A>C			Sensitive	P29992							
dbmcs	FR900359	GNA11	c.626A>T			Sensitive	P29992							
dbmcs	AEB071 + Binimetinib	GNA11	c.626A>T			Sensitive	P29992							
dbmcs	Trametinib	GNA11	c.626A>T			Sensitive	P29992							
dbmcs	TAK-733	GNA11	c.626A>T			Sensitive	P29992							
dbmcs	Refametinib	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	Enzastaurin	GNAQ	c.626A>C			Sensitive	P50148							
dbmcs	Sotrastaurin	GNAQ	c.626A>C			Sensitive	P50148							
dbmcs	TAK-733	GNAQ	c.626A>C			Sensitive	P50148							
dbmcs	FR900359	GNAQ	c.626A>C			Sensitive	P50148							
dbmcs	Selumetinib	GNAQ	c.626A>C			Sensitive	P50148							
dbmcs	Sotrastaurin	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	TAK-733	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	AEB071 + PD-0325901	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	FR900359	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	Omipalisib + Trametinib	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	Enzastaurin	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	Trametinib	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	Selumetinib	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	NAV-2729	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	U0126	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	Verteporfin	GNAQ	c.626A>T			Sensitive	P50148							
dbmcs	Radioactive Iodine	GNAS	c.602G>A			Sensitive	O95467							
dbmcs	JAK inhibitors	GNAS	c.601C>T			Sensitive	O95467							
dbmcs	JAK inhibitors	GNAS	c.602G>A			Sensitive	O95467							
dbmcs	JAK inhibitors	GNAS	c.602G>T			Sensitive	O95467							
dbmcs	Folfox Protocol	GSTP1	c.313A>G			Sensitive	P09211							
dbmcs	Binimetinib	HRAS	c.182A>G			Sensitive	Q9HDD0							
dbmcs	Everolimus	HRAS	c.182A>G			Sensitive	Q9HDD0							
dbmcs	Pz-1	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	Binimetinib + Everolimus	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	Rigosertib	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	SR-9009	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	Binimetinib	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	SR-9011	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	Everolimus	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	CI-1040	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	Everolimus + Selumetinib	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	SF1126	HRAS	c.35G>T			Sensitive	Q9HDD0							
dbmcs	Everolimus + Selumetinib	HRAS	c.182A>T			Sensitive	Q9HDD0							
dbmcs	Binimetinib + Everolimus	HRAS	c.182A>T			Sensitive	Q9HDD0							
dbmcs	Selumetinib	HRAS	c.182A>T			Sensitive	Q9HDD0							
dbmcs	AZD8055 + Binimetinib	HRAS	c.182A>T			Sensitive	Q9HDD0							
dbmcs	Binimetinib	HRAS	c.182A>T			Sensitive	Q9HDD0							
dbmcs	Sirolimus + Trametinib	HRAS	c.182A>T			Sensitive	Q9HDD0							
dbmcs	Everolimus	HRAS	c.182A>T			Sensitive	Q9HDD0							
dbmcs	NS1	HRAS	c.182A>T			Sensitive	Q9HDD0							
dbmcs	MK2206	HRAS	c.37G>C			Sensitive	Q9HDD0							
dbmcs	Oxaliplatin + Fluorouracil	HSPH1	c.1138-20_1138-4			Sensitive	Q92598							
dbmcs	GSK321	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	AGI-5198	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Bevacizumab	IDH1	c.395G>T			Sensitive	O75874							
dbmcs	Temozolomide	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	AGI-5198	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	Bevacizumab	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	Ivosidenib	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	BPTES	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	Bevacizumab	IDH1	c.394C>A			Sensitive	O75874							
dbmcs	Cetuximab	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	IDH1 inhibitors	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Dasatinib	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	PARP inhibitors	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	BAY1436032	IDH1	c.395G>T			Sensitive	O75874							
dbmcs	Ivosidenib	IDH1	c.395G>T			Sensitive	O75874							
dbmcs	Ivosidenib	IDH1	c.394C>G			Sensitive	O75874							
dbmcs	BAY1436032	IDH1	c.394C>G			Sensitive	O75874							
dbmcs	Niraparib	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Decitabine	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	BAY1436032	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Olaparib	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Berzosertib	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Temozolomide + Vandetanib	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Cisplatin + Talazoparib	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Azacitidine	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Talazoparib	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Metformin	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Ivosidenib	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	BPTES	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Rucaparib	IDH1	c.395G>A			Sensitive	O75874							
dbmcs	Saracatinib	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	Talazoparib	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	BAY1436032	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	Olaparib	IDH1	c.394C>T			Sensitive	O75874							
dbmcs	Dasatinib	IDH1	c.394C>A			Sensitive	O75874							
dbmcs	Saracatinib	IDH1	c.394C>A			Sensitive	O75874							
dbmcs	Ivosidenib	IDH1	c.394C>A			Sensitive	O75874							
dbmcs	BAY1436032	IDH1	c.394C>A			Sensitive	O75874							
dbmcs	Enasidenib	IDH2	c.418_419delCGinsAA			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.515G>A			Sensitive	P48735							
dbmcs	IDH2 inhibitors	IDH2	c.419G>A			Sensitive	P48735							
dbmcs	IDH2 inhibitors	IDH2	c.515G>A			Sensitive	P48735							
dbmcs	Dasatinib	IDH2	c.515G>A			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.419G>T			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.514A>T			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.516G>C			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.515G>A			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.418C>T			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.418C>G			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.419G>A			Sensitive	P48735							
dbmcs	AGI-6780	IDH2	c.419G>A			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.515G>T			Sensitive	P48735							
dbmcs	Enasidenib	IDH2	c.514A>G			Sensitive	P48735							
dbmcs	Ruxolitinib	IL7R	c.553A>T			Sensitive	P16871							
dbmcs	Ruxolitinib	JAK1	c.2108G>T			Sensitive	P23458							
dbmcs	Ruxolitinib	JAK1	c.1937C>T			Sensitive	P23458							
dbmcs	Ruxolitinib	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Ruxolitinib	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Peginterferon alfa-2a	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Fedratinib	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Ruxolitinib	JAK2	c.2080T>C			Sensitive	O60674							
dbmcs	Ruxolitinib	JAK2	c.2047A>G			Sensitive	O60674							
dbmcs	CHZ868	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	BMS-911543	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	AZD1208 + Ruxolitinib	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Gandotinib	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Ruxolitinib + ZSTK474	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Ropeginterferon alfa-2b	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	SHP099	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Ropeginterferon alfa-2b	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Ruxolitinib + SGI-1776	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Go6976	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	NS-018	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	BEZ235 + Ruxolitinib	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	A-1155463	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	Pictilisib + Ruxolitinib	JAK2	c.1849G>T			Sensitive	O60674							
dbmcs	JAK inhibitors	JAK3	c.1970G>A			Sensitive	P52333							
dbmcs	JAK inhibitors	JAK3	c.260T>C			Sensitive	P52333							
dbmcs	JAK inhibitors	JAK3	c.1503G>T			Sensitive	P52333							
dbmcs	JAK inhibitors	JAK3	c.1715C>T			Sensitive	P52333							
dbmcs	JAK inhibitors	JAK3	c.1718C>T			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.1766G>A			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.1715C>T			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.1747C>T			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.1718C>T			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.2021T>C			Sensitive	P52333							
dbmcs	Ruxolitinib	JAK3	c.2021T>C			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.467T>C			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.1533G>C			Sensitive	P52333							
dbmcs	NIBR3049	JAK3	c.2570T>C			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.2570T>C			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.548A>G			Sensitive	P52333							
dbmcs	JANEX-1	JAK3	c.260T>C			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.515G>A			Sensitive	P52333							
dbmcs	Tofacitinib	JAK3	c.2164G>A			Sensitive	P52333							
dbmcs	Amiloride	KCNJ5	c.503T>G			Sensitive	P48544							
dbmcs	Verapamil	KCNJ5	c.503T>G			Sensitive	P48544							
dbmcs	Sunitinib	KDR	c.3193G>A			Sensitive	P35968							
dbmcs	Sorafenib	KDR	c.3193G>A			Sensitive	P35968							
dbmcs	Sorafenib	KDR	c.2150A>T			Sensitive	P35968							
dbmcs	Sunitinib	KDR	c.2150A>T			Sensitive	P35968							
dbmcs	Regorafenib	KDR	c.2881C>T			Sensitive	P35968							
dbmcs	VEGFR inhibitors	KDR	c.3193G>A			Sensitive	P35968							
dbmcs	Cabozantinib	KDR	c.3095G>A			Sensitive	P35968							
dbmcs	Lenvatinib	KDR	c.3095G>A			Sensitive	P35968							
dbmcs	unspecified VEGFR2 antibody	KDR	c.1416A>T			Sensitive	P35968							
dbmcs	Dasatinib	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.2446G>T			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.2446_2447delGAinsTT			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.2458G>T			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1657T>A			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.2458G>T			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.2485G>C			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1961T>C			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.2009C>T			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.2460T>G			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.2089C>T			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1657T>A			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.1727T>C			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1648_1774			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1727T>C			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1727T>C			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1961T>C			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1679_1681delTTG			Sensitive	P10721							
dbmcs	Selumetinib	KIT	c.2586G>C			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1347_1540			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1648_1774			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1621A>C			Sensitive	P10721							
dbmcs	Midostaurin	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1249_1257delinsTAT			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1451_1462del12			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1735_1737delGAT			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.2458G>T			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1924A>G			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	PD-180970	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Tandutinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1678_1728del51			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1669_1674delTGGAAG			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1669_1674delTGGAAG			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1672_1677delAAGGTT			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1651_1662del12			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.1924A>G			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.2458G>T			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1674delinsTCCT			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1674delinsTCCT			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1674delinsTCCT			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1674delinsTCCT			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1648_1774			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1705_1728del24			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1883G>A			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.1883G>A			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.2466T>A			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1679T>G			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1679T>G			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1679T>G			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1924A>G			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1924A>G			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.2362_2484			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.2485_2580			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1648_1776			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1879_1992			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.1729_1734delCCTTAT			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1246_1266			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1345_1542			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1345_1542			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1345_1542			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1648_1776			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1648_1776			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1990_2142			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1990_2142			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1990_2142			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.2362_2484			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.2362_2484			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.2362_2484			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1879_1992			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1879_1992			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1733A>G			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.1730_1738delCTTATGATC			Sensitive	P10721							
dbmcs	Motesanib	KIT	c.1654_1677del24			Sensitive	P10721							
dbmcs	Avapritinib	KIT	c.1679T>G			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1679T>G			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1679T>G			Sensitive	P10721							
dbmcs	Midostaurin	KIT	c.1679T>G			Sensitive	P10721							
dbmcs	Ripretinib	KIT	c.1679T>G			Sensitive	P10721							
dbmcs	Cabozantinib	KIT	c.1673_1693del21			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1673_1693del21			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1679_1681delTTG			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1679_1681delTTG			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1672_1674delinsAACCCT			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1672_1674delinsAACCCT			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1672_1674delinsAACCCT			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1672_1674delinsAACCCT			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.1676T>G			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.1727T>C			Sensitive	P10721							
dbmcs	Bevacizumab + Sorafenib	KIT	c.1727T>C			Sensitive	P10721							
dbmcs	SEL201	KIT	c.1727T>C			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.2009C>T			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.2009C>T			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1669_1674delTGGAAG			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1669_1674delTGGAAG			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.1669_1674delTGGAAG			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1669_1674delTGGAAG			Sensitive	P10721							
dbmcs	PD-0325901	KIT	c.1669_1674delTGGAAG			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1669T>G			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1676T>C			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1676T>C			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.1676T>C			Sensitive	P10721							
dbmcs	Midostaurin	KIT	c.1427G>T			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1427G>T			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1678_1728del51			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1678_1728del51			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.1652_1666del15			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Avapritinib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Motesanib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.1679T>A			Sensitive	P10721							
dbmcs	Flumatinib	KIT	c.1249_1257delinsATC			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1249_1257delinsATC			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.2458G>T			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.2458G>T			Sensitive	P10721							
dbmcs	SEL201	KIT	c.2458G>T			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1669T>A			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.2446G>C			Sensitive	P10721							
dbmcs	Flumatinib	KIT	c.2446G>C			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.2446G>C			Sensitive	P10721							
dbmcs	Gilteritinib	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	Crenolanib	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	Ripretinib	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	Cytarabine + Dasatinib	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	Avapritinib	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	Midostaurin	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	BPR1J373	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	FF-10101	KIT	c.2447A>T			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1327T>A			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1679_1735del57			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.1679_1735del57			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1679_1735del57			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1679_1735del57			Sensitive	P10721							
dbmcs	Infigratinib + Imatinib	KIT	c.1679_1735del57			Sensitive	P10721							
dbmcs	Avapritinib	KIT	c.2459A>T			Sensitive	P10721							
dbmcs	Motesanib	KIT	c.2467T>G			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.1961T>C			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1961T>C			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1924A>G			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.1924A>G			Sensitive	P10721							
dbmcs	Infigratinib + Imatinib	KIT	c.1924A>G			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1924A>G			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.2460T>G			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1651_1671delinsCTT			Sensitive	P10721							
dbmcs	Flumatinib	KIT	c.1504_1509			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1504_1509			Sensitive	P10721							
dbmcs	Cabozantinib	KIT	c.1504_1509			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1504_1509			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1504_1509			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.2465A>T			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.1651_1665delinsACACTT			Sensitive	P10721							
dbmcs	Dasatinib	KIT	c.2485G>C			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.2485G>C			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.2485G>C			Sensitive	P10721							
dbmcs	G007-LK + Imatinib	KIT	c.1679_1681delTTG			Sensitive	P10721							
dbmcs	Avapritinib	KIT	c.1670_1675delGGAAGG			Sensitive	P10721							
dbmcs	Nilotinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Axitinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Flumatinib	KIT	c.1676T>A			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	Avapritinib	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	Flumatinib	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	BPR1J373	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	Ripretinib	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	Midostaurin	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.2466T>G			Sensitive	P10721							
dbmcs	Avapritinib	KIT	c.2446G>T			Sensitive	P10721							
dbmcs	Ripretinib	KIT	c.2446G>T			Sensitive	P10721							
dbmcs	Midostaurin	KIT	c.2446G>T			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1514A>T			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.1514A>T			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1676_1681delTTGTTG			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1676_1681delTTGTTG			Sensitive	P10721							
dbmcs	Flumatinib	KIT	c.1676_1681delTTGTTG			Sensitive	P10721							
dbmcs	Ponatinib	KIT	c.1650_1673del24			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1650_1673del24			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1650_1673del24			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1650_1673del24			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.2009C>T			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.2009C>T			Sensitive	P10721							
dbmcs	Regorafenib	KIT	c.1961T>C			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.2448C>T			Sensitive	P10721							
dbmcs	Imatinib	KIT	c.1961T>C			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.2448C>T			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.2448C>T			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.2009C>T			Sensitive	P10721							
dbmcs	Sunitinib	KIT	c.1961T>C			Sensitive	P10721							
dbmcs	Sorafenib	KIT	c.1961T>C			Sensitive	P10721							
dbmcs	Avapritinib	KIT	c.2448C>T			Sensitive	P10721							
dbmcs	Dactolisib + Selumetinib	KRAS	c.35G>A			Sensitive	P01116							
dbmcs	Abemaciclib	KRAS	c.437C>T			Sensitive	P01116							
dbmcs	Palbociclib	KRAS	c.35G>T			Sensitive	P01116							
dbmcs	MK-2206	KRAS	c.35G>A			Sensitive	P01116							
dbmcs	Docetaxel + Selumetinib	KRAS	c.34G>T			Sensitive	P01116							
dbmcs	Docetaxel + Selumetinib	KRAS	c.35G>T			Sensitive	P01116							
dbmcs	EGFR inhibitor + ARS-853	KRAS	c.34G>T			Sensitive	P01116							
dbmcs	Irinotecan + Selumetinib	KRAS	c.1-11_111			Sensitive	P01116							
dbmcs	Therapeutic Tumor Infiltrating Lymphocytes	KRAS	c.35G>A			Sensitive	P01116							
dbmcs	Selumetinib + Dactolisib	KRAS	c.35G>T			Sensitive	P01116							
dbmcs	Dactolisib + Selumetinib	KRAS	c.38G>A			Sensitive	P01116							
dbmcs	Dactolisib + Selumetinib	KRAS	c.436G>A			Sensitive	P01116							
dbmcs	Selumetinib + Dactolisib	KRAS	c.437C>T			Sensitive	P01116							
dbmcs	Selumetinib + Dactolisib	KRAS	c.34G>T			Sensitive	P01116							
dbmcs	Selumetinib + Dactolisib	KRAS	c.35G>A			Sensitive	P01116							
dbmcs	MEK inhibitors	KRAS	c.34_36			Sensitive	P01116							
dbmcs	Panitumumab + Trametinib	MAP2K1	c.170A>C			Sensitive	Q02750							
dbmcs	Trametinib	MAP2K1	c.167A>C			Sensitive	Q02750							
dbmcs	Selumetinib	MAP2K1	c.166_180del15			Sensitive	Q02750							
dbmcs	Selumetinib	MAP2K1	c.171G>T			Sensitive	Q02750							
dbmcs	BRAF inhibitors	MAP2K1	c.370C>T			Sensitive	Q02750							
dbmcs	BRAF inhibitors	MAP2K1	c.332T>G			Sensitive	Q02750							
dbmcs	MEK inhibitors	MAP2K1	c.166_180del15			Sensitive	Q02750							
dbmcs	Cobimetinib	MAP2K1	c.314_322delCCGCAATCC			Sensitive	Q02750							
dbmcs	PLX4720	MAP2K1	c.361T>A			Sensitive	Q02750							
dbmcs	Cetuximab + Trametinib	MAP2K1	c.361T>A			Sensitive	Q02750							
dbmcs	Selumetinib	MAP2K1	c.361T>A			Sensitive	Q02750							
dbmcs	Cetuximab + Trametinib	MAP2K1	c.170A>C			Sensitive	Q02750							
dbmcs	Selumetinib	MAP2K1	c.167A>C			Sensitive	Q02750							
dbmcs	PLX4720	MAP2K1	c.167A>C			Sensitive	Q02750							
dbmcs	Refametinib	MAP2K1	c.167A>C			Sensitive	Q02750							
dbmcs	Cobimetinib	MAP2K1	c.167A>C			Sensitive	Q02750							
dbmcs	PD-0325901	MAP2K1	c.167A>C			Sensitive	Q02750							
dbmcs	Panitumumab + Trametinib	MAP2K1	c.171G>C			Sensitive	Q02750							
dbmcs	Selumetinib	MAP2K1	c.171G>C			Sensitive	Q02750							
dbmcs	PLX4720	MAP2K1	c.171G>C			Sensitive	Q02750							
dbmcs	Cetuximab + Trametinib	MAP2K1	c.171G>C			Sensitive	Q02750							
dbmcs	Trametinib	MAP2K1	c.171G>C			Sensitive	Q02750							
dbmcs	Selumetinib	MAP2K1	c.332T>G			Sensitive	Q02750							
dbmcs	PLX4720	MAP2K1	c.332T>G			Sensitive	Q02750							
dbmcs	Cobimetinib	MAP2K1	c.371C>T			Sensitive	Q02750							
dbmcs	PLX4720	MAP2K1	c.632T>A			Sensitive	Q02750							
dbmcs	Cobimetinib	MAP2K1	c.371C>A			Sensitive	Q02750							
dbmcs	PLX4720	MAP2K1	c.385T>C			Sensitive	Q02750							
dbmcs	Selumetinib	MAP2K1	c.385T>C			Sensitive	Q02750							
dbmcs	RO4927350	MAP2K1	c.385T>C			Sensitive	Q02750							
dbmcs	CI-1040	MAP2K1	c.158T>C			Sensitive	Q02750							
dbmcs	Trametinib	MAP2K1	c.157T>C			Sensitive	Q02750							
dbmcs	PLX4720	MAP2K1	c.157T>C			Sensitive	Q02750							
dbmcs	Cetuximab + Trametinib	MAP2K1	c.157T>C			Sensitive	Q02750							
dbmcs	Selumetinib	MAP2K1	c.157T>C			Sensitive	Q02750							
dbmcs	Erlotinib	MAPK1	c.964G>A			Sensitive	Q9H706							
dbmcs	Crizotinib	MET	c.3335A>T			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3328G>A			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3335A>G			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3803T>C			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.2962C>T			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3029C>T			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3683A>T			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3010C>G			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3750G>C			Sensitive	P08581							
dbmcs	MET inhibitors	MET	c.3335A>T			Sensitive	P08581							
dbmcs	MET inhibitors	MET	c.3803T>C			Sensitive	P08581							
dbmcs	MET inhibitors	MET	c.3281A>G			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3394_3990			Sensitive	P08581							
dbmcs	Bevacizumab + Sorafenib	MET	c.1124A>G			Sensitive	P08581							
dbmcs	Capmatinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Merestinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Savolitinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Glesatinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Tepotinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3683A>T			Sensitive	P08581							
dbmcs	Glesatinib	MET	c.3683A>T			Sensitive	P08581							
dbmcs	Merestinib	MET	c.3683A>T			Sensitive	P08581							
dbmcs	SU11274	MET	c.3616G>C			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3598T>A			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3682G>A			Sensitive	P08581							
dbmcs	Altiratinib	MET	c.3682G>A			Sensitive	P08581							
dbmcs	BMS-777607	MET	c.3682G>A			Sensitive	P08581							
dbmcs	Merestinib	MET	c.3682G>A			Sensitive	P08581							
dbmcs	Altiratinib	MET	c.3749T>C			Sensitive	P08581							
dbmcs	Glesatinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Tepotinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Capmatinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Savolitinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Merestinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	SU11274	MET	c.3328G>A			Sensitive	P08581							
dbmcs	K252a	MET	c.3803T>C			Sensitive	P08581							
dbmcs	SU11274	MET	c.3803T>C			Sensitive	P08581							
dbmcs	SU11274	MET	c.3335A>T			Sensitive	P08581							
dbmcs	SU11274	MET	c.3712G>A			Sensitive	P08581							
dbmcs	Altiratinib	MET	c.3688T>G			Sensitive	P08581							
dbmcs	Altiratinib	MET	c.3682G>C			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3682G>C			Sensitive	P08581							
dbmcs	SU11274	MET	c.3334C>T			Sensitive	P08581							
dbmcs	BMS-777607	MET	c.3688T>C			Sensitive	P08581							
dbmcs	Altiratinib	MET	c.3688T>C			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3688T>C			Sensitive	P08581							
dbmcs	Glesatinib	MET	c.3689A>G			Sensitive	P08581							
dbmcs	Merestinib	MET	c.3689A>G			Sensitive	P08581							
dbmcs	Altiratinib	MET	c.3689A>G			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3446T>C			Sensitive	P08581							
dbmcs	SU11274	MET	c.504G>C			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3028G>C			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3028G>A			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3008A>G			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Crizotinib	MET	c.3007T>A			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3028G>C			Sensitive	P08581							
dbmcs	Capmatinib	MET	c.3028G>C			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3028G>A			Sensitive	P08581							
dbmcs	Capmatinib	MET	c.3028G>A			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Capmatinib	MET	c.3028G>T			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3008A>G			Sensitive	P08581							
dbmcs	Capmatinib	MET	c.3008A>G			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Capmatinib	MET	c.3008A>T			Sensitive	P08581							
dbmcs	Cabozantinib	MET	c.3007T>A			Sensitive	P08581							
dbmcs	Capmatinib	MET	c.3007T>A			Sensitive	P08581							
dbmcs	Temozolomide	MGMT	c.66C>T			Sensitive	P16455							
dbmcs	JAK inhibitors	MPL	c.1544_1545delGGinsTT			Sensitive	P40238							
dbmcs	Everolimus	MPL	c.1544G>T			Sensitive	P40238							
dbmcs	BMS-911543	MPL	c.1544G>T			Sensitive	P40238							
dbmcs	BEZ235 + Ruxolitinib	MPL	c.1544G>T			Sensitive	P40238							
dbmcs	Ruxolitinib + TGX-221	MPL	c.1544G>T			Sensitive	P40238							
dbmcs	CHZ868	MPL	c.1544G>T			Sensitive	P40238							
dbmcs	NS-018	MPL	c.1544G>T			Sensitive	P40238							
dbmcs	MK2206	MPL	c.1544G>T			Sensitive	P40238							
dbmcs	Pictilisib + Ruxolitinib	MPL	c.1544G>T			Sensitive	P40238							
dbmcs	Everolimus	MPL	c.1543_1544delTGinsAA			Sensitive	P40238							
dbmcs	Fluorouracil	MTHFR	c.665C>T			Sensitive	P42898							
dbmcs	Everolimus	MTOR	c.6040G>A			Sensitive	P42345							
dbmcs	Everolimus	MTOR	c.7255G>A			Sensitive	P42345							
dbmcs	Everolimus	MTOR	c.4261A>G			Sensitive	P42345							
dbmcs	Everolimus	MTOR	c.5917A>T			Sensitive	P42345							
dbmcs	Everolimus	MTOR	c.5312A>G			Sensitive	P42345							
dbmcs	Everolimus	MTOR	c.6667C>A			Sensitive	P42345							
dbmcs	Sirolimus	MTOR	c.4379T>C			Sensitive	P42345							
dbmcs	Sirolimus	MTOR	c.6644C>A			Sensitive	P42345							
dbmcs	Sirolimus	MTOR	c.7514G>C			Sensitive	P42345							
dbmcs	LY-294002	MTOR	c.5902C>T			Sensitive	P42345							
dbmcs	Capivasertib	MTOR	c.5902C>T			Sensitive	P42345							
dbmcs	LY-294002 + Capivasertib	MTOR	c.6637C>T			Sensitive	P42345							
dbmcs	Sirolimus	MTOR	c.4448G>A			Sensitive	P42345							
dbmcs	Sirolimus	MTOR	c.5395G>A			Sensitive	P42345							
dbmcs	Pazopanib + Everolimus	MTOR	c.6040_7255			Sensitive	P42345							
dbmcs	Temsirolimus	MTOR	c.4379T>C			Sensitive	P42345							
dbmcs	Temsirolimus	MTOR	c.6625C>G			Sensitive	P42345							
dbmcs	Temsirolimus	MTOR	c.7280T>A			Sensitive	P42345							
dbmcs	Ibrutinib	MYD88	c.794T>C			Sensitive	Q99836							
dbmcs	IMG-2005-5	MYD88	c.794T>C			Sensitive	Q99836							
dbmcs	IRAK-1 or IRAK-4 inhibitors	MYD88	c.794T>C			Sensitive	Q99836							
dbmcs	Ibrutinib	MYD88	c.794T>C			Sensitive	Q99836							
dbmcs	Vorinostat	MYD88	c.794T>C			Sensitive	Q99836							
dbmcs	Everolimus	NF1	c.4931A>C			Sensitive	P21359							
dbmcs	Temsirolimus	NF2	c.476_477insCG			Sensitive	Q8NCF5							
dbmcs	MRK-003	NOTCH1	c.4655C>G			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.5047C>T			Sensitive	P46531							
dbmcs	WNT-974	NOTCH1	c.1433G>T			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.5039T>G			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.4795G>A			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.5026G>A			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.5119G>A			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.4655C>T			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.4724T>C			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.4699G>A			Sensitive	P46531							
dbmcs	MRK-003	NOTCH1	c.4709C>G			Sensitive	P46531							
dbmcs	Daunorubicin	NPM1	c.847_882+3			Sensitive	P06748							
dbmcs	Valproic acid	NPM1	c.847_882+3			Sensitive	P06748							
dbmcs	Tretinoin + NSC348884	NPM1	c.847_882+3			Sensitive	P06748							
dbmcs	Anti-CD33 + Anti-CD123	NPM1	c.847_882+3			Sensitive	P06748							
dbmcs	Anti-CD33	NPM1	c.847_882+3			Sensitive	P06748							
dbmcs	NSC348884	NPM1	c.863_864			Sensitive	P06748							
dbmcs	Induction Therapy	NPM1	c.863_864			Sensitive	P06748							
dbmcs	Amrubicin	NQO1	c.559C>T			Sensitive	P15559							
dbmcs	Tanespimycin	NRAS	c.38G>A			Sensitive	P01111							
dbmcs	Temozolomide	NRAS	c.182A>T			Sensitive	P01111							
dbmcs	Temozolomide	NRAS	c.182A>G			Sensitive	P01111							
dbmcs	Everolimus + Binimetinib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Binimetinib	NRAS	c.182A>T			Sensitive	P01111							
dbmcs	Binimetinib	NRAS	c.182A>G			Sensitive	P01111							
dbmcs	Selumetinib	NRAS	c.182A>T			Sensitive	P01111							
dbmcs	Selumetinib	NRAS	c.182A>G			Sensitive	P01111							
dbmcs	Selumetinib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Selumetinib + Dactolisib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Trametinib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	ERK inhibitors	NRAS	c.34G>T			Sensitive	P01111							
dbmcs	N-Arachidonoyl Dopamine	NRAS	c.35G>A			Sensitive	P01111							
dbmcs	Alpelisib + Binimetinib	NRAS	c.35G>A			Sensitive	P01111							
dbmcs	Binimetinib	NRAS	c.35G>A			Sensitive	P01111							
dbmcs	Cetuximab + Trametinib	NRAS	c.35G>T			Sensitive	P01111							
dbmcs	Compound 3144	NRAS	c.38G>T			Sensitive	P01111							
dbmcs	Alpelisib + Binimetinib	NRAS	c.183A>T			Sensitive	P01111							
dbmcs	MK2206	NRAS	c.182A>G			Sensitive	P01111							
dbmcs	RAF709	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Binimetinib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Pimasertib + Regorafenib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Everolimus + Pimasertib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Pimasertib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Pimasertib + Sorafenib	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	LY3009120	NRAS	c.181C>A			Sensitive	P01111							
dbmcs	Selumetinib	NRAS	c.38G>A			Sensitive	P01111							
dbmcs	Compound 3144	NRAS	c.38G>A			Sensitive	P01111							
dbmcs	LY3009120	NRAS	c.38G>A			Sensitive	P01111							
dbmcs	RAF709	NRAS	c.182A>T			Sensitive	P01111							
dbmcs	CCT196969	NRAS	c.182A>T			Sensitive	P01111							
dbmcs	CCT241161	NRAS	c.182A>T			Sensitive	P01111							
dbmcs	Crenolanib	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.1973T>C			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.1729C>T			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.2522G>A			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.2533C>T			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.2558G>A			Sensitive	P16234							
dbmcs	Dasatinib	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1729C>T			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2522G>A			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2533C>T			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2558G>A			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.2524_2525delGAinsAT			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.2524G>T			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.2529_2531delCAT			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.2524_2529delinsGTAATG			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1682T>C			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2529_2531delCAT			Sensitive	P16234							
dbmcs	Ponatinib	PDGFRA	c.2021C>T			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1682T>A			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2242A>G			Sensitive	P16234							
dbmcs	Sunitinib	PDGFRA	c.2242A>G			Sensitive	P16234							
dbmcs	Regorafenib	PDGFRA	c.2242A>G			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1654_1788			Sensitive	P16234							
dbmcs	Sunitinib	PDGFRA	c.1654_1788			Sensitive	P16234							
dbmcs	Regorafenib	PDGFRA	c.1654_1788			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1891_2004			Sensitive	P16234							
dbmcs	Sunitinib	PDGFRA	c.1891_2004			Sensitive	P16234							
dbmcs	Regorafenib	PDGFRA	c.1891_2004			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2440_2562			Sensitive	P16234							
dbmcs	Sunitinib	PDGFRA	c.2440_2562			Sensitive	P16234							
dbmcs	Regorafenib	PDGFRA	c.2440_2562			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1950C>A			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2242A>G			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.661C>T			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2533_2544delinsCCT			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2533_2544delinsCCT			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1683_1684insGAGAGG			Sensitive	P16234							
dbmcs	Ripretinib	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Omipalisib	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Avapritinib	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Midostaurin	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Regorafenib	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Avapritinib	PDGFRA	c.2525A>T			Sensitive	P16234							
dbmcs	Trametinib	PDGFRA	c.863A>G			Sensitive	P16234							
dbmcs	Omipalisib	PDGFRA	c.863A>G			Sensitive	P16234							
dbmcs	Sunitinib	PDGFRA	c.1682T>A			Sensitive	P16234							
dbmcs	Avapritinib	PDGFRA	c.1682T>A			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1682T>A			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.1682T>A			Sensitive	P16234							
dbmcs	Omipalisib	PDGFRA	c.1682T>A			Sensitive	P16234							
dbmcs	Nilotinib	PDGFRA	c.1682T>A			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2524G>T			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1973T>C			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2544C>G			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1698_1712del15			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2546A>C			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.1977C>G			Sensitive	P16234							
dbmcs	Crenolanib	PDGFRA	c.1977C>G			Sensitive	P16234							
dbmcs	Imatinib	PDGFRA	c.2536G>T			Sensitive	P16234							
dbmcs	Sorafenib	PDGFRA	c.2537A>T			Sensitive	P16234							
dbmcs	CH-5132799	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Sirolimus	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	CH-5132799	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	MK-2206	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Pictilisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Idelalisib	PIK3CA	c.1412C>T			Sensitive	P42336							
dbmcs	Dactolisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Cetuximab + Dactolisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Alpelisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Taselisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	AZD5363 + Trastuzumab	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	AZD5363 + Lapatinib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Apitolisib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Apitolisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Everolimus + Fulvestrant	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Perifosine	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Temsirolimus	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Perifosine	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Temsirolimus	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Trastuzumab emtansine	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	PI103	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Trastuzumab emtansine	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	PI103	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Fulvestrant + Alpelisib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Cetuximab	PIK3CA	c.1625A>T			Sensitive	P42336							
dbmcs	Alpelisib	PIK3CA	c.1348_1374del27			Sensitive	P42336							
dbmcs	Apitolisib	PIK3CA	c.263G>A			Sensitive	P42336							
dbmcs	Cetuximab + Floxuridine + Fluorouracil + Irinotecan	PIK3CA	c.263G>A			Sensitive	P42336							
dbmcs	Trametinib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	VS-5584	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Gemcitabine + LY2780301	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Cetuximab + Irinotecan	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	PD-0325901 + Pictilisib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Dactolisib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	MK2206 + Temsirolimus	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Alpelisib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	MK2206	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Lapatinib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Capivasertib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Miransertib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Neratinib	PIK3CA	c.1624G>A			Sensitive	P42336							
dbmcs	Neratinib	PIK3CA	c.3145G>C			Sensitive	P42336							
dbmcs	MK2206	PIK3CA	c.3145G>C			Sensitive	P42336							
dbmcs	Alpelisib	PIK3CA	c.3145G>C			Sensitive	P42336							
dbmcs	Dactolisib	PIK3CA	c.3145G>C			Sensitive	P42336							
dbmcs	Lapatinib	PIK3CA	c.3145G>C			Sensitive	P42336							
dbmcs	Trametinib	PIK3CA	c.3145G>C			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.1634A>G			Sensitive	P42336							
dbmcs	Sirolimus	PIK3CA	c.3127A>G			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.1634A>C			Sensitive	P42336							
dbmcs	BAY1125976	PIK3CA	c.1616C>G			Sensitive	P42336							
dbmcs	CYH33	PIK3CA	c.1616C>G			Sensitive	P42336							
dbmcs	MK2206	PIK3CA	c.1035T>G			Sensitive	P42336							
dbmcs	Dactolisib	PIK3CA	c.1035T>G			Sensitive	P42336							
dbmcs	Lapatinib	PIK3CA	c.1035T>G			Sensitive	P42336							
dbmcs	Trametinib	PIK3CA	c.1035T>G			Sensitive	P42336							
dbmcs	Neratinib	PIK3CA	c.1035T>G			Sensitive	P42336							
dbmcs	Alpelisib	PIK3CA	c.1035T>G			Sensitive	P42336							
dbmcs	Lapatinib	PIK3CA	c.1636C>A			Sensitive	P42336							
dbmcs	Dactolisib	PIK3CA	c.1636C>A			Sensitive	P42336							
dbmcs	Trametinib	PIK3CA	c.1636C>A			Sensitive	P42336							
dbmcs	MK2206	PIK3CA	c.1636C>A			Sensitive	P42336							
dbmcs	Alpelisib	PIK3CA	c.1636C>A			Sensitive	P42336							
dbmcs	Neratinib	PIK3CA	c.1636C>A			Sensitive	P42336							
dbmcs	Trametinib	PIK3CA	c.3140A>T			Sensitive	P42336							
dbmcs	Alpelisib	PIK3CA	c.3140A>T			Sensitive	P42336							
dbmcs	MK2206	PIK3CA	c.3140A>T			Sensitive	P42336							
dbmcs	Lapatinib	PIK3CA	c.3140A>T			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.3140A>T			Sensitive	P42336							
dbmcs	Dactolisib	PIK3CA	c.3140A>T			Sensitive	P42336							
dbmcs	Neratinib	PIK3CA	c.3140A>T			Sensitive	P42336							
dbmcs	Temsirolimus	PIK3CA	c.3139_3141			Sensitive	P42336							
dbmcs	Taselisib	PIK3CA	c.3139_3141			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.1258T>C			Sensitive	P42336							
dbmcs	DS-7423	PIK3CA	c.1258T>C			Sensitive	P42336							
dbmcs	Sirolimus	PIK3CA	c.1258T>C			Sensitive	P42336							
dbmcs	Sirolimus	PIK3CA	c.1173A>G			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.1636C>G			Sensitive	P42336							
dbmcs	YM-024	PIK3CA	c.3139C>T			Sensitive	P42336							
dbmcs	CH-5132799	PIK3CA	c.3139C>T			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.3139C>T			Sensitive	P42336							
dbmcs	LY-3023414	PIK3CA	c.353G>A			Sensitive	P42336							
dbmcs	Miransertib	PIK3CA	c.333G>C			Sensitive	P42336							
dbmcs	DHM25	PIK3CA	c.333G>C			Sensitive	P42336							
dbmcs	AZD8835	PIK3CA	c.333G>C			Sensitive	P42336							
dbmcs	BAY1125976	PIK3CA	c.333G>C			Sensitive	P42336							
dbmcs	ARQ 751	PIK3CA	c.333G>C			Sensitive	P42336							
dbmcs	Capivasertib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	MK2206 + Temsirolimus	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	SHR-A1307	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Everolimus	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Trametinib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	CYH33	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Miransertib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	CH-5132799	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	MK2206	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	A66	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Rigosertib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Taselisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	ARQ 751	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Gedatolisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	PF-04691502	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Metformin	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Neratinib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Radiotherapy + Taselisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Buparlisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	BAY1125976	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Sirolimus + Trametinib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Lapatinib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Sirolimus	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Cisplatin + Pictilisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Pictilisib	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Buparlisib + Paclitaxel	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	DHM25	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	M2698	PIK3CA	c.3140A>G			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.1635G>C			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.1637A>G			Sensitive	P42336							
dbmcs	CH-5132799	PIK3CA	c.1637A>G			Sensitive	P42336							
dbmcs	Alpelisib + Letrozole	PIK3CA	c.1340_1366del27			Sensitive	P42336							
dbmcs	DS-7423	PIK3CA	c.1634A>T			Sensitive	P42336							
dbmcs	Dactolisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Lapatinib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Alpelisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	MK2206	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Pictilisib + Sorafenib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Everolimus	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Miransertib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Trametinib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Cisplatin + Pictilisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	CYH33	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	LY-3023414	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Gemcitabine + Pictilisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Carboplatin + Paclitaxel + Temsirolimus	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	CH-5132799	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Buparlisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	PW12	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Alpelisib + Fulvestrant	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	DHM25	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	LY2780301	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Sirolimus	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	WYE-125132	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	ARQ 751	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Rigosertib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Voxtalisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Gedatolisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Dactolisib + WEHI-539	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	AZD8835	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Neratinib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	BAY1125976	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Pilaralisib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	PKI-402	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Capivasertib	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Cetuximab + Irinotecan	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	Copanlisib + Paclitaxel	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	LY-294002	PIK3CA	c.1633G>A			Sensitive	P42336							
dbmcs	MTOR inhibitors	PIK3R2	c.512C>T			Sensitive	P30530							
dbmcs	MTOR inhibitors	PIK3R2	c.1681A>G			Sensitive	P30530							
dbmcs	Nivolumab	PMS2	c.2118delG			Sensitive	P54278							
dbmcs	Pembrolizumab	POLD1	c.851G>A			Sensitive	P28340							
dbmcs	Pembrolizumab	POLD1	c.1120G>A			Sensitive	P28340							
dbmcs	Bevacizumab + FOLFIRI Regimen	PPP1R15A	c.752G>C			Sensitive	O75807							
dbmcs	ACLY SiRNA	PRKAA2	c.514_516			Sensitive	P54646							
dbmcs	MTOR inhibitors	PTEN	c.697C>T			Sensitive	P60484							
dbmcs	MK-2206 + PD184352	PTEN	c.950_953			Sensitive	P60484							
dbmcs	Perifosine	PTEN	c.388C>T			Sensitive	P60484							
dbmcs	Temsirolimus	PTEN	c.388C>T			Sensitive	P60484							
dbmcs	Carboplatin + Paclitaxel + Temsirolimus	PTEN	c.389G>A			Sensitive	P60484							
dbmcs	AZD-6482	PTEN	c.377C>G			Sensitive	P60484							
dbmcs	Alpelisib	PTEN	c.377C>G			Sensitive	P60484							
dbmcs	DHM25	PTEN	c.823_824delGTinsTA			Sensitive	P60484							
dbmcs	BAY1125976	PTEN	c.323T>G			Sensitive	P60484							
dbmcs	DHM25	PTEN	c.323T>G			Sensitive	P60484							
dbmcs	MK2206	PTEN	c.388C>T			Sensitive	P60484							
dbmcs	SHP099	PTPN11	c.205G>A			Sensitive	Q9UIB8							
dbmcs	Cryptotanshinone	PTPN11	c.226G>A			Sensitive	Q9UIB8							
dbmcs	U0126	PTPN11	c.226G>A			Sensitive	Q9UIB8							
dbmcs	PD98059	PTPN11	c.226G>A			Sensitive	Q9UIB8							
dbmcs	II-B08	PTPN11	c.226G>A			Sensitive	Q9UIB8							
dbmcs	Cixutumumab	PTPRD	c.757G>A			Sensitive	P23468							
dbmcs	Teprotumumab	PTPRD	c.757G>A			Sensitive	P23468							
dbmcs	AZD7762 + Irinotecan	RAD50	c.3709C>T			Sensitive	Q92878							
dbmcs	Irinotecan + CHK1 or CHK2 inhibitors	RAD50	c.3709C>T			Sensitive	Q92878							
dbmcs	Cabozantinib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Cabozantinib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Sunitinib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Sunitinib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	AZD1480	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.1901G>T			Sensitive	P07949							
dbmcs	Everolimus	RET	c.1858T>C			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.2671T>G			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2671T>G			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.2671T>G			Sensitive	P07949							
dbmcs	Dovitinib	RET	c.2071G>A			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2417A>G			Sensitive	P07949							
dbmcs	ALW-II-41-27	RET	c.1901G>A			Sensitive	P07949							
dbmcs	HG-6-63-01	RET	c.1901G>A			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.1901G>A			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.1901G>A			Sensitive	P07949							
dbmcs	XMD15-44	RET	c.1901G>A			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.2370G>T			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2370G>T			Sensitive	P07949							
dbmcs	Selpercatinib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	HG-6-63-01	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Pz-1	RET	c.2753T>C			Sensitive	P07949							
dbmcs	XMD15-44	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Pralsetinib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Cabozantinib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2753T>C			Sensitive	P07949							
dbmcs	ALW-II-41-27	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Everolimus	RET	c.2753T>C			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.2372A>T			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2372A>T			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2650G>A			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.2647_2648delGCinsTT			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2647_2648delGCinsTT			Sensitive	P07949							
dbmcs	Pralsetinib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Selpercatinib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Regorafenib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Agerafenib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	AZD1480	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Lenvatinib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	ALW-II-41-27	RET	c.1902C>G			Sensitive	P07949							
dbmcs	XMD15-44	RET	c.1902C>G			Sensitive	P07949							
dbmcs	HG-6-63-01	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.1902C>G			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.2304G>C			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2304G>C			Sensitive	P07949							
dbmcs	Pz-1	RET	c.2410G>C			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2410G>C			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.1900T>C			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.1900T>C			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.1900T>C			Sensitive	P07949							
dbmcs	Vandetanib	RET	c.1900T>C			Sensitive	P07949							
dbmcs	Pz-1	RET	c.1900T>C			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.2410G>A			Sensitive	P07949							
dbmcs	Pz-1	RET	c.2410G>A			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2410G>A			Sensitive	P07949							
dbmcs	Sorafenib	RET	c.1852T>C			Sensitive	P07949							
dbmcs	Ponatinib	RET	c.2693A>T			Sensitive	P07949							
dbmcs	Cabozantinib	ROS1	c.6094G>A			Sensitive	P08922							
dbmcs	Lorlatinib	ROS1	c.5957C>A			Sensitive	P08922							
dbmcs	Lorlatinib	ROS1	c.5957C>T			Sensitive	P08922							
dbmcs	Foretinib	ROS1	c.6094G>A			Sensitive	P08922							
dbmcs	Lorlatinib	ROS1	c.6094G>A			Sensitive	P08922							
dbmcs	Lorlatinib	ROS1	c.6076C>A			Sensitive	P08922							
dbmcs	Foretinib	ROS1	c.6076C>A			Sensitive	P08922							
dbmcs	Foretinib	ROS1	c.6302G>C			Sensitive	P08922							
dbmcs	Spliceostatin A	SF3B1	c.2098A>G			Sensitive	O75533							
dbmcs	Spliceostatin A	SF3B1	c.1998G>T			Sensitive	O75533							
dbmcs	Spliceosome inhibitors	SF3B1	c.2098A>G			Sensitive	O75533							
dbmcs	Spliceosome inhibitors	SF3B1	c.1998G>C			Sensitive	O75533							
dbmcs	Spliceostatin A	SF3B1	c.1998G>C			Sensitive	O75533							
dbmcs	E7107	SF3B1	c.2098A>G			Sensitive	O75533							
dbmcs	Vismodegib	SMO	c.1921C>G			Sensitive	Q99835							
dbmcs	Patidegib	SMO	c.1417G>C			Sensitive	Q99835							
dbmcs	JQ1	SMO	c.1376C>T			Sensitive	Q99835							
dbmcs	JQ1	SMO	c.722C>T			Sensitive	Q99835							
dbmcs	JQ1	SMO	c.1222A>G			Sensitive	Q99835							
dbmcs	TAK-441	SMO	c.1417G>C			Sensitive	Q99835							
dbmcs	JQ1	SMO	c.961G>A			Sensitive	Q99835							
dbmcs	Arsenic trioxide + Posaconazole	SMO	c.1160G>A			Sensitive	Q99835							
dbmcs	Posaconazole	SMO	c.1160G>A			Sensitive	Q99835							
dbmcs	MRT-92	SMO	c.1198_1199delCGinsGC			Sensitive	Q99835							
dbmcs	JQ1	SMO	c.843G>T			Sensitive	Q99835							
dbmcs	JQ1	SMO	c.1406G>A			Sensitive	Q99835							
dbmcs	Arsenic trioxide + Posaconazole	SMO	c.1552G>A			Sensitive	Q99835							
dbmcs	Posaconazole	SMO	c.1552G>A			Sensitive	Q99835							
dbmcs	Sonidegib	SMO	c.1604G>T			Sensitive	Q99835							
dbmcs	Arsenic trioxide	SMO	c.1604G>T			Sensitive	Q99835							
dbmcs	Arsenic trioxide + Posaconazole	SMO	c.655A>G			Sensitive	Q99835							
dbmcs	Posaconazole	SMO	c.655A>G			Sensitive	Q99835							
dbmcs	Posaconazole	SMO	c.1418A>G			Sensitive	Q99835							
dbmcs	Arsenic trioxide + Posaconazole	SMO	c.1418A>G			Sensitive	Q99835							
dbmcs	Posaconazole	SMO	c.1150G>A			Sensitive	Q99835							
dbmcs	Arsenic trioxide + Posaconazole	SMO	c.1150G>A			Sensitive	Q99835							
dbmcs	Olaparib	STAG2	c.1958C>A			Sensitive	Q8N3U4							
dbmcs	Camptothecin	STAG2	c.1958C>A			Sensitive	Q8N3U4							
dbmcs	Everolimus	STK11	c.582C>G			Sensitive	Q15831							
dbmcs	Everolimus	STK11	c.582C>A			Sensitive	Q15831							
dbmcs	Everolimus + Radiotherapy	STK11	c.892T>C			Sensitive	Q15831							
dbmcs	Trametinib	STK11	c.995G>A			Sensitive	Q15831							
dbmcs	Trametinib	STK11	c.109C>T			Sensitive	Q15831							
dbmcs	Everolimus + Exemestane	STK11	c.1060T>C			Sensitive	Q15831							
dbmcs	Trametinib	STK11	c.595G>T			Sensitive	Q15831							
dbmcs	Doxorubicin	TP53	c.524G>A			Sensitive	Q12888							
dbmcs	Mitomycin + Cisplatin + Etoposide	TP53	c.659A>G			Sensitive	Q12888							
dbmcs	EAP Protocol	TP53	c.524G>A			Sensitive	Q12888							
dbmcs	EAP Protocol	TP53	c.845G>T			Sensitive	Q12888							
dbmcs	EAP Protocol	TP53	c.638G>C			Sensitive	Q12888							
dbmcs	HSP90 inhibitors	TP53	c.743G>A			Sensitive	Q12888							
dbmcs	HSP90 inhibitors	TP53	c.524G>A			Sensitive	Q12888							
dbmcs	CP-31398	TP53	c.747G>C			Sensitive	Q12888							
dbmcs	APR-246	TP53	c.517G>A			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.742C>T			Sensitive	Q12888							
dbmcs	Cisplatin + Irinotecan	TP53	c.215C>G			Sensitive	Q12888							
dbmcs	Daunoxome	TP53	c.215C>G			Sensitive	Q12888							
dbmcs	Cyclophosphamide + Doxorubicin + Fluorouracil	TP53	c.215C>G			Sensitive	Q12888							
dbmcs	Epirubicin	TP53	c.215C>G			Sensitive	Q12888							
dbmcs	Doxorubicin + Ifosfamide	TP53	c.215C>G			Sensitive	Q12888							
dbmcs	Doxorubicin	TP53	c.215C>G			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.487T>C			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.404G>A			Sensitive	Q12888							
dbmcs	Tanespimycin	TP53	c.743G>A			Sensitive	Q12888							
dbmcs	ReACp53	TP53	c.743G>A			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.743G>A			Sensitive	Q12888							
dbmcs	Napabucasin	TP53	c.743G>A			Sensitive	Q12888							
dbmcs	Ganetespib	TP53	c.743G>A			Sensitive	Q12888							
dbmcs	NSC59984	TP53	c.524G>A			Sensitive	Q12888							
dbmcs	ReACp53	TP53	c.524G>A			Sensitive	Q12888							
dbmcs	NSC319726	TP53	c.524G>A			Sensitive	Q12888							
dbmcs	Ganetespib	TP53	c.524G>A			Sensitive	Q12888							
dbmcs	Alvespimycin + Vorinostat	TP53	c.524G>A			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.839G>A			Sensitive	Q12888							
dbmcs	Ganetespib	TP53	c.839G>A			Sensitive	Q12888							
dbmcs	YW3-56	TP53	c.839G>A			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.488A>G			Sensitive	Q12888							
dbmcs	ReACp53	TP53	c.979_980delTAinsCT			Sensitive	Q12888							
dbmcs	ReACp53	TP53	c.701A>G			Sensitive	Q12888							
dbmcs	Vemurafenib	TP53	c.775G>T			Sensitive	Q12888							
dbmcs	Selumetinib	TP53	c.775G>T			Sensitive	Q12888							
dbmcs	LY3009120	TP53	c.775G>T			Sensitive	Q12888							
dbmcs	MK-1775 + Carboplatin	TP53	c.489C>A			Sensitive	Q12888							
dbmcs	Ibrutinib + Rituximab	TP53	c.730G>A			Sensitive	Q12888							
dbmcs	CP-31398	TP53	c.659A>G			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.818G>A			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.452C>A			Sensitive	Q12888							
dbmcs	NSC59984	TP53	c.524G>T			Sensitive	Q12888							
dbmcs	NSC319726	TP53	c.524G>T			Sensitive	Q12888							
dbmcs	Gedatolisib	TP53	c.472C>G			Sensitive	Q12888							
dbmcs	APR-246	TP53	c.818G>T			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.332T>A			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.713G>T			Sensitive	Q12888							
dbmcs	Tanespimycin	TP53	c.580C>T			Sensitive	Q12888							
dbmcs	Tanespimycin + Vorinostat	TP53	c.580C>T			Sensitive	Q12888							
dbmcs	Ganetespib	TP53	c.580C>T			Sensitive	Q12888							
dbmcs	Vorinostat	TP53	c.580C>T			Sensitive	Q12888							
dbmcs	APR-246	TP53	c.722C>T			Sensitive	Q12888							
dbmcs	Ganetespib	TP53	c.722C>T			Sensitive	Q12888							
dbmcs	APR-246 + Cisplatin	TP53	c.833C>G			Sensitive	Q12888							
dbmcs	Cisplatin	TPMT	c.238G>C			Sensitive	P51580							
dbmcs	Cisplatin	TPMT	c.719A>G			Sensitive	P51580							
dbmcs	Cisplatin	TPMT	c.460G>A			Sensitive	P51580							
dbmcs	Cisplatin	TPMT	c.500C>G			Sensitive	P51580							
dbmcs	Mercaptopurine	TPMT	c.238G>C			Sensitive	P51580							
dbmcs	Mercaptopurine	TPMT	c.719A>G			Sensitive	P51580							
dbmcs	Mercaptopurine	TPMT	c.460G>A			Sensitive	P51580							
dbmcs	Mercaptopurine	TPMT	c.500C>G			Sensitive	P51580							
dbmcs	Tioguanine	TPMT	c.238G>C			Sensitive	P51580							
dbmcs	Tioguanine	TPMT	c.719A>G			Sensitive	P51580							
dbmcs	Tioguanine	TPMT	c.460G>A			Sensitive	P51580							
dbmcs	Tioguanine	TPMT	c.500C>G			Sensitive	P51580							
dbmcs	Everolimus	TSC2	c.3532C>T			Sensitive	P49815							
dbmcs	Temsirolimus	TSC2	c.196G>A			Sensitive	P49815							
dbmcs	Irinotecan	UGT1A1	c.211G>A			Sensitive	P22309							
dbmcs	Irinotecan	UGT1A1	c.686C>A			Sensitive	P22309							
dbmcs	Nilotinib	UGT1A1	c.211G>A			Sensitive	P22309							
dbmcs	Nilotinib	UGT1A1	c.686C>A			Sensitive	P22309							
dbmcs	Ruxolitinib	VHL	c.598C>T			Sensitive	P40337							
dbmcs	Gemcitabine + PLATINUM	WEE1	c.1141+1133A>G			Sensitive	P30291							
dbmcs	Gemcitabine	XRCC1	c.580C>T			Sensitive	P18887							
dbmcs	Vinorelbine	XRCC1	c.580C>T			Sensitive	P18887							
dbmcs	Docetaxel	XRCC1	c.580C>T			Sensitive	P18887							
dbmcs	Cisplatin	XRCC1	c.1196A>G			Sensitive	P18887							
dbmcs	Carboplatin	XRCC1	c.1196A>G			Sensitive	P18887							
depmep	TAE-684	ALK	p.A96T	-1.21145593			Q9UM73							
depmep	TAE-684	ALK	p.R317T	2.375909478			Q9UM73							
depmep	TAE-684	ALK	p.G882C	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.G689R	0.7916695			Q9UM73							
depmep	TAE-684	ALK	p.R753Q	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.T533A	1.072297348			Q9UM73							
depmep	TAE-684	ALK	p.S874F	0.004509557			Q9UM73							
depmep	TAE-684	ALK	p.R1192W+p.G5R	-0.5097258410000001			Q9UM73							
depmep	TAE-684	ALK	p.K575N	1.00134277			Q9UM73							
depmep	TAE-684	ALK	p.G893R	-0.67521967			Q9UM73							
depmep	TAE-684	ALK	p.E949K	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.G452R+p.P158T	-0.474408737			Q9UM73							
depmep	TAE-684	ALK	p.E1435del	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.V1476M	-2.045138043			Q9UM73							
depmep	TAE-684	ALK	p.P236R	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.V1185M	-1.6792311000000002			Q9UM73							
depmep	TAE-684	ALK	p.N1353S	-1.51536184			Q9UM73							
depmep	TAE-684	ALK	p.E1435del	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.G452R+p.L143R	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.N369K	1.329537735			Q9UM73							
depmep	TAE-684	ALK	p.Q450H	1.3745161280000002			Q9UM73							
depmep	TAE-684	ALK	p.S553A	1.7506161			Q9UM73							
depmep	TAE-684	ALK	p.S289Y+p.Y262H	1.121190044			Q9UM73							
depmep	TAE-684	ALK	p.V132L	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.G129V	2.41169076			Q9UM73							
depmep	TAE-684	ALK	p.C928Y	0.046212288			Q9UM73							
depmep	TAE-684	ALK	p.N941S	-1.033918607			Q9UM73							
depmep	TAE-684	ALK	p.S235P	-0.346844461			Q9UM73							
depmep	TAE-684	ALK	p.T1312I	-2.067248975			Q9UM73							
depmep	TAE-684	ALK	p.V526F	-1.641563811			Q9UM73							
depmep	TAE-684	ALK	p.P379S	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.P279L	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.F1174L	-1.910685129			Q9UM73							
depmep	TAE-684	ALK	p.H281Q	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.R48C	0.104895108			Q9UM73							
depmep	TAE-684	ALK	p.P1543S	-1.937684034			Q9UM73							
depmep	TAE-684	ALK	p.G103R	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.R918I	2.602063752			Q9UM73							
depmep	TAE-684	ALK	p.T1090I	2.602063752			Q9UM73							
depmep	L-685458	APP	p.R102P	0.496310405			Q92624							
depmep	L-685458	APP	p.A213G	0.496310405			Q92624							
depmep	L-685458	APP	p.T274A	0.496310405			Q92624							
depmep	L-685458	APP	p.E462K	0.496310405			Q92624							
depmep	L-685458	APP	p.R288Q	0.496310405			Q92624							
depmep	L-685458	APP	p.M406V	0.496310405			Q92624							
depmep	L-685458	APP	p.A369V+p.V185M	0.496310405			Q92624							
depmep	L-685458	APP	p.F179S	-0.370815345			Q92624							
depmep	L-685458	APP	p.E556G	-4.105908864			Q92624							
depmep	L-685458	APP	p.K510N	0.496310405			Q92624							
depmep	L-685458	APP	p.R540H	0.496310405			Q92624							
depmep	L-685458	APP	p.D252N	0.496310405			Q92624							
depmep	L-685458	APP	p.D177N	0.475712809			Q92624							
depmep	L-685458	APP	p.R100Q	-1.542777454			Q92624							
depmep	L-685458	APP	p.N550K	0.496310405			Q92624							
depmep	L-685458	APP	p.Y538H	0.496310405			Q92624							
depmep	L-685458	APP	p.K510N	0.496310405			Q92624							
depmep	LBW242	BIRC2	p.T591A	0.0			Q13490							
depmep	PLX-4720	BRAF	p.L597R	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-1.591786895			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V226M	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.586846504			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-3.432277446			P15056							
depmep	PLX-4720	BRAF	p.S273N	0.0			P15056							
depmep	PLX-4720	BRAF	p.L485W	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.369184509			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.50630191			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.411543534			P15056							
depmep	PLX-4720	BRAF	p.V600E	-3.168067609			P15056							
depmep	PLX-4720	BRAF	p.I326V	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-3.977523157			P15056							
depmep	PLX-4720	BRAF	p.V600E	-1.616786134			P15056							
depmep	PLX-4720	BRAF	p.R682Q	0.0			P15056							
depmep	PLX-4720	BRAF	p.R682Q	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-0.435736294			P15056							
depmep	PLX-4720	BRAF	p.V600E	-3.493987872			P15056							
depmep	PLX-4720	BRAF	p.V600E	-3.948125951			P15056							
depmep	PLX-4720	BRAF	p.V600E+p.T119S	-3.745614535			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.204017234			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.A728V	-2.5127896730000003			P15056							
depmep	PLX-4720	BRAF	p.K601N	-2.531628872			P15056							
depmep	PLX-4720	BRAF	p.V600E	-3.489386066			P15056							
depmep	PLX-4720	BRAF	p.D22N	0.0			P15056							
depmep	PLX-4720	BRAF	p.M650I	0.0			P15056							
depmep	PLX-4720	BRAF	p.D22N	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E+p.I208V	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.191660995			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.570706985			P15056							
depmep	PLX-4720	BRAF	p.P74A	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-3.3695539039999995			P15056							
depmep	PLX-4720	BRAF	p.GAGA30del	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.554444393			P15056							
depmep	PLX-4720	BRAF	p.E375D	0.0			P15056							
depmep	PLX-4720	BRAF	p.G466V	0.0			P15056							
depmep	PLX-4720	BRAF	p.L597V	-1.652229805			P15056							
depmep	PLX-4720	BRAF	p.A747V	0.0			P15056							
depmep	PLX-4720	BRAF	p.A747V	0.0			P15056							
depmep	PLX-4720	BRAF	p.NVTAP486del	0.0			P15056							
depmep	PLX-4720	BRAF	p.I326V	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.283286521			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.719988400000001			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-1.685911125			P15056							
depmep	PLX-4720	BRAF	p.E275K	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.521185369			P15056							
depmep	PLX-4720	BRAF	p.A400V	0.0			P15056							
depmep	PLX-4720	BRAF	p.GAGA30del	0.0			P15056							
depmep	PLX-4720	BRAF	p.599_599T>TT	0.0			P15056							
depmep	PLX-4720	BRAF	p.S683N	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-3.389738739			P15056							
depmep	PLX-4720	BRAF	p.I326V	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.013255916			P15056							
depmep	PLX-4720	BRAF	p.V600E	0.0			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.618961372			P15056							
depmep	PLX-4720	BRAF	p.V600E	-4.436979226			P15056							
depmep	PLX-4720	BRAF	p.I326T	0.0			P15056							
depmep	RAF-265	BRAF	p.L597R	0.154406295			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.420324197			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.185635168			P15056							
depmep	RAF-265	BRAF	p.V600E	0.240380146			P15056							
depmep	RAF-265	BRAF	p.V226M	-2.28399852			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.655861135			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.545057919			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.600815429			P15056							
depmep	RAF-265	BRAF	p.V600E	1.71509014			P15056							
depmep	RAF-265	BRAF	p.S273N	1.71509014			P15056							
depmep	RAF-265	BRAF	p.L485W	-2.901276137			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.767013527			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.665575189			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.63115254			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.855059788			P15056							
depmep	RAF-265	BRAF	p.I326V	1.71509014			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.369413896			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.689876851			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.831714982			P15056							
depmep	RAF-265	BRAF	p.R682Q	-1.450560944			P15056							
depmep	RAF-265	BRAF	p.R682Q	1.71509014			P15056							
depmep	RAF-265	BRAF	p.G464E	-2.836891095			P15056							
depmep	RAF-265	BRAF	p.V600E	-1.303835115			P15056							
depmep	RAF-265	BRAF	p.V600E	1.71509014			P15056							
depmep	RAF-265	BRAF	p.V600E	-0.981842711			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.823294157			P15056							
depmep	RAF-265	BRAF	p.V600E+p.T119S	-2.539193077			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.314674052			P15056							
depmep	RAF-265	BRAF	p.V600E	-0.415425535			P15056							
depmep	RAF-265	BRAF	p.A728V	-2.813502269			P15056							
depmep	RAF-265	BRAF	p.K601N	-2.947737211			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.6061032980000003			P15056							
depmep	RAF-265	BRAF	p.D22N	-2.169930728			P15056							
depmep	RAF-265	BRAF	p.M650I	-0.592927262			P15056							
depmep	RAF-265	BRAF	p.D22N	1.71509014			P15056							
depmep	RAF-265	BRAF	p.V600E+p.I208V	-1.4197936619999998			P15056							
depmep	RAF-265	BRAF	p.V600E	-1.897413852			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.798588423			P15056							
depmep	RAF-265	BRAF	p.P74A	-1.967693156			P15056							
depmep	RAF-265	BRAF	p.V600E	-1.2999709659999998			P15056							
depmep	RAF-265	BRAF	p.GAGA30del	-1.503201816			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.323595287			P15056							
depmep	RAF-265	BRAF	p.E375D	1.71509014			P15056							
depmep	RAF-265	BRAF	p.G466V	-2.766248149			P15056							
depmep	RAF-265	BRAF	p.L597V	-1.44375083			P15056							
depmep	RAF-265	BRAF	p.A747V	-0.849099438			P15056							
depmep	RAF-265	BRAF	p.A747V	-1.229796698			P15056							
depmep	RAF-265	BRAF	p.NVTAP486del	-2.230062583			P15056							
depmep	RAF-265	BRAF	p.I326V	-2.238284797			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.8490664530000003			P15056							
depmep	RAF-265	BRAF	p.V600E	1.71509014			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.931706444			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.9217107980000003			P15056							
depmep	RAF-265	BRAF	p.V600E	0.6985051999999999			P15056							
depmep	RAF-265	BRAF	p.E275K	-2.313363802			P15056							
depmep	RAF-265	BRAF	p.V600E	1.71509014			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.714680796			P15056							
depmep	RAF-265	BRAF	p.A400V	-2.06580682			P15056							
depmep	RAF-265	BRAF	p.GAGA30del	-2.58901554			P15056							
depmep	RAF-265	BRAF	p.599_599T>TT	-1.683414023			P15056							
depmep	RAF-265	BRAF	p.S683N	-0.956104546			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.904886833			P15056							
depmep	RAF-265	BRAF	p.I326V	-1.719013928			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.902219892			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.528262921			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.840206877			P15056							
depmep	RAF-265	BRAF	p.V600E	-2.807364797			P15056							
depmep	RAF-265	BRAF	p.I326T	-0.8931330940000001			P15056							
depmep	LBW242	XIAP	p.E350del	0.0			P98170							
gdsc	Nilotinib	ABL1	R608H	0.365148779			P00519							
gdsc	Nilotinib	ABL1	A1045T	0.620030367			P00519							
gdsc	Nilotinib	ABL1	V587M	0.146038215			P00519							
gdsc	Nilotinib	ABL1	P460L	0.494473543			P00519							
gdsc	Nilotinib	ABL1	G1079D	1.597724697			P00519							
gdsc	Nilotinib	ABL1	P919S+A941V	0.537918421			P00519							
gdsc	Nilotinib	ABL1	T719I	0.7008483109999999			P00519							
gdsc	Nilotinib	ABL1	N115S+R895G	0.844796392			P00519							
gdsc	Nilotinib	ABL1	A988T	0.14613666			P00519							
gdsc	Nilotinib	ABL1	A156T	0.123777179			P00519							
gdsc	Nilotinib	ABL1	E216K	1.925224342			P00519							
gdsc	Nilotinib	ABL1	G772V	-0.63717415			P00519							
gdsc	Nilotinib	ABL1	N617D+A964V	-0.068422895			P00519							
gdsc	Nilotinib	ABL1	E546K	-0.430816251			P00519							
gdsc	Nilotinib	ABL1	R13K	-0.458538478			P00519							
gdsc	Nilotinib	ABL1	Y276C	-0.477649361			P00519							
gdsc	Nilotinib	ABL1	I1146T	1.750393864			P00519							
gdsc	Nilotinib	ABL1	R502W	0.707144861			P00519							
gdsc	Nilotinib	ABL1	R153C	-0.601898809			P00519							
gdsc	Nilotinib	ABL1	V390I	-0.227233956			P00519							
gdsc	Nilotinib	ABL1	K628delK	0.387712531			P00519							
gdsc	Nilotinib	ABL1	H571R	0.070918648			P00519							
gdsc	Nilotinib	ABL1	K7R	-0.044279175			P00519							
gdsc	Nilotinib	ABL1	E216K	-0.029604093			P00519							
gdsc	Nilotinib	ABL1	R608H	0.5846810029999999			P00519							
gdsc	Nilotinib	ABL1	P681L	0.595897354			P00519							
gdsc	Nilotinib	ABL1	G35R+K628delK	-0.326242224			P00519							
gdsc	Nilotinib	ABL1	E810G	-4.009460094			P00519							
gdsc	Nilotinib	ABL1	K628delK	1.007330566			P00519							
gdsc	Nilotinib	ABL1	K106E	1.244156431			P00519							
gdsc	Nilotinib	ABL1	Q1131L	-0.229595847			P00519							
gdsc	Nilotinib	ABL1	L947M+N789S	-0.225629183			P00519							
gdsc	Nilotinib	ABL1	A844V	0.571237387			P00519							
gdsc	Nilotinib	ABL1	R185K	-0.120773277			P00519							
gdsc	Nilotinib	ABL1	R351W	0.405337627			P00519							
gdsc	Nilotinib	ABL1	G340W	-0.027843821			P00519							
gdsc	Nilotinib	ABL1	A666D	0.926020039			P00519							
gdsc	Nilotinib	ABL1	D579N	0.13777693300000002			P00519							
gdsc	Nilotinib	ABL1	K628delK	1.717334526			P00519							
gdsc	Nilotinib	ABL1	V741I	0.297170208			P00519							
gdsc	Nilotinib	ABL1	R649H	0.370719693			P00519							
gdsc	Nilotinib	ABL1	F766I	-0.629140409			P00519							
gdsc	Nilotinib	ABL1	P131S	-0.880666967			P00519							
gdsc	Nilotinib	ABL1	V1147E	-0.14978196800000002			P00519							
gdsc	Nilotinib	ABL1	N115S	0.944453699			P00519							
gdsc	Nilotinib	ABL1	T243I	0.100726846			P00519							
gdsc	Nilotinib	ABL1	T954M	0.051761988			P00519							
gdsc	Nilotinib	ABL1	A846S	0.6874992459999999			P00519							
gdsc	Nilotinib	ABL1	S1063C	0.07093306099999999			P00519							
gdsc	Nilotinib	ABL1	R839W	0.540229376			P00519							
gdsc	Nilotinib	ABL1	H415Q	0.7620164			P00519							
gdsc	Nilotinib	ABL1	K628delK	-0.301640256			P00519							
gdsc	Nilotinib	ABL1	K628delK	1.155809109			P00519							
gdsc	Nilotinib	ABL1	P845S	1.604375371			P00519							
gdsc	Nilotinib	ABL1	G720S+E890K	0.298408716			P00519							
gdsc	Nilotinib	ABL1	P970S	0.475152347			P00519							
gdsc	Nilotinib	ABL1	P933L	0.080868129			P00519							
gdsc	Nilotinib	ABL1	K908E	-0.134288713			P00519							
gdsc	AKT inhibitor VIII	AKT1	A230T+Q59*	-0.655526909			P31749							
gdsc	AT13148	AKT1	R406H	-0.8113906879999999			P31749							
gdsc	AT13148	AKT1	Q59*	0.500562521			P31749							
gdsc	AT13148	AKT1	S266L	0.49408607			P31749							
gdsc	AT13148	AKT1	Y272C	-0.057076426			P31749							
gdsc	AT13148	AKT1	R86H	0.220548895			P31749							
gdsc	AT13148	AKT1	E17K	0.971728912			P31749							
gdsc	AT13148	AKT1	R200H	-0.911317389			P31749							
gdsc	AT13148	AKT1	G478S	0.566527404			P31749							
gdsc	AT13148	AKT1	E49K+E17K	-0.033916197			P31749							
gdsc	AT13148	AKT1	D3N	0.368037309			P31749							
gdsc	AT13148	AKT1	R346C	0.259190158			P31749							
gdsc	AT13148	AKT1	G311D+K307N+Y215H	-0.187629849			P31749							
gdsc	AT13148	AKT1	Q104H	2.110961558			P31749							
gdsc	AT13148	AKT1	V337M	0.379863897			P31749							
gdsc	AT7867	AKT1	R406H	0.133493332			P31749							
gdsc	AT7867	AKT1	Q59*	-0.436206235			P31749							
gdsc	AT7867	AKT1	S266L	1.087629002			P31749							
gdsc	AT7867	AKT1	Y272C	0.7485884890000001			P31749							
gdsc	AT7867	AKT1	R86H	0.158216536			P31749							
gdsc	AT7867	AKT1	E17K	-0.308907331			P31749							
gdsc	AT7867	AKT1	R200H	-0.8382900879999999			P31749							
gdsc	AT7867	AKT1	I75M	0.301773814			P31749							
gdsc	AT7867	AKT1	E49K+E17K	0.392453013			P31749							
gdsc	AT7867	AKT1	D3N	0.59765359			P31749							
gdsc	AT7867	AKT1	R346C	0.586856741			P31749							
gdsc	AT7867	AKT1	G311D+K307N+Y215H	0.473353844			P31749							
gdsc	AT7867	AKT1	Q104H	1.694066178			P31749							
gdsc	AT7867	AKT1	A230T+Q59*	-0.026679588			P31749							
gdsc	AT7867	AKT1	V337M	-0.129402818			P31749							
gdsc	AT7867	AKT1	R86H	0.051619049000000014			P31749							
gdsc	Capivasertib	AKT1	R406H	-1.104249384			P31749							
gdsc	Capivasertib	AKT1	Q59*	0.720858425			P31749							
gdsc	Capivasertib	AKT1	S266L	-0.05635004			P31749							
gdsc	Capivasertib	AKT1	Y272C	-0.463253164			P31749							
gdsc	Capivasertib	AKT1	R86H	-1.434664504			P31749							
gdsc	Capivasertib	AKT1	E17K	0.189023373			P31749							
gdsc	Capivasertib	AKT1	R200H	-0.464057166			P31749							
gdsc	Capivasertib	AKT1	I75M	-0.307550541			P31749							
gdsc	Capivasertib	AKT1	G478S	1.053708064			P31749							
gdsc	Capivasertib	AKT1	E49K+E17K	-0.265139297			P31749							
gdsc	Capivasertib	AKT1	D3N	-1.445701902			P31749							
gdsc	Capivasertib	AKT1	R346C	-1.179937534			P31749							
gdsc	Capivasertib	AKT1	G311D+K307N+Y215H	-2.214254165			P31749							
gdsc	Capivasertib	AKT1	Q104H	2.395637447			P31749							
gdsc	Capivasertib	AKT1	R86H	0.645487254			P31749							
gdsc	GSK690693	AKT1	A230T+Q59*	-1.3206271859999998			P31749							
gdsc	MK-2206	AKT1	R86H	-1.239869713			P31749							
gdsc	MK-2206	AKT1	A230T+Q59*	-0.050765871			P31749							
gdsc	Uprosertib	AKT1	A230T+Q59*	-0.594811441			P31749							
gdsc	Alectinib	ALK	W582G	0.437944585			Q9UM73							
gdsc	Alectinib	ALK	P1027L+G872S	1.214855623			Q9UM73							
gdsc	Alectinib	ALK	T1012M+S737L	0.688332197			Q9UM73							
gdsc	Alectinib	ALK	C928Y	0.704028895			Q9UM73							
gdsc	Alectinib	ALK	S531N	0.370876496			Q9UM73							
gdsc	Alectinib	ALK	K1525E	0.380707003			Q9UM73							
gdsc	Alectinib	ALK	A96T	0.804978225			Q9UM73							
gdsc	Alectinib	ALK	K1109N	0.645790014			Q9UM73							
gdsc	Alectinib	ALK	P157L	1.286439038			Q9UM73							
gdsc	Alectinib	ALK	R1209*	0.463376993			Q9UM73							
gdsc	Alectinib	ALK	R317T	0.780465946			Q9UM73							
gdsc	Alectinib	ALK	V1013L	0.088264231			Q9UM73							
gdsc	Alectinib	ALK	P1218S	1.204257848			Q9UM73							
gdsc	Alectinib	ALK	R412C	0.872162441			Q9UM73							
gdsc	Alectinib	ALK	N787T+T901A	0.368382728			Q9UM73							
gdsc	Alectinib	ALK	P1398L	0.895328595			Q9UM73							
gdsc	Alectinib	ALK	T901A+Q897L+N863S+Q364H	0.446074661			Q9UM73							
gdsc	Alectinib	ALK	T648I	-1.3669594930000002			Q9UM73							
gdsc	Alectinib	ALK	G882C	0.875950789			Q9UM73							
gdsc	Alectinib	ALK	A1148V	0.884391327			Q9UM73							
gdsc	Alectinib	ALK	A1289V+D305G	0.502989339			Q9UM73							
gdsc	Alectinib	ALK	G689R+G385S	0.296527954			Q9UM73							
gdsc	Alectinib	ALK	H224N	0.450643311			Q9UM73							
gdsc	Alectinib	ALK	R753Q	0.78372165			Q9UM73							
gdsc	Alectinib	ALK	T533A	0.693148505			Q9UM73							
gdsc	Alectinib	ALK	T1012M	0.3793045920000001			Q9UM73							
gdsc	Alectinib	ALK	K1525E	0.610796087			Q9UM73							
gdsc	Alectinib	ALK	D1349N	0.817075579			Q9UM73							
gdsc	Alectinib	ALK	T1012M	0.314794259			Q9UM73							
gdsc	Alectinib	ALK	E1435delE	0.579359439			Q9UM73							
gdsc	Alectinib	ALK	T648I	0.554200166			Q9UM73							
gdsc	Alectinib	ALK	G893R	0.682682262			Q9UM73							
gdsc	Alectinib	ALK	E1460D	-0.015384459			Q9UM73							
gdsc	Alectinib	ALK	F1174L	0.673187102			Q9UM73							
gdsc	Alectinib	ALK	E949K	1.225309424			Q9UM73							
gdsc	Alectinib	ALK	P1298S	0.050849411			Q9UM73							
gdsc	Alectinib	ALK	T1012M	1.071994514			Q9UM73							
gdsc	Alectinib	ALK	M1478T	0.848016318			Q9UM73							
gdsc	Alectinib	ALK	M1478T	0.6065675229999999			Q9UM73							
gdsc	Alectinib	ALK	T1012M	0.7195751029999999			Q9UM73							
gdsc	Alectinib	ALK	G925R	-0.265566479			Q9UM73							
gdsc	Alectinib	ALK	R1061W	-1.472302098			Q9UM73							
gdsc	Alectinib	ALK	V163L	-0.495865895			Q9UM73							
gdsc	Alectinib	ALK	D1091N	-0.458274515			Q9UM73							
gdsc	Alectinib	ALK	M1478T	-0.065835721			Q9UM73							
gdsc	Alectinib	ALK	V1476M	0.991985965			Q9UM73							
gdsc	Alectinib	ALK	G1580V+R311H	0.911624296			Q9UM73							
gdsc	Alectinib	ALK	P236R	0.8442546320000001			Q9UM73							
gdsc	Alectinib	ALK	I981V	0.722756746			Q9UM73							
gdsc	Alectinib	ALK	T1012M	1.016199632			Q9UM73							
gdsc	Alectinib	ALK	A1200V	0.922832922			Q9UM73							
gdsc	Alectinib	ALK	V712L	1.156302132			Q9UM73							
gdsc	Alectinib	ALK	G1531S	0.693813273			Q9UM73							
gdsc	Alectinib	ALK	E314G	0.798497034			Q9UM73							
gdsc	Alectinib	ALK	E1435delE	0.594128899			Q9UM73							
gdsc	Alectinib	ALK	F1174L	0.17116351300000002			Q9UM73							
gdsc	Alectinib	ALK	N1353S	1.254351841			Q9UM73							
gdsc	Alectinib	ALK	G744R	0.996936175			Q9UM73							
gdsc	Alectinib	ALK	G452R+L143R	0.910479615			Q9UM73							
gdsc	Alectinib	ALK	N369K	1.100631079			Q9UM73							
gdsc	Alectinib	ALK	K1518N	-0.182703931			Q9UM73							
gdsc	Alectinib	ALK	Q450H	1.585972075			Q9UM73							
gdsc	Alectinib	ALK	A900G	0.763858006			Q9UM73							
gdsc	Alectinib	ALK	H755N	0.822297739			Q9UM73							
gdsc	Alectinib	ALK	G940C	-0.224507285			Q9UM73							
gdsc	Alectinib	ALK	S289Y+Y262H	1.192566939			Q9UM73							
gdsc	Alectinib	ALK	R412C	0.374272619			Q9UM73							
gdsc	Alectinib	ALK	K1525E	0.6960528659999999			Q9UM73							
gdsc	Alectinib	ALK	M1478T	0.54528801			Q9UM73							
gdsc	Alectinib	ALK	S439R	-0.6282098070000001			Q9UM73							
gdsc	Alectinib	ALK	M1478T	0.586347204			Q9UM73							
gdsc	Alectinib	ALK	G129V	0.557708268			Q9UM73							
gdsc	Alectinib	ALK	A206T	0.379224606			Q9UM73							
gdsc	Alectinib	ALK	T1012M	0.3864985420000001			Q9UM73							
gdsc	Alectinib	ALK	Q390R	0.243890424			Q9UM73							
gdsc	Alectinib	ALK	C928Y	-1.269008729			Q9UM73							
gdsc	Alectinib	ALK	N941S	0.6760138459999999			Q9UM73							
gdsc	Alectinib	ALK	M1478T	0.928264823			Q9UM73							
gdsc	Alectinib	ALK	S235P	0.7103809240000001			Q9UM73							
gdsc	Alectinib	ALK	T1312I	0.108652224			Q9UM73							
gdsc	Alectinib	ALK	V526F	0.564485109			Q9UM73							
gdsc	Alectinib	ALK	P379S	0.85530151			Q9UM73							
gdsc	Alectinib	ALK	P279L	0.384655914			Q9UM73							
gdsc	Alectinib	ALK	F1174L	-0.514733572			Q9UM73							
gdsc	Alectinib	ALK	R1192Q	0.727125729			Q9UM73							
gdsc	Alectinib	ALK	D951E	0.718841607			Q9UM73							
gdsc	Alectinib	ALK	R395C	1.066351689			Q9UM73							
gdsc	Alectinib	ALK	M1223I+A195V+R133H	0.7999586940000001			Q9UM73							
gdsc	Alectinib	ALK	R1113W+R1436C	-0.26430981800000003			Q9UM73							
gdsc	Alectinib	ALK	H281Q	0.974079299			Q9UM73							
gdsc	Alectinib	ALK	T1012M	0.363833037			Q9UM73							
gdsc	Alectinib	ALK	P367S	1.028080136			Q9UM73							
gdsc	Alectinib	ALK	Q610K	1.73625524			Q9UM73							
gdsc	Alectinib	ALK	R48C	-0.149668759			Q9UM73							
gdsc	Alectinib	ALK	G640R	0.970456847			Q9UM73							
gdsc	Alectinib	ALK	P1543S	0.431902426			Q9UM73							
gdsc	Alectinib	ALK	G103R	0.123147363			Q9UM73							
gdsc	Alectinib	ALK	P157H	0.957316127			Q9UM73							
gdsc	Alectinib	ALK	R1275Q	0.128682949			Q9UM73							
gdsc	Alectinib	ALK	S619C	0.7323662559999999			Q9UM73							
gdsc	Alectinib	ALK	M1478T	0.687251505			Q9UM73							
gdsc	NVP-TAE684	ALK	P1027L+G872S	-0.034425142			Q9UM73							
gdsc	NVP-TAE684	ALK	T1012M+S737L	0.356330403			Q9UM73							
gdsc	NVP-TAE684	ALK	A96T	-1.269820433			Q9UM73							
gdsc	NVP-TAE684	ALK	R1209*	-1.325393726			Q9UM73							
gdsc	NVP-TAE684	ALK	P1218S	0.341142649			Q9UM73							
gdsc	NVP-TAE684	ALK	R412C	0.193580766			Q9UM73							
gdsc	NVP-TAE684	ALK	N787T+T901A	-1.091303592			Q9UM73							
gdsc	NVP-TAE684	ALK	T901A+Q897L+N863S+Q364H	-1.414438259			Q9UM73							
gdsc	NVP-TAE684	ALK	T648I	0.027292218			Q9UM73							
gdsc	NVP-TAE684	ALK	A1289V+D305G	-0.795263845			Q9UM73							
gdsc	NVP-TAE684	ALK	H224N	-1.263884328			Q9UM73							
gdsc	NVP-TAE684	ALK	T648I	-0.315869619			Q9UM73							
gdsc	NVP-TAE684	ALK	G893R	-1.339209285			Q9UM73							
gdsc	NVP-TAE684	ALK	E1460D	-1.683781828			Q9UM73							
gdsc	NVP-TAE684	ALK	F1174L	-1.294826252			Q9UM73							
gdsc	NVP-TAE684	ALK	E949K	-0.310581693			Q9UM73							
gdsc	NVP-TAE684	ALK	P1298S	-1.732323511			Q9UM73							
gdsc	NVP-TAE684	ALK	T1012M	-0.307164241			Q9UM73							
gdsc	NVP-TAE684	ALK	F1174L	-2.287946826			Q9UM73							
gdsc	NVP-TAE684	ALK	D1091N	-2.642329731			Q9UM73							
gdsc	NVP-TAE684	ALK	M1478T	-2.46072723			Q9UM73							
gdsc	NVP-TAE684	ALK	V1476M	-1.18637962			Q9UM73							
gdsc	NVP-TAE684	ALK	I981V	-0.579791952			Q9UM73							
gdsc	NVP-TAE684	ALK	T1012M	-2.407389975			Q9UM73							
gdsc	NVP-TAE684	ALK	A1200V	0.577058228			Q9UM73							
gdsc	NVP-TAE684	ALK	V712L	-0.8937217759999999			Q9UM73							
gdsc	NVP-TAE684	ALK	G1531S	0.318461147			Q9UM73							
gdsc	NVP-TAE684	ALK	E314G	-2.348747611			Q9UM73							
gdsc	NVP-TAE684	ALK	E1435delE	-1.496446444			Q9UM73							
gdsc	NVP-TAE684	ALK	F1174L	-2.270582283			Q9UM73							
gdsc	NVP-TAE684	ALK	N1353S	-2.075654799			Q9UM73							
gdsc	NVP-TAE684	ALK	A900G	-1.590454222			Q9UM73							
gdsc	NVP-TAE684	ALK	H755N	-0.978944191			Q9UM73							
gdsc	NVP-TAE684	ALK	S289Y+Y262H	-0.469329095			Q9UM73							
gdsc	NVP-TAE684	ALK	R412C	-1.996426553			Q9UM73							
gdsc	NVP-TAE684	ALK	K1525E	-1.178510238			Q9UM73							
gdsc	NVP-TAE684	ALK	A206T	-1.5627715569999998			Q9UM73							
gdsc	NVP-TAE684	ALK	T1012M	-2.51162878			Q9UM73							
gdsc	NVP-TAE684	ALK	C928Y	-0.66419496			Q9UM73							
gdsc	NVP-TAE684	ALK	S235P	-1.724476051			Q9UM73							
gdsc	NVP-TAE684	ALK	T1312I	-2.335758568			Q9UM73							
gdsc	NVP-TAE684	ALK	V526F	0.216419276			Q9UM73							
gdsc	NVP-TAE684	ALK	P379S	-1.218241673			Q9UM73							
gdsc	NVP-TAE684	ALK	R1192Q	-1.36174148			Q9UM73							
gdsc	NVP-TAE684	ALK	D951E	-0.664719309			Q9UM73							
gdsc	NVP-TAE684	ALK	R395C	-1.438244889			Q9UM73							
gdsc	NVP-TAE684	ALK	Q610K	-1.560588251			Q9UM73							
gdsc	NVP-TAE684	ALK	R48C	-1.502983921			Q9UM73							
gdsc	NVP-TAE684	ALK	T1012M	-0.676378817			Q9UM73							
gdsc	NVP-TAE684	ALK	P157H	-0.656566719			Q9UM73							
gdsc	NVP-TAE684	ALK	R1275Q	-1.766745691			Q9UM73							
gdsc	NVP-TAE684	ALK	S619C	-1.533845859			Q9UM73							
gdsc	AZD3514	AR	H875Y	0.195728523			O95154							
gdsc	AZD3514	AR	V716M	-0.709401547			O95154							
gdsc	AZD3514	AR	S598G	0.625484377			O95154							
gdsc	AZD3514	AR	E773V	0.342488774			O95154							
gdsc	AZD3514	AR	Q98R+G624W	-0.565693185			O95154							
gdsc	AZD3514	AR	T282S	0.17663866399999995			O95154							
gdsc	AZD3514	AR	F827L	-0.383223286			O95154							
gdsc	AZD3514	AR	P555L	0.271086067			O95154							
gdsc	AZD3514	AR	Q118H	0.85559716			O95154							
gdsc	AZD3514	AR	R386C	0.242625469			O95154							
gdsc	AZD3514	AR	V33A	-0.136288083			O95154							
gdsc	AZD3514	AR	Q592H	0.893869305			O95154							
gdsc	AZD3514	AR	A403V	0.382156813			O95154							
gdsc	AZD3514	AR	E707K	0.362729238			O95154							
gdsc	AZD3514	AR	P392S	0.163468321			O95154							
gdsc	AZD3514	AR	V912I	0.907846613			O95154							
gdsc	AZD3514	AR	A270T	0.30204221			O95154							
gdsc	AZD3514	AR	C602Y	-0.032034466			O95154							
gdsc	AZD3514	AR	Y552H	0.457804674			O95154							
gdsc	AZD3514	AR	P146L	0.432331977			O95154							
gdsc	AZD3514	AR	A680G	0.41648064			O95154							
gdsc	AZD3514	AR	L635F+R711G+E830*	0.797026487			O95154							
gdsc	AZD3514	AR	S244L	-0.186268319			O95154							
gdsc	AZD3514	AR	G329C	0.012560084			O95154							
gdsc	AZD3514	AR	A871V	0.967364076			O95154							
gdsc	AZD3514	AR	K610R	-0.064281041			O95154							
gdsc	AZD3514	AR	E494Q	0.078577698			O95154							
gdsc	AZD3514	AR	E666K	1.129978627			O95154							
gdsc	AZD3514	AR	T878A	-0.513882171			O95154							
gdsc	AZD3514	AR	Q868H	0.174116457			O95154							
gdsc	AZD3514	AR	A52T	1.358554505			O95154							
gdsc	AZD3514	AR	R485W	-0.4657504870000001			O95154							
gdsc	AZD3514	AR	A417V	-0.554283114			O95154							
gdsc	AZD3514	AR	E523D	0.773615045			O95154							
gdsc	AZD3514	AR	A810P	0.679889882			O95154							
gdsc	AZD3514	AR	V716L	0.347198435			O95154							
gdsc	AZD3514	AR	P486R	1.005251699			O95154							
gdsc	AZD3514	AR	T559S	0.265792808			O95154							
gdsc	AZD3514	AR	A588S	0.328006669			O95154							
gdsc	AZD3514	AR	L249M	1.239966904			O95154							
gdsc	AZD3514	AR	D354E	0.683238605			O95154							
gdsc	AZD3514	AR	Q799E	-0.193918482			O95154							
gdsc	AZD3514	AR	V33A	0.209973634			O95154							
gdsc	AZD3514	AR	Y514H	0.403975657			O95154							
gdsc	AZD3514	AR	Y514H	1.036102973			O95154							
gdsc	AZD3514	AR	L548F	-0.382185845			O95154							
gdsc	AZD3514	AR	G334R	0.7751341759999999			O95154							
gdsc	AZD3514	AR	T306I	-0.126074238			O95154							
gdsc	AZD3514	AR	A385S	0.401116325			O95154							
gdsc	AZD3514	AR	E32K+S397I+R775H+T851A	0.994982161			O95154							
gdsc	AZD3514	AR	S176R	1.33008502			O95154							
gdsc	AZD3514	AR	Q641H+P818S	1.242804906			O95154							
gdsc	AZD3514	AR	A52T	-0.12747665			O95154							
gdsc	AZD3514	AR	D733N	0.997701073			O95154							
gdsc	AZD3514	AR	S434F	0.548640882			O95154							
gdsc	AZD3514	AR	P392S	0.502297317			O95154							
gdsc	Bicalutamide	AR	H875Y	0.97673497			O95154							
gdsc	Bicalutamide	AR	V716M	0.822562644			O95154							
gdsc	Bicalutamide	AR	S598G	0.569166109			O95154							
gdsc	Bicalutamide	AR	E773V	-0.265369181			O95154							
gdsc	Bicalutamide	AR	E323K	-0.505417341			O95154							
gdsc	Bicalutamide	AR	Q98R+G624W	0.06475476200000001			O95154							
gdsc	Bicalutamide	AR	T282S	1.028552347			O95154							
gdsc	Bicalutamide	AR	F827L	0.68747129			O95154							
gdsc	Bicalutamide	AR	P555L	0.995414502			O95154							
gdsc	Bicalutamide	AR	Q118H	1.286173625			O95154							
gdsc	Bicalutamide	AR	R386C	0.476304343			O95154							
gdsc	Bicalutamide	AR	V33A	0.633806867			O95154							
gdsc	Bicalutamide	AR	Q592H	0.618207086			O95154							
gdsc	Bicalutamide	AR	A403V	0.619163229			O95154							
gdsc	Bicalutamide	AR	E707K	0.688511285			O95154							
gdsc	Bicalutamide	AR	P392S	0.600379694			O95154							
gdsc	Bicalutamide	AR	V912I	0.608042047			O95154							
gdsc	Bicalutamide	AR	A270T	0.5788697389999999			O95154							
gdsc	Bicalutamide	AR	C602Y	1.11444992			O95154							
gdsc	Bicalutamide	AR	Y552H	0.6768596570000001			O95154							
gdsc	Bicalutamide	AR	P146L	1.283327308			O95154							
gdsc	Bicalutamide	AR	A680G	0.973703357			O95154							
gdsc	Bicalutamide	AR	L635F+R711G+E830*	0.65116654			O95154							
gdsc	Bicalutamide	AR	S244L	0.689431056			O95154							
gdsc	Bicalutamide	AR	G329C	0.817031657			O95154							
gdsc	Bicalutamide	AR	A871V	0.209077583			O95154							
gdsc	Bicalutamide	AR	K610R	0.467831796			O95154							
gdsc	Bicalutamide	AR	E494Q	0.5574647389999999			O95154							
gdsc	Bicalutamide	AR	T878A	-0.172857359			O95154							
gdsc	Bicalutamide	AR	Q868H	0.520098706			O95154							
gdsc	Bicalutamide	AR	A52T	1.7028219180000002			O95154							
gdsc	Bicalutamide	AR	R485W	0.596958759			O95154							
gdsc	Bicalutamide	AR	A417V	0.27823321			O95154							
gdsc	Bicalutamide	AR	E523D	1.099206453			O95154							
gdsc	Bicalutamide	AR	A810P	0.8476273540000001			O95154							
gdsc	Bicalutamide	AR	V716L	0.33888972100000003			O95154							
gdsc	Bicalutamide	AR	P486R	1.147912366			O95154							
gdsc	Bicalutamide	AR	T559S	0.226787166			O95154							
gdsc	Bicalutamide	AR	A588S	0.884511534			O95154							
gdsc	Bicalutamide	AR	L249M	1.199629143			O95154							
gdsc	Bicalutamide	AR	D354E	0.010414105			O95154							
gdsc	Bicalutamide	AR	Q799E	0.48515372			O95154							
gdsc	Bicalutamide	AR	V33A	0.504703579			O95154							
gdsc	Bicalutamide	AR	Y514H	0.628595814			O95154							
gdsc	Bicalutamide	AR	Y514H	1.213139665			O95154							
gdsc	Bicalutamide	AR	L548F	0.205372222			O95154							
gdsc	Bicalutamide	AR	D354E	0.855086302			O95154							
gdsc	Bicalutamide	AR	G334R	1.095853973			O95154							
gdsc	Bicalutamide	AR	T306I	0.57004944			O95154							
gdsc	Bicalutamide	AR	A385S	0.780036987			O95154							
gdsc	Bicalutamide	AR	E32K+S397I+R775H+T851A	1.149464265			O95154							
gdsc	Bicalutamide	AR	S176R	0.8423362120000001			O95154							
gdsc	Bicalutamide	AR	Q641H+P818S	1.110585416			O95154							
gdsc	Bicalutamide	AR	A52T	0.841023842			O95154							
gdsc	Bicalutamide	AR	D733N	1.108281449			O95154							
gdsc	Bicalutamide	AR	S434F	0.796353077			O95154							
gdsc	Bicalutamide	AR	P392S	1.220908262			O95154							
gdsc	QS11	ARFGAP1	R355C	-0.784963498			Q9NP61							
gdsc	QS11	ARFGAP1	R122G	0.198693909			Q9NP61							
gdsc	QS11	ARFGAP1	G308S	0.305934242			Q9NP61							
gdsc	QS11	ARFGAP1	R282H	1.220633534			Q9NP61							
gdsc	QS11	ARFGAP1	Y103H	1.650984835			Q9NP61							
gdsc	QS11	ARFGAP1	V184M	-1.336389058			Q9NP61							
gdsc	QS11	ARFGAP1	A27V	1.5535874509999998			Q9NP61							
gdsc	QS11	ARFGAP1	A286V	0.189713618			Q9NP61							
gdsc	QS11	ARFGAP1	S280N	-0.543386134			Q9NP61							
gdsc	QS11	ARFGAP1	P352L	-0.929234128			Q9NP61							
gdsc	QS11	ARFGAP1	P352L	-1.4433224830000002			Q9NP61							
gdsc	QS11	ARFGAP1	K288E	1.514539743			Q9NP61							
gdsc	QS11	ARFGAP1	E267D	0.892330622			Q9NP61							
gdsc	QS11	ARFGAP1	G242D	-0.058240065999999986			Q9NP61							
gdsc	QS11	ARFGAP1	S223L	1.112713621			Q9NP61							
gdsc	QS11	ARFGAP1	L358P	0.042533888			Q9NP61							
gdsc	QS11	ARFGAP1	E120K	-0.072526059			Q9NP61							
gdsc	QS11	ARFGAP1	S280N	-1.339297565			Q9NP61							
gdsc	QS11	ARFGAP1	P323H	0.26290563			Q9NP61							
gdsc	QS11	ARFGAP1	C279Y	0.350329125			Q9NP61							
gdsc	QS11	ARFGAP1	A27T	-0.20419513			Q9NP61							
gdsc	QS11	ARFGAP1	R282H	1.227412744			Q9NP61							
gdsc	QS11	ARFGAP1	V15M	0.892998945			Q9NP61							
gdsc	QS11	ARFGAP1	G388C	-0.067533782			Q9NP61							
gdsc	QS11	ARFGAP1	R84Q	0.4139679120000001			Q9NP61							
gdsc	QS11	ARFGAP1	Q317H+A318S	1.336195908			Q9NP61							
gdsc	QS11	ARFGAP1	D333N	0.459668039			Q9NP61							
gdsc	QS11	ARFGAP1	R220W	-0.082639773			Q9NP61							
gdsc	QS11	ARFGAP1	K288E	0.531852234			Q9NP61							
gdsc	QS11	ARFGAP1	I41V	-0.18586543			Q9NP61							
gdsc	QS11	ARFGAP1	A27T	-0.789827205			Q9NP61							
gdsc	QS11	ARFGAP1	S371R	-0.515519206			Q9NP61							
gdsc	QS11	ARFGAP1	V184M	-0.215471893			Q9NP61							
gdsc	QS11	ARFGAP1	T312M	-0.8040972			Q9NP61							
gdsc	QS11	ARFGAP1	K288E	-0.634802384			Q9NP61							
gdsc	QS11	ARFGAP1	A349T	0.331224454			Q9NP61							
gdsc	QS11	ARFGAP1	S371R	-0.7672559059999999			Q9NP61							
gdsc	QS11	ARFGAP1	R182H+G336D+G394C	-0.376556647			Q9NP61							
gdsc	QS11	ARFGAP1	A81S	-0.243812808			Q9NP61							
gdsc	QS11	ARFGAP1	K288E	0.7545228159999999			Q9NP61							
gdsc	QS11	ARFGAP1	S280N	0.264184804			Q9NP61							
gdsc	QS11	ARFGAP1	L99S	1.299086218			Q9NP61							
gdsc	QS11	ARFGAP1	R297C	0.12919841			Q9NP61							
gdsc	CP466722	ATM	K1101E	-0.3663588			Q13315							
gdsc	CP466722	ATM	S333F+H1876Q	-0.5733160939999999			Q13315							
gdsc	CP466722	ATM	R2461C+T2921M	0.14805957			Q13315							
gdsc	CP466722	ATM	S49C	-0.7009971509999999			Q13315							
gdsc	CP466722	ATM	R2436S	-0.841874621			Q13315							
gdsc	CP466722	ATM	Q2800*	0.530834345			Q13315							
gdsc	CP466722	ATM	S49C	-0.029618905			Q13315							
gdsc	CP466722	ATM	P604S	-0.8214516709999999			Q13315							
gdsc	CP466722	ATM	K1572T	-2.087964262			Q13315							
gdsc	CP466722	ATM	P2974L	-0.764741993			Q13315							
gdsc	CP466722	ATM	H291R	-0.6216587029999999			Q13315							
gdsc	CP466722	ATM	V410A+H1083Y	-0.878798271			Q13315							
gdsc	CP466722	ATM	D2721N+V2906A	-0.505429191			Q13315							
gdsc	CP466722	ATM	S49C	0.402341584			Q13315							
gdsc	CP466722	ATM	K482Q	-0.4147440670000001			Q13315							
gdsc	CP466722	ATM	E2468K	-0.327849661			Q13315							
gdsc	CP466722	ATM	S49C	1.351720786			Q13315							
gdsc	CP466722	ATM	V2906I	1.572007209			Q13315							
gdsc	CP466722	ATM	L2307F	-1.063910059			Q13315							
gdsc	CP466722	ATM	F582L	-0.013038218999999998			Q13315							
gdsc	CP466722	ATM	R1618Q	1.303467642			Q13315							
gdsc	CP466722	ATM	R1585S	-0.245661361			Q13315							
gdsc	CP466722	ATM	T2640I	0.686447503			Q13315							
gdsc	CP466722	ATM	A1670V	-0.013931686			Q13315							
gdsc	CP466722	ATM	H683R	0.161219249			Q13315							
gdsc	CP466722	ATM	P2518S	0.209182667			Q13315							
gdsc	CP466722	ATM	A2843V	0.984477406			Q13315							
gdsc	CP466722	ATM	L345F	-0.7128557329999999			Q13315							
gdsc	CP466722	ATM	I159V	-1.053862703			Q13315							
gdsc	CP466722	ATM	I159V+I2998T	0.84287829			Q13315							
gdsc	CP466722	ATM	S49C	0.478808851			Q13315							
gdsc	CP466722	ATM	K2318Q	-0.01620505			Q13315							
gdsc	CP466722	ATM	W57*	-0.282061254			Q13315							
gdsc	CP466722	ATM	F582L	-0.208402365			Q13315							
gdsc	CP466722	ATM	E3015D+R2849*	-0.219590847			Q13315							
gdsc	CP466722	ATM	L1472F	0.231471351			Q13315							
gdsc	CP466722	ATM	P604S+F1463C	-1.117199916			Q13315							
gdsc	CP466722	ATM	S49C	-1.180207707			Q13315							
gdsc	CP466722	ATM	I1688T	-0.267231953			Q13315							
gdsc	CP466722	ATM	V410A	-1.311261187			Q13315							
gdsc	CP466722	ATM	K31*	0.224475291			Q13315							
gdsc	CP466722	ATM	R2832C	-0.627817582			Q13315							
gdsc	CP466722	ATM	T935R	-0.4886796470000001			Q13315							
gdsc	CP466722	ATM	W2638*	-1.155720904			Q13315							
gdsc	CP466722	ATM	M1040V+L1824F	-0.811758028			Q13315							
gdsc	CP466722	ATM	V410A	0.055915749			Q13315							
gdsc	CP466722	ATM	R250*+E277*+R337C+E1133K+L1439I	-0.104450322			Q13315							
gdsc	CP466722	ATM	S49C	-0.40376651			Q13315							
gdsc	CP466722	ATM	A1127V	-0.753494855			Q13315							
gdsc	CP466722	ATM	E586D	-0.54858815			Q13315							
gdsc	CP466722	ATM	P2353H	0.823857159			Q13315							
gdsc	CP466722	ATM	P2648S	-0.35041385			Q13315							
gdsc	CP466722	ATM	L581V+I2606V	0.414778431			Q13315							
gdsc	CP466722	ATM	V2166A	-0.323740779			Q13315							
gdsc	CP466722	ATM	D130Y	0.515119872			Q13315							
gdsc	CP466722	ATM	W2845*	-0.38976254			Q13315							
gdsc	CP466722	ATM	S1691R	-0.6094837329999999			Q13315							
gdsc	CP466722	ATM	S49C	1.160992241			Q13315							
gdsc	CP466722	ATM	F2265L	-0.53489405			Q13315							
gdsc	CP466722	ATM	A2688V	-0.662535411			Q13315							
gdsc	CP466722	ATM	P960R	-0.163704722			Q13315							
gdsc	CP466722	ATM	V551L	-1.053325319			Q13315							
gdsc	CP466722	ATM	L787F+L1809P+N1784S	-1.777727395			Q13315							
gdsc	CP466722	ATM	S1383L	-1.834088693			Q13315							
gdsc	CP466722	ATM	L2332P	-1.009338066			Q13315							
gdsc	CP466722	ATM	Q2762R	-0.535181405			Q13315							
gdsc	CP466722	ATM	M1644T+I2223M	0.142943464			Q13315							
gdsc	CP466722	ATM	A2635G	0.146533329			Q13315							
gdsc	CP466722	ATM	R924W+D2661N	0.174614737			Q13315							
gdsc	CP466722	ATM	Q1128R	-1.314043495			Q13315							
gdsc	CP466722	ATM	S2218R	0.057589518			Q13315							
gdsc	CP466722	ATM	S49C	1.375573037			Q13315							
gdsc	CP466722	ATM	C2464R	0.306229892			Q13315							
gdsc	CP466722	ATM	N2826I	-0.34943388			Q13315							
gdsc	CP466722	ATM	Q912*	-0.533821653			Q13315							
gdsc	CP466722	ATM	N1005S+L2307F	-1.5596728619999998			Q13315							
gdsc	CP466722	ATM	E632Q	-0.807466661			Q13315							
gdsc	CP466722	ATM	N1005I	-0.345155548			Q13315							
gdsc	CP466722	ATM	E1856Q	-0.311271345			Q13315							
gdsc	CP466722	ATM	S49C	1.028581971			Q13315							
gdsc	CP466722	ATM	S333F	0.024072656			Q13315							
gdsc	CP466722	ATM	F1896L+C2464R	-0.925473034			Q13315							
gdsc	CP466722	ATM	T1854I	-0.591892269			Q13315							
gdsc	CP466722	ATM	R32C+S2165F	-1.163678567			Q13315							
gdsc	CP466722	ATM	R451H	-0.28950227			Q13315							
gdsc	CP466722	ATM	V410A	-0.6163423370000001			Q13315							
gdsc	CP466722	ATM	M1040V	0.194662051			Q13315							
gdsc	CP466722	ATM	M779I	-0.249216862			Q13315							
gdsc	CP466722	ATM	T2059I	-0.905202946			Q13315							
gdsc	CP466722	ATM	T2335I	-0.022381112			Q13315							
gdsc	CP466722	ATM	P604S	0.619282839			Q13315							
gdsc	CP466722	ATM	G506C	-0.083966939			Q13315							
gdsc	CP466722	ATM	G2022V	0.540707511			Q13315							
gdsc	CP466722	ATM	V1521L+G1998E	-0.871536777			Q13315							
gdsc	CP466722	ATM	Q65P	0.06947357700000001			Q13315							
gdsc	CP466722	ATM	W1279*	0.877063475			Q13315							
gdsc	CP466722	ATM	R2244T	-0.234187301			Q13315							
gdsc	CP466722	ATM	F582L	-0.579776548			Q13315							
gdsc	CP466722	ATM	E848Q+L2965F	-0.579117112			Q13315							
gdsc	CP466722	ATM	I1453T	-0.599250929			Q13315							
gdsc	CP466722	ATM	S49C	-0.669395199			Q13315							
gdsc	CP466722	ATM	M1210V	0.788597799			Q13315							
gdsc	CP466722	ATM	Q1919P	-0.8057235709999999			Q13315							
gdsc	CP466722	ATM	S49C	-0.210054212			Q13315							
gdsc	CP466722	ATM	Q1361R	0.83695996			Q13315							
gdsc	CP466722	ATM	S2058L	-0.478564747			Q13315							
gdsc	CP466722	ATM	D351N	-0.911777749			Q13315							
gdsc	CP466722	ATM	D814E	-0.183526892			Q13315							
gdsc	CP466722	ATM	L2307F	1.6187234469999998			Q13315							
gdsc	CP466722	ATM	D1725H	0.908016064			Q13315							
gdsc	CP466722	ATM	P383A	-0.488622769			Q13315							
gdsc	CP466722	ATM	R337C	-0.063629308			Q13315							
gdsc	CP466722	ATM	N1223S	-0.261964171			Q13315							
gdsc	CP466722	ATM	M1064I	-0.426346696			Q13315							
gdsc	CP466722	ATM	Q2733P	-0.6860860870000001			Q13315							
gdsc	CP466722	ATM	M1040V+C1482R	-0.800283968			Q13315							
gdsc	CP466722	ATM	C1726F	-0.60963067			Q13315							
gdsc	CP466722	ATM	R1618*	-0.638235834			Q13315							
gdsc	CP466722	ATM	I159V	-1.199447464			Q13315							
gdsc	CP466722	ATM	S2218N	0.205759883			Q13315							
gdsc	CP466722	ATM	N230T	-0.271839115			Q13315							
gdsc	CP466722	ATM	V613L	-0.493960464			Q13315							
gdsc	CP466722	ATM	T935R	0.453676833			Q13315							
gdsc	CP466722	ATM	R1304G+K2318Q	-1.442263121			Q13315							
gdsc	CP466722	ATM	S49C	-0.129647514			Q13315							
gdsc	CP466722	ATM	E2351G	-0.284896294			Q13315							
gdsc	CP466722	ATM	F1234S	-0.005092999			Q13315							
gdsc	CP466722	ATM	S49C	-0.487939041			Q13315							
gdsc	CP466722	ATM	K2749I	-0.619494356			Q13315							
gdsc	CP466722	ATM	S49C	-0.162203958			Q13315							
gdsc	CP466722	ATM	Q2825P	-0.5951005739999999			Q13315							
gdsc	CP466722	ATM	M1967V	-1.273072582			Q13315							
gdsc	CP466722	ATM	K2749I	0.989007544			Q13315							
gdsc	CP466722	ATM	S333F	-1.308530425			Q13315							
gdsc	CP466722	ATM	Q1128R+L2332P	-0.48975086			Q13315							
gdsc	CP466722	ATM	M1040V+L2332P	0.270807599			Q13315							
gdsc	CP466722	ATM	V1570A	-0.28578976100000003			Q13315							
gdsc	CP466722	ATM	L2307F	-0.119833004			Q13315							
gdsc	CP466722	ATM	L2332P	-0.27736225800000003			Q13315							
gdsc	CP466722	ATM	F582L+R1086H	0.125008358			Q13315							
gdsc	CP466722	ATM	V2587M	-0.60651894			Q13315							
gdsc	CP466722	ATM	I2920N	-0.020402805			Q13315							
gdsc	CP466722	ATM	L1419I+L1794M	-0.8034733140000001			Q13315							
gdsc	CP466722	ATM	S974F+F1236Y	0.361963155			Q13315							
gdsc	CP466722	ATM	Y2167*	0.6793299840000001			Q13315							
gdsc	CP466722	ATM	S1691R	-1.261497207			Q13315							
gdsc	CP466722	ATM	S49C	0.248257629			Q13315							
gdsc	CP466722	ATM	K1964E	-1.09254307			Q13315							
gdsc	CP466722	ATM	F582L	-0.723704722			Q13315							
gdsc	CP466722	ATM	S49C	0.262074966			Q13315							
gdsc	CP466722	ATM	H448R	-0.363046218			Q13315							
gdsc	CP466722	ATM	Q2210*	0.721547485			Q13315							
gdsc	CP466722	ATM	G2917R	0.310746996			Q13315							
gdsc	CP466722	ATM	N1650S	-0.17002535			Q13315							
gdsc	CP466722	ATM	L944V	0.488314676			Q13315							
gdsc	CP466722	ATM	Q1128E	0.914068888			Q13315							
gdsc	CP466722	ATM	R23*+T935R+T1350M	0.246400189			Q13315							
gdsc	CP466722	ATM	N1650S	1.114537289			Q13315							
gdsc	CP466722	ATM	T935R	-0.937335172			Q13315							
gdsc	CP466722	ATM	N1650S	0.259350721			Q13315							
gdsc	CP466722	ATM	P604S+R832C	-0.586123837			Q13315							
gdsc	CP466722	ATM	S333F	-1.184519811			Q13315							
gdsc	CP466722	ATM	L243W	-0.209420253			Q13315							
gdsc	CP466722	ATM	L2307F	1.4293528780000002			Q13315							
gdsc	CP466722	ATM	A1090T	-0.499626395			Q13315							
gdsc	KU-55933	ATM	K1101E	1.291724002			Q13315							
gdsc	KU-55933	ATM	S333F+H1876Q	0.243938415			Q13315							
gdsc	KU-55933	ATM	R2461C+T2921M	-0.279422919			Q13315							
gdsc	KU-55933	ATM	S49C	0.939679041			Q13315							
gdsc	KU-55933	ATM	R2436S	0.421438552			Q13315							
gdsc	KU-55933	ATM	Q2800*	0.047933794			Q13315							
gdsc	KU-55933	ATM	S49C	1.011416503			Q13315							
gdsc	KU-55933	ATM	P604S	1.114604832			Q13315							
gdsc	KU-55933	ATM	K1572T	-0.509145848			Q13315							
gdsc	KU-55933	ATM	P2974L	0.687022806			Q13315							
gdsc	KU-55933	ATM	H291R	1.009903297			Q13315							
gdsc	KU-55933	ATM	D2721N+V2906A	-0.061490438			Q13315							
gdsc	KU-55933	ATM	S49C	0.315850067			Q13315							
gdsc	KU-55933	ATM	K482Q	1.216268374			Q13315							
gdsc	KU-55933	ATM	E2468K	1.810485224			Q13315							
gdsc	KU-55933	ATM	S49C	0.514545161			Q13315							
gdsc	KU-55933	ATM	V2906I	1.000597139			Q13315							
gdsc	KU-55933	ATM	L2307F	0.774330174			Q13315							
gdsc	KU-55933	ATM	F582L	1.031969206			Q13315							
gdsc	KU-55933	ATM	R1618Q	1.196450084			Q13315							
gdsc	KU-55933	ATM	R1585S	0.685542779			Q13315							
gdsc	KU-55933	ATM	T2640I	1.197056196			Q13315							
gdsc	KU-55933	ATM	E1533G	1.35505292			Q13315							
gdsc	KU-55933	ATM	D479A	0.221172781			Q13315							
gdsc	KU-55933	ATM	A1670V	1.170852372			Q13315							
gdsc	KU-55933	ATM	H683R	1.06368373			Q13315							
gdsc	KU-55933	ATM	P2518S	1.002508853			Q13315							
gdsc	KU-55933	ATM	A2843V	1.406908963			Q13315							
gdsc	KU-55933	ATM	L345F	0.232452506			Q13315							
gdsc	KU-55933	ATM	I159V	0.134620831			Q13315							
gdsc	KU-55933	ATM	I159V+I2998T	0.487821137			Q13315							
gdsc	KU-55933	ATM	S49C	0.82199498			Q13315							
gdsc	KU-55933	ATM	S49C	1.167885209			Q13315							
gdsc	KU-55933	ATM	K2318Q	0.51510743			Q13315							
gdsc	KU-55933	ATM	W57*	1.557456969			Q13315							
gdsc	KU-55933	ATM	F582L	1.306401034			Q13315							
gdsc	KU-55933	ATM	E3015D+R2849*	0.367576948			Q13315							
gdsc	KU-55933	ATM	L1472F	0.007759197			Q13315							
gdsc	KU-55933	ATM	P604S+F1463C	1.561946818			Q13315							
gdsc	KU-55933	ATM	S49C	-0.044900272000000005			Q13315							
gdsc	KU-55933	ATM	I1688T	0.8076491459999999			Q13315							
gdsc	KU-55933	ATM	V410A	1.233325742			Q13315							
gdsc	KU-55933	ATM	K31*	0.037341352			Q13315							
gdsc	KU-55933	ATM	R2832C	0.504016115			Q13315							
gdsc	KU-55933	ATM	T935R	0.587730656			Q13315							
gdsc	KU-55933	ATM	P534A	1.157605598			Q13315							
gdsc	KU-55933	ATM	W2638*	1.093126647			Q13315							
gdsc	KU-55933	ATM	M1040V+L1824F	0.8623088740000001			Q13315							
gdsc	KU-55933	ATM	V410A	1.300932194			Q13315							
gdsc	KU-55933	ATM	R250*+E277*+R337C+E1133K+L1439I	1.059894198			Q13315							
gdsc	KU-55933	ATM	S49C	0.946604009			Q13315							
gdsc	KU-55933	ATM	A1127V	0.74261802			Q13315							
gdsc	KU-55933	ATM	E586D	0.5560878220000001			Q13315							
gdsc	KU-55933	ATM	P2353H	0.506118843			Q13315							
gdsc	KU-55933	ATM	P2648S	0.702396007			Q13315							
gdsc	KU-55933	ATM	L581V+I2606V	0.631358863			Q13315							
gdsc	KU-55933	ATM	V2166A	-0.308670929			Q13315							
gdsc	KU-55933	ATM	D130Y	0.854239777			Q13315							
gdsc	KU-55933	ATM	W2845*	0.833805571			Q13315							
gdsc	KU-55933	ATM	S1691R	0.153772308			Q13315							
gdsc	KU-55933	ATM	S49C	0.914611011			Q13315							
gdsc	KU-55933	ATM	R248Q	0.849530116			Q13315							
gdsc	KU-55933	ATM	F2265L	1.197296744			Q13315							
gdsc	KU-55933	ATM	A2688V	1.038800556			Q13315							
gdsc	KU-55933	ATM	P960R	0.48039671			Q13315							
gdsc	KU-55933	ATM	T2674R	1.134913432			Q13315							
gdsc	KU-55933	ATM	A502G+Q1128R	1.39157842			Q13315							
gdsc	KU-55933	ATM	V551L	0.6848513490000001			Q13315							
gdsc	KU-55933	ATM	T2438I	0.207297973			Q13315							
gdsc	KU-55933	ATM	L787F+L1809P+N1784S	-0.527767644			Q13315							
gdsc	KU-55933	ATM	S2581I	0.609276364			Q13315							
gdsc	KU-55933	ATM	S1383L	0.106276953			Q13315							
gdsc	KU-55933	ATM	L2332P	0.138544857			Q13315							
gdsc	KU-55933	ATM	Q2762R	1.129983367			Q13315							
gdsc	KU-55933	ATM	M1644T+I2223M	0.8363188909999999			Q13315							
gdsc	KU-55933	ATM	A2635G	0.9518943			Q13315							
gdsc	KU-55933	ATM	R924W+D2661N	0.970344867			Q13315							
gdsc	KU-55933	ATM	Q1128R	-0.280523164			Q13315							
gdsc	KU-55933	ATM	S2218R	1.502554369			Q13315							
gdsc	KU-55933	ATM	S49C	-0.395088386			Q13315							
gdsc	KU-55933	ATM	C2464R	0.70559187			Q13315							
gdsc	KU-55933	ATM	N2826I	0.318093807			Q13315							
gdsc	KU-55933	ATM	Q912*	1.410378554			Q13315							
gdsc	KU-55933	ATM	N1005S+L2307F	-0.264770772			Q13315							
gdsc	KU-55933	ATM	E632Q	-0.146903632			Q13315							
gdsc	KU-55933	ATM	N1005I	1.0090289609999998			Q13315							
gdsc	KU-55933	ATM	E1856Q	1.168231216			Q13315							
gdsc	KU-55933	ATM	S49C	0.857916738			Q13315							
gdsc	KU-55933	ATM	S333F	0.69985958			Q13315							
gdsc	KU-55933	ATM	F1896L+C2464R	0.021373295			Q13315							
gdsc	KU-55933	ATM	T1854I	-0.286019645			Q13315							
gdsc	KU-55933	ATM	R32C+S2165F	0.032270867			Q13315							
gdsc	KU-55933	ATM	R451H	0.35653303299999994			Q13315							
gdsc	KU-55933	ATM	V410A	1.196281226			Q13315							
gdsc	KU-55933	ATM	M1040V	0.39976309			Q13315							
gdsc	KU-55933	ATM	M779I	0.54551197			Q13315							
gdsc	KU-55933	ATM	T2059I	0.3792068320000001			Q13315							
gdsc	KU-55933	ATM	T2335I	0.17228686399999998			Q13315							
gdsc	KU-55933	ATM	P604S	1.207495777			Q13315							
gdsc	KU-55933	ATM	G506C	1.045038235			Q13315							
gdsc	KU-55933	ATM	G2022V	0.426518517			Q13315							
gdsc	KU-55933	ATM	V1521L+G1998E	1.181619005			Q13315							
gdsc	KU-55933	ATM	W1279*	-0.279862543			Q13315							
gdsc	KU-55933	ATM	R2244T	1.102657377			Q13315							
gdsc	KU-55933	ATM	F582L	1.418228384			Q13315							
gdsc	KU-55933	ATM	E2118V	1.686871636			Q13315							
gdsc	KU-55933	ATM	E848Q+L2965F	1.114612535			Q13315							
gdsc	KU-55933	ATM	I1453T	0.663585886			Q13315							
gdsc	KU-55933	ATM	S49C	0.892178354			Q13315							
gdsc	KU-55933	ATM	M1210V	1.3524495419999998			Q13315							
gdsc	KU-55933	ATM	Q1919P	0.8175513440000001			Q13315							
gdsc	KU-55933	ATM	S49C	0.564863707			Q13315							
gdsc	KU-55933	ATM	Q1361R	0.6332637010000001			Q13315							
gdsc	KU-55933	ATM	S2058L	1.754532802			Q13315							
gdsc	KU-55933	ATM	D351N	0.930074271			Q13315							
gdsc	KU-55933	ATM	D814E	1.043942731			Q13315							
gdsc	KU-55933	ATM	L2307F	1.889078388			Q13315							
gdsc	KU-55933	ATM	D1725H	0.255357374			Q13315							
gdsc	KU-55933	ATM	P383A	0.635922181			Q13315							
gdsc	KU-55933	ATM	R337C	0.720962702			Q13315							
gdsc	KU-55933	ATM	N1223S	0.903428454			Q13315							
gdsc	KU-55933	ATM	M1064I	0.940141772			Q13315							
gdsc	KU-55933	ATM	Q2733P	1.389784376			Q13315							
gdsc	KU-55933	ATM	M1040V+C1482R	0.977167922			Q13315							
gdsc	KU-55933	ATM	E347K	-0.290130304			Q13315							
gdsc	KU-55933	ATM	S2146T	1.7074196			Q13315							
gdsc	KU-55933	ATM	R1618*	0.568881938			Q13315							
gdsc	KU-55933	ATM	I159V	0.993518723			Q13315							
gdsc	KU-55933	ATM	S49C	-0.828255174			Q13315							
gdsc	KU-55933	ATM	S2218N	0.208373333			Q13315							
gdsc	KU-55933	ATM	N230T	0.663528415			Q13315							
gdsc	KU-55933	ATM	V613L	0.410945055			Q13315							
gdsc	KU-55933	ATM	T935R	2.144514562			Q13315							
gdsc	KU-55933	ATM	R1304G+K2318Q	0.00359579			Q13315							
gdsc	KU-55933	ATM	S49C	0.588953544			Q13315							
gdsc	KU-55933	ATM	E2351G	0.183029798			Q13315							
gdsc	KU-55933	ATM	F1234S	-0.159737444			Q13315							
gdsc	KU-55933	ATM	S49C	1.194868742			Q13315							
gdsc	KU-55933	ATM	K2749I	0.990138598			Q13315							
gdsc	KU-55933	ATM	S49C	-1.083178849			Q13315							
gdsc	KU-55933	ATM	Q2825P	-0.027213417			Q13315							
gdsc	KU-55933	ATM	M1967V	0.005644601999999999			Q13315							
gdsc	KU-55933	ATM	K2749I	1.691048654			Q13315							
gdsc	KU-55933	ATM	S333F	-0.074965318			Q13315							
gdsc	KU-55933	ATM	Q1128R+L2332P	0.631925278			Q13315							
gdsc	KU-55933	ATM	M1040V+L2332P	0.418313788			Q13315							
gdsc	KU-55933	ATM	V1570A	0.979560968			Q13315							
gdsc	KU-55933	ATM	L2307F	0.822252711			Q13315							
gdsc	KU-55933	ATM	L2332P	0.685301045			Q13315							
gdsc	KU-55933	ATM	F582L+R1086H	0.147904931			Q13315							
gdsc	KU-55933	ATM	I2920N	1.966019643			Q13315							
gdsc	KU-55933	ATM	L1419I+L1794M	0.273613606			Q13315							
gdsc	KU-55933	ATM	S974F+F1236Y	1.573760964			Q13315							
gdsc	KU-55933	ATM	Y2167*	0.089432019			Q13315							
gdsc	KU-55933	ATM	S1691R	-0.117135421			Q13315							
gdsc	KU-55933	ATM	S49C	0.065260418			Q13315							
gdsc	KU-55933	ATM	K1964E	0.999991027			Q13315							
gdsc	KU-55933	ATM	F582L	0.401577279			Q13315							
gdsc	KU-55933	ATM	S49C	1.159245596			Q13315							
gdsc	KU-55933	ATM	H448R	1.685943805			Q13315							
gdsc	KU-55933	ATM	Q2210*	1.848983167			Q13315							
gdsc	KU-55933	ATM	G2917R	0.403565065			Q13315							
gdsc	KU-55933	ATM	L944V	0.160976923			Q13315							
gdsc	KU-55933	ATM	Q1128E	0.911969714			Q13315							
gdsc	KU-55933	ATM	R23*+T935R+T1350M	0.336616658			Q13315							
gdsc	KU-55933	ATM	N1650S	0.55414625			Q13315							
gdsc	KU-55933	ATM	T935R	0.574057885			Q13315							
gdsc	KU-55933	ATM	N1650S	0.106176823			Q13315							
gdsc	KU-55933	ATM	S333F	0.813047867			Q13315							
gdsc	KU-55933	ATM	L243W	-0.181553326			Q13315							
gdsc	KU-55933	ATM	L2307F	1.233950814			Q13315							
gdsc	KU-55933	ATM	A1090T	-0.280664768			Q13315							
gdsc	KU-60019	ATM	K1101E	1.019134209			Q13315							
gdsc	KU-60019	ATM	S333F+H1876Q	-0.419118975			Q13315							
gdsc	KU-60019	ATM	R2461C+T2921M	-0.625974954			Q13315							
gdsc	KU-60019	ATM	S49C	-0.319666261			Q13315							
gdsc	KU-60019	ATM	R2436S	0.006658344			Q13315							
gdsc	KU-60019	ATM	Q2800*	-0.465876094			Q13315							
gdsc	KU-60019	ATM	S49C	-0.103965077			Q13315							
gdsc	KU-60019	ATM	P604S	-0.207379143			Q13315							
gdsc	KU-60019	ATM	K1572T	-1.020906331			Q13315							
gdsc	KU-60019	ATM	P2974L	-0.040597648			Q13315							
gdsc	KU-60019	ATM	H291R	1.020152098			Q13315							
gdsc	KU-60019	ATM	D2721N+V2906A	-0.039034673			Q13315							
gdsc	KU-60019	ATM	S49C	-0.326181224			Q13315							
gdsc	KU-60019	ATM	K482Q	0.406548818			Q13315							
gdsc	KU-60019	ATM	E2468K	0.808271848			Q13315							
gdsc	KU-60019	ATM	S49C	-0.339467102			Q13315							
gdsc	KU-60019	ATM	V2906I	0.161223396			Q13315							
gdsc	KU-60019	ATM	L2307F	-0.20198694			Q13315							
gdsc	KU-60019	ATM	F582L	0.266014397			Q13315							
gdsc	KU-60019	ATM	R1618Q	0.582021473			Q13315							
gdsc	KU-60019	ATM	R1585S	1.411824809			Q13315							
gdsc	KU-60019	ATM	T2640I	1.530366788			Q13315							
gdsc	KU-60019	ATM	E1533G	1.617942552			Q13315							
gdsc	KU-60019	ATM	D479A	0.327010702			Q13315							
gdsc	KU-60019	ATM	A1670V	-0.13787061			Q13315							
gdsc	KU-60019	ATM	H683R	-0.324135966			Q13315							
gdsc	KU-60019	ATM	P2518S	-0.127014511			Q13315							
gdsc	KU-60019	ATM	A2843V	-0.13086447699999998			Q13315							
gdsc	KU-60019	ATM	L345F	0.238178278			Q13315							
gdsc	KU-60019	ATM	I159V	-0.444856512			Q13315							
gdsc	KU-60019	ATM	I159V+I2998T	-0.047229922			Q13315							
gdsc	KU-60019	ATM	S49C	-0.375575493			Q13315							
gdsc	KU-60019	ATM	S49C	0.840763712			Q13315							
gdsc	KU-60019	ATM	K2318Q	-1.119387369			Q13315							
gdsc	KU-60019	ATM	W57*	0.212590047			Q13315							
gdsc	KU-60019	ATM	F582L	0.4195917770000001			Q13315							
gdsc	KU-60019	ATM	E3015D+R2849*	0.27180238100000004			Q13315							
gdsc	KU-60019	ATM	L1472F	0.530952842			Q13315							
gdsc	KU-60019	ATM	P604S+F1463C	1.219134547			Q13315							
gdsc	KU-60019	ATM	S49C	0.276054051			Q13315							
gdsc	KU-60019	ATM	I1688T	-0.026232262000000003			Q13315							
gdsc	KU-60019	ATM	V410A	1.31025811			Q13315							
gdsc	KU-60019	ATM	K31*	-0.017553546			Q13315							
gdsc	KU-60019	ATM	R2832C	0.389825936			Q13315							
gdsc	KU-60019	ATM	T935R	-0.183799435			Q13315							
gdsc	KU-60019	ATM	P534A	0.622975796			Q13315							
gdsc	KU-60019	ATM	W2638*	0.36120122			Q13315							
gdsc	KU-60019	ATM	M1040V+L1824F	0.212148053			Q13315							
gdsc	KU-60019	ATM	V410A	1.761304903			Q13315							
gdsc	KU-60019	ATM	R250*+E277*+R337C+E1133K+L1439I	0.678544349			Q13315							
gdsc	KU-60019	ATM	S49C	0.296062854			Q13315							
gdsc	KU-60019	ATM	A1127V	-0.5148633260000001			Q13315							
gdsc	KU-60019	ATM	E586D	0.030524814			Q13315							
gdsc	KU-60019	ATM	P2353H	-0.202502994			Q13315							
gdsc	KU-60019	ATM	P2648S	-0.167684442			Q13315							
gdsc	KU-60019	ATM	L581V+I2606V	0.083421261			Q13315							
gdsc	KU-60019	ATM	V2166A	-0.241031092			Q13315							
gdsc	KU-60019	ATM	D130Y	0.451580622			Q13315							
gdsc	KU-60019	ATM	W2845*	0.006424905			Q13315							
gdsc	KU-60019	ATM	S1691R	0.20587127			Q13315							
gdsc	KU-60019	ATM	S49C	0.180595278			Q13315							
gdsc	KU-60019	ATM	R248Q	-0.153864736			Q13315							
gdsc	KU-60019	ATM	F2265L	-0.57589755			Q13315							
gdsc	KU-60019	ATM	A2688V	0.475464867			Q13315							
gdsc	KU-60019	ATM	P960R	0.106352198			Q13315							
gdsc	KU-60019	ATM	T2674R	0.435223303			Q13315							
gdsc	KU-60019	ATM	A502G+Q1128R	0.262560803			Q13315							
gdsc	KU-60019	ATM	V551L	-0.07465189400000001			Q13315							
gdsc	KU-60019	ATM	T2438I	0.668580533			Q13315							
gdsc	KU-60019	ATM	L787F+L1809P+N1784S	-0.4705004370000001			Q13315							
gdsc	KU-60019	ATM	S2581I	0.16332731			Q13315							
gdsc	KU-60019	ATM	S1383L	-0.256156043			Q13315							
gdsc	KU-60019	ATM	L2332P	0.368832424			Q13315							
gdsc	KU-60019	ATM	Q2762R	-0.334019797			Q13315							
gdsc	KU-60019	ATM	M1644T+I2223M	0.660571324			Q13315							
gdsc	KU-60019	ATM	A2635G	0.13115361			Q13315							
gdsc	KU-60019	ATM	R924W+D2661N	-0.606903462			Q13315							
gdsc	KU-60019	ATM	Q1128R	-0.245259064			Q13315							
gdsc	KU-60019	ATM	S2218R	0.736326424			Q13315							
gdsc	KU-60019	ATM	S49C	-0.248828784			Q13315							
gdsc	KU-60019	ATM	C2464R	0.745393218			Q13315							
gdsc	KU-60019	ATM	N2826I	-0.164179895			Q13315							
gdsc	KU-60019	ATM	Q912*	0.102822767			Q13315							
gdsc	KU-60019	ATM	N1005S+L2307F	-0.275091856			Q13315							
gdsc	KU-60019	ATM	E632Q	-0.679750055			Q13315							
gdsc	KU-60019	ATM	N1005I	-0.449584541			Q13315							
gdsc	KU-60019	ATM	E1856Q	0.516037038			Q13315							
gdsc	KU-60019	ATM	S49C	0.079239503			Q13315							
gdsc	KU-60019	ATM	S333F	-0.103802144			Q13315							
gdsc	KU-60019	ATM	F1896L+C2464R	-0.326066282			Q13315							
gdsc	KU-60019	ATM	T1854I	-0.627859056			Q13315							
gdsc	KU-60019	ATM	R32C+S2165F	-0.109872743			Q13315							
gdsc	KU-60019	ATM	R451H	1.146442001			Q13315							
gdsc	KU-60019	ATM	V410A	1.110197338			Q13315							
gdsc	KU-60019	ATM	M1040V	0.039948877			Q13315							
gdsc	KU-60019	ATM	M779I	-0.591056273			Q13315							
gdsc	KU-60019	ATM	T2059I	-0.05684358			Q13315							
gdsc	KU-60019	ATM	T2335I	0.682279373			Q13315							
gdsc	KU-60019	ATM	P604S	1.352610698			Q13315							
gdsc	KU-60019	ATM	G506C	-0.085147761			Q13315							
gdsc	KU-60019	ATM	G2022V	0.680045705			Q13315							
gdsc	KU-60019	ATM	V1521L+G1998E	0.158528776			Q13315							
gdsc	KU-60019	ATM	Q65P	-0.327632811			Q13315							
gdsc	KU-60019	ATM	W1279*	0.776524145			Q13315							
gdsc	KU-60019	ATM	R2244T	1.021392761			Q13315							
gdsc	KU-60019	ATM	F582L	0.386634221			Q13315							
gdsc	KU-60019	ATM	E2118V	1.794484049			Q13315							
gdsc	KU-60019	ATM	E848Q+L2965F	0.5132748739999999			Q13315							
gdsc	KU-60019	ATM	I1453T	-0.034890835			Q13315							
gdsc	KU-60019	ATM	S49C	0.428957184			Q13315							
gdsc	KU-60019	ATM	M1210V	0.689007037			Q13315							
gdsc	KU-60019	ATM	Q1919P	0.288835725			Q13315							
gdsc	KU-60019	ATM	S49C	0.041129699			Q13315							
gdsc	KU-60019	ATM	Q1361R	-0.590759438			Q13315							
gdsc	KU-60019	ATM	S2058L	0.622188976			Q13315							
gdsc	KU-60019	ATM	D351N	-0.086264595			Q13315							
gdsc	KU-60019	ATM	D814E	0.268906908			Q13315							
gdsc	KU-60019	ATM	L2307F	1.786335014			Q13315							
gdsc	KU-60019	ATM	D1725H	1.479180846			Q13315							
gdsc	KU-60019	ATM	P383A	0.77758884			Q13315							
gdsc	KU-60019	ATM	R337C	0.393007579			Q13315							
gdsc	KU-60019	ATM	N1223S	1.241295847			Q13315							
gdsc	KU-60019	ATM	M1064I	1.023179695			Q13315							
gdsc	KU-60019	ATM	Q2733P	0.4456143			Q13315							
gdsc	KU-60019	ATM	M1040V+C1482R	1.04745735			Q13315							
gdsc	KU-60019	ATM	E347K	-0.450345291			Q13315							
gdsc	KU-60019	ATM	S2146T	0.339137088			Q13315							
gdsc	KU-60019	ATM	R1618*	-0.27901766			Q13315							
gdsc	KU-60019	ATM	I159V	0.993743868			Q13315							
gdsc	KU-60019	ATM	S49C	-1.006638706			Q13315							
gdsc	KU-60019	ATM	S2218N	-0.138330378			Q13315							
gdsc	KU-60019	ATM	N230T	0.284078665			Q13315							
gdsc	KU-60019	ATM	V613L	0.298372952			Q13315							
gdsc	KU-60019	ATM	T935R	1.059069459			Q13315							
gdsc	KU-60019	ATM	R1304G+K2318Q	-0.6146182060000001			Q13315							
gdsc	KU-60019	ATM	S49C	0.785480737			Q13315							
gdsc	KU-60019	ATM	E2351G	-0.103240468			Q13315							
gdsc	KU-60019	ATM	F1234S	0.22809478			Q13315							
gdsc	KU-60019	ATM	S49C	0.4108858070000001			Q13315							
gdsc	KU-60019	ATM	K2749I	-0.076709001			Q13315							
gdsc	KU-60019	ATM	S49C	0.128288354			Q13315							
gdsc	KU-60019	ATM	Q2825P	-0.392218389			Q13315							
gdsc	KU-60019	ATM	M1967V	0.682696482			Q13315							
gdsc	KU-60019	ATM	K2749I	2.059030269			Q13315							
gdsc	KU-60019	ATM	S333F	-0.083030221			Q13315							
gdsc	KU-60019	ATM	Q1128R+L2332P	-0.221789558			Q13315							
gdsc	KU-60019	ATM	M1040V+L2332P	1.046871975			Q13315							
gdsc	KU-60019	ATM	V1570A	0.163621182			Q13315							
gdsc	KU-60019	ATM	L2307F	1.095886462			Q13315							
gdsc	KU-60019	ATM	L2332P	0.985489962			Q13315							
gdsc	KU-60019	ATM	F582L+R1086H	-0.063276187			Q13315							
gdsc	KU-60019	ATM	I2920N	1.837168428			Q13315							
gdsc	KU-60019	ATM	L1419I+L1794M	-0.011312311			Q13315							
gdsc	KU-60019	ATM	S974F+F1236Y	0.625643755			Q13315							
gdsc	KU-60019	ATM	Y2167*	0.7363495309999999			Q13315							
gdsc	KU-60019	ATM	S1691R	-0.077618465			Q13315							
gdsc	KU-60019	ATM	S49C	0.05668834900000001			Q13315							
gdsc	KU-60019	ATM	K1964E	0.26496747600000004			Q13315							
gdsc	KU-60019	ATM	F582L	-1.078630936			Q13315							
gdsc	KU-60019	ATM	S49C	0.7658570490000001			Q13315							
gdsc	KU-60019	ATM	H448R	0.512685352			Q13315							
gdsc	KU-60019	ATM	Q2210*	1.593905446			Q13315							
gdsc	KU-60019	ATM	G2917R	0.237655707			Q13315							
gdsc	KU-60019	ATM	L944V	0.012076617			Q13315							
gdsc	KU-60019	ATM	Q1128E	-0.149991663			Q13315							
gdsc	KU-60019	ATM	R23*+T935R+T1350M	0.449325625			Q13315							
gdsc	KU-60019	ATM	N1650S	0.122442307			Q13315							
gdsc	KU-60019	ATM	T935R	0.207402843			Q13315							
gdsc	KU-60019	ATM	N1650S	-0.25393778			Q13315							
gdsc	KU-60019	ATM	S333F	0.889033445			Q13315							
gdsc	KU-60019	ATM	L243W	-0.03683537			Q13315							
gdsc	KU-60019	ATM	L2307F	-0.37830744			Q13315							
gdsc	KU-60019	ATM	A1090T	-0.796887846			Q13315							
gdsc	Thapsigargin	ATP2A3	R637H	-4.865856875			Q93084							
gdsc	Thapsigargin	ATP2A3	R533H	-3.783077361			Q93084							
gdsc	Thapsigargin	ATP2A3	Y858H	-4.356094843			Q93084							
gdsc	Thapsigargin	ATP2A3	*1053C	-4.510362468			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N+C344R	-5.054363008999999			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-3.737099359			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-4.491177812			Q93084							
gdsc	Thapsigargin	ATP2A3	T645M	-1.291849016			Q93084							
gdsc	Thapsigargin	ATP2A3	E117K	-4.983008293			Q93084							
gdsc	Thapsigargin	ATP2A3	E245K+M239I	-4.693620965			Q93084							
gdsc	Thapsigargin	ATP2A3	G717S	-4.452898557			Q93084							
gdsc	Thapsigargin	ATP2A3	A199G	-4.408833096			Q93084							
gdsc	Thapsigargin	ATP2A3	R1002G+A682T+M599I	-4.5467890230000005			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-4.932080673			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N+D458N	-3.823682119			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-4.930643305			Q93084							
gdsc	Thapsigargin	ATP2A3	R560H	-5.114262033			Q93084							
gdsc	Thapsigargin	ATP2A3	K205delK	-3.984003753			Q93084							
gdsc	Thapsigargin	ATP2A3	R656C	-4.536827577			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-4.766699812			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-4.627054118			Q93084							
gdsc	Thapsigargin	ATP2A3	D458N	-0.685392288			Q93084							
gdsc	Thapsigargin	ATP2A3	A719T+A682T	-4.448169936			Q93084							
gdsc	Thapsigargin	ATP2A3	P863S	-4.186041054			Q93084							
gdsc	Thapsigargin	ATP2A3	R678H	-4.378881806			Q93084							
gdsc	Thapsigargin	ATP2A3	K1052M	-4.62783205			Q93084							
gdsc	Thapsigargin	ATP2A3	E125D	-5.121656242			Q93084							
gdsc	Thapsigargin	ATP2A3	G640S	-4.301442864			Q93084							
gdsc	Thapsigargin	ATP2A3	R524H+R328C+L180R	-4.72983304			Q93084							
gdsc	Thapsigargin	ATP2A3	L901F	-4.7060317430000005			Q93084							
gdsc	Thapsigargin	ATP2A3	E123K	-5.280465856			Q93084							
gdsc	Thapsigargin	ATP2A3	E113K	-3.485302819			Q93084							
gdsc	Thapsigargin	ATP2A3	R656C	-3.286751106			Q93084							
gdsc	Thapsigargin	ATP2A3	A313V+S178F	-1.5291818190000002			Q93084							
gdsc	Thapsigargin	ATP2A3	R324W	-4.659073771			Q93084							
gdsc	Thapsigargin	ATP2A3	A746G	-3.740126364			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-2.408862892			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-3.567696118			Q93084							
gdsc	Thapsigargin	ATP2A3	R464W	-4.211987146			Q93084							
gdsc	Thapsigargin	ATP2A3	G841R	-5.129559989			Q93084							
gdsc	Thapsigargin	ATP2A3	L1040P	-4.684359243			Q93084							
gdsc	Thapsigargin	ATP2A3	T506A+H504R	-3.734538048			Q93084							
gdsc	Thapsigargin	ATP2A3	V146I	-4.484560349			Q93084							
gdsc	Thapsigargin	ATP2A3	R502C	-3.711011663			Q93084							
gdsc	Thapsigargin	ATP2A3	D568Y	-4.874048569			Q93084							
gdsc	Thapsigargin	ATP2A3	A569T	-1.6444118090000002			Q93084							
gdsc	Thapsigargin	ATP2A3	D738N	-4.248794669			Q93084							
gdsc	Thapsigargin	ATP2A3	G509C	-5.202872275			Q93084							
gdsc	Thapsigargin	ATP2A3	Q56*	-3.973349692			Q93084							
gdsc	Thapsigargin	ATP2A3	E878K+P505H	-4.292942485			Q93084							
gdsc	Thapsigargin	ATP2A3	D887N	-3.285036455			Q93084							
gdsc	Thapsigargin	ATP2A3	R822Q	-4.181778719			Q93084							
gdsc	Thapsigargin	ATP2A3	V99M	-3.912803675			Q93084							
gdsc	Thapsigargin	ATP2A3	S877T	-4.305796442			Q93084							
gdsc	Thapsigargin	ATP2A3	A677T	-4.39096968			Q93084							
gdsc	Thapsigargin	ATP2A3	Y434C	-4.728212594			Q93084							
gdsc	AZ20	ATR	D331G	-0.80323395			Q13535							
gdsc	AZ20	ATR	F2513I	-1.449920394			Q13535							
gdsc	AZ20	ATR	R2066Q	-1.804099484			Q13535							
gdsc	AZ20	ATR	T1469A	-1.5432237080000002			Q13535							
gdsc	AZ20	ATR	H1999Y	-0.840968119			Q13535							
gdsc	AZ20	ATR	Y2132D	-0.07947946			Q13535							
gdsc	AZ20	ATR	V1689L	-0.07419390299999999			Q13535							
gdsc	AZ20	ATR	T2556S+I475S	-1.7582216119999998			Q13535							
gdsc	AZ20	ATR	I1526V	-2.01753086			Q13535							
gdsc	AZ20	ATR	Y2132D	-1.851992397			Q13535							
gdsc	AZ20	ATR	R1351L	-0.249120287			Q13535							
gdsc	AZ20	ATR	E1260Q	-2.181657431			Q13535							
gdsc	AZ20	ATR	E330Q	-0.467313462			Q13535							
gdsc	AZ20	ATR	R2008L	-2.440298948			Q13535							
gdsc	AZ20	ATR	I1753V	-1.487175242			Q13535							
gdsc	AZ20	ATR	A1206T	-1.333617414			Q13535							
gdsc	AZ20	ATR	F2427L	-1.5451095869999998			Q13535							
gdsc	AZ20	ATR	P2434A+N1612S+M593T	-1.6027476880000002			Q13535							
gdsc	AZ20	ATR	I2435V+F2427L+L2393I+K1262E+Q680H+S673R	-0.645451705			Q13535							
gdsc	AZ20	ATR	I1753V	-1.607127928			Q13535							
gdsc	AZ20	ATR	L1599P	-0.73241721			Q13535							
gdsc	AZ20	ATR	H2203P	-1.183686185			Q13535							
gdsc	AZ20	ATR	R2008L	-2.153263784			Q13535							
gdsc	AZ20	ATR	D626E	-1.7351153			Q13535							
gdsc	AZ20	ATR	D836E	-1.046368956			Q13535							
gdsc	AZ20	ATR	P1605L	-0.818620187			Q13535							
gdsc	AZ20	ATR	H2153R+V1267I	-0.633636374			Q13535							
gdsc	AZ20	ATR	I1851V+T1798A	-1.089009491			Q13535							
gdsc	AZ20	ATR	R109W	-0.818302022			Q13535							
gdsc	AZ20	ATR	R1015Q	-0.408302573			Q13535							
gdsc	AZ20	ATR	R796T	-1.4459785930000002			Q13535							
gdsc	AZ20	ATR	M2087V	-0.999604727			Q13535							
gdsc	AZ20	ATR	T1751A	-1.989349322			Q13535							
gdsc	AZ20	ATR	P2434A+N1612S+I1453M	-1.570066229			Q13535							
gdsc	AZ20	ATR	R1631H+I1264M	-0.970912468			Q13535							
gdsc	AZ20	ATR	G1873C	-1.7170569569999998			Q13535							
gdsc	AZ20	ATR	T2556S	-1.024073162			Q13535							
gdsc	AZ20	ATR	R109W	-0.962410311			Q13535							
gdsc	AZ20	ATR	H2517L	-0.3819215970000001			Q13535							
gdsc	AZ20	ATR	K1228E	-0.109647598			Q13535							
gdsc	AZ20	ATR	R109W	-0.7196473859999999			Q13535							
gdsc	AZ20	ATR	F982V+R109W	-1.165490385			Q13535							
gdsc	AZ20	ATR	Q713E	-1.221478417			Q13535							
gdsc	AZ20	ATR	R109W	-1.953586943			Q13535							
gdsc	AZ20	ATR	E2034K	-1.474973611			Q13535							
gdsc	AZ20	ATR	K1379N	-1.411028509			Q13535							
gdsc	AZ20	ATR	G332D	-1.4462209190000002			Q13535							
gdsc	AZ20	ATR	A2101P	-1.903825926			Q13535							
gdsc	AZ20	ATR	S601F	-0.839418771			Q13535							
gdsc	AZ20	ATR	T415A	-1.924094236			Q13535							
gdsc	AZ20	ATR	Y2132D	-1.710869638			Q13535							
gdsc	AZ20	ATR	V1338L	-0.849508787			Q13535							
gdsc	AZ20	ATR	T64A	-2.01206815			Q13535							
gdsc	AZ20	ATR	I1526V+V666E	-1.243154472			Q13535							
gdsc	AZ20	ATR	S924N	-0.990440173			Q13535							
gdsc	AZ20	ATR	C234*	-1.119960302			Q13535							
gdsc	AZ20	ATR	S1693G	-1.048083607			Q13535							
gdsc	AZ20	ATR	Y2132D	-1.29870762			Q13535							
gdsc	AZ20	ATR	I1900V	-0.950595573			Q13535							
gdsc	AZ20	ATR	Y575C	-0.41608012			Q13535							
gdsc	AZ20	ATR	Y1527S	1.200486682			Q13535							
gdsc	AZ20	ATR	P1991S	-0.278101086			Q13535							
gdsc	AZ20	ATR	R2363*+A2366T	-1.371784097			Q13535							
gdsc	AZ20	ATR	H453P	0.148397879			Q13535							
gdsc	AZ20	ATR	G720S	-0.68635863			Q13535							
gdsc	AZ20	ATR	R2190C	-0.905461862			Q13535							
gdsc	AZ20	ATR	P1914S+C1858R	0.07287740200000001			Q13535							
gdsc	AZ20	ATR	D1071Y	-0.53181787			Q13535							
gdsc	AZ20	ATR	Y2132D	-1.21721075			Q13535							
gdsc	AZ20	ATR	C1858R	-0.983316136			Q13535							
gdsc	AZ20	ATR	Q1088*	-0.24297385			Q13535							
gdsc	AZ20	ATR	L1881I	-1.08690854			Q13535							
gdsc	AZ20	ATR	L2428F+R1696G	-1.4479598619999998			Q13535							
gdsc	AZ20	ATR	M328V	-1.186805024			Q13535							
gdsc	AZ20	ATR	G5V	-0.345612354			Q13535							
gdsc	AZ20	ATR	D331G	-2.774626837			Q13535							
gdsc	AZ20	ATR	F2427L	-0.711141082			Q13535							
gdsc	AZ20	ATR	R1959M	-1.801430341			Q13535							
gdsc	AZ20	ATR	S2449L	0.006987173			Q13535							
gdsc	AZ20	ATR	I1114delI	-1.304307193			Q13535							
gdsc	AZ20	ATR	Y2132D	-1.315865386			Q13535							
gdsc	AZ20	ATR	P1833L	-1.889327231			Q13535							
gdsc	AZ20	ATR	A1232D	-1.300759987			Q13535							
gdsc	AZ20	ATR	D1915G	-1.195336212			Q13535							
gdsc	AZ20	ATR	R109W	-1.293399549			Q13535							
gdsc	AZ20	ATR	I1526V	-1.343636924			Q13535							
gdsc	AZ20	ATR	D1586Y+A1550V	-0.395063501			Q13535							
gdsc	AZ20	ATR	F1522L	-0.75318854			Q13535							
gdsc	AZ20	ATR	Y2637C	-1.128016317			Q13535							
gdsc	AZ20	ATR	Y2132D	-0.8552606290000001			Q13535							
gdsc	AZ20	ATR	R1051H	-0.312968814			Q13535							
gdsc	AZ20	ATR	R1653*	-1.153715343			Q13535							
gdsc	AZ20	ATR	L1483F	-1.342843587			Q13535							
gdsc	AZ20	ATR	V2158F	-1.970252946			Q13535							
gdsc	AZ20	ATR	R109W	-0.25778300600000004			Q13535							
gdsc	AZ20	ATR	E910*+S138I	-0.563787754			Q13535							
gdsc	AZ20	ATR	I2068V+R2066Q	-0.291085389			Q13535							
gdsc	AZ20	ATR	I2376V	-0.6508391689999999			Q13535							
gdsc	AZ20	ATR	A1896V	0.011138713			Q13535							
gdsc	AZ20	ATR	P2434S	-1.473651778			Q13535							
gdsc	AZ20	ATR	M2189V	-1.459232476			Q13535							
gdsc	AZ20	ATR	A1393V	-0.6580236389999999			Q13535							
gdsc	AZ20	ATR	D2037G	0.012406038			Q13535							
gdsc	AZ20	ATR	S1863N	-1.871212602			Q13535							
gdsc	AZ20	ATR	P2434A+Q1926H+N1612S	0.7605537179999999			Q13535							
gdsc	AZD6738	ATR	D331G	-0.03056226			Q13535							
gdsc	AZD6738	ATR	F2513I	-0.888120613			Q13535							
gdsc	AZD6738	ATR	R2066Q	-2.057397665			Q13535							
gdsc	AZD6738	ATR	T1469A	-0.8643985209999999			Q13535							
gdsc	AZD6738	ATR	H1999Y	-0.049706475			Q13535							
gdsc	AZD6738	ATR	Y2132D	1.005016368			Q13535							
gdsc	AZD6738	ATR	V1689L	-0.513414108			Q13535							
gdsc	AZD6738	ATR	T2556S+I475S	-1.672633814			Q13535							
gdsc	AZD6738	ATR	I1526V	-1.5019750159999998			Q13535							
gdsc	AZD6738	ATR	Y2132D	-0.845981214			Q13535							
gdsc	AZD6738	ATR	R1351L	0.363948871			Q13535							
gdsc	AZD6738	ATR	E1260Q	-1.879909094			Q13535							
gdsc	AZD6738	ATR	E330Q	-0.033893873			Q13535							
gdsc	AZD6738	ATR	R2008L	-2.138213091			Q13535							
gdsc	AZD6738	ATR	I1753V	-0.93285097			Q13535							
gdsc	AZD6738	ATR	A1206T	-1.594862291			Q13535							
gdsc	AZD6738	ATR	F2427L	-1.619153848			Q13535							
gdsc	AZD6738	ATR	P2434A+N1612S+M593T	-1.378616607			Q13535							
gdsc	AZD6738	ATR	I2435V+F2427L+L2393I+K1262E+Q680H+S673R	-0.770641848			Q13535							
gdsc	AZD6738	ATR	I1753V	-1.146636675			Q13535							
gdsc	AZD6738	ATR	L1599P	0.004311653			Q13535							
gdsc	AZD6738	ATR	H2203P	0.179534935			Q13535							
gdsc	AZD6738	ATR	R2008L	-1.96351521			Q13535							
gdsc	AZD6738	ATR	D626E	-1.189183244			Q13535							
gdsc	AZD6738	ATR	D836E	-0.993026369			Q13535							
gdsc	AZD6738	ATR	P1605L	-0.6751374			Q13535							
gdsc	AZD6738	ATR	H2153R+V1267I	-1.157278884			Q13535							
gdsc	AZD6738	ATR	I1851V+T1798A	0.163910011			Q13535							
gdsc	AZD6738	ATR	R109W	-0.302466903			Q13535							
gdsc	AZD6738	ATR	R1015Q	0.627441354			Q13535							
gdsc	AZD6738	ATR	R796T	-0.634874088			Q13535							
gdsc	AZD6738	ATR	M2087V	-0.899498503			Q13535							
gdsc	AZD6738	ATR	T1751A	-1.945799915			Q13535							
gdsc	AZD6738	ATR	P2434A+N1612S+I1453M	-1.437404498			Q13535							
gdsc	AZD6738	ATR	R1631H+I1264M	-1.337652066			Q13535							
gdsc	AZD6738	ATR	G1873C	-0.507660501			Q13535							
gdsc	AZD6738	ATR	T2556S	0.615009009			Q13535							
gdsc	AZD6738	ATR	R109W	-0.8935541029999999			Q13535							
gdsc	AZD6738	ATR	H2517L	-0.189166755			Q13535							
gdsc	AZD6738	ATR	R109W	-1.6297420459999998			Q13535							
gdsc	AZD6738	ATR	K1228E	1.229279641			Q13535							
gdsc	AZD6738	ATR	R109W	0.6890799			Q13535							
gdsc	AZD6738	ATR	F982V+R109W	0.041763633			Q13535							
gdsc	AZD6738	ATR	Q713E	0.072932654			Q13535							
gdsc	AZD6738	ATR	R109W	-0.637022832			Q13535							
gdsc	AZD6738	ATR	E2034K	-0.983499214			Q13535							
gdsc	AZD6738	ATR	K1379N	-1.080101571			Q13535							
gdsc	AZD6738	ATR	G332D	-1.361118761			Q13535							
gdsc	AZD6738	ATR	A2101P	-0.5629790179999999			Q13535							
gdsc	AZD6738	ATR	S601F	-0.983015014			Q13535							
gdsc	AZD6738	ATR	T415A	-1.912512937			Q13535							
gdsc	AZD6738	ATR	Y2132D	0.40676626			Q13535							
gdsc	AZD6738	ATR	Y2132D	-1.465275741			Q13535							
gdsc	AZD6738	ATR	V1338L	0.7184559359999999			Q13535							
gdsc	AZD6738	ATR	I1526V+V666E	-0.191503546			Q13535							
gdsc	AZD6738	ATR	S924N	-0.344576095			Q13535							
gdsc	AZD6738	ATR	C234*	-0.443461803			Q13535							
gdsc	AZD6738	ATR	S1693G	-0.233409122			Q13535							
gdsc	AZD6738	ATR	Y2132D	-0.061523024			Q13535							
gdsc	AZD6738	ATR	I1900V	0.535188694			Q13535							
gdsc	AZD6738	ATR	Y575C	0.535194969			Q13535							
gdsc	AZD6738	ATR	Y1527S	0.028204644			Q13535							
gdsc	AZD6738	ATR	P1991S	0.52842002			Q13535							
gdsc	AZD6738	ATR	R2363*+A2366T	-0.8095428090000001			Q13535							
gdsc	AZD6738	ATR	H453P	0.436291553			Q13535							
gdsc	AZD6738	ATR	G720S	0.170861751			Q13535							
gdsc	AZD6738	ATR	R2190C	-0.325460674			Q13535							
gdsc	AZD6738	ATR	P1914S+C1858R	0.219281464			Q13535							
gdsc	AZD6738	ATR	D1071Y	0.401498823			Q13535							
gdsc	AZD6738	ATR	Y2132D	0.6879821420000001			Q13535							
gdsc	AZD6738	ATR	C1858R	0.174186845			Q13535							
gdsc	AZD6738	ATR	Q1088*	0.415983775			Q13535							
gdsc	AZD6738	ATR	L1881I	-0.521179108			Q13535							
gdsc	AZD6738	ATR	L2428F+R1696G	-0.362871194			Q13535							
gdsc	AZD6738	ATR	M328V	-0.39532808			Q13535							
gdsc	AZD6738	ATR	G5V	-0.403345673			Q13535							
gdsc	AZD6738	ATR	D331G	-1.219590761			Q13535							
gdsc	AZD6738	ATR	F2427L	-0.972659113			Q13535							
gdsc	AZD6738	ATR	R1959M	-1.110308133			Q13535							
gdsc	AZD6738	ATR	S2449L	1.660951784			Q13535							
gdsc	AZD6738	ATR	I1114delI	0.205299993			Q13535							
gdsc	AZD6738	ATR	Y2132D	-0.488996626			Q13535							
gdsc	AZD6738	ATR	P1833L	-1.247322602			Q13535							
gdsc	AZD6738	ATR	A1232D	-0.544973803			Q13535							
gdsc	AZD6738	ATR	D1915G	1.008475408			Q13535							
gdsc	AZD6738	ATR	R109W	-0.304118302			Q13535							
gdsc	AZD6738	ATR	I1526V	-0.673315078			Q13535							
gdsc	AZD6738	ATR	D1586Y+A1550V	0.507533212			Q13535							
gdsc	AZD6738	ATR	F1522L	-0.5246734279999999			Q13535							
gdsc	AZD6738	ATR	Y2637C	-0.299113846			Q13535							
gdsc	AZD6738	ATR	Y2132D	0.598594456			Q13535							
gdsc	AZD6738	ATR	R1051H	0.121786784			Q13535							
gdsc	AZD6738	ATR	R1653*	-0.668461443			Q13535							
gdsc	AZD6738	ATR	L1483F	-0.449934115			Q13535							
gdsc	AZD6738	ATR	V2158F	-0.913998712			Q13535							
gdsc	AZD6738	ATR	R109W	0.021467419			Q13535							
gdsc	AZD6738	ATR	S2452N+Q1293R+L462S+M211V	0.921540121			Q13535							
gdsc	AZD6738	ATR	Q1137*	-0.16452472099999998			Q13535							
gdsc	AZD6738	ATR	E910*+S138I	0.123254603			Q13535							
gdsc	AZD6738	ATR	I2068V+R2066Q	-0.917584652			Q13535							
gdsc	AZD6738	ATR	I2376V	-0.597613893			Q13535							
gdsc	AZD6738	ATR	A1896V	0.8927238129999999			Q13535							
gdsc	AZD6738	ATR	P2434S	-0.347751926			Q13535							
gdsc	AZD6738	ATR	M2189V	0.016561139			Q13535							
gdsc	AZD6738	ATR	A1393V	-0.030519409			Q13535							
gdsc	AZD6738	ATR	D2037G	-0.624534487			Q13535							
gdsc	AZD6738	ATR	S1863N	-1.1103196990000002			Q13535							
gdsc	AZD6738	ATR	P2434A+Q1926H+N1612S	1.780972456			Q13535							
gdsc	VE-822	ATR	D331G	0.7559992879999999			Q13535							
gdsc	VE-822	ATR	F2513I	0.309287113			Q13535							
gdsc	VE-822	ATR	R2066Q	-0.993980861			Q13535							
gdsc	VE-822	ATR	T1469A	1.2792598999999998			Q13535							
gdsc	VE-822	ATR	H1999Y	1.0951968090000002			Q13535							
gdsc	VE-822	ATR	Y2132D	2.011854856			Q13535							
gdsc	VE-822	ATR	T2556S+I475S	-0.8344330120000001			Q13535							
gdsc	VE-822	ATR	I1526V	0.095827299			Q13535							
gdsc	VE-822	ATR	Y2132D	0.979683612			Q13535							
gdsc	VE-822	ATR	E330Q	1.061094572			Q13535							
gdsc	VE-822	ATR	R2008L	-0.933794483			Q13535							
gdsc	VE-822	ATR	I1753V	-0.20176535			Q13535							
gdsc	VE-822	ATR	A1206T	-1.5058829480000002			Q13535							
gdsc	VE-822	ATR	F2427L	-0.7093387440000001			Q13535							
gdsc	VE-822	ATR	P2434A+N1612S+M593T	0.241028723			Q13535							
gdsc	VE-822	ATR	I2435V+F2427L+L2393I+K1262E+Q680H+S673R	-1.862502484			Q13535							
gdsc	VE-822	ATR	I1753V	-1.05600335			Q13535							
gdsc	VE-822	ATR	L1599P	0.344454046			Q13535							
gdsc	VE-822	ATR	H2203P	0.508613797			Q13535							
gdsc	VE-822	ATR	R2008L	-0.468424963			Q13535							
gdsc	VE-822	ATR	D626E	0.541960616			Q13535							
gdsc	VE-822	ATR	D836E	0.007373473			Q13535							
gdsc	VE-822	ATR	P1605L	-0.325831065			Q13535							
gdsc	VE-822	ATR	H2153R+V1267I	-0.610993977			Q13535							
gdsc	VE-822	ATR	I1851V+T1798A	-1.3491879130000002			Q13535							
gdsc	VE-822	ATR	R109W	-0.123426424			Q13535							
gdsc	VE-822	ATR	R1015Q	0.975256566			Q13535							
gdsc	VE-822	ATR	R796T	0.593960633			Q13535							
gdsc	VE-822	ATR	P2434A+N1612S+I1453M	0.124420613			Q13535							
gdsc	VE-822	ATR	R1631H+I1264M	-0.7747141040000001			Q13535							
gdsc	VE-822	ATR	G1873C	0.344510925			Q13535							
gdsc	VE-822	ATR	T2556S	1.828841055			Q13535							
gdsc	VE-822	ATR	R109W	-1.4757011830000002			Q13535							
gdsc	VE-822	ATR	K1228E	1.411354969			Q13535							
gdsc	VE-822	ATR	R109W	0.999650941			Q13535							
gdsc	VE-822	ATR	Q713E	0.617841916			Q13535							
gdsc	VE-822	ATR	R109W	-0.529293884			Q13535							
gdsc	VE-822	ATR	E2034K	-1.483973455			Q13535							
gdsc	VE-822	ATR	K1379N	-0.385727126			Q13535							
gdsc	VE-822	ATR	G332D	0.221144934			Q13535							
gdsc	VE-822	ATR	A2101P	0.448307736			Q13535							
gdsc	VE-822	ATR	S601F	-1.216522875			Q13535							
gdsc	VE-822	ATR	Y2132D	1.3028876			Q13535							
gdsc	VE-822	ATR	Y2132D	-0.032302269			Q13535							
gdsc	VE-822	ATR	V1338L	-0.11210167			Q13535							
gdsc	VE-822	ATR	S1693G	1.16297114			Q13535							
gdsc	VE-822	ATR	I1900V	2.060790541			Q13535							
gdsc	VE-822	ATR	Y575C	1.039215887			Q13535							
gdsc	VE-822	ATR	R2363*+A2366T	-1.434409143			Q13535							
gdsc	VE-822	ATR	G720S	0.81384002			Q13535							
gdsc	VE-822	ATR	R2190C	-1.227681733			Q13535							
gdsc	VE-822	ATR	P1914S+C1858R	0.853686397			Q13535							
gdsc	VE-822	ATR	C1858R	1.608561741			Q13535							
gdsc	VE-822	ATR	I2164V	2.249554406			Q13535							
gdsc	VE-822	ATR	Q1088*	2.582223338			Q13535							
gdsc	VE-822	ATR	L1881I	0.200973791			Q13535							
gdsc	VE-822	ATR	L2428F+R1696G	0.630266914			Q13535							
gdsc	VE-822	ATR	M328V	1.450211304			Q13535							
gdsc	VE-822	ATR	G5V	0.328119834			Q13535							
gdsc	VE-822	ATR	F2427L	-0.229711079			Q13535							
gdsc	VE-822	ATR	R1959M	0.8063895240000001			Q13535							
gdsc	VE-822	ATR	I1114delI	1.037783852			Q13535							
gdsc	VE-822	ATR	A1232D	-0.508636904			Q13535							
gdsc	VE-822	ATR	D1915G	1.594350402			Q13535							
gdsc	VE-822	ATR	R109W	0.412755688			Q13535							
gdsc	VE-822	ATR	D1586Y+A1550V	0.788151066			Q13535							
gdsc	VE-822	ATR	F1522L	0.17234078			Q13535							
gdsc	VE-822	ATR	Y2637C	0.543605354			Q13535							
gdsc	VE-822	ATR	R1051H	1.2638677390000002			Q13535							
gdsc	VE-822	ATR	V2158F	-0.268756416			Q13535							
gdsc	VE-822	ATR	R109W	0.968613034			Q13535							
gdsc	VE-822	ATR	S2452N+Q1293R+L462S+M211V	1.455142554			Q13535							
gdsc	VE-822	ATR	Q1137*	0.6941266979999999			Q13535							
gdsc	VE-822	ATR	E910*+S138I	0.7869726140000001			Q13535							
gdsc	VE-822	ATR	I2068V+R2066Q	-0.718099223			Q13535							
gdsc	VE-822	ATR	I2376V	1.390228147			Q13535							
gdsc	VE-822	ATR	A1896V	1.993942264			Q13535							
gdsc	VE-822	ATR	P2434S	1.357715546			Q13535							
gdsc	VE-822	ATR	M2189V	1.49697494			Q13535							
gdsc	VE-822	ATR	D2037G	0.962704184			Q13535							
gdsc	VE-822	ATR	S1863N	-1.375737748			Q13535							
gdsc	VE-822	ATR	P2434A+Q1926H+N1612S	2.007539789			Q13535							
gdsc	VE821	ATR	D331G	1.066060187			Q13535							
gdsc	VE821	ATR	F2513I	0.904052341			Q13535							
gdsc	VE821	ATR	H1999Y	1.53041241			Q13535							
gdsc	VE821	ATR	Y2132D	2.1988785930000003			Q13535							
gdsc	VE821	ATR	T2556S+I475S	-0.559503497			Q13535							
gdsc	VE821	ATR	I1526V	0.459415048			Q13535							
gdsc	VE821	ATR	Y2132D	0.7014397370000001			Q13535							
gdsc	VE821	ATR	R1351L	1.5187540869999998			Q13535							
gdsc	VE821	ATR	E330Q	0.7077141509999999			Q13535							
gdsc	VE821	ATR	R2008L	-0.715479256			Q13535							
gdsc	VE821	ATR	I1753V	0.379714591			Q13535							
gdsc	VE821	ATR	A1206T	-1.287413083			Q13535							
gdsc	VE821	ATR	F2427L	-0.8325269890000001			Q13535							
gdsc	VE821	ATR	P2434A+N1612S+M593T	0.061720914			Q13535							
gdsc	VE821	ATR	I2435V+F2427L+L2393I+K1262E+Q680H+S673R	-0.368917741			Q13535							
gdsc	VE821	ATR	I1753V	-0.049983199000000006			Q13535							
gdsc	VE821	ATR	L1599P	1.220725962			Q13535							
gdsc	VE821	ATR	H2203P	0.202164685			Q13535							
gdsc	VE821	ATR	D626E	1.017478807			Q13535							
gdsc	VE821	ATR	P1605L	-0.278878426			Q13535							
gdsc	VE821	ATR	H2153R+V1267I	-0.080366409			Q13535							
gdsc	VE821	ATR	I1851V+T1798A	-0.075785317			Q13535							
gdsc	VE821	ATR	R109W	0.526548903			Q13535							
gdsc	VE821	ATR	R796T	1.49658864			Q13535							
gdsc	VE821	ATR	P2434A+N1612S+I1453M	0.135213908			Q13535							
gdsc	VE821	ATR	R1631H+I1264M	-0.214347357			Q13535							
gdsc	VE821	ATR	G1873C	0.238385056			Q13535							
gdsc	VE821	ATR	T2556S	1.368660517			Q13535							
gdsc	VE821	ATR	R109W	-1.131919607			Q13535							
gdsc	VE821	ATR	K1228E	0.620383083			Q13535							
gdsc	VE821	ATR	R109W	2.110812844			Q13535							
gdsc	VE821	ATR	F982V+R109W	0.39608376			Q13535							
gdsc	VE821	ATR	Q713E	1.667918641			Q13535							
gdsc	VE821	ATR	R109W	0.552536469			Q13535							
gdsc	VE821	ATR	K1379N	-0.07542864099999999			Q13535							
gdsc	VE821	ATR	G332D	0.450725666			Q13535							
gdsc	VE821	ATR	A2101P	2.996131409			Q13535							
gdsc	VE821	ATR	S601F	0.425511293			Q13535							
gdsc	VE821	ATR	Y2132D	-0.229513189			Q13535							
gdsc	VE821	ATR	V1338L	1.795126895			Q13535							
gdsc	VE821	ATR	I1526V+V666E	0.28755655			Q13535							
gdsc	VE821	ATR	S924N	1.389367859			Q13535							
gdsc	VE821	ATR	S1693G	1.2554378659999998			Q13535							
gdsc	VE821	ATR	I1900V	1.534657563			Q13535							
gdsc	VE821	ATR	Y575C	1.748927304			Q13535							
gdsc	VE821	ATR	P1991S	1.797875432			Q13535							
gdsc	VE821	ATR	R2363*+A2366T	0.152958826			Q13535							
gdsc	VE821	ATR	G720S	1.251760313			Q13535							
gdsc	VE821	ATR	R2190C	0.504084251			Q13535							
gdsc	VE821	ATR	P1914S+C1858R	2.249396805			Q13535							
gdsc	VE821	ATR	D1071Y	1.46014431			Q13535							
gdsc	VE821	ATR	Y2132D	2.771822607			Q13535							
gdsc	VE821	ATR	C1858R	1.924305754			Q13535							
gdsc	VE821	ATR	Q1088*	2.890485453			Q13535							
gdsc	VE821	ATR	L1881I	0.094478804			Q13535							
gdsc	VE821	ATR	L2428F+R1696G	1.901427547			Q13535							
gdsc	VE821	ATR	M328V	0.975208575			Q13535							
gdsc	VE821	ATR	G5V	0.963937737			Q13535							
gdsc	VE821	ATR	F2427L	0.160045536			Q13535							
gdsc	VE821	ATR	S2449L	2.819342254			Q13535							
gdsc	VE821	ATR	I1114delI	2.236437386			Q13535							
gdsc	VE821	ATR	A1232D	-0.026363794			Q13535							
gdsc	VE821	ATR	D1915G	1.890630698			Q13535							
gdsc	VE821	ATR	R109W	1.246746114			Q13535							
gdsc	VE821	ATR	D1586Y+A1550V	1.458166596			Q13535							
gdsc	VE821	ATR	F1522L	0.011938568			Q13535							
gdsc	VE821	ATR	Y2637C	1.7645345369999998			Q13535							
gdsc	VE821	ATR	R1051H	1.598749601			Q13535							
gdsc	VE821	ATR	L1483F	0.861055722			Q13535							
gdsc	VE821	ATR	V2158F	1.44529131			Q13535							
gdsc	VE821	ATR	R109W	1.1261174040000002			Q13535							
gdsc	VE821	ATR	Q1137*	-0.140645808			Q13535							
gdsc	VE821	ATR	I2068V+R2066Q	-0.321725146			Q13535							
gdsc	VE821	ATR	A1896V	2.423253754			Q13535							
gdsc	VE821	ATR	P2434S	1.752868513			Q13535							
gdsc	VE821	ATR	M2189V	1.069263159			Q13535							
gdsc	VE821	ATR	A1393V	1.309667403			Q13535							
gdsc	VE821	ATR	D2037G	0.552292365			Q13535							
gdsc	VE821	ATR	S1863N	-0.8120157590000001			Q13535							
gdsc	VE821	ATR	P2434A+Q1926H+N1612S	2.546127389			Q13535							
gdsc	Alisertib	AURKA	S104L	-1.523802383			O14965							
gdsc	Alisertib	AURKA	P110H	-0.146972924			O14965							
gdsc	Alisertib	AURKA	D311G	-1.5709149480000002			O14965							
gdsc	Alisertib	AURKA	P297H	-0.354712876			O14965							
gdsc	Alisertib	AURKA	F133L	-0.118087715			O14965							
gdsc	Alisertib	AURKA	T333I+S10P	-0.349805015			O14965							
gdsc	Alisertib	AURKA	S361L	0.194232499			O14965							
gdsc	Alisertib	AURKA	Y197C	0.106204677			O14965							
gdsc	Alisertib	AURKA	Q394*	-0.45124883			O14965							
gdsc	Alisertib	AURKA	Y246H	0.13624794			O14965							
gdsc	Alisertib	AURKA	V174M	0.102227912			O14965							
gdsc	Alisertib	AURKA	R343Q	-1.508572944			O14965							
gdsc	Alisertib	AURKA	L222P	-0.6764332040000001			O14965							
gdsc	Alisertib	AURKA	A17G	-3.310447533			O14965							
gdsc	Alisertib	AURKA	V84A	-0.458208079			O14965							
gdsc	Alisertib	AURKA	G173V	-0.941765051			O14965							
gdsc	Alisertib	AURKA	Q29*	-2.012635158			O14965							
gdsc	Alisertib	AURKA	V19L	-0.266284216			O14965							
gdsc	CD532	AURKA	S104L	-1.877642839			O14965							
gdsc	CD532	AURKA	P110H	-1.851932556			O14965							
gdsc	CD532	AURKA	D311G	-1.479820729			O14965							
gdsc	CD532	AURKA	P297H	-3.063882633			O14965							
gdsc	CD532	AURKA	F133L	-1.959109493			O14965							
gdsc	CD532	AURKA	T333I+S10P	-0.395650061			O14965							
gdsc	CD532	AURKA	S361L	-0.963329848			O14965							
gdsc	CD532	AURKA	Y197C	-0.910358748			O14965							
gdsc	CD532	AURKA	Q394*	-1.352620177			O14965							
gdsc	CD532	AURKA	Y246H	-1.542912653			O14965							
gdsc	CD532	AURKA	V174M	-1.980347701			O14965							
gdsc	CD532	AURKA	R343Q	-1.812423895			O14965							
gdsc	CD532	AURKA	L222P	-2.105115511			O14965							
gdsc	CD532	AURKA	A17G	-3.048033074			O14965							
gdsc	CD532	AURKA	V84A	-0.907407582			O14965							
gdsc	CD532	AURKA	G173V	-1.845607781			O14965							
gdsc	CD532	AURKA	Q29*	-1.7116813430000002			O14965							
gdsc	CD532	AURKA	V19L	-1.663887967			O14965							
gdsc	BAM7	BAX	R78M	1.242679892			Q07812							
gdsc	BAM7	BAX	P130L	1.4456017719999998			Q07812							
gdsc	BAM7	BAX	G108V	1.372699486			Q07812							
gdsc	BAM7	BAX	A213V	1.243606538			Q07812							
gdsc	BAM7	BAX	L144I	1.705628518			Q07812							
gdsc	BAM7	BAX	G11E	1.054637673			Q07812							
gdsc	BAM7	BAX	I136L	1.610618256			Q07812							
gdsc	BAM7	BAX	F214L	1.384850163			Q07812							
gdsc	BAM7	BAX	Q153*	1.024245575			Q07812							
gdsc	BAM7	BAX	G39A	1.301027198			Q07812							
gdsc	BAM7	BAX	G67R	1.598660728			Q07812							
gdsc	BAM7	BAX	G67R	1.882151648			Q07812							
gdsc	BAM7	BAX	R37_G39delRMG	1.483474583			Q07812							
gdsc	BAM7	BAX	D208E	1.288271593			Q07812							
gdsc	BAM7	BAX	R195T	1.04009158			Q07812							
gdsc	BAM7	BAX	G11E	1.13094023			Q07812							
gdsc	BAM7	BAX	Q32P	0.34027762100000003			Q07812							
gdsc	BAM7	BAX	I31T	1.834101135			Q07812							
gdsc	BAM7	BAX	E75K	1.155111238			Q07812							
gdsc	BAM7	BAX	P88S	0.944434916			Q07812							
gdsc	BAM7	BAX	V83M	1.382385426			Q07812							
gdsc	Venetoclax	BCL2	A43T	-0.35431299200000005			P10415							
gdsc	Venetoclax	BCL2	G5W	-0.584544273			P10415							
gdsc	Venetoclax	BCL2	E200D	0.10357463			P10415							
gdsc	Venetoclax	BCL2	A43T	-0.7054295290000001			P10415							
gdsc	Venetoclax	BCL2	A43T	-1.338913635			P10415							
gdsc	Venetoclax	BCL2	T7K	-0.652480944			P10415							
gdsc	Venetoclax	BCL2	R98H+A82T	-1.068522553			P10415							
gdsc	Venetoclax	BCL2	Q73H	-4.2055782389999985			P10415							
gdsc	Venetoclax	BCL2	P59L+G47D	-1.036943708			P10415							
gdsc	Venetoclax	BCL2	A43T	0.320508775			P10415							
gdsc	Venetoclax	BCL2	A43T	0.231266351			P10415							
gdsc	Venetoclax	BCL2	A43T	-1.004844662			P10415							
gdsc	Venetoclax	BCL2	A61T	0.029857084			P10415							
gdsc	Venetoclax	BCL2	A43T	0.17286512899999998			P10415							
gdsc	Venetoclax	BCL2	A43T	-0.565102478			P10415							
gdsc	Venetoclax	BCL2	A43T	-0.730134959			P10415							
gdsc	Venetoclax	BCL2	R129C+T7R+I48F	-2.077520533			P10415							
gdsc	Venetoclax	BCL2	A43T	-0.159243312			P10415							
gdsc	Venetoclax	BCL2	A131T+I48M+A4T	-3.270543685			P10415							
gdsc	Venetoclax	BCL2	G155A+A131V+P91S+L86V+N11H+G5E	-3.77514399			P10415							
gdsc	Venetoclax	BCL2	E13D+P59A+N11H	-3.08064225			P10415							
gdsc	Venetoclax	BCL2	A4T	-2.072435237			P10415							
gdsc	Venotoclax	BCL2	A43T	-0.660856309			P10415							
gdsc	Venotoclax	BCL2	G128E	-0.7574295459999999			P10415							
gdsc	Venotoclax	BCL2	A43T	-0.50603471			P10415							
gdsc	Venotoclax	BCL2	G5W	-1.378393264			P10415							
gdsc	Venotoclax	BCL2	E200D	-0.845336509			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.057504707			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.87430478			P10415							
gdsc	Venotoclax	BCL2	L95V+P59A+G8E	-2.748158173			P10415							
gdsc	Venotoclax	BCL2	T7K	-0.799052193			P10415							
gdsc	Venotoclax	BCL2	R98H+A82T	-1.385477604			P10415							
gdsc	Venotoclax	BCL2	Q73H	-4.129016174			P10415							
gdsc	Venotoclax	BCL2	P59L+G47D	-3.254263982			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.190985597			P10415							
gdsc	Venotoclax	BCL2	A43T	-0.8520339570000001			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.238543756			P10415							
gdsc	Venotoclax	BCL2	A43T	-0.548217255			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.09467246			P10415							
gdsc	Venotoclax	BCL2	A61T	-1.131145822			P10415							
gdsc	Venotoclax	BCL2	A42V+V35M+G200S+E13D	-4.27147143			P10415							
gdsc	Venotoclax	BCL2	A43T	-0.992391225			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.057027164			P10415							
gdsc	Venotoclax	BCL2	A60V+D31H	-2.653313806			P10415							
gdsc	Venotoclax	BCL2	G47D	-1.028772751			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.256212836			P10415							
gdsc	Venotoclax	BCL2	A43T	-0.68356388			P10415							
gdsc	Venotoclax	BCL2	S117R+P59T	-2.828004973			P10415							
gdsc	Venotoclax	BCL2	R129C+T7R+I48F	-3.454731198			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.344671402			P10415							
gdsc	Venotoclax	BCL2	A43T	-1.464778134			P10415							
gdsc	Venotoclax	BCL2	A131T+I48M+A4T	-2.910273259			P10415							
gdsc	Venotoclax	BCL2	G155A+A131V+P91S+L86V+N11H+G5E	-3.648915113			P10415							
gdsc	Venotoclax	BCL2	E13D+P59A+N11H	-1.207972727			P10415							
gdsc	Venotoclax	BCL2	A4T	-1.123633708			P10415							
gdsc	Venotoclax	BCL2	A43T	-0.550977641			P10415							
gdsc	Sepantronium bromide	BIRC5	Q115R	-0.387664667			O15392							
gdsc	Sepantronium bromide	BIRC5	E146*	-4.223187671			O15392							
gdsc	Sepantronium bromide	BIRC5	P47H	-3.246062355			O15392							
gdsc	Sepantronium bromide	BIRC5	A157T	-4.393933763			O15392							
gdsc	Sepantronium bromide	BIRC5	P26L	-4.891736609			O15392							
gdsc	Sepantronium bromide	BIRC5	H17Y	-4.602383052			O15392							
gdsc	Sepantronium bromide	BIRC5	A151V	-2.430857461			O15392							
gdsc	Sepantronium bromide	BIRC5	K23N+E139*	-1.204298729			O15392							
gdsc	Sepantronium bromide	BIRC5	L121I	-4.423560154			O15392							
gdsc	Sepantronium bromide	BIRC5	E98K	-2.460242577			O15392							
gdsc	Sepantronium bromide	BIRC5	G106R	-4.484849162			O15392							
gdsc	QL-XII-61	BMX	A150D	0.690484694			P51813							
gdsc	QL-XII-61	BMX	N494D	0.108040187			P51813							
gdsc	WZ-1-84	BMX	E278G+S665A	0.43851574			P51813							
gdsc	WZ-1-84	BMX	S284L	0.597615079			P51813							
gdsc	WZ-1-84	BMX	T272A	0.106418556			P51813							
gdsc	WZ-1-84	BMX	M464I	1.013382367			P51813							
gdsc	WZ-1-84	BMX	V403G	0.540508436			P51813							
gdsc	WZ-1-84	BMX	A150D	1.4033072480000002			P51813							
gdsc	WZ-1-84	BMX	K59E	0.15852581300000002			P51813							
gdsc	WZ-1-84	BMX	T144N	0.8983881859999999			P51813							
gdsc	WZ-1-84	BMX	N494D	-0.189881291			P51813							
gdsc	WZ-1-84	BMX	P185R	1.098648626			P51813							
gdsc	WZ-1-84	BMX	R656C	1.125712144			P51813							
gdsc	WZ-1-84	BMX	S402F	0.020335854			P51813							
gdsc	AZ628	BRAF	V600E	-3.537221073			P15056							
gdsc	AZ628	BRAF	V600E	-0.131887106			P15056							
gdsc	AZ628	BRAF	V600E	-0.7824679520000001			P15056							
gdsc	AZ628	BRAF	V600E	-3.436429344			P15056							
gdsc	AZ628	BRAF	V600E	-3.652534603			P15056							
gdsc	AZ628	BRAF	V600E	-1.905092658			P15056							
gdsc	AZ628	BRAF	D361G	-0.459738544			P15056							
gdsc	AZ628	BRAF	E296K	1.504472835			P15056							
gdsc	AZ628	BRAF	V600E	-3.919054982			P15056							
gdsc	AZ628	BRAF	V600E	-2.078089911			P15056							
gdsc	AZ628	BRAF	K601N	-0.095711765			P15056							
gdsc	AZ628	BRAF	V600E	-2.942553013			P15056							
gdsc	AZ628	BRAF	A712T	-1.398665723			P15056							
gdsc	AZ628	BRAF	V600E+I208V	-0.961555948			P15056							
gdsc	AZ628	BRAF	V600E	-2.94168917			P15056							
gdsc	AZ628	BRAF	E204V	-1.86985048			P15056							
gdsc	AZ628	BRAF	V600E	-1.199759704			P15056							
gdsc	AZ628	BRAF	K601N	-2.293927367			P15056							
gdsc	AZ628	BRAF	V600E	-3.190924399			P15056							
gdsc	AZ628	BRAF	V600E	-3.697753039			P15056							
gdsc	AZ628	BRAF	I326V	-0.617539749			P15056							
gdsc	AZ628	BRAF	G466V	0.192020754			P15056							
gdsc	AZ628	BRAF	A320S	0.7441371509999999			P15056							
gdsc	AZ628	BRAF	V600E	0.646756357			P15056							
gdsc	AZ628	BRAF	V600E	-3.295153132			P15056							
gdsc	AZ628	BRAF	V600E	-4.012923526			P15056							
gdsc	AZ628	BRAF	V600E	-3.978096087			P15056							
gdsc	AZ628	BRAF	V600E	-2.061277564			P15056							
gdsc	AZ628	BRAF	A400V	-2.10184855			P15056							
gdsc	AZ628	BRAF	T599_V600insT	-1.556901218			P15056							
gdsc	AZ628	BRAF	V600E	-2.899228158			P15056							
gdsc	AZ628	BRAF	I326V	-0.504178456			P15056							
gdsc	AZ628	BRAF	V600E	-3.278266724			P15056							
gdsc	Dabrafenib	BRAF	L597R	1.584171859			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.737674662			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.966710295			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.122909428			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.6354197			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.725946091			P15056							
gdsc	Dabrafenib	BRAF	V226M	0.60408856			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.900709729			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.010613896			P15056							
gdsc	Dabrafenib	BRAF	V600E	1.039680647			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.795596405			P15056							
gdsc	Dabrafenib	BRAF	V600E	-1.789339675			P15056							
gdsc	Dabrafenib	BRAF	V487_P492delinsA	0.644807951			P15056							
gdsc	Dabrafenib	BRAF	A115V	0.6645874629999999			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.758091266			P15056							
gdsc	Dabrafenib	BRAF	G466V	0.061101175			P15056							
gdsc	Dabrafenib	BRAF	R146Q	1.166923606			P15056							
gdsc	Dabrafenib	BRAF	R506G+S273N	1.4972210869999998			P15056							
gdsc	Dabrafenib	BRAF	V600E	-1.655144656			P15056							
gdsc	Dabrafenib	BRAF	V600E	-1.683840484			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.209786611			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.964941234			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.574210154			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.948963698			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.879391682			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.920957488			P15056							
gdsc	Dabrafenib	BRAF	V600E	-4.4519314130000005			P15056							
gdsc	Dabrafenib	BRAF	I326V	1.820562178			P15056							
gdsc	Dabrafenib	BRAF	V600E	-1.825259088			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.430839069			P15056							
gdsc	Dabrafenib	BRAF	V600E	-4.367482992			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.392623326			P15056							
gdsc	Dabrafenib	BRAF	T529A	1.31381723			P15056							
gdsc	Dabrafenib	BRAF	D361G	-0.115328258			P15056							
gdsc	Dabrafenib	BRAF	E296K	1.340420372			P15056							
gdsc	Dabrafenib	BRAF	G469V	-0.390897869			P15056							
gdsc	Dabrafenib	BRAF	R354Q	1.345112705			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.190997857			P15056							
gdsc	Dabrafenib	BRAF	V600E+T119S	-1.53525064			P15056							
gdsc	Dabrafenib	BRAF	N581Y	0.573354606			P15056							
gdsc	Dabrafenib	BRAF	V600E	-1.223185033			P15056							
gdsc	Dabrafenib	BRAF	G464E	-0.470924907			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.41054098			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.877715297			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.937643806			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.035082567			P15056							
gdsc	Dabrafenib	BRAF	D22N	0.103649283			P15056							
gdsc	Dabrafenib	BRAF	K601N	-1.199913255			P15056							
gdsc	Dabrafenib	BRAF	A728V	-0.109547211			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.534336264			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.7409013410000003			P15056							
gdsc	Dabrafenib	BRAF	A712T	0.287080622			P15056							
gdsc	Dabrafenib	BRAF	I326V	1.189936767			P15056							
gdsc	Dabrafenib	BRAF	C194G	1.42451998			P15056							
gdsc	Dabrafenib	BRAF	V600E+I208V	-1.263386628			P15056							
gdsc	Dabrafenib	BRAF	D211G	1.587958719			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.569024683			P15056							
gdsc	Dabrafenib	BRAF	E204V	0.917566405			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.808379726			P15056							
gdsc	Dabrafenib	BRAF	G464V	0.68114152			P15056							
gdsc	Dabrafenib	BRAF	P74A	1.116433173			P15056							
gdsc	Dabrafenib	BRAF	V600E	-1.468760566			P15056							
gdsc	Dabrafenib	BRAF	K601N	-1.220581257			P15056							
gdsc	Dabrafenib	BRAF	V600E	-4.009180208			P15056							
gdsc	Dabrafenib	BRAF	S727G	0.8774564429999999			P15056							
gdsc	Dabrafenib	BRAF	V600E	-4.4123725999999985			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.96007338			P15056							
gdsc	Dabrafenib	BRAF	I326V	1.54839348			P15056							
gdsc	Dabrafenib	BRAF	E375D	0.8772611859999999			P15056							
gdsc	Dabrafenib	BRAF	G466V	1.226180372			P15056							
gdsc	Dabrafenib	BRAF	G469A	0.407290878			P15056							
gdsc	Dabrafenib	BRAF	L597V	0.155750111			P15056							
gdsc	Dabrafenib	BRAF	A320S	1.148619975			P15056							
gdsc	Dabrafenib	BRAF	L485*+L485_P490delinsY	0.6826363870000001			P15056							
gdsc	Dabrafenib	BRAF	G596R	0.479748929			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.337018191			P15056							
gdsc	Dabrafenib	BRAF	A747V	-0.096840519			P15056							
gdsc	Dabrafenib	BRAF	N486_P490delNVTAP	-2.179648867			P15056							
gdsc	Dabrafenib	BRAF	I326V	0.630045726			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.990133671			P15056							
gdsc	Dabrafenib	BRAF	V600E	1.001549854			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.135190037			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.742431392			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.79098255			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.402159847			P15056							
gdsc	Dabrafenib	BRAF	V600E	-1.800240103			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.526480509			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.989901432			P15056							
gdsc	Dabrafenib	BRAF	D287H+E275K	0.274249935			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.875777783			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.470536407			P15056							
gdsc	Dabrafenib	BRAF	A400V	0.976318037			P15056							
gdsc	Dabrafenib	BRAF	V120I+S76P	1.252081506			P15056							
gdsc	Dabrafenib	BRAF	R726C	0.716911002			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.291706077			P15056							
gdsc	Dabrafenib	BRAF	T599_V600insT	0.712035225			P15056							
gdsc	Dabrafenib	BRAF	S683N	1.189452685			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.087158116			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.263452105			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.457232209			P15056							
gdsc	Dabrafenib	BRAF	I326V	1.372616688			P15056							
gdsc	Dabrafenib	BRAF	V645I	1.602265556			P15056							
gdsc	Dabrafenib	BRAF	K601N	-0.324875538			P15056							
gdsc	Dabrafenib	BRAF	V600E	-2.050249291			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.581132966			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.511243244			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.925329653			P15056							
gdsc	Dabrafenib	BRAF	V600E	-0.116111278			P15056							
gdsc	Dabrafenib	BRAF	V600E	-1.361161513			P15056							
gdsc	Dabrafenib	BRAF	V600E	-3.455896192			P15056							
gdsc	Dabrafenib	BRAF	V600E	0.3083658			P15056							
gdsc	Dabrafenib	BRAF	I326T	2.36412149			P15056							
gdsc	HG6-64-1	BRAF	L597R	-0.585527797			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.06045164			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.190064197			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.282942785			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.148246031			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.571244089			P15056							
gdsc	HG6-64-1	BRAF	V226M	-1.107060724			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.746204244			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.200206437			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.027733533			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.306271194			P15056							
gdsc	HG6-64-1	BRAF	V600E	-0.46338825			P15056							
gdsc	HG6-64-1	BRAF	V487_P492delinsA	-1.889661393			P15056							
gdsc	HG6-64-1	BRAF	A115V	-1.720320955			P15056							
gdsc	HG6-64-1	BRAF	V600E	0.953594731			P15056							
gdsc	HG6-64-1	BRAF	G466V	-1.069382249			P15056							
gdsc	HG6-64-1	BRAF	R146Q	-1.838902039			P15056							
gdsc	HG6-64-1	BRAF	R506G+S273N	-0.670535732			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.10573762			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.811269142			P15056							
gdsc	HG6-64-1	BRAF	V600E	0.327513129			P15056							
gdsc	HG6-64-1	BRAF	V600E	0.182908931			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.498031847			P15056							
gdsc	HG6-64-1	BRAF	V600E	0.228528479			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.841746558			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.44732057			P15056							
gdsc	HG6-64-1	BRAF	I326V	1.161546214			P15056							
gdsc	HG6-64-1	BRAF	V600E	-0.455809185			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.745053639			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.839317371			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.154831499			P15056							
gdsc	HG6-64-1	BRAF	T529A	-1.776731429			P15056							
gdsc	HG6-64-1	BRAF	D361G	-1.132086688			P15056							
gdsc	HG6-64-1	BRAF	E296K	0.605189996			P15056							
gdsc	HG6-64-1	BRAF	R354Q	-0.191664078			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.296684198			P15056							
gdsc	HG6-64-1	BRAF	V600E+T119S	-1.116895971			P15056							
gdsc	HG6-64-1	BRAF	N581Y	0.804564671			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.876596511			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.0354897509999998			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.774159452			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.313291632			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.053376187			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.341820365			P15056							
gdsc	HG6-64-1	BRAF	K601N	0.892293888			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.165399143			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.4159307280000002			P15056							
gdsc	HG6-64-1	BRAF	A712T	-1.391216412			P15056							
gdsc	HG6-64-1	BRAF	I326V	-2.197587569			P15056							
gdsc	HG6-64-1	BRAF	C194G	-1.0749599			P15056							
gdsc	HG6-64-1	BRAF	V600E+I208V	-1.552603334			P15056							
gdsc	HG6-64-1	BRAF	D211G	-1.412536976			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.613307544			P15056							
gdsc	HG6-64-1	BRAF	E204V	-0.08726589400000001			P15056							
gdsc	HG6-64-1	BRAF	V600E	-0.8045474890000001			P15056							
gdsc	HG6-64-1	BRAF	G464V	-1.420571661			P15056							
gdsc	HG6-64-1	BRAF	P74A	-0.5218943420000001			P15056							
gdsc	HG6-64-1	BRAF	V600E	0.111265674			P15056							
gdsc	HG6-64-1	BRAF	K601N	-4.050526164			P15056							
gdsc	HG6-64-1	BRAF	S727G	-1.784143413			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.437552867			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.2867874190000002			P15056							
gdsc	HG6-64-1	BRAF	I326V	-0.012965936			P15056							
gdsc	HG6-64-1	BRAF	E375D	-1.155941309			P15056							
gdsc	HG6-64-1	BRAF	G466V	0.454002107			P15056							
gdsc	HG6-64-1	BRAF	G469A	-1.670907134			P15056							
gdsc	HG6-64-1	BRAF	L597V	-1.523133735			P15056							
gdsc	HG6-64-1	BRAF	A320S	0.557758037			P15056							
gdsc	HG6-64-1	BRAF	L485*+L485_P490delinsY	-2.161829929			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.472040219			P15056							
gdsc	HG6-64-1	BRAF	A747V	-1.665373919			P15056							
gdsc	HG6-64-1	BRAF	N486_P490delNVTAP	-0.5005352670000001			P15056							
gdsc	HG6-64-1	BRAF	I326V	-0.750873702			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.128515189			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.07098729			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.152514969			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.655510826			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.703766931			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.266232852			P15056							
gdsc	HG6-64-1	BRAF	V600E	0.437281595			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.141111329			P15056							
gdsc	HG6-64-1	BRAF	V600E	0.06723754			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.170218414			P15056							
gdsc	HG6-64-1	BRAF	D287H+E275K	-1.17610712			P15056							
gdsc	HG6-64-1	BRAF	V600E	0.447939803			P15056							
gdsc	HG6-64-1	BRAF	A400V	-1.518700764			P15056							
gdsc	HG6-64-1	BRAF	T599_V600insT	-1.142834361			P15056							
gdsc	HG6-64-1	BRAF	S683N	-1.53905617			P15056							
gdsc	HG6-64-1	BRAF	V600E	-0.79012167			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.01587131			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.185489622			P15056							
gdsc	HG6-64-1	BRAF	I326V	-0.160417024			P15056							
gdsc	HG6-64-1	BRAF	V645I	-1.018256739			P15056							
gdsc	HG6-64-1	BRAF	V600E	-0.784686215			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.575305572			P15056							
gdsc	HG6-64-1	BRAF	V600E	-0.300020652			P15056							
gdsc	HG6-64-1	BRAF	V600E	-0.256600407			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.812099213			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.672122827			P15056							
gdsc	HG6-64-1	BRAF	V600E	-1.816017315			P15056							
gdsc	HG6-64-1	BRAF	V600E	-2.279660927			P15056							
gdsc	PLX-4720	BRAF	L597R	1.272924675			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.62620129			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.306721747			P15056							
gdsc	PLX-4720	BRAF	V600E	0.892346348			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.138016153			P15056							
gdsc	PLX-4720	BRAF	V600E	0.032666328			P15056							
gdsc	PLX-4720	BRAF	V226M	0.7922833020000001			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.845535998			P15056							
gdsc	PLX-4720	BRAF	V600E	0.218761575			P15056							
gdsc	PLX-4720	BRAF	V600E	0.942755816			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.105376033			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.8638979059999999			P15056							
gdsc	PLX-4720	BRAF	V487_P492delinsA	0.469187278			P15056							
gdsc	PLX-4720	BRAF	A115V	0.668325985			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.716675318			P15056							
gdsc	PLX-4720	BRAF	G466V	0.017101592			P15056							
gdsc	PLX-4720	BRAF	R146Q	1.301699959			P15056							
gdsc	PLX-4720	BRAF	R506G+S273N	1.261179839			P15056							
gdsc	PLX-4720	BRAF	V600E	0.084187018			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.340147234			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.663478876			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.647054511			P15056							
gdsc	PLX-4720	BRAF	V600E	0.7447444209999999			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.8313414309999999			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.8006421730000002			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.130465765			P15056							
gdsc	PLX-4720	BRAF	V600E	-2.030283442			P15056							
gdsc	PLX-4720	BRAF	I326V	1.411741684			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.313110769			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.963262684			P15056							
gdsc	PLX-4720	BRAF	V600E	-2.214399104			P15056							
gdsc	PLX-4720	BRAF	V600E	0.515355379			P15056							
gdsc	PLX-4720	BRAF	T529A	0.8591989109999999			P15056							
gdsc	PLX-4720	BRAF	D361G	0.628678498			P15056							
gdsc	PLX-4720	BRAF	E296K	1.5056038880000002			P15056							
gdsc	PLX-4720	BRAF	G469V	0.928828675			P15056							
gdsc	PLX-4720	BRAF	R354Q	1.262934526			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.39783345			P15056							
gdsc	PLX-4720	BRAF	V600E+T119S	-0.550416152			P15056							
gdsc	PLX-4720	BRAF	N581Y	1.093419072			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.072099599			P15056							
gdsc	PLX-4720	BRAF	G464E	1.130376495			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.8701151			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.07931542			P15056							
gdsc	PLX-4720	BRAF	V600E	-2.2395276180000003			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.4292880570000001			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.153381936			P15056							
gdsc	PLX-4720	BRAF	D22N	0.045552658			P15056							
gdsc	PLX-4720	BRAF	K601N	-0.236291274			P15056							
gdsc	PLX-4720	BRAF	A728V	0.325721631			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.948757735			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.208366952			P15056							
gdsc	PLX-4720	BRAF	A712T	1.385179069			P15056							
gdsc	PLX-4720	BRAF	I326V	0.579230907			P15056							
gdsc	PLX-4720	BRAF	C194G	1.0709089			P15056							
gdsc	PLX-4720	BRAF	V600E+I208V	-0.656449528			P15056							
gdsc	PLX-4720	BRAF	D211G	1.5613550630000002			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.434906456			P15056							
gdsc	PLX-4720	BRAF	E204V	1.400891661			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.915460094			P15056							
gdsc	PLX-4720	BRAF	G464V	1.474473655			P15056							
gdsc	PLX-4720	BRAF	P74A	1.472030902			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.343028716			P15056							
gdsc	PLX-4720	BRAF	K601N	0.197158559			P15056							
gdsc	PLX-4720	BRAF	V600E	-2.015047257			P15056							
gdsc	PLX-4720	BRAF	S727G	0.941404586			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.986245911			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.617004057			P15056							
gdsc	PLX-4720	BRAF	I326V	1.47262239			P15056							
gdsc	PLX-4720	BRAF	E375D	0.882219657			P15056							
gdsc	PLX-4720	BRAF	G466V	1.6500091419999998			P15056							
gdsc	PLX-4720	BRAF	G469A	0.408542188			P15056							
gdsc	PLX-4720	BRAF	L597V	1.318545401			P15056							
gdsc	PLX-4720	BRAF	A320S	1.743524962			P15056							
gdsc	PLX-4720	BRAF	L485*+L485_P490delinsY	1.232361193			P15056							
gdsc	PLX-4720	BRAF	G596R	1.061885855			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.174361971			P15056							
gdsc	PLX-4720	BRAF	A747V	0.586035239			P15056							
gdsc	PLX-4720	BRAF	N486_P490delNVTAP	1.079477864			P15056							
gdsc	PLX-4720	BRAF	I326V	0.700566844			P15056							
gdsc	PLX-4720	BRAF	V600E	0.394075755			P15056							
gdsc	PLX-4720	BRAF	V600E	0.210793167			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.154382831			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.834555305			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.176084187			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.483820572			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.605870431			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.497248565			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.7477588070000001			P15056							
gdsc	PLX-4720	BRAF	D287H+E275K	0.8790148720000001			P15056							
gdsc	PLX-4720	BRAF	V600E	0.582125386			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.402845208			P15056							
gdsc	PLX-4720	BRAF	A400V	1.190909571			P15056							
gdsc	PLX-4720	BRAF	V120I+S76P	1.641213959			P15056							
gdsc	PLX-4720	BRAF	R726C	1.492896325			P15056							
gdsc	PLX-4720	BRAF	V600E	0.074058074			P15056							
gdsc	PLX-4720	BRAF	T599_V600insT	0.66370646			P15056							
gdsc	PLX-4720	BRAF	S683N	1.236557509			P15056							
gdsc	PLX-4720	BRAF	V600E	0.612846639			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.071750277			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.7103410370000001			P15056							
gdsc	PLX-4720	BRAF	I326V	1.110608176			P15056							
gdsc	PLX-4720	BRAF	V645I	1.3742545309999998			P15056							
gdsc	PLX-4720	BRAF	K601N	1.431553736			P15056							
gdsc	PLX-4720	BRAF	V600E	-1.009358935			P15056							
gdsc	PLX-4720	BRAF	V600E	0.288379374			P15056							
gdsc	PLX-4720	BRAF	V600E	1.040412707			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.4757728570000001			P15056							
gdsc	PLX-4720	BRAF	V600E	0.075413292			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.7147916809999999			P15056							
gdsc	PLX-4720	BRAF	V600E	0.438176054			P15056							
gdsc	PLX-4720	BRAF	V600E	-0.13023420300000002			P15056							
gdsc	PLX-4720	BRAF	I326T	2.070169057			P15056							
gdsc	SB590885	BRAF	L597R	0.415511335			P15056							
gdsc	SB590885	BRAF	V600E	-2.871232661			P15056							
gdsc	SB590885	BRAF	V600E	-0.519036788			P15056							
gdsc	SB590885	BRAF	V600E	0.098544434			P15056							
gdsc	SB590885	BRAF	V600E	-1.814110699			P15056							
gdsc	SB590885	BRAF	V600E	0.292461731			P15056							
gdsc	SB590885	BRAF	V226M	0.7209852170000001			P15056							
gdsc	SB590885	BRAF	V600E	-2.15674404			P15056							
gdsc	SB590885	BRAF	V600E	0.571735345			P15056							
gdsc	SB590885	BRAF	V600E	0.890572128			P15056							
gdsc	SB590885	BRAF	V600E	0.215054191			P15056							
gdsc	SB590885	BRAF	V600E	-1.397529929			P15056							
gdsc	SB590885	BRAF	V487_P492delinsA	0.902787386			P15056							
gdsc	SB590885	BRAF	A115V	0.925105694			P15056							
gdsc	SB590885	BRAF	V600E	-2.814816263			P15056							
gdsc	SB590885	BRAF	G466V	0.305088174			P15056							
gdsc	SB590885	BRAF	R146Q	0.812672232			P15056							
gdsc	SB590885	BRAF	R506G+S273N	-0.409068063			P15056							
gdsc	SB590885	BRAF	V600E	-0.621482735			P15056							
gdsc	SB590885	BRAF	V600E	-2.641724804			P15056							
gdsc	SB590885	BRAF	V600E	-2.381560602			P15056							
gdsc	SB590885	BRAF	V600E	-1.127166102			P15056							
gdsc	SB590885	BRAF	V600E	0.115290423			P15056							
gdsc	SB590885	BRAF	V600E	-1.891959048			P15056							
gdsc	SB590885	BRAF	V600E	-1.580704886			P15056							
gdsc	SB590885	BRAF	V600E	-0.8700200159999999			P15056							
gdsc	SB590885	BRAF	V600E	-2.8481150910000004			P15056							
gdsc	SB590885	BRAF	I326V	1.448026812			P15056							
gdsc	SB590885	BRAF	V600E	-0.546355075			P15056							
gdsc	SB590885	BRAF	V600E	-0.654551086			P15056							
gdsc	SB590885	BRAF	V600E	-3.154846225			P15056							
gdsc	SB590885	BRAF	V600E	-0.222080468			P15056							
gdsc	SB590885	BRAF	T529A	0.563583347			P15056							
gdsc	SB590885	BRAF	D361G	-0.592887643			P15056							
gdsc	SB590885	BRAF	E296K	-0.636275894			P15056							
gdsc	SB590885	BRAF	R354Q	0.901742835			P15056							
gdsc	SB590885	BRAF	V600E	-2.123157856			P15056							
gdsc	SB590885	BRAF	V600E+T119S	-0.752712775			P15056							
gdsc	SB590885	BRAF	N581Y	1.034689896			P15056							
gdsc	SB590885	BRAF	V600E	-0.130331834			P15056							
gdsc	SB590885	BRAF	G464E	-0.8668040090000001			P15056							
gdsc	SB590885	BRAF	V600E	-0.893530996			P15056							
gdsc	SB590885	BRAF	V600E	-0.432016775			P15056							
gdsc	SB590885	BRAF	V600E	-3.102887682			P15056							
gdsc	SB590885	BRAF	V600E	-0.7384143409999999			P15056							
gdsc	SB590885	BRAF	V600E	-0.35760543			P15056							
gdsc	SB590885	BRAF	D22N	-0.872129855			P15056							
gdsc	SB590885	BRAF	K601N	-0.157374023			P15056							
gdsc	SB590885	BRAF	A728V	-0.382958445			P15056							
gdsc	SB590885	BRAF	V600E	-0.941532926			P15056							
gdsc	SB590885	BRAF	A712T	0.6502200229999999			P15056							
gdsc	SB590885	BRAF	I326V	0.34750415799999995			P15056							
gdsc	SB590885	BRAF	C194G	0.8889345			P15056							
gdsc	SB590885	BRAF	V600E+I208V	-1.068211499			P15056							
gdsc	SB590885	BRAF	D211G	0.050401493			P15056							
gdsc	SB590885	BRAF	V600E	-0.309773543			P15056							
gdsc	SB590885	BRAF	E204V	0.888833777			P15056							
gdsc	SB590885	BRAF	V600E	-2.692906007			P15056							
gdsc	SB590885	BRAF	G464V	0.084281549			P15056							
gdsc	SB590885	BRAF	P74A	1.2967227959999998			P15056							
gdsc	SB590885	BRAF	V600E	0.149284828			P15056							
gdsc	SB590885	BRAF	K601N	0.303131789			P15056							
gdsc	SB590885	BRAF	V600E	-3.0561513			P15056							
gdsc	SB590885	BRAF	V600E	-0.770250916			P15056							
gdsc	SB590885	BRAF	I326V	0.47932372			P15056							
gdsc	SB590885	BRAF	E375D	0.917687192			P15056							
gdsc	SB590885	BRAF	G466V	0.751188904			P15056							
gdsc	SB590885	BRAF	G469A	0.6416100339999999			P15056							
gdsc	SB590885	BRAF	L597V	0.8624646509999999			P15056							
gdsc	SB590885	BRAF	A320S	1.051655105			P15056							
gdsc	SB590885	BRAF	L485*+L485_P490delinsY	0.7739545390000001			P15056							
gdsc	SB590885	BRAF	G596R	1.552817221			P15056							
gdsc	SB590885	BRAF	V600E	0.787739289			P15056							
gdsc	SB590885	BRAF	A747V	0.463349146			P15056							
gdsc	SB590885	BRAF	N486_P490delNVTAP	-1.286283807			P15056							
gdsc	SB590885	BRAF	I326V	-0.655715911			P15056							
gdsc	SB590885	BRAF	V600E	-0.443364043			P15056							
gdsc	SB590885	BRAF	V600E	0.55822847			P15056							
gdsc	SB590885	BRAF	V600E	-2.069383348			P15056							
gdsc	SB590885	BRAF	V600E	-1.725466093			P15056							
gdsc	SB590885	BRAF	V600E	-0.162480649			P15056							
gdsc	SB590885	BRAF	V600E	-1.3423589340000002			P15056							
gdsc	SB590885	BRAF	V600E	-1.09352067			P15056							
gdsc	SB590885	BRAF	V600E	1.304127078			P15056							
gdsc	SB590885	BRAF	V600E	-1.279678195			P15056							
gdsc	SB590885	BRAF	A400V	-0.269169971			P15056							
gdsc	SB590885	BRAF	R726C	0.99414024			P15056							
gdsc	SB590885	BRAF	V600E	0.367285446			P15056							
gdsc	SB590885	BRAF	T599_V600insT	0.319474296			P15056							
gdsc	SB590885	BRAF	S683N	-0.284555022			P15056							
gdsc	SB590885	BRAF	V600E	0.629780484			P15056							
gdsc	SB590885	BRAF	V600E	0.308250265			P15056							
gdsc	SB590885	BRAF	V600E	-0.560107239			P15056							
gdsc	SB590885	BRAF	I326V	1.129372515			P15056							
gdsc	SB590885	BRAF	V645I	0.8572774470000001			P15056							
gdsc	SB590885	BRAF	K601N	0.50477568			P15056							
gdsc	SB590885	BRAF	V600E	-1.594845127			P15056							
gdsc	SB590885	BRAF	V600E	0.608684471			P15056							
gdsc	SB590885	BRAF	V600E	-1.809149824			P15056							
gdsc	SB590885	BRAF	V600E	-0.128325088			P15056							
gdsc	SB590885	BRAF	V600E	-1.063384525			P15056							
gdsc	SB590885	BRAF	V600E	-0.580310969			P15056							
gdsc	SB590885	BRAF	I326T	1.963466033			P15056							
gdsc	AZD5153	BRD4	K535R	-1.265243488			O60885							
gdsc	AZD5153	BRD4	R444C	-0.538957311			O60885							
gdsc	AZD5153	BRD4	D818Y	-0.146541624			O60885							
gdsc	AZD5153	BRD4	P1150L	0.025004634			O60885							
gdsc	AZD5153	BRD4	P781S	0.044641355999999986			O60885							
gdsc	AZD5153	BRD4	E844Q	-0.6338751460000001			O60885							
gdsc	AZD5153	BRD4	P723L+W750L	-2.455055373			O60885							
gdsc	AZD5153	BRD4	A3T	-1.577895323			O60885							
gdsc	AZD5153	BRD4	A3T	-2.996094083			O60885							
gdsc	AZD5153	BRD4	S703L	-1.724364664			O60885							
gdsc	AZD5153	BRD4	E1339G+P750L+E451G	-2.394153273			O60885							
gdsc	AZD5153	BRD4	T29A	-2.196481992			O60885							
gdsc	AZD5153	BRD4	R1263*	-3.089690677			O60885							
gdsc	AZD5153	BRD4	W120*	1.728035699			O60885							
gdsc	AZD5153	BRD4	A292T+Q235*	-1.773406997			O60885							
gdsc	AZD5153	BRD4	K285N	-0.436284443			O60885							
gdsc	AZD5153	BRD4	H740Y	-2.920190861			O60885							
gdsc	AZD5153	BRD4	R745K	-1.048669574			O60885							
gdsc	AZD5153	BRD4	*1363*	0.915800128			O60885							
gdsc	AZD5153	BRD4	C357Y	0.5848434770000001			O60885							
gdsc	AZD5153	BRD4	P1131A+R1121C+R1097C	-0.197860283			O60885							
gdsc	AZD5153	BRD4	M1320V	-0.69977367			O60885							
gdsc	AZD5153	BRD4	A202G	0.296453301			O60885							
gdsc	AZD5153	BRD4	H764R	-1.407166694			O60885							
gdsc	AZD5153	BRD4	A3T	-0.8240817109999999			O60885							
gdsc	AZD5153	BRD4	H764Q	-3.5175630210000004			O60885							
gdsc	AZD5153	BRD4	W81L	-0.572349751			O60885							
gdsc	AZD5153	BRD4	I360V	-1.925882355			O60885							
gdsc	AZD5153	BRD4	V1110delV	0.450218499			O60885							
gdsc	AZD5153	BRD4	R616W	-0.910181003			O60885							
gdsc	AZD5153	BRD4	H77Y	-3.0606855860000004			O60885							
gdsc	AZD5153	BRD4	T73I+E1113delE	0.8299348679999999			O60885							
gdsc	AZD5153	BRD4	P732L	-0.846072968			O60885							
gdsc	AZD5153	BRD4	A751T	0.004830528			O60885							
gdsc	AZD5153	BRD4	A1268V+R1256W+A40T	-0.056819288			O60885							
gdsc	AZD5153	BRD4	A1203T	-1.376893685			O60885							
gdsc	AZD5153	BRD4	G742S	-0.907613174			O60885							
gdsc	AZD5153	BRD4	S947F	0.233714498			O60885							
gdsc	AZD5153	BRD4	V938G	-0.681703477			O60885							
gdsc	AZD5153	BRD4	A861V	-3.584182599			O60885							
gdsc	PFI-1	BRD4	K535R	0.1236569			O60885							
gdsc	PFI-1	BRD4	R444C	-0.259411747			O60885							
gdsc	PFI-1	BRD4	D818Y	-0.429892717			O60885							
gdsc	PFI-1	BRD4	E1113delE	0.003947133			O60885							
gdsc	PFI-1	BRD4	P1150L	-0.533376104			O60885							
gdsc	PFI-1	BRD4	P781S	0.27656062600000003			O60885							
gdsc	PFI-1	BRD4	E844Q	0.101688158			O60885							
gdsc	PFI-1	BRD4	P723L+W750L	-0.039993906			O60885							
gdsc	PFI-1	BRD4	A3T	-0.459690553			O60885							
gdsc	PFI-1	BRD4	A3T	-0.8936364590000001			O60885							
gdsc	PFI-1	BRD4	S703L	-0.567459382			O60885							
gdsc	PFI-1	BRD4	E1339G+P750L+E451G	1.277655452			O60885							
gdsc	PFI-1	BRD4	G182delG	0.18565332			O60885							
gdsc	PFI-1	BRD4	T29A	-0.7501330970000001			O60885							
gdsc	PFI-1	BRD4	R1263*	-0.706902446			O60885							
gdsc	PFI-1	BRD4	W120*	0.930959443			O60885							
gdsc	PFI-1	BRD4	A292T+Q235*	-0.282885993			O60885							
gdsc	PFI-1	BRD4	K285N	0.414047305			O60885							
gdsc	PFI-1	BRD4	H740Y	-0.426824239			O60885							
gdsc	PFI-1	BRD4	R745K	0.019363587			O60885							
gdsc	PFI-1	BRD4	*1363*	0.036125573			O60885							
gdsc	PFI-1	BRD4	C357Y	-0.250581947			O60885							
gdsc	PFI-1	BRD4	P1131A+R1121C+R1097C	-0.60601118			O60885							
gdsc	PFI-1	BRD4	P784L+K629*	-0.150312789			O60885							
gdsc	PFI-1	BRD4	M1320V	0.7019706029999999			O60885							
gdsc	PFI-1	BRD4	A202G	0.225460001			O60885							
gdsc	PFI-1	BRD4	H764R	0.08481063800000001			O60885							
gdsc	PFI-1	BRD4	A3T	-0.329465367			O60885							
gdsc	PFI-1	BRD4	H764Q	-0.6871922559999999			O60885							
gdsc	PFI-1	BRD4	W81L	0.269362528			O60885							
gdsc	PFI-1	BRD4	I360V	0.130145201			O60885							
gdsc	PFI-1	BRD4	R616W	0.247608858			O60885							
gdsc	PFI-1	BRD4	H77Y	-0.518252931			O60885							
gdsc	PFI-1	BRD4	T73I+E1113delE	-0.373310423			O60885							
gdsc	PFI-1	BRD4	P732L	0.28233202			O60885							
gdsc	PFI-1	BRD4	A751T	-0.417500306			O60885							
gdsc	PFI-1	BRD4	A1268V+R1256W+A40T	0.666428628			O60885							
gdsc	PFI-1	BRD4	G742S	-0.611456708			O60885							
gdsc	PFI-1	BRD4	S947F	0.5964810629999999			O60885							
gdsc	PFI-1	BRD4	V938G	-0.00652622			O60885							
gdsc	PFI-1	BRD4	A861V	-0.77273876			O60885							
gdsc	RVX-208	BRD4	K535R	0.920718344			O60885							
gdsc	RVX-208	BRD4	R444C	1.0674608209999998			O60885							
gdsc	RVX-208	BRD4	D818Y	1.803321552			O60885							
gdsc	RVX-208	BRD4	P1150L	1.288286998			O60885							
gdsc	RVX-208	BRD4	P781S	1.562563002			O60885							
gdsc	RVX-208	BRD4	E844Q	0.890305509			O60885							
gdsc	RVX-208	BRD4	P723L+W750L	-0.145905295			O60885							
gdsc	RVX-208	BRD4	A3T	0.328844443			O60885							
gdsc	RVX-208	BRD4	A3T	0.107865997			O60885							
gdsc	RVX-208	BRD4	S703L	0.6826004990000001			O60885							
gdsc	RVX-208	BRD4	E1339G+P750L+E451G	0.918558737			O60885							
gdsc	RVX-208	BRD4	T29A	1.000201359			O60885							
gdsc	RVX-208	BRD4	R1263*	0.17999035100000002			O60885							
gdsc	RVX-208	BRD4	W120*	0.852039289			O60885							
gdsc	RVX-208	BRD4	A292T+Q235*	1.7242189119999998			O60885							
gdsc	RVX-208	BRD4	K285N	1.246637097			O60885							
gdsc	RVX-208	BRD4	H740Y	0.469371754			O60885							
gdsc	RVX-208	BRD4	R745K	0.777591802			O60885							
gdsc	RVX-208	BRD4	*1363*	1.425109502			O60885							
gdsc	RVX-208	BRD4	C357Y	0.807027037			O60885							
gdsc	RVX-208	BRD4	P1131A+R1121C+R1097C	1.26914974			O60885							
gdsc	RVX-208	BRD4	M1320V	1.3669594930000002			O60885							
gdsc	RVX-208	BRD4	A202G	1.80010673			O60885							
gdsc	RVX-208	BRD4	H764R	1.762480985			O60885							
gdsc	RVX-208	BRD4	A3T	0.237188829			O60885							
gdsc	RVX-208	BRD4	H764Q	-0.123594097			O60885							
gdsc	RVX-208	BRD4	W81L	1.967177358			O60885							
gdsc	RVX-208	BRD4	I360V	1.094184253			O60885							
gdsc	RVX-208	BRD4	V1110delV	2.580855291			O60885							
gdsc	RVX-208	BRD4	R616W	1.608403548			O60885							
gdsc	RVX-208	BRD4	H77Y	0.603032759			O60885							
gdsc	RVX-208	BRD4	T73I+E1113delE	0.422991455			O60885							
gdsc	RVX-208	BRD4	P732L	0.7474390679999999			O60885							
gdsc	RVX-208	BRD4	A751T	1.165624287			O60885							
gdsc	RVX-208	BRD4	A1268V+R1256W+A40T	1.771299528			O60885							
gdsc	RVX-208	BRD4	A1203T	0.466075169			O60885							
gdsc	RVX-208	BRD4	G742S	0.594127121			O60885							
gdsc	RVX-208	BRD4	S947F	1.777041298			O60885							
gdsc	RVX-208	BRD4	V938G	0.996823603			O60885							
gdsc	RVX-208	BRD4	A861V	0.16780293899999998			O60885							
gdsc	I-BRD9	BRD9	A537V+S424N	0.472824163			Q9H8M2							
gdsc	I-BRD9	BRD9	T448A	0.628598477			Q9H8M2							
gdsc	I-BRD9	BRD9	R85K	0.670099664			Q9H8M2							
gdsc	I-BRD9	BRD9	R545W	1.546155915			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	1.3544029640000002			Q9H8M2							
gdsc	I-BRD9	BRD9	M186I	0.8310208920000001			Q9H8M2							
gdsc	I-BRD9	BRD9	S548P	-0.008660942			Q9H8M2							
gdsc	I-BRD9	BRD9	D345E+A266T+N246S	0.235361013			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	-0.06883191599999999			Q9H8M2							
gdsc	I-BRD9	BRD9	S391L+D345E+A266T	0.449339252			Q9H8M2							
gdsc	I-BRD9	BRD9	K67N	0.409073988			Q9H8M2							
gdsc	I-BRD9	BRD9	A287V	0.941401987			Q9H8M2							
gdsc	I-BRD9	BRD9	L300V	-0.465774779			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	-0.49605312			Q9H8M2							
gdsc	I-BRD9	BRD9	D518N	-0.558604105			Q9H8M2							
gdsc	I-BRD9	BRD9	S491L	0.365215897			Q9H8M2							
gdsc	I-BRD9	BRD9	T417R	1.163734261			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	-0.16706114800000002			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	0.547969004			Q9H8M2							
gdsc	I-BRD9	BRD9	P582S	0.776457787			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	-0.023002628			Q9H8M2							
gdsc	I-BRD9	BRD9	R541H	-0.43308858			Q9H8M2							
gdsc	I-BRD9	BRD9	A389V+V116L+D109N	0.640275759			Q9H8M2							
gdsc	I-BRD9	BRD9	D400N	0.449419237			Q9H8M2							
gdsc	I-BRD9	BRD9	R85K	0.247341055			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	0.191993499			Q9H8M2							
gdsc	I-BRD9	BRD9	G542S	1.3464826280000002			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	0.425715107			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	0.296105513			Q9H8M2							
gdsc	I-BRD9	BRD9	E61D	0.620719614			Q9H8M2							
gdsc	I-BRD9	BRD9	A592V	1.298701695			Q9H8M2							
gdsc	I-BRD9	BRD9	P260S	0.418596403			Q9H8M2							
gdsc	I-BRD9	BRD9	R328K	1.351806103			Q9H8M2							
gdsc	I-BRD9	BRD9	S491L	1.696787461			Q9H8M2							
gdsc	I-BRD9	BRD9	A266T	0.114690236			Q9H8M2							
gdsc	I-BRD9	BRD9	S494A	0.8737905890000001			Q9H8M2							
gdsc	XMD11-85h	BRSK2	M700V+S664T	-0.409137976			Q8IWQ3							
gdsc	Ibrutinib	BTK	V147I	-0.595053767			Q06187							
gdsc	Ibrutinib	BTK	E239D	1.673394385			Q06187							
gdsc	Ibrutinib	BTK	K60N	0.7705465659999999			Q06187							
gdsc	Ibrutinib	BTK	M630L	0.958224407			Q06187							
gdsc	Ibrutinib	BTK	K537R	-1.4624567780000002			Q06187							
gdsc	Ibrutinib	BTK	E33delE	0.511032319			Q06187							
gdsc	Ibrutinib	BTK	D583A	0.578524035			Q06187							
gdsc	Ibrutinib	BTK	P237Q	0.7261819			Q06187							
gdsc	Ibrutinib	BTK	R80H	-1.497701919			Q06187							
gdsc	Ibrutinib	BTK	R289P	0.602270824			Q06187							
gdsc	Ibrutinib	BTK	R116K	-0.31685255100000004			Q06187							
gdsc	Ibrutinib	BTK	I504S	0.043113931			Q06187							
gdsc	Ibrutinib	BTK	E274D	1.099761904			Q06187							
gdsc	Ibrutinib	BTK	Q324L	1.762011737			Q06187							
gdsc	Ibrutinib	BTK	D171N	1.251519172			Q06187							
gdsc	Ibrutinib	BTK	E623D	1.7076334869999998			Q06187							
gdsc	Ibrutinib	BTK	G81R	0.244871579			Q06187							
gdsc	Ibrutinib	BTK	E473*	1.7438668919999998			Q06187							
gdsc	Ibrutinib	BTK	T529S	1.741504655			Q06187							
gdsc	Ibrutinib	BTK	L63M	1.893084769			Q06187							
gdsc	Ibrutinib	BTK	H177Y	2.531333638			Q06187							
gdsc	Ibrutinib	BTK	I166N	1.241173203			Q06187							
gdsc	Ibrutinib	BTK	M523I	0.774394162			Q06187							
gdsc	Ibrutinib	BTK	Y452H	2.062591695			Q06187							
gdsc	Ibrutinib	BTK	Y395C	2.108088599			Q06187							
gdsc	Ibrutinib	BTK	V461M	-1.177550413			Q06187							
gdsc	LFM-A13	BTK	I231M	0.617071093			Q06187							
gdsc	LFM-A13	BTK	Q413*	1.095823066			Q06187							
gdsc	LFM-A13	BTK	V147I	1.45034402			Q06187							
gdsc	LFM-A13	BTK	E239D	1.38730779			Q06187							
gdsc	LFM-A13	BTK	K60N	1.292855648			Q06187							
gdsc	LFM-A13	BTK	M630L	0.237470259			Q06187							
gdsc	LFM-A13	BTK	K537R	0.6846854529999999			Q06187							
gdsc	LFM-A13	BTK	E33delE	0.995033114			Q06187							
gdsc	LFM-A13	BTK	P600L	0.6035997670000001			Q06187							
gdsc	LFM-A13	BTK	D583A	1.194583757			Q06187							
gdsc	LFM-A13	BTK	C498F	0.8955691440000001			Q06187							
gdsc	LFM-A13	BTK	P237Q	1.5871493419999998			Q06187							
gdsc	LFM-A13	BTK	V139L	0.75856297			Q06187							
gdsc	LFM-A13	BTK	R289P	-0.06777314599999999			Q06187							
gdsc	LFM-A13	BTK	R116K	0.17838116199999998			Q06187							
gdsc	LFM-A13	BTK	I504S	1.3666970230000002			Q06187							
gdsc	LFM-A13	BTK	E274D	1.303100894			Q06187							
gdsc	LFM-A13	BTK	Q324L	0.8305771209999999			Q06187							
gdsc	LFM-A13	BTK	D171N	1.253173389			Q06187							
gdsc	LFM-A13	BTK	E623D	1.4207351869999998			Q06187							
gdsc	LFM-A13	BTK	G81R	1.83311287			Q06187							
gdsc	LFM-A13	BTK	E473*	1.210393027			Q06187							
gdsc	LFM-A13	BTK	W622C	0.898130456			Q06187							
gdsc	LFM-A13	BTK	T529S	1.282291052			Q06187							
gdsc	LFM-A13	BTK	I166N	1.393165687			Q06187							
gdsc	LFM-A13	BTK	I298N	1.6882361280000002			Q06187							
gdsc	LFM-A13	BTK	D460N	0.936286474			Q06187							
gdsc	LFM-A13	BTK	P108L	1.118166258			Q06187							
gdsc	LFM-A13	BTK	Y452H	1.033878192			Q06187							
gdsc	LFM-A13	BTK	V461M	0.925095029			Q06187							
gdsc	QL-X-138	BTK	I231M	-0.997795871			Q06187							
gdsc	QL-X-138	BTK	Q413*	-1.104177101			Q06187							
gdsc	QL-X-138	BTK	V147I	-0.145668301			Q06187							
gdsc	QL-X-138	BTK	E239D	-0.597504877			Q06187							
gdsc	QL-X-138	BTK	K60N	-0.6548194820000001			Q06187							
gdsc	QL-X-138	BTK	M630L	-1.984921684			Q06187							
gdsc	QL-X-138	BTK	K537R	-0.44135315			Q06187							
gdsc	QL-X-138	BTK	E33delE	-2.138307692			Q06187							
gdsc	QL-X-138	BTK	P600L	-1.130728712			Q06187							
gdsc	QL-X-138	BTK	D583A	-0.505492587			Q06187							
gdsc	QL-X-138	BTK	C498F	-0.616443059			Q06187							
gdsc	QL-X-138	BTK	P237Q	-0.7601591240000001			Q06187							
gdsc	QL-X-138	BTK	V139L	1.177227508			Q06187							
gdsc	QL-X-138	BTK	R289P	-3.045419031			Q06187							
gdsc	QL-X-138	BTK	R116K	-0.568620652			Q06187							
gdsc	QL-X-138	BTK	I504S	-1.626619492			Q06187							
gdsc	QL-X-138	BTK	E274D	-0.114318156			Q06187							
gdsc	QL-X-138	BTK	Q324L	-2.047782539			Q06187							
gdsc	QL-X-138	BTK	D171N	0.631514686			Q06187							
gdsc	QL-X-138	BTK	E623D	0.740335176			Q06187							
gdsc	QL-X-138	BTK	G81R	-0.648831831			Q06187							
gdsc	QL-X-138	BTK	E473*	-0.8710337579999999			Q06187							
gdsc	QL-X-138	BTK	W622C	-1.726868504			Q06187							
gdsc	QL-X-138	BTK	T529S	-2.438430843			Q06187							
gdsc	QL-X-138	BTK	L63M	0.680815935			Q06187							
gdsc	QL-X-138	BTK	H177Y	-0.797259334			Q06187							
gdsc	QL-X-138	BTK	I166N	-0.05801433			Q06187							
gdsc	QL-X-138	BTK	M523I	0.359133448			Q06187							
gdsc	QL-X-138	BTK	I298N	-0.352113096			Q06187							
gdsc	QL-X-138	BTK	D460N	-1.906008639			Q06187							
gdsc	QL-X-138	BTK	P108L	1.407721852			Q06187							
gdsc	QL-X-138	BTK	Y452H	0.058190298			Q06187							
gdsc	QL-X-138	BTK	Y395C	-0.062880407			Q06187							
gdsc	QL-X-138	BTK	V461M	-0.436417159			Q06187							
gdsc	QL-XII-47	BTK	Q324L	-2.266543907			Q06187							
gdsc	QL-XII-47	BTK	M523I	0.559725086			Q06187							
gdsc	XMD15-27	CAMK2B	R646H	1.190205887			Q13554							
gdsc	XMD15-27	CAMK2B	A407T	1.576880396			Q13554							
gdsc	XMD15-27	CAMK2B	P234L	1.3722302380000002			Q13554							
gdsc	XMD15-27	CAMK2B	W215*+R75C+T3I	1.243293706			Q13554							
gdsc	XMD15-27	CAMK2B	E13D	1.287409528			Q13554							
gdsc	XMD15-27	CAMK2B	A472V	0.961493145			Q13554							
gdsc	XMD15-27	CAMK2B	P354S	0.507541992			Q13554							
gdsc	XMD15-27	CAMK2B	V515M	1.191899208			Q13554							
gdsc	XMD15-27	CAMK2B	P464S	0.86346358			Q13554							
gdsc	XMD15-27	CAMK2B	A472V	0.027618084			Q13554							
gdsc	XMD15-27	CAMK2B	L142M	0.634839711			Q13554							
gdsc	XMD15-27	CAMK2B	C616Y	1.193655926			Q13554							
gdsc	XMD15-27	CAMK2B	A472V	1.063571158			Q13554							
gdsc	XMD15-27	CAMK2B	G302R	1.580538397			Q13554							
gdsc	XMD15-27	CAMK2B	R260L	1.060481943			Q13554							
gdsc	XMD15-27	CAMK2B	A472V	0.609199933			Q13554							
gdsc	XMD15-27	CAMK2B	S513L	1.675521998			Q13554							
gdsc	XMD15-27	CAMK2B	N386S	1.239572902			Q13554							
gdsc	XMD15-27	CAMK2B	Q168*	1.47269847			Q13554							
gdsc	XMD15-27	CAMK2B	A472V	1.075872327			Q13554							
gdsc	XMD15-27	CAMK2B	Q624E	1.482577561			Q13554							
gdsc	Rapamycin	CASTOR1	D190V	-3.80641652			Q8WTX7							
gdsc	Rapamycin	CASTOR1	R165C	-3.360787408			Q8WTX7							
gdsc	Rapamycin	CASTOR1	H168R	-3.662218174			Q8WTX7							
gdsc	Rapamycin	CASTOR1	D242N	-3.441422805			Q8WTX7							
gdsc	Rapamycin	CASTOR1	D190V	-2.983301308			Q8WTX7							
gdsc	Rapamycin	CASTOR1	Y236C	-2.672180891			Q8WTX7							
gdsc	Rapamycin	CASTOR1	K213E	-3.098684595			Q8WTX7							
gdsc	Rapamycin	CASTOR1	E146K	-2.63359951			Q8WTX7							
gdsc	Rapamycin	CASTOR1	P170S	-2.962007842			Q8WTX7							
gdsc	Rapamycin	CASTOR1	R126Q	-2.3088094740000003			Q8WTX7							
gdsc	Rapamycin	CASTOR1	Q181*	-3.219448393			Q8WTX7							
gdsc	Rapamycin	CASTOR1	R99C	-1.683797691			Q8WTX7							
gdsc	Rapamycin	CASTOR1	H168R	-2.161840593			Q8WTX7							
gdsc	BDP-00009066	CDC42BPB	A1455V	-0.50403152			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R745*	-0.33308485600000004			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	V1156M	0.336508233			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	V1090M	-1.275919471			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	Y1306C	-1.248028251			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	M1444T	-0.88561303			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	I887N	-0.821791165			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	V372M	0.078851426			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	V666G	-0.538584045			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	N1219Y	-0.78760835			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	S1190N	-0.614680417			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R326H	-1.003493797			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R570Q	-0.7053910179999999			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	H962R	-0.533492824			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	V1121I	-0.727568907			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R570Q	-0.691206933			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R644H	-0.292803595			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	M274L	-0.5363397129999999			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	I1294T	-0.427632388			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	F336L	-0.994962609			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	Q817H	2.280772428			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	Q301*	-0.311195507			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	E1433Q	0.6054311379999999			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	G1374S	0.115612142			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	D503V	-0.727572462			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	E1356D	-0.235637111			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	E752K	-0.197063984			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	E750K	-0.6941918709999999			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	A355T	-0.536605739			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R583H	-0.570948525			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	D241H	0.149706678			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	D411N	0.67031829			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	L1239P	0.255436767			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	P985S	0.250877004			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	S1415L	-0.268760564			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	V1651M	-0.428413283			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	A1532V	-0.705380353			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	K96N	1.170290697			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	M1595T	-0.426780395			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	S1060F+D939E	-0.039787129			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	M184V	-0.5340610170000001			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	H1591N	-0.402631309			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R570Q	-0.411055257			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R671Q	0.501951306			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	S1434N	-0.496772989			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	A1593T	-0.5316815979999999			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	G1389D	-0.227344102			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	R1289W+L490R	0.407195219			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	G670D	-0.25956934800000003			Q9Y5S2							
gdsc	BDP-00009066	CDC42BPB	E297A	-1.317501829			Q9Y5S2							
gdsc	RO-3306	CDK1	R59C	1.019119397			P06493							
gdsc	RO-3306	CDK1	S233Y	-0.769664833			P06493							
gdsc	RO-3306	CDK1	A250V	0.024852958			P06493							
gdsc	RO-3306	CDK1	*298W	0.46244857			P06493							
gdsc	RO-3306	CDK1	G177R	-0.135623315			P06493							
gdsc	RO-3306	CDK1	S178L	0.887552825			P06493							
gdsc	RO-3306	CDK1	P95S	0.7668346490000001			P06493							
gdsc	RO-3306	CDK1	L282R	0.371168591			P06493							
gdsc	RO-3306	CDK1	S248N	0.585289026			P06493							
gdsc	THZ-2-102-1	CDK7	F276delF	-3.4298391360000005			P50613							
gdsc	THZ-2-102-1	CDK7	I133T	-4.743546692			P50613							
gdsc	THZ-2-102-1	CDK7	M196V	-3.876583305			P50613							
gdsc	THZ-2-102-1	CDK7	L206S	-3.869403575			P50613							
gdsc	THZ-2-102-1	CDK7	D216N	-3.6024637160000004			P50613							
gdsc	THZ-2-102-1	CDK7	L271V	-0.151970562			P50613							
gdsc	THZ-2-102-1	CDK7	R209M	-2.041565004			P50613							
gdsc	THZ-2-102-1	CDK7	M240I	-2.072277043			P50613							
gdsc	CDK9_5038	CDK9	L165P	-4.855096167			P50750							
gdsc	CDK9_5038	CDK9	D323N+F336L	-4.441995652			P50750							
gdsc	CDK9_5038	CDK9	R358S	-3.386581232			P50750							
gdsc	CDK9_5038	CDK9	R358C	-3.225675407			P50750							
gdsc	CDK9_5038	CDK9	D14N+D285N	-3.717291409			P50750							
gdsc	CDK9_5038	CDK9	S226N	-3.525757085			P50750							
gdsc	CDK9_5038	CDK9	D290Y	-3.3575714010000004			P50750							
gdsc	CDK9_5038	CDK9	A361T	-3.165005561			P50750							
gdsc	CDK9_5038	CDK9	K3N	-0.36996407			P50750							
gdsc	CDK9_5038	CDK9	A340T	-2.822480645			P50750							
gdsc	CDK9_5038	CDK9	S347C	-3.610351466000001			P50750							
gdsc	CDK9_5038	CDK9	A239T	-3.285444677			P50750							
gdsc	CDK9_5038	CDK9	E9K	-2.39602671			P50750							
gdsc	CDK9_5038	CDK9	R184C	-2.990683512			P50750							
gdsc	CDK9_5038	CDK9	F30L	-0.969626183			P50750							
gdsc	CDK9_5576	CDK9	L165P	-3.51819935			P50750							
gdsc	CDK9_5576	CDK9	D323N+F336L	-2.7888452860000004			P50750							
gdsc	CDK9_5576	CDK9	R358S	-2.479745398			P50750							
gdsc	CDK9_5576	CDK9	R358C	-2.273640096			P50750							
gdsc	CDK9_5576	CDK9	D14N+D285N	-2.197121876			P50750							
gdsc	CDK9_5576	CDK9	S226N	-2.549873671			P50750							
gdsc	CDK9_5576	CDK9	D290Y	-2.42021253			P50750							
gdsc	CDK9_5576	CDK9	A361T	-1.768532625			P50750							
gdsc	CDK9_5576	CDK9	K3N	0.560875692			P50750							
gdsc	CDK9_5576	CDK9	A340T	-1.62153301			P50750							
gdsc	CDK9_5576	CDK9	S347C	-2.262288089			P50750							
gdsc	CDK9_5576	CDK9	A239T	-1.671304692			P50750							
gdsc	CDK9_5576	CDK9	E9K	-1.854473723			P50750							
gdsc	CDK9_5576	CDK9	R184C	-2.018830179			P50750							
gdsc	CDK9_5576	CDK9	F30L	-0.342900551			P50750							
gdsc	KIN001-270	CDK9	L165P	0.364852704			P50750							
gdsc	KIN001-270	CDK9	D323N+F336L	0.252626612			P50750							
gdsc	KIN001-270	CDK9	R358S	-0.018880712			P50750							
gdsc	KIN001-270	CDK9	A288T	1.327987624			P50750							
gdsc	KIN001-270	CDK9	D14N+D285N	0.485703004			P50750							
gdsc	KIN001-270	CDK9	S226N	0.966747892			P50750							
gdsc	KIN001-270	CDK9	D290Y	1.128794842			P50750							
gdsc	KIN001-270	CDK9	A361T	0.817594003			P50750							
gdsc	KIN001-270	CDK9	K3N	0.8050042940000001			P50750							
gdsc	KIN001-270	CDK9	G216R	0.402814979			P50750							
gdsc	KIN001-270	CDK9	A340T	0.926979723			P50750							
gdsc	KIN001-270	CDK9	S347C	1.592366763			P50750							
gdsc	KIN001-270	CDK9	Y19H	1.145451959			P50750							
gdsc	KIN001-270	CDK9	A239T	1.3702323790000002			P50750							
gdsc	KIN001-270	CDK9	E9K	1.262017409			P50750							
gdsc	KIN001-270	CDK9	R184C	1.607591844			P50750							
gdsc	KIN001-270	CDK9	F30L	1.673354096			P50750							
gdsc	THZ-2-49	CDK9	L165P	1.248652138			P50750							
gdsc	THZ-2-49	CDK9	D323N+F336L	-1.793347664			P50750							
gdsc	THZ-2-49	CDK9	A288T	1.547889525			P50750							
gdsc	THZ-2-49	CDK9	D14N+D285N	-1.934767849			P50750							
gdsc	THZ-2-49	CDK9	S226N	-1.269824581			P50750							
gdsc	THZ-2-49	CDK9	D290Y	-0.912138573			P50750							
gdsc	THZ-2-49	CDK9	A361T	-0.8052300309999999			P50750							
gdsc	THZ-2-49	CDK9	K3N	-0.245209887			P50750							
gdsc	THZ-2-49	CDK9	G216R	1.496554869			P50750							
gdsc	THZ-2-49	CDK9	A340T	-0.036575861			P50750							
gdsc	THZ-2-49	CDK9	S347C	0.155927767			P50750							
gdsc	THZ-2-49	CDK9	Y19H	1.056977988			P50750							
gdsc	THZ-2-49	CDK9	A239T	1.535225756			P50750							
gdsc	THZ-2-49	CDK9	E9K	1.502621912			P50750							
gdsc	THZ-2-49	CDK9	R184C	-0.956135305			P50750							
gdsc	THZ-2-49	CDK9	F30L	1.86177195			P50750							
gdsc	AZD7762	CHEK1	Y173H	-2.256352048			O14757							
gdsc	AZD7762	CHEK1	A253D	-2.155163042			O14757							
gdsc	Lenalidomide	CRBN	Q297*	0.307665483			Q96SW2							
gdsc	Lenalidomide	CRBN	R295*	0.277627098			Q96SW2							
gdsc	Lenalidomide	CRBN	E30K	0.972948838			Q96SW2							
gdsc	Lenalidomide	CRBN	E30K	0.875686541			Q96SW2							
gdsc	Lenalidomide	CRBN	E187K	0.620841074			Q96SW2							
gdsc	Lenalidomide	CRBN	T51A	0.53851117			Q96SW2							
gdsc	Lenalidomide	CRBN	D313H	1.113993388			Q96SW2							
gdsc	Lenalidomide	CRBN	P345S	0.465408031			Q96SW2							
gdsc	Lenalidomide	CRBN	M109I	0.462892341			Q96SW2							
gdsc	Lenalidomide	CRBN	W223*	-0.158637793			Q96SW2							
gdsc	Lenalidomide	CRBN	E30K	0.601199019			Q96SW2							
gdsc	Lenalidomide	CRBN	G383V	0.8429215409999999			Q96SW2							
gdsc	Lenalidomide	CRBN	G69D	0.6445209120000001			Q96SW2							
gdsc	Lenalidomide	CRBN	K204E	0.216587541			Q96SW2							
gdsc	Lenalidomide	CRBN	G151A	0.270248886			Q96SW2							
gdsc	Lenalidomide	CRBN	R373Q	0.413951323			Q96SW2							
gdsc	Lenalidomide	CRBN	E30K	0.683937737			Q96SW2							
gdsc	Lenalidomide	CRBN	P424L	0.576231119			Q96SW2							
gdsc	Lenalidomide	CRBN	G354*	1.116214613			Q96SW2							
gdsc	Lenalidomide	CRBN	W224delW	0.373486984			Q96SW2							
gdsc	Lenalidomide	CRBN	E30K	0.019609468			Q96SW2							
gdsc	Lenalidomide	CRBN	S379N	0.08646663199999999			Q96SW2							
gdsc	Lenalidomide	CRBN	E30K	0.910151971			Q96SW2							
gdsc	Lenalidomide	CRBN	V33F	0.3691790270000001			Q96SW2							
gdsc	Lenalidomide	CRBN	E30K	0.99636502			Q96SW2							
gdsc	GW-2580	CSF1R	E694K	1.591459669			P07333							
gdsc	GW-2580	CSF1R	A245S	1.289133066			P07333							
gdsc	GW-2580	CSF1R	V279M	1.601634409			P07333							
gdsc	GW-2580	CSF1R	A245S	1.059235355			P07333							
gdsc	GW-2580	CSF1R	V279M	1.630014429			P07333							
gdsc	GW-2580	CSF1R	S938G+S937_S938insGS	1.25168803			P07333							
gdsc	GW-2580	CSF1R	A792P	1.446751193			P07333							
gdsc	GW-2580	CSF1R	R106Q	1.966497185			P07333							
gdsc	GW-2580	CSF1R	N241D	1.5729771069999998			P07333							
gdsc	GW-2580	CSF1R	R486S	1.547012055			P07333							
gdsc	GW-2580	CSF1R	A14T	1.53710808			P07333							
gdsc	GW-2580	CSF1R	N241D	1.770236018			P07333							
gdsc	GW-2580	CSF1R	R710H	1.607458535			P07333							
gdsc	GW-2580	CSF1R	P90T	1.690560446			P07333							
gdsc	GW-2580	CSF1R	R753W	1.5805324719999998			P07333							
gdsc	GW-2580	CSF1R	Y571D	-2.736351729			P07333							
gdsc	GW-2580	CSF1R	V279M	1.575035991			P07333							
gdsc	GW-2580	CSF1R	G377D	1.2784227190000002			P07333							
gdsc	GW-2580	CSF1R	V279M	1.7789366569999998			P07333							
gdsc	GW-2580	CSF1R	A245S	1.358889851			P07333							
gdsc	GW-2580	CSF1R	P510A	1.716310426			P07333							
gdsc	GW-2580	CSF1R	V279M	1.459701724			P07333							
gdsc	GW-2580	CSF1R	V659A	1.30773057			P07333							
gdsc	GW-2580	CSF1R	A245S	1.178503721			P07333							
gdsc	GW-2580	CSF1R	V279M	0.932289571			P07333							
gdsc	GW-2580	CSF1R	V279M	1.057599504			P07333							
gdsc	GW-2580	CSF1R	V279M	1.860652747			P07333							
gdsc	GW-2580	CSF1R	E920D+S188P	1.207837048			P07333							
gdsc	GW-2580	CSF1R	V279M	0.854866626			P07333							
gdsc	GW-2580	CSF1R	V279M	1.459829701			P07333							
gdsc	GW-2580	CSF1R	V279M	1.879566637			P07333							
gdsc	GW-2580	CSF1R	H623Y	2.001401647			P07333							
gdsc	GW-2580	CSF1R	G589E+D358N	1.751462546			P07333							
gdsc	GW-2580	CSF1R	V279M	0.99335816			P07333							
gdsc	GW-2580	CSF1R	G747R	1.5586763019999998			P07333							
gdsc	GW-2580	CSF1R	C972Y	1.481243878			P07333							
gdsc	GW-2580	CSF1R	V279M	1.929110805			P07333							
gdsc	GW-2580	CSF1R	V279M	1.797493279			P07333							
gdsc	GW-2580	CSF1R	A245S	1.695463257			P07333							
gdsc	GW-2580	CSF1R	Q970*	1.331257547			P07333							
gdsc	GW-2580	CSF1R	V279M	1.801578462			P07333							
gdsc	GW-2580	CSF1R	E920D	1.472769568			P07333							
gdsc	GW-2580	CSF1R	R710H	1.398892052			P07333							
gdsc	GW-2580	CSF1R	V279M	1.805437315			P07333							
gdsc	GW-2580	CSF1R	E920D	-0.748090209			P07333							
gdsc	GW-2580	CSF1R	Q460H	1.249206704			P07333							
gdsc	GW-2580	CSF1R	R256H	1.38504746			P07333							
gdsc	GW-2580	CSF1R	G747R	1.673249819			P07333							
gdsc	GW-2580	CSF1R	I827N	1.878011957			P07333							
gdsc	GW-2580	CSF1R	G714S+P517T	2.15302679			P07333							
gdsc	GW-2580	CSF1R	E920D	1.562558855			P07333							
gdsc	GW-2580	CSF1R	L207P	1.631900308			P07333							
gdsc	GW-2580	CSF1R	P90T	2.142868639			P07333							
gdsc	GW-2580	CSF1R	P202S	1.17075165			P07333							
gdsc	GW-2580	CSF1R	E664G	0.918008911			P07333							
gdsc	GW-2580	CSF1R	A245S	1.984376598			P07333							
gdsc	GW-2580	CSF1R	G747R	1.735090415			P07333							
gdsc	GW-2580	CSF1R	M726I	2.1495891940000003			P07333							
gdsc	GW-2580	CSF1R	G690S+A245S	1.370227639			P07333							
gdsc	GW-2580	CSF1R	V279M	1.784152893			P07333							
gdsc	GW-2580	CSF1R	V279M	0.742507818			P07333							
gdsc	GW-2580	CSF1R	V279M	1.688468382			P07333							
gdsc	GW-2580	CSF1R	A245S	2.021530132			P07333							
gdsc	GW-2580	CSF1R	V279M	1.916304247			P07333							
gdsc	GW-2580	CSF1R	A245S	1.4561734780000002			P07333							
gdsc	GW-2580	CSF1R	E944Q+P90T	1.553785341			P07333							
gdsc	GW-2580	CSF1R	V279M	1.523452491			P07333							
gdsc	GW-2580	CSF1R	E920D	1.670878695			P07333							
gdsc	GW-2580	CSF1R	V279M	1.328226395			P07333							
gdsc	GW-2580	CSF1R	V279M	0.961240154			P07333							
gdsc	GW-2580	CSF1R	V279M	1.670874548			P07333							
gdsc	GW-2580	CSF1R	A960T	2.097619394			P07333							
gdsc	GW-2580	CSF1R	G145D	0.940631757			P07333							
gdsc	GW-2580	CSF1R	L536V	0.95198495			P07333							
gdsc	GW-2580	CSF1R	V279M	1.287993718			P07333							
gdsc	GW-2580	CSF1R	V279M	2.229940791			P07333							
gdsc	GW-2580	CSF1R	T600M	0.8302062259999999			P07333							
gdsc	GW-2580	CSF1R	D89N	1.565611336			P07333							
gdsc	GW-2580	CSF1R	V279M	1.694019372			P07333							
gdsc	GW-2580	CSF1R	V315L+R106L	1.189961783			P07333							
gdsc	GW-2580	CSF1R	V279M	1.7806240530000002			P07333							
gdsc	GW-2580	CSF1R	V279M	1.650936251			P07333							
gdsc	GW-2580	CSF1R	V279M	1.237860621			P07333							
gdsc	QL-XI-92	DDR1	R276Q	0.830363827			Q08345							
gdsc	QL-XI-92	DDR1	F670L	0.6019378479999999			Q08345							
gdsc	QL-XI-92	DDR1	S17G	-0.131093177			Q08345							
gdsc	QL-XI-92	DDR1	R248W	0.8471903940000001			Q08345							
gdsc	QL-XI-92	DDR1	F241L	0.646573279			Q08345							
gdsc	QL-XI-92	DDR1	V832M	1.100398825			Q08345							
gdsc	QL-XI-92	DDR1	R349C	1.407221202			Q08345							
gdsc	QL-XI-92	DDR1	R60C	0.257055435			Q08345							
gdsc	QL-XI-92	DDR1	R319C	-0.442601515			Q08345							
gdsc	QL-XI-92	DDR1	S17G	0.064112183			Q08345							
gdsc	QL-XI-92	DDR1	R488Q	1.167094242			Q08345							
gdsc	QL-XI-92	DDR1	T292M	1.151881603			Q08345							
gdsc	QL-XI-92	DDR1	D367_V369delinsE	0.888103836			Q08345							
gdsc	QL-XI-92	DDR1	R761C	1.213859063			Q08345							
gdsc	QL-XI-92	DDR1	D801E	0.23375064			Q08345							
gdsc	QL-XI-92	DDR1	P43T	1.387808439			Q08345							
gdsc	QL-XI-92	DDR1	P812L	0.040857749			Q08345							
gdsc	QL-XI-92	DDR1	R692L	-0.319283516			Q08345							
gdsc	QL-XI-92	DDR1	H25R	-0.452738929			Q08345							
gdsc	QL-XI-92	DDR1	R248Q	0.407236693			Q08345							
gdsc	QL-XI-92	DDR1	V100A	1.222538372			Q08345							
gdsc	QL-XI-92	DDR1	T827M	-0.179240265			Q08345							
gdsc	QL-XI-92	DDR1	Q755*	0.042652977			Q08345							
gdsc	QL-XI-92	DDR1	L685P	0.911888544			Q08345							
gdsc	QL-XI-92	DDR1	R868W	1.267934554			Q08345							
gdsc	QL-XI-92	DDR1	C185W	1.827979582			Q08345							
gdsc	QL-XI-92	DDR1	R172W	0.8365807690000001			Q08345							
gdsc	QL-XI-92	DDR1	V454M	1.122733723			Q08345							
gdsc	QL-XI-92	DDR1	R444C	1.175028797			Q08345							
gdsc	QL-XI-92	DDR1	S360R	-1.09099787			Q08345							
gdsc	QL-XI-92	DDR1	S17G	-0.56142611			Q08345							
gdsc	QL-XI-92	DDR1	D630E	0.491821594			Q08345							
gdsc	QL-XI-92	DDR1	C185W	0.40998997			Q08345							
gdsc	QL-XI-92	DDR1	A59G	0.032773887			Q08345							
gdsc	QL-XI-92	DDR1	L557R	-0.237850634			Q08345							
gdsc	QL-XI-92	DDR1	F670L	-1.500408982			Q08345							
gdsc	QL-XI-92	DDR1	R135C	-0.522858315			Q08345							
gdsc	QL-XI-92	DDR1	M311V	0.80324817			Q08345							
gdsc	QL-XI-92	DDR1	G108R+R761H	0.418745709			Q08345							
gdsc	QL-XI-92	DDR1	A353V	1.4046829980000002			Q08345							
gdsc	QL-XI-92	DDR1	F670L	0.760080323			Q08345							
gdsc	QL-XI-92	DDR1	R248W	0.384354339			Q08345							
gdsc	QL-XI-92	DDR1	R525Q	0.954604325			Q08345							
gdsc	QL-XI-92	DDR1	I690T	1.281500085			Q08345							
gdsc	QL-XI-92	DDR1	P381S	1.894833192			Q08345							
gdsc	QL-XI-92	DDR1	R307H	1.084451506			Q08345							
gdsc	QL-XI-92	DDR1	R440L	1.041061477			Q08345							
gdsc	QL-XI-92	DDR1	R248Q	0.92992615			Q08345							
gdsc	QL-XI-92	DDR1	A196S	1.114667043			Q08345							
gdsc	QL-XI-92	DDR1	T827M	1.06952089			Q08345							
gdsc	QL-XI-92	DDR1	W187C	0.772501766			Q08345							
gdsc	Pyrimethamine	DHFR	A125V	1.996395743			P00374							
gdsc	Pyrimethamine	DHFR	T57A	0.410211559			P00374							
gdsc	Pyrimethamine	DHFR	I176T	0.282034592			P00374							
gdsc	EPZ004777	DOT1L	A1053T	2.018757303			Q8TEK3							
gdsc	EPZ004777	DOT1L	K521delK	1.28122221			Q8TEK3							
gdsc	EPZ004777	DOT1L	S997L	1.655759669			Q8TEK3							
gdsc	EPZ004777	DOT1L	P474L	1.556008936			Q8TEK3							
gdsc	EPZ004777	DOT1L	S1407R	1.558736736			Q8TEK3							
gdsc	EPZ004777	DOT1L	K333E	0.8237819140000001			Q8TEK3							
gdsc	EPZ004777	DOT1L	G1452_A1458delGGAASSA	1.905827339			Q8TEK3							
gdsc	EPZ004777	DOT1L	S1299T	0.810512033			Q8TEK3							
gdsc	EPZ004777	DOT1L	T100M	0.931162665			Q8TEK3							
gdsc	EPZ004777	DOT1L	R411L	1.251159533			Q8TEK3							
gdsc	EPZ004777	DOT1L	A897V+A1335T	0.530143508			Q8TEK3							
gdsc	EPZ004777	DOT1L	F243L+T984M	1.602351909			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1475T	1.376196331			Q8TEK3							
gdsc	EPZ004777	DOT1L	A528V	1.117080234			Q8TEK3							
gdsc	EPZ004777	DOT1L	E1343K	1.048464574			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1530V	1.552035141			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1475T	1.6528979680000002			Q8TEK3							
gdsc	EPZ004777	DOT1L	A687V	1.257442834			Q8TEK3							
gdsc	EPZ004777	DOT1L	T790M	0.709235651			Q8TEK3							
gdsc	EPZ004777	DOT1L	Q745P	0.521570846			Q8TEK3							
gdsc	EPZ004777	DOT1L	T1403S	1.1939954190000002			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1475T	0.967800738			Q8TEK3							
gdsc	EPZ004777	DOT1L	P479T	1.315359404			Q8TEK3							
gdsc	EPZ004777	DOT1L	K1203N	1.057778435			Q8TEK3							
gdsc	EPZ004777	DOT1L	T306M	1.551168928			Q8TEK3							
gdsc	EPZ004777	DOT1L	R231L	1.951111541			Q8TEK3							
gdsc	EPZ004777	DOT1L	G1453S	0.468419631			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1475T	2.052485683			Q8TEK3							
gdsc	EPZ004777	DOT1L	G836V	0.91270795			Q8TEK3							
gdsc	EPZ004777	DOT1L	A376G+G926W+A935V+A1364T	0.959187787			Q8TEK3							
gdsc	EPZ004777	DOT1L	S1152N	2.447241092			Q8TEK3							
gdsc	EPZ004777	DOT1L	T1317I	1.3920257459999998			Q8TEK3							
gdsc	EPZ004777	DOT1L	A717S	1.226160232			Q8TEK3							
gdsc	EPZ004777	DOT1L	Y58*	1.781440497			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1522T	1.5942982630000002			Q8TEK3							
gdsc	EPZ004777	DOT1L	S1083R	0.602946849			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1454T	1.558249713			Q8TEK3							
gdsc	EPZ004777	DOT1L	S304L	0.895938262			Q8TEK3							
gdsc	EPZ004777	DOT1L	S132F+H1339Y	1.75356883			Q8TEK3							
gdsc	EPZ004777	DOT1L	P389T	1.065302399			Q8TEK3							
gdsc	EPZ004777	DOT1L	G1453S	1.00024935			Q8TEK3							
gdsc	EPZ004777	DOT1L	R1011W+A1335V	0.8066798409999999			Q8TEK3							
gdsc	EPZ004777	DOT1L	G165C	1.561076458			Q8TEK3							
gdsc	EPZ004777	DOT1L	G1453S	2.254924096			Q8TEK3							
gdsc	EPZ004777	DOT1L	P709Q	1.598371003			Q8TEK3							
gdsc	EPZ004777	DOT1L	V1418F	0.27915511600000004			Q8TEK3							
gdsc	EPZ004777	DOT1L	G1536R	1.966141694			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1475T	1.314278712			Q8TEK3							
gdsc	EPZ004777	DOT1L	I85T+A1000T	1.48599442			Q8TEK3							
gdsc	EPZ004777	DOT1L	E47V+I48F	0.8871416409999999			Q8TEK3							
gdsc	EPZ004777	DOT1L	R1091*	1.296546828			Q8TEK3							
gdsc	EPZ004777	DOT1L	A777D+R782K	0.960987163			Q8TEK3							
gdsc	EPZ004777	DOT1L	K1255N	0.609823227			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1475T	1.649777943			Q8TEK3							
gdsc	EPZ004777	DOT1L	Q443E	1.4359501959999998			Q8TEK3							
gdsc	EPZ004777	DOT1L	K1255N	1.194025636			Q8TEK3							
gdsc	EPZ004777	DOT1L	T93M	1.7573554			Q8TEK3							
gdsc	EPZ004777	DOT1L	T1184A	1.78755968			Q8TEK3							
gdsc	EPZ004777	DOT1L	T1051A+R1276Q	1.439267518			Q8TEK3							
gdsc	EPZ004777	DOT1L	A483T	1.21699627			Q8TEK3							
gdsc	EPZ004777	DOT1L	P298S	1.679091719			Q8TEK3							
gdsc	EPZ004777	DOT1L	S1059L	2.514393314			Q8TEK3							
gdsc	EPZ004777	DOT1L	A1475T	1.305512307			Q8TEK3							
gdsc	EPZ004777	DOT1L	W208C	1.321785493			Q8TEK3							
gdsc	EPZ004777	DOT1L	F1318C	1.632216695			Q8TEK3							
gdsc	EPZ004777	DOT1L	A854T	2.098362369			Q8TEK3							
gdsc	EPZ004777	DOT1L	M713V	0.258510578			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1053T	2.344508383			Q8TEK3							
gdsc	EPZ5676	DOT1L	K521delK	1.290448975			Q8TEK3							
gdsc	EPZ5676	DOT1L	S997L	2.099282498			Q8TEK3							
gdsc	EPZ5676	DOT1L	P474L	1.715826958			Q8TEK3							
gdsc	EPZ5676	DOT1L	S1407R	2.135977449			Q8TEK3							
gdsc	EPZ5676	DOT1L	K333E	1.459468878			Q8TEK3							
gdsc	EPZ5676	DOT1L	G1452_A1458delGGAASSA	2.250593625			Q8TEK3							
gdsc	EPZ5676	DOT1L	S1299T	1.83378534			Q8TEK3							
gdsc	EPZ5676	DOT1L	T100M	1.688016909			Q8TEK3							
gdsc	EPZ5676	DOT1L	R411L	1.158304138			Q8TEK3							
gdsc	EPZ5676	DOT1L	A897V+A1335T	0.872135187			Q8TEK3							
gdsc	EPZ5676	DOT1L	F243L+T984M	1.341733863			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1475T	1.802066669			Q8TEK3							
gdsc	EPZ5676	DOT1L	A528V	1.389706168			Q8TEK3							
gdsc	EPZ5676	DOT1L	E1343K	0.998889598			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1530V	2.060643013			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1475T	1.894400678			Q8TEK3							
gdsc	EPZ5676	DOT1L	A687V	1.181201896			Q8TEK3							
gdsc	EPZ5676	DOT1L	T790M	0.985927216			Q8TEK3							
gdsc	EPZ5676	DOT1L	Q745P	1.07381285			Q8TEK3							
gdsc	EPZ5676	DOT1L	T1403S	1.6635229969999998			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1475T	1.127452864			Q8TEK3							
gdsc	EPZ5676	DOT1L	P479T	1.621262837			Q8TEK3							
gdsc	EPZ5676	DOT1L	K1203N	1.126822461			Q8TEK3							
gdsc	EPZ5676	DOT1L	T306M	2.049241236			Q8TEK3							
gdsc	EPZ5676	DOT1L	R231L	2.071894891			Q8TEK3							
gdsc	EPZ5676	DOT1L	G1453S	1.162349031			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1475T	1.723141183			Q8TEK3							
gdsc	EPZ5676	DOT1L	G836V	0.8917754640000001			Q8TEK3							
gdsc	EPZ5676	DOT1L	A376G+G926W+A935V+A1364T	0.559788482			Q8TEK3							
gdsc	EPZ5676	DOT1L	S1152N	2.571140911			Q8TEK3							
gdsc	EPZ5676	DOT1L	T1317I	1.5684908119999998			Q8TEK3							
gdsc	EPZ5676	DOT1L	A717S	1.827651346			Q8TEK3							
gdsc	EPZ5676	DOT1L	Y58*	1.723299376			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1522T	1.717537462			Q8TEK3							
gdsc	EPZ5676	DOT1L	S1083R	1.289544251			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1454T	1.378523018			Q8TEK3							
gdsc	EPZ5676	DOT1L	S304L	1.508957352			Q8TEK3							
gdsc	EPZ5676	DOT1L	S132F+H1339Y	1.84663515			Q8TEK3							
gdsc	EPZ5676	DOT1L	P389T	2.452585304			Q8TEK3							
gdsc	EPZ5676	DOT1L	G1453S	1.360532219			Q8TEK3							
gdsc	EPZ5676	DOT1L	R1011W+A1335V	1.696839007			Q8TEK3							
gdsc	EPZ5676	DOT1L	G165C	1.555364905			Q8TEK3							
gdsc	EPZ5676	DOT1L	G1453S	2.854193984			Q8TEK3							
gdsc	EPZ5676	DOT1L	P709Q	2.19936206			Q8TEK3							
gdsc	EPZ5676	DOT1L	V1418F	0.369976512			Q8TEK3							
gdsc	EPZ5676	DOT1L	G1536R	1.989016346			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1475T	1.314278712			Q8TEK3							
gdsc	EPZ5676	DOT1L	I85T+A1000T	1.13860165			Q8TEK3							
gdsc	EPZ5676	DOT1L	E47V+I48F	0.8543061359999999			Q8TEK3							
gdsc	EPZ5676	DOT1L	R1091*	1.670397005			Q8TEK3							
gdsc	EPZ5676	DOT1L	A777D+R782K	0.931603474			Q8TEK3							
gdsc	EPZ5676	DOT1L	K1255N	0.6316930239999999			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1475T	1.957255608			Q8TEK3							
gdsc	EPZ5676	DOT1L	Q443E	1.250341312			Q8TEK3							
gdsc	EPZ5676	DOT1L	K1255N	1.4873707619999998			Q8TEK3							
gdsc	EPZ5676	DOT1L	T93M	1.761232027			Q8TEK3							
gdsc	EPZ5676	DOT1L	T1184A	1.816253124			Q8TEK3							
gdsc	EPZ5676	DOT1L	T1051A+R1276Q	1.567597938			Q8TEK3							
gdsc	EPZ5676	DOT1L	A483T	1.206765836			Q8TEK3							
gdsc	EPZ5676	DOT1L	P298S	1.793300857			Q8TEK3							
gdsc	EPZ5676	DOT1L	S1059L	2.726918187			Q8TEK3							
gdsc	EPZ5676	DOT1L	A1475T	1.320018111			Q8TEK3							
gdsc	EPZ5676	DOT1L	W208C	1.448740756			Q8TEK3							
gdsc	EPZ5676	DOT1L	F1318C	1.972547047			Q8TEK3							
gdsc	EPZ5676	DOT1L	A854T	1.393786018			Q8TEK3							
gdsc	EPZ5676	DOT1L	M713V	0.577463487			Q8TEK3							
gdsc	SGC0946	DOT1L	A1053T	-0.35704257			Q8TEK3							
gdsc	SGC0946	DOT1L	K521delK	-0.66732565			Q8TEK3							
gdsc	SGC0946	DOT1L	S997L	-0.464052426			Q8TEK3							
gdsc	SGC0946	DOT1L	P474L	-0.518257671			Q8TEK3							
gdsc	SGC0946	DOT1L	S1407R	-0.816963599			Q8TEK3							
gdsc	SGC0946	DOT1L	K333E	-0.526316649			Q8TEK3							
gdsc	SGC0946	DOT1L	G1452_A1458delGGAASSA	-0.218466311			Q8TEK3							
gdsc	SGC0946	DOT1L	Y738*	-0.5417011079999999			Q8TEK3							
gdsc	SGC0946	DOT1L	S1299T	-0.181656418			Q8TEK3							
gdsc	SGC0946	DOT1L	T100M	-0.398615447			Q8TEK3							
gdsc	SGC0946	DOT1L	R411L	-0.80733039			Q8TEK3							
gdsc	SGC0946	DOT1L	A897V+A1335T	-0.865973938			Q8TEK3							
gdsc	SGC0946	DOT1L	F243L+T984M	-0.145071077			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.158705336			Q8TEK3							
gdsc	SGC0946	DOT1L	A528V	-0.6145328879999999			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.582853321			Q8TEK3							
gdsc	SGC0946	DOT1L	E1343K	-0.8858281020000001			Q8TEK3							
gdsc	SGC0946	DOT1L	A1530V	-0.487539706			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.47485994			Q8TEK3							
gdsc	SGC0946	DOT1L	A687V	-0.577061783			Q8TEK3							
gdsc	SGC0946	DOT1L	T790M	-1.08933358			Q8TEK3							
gdsc	SGC0946	DOT1L	Q745P	-1.253482074			Q8TEK3							
gdsc	SGC0946	DOT1L	T1403S	-0.445792046			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.757952118			Q8TEK3							
gdsc	SGC0946	DOT1L	P479T	-1.066947729			Q8TEK3							
gdsc	SGC0946	DOT1L	K1203N	-2.084988211			Q8TEK3							
gdsc	SGC0946	DOT1L	T306M	-1.019425119			Q8TEK3							
gdsc	SGC0946	DOT1L	R231L	-0.627727524			Q8TEK3							
gdsc	SGC0946	DOT1L	G1453S	-0.821691628			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.99597635			Q8TEK3							
gdsc	SGC0946	DOT1L	G1453S	-0.450041939			Q8TEK3							
gdsc	SGC0946	DOT1L	G836V	-0.970973494			Q8TEK3							
gdsc	SGC0946	DOT1L	A376G+G926W+A935V+A1364T	-0.912732835			Q8TEK3							
gdsc	SGC0946	DOT1L	S1152N	-0.7620746270000001			Q8TEK3							
gdsc	SGC0946	DOT1L	T1317I	-2.493497561			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.757517826			Q8TEK3							
gdsc	SGC0946	DOT1L	A717S	-0.222101205			Q8TEK3							
gdsc	SGC0946	DOT1L	Y58*	-0.492438963			Q8TEK3							
gdsc	SGC0946	DOT1L	S1083R	-0.79973118			Q8TEK3							
gdsc	SGC0946	DOT1L	A1454T	-1.169148386			Q8TEK3							
gdsc	SGC0946	DOT1L	S304L	-2.017369111			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.829556863			Q8TEK3							
gdsc	SGC0946	DOT1L	S132F+H1339Y	-0.275136885			Q8TEK3							
gdsc	SGC0946	DOT1L	P389T	-0.973037118			Q8TEK3							
gdsc	SGC0946	DOT1L	G1453S	-0.832397827			Q8TEK3							
gdsc	SGC0946	DOT1L	G1453S	-0.657483293			Q8TEK3							
gdsc	SGC0946	DOT1L	R1011W+A1335V	-0.745284794			Q8TEK3							
gdsc	SGC0946	DOT1L	G1453S	-0.168832085			Q8TEK3							
gdsc	SGC0946	DOT1L	G165C	-0.961048189			Q8TEK3							
gdsc	SGC0946	DOT1L	P709Q	-0.174676355			Q8TEK3							
gdsc	SGC0946	DOT1L	V1418F	-0.8105932029999999			Q8TEK3							
gdsc	SGC0946	DOT1L	G1536R	-0.218790992			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.977948817			Q8TEK3							
gdsc	SGC0946	DOT1L	I85T+A1000T	-0.75748524			Q8TEK3							
gdsc	SGC0946	DOT1L	G594S	-0.5033513470000001			Q8TEK3							
gdsc	SGC0946	DOT1L	V441M	-1.028711133			Q8TEK3							
gdsc	SGC0946	DOT1L	G1095R	-0.397648512			Q8TEK3							
gdsc	SGC0946	DOT1L	E47V+I48F	-0.760685842			Q8TEK3							
gdsc	SGC0946	DOT1L	R1091*	-0.615400286			Q8TEK3							
gdsc	SGC0946	DOT1L	A777D+R782K	-1.2916398690000002			Q8TEK3							
gdsc	SGC0946	DOT1L	K1255N	-0.853442885			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.682476078			Q8TEK3							
gdsc	SGC0946	DOT1L	P752S	-0.184400215			Q8TEK3							
gdsc	SGC0946	DOT1L	Q443E	-0.662140816			Q8TEK3							
gdsc	SGC0946	DOT1L	K1255N	-0.394958039			Q8TEK3							
gdsc	SGC0946	DOT1L	T93M	-0.708436982			Q8TEK3							
gdsc	SGC0946	DOT1L	T1184A	-0.673133185			Q8TEK3							
gdsc	SGC0946	DOT1L	A483T	-0.217969808			Q8TEK3							
gdsc	SGC0946	DOT1L	P298S	-0.465800848			Q8TEK3							
gdsc	SGC0946	DOT1L	S1059L	-0.050137245			Q8TEK3							
gdsc	SGC0946	DOT1L	A1475T	-0.429930636			Q8TEK3							
gdsc	SGC0946	DOT1L	W208C	-0.7177081829999999			Q8TEK3							
gdsc	SGC0946	DOT1L	F1318C	-0.5904957820000001			Q8TEK3							
gdsc	SGC0946	DOT1L	A854T	-0.751243413			Q8TEK3							
gdsc	SGC0946	DOT1L	M713V	-0.77475617			Q8TEK3							
gdsc	Dyrk1b_0191	DYRK1B	C490Y	-0.179349282			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R344C	-0.5995868679999999			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R70Q	-0.204930404			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	L28P	-0.8102027559999999			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	G352A	-0.7649843190000001			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	A464T	0.8694352340000001			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	P578S	-0.669833045			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	P578S	-0.94508428			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	L28P	-0.193783396			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	G429S	-0.510375846			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	A36P	0.7763523240000001			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	S314N	-0.434678809			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	K361E	0.28948449600000004			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R595Q	0.584640255			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	K145R	0.8059913740000001			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	Q272H	-0.901395047			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	Q275R+R102H	-0.82287008			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	T308A	-0.638135111			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	T230A	-0.783312243			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	I257N	-1.143904388			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R551H	-0.160728079			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	P578S	-0.6713835779999999			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R593Q	-0.68538814			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R349W	-0.393641538			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	C264R	0.046445472			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	K345N	-0.435838894			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	H237Y	-0.17396655800000002			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	L28P	-0.822737956			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R593W	-0.659885226			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	T308N	-0.256457618			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	P578S	1.500778692			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	A254T	-1.085212256			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	P578S	-0.916937699			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R202C	-0.8937751			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R280H	-0.333774508			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R484C	-0.0843248			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	G352A	-0.036979936			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	R324H+R110H+R102H	0.356698336			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	S462R	-1.202183559			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	P558S	-0.602398801			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	P552L	-0.403246308			Q9Y463							
gdsc	Dyrk1b_0191	DYRK1B	G118D	-0.474914449			Q9Y463							
gdsc	Zibotentan	EDNRA	S31N	1.354613889			P25101							
gdsc	Zibotentan	EDNRA	I86V	1.928450777			P25101							
gdsc	Zibotentan	EDNRA	W146G	1.4716681390000002			P25101							
gdsc	Zibotentan	EDNRA	A178T	1.643335856			P25101							
gdsc	Zibotentan	EDNRA	F315V	1.410607845			P25101							
gdsc	Zibotentan	EDNRA	I136L	1.7694035769999998			P25101							
gdsc	Zibotentan	EDNRA	R232G	1.633590075			P25101							
gdsc	Zibotentan	EDNRA	I86T+K237I	1.202526015			P25101							
gdsc	Zibotentan	EDNRA	F37L	1.6104458430000002			P25101							
gdsc	Zibotentan	EDNRA	A293V	1.690850171			P25101							
gdsc	Zibotentan	EDNRA	G197R	2.016217913			P25101							
gdsc	Zibotentan	EDNRA	E249K	1.51283161			P25101							
gdsc	Zibotentan	EDNRA	R340*	2.033713988			P25101							
gdsc	Zibotentan	EDNRA	T50A	0.938053856			P25101							
gdsc	Zibotentan	EDNRA	E281K	2.350661337			P25101							
gdsc	Zibotentan	EDNRA	A368P	1.753158238			P25101							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	G163V	1.408145479			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	E673D	1.289140768			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	D609N	1.6693269780000002			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	D609N	1.57509761			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R532C	1.211387809			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	Q286K	2.130440086			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R247C	1.703753304			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	S438N	1.261920241			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	D609N	1.942351654			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	Y713C	1.391703434			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	A164T+G449S	1.485859334			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	G163V	2.1030441840000003			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	E545D	1.570999393			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	Y641H	1.945584251			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	E434*	1.704269358			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	P221L	1.950487655			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	E662K	1.280789696			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	G623S	1.23729539			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R265S	1.516670318			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	W194C	1.537691085			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	Y69H	1.202793226			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	T291M	1.949738162			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R303H	1.491413878			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	Y69H	1.4754055330000002			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	V481I	1.407891895			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	T694I	1.412369895			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	D179G	1.5267170819999998			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	L193V	0.984394458			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	D609N	1.767105329			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	E196*	2.181127157			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	I349V	1.672090919			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	V120I	1.75337568			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	E434*	1.512375989			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R178Q	1.138218312			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	C482W	1.277266189			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R178Q	1.794794511			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	D584N	1.715348231			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	T149M	1.580312068			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R247C	1.162014277			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	V52A+H103R+K151N+V176I	2.055679175			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	T291M	2.070179055			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	D609N	0.772955609			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	D609N	1.897954994			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	P394L	1.705979862			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R178Q	1.297167159			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R493L	2.2379399280000003			O00418							
gdsc	eEF2K Inhibitor, A-484954	EEF2K	R111H	1.4715952630000002			O00418							
gdsc	AST-1306	EGFR	Y1069C	-2.294908522			P00533							
gdsc	AST-1306	EGFR	V1011M	-2.524492809			P00533							
gdsc	AST-1306	EGFR	V904I	-0.6855421859999999			P00533							
gdsc	AST-1306	EGFR	A1118T	-0.197719272			P00533							
gdsc	AST-1306	EGFR	C523R	-0.599149614			P00533							
gdsc	AST-1306	EGFR	R451C	-0.719466678			P00533							
gdsc	AST-1306	EGFR	L76P	-0.985120844			P00533							
gdsc	AST-1306	EGFR	S768I	-2.065578411			P00533							
gdsc	AST-1306	EGFR	P1071L	0.323641242			P00533							
gdsc	AST-1306	EGFR	Q486E+T940A	-0.163662656			P00533							
gdsc	AST-1306	EGFR	D1127N	-1.717202708			P00533							
gdsc	AST-1306	EGFR	S1162N+S1130G	2.157808735			P00533							
gdsc	AST-1306	EGFR	V592F	-0.7341093459999999			P00533							
gdsc	AST-1306	EGFR	G659R	-0.8282225870000001			P00533							
gdsc	AST-1306	EGFR	G614S	-2.074402286			P00533							
gdsc	AST-1306	EGFR	Q701R	-0.279193035			P00533							
gdsc	AST-1306	EGFR	A864V	-1.162297485			P00533							
gdsc	AST-1306	EGFR	V292M	-0.107679364			P00533							
gdsc	AST-1306	EGFR	K28N	-0.860097082			P00533							
gdsc	AST-1306	EGFR	C251Y	-0.693152653			P00533							
gdsc	AST-1306	EGFR	G719S	-0.31069545			P00533							
gdsc	AZD3759	EGFR	S703F	0.283742726			P00533							
gdsc	AZD3759	EGFR	Y1069C	-1.856506538			P00533							
gdsc	AZD3759	EGFR	A1118T	-0.549760678			P00533							
gdsc	AZD3759	EGFR	V1011M	-0.427519816			P00533							
gdsc	AZD3759	EGFR	V323I+E928G	-0.295915918			P00533							
gdsc	AZD3759	EGFR	G682V	0.8232510470000001			P00533							
gdsc	AZD3759	EGFR	Q71*	-0.5120881270000001			P00533							
gdsc	AZD3759	EGFR	H988P	-0.349227103			P00533							
gdsc	AZD3759	EGFR	E866D+H988P	0.13936663400000002			P00533							
gdsc	AZD3759	EGFR	N234D	0.420392817			P00533							
gdsc	AZD3759	EGFR	E711K	-0.469452332			P00533							
gdsc	AZD3759	EGFR	V904I	-0.81908588			P00533							
gdsc	AZD3759	EGFR	A1118T	-0.145475744			P00533							
gdsc	AZD3759	EGFR	S703F	0.413216642			P00533							
gdsc	AZD3759	EGFR	A1210V	0.6020569370000001			P00533							
gdsc	AZD3759	EGFR	C523R	0.057388073			P00533							
gdsc	AZD3759	EGFR	E746K+E746_A750delELREA	-3.184334784			P00533							
gdsc	AZD3759	EGFR	I646L	-0.04847651			P00533							
gdsc	AZD3759	EGFR	R165W	-0.387504581			P00533							
gdsc	AZD3759	EGFR	D191Y	0.126411362			P00533							
gdsc	AZD3759	EGFR	S1060A	-0.098081704			P00533							
gdsc	AZD3759	EGFR	R451C	-0.420071098			P00533							
gdsc	AZD3759	EGFR	L76P	-0.554989356			P00533							
gdsc	AZD3759	EGFR	W1157C	-0.33380176300000003			P00533							
gdsc	AZD3759	EGFR	G573*	-0.285087074			P00533							
gdsc	AZD3759	EGFR	A1048V	-0.449892633			P00533							
gdsc	AZD3759	EGFR	L861Q	-1.083500568			P00533							
gdsc	AZD3759	EGFR	S768I	-1.523210165			P00533							
gdsc	AZD3759	EGFR	P672R	0.143394345			P00533							
gdsc	AZD3759	EGFR	T1085N	-0.143393752			P00533							
gdsc	AZD3759	EGFR	L62R	0.463786993			P00533							
gdsc	AZD3759	EGFR	P1071L	-0.188912579			P00533							
gdsc	AZD3759	EGFR	A755D+L747_P753delinsS	-1.219127438			P00533							
gdsc	AZD3759	EGFR	Q486E+T940A	0.635909146			P00533							
gdsc	AZD3759	EGFR	S703F	0.307386422			P00533							
gdsc	AZD3759	EGFR	H988P	-0.45358322			P00533							
gdsc	AZD3759	EGFR	L469W	-0.06430237			P00533							
gdsc	AZD3759	EGFR	T678M	-0.557376477			P00533							
gdsc	AZD3759	EGFR	S703F	-1.145901655			P00533							
gdsc	AZD3759	EGFR	A1048V	-0.2860232			P00533							
gdsc	AZD3759	EGFR	A1048V	0.513217403			P00533							
gdsc	AZD3759	EGFR	G917R	-0.452496603			P00533							
gdsc	AZD3759	EGFR	E257D	-0.312154147			P00533							
gdsc	AZD3759	EGFR	S77F	-0.199660252			P00533							
gdsc	AZD3759	EGFR	R1068*+A1076T+A1086V	-0.706663675			P00533							
gdsc	AZD3759	EGFR	Q1159H	0.32642829			P00533							
gdsc	AZD3759	EGFR	D1127N	-1.035944187			P00533							
gdsc	AZD3759	EGFR	E746_A750delELREA	-0.914355651			P00533							
gdsc	AZD3759	EGFR	C311F	1.177063983			P00533							
gdsc	AZD3759	EGFR	T790M+L858R	0.209358043			P00533							
gdsc	AZD3759	EGFR	N650S	-0.300954408			P00533							
gdsc	AZD3759	EGFR	S703F	0.463753814			P00533							
gdsc	AZD3759	EGFR	S703F	-0.057042655			P00533							
gdsc	AZD3759	EGFR	E282K	-0.565674818			P00533							
gdsc	AZD3759	EGFR	S703F	0.075214162			P00533							
gdsc	AZD3759	EGFR	N1044S	-0.749049442			P00533							
gdsc	AZD3759	EGFR	S703F	-0.008140148			P00533							
gdsc	AZD3759	EGFR	S703F	-0.65324762			P00533							
gdsc	AZD3759	EGFR	A1048V	-0.099234679			P00533							
gdsc	AZD3759	EGFR	A1048V	-0.244371521			P00533							
gdsc	AZD3759	EGFR	E746_A750delELREA	-2.976514239			P00533							
gdsc	AZD3759	EGFR	A750P+L747_E749delLRE	-2.485960563			P00533							
gdsc	AZD3759	EGFR	S1056F	0.469167939			P00533							
gdsc	AZD3759	EGFR	G659R	-0.448605756			P00533							
gdsc	AZD3759	EGFR	G614S	-0.088150474			P00533							
gdsc	AZD3759	EGFR	T751I	-0.154975052			P00533							
gdsc	AZD3759	EGFR	H988P	-0.105304093			P00533							
gdsc	AZD3759	EGFR	G312E	-1.368638595			P00533							
gdsc	AZD3759	EGFR	A289V	0.410315836			P00533							
gdsc	AZD3759	EGFR	Q701R	-0.569931229			P00533							
gdsc	AZD3759	EGFR	S703F	-0.13213298699999998			P00533							
gdsc	AZD3759	EGFR	R675Q	0.014624894			P00533							
gdsc	AZD3759	EGFR	A864V	-1.4159698319999998			P00533							
gdsc	AZD3759	EGFR	V292M	-0.709223802			P00533							
gdsc	AZD3759	EGFR	R165Q	0.391656714			P00533							
gdsc	AZD3759	EGFR	V738D	-1.119035433			P00533							
gdsc	AZD3759	EGFR	S811F	0.378148061			P00533							
gdsc	AZD3759	EGFR	C251Y	-0.206172252			P00533							
gdsc	AZD3759	EGFR	V654M	-0.16338655800000002			P00533							
gdsc	AZD3759	EGFR	G719S	-2.267896549			P00533							
gdsc	AZD3759	EGFR	E746_A750delELREA	0.1817524			P00533							
gdsc	AZD3759	EGFR	L883F	-0.570042023			P00533							
gdsc	AZD3759	EGFR	K327E	0.778168883			P00533							
gdsc	AZD3759	EGFR	A202_Q208delinsE	0.508977582			P00533							
gdsc	AZD8931	EGFR	V323I+E928G	-0.479792968			P00533							
gdsc	AZD8931	EGFR	C523R	-0.637487525			P00533							
gdsc	AZD8931	EGFR	R451C	-1.195583871			P00533							
gdsc	AZD8931	EGFR	P1071L	-0.930850426			P00533							
gdsc	AZD8931	EGFR	Q486E+T940A	-0.096970202			P00533							
gdsc	AZD8931	EGFR	R1068*+A1076T+A1086V	-0.154912841			P00533							
gdsc	CI-1033	EGFR	Y1069C	-2.924930739			P00533							
gdsc	CI-1033	EGFR	A1118T	-0.180914034			P00533							
gdsc	CI-1033	EGFR	C523R	0.303814924			P00533							
gdsc	CI-1033	EGFR	R451C	-0.8166952040000001			P00533							
gdsc	CI-1033	EGFR	L76P	-0.970164752			P00533							
gdsc	CI-1033	EGFR	P1071L	-0.113297304			P00533							
gdsc	CI-1033	EGFR	Q486E+T940A	0.478337826			P00533							
gdsc	CI-1033	EGFR	G614S	-1.289195277			P00533							
gdsc	CI-1033	EGFR	A864V	-1.186425242			P00533							
gdsc	Cetuximab	EGFR	S703F	2.199210384			P00533							
gdsc	Cetuximab	EGFR	R832C	2.022847225			P00533							
gdsc	Cetuximab	EGFR	Y1069C	1.24886958			P00533							
gdsc	Cetuximab	EGFR	A1118T	2.220741873			P00533							
gdsc	Cetuximab	EGFR	V1011M	2.098864204			P00533							
gdsc	Cetuximab	EGFR	V323I+E928G	2.30565264			P00533							
gdsc	Cetuximab	EGFR	G682V	2.46488825			P00533							
gdsc	Cetuximab	EGFR	Q71*	1.985190079			P00533							
gdsc	Cetuximab	EGFR	H988P	2.009478399			P00533							
gdsc	Cetuximab	EGFR	E866D+H988P	2.3300742690000003			P00533							
gdsc	Cetuximab	EGFR	N234D	2.127224672			P00533							
gdsc	Cetuximab	EGFR	E711K	2.12523333			P00533							
gdsc	Cetuximab	EGFR	V904I	2.025071413			P00533							
gdsc	Cetuximab	EGFR	A1118T	1.855966192			P00533							
gdsc	Cetuximab	EGFR	S703F	2.2842775680000003			P00533							
gdsc	Cetuximab	EGFR	A1210V	1.6303669580000002			P00533							
gdsc	Cetuximab	EGFR	C523R	2.500511988			P00533							
gdsc	Cetuximab	EGFR	L858R	-0.495761617			P00533							
gdsc	Cetuximab	EGFR	E746K+E746_A750delELREA	2.313161792			P00533							
gdsc	Cetuximab	EGFR	A1210V	2.822237727			P00533							
gdsc	Cetuximab	EGFR	S703F	1.3460068630000002			P00533							
gdsc	Cetuximab	EGFR	I646L	1.996010036			P00533							
gdsc	Cetuximab	EGFR	R165W	1.767349433			P00533							
gdsc	Cetuximab	EGFR	A289D	1.476695965			P00533							
gdsc	Cetuximab	EGFR	D191Y	2.264829848			P00533							
gdsc	Cetuximab	EGFR	S1060A	2.002397021			P00533							
gdsc	Cetuximab	EGFR	R451C	1.796831474			P00533							
gdsc	Cetuximab	EGFR	L76P	1.978455898			P00533							
gdsc	Cetuximab	EGFR	W1157C	2.089667656			P00533							
gdsc	Cetuximab	EGFR	G573*	1.895655561			P00533							
gdsc	Cetuximab	EGFR	G598V	2.953590412			P00533							
gdsc	Cetuximab	EGFR	A1048V	2.068412265			P00533							
gdsc	Cetuximab	EGFR	L861Q	1.65794653			P00533							
gdsc	Cetuximab	EGFR	S768I	0.120913696			P00533							
gdsc	Cetuximab	EGFR	A702D	1.336151471			P00533							
gdsc	Cetuximab	EGFR	P672R	2.055126387			P00533							
gdsc	Cetuximab	EGFR	T1085N	2.166853607			P00533							
gdsc	Cetuximab	EGFR	L62R	2.263454691			P00533							
gdsc	Cetuximab	EGFR	P1071L	1.898119112			P00533							
gdsc	Cetuximab	EGFR	A755D+L747_P753delinsS	1.5686110869999998			P00533							
gdsc	Cetuximab	EGFR	Q486E+T940A	1.781078489			P00533							
gdsc	Cetuximab	EGFR	S703F	2.265932462			P00533							
gdsc	Cetuximab	EGFR	H988P	1.584357554			P00533							
gdsc	Cetuximab	EGFR	L469W	1.904868699			P00533							
gdsc	Cetuximab	EGFR	T678M	2.021655738			P00533							
gdsc	Cetuximab	EGFR	S703F	0.308487259			P00533							
gdsc	Cetuximab	EGFR	A1048V	2.272353812			P00533							
gdsc	Cetuximab	EGFR	A1048V	2.66404489			P00533							
gdsc	Cetuximab	EGFR	E257D	2.198949691			P00533							
gdsc	Cetuximab	EGFR	S77F	2.108252717			P00533							
gdsc	Cetuximab	EGFR	F961L	2.268569019			P00533							
gdsc	Cetuximab	EGFR	R1068*+A1076T+A1086V	1.914433773			P00533							
gdsc	Cetuximab	EGFR	Q1159H	1.196595243			P00533							
gdsc	Cetuximab	EGFR	D1127N	-0.076076227			P00533							
gdsc	Cetuximab	EGFR	C311F	2.347096949			P00533							
gdsc	Cetuximab	EGFR	T790M+L858R	0.876622074			P00533							
gdsc	Cetuximab	EGFR	N650S	2.168874572			P00533							
gdsc	Cetuximab	EGFR	S1162N+S1130G	2.671879908			P00533							
gdsc	Cetuximab	EGFR	V592F	2.150572126			P00533							
gdsc	Cetuximab	EGFR	S703F	1.46891901			P00533							
gdsc	Cetuximab	EGFR	E282K	1.575954935			P00533							
gdsc	Cetuximab	EGFR	S703F	1.937786559			P00533							
gdsc	Cetuximab	EGFR	N1044S	2.397534583			P00533							
gdsc	Cetuximab	EGFR	S703F	2.383783012			P00533							
gdsc	Cetuximab	EGFR	S703F	2.16013009			P00533							
gdsc	Cetuximab	EGFR	A1048V	2.316795501			P00533							
gdsc	Cetuximab	EGFR	A1048V	1.894068294			P00533							
gdsc	Cetuximab	EGFR	E746_A750delELREA	1.620838025			P00533							
gdsc	Cetuximab	EGFR	A750P+L747_E749delLRE	0.8660610329999999			P00533							
gdsc	Cetuximab	EGFR	S1056F	2.151969205			P00533							
gdsc	Cetuximab	EGFR	R677C	1.866847767			P00533							
gdsc	Cetuximab	EGFR	G659R	2.114686509			P00533							
gdsc	Cetuximab	EGFR	G614S	1.862462787			P00533							
gdsc	Cetuximab	EGFR	T751I	2.323740015			P00533							
gdsc	Cetuximab	EGFR	H988P	2.350010196			P00533							
gdsc	Cetuximab	EGFR	G312E	0.35558328			P00533							
gdsc	Cetuximab	EGFR	A289V	1.625282846			P00533							
gdsc	Cetuximab	EGFR	Q701R	1.689735115			P00533							
gdsc	Cetuximab	EGFR	S703F	1.953034747			P00533							
gdsc	Cetuximab	EGFR	P753S	1.910148923			P00533							
gdsc	Cetuximab	EGFR	V292M	1.770130556			P00533							
gdsc	Cetuximab	EGFR	K28N	2.393012147			P00533							
gdsc	Cetuximab	EGFR	R165Q	2.386924366			P00533							
gdsc	Cetuximab	EGFR	V738D	1.586940195			P00533							
gdsc	Cetuximab	EGFR	S811F	2.128516288			P00533							
gdsc	Cetuximab	EGFR	C251Y	2.171845291			P00533							
gdsc	Cetuximab	EGFR	V654M	0.740062633			P00533							
gdsc	Cetuximab	EGFR	G719S	0.7400602629999999			P00533							
gdsc	Cetuximab	EGFR	E746_A750delELREA	2.271030201			P00533							
gdsc	Cetuximab	EGFR	L883F	2.042024772			P00533							
gdsc	Cetuximab	EGFR	K327E	2.916370519			P00533							
gdsc	Cetuximab	EGFR	A202_Q208delinsE	2.1745008080000003			P00533							
gdsc	Erlotinib	EGFR	S703F	-0.322852644			P00533							
gdsc	Erlotinib	EGFR	R832C	-1.6875968369999998			P00533							
gdsc	Erlotinib	EGFR	R108K	-0.112672826			P00533							
gdsc	Erlotinib	EGFR	Y1069C	-2.009052403			P00533							
gdsc	Erlotinib	EGFR	A1118T	-0.244553682			P00533							
gdsc	Erlotinib	EGFR	V1011M	-0.5654864079999999			P00533							
gdsc	Erlotinib	EGFR	V323I+E928G	0.325818342			P00533							
gdsc	Erlotinib	EGFR	G682V	0.5619492739999999			P00533							
gdsc	Erlotinib	EGFR	Q71*	-0.139240102			P00533							
gdsc	Erlotinib	EGFR	H988P	-0.46689059			P00533							
gdsc	Erlotinib	EGFR	E866D+H988P	0.142906054			P00533							
gdsc	Erlotinib	EGFR	N234D	0.81967007			P00533							
gdsc	Erlotinib	EGFR	E711K	-0.196545282			P00533							
gdsc	Erlotinib	EGFR	V904I	-0.305907459			P00533							
gdsc	Erlotinib	EGFR	A1118T	-0.08887686			P00533							
gdsc	Erlotinib	EGFR	S703F	0.41084374			P00533							
gdsc	Erlotinib	EGFR	A1210V	0.7519828340000001			P00533							
gdsc	Erlotinib	EGFR	C523R	0.448737137			P00533							
gdsc	Erlotinib	EGFR	E746K+E746_A750delELREA	-3.261645749			P00533							
gdsc	Erlotinib	EGFR	A1210V	0.472389279			P00533							
gdsc	Erlotinib	EGFR	I646L	0.04390312			P00533							
gdsc	Erlotinib	EGFR	R165W	-0.7538573390000001			P00533							
gdsc	Erlotinib	EGFR	D191Y	0.110581947			P00533							
gdsc	Erlotinib	EGFR	S1060A	-0.097072702			P00533							
gdsc	Erlotinib	EGFR	R451C	-0.917811614			P00533							
gdsc	Erlotinib	EGFR	L76P	-0.362270046			P00533							
gdsc	Erlotinib	EGFR	W1157C	-0.183927339			P00533							
gdsc	Erlotinib	EGFR	G573*	-0.142051081			P00533							
gdsc	Erlotinib	EGFR	G598V	0.188262623			P00533							
gdsc	Erlotinib	EGFR	A1048V	-0.943290828			P00533							
gdsc	Erlotinib	EGFR	L861Q	-0.824689008			P00533							
gdsc	Erlotinib	EGFR	S768I	-1.7408102630000002			P00533							
gdsc	Erlotinib	EGFR	P672R	0.386235478			P00533							
gdsc	Erlotinib	EGFR	T1085N	-0.042477504000000006			P00533							
gdsc	Erlotinib	EGFR	L62R	0.584574489			P00533							
gdsc	Erlotinib	EGFR	P1071L	0.65219434			P00533							
gdsc	Erlotinib	EGFR	A755D+L747_P753delinsS	-1.404567463			P00533							
gdsc	Erlotinib	EGFR	Q486E+T940A	0.552209627			P00533							
gdsc	Erlotinib	EGFR	S703F	0.364924394			P00533							
gdsc	Erlotinib	EGFR	H988P	-1.548592804			P00533							
gdsc	Erlotinib	EGFR	L469W	0.132775241			P00533							
gdsc	Erlotinib	EGFR	T678M	-0.317218707			P00533							
gdsc	Erlotinib	EGFR	S703F	-0.69676444			P00533							
gdsc	Erlotinib	EGFR	A1048V	-0.312059641			P00533							
gdsc	Erlotinib	EGFR	A1048V	0.910377708			P00533							
gdsc	Erlotinib	EGFR	G917R	-0.258364234			P00533							
gdsc	Erlotinib	EGFR	E257D	-0.13294039300000002			P00533							
gdsc	Erlotinib	EGFR	S77F	-0.22850004			P00533							
gdsc	Erlotinib	EGFR	F961L	0.115929714			P00533							
gdsc	Erlotinib	EGFR	R1068*+A1076T+A1086V	-0.160845582			P00533							
gdsc	Erlotinib	EGFR	Q1159H	-0.18837982600000006			P00533							
gdsc	Erlotinib	EGFR	D1127N	-1.53644509			P00533							
gdsc	Erlotinib	EGFR	E746_A750delELREA	-0.7925976640000001			P00533							
gdsc	Erlotinib	EGFR	C311F	0.81080235			P00533							
gdsc	Erlotinib	EGFR	T790M+L858R	-0.403447406			P00533							
gdsc	Erlotinib	EGFR	N650S	-0.089840241			P00533							
gdsc	Erlotinib	EGFR	S703F	0.258556791			P00533							
gdsc	Erlotinib	EGFR	S703F	-0.831372236			P00533							
gdsc	Erlotinib	EGFR	E282K	-0.994459038			P00533							
gdsc	Erlotinib	EGFR	S703F	0.128925867			P00533							
gdsc	Erlotinib	EGFR	N1044S	-0.670232577			P00533							
gdsc	Erlotinib	EGFR	S703F	0.490668026			P00533							
gdsc	Erlotinib	EGFR	S703F	0.7717327209999999			P00533							
gdsc	Erlotinib	EGFR	A1048V	0.262280772			P00533							
gdsc	Erlotinib	EGFR	A1048V	-0.5269846570000001			P00533							
gdsc	Erlotinib	EGFR	E746_A750delELREA	-2.9210671460000004			P00533							
gdsc	Erlotinib	EGFR	A750P+L747_E749delLRE	-2.537700479			P00533							
gdsc	Erlotinib	EGFR	S1056F	0.490883098			P00533							
gdsc	Erlotinib	EGFR	G659R	-0.05976853			P00533							
gdsc	Erlotinib	EGFR	G614S	-0.584736788			P00533							
gdsc	Erlotinib	EGFR	T751I	-0.150051588			P00533							
gdsc	Erlotinib	EGFR	H988P	-0.105095731			P00533							
gdsc	Erlotinib	EGFR	G312E	-1.178631697			P00533							
gdsc	Erlotinib	EGFR	A289V	0.22925113			P00533							
gdsc	Erlotinib	EGFR	Q701R	-0.009021714			P00533							
gdsc	Erlotinib	EGFR	S703F	-0.011967954			P00533							
gdsc	Erlotinib	EGFR	R675Q	0.649364475			P00533							
gdsc	Erlotinib	EGFR	A864V	-1.244009427			P00533							
gdsc	Erlotinib	EGFR	V292M	-0.450329294			P00533							
gdsc	Erlotinib	EGFR	R165Q	0.5401405029999999			P00533							
gdsc	Erlotinib	EGFR	R98Q	-0.275263084			P00533							
gdsc	Erlotinib	EGFR	V738D	-0.586471594			P00533							
gdsc	Erlotinib	EGFR	S811F	0.466551106			P00533							
gdsc	Erlotinib	EGFR	C251Y	-0.013775409			P00533							
gdsc	Erlotinib	EGFR	V654M	-0.490108128			P00533							
gdsc	Erlotinib	EGFR	G719S	-1.643935451			P00533							
gdsc	Erlotinib	EGFR	E746_A750delELREA	1.040679917			P00533							
gdsc	Erlotinib	EGFR	L883F	0.281541685			P00533							
gdsc	Erlotinib	EGFR	K327E	1.463059928			P00533							
gdsc	Erlotinib	EGFR	A202_Q208delinsE	-0.223016001			P00533							
gdsc	Gefitinib	EGFR	S703F	-0.7175001959999999			P00533							
gdsc	Gefitinib	EGFR	R832C	-1.719833933			P00533							
gdsc	Gefitinib	EGFR	Y1069C	-1.774798141			P00533							
gdsc	Gefitinib	EGFR	A1118T	-0.520891275			P00533							
gdsc	Gefitinib	EGFR	V1011M	-0.8096883840000001			P00533							
gdsc	Gefitinib	EGFR	V323I+E928G	-0.697968678			P00533							
gdsc	Gefitinib	EGFR	G682V	1.377936613			P00533							
gdsc	Gefitinib	EGFR	Q71*	-0.640131506			P00533							
gdsc	Gefitinib	EGFR	H988P	-0.354948524			P00533							
gdsc	Gefitinib	EGFR	E866D+H988P	-0.027973195			P00533							
gdsc	Gefitinib	EGFR	N234D	0.624203652			P00533							
gdsc	Gefitinib	EGFR	E711K	-0.202335975			P00533							
gdsc	Gefitinib	EGFR	V904I	-0.420459175			P00533							
gdsc	Gefitinib	EGFR	A1118T	-0.431478416			P00533							
gdsc	Gefitinib	EGFR	S703F	-0.010615575			P00533							
gdsc	Gefitinib	EGFR	A1210V	0.471009799			P00533							
gdsc	Gefitinib	EGFR	C523R	0.184919306			P00533							
gdsc	Gefitinib	EGFR	L858R	-4.255177507			P00533							
gdsc	Gefitinib	EGFR	E746K+E746_A750delELREA	-3.5127646360000004			P00533							
gdsc	Gefitinib	EGFR	A1210V	-2.0751861430000003			P00533							
gdsc	Gefitinib	EGFR	S703F	-1.135531986			P00533							
gdsc	Gefitinib	EGFR	I646L	-0.490957606			P00533							
gdsc	Gefitinib	EGFR	R165W	-0.142736687			P00533							
gdsc	Gefitinib	EGFR	A289D	-0.568740927			P00533							
gdsc	Gefitinib	EGFR	D191Y	0.137644184			P00533							
gdsc	Gefitinib	EGFR	S1060A	-0.458075229			P00533							
gdsc	Gefitinib	EGFR	R451C	-0.321404762			P00533							
gdsc	Gefitinib	EGFR	L76P	-0.912405367			P00533							
gdsc	Gefitinib	EGFR	W1157C	0.009066316			P00533							
gdsc	Gefitinib	EGFR	G573*	-0.160493954			P00533							
gdsc	Gefitinib	EGFR	G598V	-0.505849855			P00533							
gdsc	Gefitinib	EGFR	A1048V	-1.866401184			P00533							
gdsc	Gefitinib	EGFR	L861Q	-1.27669636			P00533							
gdsc	Gefitinib	EGFR	S768I	-2.219636974			P00533							
gdsc	Gefitinib	EGFR	A702D	-1.762227994			P00533							
gdsc	Gefitinib	EGFR	P672R	0.470930159			P00533							
gdsc	Gefitinib	EGFR	T1085N	-0.3139993			P00533							
gdsc	Gefitinib	EGFR	L62R	0.263062349			P00533							
gdsc	Gefitinib	EGFR	P1071L	0.525743205			P00533							
gdsc	Gefitinib	EGFR	A755D+L747_P753delinsS	-1.147035544			P00533							
gdsc	Gefitinib	EGFR	Q486E+T940A	0.382764655			P00533							
gdsc	Gefitinib	EGFR	S703F	0.350736007			P00533							
gdsc	Gefitinib	EGFR	H988P	-1.93359384			P00533							
gdsc	Gefitinib	EGFR	L469W	0.147839546			P00533							
gdsc	Gefitinib	EGFR	T678M	-0.281752043			P00533							
gdsc	Gefitinib	EGFR	S703F	-1.039518593			P00533							
gdsc	Gefitinib	EGFR	A1048V	-0.14552612199999998			P00533							
gdsc	Gefitinib	EGFR	A1048V	0.5826768379999999			P00533							
gdsc	Gefitinib	EGFR	G917R	-0.360991688			P00533							
gdsc	Gefitinib	EGFR	E257D	-0.273145786			P00533							
gdsc	Gefitinib	EGFR	S77F	-0.237041303			P00533							
gdsc	Gefitinib	EGFR	F961L	-0.443367598			P00533							
gdsc	Gefitinib	EGFR	R1068*+A1076T+A1086V	-0.494230107			P00533							
gdsc	Gefitinib	EGFR	Q1159H	0.773167095			P00533							
gdsc	Gefitinib	EGFR	D1127N	-0.978340217			P00533							
gdsc	Gefitinib	EGFR	E746_A750delELREA	-0.091130199			P00533							
gdsc	Gefitinib	EGFR	C311F	0.6863752790000001			P00533							
gdsc	Gefitinib	EGFR	T790M+L858R	-0.283138944			P00533							
gdsc	Gefitinib	EGFR	N650S	-0.093118758			P00533							
gdsc	Gefitinib	EGFR	S1162N+S1130G	-0.35773222200000004			P00533							
gdsc	Gefitinib	EGFR	V592F	-0.089918449			P00533							
gdsc	Gefitinib	EGFR	S703F	1.040036703			P00533							
gdsc	Gefitinib	EGFR	S703F	-0.188948629			P00533							
gdsc	Gefitinib	EGFR	E282K	-0.4406469120000001			P00533							
gdsc	Gefitinib	EGFR	S703F	0.02156308			P00533							
gdsc	Gefitinib	EGFR	N1044S	-0.902062021			P00533							
gdsc	Gefitinib	EGFR	S703F	0.027081502			P00533							
gdsc	Gefitinib	EGFR	S703F	-0.292841345			P00533							
gdsc	Gefitinib	EGFR	A1048V	-0.098427414			P00533							
gdsc	Gefitinib	EGFR	A1048V	-0.523635451			P00533							
gdsc	Gefitinib	EGFR	E746_A750delELREA	-2.624379142			P00533							
gdsc	Gefitinib	EGFR	A750P+L747_E749delLRE	-2.738831117			P00533							
gdsc	Gefitinib	EGFR	S1056F	-0.398445962			P00533							
gdsc	Gefitinib	EGFR	R677C	-1.303724188			P00533							
gdsc	Gefitinib	EGFR	G659R	-0.375313647			P00533							
gdsc	Gefitinib	EGFR	G614S	-0.647935814			P00533							
gdsc	Gefitinib	EGFR	T751I	-0.300867496			P00533							
gdsc	Gefitinib	EGFR	H988P	-0.297850717			P00533							
gdsc	Gefitinib	EGFR	G312E	-1.840769098			P00533							
gdsc	Gefitinib	EGFR	A289V	0.074173047			P00533							
gdsc	Gefitinib	EGFR	Q701R	-0.559831284			P00533							
gdsc	Gefitinib	EGFR	S703F	0.159980837			P00533							
gdsc	Gefitinib	EGFR	P753S	-1.4310136130000002			P00533							
gdsc	Gefitinib	EGFR	R675Q	0.490724629			P00533							
gdsc	Gefitinib	EGFR	A864V	-1.000864349			P00533							
gdsc	Gefitinib	EGFR	V292M	0.284813025			P00533							
gdsc	Gefitinib	EGFR	K28N	-0.122508072			P00533							
gdsc	Gefitinib	EGFR	R165Q	0.56567661			P00533							
gdsc	Gefitinib	EGFR	V738D	-0.684216575			P00533							
gdsc	Gefitinib	EGFR	S811F	-0.081195753			P00533							
gdsc	Gefitinib	EGFR	C251Y	0.028955829			P00533							
gdsc	Gefitinib	EGFR	V654M	0.049019786			P00533							
gdsc	Gefitinib	EGFR	G719S	-1.746690969			P00533							
gdsc	Gefitinib	EGFR	E746_A750delELREA	0.372852905			P00533							
gdsc	Gefitinib	EGFR	L883F	0.013549474			P00533							
gdsc	Gefitinib	EGFR	K327E	1.130467942			P00533							
gdsc	Gefitinib	EGFR	A202_Q208delinsE	0.7191528970000001			P00533							
gdsc	Lapatinib	EGFR	Y1069C	-2.100315792			P00533							
gdsc	Lapatinib	EGFR	V323I+E928G	-0.0022363120000000003			P00533							
gdsc	Lapatinib	EGFR	H988P	-0.321658932			P00533							
gdsc	Lapatinib	EGFR	A1118T	-0.279225622			P00533							
gdsc	Lapatinib	EGFR	C523R	0.093231474			P00533							
gdsc	Lapatinib	EGFR	R451C	-0.695441421			P00533							
gdsc	Lapatinib	EGFR	L76P	-0.227574525			P00533							
gdsc	Lapatinib	EGFR	G573*	0.077837941			P00533							
gdsc	Lapatinib	EGFR	P1071L	0.129667535			P00533							
gdsc	Lapatinib	EGFR	Q486E+T940A	-0.123740228			P00533							
gdsc	Lapatinib	EGFR	R1068*+A1076T+A1086V	-0.515433421			P00533							
gdsc	Lapatinib	EGFR	C311F	2.20150804			P00533							
gdsc	Lapatinib	EGFR	S703F	-2.772591059			P00533							
gdsc	Lapatinib	EGFR	G614S	-0.486759971			P00533							
gdsc	Lapatinib	EGFR	H988P	-0.059526595			P00533							
gdsc	Lapatinib	EGFR	A864V	-0.396324309			P00533							
gdsc	Lapatinib	EGFR	R165Q	0.28805246			P00533							
gdsc	Osimertinib	EGFR	S703F	-1.4334789419999998			P00533							
gdsc	Osimertinib	EGFR	Y1069C	-2.489594864			P00533							
gdsc	Osimertinib	EGFR	A1118T	-0.8618798679999999			P00533							
gdsc	Osimertinib	EGFR	V1011M	-1.965395164			P00533							
gdsc	Osimertinib	EGFR	V323I+E928G	-2.015243868			P00533							
gdsc	Osimertinib	EGFR	G682V	0.32651657			P00533							
gdsc	Osimertinib	EGFR	Q71*	-0.406038689			P00533							
gdsc	Osimertinib	EGFR	H988P	-1.084869208			P00533							
gdsc	Osimertinib	EGFR	E866D+H988P	-1.180035886			P00533							
gdsc	Osimertinib	EGFR	N234D	-0.032810028			P00533							
gdsc	Osimertinib	EGFR	E711K	-0.485647903			P00533							
gdsc	Osimertinib	EGFR	V904I	-1.646893727			P00533							
gdsc	Osimertinib	EGFR	A1118T	-0.048093765			P00533							
gdsc	Osimertinib	EGFR	S703F	-0.6679998979999999			P00533							
gdsc	Osimertinib	EGFR	A1210V	-0.20116338600000006			P00533							
gdsc	Osimertinib	EGFR	C523R	-0.88718667			P00533							
gdsc	Osimertinib	EGFR	E746K+E746_A750delELREA	-3.771131091			P00533							
gdsc	Osimertinib	EGFR	I646L	-0.130760793			P00533							
gdsc	Osimertinib	EGFR	R165W	-0.656141315			P00533							
gdsc	Osimertinib	EGFR	D191Y	-0.838053687			P00533							
gdsc	Osimertinib	EGFR	S1060A	-0.25461262			P00533							
gdsc	Osimertinib	EGFR	R451C	-0.763231749			P00533							
gdsc	Osimertinib	EGFR	L76P	-0.388776053			P00533							
gdsc	Osimertinib	EGFR	W1157C	-0.468780454			P00533							
gdsc	Osimertinib	EGFR	G573*	-0.200934687			P00533							
gdsc	Osimertinib	EGFR	A1048V	-2.550603612			P00533							
gdsc	Osimertinib	EGFR	L861Q	-1.522893186			P00533							
gdsc	Osimertinib	EGFR	S768I	-2.061316668			P00533							
gdsc	Osimertinib	EGFR	P672R	-0.378052671			P00533							
gdsc	Osimertinib	EGFR	T1085N	-1.485196343			P00533							
gdsc	Osimertinib	EGFR	L62R	0.29112982600000004			P00533							
gdsc	Osimertinib	EGFR	P1071L	-1.360019127			P00533							
gdsc	Osimertinib	EGFR	A755D+L747_P753delinsS	-1.479843836			P00533							
gdsc	Osimertinib	EGFR	Q486E+T940A	-0.046858434			P00533							
gdsc	Osimertinib	EGFR	S703F	0.108348872			P00533							
gdsc	Osimertinib	EGFR	H988P	-2.75817235			P00533							
gdsc	Osimertinib	EGFR	L469W	-0.355811386			P00533							
gdsc	Osimertinib	EGFR	T678M	-1.106000176			P00533							
gdsc	Osimertinib	EGFR	S703F	-1.346352874			P00533							
gdsc	Osimertinib	EGFR	A1048V	-1.011612615			P00533							
gdsc	Osimertinib	EGFR	A1048V	0.503197893			P00533							
gdsc	Osimertinib	EGFR	G917R	-1.159372388			P00533							
gdsc	Osimertinib	EGFR	E257D	-0.590276563			P00533							
gdsc	Osimertinib	EGFR	S77F	-1.4268597019999998			P00533							
gdsc	Osimertinib	EGFR	R1068*+A1076T+A1086V	-1.242901481			P00533							
gdsc	Osimertinib	EGFR	Q1159H	0.184199362			P00533							
gdsc	Osimertinib	EGFR	D1127N	-1.2230757559999998			P00533							
gdsc	Osimertinib	EGFR	E746_A750delELREA	-1.23759104			P00533							
gdsc	Osimertinib	EGFR	C311F	0.7055492109999999			P00533							
gdsc	Osimertinib	EGFR	T790M+L858R	-3.580952965			P00533							
gdsc	Osimertinib	EGFR	N650S	-0.464806066			P00533							
gdsc	Osimertinib	EGFR	S703F	0.5418119020000001			P00533							
gdsc	Osimertinib	EGFR	S703F	-1.137461709			P00533							
gdsc	Osimertinib	EGFR	E282K	-1.314763364			P00533							
gdsc	Osimertinib	EGFR	S703F	-0.822490297			P00533							
gdsc	Osimertinib	EGFR	N1044S	-0.754495562			P00533							
gdsc	Osimertinib	EGFR	S703F	-0.418079756			P00533							
gdsc	Osimertinib	EGFR	S703F	-3.2920005210000003			P00533							
gdsc	Osimertinib	EGFR	A1048V	-0.93224158			P00533							
gdsc	Osimertinib	EGFR	A1048V	-0.743324854			P00533							
gdsc	Osimertinib	EGFR	E746_A750delELREA	-3.5068781510000004			P00533							
gdsc	Osimertinib	EGFR	A750P+L747_E749delLRE	-3.1639604180000003			P00533							
gdsc	Osimertinib	EGFR	S1056F	-0.028630048			P00533							
gdsc	Osimertinib	EGFR	G659R	-1.051586969			P00533							
gdsc	Osimertinib	EGFR	G614S	-0.700386892			P00533							
gdsc	Osimertinib	EGFR	T751I	-0.966673832			P00533							
gdsc	Osimertinib	EGFR	H988P	-1.285353013			P00533							
gdsc	Osimertinib	EGFR	G312E	-2.196964275			P00533							
gdsc	Osimertinib	EGFR	A289V	0.217385618			P00533							
gdsc	Osimertinib	EGFR	Q701R	-0.7034767			P00533							
gdsc	Osimertinib	EGFR	S703F	-0.823705483			P00533							
gdsc	Osimertinib	EGFR	R675Q	0.467385153			P00533							
gdsc	Osimertinib	EGFR	A864V	-1.807137154			P00533							
gdsc	Osimertinib	EGFR	V292M	-1.048678461			P00533							
gdsc	Osimertinib	EGFR	R165Q	-0.572972453			P00533							
gdsc	Osimertinib	EGFR	V738D	-1.415130874			P00533							
gdsc	Osimertinib	EGFR	S811F	-0.624222384			P00533							
gdsc	Osimertinib	EGFR	C251Y	-0.228345401			P00533							
gdsc	Osimertinib	EGFR	V654M	-0.631514094			P00533							
gdsc	Osimertinib	EGFR	G719S	-2.381335458			P00533							
gdsc	Osimertinib	EGFR	E746_A750delELREA	-0.329852852			P00533							
gdsc	Osimertinib	EGFR	L883F	-0.506208309			P00533							
gdsc	Osimertinib	EGFR	K327E	0.458980756			P00533							
gdsc	Osimertinib	EGFR	A202_Q208delinsE	-0.431607368			P00533							
gdsc	PF-00299804	EGFR	Y1069C	-3.216567139			P00533							
gdsc	PF-00299804	EGFR	A1118T	0.157400092			P00533							
gdsc	PF-00299804	EGFR	C523R	-0.46565332			P00533							
gdsc	PF-00299804	EGFR	R451C	-1.114797982			P00533							
gdsc	PF-00299804	EGFR	L76P	-1.343148716			P00533							
gdsc	PF-00299804	EGFR	P1071L	-0.119539131			P00533							
gdsc	PF-00299804	EGFR	Q486E+T940A	-0.467146974			P00533							
gdsc	PF-00299804	EGFR	G614S	-1.759238909			P00533							
gdsc	PF-00299804	EGFR	A864V	-1.432484752			P00533							
gdsc	Pelitinib	EGFR	S703F	-2.198211455			P00533							
gdsc	Pelitinib	EGFR	R832C	-1.218255893			P00533							
gdsc	Pelitinib	EGFR	R108K	-1.446678317			P00533							
gdsc	Pelitinib	EGFR	Y1069C	-3.2400929310000004			P00533							
gdsc	Pelitinib	EGFR	A1118T	-2.177952031			P00533							
gdsc	Pelitinib	EGFR	V1011M	-2.500277364			P00533							
gdsc	Pelitinib	EGFR	V323I+E928G	-0.723493205			P00533							
gdsc	Pelitinib	EGFR	R255Q	-0.824108965			P00533							
gdsc	Pelitinib	EGFR	G682V	-0.903372761			P00533							
gdsc	Pelitinib	EGFR	Q71*	-1.043708107			P00533							
gdsc	Pelitinib	EGFR	H988P	-1.586915311			P00533							
gdsc	Pelitinib	EGFR	E866D+H988P	-1.021985838			P00533							
gdsc	Pelitinib	EGFR	N234D	1.020775984			P00533							
gdsc	Pelitinib	EGFR	E711K	0.35012294			P00533							
gdsc	Pelitinib	EGFR	V904I	-1.068389837			P00533							
gdsc	Pelitinib	EGFR	A1118T	0.905406168			P00533							
gdsc	Pelitinib	EGFR	S703F	-0.338731236			P00533							
gdsc	Pelitinib	EGFR	A1210V	0.513010626			P00533							
gdsc	Pelitinib	EGFR	C523R	-0.870876749			P00533							
gdsc	Pelitinib	EGFR	L858R	-3.366344915			P00533							
gdsc	Pelitinib	EGFR	E746K+E746_A750delELREA	-3.301210104			P00533							
gdsc	Pelitinib	EGFR	A1210V	-2.8581061610000003			P00533							
gdsc	Pelitinib	EGFR	S703F	-0.057014808			P00533							
gdsc	Pelitinib	EGFR	I646L	-0.028553618			P00533							
gdsc	Pelitinib	EGFR	R165W	-1.94796367			P00533							
gdsc	Pelitinib	EGFR	A289D	-0.037411265			P00533							
gdsc	Pelitinib	EGFR	D191Y	-0.477457986			P00533							
gdsc	Pelitinib	EGFR	S1060A	0.557020393			P00533							
gdsc	Pelitinib	EGFR	L76P	-2.544624848			P00533							
gdsc	Pelitinib	EGFR	W1157C	-0.644480623			P00533							
gdsc	Pelitinib	EGFR	G573*	-0.651543041			P00533							
gdsc	Pelitinib	EGFR	G598V	0.736913577			P00533							
gdsc	Pelitinib	EGFR	A1048V	-3.918314376			P00533							
gdsc	Pelitinib	EGFR	L861Q	-1.324520996			P00533							
gdsc	Pelitinib	EGFR	S768I	-4.335439047			P00533							
gdsc	Pelitinib	EGFR	A702D	-0.6078781			P00533							
gdsc	Pelitinib	EGFR	P672R	-0.319550727			P00533							
gdsc	Pelitinib	EGFR	T1085N	-1.163443943			P00533							
gdsc	Pelitinib	EGFR	L62R	0.662927636			P00533							
gdsc	Pelitinib	EGFR	P1071L	-1.033624016			P00533							
gdsc	Pelitinib	EGFR	A755D+L747_P753delinsS	0.014547278			P00533							
gdsc	Pelitinib	EGFR	Q486E+T940A	-1.060480758			P00533							
gdsc	Pelitinib	EGFR	S703F	0.926047745			P00533							
gdsc	Pelitinib	EGFR	H988P	-3.983503103			P00533							
gdsc	Pelitinib	EGFR	L469W	-0.031502414			P00533							
gdsc	Pelitinib	EGFR	T678M	-1.530101355			P00533							
gdsc	Pelitinib	EGFR	S703F	-2.0698626680000003			P00533							
gdsc	Pelitinib	EGFR	A1048V	-2.369225069			P00533							
gdsc	Pelitinib	EGFR	A1048V	0.092282463			P00533							
gdsc	Pelitinib	EGFR	E257D	-0.938470372			P00533							
gdsc	Pelitinib	EGFR	S77F	-0.27821543600000004			P00533							
gdsc	Pelitinib	EGFR	F961L	-0.8508910540000001			P00533							
gdsc	Pelitinib	EGFR	R1068*+A1076T+A1086V	-2.782628936			P00533							
gdsc	Pelitinib	EGFR	Q1159H	0.8060482529999999			P00533							
gdsc	Pelitinib	EGFR	D1127N	-1.142542858			P00533							
gdsc	Pelitinib	EGFR	C311F	1.010308556			P00533							
gdsc	Pelitinib	EGFR	T790M+L858R	-3.303155823			P00533							
gdsc	Pelitinib	EGFR	N650S	0.476983998			P00533							
gdsc	Pelitinib	EGFR	S1162N+S1130G	0.43804116			P00533							
gdsc	Pelitinib	EGFR	V592F	1.246547632			P00533							
gdsc	Pelitinib	EGFR	S703F	0.372853618			P00533							
gdsc	Pelitinib	EGFR	S703F	-1.2576111			P00533							
gdsc	Pelitinib	EGFR	E282K	-2.659036616			P00533							
gdsc	Pelitinib	EGFR	S703F	-0.35702361			P00533							
gdsc	Pelitinib	EGFR	N1044S	1.016248808			P00533							
gdsc	Pelitinib	EGFR	A1048V	-1.491106379			P00533							
gdsc	Pelitinib	EGFR	A1048V	-2.972239462			P00533							
gdsc	Pelitinib	EGFR	E746_A750delELREA	-2.839875998			P00533							
gdsc	Pelitinib	EGFR	A750P+L747_E749delLRE	-2.997229284			P00533							
gdsc	Pelitinib	EGFR	S1056F	0.828032399			P00533							
gdsc	Pelitinib	EGFR	G659R	-2.07871913			P00533							
gdsc	Pelitinib	EGFR	G614S	0.114117896			P00533							
gdsc	Pelitinib	EGFR	T751I	-1.334974204			P00533							
gdsc	Pelitinib	EGFR	H988P	0.64353087			P00533							
gdsc	Pelitinib	EGFR	G312E	-1.482243399			P00533							
gdsc	Pelitinib	EGFR	A289V	-0.189780569			P00533							
gdsc	Pelitinib	EGFR	Q701R	-1.227889102			P00533							
gdsc	Pelitinib	EGFR	S703F	-0.464320821			P00533							
gdsc	Pelitinib	EGFR	P753S	0.6276309489999999			P00533							
gdsc	Pelitinib	EGFR	R675Q	-0.38811484			P00533							
gdsc	Pelitinib	EGFR	A864V	-1.375683239			P00533							
gdsc	Pelitinib	EGFR	V292M	-1.739756825			P00533							
gdsc	Pelitinib	EGFR	K28N	-0.762078774			P00533							
gdsc	Pelitinib	EGFR	R165Q	-1.024686976			P00533							
gdsc	Pelitinib	EGFR	R98Q	-1.59490793			P00533							
gdsc	Pelitinib	EGFR	V738D	-2.490180832			P00533							
gdsc	Pelitinib	EGFR	S811F	-1.312622717			P00533							
gdsc	Pelitinib	EGFR	C251Y	-0.975223387			P00533							
gdsc	Pelitinib	EGFR	V654M	1.884084926			P00533							
gdsc	Pelitinib	EGFR	G719S	0.190302548			P00533							
gdsc	Pelitinib	EGFR	E746_A750delELREA	-0.153581528			P00533							
gdsc	Pelitinib	EGFR	L883F	0.239517294			P00533							
gdsc	Pelitinib	EGFR	K327E	1.545882779			P00533							
gdsc	Pelitinib	EGFR	A202_Q208delinsE	0.769377001			P00533							
gdsc	Sapitinib	EGFR	V323I+E928G	-1.2317681			P00533							
gdsc	Sapitinib	EGFR	C523R	0.6207350189999999			P00533							
gdsc	Sapitinib	EGFR	R451C	0.991194998			P00533							
gdsc	Sapitinib	EGFR	P1071L	1.20962576			P00533							
gdsc	Sapitinib	EGFR	Q486E+T940A	1.936865838			P00533							
gdsc	Sapitinib	EGFR	R1068*+A1076T+A1086V	0.294091065			P00533							
gdsc	IOX2	EGLN1	G409C	-2.165551918			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.934994178			Q9GZT9							
gdsc	IOX2	EGLN1	A379V+A194T	-1.1539914409999998			Q9GZT9							
gdsc	IOX2	EGLN1	S34G	-2.162942615			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.654910638			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.857145237			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.6554261			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.835262405			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.72335981			Q9GZT9							
gdsc	IOX2	EGLN1	C208Y	-1.407804207			Q9GZT9							
gdsc	IOX2	EGLN1	S418L	-1.6354854330000002			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.689650982			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.675226348			Q9GZT9							
gdsc	IOX2	EGLN1	R281L	-1.914504278			Q9GZT9							
gdsc	IOX2	EGLN1	A140V	-2.128500291			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.241212307			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.907398016			Q9GZT9							
gdsc	IOX2	EGLN1	P84L	-1.159297735			Q9GZT9							
gdsc	IOX2	EGLN1	K186N	-1.774052213			Q9GZT9							
gdsc	IOX2	EGLN1	R252Q	-1.550218583			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.679892166			Q9GZT9							
gdsc	IOX2	EGLN1	S420L	-1.7168543269999998			Q9GZT9							
gdsc	IOX2	EGLN1	D4E	-1.4092113590000002			Q9GZT9							
gdsc	GSK2606414	EIF2AK3	E672K	0.31366794600000003			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	I586L+A422T	0.53958179			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	Y1019C	-0.462745404			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	0.7129096490000001			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E994A	0.199135903			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A342V	0.249313437			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	0.394127375			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	L827S	0.408470839			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A50V	0.5959650089999999			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	V132M	-0.204746734			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A342D	0.6992475429999999			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	L181H	0.694111293			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	I917N	0.640461799			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	D307E	1.705322796			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	D777E	0.391475413			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E967G	-0.114913603			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	I586L	1.114675338			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	I586L	0.750091623			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	M1053V	0.608378157			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E809*	0.7245993740000001			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	R240H	-0.07692585			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A52T	0.862690388			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	T428A+R240H	-0.200777086			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	0.250198017			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A52T	-0.608148865			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	I586L	0.401610458			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E1050K	-0.026562869			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A38T	-0.430090015			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	D691N	-1.124726249			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	M1053V	0.369719966			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	S1022N	0.943049095			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	R718T	0.027520324			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	G327*	0.215697629			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	0.259103655			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	I586L	-0.118775419			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A1068V	-0.373317533			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	-0.100935703			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	Q667K	0.804112605			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	R240H	1.14025883			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E820*	0.8414663990000001			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	P483Q	0.814010063			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	-0.302074797			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	1.138588023			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	S732N+N478H	1.623282025			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	Q558E	0.779883533			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	0.7114402870000001			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	M390L	0.036969864			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	D357N	-0.005575874000000001			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	Y186H	1.504949193			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	Q887*+V568A	0.362368415			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	0.634073628			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	0.5026131110000001			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	I310L	0.6671864160000001			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A468S	-0.3828968270000001			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	R240H	1.122317206			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K	0.536041101			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	E672K+P53T	-0.17234492699999998			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	F335V	1.599327866			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	A116D	0.03905304			Q9NZJ5							
gdsc	GSK2606414	EIF2AK3	D366delD	0.803428285			Q9NZJ5							
gdsc	EphB4_9721	EPHB4	T587A	0.214946951			P54760							
gdsc	EphB4_9721	EPHB4	A645S	-0.376730838			P54760							
gdsc	EphB4_9721	EPHB4	D576E	0.513231623			P54760							
gdsc	EphB4_9721	EPHB4	D576E	-1.86177906			P54760							
gdsc	EphB4_9721	EPHB4	A371V	-0.27274206100000004			P54760							
gdsc	EphB4_9721	EPHB4	S575L+W9*	-0.006270859			P54760							
gdsc	EphB4_9721	EPHB4	E609Q	1.284152047			P54760							
gdsc	EphB4_9721	EPHB4	R105C+R102W	0.285295036			P54760							
gdsc	EphB4_9721	EPHB4	T356S	-0.1214416			P54760							
gdsc	EphB4_9721	EPHB4	G533S	0.256209959			P54760							
gdsc	EphB4_9721	EPHB4	S825N	-0.092262318			P54760							
gdsc	EphB4_9721	EPHB4	V387L	0.5896728210000001			P54760							
gdsc	EphB4_9721	EPHB4	R333H	0.604577367			P54760							
gdsc	EphB4_9721	EPHB4	A725S	-0.465613623			P54760							
gdsc	EphB4_9721	EPHB4	A882T	0.013499173			P54760							
gdsc	EphB4_9721	EPHB4	G382S	0.136434427			P54760							
gdsc	EphB4_9721	EPHB4	R889G	-0.162448655			P54760							
gdsc	EphB4_9721	EPHB4	R656Q	-0.29408988			P54760							
gdsc	EphB4_9721	EPHB4	T775M	-0.689533163			P54760							
gdsc	EphB4_9721	EPHB4	V718L	-0.727238301			P54760							
gdsc	EphB4_9721	EPHB4	A955V	1.574873058			P54760							
gdsc	EphB4_9721	EPHB4	G462R	0.042650015			P54760							
gdsc	EphB4_9721	EPHB4	P235S	-0.8515694490000001			P54760							
gdsc	EphB4_9721	EPHB4	D576E	-1.465324405			P54760							
gdsc	EphB4_9721	EPHB4	G382S	-1.855709646			P54760							
gdsc	EphB4_9721	EPHB4	P599R	1.066121805			P54760							
gdsc	EphB4_9721	EPHB4	R394Q	-0.124506524			P54760							
gdsc	EphB4_9721	EPHB4	G375R	0.035405704			P54760							
gdsc	EphB4_9721	EPHB4	T403S	0.800435052			P54760							
gdsc	EphB4_9721	EPHB4	D576E	-0.134196019			P54760							
gdsc	EphB4_9721	EPHB4	D576E	0.038826118			P54760							
gdsc	EphB4_9721	EPHB4	A371V	-0.8065583820000001			P54760							
gdsc	EphB4_9721	EPHB4	K635N	0.504423152			P54760							
gdsc	EphB4_9721	EPHB4	V113I	-1.816686823			P54760							
gdsc	EphB4_9721	EPHB4	I878V	0.07972534099999999			P54760							
gdsc	EphB4_9721	EPHB4	D576G	-0.438034643			P54760							
gdsc	EphB4_9721	EPHB4	R105C	-1.5941856909999998			P54760							
gdsc	EphB4_9721	EPHB4	L21V	0.06072317			P54760							
gdsc	EphB4_9721	EPHB4	M185V	-0.680212193			P54760							
gdsc	EphB4_9721	EPHB4	A800T	-0.7201213740000001			P54760							
gdsc	EphB4_9721	EPHB4	A863S	-1.3883274559999998			P54760							
gdsc	EphB4_9721	EPHB4	Q244L	-0.6682380760000001			P54760							
gdsc	EphB4_9721	EPHB4	R917Q	0.54482291			P54760							
gdsc	EphB4_9721	EPHB4	E432D	-1.1173895109999998			P54760							
gdsc	EphB4_9721	EPHB4	A476S	-0.29085195			P54760							
gdsc	EphB4_9721	EPHB4	P208L	0.977152517			P54760							
gdsc	EphB4_9721	EPHB4	R360H	-0.027051076			P54760							
gdsc	EphB4_9721	EPHB4	R923G	-0.800003723			P54760							
gdsc	EphB4_9721	EPHB4	V113I	0.418016953			P54760							
gdsc	EphB4_9721	EPHB4	T140M	-1.791714183			P54760							
gdsc	EphB4_9721	EPHB4	S848F	-0.4741851			P54760							
gdsc	EphB4_9721	EPHB4	A882T	0.760610004			P54760							
gdsc	EphB4_9721	EPHB4	G579R	-1.577822447			P54760							
gdsc	EphB4_9721	EPHB4	P36S	1.704711352			P54760							
gdsc	EphB4_9721	EPHB4	V689I+Y308H	1.197678305			P54760							
gdsc	EphB4_9721	EPHB4	A371V	0.942399731			P54760							
gdsc	EphB4_9721	EPHB4	D576E	-0.810135212			P54760							
gdsc	EphB4_9721	EPHB4	I610T	-0.388651039			P54760							
gdsc	EphB4_9721	EPHB4	V113I	-0.654135162			P54760							
gdsc	EphB4_9721	EPHB4	D576E	-0.506471372			P54760							
gdsc	EphB4_9721	EPHB4	A371V	0.220108678			P54760							
gdsc	NVP-BHG712	EPHB4	T587A	-0.361709572			P54760							
gdsc	NVP-BHG712	EPHB4	A645S	0.857561839			P54760							
gdsc	NVP-BHG712	EPHB4	D576E	0.930410802			P54760							
gdsc	NVP-BHG712	EPHB4	D576E	-0.303913277			P54760							
gdsc	NVP-BHG712	EPHB4	A371V	1.119431213			P54760							
gdsc	NVP-BHG712	EPHB4	S575L+W9*	-0.159773586			P54760							
gdsc	NVP-BHG712	EPHB4	R795Q	0.009582848			P54760							
gdsc	NVP-BHG712	EPHB4	E609Q	0.198285687			P54760							
gdsc	NVP-BHG712	EPHB4	R105C+R102W	0.98588041			P54760							
gdsc	NVP-BHG712	EPHB4	T356S	1.13227806			P54760							
gdsc	NVP-BHG712	EPHB4	G533S	-1.4955577169999998			P54760							
gdsc	NVP-BHG712	EPHB4	S825N	-1.385461015			P54760							
gdsc	NVP-BHG712	EPHB4	V387L	0.152370489			P54760							
gdsc	NVP-BHG712	EPHB4	R333H	1.333240594			P54760							
gdsc	NVP-BHG712	EPHB4	A725S	-0.065163843			P54760							
gdsc	NVP-BHG712	EPHB4	A882T	1.341937677			P54760							
gdsc	NVP-BHG712	EPHB4	G382S	0.289001028			P54760							
gdsc	NVP-BHG712	EPHB4	R889G	1.217127802			P54760							
gdsc	NVP-BHG712	EPHB4	R656Q	0.921230844			P54760							
gdsc	NVP-BHG712	EPHB4	T775M	-0.7877102570000001			P54760							
gdsc	NVP-BHG712	EPHB4	V718L	1.721184798			P54760							
gdsc	NVP-BHG712	EPHB4	G462R	-0.633866258			P54760							
gdsc	NVP-BHG712	EPHB4	P235S	1.168188561			P54760							
gdsc	NVP-BHG712	EPHB4	P599R	-1.424656251			P54760							
gdsc	NVP-BHG712	EPHB4	R394Q	-0.542805499			P54760							
gdsc	NVP-BHG712	EPHB4	T403S	-0.306609082			P54760							
gdsc	NVP-BHG712	EPHB4	D576E	1.067327512			P54760							
gdsc	NVP-BHG712	EPHB4	A371V	-0.32164516			P54760							
gdsc	NVP-BHG712	EPHB4	K635N	0.3000799000000001			P54760							
gdsc	NVP-BHG712	EPHB4	V113I	-0.221727939			P54760							
gdsc	NVP-BHG712	EPHB4	I878V	1.547694005			P54760							
gdsc	NVP-BHG712	EPHB4	D576G	0.092872578			P54760							
gdsc	NVP-BHG712	EPHB4	R105C	-0.076533033			P54760							
gdsc	NVP-BHG712	EPHB4	L21V	-0.227012903			P54760							
gdsc	NVP-BHG712	EPHB4	M185V	0.260516731			P54760							
gdsc	NVP-BHG712	EPHB4	A800T	0.651253909			P54760							
gdsc	NVP-BHG712	EPHB4	A863S	-0.442638842			P54760							
gdsc	NVP-BHG712	EPHB4	Q244L	0.028869412			P54760							
gdsc	NVP-BHG712	EPHB4	R917Q	0.26460369100000003			P54760							
gdsc	NVP-BHG712	EPHB4	E432D	-0.075707702			P54760							
gdsc	NVP-BHG712	EPHB4	A476S	0.7417749140000001			P54760							
gdsc	NVP-BHG712	EPHB4	P208L	0.26222368			P54760							
gdsc	NVP-BHG712	EPHB4	R360H	0.756450761			P54760							
gdsc	NVP-BHG712	EPHB4	R923G	-0.05412763			P54760							
gdsc	NVP-BHG712	EPHB4	T140M	0.559636806			P54760							
gdsc	NVP-BHG712	EPHB4	S848F	0.034528826			P54760							
gdsc	NVP-BHG712	EPHB4	K162R	-0.498614431			P54760							
gdsc	NVP-BHG712	EPHB4	A882T	0.523276017			P54760							
gdsc	NVP-BHG712	EPHB4	G579R	0.113767737			P54760							
gdsc	NVP-BHG712	EPHB4	P36S	0.06304808			P54760							
gdsc	NVP-BHG712	EPHB4	V689I+Y308H	0.171383917			P54760							
gdsc	NVP-BHG712	EPHB4	V84I	-0.328310614			P54760							
gdsc	NVP-BHG712	EPHB4	A371V	-0.557811953			P54760							
gdsc	NVP-BHG712	EPHB4	D576E	-1.577937389			P54760							
gdsc	NVP-BHG712	EPHB4	I610T	0.500854616			P54760							
gdsc	NVP-BHG712	EPHB4	V113I	1.008248487			P54760							
gdsc	NVP-BHG712	EPHB4	D576E	0.8084424840000001			P54760							
gdsc	NVP-BHG712	EPHB4	A371V	1.556174832			P54760							
gdsc	Afatinib	ERBB2	L720P	-0.739731872			P04626							
gdsc	Afatinib	ERBB2	L755S	-1.223019765			P04626							
gdsc	Afatinib	ERBB2	A359D+R1161Q	0.276684755			P04626							
gdsc	Afatinib	ERBB2	A830V	-0.339655098			P04626							
gdsc	Afatinib	ERBB2	K1096R	-0.136254131			P04626							
gdsc	Afatinib	ERBB2	S335I+T479M	-0.248994086			P04626							
gdsc	Afatinib	ERBB2	A586G	0.230082525			P04626							
gdsc	Afatinib	ERBB2	P230L	-0.36770495			P04626							
gdsc	Afatinib	ERBB2	E930D	0.497600728			P04626							
gdsc	Afatinib	ERBB2	E744K	0.58001102			P04626							
gdsc	Afatinib	ERBB2	R226H	-0.251475388			P04626							
gdsc	Afatinib	ERBB2	V541M	0.425751018			P04626							
gdsc	Afatinib	ERBB2	S413L+F425L+L436V	-3.292935532			P04626							
gdsc	Afatinib	ERBB2	G518V	-0.611062448			P04626							
gdsc	Afatinib	ERBB2	R1048C	0.454956323			P04626							
gdsc	Afatinib	ERBB2	R1146W	-1.227147904			P04626							
gdsc	Afatinib	ERBB2	R678Q	-0.467436228			P04626							
gdsc	CP724714	ERBB2	S310F	0.740229714			P04626							
gdsc	CP724714	ERBB2	R143Q	1.369282034			P04626							
gdsc	CP724714	ERBB2	L720P	0.460241564			P04626							
gdsc	CP724714	ERBB2	E936K	0.5161229479999999			P04626							
gdsc	CP724714	ERBB2	L755S	0.636864824			P04626							
gdsc	CP724714	ERBB2	R143Q+D277H+S310F+L1024M	-0.963399168			P04626							
gdsc	CP724714	ERBB2	A359D+R1161Q	0.8296178890000001			P04626							
gdsc	CP724714	ERBB2	L755S	0.723638363			P04626							
gdsc	CP724714	ERBB2	V842I	0.143636671			P04626							
gdsc	CP724714	ERBB2	K591M	0.7037907170000001			P04626							
gdsc	CP724714	ERBB2	A830V	0.6343823129999999			P04626							
gdsc	CP724714	ERBB2	L1090P	0.498539186			P04626							
gdsc	CP724714	ERBB2	V1253M	0.506438785			P04626							
gdsc	CP724714	ERBB2	K1096R	0.494885925			P04626							
gdsc	CP724714	ERBB2	R816H	1.243819832			P04626							
gdsc	CP724714	ERBB2	T798I+V842I+V1253M	1.21689377			P04626							
gdsc	CP724714	ERBB2	D1144H	0.395257244			P04626							
gdsc	CP724714	ERBB2	D1125E	1.091397797			P04626							
gdsc	CP724714	ERBB2	D592E	0.6680283370000001			P04626							
gdsc	CP724714	ERBB2	R499Q	1.292443279			P04626							
gdsc	CP724714	ERBB2	R678Q	1.269056128			P04626							
gdsc	CP724714	ERBB2	A586G	0.318278662			P04626							
gdsc	CP724714	ERBB2	P230L	0.978719047			P04626							
gdsc	CP724714	ERBB2	V1253M	0.529367945			P04626							
gdsc	CP724714	ERBB2	L755S	1.197517741			P04626							
gdsc	CP724714	ERBB2	E930D	0.275764326			P04626							
gdsc	CP724714	ERBB2	E744K	1.3982806069999998			P04626							
gdsc	CP724714	ERBB2	R143Q	1.110430777			P04626							
gdsc	CP724714	ERBB2	W452S	1.241170833			P04626							
gdsc	CP724714	ERBB2	R896H	0.820737727			P04626							
gdsc	CP724714	ERBB2	P1149S	1.000861979			P04626							
gdsc	CP724714	ERBB2	R226H	0.150540304			P04626							
gdsc	CP724714	ERBB2	S335C	0.6755404509999999			P04626							
gdsc	CP724714	ERBB2	G776delinsVC	1.319910279			P04626							
gdsc	CP724714	ERBB2	V541M	1.859089772			P04626							
gdsc	CP724714	ERBB2	N319Y	0.768213954			P04626							
gdsc	CP724714	ERBB2	R647G	0.8807718370000001			P04626							
gdsc	CP724714	ERBB2	S1007*	0.90018223			P04626							
gdsc	CP724714	ERBB2	P1162S	1.560359552			P04626							
gdsc	CP724714	ERBB2	S310F	0.806951792			P04626							
gdsc	CP724714	ERBB2	A386T	0.325322121			P04626							
gdsc	CP724714	ERBB2	S1050L+D1144H	0.760009817			P04626							
gdsc	CP724714	ERBB2	G776V	0.5327184460000001			P04626							
gdsc	CP724714	ERBB2	S1122T	1.028488358			P04626							
gdsc	CP724714	ERBB2	L796P	0.821016195			P04626							
gdsc	CP724714	ERBB2	G518V	1.013930416			P04626							
gdsc	CP724714	ERBB2	R1048C	1.1318431759999998			P04626							
gdsc	CP724714	ERBB2	Q178H	1.287925582			P04626							
gdsc	CP724714	ERBB2	S1050L	0.6977509270000001			P04626							
gdsc	CP724714	ERBB2	D1144H	1.661683924			P04626							
gdsc	CP724714	ERBB2	D1144H	0.145046192			P04626							
gdsc	CP724714	ERBB2	R103*+V777M+C965*	0.342130913			P04626							
gdsc	CP724714	ERBB2	R1146W	-0.349574892			P04626							
gdsc	CP724714	ERBB2	R143Q	0.771736868			P04626							
gdsc	CP724714	ERBB2	S1050L	0.528837079			P04626							
gdsc	CP724714	ERBB2	R678Q	0.874376557			P04626							
gdsc	CP724714	ERBB2	R143Q	0.724522351			P04626							
gdsc	CP724714	ERBB2	R432W	1.071694717			P04626							
gdsc	CP724714	ERBB2	S653C	1.004296614			P04626							
gdsc	Fulvestrant	ESR1	K299N	0.163366424			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.54970075			P03372							
gdsc	Fulvestrant	ESR1	K299R	0.498831808			P03372							
gdsc	Fulvestrant	ESR1	R158H	-0.04530987			P03372							
gdsc	Fulvestrant	ESR1	G160S	0.595625984			P03372							
gdsc	Fulvestrant	ESR1	R158H	0.460537236			P03372							
gdsc	Fulvestrant	ESR1	R555H	0.804853543			P03372							
gdsc	Fulvestrant	ESR1	R164I	-0.727905792			P03372							
gdsc	Fulvestrant	ESR1	D426G	0.5518971779999999			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.429585694			P03372							
gdsc	Fulvestrant	ESR1	T182A	0.19199721600000005			P03372							
gdsc	Fulvestrant	ESR1	A569T	0.558388649			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.382800866			P03372							
gdsc	Fulvestrant	ESR1	E247K	0.51267528			P03372							
gdsc	Fulvestrant	ESR1	P146Q	-0.286880748			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.307781755			P03372							
gdsc	Fulvestrant	ESR1	R241L	1.07310248			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.856955135			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.53043441			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.487178609			P03372							
gdsc	Fulvestrant	ESR1	D321N	0.5655282189999999			P03372							
gdsc	Fulvestrant	ESR1	M297I	0.8352036559999999			P03372							
gdsc	Fulvestrant	ESR1	E181A	0.060528242			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.113985081			P03372							
gdsc	Fulvestrant	ESR1	V392I	0.164027527			P03372							
gdsc	Fulvestrant	ESR1	P146Q	1.089473579			P03372							
gdsc	Fulvestrant	ESR1	R548C	-0.065433147			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.324894436			P03372							
gdsc	Fulvestrant	ESR1	I298V	0.094860919			P03372							
gdsc	Fulvestrant	ESR1	E61K+S341L+D480G	1.544784905			P03372							
gdsc	Fulvestrant	ESR1	G276D	0.965599909			P03372							
gdsc	Fulvestrant	ESR1	G160C	0.053019683			P03372							
gdsc	Fulvestrant	ESR1	G160C	0.678017008			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.32926436600000003			P03372							
gdsc	Fulvestrant	ESR1	P146Q	0.8418360490000001			P03372							
gdsc	GDC0810	ESR1	P146Q	1.112037596			P03372							
gdsc	GDC0810	ESR1	G160C	1.366579711			P03372							
gdsc	Tamoxifen	ESR1	K299N	0.382905092			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.733214116			P03372							
gdsc	Tamoxifen	ESR1	K299R	1.5015048080000002			P03372							
gdsc	Tamoxifen	ESR1	R158H	0.17019898			P03372							
gdsc	Tamoxifen	ESR1	G160S	0.562104727			P03372							
gdsc	Tamoxifen	ESR1	R158H	0.260496131			P03372							
gdsc	Tamoxifen	ESR1	R555H	0.495666706			P03372							
gdsc	Tamoxifen	ESR1	R164I	-0.41748931			P03372							
gdsc	Tamoxifen	ESR1	D426G	0.457796972			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.5999605			P03372							
gdsc	Tamoxifen	ESR1	T182A	0.6242558779999999			P03372							
gdsc	Tamoxifen	ESR1	A569T	0.800053564			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.772731795			P03372							
gdsc	Tamoxifen	ESR1	E247K	0.085792385			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.26993601300000003			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.423875573			P03372							
gdsc	Tamoxifen	ESR1	R241L	0.218256266			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.877953387			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.097863561			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.337654916			P03372							
gdsc	Tamoxifen	ESR1	D321N	0.7828734159999999			P03372							
gdsc	Tamoxifen	ESR1	M297I	1.074115173			P03372							
gdsc	Tamoxifen	ESR1	E181A	1.233132			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.30216617100000004			P03372							
gdsc	Tamoxifen	ESR1	V392I	0.480663173			P03372							
gdsc	Tamoxifen	ESR1	P146Q	1.801125998			P03372							
gdsc	Tamoxifen	ESR1	R548C	0.007937462			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.551549406			P03372							
gdsc	Tamoxifen	ESR1	I298V	0.23218553			P03372							
gdsc	Tamoxifen	ESR1	E61K+S341L+D480G	1.146276697			P03372							
gdsc	Tamoxifen	ESR1	G276D	1.097181435			P03372							
gdsc	Tamoxifen	ESR1	G160C	0.83644509			P03372							
gdsc	Tamoxifen	ESR1	G160C	0.721556603			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.533293479			P03372							
gdsc	Tamoxifen	ESR1	P146Q	0.66764029			P03372							
gdsc	GSK343	EZH2	A345T	-0.050227302			Q15910							
gdsc	GSK343	EZH2	G648E	-0.041496447			Q15910							
gdsc	GSK343	EZH2	R347Q	-0.7043903109999999			Q15910							
gdsc	GSK343	EZH2	P132S	0.15126669			Q15910							
gdsc	GSK343	EZH2	R16Q	-0.649929705			Q15910							
gdsc	GSK343	EZH2	Y646N	-0.235150089			Q15910							
gdsc	GSK343	EZH2	P219S	-0.17549042899999998			Q15910							
gdsc	GSK343	EZH2	S220A+L71M	-0.904349176			Q15910							
gdsc	GSK343	EZH2	P193R	0.03253393			Q15910							
gdsc	GSK343	EZH2	R690C+N376H	-0.681576686			Q15910							
gdsc	GSK343	EZH2	S44F	-0.075235491			Q15910							
gdsc	GSK343	EZH2	R418Q	-0.062193717			Q15910							
gdsc	GSK343	EZH2	N546H+R78H	-0.184512787			Q15910							
gdsc	GSK343	EZH2	Y646N	0.116332011			Q15910							
gdsc	GSK343	EZH2	F224V+N268D	-0.620338054			Q15910							
gdsc	GSK343	EZH2	E749A	-0.33740110799999995			Q15910							
gdsc	GSK343	EZH2	Y646N	-0.406929193			Q15910							
gdsc	GSK343	EZH2	G159R	-0.811303			Q15910							
gdsc	GSK343	EZH2	H279Y	-0.552075516			Q15910							
gdsc	GSK343	EZH2	Y701C	0.084555277			Q15910							
gdsc	GSK343	EZH2	Y646S	-0.666182747			Q15910							
gdsc	GSK343	EZH2	D491Y	0.495346286			Q15910							
gdsc	GSK343	EZH2	S537N	0.159961996			Q15910							
gdsc	GSK343	EZH2	E403_E404delEE	0.560916573			Q15910							
gdsc	GSK343	EZH2	D189_G190insD	0.164969085			Q15910							
gdsc	GSK343	EZH2	R690H	-0.460278298			Q15910							
gdsc	GSK343	EZH2	W504R	-0.561222888			Q15910							
gdsc	GSK343	EZH2	E169K	0.011682614			Q15910							
gdsc	GSK343	EZH2	S538L	-0.538444811			Q15910							
gdsc	GSK343	EZH2	Y646C	-0.397374192			Q15910							
gdsc	GSK343	EZH2	T80P	0.374386376			Q15910							
gdsc	GSK343	EZH2	K291T	0.013066659			Q15910							
gdsc	GSK343	EZH2	E747*	-0.15479612199999998			Q15910							
gdsc	GSK343	EZH2	Y646F	-1.2563864340000002			Q15910							
gdsc	GSK343	EZH2	Y646N	-0.74805229			Q15910							
gdsc	GSK343	EZH2	Y646N	-0.43368936			Q15910							
gdsc	GSK343	EZH2	S624C	0.016104328			Q15910							
gdsc	C-75	FAS	A16T	0.282513912			P49327							
gdsc	C-75	FAS	D269N	0.527954869			P49327							
gdsc	C-75	FAS	I184V	0.25597889			P49327							
gdsc	C-75	FAS	A16T+T122I	0.847114556			P49327							
gdsc	C-75	FAS	T122I	1.857819484			P49327							
gdsc	C-75	FAS	A16T	0.855247002			P49327							
gdsc	C-75	FAS	R102K	0.188782824			P49327							
gdsc	C-75	FAS	I184V	0.741904076			P49327							
gdsc	C-75	FAS	A16T	0.384959859			P49327							
gdsc	C-75	FAS	A16T	0.161049206			P49327							
gdsc	C-75	FAS	A16T+Q273R	0.467100167			P49327							
gdsc	C-75	FAS	W176G	1.836908328			P49327							
gdsc	C-75	FAS	F134S	-0.094451549			P49327							
gdsc	C-75	FAS	R279H	0.876697912			P49327							
gdsc	C-75	FAS	A16T	1.26694155			P49327							
gdsc	C-75	FAS	V267F	2.545970973			P49327							
gdsc	C-75	FAS	A16T	1.93890991			P49327							
gdsc	C-75	FAS	A16T	1.959943119			P49327							
gdsc	C-75	FAS	I313V	1.665158255			P49327							
gdsc	C-75	FAS	A16T	1.603411271			P49327							
gdsc	C-75	FAS	A16T+T122I	0.782132013			P49327							
gdsc	C-75	FAS	R192I	0.763586648			P49327							
gdsc	C-75	FAS	C59Y	1.866120788			P49327							
gdsc	C-75	FAS	R105S	1.562575445			P49327							
gdsc	IGF1R_3801	FCGR1A	S66L	-2.433070041			P12314							
gdsc	IGF1R_3801	FCGR1A	C168F	0.510112783			P12314							
gdsc	IGF1R_3801	FCGR1A	R175H	-2.405574601			P12314							
gdsc	IGF1R_3801	FCGR1A	S66L	1.506938164			P12314							
gdsc	IGF1R_3801	FCGR1A	Y176C	-1.086625332			P12314							
gdsc	IGF1R_3801	FCGR1A	T67N	1.296388042			P12314							
gdsc	IGF1R_3801	FCGR1A	E359delE	0.628447985			P12314							
gdsc	IGF1R_3801	FCGR1A	T63I	-1.797530013			P12314							
gdsc	IGF1R_3801	FCGR1A	R237G	-0.631767085			P12314							
gdsc	IGF1R_3801	FCGR1A	E316K	-0.5229910320000001			P12314							
gdsc	IGF1R_3801	FCGR1A	S66L	-0.637067454			P12314							
gdsc	IGF1R_3801	FCGR1A	S66L	0.427289932			P12314							
gdsc	IGF1R_3801	FCGR1A	Q64E	-1.247108123			P12314							
gdsc	IGF1R_3801	FCGR1A	K234R	-2.365170696			P12314							
gdsc	IGF1R_3801	FCGR1A	G238A	-0.425356062			P12314							
gdsc	IGF1R_3801	FCGR1A	S66L	-1.200143041			P12314							
gdsc	IGF1R_3801	FCGR1A	R314C	-1.018657259			P12314							
gdsc	IGFR_3801	FCGR1A	S66L	-2.982701557			P12314							
gdsc	IGFR_3801	FCGR1A	C168F	-1.7177140219999998			P12314							
gdsc	IGFR_3801	FCGR1A	S66L	-0.65225817			P12314							
gdsc	IGFR_3801	FCGR1A	R175H	-2.845529487			P12314							
gdsc	IGFR_3801	FCGR1A	Y176C	-0.757600182			P12314							
gdsc	IGFR_3801	FCGR1A	T67N	-1.151784436			P12314							
gdsc	IGFR_3801	FCGR1A	E359delE	-0.656569089			P12314							
gdsc	IGFR_3801	FCGR1A	T63I	-1.096240767			P12314							
gdsc	IGFR_3801	FCGR1A	R237G	-2.010474959			P12314							
gdsc	IGFR_3801	FCGR1A	E316K	-2.177885081			P12314							
gdsc	IGFR_3801	FCGR1A	S66L	-1.3939057			P12314							
gdsc	IGFR_3801	FCGR1A	S66L	-1.276705698			P12314							
gdsc	IGFR_3801	FCGR1A	Q64E	-1.982943377			P12314							
gdsc	IGFR_3801	FCGR1A	S66L	-2.108577992			P12314							
gdsc	IGFR_3801	FCGR1A	S66L	-3.585308913			P12314							
gdsc	IGFR_3801	FCGR1A	S161R	-1.818766444			P12314							
gdsc	IGFR_3801	FCGR1A	K234R	-3.371356743			P12314							
gdsc	IGFR_3801	FCGR1A	G238A	0.537755752			P12314							
gdsc	IGFR_3801	FCGR1A	S66L	-1.901786593			P12314							
gdsc	IGFR_3801	FCGR1A	R314C	-1.708384757			P12314							
gdsc	IGFR_3801	FCGR1A	S66L	0.08975018300000001			P12314							
gdsc	AZD4547	FGFR1	S628F	-0.7217590540000001			P11362							
gdsc	AZD4547	FGFR1	S140L	-1.705894706			P11362							
gdsc	PD173074	FGFR1	S628F	0.740076568			P11362							
gdsc	PD173074	FGFR1	S140L	-1.997916433			P11362							
gdsc	FGFR_0939	FGFR4	T179A	0.357835907			P22455							
gdsc	FGFR_0939	FGFR4	A374T	-0.893324812			P22455							
gdsc	FGFR_0939	FGFR4	D465N	-0.447542246			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.62203493			P22455							
gdsc	FGFR_0939	FGFR4	T179A	0.34714155700000005			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.232309717			P22455							
gdsc	FGFR_0939	FGFR4	T667I	-0.301121489			P22455							
gdsc	FGFR_0939	FGFR4	D127H	-0.214948729			P22455							
gdsc	FGFR_0939	FGFR4	P463S	-0.472310478			P22455							
gdsc	FGFR_0939	FGFR4	S591F	-0.646067297			P22455							
gdsc	FGFR_0939	FGFR4	A328T	0.484035159			P22455							
gdsc	FGFR_0939	FGFR4	I339V	-0.713950645			P22455							
gdsc	FGFR_0939	FGFR4	L787M	-0.914212862			P22455							
gdsc	FGFR_0939	FGFR4	T122N	-1.136800496			P22455							
gdsc	FGFR_0939	FGFR4	I357N	0.454249173			P22455							
gdsc	FGFR_0939	FGFR4	V263E	-1.049425585			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.073209194			P22455							
gdsc	FGFR_0939	FGFR4	G448D	-0.274915888			P22455							
gdsc	FGFR_0939	FGFR4	R723C+D770N	-1.248076243			P22455							
gdsc	FGFR_0939	FGFR4	P455L+T361R+D363E	-0.2631681			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.753105			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.7000112559999999			P22455							
gdsc	FGFR_0939	FGFR4	P786L	-0.875841179			P22455							
gdsc	FGFR_0939	FGFR4	E326K	-0.444539533			P22455							
gdsc	FGFR_0939	FGFR4	S773N	-1.161879191			P22455							
gdsc	FGFR_0939	FGFR4	Y367C	-1.909677897			P22455							
gdsc	FGFR_0939	FGFR4	R183H	0.523672982			P22455							
gdsc	FGFR_0939	FGFR4	R59W	0.450345884			P22455							
gdsc	FGFR_0939	FGFR4	A374V	-1.1744848959999998			P22455							
gdsc	FGFR_0939	FGFR4	A328T	-0.6512556860000001			P22455							
gdsc	FGFR_0939	FGFR4	L757F	-1.071325599			P22455							
gdsc	FGFR_0939	FGFR4	A328T	0.629891278			P22455							
gdsc	FGFR_0939	FGFR4	C101Y	0.19137139			P22455							
gdsc	FGFR_0939	FGFR4	S772N	0.111418535			P22455							
gdsc	FGFR_0939	FGFR4	P691L	0.51928504			P22455							
gdsc	FGFR_0939	FGFR4	R707Q	-0.406709381			P22455							
gdsc	FGFR_0939	FGFR4	P712T	-0.572084911			P22455							
gdsc	FGFR_0939	FGFR4	H713R	0.002139462			P22455							
gdsc	FGFR_0939	FGFR4	V672A	0.25227467600000003			P22455							
gdsc	FGFR_0939	FGFR4	A374T	-0.36751296			P22455							
gdsc	FGFR_0939	FGFR4	D127H	0.228466861			P22455							
gdsc	FGFR_0939	FGFR4	C333Y	-1.503761853			P22455							
gdsc	FGFR_0939	FGFR4	P352L	-0.412139504			P22455							
gdsc	FGFR_0939	FGFR4	D127H	-0.242456611			P22455							
gdsc	FGFR_0939	FGFR4	D127H	-0.334032832			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.729333327			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.8141522590000001			P22455							
gdsc	FGFR_0939	FGFR4	R391Q	0.602120333			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.46905833			P22455							
gdsc	FGFR_0939	FGFR4	F796V	-0.521491453			P22455							
gdsc	FGFR_0939	FGFR4	R234H	-0.365859928			P22455							
gdsc	FGFR_0939	FGFR4	A515V+P545H+V750I	0.662473792			P22455							
gdsc	FGFR_0939	FGFR4	D127H	-1.3704071619999998			P22455							
gdsc	FGFR_0939	FGFR4	T179A+R616C	-0.113980439			P22455							
gdsc	FGFR_0939	FGFR4	L589P	0.307007232			P22455							
gdsc	FGFR_0939	FGFR4	R606Q	-0.953255829			P22455							
gdsc	FGFR_0939	FGFR4	A749S+E753V	-2.442367905			P22455							
gdsc	FGFR_0939	FGFR4	T179A	-0.383403401			P22455							
gdsc	Quizartinib	FLT3	Y376C	0.025821671			P36888							
gdsc	Quizartinib	FLT3	Q771P+V557I	-0.766512338			P36888							
gdsc	Quizartinib	FLT3	E661V	0.138682906			P36888							
gdsc	Quizartinib	FLT3	V491L	-3.797632934			P36888							
gdsc	Quizartinib	FLT3	A627T	-0.508130922			P36888							
gdsc	Quizartinib	FLT3	A642V	-1.681054621			P36888							
gdsc	Quizartinib	FLT3	V194M	-0.331898702			P36888							
gdsc	Quizartinib	FLT3	Q910*	-0.575884516			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.137708269			P36888							
gdsc	Quizartinib	FLT3	G831E	-0.864479691			P36888							
gdsc	Quizartinib	FLT3	G757E	-0.32143423600000004			P36888							
gdsc	Quizartinib	FLT3	V557I	0.013378306			P36888							
gdsc	Quizartinib	FLT3	V557I	-1.3661791909999998			P36888							
gdsc	Quizartinib	FLT3	I417L+R243K	-0.3496525070000001			P36888							
gdsc	Quizartinib	FLT3	L442P	0.021302789			P36888							
gdsc	Quizartinib	FLT3	V557I	-1.7934940069999998			P36888							
gdsc	Quizartinib	FLT3	A988P+Q771P	-0.03019717			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.655712356			P36888							
gdsc	Quizartinib	FLT3	F406C+V220G	-0.114561074			P36888							
gdsc	Quizartinib	FLT3	R311W	-0.13718925199999998			P36888							
gdsc	Quizartinib	FLT3	P116S	-0.730722111			P36888							
gdsc	Quizartinib	FLT3	S740*	0.040788428			P36888							
gdsc	Quizartinib	FLT3	D358V	-0.471735768			P36888							
gdsc	Quizartinib	FLT3	S519F	-0.487420025			P36888							
gdsc	Quizartinib	FLT3	K634N	-0.287013242			P36888							
gdsc	Quizartinib	FLT3	K207E	-0.402443491			P36888							
gdsc	Quizartinib	FLT3	D358V	-0.043727745			P36888							
gdsc	Quizartinib	FLT3	A445T	-0.231876018			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.37284473			P36888							
gdsc	Quizartinib	FLT3	V557I	-1.260074651			P36888							
gdsc	Quizartinib	FLT3	T820N	-1.6930038530000002			P36888							
gdsc	Quizartinib	FLT3	P336L	-0.08087298400000001			P36888							
gdsc	Quizartinib	FLT3	E293K	-0.478126309			P36888							
gdsc	Quizartinib	FLT3	V194M	-0.4952834820000001			P36888							
gdsc	Quizartinib	FLT3	D358V	-0.8889990809999999			P36888							
gdsc	Quizartinib	FLT3	M737V	-0.238132065			P36888							
gdsc	Quizartinib	FLT3	I417L	-0.308777577			P36888							
gdsc	Quizartinib	FLT3	S404F	0.065837498			P36888							
gdsc	Quizartinib	FLT3	C368Y	-0.106445811			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.30454427300000003			P36888							
gdsc	Quizartinib	FLT3	A988P	-1.172016013			P36888							
gdsc	Quizartinib	FLT3	T820N	0.046061542			P36888							
gdsc	Quizartinib	FLT3	P738R	-1.063168861			P36888							
gdsc	Quizartinib	FLT3	Y599F+E598_Y599insFDFREYE	-5.769805531			P36888							
gdsc	Quizartinib	FLT3	A443T	-1.575278318			P36888							
gdsc	Quizartinib	FLT3	A627T	-0.986291594			P36888							
gdsc	Quizartinib	FLT3	V592A+V194M	-4.911756669			P36888							
gdsc	Quizartinib	FLT3	D600_L601insHVDFREYEYD	-5.702887933			P36888							
gdsc	Quizartinib	FLT3	A988P	-0.48060408			P36888							
gdsc	Quizartinib	FLT3	S448C	0.026929617000000003			P36888							
gdsc	Quizartinib	FLT3	R485T	-0.053690376			P36888							
gdsc	Quizartinib	FLT3	P937H	-1.000277197			P36888							
gdsc	Quizartinib	FLT3	P738H+I417L	-0.739664483			P36888							
gdsc	Quizartinib	FLT3	V557I	0.175507019			P36888							
gdsc	Quizartinib	FLT3	I417L	0.117737978			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.017563618			P36888							
gdsc	Quizartinib	FLT3	D362E	0.433780602			P36888							
gdsc	Quizartinib	FLT3	V194M	-0.27649486			P36888							
gdsc	Quizartinib	FLT3	I417L	-0.059921538			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.627642206			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.68268878			P36888							
gdsc	Quizartinib	FLT3	N100S	0.005042638			P36888							
gdsc	Quizartinib	FLT3	A680V	-0.884105156			P36888							
gdsc	Quizartinib	FLT3	V194M	0.033884796			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.77176116			P36888							
gdsc	Quizartinib	FLT3	D358V	0.234454512			P36888							
gdsc	Quizartinib	FLT3	P336L	-0.175263507			P36888							
gdsc	Quizartinib	FLT3	D787H	0.021960447			P36888							
gdsc	Quizartinib	FLT3	V194M	-0.211585193			P36888							
gdsc	Quizartinib	FLT3	E716D	-0.125356739			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.204457601			P36888							
gdsc	Quizartinib	FLT3	V194M	-0.7026454440000001			P36888							
gdsc	Quizartinib	FLT3	G739R	-0.290732861			P36888							
gdsc	Quizartinib	FLT3	A450V+S59A	-0.036508318			P36888							
gdsc	Quizartinib	FLT3	H222R	-0.222331089			P36888							
gdsc	Quizartinib	FLT3	A948T	-0.78952326			P36888							
gdsc	Quizartinib	FLT3	D358V	-0.812663345			P36888							
gdsc	Quizartinib	FLT3	T432M	-0.941162623			P36888							
gdsc	Quizartinib	FLT3	K709T	-0.47721092			P36888							
gdsc	Quizartinib	FLT3	E991K	0.340960163			P36888							
gdsc	Quizartinib	FLT3	T382S	0.390317698			P36888							
gdsc	Quizartinib	FLT3	I417L	-0.356582209			P36888							
gdsc	Quizartinib	FLT3	V557I	-0.048830223			P36888							
gdsc	Quizartinib	FLT3	V194M	-0.455055545			P36888							
gdsc	Quizartinib	FLT3	L168F	-0.36208343			P36888							
gdsc	Quizartinib	FLT3	C272S	0.19739696			P36888							
gdsc	FTI-277	FNTA	K330T	-0.464867092			P49354							
gdsc	FTI-277	FNTA	W208*	-1.565859588			P49354							
gdsc	FTI-277	FNTA	F117L	-0.232345858			P49354							
gdsc	FTI-277	FNTA	V64I	-0.714011671			P49354							
gdsc	FTI-277	FNTA	S290Y	-0.410298062			P49354							
gdsc	FTI-277	FNTA	L280F	-0.466637437			P49354							
gdsc	FTI-277	FNTA	P304S	0.227810388			P49354							
gdsc	FTI-277	FNTA	N329S	-0.980859102			P49354							
gdsc	FTI-277	FNTA	R287C	-0.139086388			P49354							
gdsc	FTI-277	FNTA	Q221R	-0.143894402			P49354							
gdsc	FTI-277	FNTA	*380Q	-0.6608071329999999			P49354							
gdsc	FTI-277	FNTA	S235C+S245F	-0.09056248			P49354							
gdsc	FTI-277	FNTA	W72C	-0.541876483			P49354							
gdsc	FTI-277	FNTA	K336R	0.040887373			P49354							
gdsc	FTI-277	FNTA	V64I	-0.307276813			P49354							
gdsc	FTI-277	FNTA	N85S	-0.97944958			P49354							
gdsc	FTI-277	FNTA	V64I	0.004057336			P49354							
gdsc	Tipifarnib	FNTA	K330T	-0.583454693			P49354							
gdsc	Tipifarnib	FNTA	W208*	-0.938837713			P49354							
gdsc	Tipifarnib	FNTA	F117L	0.86442933			P49354							
gdsc	Tipifarnib	FNTA	V64I	-0.7591027229999999			P49354							
gdsc	Tipifarnib	FNTA	S290Y	-1.335909737			P49354							
gdsc	Tipifarnib	FNTA	L280F	-2.033280289			P49354							
gdsc	Tipifarnib	FNTA	P304S	0.249611457			P49354							
gdsc	Tipifarnib	FNTA	N329S	-2.0006794080000003			P49354							
gdsc	Tipifarnib	FNTA	R287C	-1.420610765			P49354							
gdsc	Tipifarnib	FNTA	Q221R	-0.212498212			P49354							
gdsc	Tipifarnib	FNTA	*380Q	-1.351114081			P49354							
gdsc	Tipifarnib	FNTA	S235C+S245F	-1.641199356			P49354							
gdsc	Tipifarnib	FNTA	W72C	-0.138288311			P49354							
gdsc	Tipifarnib	FNTA	K336R	-0.418579814			P49354							
gdsc	Tipifarnib	FNTA	V64I	-1.4628235269999998			P49354							
gdsc	Tipifarnib	FNTA	N85S	-0.440936633			P49354							
gdsc	Tipifarnib	FNTA	V64I	0.8469705820000001			P49354							
gdsc	BPTES	GLS	D585V	1.143762785			Q9UI32							
gdsc	BPTES	GLS	R307L	-0.161774999			Q9UI32							
gdsc	BPTES	GLS	D467N	1.64105479			Q9UI32							
gdsc	BPTES	GLS	E569D	-0.010867355			Q9UI32							
gdsc	BPTES	GLS	V453I	0.84743035			Q9UI32							
gdsc	BPTES	GLS	K346Q	0.480771161			Q9UI32							
gdsc	BPTES	GLS	A432S	1.033997282			Q9UI32							
gdsc	BPTES	GLS	F472L	0.449547214			Q9UI32							
gdsc	BPTES	GLS	R272M+R454*+E592G	1.211788922			Q9UI32							
gdsc	BPTES	GLS	L478R	0.492663515			Q9UI32							
gdsc	BPTES	GLS	V575L	0.989736301			Q9UI32							
gdsc	BPTES	GLS	H89P	0.5874006420000001			Q9UI32							
gdsc	BPTES	GLS	D634G	1.791772247			Q9UI32							
gdsc	BPTES	GLS	D12N	1.270383886			Q9UI32							
gdsc	BPTES	GLS	N331S	-0.8332059759999999			Q9UI32							
gdsc	BPTES	GLS	N654S	1.233092896			Q9UI32							
gdsc	BPTES	GLS	G243E	0.7036011209999999			Q9UI32							
gdsc	BPTES	GLS	G667R	0.535241246			Q9UI32							
gdsc	BPTES	GLS	E569D	0.703656815			Q9UI32							
gdsc	BPTES	GLS	A432S	1.43482566			Q9UI32							
gdsc	BPTES	GLS	N654S	0.699201922			Q9UI32							
gdsc	BPTES	GLS	V587A	1.4454886080000002			Q9UI32							
gdsc	AZD7969	GSK3B	A410V	-0.694687781			P49841							
gdsc	AZD7969	GSK3B	R96*	-0.867186162			P49841							
gdsc	AZD7969	GSK3B	L75V	-0.468237146			P49841							
gdsc	AZD7969	GSK3B	H310Q	-0.311508339			P49841							
gdsc	AZD7969	GSK3B	G65E	1.021061562			P49841							
gdsc	AZD7969	GSK3B	R332H	0.439550811			P49841							
gdsc	AZD7969	GSK3B	R332H	0.011798149			P49841							
gdsc	AZD7969	GSK3B	D33G	-0.012929795			P49841							
gdsc	AZD7969	GSK3B	R319Q	-0.977468904			P49841							
gdsc	AZD7969	GSK3B	V126I	-1.16773531			P49841							
gdsc	AZD7969	GSK3B	H310Q	-0.944661246			P49841							
gdsc	AZD7969	GSK3B	S21L	-0.005965135999999999			P49841							
gdsc	AZD7969	GSK3B	R367*+F318L	-1.075520983			P49841							
gdsc	AZD7969	GSK3B	P392S	-1.214557603			P49841							
gdsc	AZD7969	GSK3B	R319*	0.703973794			P49841							
gdsc	AZD7969	GSK3B	T403A	-0.117531201			P49841							
gdsc	AZD7969	GSK3B	Q164*	-0.031011837			P49841							
gdsc	KIN001-042	GSK3B	A410V	0.346781326			P49841							
gdsc	KIN001-042	GSK3B	R96*	0.976794656			P49841							
gdsc	KIN001-042	GSK3B	L75V	1.06011875			P49841							
gdsc	KIN001-042	GSK3B	H310Q	1.297897693			P49841							
gdsc	KIN001-042	GSK3B	G65E	0.450608354			P49841							
gdsc	KIN001-042	GSK3B	R332H	1.6525377369999998			P49841							
gdsc	KIN001-042	GSK3B	R332H	0.920449949			P49841							
gdsc	KIN001-042	GSK3B	D33G	1.121032107			P49841							
gdsc	KIN001-042	GSK3B	R319Q	1.059580773			P49841							
gdsc	KIN001-042	GSK3B	V126I	0.7203370379999999			P49841							
gdsc	KIN001-042	GSK3B	H310Q	1.037953302			P49841							
gdsc	KIN001-042	GSK3B	S21L	0.707033386			P49841							
gdsc	KIN001-042	GSK3B	R367*+F318L	0.958804449			P49841							
gdsc	KIN001-042	GSK3B	P392S	1.10323268			P49841							
gdsc	KIN001-042	GSK3B	R319*	1.55652736			P49841							
gdsc	KIN001-042	GSK3B	T403A	1.5594649			P49841							
gdsc	KIN001-042	GSK3B	Q164*	1.831773262			P49841							
gdsc	TWS119	GSK3B	A410V	-0.312349075			P49841							
gdsc	TWS119	GSK3B	R96*	-0.414235715			P49841							
gdsc	TWS119	GSK3B	L75V	-0.902284366			P49841							
gdsc	TWS119	GSK3B	H310Q	-0.14139174699999998			P49841							
gdsc	TWS119	GSK3B	G65E	0.500859356			P49841							
gdsc	TWS119	GSK3B	R332H	0.648341253			P49841							
gdsc	TWS119	GSK3B	R332H	-0.623766171			P49841							
gdsc	TWS119	GSK3B	D33G	-0.255167186			P49841							
gdsc	TWS119	GSK3B	R319Q	0.8043543390000001			P49841							
gdsc	TWS119	GSK3B	V126I	-2.2340508580000003			P49841							
gdsc	TWS119	GSK3B	H310Q	-0.399987049			P49841							
gdsc	TWS119	GSK3B	S21L	-0.635351618			P49841							
gdsc	TWS119	GSK3B	R367*+F318L	-0.409612557			P49841							
gdsc	TWS119	GSK3B	P392S	-1.057982842			P49841							
gdsc	TWS119	GSK3B	R319*	0.066719708			P49841							
gdsc	TWS119	GSK3B	T403A	1.014287091			P49841							
gdsc	TWS119	GSK3B	Q164*	0.20675111			P49841							
gdsc	AR-42	HDAC1	M245I	-2.616831557			Q13547							
gdsc	AR-42	HDAC1	D104N+A376T	-2.539460751			Q13547							
gdsc	AR-42	HDAC1	E250G	-2.568232996			Q13547							
gdsc	AR-42	HDAC1	E146K	-2.238633727			Q13547							
gdsc	AR-42	HDAC1	Y67H	-1.945090119			Q13547							
gdsc	AR-42	HDAC1	S88N	-2.692074159			Q13547							
gdsc	AR-42	HDAC1	D210G	-2.750173214			Q13547							
gdsc	AR-42	HDAC1	E455delE	-2.967263182			Q13547							
gdsc	AR-42	HDAC1	R77C	-1.312370911			Q13547							
gdsc	AR-42	HDAC1	E463delE	-2.718052838			Q13547							
gdsc	AR-42	HDAC1	V224D	-1.964467333			Q13547							
gdsc	AR-42	HDAC1	K476Q	-1.330086797			Q13547							
gdsc	AR-42	HDAC1	N83I+E250K	1.113981538			Q13547							
gdsc	AR-42	HDAC1	D422N	-2.545568084			Q13547							
gdsc	AR-42	HDAC1	S78P+A282T	-1.940291585			Q13547							
gdsc	Belinostat	HDAC1	M245I	-2.6146547680000003			Q13547							
gdsc	Belinostat	HDAC1	D104N+A376T	-2.053912978			Q13547							
gdsc	Belinostat	HDAC1	E250G	-2.293551732			Q13547							
gdsc	Belinostat	HDAC1	Y67H	-1.7785622069999998			Q13547							
gdsc	Belinostat	HDAC1	S88N	-2.4540718480000003			Q13547							
gdsc	Belinostat	HDAC1	D210G	-2.606589274			Q13547							
gdsc	Belinostat	HDAC1	E455delE	-2.79054868			Q13547							
gdsc	Belinostat	HDAC1	R77C	-1.278178616			Q13547							
gdsc	Belinostat	HDAC1	E463delE	-2.512950613			Q13547							
gdsc	Belinostat	HDAC1	V224D	-1.977982502			Q13547							
gdsc	Belinostat	HDAC1	K476Q	-1.016245846			Q13547							
gdsc	Belinostat	HDAC1	N83I+E250K	-0.327330644			Q13547							
gdsc	Belinostat	HDAC1	D422N	-2.367964262			Q13547							
gdsc	Belinostat	HDAC1	S78P+A282T	-1.731166981			Q13547							
gdsc	CAY10603	HDAC1	D104N+A376T	-1.570478006			Q13547							
gdsc	CAY10603	HDAC1	N83I+E250K	-0.6940852240000001			Q13547							
gdsc	CAY10603	HDAC1	D422N	-1.72478355			Q13547							
gdsc	CAY10603	HDAC1	S78P+A282T	-1.171011751			Q13547							
gdsc	Dacinostat	HDAC1	M245I	-4.343496839			Q13547							
gdsc	Dacinostat	HDAC1	D104N+A376T	-3.820081589			Q13547							
gdsc	Dacinostat	HDAC1	E250G	-3.716777725			Q13547							
gdsc	Dacinostat	HDAC1	E146K	-2.928597627			Q13547							
gdsc	Dacinostat	HDAC1	Y67H	-3.489402221			Q13547							
gdsc	Dacinostat	HDAC1	S88N	-3.504690697			Q13547							
gdsc	Dacinostat	HDAC1	D210G	-3.581150262			Q13547							
gdsc	Dacinostat	HDAC1	E455delE	-3.387933874			Q13547							
gdsc	Dacinostat	HDAC1	R77C	-0.957496835			Q13547							
gdsc	Dacinostat	HDAC1	E463delE	-3.930693752			Q13547							
gdsc	Dacinostat	HDAC1	V224D	-2.9937235510000004			Q13547							
gdsc	Dacinostat	HDAC1	K476Q	-2.333351895			Q13547							
gdsc	Dacinostat	HDAC1	S78P+A282T	-2.634553961			Q13547							
gdsc	Entinostat	HDAC1	D422N	-0.730482155			Q13547							
gdsc	JQ12	HDAC1	E455delE	-0.84191728			Q13547							
gdsc	JQ12	HDAC1	R77C	1.506729609			Q13547							
gdsc	Parthenolide	HDAC1	D104N+A376T	-0.542784762			Q13547							
gdsc	Parthenolide	HDAC1	E250G	-0.913732357			Q13547							
gdsc	Parthenolide	HDAC1	D210G	0.749885438			Q13547							
gdsc	Parthenolide	HDAC1	E455delE	1.003460025			Q13547							
gdsc	Parthenolide	HDAC1	R77C	1.417939844			Q13547							
gdsc	Parthenolide	HDAC1	E463delE	-0.30475105			Q13547							
gdsc	ACY-1215	HDAC6	Y1149*	1.83719509			Q9UBN7							
gdsc	ACY-1215	HDAC6	P748T	-0.42347196			Q9UBN7							
gdsc	ACY-1215	HDAC6	L119P	-1.036142077			Q9UBN7							
gdsc	ACY-1215	HDAC6	G930R	-0.80711591			Q9UBN7							
gdsc	ACY-1215	HDAC6	R243H	-1.307056322			Q9UBN7							
gdsc	ACY-1215	HDAC6	I1122V	1.410772556			Q9UBN7							
gdsc	ACY-1215	HDAC6	S1025L	-0.275106668			Q9UBN7							
gdsc	ACY-1215	HDAC6	R745Q	-0.619598041			Q9UBN7							
gdsc	ACY-1215	HDAC6	A612T	-0.740819236			Q9UBN7							
gdsc	ACY-1215	HDAC6	G1126C	-1.444462424			Q9UBN7							
gdsc	ACY-1215	HDAC6	N1200D	-1.383871378			Q9UBN7							
gdsc	ACY-1215	HDAC6	S925Y	0.07424900400000001			Q9UBN7							
gdsc	ACY-1215	HDAC6	R418W	-1.246922675			Q9UBN7							
gdsc	ACY-1215	HDAC6	E779Q	-1.867120903			Q9UBN7							
gdsc	ACY-1215	HDAC6	S1025L	-0.750745133			Q9UBN7							
gdsc	ACY-1215	HDAC6	A234T	-1.084176			Q9UBN7							
gdsc	ACY-1215	HDAC6	S1068F	-0.7401319540000001			Q9UBN7							
gdsc	ACY-1215	HDAC6	P45S	-0.547966041			Q9UBN7							
gdsc	ACY-1215	HDAC6	E436D	-1.144756974			Q9UBN7							
gdsc	ACY-1215	HDAC6	P1123A	-1.852724116			Q9UBN7							
gdsc	ACY-1215	HDAC6	I1177F	-0.8124506429999999			Q9UBN7							
gdsc	ACY-1215	HDAC6	G1083D	-1.168263214			Q9UBN7							
gdsc	ACY-1215	HDAC6	L199M	-1.910516263			Q9UBN7							
gdsc	ACY-1215	HDAC6	S563T	-1.729890177			Q9UBN7							
gdsc	ACY-1215	HDAC6	N1200D	-0.231723157			Q9UBN7							
gdsc	ACY-1215	HDAC6	G73A	0.344852196			Q9UBN7							
gdsc	ACY-1215	HDAC6	I1177F	-0.715793865			Q9UBN7							
gdsc	ACY-1215	HDAC6	A770V	-0.496863047			Q9UBN7							
gdsc	ACY-1215	HDAC6	G1083D	-0.000881025			Q9UBN7							
gdsc	ACY-1215	HDAC6	N1200D	-2.06026323			Q9UBN7							
gdsc	ACY-1215	HDAC6	P1033S	-0.143778868			Q9UBN7							
gdsc	ACY-1215	HDAC6	G1083D	-0.7885071490000001			Q9UBN7							
gdsc	ACY-1215	HDAC6	T1099I+N1200D	-0.159627242			Q9UBN7							
gdsc	ACY-1215	HDAC6	R835W	-0.951180948			Q9UBN7							
gdsc	ACY-1215	HDAC6	Q487K	-1.716274284			Q9UBN7							
gdsc	ACY-1215	HDAC6	R835Q	-1.3722172030000002			Q9UBN7							
gdsc	ACY-1215	HDAC6	R835Q	0.156005975			Q9UBN7							
gdsc	ACY-1215	HDAC6	R529H	-0.757927233			Q9UBN7							
gdsc	ACY-1215	HDAC6	A390T+A617T	-0.934074728			Q9UBN7							
gdsc	ACY-1215	HDAC6	W474*	-0.7984988120000001			Q9UBN7							
gdsc	ACY-1215	HDAC6	S1025L	-0.720590029			Q9UBN7							
gdsc	ACY-1215	HDAC6	T4I+V395I	-0.35157275			Q9UBN7							
gdsc	ACY-1215	HDAC6	S1025L	-0.549239884			Q9UBN7							
gdsc	ACY-1215	HDAC6	G521R	1.333350203			Q9UBN7							
gdsc	ACY-1215	HDAC6	S1089L	-1.203162344			Q9UBN7							
gdsc	Linsitinib	IGF1R	V1303I	0.466850536			P08069							
gdsc	Linsitinib	IGF1R	A241T	0.905518634			P08069							
gdsc	Linsitinib	IGF1R	R595H	-0.07163220000000001			P08069							
gdsc	Linsitinib	IGF1R	V554M	-0.083478434			P08069							
gdsc	Linsitinib	IGF1R	R107H	0.132007806			P08069							
gdsc	Linsitinib	IGF1R	D1318N	0.31214801600000003			P08069							
gdsc	Linsitinib	IGF1R	Y517C	-0.538331169			P08069							
gdsc	Linsitinib	IGF1R	G929E	-0.290598959			P08069							
gdsc	Linsitinib	IGF1R	G1229S	0.5621956770000001			P08069							
gdsc	Linsitinib	IGF1R	R739W+L17V	-0.069605892			P08069							
gdsc	Linsitinib	IGF1R	L17V+Y58F+M186L	0.145143347			P08069							
gdsc	Linsitinib	IGF1R	L133P+I298V+K630R	0.860756408			P08069							
gdsc	Linsitinib	IGF1R	R1353H	0.505392909			P08069							
gdsc	Linsitinib	IGF1R	S522N	0.697392585			P08069							
gdsc	Linsitinib	IGF1R	R437H	-1.755470338			P08069							
gdsc	Linsitinib	IGF1R	Y201H+D435G	0.172012465			P08069							
gdsc	Linsitinib	IGF1R	V492I	1.290237235			P08069							
gdsc	Linsitinib	IGF1R	N792D+R1246C	0.451439085			P08069							
gdsc	Linsitinib	IGF1R	K339N	0.777669387			P08069							
gdsc	Linsitinib	IGF1R	R437H	0.412059519			P08069							
gdsc	Linsitinib	IGF1R	V942I	1.158418487			P08069							
gdsc	Linsitinib	IGF1R	R437H	0.785844421			P08069							
gdsc	Linsitinib	IGF1R	R794Q	-0.6686634810000001			P08069							
gdsc	Linsitinib	IGF1R	S343F	-0.447245105			P08069							
gdsc	Linsitinib	IGF1R	T104M	-0.040959656			P08069							
gdsc	Linsitinib	IGF1R	D1146N	-1.177363154			P08069							
gdsc	Linsitinib	IGF1R	V579I	0.34435355			P08069							
gdsc	Linsitinib	IGF1R	R461H	0.015880434			P08069							
gdsc	Linsitinib	IGF1R	G1322*	0.72476532			P08069							
gdsc	Linsitinib	IGF1R	D38N	1.153853229			P08069							
gdsc	Linsitinib	IGF1R	G310S	-0.047958906			P08069							
gdsc	Linsitinib	IGF1R	S915L	-0.020355736			P08069							
gdsc	Linsitinib	IGF1R	P989S	1.66872155			P08069							
gdsc	Linsitinib	IGF1R	V388M	-0.028950082			P08069							
gdsc	Linsitinib	IGF1R	E302K	1.310192042			P08069							
gdsc	Linsitinib	IGF1R	E1037K	-0.207703976			P08069							
gdsc	Linsitinib	IGF1R	R595H	-0.457660108			P08069							
gdsc	Linsitinib	IGF1R	G410V	0.278939053			P08069							
gdsc	Linsitinib	IGF1R	D1341N	-1.4567025669999998			P08069							
gdsc	Linsitinib	IGF1R	T524S	0.643789912			P08069							
gdsc	Linsitinib	IGF1R	R437H	-0.52415852			P08069							
gdsc	Linsitinib	IGF1R	E1289*	0.396752903			P08069							
gdsc	Linsitinib	IGF1R	N284Y	0.519864956			P08069							
gdsc	Linsitinib	IGF1R	L17V	-0.8670972159999999			P08069							
gdsc	Linsitinib	IGF1R	D162N	-0.153260797			P08069							
gdsc	Linsitinib	IGF1R	R650Q	0.7398003040000001			P08069							
gdsc	Linsitinib	IGF1R	V259I	-0.599749424			P08069							
gdsc	Linsitinib	IGF1R	R437H	-0.182425075			P08069							
gdsc	Linsitinib	IGF1R	R437H	1.034455438			P08069							
gdsc	Linsitinib	IGF1R	R279H	0.7305561909999999			P08069							
gdsc	Linsitinib	IGF1R	P842S	1.058748575			P08069							
gdsc	Linsitinib	IGF1R	R252C	0.6984123790000001			P08069							
gdsc	Linsitinib	IGF1R	R275C+A395T+M826I+S1308L	1.093953184			P08069							
gdsc	Linsitinib	IGF1R	R1337C+R471C+T79A	-0.280256546			P08069							
gdsc	Linsitinib	IGF1R	F777L	0.992028624			P08069							
gdsc	Linsitinib	IGF1R	T677I	0.184578245			P08069							
gdsc	Linsitinib	IGF1R	M446V	0.050374879			P08069							
gdsc	Linsitinib	IGF1R	P190S	0.213644035			P08069							
gdsc	Linsitinib	IGF1R	A828T	-0.465804513			P08069							
gdsc	Linsitinib	IGF1R	S1009L	1.7789145380000002			P08069							
gdsc	NVP-ADW742	IGF1R	V1303I	0.560659435			P08069							
gdsc	NVP-ADW742	IGF1R	A241T	-0.5027481979999999			P08069							
gdsc	NVP-ADW742	IGF1R	R595H	-0.329727837			P08069							
gdsc	NVP-ADW742	IGF1R	V554M	-0.560095389			P08069							
gdsc	NVP-ADW742	IGF1R	R107H	-0.304152048			P08069							
gdsc	NVP-ADW742	IGF1R	D1318N	0.7788976390000001			P08069							
gdsc	NVP-ADW742	IGF1R	Y517C	-1.031908773			P08069							
gdsc	NVP-ADW742	IGF1R	G1229S	-0.622563427			P08069							
gdsc	NVP-ADW742	IGF1R	R739W+L17V	-0.536945233			P08069							
gdsc	NVP-ADW742	IGF1R	L17V+Y58F+M186L	-0.46310919			P08069							
gdsc	NVP-ADW742	IGF1R	L133P+I298V+K630R	1.092778287			P08069							
gdsc	NVP-ADW742	IGF1R	R1353H	-0.351573935			P08069							
gdsc	NVP-ADW742	IGF1R	S522N	-0.507875561			P08069							
gdsc	NVP-ADW742	IGF1R	R437H	-2.002753105			P08069							
gdsc	NVP-ADW742	IGF1R	Y201H+D435G	-0.187947421			P08069							
gdsc	NVP-ADW742	IGF1R	V492I	0.2586113			P08069							
gdsc	NVP-ADW742	IGF1R	N792D+R1246C	-0.413959025			P08069							
gdsc	NVP-ADW742	IGF1R	K339N	1.636838669			P08069							
gdsc	NVP-ADW742	IGF1R	V942I	-0.279304423			P08069							
gdsc	NVP-ADW742	IGF1R	R437H	0.506490331			P08069							
gdsc	NVP-ADW742	IGF1R	S343F	-0.780180368			P08069							
gdsc	NVP-ADW742	IGF1R	D1146N	-0.5925025279999999			P08069							
gdsc	NVP-ADW742	IGF1R	V579I	-0.434420486			P08069							
gdsc	NVP-ADW742	IGF1R	R461H	-1.4339920330000002			P08069							
gdsc	NVP-ADW742	IGF1R	D38N	1.310136058			P08069							
gdsc	NVP-ADW742	IGF1R	G310S	-0.545098415			P08069							
gdsc	NVP-ADW742	IGF1R	S915L	0.130926688			P08069							
gdsc	NVP-ADW742	IGF1R	P989S	-0.115589628			P08069							
gdsc	NVP-ADW742	IGF1R	V388M	-0.4761468170000001			P08069							
gdsc	NVP-ADW742	IGF1R	E302K	1.427076551			P08069							
gdsc	NVP-ADW742	IGF1R	E1037K	-0.108895143			P08069							
gdsc	NVP-ADW742	IGF1R	G410V	0.226068482			P08069							
gdsc	NVP-ADW742	IGF1R	T524S	-0.601293224			P08069							
gdsc	NVP-ADW742	IGF1R	R437H	-0.249453856			P08069							
gdsc	NVP-ADW742	IGF1R	E1289*	0.241483158			P08069							
gdsc	NVP-ADW742	IGF1R	N284Y	1.186628464			P08069							
gdsc	NVP-ADW742	IGF1R	D162N	0.137577922			P08069							
gdsc	NVP-ADW742	IGF1R	V259I	-0.839956155			P08069							
gdsc	NVP-ADW742	IGF1R	R437H	0.654261361			P08069							
gdsc	NVP-ADW742	IGF1R	R437H	1.2315868			P08069							
gdsc	NVP-ADW742	IGF1R	R279H	1.432125114			P08069							
gdsc	NVP-ADW742	IGF1R	P842S	0.998003833			P08069							
gdsc	NVP-ADW742	IGF1R	R252C	0.95818471			P08069							
gdsc	NVP-ADW742	IGF1R	R1337C+R471C+T79A	-0.213598456			P08069							
gdsc	NVP-ADW742	IGF1R	T677I	-0.550792194			P08069							
gdsc	NVP-ADW742	IGF1R	M446V	-0.5727390139999999			P08069							
gdsc	NVP-ADW742	IGF1R	P190S	-0.174910386			P08069							
gdsc	NVP-ADW742	IGF1R	A828T	-1.287709918			P08069							
gdsc	NVP-ADW742	IGF1R	S1009L	1.863008466			P08069							
gdsc	IMD-0354	IKBKB	R57W	-1.249047325			Q96Q05							
gdsc	IMD-0354	IKBKB	C464R	-2.265568677			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.042252286			Q96Q05							
gdsc	IMD-0354	IKBKB	R645W	-1.936800664			Q96Q05							
gdsc	IMD-0354	IKBKB	Q611*	-1.706799861			Q96Q05							
gdsc	IMD-0354	IKBKB	H284Y	-1.983717162			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q+M590I	-0.994125428			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.028166553			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.608887015			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.284397842			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.337198898			Q96Q05							
gdsc	IMD-0354	IKBKB	S239T+D242N+R526Q	-1.440618975			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.897793838			Q96Q05							
gdsc	IMD-0354	IKBKB	D90N	-1.707661926			Q96Q05							
gdsc	IMD-0354	IKBKB	Y199C	-1.650371613			Q96Q05							
gdsc	IMD-0354	IKBKB	A360S	-1.5631495619999998			Q96Q05							
gdsc	IMD-0354	IKBKB	P296L	-1.826320625			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.312831185			Q96Q05							
gdsc	IMD-0354	IKBKB	V327A	-1.101888925			Q96Q05							
gdsc	IMD-0354	IKBKB	A755V	-2.023762614			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	0.106834481			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q+N677D	-1.505933902			Q96Q05							
gdsc	IMD-0354	IKBKB	T8R	-0.5160666620000001			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.881858961			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-0.168083777			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.489836091			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.763501837			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.589606376			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-0.8635423809999999			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.400397555			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.085299858			Q96Q05							
gdsc	IMD-0354	IKBKB	G374S+R526Q	-1.556051595			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.899927968			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.611275321			Q96Q05							
gdsc	IMD-0354	IKBKB	S507*	-2.120705562			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.11312709			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.288123979			Q96Q05							
gdsc	IMD-0354	IKBKB	*757*	0.082212592			Q96Q05							
gdsc	IMD-0354	IKBKB	E502K	-1.913003514			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.294047641			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.332629656			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.927073842			Q96Q05							
gdsc	IMD-0354	IKBKB	G685W	-2.437536784			Q96Q05							
gdsc	IMD-0354	IKBKB	F734L	-1.767842972			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.933087563			Q96Q05							
gdsc	IMD-0354	IKBKB	T344M	-2.133403695			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	0.30971548			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.417032157			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.831407699			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.513834094			Q96Q05							
gdsc	IMD-0354	IKBKB	R20H	-0.068423102			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-0.626646832			Q96Q05							
gdsc	IMD-0354	IKBKB	T344M	-1.949140344			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.324105578			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-0.806058917			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-0.293306615			Q96Q05							
gdsc	IMD-0354	IKBKB	A710T	-0.5041660139999999			Q96Q05							
gdsc	IMD-0354	IKBKB	T344M	-2.05529169			Q96Q05							
gdsc	IMD-0354	IKBKB	I413S	-1.999255667			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.554897435			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-2.259572138			Q96Q05							
gdsc	IMD-0354	IKBKB	R55*	-1.115439643			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.47415776			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-1.875918116			Q96Q05							
gdsc	IMD-0354	IKBKB	R118W	-1.151354884			Q96Q05							
gdsc	IMD-0354	IKBKB	K337N	-1.74529004			Q96Q05							
gdsc	IMD-0354	IKBKB	R526Q	-0.89949554			Q96Q05							
gdsc	KIN001-260	IKBKB	R57W	1.131496573			Q96Q05							
gdsc	KIN001-260	IKBKB	C464R	0.7380428529999999			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.525398211			Q96Q05							
gdsc	KIN001-260	IKBKB	R645W	-0.167155354			Q96Q05							
gdsc	KIN001-260	IKBKB	Q611*	1.5218356000000002			Q96Q05							
gdsc	KIN001-260	IKBKB	H284Y	0.12999471			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q+M590I	1.672151352			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.987281636			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.943854195			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.060196958			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.582829622			Q96Q05							
gdsc	KIN001-260	IKBKB	S239T+D242N+R526Q	0.413050153			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.41228881			Q96Q05							
gdsc	KIN001-260	IKBKB	D90N	1.7719992530000002			Q96Q05							
gdsc	KIN001-260	IKBKB	Y199C	1.461626707			Q96Q05							
gdsc	KIN001-260	IKBKB	A360S	1.021436012			Q96Q05							
gdsc	KIN001-260	IKBKB	P296L	1.399510606			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.7098518359999999			Q96Q05							
gdsc	KIN001-260	IKBKB	V327A	1.668877282			Q96Q05							
gdsc	KIN001-260	IKBKB	A755V	0.874212439			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.4889947630000002			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q+N677D	1.184098554			Q96Q05							
gdsc	KIN001-260	IKBKB	T8R	1.207941918			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.204721763			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.5151938459999998			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.12474648			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.121161861			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.5276934969999998			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.283890169			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.459108647			Q96Q05							
gdsc	KIN001-260	IKBKB	G374S+R526Q	1.275247001			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.265210395			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.464286457			Q96Q05							
gdsc	KIN001-260	IKBKB	S507*	1.304889013			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.808930013			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.5135391220000001			Q96Q05							
gdsc	KIN001-260	IKBKB	*757*	1.902275985			Q96Q05							
gdsc	KIN001-260	IKBKB	E502K	-0.065556068			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.457553461			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.6264507189999999			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	-0.323263236			Q96Q05							
gdsc	KIN001-260	IKBKB	G685W	0.74068178			Q96Q05							
gdsc	KIN001-260	IKBKB	F734L	1.667016879			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	-0.118989305			Q96Q05							
gdsc	KIN001-260	IKBKB	T344M	1.079556989			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.7501821869999998			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.447482319			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.028826075			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	-0.143627191			Q96Q05							
gdsc	KIN001-260	IKBKB	R20H	0.520524518			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.774560564			Q96Q05							
gdsc	KIN001-260	IKBKB	T344M	-0.288469569			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.445072177			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	2.066003222			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	2.338188348			Q96Q05							
gdsc	KIN001-260	IKBKB	A710T	1.7859617490000002			Q96Q05							
gdsc	KIN001-260	IKBKB	T344M	1.188607956			Q96Q05							
gdsc	KIN001-260	IKBKB	I413S	1.237110535			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.341482057			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.7587785480000002			Q96Q05							
gdsc	KIN001-260	IKBKB	R55*	1.02657878			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	0.582087238			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.622642141			Q96Q05							
gdsc	KIN001-260	IKBKB	R118W	1.339020875			Q96Q05							
gdsc	KIN001-260	IKBKB	K337N	1.73102834			Q96Q05							
gdsc	KIN001-260	IKBKB	R526Q	1.607784401			Q96Q05							
gdsc	IRAK4_4710	IRAK4	I5V	0.660600948			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	R183Q	1.462761908			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	I381V	0.649778029			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	R183Q	0.194244349			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	Q139*	0.918279677			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	H390R	1.4741619069999998			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	M218I	0.8092168609999999			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	R183Q	1.801610456			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	H306N	1.597026656			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	R183Q	1.696514325			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	K416R	1.5376549430000002			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	A38V	1.421053944			Q9NWZ3							
gdsc	IRAK4_4710	IRAK4	W74*	1.278889005			Q9NWZ3							
gdsc	BMS-509744	ITK	T504S	0.027978908			Q08881							
gdsc	BMS-509744	ITK	P156H	-0.6348100870000001			Q08881							
gdsc	BMS-509744	ITK	C143Y	-0.04178321			Q08881							
gdsc	BMS-509744	ITK	T504S	-0.20810553			Q08881							
gdsc	BMS-509744	ITK	V176A	0.161529118			Q08881							
gdsc	BMS-509744	ITK	R19K	0.06452396			Q08881							
gdsc	BMS-509744	ITK	K385N	0.918228131			Q08881							
gdsc	BMS-509744	ITK	P558T	-0.7368596609999999			Q08881							
gdsc	BMS-509744	ITK	R581W	-1.324224753			Q08881							
gdsc	BMS-509744	ITK	P23L	-0.274063895			Q08881							
gdsc	BMS-509744	ITK	R581W	-0.597048071			Q08881							
gdsc	BMS-509744	ITK	F26I	1.235211621			Q08881							
gdsc	BMS-509744	ITK	R394Q	0.833316178			Q08881							
gdsc	BMS-509744	ITK	R265T	0.296242377			Q08881							
gdsc	BMS-509744	ITK	R610H	-0.213583644			Q08881							
gdsc	BMS-509744	ITK	N151H	-0.601302704			Q08881							
gdsc	BMS-509744	ITK	L508M	1.183218714			Q08881							
gdsc	BMS-509744	ITK	M438L	0.105188558			Q08881							
gdsc	BMS-509744	ITK	G216W	-0.574710803			Q08881							
gdsc	AZD1480	JAK1	S333P+S22F+E347_N348insY	-1.032346027			P23458							
gdsc	AZD1480	JAK1	L799P+C657R+D82A	-0.300188325			P23458							
gdsc	AZD1480	JAK1	E897K+R755Q	-0.781515829			P23458							
gdsc	AZD1480	JAK1	A760V	0.169156767			P23458							
gdsc	AZD1480	JAK1	A906V	0.388404565			P23458							
gdsc	JAK1_3715	JAK1	A193V	0.740640898			P23458							
gdsc	JAK1_3715	JAK1	R1113H	0.951021569			P23458							
gdsc	JAK1_3715	JAK1	I375V	1.4471303830000002			P23458							
gdsc	JAK1_3715	JAK1	K939E	0.961409605			P23458							
gdsc	JAK1_3715	JAK1	V938A	1.258981517			P23458							
gdsc	JAK1_3715	JAK1	P370S	0.7496028229999999			P23458							
gdsc	JAK1_3715	JAK1	I943N+A428P+G282C	1.094626247			P23458							
gdsc	JAK1_3715	JAK1	S333P+S22F+E347_N348insY	-0.071238589			P23458							
gdsc	JAK1_3715	JAK1	F837L	0.934388745			P23458							
gdsc	JAK1_3715	JAK1	K982T	1.129492197			P23458							
gdsc	JAK1_3715	JAK1	L799P+C657R+D82A	1.30209604			P23458							
gdsc	JAK1_3715	JAK1	S102F	0.398493395			P23458							
gdsc	JAK1_3715	JAK1	Y654F	-0.236292992			P23458							
gdsc	JAK1_3715	JAK1	E897K+R755Q	0.519736513			P23458							
gdsc	JAK1_3715	JAK1	K768R	0.5778379379999999			P23458							
gdsc	JAK1_3715	JAK1	E1051Q	1.281189623			P23458							
gdsc	JAK1_3715	JAK1	A760V	0.895266977			P23458							
gdsc	JAK1_3715	JAK1	R681W	1.556203864			P23458							
gdsc	JAK1_3715	JAK1	A449T	1.231577912			P23458							
gdsc	JAK1_3715	JAK1	Q161*	1.134488028			P23458							
gdsc	JAK1_3715	JAK1	H525Y	1.691614476			P23458							
gdsc	JAK1_3715	JAK1	I62V	1.197513001			P23458							
gdsc	JAK1_3715	JAK1	L423V	1.560424725			P23458							
gdsc	JAK1_3715	JAK1	T593M	0.447467			P23458							
gdsc	JAK1_3715	JAK1	V658F	-0.555920149			P23458							
gdsc	JAK1_3715	JAK1	F516S	1.193982385			P23458							
gdsc	JAK1_3715	JAK1	M299T	1.017440295			P23458							
gdsc	JAK1_3715	JAK1	P969S	0.33954471700000005			P23458							
gdsc	JAK1_3715	JAK1	L881F	0.799924923			P23458							
gdsc	JAK1_3715	JAK1	A906V	1.5162804630000002			P23458							
gdsc	JAK1_3715	JAK1	G948R	2.014812539			P23458							
gdsc	JAK1_3715	JAK1	R343Q	0.362895134			P23458							
gdsc	JAK1_3715	JAK1	K205T	0.462154697			P23458							
gdsc	JAK1_8709	JAK1	A193V	0.090540558			P23458							
gdsc	JAK1_8709	JAK1	R1113H	0.591374437			P23458							
gdsc	JAK1_8709	JAK1	I375V	1.418809019			P23458							
gdsc	JAK1_8709	JAK1	K939E	0.533838835			P23458							
gdsc	JAK1_8709	JAK1	V938A	-0.043874088			P23458							
gdsc	JAK1_8709	JAK1	P370S	1.1344909909999998			P23458							
gdsc	JAK1_8709	JAK1	I943N+A428P+G282C	0.793906463			P23458							
gdsc	JAK1_8709	JAK1	S333P+S22F+E347_N348insY	-0.897978779			P23458							
gdsc	JAK1_8709	JAK1	F837L	0.77252428			P23458							
gdsc	JAK1_8709	JAK1	K982T	0.844261742			P23458							
gdsc	JAK1_8709	JAK1	L799P+C657R+D82A	0.989470275			P23458							
gdsc	JAK1_8709	JAK1	S102F	0.652625511			P23458							
gdsc	JAK1_8709	JAK1	Y654F	-0.31687328800000003			P23458							
gdsc	JAK1_8709	JAK1	E897K+R755Q	0.447971205			P23458							
gdsc	JAK1_8709	JAK1	E1051Q	1.283798926			P23458							
gdsc	JAK1_8709	JAK1	R681W	1.644228731			P23458							
gdsc	JAK1_8709	JAK1	A449T	0.316964531			P23458							
gdsc	JAK1_8709	JAK1	Q161*	1.119037803			P23458							
gdsc	JAK1_8709	JAK1	H525Y	1.75065499			P23458							
gdsc	JAK1_8709	JAK1	I62V	1.140484566			P23458							
gdsc	JAK1_8709	JAK1	V658F	-1.555904659			P23458							
gdsc	JAK1_8709	JAK1	F516S	1.741309135			P23458							
gdsc	JAK1_8709	JAK1	M299T	0.431215143			P23458							
gdsc	JAK1_8709	JAK1	P969S	0.370931005			P23458							
gdsc	JAK1_8709	JAK1	L881F	1.376184481			P23458							
gdsc	JAK1_8709	JAK1	A906V	0.76468156			P23458							
gdsc	JAK1_8709	JAK1	G948R	2.05762371			P23458							
gdsc	JAK1_8709	JAK1	R343Q	2.24892341			P23458							
gdsc	JAK_8517	JAK1	S333P+S22F+E347_N348insY	-0.7351864840000001			P23458							
gdsc	JAK_8517	JAK1	L799P+C657R+D82A	0.650395398			P23458							
gdsc	JAK_8517	JAK1	E897K+R755Q	0.265369181			P23458							
gdsc	JAK_8517	JAK1	A906V	-0.003056036			P23458							
gdsc	Ruxolitinib	JAK1	S333P+S22F+E347_N348insY	0.317590265			P23458							
gdsc	Ruxolitinib	JAK1	L799P+C657R+D82A	1.288256776			P23458							
gdsc	Ruxolitinib	JAK1	E897K+R755Q	1.103708487			P23458							
gdsc	Ruxolitinib	JAK1	A760V	1.5172284390000002			P23458							
gdsc	Ruxolitinib	JAK1	A906V	1.681155231			P23458							
gdsc	AZ960	JAK2	L383P	-1.434470761			O60674							
gdsc	AZ960	JAK2	D194N+D319N	-0.501123604			O60674							
gdsc	AZ960	JAK2	T7M	0.030471491			O60674							
gdsc	AZ960	JAK2	H172R	-0.218145184			O60674							
gdsc	AZ960	JAK2	V563I+R1063C+D1128N+N1129S	0.968036547			O60674							
gdsc	AZ960	JAK2	H606Q	-1.027885209			O60674							
gdsc	Fedratinib	JAK2	G1093R	-0.198258433			O60674							
gdsc	Fedratinib	JAK2	N337D	-0.260015489			O60674							
gdsc	Fedratinib	JAK2	G571S	-0.326198998			O60674							
gdsc	Fedratinib	JAK2	P275S+G276A+S277R+K926R	-1.023554738			O60674							
gdsc	Fedratinib	JAK2	N337D	-0.6730466829999999			O60674							
gdsc	Fedratinib	JAK2	F537L+V984A	0.441650577			O60674							
gdsc	Fedratinib	JAK2	N691H+K912T	0.101257422			O60674							
gdsc	Fedratinib	JAK2	L383P	0.3965921120000001			O60674							
gdsc	Fedratinib	JAK2	V617F	-1.624027963			O60674							
gdsc	Fedratinib	JAK2	D194N+D319N	0.376352833			O60674							
gdsc	Fedratinib	JAK2	V149A	-0.7113656340000001			O60674							
gdsc	Fedratinib	JAK2	E846D	1.149070855			O60674							
gdsc	Fedratinib	JAK2	F560L	1.47765579			O60674							
gdsc	Fedratinib	JAK2	C675W	-1.283731383			O60674							
gdsc	Fedratinib	JAK2	S411N	1.523745179			O60674							
gdsc	Fedratinib	JAK2	T7M	-0.429352964			O60674							
gdsc	Fedratinib	JAK2	P811T	-0.454904461			O60674							
gdsc	Fedratinib	JAK2	L634P	0.427990841			O60674							
gdsc	Fedratinib	JAK2	I67M	-0.235912024			O60674							
gdsc	Fedratinib	JAK2	H172R	0.174940011			O60674							
gdsc	Fedratinib	JAK2	N1108S	0.94138836			O60674							
gdsc	Fedratinib	JAK2	S507*	0.327439661			O60674							
gdsc	Fedratinib	JAK2	W157*	-0.323596805			O60674							
gdsc	Fedratinib	JAK2	R426*	0.231913937			O60674							
gdsc	Fedratinib	JAK2	S797C	-0.253133186			O60674							
gdsc	Fedratinib	JAK2	R1117M	-0.954375033			O60674							
gdsc	Fedratinib	JAK2	N1108S	-0.337048579			O60674							
gdsc	Fedratinib	JAK2	N337D	-1.046143812			O60674							
gdsc	Fedratinib	JAK2	Y42H	1.517415072			O60674							
gdsc	Fedratinib	JAK2	F85S	0.664953341			O60674							
gdsc	Fedratinib	JAK2	E592K	0.968429956			O60674							
gdsc	Fedratinib	JAK2	S797C	-0.574801453			O60674							
gdsc	Fedratinib	JAK2	V563I+R1063C+D1128N+N1129S	-0.939510776			O60674							
gdsc	Fedratinib	JAK2	F547V	-0.055624246			O60674							
gdsc	Fedratinib	JAK2	Y96H	-2.025620054			O60674							
gdsc	Fedratinib	JAK2	H606Q	-0.806126461			O60674							
gdsc	Fedratinib	JAK2	T108A	1.561647613			O60674							
gdsc	Fedratinib	JAK2	Y934N	-0.522829283			O60674							
gdsc	JAK3_7406	JAK3	N108S	-0.011146416			P52333							
gdsc	JAK3_7406	JAK3	D740Y	0.052921923			P52333							
gdsc	JAK3_7406	JAK3	F358C	0.805076578			P52333							
gdsc	JAK3_7406	JAK3	P37A	1.5002507880000002			P52333							
gdsc	JAK3_7406	JAK3	K830M	1.165290718			P52333							
gdsc	JAK3_7406	JAK3	R40H	0.8147358570000001			P52333							
gdsc	JAK3_7406	JAK3	P1045S	1.120744752			P52333							
gdsc	JAK3_7406	JAK3	R925S	-0.628143448			P52333							
gdsc	JAK3_7406	JAK3	V957M	1.4543444769999998			P52333							
gdsc	JAK3_7406	JAK3	T321N	-0.22744364			P52333							
gdsc	JAK3_7406	JAK3	S504C	-0.291351415			P52333							
gdsc	JAK3_7406	JAK3	Y1023H	0.758074762			P52333							
gdsc	JAK3_7406	JAK3	H645Y	-0.390196831			P52333							
gdsc	JAK3_7406	JAK3	H315R	0.957541272			P52333							
gdsc	JAK3_7406	JAK3	R918H+M598T	0.207433652			P52333							
gdsc	JAK3_7406	JAK3	A573V	-0.688091648			P52333							
gdsc	JAK3_7406	JAK3	R395C	1.066358799			P52333							
gdsc	JAK3_7406	JAK3	F71L	1.051536608			P52333							
gdsc	JAK3_7406	JAK3	P132T	0.437577837			P52333							
gdsc	JAK3_7406	JAK3	H1113R+G987C+V963I	1.017202116			P52333							
gdsc	JAK3_7406	JAK3	A573T	0.5734505879999999			P52333							
gdsc	JAK3_7406	JAK3	E1115K	-0.096616489			P52333							
gdsc	JAK3_7406	JAK3	P132T	-0.07235957			P52333							
gdsc	JAK3_7406	JAK3	P132T	0.541321917			P52333							
gdsc	JAK3_7406	JAK3	M937T	-0.008722561			P52333							
gdsc	JAK3_7406	JAK3	K885E	-0.534995958			P52333							
gdsc	JAK3_7406	JAK3	P672H+A251T	1.008844526			P52333							
gdsc	JAK3_7406	JAK3	L1017M	-0.080667392			P52333							
gdsc	JAK3_7406	JAK3	D230H	-0.092220844			P52333							
gdsc	JAK3_7406	JAK3	V469L	0.734783594			P52333							
gdsc	JAK3_7406	JAK3	W803S	0.831348537			P52333							
gdsc	JAK3_7406	JAK3	M1097L	0.409364898			P52333							
gdsc	JAK3_7406	JAK3	L605M	0.616379663			P52333							
gdsc	JAK3_7406	JAK3	P132T	1.142157743			P52333							
gdsc	JAK3_7406	JAK3	H879R+P132T	0.925613453			P52333							
gdsc	JAK3_7406	JAK3	P725S	-0.418864206			P52333							
gdsc	JAK3_7406	JAK3	R210W	0.418801403			P52333							
gdsc	JAK3_7406	JAK3	G153S	0.983222523			P52333							
gdsc	JAK3_7406	JAK3	E698K	-0.105996115			P52333							
gdsc	JAK3_7406	JAK3	A1090T	1.600817965			P52333							
gdsc	JAK3_7406	JAK3	F1123I	-0.104183704			P52333							
gdsc	JAK3_7406	JAK3	R121H	-0.447862187			P52333							
gdsc	JAK3_7406	JAK3	A280V	-0.377424045			P52333							
gdsc	JAK3_7406	JAK3	H645Y	-0.197275501			P52333							
gdsc	JAK3_7406	JAK3	S789L+P132T	-0.057677206			P52333							
gdsc	JAK3_7406	JAK3	I991V	0.13297609300000002			P52333							
gdsc	JAK3_7406	JAK3	L1073I	0.890354093			P52333							
gdsc	JAK3_7406	JAK3	P693L	0.797424045			P52333							
gdsc	JAK3_7406	JAK3	R403H	1.395737663			P52333							
gdsc	JAK3_7406	JAK3	V1016D	0.208939156			P52333							
gdsc	JAK3_7406	JAK3	R403H+R272H	1.064581937			P52333							
gdsc	JAK3_7406	JAK3	A1079D	-0.017555916			P52333							
gdsc	JAK3_7406	JAK3	Q510R	1.506548309			P52333							
gdsc	JAK3_7406	JAK3	E1072K+P423L	1.493862618			P52333							
gdsc	JAK3_7406	JAK3	M511I	-1.863263234			P52333							
gdsc	WHI-P97	JAK3	N108S	0.986107332			P52333							
gdsc	WHI-P97	JAK3	R925S	0.578007388			P52333							
gdsc	WHI-P97	JAK3	D740Y	1.303362773			P52333							
gdsc	WHI-P97	JAK3	F358C	-0.248671183			P52333							
gdsc	WHI-P97	JAK3	P37A	-0.438320221			P52333							
gdsc	WHI-P97	JAK3	K830M	1.078291442			P52333							
gdsc	WHI-P97	JAK3	R40H	1.362541335			P52333							
gdsc	WHI-P97	JAK3	P1045S	0.810179056			P52333							
gdsc	WHI-P97	JAK3	V957M	1.611461954			P52333							
gdsc	WHI-P97	JAK3	T321N	0.625678119			P52333							
gdsc	WHI-P97	JAK3	S504C	-0.14002310699999998			P52333							
gdsc	WHI-P97	JAK3	Y1023H	0.434083955			P52333							
gdsc	WHI-P97	JAK3	H645Y	1.152578958			P52333							
gdsc	WHI-P97	JAK3	H315R	-0.106346866			P52333							
gdsc	WHI-P97	JAK3	R918H+M598T	0.397711316			P52333							
gdsc	WHI-P97	JAK3	A573V	0.13220230800000002			P52333							
gdsc	WHI-P97	JAK3	R395C	1.038618663			P52333							
gdsc	WHI-P97	JAK3	F71L	0.8532047070000001			P52333							
gdsc	WHI-P97	JAK3	P132T	1.259462615			P52333							
gdsc	WHI-P97	JAK3	H1113R+G987C+V963I	1.021459712			P52333							
gdsc	WHI-P97	JAK3	A573T	1.281109045			P52333							
gdsc	WHI-P97	JAK3	E1115K	0.509919633			P52333							
gdsc	WHI-P97	JAK3	P132T	1.10420554			P52333							
gdsc	WHI-P97	JAK3	P132T	0.16179692099999998			P52333							
gdsc	WHI-P97	JAK3	P672H+A251T	0.5219506279999999			P52333							
gdsc	WHI-P97	JAK3	L1017M	0.447800569			P52333							
gdsc	WHI-P97	JAK3	D230H	1.204708136			P52333							
gdsc	WHI-P97	JAK3	V469L	-0.711938567			P52333							
gdsc	WHI-P97	JAK3	W803S	0.867847375			P52333							
gdsc	WHI-P97	JAK3	M1097L	0.6996006640000001			P52333							
gdsc	WHI-P97	JAK3	L605M	1.400946196			P52333							
gdsc	WHI-P97	JAK3	P132T	1.193702732			P52333							
gdsc	WHI-P97	JAK3	H879R+P132T	0.278283571			P52333							
gdsc	WHI-P97	JAK3	P725S	0.25267401			P52333							
gdsc	WHI-P97	JAK3	R210W	0.567894859			P52333							
gdsc	WHI-P97	JAK3	G153S	1.52437025			P52333							
gdsc	WHI-P97	JAK3	E698K	1.400721052			P52333							
gdsc	WHI-P97	JAK3	F1123I	-1.61358068			P52333							
gdsc	WHI-P97	JAK3	R121H	0.4557369020000001			P52333							
gdsc	WHI-P97	JAK3	A280V	0.506951284			P52333							
gdsc	WHI-P97	JAK3	H645Y	1.188203288			P52333							
gdsc	WHI-P97	JAK3	S789L+P132T	0.6733055990000001			P52333							
gdsc	WHI-P97	JAK3	I991V	0.7865122529999999			P52333							
gdsc	WHI-P97	JAK3	L1073I	0.418447689			P52333							
gdsc	WHI-P97	JAK3	P693L	0.5567241510000001			P52333							
gdsc	WHI-P97	JAK3	R403H	-0.43340319			P52333							
gdsc	WHI-P97	JAK3	V1016D	1.192365494			P52333							
gdsc	WHI-P97	JAK3	R403H+R272H	0.457319429			P52333							
gdsc	WHI-P97	JAK3	A1079D	-0.432372859			P52333							
gdsc	WHI-P97	JAK3	Q510R	1.301700853			P52333							
gdsc	WHI-P97	JAK3	E1072K+P423L	1.954024196			P52333							
gdsc	WHI-P97	JAK3	M511I	0.6016386429999999			P52333							
gdsc	ARRY-520	KIF11	H526Q	-5.280725956			P52732							
gdsc	ARRY-520	KIF11	S61T	-2.121096009			P52732							
gdsc	ARRY-520	KIF11	S175A	-2.993458118			P52732							
gdsc	ARRY-520	KIF11	T437A	-4.369145504			P52732							
gdsc	ARRY-520	KIF11	L1042F	-3.007774327			P52732							
gdsc	ARRY-520	KIF11	T300S	-0.960237077			P52732							
gdsc	ARRY-520	KIF11	H718L	-2.434502077			P52732							
gdsc	ARRY-520	KIF11	Q928*	-5.60313957			P52732							
gdsc	ARRY-520	KIF11	E945K	-5.183233775			P52732							
gdsc	ARRY-520	KIF11	H718L	-2.2994309580000003			P52732							
gdsc	ARRY-520	KIF11	I647M	-2.841199016			P52732							
gdsc	ARRY-520	KIF11	R329K	-5.129359729			P52732							
gdsc	ARRY-520	KIF11	A133V	-4.74190077			P52732							
gdsc	ARRY-520	KIF11	P642A	-2.72652537			P52732							
gdsc	ARRY-520	KIF11	P642A	-5.709057476			P52732							
gdsc	ARRY-520	KIF11	V794I	-4.477879491			P52732							
gdsc	ARRY-520	KIF11	G96S	-3.288762591			P52732							
gdsc	ARRY-520	KIF11	E616K	-1.714457134			P52732							
gdsc	ARRY-520	KIF11	A282V	-1.829989883			P52732							
gdsc	ARRY-520	KIF11	T907S	-2.224357215			P52732							
gdsc	ARRY-520	KIF11	N838H	-1.595374216			P52732							
gdsc	ARRY-520	KIF11	H718L	-3.854223523			P52732							
gdsc	ARRY-520	KIF11	H718L	-4.6218207			P52732							
gdsc	ARRY-520	KIF11	F772L	-4.807796924			P52732							
gdsc	ARRY-520	KIF11	S61T	-4.923206437			P52732							
gdsc	ARRY-520	KIF11	S780L	-4.091184837			P52732							
gdsc	ARRY-520	KIF11	H718L	-3.95128319			P52732							
gdsc	ARRY-520	KIF11	L1042F	-1.334859262			P52732							
gdsc	ARRY-520	KIF11	N456S+M606V	-5.2320954			P52732							
gdsc	ARRY-520	KIF11	N838H	-1.5766836919999998			P52732							
gdsc	ARRY-520	KIF11	P88Q	-5.184240999			P52732							
gdsc	ARRY-520	KIF11	P642A+H718L	-2.7499237780000003			P52732							
gdsc	ARRY-520	KIF11	Q751R	-3.673349777			P52732							
gdsc	ARRY-520	KIF11	H718L	-2.877686597			P52732							
gdsc	ARRY-520	KIF11	I592V	-4.475629827			P52732							
gdsc	ARRY-520	KIF11	S996C	-4.336019682			P52732							
gdsc	AZD4877	KIF11	H718L	-4.315867498			P52732							
gdsc	AZD4877	KIF11	H526Q	-4.310059962			P52732							
gdsc	AZD4877	KIF11	S61T	-3.438991248			P52732							
gdsc	AZD4877	KIF11	S175A	-2.145199474			P52732							
gdsc	AZD4877	KIF11	L1042F	-3.651011324			P52732							
gdsc	AZD4877	KIF11	T300S	-4.483797822			P52732							
gdsc	AZD4877	KIF11	P642A	-4.082247205			P52732							
gdsc	AZD4877	KIF11	H718L	-3.843495994			P52732							
gdsc	AZD4877	KIF11	Q928*	-4.663865195			P52732							
gdsc	AZD4877	KIF11	S3L	-3.582676503			P52732							
gdsc	AZD4877	KIF11	E945K	-4.645768933			P52732							
gdsc	AZD4877	KIF11	H718L	-3.862338194			P52732							
gdsc	AZD4877	KIF11	I647M	-3.168600759			P52732							
gdsc	AZD4877	KIF11	R329K	-4.60761647			P52732							
gdsc	AZD4877	KIF11	A133V	-4.205113138			P52732							
gdsc	AZD4877	KIF11	P642A	-3.525361305			P52732							
gdsc	AZD4877	KIF11	P642A	-4.761819515			P52732							
gdsc	AZD4877	KIF11	V794I	-3.651536858			P52732							
gdsc	AZD4877	KIF11	G96S	-4.854831919			P52732							
gdsc	AZD4877	KIF11	E616K	-2.928135489			P52732							
gdsc	AZD4877	KIF11	A282V	-3.2137848310000003			P52732							
gdsc	AZD4877	KIF11	T907S	-3.78496798			P52732							
gdsc	AZD4877	KIF11	N838H	-1.7957176030000002			P52732							
gdsc	AZD4877	KIF11	H718L	-4.319314574			P52732							
gdsc	AZD4877	KIF11	H718L	-4.486611532			P52732							
gdsc	AZD4877	KIF11	F772L	-4.799939984			P52732							
gdsc	AZD4877	KIF11	S61T	-4.155196298			P52732							
gdsc	AZD4877	KIF11	S780L	-3.80489028			P52732							
gdsc	AZD4877	KIF11	H718L	-2.3598335930000003			P52732							
gdsc	AZD4877	KIF11	L1042F	-2.297921899			P52732							
gdsc	AZD4877	KIF11	N456S+M606V	-4.476292225			P52732							
gdsc	AZD4877	KIF11	N838H	-1.158845076			P52732							
gdsc	AZD4877	KIF11	P88Q	-5.56688602			P52732							
gdsc	AZD4877	KIF11	P642A+H718L	-4.534591539			P52732							
gdsc	AZD4877	KIF11	Q751R	-3.5354430260000003			P52732							
gdsc	AZD4877	KIF11	H718L	-4.102152323			P52732							
gdsc	AZD4877	KIF11	I592V	-4.486960505			P52732							
gdsc	AZD4877	KIF11	S996C	-3.257276174			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	H718L	-2.134906829			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	H526Q	0.045180517			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	S61T	-1.663800872			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	T437A	-1.666278051			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	S3L	0.422311875			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	H718L	-0.8845270059999999			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	I647M	-0.3880283370000001			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	A133V	-1.372682304			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	P642A	-1.368136761			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	P642A	-1.311020638			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	V794I	0.293664476			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	S61T	-1.672955354			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	N456S+M606V	-1.694060846			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	N838H	0.760066103			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	Q751R	-1.365378744			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	H718L	-1.288522214			P52732							
gdsc	S-Trityl-L-cysteine	KIF11	I592V	-1.648852482			P52732							
gdsc	Amuvatinib	KIT	E640K	0.532687637			P10721							
gdsc	Amuvatinib	KIT	A168V+E306K	-0.933542084			P10721							
gdsc	Amuvatinib	KIT	N400S	1.103280079			P10721							
gdsc	Amuvatinib	KIT	G265S	0.7834751759999999			P10721							
gdsc	Amuvatinib	KIT	K581N+I920S	0.230853389			P10721							
gdsc	Masitinib	KIT	M882V	0.519415979			P10721							
gdsc	Masitinib	KIT	G265S	0.36712666			P10721							
gdsc	OSI-930	KIT	T232M	1.065216488			P10721							
gdsc	OSI-930	KIT	D910Y	1.09925296			P10721							
gdsc	OSI-930	KIT	N130D	0.7554814559999999			P10721							
gdsc	OSI-930	KIT	S715N	0.512720901			P10721							
gdsc	OSI-930	KIT	A701S	-0.882581286			P10721							
gdsc	OSI-930	KIT	E640K	0.455402148			P10721							
gdsc	OSI-930	KIT	M882V	0.401055892			P10721							
gdsc	OSI-930	KIT	D737H	0.575604863			P10721							
gdsc	OSI-930	KIT	E306K	0.121914995			P10721							
gdsc	OSI-930	KIT	A168V+E306K	-0.709310305			P10721							
gdsc	OSI-930	KIT	N400S	0.557662647			P10721							
gdsc	OSI-930	KIT	T304A	1.421409435			P10721							
gdsc	OSI-930	KIT	N655S	0.7860738140000001			P10721							
gdsc	OSI-930	KIT	Y125H+T488M	0.21491318			P10721							
gdsc	OSI-930	KIT	K623N	0.931630728			P10721							
gdsc	OSI-930	KIT	R135H+V532I	0.614072528			P10721							
gdsc	OSI-930	KIT	D159N	0.7506550759999999			P10721							
gdsc	OSI-930	KIT	T446N	1.075104466			P10721							
gdsc	OSI-930	KIT	A895E	0.985900554			P10721							
gdsc	OSI-930	KIT	G169D	0.8851911809999999			P10721							
gdsc	OSI-930	KIT	D131N	-0.228442569			P10721							
gdsc	OSI-930	KIT	N822K	-3.418759671			P10721							
gdsc	OSI-930	KIT	G510A	0.906335184			P10721							
gdsc	OSI-930	KIT	T304A	1.391110357			P10721							
gdsc	OSI-930	KIT	A794E	0.788932553			P10721							
gdsc	OSI-930	KIT	E191K	1.313075375			P10721							
gdsc	OSI-930	KIT	D266N	0.840459767			P10721							
gdsc	OSI-930	KIT	T232M	1.172056894			P10721							
gdsc	OSI-930	KIT	G779C	1.090038045			P10721							
gdsc	OSI-930	KIT	V532I	0.16223299			P10721							
gdsc	OSI-930	KIT	Q21P	1.077180533			P10721							
gdsc	OSI-930	KIT	K626R	0.233907648			P10721							
gdsc	OSI-930	KIT	R112I	0.958123092			P10721							
gdsc	OSI-930	KIT	M535T	1.4552053580000002			P10721							
gdsc	OSI-930	KIT	R205W	1.0127727			P10721							
gdsc	OSI-930	KIT	V374I+E885K	1.667611142			P10721							
gdsc	OSI-930	KIT	E306*+R946P	1.104843054			P10721							
gdsc	OSI-930	KIT	E306K	0.026809343			P10721							
gdsc	OSI-930	KIT	A178T	1.4181146269999998			P10721							
gdsc	OSI-930	KIT	R55W	0.466791483			P10721							
gdsc	OSI-930	KIT	N400S	0.147399542			P10721							
gdsc	OSI-930	KIT	D910Y	-0.47438536			P10721							
gdsc	OSI-930	KIT	T520S	-0.9775323			P10721							
gdsc	OSI-930	KIT	P155H	1.017616263			P10721							
gdsc	OSI-930	KIT	G265S	1.5820225719999998			P10721							
gdsc	OSI-930	KIT	A895T	0.980732902			P10721							
gdsc	OSI-930	KIT	K581N+I920S	1.594755069			P10721							
gdsc	OSI-930	KIT	G676D	-0.367888595			P10721							
gdsc	OSI-930	KIT	R177H	0.273251006			P10721							
gdsc	OSI-930	KIT	Q515K	0.365726026			P10721							
gdsc	UNC1215	L3MBTL3	A58S	-0.67373752			Q96JM7							
gdsc	UNC1215	L3MBTL3	G136R	-0.289636764			Q96JM7							
gdsc	UNC1215	L3MBTL3	R145W	-0.893462268			Q96JM7							
gdsc	UNC1215	L3MBTL3	R210W	-0.512876132			Q96JM7							
gdsc	UNC1215	L3MBTL3	R145W	0.011722311			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.11085923			Q96JM7							
gdsc	UNC1215	L3MBTL3	P525L	0.047618			Q96JM7							
gdsc	UNC1215	L3MBTL3	R145W	-0.048045181			Q96JM7							
gdsc	UNC1215	L3MBTL3	P81S+W415R	-0.066183509			Q96JM7							
gdsc	UNC1215	L3MBTL3	S524Y	-0.152457584			Q96JM7							
gdsc	UNC1215	L3MBTL3	D312E	-0.681194533			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.422380603			Q96JM7							
gdsc	UNC1215	L3MBTL3	R145W	-0.300739928			Q96JM7							
gdsc	UNC1215	L3MBTL3	S134F	-0.266512084			Q96JM7							
gdsc	UNC1215	L3MBTL3	P461S	-0.107287139			Q96JM7							
gdsc	UNC1215	L3MBTL3	F298L	-0.046825848			Q96JM7							
gdsc	UNC1215	L3MBTL3	Y301C	-0.070572044			Q96JM7							
gdsc	UNC1215	L3MBTL3	R210W	-0.030594135			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.295009416			Q96JM7							
gdsc	UNC1215	L3MBTL3	R171Q	-0.115160669			Q96JM7							
gdsc	UNC1215	L3MBTL3	Q352E	0.338250731			Q96JM7							
gdsc	UNC1215	L3MBTL3	R145W	0.121234823			Q96JM7							
gdsc	UNC1215	L3MBTL3	Y138C	-0.433159086			Q96JM7							
gdsc	UNC1215	L3MBTL3	A287T	-0.567035163			Q96JM7							
gdsc	UNC1215	L3MBTL3	L346H	-0.468038071			Q96JM7							
gdsc	UNC1215	L3MBTL3	S579C	0.423532986			Q96JM7							
gdsc	UNC1215	L3MBTL3	S601I	-0.043295231			Q96JM7							
gdsc	UNC1215	L3MBTL3	E712G	0.230297639			Q96JM7							
gdsc	UNC1215	L3MBTL3	I364T	0.018788876			Q96JM7							
gdsc	UNC1215	L3MBTL3	E338K	0.108460851			Q96JM7							
gdsc	UNC1215	L3MBTL3	V286I	-0.377497513			Q96JM7							
gdsc	UNC1215	L3MBTL3	Y138C	0.008928745			Q96JM7							
gdsc	UNC1215	L3MBTL3	R145W	0.052418904			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.494378165			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	0.410397599			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.018768732			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.424947247			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.603515634			Q96JM7							
gdsc	UNC1215	L3MBTL3	T746A	-0.33245386			Q96JM7							
gdsc	UNC1215	L3MBTL3	E53G	0.538171676			Q96JM7							
gdsc	UNC1215	L3MBTL3	T644P	0.041452603			Q96JM7							
gdsc	UNC1215	L3MBTL3	R210L+R372Q+R599C	-0.198844401			Q96JM7							
gdsc	UNC1215	L3MBTL3	Y138C	-0.035781932			Q96JM7							
gdsc	UNC1215	L3MBTL3	G737E	0.068309345			Q96JM7							
gdsc	UNC1215	L3MBTL3	L600V	-0.270127426			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.187414185			Q96JM7							
gdsc	UNC1215	L3MBTL3	P92S	-0.480157939			Q96JM7							
gdsc	UNC1215	L3MBTL3	I388F	0.336101196			Q96JM7							
gdsc	UNC1215	L3MBTL3	N54S	-0.476038392			Q96JM7							
gdsc	UNC1215	L3MBTL3	K101R	0.18775427100000006			Q96JM7							
gdsc	UNC1215	L3MBTL3	S256P	-0.174096905			Q96JM7							
gdsc	A-770041	LCK	A143S	0.4357281			P06239							
gdsc	JW-7-24-1	LCK	E482Q	-0.46174292			P06239							
gdsc	JW-7-24-1	LCK	A353V+P447L+A500T+P232_W233insQKP	-2.338201975			P06239							
gdsc	JW-7-24-1	LCK	E467D	-0.437246046			P06239							
gdsc	JW-7-24-1	LCK	A160T	-1.567773906			P06239							
gdsc	JW-7-24-1	LCK	N339S+R458H	-0.04995239			P06239							
gdsc	JW-7-24-1	LCK	R484W	-1.510228824			P06239							
gdsc	JW-7-24-1	LCK	G175V+A353T	-1.357730951			P06239							
gdsc	JW-7-24-1	LCK	R363H	-0.52433301			P06239							
gdsc	JW-7-24-1	LCK	R139Q	-1.860089294			P06239							
gdsc	JW-7-24-1	LCK	T416I	-0.218159996			P06239							
gdsc	JW-7-24-1	LCK	E448Q	-0.517037745			P06239							
gdsc	JW-7-24-1	LCK	A143S	-1.120023698			P06239							
gdsc	JW-7-24-1	LCK	S377R	-0.7530421970000001			P06239							
gdsc	JW-7-24-1	LCK	A289D+A396V	-1.430276562			P06239							
gdsc	JW-7-24-1	LCK	G456S	1.61279386			P06239							
gdsc	JW-7-24-1	LCK	*510S	1.376186851			P06239							
gdsc	JW-7-24-1	LCK	R45Q	-1.417618125			P06239							
gdsc	JW-7-24-1	LCK	V167I	-0.152388264			P06239							
gdsc	JW-7-24-1	LCK	R45W	-0.48855878			P06239							
gdsc	JW-7-24-1	LCK	R480H	0.8814674140000001			P06239							
gdsc	JW-7-24-1	LCK	R45Q	-0.485657975			P06239							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R483H	1.163172585			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	F411L	1.599606927			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	F580Y	1.354417776			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	K66T	1.498912958			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	W434*	1.245609136			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	K66T	1.297164197			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G480R	1.7612474319999998			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	H259Q	1.800077105			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	F580Y	1.599686912			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	F580Y	0.995210267			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	P576L	0.916479708			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	P577S	0.221703055			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.163935113			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	0.23937569			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	K66T	1.966682041			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.512474934			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G207D	1.038214588			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	S534F	0.183477124			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.5587468080000002			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	K316M	0.989649205			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R389*+R634H	0.900903877			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	-0.714160385			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A+H259R	0.996515511			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R634H	1.487501109			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	L112F	0.979908164			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R389*	1.382661524			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R585H	1.328784516			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R248H	0.980664174			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R200C+S281N	1.39265615			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	T420S	1.761743342			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	E528K	1.5120738219999998			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	D531Y	1.026044359			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R320L	0.713521686			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	K66T	2.029926826			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	0.315937755			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	-0.180366579			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.610093907			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	2.5783396			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.6473114290000002			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	A312T	1.30162857			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.7556235669999998			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R506C	2.098660982			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	2.07492071			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	0.861451502			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R422Q	1.974489212			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	H259R	2.565631395			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R389*	1.0699356290000002			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	S439G	1.190044731			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.921860569			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	H259Q	1.46014431			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.189331972			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	G190A	1.069493043			P53667							
gdsc	LIMK1 inhibitor BMS4	LIMK1	R9I	1.32911927			P53667							
gdsc	GSK2578215A	LRRK2	A356T	1.419930593			Q5S007							
gdsc	GSK2578215A	LRRK2	Q2120*	1.5620108069999998			Q5S007							
gdsc	GSK2578215A	LRRK2	V1456A	1.180374195			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	1.65620818			Q5S007							
gdsc	GSK2578215A	LRRK2	V1581D+A1440P	0.632928355			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	0.22674747			Q5S007							
gdsc	GSK2578215A	LRRK2	L1982S	0.576508402			Q5S007							
gdsc	GSK2578215A	LRRK2	A419V	0.908936785			Q5S007							
gdsc	GSK2578215A	LRRK2	A259E+V2495I	1.697673226			Q5S007							
gdsc	GSK2578215A	LRRK2	A419V	0.442387628			Q5S007							
gdsc	GSK2578215A	LRRK2	T149S	1.524145106			Q5S007							
gdsc	GSK2578215A	LRRK2	N202Y	1.729390119			Q5S007							
gdsc	GSK2578215A	LRRK2	M1431T	0.743046979			Q5S007							
gdsc	GSK2578215A	LRRK2	D174G	1.933967995			Q5S007							
gdsc	GSK2578215A	LRRK2	G1213S	1.7374301369999998			Q5S007							
gdsc	GSK2578215A	LRRK2	R1728L	1.861174726			Q5S007							
gdsc	GSK2578215A	LRRK2	P1262A	2.254887954			Q5S007							
gdsc	GSK2578215A	LRRK2	G135E	1.390219852			Q5S007							
gdsc	GSK2578215A	LRRK2	L2393*	1.024581514			Q5S007							
gdsc	GSK2578215A	LRRK2	Q536K	0.945709944			Q5S007							
gdsc	GSK2578215A	LRRK2	E522V	0.698594625			Q5S007							
gdsc	GSK2578215A	LRRK2	Q1779K	1.289288297			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	0.554006424			Q5S007							
gdsc	GSK2578215A	LRRK2	W82S	1.6759663619999998			Q5S007							
gdsc	GSK2578215A	LRRK2	C236Y+G440*+S2352P	0.908126858			Q5S007							
gdsc	GSK2578215A	LRRK2	Q103H	1.951747277			Q5S007							
gdsc	GSK2578215A	LRRK2	E519*+F215V	1.244162288			Q5S007							
gdsc	GSK2578215A	LRRK2	I1371V	1.679488684			Q5S007							
gdsc	GSK2578215A	LRRK2	P755L	1.23816812			Q5S007							
gdsc	GSK2578215A	LRRK2	E1874V	1.090582538			Q5S007							
gdsc	GSK2578215A	LRRK2	D392G	0.938499997			Q5S007							
gdsc	GSK2578215A	LRRK2	S1204N+Q1365R	1.074280913			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	1.4294915190000002			Q5S007							
gdsc	GSK2578215A	LRRK2	E11*+I974V+A1975V	1.171357169			Q5S007							
gdsc	GSK2578215A	LRRK2	H572Q	0.35584634299999995			Q5S007							
gdsc	GSK2578215A	LRRK2	T1410M	1.984904502			Q5S007							
gdsc	GSK2578215A	LRRK2	L119P	2.174859261			Q5S007							
gdsc	GSK2578215A	LRRK2	K17N+K1046T+K1179Q+R1771I+S2454L	1.287103806			Q5S007							
gdsc	GSK2578215A	LRRK2	C249Y	0.949253595			Q5S007							
gdsc	GSK2578215A	LRRK2	S210N+P396T	1.073018328			Q5S007							
gdsc	GSK2578215A	LRRK2	R1320S	0.813759442			Q5S007							
gdsc	GSK2578215A	LRRK2	L2145S	0.217799173			Q5S007							
gdsc	GSK2578215A	LRRK2	S1091P	1.543236742			Q5S007							
gdsc	GSK2578215A	LRRK2	R2443*	1.66758448			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	0.512030656			Q5S007							
gdsc	GSK2578215A	LRRK2	A211V+R1462H	1.041242185			Q5S007							
gdsc	GSK2578215A	LRRK2	E1190*	1.498516586			Q5S007							
gdsc	GSK2578215A	LRRK2	P1262A	1.996934312			Q5S007							
gdsc	GSK2578215A	LRRK2	P1262A	-0.044128264			Q5S007							
gdsc	GSK2578215A	LRRK2	R948*+G1451A	0.965756073			Q5S007							
gdsc	GSK2578215A	LRRK2	G1397C	1.4305609540000002			Q5S007							
gdsc	GSK2578215A	LRRK2	L1136P	1.173533958			Q5S007							
gdsc	GSK2578215A	LRRK2	G1939W	1.582593134			Q5S007							
gdsc	GSK2578215A	LRRK2	T1368I	0.8058349579999999			Q5S007							
gdsc	GSK2578215A	LRRK2	E110*	0.993045921			Q5S007							
gdsc	GSK2578215A	LRRK2	P1446L	1.5235135169999998			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	2.020973788			Q5S007							
gdsc	GSK2578215A	LRRK2	A419V	1.367260476			Q5S007							
gdsc	GSK2578215A	LRRK2	Q1002*	0.253168735			Q5S007							
gdsc	GSK2578215A	LRRK2	P1446L	0.5233026789999999			Q5S007							
gdsc	GSK2578215A	LRRK2	M1947T	1.383021755			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	0.981022627			Q5S007							
gdsc	GSK2578215A	LRRK2	S1283F	1.579705956			Q5S007							
gdsc	GSK2578215A	LRRK2	K1383Q+L1304H	0.885158002			Q5S007							
gdsc	GSK2578215A	LRRK2	S423P	0.467745976			Q5S007							
gdsc	GSK2578215A	LRRK2	L893M+R2143C	1.927573307			Q5S007							
gdsc	GSK2578215A	LRRK2	F283L+P1942L+H2391Y	1.772620177			Q5S007							
gdsc	GSK2578215A	LRRK2	P1546L	1.703419143			Q5S007							
gdsc	GSK2578215A	LRRK2	K906N	1.324114551			Q5S007							
gdsc	GSK2578215A	LRRK2	P1262A	0.929445052			Q5S007							
gdsc	GSK2578215A	LRRK2	V67L+Y2099C+W2376*	0.875846511			Q5S007							
gdsc	GSK2578215A	LRRK2	V490L	1.197762437			Q5S007							
gdsc	GSK2578215A	LRRK2	H1928R	0.774392385			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	1.70470839			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	1.23002501			Q5S007							
gdsc	GSK2578215A	LRRK2	R772*	1.075480102			Q5S007							
gdsc	GSK2578215A	LRRK2	S2454L	1.562150041			Q5S007							
gdsc	GSK2578215A	LRRK2	A419V	0.482005306			Q5S007							
gdsc	GSK2578215A	LRRK2	V771I+T1410M	0.558959596			Q5S007							
gdsc	GSK2578215A	LRRK2	D944V	1.345044075			Q5S007							
gdsc	GSK2578215A	LRRK2	C228S	0.5481988879999999			Q5S007							
gdsc	GSK2578215A	LRRK2	T1410M	1.610734975			Q5S007							
gdsc	GSK2578215A	LRRK2	R1639T	1.170470812			Q5S007							
gdsc	GSK2578215A	LRRK2	K1035N	0.8265233409999999			Q5S007							
gdsc	GSK2578215A	LRRK2	L1932F	1.135690772			Q5S007							
gdsc	GSK2578215A	LRRK2	R1067G	1.613423079			Q5S007							
gdsc	GSK2578215A	LRRK2	L1776I	1.267440422			Q5S007							
gdsc	GSK2578215A	LRRK2	W82L	1.237482023			Q5S007							
gdsc	GSK2578215A	LRRK2	T1452I	1.660794605			Q5S007							
gdsc	GSK2578215A	LRRK2	D1064G+S1145L	2.129500406			Q5S007							
gdsc	GSK2578215A	LRRK2	D478Y	1.010201317			Q5S007							
gdsc	GSK2578215A	LRRK2	E752D+P2103S+T2310M+V2396L	0.7207446679999999			Q5S007							
gdsc	GSK2578215A	LRRK2	Q1648P+P2119T+L2291R	1.52136339			Q5S007							
gdsc	GSK2578215A	LRRK2	R715S	1.587698576			Q5S007							
gdsc	GSK2578215A	LRRK2	T1410M	0.912827632			Q5S007							
gdsc	GSK2578215A	LRRK2	R1320S	1.0657438			Q5S007							
gdsc	GSK2578215A	LRRK2	Q2490K	0.984999978			Q5S007							
gdsc	GSK2578215A	LRRK2	S1001G	0.6614250939999999			Q5S007							
gdsc	GSK2578215A	LRRK2	E193D	0.764263265			Q5S007							
gdsc	GSK2578215A	LRRK2	V1450I+G2385R	0.84774496			Q5S007							
gdsc	GSK2578215A	LRRK2	P1262A	2.004448796			Q5S007							
gdsc	GSK2578215A	LRRK2	R2394S	1.857071769			Q5S007							
gdsc	GSK2578215A	LRRK2	A2135D+G2385R	1.72847947			Q5S007							
gdsc	GSK2578215A	LRRK2	Q536K	1.777810343			Q5S007							
gdsc	GSK2578215A	LRRK2	V366M	1.314278712			Q5S007							
gdsc	GSK2578215A	LRRK2	A419V	0.607879877			Q5S007							
gdsc	GSK2578215A	LRRK2	L1603I	0.5314309770000001			Q5S007							
gdsc	GSK2578215A	LRRK2	I1371V	1.539245765			Q5S007							
gdsc	GSK2578215A	LRRK2	W82C+S83A	1.779641121			Q5S007							
gdsc	GSK2578215A	LRRK2	R1957C	2.345513237			Q5S007							
gdsc	GSK2578215A	LRRK2	R1707T	1.692759749			Q5S007							
gdsc	GSK2578215A	LRRK2	R1320S	1.863507338			Q5S007							
gdsc	GSK2578215A	LRRK2	R767C	0.991437917			Q5S007							
gdsc	GSK2578215A	LRRK2	S1204G	0.897648765			Q5S007							
gdsc	GSK2578215A	LRRK2	G1424R	-0.206624318			Q5S007							
gdsc	GSK2578215A	LRRK2	R1320S	1.565133201			Q5S007							
gdsc	GSK2578215A	LRRK2	P1446L	0.925826155			Q5S007							
gdsc	GSK2578215A	LRRK2	P1930L	1.289783022			Q5S007							
gdsc	GSK2578215A	LRRK2	I1006M	0.889560164			Q5S007							
gdsc	GSK2578215A	LRRK2	R493C	0.899458214			Q5S007							
gdsc	GSK2578215A	LRRK2	L119P	1.713379404			Q5S007							
gdsc	GSK2578215A	LRRK2	L708F	1.5543760480000002			Q5S007							
gdsc	GSK2578215A	LRRK2	V2152I	0.804286203			Q5S007							
gdsc	GSK2578215A	LRRK2	L117S	0.905287079			Q5S007							
gdsc	GSK2578215A	LRRK2	V2495I	1.084531491			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	1.417829049			Q5S007							
gdsc	GSK2578215A	LRRK2	P1446L	1.4394381530000002			Q5S007							
gdsc	GSK2578215A	LRRK2	S634T	1.31423783			Q5S007							
gdsc	GSK2578215A	LRRK2	P755L	2.095914815			Q5S007							
gdsc	GSK2578215A	LRRK2	N363H	1.732386907			Q5S007							
gdsc	GSK2578215A	LRRK2	E2516K	1.60171795			Q5S007							
gdsc	GSK2578215A	LRRK2	A628V	0.424384979			Q5S007							
gdsc	GSK2578215A	LRRK2	N202S	1.4816538769999998			Q5S007							
gdsc	GSK2578215A	LRRK2	E413K+L730P+E2117K	2.184724725			Q5S007							
gdsc	GSK2578215A	LRRK2	P1446L	1.157774457			Q5S007							
gdsc	GSK2578215A	LRRK2	G2385R	1.7097225880000002			Q5S007							
gdsc	GSK2578215A	LRRK2	P1446L	1.6221012030000002			Q5S007							
gdsc	GSK2578215A	LRRK2	F511V	1.083098863			Q5S007							
gdsc	GSK2578215A	LRRK2	C371*+K492T	2.176364765			Q5S007							
gdsc	GSK2578215A	LRRK2	S569C	1.303044608			Q5S007							
gdsc	KIN001-266	MAP3K8	W72L	0.176331757			P41279							
gdsc	KIN001-266	MAP3K8	R146Q	0.834467376			P41279							
gdsc	KIN001-266	MAP3K8	A148T	0.07549263			P41279							
gdsc	KIN001-266	MAP3K8	F271Y	0.215644306			P41279							
gdsc	KIN001-266	MAP3K8	R59C	-0.388661111			P41279							
gdsc	KIN001-266	MAP3K8	A354T	-0.332319958			P41279							
gdsc	KIN001-266	MAP3K8	R376C	0.089033869			P41279							
gdsc	KIN001-266	MAP3K8	R59C	-0.280031401			P41279							
gdsc	KIN001-266	MAP3K8	R59C	-0.253056163			P41279							
gdsc	KIN001-266	MAP3K8	N22H	-0.092026509			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.8605758090000001			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.8880688790000001			P41279							
gdsc	KIN001-266	MAP3K8	R59C	1.525111449			P41279							
gdsc	KIN001-266	MAP3K8	P359S	0.107068512			P41279							
gdsc	KIN001-266	MAP3K8	R59C	-0.013801932			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.947867773			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.014239186			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.542257451			P41279							
gdsc	KIN001-266	MAP3K8	A148T	-0.22100807			P41279							
gdsc	KIN001-266	MAP3K8	T6P	1.768225718			P41279							
gdsc	KIN001-266	MAP3K8	T429P	-0.161764927			P41279							
gdsc	KIN001-266	MAP3K8	R59C	-0.07908071700000001			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.946494986			P41279							
gdsc	KIN001-266	MAP3K8	A148T	0.30918876100000003			P41279							
gdsc	KIN001-266	MAP3K8	R59C	-0.305794416			P41279							
gdsc	KIN001-266	MAP3K8	R59C	1.421597845			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.332655897			P41279							
gdsc	KIN001-266	MAP3K8	R59C+R146Q	-0.089109707			P41279							
gdsc	KIN001-266	MAP3K8	R59C	-0.131402454			P41279							
gdsc	KIN001-266	MAP3K8	R408C	-0.17902104600000002			P41279							
gdsc	KIN001-266	MAP3K8	A40V	0.141088394			P41279							
gdsc	KIN001-266	MAP3K8	E188K	2.132924968			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.631997562			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.271147092			P41279							
gdsc	KIN001-266	MAP3K8	R59C	0.961224749			P41279							
gdsc	KIN001-266	MAP3K8	R59C	-0.081655064			P41279							
gdsc	KIN001-266	MAP3K8	R59C	1.913584149			P41279							
gdsc	ERK_2440	MAPK1	T185A	0.362908169			Q9H706							
gdsc	ERK_6604	MAPK1	T185A	1.861187168			Q9H706							
gdsc	VX-11e	MAPK1	R79K	-0.06671893400000001			Q9H706							
gdsc	VX-11e	MAPK1	H61Q	1.132127313			Q9H706							
gdsc	VX-11e	MAPK1	V214I	0.137827962			Q9H706							
gdsc	VX-11e	MAPK1	I211M	0.940381738			Q9H706							
gdsc	VX-11e	MAPK1	T185A	-0.553113549			Q9H706							
gdsc	VX-11e	MAPK1	L76P	0.705290383			Q9H706							
gdsc	VX-11e	MAPK1	R135K	0.309511358			Q9H706							
gdsc	ERK_2440	MAPK3	G153D+H62R	0.362908169			Q16644							
gdsc	ERK_6604	MAPK3	G153D+H62R	1.861187168			Q16644							
gdsc	XMD8-92	MAPK7	G622S	-0.291530345			Q13164							
gdsc	XMD8-92	MAPK7	A296T	-0.179982648			Q13164							
gdsc	XMD8-92	MAPK7	A658V+E723D	1.258275275			Q13164							
gdsc	XMD8-92	MAPK7	P361L	1.472222112			Q13164							
gdsc	XMD8-92	MAPK7	G697R	-0.35742235200000005			Q13164							
gdsc	XMD8-92	MAPK7	M704V	1.305924677			Q13164							
gdsc	XMD8-92	MAPK7	P728H	1.133975529			Q13164							
gdsc	XMD8-92	MAPK7	A653T	0.041681302			Q13164							
gdsc	XMD8-92	MAPK7	G697R	-0.465147338			Q13164							
gdsc	XMD8-92	MAPK7	E723K	0.399998899			Q13164							
gdsc	XMD8-92	MAPK7	A478S	0.471017677			Q13164							
gdsc	XMD8-92	MAPK7	G697R	-0.005072854			Q13164							
gdsc	XMD8-92	MAPK7	D447N	-0.504309395			Q13164							
gdsc	XMD8-92	MAPK7	R543Q	-0.456249402			Q13164							
gdsc	XMD8-92	MAPK7	D364E	0.7269337640000001			Q13164							
gdsc	XMD8-92	MAPK7	S247F	1.148681001			Q13164							
gdsc	XMD8-92	MAPK7	A621T	1.112041151			Q13164							
gdsc	XMD8-92	MAPK7	D761N	0.506639637			Q13164							
gdsc	XMD8-92	MAPK7	D387Y	1.340150743			Q13164							
gdsc	XMD8-92	MAPK7	R392C	0.235809524			Q13164							
gdsc	XMD8-92	MAPK7	R318H	-0.7926936459999999			Q13164							
gdsc	XMD8-92	MAPK7	G697R	0.073536245			Q13164							
gdsc	XMD8-92	MAPK7	A296T	0.456013593			Q13164							
gdsc	XMD8-92	MAPK7	A653V	-0.538653959			Q13164							
gdsc	XMD8-92	MAPK7	P589S	-0.013371196			Q13164							
gdsc	XMD8-92	MAPK7	L669F	-0.60117058			Q13164							
gdsc	XMD8-92	MAPK7	W781C+I381V	0.37478571			Q13164							
gdsc	XMD8-92	MAPK7	K104N	0.688822774			Q13164							
gdsc	XMD8-92	MAPK7	E461*	1.047923636			Q13164							
gdsc	ZG-10	MAPK8	C79Y	1.3487536219999998			P35916							
gdsc	ZG-10	MAPK8	A419S	-1.124537839			P35916							
gdsc	ZG-10	MAPK8	I304M	-0.709193585			P35916							
gdsc	ZG-10	MAPK8	D277V	0.443351009			P35916							
gdsc	ZG-10	MAPK8	A282D	-0.774500217			P35916							
gdsc	ZG-10	MAPK8	M200T	-1.72411345			P35916							
gdsc	ZG-10	MAPK8	H149R	-0.6119141060000001			P35916							
gdsc	ZG-10	MAPK8	D277G	-0.383671204			P35916							
gdsc	AZD5991	MCL1	M120V	-2.509715646			Q07820							
gdsc	AZD5991	MCL1	D88N	-0.65800231			Q07820							
gdsc	AZD5991	MCL1	E322Q	0.432074839			Q07820							
gdsc	AZD5991	MCL1	G18_A19insG	-0.66888033			Q07820							
gdsc	AZD5991	MCL1	M120V	0.829630923			Q07820							
gdsc	AZD5991	MCL1	S247F	1.744451082			Q07820							
gdsc	AZD5991	MCL1	E110delE	-2.7354233060000004			Q07820							
gdsc	AZD5991	MCL1	D256N+D236Y	-2.33012463			Q07820							
gdsc	AZD5991	MCL1	E52Q	1.836621565			Q07820							
gdsc	AZD5991	MCL1	D72G	0.467607334			Q07820							
gdsc	AZD5991	MCL1	R215G	0.126779295			Q07820							
gdsc	AZD5991	MCL1	M231L	2.410451936			Q07820							
gdsc	AZD5991	MCL1	A193T	-0.933318718			Q07820							
gdsc	AZD5991	MCL1	Y15H	-3.525018849			Q07820							
gdsc	MIM1	MCL1	M120V	-0.14322026			Q07820							
gdsc	MIM1	MCL1	D88N	-0.221949257			Q07820							
gdsc	MIM1	MCL1	R263K	-0.008137186			Q07820							
gdsc	MIM1	MCL1	E322Q	-0.090975253			Q07820							
gdsc	MIM1	MCL1	G18_A19insG	0.500805404			Q07820							
gdsc	MIM1	MCL1	M120V	-0.225548613			Q07820							
gdsc	MIM1	MCL1	S247F	1.5967358269999998			Q07820							
gdsc	MIM1	MCL1	E110delE	0.366902324			Q07820							
gdsc	MIM1	MCL1	N260S	0.388553871			Q07820							
gdsc	MIM1	MCL1	D256N+D236Y	-0.441586856			Q07820							
gdsc	MIM1	MCL1	E52Q	0.8483581590000001			Q07820							
gdsc	MIM1	MCL1	D72G	-0.008821559			Q07820							
gdsc	MIM1	MCL1	R215G	0.377257155			Q07820							
gdsc	MIM1	MCL1	M231L	0.167960295			Q07820							
gdsc	MIM1	MCL1	A193T	0.657774203			Q07820							
gdsc	MIM1	MCL1	Y15H	-1.125944409			Q07820							
gdsc	MIM1	MCL1	G344V	0.685748593			Q07820							
gdsc	UMI-77	MCL1	M120V	-0.377219638			Q07820							
gdsc	UMI-77	MCL1	D88N	-0.319147837			Q07820							
gdsc	UMI-77	MCL1	E322Q	-0.020889827			Q07820							
gdsc	UMI-77	MCL1	G18_A19insG	1.7337004459999998			Q07820							
gdsc	UMI-77	MCL1	M120V	-0.010936084			Q07820							
gdsc	UMI-77	MCL1	S247F	-0.255067056			Q07820							
gdsc	UMI-77	MCL1	E110delE	-0.644571865			Q07820							
gdsc	UMI-77	MCL1	D256N+D236Y	-0.639001916			Q07820							
gdsc	UMI-77	MCL1	E52Q	-0.318115729			Q07820							
gdsc	UMI-77	MCL1	D72G	0.344906704			Q07820							
gdsc	UMI-77	MCL1	R215G	-0.055650908			Q07820							
gdsc	UMI-77	MCL1	M231L	-0.3688022070000001			Q07820							
gdsc	UMI-77	MCL1	Y15H	-0.638533853			Q07820							
gdsc	UMI-77	MCL1	G344V	-0.475392584			Q07820							
gdsc	MCT1_6447	MCTS1	R73K	0.453121082			Q9ULC4							
gdsc	MCT1_6447	MCTS1	I31L	0.34444693600000004			Q9ULC4							
gdsc	MCT1_6447	MCTS1	R73K	0.32932317			Q9ULC4							
gdsc	MCT1_6447	MCTS1	R73K	0.08653832300000001			Q9ULC4							
gdsc	MCT1_6447	MCTS1	G121R	1.056066154			Q9ULC4							
gdsc	MCT1_6447	MCTS1	K88E	0.879710105			Q9ULC4							
gdsc	MCT1_6447	MCTS1	R73K	1.224726419			Q9ULC4							
gdsc	MCT1_6447	MCTS1	E8K	1.107342747			Q9ULC4							
gdsc	MCT1_6447	MCTS1	I31L	1.083563371			Q9ULC4							
gdsc	MCT1_6447	MCTS1	I112V	1.132735458			Q9ULC4							
gdsc	MCT1_6447	MCTS1	A137S	1.342671173			Q9ULC4							
gdsc	MCT1_6447	MCTS1	R73K	0.267327936			Q9ULC4							
gdsc	MCT1_6447	MCTS1	R73K	0.681423232			Q9ULC4							
gdsc	Nutlin-3a (-)	MDM2	L181V	-0.737729306			Q00987							
gdsc	Nutlin-3a (-)	MDM2	C314Y	0.047568609000000005			Q00987							
gdsc	Nutlin-3a (-)	MDM2	H134D	1.6320460209999998			Q00987							
gdsc	Nutlin-3a (-)	MDM2	E338_G341delEDKG	0.675227738			Q00987							
gdsc	Nutlin-3a (-)	MDM2	K475N	1.4325660669999998			Q00987							
gdsc	Nutlin-3a (-)	MDM2	P225Q	0.409455563			Q00987							
gdsc	Nutlin-3a (-)	MDM2	M465I	-0.959388264			Q00987							
gdsc	Nutlin-3a (-)	MDM2	E210G	0.101786036			Q00987							
gdsc	Nutlin-3a (-)	MDM2	D386V	-1.1834095690000002			Q00987							
gdsc	Nutlin-3a (-)	MDM2	S4R	0.293127438			Q00987							
gdsc	Nutlin-3a (-)	MDM2	S304P	-0.602319038			Q00987							
gdsc	Nutlin-3a (-)	MDM2	E333D	-1.040007895			Q00987							
gdsc	Nutlin-3a (-)	MDM2	R189H	1.265372058			Q00987							
gdsc	Nutlin-3a (-)	MDM2	D245H	1.745130784			Q00987							
gdsc	Nutlin-3a (-)	MDM2	I410S	1.308708351			Q00987							
gdsc	Nutlin-3a (-)	MDM2	D52N	1.549391729			Q00987							
gdsc	Nutlin-3a (-)	MDM2	S431N	1.426721553			Q00987							
gdsc	Serdemetan	MDM2	L181V	-0.7696809459999999			Q00987							
gdsc	Serdemetan	MDM2	C314Y	-0.29101429100000004			Q00987							
gdsc	Serdemetan	MDM2	H134D	-1.086944682			Q00987							
gdsc	Serdemetan	MDM2	E338_G341delEDKG	-0.195319116			Q00987							
gdsc	Serdemetan	MDM2	K475N	0.277587994			Q00987							
gdsc	Serdemetan	MDM2	P225Q	0.364264366			Q00987							
gdsc	Serdemetan	MDM2	M465I	0.312583699			Q00987							
gdsc	Serdemetan	MDM2	E210G	-0.006003056			Q00987							
gdsc	Serdemetan	MDM2	D386V	-0.080531713			Q00987							
gdsc	Serdemetan	MDM2	S4R	0.034524679			Q00987							
gdsc	Serdemetan	MDM2	S304P	-0.216322701			Q00987							
gdsc	Serdemetan	MDM2	E333D	0.442647137			Q00987							
gdsc	Serdemetan	MDM2	D245H	-0.190522952			Q00987							
gdsc	Serdemetan	MDM2	I410S	0.519319996			Q00987							
gdsc	Serdemetan	MDM2	D52N	0.83732256			Q00987							
gdsc	Serdemetan	MDM2	S431N	0.327686135			Q00987							
gdsc	NSC-207895	MDM4	S161*	-0.608194487			O15151							
gdsc	NSC-207895	MDM4	P388A	0.469957721			O15151							
gdsc	NSC-207895	MDM4	I175T	-0.18119428			O15151							
gdsc	NSC-207895	MDM4	S367L	0.4852687120000001			O15151							
gdsc	NSC-207895	MDM4	V267A	0.361564413			O15151							
gdsc	NSC-207895	MDM4	G279V	-0.071652736			O15151							
gdsc	NSC-207895	MDM4	A8T	0.461825868			O15151							
gdsc	NSC-207895	MDM4	H163N	1.873185577			O15151							
gdsc	NSC-207895	MDM4	S127T	0.602113816			O15151							
gdsc	NSC-207895	MDM4	S127T+I130F+Q135R	-0.415859124			O15151							
gdsc	NSC-207895	MDM4	S367L	-0.49159645			O15151							
gdsc	NSC-207895	MDM4	P388A	0.074951691			O15151							
gdsc	NSC-207895	MDM4	R363Q	-0.066923523			O15151							
gdsc	NSC-207895	MDM4	D375G	1.510578983			O15151							
gdsc	NSC-207895	MDM4	P388A	0.445944314			O15151							
gdsc	NSC-207895	MDM4	A8T	1.251631151			O15151							
gdsc	NSC-207895	MDM4	C76Y	0.543927665			O15151							
gdsc	NSC-207895	MDM4	D233Y	1.672558389			O15151							
gdsc	NSC-207895	MDM4	R87C	-0.246518686			O15151							
gdsc	NSC-207895	MDM4	E297D	1.204622226			O15151							
gdsc	NSC-207895	MDM4	S367L	1.465961326			O15151							
gdsc	NSC-207895	MDM4	R322C	0.03117477			O15151							
gdsc	NSC-207895	MDM4	R87C	1.830949116			O15151							
gdsc	NSC-207895	MDM4	I19M	-0.278932342			O15151							
gdsc	NSC-207895	MDM4	K384E	1.303579622			O15151							
gdsc	NSC-207895	MDM4	I175T	2.050707636			O15151							
gdsc	NSC-207895	MDM4	C389R	1.571622094			O15151							
gdsc	NSC-207895	MDM4	P388A	0.380006686			O15151							
gdsc	NSC-207895	MDM4	R87C	0.345433423			O15151							
gdsc	NSC-207895	MDM4	T422I	1.068588319			O15151							
gdsc	NSC-207895	MDM4	V226M	0.969522498			O15151							
gdsc	NSC-207895	MDM4	S127T+I130F+Q135R	0.111097409			O15151							
gdsc	NSC-207895	MDM4	K280N	-0.33098568300000003			O15151							
gdsc	NSC-207895	MDM4	I175T	1.550884535			O15151							
gdsc	AZD6094	MET	G344R	0.129140939			P08581							
gdsc	AZD6094	MET	L604V	-1.239385084			P08581							
gdsc	AZD6094	MET	S244Y	0.31384569100000004			P08581							
gdsc	AZD6094	MET	V1238I	0.494387645			P08581							
gdsc	AZD6094	MET	M362T	-6.64e-05			P08581							
gdsc	AZD6094	MET	P472S+E493K+P761S	0.17407735300000002			P08581							
gdsc	AZD6094	MET	V1289M	-0.382818619			P08581							
gdsc	AZD6094	MET	I333L	-8.41e-05			P08581							
gdsc	AZD6094	MET	I583M	0.29368462			P08581							
gdsc	AZD6094	MET	V910F	0.212715061			P08581							
gdsc	AZD6094	MET	L905_H906delinsY	0.596656438			P08581							
gdsc	AZD6094	MET	L876V+K898Q	-0.055825691			P08581							
gdsc	AZD6094	MET	I316M	0.242220802			P08581							
gdsc	AZD6094	MET	G843R	0.7325126000000001			P08581							
gdsc	AZD6094	MET	A1381T	0.231898532			P08581							
gdsc	AZD6094	MET	T950A	0.204344437			P08581							
gdsc	AZD6094	MET	A1381V	-0.089020242			P08581							
gdsc	AZD6094	MET	L1158F	0.494699885			P08581							
gdsc	AZD6094	MET	S572N	0.051629120999999986			P08581							
gdsc	AZD6094	MET	D1198H	-0.133929994			P08581							
gdsc	AZD6094	MET	K303T	0.304900949			P08581							
gdsc	AZD6094	MET	R988C	0.020304452			P08581							
gdsc	AZD6094	MET	R1166*	0.228955661			P08581							
gdsc	AZD6094	MET	Y989*	-0.297276263			P08581							
gdsc	AZD6094	MET	L455I+R1188*	0.362657548			P08581							
gdsc	AZD6094	MET	M636V	0.567768659			P08581							
gdsc	AZD6094	MET	I316M	-0.083722243			P08581							
gdsc	AZD6094	MET	H159R	-0.324762815			P08581							
gdsc	AZD6094	MET	R988C	0.526540608			P08581							
gdsc	AZD6094	MET	A48T+E157G	0.168088517			P08581							
gdsc	AZD6094	MET	F523Y+V136I+A954V	0.4733337			P08581							
gdsc	AZD6094	MET	R988C	0.333674378			P08581							
gdsc	AZD6094	MET	W1338L	-0.25286479			P08581							
gdsc	AZD6094	MET	T86I	0.555639311			P08581							
gdsc	AZD6094	MET	E34K	0.495135361			P08581							
gdsc	AZD6094	MET	L530V	-0.660493116			P08581							
gdsc	AZD6094	MET	D946H	0.52773565			P08581							
gdsc	AZD6094	MET	S135N	0.114392809			P08581							
gdsc	AZD6094	MET	R988C	0.232488647			P08581							
gdsc	AZD6094	MET	H906Y	-0.699992297			P08581							
gdsc	AZD6094	MET	R1040Q	0.26132962			P08581							
gdsc	AZD6094	MET	P366S	0.4774283620000001			P08581							
gdsc	AZD6094	MET	G24E	0.132023378			P08581							
gdsc	AZD6094	MET	R988C	0.25500543800000003			P08581							
gdsc	AZD6094	MET	R988C	0.781457173			P08581							
gdsc	AZD6094	MET	S323G	-0.198740716			P08581							
gdsc	AZD6094	MET	V13L+V941L	0.986936218			P08581							
gdsc	AZD6094	MET	Y989C	0.235399525			P08581							
gdsc	AZD6094	MET	E168K	0.494874075			P08581							
gdsc	AZD6094	MET	R976T	0.591580029			P08581							
gdsc	AZD6094	MET	E740K	0.436554616			P08581							
gdsc	AZD6094	MET	R988C	0.244420698			P08581							
gdsc	AZD6094	MET	I316M	0.35081377700000005			P08581							
gdsc	AZD6094	MET	I638L	0.544882751			P08581							
gdsc	AZD6094	MET	T273N	0.15160559099999998			P08581							
gdsc	AZD6094	MET	V1007I	-0.8827424420000001			P08581							
gdsc	AZD6094	MET	N375K	0.52246609			P08581							
gdsc	AZD6094	MET	V136I	-0.150765448			P08581							
gdsc	AZD6094	MET	M362T	-0.011526198			P08581							
gdsc	AZD6094	MET	L893*	0.366393164			P08581							
gdsc	AZD6094	MET	T17I	-0.16067594			P08581							
gdsc	AZD6094	MET	M362T	0.534562259			P08581							
gdsc	AZD6094	MET	V122D	0.7504571859999999			P08581							
gdsc	AZD6094	MET	A320V+R591W	0.7355976679999999			P08581							
gdsc	AZD6094	MET	R1166*	0.6007244389999999			P08581							
gdsc	AZD6094	MET	S1159L	0.2387915			P08581							
gdsc	AZD6094	MET	A347T	-0.6179876670000001			P08581							
gdsc	AZD6094	MET	T200A	0.153385415			P08581							
gdsc	AZD6094	MET	R811H	0.040867228			P08581							
gdsc	AZD6094	MET	R191W	-0.304540718			P08581							
gdsc	AZD6094	MET	E302K	1.005469733			P08581							
gdsc	AZD6094	MET	D741N	0.611197199			P08581							
gdsc	AZD6094	MET	K595T	0.272708882			P08581							
gdsc	AZD6094	MET	E815D	0.226555505			P08581							
gdsc	AZD6094	MET	N375K	0.018521073			P08581							
gdsc	AZD6094	MET	A347T	-0.403524183			P08581							
gdsc	AZD6094	MET	G1260S	-0.021901199			P08581							
gdsc	Crizotinib	MET	L876V+K898Q	-0.487046112			P08581							
gdsc	Crizotinib	MET	I316M	-0.28892682			P08581							
gdsc	Crizotinib	MET	A48T+E157G	-1.317417964			P08581							
gdsc	Crizotinib	MET	V122D	-0.349732493			P08581							
gdsc	Crizotinib	MET	A320V+R591W	0.580736966			P08581							
gdsc	Crizotinib	MET	S1159L	-0.493479366			P08581							
gdsc	JNJ38877605	MET	G344R	0.333397096			P08581							
gdsc	JNJ38877605	MET	L604V	0.080671539			P08581							
gdsc	JNJ38877605	MET	S244Y	1.786523424			P08581							
gdsc	JNJ38877605	MET	V1238I	0.295735802			P08581							
gdsc	JNJ38877605	MET	M362T	1.961156528			P08581							
gdsc	JNJ38877605	MET	P472S+E493K+P761S	1.490922708			P08581							
gdsc	JNJ38877605	MET	I333L	0.80955991			P08581							
gdsc	JNJ38877605	MET	I583M	1.057597727			P08581							
gdsc	JNJ38877605	MET	V910F	0.780380628			P08581							
gdsc	JNJ38877605	MET	L905_H906delinsY	1.483488802			P08581							
gdsc	JNJ38877605	MET	L876V+K898Q	1.110329462			P08581							
gdsc	JNJ38877605	MET	I316M	1.082551407			P08581							
gdsc	JNJ38877605	MET	G843R	1.810721094			P08581							
gdsc	JNJ38877605	MET	A1381T	1.165764113			P08581							
gdsc	JNJ38877605	MET	T950A	0.511547189			P08581							
gdsc	JNJ38877605	MET	A1381V	1.7889828280000002			P08581							
gdsc	JNJ38877605	MET	L1158F	1.464824348			P08581							
gdsc	JNJ38877605	MET	S572N	0.645669147			P08581							
gdsc	JNJ38877605	MET	D1198H	0.277411434			P08581							
gdsc	JNJ38877605	MET	K303T	0.855405787			P08581							
gdsc	JNJ38877605	MET	R988C	0.372397997			P08581							
gdsc	JNJ38877605	MET	R1166*	0.970228148			P08581							
gdsc	JNJ38877605	MET	Y989*	1.072169889			P08581							
gdsc	JNJ38877605	MET	L455I+R1188*	1.077934766			P08581							
gdsc	JNJ38877605	MET	M636V	-0.048684472			P08581							
gdsc	JNJ38877605	MET	I316M	1.370235934			P08581							
gdsc	JNJ38877605	MET	H159R	0.933029585			P08581							
gdsc	JNJ38877605	MET	A48T+E157G	0.828720274			P08581							
gdsc	JNJ38877605	MET	F523Y+V136I+A954V	0.556619874			P08581							
gdsc	JNJ38877605	MET	R988C	1.299538283			P08581							
gdsc	JNJ38877605	MET	W1338L	1.10507116			P08581							
gdsc	JNJ38877605	MET	T86I	1.7703557			P08581							
gdsc	JNJ38877605	MET	E34K	0.843351685			P08581							
gdsc	JNJ38877605	MET	L530V	0.800330775			P08581							
gdsc	JNJ38877605	MET	D946H	1.4673198930000002			P08581							
gdsc	JNJ38877605	MET	S135N	1.021193686			P08581							
gdsc	JNJ38877605	MET	R988C	0.815519714			P08581							
gdsc	JNJ38877605	MET	R1040Q	0.641855915			P08581							
gdsc	JNJ38877605	MET	P366S	1.882627414			P08581							
gdsc	JNJ38877605	MET	G24E	1.594975473			P08581							
gdsc	JNJ38877605	MET	R988C	1.68284985			P08581							
gdsc	JNJ38877605	MET	R988C	0.376354018			P08581							
gdsc	JNJ38877605	MET	S323G	1.0526564040000002			P08581							
gdsc	JNJ38877605	MET	V13L+V941L	0.756805067			P08581							
gdsc	JNJ38877605	MET	Y989C	0.706724701			P08581							
gdsc	JNJ38877605	MET	E168K	0.058610962			P08581							
gdsc	JNJ38877605	MET	E740K	1.114693113			P08581							
gdsc	JNJ38877605	MET	R988C	0.889951204			P08581							
gdsc	JNJ38877605	MET	I316M	0.732850909			P08581							
gdsc	JNJ38877605	MET	I638L	1.663361249			P08581							
gdsc	JNJ38877605	MET	T273N	1.257822617			P08581							
gdsc	JNJ38877605	MET	V1007I	-0.331009974			P08581							
gdsc	JNJ38877605	MET	N375K	0.8172865029999999			P08581							
gdsc	JNJ38877605	MET	V136I	-0.051916477			P08581							
gdsc	JNJ38877605	MET	L893*	1.666444539			P08581							
gdsc	JNJ38877605	MET	T17I	0.376128281			P08581							
gdsc	JNJ38877605	MET	M362T	1.07631195			P08581							
gdsc	JNJ38877605	MET	V122D	0.447640598			P08581							
gdsc	JNJ38877605	MET	A320V+R591W	2.010967906			P08581							
gdsc	JNJ38877605	MET	R1166*	0.971099693			P08581							
gdsc	JNJ38877605	MET	S1159L	1.4355117569999998			P08581							
gdsc	JNJ38877605	MET	A347T	0.4223178			P08581							
gdsc	JNJ38877605	MET	T200A	1.02202672			P08581							
gdsc	JNJ38877605	MET	R811H	0.536801259			P08581							
gdsc	JNJ38877605	MET	R191W	0.889289991			P08581							
gdsc	JNJ38877605	MET	E302K	0.435051482			P08581							
gdsc	JNJ38877605	MET	D741N	1.736444835			P08581							
gdsc	JNJ38877605	MET	K595T	0.117409741			P08581							
gdsc	JNJ38877605	MET	N375K	-0.078815877			P08581							
gdsc	JNJ38877605	MET	A347T	0.581138078			P08581							
gdsc	JNJ38877605	MET	G1260S	1.3778884669999998			P08581							
gdsc	PHA-665752	MET	L604V	-0.961502032			P08581							
gdsc	PHA-665752	MET	L876V+K898Q	0.07068106099999999			P08581							
gdsc	PHA-665752	MET	I316M	0.427017981			P08581							
gdsc	PHA-665752	MET	A1381T	0.195613581			P08581							
gdsc	PHA-665752	MET	A1381V	0.450669973			P08581							
gdsc	PHA-665752	MET	R988C	0.483885853			P08581							
gdsc	PHA-665752	MET	I316M	0.019124815			P08581							
gdsc	PHA-665752	MET	A48T+E157G	-0.840141603			P08581							
gdsc	PHA-665752	MET	F523Y+V136I+A954V	-0.03848781			P08581							
gdsc	PHA-665752	MET	W1338L	-0.289806807			P08581							
gdsc	PHA-665752	MET	T86I	0.078388103			P08581							
gdsc	PHA-665752	MET	E34K	0.336847134			P08581							
gdsc	PHA-665752	MET	L530V	-0.569794957			P08581							
gdsc	PHA-665752	MET	R988C	0.040336362			P08581							
gdsc	PHA-665752	MET	R1040Q	0.165188304			P08581							
gdsc	PHA-665752	MET	G24E	0.37956173			P08581							
gdsc	PHA-665752	MET	S323G	0.31349257			P08581							
gdsc	PHA-665752	MET	V13L+V941L	0.848786548			P08581							
gdsc	PHA-665752	MET	Y989C	0.359536338			P08581							
gdsc	PHA-665752	MET	R988C	0.502872619			P08581							
gdsc	PHA-665752	MET	T273N	-0.231929342			P08581							
gdsc	PHA-665752	MET	M362T	0.522591104			P08581							
gdsc	PHA-665752	MET	R1166*	0.5998345270000001			P08581							
gdsc	PHA-665752	MET	R811H	-0.5194953720000001			P08581							
gdsc	PHA-665752	MET	R191W	-1.169026927			P08581							
gdsc	PHA-665752	MET	E302K	0.931608807			P08581							
gdsc	PHA-665752	MET	K595T	-0.555578286			P08581							
gdsc	PHA-665752	MET	G24E+M362T	-1.265149876			P08581							
gdsc	PHA-665752	MET	E815D	0.379600242			P08581							
gdsc	PHA-665752	MET	N375K	0.424744025			P08581							
gdsc	PHA-665752	MET	A347T	-0.149511158			P08581							
gdsc	PHA-665752	MET	G1260S	0.079600919			P08581							
gdsc	SU11274	MET	G344R	-0.5363053489999999			P08581							
gdsc	SU11274	MET	L604V	0.373491724			P08581							
gdsc	SU11274	MET	S244Y	1.430805058			P08581							
gdsc	SU11274	MET	V1238I	0.678616039			P08581							
gdsc	SU11274	MET	M362T	-0.14800802400000002			P08581							
gdsc	SU11274	MET	P472S+E493K+P761S	-0.332344843			P08581							
gdsc	SU11274	MET	I333L	0.7231223090000001			P08581							
gdsc	SU11274	MET	I583M	-0.02213997			P08581							
gdsc	SU11274	MET	V910F	0.272098623			P08581							
gdsc	SU11274	MET	L905_H906delinsY	1.103533662			P08581							
gdsc	SU11274	MET	L876V+K898Q	0.306125615			P08581							
gdsc	SU11274	MET	I316M	0.298812576			P08581							
gdsc	SU11274	MET	G843R	0.891162242			P08581							
gdsc	SU11274	MET	A1381T	0.856977057			P08581							
gdsc	SU11274	MET	T950A	0.102124227			P08581							
gdsc	SU11274	MET	A1381V	0.081963748			P08581							
gdsc	SU11274	MET	L1158F	1.120806963			P08581							
gdsc	SU11274	MET	S572N	-0.17608528399999998			P08581							
gdsc	SU11274	MET	D1198H	-0.160351259			P08581							
gdsc	SU11274	MET	K303T	0.921166263			P08581							
gdsc	SU11274	MET	R988C	-0.266654281			P08581							
gdsc	SU11274	MET	R1166*	0.934472878			P08581							
gdsc	SU11274	MET	Y989*	0.572466471			P08581							
gdsc	SU11274	MET	L455I+R1188*	0.260211601			P08581							
gdsc	SU11274	MET	M636V	1.331955494			P08581							
gdsc	SU11274	MET	I316M	0.281612743			P08581							
gdsc	SU11274	MET	H159R	0.545274383			P08581							
gdsc	SU11274	MET	A48T+E157G	-0.512598849			P08581							
gdsc	SU11274	MET	F523Y+V136I+A954V	0.283437596			P08581							
gdsc	SU11274	MET	R988C	0.900057216			P08581							
gdsc	SU11274	MET	W1338L	0.024330979			P08581							
gdsc	SU11274	MET	T86I	1.000152775			P08581							
gdsc	SU11274	MET	E34K	0.910489095			P08581							
gdsc	SU11274	MET	L530V	0.168080222			P08581							
gdsc	SU11274	MET	D946H	1.44384624			P08581							
gdsc	SU11274	MET	S135N	1.161552139			P08581							
gdsc	SU11274	MET	R988C	0.462414798			P08581							
gdsc	SU11274	MET	R1040Q	0.346853609			P08581							
gdsc	SU11274	MET	P366S	1.529256472			P08581							
gdsc	SU11274	MET	G24E	1.198180139			P08581							
gdsc	SU11274	MET	R988C	1.1784640240000002			P08581							
gdsc	SU11274	MET	R988C	0.8704744520000001			P08581							
gdsc	SU11274	MET	S323G	0.418216028			P08581							
gdsc	SU11274	MET	V13L+V941L	1.241420861			P08581							
gdsc	SU11274	MET	Y989C	1.148515105			P08581							
gdsc	SU11274	MET	E168K	0.8767304990000001			P08581							
gdsc	SU11274	MET	E740K	1.097044769			P08581							
gdsc	SU11274	MET	R988C	0.334515114			P08581							
gdsc	SU11274	MET	I316M	0.051273038			P08581							
gdsc	SU11274	MET	I638L	1.273704763			P08581							
gdsc	SU11274	MET	T273N	0.016302218			P08581							
gdsc	SU11274	MET	V1007I	0.456244069			P08581							
gdsc	SU11274	MET	N375K	1.655193846			P08581							
gdsc	SU11274	MET	V136I	0.303498537			P08581							
gdsc	SU11274	MET	M362T	1.049321307			P08581							
gdsc	SU11274	MET	L893*	1.269816878			P08581							
gdsc	SU11274	MET	T17I	-0.472314626			P08581							
gdsc	SU11274	MET	M362T	0.392851756			P08581							
gdsc	SU11274	MET	V122D	0.885328045			P08581							
gdsc	SU11274	MET	A320V+R591W	1.660619822			P08581							
gdsc	SU11274	MET	R1166*	0.68266508			P08581							
gdsc	SU11274	MET	S1159L	0.648282597			P08581							
gdsc	SU11274	MET	A347T	0.128750492			P08581							
gdsc	SU11274	MET	T200A	-0.190168646			P08581							
gdsc	SU11274	MET	R811H	-0.211957273			P08581							
gdsc	SU11274	MET	R191W	-0.210930497			P08581							
gdsc	SU11274	MET	E302K	0.846780987			P08581							
gdsc	SU11274	MET	D741N	1.532317248			P08581							
gdsc	SU11274	MET	K595T	-0.550145793			P08581							
gdsc	SU11274	MET	E815D	-0.492403414			P08581							
gdsc	SU11274	MET	N375K	-0.259843668			P08581							
gdsc	SU11274	MET	A347T	-0.422462366			P08581							
gdsc	SU11274	MET	G1260S	0.996852635			P08581							
gdsc	Savolitinib	MET	G344R	0.204279263			P08581							
gdsc	Savolitinib	MET	L604V	-0.640647246			P08581							
gdsc	Savolitinib	MET	S244Y	-0.16080747199999998			P08581							
gdsc	Savolitinib	MET	M362T	0.368271933			P08581							
gdsc	Savolitinib	MET	P472S+E493K+P761S	0.174721976			P08581							
gdsc	Savolitinib	MET	I333L	-0.024804967			P08581							
gdsc	Savolitinib	MET	V910F	-1.002925604			P08581							
gdsc	Savolitinib	MET	L905_H906delinsY	-0.02690888			P08581							
gdsc	Savolitinib	MET	L876V+K898Q	-0.888174342			P08581							
gdsc	Savolitinib	MET	I316M	0.051150986			P08581							
gdsc	Savolitinib	MET	G843R	0.434304951			P08581							
gdsc	Savolitinib	MET	A1381T	-0.314290647			P08581							
gdsc	Savolitinib	MET	T950A	-0.526902616			P08581							
gdsc	Savolitinib	MET	A1381V	-0.076219016			P08581							
gdsc	Savolitinib	MET	L1158F	0.08555242800000001			P08581							
gdsc	Savolitinib	MET	S572N	-0.670295184			P08581							
gdsc	Savolitinib	MET	K303T	-0.717581392			P08581							
gdsc	Savolitinib	MET	R988C	-0.29035841100000004			P08581							
gdsc	Savolitinib	MET	R1166*	-0.26160868			P08581							
gdsc	Savolitinib	MET	Y989*	-0.951695225			P08581							
gdsc	Savolitinib	MET	M636V	0.018435756			P08581							
gdsc	Savolitinib	MET	I316M	-1.1333628999999998			P08581							
gdsc	Savolitinib	MET	H159R	-1.0863753040000002			P08581							
gdsc	Savolitinib	MET	A48T+E157G	-0.792267057			P08581							
gdsc	Savolitinib	MET	F523Y+V136I+A954V	0.23087531100000006			P08581							
gdsc	Savolitinib	MET	W1338L	-0.49635825			P08581							
gdsc	Savolitinib	MET	T86I	0.33994583			P08581							
gdsc	Savolitinib	MET	D946H	-0.060697101			P08581							
gdsc	Savolitinib	MET	S135N	-0.825633429			P08581							
gdsc	Savolitinib	MET	R988C	-0.573971382			P08581							
gdsc	Savolitinib	MET	H906Y	-1.138209425			P08581							
gdsc	Savolitinib	MET	R1040Q	-0.349090239			P08581							
gdsc	Savolitinib	MET	P366S	0.530778059			P08581							
gdsc	Savolitinib	MET	R988C	-0.622894626			P08581							
gdsc	Savolitinib	MET	S323G	-1.251370458			P08581							
gdsc	Savolitinib	MET	V13L+V941L	1.174819058			P08581							
gdsc	Savolitinib	MET	Y989C	0.213508991			P08581							
gdsc	Savolitinib	MET	E168K	0.264651682			P08581							
gdsc	Savolitinib	MET	E740K	-0.337977595			P08581							
gdsc	Savolitinib	MET	R988C	0.093497057			P08581							
gdsc	Savolitinib	MET	I316M	-0.20235665			P08581							
gdsc	Savolitinib	MET	T273N	0.31883619			P08581							
gdsc	Savolitinib	MET	V1007I	-0.919554704			P08581							
gdsc	Savolitinib	MET	N375K	0.7224924979999999			P08581							
gdsc	Savolitinib	MET	L893*	0.846641753			P08581							
gdsc	Savolitinib	MET	T17I	-0.699503497			P08581							
gdsc	Savolitinib	MET	M362T	0.18974502			P08581							
gdsc	Savolitinib	MET	R1166*	0.989959075			P08581							
gdsc	Savolitinib	MET	S1159L	0.156643489			P08581							
gdsc	Savolitinib	MET	A347T	-1.352666391			P08581							
gdsc	Savolitinib	MET	T200A	0.237645042			P08581							
gdsc	Savolitinib	MET	R811H	-0.5451215220000001			P08581							
gdsc	Savolitinib	MET	R191W	0.138998701			P08581							
gdsc	Savolitinib	MET	E302K	1.032638714			P08581							
gdsc	Savolitinib	MET	D741N	0.092825179			P08581							
gdsc	Savolitinib	MET	E815D	0.5440520870000001			P08581							
gdsc	Savolitinib	MET	N375K	0.301159408			P08581							
gdsc	Savolitinib	MET	A347T	-0.913020782			P08581							
gdsc	Savolitinib	MET	G1260S	-0.682845788			P08581							
gdsc	MetAP2 Inhibitor, A832234	METAP2	Y320C	-0.282749721			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	A51S	-0.066707266			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	C121R+N434T+E470D+D476G	-0.274674154			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E164D	0.21255983			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	G94A	-0.275537404			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	K106delK	-0.327016035			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E164D	0.074385276			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E164D	-0.550452107			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E164D	0.059676249			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E83_D84delED	-0.67773146			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	P130L	-1.037121454			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	I208M	0.168928068			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	M184L	-0.543809168			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	P125A+K100N	0.184044724			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E164D+N407S	-0.398960866			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	P119A	-0.691228262			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E164D	-0.873294087			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E32G	-1.115279673			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	V118L	-0.5711541170000001			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	E164D	-0.446844299			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	R205C	0.053625203			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	N386K	-0.5603039439999999			P50579							
gdsc	MetAP2 Inhibitor, A832234	METAP2	N407S	-0.201338169			P50579							
gdsc	Mirin	MRE11	P358Q	0.355246193			P49959							
gdsc	Mirin	MRE11	R572Q	0.804494994			P49959							
gdsc	Mirin	MRE11	A492D	0.232119324			P49959							
gdsc	Mirin	MRE11	L116I	0.655943623			P49959							
gdsc	Mirin	MRE11	S334R	0.6382899910000001			P49959							
gdsc	Mirin	MRE11	A47S	2.530338738			P49959							
gdsc	Mirin	MRE11	M698V	1.630188266			P49959							
gdsc	Mirin	MRE11	A492D	1.352730466			P49959							
gdsc	Mirin	MRE11	R351H	2.053632141			P49959							
gdsc	Mirin	MRE11	V444M	1.414349386			P49959							
gdsc	Mirin	MRE11	R400S	0.873769164			P49959							
gdsc	Mirin	MRE11	M698V	0.577301597			P49959							
gdsc	Mirin	MRE11	S334R	1.676008211			P49959							
gdsc	Mirin	MRE11	A492D	1.098786072			P49959							
gdsc	Mirin	MRE11	A177T	0.071853727			P49959							
gdsc	Mirin	MRE11	A564T	0.877730349			P49959							
gdsc	Mirin	MRE11	S209F	2.257546654			P49959							
gdsc	Mirin	MRE11	H302Y	1.395988876			P49959							
gdsc	Mirin	MRE11	T36M	1.651346555			P49959							
gdsc	Mirin	MRE11	S613L	3.237400217			P49959							
gdsc	Mirin	MRE11	R525K+A440T	1.736435991			P49959							
gdsc	Mirin	MRE11	S334R	0.548341084			P49959							
gdsc	Mirin	MRE11	Q232K	2.337395761			P49959							
gdsc	Mirin	MRE11	A492D	2.04632433			P49959							
gdsc	Mirin	MRE11	V17I	1.445457037			P49959							
gdsc	Mirin	MRE11	R305W	0.774477289			P49959							
gdsc	Mirin	MRE11	S334R	0.06343921200000001			P49959							
gdsc	Mirin	MRE11	G589E	0.714423448			P49959							
gdsc	Mirin	MRE11	M698V+S334R	0.654112647			P49959							
gdsc	Mirin	MRE11	A551T	0.542190911			P49959							
gdsc	Mirin	MRE11	G182*+L181F	1.517375968			P49959							
gdsc	Mirin	MRE11	G593E	1.915679768			P49959							
gdsc	Mirin	MRE11	Q48L	1.4348872780000002			P49959							
gdsc	Mirin	MRE11	D131Y	2.145382213			P49959							
gdsc	Mirin	MRE11	D86N	0.314886687			P49959							
gdsc	Mirin	MRE11	G285C	1.487744266			P49959							
gdsc	Mirin	MRE11	E248K	3.197368355			P49959							
gdsc	Mirin	MRE11	A492D	0.88025217			P49959							
gdsc	Mirin	MRE11	A492D	1.840396511			P49959							
gdsc	Mirin	MRE11	L61F	2.14654572			P49959							
gdsc	Mirin	MRE11	R87W	1.171500591			P49959							
gdsc	Mirin	MRE11	R576*	1.760156209			P49959							
gdsc	Mirin	MRE11	L473S	1.43787189			P49959							
gdsc	Mirin	MRE11	R488H	1.199504327			P49959							
gdsc	Mirin	MRE11	M698V	1.485042416			P49959							
gdsc	Mirin	MRE11	S334R	0.8721984709999999			P49959							
gdsc	Mirin	MRE11	M157V	0.00639291			P49959							
gdsc	Mirin	MRE11	V444M	1.255006178			P49959							
gdsc	Mirin	MRE11	S547G+R349Q	2.189452036			P49959							
gdsc	Mirin	MRE11	E494K+R483L+R80I	1.116093508			P49959							
gdsc	Mirin	MRE11	R388W	1.7392650630000002			P49959							
gdsc	Mirin	MRE11	E552K	2.379080348			P49959							
gdsc	Mirin	MRE11	D468H+L169P	1.677001297			P49959							
gdsc	Mirin	MRE11	R380C	2.757101226			P49959							
gdsc	Mirin	MRE11	E471Q	2.2025221040000003			P49959							
gdsc	JW-7-52-1	MTOR	A2467S	-3.0841971580000003			P42345							
gdsc	JW-7-52-1	MTOR	I2017T	-4.3845489230000005			P42345							
gdsc	JW-7-52-1	MTOR	Y1151C	-1.815307518			P42345							
gdsc	JW-7-52-1	MTOR	T2509A	-3.322086304			P42345							
gdsc	JW-7-52-1	MTOR	A329T	-1.352837619			P42345							
gdsc	JW-7-52-1	MTOR	M135T	-2.562061674			P42345							
gdsc	JW-7-52-1	MTOR	G2238D+P1408S+M488I	-0.124165845			P42345							
gdsc	JW-7-52-1	MTOR	G1491S+A329T	-2.999325495			P42345							
gdsc	JW-7-52-1	MTOR	Q1207P	-3.561491026			P42345							
gdsc	JW-7-52-1	MTOR	V1591L	-4.206509032			P42345							
gdsc	JW-7-52-1	MTOR	A954T	-3.5902614930000003			P42345							
gdsc	JW-7-52-1	MTOR	N1765D	-3.117042735			P42345							
gdsc	JW-7-52-1	MTOR	F1888V	-2.964247435			P42345							
gdsc	JW-7-52-1	MTOR	T1834M	-2.900998502			P42345							
gdsc	JW-7-52-1	MTOR	R1208C	-3.751811348			P42345							
gdsc	JW-7-52-1	MTOR	P1254T+S275T+M825I	-3.495450898			P42345							
gdsc	JW-7-52-1	MTOR	T2232I	-1.810543941			P42345							
gdsc	JW-7-52-1	MTOR	P1254L	-3.1053707860000004			P42345							
gdsc	JW-7-52-1	MTOR	P2490A	-2.913837647			P42345							
gdsc	JW-7-52-1	MTOR	T2471M	-1.281185476			P42345							
gdsc	JW-7-52-1	MTOR	P2466S	-3.91038456			P42345							
gdsc	JW-7-52-1	MTOR	S2215F	-2.213842388			P42345							
gdsc	JW-7-52-1	MTOR	T571K	-3.629152784			P42345							
gdsc	JW-7-52-1	MTOR	A1134T	-3.190180831			P42345							
gdsc	JW-7-52-1	MTOR	H1454P+W1449_E1455delinsCP*	-4.599505354			P42345							
gdsc	JW-7-52-1	MTOR	W1456R	-4.100152687			P42345							
gdsc	JW-7-52-1	MTOR	M2345V+F1545L	-2.725870082			P42345							
gdsc	JW-7-52-1	MTOR	V1885I+S383G	-3.107588456			P42345							
gdsc	JW-7-52-1	MTOR	M476V	-1.777653335			P42345							
gdsc	JW-7-52-1	MTOR	A41T	-3.8154608			P42345							
gdsc	JW-7-52-1	MTOR	L2427R	-1.793310929			P42345							
gdsc	JW-7-52-1	MTOR	P1609L	-0.613821314			P42345							
gdsc	JW-7-52-1	MTOR	P1312L	-3.944213069			P42345							
gdsc	JW-7-52-1	MTOR	P1408S	-0.236589827			P42345							
gdsc	QL-VIII-58	MTOR	G2238D+P1408S+M488I	0.195019319			P42345							
gdsc	QL-VIII-58	MTOR	Y861H	-1.508779606			P42345							
gdsc	QL-VIII-58	MTOR	T1948M	-2.088286574			P42345							
gdsc	QL-VIII-58	MTOR	I2500M+C1497F+R1161*+R281C	-3.435441672			P42345							
gdsc	QL-VIII-58	MTOR	A695V	-1.292907787			P42345							
gdsc	QL-VIII-58	MTOR	R1709H	-2.867028982			P42345							
gdsc	QL-VIII-58	MTOR	T647I	-2.934126102			P42345							
gdsc	QL-VIII-58	MTOR	T1834_T1837delTAAT	-1.1489097			P42345							
gdsc	QL-VIII-58	MTOR	P770A	-1.411414217			P42345							
gdsc	QL-VIII-58	MTOR	L1894V	-2.234741102			P42345							
gdsc	QL-VIII-58	MTOR	P1609L	-1.712298119			P42345							
gdsc	Temsirolimus	MTOR	V420I+R1749Q	-3.145074374			P42345							
gdsc	Temsirolimus	MTOR	H262R+I261V	-3.3423557999999995			P42345							
gdsc	Temsirolimus	MTOR	R2152C	-3.93214297			P42345							
gdsc	Temsirolimus	MTOR	A1134V	-2.957961172			P42345							
gdsc	Temsirolimus	MTOR	A2467S	-3.24841438			P42345							
gdsc	Temsirolimus	MTOR	R1201Q+G803*	-3.696640945			P42345							
gdsc	Temsirolimus	MTOR	I2017T	-4.311128212			P42345							
gdsc	Temsirolimus	MTOR	Y1151C	-2.719582041			P42345							
gdsc	Temsirolimus	MTOR	R1612Q	-3.242568925			P42345							
gdsc	Temsirolimus	MTOR	Q188*	-3.074498183			P42345							
gdsc	Temsirolimus	MTOR	P1193L	-2.185803639			P42345							
gdsc	Temsirolimus	MTOR	T2509A	-3.762268111			P42345							
gdsc	Temsirolimus	MTOR	P453L	-2.747412235			P42345							
gdsc	Temsirolimus	MTOR	A329T	-1.705600079			P42345							
gdsc	Temsirolimus	MTOR	M135T	-2.14187682			P42345							
gdsc	Temsirolimus	MTOR	G2238D+P1408S+M488I	-0.72492524			P42345							
gdsc	Temsirolimus	MTOR	P1537S	-1.578126392			P42345							
gdsc	Temsirolimus	MTOR	R1784C	-2.398454712			P42345							
gdsc	Temsirolimus	MTOR	G1491S+A329T	-3.368146069			P42345							
gdsc	Temsirolimus	MTOR	Y861H	-2.698567792			P42345							
gdsc	Temsirolimus	MTOR	Q1207P	-3.817719945			P42345							
gdsc	Temsirolimus	MTOR	V1591L	-2.844735558			P42345							
gdsc	Temsirolimus	MTOR	K1197N	-2.3491439830000003			P42345							
gdsc	Temsirolimus	MTOR	T1948M	-1.792665121			P42345							
gdsc	Temsirolimus	MTOR	A954T	-4.439301032			P42345							
gdsc	Temsirolimus	MTOR	Q2072R+H642R	-1.585268796			P42345							
gdsc	Temsirolimus	MTOR	I2500M+C1497F+R1161*+R281C	-1.5364924880000002			P42345							
gdsc	Temsirolimus	MTOR	N1765D	-3.407677244			P42345							
gdsc	Temsirolimus	MTOR	A695V	-1.363888052			P42345							
gdsc	Temsirolimus	MTOR	E1799K	-3.156657451			P42345							
gdsc	Temsirolimus	MTOR	F1888V	-1.317321121			P42345							
gdsc	Temsirolimus	MTOR	A1836T	-3.500068724			P42345							
gdsc	Temsirolimus	MTOR	S1178F	-3.3867572			P42345							
gdsc	Temsirolimus	MTOR	T1834M	-3.1182662160000003			P42345							
gdsc	Temsirolimus	MTOR	R1208C	-3.244425772			P42345							
gdsc	Temsirolimus	MTOR	P1254T+S275T+M825I	-2.526272633			P42345							
gdsc	Temsirolimus	MTOR	T2232I	-2.168765555			P42345							
gdsc	Temsirolimus	MTOR	P1254L	-2.3644905240000003			P42345							
gdsc	Temsirolimus	MTOR	P1128L	-3.186302426			P42345							
gdsc	Temsirolimus	MTOR	W1304R	-3.2538036210000003			P42345							
gdsc	Temsirolimus	MTOR	A1134V	-3.131178237			P42345							
gdsc	Temsirolimus	MTOR	L573F	-3.762298921			P42345							
gdsc	Temsirolimus	MTOR	E2000Q	-1.99983571			P42345							
gdsc	Temsirolimus	MTOR	R1709H	-3.941280862			P42345							
gdsc	Temsirolimus	MTOR	P2490A	-3.154408379			P42345							
gdsc	Temsirolimus	MTOR	T2471M	-2.680132629			P42345							
gdsc	Temsirolimus	MTOR	R1482C	-4.3935736510000005			P42345							
gdsc	Temsirolimus	MTOR	K1981E	-5.084235498			P42345							
gdsc	Temsirolimus	MTOR	P2466S	-4.931180096			P42345							
gdsc	Temsirolimus	MTOR	S2215F	-3.275135442			P42345							
gdsc	Temsirolimus	MTOR	T571K	-3.081504907			P42345							
gdsc	Temsirolimus	MTOR	R2430M+C1483Y	-5.0651663760000005			P42345							
gdsc	Temsirolimus	MTOR	A1134T	-4.221260718			P42345							
gdsc	Temsirolimus	MTOR	E427D	-2.625885317			P42345							
gdsc	Temsirolimus	MTOR	H1454P+W1449_E1455delinsCP*	-4.303702601			P42345							
gdsc	Temsirolimus	MTOR	W1456R	-2.457285486			P42345							
gdsc	Temsirolimus	MTOR	L2209V	-2.677102069			P42345							
gdsc	Temsirolimus	MTOR	S645C	-2.551457975			P42345							
gdsc	Temsirolimus	MTOR	Q2072*	-2.682560631			P42345							
gdsc	Temsirolimus	MTOR	F140L	-2.213931853			P42345							
gdsc	Temsirolimus	MTOR	A1832T	-2.39297956			P42345							
gdsc	Temsirolimus	MTOR	H1647Q	-2.511948721			P42345							
gdsc	Temsirolimus	MTOR	L1037V+R260Q	-2.663496842			P42345							
gdsc	Temsirolimus	MTOR	M2345V+F1545L	-2.574308927			P42345							
gdsc	Temsirolimus	MTOR	A1728S+A41P	-1.502697158			P42345							
gdsc	Temsirolimus	MTOR	P1951S	-4.103243087			P42345							
gdsc	Temsirolimus	MTOR	D1332E	-1.60035642			P42345							
gdsc	Temsirolimus	MTOR	T647I	-5.170253619			P42345							
gdsc	Temsirolimus	MTOR	T1834_T1837delTAAT	-1.971522048			P42345							
gdsc	Temsirolimus	MTOR	V1885I+S383G	-2.9854577960000004			P42345							
gdsc	Temsirolimus	MTOR	R1811H	-2.147277911			P42345							
gdsc	Temsirolimus	MTOR	P770A	-3.3270862830000003			P42345							
gdsc	Temsirolimus	MTOR	L2138F	-5.229612888999999			P42345							
gdsc	Temsirolimus	MTOR	A1836T	-3.206126965			P42345							
gdsc	Temsirolimus	MTOR	M476V	-3.238408497			P42345							
gdsc	Temsirolimus	MTOR	D259Y	-3.126129082			P42345							
gdsc	Temsirolimus	MTOR	A41T	-3.596734389			P42345							
gdsc	Temsirolimus	MTOR	G1822V	-2.567775597			P42345							
gdsc	Temsirolimus	MTOR	L1894V	-4.1546713560000015			P42345							
gdsc	Temsirolimus	MTOR	R1896*	-2.3765570680000003			P42345							
gdsc	Temsirolimus	MTOR	L2427R	-3.114615325			P42345							
gdsc	Temsirolimus	MTOR	P1609L	-1.5221431			P42345							
gdsc	Temsirolimus	MTOR	P1312L	-3.860696419			P42345							
gdsc	Temsirolimus	MTOR	E1033K	-3.924832301			P42345							
gdsc	Temsirolimus	MTOR	P1408S	-4.72632553			P42345							
gdsc	Torin 2	MTOR	V420I+R1749Q	-2.352189355			P42345							
gdsc	Torin 2	MTOR	H262R+I261V	-2.972001875			P42345							
gdsc	Torin 2	MTOR	R2152C	-2.723688553			P42345							
gdsc	Torin 2	MTOR	A1134V	-1.837663153			P42345							
gdsc	Torin 2	MTOR	A2467S	-3.16311909			P42345							
gdsc	Torin 2	MTOR	R1201Q+G803*	-4.10612197			P42345							
gdsc	Torin 2	MTOR	I2017T	-2.8138220730000003			P42345							
gdsc	Torin 2	MTOR	Y1151C	-1.333979422			P42345							
gdsc	Torin 2	MTOR	P1193L	-1.881723282			P42345							
gdsc	Torin 2	MTOR	T2509A	-3.251980545			P42345							
gdsc	Torin 2	MTOR	P453L	-3.277036133			P42345							
gdsc	Torin 2	MTOR	A329T	-2.187765949			P42345							
gdsc	Torin 2	MTOR	M135T	-2.082685815			P42345							
gdsc	Torin 2	MTOR	G2238D+P1408S+M488I	-0.03391679			P42345							
gdsc	Torin 2	MTOR	P1537S	-2.2158396540000003			P42345							
gdsc	Torin 2	MTOR	G1491S+A329T	-3.041795394			P42345							
gdsc	Torin 2	MTOR	Y861H	-2.691722223			P42345							
gdsc	Torin 2	MTOR	Q1207P	-3.56092461			P42345							
gdsc	Torin 2	MTOR	V1591L	-2.6703098240000003			P42345							
gdsc	Torin 2	MTOR	K1197N	-2.869944007			P42345							
gdsc	Torin 2	MTOR	T1948M	-1.907110661			P42345							
gdsc	Torin 2	MTOR	A954T	-3.248621749			P42345							
gdsc	Torin 2	MTOR	Q2072R+H642R	-2.934233935			P42345							
gdsc	Torin 2	MTOR	I2500M+C1497F+R1161*+R281C	-0.988570291			P42345							
gdsc	Torin 2	MTOR	N1765D	-2.728880497			P42345							
gdsc	Torin 2	MTOR	A695V	-1.678005102			P42345							
gdsc	Torin 2	MTOR	E1799K	-2.154508595			P42345							
gdsc	Torin 2	MTOR	A1836T	-3.352484327			P42345							
gdsc	Torin 2	MTOR	S1178F	-0.8689126620000001			P42345							
gdsc	Torin 2	MTOR	T1834M	-3.186444029			P42345							
gdsc	Torin 2	MTOR	R1208C	-1.86936879			P42345							
gdsc	Torin 2	MTOR	P1254T+S275T+M825I	-3.381484085			P42345							
gdsc	Torin 2	MTOR	T2232I	1.367533019			P42345							
gdsc	Torin 2	MTOR	P1254L	-1.250818262			P42345							
gdsc	Torin 2	MTOR	P1128L	-3.68858967			P42345							
gdsc	Torin 2	MTOR	W1304R	-0.643205596			P42345							
gdsc	Torin 2	MTOR	A1134V	-1.6899253019999998			P42345							
gdsc	Torin 2	MTOR	L573F	-2.660584779			P42345							
gdsc	Torin 2	MTOR	E2000Q	-2.192734526			P42345							
gdsc	Torin 2	MTOR	R1709H	-1.739703501			P42345							
gdsc	Torin 2	MTOR	R1208C	-0.028071928			P42345							
gdsc	Torin 2	MTOR	P2490A	-2.404108794			P42345							
gdsc	Torin 2	MTOR	R1482C	-2.34424295			P42345							
gdsc	Torin 2	MTOR	K1981E	-3.16309539			P42345							
gdsc	Torin 2	MTOR	S2215F	-2.7863284110000004			P42345							
gdsc	Torin 2	MTOR	T571K	-3.504856593			P42345							
gdsc	Torin 2	MTOR	A1134T	-3.1047759310000003			P42345							
gdsc	Torin 2	MTOR	E427D	-4.220844201			P42345							
gdsc	Torin 2	MTOR	H1454P+W1449_E1455delinsCP*	-3.3915681760000003			P42345							
gdsc	Torin 2	MTOR	W1456R	-3.603270088			P42345							
gdsc	Torin 2	MTOR	S645C	-2.141818164			P42345							
gdsc	Torin 2	MTOR	Q2072*	-2.662670325			P42345							
gdsc	Torin 2	MTOR	F140L	-2.422532107			P42345							
gdsc	Torin 2	MTOR	A1832T	1.388188222			P42345							
gdsc	Torin 2	MTOR	H1647Q	-0.916586948			P42345							
gdsc	Torin 2	MTOR	L1037V+R260Q	-1.437703358			P42345							
gdsc	Torin 2	MTOR	M2345V+F1545L	-2.974576814			P42345							
gdsc	Torin 2	MTOR	T1837N+V1801G	-1.03785258			P42345							
gdsc	Torin 2	MTOR	A1728S+A41P	-2.581873772			P42345							
gdsc	Torin 2	MTOR	P1951S	-1.240506065			P42345							
gdsc	Torin 2	MTOR	D1332E	-2.49811361			P42345							
gdsc	Torin 2	MTOR	T1834_T1837delTAAT	2.465039926			P42345							
gdsc	Torin 2	MTOR	V1885I+S383G	-3.317391455			P42345							
gdsc	Torin 2	MTOR	R1811H	-0.990443727			P42345							
gdsc	Torin 2	MTOR	P770A	-2.651794675			P42345							
gdsc	Torin 2	MTOR	L2138F	-2.512785902			P42345							
gdsc	Torin 2	MTOR	A1836T	-1.816487748			P42345							
gdsc	Torin 2	MTOR	M476V	-2.269654452			P42345							
gdsc	Torin 2	MTOR	D259Y	-0.407193442			P42345							
gdsc	Torin 2	MTOR	A41T	-2.963526973			P42345							
gdsc	Torin 2	MTOR	G1822V	-3.624960955			P42345							
gdsc	Torin 2	MTOR	R1208C+T1143M+S1087N	-1.845418779			P42345							
gdsc	Torin 2	MTOR	T588M	-2.469005427			P42345							
gdsc	Torin 2	MTOR	L1894V	-2.824774746			P42345							
gdsc	Torin 2	MTOR	R1896*	-0.661747406			P42345							
gdsc	Torin 2	MTOR	L2427R	-3.30961213			P42345							
gdsc	Torin 2	MTOR	P1609L	-1.460802561			P42345							
gdsc	Torin 2	MTOR	P1312L	-2.887015862			P42345							
gdsc	Torin 2	MTOR	L1129P	-1.096409626			P42345							
gdsc	Torin 2	MTOR	E1033K	-2.620113923			P42345							
gdsc	Torin 2	MTOR	P1408S	-2.166885009			P42345							
gdsc	WYE-125132	MTOR	V420I+R1749Q	-2.8288551889999995			P42345							
gdsc	WYE-125132	MTOR	H262R+I261V	-2.880438689			P42345							
gdsc	WYE-125132	MTOR	R2152C	-3.3640087480000003			P42345							
gdsc	WYE-125132	MTOR	A1134V	-1.821055213			P42345							
gdsc	WYE-125132	MTOR	A2467S	-2.579807185			P42345							
gdsc	WYE-125132	MTOR	R1201Q+G803*	-3.5026110760000004			P42345							
gdsc	WYE-125132	MTOR	I2017T	-1.531747278			P42345							
gdsc	WYE-125132	MTOR	Y1151C	-0.72200903			P42345							
gdsc	WYE-125132	MTOR	R1612Q	0.6822770029999999			P42345							
gdsc	WYE-125132	MTOR	P1193L	-1.317891091			P42345							
gdsc	WYE-125132	MTOR	T2509A	-3.480823042			P42345							
gdsc	WYE-125132	MTOR	P453L	-2.746009823			P42345							
gdsc	WYE-125132	MTOR	A329T	-0.928883377			P42345							
gdsc	WYE-125132	MTOR	M135T	-1.3901114280000002			P42345							
gdsc	WYE-125132	MTOR	G2238D+P1408S+M488I	0.13979974			P42345							
gdsc	WYE-125132	MTOR	P1537S	-1.258526489			P42345							
gdsc	WYE-125132	MTOR	R1784C	0.856507217			P42345							
gdsc	WYE-125132	MTOR	G1491S+A329T	-3.390750547			P42345							
gdsc	WYE-125132	MTOR	Y861H	-2.079545054			P42345							
gdsc	WYE-125132	MTOR	Q1207P	-3.33613234			P42345							
gdsc	WYE-125132	MTOR	V1591L	-2.6137062			P42345							
gdsc	WYE-125132	MTOR	K1197N	-2.8777292560000003			P42345							
gdsc	WYE-125132	MTOR	T1948M	-0.220789443			P42345							
gdsc	WYE-125132	MTOR	A954T	-2.775208657			P42345							
gdsc	WYE-125132	MTOR	Q2072R+H642R	-2.415433548			P42345							
gdsc	WYE-125132	MTOR	I2500M+C1497F+R1161*+R281C	-0.053964696			P42345							
gdsc	WYE-125132	MTOR	N1765D	-1.825329991			P42345							
gdsc	WYE-125132	MTOR	A695V	-1.002260836			P42345							
gdsc	WYE-125132	MTOR	E1799K	-0.7898100229999999			P42345							
gdsc	WYE-125132	MTOR	A1836T	-3.456128869			P42345							
gdsc	WYE-125132	MTOR	S1178F	-0.977284049			P42345							
gdsc	WYE-125132	MTOR	T1834M	-2.717809919			P42345							
gdsc	WYE-125132	MTOR	R1208C	-1.521443968			P42345							
gdsc	WYE-125132	MTOR	P1254T+S275T+M825I	-3.113723043			P42345							
gdsc	WYE-125132	MTOR	T2232I	-0.215986762			P42345							
gdsc	WYE-125132	MTOR	P1254L	-0.7565621490000001			P42345							
gdsc	WYE-125132	MTOR	P1128L	-3.786850304			P42345							
gdsc	WYE-125132	MTOR	W1304R	-0.8709034109999999			P42345							
gdsc	WYE-125132	MTOR	A1134V	0.267998036			P42345							
gdsc	WYE-125132	MTOR	E2000Q	-1.020652155			P42345							
gdsc	WYE-125132	MTOR	R1709H	-1.100395271			P42345							
gdsc	WYE-125132	MTOR	R1208C	-0.76884495			P42345							
gdsc	WYE-125132	MTOR	P2490A	-2.33353675			P42345							
gdsc	WYE-125132	MTOR	T2471M	-0.8468141659999999			P42345							
gdsc	WYE-125132	MTOR	R1482C	-2.339251858			P42345							
gdsc	WYE-125132	MTOR	K1981E	-2.429326723			P42345							
gdsc	WYE-125132	MTOR	P2466S	-3.424305328			P42345							
gdsc	WYE-125132	MTOR	S2215F	-2.632158546			P42345							
gdsc	WYE-125132	MTOR	T571K	-3.35613344			P42345							
gdsc	WYE-125132	MTOR	A1134T	-2.548770464			P42345							
gdsc	WYE-125132	MTOR	E427D	-4.511758955			P42345							
gdsc	WYE-125132	MTOR	H1454P+W1449_E1455delinsCP*	-3.445003191			P42345							
gdsc	WYE-125132	MTOR	W1456R	-3.1212742610000004			P42345							
gdsc	WYE-125132	MTOR	S645C	-1.769552291			P42345							
gdsc	WYE-125132	MTOR	Q2072*	-1.735472568			P42345							
gdsc	WYE-125132	MTOR	F140L	-0.639357407			P42345							
gdsc	WYE-125132	MTOR	A1832T	-1.131868653			P42345							
gdsc	WYE-125132	MTOR	H1647Q	-0.947198858			P42345							
gdsc	WYE-125132	MTOR	L1037V+R260Q	-1.423788261			P42345							
gdsc	WYE-125132	MTOR	M2345V+F1545L	-2.215394105			P42345							
gdsc	WYE-125132	MTOR	T1837N+V1801G	-0.780894905			P42345							
gdsc	WYE-125132	MTOR	A1728S+A41P	-1.799017743			P42345							
gdsc	WYE-125132	MTOR	P1951S	-0.061814527			P42345							
gdsc	WYE-125132	MTOR	D1332E	-2.443192051			P42345							
gdsc	WYE-125132	MTOR	T647I	-2.12651606			P42345							
gdsc	WYE-125132	MTOR	T1834_T1837delTAAT	1.6535568109999998			P42345							
gdsc	WYE-125132	MTOR	V1885I+S383G	-3.127955712			P42345							
gdsc	WYE-125132	MTOR	R1811H	-1.6254416319999998			P42345							
gdsc	WYE-125132	MTOR	P770A	-1.782184658			P42345							
gdsc	WYE-125132	MTOR	L2138F	-1.879698169			P42345							
gdsc	WYE-125132	MTOR	A1836T	-0.626004578			P42345							
gdsc	WYE-125132	MTOR	M476V	-1.455258089			P42345							
gdsc	WYE-125132	MTOR	D259Y	-0.30776442800000003			P42345							
gdsc	WYE-125132	MTOR	A41T	-3.176668031			P42345							
gdsc	WYE-125132	MTOR	G1822V	-2.180560149			P42345							
gdsc	WYE-125132	MTOR	R1208C+T1143M+S1087N	-1.059009618			P42345							
gdsc	WYE-125132	MTOR	T588M	-1.698492039			P42345							
gdsc	WYE-125132	MTOR	L1894V	-2.592014149			P42345							
gdsc	WYE-125132	MTOR	R1896*	-0.07186899299999999			P42345							
gdsc	WYE-125132	MTOR	L2427R	-2.787135375			P42345							
gdsc	WYE-125132	MTOR	P1609L	-1.194668482			P42345							
gdsc	WYE-125132	MTOR	P1312L	-1.354500132			P42345							
gdsc	WYE-125132	MTOR	L1129P	-2.089974563			P42345							
gdsc	WYE-125132	MTOR	E1033K	-1.818786589			P42345							
gdsc	Pevonedistat	NAE1	S388N	-0.943417119			Q8TBC4							
gdsc	Pevonedistat	NAE1	T277A	-2.361461039			Q8TBC4							
gdsc	Pevonedistat	NAE1	A359S	-1.365599741			Q8TBC4							
gdsc	Pevonedistat	NAE1	T6I	-1.619493959			Q8TBC4							
gdsc	Pevonedistat	NAE1	E90Q	-2.097049423			Q8TBC4							
gdsc	Pevonedistat	NAE1	R312H	-2.211246659			Q8TBC4							
gdsc	Pevonedistat	NAE1	R166delinsSQ	-1.961824851			Q8TBC4							
gdsc	Pevonedistat	NAE1	S104F	-2.587981105			Q8TBC4							
gdsc	Pevonedistat	NAE1	Q25R	0.31199763			Q8TBC4							
gdsc	Pevonedistat	NAE1	V395M+R312H	-2.717716899			Q8TBC4							
gdsc	Pevonedistat	NAE1	F499L	-2.110634169			Q8TBC4							
gdsc	Pevonedistat	NAE1	F292L	-1.934496138			Q8TBC4							
gdsc	Pevonedistat	NAE1	I221V	-2.002249077			Q8TBC4							
gdsc	Pevonedistat	NAE1	C398R+G372D	-0.637186746			Q8TBC4							
gdsc	Pevonedistat	NAE1	D180N	-0.894608726			Q8TBC4							
gdsc	Pevonedistat	NAE1	K190R	-1.677213861			Q8TBC4							
gdsc	Pevonedistat	NAE1	Q469R	-2.14885751			Q8TBC4							
gdsc	Pevonedistat	NAE1	S379L	0.579731875			Q8TBC4							
gdsc	Pevonedistat	NAE1	I457M	-2.063632725			Q8TBC4							
gdsc	Pevonedistat	NAE1	I250F	-1.64792098			Q8TBC4							
gdsc	Pevonedistat	NAE1	R312H	-0.918977032			Q8TBC4							
gdsc	Pevonedistat	NAE1	I371V+K209R	-3.017889508			Q8TBC4							
gdsc	Pevonedistat	NAE1	K440E	-0.37842789			Q8TBC4							
gdsc	Pevonedistat	NAE1	N293T	-0.799080632			Q8TBC4							
gdsc	Pevonedistat	NAE1	G42*	-0.848005653			Q8TBC4							
gdsc	Pevonedistat	NAE1	S121L	-1.405639861			Q8TBC4							
gdsc	Pevonedistat	NAE1	D64N	-1.126659523			Q8TBC4							
gdsc	Pevonedistat	NAE1	R312H	2.49686169			Q8TBC4							
gdsc	Daporinad	NAMPT	K339E	-4.370538881			P43490							
gdsc	Daporinad	NAMPT	E263G	-4.850660878			P43490							
gdsc	Daporinad	NAMPT	K228*	-4.869350612			P43490							
gdsc	Daporinad	NAMPT	V266I	-1.447397225			P43490							
gdsc	Daporinad	NAMPT	T44R	-4.62937962			P43490							
gdsc	Daporinad	NAMPT	K423*	-5.754768267999999			P43490							
gdsc	Daporinad	NAMPT	Y142C	-3.332289484			P43490							
gdsc	Daporinad	NAMPT	V300I	-3.470506697			P43490							
gdsc	Daporinad	NAMPT	K342R	-5.390294543			P43490							
gdsc	Daporinad	NAMPT	E487D	-2.8305078260000003			P43490							
gdsc	Daporinad	NAMPT	R349K	-3.5325249110000003			P43490							
gdsc	Daporinad	NAMPT	Y36C	-2.515725219			P43490							
gdsc	Daporinad	NAMPT	T44R	-4.816253529			P43490							
gdsc	Daporinad	NAMPT	A252S	-4.382541585			P43490							
gdsc	Daporinad	NAMPT	Q268K	-3.924008726			P43490							
gdsc	Daporinad	NAMPT	L226R	-0.299491563			P43490							
gdsc	Daporinad	NAMPT	I206T	-1.442988914			P43490							
gdsc	Daporinad	NAMPT	T233M	-5.870758415			P43490							
gdsc	Daporinad	NAMPT	G100R	-4.535124776			P43490							
gdsc	Daporinad	NAMPT	Q362E	-3.481940468			P43490							
gdsc	Daporinad	NAMPT	A83V	-3.523360484			P43490							
gdsc	Daporinad	NAMPT	V221A	-2.883620578			P43490							
gdsc	Daporinad	NAMPT	E336D	-0.837556592			P43490							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	P522S	-1.828442313			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	T282A	-1.539507051			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	N588S	-0.7260491840000001			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	N588S	-1.6181896180000002			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	N588S	-1.138199353			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	A502V	-1.34532906			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	A16V	-1.920092002			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	V118G+G313S	-1.135455556			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	R421Q	-1.799607265			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	A336G	-0.743127557			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	V386I	-1.5757363080000002			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	K250R	-0.720288455			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	V386I	-0.75747339			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	T611A	-0.8165506370000001			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	A93T+R192Q	0.516894364			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	I598V	-1.88664446			P49116							
gdsc	(5Z)-7-Oxozeaenol	NR2C2	D249N	-1.386157184			P49116							
gdsc	NG-25	NR2C2	A93T+R192Q	-0.263376655			P49116							
gdsc	AZD1332	NTRK1	R692H	0.207756048			P04629							
gdsc	AZD1332	NTRK1	K665N	0.85447644			P04629							
gdsc	GW441756	NTRK1	A107V	-0.739458891			P04629							
gdsc	GW441756	NTRK1	R314H	-0.7885397359999999			P04629							
gdsc	GW441756	NTRK1	G89S	-0.114434283			P04629							
gdsc	GW441756	NTRK1	T678I	0.029701853			P04629							
gdsc	GW441756	NTRK1	Q289K	0.08782757			P04629							
gdsc	GW441756	NTRK1	R104S	-0.578015091			P04629							
gdsc	GW441756	NTRK1	S475C	-0.389859708			P04629							
gdsc	GW441756	NTRK1	R574C	0.188279212			P04629							
gdsc	GW441756	NTRK1	R444Q	0.291417181			P04629							
gdsc	GW441756	NTRK1	L437R	-3.098201128			P04629							
gdsc	GW441756	NTRK1	G423_V426delGLAV	-0.392482045			P04629							
gdsc	GW441756	NTRK1	R444Q	0.474931038			P04629							
gdsc	GW441756	NTRK1	V170A	0.000626256			P04629							
gdsc	GW441756	NTRK1	M671T	0.353574756			P04629							
gdsc	GW441756	NTRK1	G64D	-1.543972016			P04629							
gdsc	GW441756	NTRK1	A421V	0.300498787			P04629							
gdsc	GW441756	NTRK1	D412N	0.182766734			P04629							
gdsc	GW441756	NTRK1	M1I	-0.434179345			P04629							
gdsc	GW441756	NTRK1	R444Q	-0.103040208			P04629							
gdsc	GW441756	NTRK1	A5T	-0.945144713			P04629							
gdsc	GW441756	NTRK1	W514*	-0.084576606			P04629							
gdsc	GW441756	NTRK1	R692H	0.065190505			P04629							
gdsc	GW441756	NTRK1	V135L	0.117153788			P04629							
gdsc	GW441756	NTRK1	T434M	0.201179383			P04629							
gdsc	GW441756	NTRK1	N440S	-0.10754961			P04629							
gdsc	GW441756	NTRK1	V420M	-0.298794801			P04629							
gdsc	GW441756	NTRK1	L62P	-0.6294943129999999			P04629							
gdsc	GW441756	NTRK1	G595E	-0.504078326			P04629							
gdsc	GW441756	NTRK1	S419L	-0.245536939			P04629							
gdsc	GW441756	NTRK1	R85H+R444Q	0.095572531			P04629							
gdsc	GW441756	NTRK1	V282I	-1.221208837			P04629							
gdsc	GW441756	NTRK1	A454V	-1.567250742			P04629							
gdsc	GW441756	NTRK1	R161H	0.557201694			P04629							
gdsc	GW441756	NTRK1	P149L	0.513852547			P04629							
gdsc	GW441756	NTRK1	R748W	0.32410812			P04629							
gdsc	GW441756	NTRK1	G166R	-0.490470136			P04629							
gdsc	GW441756	NTRK1	E581K	-0.038953503			P04629							
gdsc	GW441756	NTRK1	Q289K	-0.6283454860000001			P04629							
gdsc	GW441756	NTRK1	R314C	0.211595857			P04629							
gdsc	GW441756	NTRK1	A65S	-1.125202607			P04629							
gdsc	GW441756	NTRK1	E518D	-0.726809342			P04629							
gdsc	GW441756	NTRK1	D738N	-1.175810877			P04629							
gdsc	GW441756	NTRK1	K665N	0.5995459870000001			P04629							
gdsc	GW441756	NTRK1	P309L	0.202031376			P04629							
gdsc	GW441756	NTRK1	G89S	0.305809228			P04629							
gdsc	GW441756	NTRK1	S277F	0.982709432			P04629							
gdsc	GW441756	NTRK1	P387L	-0.276131074			P04629							
gdsc	GW441756	NTRK1	E492K	-0.601911778			P04629							
gdsc	WZ4003	NUAK1	D644E	-0.766673493			O60285							
gdsc	WZ4003	NUAK1	C657R	1.242428086			O60285							
gdsc	IPA-3	PAK1	E177D+D183_A184insD	-0.446524949			Q13153							
gdsc	IPA-3	PAK1	P73L	1.28500878			Q13153							
gdsc	IPA-3	PAK1	I536V	-0.532235571			Q13153							
gdsc	IPA-3	PAK1	T406A	2.320172664			Q13153							
gdsc	IPA-3	PAK1	M531I	0.767046166			Q13153							
gdsc	IPA-3	PAK1	S259N	2.150390826			Q13153							
gdsc	IPA-3	PAK1	V445F+I312S	0.524969931			Q13153							
gdsc	IPA-3	PAK1	N111H	1.631278199			Q13153							
gdsc	IPA-3	PAK1	R371C	-0.414428273			Q13153							
gdsc	IPA-3	PAK1	S382L	-0.71114286			Q13153							
gdsc	IPA-3	PAK1	D505G	0.343072964			Q13153							
gdsc	IPA-3	PAK1	N4S	1.919975282			Q13153							
gdsc	IPA-3	PAK1	K11N	-0.011235881			Q13153							
gdsc	IPA-3	PAK1	D183_A184insD	0.386509799			Q13153							
gdsc	IPA-3	PAK1	G364V	1.192483991			Q13153							
gdsc	IPA-3	PAK1	D180G	-0.409734609			Q13153							
gdsc	IPA-3	PAK1	V403A	0.527167457			Q13153							
gdsc	IPA-3	PAK1	D183_A184insD	0.502225626			Q13153							
gdsc	IPA-3	PAK1	D178E	-0.413714329			Q13153							
gdsc	PAK_5339	PAK1	R53Q	0.051640379000000014			Q13153							
gdsc	Niraparib	PARP1	K230N	0.661816727			P09874							
gdsc	Niraparib	PARP1	A220V	1.536886491			P09874							
gdsc	Niraparib	PARP1	Y570C	1.291232832			P09874							
gdsc	Olaparib	PARP1	K230N	1.467340581			P09874							
gdsc	Olaparib	PARP1	A220V	0.982423946			P09874							
gdsc	Olaparib	PARP1	Y570C	-0.072472007			P09874							
gdsc	Rucaparib	PARP1	K230N	1.061102274			P09874							
gdsc	Rucaparib	PARP1	A220V	0.18973791			P09874							
gdsc	Rucaparib	PARP1	Y570C	0.27180534300000003			P09874							
gdsc	Talazoparib	PARP1	K230N	0.578229955			P09874							
gdsc	Talazoparib	PARP1	A220V	0.528659141			P09874							
gdsc	Talazoparib	PARP1	Y570C	-0.58018003			P09874							
gdsc	Veliparib	PARP1	K230N	1.274275326			P09874							
gdsc	Veliparib	PARP1	A220V	0.240645977			P09874							
gdsc	Veliparib	PARP1	Y570C	0.3754190770000001			P09874							
gdsc	PFI3	PBRM1	A715T	0.896797957			Q86U86							
gdsc	PFI3	PBRM1	K1424N	0.613187948			Q86U86							
gdsc	PFI3	PBRM1	Y1043F	1.634679654			Q86U86							
gdsc	PFI3	PBRM1	V49L	1.525311709			Q86U86							
gdsc	PFI3	PBRM1	R202C	1.156452031			Q86U86							
gdsc	BX-912	PDPK1	Q540L	-0.006558806			O15530							
gdsc	BX-912	PDPK1	R505Q	-0.014236816			O15530							
gdsc	BX-912	PDPK1	G61V	1.348739995			O15530							
gdsc	BX-912	PDPK1	H517Q	-1.453712888			O15530							
gdsc	BX-912	PDPK1	N378S	0.567043458			O15530							
gdsc	BX-912	PDPK1	A532T	-1.663408055			O15530							
gdsc	BX-912	PDPK1	T402A	0.426698632			O15530							
gdsc	BX-912	PDPK1	G384C	0.588199904			O15530							
gdsc	KIN001-244	PDPK1	Q540L	0.154826338			O15530							
gdsc	KIN001-244	PDPK1	R505Q	0.605326268			O15530							
gdsc	KIN001-244	PDPK1	G61V	0.502125496			O15530							
gdsc	KIN001-244	PDPK1	H517Q	-0.794132792			O15530							
gdsc	KIN001-244	PDPK1	N378S	1.2697979190000002			O15530							
gdsc	KIN001-244	PDPK1	A532T	-0.285385686			O15530							
gdsc	KIN001-244	PDPK1	T402A	-0.203934437			O15530							
gdsc	KIN001-244	PDPK1	G384C	0.7947554929999999			O15530							
gdsc	OSU-03012	PDPK1	Q540L	-0.613077746			O15530							
gdsc	OSU-03012	PDPK1	R505Q	-0.844771871			O15530							
gdsc	OSU-03012	PDPK1	G61V	-2.083629644			O15530							
gdsc	OSU-03012	PDPK1	H517Q	-0.9136974			O15530							
gdsc	OSU-03012	PDPK1	N378S	-1.147632302			O15530							
gdsc	OSU-03012	PDPK1	A532T	-1.531340241			O15530							
gdsc	OSU-03012	PDPK1	G384C	-0.6811613540000001			O15530							
gdsc	AZD6482	PIK3CB	R153C	-0.229904523			P42338							
gdsc	AZD6482	PIK3CB	R811*	0.13370346			P42338							
gdsc	AZD6482	PIK3CB	D1067V	-2.105548617			P42338							
gdsc	AZD6482	PIK3CB	N717S	-0.551834846			P42338							
gdsc	AZD6482	PIK3CB	A1048V	-0.45116977			P42338							
gdsc	AZD6482	PIK3CB	G974R	1.01188834			P42338							
gdsc	AZD6482	PIK3CB	R668Q	-0.820336562			P42338							
gdsc	AZD6482	PIK3CB	Y638*	0.419584935			P42338							
gdsc	AZD6482	PIK3CB	D1067N	-0.288121454			P42338							
gdsc	AZD6482	PIK3CB	P437H	1.087553353			P42338							
gdsc	AZD6482	PIK3CB	T721P	-0.548520338			P42338							
gdsc	AZD6482	PIK3CB	A906V	0.493706992			P42338							
gdsc	AZD6482	PIK3CB	A686T	-0.296055426			P42338							
gdsc	AZD6482	PIK3CB	G666D+P384Q	-0.30002558			P42338							
gdsc	AZD6482	PIK3CB	L915P	0.997090452			P42338							
gdsc	AZD6482	PIK3CB	N717S	0.732608165			P42338							
gdsc	AZD6482	PIK3CB	R321Q	0.117281764			P42338							
gdsc	AZD6482	PIK3CB	A515T	-0.327014411			P42338							
gdsc	AZD6482	PIK3CB	D239G	0.548261085			P42338							
gdsc	AZD6482	PIK3CB	R321Q	-1.727401683			P42338							
gdsc	AZD6482	PIK3CB	R562Q+R149Q	0.6153254260000001			P42338							
gdsc	AZD6482	PIK3CB	R628Q+C286Y	0.32631834			P42338							
gdsc	AZD6482	PIK3CB	R529*	0.448279554			P42338							
gdsc	AZD6482	PIK3CB	V369I	-1.283091304			P42338							
gdsc	AZD6482	PIK3CB	R896L	-0.28810304			P42338							
gdsc	AZD6482	PIK3CB	R896L	-0.414507337			P42338							
gdsc	AZD6482	PIK3CB	E1051K	-1.252427819			P42338							
gdsc	AZD6482	PIK3CB	L642P	-1.195738611			P42338							
gdsc	AZD6482	PIK3CB	E1051K	-1.961870826			P42338							
gdsc	AZD6482	PIK3CB	L535R	0.232693579			P42338							
gdsc	AZD6482	PIK3CB	R896L	-1.02804682			P42338							
gdsc	AZD6482	PIK3CB	W18*	0.266519787			P42338							
gdsc	AZD6482	PIK3CB	M68I	0.100707003			P42338							
gdsc	AZD6482	PIK3CB	M630R	0.515766995			P42338							
gdsc	AZD6482	PIK3CB	L99R	0.489413329			P42338							
gdsc	AZD6482	PIK3CB	K718R	-0.583253165			P42338							
gdsc	AZD6482	PIK3CB	R896L	0.367626155			P42338							
gdsc	AZD6482	PIK3CB	D1067V	-2.807247862			P42338							
gdsc	AZD6482	PIK3CB	L933P	-1.380259512			P42338							
gdsc	AZD6482	PIK3CB	R48Q	0.184985307			P42338							
gdsc	AZD6482	PIK3CB	C392Y	-0.154394645			P42338							
gdsc	AZD6482	PIK3CB	R668W	0.629433487			P42338							
gdsc	AZD6482	PIK3CB	I1021M+K720N+R306Q	-1.153086125			P42338							
gdsc	AZD6482	PIK3CB	I767F	-0.768299087			P42338							
gdsc	AZD6482	PIK3CB	I965N	1.038259878			P42338							
gdsc	TGX221	PIK3CB	R811*	0.7420190179999999			P42338							
gdsc	TGX221	PIK3CB	D1067V	-2.018695685			P42338							
gdsc	TGX221	PIK3CB	N717S	0.7002784670000001			P42338							
gdsc	TGX221	PIK3CB	R668Q	1.201105236			P42338							
gdsc	TGX221	PIK3CB	D1067N	0.549567528			P42338							
gdsc	TGX221	PIK3CB	P437H	1.6416680119999998			P42338							
gdsc	TGX221	PIK3CB	T721P	-0.315854214			P42338							
gdsc	TGX221	PIK3CB	A906V	1.257971923			P42338							
gdsc	TGX221	PIK3CB	G666D+P384Q	0.27730952600000003			P42338							
gdsc	TGX221	PIK3CB	N717S	1.322133282			P42338							
gdsc	TGX221	PIK3CB	R321Q	0.122771728			P42338							
gdsc	TGX221	PIK3CB	R321Q	-0.292187411			P42338							
gdsc	TGX221	PIK3CB	R562Q+R149Q	0.685205655			P42338							
gdsc	TGX221	PIK3CB	V369I	-0.082857808			P42338							
gdsc	TGX221	PIK3CB	L642P	1.318648287			P42338							
gdsc	TGX221	PIK3CB	R896L	0.511016322			P42338							
gdsc	TGX221	PIK3CB	M630R	1.407746144			P42338							
gdsc	TGX221	PIK3CB	L99R	0.7718073740000001			P42338							
gdsc	TGX221	PIK3CB	K718R	1.061416884			P42338							
gdsc	TGX221	PIK3CB	R896L	0.883355663			P42338							
gdsc	TGX221	PIK3CB	L933P	-0.367221458			P42338							
gdsc	TGX221	PIK3CB	R668W	0.30448621			P42338							
gdsc	TGX221	PIK3CB	I767F	-0.4744967470000001			P42338							
gdsc	Alpelisib	PIK3CD	A742V	0.079841468			Q15025							
gdsc	Alpelisib	PIK3CD	V296I	-0.138721418			Q15025							
gdsc	Alpelisib	PIK3CD	R437C	0.285349544			Q15025							
gdsc	Alpelisib	PIK3CD	G772S	0.944382185			Q15025							
gdsc	Alpelisib	PIK3CD	G985D	-0.900362938			Q15025							
gdsc	Alpelisib	PIK3CD	N334K	-0.83695759			Q15025							
gdsc	Alpelisib	PIK3CD	R437C	-0.438240828			Q15025							
gdsc	Alpelisib	PIK3CD	F609L	1.306652248			Q15025							
gdsc	Alpelisib	PIK3CD	V296I	0.222755308			Q15025							
gdsc	Alpelisib	PIK3CD	V296I	0.076306111			Q15025							
gdsc	Alpelisib	PIK3CD	A215V+S764N	1.433555965			Q15025							
gdsc	Alpelisib	PIK3CD	C7R	-0.266283385			Q15025							
gdsc	Alpelisib	PIK3CD	L725I+E1021K	0.395293385			Q15025							
gdsc	Alpelisib	PIK3CD	S174L	2.083187057			Q15025							
gdsc	Alpelisib	PIK3CD	G593R	-0.38537993			Q15025							
gdsc	Alpelisib	PIK3CD	A396T	-0.369922596			Q15025							
gdsc	Alpelisib	PIK3CD	M762I	0.200934094			Q15025							
gdsc	Alpelisib	PIK3CD	R437C	0.175902206			Q15025							
gdsc	Alpelisib	PIK3CD	E766G	1.189396553			Q15025							
gdsc	Alpelisib	PIK3CD	E451K	-0.503662994			Q15025							
gdsc	Alpelisib	PIK3CD	E1021K	-0.119863221			Q15025							
gdsc	Alpelisib	PIK3CD	V296I	-0.518888075			Q15025							
gdsc	Alpelisib	PIK3CD	G4E	-1.429205349			Q15025							
gdsc	Alpelisib	PIK3CD	V296I	0.714690066			Q15025							
gdsc	Alpelisib	PIK3CD	E234D	1.626016935			Q15025							
gdsc	Alpelisib	PIK3CD	A152T	-0.09315223			Q15025							
gdsc	Alpelisib	PIK3CD	A388T+R460H+S738N	0.414612536			Q15025							
gdsc	Alpelisib	PIK3CD	P186S	0.54862133			Q15025							
gdsc	Alpelisib	PIK3CD	A468V	1.255006537			Q15025							
gdsc	Alpelisib	PIK3CD	A487T	1.108894464			Q15025							
gdsc	Alpelisib	PIK3CD	F932C	1.114494038			Q15025							
gdsc	Alpelisib	PIK3CD	R38C	-0.364690955			Q15025							
gdsc	Alpelisib	PIK3CD	C132Y	0.633793975			Q15025							
gdsc	Alpelisib	PIK3CD	E1021K	-0.333267341			Q15025							
gdsc	Alpelisib	PIK3CD	M387T	-0.330954281			Q15025							
gdsc	Alpelisib	PIK3CD	G971R	-0.35590677600000004			Q15025							
gdsc	Alpelisib	PIK3CD	R437C	0.841697468			Q15025							
gdsc	Alpelisib	PIK3CD	R229Q	0.354196865			Q15025							
gdsc	Alpelisib	PIK3CD	P294H	1.02435637			Q15025							
gdsc	Alpelisib	PIK3CD	G819E	1.359383983			Q15025							
gdsc	Alpelisib	PIK3CD	E83K	-1.4826456959999998			Q15025							
gdsc	Alpelisib	PIK3CD	R229W	0.606036657			Q15025							
gdsc	Alpelisib	PIK3CD	E1021K	1.340511567			Q15025							
gdsc	Alpelisib	PIK3CD	M683I	0.209234213			Q15025							
gdsc	Alpelisib	PIK3CD	R821C	-1.412521571			Q15025							
gdsc	GNE-317	PIK3CD	A742V	-0.466564561			Q15025							
gdsc	GNE-317	PIK3CD	V296I	-1.304852872			Q15025							
gdsc	GNE-317	PIK3CD	R437C	-0.774203975			Q15025							
gdsc	GNE-317	PIK3CD	G772S	-0.36974722			Q15025							
gdsc	GNE-317	PIK3CD	G985D	-1.308759124			Q15025							
gdsc	GNE-317	PIK3CD	N334K	-1.744237787			Q15025							
gdsc	GNE-317	PIK3CD	R437C	-1.924667762			Q15025							
gdsc	GNE-317	PIK3CD	F609L	0.228524332			Q15025							
gdsc	GNE-317	PIK3CD	V296I	-1.084250654			Q15025							
gdsc	GNE-317	PIK3CD	V296I	-2.293020865			Q15025							
gdsc	GNE-317	PIK3CD	A215V+S764N	-0.8533172790000001			Q15025							
gdsc	GNE-317	PIK3CD	C7R	-1.5731347080000002			Q15025							
gdsc	GNE-317	PIK3CD	S174L	0.187702132			Q15025							
gdsc	GNE-317	PIK3CD	G593R	-1.066268741			Q15025							
gdsc	GNE-317	PIK3CD	A396T	-2.915000695			Q15025							
gdsc	GNE-317	PIK3CD	M762I	-1.116419613			Q15025							
gdsc	GNE-317	PIK3CD	R437C	-1.138034642			Q15025							
gdsc	GNE-317	PIK3CD	E766G	-0.697774034			Q15025							
gdsc	GNE-317	PIK3CD	E451K	-1.216683438			Q15025							
gdsc	GNE-317	PIK3CD	E1021K	-2.188181873			Q15025							
gdsc	GNE-317	PIK3CD	V296I	-2.316381947			Q15025							
gdsc	GNE-317	PIK3CD	G4E	-1.322562241			Q15025							
gdsc	GNE-317	PIK3CD	V296I	-1.38990939			Q15025							
gdsc	GNE-317	PIK3CD	E234D	-0.5586260270000001			Q15025							
gdsc	GNE-317	PIK3CD	A152T	-1.836878111			Q15025							
gdsc	GNE-317	PIK3CD	A388T+R460H+S738N	-0.527931762			Q15025							
gdsc	GNE-317	PIK3CD	P186S	-1.197414056			Q15025							
gdsc	GNE-317	PIK3CD	A487T	-0.446036742			Q15025							
gdsc	GNE-317	PIK3CD	F932C	-0.38130956			Q15025							
gdsc	GNE-317	PIK3CD	R38C	-1.455541889			Q15025							
gdsc	GNE-317	PIK3CD	C132Y	-0.380036903			Q15025							
gdsc	GNE-317	PIK3CD	E1021K	-0.872081271			Q15025							
gdsc	GNE-317	PIK3CD	G971R	-1.303946962			Q15025							
gdsc	GNE-317	PIK3CD	R437C	-2.0238769640000003			Q15025							
gdsc	GNE-317	PIK3CD	R229Q	-0.903263151			Q15025							
gdsc	GNE-317	PIK3CD	E83K	-2.581136721			Q15025							
gdsc	GNE-317	PIK3CD	R229W	-1.7231731769999998			Q15025							
gdsc	GNE-317	PIK3CD	E1021K	-0.968758786			Q15025							
gdsc	GNE-317	PIK3CD	M683I	-1.045482599			Q15025							
gdsc	IC-87114	PIK3CD	A742V	0.763919624			Q15025							
gdsc	IC-87114	PIK3CD	V296I	0.769195108			Q15025							
gdsc	IC-87114	PIK3CD	R437C	1.880903283			Q15025							
gdsc	IC-87114	PIK3CD	G772S	-0.283535356			Q15025							
gdsc	IC-87114	PIK3CD	G985D	1.103418128			Q15025							
gdsc	IC-87114	PIK3CD	N334K	-2.133539374			Q15025							
gdsc	IC-87114	PIK3CD	R437C	1.7792637080000002			Q15025							
gdsc	IC-87114	PIK3CD	F609L	1.7108086130000002			Q15025							
gdsc	IC-87114	PIK3CD	V296I	1.333216894			Q15025							
gdsc	IC-87114	PIK3CD	V296I	1.038275614			Q15025							
gdsc	IC-87114	PIK3CD	A215V+S764N	1.506163786			Q15025							
gdsc	IC-87114	PIK3CD	C7R	1.457872131			Q15025							
gdsc	IC-87114	PIK3CD	L725I+E1021K	1.447465729			Q15025							
gdsc	IC-87114	PIK3CD	S174L	1.801538173			Q15025							
gdsc	IC-87114	PIK3CD	G593R	1.639296295			Q15025							
gdsc	IC-87114	PIK3CD	E200K	0.922999411			Q15025							
gdsc	IC-87114	PIK3CD	A396T	1.111393565			Q15025							
gdsc	IC-87114	PIK3CD	M762I	1.238080432			Q15025							
gdsc	IC-87114	PIK3CD	R437C	1.6615203980000002			Q15025							
gdsc	IC-87114	PIK3CD	E451K	1.5762452530000002			Q15025							
gdsc	IC-87114	PIK3CD	E1021K	0.564304401			Q15025							
gdsc	IC-87114	PIK3CD	V296I	1.030121246			Q15025							
gdsc	IC-87114	PIK3CD	G4E	1.516914422			Q15025							
gdsc	IC-87114	PIK3CD	V296I	0.8175163879999999			Q15025							
gdsc	IC-87114	PIK3CD	E234D	1.59511767			Q15025							
gdsc	IC-87114	PIK3CD	A388T+R460H+S738N	0.549679507			Q15025							
gdsc	IC-87114	PIK3CD	R88H	1.690030765			Q15025							
gdsc	IC-87114	PIK3CD	P186S	1.858626449			Q15025							
gdsc	IC-87114	PIK3CD	V296I	1.592248858			Q15025							
gdsc	IC-87114	PIK3CD	V296I	2.182927718			Q15025							
gdsc	IC-87114	PIK3CD	A487T	1.50796731			Q15025							
gdsc	IC-87114	PIK3CD	F932C	1.824543763			Q15025							
gdsc	IC-87114	PIK3CD	R38C	1.991910634			Q15025							
gdsc	IC-87114	PIK3CD	C132Y	1.68108069			Q15025							
gdsc	IC-87114	PIK3CD	E1021K	0.409369046			Q15025							
gdsc	IC-87114	PIK3CD	M387T	0.98770941			Q15025							
gdsc	IC-87114	PIK3CD	G971R	0.384590148			Q15025							
gdsc	IC-87114	PIK3CD	R437C	1.34153538			Q15025							
gdsc	IC-87114	PIK3CD	R229Q	1.505509091			Q15025							
gdsc	IC-87114	PIK3CD	P294H	1.565606597			Q15025							
gdsc	IC-87114	PIK3CD	G819E	1.572328929			Q15025							
gdsc	IC-87114	PIK3CD	E83K	-2.870640176			Q15025							
gdsc	IC-87114	PIK3CD	R229W	1.473299842			Q15025							
gdsc	IC-87114	PIK3CD	E1021K	1.344055218			Q15025							
gdsc	IC-87114	PIK3CD	M683I	0.787872005			Q15025							
gdsc	IC-87114	PIK3CD	R821C	1.451962096			Q15025							
gdsc	IC-87114	PIK3CD	P658L	1.495955866			Q15025							
gdsc	Idelalisib	PIK3CD	A742V	0.34205389			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	1.3562864730000002			Q15025							
gdsc	Idelalisib	PIK3CD	R437C	1.608254242			Q15025							
gdsc	Idelalisib	PIK3CD	G772S	0.129543236			Q15025							
gdsc	Idelalisib	PIK3CD	G985D	0.766169289			Q15025							
gdsc	Idelalisib	PIK3CD	N334K	-2.557110872			Q15025							
gdsc	Idelalisib	PIK3CD	R437C	0.968349971			Q15025							
gdsc	Idelalisib	PIK3CD	F609L	1.465326182			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	1.224971115			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	1.665762589			Q15025							
gdsc	Idelalisib	PIK3CD	A215V+S764N	1.505641215			Q15025							
gdsc	Idelalisib	PIK3CD	C7R	0.986462822			Q15025							
gdsc	Idelalisib	PIK3CD	L725I+E1021K	1.63629773			Q15025							
gdsc	Idelalisib	PIK3CD	S174L	1.908347177			Q15025							
gdsc	Idelalisib	PIK3CD	G593R	1.7369828109999998			Q15025							
gdsc	Idelalisib	PIK3CD	E200K	0.214726547			Q15025							
gdsc	Idelalisib	PIK3CD	M762I	0.6625117110000001			Q15025							
gdsc	Idelalisib	PIK3CD	R437C	1.25739899			Q15025							
gdsc	Idelalisib	PIK3CD	E766G	0.686028616			Q15025							
gdsc	Idelalisib	PIK3CD	E451K	0.594448248			Q15025							
gdsc	Idelalisib	PIK3CD	E1021K	1.024130633			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	1.453450418			Q15025							
gdsc	Idelalisib	PIK3CD	G4E	0.921307867			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	0.053488931			Q15025							
gdsc	Idelalisib	PIK3CD	E234D	0.773456259			Q15025							
gdsc	Idelalisib	PIK3CD	A388T+R460H+S738N	0.142638927			Q15025							
gdsc	Idelalisib	PIK3CD	R88H	1.047653463			Q15025							
gdsc	Idelalisib	PIK3CD	P186S	1.4621155069999998			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	0.362883284			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	2.071985541			Q15025							
gdsc	Idelalisib	PIK3CD	A487T	1.530636369			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	1.763803411			Q15025							
gdsc	Idelalisib	PIK3CD	F932C	0.8525263120000001			Q15025							
gdsc	Idelalisib	PIK3CD	R38C	1.950204447			Q15025							
gdsc	Idelalisib	PIK3CD	C132Y	0.977947039			Q15025							
gdsc	Idelalisib	PIK3CD	E1021K	-0.283773535			Q15025							
gdsc	Idelalisib	PIK3CD	M387T	1.038414848			Q15025							
gdsc	Idelalisib	PIK3CD	G971R	-0.647230937			Q15025							
gdsc	Idelalisib	PIK3CD	R437C	1.11673837			Q15025							
gdsc	Idelalisib	PIK3CD	R229Q	1.421194363			Q15025							
gdsc	Idelalisib	PIK3CD	P294H	1.036489865			Q15025							
gdsc	Idelalisib	PIK3CD	G819E	0.71666778			Q15025							
gdsc	Idelalisib	PIK3CD	E83K	-3.593963338			Q15025							
gdsc	Idelalisib	PIK3CD	R229W	0.644527429			Q15025							
gdsc	Idelalisib	PIK3CD	E1021K	2.349840746			Q15025							
gdsc	Idelalisib	PIK3CD	V296I	1.074643513			Q15025							
gdsc	Idelalisib	PIK3CD	M683I	1.130229248			Q15025							
gdsc	Idelalisib	PIK3CD	R821C	2.035992092			Q15025							
gdsc	Idelalisib	PIK3CD	P658L	1.097618887			Q15025							
gdsc	AS605240	PIK3CG	N16S	0.059128201			P48736							
gdsc	AS605240	PIK3CG	D358Y	-0.7602639929999999			P48736							
gdsc	AS605240	PIK3CG	R178C	-0.348519676			P48736							
gdsc	AS605240	PIK3CG	D946N	0.7667635509999999			P48736							
gdsc	AS605240	PIK3CG	T827R	-0.101558404			P48736							
gdsc	AS605240	PIK3CG	R49S	-0.462504263			P48736							
gdsc	AS605240	PIK3CG	V332L	-0.6682706629999999			P48736							
gdsc	AS605240	PIK3CG	E14*	-0.100945775			P48736							
gdsc	AS605240	PIK3CG	A30G	0.561781008			P48736							
gdsc	AS605240	PIK3CG	R362S	0.7827665640000001			P48736							
gdsc	AS605240	PIK3CG	D358Y	0.642115424			P48736							
gdsc	AS605240	PIK3CG	M259I	0.953771884			P48736							
gdsc	AS605240	PIK3CG	H295Q	0.103228026			P48736							
gdsc	AS605240	PIK3CG	V381I	0.380113926			P48736							
gdsc	AS605240	PIK3CG	P142L	-0.3861780070000001			P48736							
gdsc	AS605240	PIK3CG	G276S	-0.235340869			P48736							
gdsc	AS605240	PIK3CG	A569T	1.290310926			P48736							
gdsc	AS605240	PIK3CG	A528V	-0.025716208			P48736							
gdsc	AS605240	PIK3CG	W855L	0.540327136			P48736							
gdsc	AS605240	PIK3CG	R273H+L466M	0.7647982790000001			P48736							
gdsc	AS605240	PIK3CG	I158M	-0.179299514			P48736							
gdsc	AS605240	PIK3CG	D192N	0.215646083			P48736							
gdsc	AS605240	PIK3CG	E4D+D731N	0.99938373			P48736							
gdsc	AS605240	PIK3CG	T330M	-0.821332582			P48736							
gdsc	AS605240	PIK3CG	P39S	-0.357136775			P48736							
gdsc	AS605240	PIK3CG	L651V	0.330720842			P48736							
gdsc	AS605240	PIK3CG	V11M	1.16269682			P48736							
gdsc	AS605240	PIK3CG	N386S	-1.826635827			P48736							
gdsc	AS605240	PIK3CG	A197T	-1.852344925			P48736							
gdsc	AS605240	PIK3CG	G996A	0.184495012			P48736							
gdsc	AS605240	PIK3CG	H909L	1.218870299			P48736							
gdsc	AS605240	PIK3CG	G343S	0.915498554			P48736							
gdsc	AS605240	PIK3CG	I643V	0.108262369			P48736							
gdsc	AS605240	PIK3CG	R477C	-0.18049337			P48736							
gdsc	AS605240	PIK3CG	I287M	0.239398797			P48736							
gdsc	AS605240	PIK3CG	Y672*	-1.105302229			P48736							
gdsc	AS605240	PIK3CG	R477C	0.138249207			P48736							
gdsc	AS605240	PIK3CG	A621S	1.203886952			P48736							
gdsc	AS605240	PIK3CG	T330M	-0.645325506			P48736							
gdsc	AS605240	PIK3CG	I888V	-1.351089789			P48736							
gdsc	AS605240	PIK3CG	V305M	-0.718641347			P48736							
gdsc	AS605240	PIK3CG	R21P+A243T	-0.590355956			P48736							
gdsc	AS605240	PIK3CG	R472P	-0.786599348			P48736							
gdsc	AS605240	PIK3CG	M1039T	0.368516629			P48736							
gdsc	AS605240	PIK3CG	G426E+E511K	-0.467016627			P48736							
gdsc	AS605240	PIK3CG	R178L+T1056I	0.050877851			P48736							
gdsc	AS605240	PIK3CG	H693Q	0.142581456			P48736							
gdsc	AS605240	PIK3CG	P538L	-0.829864362			P48736							
gdsc	AS605240	PIK3CG	I643V	1.782226725			P48736							
gdsc	AS605240	PIK3CG	V332D	1.840002283			P48736							
gdsc	AS605240	PIK3CG	P563T	1.020723846			P48736							
gdsc	AS605240	PIK3CG	T627I	-5.33e-06			P48736							
gdsc	AS605240	PIK3CG	P208L	-0.449958991			P48736							
gdsc	AS605240	PIK3CG	I643V	1.232431683			P48736							
gdsc	AS605240	PIK3CG	T309M+R542W	-0.17453475100000002			P48736							
gdsc	AS605240	PIK3CG	L1092H	0.068304605			P48736							
gdsc	AS605240	PIK3CG	L211P	-0.100794099			P48736							
gdsc	AS605240	PIK3CG	E981*	0.684372621			P48736							
gdsc	AS605240	PIK3CG	R839C	0.099949215			P48736							
gdsc	AS605240	PIK3CG	M35I	0.417480754			P48736							
gdsc	AS605240	PIK3CG	I220M	0.235237777			P48736							
gdsc	AS605240	PIK3CG	I643V	0.099102555			P48736							
gdsc	AS605240	PIK3CG	T330M	0.513732865			P48736							
gdsc	AS605240	PIK3CG	I643V	-0.10007897			P48736							
gdsc	AS605240	PIK3CG	A314T	0.664061059			P48736							
gdsc	AS605240	PIK3CG	E108K	-1.323427861			P48736							
gdsc	AS605240	PIK3CG	G65D+T955I	0.329164977			P48736							
gdsc	AS605240	PIK3CG	A243T+P324S+E347K+F698L	0.361740381			P48736							
gdsc	AS605240	PIK3CG	A1064V+R184H+S515P	0.037892362			P48736							
gdsc	AS605240	PIK3CG	F350L+E573*+K587Q+E781K+G977D	-1.047477495			P48736							
gdsc	AS605240	PIK3CG	R849*	0.6451637579999999			P48736							
gdsc	AS605240	PIK3CG	A253T	0.6882350290000001			P48736							
gdsc	AS605240	PIK3CG	R362K	2.215186143			P48736							
gdsc	AS605240	PIK3CG	Q246*	0.895365922			P48736							
gdsc	AS605240	PIK3CG	E36K	-0.776927035			P48736							
gdsc	CZC24832	PIK3CG	N16S	0.965281493			P48736							
gdsc	CZC24832	PIK3CG	R178C	0.989605954			P48736							
gdsc	CZC24832	PIK3CG	D946N	0.371601697			P48736							
gdsc	CZC24832	PIK3CG	T827R	1.970178886			P48736							
gdsc	CZC24832	PIK3CG	R49S	0.6545238320000001			P48736							
gdsc	CZC24832	PIK3CG	A557V	1.841605547			P48736							
gdsc	CZC24832	PIK3CG	A885T+E781K	0.245924424			P48736							
gdsc	CZC24832	PIK3CG	E14*	1.778611383			P48736							
gdsc	CZC24832	PIK3CG	R362S	0.696715856			P48736							
gdsc	CZC24832	PIK3CG	D358Y	1.4225393030000002			P48736							
gdsc	CZC24832	PIK3CG	M259I	1.219792206			P48736							
gdsc	CZC24832	PIK3CG	H295Q	0.7280156409999999			P48736							
gdsc	CZC24832	PIK3CG	V381I	0.8423403140000001			P48736							
gdsc	CZC24832	PIK3CG	P142L	1.148951174			P48736							
gdsc	CZC24832	PIK3CG	G276S	1.873160692			P48736							
gdsc	CZC24832	PIK3CG	A569T	1.745764621			P48736							
gdsc	CZC24832	PIK3CG	A528V	0.922791448			P48736							
gdsc	CZC24832	PIK3CG	R273H+L466M	1.406158877			P48736							
gdsc	CZC24832	PIK3CG	I158M	0.7856655920000001			P48736							
gdsc	CZC24832	PIK3CG	E4D+D731N	1.597902348			P48736							
gdsc	CZC24832	PIK3CG	T330M	0.203400608			P48736							
gdsc	CZC24832	PIK3CG	P39S	1.476557916			P48736							
gdsc	CZC24832	PIK3CG	L651V	2.120119002			P48736							
gdsc	CZC24832	PIK3CG	N386S	0.941815541			P48736							
gdsc	CZC24832	PIK3CG	A197T	0.350548344			P48736							
gdsc	CZC24832	PIK3CG	G436S	2.055178526			P48736							
gdsc	CZC24832	PIK3CG	H909L	1.575361266			P48736							
gdsc	CZC24832	PIK3CG	G343S	1.741290768			P48736							
gdsc	CZC24832	PIK3CG	I643V	1.412313609			P48736							
gdsc	CZC24832	PIK3CG	I287M	0.7307831370000001			P48736							
gdsc	CZC24832	PIK3CG	Y672*	1.594458234			P48736							
gdsc	CZC24832	PIK3CG	R477C	0.721882831			P48736							
gdsc	CZC24832	PIK3CG	A621S	1.806011433			P48736							
gdsc	CZC24832	PIK3CG	T330M	1.684791422			P48736							
gdsc	CZC24832	PIK3CG	I888V	1.043244784			P48736							
gdsc	CZC24832	PIK3CG	V305M	1.075763309			P48736							
gdsc	CZC24832	PIK3CG	A84V	-0.14594380699999998			P48736							
gdsc	CZC24832	PIK3CG	R21P+A243T	0.8817778759999999			P48736							
gdsc	CZC24832	PIK3CG	T1081I	0.994134315			P48736							
gdsc	CZC24832	PIK3CG	M1039T	2.591634958			P48736							
gdsc	CZC24832	PIK3CG	S806F	1.167490614			P48736							
gdsc	CZC24832	PIK3CG	H693Q	0.76960807			P48736							
gdsc	CZC24832	PIK3CG	P538L	1.314481341			P48736							
gdsc	CZC24832	PIK3CG	I643V	2.309190959			P48736							
gdsc	CZC24832	PIK3CG	V332D	1.410828842			P48736							
gdsc	CZC24832	PIK3CG	P563T	1.037279055			P48736							
gdsc	CZC24832	PIK3CG	P208L	1.210248461			P48736							
gdsc	CZC24832	PIK3CG	I643V	1.6498028269999998			P48736							
gdsc	CZC24832	PIK3CG	L1092H	0.7933898159999999			P48736							
gdsc	CZC24832	PIK3CG	L211P	0.311430723			P48736							
gdsc	CZC24832	PIK3CG	R839C	1.825900553			P48736							
gdsc	CZC24832	PIK3CG	M35I	0.8411251270000001			P48736							
gdsc	CZC24832	PIK3CG	I220M	1.658182339			P48736							
gdsc	CZC24832	PIK3CG	I643V	1.194770389			P48736							
gdsc	CZC24832	PIK3CG	T330M	0.606921237			P48736							
gdsc	CZC24832	PIK3CG	A314T	1.258296605			P48736							
gdsc	CZC24832	PIK3CG	G65D+T955I	1.058362625			P48736							
gdsc	CZC24832	PIK3CG	A243T+P324S+E347K+F698L	1.838298889			P48736							
gdsc	CZC24832	PIK3CG	A1064V+R184H+S515P	1.30143068			P48736							
gdsc	CZC24832	PIK3CG	F350L+E573*+K587Q+E781K+G977D	0.839467948			P48736							
gdsc	CZC24832	PIK3CG	A253T	1.774856807			P48736							
gdsc	CZC24832	PIK3CG	R362K	1.776497397			P48736							
gdsc	CZC24832	PIK3CG	Q246*	1.626828639			P48736							
gdsc	CZC24832	PIK3CG	Q48*	1.077261703			P48736							
gdsc	CZC24832	PIK3CG	E36K	1.364340711			P48736							
gdsc	CZC24832	PIK3CG	N979S	1.962875918			P48736							
gdsc	PIK-93	PIK3CG	N16S	-1.4885663969999998			P48736							
gdsc	PIK-93	PIK3CG	D358Y	-0.525691577			P48736							
gdsc	PIK-93	PIK3CG	R178C	0.10191982			P48736							
gdsc	PIK-93	PIK3CG	D946N	-0.133739806			P48736							
gdsc	PIK-93	PIK3CG	T827R	0.901058515			P48736							
gdsc	PIK-93	PIK3CG	R49S	-2.9255380360000003			P48736							
gdsc	PIK-93	PIK3CG	V332L	-0.300555666			P48736							
gdsc	PIK-93	PIK3CG	E14*	-0.225474813			P48736							
gdsc	PIK-93	PIK3CG	A30G	-0.499711713			P48736							
gdsc	PIK-93	PIK3CG	R362S	-1.205270997			P48736							
gdsc	PIK-93	PIK3CG	D358Y	-0.035110646			P48736							
gdsc	PIK-93	PIK3CG	M259I	-1.6315495569999998			P48736							
gdsc	PIK-93	PIK3CG	H295Q	-0.98752337			P48736							
gdsc	PIK-93	PIK3CG	V381I	-0.932042505			P48736							
gdsc	PIK-93	PIK3CG	P142L	-1.412058248			P48736							
gdsc	PIK-93	PIK3CG	G276S	-1.00930785			P48736							
gdsc	PIK-93	PIK3CG	A569T	1.26401112			P48736							
gdsc	PIK-93	PIK3CG	A528V	-0.333327182			P48736							
gdsc	PIK-93	PIK3CG	W855L	-0.513760119			P48736							
gdsc	PIK-93	PIK3CG	R273H+L466M	0.56559898			P48736							
gdsc	PIK-93	PIK3CG	I158M	-0.507427642			P48736							
gdsc	PIK-93	PIK3CG	D192N	-1.811298174			P48736							
gdsc	PIK-93	PIK3CG	E4D+D731N	1.208955659			P48736							
gdsc	PIK-93	PIK3CG	T330M	-0.376551908			P48736							
gdsc	PIK-93	PIK3CG	P39S	-0.560511314			P48736							
gdsc	PIK-93	PIK3CG	L651V	0.7520035709999999			P48736							
gdsc	PIK-93	PIK3CG	V11M	-0.210983821			P48736							
gdsc	PIK-93	PIK3CG	N386S	-0.521454719			P48736							
gdsc	PIK-93	PIK3CG	G996A	0.6799248379999999			P48736							
gdsc	PIK-93	PIK3CG	H909L	-0.25988929			P48736							
gdsc	PIK-93	PIK3CG	G343S	-0.180813312			P48736							
gdsc	PIK-93	PIK3CG	I643V	1.397048239			P48736							
gdsc	PIK-93	PIK3CG	R477C	0.068336599			P48736							
gdsc	PIK-93	PIK3CG	I287M	-1.226384783			P48736							
gdsc	PIK-93	PIK3CG	Y672*	-1.087204783			P48736							
gdsc	PIK-93	PIK3CG	R477C	-0.08441545			P48736							
gdsc	PIK-93	PIK3CG	A621S	0.475399694			P48736							
gdsc	PIK-93	PIK3CG	T330M	-0.269847181			P48736							
gdsc	PIK-93	PIK3CG	I888V	-2.395632707			P48736							
gdsc	PIK-93	PIK3CG	V305M	-0.556741333			P48736							
gdsc	PIK-93	PIK3CG	R21P+A243T	-0.802771219			P48736							
gdsc	PIK-93	PIK3CG	G65D	-0.460413977			P48736							
gdsc	PIK-93	PIK3CG	R472P	-0.729114107			P48736							
gdsc	PIK-93	PIK3CG	M1039T	0.201242186			P48736							
gdsc	PIK-93	PIK3CG	G426E+E511K	0.280429551			P48736							
gdsc	PIK-93	PIK3CG	S806F	0.8025051940000001			P48736							
gdsc	PIK-93	PIK3CG	R178L+T1056I	-0.977300046			P48736							
gdsc	PIK-93	PIK3CG	H693Q	0.788817019			P48736							
gdsc	PIK-93	PIK3CG	P538L	0.747705686			P48736							
gdsc	PIK-93	PIK3CG	I643V	0.8051358259999999			P48736							
gdsc	PIK-93	PIK3CG	V332D	1.98653739			P48736							
gdsc	PIK-93	PIK3CG	P563T	-0.446315802			P48736							
gdsc	PIK-93	PIK3CG	T627I	-1.75014012			P48736							
gdsc	PIK-93	PIK3CG	P208L	0.287848053			P48736							
gdsc	PIK-93	PIK3CG	I643V	0.820663667			P48736							
gdsc	PIK-93	PIK3CG	T309M+R542W	-0.228366731			P48736							
gdsc	PIK-93	PIK3CG	L1092H	-0.091653836			P48736							
gdsc	PIK-93	PIK3CG	L211P	-2.640836077			P48736							
gdsc	PIK-93	PIK3CG	E981*	1.296166453			P48736							
gdsc	PIK-93	PIK3CG	R839C	0.7413015190000001			P48736							
gdsc	PIK-93	PIK3CG	M35I	-1.682750905			P48736							
gdsc	PIK-93	PIK3CG	I220M	0.8885724909999999			P48736							
gdsc	PIK-93	PIK3CG	I643V	-0.553777724			P48736							
gdsc	PIK-93	PIK3CG	T330M	-0.752953324			P48736							
gdsc	PIK-93	PIK3CG	I643V	0.1262034			P48736							
gdsc	PIK-93	PIK3CG	A314T	0.28845061			P48736							
gdsc	PIK-93	PIK3CG	E108K	0.042624538			P48736							
gdsc	PIK-93	PIK3CG	G65D+T955I	-0.192703296			P48736							
gdsc	PIK-93	PIK3CG	A243T+P324S+E347K+F698L	0.125532707			P48736							
gdsc	PIK-93	PIK3CG	A1064V+R184H+S515P	-0.309800205			P48736							
gdsc	PIK-93	PIK3CG	F350L+E573*+K587Q+E781K+G977D	1.49142632			P48736							
gdsc	PIK-93	PIK3CG	R849*	0.512258763			P48736							
gdsc	PIK-93	PIK3CG	A253T	0.230857537			P48736							
gdsc	PIK-93	PIK3CG	R362K	2.350661337			P48736							
gdsc	PIK-93	PIK3CG	Q246*	1.391166643			P48736							
gdsc	PIK-93	PIK3CG	E36K	0.942200656			P48736							
gdsc	YM201636	PIKFYVE	I229V	-0.892601388			Q9Y2I7							
gdsc	YM201636	PIKFYVE	Q78L	-0.433641961			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A512V	-0.557078457			Q9Y2I7							
gdsc	YM201636	PIKFYVE	T1571N	-0.6562189310000001			Q9Y2I7							
gdsc	YM201636	PIKFYVE	M859V+E920*	-0.241743852			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R176H	-0.7984460809999999			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A1827T	-1.362997548			Q9Y2I7							
gdsc	YM201636	PIKFYVE	Y1026H+S1034Y+D1510V	0.18333078			Q9Y2I7							
gdsc	YM201636	PIKFYVE	T1764N	-0.7131134640000001			Q9Y2I7							
gdsc	YM201636	PIKFYVE	L2094F	1.094692012			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1858Q	-0.674865018			Q9Y2I7							
gdsc	YM201636	PIKFYVE	N654H+N1100S+I1120V+I1427V+I1805T	-1.228191862			Q9Y2I7							
gdsc	YM201636	PIKFYVE	P1593R	-1.249941385			Q9Y2I7							
gdsc	YM201636	PIKFYVE	K162N	-0.600023529			Q9Y2I7							
gdsc	YM201636	PIKFYVE	Q293P	-1.686523255			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1858Q	-0.980220403			Q9Y2I7							
gdsc	YM201636	PIKFYVE	P1521H	0.921797259			Q9Y2I7							
gdsc	YM201636	PIKFYVE	P77S	-2.064705681			Q9Y2I7							
gdsc	YM201636	PIKFYVE	P584L	-0.455924128			Q9Y2I7							
gdsc	YM201636	PIKFYVE	P450S	0.749178604			Q9Y2I7							
gdsc	YM201636	PIKFYVE	G460R	-0.568684641			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R54C+V290A+A1378V	-0.949319361			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1284H	-1.383822795			Q9Y2I7							
gdsc	YM201636	PIKFYVE	Q987H	0.249468075			Q9Y2I7							
gdsc	YM201636	PIKFYVE	E894V	-0.860274827			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1858Q	-0.9460524			Q9Y2I7							
gdsc	YM201636	PIKFYVE	H1364D	-0.926309623			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R375C+I1898F	-0.247970274			Q9Y2I7							
gdsc	YM201636	PIKFYVE	V652I	1.229416528			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1546L	-0.23758757100000005			Q9Y2I7							
gdsc	YM201636	PIKFYVE	Y46H+A878S+F1606L	-1.114898705			Q9Y2I7							
gdsc	YM201636	PIKFYVE	V2051L	-0.545602027			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1858Q	-0.831051702			Q9Y2I7							
gdsc	YM201636	PIKFYVE	H536P	-0.742791025			Q9Y2I7							
gdsc	YM201636	PIKFYVE	S1474F	-1.20475435			Q9Y2I7							
gdsc	YM201636	PIKFYVE	V337F	-0.219427913			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1386W	-0.980408221			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A965G	-1.067457266			Q9Y2I7							
gdsc	YM201636	PIKFYVE	K1446E	-0.917382063			Q9Y2I7							
gdsc	YM201636	PIKFYVE	V1279L	-0.655485435			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A901G	-0.734857655			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1881S	-0.223749497			Q9Y2I7							
gdsc	YM201636	PIKFYVE	V902F	0.866187825			Q9Y2I7							
gdsc	YM201636	PIKFYVE	I667M	0.87356663			Q9Y2I7							
gdsc	YM201636	PIKFYVE	S514C	-0.479292911			Q9Y2I7							
gdsc	YM201636	PIKFYVE	S628L	-0.895657424			Q9Y2I7							
gdsc	YM201636	PIKFYVE	E1654D	0.247752239			Q9Y2I7							
gdsc	YM201636	PIKFYVE	G1592R	-0.620358791			Q9Y2I7							
gdsc	YM201636	PIKFYVE	P818S	-0.376264552			Q9Y2I7							
gdsc	YM201636	PIKFYVE	S88P+M605T+Y1650H	-0.30747588800000003			Q9Y2I7							
gdsc	YM201636	PIKFYVE	M1473L	-1.174874159			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1858Q	0.3931764370000001			Q9Y2I7							
gdsc	YM201636	PIKFYVE	S639L	-0.08712073599999999			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A1865V	0.100510299			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A1865V	-0.08841353699999999			Q9Y2I7							
gdsc	YM201636	PIKFYVE	T1205A	0.5159914170000001			Q9Y2I7							
gdsc	YM201636	PIKFYVE	G1592R	-0.7646626			Q9Y2I7							
gdsc	YM201636	PIKFYVE	L419M	-0.629566004			Q9Y2I7							
gdsc	YM201636	PIKFYVE	G1592R	0.995642189			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A106V	-0.6787896370000001			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A513T+R1560H	-1.364952155			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A691V	-1.132710574			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1858Q	-0.118338165			Q9Y2I7							
gdsc	YM201636	PIKFYVE	A1674T	-0.63886446			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R379I	0.188732463			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1858Q	-0.428698861			Q9Y2I7							
gdsc	YM201636	PIKFYVE	T1564A	0.556830206			Q9Y2I7							
gdsc	YM201636	PIKFYVE	Q331H	0.247735057			Q9Y2I7							
gdsc	YM201636	PIKFYVE	R1401H	0.307820121			Q9Y2I7							
gdsc	GW843682X	PLK1	I296V	-3.485222833			P53350							
gdsc	GW843682X	PLK1	S375G	-4.318838217			P53350							
gdsc	GW843682X	PLK1	R354H	-3.4426581360000004			P53350							
gdsc	GW843682X	PLK1	P151S+R500H	-4.642503158			P53350							
gdsc	GW843682X	PLK1	K178*	-3.72152175			P53350							
gdsc	GW843682X	PLK1	Y421*	-4.489464938			P53350							
gdsc	GW843682X	PLK1	N297D	-3.411716212			P53350							
gdsc	GW843682X	PLK1	P250H	-2.424602842			P53350							
gdsc	GW843682X	PLK1	N297D	-2.600230727			P53350							
gdsc	GW843682X	PLK1	S107N	-0.927463783			P53350							
gdsc	GW843682X	PLK1	E568*	-2.784754179			P53350							
gdsc	GW843682X	PLK1	L286F	-2.098067312			P53350							
gdsc	GW843682X	PLK1	S224R	-4.071943895			P53350							
gdsc	NPK76-II-72-1	PLK3	W467C	-0.238497628			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	W463*	-0.139035435			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	Q103E	1.873847974			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	W151L	-1.661479517			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	Q307H	0.469026928			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	V427L	-2.01187974			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	R163L	-0.17699771			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	A486D	0.637308595			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	G475V	-0.044082643			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	R34L	0.71862298			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	T262M	-0.08679486900000001			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	R179C+G256E	-0.5207235929999999			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	R484H	0.439191766			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	P101S	-0.05402513			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	A453T	-0.251073709			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	A456V	-1.276622158			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	C255Y	0.16714942900000002			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	C221Y	-2.798234392			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	T268M+S611G	-1.991156401			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	R34L	0.590062083			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	R377C	-0.6766241059999999			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	R610H	1.58091581			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	R354K	1.202351824			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	D264N	-0.849901012			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	T82A	-0.7964636270000001			Q9H4B4							
gdsc	NPK76-II-72-1	PLK3	A437P	1.48336438			Q9H4B4							
gdsc	IWP-2	PORCN	L159I+R225C	0.093079355			Q9H237							
gdsc	IWP-2	PORCN	R243*	0.012519795			Q9H237							
gdsc	IWP-2	PORCN	H341Y	-0.362943718			Q9H237							
gdsc	IWP-2	PORCN	G211A	0.146528589			Q9H237							
gdsc	IWP-2	PORCN	V180I	-0.315059692			Q9H237							
gdsc	IWP-2	PORCN	L202M	-0.28552966			Q9H237							
gdsc	LGK974	PORCN	L159I+R225C	-0.747224762			Q9H237							
gdsc	LGK974	PORCN	R243*	0.022774914			Q9H237							
gdsc	LGK974	PORCN	H341Y	-0.105344083			Q9H237							
gdsc	LGK974	PORCN	G211A	0.606805756			Q9H237							
gdsc	LGK974	PORCN	R370W	-0.22130135			Q9H237							
gdsc	LGK974	PORCN	V180I	0.436489255			Q9H237							
gdsc	LGK974	PORCN	L202M	0.051738554000000006			Q9H237							
gdsc	Wnt-C59	PORCN	L159I+R225C	-0.074200549			Q9H237							
gdsc	Wnt-C59	PORCN	R243*	0.922544529			Q9H237							
gdsc	Wnt-C59	PORCN	H341Y	-0.021201078			Q9H237							
gdsc	Wnt-C59	PORCN	G211A	0.971281611			Q9H237							
gdsc	Wnt-C59	PORCN	R370W	-0.276978327			Q9H237							
gdsc	Wnt-C59	PORCN	V180I	0.553750831			Q9H237							
gdsc	Wnt-C59	PORCN	L202M	-0.060141638			Q9H237							
gdsc	CCT007093	PPM1D	I496V	0.725273029			O15297							
gdsc	CCT007093	PPM1D	P267S	1.5138731980000002			O15297							
gdsc	CCT007093	PPM1D	N443D	0.704946062			O15297							
gdsc	CCT007093	PPM1D	R572*	1.552947567			O15297							
gdsc	CCT007093	PPM1D	T501A	0.4504146120000001			O15297							
gdsc	CCT007093	PPM1D	N448S	0.102806769			O15297							
gdsc	CCT007093	PPM1D	A82S	0.975407649			O15297							
gdsc	CCT007093	PPM1D	N448S	1.22330327			O15297							
gdsc	CCT007093	PPM1D	P88S	0.629670874			O15297							
gdsc	CCT007093	PPM1D	R441C	0.640439877			O15297							
gdsc	CCT007093	PPM1D	N448S	1.202127865			O15297							
gdsc	CCT007093	PPM1D	I320L	1.020870782			O15297							
gdsc	CCT007093	PPM1D	P88S	0.670762061			O15297							
gdsc	CCT007093	PPM1D	R458*	0.762799236			O15297							
gdsc	CCT007093	PPM1D	P88S	1.04824891			O15297							
gdsc	CCT007093	PPM1D	P88S	0.212145091			O15297							
gdsc	CCT007093	PPM1D	P88S	0.715536727			O15297							
gdsc	CCT007093	PPM1D	P88S	1.240573608			O15297							
gdsc	CCT007093	PPM1D	Y392C	0.7358761359999999			O15297							
gdsc	CCT007093	PPM1D	I526M	0.957033512			O15297							
gdsc	CCT007093	PPM1D	F445L	0.209589704			O15297							
gdsc	CCT007093	PPM1D	N448S	0.692739691			O15297							
gdsc	CCT007093	PPM1D	T532A	0.498924893			O15297							
gdsc	CCT007093	PPM1D	A82S	0.5856421470000001			O15297							
gdsc	CCT007093	PPM1D	A82S	-0.035045473			O15297							
gdsc	CCT007093	PPM1D	H342Y	0.150136821			O15297							
gdsc	CCT007093	PPM1D	T517I	0.097917585			O15297							
gdsc	CCT007093	PPM1D	R243C	0.6246460110000001			O15297							
gdsc	CCT007093	PPM1D	R557L	-0.241745629			O15297							
gdsc	CCT007093	PPM1D	P88S	1.048795181			O15297							
gdsc	CCT007093	PPM1D	P48S	0.6645054229999999			O15297							
gdsc	CCT007093	PPM1D	P88S	2.141531994			O15297							
gdsc	CCT007093	PPM1D	I496V	1.14268624			O15297							
gdsc	CCT007093	PPM1D	P88S	1.043104957			O15297							
gdsc	CCT007093	PPM1D	P88S	1.297138128			O15297							
gdsc	CCT007093	PPM1D	L538F	0.625671602			O15297							
gdsc	CCT007093	PPM1D	P411S	0.7174931109999999			O15297							
gdsc	CCT007093	PPM1D	G340D	0.259234594			O15297							
gdsc	CCT007093	PPM1D	P88S	0.731552775			O15297							
gdsc	CCT007093	PPM1D	R458*	0.617533231			O15297							
gdsc	Enzastaurin	PRKCB	M137I	0.655419076			P05771							
gdsc	Enzastaurin	PRKCB	E319K	0.423953058			P05771							
gdsc	Enzastaurin	PRKCB	A621T	0.130597267			P05771							
gdsc	Enzastaurin	PRKCB	S295N	1.174462382			P05771							
gdsc	Enzastaurin	PRKCB	P669R	0.15425696			P05771							
gdsc	Enzastaurin	PRKCB	N298S	1.075786416			P05771							
gdsc	Enzastaurin	PRKCB	R465H	0.048259068			P05771							
gdsc	Enzastaurin	PRKCB	S664F	-0.119709767			P05771							
gdsc	Enzastaurin	PRKCB	M337I	0.546769222			P05771							
gdsc	Enzastaurin	PRKCB	R158H	-0.00639765			P05771							
gdsc	Enzastaurin	PRKCB	C50*	0.288643167			P05771							
gdsc	Enzastaurin	PRKCB	P616T	0.901577532			P05771							
gdsc	Enzastaurin	PRKCB	V325I	1.013446948			P05771							
gdsc	Enzastaurin	PRKCB	G436D	1.298988458			P05771							
gdsc	Enzastaurin	PRKCB	A570T	-0.867627563			P05771							
gdsc	Enzastaurin	PRKCB	G543V	0.8679279529999999			P05771							
gdsc	Enzastaurin	PRKCB	L469P	-0.425514255			P05771							
gdsc	Enzastaurin	PRKCB	N298S	0.106487877			P05771							
gdsc	Enzastaurin	PRKCB	A509T	0.181998282			P05771							
gdsc	Enzastaurin	PRKCB	A509T	-0.014224966			P05771							
gdsc	Enzastaurin	PRKCB	D341N+I512M+R631Q	0.8726702009999999			P05771							
gdsc	Enzastaurin	PRKCB	T321M+*674*	0.024736238			P05771							
gdsc	Enzastaurin	PRKCB	G294E	-0.755683494			P05771							
gdsc	Enzastaurin	PRKCB	R610H	0.7001125709999999			P05771							
gdsc	Enzastaurin	PRKCB	Q433H	0.914996719			P05771							
gdsc	Enzastaurin	PRKCB	G294E+A559V	0.506859449			P05771							
gdsc	Enzastaurin	PRKCB	K489N	-1.153410806			P05771							
gdsc	Enzastaurin	PRKCB	E385D	0.18313526			P05771							
gdsc	Enzastaurin	PRKCB	P221T	1.494048066			P05771							
gdsc	Enzastaurin	PRKCB	A451V	-1.057161066			P05771							
gdsc	Enzastaurin	PRKCB	C50S	2.025142511			P05771							
gdsc	Enzastaurin	PRKCB	D475Y	0.74242961			P05771							
gdsc	Enzastaurin	PRKCB	P588H	0.149190623			P05771							
gdsc	Enzastaurin	PRKCB	I201T	0.612306923			P05771							
gdsc	Enzastaurin	PRKCB	E243K+E366*	0.137808991			P05771							
gdsc	Enzastaurin	PRKCB	Q128H+R336L	0.342534395			P05771							
gdsc	Enzastaurin	PRKCB	T40I	0.771252808			P05771							
gdsc	Enzastaurin	PRKCB	P588H	-0.542383058			P05771							
gdsc	Enzastaurin	PRKCB	M357I	0.278077979			P05771							
gdsc	Enzastaurin	PRKCB	C115F	-0.446024892			P05771							
gdsc	Enzastaurin	PRKCB	D475Y	1.253059632			P05771							
gdsc	Enzastaurin	PRKCB	A621T	0.079547003			P05771							
gdsc	Enzastaurin	PRKCB	R624Q	-1.330217144			P05771							
gdsc	Enzastaurin	PRKCB	R161S	1.6156164569999998			P05771							
gdsc	Enzastaurin	PRKCB	V316A+C488Y+E612D	-1.037498867			P05771							
gdsc	Enzastaurin	PRKCB	S16N	-0.856956913			P05771							
gdsc	Enzastaurin	PRKCB	A89T	0.82461554			P05771							
gdsc	Enzastaurin	PRKCB	E657K	0.731918338			P05771							
gdsc	Enzastaurin	PRKCB	V316A	-1.308109168			P05771							
gdsc	kb NB 142-70	PRKD1	S340G	0.13147947699999998			Q15139							
gdsc	kb NB 142-70	PRKD1	A489T	-0.147249051			Q15139							
gdsc	kb NB 142-70	PRKD1	D616H	-0.020337632			Q15139							
gdsc	kb NB 142-70	PRKD1	M349L	-0.3643455370000001			Q15139							
gdsc	kb NB 142-70	PRKD1	M166V	-0.003191123			Q15139							
gdsc	kb NB 142-70	PRKD1	I84V	-1.103119515			Q15139							
gdsc	kb NB 142-70	PRKD1	H450R	0.661889602			Q15139							
gdsc	kb NB 142-70	PRKD1	P593S	-0.174611774			Q15139							
gdsc	kb NB 142-70	PRKD1	W540*+A137T	0.80887559			Q15139							
gdsc	kb NB 142-70	PRKD1	H397N	1.4303287			Q15139							
gdsc	kb NB 142-70	PRKD1	K276*	-0.963646827			Q15139							
gdsc	kb NB 142-70	PRKD1	K834E	0.005775541			Q15139							
gdsc	kb NB 142-70	PRKD1	L7P	-0.648196687			Q15139							
gdsc	kb NB 142-70	PRKD1	R611L	0.425628605			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	0.8300190009999999			Q15139							
gdsc	kb NB 142-70	PRKD1	A495V	-0.207159924			Q15139							
gdsc	kb NB 142-70	PRKD1	P687L	0.650173809			Q15139							
gdsc	kb NB 142-70	PRKD1	P729S	0.919938042			Q15139							
gdsc	kb NB 142-70	PRKD1	N894S	-0.6494320179999999			Q15139							
gdsc	kb NB 142-70	PRKD1	S633N	-0.512845323			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.370944039			Q15139							
gdsc	kb NB 142-70	PRKD1	L7P	-0.635774059			Q15139							
gdsc	kb NB 142-70	PRKD1	I579S+D127N	0.408925274			Q15139							
gdsc	kb NB 142-70	PRKD1	P475T	-0.040959063			Q15139							
gdsc	kb NB 142-70	PRKD1	I816V+G32V	-0.5173730910000001			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.784030927			Q15139							
gdsc	kb NB 142-70	PRKD1	A26T+R216H	-0.603185028			Q15139							
gdsc	kb NB 142-70	PRKD1	V650A	-0.184147224			Q15139							
gdsc	kb NB 142-70	PRKD1	M349L	-0.311409394			Q15139							
gdsc	kb NB 142-70	PRKD1	Q884*	0.622634525			Q15139							
gdsc	kb NB 142-70	PRKD1	P322L	-1.152837874			Q15139							
gdsc	kb NB 142-70	PRKD1	N411S	-0.424755875			Q15139							
gdsc	kb NB 142-70	PRKD1	D623Y	-0.033023323			Q15139							
gdsc	kb NB 142-70	PRKD1	G607E	0.188256106			Q15139							
gdsc	kb NB 142-70	PRKD1	E878Q	-0.84324563			Q15139							
gdsc	kb NB 142-70	PRKD1	M349L	-0.584887914			Q15139							
gdsc	kb NB 142-70	PRKD1	L7P	-0.34119775			Q15139							
gdsc	kb NB 142-70	PRKD1	R447Q	-0.002600416			Q15139							
gdsc	kb NB 142-70	PRKD1	M349L	-0.498402914			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.633870406			Q15139							
gdsc	kb NB 142-70	PRKD1	D392E	-0.835808762			Q15139							
gdsc	kb NB 142-70	PRKD1	I334F	0.651846986			Q15139							
gdsc	kb NB 142-70	PRKD1	Y768*	0.23509558			Q15139							
gdsc	kb NB 142-70	PRKD1	V711I	-0.415652939			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.652505236			Q15139							
gdsc	kb NB 142-70	PRKD1	G914D+G608E	0.715082291			Q15139							
gdsc	kb NB 142-70	PRKD1	R105C	-1.050365858			Q15139							
gdsc	kb NB 142-70	PRKD1	E501K	-1.097917499			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.156946249			Q15139							
gdsc	kb NB 142-70	PRKD1	V711L	-0.088715112			Q15139							
gdsc	kb NB 142-70	PRKD1	L27R	2.112945789			Q15139							
gdsc	kb NB 142-70	PRKD1	Q143P	-0.558534784			Q15139							
gdsc	kb NB 142-70	PRKD1	S776Y	0.159617762			Q15139							
gdsc	kb NB 142-70	PRKD1	S358I	-0.44019188			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.856434933			Q15139							
gdsc	kb NB 142-70	PRKD1	L705I	-0.228244679			Q15139							
gdsc	kb NB 142-70	PRKD1	E819*	-0.699160448			Q15139							
gdsc	kb NB 142-70	PRKD1	S136P	-0.686395957			Q15139							
gdsc	kb NB 142-70	PRKD1	R626*	-0.216143178			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.17363595199999998			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	0.08077877900000001			Q15139							
gdsc	kb NB 142-70	PRKD1	C861R+G787D	-0.5777206260000001			Q15139							
gdsc	kb NB 142-70	PRKD1	G238R	0.6373435510000001			Q15139							
gdsc	kb NB 142-70	PRKD1	K911E	-0.397605853			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	0.551381124			Q15139							
gdsc	kb NB 142-70	PRKD1	L7P	-0.409725721			Q15139							
gdsc	kb NB 142-70	PRKD1	R416M	0.399878625			Q15139							
gdsc	kb NB 142-70	PRKD1	R748W	-0.15872133300000002			Q15139							
gdsc	kb NB 142-70	PRKD1	Q884H+R866C+P809S	0.040149137			Q15139							
gdsc	kb NB 142-70	PRKD1	E819K	-1.0950954940000002			Q15139							
gdsc	kb NB 142-70	PRKD1	R201Q	0.002006153			Q15139							
gdsc	kb NB 142-70	PRKD1	R611C	0.951904372			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-1.053271403			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.5037915629999999			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.093539123			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.497664086			Q15139							
gdsc	kb NB 142-70	PRKD1	M349L	1.030460148			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.687628325			Q15139							
gdsc	kb NB 142-70	PRKD1	G181S	0.146946291			Q15139							
gdsc	kb NB 142-70	PRKD1	H899R	-0.465268797			Q15139							
gdsc	kb NB 142-70	PRKD1	L7P	-0.21750056			Q15139							
gdsc	XMD13-2	RIPK1	I221K	-0.753568916			Q13546							
gdsc	XMD13-2	RIPK1	V461I	1.199064719			Q13546							
gdsc	XMD13-2	RIPK1	V326L	0.952829833			Q13546							
gdsc	XMD13-2	RIPK1	T277A	0.828639696			Q13546							
gdsc	XMD13-2	RIPK1	E234K	1.255534441			Q13546							
gdsc	XMD13-2	RIPK1	I615T	0.919256684			Q13546							
gdsc	XMD13-2	RIPK1	K242T	0.936365274			Q13546							
gdsc	XMD13-2	RIPK1	I135T	-0.7568400240000001			Q13546							
gdsc	XMD13-2	RIPK1	H445Q	-0.065133626			Q13546							
gdsc	XMD13-2	RIPK1	L79V	0.477552783			Q13546							
gdsc	XMD13-2	RIPK1	Y192C	0.308584427			Q13546							
gdsc	XMD13-2	RIPK1	E93D	0.894842758			Q13546							
gdsc	XMD13-2	RIPK1	S520C	-0.647798537			Q13546							
gdsc	XMD13-2	RIPK1	T562M	0.915997426			Q13546							
gdsc	XMD13-2	RIPK1	T579A	-0.386551273			Q13546							
gdsc	XMD13-2	RIPK1	Y531H	1.324390649			Q13546							
gdsc	XMD13-2	RIPK1	R413H	-0.278078572			Q13546							
gdsc	XMD13-2	RIPK1	N186S	0.124769587			Q13546							
gdsc	XMD13-2	RIPK1	R424I	0.353679626			Q13546							
gdsc	XMD13-2	RIPK1	L168M	1.332870291			Q13546							
gdsc	GSK269962A	ROCK1	D1014V+M489T+C231Y	0.339451176			Q13464							
gdsc	GSK269962A	ROCK1	K1083I	-0.936374161			Q13464							
gdsc	GSK269962A	ROCK1	K647R+M14I	-1.078079601			Q13464							
gdsc	GSK269962A	ROCK1	K666N+R115I	0.451148825			Q13464							
gdsc	GSK269962A	ROCK1	R1262*+R1012Q+R630Q+K50T	-1.187908824			Q13464							
gdsc	GSK269962A	ROCK1	T949I	-0.373532462			Q13464							
gdsc	GSK269962A	ROCK1	R349Q	0.303367598			Q13464							
gdsc	GSK429286A	ROCK1	D1014V+M489T+C231Y	1.331502243			Q13464							
gdsc	GSK429286A	ROCK1	K1083I	1.612624409			Q13464							
gdsc	GSK429286A	ROCK1	K647R+M14I	0.619095614			Q13464							
gdsc	GSK429286A	ROCK1	K666N+R115I	1.57053844			Q13464							
gdsc	GSK429286A	ROCK1	R1262*+R1012Q+R630Q+K50T	1.048719343			Q13464							
gdsc	GSK429286A	ROCK1	T949I	0.8671002520000001			Q13464							
gdsc	GSK429286A	ROCK1	R349Q	1.393765874			Q13464							
gdsc	CMK	RPS6KA2	A657S	-2.377297082			Q15349							
gdsc	CMK	RPS6KA2	G309A	-0.476464981			Q15349							
gdsc	CMK	RPS6KA2	E336K	1.099630965			Q15349							
gdsc	CMK	RPS6KA2	V16M	0.928158768			Q15349							
gdsc	CMK	RPS6KA2	L175I	-0.023253249			Q15349							
gdsc	CMK	RPS6KA2	V453M	-0.270937353			Q15349							
gdsc	CMK	RPS6KA2	R326Q	-1.291061604			Q15349							
gdsc	CMK	RPS6KA2	R747C	0.133827494			Q15349							
gdsc	CMK	RPS6KA2	R576*	0.275534442			Q15349							
gdsc	CMK	RPS6KA2	R525W	0.378824087			Q15349							
gdsc	CMK	RPS6KA2	V673I	-0.545394658			Q15349							
gdsc	PF-4708671	RPS6KB1	N145S	0.624739623			P42345							
gdsc	PF-4708671	RPS6KB1	P368L	-0.116744973			P42345							
gdsc	PF-4708671	RPS6KB1	D193H	0.7609540359999999			P42345							
gdsc	PF-4708671	RPS6KB1	E84K	0.633514323			P42345							
gdsc	PF-4708671	RPS6KB1	T478A	1.282440358			P42345							
gdsc	PF-4708671	RPS6KB1	D37N	0.791329746			P42345							
gdsc	PF-4708671	RPS6KB1	N311S	-1.139482675			P42345							
gdsc	PF-4708671	RPS6KB1	H210P	0.632600711			P42345							
gdsc	PF-4708671	RPS6KB1	P88L	0.133047191			P42345							
gdsc	PF-4708671	RPS6KB1	K141I	1.054778092			P42345							
gdsc	PF-4708671	RPS6KB1	T140A	0.659103739			P42345							
gdsc	PF-4708671	RPS6KB1	D37N	0.450696042			P42345							
gdsc	PF-4708671	RPS6KB1	P505L	0.60786388			P42345							
gdsc	PF-4708671	RPS6KB1	Q374E	0.456495875			P42345							
gdsc	CAY10566	SCD	T37M	-0.287975437			O00767							
gdsc	CAY10566	SCD	M38V	-0.245690393			O00767							
gdsc	CAY10566	SCD	S198N+A267T	-1.229119693			O00767							
gdsc	CAY10566	SCD	M224I	0.638731151			O00767							
gdsc	GSK650394	SGK2	R273*	0.33401802			Q9HBY8							
gdsc	GSK650394	SGK2	R334M	-0.982756238			Q9HBY8							
gdsc	GSK650394	SGK2	H211Y	0.009652169			Q9HBY8							
gdsc	GSK650394	SGK2	Y121C	-0.601297964			Q9HBY8							
gdsc	GSK650394	SGK2	Q137H	2.182722719			Q9HBY8							
gdsc	RU-SKI 43	SHH	A391V+R163C	0.374538052			Q15465							
gdsc	RU-SKI 43	SHH	A430T	0.4359094			Q15465							
gdsc	RU-SKI 43	SHH	R153H	0.6594912239999999			Q15465							
gdsc	RU-SKI 43	SHH	G290D	0.51157385			Q15465							
gdsc	RU-SKI 43	SHH	A365V+R326Q	0.040504628			Q15465							
gdsc	RU-SKI 43	SHH	D154E	1.1066750159999998			Q15465							
gdsc	RU-SKI 43	SHH	Q441H+R258L+D246E	0.647436529			Q15465							
gdsc	RU-SKI 43	SHH	N107D	1.3987012719999998			Q15465							
gdsc	RU-SKI 43	SHH	T240A	1.687810724			Q15465							
gdsc	RU-SKI 43	SHH	N81S+A373V	1.090943954			Q15465							
gdsc	RU-SKI 43	SHH	S112T	0.274961509			Q15465							
gdsc	RU-SKI 43	SHH	R33T	2.036381354			Q15465							
gdsc	RU-SKI 43	SHH	G221R	1.189629399			Q15465							
gdsc	RU-SKI 43	SHH	I85V	0.789555255			Q15465							
gdsc	RU-SKI 43	SHH	R123W	0.293167973			Q15465							
gdsc	RU-SKI 43	SHH	R34K	1.880569714			Q15465							
gdsc	RU-SKI 43	SHH	D246N+A145T	0.936322023			Q15465							
gdsc	RU-SKI 43	SHH	K103N	0.924765608			Q15465							
gdsc	RU-SKI 43	SHH	A341T	1.17083282			Q15465							
gdsc	RU-SKI 43	SHH	A269T	1.4091775869999998			Q15465							
gdsc	RU-SKI 43	SHH	S177Y	0.138973816			Q15465							
gdsc	Selisistat	SIRT1	T177I	1.714455949			Q96EB6							
gdsc	Selisistat	SIRT1	S668F	1.216262774			Q96EB6							
gdsc	Selisistat	SIRT1	P114Q	2.3275739840000003			Q96EB6							
gdsc	Selisistat	SIRT1	L478V	0.935917356			Q96EB6							
gdsc	Selisistat	SIRT1	E520*+E687K	1.64679182			Q96EB6							
gdsc	Selisistat	SIRT1	R181W	1.49505529			Q96EB6							
gdsc	Selisistat	SIRT1	M407T	1.403332725			Q96EB6							
gdsc	Selisistat	SIRT1	G355V	0.952972622			Q96EB6							
gdsc	Selisistat	SIRT1	P393R	1.249463842			Q96EB6							
gdsc	Selisistat	SIRT1	A712T	1.801140023			Q96EB6							
gdsc	Selisistat	SIRT1	P114Q	0.533659905			Q96EB6							
gdsc	Selisistat	SIRT1	G495D	1.859918065			Q96EB6							
gdsc	Selisistat	SIRT1	P114Q	1.982879981			Q96EB6							
gdsc	Selisistat	SIRT1	E536K	1.944681304			Q96EB6							
gdsc	Selisistat	SIRT1	E536K	1.5999470130000002			Q96EB6							
gdsc	Selisistat	SIRT1	R649H	1.354527386			Q96EB6							
gdsc	Selisistat	SIRT1	I270K	1.724038205			Q96EB6							
gdsc	Selisistat	SIRT1	L107V	1.425348866			Q96EB6							
gdsc	Selisistat	SIRT1	A712T	1.78853965			Q96EB6							
gdsc	Selisistat	SIRT1	R199Q	1.64223502			Q96EB6							
gdsc	Selisistat	SIRT1	K238T+E725G	2.011060334			Q96EB6							
gdsc	Selisistat	SIRT1	E536K	0.57844168			Q96EB6							
gdsc	Selisistat	SIRT1	P114Q	2.024007903			Q96EB6							
gdsc	Selisistat	SIRT1	V383I	1.593168987			Q96EB6							
gdsc	Selisistat	SIRT1	D379N	1.812846337			Q96EB6							
gdsc	Selisistat	SIRT1	E536K	1.391633521			Q96EB6							
gdsc	MCT4_1422	SLC16A3	A15V	0.997301146			O15427							
gdsc	MCT4_1422	SLC16A3	Y57*	0.901735133			O15427							
gdsc	MCT4_1422	SLC16A3	Y57*	1.074251881			O15427							
gdsc	MCT4_1422	SLC16A3	E8K	1.606325704			O15427							
gdsc	MCT4_1422	SLC16A3	R224W	1.149934106			O15427							
gdsc	MCT4_1422	SLC16A3	L270M+A434V	0.7154875509999999			O15427							
gdsc	MCT4_1422	SLC16A3	R224Q	1.108277688			O15427							
gdsc	MCT4_1422	SLC16A3	Y57*	1.181384381			O15427							
gdsc	MCT4_1422	SLC16A3	R224Q	0.401857524			O15427							
gdsc	MCT4_1422	SLC16A3	A15V	1.1906621000000002			O15427							
gdsc	MCT4_1422	SLC16A3	E425D	0.592735374			O15427							
gdsc	MCT4_1422	SLC16A3	C78Y	0.834037232			O15427							
gdsc	MCT4_1422	SLC16A3	V42I	1.267302965			O15427							
gdsc	MCT4_1422	SLC16A3	H459N	1.376016215			O15427							
gdsc	MCT4_1422	SLC16A3	L96F+R291W+P292S	0.413916366			O15427							
gdsc	MCT4_1422	SLC16A3	Y57*	-0.665644178			O15427							
gdsc	MCT4_1422	SLC16A3	F408delF	1.131193813			O15427							
gdsc	MCT4_1422	SLC16A3	I55M	1.090441527			O15427							
gdsc	MCT4_1422	SLC16A3	Y57*	0.54307508			O15427							
gdsc	MCT4_1422	SLC16A3	A15V	1.3434733980000002			O15427							
gdsc	MCT4_1422	SLC16A3	G18R	1.064314134			O15427							
gdsc	MCT4_1422	SLC16A3	A308T	0.6502869729999999			O15427							
gdsc	MCT4_1422	SLC16A3	R216H	0.956787631			O15427							
gdsc	MCT4_1422	SLC16A3	F130L	1.172256561			O15427							
gdsc	MCT4_1422	SLC16A3	G56A	0.841405373			O15427							
gdsc	MCT4_1422	SLC16A3	G370V	-0.79914462			O15427							
gdsc	MCT4_1422	SLC16A3	P39S	1.543907435			O15427							
gdsc	MCT4_1422	SLC16A3	A15V	1.149244454			O15427							
gdsc	MCT4_1422	SLC16A3	R84C	2.36921085			O15427							
gdsc	MCT4_1422	SLC16A3	V295I	1.1072603909999998			O15427							
gdsc	MCT4_1422	SLC16A3	T397I	0.862261429			O15427							
gdsc	MCT4_1422	SLC16A3	A15V	0.731113151			O15427							
gdsc	MCT4_1422	SLC16A3	S214F	1.540022512			O15427							
gdsc	Cyclopamine	SMO	A68G	0.668397455			Q99835							
gdsc	Cyclopamine	SMO	Y130C	1.251965313			Q99835							
gdsc	Cyclopamine	SMO	G497V	1.036280718			Q99835							
gdsc	Cyclopamine	SMO	S574C	0.904153063			Q99835							
gdsc	Cyclopamine	SMO	C273R	1.302283858			Q99835							
gdsc	Cyclopamine	SMO	P647S	1.221991509			Q99835							
gdsc	Cyclopamine	SMO	R138Q	-0.364544019			Q99835							
gdsc	Cyclopamine	SMO	R763Q	1.300994611			Q99835							
gdsc	Cyclopamine	SMO	R726Q	1.169445814			Q99835							
gdsc	Cyclopamine	SMO	V157M	1.318866914			Q99835							
gdsc	Cyclopamine	SMO	P663S	1.192600118			Q99835							
gdsc	Cyclopamine	SMO	R763Q	1.331015813			Q99835							
gdsc	Vismodegib	SMO	R168H	0.14136686199999998			Q99835							
gdsc	Vismodegib	SMO	N608S	0.8609982509999999			Q99835							
gdsc	Vismodegib	SMO	A68G	0.660482451			Q99835							
gdsc	Vismodegib	SMO	P647S	0.963539587			Q99835							
gdsc	Vismodegib	SMO	A572S	0.276888862			Q99835							
gdsc	Vismodegib	SMO	L267H	1.598650656			Q99835							
gdsc	Vismodegib	SMO	Y130C	0.612026085			Q99835							
gdsc	Vismodegib	SMO	G497V	1.016941423			Q99835							
gdsc	Vismodegib	SMO	R296H	0.551887106			Q99835							
gdsc	Vismodegib	SMO	P698S	-0.173874723			Q99835							
gdsc	Vismodegib	SMO	R576W	0.942092824			Q99835							
gdsc	Vismodegib	SMO	S574C	1.033068858			Q99835							
gdsc	Vismodegib	SMO	V404M	0.293525242			Q99835							
gdsc	Vismodegib	SMO	T640A	1.129331041			Q99835							
gdsc	Vismodegib	SMO	E194K+R668C	1.37050907			Q99835							
gdsc	Vismodegib	SMO	K575M	0.73405543			Q99835							
gdsc	Vismodegib	SMO	K575M	0.59457267			Q99835							
gdsc	Vismodegib	SMO	T179M	1.306011772			Q99835							
gdsc	Vismodegib	SMO	A729T	0.300868498			Q99835							
gdsc	Vismodegib	SMO	P647S	1.502160959			Q99835							
gdsc	Vismodegib	SMO	C273R	1.153808364			Q99835							
gdsc	Vismodegib	SMO	A324T	0.8675019559999999			Q99835							
gdsc	Vismodegib	SMO	P698R	1.06925131			Q99835							
gdsc	Vismodegib	SMO	P647S	1.243507593			Q99835							
gdsc	Vismodegib	SMO	P505S	1.255007129			Q99835							
gdsc	Vismodegib	SMO	R138Q	0.015946135			Q99835							
gdsc	Vismodegib	SMO	R763Q	0.207093566			Q99835							
gdsc	Vismodegib	SMO	R726Q	1.106268572			Q99835							
gdsc	Vismodegib	SMO	P647S	1.561581848			Q99835							
gdsc	Vismodegib	SMO	V157M	0.864269952			Q99835							
gdsc	Vismodegib	SMO	P663S	0.917262973			Q99835							
gdsc	Vismodegib	SMO	P647S	1.462110175			Q99835							
gdsc	Vismodegib	SMO	R726Q	0.966882386			Q99835							
gdsc	Vismodegib	SMO	K575M	1.15182117			Q99835							
gdsc	Vismodegib	SMO	Y322H	0.93761127			Q99835							
gdsc	Vismodegib	SMO	R763Q	0.46371234			Q99835							
gdsc	Vismodegib	SMO	V195L	1.63938576			Q99835							
gdsc	Vismodegib	SMO	Q710E	1.207056746			Q99835							
gdsc	Vismodegib	SMO	R629*	1.366169119			Q99835							
gdsc	Vismodegib	SMO	Q581*	0.38365106			Q99835							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	R157C	0.399337686			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	G450S	0.5248881679999999			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	V174M	0.6198611039999999			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	E393K	0.547090941			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	Q461H+Q462*	0.742965808			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	R365H	0.706808241			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	G428V	0.56150965			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	V344A	-0.04856242			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	L247P	0.274180614			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	A201T+R248H	-0.123166323			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	M276I	0.460595277			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	M431delM	0.149863094			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	E268V	0.1109641			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	Q462*+Q461H	0.5337961760000001			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	R248H	-0.082079875			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	Q462*+Q461H	0.068554633			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	M276I	-0.018503299			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	G395S	0.284073332			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	Q461H+Q462*	0.76756222			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	R365H	0.201507027			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	A322V	0.336564519			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	E429G	0.204853973			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	P48L	0.229145256			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	R80P	0.937047224			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	M276I	1.180311984			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	Q461H+Q462*	0.760761088			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	L104P	0.357856644			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	Q461H+Q462*	0.191079295			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	M276I	0.810290443			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	R248C	0.335264015			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	G395A	0.321318109			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	Q461H+Q462*	0.434099952			Q9NYA1							
gdsc	Sphingosine Kinase 1 Inhibitor II	SPHK1	M276I	0.263385542			Q9NYA1							
gdsc	WH-4-023	SRC	Q222H	-4.769612467			P12931							
gdsc	WH-4-023	SRC	H25Y	-1.07680075			P12931							
gdsc	BAY-61-3606	SYK	P355L	-0.25665550800000003			P43405							
gdsc	BAY-61-3606	SYK	G578E	-0.107383122			P43405							
gdsc	BAY-61-3606	SYK	R520S	1.776451183			P43405							
gdsc	BAY-61-3606	SYK	A620T	0.655982529			P43405							
gdsc	BAY-61-3606	SYK	G588R	-1.269873164			P43405							
gdsc	BAY-61-3606	SYK	A286P	-1.420309191			P43405							
gdsc	BAY-61-3606	SYK	V622A	-0.607062841			P43405							
gdsc	BAY-61-3606	SYK	A286P	-1.912181146			P43405							
gdsc	BAY-61-3606	SYK	D428N	-0.772099469			P43405							
gdsc	BAY-61-3606	SYK	K386N	-0.997964729			P43405							
gdsc	BAY-61-3606	SYK	I262L	-1.087536574			P43405							
gdsc	BAY-61-3606	SYK	A353T	-0.790679791			P43405							
gdsc	BAY-61-3606	SYK	K133E	-0.141573639			P43405							
gdsc	BAY-61-3606	SYK	E586D	-1.097892615			P43405							
gdsc	BAY-61-3606	SYK	H492Y	-1.0802105			P43405							
gdsc	BAY-61-3606	SYK	I262L	-0.937381385			P43405							
gdsc	BAY-61-3606	SYK	A86T	1.105484122			P43405							
gdsc	BAY-61-3606	SYK	W330C	-1.079357322			P43405							
gdsc	BAY-61-3606	SYK	E315K	0.887385745			P43405							
gdsc	BAY-61-3606	SYK	N200delN	-0.942883791			P43405							
gdsc	BAY-61-3606	SYK	Y568H	-0.560900576			P43405							
gdsc	BAY-61-3606	SYK	I438M	1.4648148680000002			P43405							
gdsc	BAY-61-3606	SYK	N381I	-1.096901388			P43405							
gdsc	BAY-61-3606	SYK	I262L	-1.07933303			P43405							
gdsc	BAY-61-3606	SYK	Y246C	-0.707179729			P43405							
gdsc	Entospletinib	SYK	G578E	0.27586445600000004			P43405							
gdsc	Entospletinib	SYK	R520S	-0.278050725			P43405							
gdsc	Entospletinib	SYK	A620T	-0.333956994			P43405							
gdsc	Entospletinib	SYK	G588R	1.403775904			P43405							
gdsc	Entospletinib	SYK	A286P	0.026362017			P43405							
gdsc	Entospletinib	SYK	V622A	1.631827432			P43405							
gdsc	Entospletinib	SYK	A286P	0.133668115			P43405							
gdsc	Entospletinib	SYK	D428N	0.098946731			P43405							
gdsc	Entospletinib	SYK	I262L	0.156125657			P43405							
gdsc	Entospletinib	SYK	A353T	-0.508100705			P43405							
gdsc	Entospletinib	SYK	K133E	0.398714985			P43405							
gdsc	Entospletinib	SYK	E586D	1.137465264			P43405							
gdsc	Entospletinib	SYK	H492Y	-0.27864321			P43405							
gdsc	Entospletinib	SYK	I262L	0.55269881			P43405							
gdsc	Entospletinib	SYK	A86T	0.799251268			P43405							
gdsc	Entospletinib	SYK	W330C	-1.117840984			P43405							
gdsc	Entospletinib	SYK	N200delN	0.067190141			P43405							
gdsc	Entospletinib	SYK	Y568H	-0.19216769			P43405							
gdsc	Entospletinib	SYK	N381I	0.216716703			P43405							
gdsc	Entospletinib	SYK	I262L	0.484536994			P43405							
gdsc	Entospletinib	SYK	S3N+R217H	0.956371707			P43405							
gdsc	PRT062607	SYK	G578E	0.01410173			P43405							
gdsc	PRT062607	SYK	R520S	0.411287511			P43405							
gdsc	PRT062607	SYK	A620T	0.016397016			P43405							
gdsc	PRT062607	SYK	G588R	1.520068811			P43405							
gdsc	PRT062607	SYK	A286P	-0.6763006090000001			P43405							
gdsc	PRT062607	SYK	V622A	1.657093352			P43405							
gdsc	PRT062607	SYK	A286P	-0.83053624			P43405							
gdsc	PRT062607	SYK	D428N	-0.30123583800000003			P43405							
gdsc	PRT062607	SYK	I262L	1.307499501			P43405							
gdsc	PRT062607	SYK	A353T	-0.614268048			P43405							
gdsc	PRT062607	SYK	K133E	0.897881612			P43405							
gdsc	PRT062607	SYK	E586D	-0.038182087			P43405							
gdsc	PRT062607	SYK	H492Y	-0.27949224			P43405							
gdsc	PRT062607	SYK	I262L	0.34641991			P43405							
gdsc	PRT062607	SYK	A86T	0.8109184770000001			P43405							
gdsc	PRT062607	SYK	W330C	-1.046347626			P43405							
gdsc	PRT062607	SYK	N200delN	-0.23665026			P43405							
gdsc	PRT062607	SYK	Y568H	0.221830439			P43405							
gdsc	PRT062607	SYK	N381I	-0.442939232			P43405							
gdsc	PRT062607	SYK	I262L	-0.239984764			P43405							
gdsc	PRT062607	SYK	S3N+R217H	1.289220754			P43405							
gdsc	TAF1_5496	TAF1	A318G	1.239905878			Q15572							
gdsc	TAF1_5496	TAF1	E1120A	1.447354935			Q15572							
gdsc	TAF1_5496	TAF1	Q1731K	1.225328383			Q15572							
gdsc	TAF1_5496	TAF1	P215L	1.246773369			Q15572							
gdsc	TAF1_5496	TAF1	R288H	-0.270045663			Q15572							
gdsc	TAF1_5496	TAF1	N181H	0.67130063			Q15572							
gdsc	TAF1_5496	TAF1	C326R+A1024T	0.475019319			Q15572							
gdsc	TAF1_5496	TAF1	G4S	0.07272809599999999			Q15572							
gdsc	TAF1_5496	TAF1	A83T	-0.294701324			Q15572							
gdsc	TAF1_5496	TAF1	A1527V	0.815400032			Q15572							
gdsc	TAF1_5496	TAF1	L290V	1.992068827			Q15572							
gdsc	TAF1_5496	TAF1	A318G	0.081995742			Q15572							
gdsc	TAF1_5496	TAF1	P808T	0.001439738			Q15572							
gdsc	TAF1_5496	TAF1	H663Y+K1030N+E1737A	-0.083565235			Q15572							
gdsc	TAF1_5496	TAF1	T11I	1.091167913			Q15572							
gdsc	TAF1_5496	TAF1	N181D+E217D+T219A+T781S+N1567S+E1713G+E1811D+E1858_E1859delEE	1.148638342			Q15572							
gdsc	TAF1_5496	TAF1	T11I	1.04972005			Q15572							
gdsc	TAF1_5496	TAF1	Q829R	0.996138691			Q15572							
gdsc	TAF1_5496	TAF1	A318G	0.544290859			Q15572							
gdsc	TAF1_5496	TAF1	R864Q+K168N	1.201497461			Q15572							
gdsc	TAF1_5496	TAF1	E703Q	-0.054697007			Q15572							
gdsc	TAF1_5496	TAF1	T355A+Q1057*+N1594D	0.294739835			Q15572							
gdsc	TAF1_5496	TAF1	T11I	-0.560605519			Q15572							
gdsc	TAF1_5496	TAF1	E706K	-0.408955491			Q15572							
gdsc	TAF1_5496	TAF1	D330N	-2.178337146			Q15572							
gdsc	TAF1_5496	TAF1	M1540I	0.694754732			Q15572							
gdsc	TAF1_5496	TAF1	G184V	-1.674081668			Q15572							
gdsc	TAF1_5496	TAF1	P459L	0.78139437			Q15572							
gdsc	TAF1_5496	TAF1	S1742Y	0.008344555			Q15572							
gdsc	TAF1_5496	TAF1	D1521Y	-1.247551894			Q15572							
gdsc	TAF1_5496	TAF1	Y986D	0.258051994			Q15572							
gdsc	TAF1_5496	TAF1	R1089H	-0.430220361			Q15572							
gdsc	TAF1_5496	TAF1	G680V	1.620792404			Q15572							
gdsc	TAF1_5496	TAF1	R1018H	-0.357284303			Q15572							
gdsc	TAF1_5496	TAF1	R1029H	1.774629293			Q15572							
gdsc	TAF1_5496	TAF1	S340P+W882R+A1157T+M1681L	0.14404193099999998			Q15572							
gdsc	TAF1_5496	TAF1	S1678F	1.276289182			Q15572							
gdsc	TAF1_5496	TAF1	N767K	0.207915935			Q15572							
gdsc	TAF1_5496	TAF1	A318G	0.246731388			Q15572							
gdsc	TAF1_5496	TAF1	D1170G	1.110524982			Q15572							
gdsc	TAF1_5496	TAF1	N181D+N1567S	0.503273732			Q15572							
gdsc	TAF1_5496	TAF1	D1671V	-0.994224373			Q15572							
gdsc	TAF1_5496	TAF1	L290V	-0.5518634060000001			Q15572							
gdsc	TAF1_5496	TAF1	E298_V299insE	0.928295039			Q15572							
gdsc	TAF1_5496	TAF1	D1168G+L290V	-0.8841205609999999			Q15572							
gdsc	TAF1_5496	TAF1	L290V	0.137036391			Q15572							
gdsc	TAF1_5496	TAF1	D1048H	0.724019923			Q15572							
gdsc	TAF1_5496	TAF1	L290V+E298_V299insE	2.553556556			Q15572							
gdsc	TAF1_5496	TAF1	S650F	1.334743135			Q15572							
gdsc	TAF1_5496	TAF1	A466V	-0.039560799			Q15572							
gdsc	TAF1_5496	TAF1	R1190H	0.710291459			Q15572							
gdsc	TAF1_5496	TAF1	C1288R	0.7430517190000001			Q15572							
gdsc	TAF1_5496	TAF1	R1018C+R1217H	1.309584455			Q15572							
gdsc	TAF1_5496	TAF1	G68D	0.35780628200000003			Q15572							
gdsc	TAF1_5496	TAF1	Q126H	-0.288899713			Q15572							
gdsc	TAF1_5496	TAF1	R1511H	-0.602773844			Q15572							
gdsc	TAF1_5496	TAF1	M1121T	1.652813835			Q15572							
gdsc	TAF1_5496	TAF1	L290V	0.389226934			Q15572							
gdsc	TAF1_5496	TAF1	L81F+L417I	0.10451905			Q15572							
gdsc	KIN001-236	TEK	G136R	1.116663124			Q02763							
gdsc	KIN001-236	TEK	I148T	1.4014018169999998			Q02763							
gdsc	KIN001-236	TEK	N618delN	1.250619187			Q02763							
gdsc	KIN001-236	TEK	I148T	0.8239555120000001			Q02763							
gdsc	KIN001-236	TEK	I148T+V462A	0.97529567			Q02763							
gdsc	KIN001-236	TEK	Q696H	1.001034985			Q02763							
gdsc	KIN001-236	TEK	V146L	1.541437959			Q02763							
gdsc	KIN001-236	TEK	V453M	1.460855292			Q02763							
gdsc	KIN001-236	TEK	I148T	0.571091906			Q02763							
gdsc	KIN001-236	TEK	L634F	1.6654912309999998			Q02763							
gdsc	KIN001-236	TEK	T391I	0.358719894			Q02763							
gdsc	KIN001-236	TEK	I148T	0.718526405			Q02763							
gdsc	KIN001-236	TEK	G217V	0.95595993			Q02763							
gdsc	KIN001-236	TEK	R50H	0.972993867			Q02763							
gdsc	KIN001-236	TEK	I148T	1.291643424			Q02763							
gdsc	KIN001-236	TEK	I148T	1.077844116			Q02763							
gdsc	KIN001-236	TEK	I463V	1.443001949			Q02763							
gdsc	KIN001-236	TEK	D982N	0.245244252			Q02763							
gdsc	KIN001-236	TEK	G344D	1.184388872			Q02763							
gdsc	KIN001-236	TEK	T391I	0.608642998			Q02763							
gdsc	KIN001-236	TEK	S1091P	0.990947932			Q02763							
gdsc	KIN001-236	TEK	I148T	1.312570578			Q02763							
gdsc	KIN001-236	TEK	K117N	1.21720601			Q02763							
gdsc	KIN001-236	TEK	F1111C	0.66490535			Q02763							
gdsc	KIN001-236	TEK	I148T	1.334474147			Q02763							
gdsc	KIN001-236	TEK	L206M	0.284196569			Q02763							
gdsc	KIN001-236	TEK	I148T	0.487143334			Q02763							
gdsc	KIN001-236	TEK	I148T	0.585410485			Q02763							
gdsc	KIN001-236	TEK	I148T	1.097780043			Q02763							
gdsc	KIN001-236	TEK	T391I	1.107138932			Q02763							
gdsc	KIN001-236	TEK	A724T	1.099994751			Q02763							
gdsc	KIN001-236	TEK	A765V	0.7152410770000001			Q02763							
gdsc	KIN001-236	TEK	D823E	0.984631452			Q02763							
gdsc	KIN001-236	TEK	I148T	0.082489875			Q02763							
gdsc	KIN001-236	TEK	I148T	0.79342655			Q02763							
gdsc	KIN001-236	TEK	T391I	0.154240963			Q02763							
gdsc	KIN001-236	TEK	G890*+A933T	-0.450601837			Q02763							
gdsc	KIN001-236	TEK	I148T	0.332309886			Q02763							
gdsc	KIN001-236	TEK	I148T	0.32308312100000003			Q02763							
gdsc	KIN001-236	TEK	I148T	1.840678308			Q02763							
gdsc	KIN001-236	TEK	I148T	-0.215003237			Q02763							
gdsc	KIN001-236	TEK	R50C	0.854376641			Q02763							
gdsc	KIN001-236	TEK	I148T	0.433750978			Q02763							
gdsc	KIN001-236	TEK	I148T	1.15548865			Q02763							
gdsc	KIN001-236	TEK	I148T	0.692203492			Q02763							
gdsc	KIN001-236	TEK	K646R	0.108367239			Q02763							
gdsc	KIN001-236	TEK	S1084*	0.86891681			Q02763							
gdsc	KIN001-236	TEK	A615T	1.566598416			Q02763							
gdsc	KIN001-236	TEK	T761I	1.018766869			Q02763							
gdsc	KIN001-236	TEK	P304L	0.561761456			Q02763							
gdsc	KIN001-236	TEK	T1105I	0.602482934			Q02763							
gdsc	KIN001-236	TEK	I148T	1.426961609			Q02763							
gdsc	KIN001-236	TEK	N1104D	1.621502793			Q02763							
gdsc	KIN001-236	TEK	I148T	0.6241038870000001			Q02763							
gdsc	KIN001-236	TEK	P282S	1.606524779			Q02763							
gdsc	KIN001-236	TEK	I148T	0.389341283			Q02763							
gdsc	KIN001-236	TEK	I148T	0.522986292			Q02763							
gdsc	KIN001-236	TEK	I148T	0.388450186			Q02763							
gdsc	KIN001-236	TEK	E300*	-0.6650167370000001			Q02763							
gdsc	KIN001-236	TEK	P469A	0.752047415			Q02763							
gdsc	KIN001-236	TEK	A724T	0.43397079			Q02763							
gdsc	KIN001-236	TEK	N449S	-0.08552813699999999			Q02763							
gdsc	KIN001-236	TEK	A724T	1.037191367			Q02763							
gdsc	KIN001-236	TEK	L747R	0.626156254			Q02763							
gdsc	KIN001-236	TEK	T391I+N449S+L911M	0.8018072470000001			Q02763							
gdsc	KIN001-236	TEK	A226V	1.160517661			Q02763							
gdsc	KIN001-236	TEK	G217*	1.22672013			Q02763							
gdsc	KIN001-236	TEK	A724T+R510L+P906T	0.762469814			Q02763							
gdsc	KIN001-236	TEK	A724T	0.792430583			Q02763							
gdsc	KIN001-236	TEK	V20L	1.295422292			Q02763							
gdsc	KIN001-236	TEK	I148T	0.619343865			Q02763							
gdsc	KIN001-236	TEK	A905T	1.089882221			Q02763							
gdsc	KIN001-236	TEK	I148T	0.292573711			Q02763							
gdsc	KIN001-236	TEK	I148T	1.4594552509999998			Q02763							
gdsc	KIN001-236	TEK	T557N	1.303802989			Q02763							
gdsc	KIN001-236	TEK	I148T	0.749934022			Q02763							
gdsc	KIN001-236	TEK	N449S	1.2167101			Q02763							
gdsc	KIN001-236	TEK	I148T	1.111859258			Q02763							
gdsc	KIN001-236	TEK	I148T	1.5674249319999998			Q02763							
gdsc	KIN001-236	TEK	I148T	-0.123335774			Q02763							
gdsc	KIN001-236	TEK	T503A+D711E	-0.043938077			Q02763							
gdsc	KIN001-236	TEK	T693S	1.44557748			Q02763							
gdsc	KIN001-236	TEK	A1006T	1.207717366			Q02763							
gdsc	KIN001-236	TEK	I148T	1.360131699			Q02763							
gdsc	KIN001-236	TEK	W1022G	1.719811418			Q02763							
gdsc	KIN001-236	TEK	R1076Q	0.516752167			Q02763							
gdsc	KIN001-236	TEK	I148T	1.310119469			Q02763							
gdsc	KIN001-236	TEK	P906A	1.209126295			Q02763							
gdsc	KIN001-236	TEK	D152N+V1103M	-0.103008807			Q02763							
gdsc	KIN001-236	TEK	E300K+D1069N	1.953191755			Q02763							
gdsc	KIN001-236	TEK	A724T	0.910115237			Q02763							
gdsc	KIN001-236	TEK	I148T	1.5140112469999998			Q02763							
gdsc	KIN001-236	TEK	I148T	1.652207723			Q02763							
gdsc	Telomerase Inhibitor IX	TEP1	D1269G	-0.8148768679999999			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1661Q+R1086W+K434N	-2.319605064			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	M262T	-0.954766073			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S195T	-1.417848009			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D2259G	-2.243487955			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S510L	-2.134344561			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	P1146L	-1.768820572			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R608Q	-2.126549239			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1661Q	-2.030682244			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1370N+R1073H	-1.821023811			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G1304E+R500W	-1.693495023			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R323Q	-0.66743526			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	T2468A	-1.819091126			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G1408R+R541C+K434N	-0.035403334			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	H1797L	-1.4888632309999998			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	A1934S+R1073H	-1.144602335			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K1955R	-2.190992621			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G813D	-1.186278898			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R804P	-1.399285462			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	T2542I	-0.828982745			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1876Q	-1.432099637			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K434N	-1.732340693			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	A1588V+R933H+P437L	-1.390822409			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	I2322M+R1661Q	-1.52951361			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R951H	-0.063766764			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1661Q	-1.86139987			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	E1059G	-1.385113819			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G427D	-1.686750769			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K434N	-0.182026128			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	H1371N	-1.339776885			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1646W	0.238863783			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K368T	-2.182699019			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	H321Y	-1.7674021640000002			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D685E	-1.746493377			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	Y1337C	-1.649659446			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R541C	0.647781948			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	P931S	-1.011624465			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G1874V	-0.208421917			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S510L	-0.928380357			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1661Q+R1073H	-2.160457142			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G427D	-0.866724616			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R500W	-0.28831196800000003			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1488W	-1.3492720459999998			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1002H	-1.886591137			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1555G	-0.904295852			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1579W	-1.749900164			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	E2368K	-1.601460811			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S195T	-1.815904151			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R933H	-1.914560564			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S1457C	-1.38770357			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	P982S	-1.006938503			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1602Y	-1.688519929			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R933H	-2.160325017			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	H1571Q	-2.080195009			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1607C	-2.353669975			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S2149N+G1780R	-1.156754198			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R500W+H321Q	-1.409029466			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1269G	0.040316218			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	Q1993*	-1.984940051			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S510L	-2.045044074			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S510L	-1.64532779			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	P890L	-1.7044873930000002			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	E1379G	-1.759376365			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	L1922M	-1.449930466			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	A1418S+R1326Q	-1.346705995			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	P391L	-1.617315703			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K434N	-1.191553197			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K434N	-1.126629903			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	A2310S+A1948V+R976C	-1.455936484			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	E1006K	-1.236987298			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	L1341P+A930V	-1.616024679			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K1955R	-1.260379781			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	E1006K	-1.361583879			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1579W	-1.516004366			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1269G	-2.190672087			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	L2487P+S1436N+R933H	-2.306007539			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S510L	-2.38481986			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R608Q	-0.8339045159999999			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S1960A+L986F	-1.144399706			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1661Q	-2.404303129			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R933H	-2.275226771			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	L533P	-2.2569302490000003			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K434N	-1.359191426			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1423W	-1.539574594			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	T1901M	-0.222499354			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1661Q+K434N	-1.5862001819999998			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	Q1612*	-0.862573668			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S876P	-1.284541902			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	P1937T	-1.202456102			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	L1419V+R933H	-1.263845817			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1622Q+A553G	-1.953880815			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	I2322M+R1661Q	-1.6786799419999998			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1622Q	0.039403199			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G1091R	-0.34235902			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K861N	-1.332370826			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	L2487P+R933H	0.357408133			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1622Q+A553G	1.4503280230000002			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1661Q+R1655L	-0.982164938			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	H613Y	-1.3436819519999998			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K1955R	-1.231747363			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R500W	-0.58591943			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G1408R+R541C+K434N	-2.045444001			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S2149N+G1780R+K434N+M262T	-1.984194705			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1646W	-0.573852885			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S195T	-2.103738576			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1493G	0.181303297			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	T54M	-1.297871624			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R620Q	-1.316873795			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	P1141L	-1.396999655			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1269G	-1.674148026			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G1091R	-1.344232963			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S2187T	-2.127703992			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1269G	1.796518642			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	A124S	-0.975512519			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R500W	-2.378977961			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K434N	-1.106680349			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1269G	-1.127980768			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R951H+R500W	-1.746552625			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	A553E	-1.864255646			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G427D	-0.921754008			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	T2500S	-1.947166185			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S510L	-1.015706685			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	E949D	-0.962926958			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S2149N+G1780R	-1.58365546			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1622Q+A553G	-0.841871658			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	E737A	-2.279025783			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	L1255M+A1570T+A1902T	-2.22745117			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	A2256T+R1861W+A553V	-1.1211115			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R976H	-1.55014156			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	T2500S	-0.985609052			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R2350Q	-1.269653352			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R2550H	-1.340878907			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	K1907E	-2.119571546			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R393Q	-0.15477183			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1147H	-1.696578314			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	P1599T	-0.604653798			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R2083W	-0.999796692			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R500W	-0.8194401859999999			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R2364*	-0.870219091			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	S2353L	-2.330708228			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	N953D	-0.580729856			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	D1269G	-1.26479794			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	V970L	-1.254844196			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	G2215R	-0.810663116			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	A2114T+G1091R	-1.988086737			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R1351*	-2.69397959			Q99973							
gdsc	Telomerase Inhibitor IX	TEP1	R2263W+R1622Q	0.165040775			Q99973							
gdsc	BIBR-1532	TERT	P785L	1.910337333			O14746							
gdsc	BIBR-1532	TERT	T878A	0.644439149			O14746							
gdsc	BIBR-1532	TERT	D848G	0.943952634			O14746							
gdsc	BIBR-1532	TERT	S284F	1.4657746930000002			O14746							
gdsc	BIBR-1532	TERT	A221V	0.650445759			O14746							
gdsc	BIBR-1532	TERT	R743Q+T117A	0.583249101			O14746							
gdsc	BIBR-1532	TERT	L397I	1.481666912			O14746							
gdsc	BIBR-1532	TERT	R972H	0.8277610409999999			O14746							
gdsc	BIBR-1532	TERT	V898A	1.079979431			O14746							
gdsc	BIBR-1532	TERT	P380S	1.648956167			O14746							
gdsc	BIBR-1532	TERT	D807G	1.000171735			O14746							
gdsc	BIBR-1532	TERT	E484K	0.759246697			O14746							
gdsc	BIBR-1532	TERT	V746M+L520V	1.344798786			O14746							
gdsc	BIBR-1532	TERT	R521H	0.925914436			O14746							
gdsc	BIBR-1532	TERT	P785Q	0.751475074			O14746							
gdsc	BIBR-1532	TERT	V741M	0.679130316			O14746							
gdsc	BIBR-1532	TERT	G225R	1.20194064			O14746							
gdsc	BIBR-1532	TERT	R865C	0.150143931			O14746							
gdsc	BIBR-1532	TERT	V640M	1.107838064			O14746							
gdsc	BIBR-1532	TERT	Q1024H	1.229931397			O14746							
gdsc	BIBR-1532	TERT	A615V	1.408406764			O14746							
gdsc	BIBR-1532	TERT	H752R	1.134758201			O14746							
gdsc	BIBR-1532	TERT	P530L	0.575939024			O14746							
gdsc	BIBR-1532	TERT	R938L	1.365082502			O14746							
gdsc	BIBR-1532	TERT	E280K	0.839755895			O14746							
gdsc	BIBR-1532	TERT	E280K	0.851042137			O14746							
gdsc	BIBR-1532	TERT	T262M	0.956808961			O14746							
gdsc	BIBR-1532	TERT	V639I	1.112330876			O14746							
gdsc	BIBR-1532	TERT	A801T+R743W+Q506*+G424S+A422T	1.317986481			O14746							
gdsc	BIBR-1532	TERT	E1068K	1.833424517			O14746							
gdsc	A-83-01	TGFB1	S209R	0.40783214			P01137							
gdsc	A-83-01	TGFB1	A221T	0.097969724			P01137							
gdsc	A-83-01	TGFB1	R141Q+E119K	0.463019725			P01137							
gdsc	A-83-01	TGFB1	R152Q	0.692520472			P01137							
gdsc	A-83-01	TGFB1	Y103H	0.514183746			P01137							
gdsc	A-83-01	TGFB1	R296Q	0.834697853			P01137							
gdsc	A-83-01	TGFB1	I300V	0.654628109			P01137							
gdsc	A-83-01	TGFB1	S138L	0.563080328			P01137							
gdsc	A-83-01	TGFB1	E169*	1.6350138159999998			P01137							
gdsc	A-83-01	TGFB1	R243C	0.246916244			P01137							
gdsc	A-83-01	TGFB1	R205L	1.168052882			P01137							
gdsc	A-83-01	TGFB1	T289A	0.353157647			P01137							
gdsc	A-83-01	TGFB1	G307D+R296Q	0.44677557			P01137							
gdsc	A-83-01	TGFB1	A221T+R218H	0.679322874			P01137							
gdsc	A-83-01	TGFB1	F134L	1.060615252			P01137							
gdsc	A-83-01	TGFB1	V20M	1.635668511			P01137							
gdsc	LY2109761	TGFB1	S209R	1.009874857			P01137							
gdsc	LY2109761	TGFB1	A221T	1.4848213			P01137							
gdsc	LY2109761	TGFB1	R141Q+E119K	0.7658677140000001			P01137							
gdsc	LY2109761	TGFB1	R152Q	2.74118759			P01137							
gdsc	LY2109761	TGFB1	Y103H	1.152690937			P01137							
gdsc	LY2109761	TGFB1	R296Q	1.019383053			P01137							
gdsc	LY2109761	TGFB1	I300V	1.6184355			P01137							
gdsc	LY2109761	TGFB1	S138L	3.1665436510000005			P01137							
gdsc	LY2109761	TGFB1	E169*	1.849879596			P01137							
gdsc	LY2109761	TGFB1	R243C	1.298799455			P01137							
gdsc	LY2109761	TGFB1	R205L	1.586897536			P01137							
gdsc	LY2109761	TGFB1	G307D+R296Q	1.298650149			P01137							
gdsc	LY2109761	TGFB1	A221T+R218H	0.929263159			P01137							
gdsc	LY2109761	TGFB1	F134L	1.1697444259999998			P01137							
gdsc	LY2109761	TGFB1	V20M	1.870015191			P01137							
gdsc	SB52334	TGFBR1	N45S	1.6262497809999998			P37173							
gdsc	SB52334	TGFBR1	V95A	1.443202801			P37173							
gdsc	SB52334	TGFBR1	E232delE	1.083984035			P37173							
gdsc	SB52334	TGFBR1	S420F	-0.295433042			P37173							
gdsc	SB52334	TGFBR1	K453N	0.668385013			P37173							
gdsc	SB52334	TGFBR1	V256L	1.310633745			P37173							
gdsc	SB52334	TGFBR1	L309R	1.485468294			P37173							
gdsc	SB52334	TGFBR1	N342S	0.408145565			P37173							
gdsc	SB52334	TGFBR1	D367H	0.6744799029999999			P37173							
gdsc	SB52334	TGFBR1	S214N	0.902588903			P37173							
gdsc	SB52334	TGFBR1	V157I	1.631881349			P37173							
gdsc	SB52334	TGFBR1	V157I	0.446648779			P37173							
gdsc	SB52334	TGFBR1	D337H+R417*	0.336682424			P37173							
gdsc	SB52334	TGFBR1	R491W	0.8868240690000001			P37173							
gdsc	SB52334	TGFBR1	L468F	1.275491697			P37173							
gdsc	SB52334	TGFBR1	Q279*	0.656052443			P37173							
gdsc	SB52334	TGFBR1	G216V	1.5943427			P37173							
gdsc	SB52334	TGFBR1	I143V	-0.290223917			P37173							
gdsc	SB52334	TGFBR1	Y299F	1.172765506			P37173							
gdsc	SB52334	TGFBR1	Y432F	0.823015831			P37173							
gdsc	SB52334	TGFBR1	R417Q	0.984511178			P37173							
gdsc	SB52334	TGFBR1	E398K	-0.770675728			P37173							
gdsc	SB52334	TGFBR1	P112L	1.6238691769999998			P37173							
gdsc	SB52334	TGFBR1	Y99*	1.073408183			P37173							
gdsc	SB52334	TGFBR1	A206V+A403T+R491Q	1.131981818			P37173							
gdsc	SB52334	TGFBR1	R491W	0.560293872			P37173							
gdsc	SB52334	TGFBR1	V56I	0.732776256			P37173							
gdsc	SB52334	TGFBR1	S118*	1.168855699			P37173							
gdsc	SB52334	TGFBR1	M148I	1.000238093			P37173							
gdsc	AZ6102	TNKS	E734K	-0.280616184			O95271							
gdsc	AZ6102	TNKS	H13Q	-0.412416787			O95271							
gdsc	AZ6102	TNKS	L976V	-0.915793611			O95271							
gdsc	MN-64	TNKS	E734K	0.965558775			O95271							
gdsc	MN-64	TNKS	H13Q	1.252583867			O95271							
gdsc	MN-64	TNKS	L976V	0.976474714			O95271							
gdsc	MN-64	TNKS	K506*+A1269V	1.594181544			O95271							
gdsc	MN-64	TNKS	L1079*	1.218640415			O95271							
gdsc	WIKI4	TNKS	E734K	0.604416804			O95271							
gdsc	WIKI4	TNKS	H13Q	0.404363734			O95271							
gdsc	WIKI4	TNKS	L976V	0.52773565			O95271							
gdsc	XAV939	TNKS	E734K	0.845382965			O95271							
gdsc	XAV939	TNKS	H13Q	0.5299066020000001			O95271							
gdsc	XAV939	TNKS	L976V	0.054487532000000005			O95271							
gdsc	XAV939	TNKS	K506*+A1269V	0.893075658			O95271							
gdsc	XAV939	TNKS	L1079*	1.178667688			O95271							
gdsc	Camptothecin	TOP1	G109V	-4.671098842			P11387							
gdsc	Camptothecin	TOP1	S111P	-1.665824208			P11387							
gdsc	Camptothecin	TOP1	F279L	-3.133567728			P11387							
gdsc	Camptothecin	TOP1	M428T	-4.373258534			P11387							
gdsc	Camptothecin	TOP1	D528E	-2.317307408			P11387							
gdsc	Camptothecin	TOP1	A351D	-4.51223235			P11387							
gdsc	Camptothecin	TOP1	K326R	-2.871238586			P11387							
gdsc	Camptothecin	TOP1	M675I	-3.340312912			P11387							
gdsc	Camptothecin	TOP1	H81R	-4.257497085			P11387							
gdsc	Camptothecin	TOP1	D156Y	-2.588878719			P11387							
gdsc	Camptothecin	TOP1	D182A	-1.861884522			P11387							
gdsc	Camptothecin	TOP1	P397A	-4.453246938			P11387							
gdsc	Camptothecin	TOP1	G244D	-4.273460402			P11387							
gdsc	Camptothecin	TOP1	K184E	-3.702111357			P11387							
gdsc	Camptothecin	TOP1	A705S	-3.734018438			P11387							
gdsc	Camptothecin	TOP1	E610K	-4.423532642			P11387							
gdsc	Camptothecin	TOP1	T258M	-4.338369476			P11387							
gdsc	Camptothecin	TOP1	E208K	-1.349391728			P11387							
gdsc	Camptothecin	TOP1	P235T	-3.207622989			P11387							
gdsc	Camptothecin	TOP1	E710D	-3.298350772			P11387							
gdsc	Camptothecin	TOP1	R405W+Y426C+R434Q+E517K	-1.192957979			P11387							
gdsc	Camptothecin	TOP1	K59N+R89Q+K150N	-1.837744324			P11387							
gdsc	Camptothecin	TOP1	I714T	-1.599993819			P11387							
gdsc	Camptothecin	TOP1	E561K	-4.018595975			P11387							
gdsc	Camptothecin	TOP1	W754C	-3.882352329			P11387							
gdsc	Irinotecan	TOP1	G109V	-1.616383725			P11387							
gdsc	Irinotecan	TOP1	S111P	1.234252981			P11387							
gdsc	Irinotecan	TOP1	F279L	-0.031340666			P11387							
gdsc	Irinotecan	TOP1	M428T	-1.636682845			P11387							
gdsc	Irinotecan	TOP1	D528E	0.415447939			P11387							
gdsc	Irinotecan	TOP1	A351D	-1.044190982			P11387							
gdsc	Irinotecan	TOP1	K326R	0.352145091			P11387							
gdsc	Irinotecan	TOP1	M675I	-0.095129944			P11387							
gdsc	Irinotecan	TOP1	H81R	-1.173480635			P11387							
gdsc	Irinotecan	TOP1	D156Y	1.095769742			P11387							
gdsc	Irinotecan	TOP1	D182A	0.943252909			P11387							
gdsc	Irinotecan	TOP1	P397A	-1.646343309			P11387							
gdsc	Irinotecan	TOP1	G244D	-1.451750579			P11387							
gdsc	Irinotecan	TOP1	K184E	-1.0037971490000002			P11387							
gdsc	Irinotecan	TOP1	A705S	-0.7875508790000001			P11387							
gdsc	Irinotecan	TOP1	E610K	-1.626149651			P11387							
gdsc	Irinotecan	TOP1	T258M	-1.263481439			P11387							
gdsc	Irinotecan	TOP1	E208K	1.317696164			P11387							
gdsc	Irinotecan	TOP1	P235T	-0.117592226			P11387							
gdsc	Irinotecan	TOP1	E710D	-0.7045846459999999			P11387							
gdsc	Irinotecan	TOP1	R405W+Y426C+R434Q+E517K	1.445588738			P11387							
gdsc	Irinotecan	TOP1	K59N+R89Q+K150N	0.903064076			P11387							
gdsc	Irinotecan	TOP1	I714T	1.326839388			P11387							
gdsc	Irinotecan	TOP1	E561K	-1.502137852			P11387							
gdsc	Irinotecan	TOP1	W754C	-1.018245482			P11387							
gdsc	SN-38	TOP1	G109V	-5.603500895			P11387							
gdsc	SN-38	TOP1	S111P	-2.569359485			P11387							
gdsc	SN-38	TOP1	F279L	-3.373051073			P11387							
gdsc	SN-38	TOP1	M428T	-5.20661029			P11387							
gdsc	SN-38	TOP1	D528E	-3.0078702560000004			P11387							
gdsc	SN-38	TOP1	A351D	-5.332099743000001			P11387							
gdsc	SN-38	TOP1	K326R	-4.363907829			P11387							
gdsc	SN-38	TOP1	M675I	-3.639678002			P11387							
gdsc	SN-38	TOP1	H81R	-4.894982789			P11387							
gdsc	SN-38	TOP1	D156Y	-3.329019614			P11387							
gdsc	SN-38	TOP1	D182A	-2.703251242			P11387							
gdsc	SN-38	TOP1	P397A	-5.410703187			P11387							
gdsc	SN-38	TOP1	G244D	-4.94931633			P11387							
gdsc	SN-38	TOP1	K184E	-7.099658296			P11387							
gdsc	SN-38	TOP1	A705S	-3.893084962			P11387							
gdsc	SN-38	TOP1	E610K	-5.940996621			P11387							
gdsc	SN-38	TOP1	T258M	-5.101494689			P11387							
gdsc	SN-38	TOP1	E208K	-1.567397435			P11387							
gdsc	SN-38	TOP1	P235T	-3.902239765			P11387							
gdsc	SN-38	TOP1	K175N	-4.092516848			P11387							
gdsc	SN-38	TOP1	E710D	-4.027395259			P11387							
gdsc	SN-38	TOP1	N296S	-3.4821727630000003			P11387							
gdsc	SN-38	TOP1	R405W+Y426C+R434Q+E517K	-1.958580776			P11387							
gdsc	SN-38	TOP1	K59N+R89Q+K150N	-3.38605573			P11387							
gdsc	SN-38	TOP1	I714T	-3.3627730380000003			P11387							
gdsc	SN-38	TOP1	E561K	-4.695500461			P11387							
gdsc	SN-38	TOP1	W754C	-4.940631302			P11387							
gdsc	Etoposide	TOP2A	Q35R	-1.199208693			P11388							
gdsc	Etoposide	TOP2A	V1097L	1.165350559			P11388							
gdsc	Etoposide	TOP2A	S1449C	-1.857867476			P11388							
gdsc	Etoposide	TOP2A	D152Y	-1.219622162			P11388							
gdsc	Etoposide	TOP2A	K893R	-0.477061021			P11388							
gdsc	Etoposide	TOP2A	V255I	-0.701624592			P11388							
gdsc	Etoposide	TOP2A	R675*	-2.160902098			P11388							
gdsc	Etoposide	TOP2A	S1392*	0.950920255			P11388							
gdsc	Etoposide	TOP2A	S1428P	-0.502970379			P11388							
gdsc	Etoposide	TOP2A	E1380K+L231P	-1.7929062619999998			P11388							
gdsc	Etoposide	TOP2A	I872V+P385A+E203D	-0.7653931340000001			P11388							
gdsc	Etoposide	TOP2A	G1198R	0.517882036			P11388							
gdsc	Etoposide	TOP2A	A903D	-0.370404878			P11388							
gdsc	Etoposide	TOP2A	Q1206H	-1.586493462			P11388							
gdsc	Etoposide	TOP2A	S1425F+S527*	-0.178621118			P11388							
gdsc	Etoposide	TOP2A	T930I	-1.6543619980000002			P11388							
gdsc	Etoposide	TOP2A	S1337L	-0.514717575			P11388							
gdsc	Etoposide	TOP2A	V776L	-1.614993163			P11388							
gdsc	Etoposide	TOP2A	H290Q	-1.547496115			P11388							
gdsc	Etoposide	TOP2A	G1197A	-1.936436286			P11388							
gdsc	Etoposide	TOP2A	R1435G	-0.79799757			P11388							
gdsc	Etoposide	TOP2A	P1457L+D222N+V1506M+E626K+A588S	0.186162857			P11388							
gdsc	Etoposide	TOP2A	A318P	-0.7492307420000001			P11388							
gdsc	Etoposide	TOP2A	P716R	-1.255077635			P11388							
gdsc	Etoposide	TOP2A	G1216C	-0.169883746			P11388							
gdsc	Etoposide	TOP2A	S1337L	-1.237257471			P11388							
gdsc	Etoposide	TOP2A	S1491F+R268H	-2.470064197			P11388							
gdsc	Etoposide	TOP2A	N774I	-0.927959693			P11388							
gdsc	Etoposide	TOP2A	P786H	-1.320829816			P11388							
gdsc	Etoposide	TOP2A	N774I	-0.250677337			P11388							
gdsc	Etoposide	TOP2A	K1196I	-1.270529637			P11388							
gdsc	Etoposide	TOP2A	P643T	-0.4537194920000001			P11388							
gdsc	Etoposide	TOP2A	K1110E	-0.998209425			P11388							
gdsc	Etoposide	TOP2A	V1001L	-1.32434325			P11388							
gdsc	Etoposide	TOP2A	G1197V	-4.1388846			P11388							
gdsc	Etoposide	TOP2A	L944S	1.059054647			P11388							
gdsc	Etoposide	TOP2A	G1197V	0.299262864			P11388							
gdsc	Etoposide	TOP2A	S1361F	-1.882927803			P11388							
gdsc	Etoposide	TOP2A	N774I	-2.718035656			P11388							
gdsc	Etoposide	TOP2A	K1489E+Y613C	-2.018798184			P11388							
gdsc	Etoposide	TOP2A	G1192R	-0.334716559			P11388							
gdsc	Etoposide	TOP2A	N774I	-1.732193757			P11388							
gdsc	Etoposide	TOP2A	K1110E	-1.263427523			P11388							
gdsc	Etoposide	TOP2A	V364L	-3.3563135560000004			P11388							
gdsc	Etoposide	TOP2A	D213G	-1.301941402			P11388							
gdsc	Etoposide	TOP2A	R635H+T530A	0.436894702			P11388							
gdsc	Etoposide	TOP2A	V68I	-0.761822821			P11388							
gdsc	MIRA-1	TP53	Q331R+P60S	1.963868923			Q12888							
gdsc	MIRA-1	TP53	R282Q	1.612008225			Q12888							
gdsc	MIRA-1	TP53	R280T	1.887332927			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.4948100009999998			Q12888							
gdsc	MIRA-1	TP53	E336*+I162N	1.658894506			Q12888							
gdsc	MIRA-1	TP53	P278A	1.4292800019999998			Q12888							
gdsc	MIRA-1	TP53	R273C	1.307648215			Q12888							
gdsc	MIRA-1	TP53	R273C	1.703218883			Q12888							
gdsc	MIRA-1	TP53	R248G	2.136801003			Q12888							
gdsc	MIRA-1	TP53	V274F	1.107596923			Q12888							
gdsc	MIRA-1	TP53	R249G	0.941657348			Q12888							
gdsc	MIRA-1	TP53	E258*+Y126D	1.579492069			Q12888							
gdsc	MIRA-1	TP53	R248Q	0.556549368			Q12888							
gdsc	MIRA-1	TP53	G389W+R213Q	0.8391177890000001			Q12888							
gdsc	MIRA-1	TP53	R273H	-0.27868823800000003			Q12888							
gdsc	MIRA-1	TP53	H179R	1.544049039			Q12888							
gdsc	MIRA-1	TP53	V272L	0.905552512			Q12888							
gdsc	MIRA-1	TP53	R175H	1.538436431			Q12888							
gdsc	MIRA-1	TP53	D259Y	1.993547077			Q12888							
gdsc	MIRA-1	TP53	D281G	-0.323825504			Q12888							
gdsc	MIRA-1	TP53	Y163C	1.160039526			Q12888							
gdsc	MIRA-1	TP53	C135F	1.762405147			Q12888							
gdsc	MIRA-1	TP53	S241C+E224*	1.472909395			Q12888							
gdsc	MIRA-1	TP53	I251T	1.540692613			Q12888							
gdsc	MIRA-1	TP53	A307V	1.258778887			Q12888							
gdsc	MIRA-1	TP53	P177L+C176F+Q38*	2.141233974			Q12888							
gdsc	MIRA-1	TP53	R248Q	0.345731443			Q12888							
gdsc	MIRA-1	TP53	K132Q	1.317923678			Q12888							
gdsc	MIRA-1	TP53	E285K	2.300794265			Q12888							
gdsc	MIRA-1	TP53	M246I	2.93655529			Q12888							
gdsc	MIRA-1	TP53	R249S	2.0553817480000003			Q12888							
gdsc	MIRA-1	TP53	Y220C	1.769006612			Q12888							
gdsc	MIRA-1	TP53	R273C	1.564915759			Q12888							
gdsc	MIRA-1	TP53	E204*	2.326716658			Q12888							
gdsc	MIRA-1	TP53	R248Q	-0.316784416			Q12888							
gdsc	MIRA-1	TP53	E224K	0.8406043329999999			Q12888							
gdsc	MIRA-1	TP53	H193L	1.586316901			Q12888							
gdsc	MIRA-1	TP53	R282W	1.6898151			Q12888							
gdsc	MIRA-1	TP53	R175H	1.6131161719999998			Q12888							
gdsc	MIRA-1	TP53	P151H	1.301216793			Q12888							
gdsc	MIRA-1	TP53	A161D	1.331058472			Q12888							
gdsc	MIRA-1	TP53	E286_E287delEE	1.206675778			Q12888							
gdsc	MIRA-1	TP53	K132E	1.470191667			Q12888							
gdsc	MIRA-1	TP53	R280T	1.340423286			Q12888							
gdsc	MIRA-1	TP53	A159V	2.05842949			Q12888							
gdsc	MIRA-1	TP53	R248W	2.180022766			Q12888							
gdsc	MIRA-1	TP53	P278H	1.171588239			Q12888							
gdsc	MIRA-1	TP53	R248Q+R175H	0.8134086909999999			Q12888							
gdsc	MIRA-1	TP53	C242R	2.151401012			Q12888							
gdsc	MIRA-1	TP53	I255S	1.197152178			Q12888							
gdsc	MIRA-1	TP53	H193R	1.4389931969999998			Q12888							
gdsc	MIRA-1	TP53	S215N	2.6835880000000003			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.776256848			Q12888							
gdsc	MIRA-1	TP53	R181C+R290C	-0.331598312			Q12888							
gdsc	MIRA-1	TP53	Y103_R110delYQGSYGFR	1.365608036			Q12888							
gdsc	MIRA-1	TP53	R248W	1.17569949			Q12888							
gdsc	MIRA-1	TP53	A347P+G245C	1.349552884			Q12888							
gdsc	MIRA-1	TP53	R248W	2.396343096			Q12888							
gdsc	MIRA-1	TP53	V157F	0.624052933			Q12888							
gdsc	MIRA-1	TP53	G245V	0.206323336			Q12888							
gdsc	MIRA-1	TP53	G245D	1.4986350819999998			Q12888							
gdsc	MIRA-1	TP53	R248W	1.454957106			Q12888							
gdsc	MIRA-1	TP53	V272M	1.452349581			Q12888							
gdsc	MIRA-1	TP53	M237I	2.006083462			Q12888							
gdsc	MIRA-1	TP53	R196*	2.035003235			Q12888							
gdsc	MIRA-1	TP53	V147D	2.082835714			Q12888							
gdsc	MIRA-1	TP53	R175H	1.13588096			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.072968559			Q12888							
gdsc	MIRA-1	TP53	S215C	-1.0274124059999998			Q12888							
gdsc	MIRA-1	TP53	R283H+G245S	1.482076319			Q12888							
gdsc	MIRA-1	TP53	R213*	1.319064211			Q12888							
gdsc	MIRA-1	TP53	G245C	1.351737968			Q12888							
gdsc	MIRA-1	TP53	S241F+E56*	2.042321607			Q12888							
gdsc	MIRA-1	TP53	R248Q	0.8825013			Q12888							
gdsc	MIRA-1	TP53	L188_P191delLAPP	1.100129245			Q12888							
gdsc	MIRA-1	TP53	R158H	1.399419363			Q12888							
gdsc	MIRA-1	TP53	V274F+P223L	1.864805472			Q12888							
gdsc	MIRA-1	TP53	C242F	1.360289893			Q12888							
gdsc	MIRA-1	TP53	G266E	0.936199378			Q12888							
gdsc	MIRA-1	TP53	R175H	1.395506001			Q12888							
gdsc	MIRA-1	TP53	K132R	1.717173084			Q12888							
gdsc	MIRA-1	TP53	Y163C+P47S	0.5654615239999999			Q12888							
gdsc	MIRA-1	TP53	G244D	1.310990421			Q12888							
gdsc	MIRA-1	TP53	E171*	1.976064037			Q12888							
gdsc	MIRA-1	TP53	R273L+Y234C	1.553572046			Q12888							
gdsc	MIRA-1	TP53	H193R	1.461276549			Q12888							
gdsc	MIRA-1	TP53	C124R	2.8375427930000003			Q12888							
gdsc	MIRA-1	TP53	R273H	2.589501421			Q12888							
gdsc	MIRA-1	TP53	K132N	1.119157485			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.078758912			Q12888							
gdsc	MIRA-1	TP53	R273H	1.5497143780000002			Q12888							
gdsc	MIRA-1	TP53	Y107*	1.740868919			Q12888							
gdsc	MIRA-1	TP53	S241F	1.863725372			Q12888							
gdsc	MIRA-1	TP53	R248Q	0.783021925			Q12888							
gdsc	MIRA-1	TP53	H179Q	0.5366027760000001			Q12888							
gdsc	MIRA-1	TP53	C135F	1.098848885			Q12888							
gdsc	MIRA-1	TP53	R248W	1.632427027			Q12888							
gdsc	MIRA-1	TP53	R175H	2.015159143			Q12888							
gdsc	MIRA-1	TP53	R213*	1.241842711			Q12888							
gdsc	MIRA-1	TP53	R175H	1.771809065			Q12888							
gdsc	MIRA-1	TP53	S241C	1.095200957			Q12888							
gdsc	MIRA-1	TP53	R273C	1.287942764			Q12888							
gdsc	MIRA-1	TP53	R273C	1.54800506			Q12888							
gdsc	MIRA-1	TP53	R181H	1.824707289			Q12888							
gdsc	MIRA-1	TP53	C176F	1.317806366			Q12888							
gdsc	MIRA-1	TP53	R175H	1.337328738			Q12888							
gdsc	MIRA-1	TP53	K164E	0.630268691			Q12888							
gdsc	MIRA-1	TP53	R248L	1.6092881280000002			Q12888							
gdsc	MIRA-1	TP53	C277F	1.492366001			Q12888							
gdsc	MIRA-1	TP53	R273H	1.971871022			Q12888							
gdsc	MIRA-1	TP53	H179D	1.818850577			Q12888							
gdsc	MIRA-1	TP53	Y220D	1.360338476			Q12888							
gdsc	MIRA-1	TP53	I232N+P152L	-0.566772692			Q12888							
gdsc	MIRA-1	TP53	L265P	1.364996591			Q12888							
gdsc	MIRA-1	TP53	N239_S240insN	0.543947217			Q12888							
gdsc	MIRA-1	TP53	H179Q+E11Q	1.933786102			Q12888							
gdsc	MIRA-1	TP53	Q317*+R248W	1.828971402			Q12888							
gdsc	MIRA-1	TP53	C275Y	1.296726351			Q12888							
gdsc	MIRA-1	TP53	M246T	1.418912704			Q12888							
gdsc	MIRA-1	TP53	R196*	-0.377181719			Q12888							
gdsc	MIRA-1	TP53	V143A	1.225595001			Q12888							
gdsc	MIRA-1	TP53	D259V	1.987061146			Q12888							
gdsc	MIRA-1	TP53	R175L+S94*	1.59374429			Q12888							
gdsc	MIRA-1	TP53	S241F	1.610840438			Q12888							
gdsc	MIRA-1	TP53	V218L	2.562295113			Q12888							
gdsc	MIRA-1	TP53	R248Q	2.418440408			Q12888							
gdsc	MIRA-1	TP53	G108delG	1.52641136			Q12888							
gdsc	MIRA-1	TP53	R175H	1.638670631			Q12888							
gdsc	MIRA-1	TP53	Y220C	1.501368807			Q12888							
gdsc	MIRA-1	TP53	R306*	2.208133205			Q12888							
gdsc	MIRA-1	TP53	Y163C	1.665639945			Q12888							
gdsc	MIRA-1	TP53	R248W	0.658740546			Q12888							
gdsc	MIRA-1	TP53	R213*	1.291841314			Q12888							
gdsc	MIRA-1	TP53	R273L	1.5569421			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.132709981			Q12888							
gdsc	MIRA-1	TP53	S241F	1.698474857			Q12888							
gdsc	MIRA-1	TP53	R213*	1.765164349			Q12888							
gdsc	MIRA-1	TP53	R248Q	2.023312326			Q12888							
gdsc	MIRA-1	TP53	G244A	1.282597959			Q12888							
gdsc	MIRA-1	TP53	N268I	1.786157269			Q12888							
gdsc	MIRA-1	TP53	G266R	1.2860557			Q12888							
gdsc	MIRA-1	TP53	R175L	2.189563548			Q12888							
gdsc	MIRA-1	TP53	R156P	1.183526214			Q12888							
gdsc	MIRA-1	TP53	G187R	3.1225439560000003			Q12888							
gdsc	MIRA-1	TP53	P151S	2.30661602			Q12888							
gdsc	MIRA-1	TP53	G245S	0.745353522			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.563355155			Q12888							
gdsc	MIRA-1	TP53	P250L	2.176280632			Q12888							
gdsc	MIRA-1	TP53	R273H	2.589289311			Q12888							
gdsc	MIRA-1	TP53	E285K+G245V	1.940788679			Q12888							
gdsc	MIRA-1	TP53	R213L	1.829778366			Q12888							
gdsc	MIRA-1	TP53	P152L	1.895456486			Q12888							
gdsc	MIRA-1	TP53	V157F	1.365080132			Q12888							
gdsc	MIRA-1	TP53	K319*	2.056447036			Q12888							
gdsc	MIRA-1	TP53	R175H	1.75073853			Q12888							
gdsc	MIRA-1	TP53	Y220C	2.064193181			Q12888							
gdsc	MIRA-1	TP53	R282W	2.197422858			Q12888							
gdsc	MIRA-1	TP53	I255T	1.810177785			Q12888							
gdsc	MIRA-1	TP53	Q192*	1.7244630159999998			Q12888							
gdsc	MIRA-1	TP53	Y126C	1.64288616			Q12888							
gdsc	MIRA-1	TP53	R248W+N247K	1.588904282			Q12888							
gdsc	MIRA-1	TP53	E294*	1.497533061			Q12888							
gdsc	MIRA-1	TP53	K320N+E271K	2.41797353			Q12888							
gdsc	MIRA-1	TP53	R249S	2.077182817			Q12888							
gdsc	MIRA-1	TP53	R267P	2.019737865			Q12888							
gdsc	MIRA-1	TP53	R248W	1.6664001030000002			Q12888							
gdsc	MIRA-1	TP53	K132Q	-0.48730449			Q12888							
gdsc	MIRA-1	TP53	R196*	0.042090117			Q12888							
gdsc	MIRA-1	TP53	S241F	1.545981132			Q12888							
gdsc	MIRA-1	TP53	R273C	0.80994384			Q12888							
gdsc	MIRA-1	TP53	K319*	1.302340144			Q12888							
gdsc	MIRA-1	TP53	R273C+R175H+T125M	0.977685161			Q12888							
gdsc	MIRA-1	TP53	C135Y	0.941215354			Q12888							
gdsc	MIRA-1	TP53	P177T	1.038936235			Q12888							
gdsc	MIRA-1	TP53	R248Q+G245S	2.289602228			Q12888							
gdsc	MIRA-1	TP53	R175H	2.511439777			Q12888							
gdsc	MIRA-1	TP53	H179R	1.662894371			Q12888							
gdsc	MIRA-1	TP53	V272M	1.020602979			Q12888							
gdsc	MIRA-1	TP53	R337L	0.312310563			Q12888							
gdsc	MIRA-1	TP53	R249S	1.61152298			Q12888							
gdsc	MIRA-1	TP53	R248Q	-0.975907114			Q12888							
gdsc	MIRA-1	TP53	R273H	1.938062065			Q12888							
gdsc	MIRA-1	TP53	A161D	2.07930095			Q12888							
gdsc	MIRA-1	TP53	K132R	0.055787772			Q12888							
gdsc	MIRA-1	TP53	D281Y	2.494125003			Q12888							
gdsc	MIRA-1	TP53	R175H	-0.34311977			Q12888							
gdsc	MIRA-1	TP53	P152L	1.667985592			Q12888							
gdsc	MIRA-1	TP53	H193R	1.536541665			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.436388042			Q12888							
gdsc	MIRA-1	TP53	I195T	1.525399396			Q12888							
gdsc	MIRA-1	TP53	R248W	1.101326064			Q12888							
gdsc	MIRA-1	TP53	R337C	2.4450086090000003			Q12888							
gdsc	MIRA-1	TP53	E339*+H179R	1.7679970180000002			Q12888							
gdsc	MIRA-1	TP53	K101*	1.6172451980000002			Q12888							
gdsc	MIRA-1	TP53	K120N	2.327442452			Q12888							
gdsc	MIRA-1	TP53	S261T	1.051999338			Q12888							
gdsc	MIRA-1	TP53	G112_V122delGFLHSGTAKSV	1.241544691			Q12888							
gdsc	MIRA-1	TP53	K319*	0.910488503			Q12888							
gdsc	MIRA-1	TP53	H179R	2.166104114			Q12888							
gdsc	MIRA-1	TP53	S241Y	1.4418442340000002			Q12888							
gdsc	MIRA-1	TP53	V216L	1.669944939			Q12888							
gdsc	MIRA-1	TP53	V272M	1.5619521509999998			Q12888							
gdsc	MIRA-1	TP53	P98L	2.100244694			Q12888							
gdsc	MIRA-1	TP53	R282W	2.102294691			Q12888							
gdsc	MIRA-1	TP53	V143M	2.112966526			Q12888							
gdsc	MIRA-1	TP53	V272M	0.081884948			Q12888							
gdsc	MIRA-1	TP53	R175H	2.346300649			Q12888							
gdsc	MIRA-1	TP53	Y126*	1.772620177			Q12888							
gdsc	MIRA-1	TP53	G244C	0.610364166			Q12888							
gdsc	MIRA-1	TP53	E11Q	1.588059991			Q12888							
gdsc	MIRA-1	TP53	R248W	1.225799408			Q12888							
gdsc	MIRA-1	TP53	E286K	1.197630906			Q12888							
gdsc	MIRA-1	TP53	G266E	1.767108291			Q12888							
gdsc	MIRA-1	TP53	R280K	1.20592273			Q12888							
gdsc	MIRA-1	TP53	E56*	1.477431831			Q12888							
gdsc	MIRA-1	TP53	Y236C	0.8758690259999999			Q12888							
gdsc	MIRA-1	TP53	E204A	1.960373855			Q12888							
gdsc	MIRA-1	TP53	R273H	1.331792561			Q12888							
gdsc	MIRA-1	TP53	H233delH	0.810394128			Q12888							
gdsc	MIRA-1	TP53	R306*+Y220C	2.023335433			Q12888							
gdsc	MIRA-1	TP53	R273C+Y220C+A74S	1.631396696			Q12888							
gdsc	MIRA-1	TP53	K132R	2.623465017			Q12888							
gdsc	MIRA-1	TP53	S215delS	2.185702324			Q12888							
gdsc	MIRA-1	TP53	R213Q	-0.502028921			Q12888							
gdsc	MIRA-1	TP53	R248W	1.316809214			Q12888							
gdsc	MIRA-1	TP53	V143A	2.00906366			Q12888							
gdsc	MIRA-1	TP53	I251L	1.981604362			Q12888							
gdsc	MIRA-1	TP53	R110C	1.823606452			Q12888							
gdsc	MIRA-1	TP53	P278S	2.293916702			Q12888							
gdsc	MIRA-1	TP53	R280G	0.38734461			Q12888							
gdsc	MIRA-1	TP53	A159V	2.268205826			Q12888							
gdsc	MIRA-1	TP53	R110P	1.291286748			Q12888							
gdsc	MIRA-1	TP53	R273H+W91*	0.779946337			Q12888							
gdsc	MIRA-1	TP53	R158H	-0.438361102			Q12888							
gdsc	MIRA-1	TP53	R337*+R306*	1.129722673			Q12888							
gdsc	MIRA-1	TP53	R273H	0.863217699			Q12888							
gdsc	MIRA-1	TP53	G244S	1.045799578			Q12888							
gdsc	MIRA-1	TP53	Q317*+E258K	1.883692109			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.013333191			Q12888							
gdsc	MIRA-1	TP53	F113L	0.032149408			Q12888							
gdsc	MIRA-1	TP53	V173M	0.821660226			Q12888							
gdsc	MIRA-1	TP53	P278L+G262S	1.54856792			Q12888							
gdsc	MIRA-1	TP53	R273C	1.575460803			Q12888							
gdsc	MIRA-1	TP53	R273H	1.52748198			Q12888							
gdsc	MIRA-1	TP53	E285K	2.107129366			Q12888							
gdsc	MIRA-1	TP53	C141W	1.333861518			Q12888							
gdsc	MIRA-1	TP53	H179R	2.979516359			Q12888							
gdsc	MIRA-1	TP53	R248L	2.04684819			Q12888							
gdsc	MIRA-1	TP53	Q144*	1.205318396			Q12888							
gdsc	MIRA-1	TP53	R273L+P36L	2.114310282			Q12888							
gdsc	MIRA-1	TP53	C176Y	1.490811914			Q12888							
gdsc	MIRA-1	TP53	Q192*	1.467395139			Q12888							
gdsc	MIRA-1	TP53	C242F	1.6259772380000002			Q12888							
gdsc	MIRA-1	TP53	V157F	2.114525946			Q12888							
gdsc	MIRA-1	TP53	R209*+R273H	2.767015778			Q12888							
gdsc	MIRA-1	TP53	R273L	2.564831541			Q12888							
gdsc	MIRA-1	TP53	M237I	1.4151699780000002			Q12888							
gdsc	MIRA-1	TP53	K291*	2.135481539			Q12888							
gdsc	MIRA-1	TP53	R175H	2.192684757			Q12888							
gdsc	MIRA-1	TP53	H214R+V147D	1.23254781			Q12888							
gdsc	MIRA-1	TP53	R273H	1.899163071			Q12888							
gdsc	MIRA-1	TP53	C242W	1.7159567130000002			Q12888							
gdsc	MIRA-1	TP53	R273L	1.4696335459999998			Q12888							
gdsc	MIRA-1	TP53	S240R	1.520437336			Q12888							
gdsc	MIRA-1	TP53	V157F	2.344594886			Q12888							
gdsc	MIRA-1	TP53	Y220C	1.742639263			Q12888							
gdsc	MIRA-1	TP53	V157F	1.908937292			Q12888							
gdsc	MIRA-1	TP53	R248Q	0.569911084			Q12888							
gdsc	MIRA-1	TP53	C176F+Q16L	1.216388381			Q12888							
gdsc	MIRA-1	TP53	R209*	1.900504456			Q12888							
gdsc	MIRA-1	TP53	R158G	1.669424145			Q12888							
gdsc	MIRA-1	TP53	Q331*	2.378188771			Q12888							
gdsc	MIRA-1	TP53	M246I	1.557254932			Q12888							
gdsc	MIRA-1	TP53	Y220C	1.911169182			Q12888							
gdsc	MIRA-1	TP53	R273H	3.178071035			Q12888							
gdsc	MIRA-1	TP53	R273C	2.376427314			Q12888							
gdsc	MIRA-1	TP53	I232S	1.398915159			Q12888							
gdsc	MIRA-1	TP53	Q192_H193delQH	1.7616971280000002			Q12888							
gdsc	MIRA-1	TP53	R213*	1.684682997			Q12888							
gdsc	MIRA-1	TP53	E285V	1.662966654			Q12888							
gdsc	MIRA-1	TP53	R248L	2.0249700980000003			Q12888							
gdsc	MIRA-1	TP53	R158L	3.536959787			Q12888							
gdsc	MIRA-1	TP53	G154V	1.523441827			Q12888							
gdsc	MIRA-1	TP53	W146*	1.914033253			Q12888							
gdsc	MIRA-1	TP53	T155N	0.943519528			Q12888							
gdsc	MIRA-1	TP53	G245C	1.898899415			Q12888							
gdsc	MIRA-1	TP53	R283P	0.761745798			Q12888							
gdsc	MIRA-1	TP53	K164N	1.67834341			Q12888							
gdsc	MIRA-1	TP53	S215I+R158L	2.079376196			Q12888							
gdsc	MIRA-1	TP53	E171*	1.100350242			Q12888							
gdsc	MIRA-1	TP53	E224D	1.860890333			Q12888							
gdsc	MIRA-1	TP53	C176W	1.615445229			Q12888							
gdsc	MIRA-1	TP53	Q165_S166insYKQ	2.136581191			Q12888							
gdsc	MIRA-1	TP53	R158L	2.359573493			Q12888							
gdsc	MIRA-1	TP53	E294*	1.457283794			Q12888							
gdsc	MIRA-1	TP53	C242S	1.490084935			Q12888							
gdsc	MIRA-1	TP53	R158L	0.862756153			Q12888							
gdsc	MIRA-1	TP53	R248Q	2.013667266			Q12888							
gdsc	MIRA-1	TP53	R273H	1.391132871			Q12888							
gdsc	MIRA-1	TP53	Y220C	1.89013301			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.38009251			Q12888							
gdsc	MIRA-1	TP53	Q192*	1.501048273			Q12888							
gdsc	MIRA-1	TP53	R273H	1.429538326			Q12888							
gdsc	MIRA-1	TP53	L145R	0.5303532470000001			Q12888							
gdsc	MIRA-1	TP53	G244S	0.856518474			Q12888							
gdsc	MIRA-1	TP53	V31I	1.835975757			Q12888							
gdsc	MIRA-1	TP53	S90F	1.797207702			Q12888							
gdsc	MIRA-1	TP53	C135Y	1.826813572			Q12888							
gdsc	MIRA-1	TP53	R175H	0.51033141			Q12888							
gdsc	MIRA-1	TP53	R249S	2.091401859			Q12888							
gdsc	MIRA-1	TP53	S215R	2.075884683			Q12888							
gdsc	MIRA-1	TP53	R273H	2.1274747000000005			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.845255253			Q12888							
gdsc	MIRA-1	TP53	L130V	2.102522797			Q12888							
gdsc	MIRA-1	TP53	R282W	3.246107837			Q12888							
gdsc	MIRA-1	TP53	R248P+E11Q	-1.1660805			Q12888							
gdsc	MIRA-1	TP53	Y236C+R196*	0.974298518			Q12888							
gdsc	MIRA-1	TP53	C238F	0.412639561			Q12888							
gdsc	MIRA-1	TP53	C176S	2.432434898			Q12888							
gdsc	MIRA-1	TP53	R282W	1.963052479			Q12888							
gdsc	MIRA-1	TP53	R248Q	2.233791349			Q12888							
gdsc	MIRA-1	TP53	G245S	3.406104789			Q12888							
gdsc	MIRA-1	TP53	I255N	2.339634011			Q12888							
gdsc	MIRA-1	TP53	R248Q	2.880833876			Q12888							
gdsc	MIRA-1	TP53	R282W	2.142769694			Q12888							
gdsc	MIRA-1	TP53	G244D	1.735619504			Q12888							
gdsc	MIRA-1	TP53	R273H+R248Q	-0.637491673			Q12888							
gdsc	MIRA-1	TP53	C275G	1.361461235			Q12888							
gdsc	MIRA-1	TP53	R267W+E171delE	1.968199394			Q12888							
gdsc	MIRA-1	TP53	G266V	1.982235358			Q12888							
gdsc	MIRA-1	TP53	K132Q	1.741945464			Q12888							
gdsc	MIRA-1	TP53	R306*	2.211989688			Q12888							
gdsc	MIRA-1	TP53	R248W	1.422885907			Q12888							
gdsc	MIRA-1	TP53	R181C	0.692524026			Q12888							
gdsc	MIRA-1	TP53	R213*	1.70457508			Q12888							
gdsc	MIRA-1	TP53	E224D	1.850763584			Q12888							
gdsc	MIRA-1	TP53	Y220C	1.0354619040000002			Q12888							
gdsc	MIRA-1	TP53	R175H	2.238123005			Q12888							
gdsc	MIRA-1	TP53	V218delV	1.509642264			Q12888							
gdsc	MIRA-1	TP53	P223L	3.083320873			Q12888							
gdsc	MIRA-1	TP53	S166*	0.931704197			Q12888							
gdsc	MIRA-1	TP53	E285K	1.054118064			Q12888							
gdsc	MIRA-1	TP53	R273C	-0.564316843			Q12888							
gdsc	MIRA-1	TP53	R273C+R248Q+S183*	1.441119625			Q12888							
gdsc	MIRA-1	TP53	Y234H+R213Q	0.732780403			Q12888							
gdsc	MIRA-1	TP53	I254N	0.553991019			Q12888							
gdsc	MIRA-1	TP53	E336*	0.791588662			Q12888							
gdsc	MIRA-1	TP53	E271*+R110L	1.895861153			Q12888							
gdsc	MIRA-1	TP53	R248L	1.283423291			Q12888							
gdsc	MIRA-1	TP53	P151S	1.501821465			Q12888							
gdsc	MIRA-1	TP53	R273H	1.921246162			Q12888							
gdsc	MIRA-1	TP53	R342*	1.189056467			Q12888							
gdsc	MIRA-1	TP53	C176W	1.020303182			Q12888							
gdsc	MIRA-1	TP53	R280S+R273C+Y205C	1.368113654			Q12888							
gdsc	MIRA-1	TP53	C176F	0.838848209			Q12888							
gdsc	MIRA-1	TP53	R175H	1.4869287690000002			Q12888							
gdsc	MIRA-1	TP53	Q100*	2.681594881			Q12888							
gdsc	MIRA-1	TP53	G245S+M237K	1.613162385			Q12888							
gdsc	MIRA-1	TP53	H193R	2.0147301840000003			Q12888							
gdsc	MIRA-1	TP53	G245S	0.894932815			Q12888							
gdsc	MIRA-1	TP53	E298*	1.880303096			Q12888							
gdsc	MIRA-1	TP53	F113C	1.823821524			Q12888							
gdsc	MIRA-1	TP53	K132N	1.359427827			Q12888							
gdsc	MIRA-1	TP53	R110L	1.598042174			Q12888							
gdsc	MIRA-1	TP53	M246R	1.419931185			Q12888							
gdsc	MIRA-1	TP53	C176F	0.822996871			Q12888							
gdsc	MIRA-1	TP53	R248Q+R175H	1.5796709999999998			Q12888							
gdsc	MIRA-1	TP53	R273H+V173L+K132N	1.720146765			Q12888							
gdsc	MIRA-1	TP53	C242F	1.782167476			Q12888							
gdsc	MIRA-1	TP53	G154V+S106R	1.74929346			Q12888							
gdsc	MIRA-1	TP53	V31I	1.151662976			Q12888							
gdsc	MIRA-1	TP53	E336*	1.961381672			Q12888							
gdsc	MIRA-1	TP53	Y205F	0.88639985			Q12888							
gdsc	MIRA-1	TP53	S215I	2.223012867			Q12888							
gdsc	MIRA-1	TP53	K164*	1.935772703			Q12888							
gdsc	MIRA-1	TP53	A161T	1.857122722			Q12888							
gdsc	MIRA-1	TP53	R175H	2.177797393			Q12888							
gdsc	MIRA-1	TP53	S166*	1.96777873			Q12888							
gdsc	MIRA-1	TP53	R273H	3.196596848			Q12888							
gdsc	MIRA-1	TP53	R248W+V218L	1.90443737			Q12888							
gdsc	MIRA-1	TP53	N239D+R158H	0.254168257			Q12888							
gdsc	MIRA-1	TP53	Y234C	0.366927585			Q12888							
gdsc	MIRA-1	TP53	R249G+Y234N	0.5589803329999999			Q12888							
gdsc	MIRA-1	TP53	G360V+G245S	2.912726146			Q12888							
gdsc	MIRA-1	TP53	R273H	2.70572086			Q12888							
gdsc	MIRA-1	TP53	R273H+R267L+R248Q	0.352869699			Q12888							
gdsc	MIRA-1	TP53	R273C	1.747694343			Q12888							
gdsc	MIRA-1	TP53	A159D	2.235924295			Q12888							
gdsc	MIRA-1	TP53	C277F	2.229577598			Q12888							
gdsc	MIRA-1	TP53	H193Y	1.131581298			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.4624224140000002			Q12888							
gdsc	MIRA-1	TP53	R273C	1.754839117			Q12888							
gdsc	MIRA-1	TP53	R273H	1.229277886			Q12888							
gdsc	MIRA-1	TP53	P191delP	1.95778055			Q12888							
gdsc	MIRA-1	TP53	P309S+R273H	2.955758313			Q12888							
gdsc	MIRA-1	TP53	G262V	2.438438546			Q12888							
gdsc	MIRA-1	TP53	R213*	2.291712659			Q12888							
gdsc	MIRA-1	TP53	R248W	2.003015576			Q12888							
gdsc	MIRA-1	TP53	I251N	1.953635526			Q12888							
gdsc	MIRA-1	TP53	Q167*	2.173158237			Q12888							
gdsc	MIRA-1	TP53	H214R+E258*	1.329317752			Q12888							
gdsc	MIRA-1	TP53	L194F	1.900402549			Q12888							
gdsc	MIRA-1	TP53	M237I	1.353933716			Q12888							
gdsc	MIRA-1	TP53	R213*	1.132782857			Q12888							
gdsc	MIRA-1	TP53	E349*	2.187094071			Q12888							
gdsc	MIRA-1	TP53	V272M	1.892857255			Q12888							
gdsc	MIRA-1	TP53	G245C	1.379902915			Q12888							
gdsc	MIRA-1	TP53	V272L	1.850835867			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.940933838			Q12888							
gdsc	MIRA-1	TP53	M237I	1.548394915			Q12888							
gdsc	MIRA-1	TP53	R273C	1.535987099			Q12888							
gdsc	MIRA-1	TP53	R283delR	1.162247716			Q12888							
gdsc	MIRA-1	TP53	E180*	1.109020071			Q12888							
gdsc	MIRA-1	TP53	L264R	2.3349125			Q12888							
gdsc	MIRA-1	TP53	R175H	1.430446605			Q12888							
gdsc	MIRA-1	TP53	R273C	2.8128391410000004			Q12888							
gdsc	MIRA-1	TP53	R175H	2.174467629			Q12888							
gdsc	MIRA-1	TP53	R213Q	2.09580402			Q12888							
gdsc	MIRA-1	TP53	A161T	0.229961107			Q12888							
gdsc	MIRA-1	TP53	Y220C	1.031215566			Q12888							
gdsc	MIRA-1	TP53	R273H	2.039311192			Q12888							
gdsc	MIRA-1	TP53	F113C	1.187839503			Q12888							
gdsc	MIRA-1	TP53	R248W	1.755233119			Q12888							
gdsc	MIRA-1	TP53	R175H	1.518600634			Q12888							
gdsc	MIRA-1	TP53	R175H	1.35046531			Q12888							
gdsc	MIRA-1	TP53	M237I	1.237110535			Q12888							
gdsc	MIRA-1	TP53	R248Q	1.350510339			Q12888							
gdsc	MIRA-1	TP53	R248Q	0.945626403			Q12888							
gdsc	MIRA-1	TP53	R248Q	0.455611888			Q12888							
gdsc	MIRA-1	TP53	H179R	2.206468323			Q12888							
gdsc	MIRA-1	TP53	F113V	1.4640398980000002			Q12888							
gdsc	MIRA-1	TP53	R110L	2.235584801			Q12888							
gdsc	MPS-1-IN-1	TTK	R854K	0.195657425			P33981							
gdsc	MPS-1-IN-1	TTK	G855R	-0.5481828910000001			P33981							
gdsc	MPS-1-IN-1	TTK	R854G+G855E	0.463782845			P33981							
gdsc	MPS-1-IN-1	TTK	K696E	0.570835953			P33981							
gdsc	MPS-1-IN-1	TTK	S37R	1.663150916			P33981							
gdsc	MPS-1-IN-1	TTK	Y726C	0.036181266			P33981							
gdsc	MPS-1-IN-1	TTK	L499F	0.180697778			P33981							
gdsc	MPS-1-IN-1	TTK	V77A+Q736R	0.26050606600000004			P33981							
gdsc	MPS-1-IN-1	TTK	R414G	1.581971025			P33981							
gdsc	MPS-1-IN-1	TTK	F540L	0.745437062			P33981							
gdsc	MPS-1-IN-1	TTK	S455N	1.495496691			P33981							
gdsc	MPS-1-IN-1	TTK	P469L	0.8115619159999999			P33981							
gdsc	MPS-1-IN-1	TTK	L609F	0.208204475			P33981							
gdsc	MPS-1-IN-1	TTK	R185W	1.953716697			P33981							
gdsc	MPS-1-IN-1	TTK	N823H	-0.776960806			P33981							
gdsc	MPS-1-IN-1	TTK	S228R	0.000686097			P33981							
gdsc	MPS-1-IN-1	TTK	S162I	0.908173665			P33981							
gdsc	MPS-1-IN-1	TTK	S76G	0.770002073			P33981							
gdsc	MPS-1-IN-1	TTK	N704S	-0.036287914			P33981							
gdsc	MPS-1-IN-1	TTK	N823H	0.043605693			P33981							
gdsc	MPS-1-IN-1	TTK	Y811C	2.113906799			P33981							
gdsc	MPS-1-IN-1	TTK	E337K	2.155405617			P33981							
gdsc	MPS-1-IN-1	TTK	M246V	0.257870102			P33981							
gdsc	MPS-1-IN-1	TTK	P469L	0.974259414			P33981							
gdsc	MPS-1-IN-1	TTK	S511C	1.05583153			P33981							
gdsc	MPS-1-IN-1	TTK	Y554H	0.291210404			P33981							
gdsc	MPS-1-IN-1	TTK	P469L	1.290909928			P33981							
gdsc	MPS-1-IN-1	TTK	R854G	-0.303419144			P33981							
gdsc	MPS-1-IN-1	TTK	K40N	2.070179055			P33981							
gdsc	MPS-1-IN-1	TTK	P469L	1.09537811			P33981							
gdsc	MPS-1-IN-1	TTK	S389F	2.680929521			P33981							
gdsc	MPS-1-IN-1	TTK	P438S	2.347865401			P33981							
gdsc	MPS-1-IN-1	TTK	S699F	1.916747426			P33981							
gdsc	TTK_3146	TTK	R854K	-0.427939295			P33981							
gdsc	TTK_3146	TTK	G855R	-0.053090189			P33981							
gdsc	TTK_3146	TTK	R854G+G855E	0.054242572			P33981							
gdsc	TTK_3146	TTK	K696E	-0.422164939			P33981							
gdsc	TTK_3146	TTK	S37R	0.744495012			P33981							
gdsc	TTK_3146	TTK	Y726C	-0.054436314000000006			P33981							
gdsc	TTK_3146	TTK	L499F	-0.451850795			P33981							
gdsc	TTK_3146	TTK	V77A+Q736R	0.242627246			P33981							
gdsc	TTK_3146	TTK	R414G	-1.462489958			P33981							
gdsc	TTK_3146	TTK	F540L	-0.26154647			P33981							
gdsc	TTK_3146	TTK	S455N	0.16512964800000002			P33981							
gdsc	TTK_3146	TTK	P469L	-0.51333827			P33981							
gdsc	TTK_3146	TTK	L609F	-0.04363354			P33981							
gdsc	TTK_3146	TTK	R185W	0.925051778			P33981							
gdsc	TTK_3146	TTK	N823H	-0.766232092			P33981							
gdsc	TTK_3146	TTK	S228R	1.10623954			P33981							
gdsc	TTK_3146	TTK	S162I	0.965096045			P33981							
gdsc	TTK_3146	TTK	S76G	0.238824679			P33981							
gdsc	TTK_3146	TTK	N704S	-0.372987519			P33981							
gdsc	TTK_3146	TTK	R624C	-0.748695728			P33981							
gdsc	TTK_3146	TTK	R172H	-0.105312387			P33981							
gdsc	TTK_3146	TTK	P275T	0.249568205			P33981							
gdsc	TTK_3146	TTK	N823H	-0.131824303			P33981							
gdsc	TTK_3146	TTK	E337K	0.251937552			P33981							
gdsc	TTK_3146	TTK	M246V	0.995584125			P33981							
gdsc	TTK_3146	TTK	P469L	-0.069308866			P33981							
gdsc	TTK_3146	TTK	S511C	-0.1065886			P33981							
gdsc	TTK_3146	TTK	Y554H	-0.520260269			P33981							
gdsc	TTK_3146	TTK	P469L	-0.373520756			P33981							
gdsc	TTK_3146	TTK	R854G	1.01988311			P33981							
gdsc	TTK_3146	TTK	K40N	0.948606009			P33981							
gdsc	TTK_3146	TTK	P469L	0.4775213820000001			P33981							
gdsc	TTK_3146	TTK	S389F	1.029259774			P33981							
gdsc	TTK_3146	TTK	P438S	1.577613893			P33981							
gdsc	TTK_3146	TTK	S699F	-0.259090028			P33981							
gdsc	TTK_3146	TTK	D608H	-0.158611131			P33981							
gdsc	Pemetrexed	TYMS	R115*	-0.473985433			P04818							
gdsc	Pemetrexed	TYMS	F142C	-1.531025039			P04818							
gdsc	Pemetrexed	TYMS	Y33H	-2.40765837			P04818							
gdsc	Pemetrexed	TYMS	F91V	0.6243545079999999			P04818							
gdsc	Pemetrexed	TYMS	P27S	1.428286998			P04818							
gdsc	Pemetrexed	TYMS	K93N	-0.550401746			P04818							
gdsc	ULK1_4989	ULK1	P574R	-1.074452141			O75385							
gdsc	ULK1_4989	ULK1	G745V	0.015616121			O75385							
gdsc	ULK1_4989	ULK1	A125T	2.150932949			O75385							
gdsc	ULK1_4989	ULK1	A728T+R959H	-1.097256879			O75385							
gdsc	ULK1_4989	ULK1	Q173*+V756M	-1.2967796740000002			O75385							
gdsc	ULK1_4989	ULK1	S330A	-2.8065321410000004			O75385							
gdsc	ULK1_4989	ULK1	S298L	-0.463964738			O75385							
gdsc	ULK1_4989	ULK1	G762R	-0.904342066			O75385							
gdsc	ULK1_4989	ULK1	A332T	-0.7731446120000001			O75385							
gdsc	ULK1_4989	ULK1	G762R	-0.485231978			O75385							
gdsc	ULK1_4989	ULK1	E73D	-0.891449597			O75385							
gdsc	ULK1_4989	ULK1	E718D	-0.5522882179999999			O75385							
gdsc	ULK1_4989	ULK1	R697H	-0.997474152			O75385							
gdsc	ULK1_4989	ULK1	T850M	0.398017038			O75385							
gdsc	ULK1_4989	ULK1	V489I	0.65800942			O75385							
gdsc	ULK1_4989	ULK1	P435L	2.396180163			O75385							
gdsc	ULK1_4989	ULK1	G301S	-1.331994006			O75385							
gdsc	ULK1_4989	ULK1	N559K	-0.530346137			O75385							
gdsc	ULK1_4989	ULK1	R603W	0.8547973059999999			O75385							
gdsc	ULK1_4989	ULK1	E320K	-0.790538187			O75385							
gdsc	ULK1_4989	ULK1	G745V	-0.625820316			O75385							
gdsc	ULK1_4989	ULK1	Q965K	-1.152536299			O75385							
gdsc	ULK1_4989	ULK1	R137H+T180I	-0.240633535			O75385							
gdsc	ULK1_4989	ULK1	A85V+R108H+Q640K	-0.7777422940000001			O75385							
gdsc	ULK1_4989	ULK1	D576N	-0.174338639			O75385							
gdsc	ULK1_4989	ULK1	R153H+V756M	-1.22526321			O75385							
gdsc	ULK1_4989	ULK1	A711V	-0.409965085			O75385							
gdsc	ULK1_4989	ULK1	E73K	0.318651335			O75385							
gdsc	ULK1_4989	ULK1	S784C	0.642878544			O75385							
gdsc	ULK1_4989	ULK1	G745V	1.172168874			O75385							
gdsc	ULK1_4989	ULK1	K686M+P805S	1.648832337			O75385							
gdsc	ULK1_4989	ULK1	G530S	-0.31409572			O75385							
gdsc	ULK1_4989	ULK1	T242I	-1.263312581			O75385							
gdsc	ULK1_4989	ULK1	R691Q	-1.642213098			O75385							
gdsc	ULK1_4989	ULK1	G762R	-1.136554023			O75385							
gdsc	ULK1_4989	ULK1	A418T	2.313365607			O75385							
gdsc	ULK1_4989	ULK1	A711V	-0.251650789			O75385							
gdsc	ULK1_4989	ULK1	P574R	-0.588035193			O75385							
gdsc	ULK1_4989	ULK1	P592S	0.373541492			O75385							
gdsc	ULK1_4989	ULK1	R266C+P435L+P634L+R697H+R845C+S1042T	-0.176362567			O75385							
gdsc	ULK1_4989	ULK1	P592L	-0.791382478			O75385							
gdsc	ULK1_4989	ULK1	C426R	-1.056369506			O75385							
gdsc	ULK1_4989	ULK1	R603Q	1.423592149			O75385							
gdsc	ULK1_4989	ULK1	S317F	0.740834048			O75385							
gdsc	ULK1_4989	ULK1	D700G	0.136326594			O75385							
gdsc	ULK1_4989	ULK1	R514Q	1.617999431			O75385							
gdsc	P22077	USP7	A197V	1.964298474			Q93009							
gdsc	P22077	USP7	W205*	0.463445721			Q93009							
gdsc	P22077	USP7	A493V	0.276960553			Q93009							
gdsc	P22077	USP7	E924K+G577D	-0.6147722520000001			Q93009							
gdsc	P22077	USP7	P694S	2.38627678			Q93009							
gdsc	Wee1 Inhibitor	WEE1	A572T	-0.3699561220000001			P30291							
gdsc	Wee1 Inhibitor	WEE1	N380D	-0.118360679			P30291							
gdsc	Embelin	XIAP	D16G	-0.497268899			P98170							
gdsc	Embelin	XIAP	E350delE	0.31697282600000004			P98170							
gdsc	Embelin	XIAP	A321G	0.801895527			P98170							
gdsc	Embelin	XIAP	T489I	-0.70383219			P98170							
gdsc	Embelin	XIAP	W210R+F270V+Y277S+T489I	-0.633819452			P98170							
gdsc	Embelin	XIAP	E350delE	0.231695903			P98170							
gdsc	Embelin	XIAP	E350delE	-0.6155614420000001			P98170							
gdsc	Embelin	XIAP	E350delE	-0.303857583			P98170							
gdsc	Embelin	XIAP	E350delE	0.3879051			P98170							
gdsc	Embelin	XIAP	R238Q	0.947092211			P98170							
gdsc	Embelin	XIAP	I380V	-0.444291874			P98170							
gdsc	Embelin	XIAP	P155T	-0.01788119			P98170							
gdsc	Embelin	XIAP	E350delE	-0.432815445			P98170							
gdsc	Embelin	XIAP	A321G	0.884077902			P98170							
gdsc	Embelin	XIAP	R182_Y190delRELASAGLY	0.061431189			P98170							
gdsc	Embelin	XIAP	E350delE	-0.442828437			P98170							
gdsc	Embelin	XIAP	A321G	-0.489206366			P98170							
gdsc	Embelin	XIAP	T437I	0.7749410259999999			P98170							
gdsc	Embelin	XIAP	Q418H	-0.528505287			P98170							
gdsc	Embelin	XIAP	T489I	1.189844471			P98170							
gdsc	Embelin	XIAP	E349D+E350delE	1.387509235			P98170							
gdsc	Embelin	XIAP	R443C	-0.199146568			P98170							
gdsc	Embelin	XIAP	P325Q	-0.271931542			P98170							
gdsc	Embelin	XIAP	E350delE	0.358037944			P98170							
gdsc	Embelin	XIAP	E350delE	0.317837853			P98170							
gdsc	Embelin	XIAP	E350delE	-0.590289005			P98170							
pharmgkb	meloxicam	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13			Metabolism/PK	P11712	Drug	5281106.0	CC1=CN=C(S1)N/C(=C\2/C(=O)C3=CC=CC=C3S(=O)(=O)N2C)/O				
pharmgkb	lornoxicam	CYP2C9	CYP2C9*1, CYP2C9*3, CYP2C9*13			Metabolism/PK	P11712	Drug	5282204.0	CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=C(S1(=O)=O)C=C(S3)Cl				
pharmgkb	siponimod	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Metabolism/PK	P11712	Drug	44599207.0					
pharmgkb	capecitabine	DPYD	rs17376848		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97450068.0	A	G
pharmgkb	capecitabine	DPYD	M166V		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97699535.0	T	C
pharmgkb	capecitabine	DPYD	C29R		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97883329.0	A	G
pharmgkb	dexlansoprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3			Metabolism/PK	P33261	Drug	9578005.0	CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F				
pharmgkb	warfarin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11		over-anticoagulation	Toxicity	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	capecitabine	DPYD	V732I		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97305364.0	C	T
pharmgkb	capecitabine	DPYD	I543V		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97515839.0	T	C
pharmgkb	atazanavir,atazanavir / ritonavir	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*36, UGT1A1*37		HIV Infections,Hyperbilirubinemia	Toxicity	P22309							
pharmgkb	azathioprine	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C		dose reduction	Dosage	P51580	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]				
pharmgkb	fluorouracil	DPYD	rs17376848		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97450068.0	A	G
pharmgkb	fluorouracil	DPYD	S534N		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97515865.0	C	T
pharmgkb	fluorouracil	DPYD	I543V		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97515839.0	T	C
pharmgkb	capecitabine	DPYD	S534N		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97515865.0	C	T
pharmgkb	fluorouracil	DPYD	C29R		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97883329.0	A	G
pharmgkb	fluorouracil	DPYD	V732I		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97305364.0	C	T
pharmgkb	warfarin	CYP4F2	V433M			Dosage	P78329	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	19	15879621.0	C	T
pharmgkb	gefitinib	EGFR	L858R		Carcinoma, Non-Small-Cell Lung	Efficacy	P00533	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	7	55191822.0	T	R
pharmgkb	efavirenz	CYP2B6	Q172H		HIV Infections	Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	41006936.0	G	W
pharmgkb	phenprocoumon	VKORC1	rs9923231			Dosage	Q8N0U8	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	mercaptopurine	NUDT15	R139C			Dosage	Q9NV35	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	13	48045719.0	C	T
pharmgkb	hydrocodone	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*17, CYP2D6*41			Metabolism/PK	P10635	Drug	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4				
pharmgkb	tropisetron	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN		Vomiting	Efficacy	P10635	Drug	656665.0					
pharmgkb	ibuprofen	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Metabolism/PK	P11712	Drug	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O				
pharmgkb	desipramine	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10		Depressive Disorder, Major,Mental Disorders	Metabolism/PK	P10635	Drug, Metabolite	2995.0	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	ivacaftor	CFTR	S1251N		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117642472.0	G	A
pharmgkb	ivacaftor	CFTR	G1244V		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117642451.0	G	W
pharmgkb	ivacaftor	CFTR	D110H		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117530953.0	G	Y
pharmgkb	ivacaftor	CFTR	L206W		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117535285.0	T	G
pharmgkb	ivacaftor	CFTR	rs397508759		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117534363.0	G	W
pharmgkb	ivacaftor	CFTR	R117G		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117530974.0	C	D
pharmgkb	ivacaftor	CFTR	D110E		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117530955.0	C	A
pharmgkb	ivacaftor	CFTR	R74W		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117509089.0	C	T
pharmgkb	ivacaftor	CFTR	P67L		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117509069.0	C	T
pharmgkb	ivacaftor	CFTR	R1070W		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117611649.0	C	T
pharmgkb	ivacaftor	CFTR	R1070Q		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117611650.0	G	M
pharmgkb	ivacaftor	CFTR	S977F		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117606695.0	C	K
pharmgkb	fluorouracil	DPYD	rs78060119		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97573943.0	C	A
pharmgkb	rasburicase	G6PD	G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham		Hemolysis,Methemoglobinemia	Toxicity	P11413	Drug						
pharmgkb	flurbiprofen	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29			Metabolism/PK	P11712	Drug	3394.0	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O				
pharmgkb	trimipramine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6		Mental Disorders	Metabolism/PK	P10635	Drug	5584.0	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C				
pharmgkb	tenoxicam	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Metabolism/PK	P11712	Drug	5312154.0	CN1/C(=C(/NC2=CC=CC=N2)\O)/C(=O)C3=C(S1(=O)=O)C=CS3				
pharmgkb	tropisetron	CYP2D6	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10			Metabolism/PK	P10635	Drug	656665.0					
pharmgkb	fluorouracil	DPYD	R592W			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97450190.0	G	A
pharmgkb	fluorouracil	DPYD	Y186C		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97699474.0	T	C
pharmgkb	celecoxib	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13			Metabolism/PK	P11712	Drug	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F				
pharmgkb	piroxicam	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Metabolism/PK	P11712	Drug	5280452.0	CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=CC=CC=C3S1(=O)=O				
pharmgkb	ivacaftor / lumacaftor	CFTR	rs113993960		Cystic Fibrosis	Efficacy	P13569	Drug	71494926.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117559592.0	CTT	-
pharmgkb	ivacaftor / tezacaftor	CFTR	rs113993960		Cystic Fibrosis	Efficacy	P13569	Drug	72722243.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C.CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F	7	117559592.0	CTT	-
pharmgkb	flucloxacillin	HLA-B	HLA-B*57:01		drug-induced liver injury	Toxicity	P01889	Drug	21319.0	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O				
pharmgkb	fluorouracil	DPYD	V732I			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97305364.0	C	T
pharmgkb	fluorouracil	DPYD	V335L			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97593343.0	C	W
pharmgkb	fluorouracil	DPYD	rs72549303			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97450066.0	G	-
pharmgkb	fluorouracil	DPYD	Y186C			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97699474.0	T	C
pharmgkb	fluorouracil	DPYD	rs78060119			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97573943.0	C	A
pharmgkb	fluorouracil	DPYD	V995F			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97079071.0	C	A
pharmgkb	fluorouracil	DPYD	R235W			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97691776.0	G	A
pharmgkb	fluorouracil	DPYD	rs72549309			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97740415.0	ATGA	-
pharmgkb	hormonal contraceptives for systemic use	F5	R534L		Thrombosis	Toxicity	P30939	Drug Class			1	169549811.0	C	T
pharmgkb	phenytoin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3		Epilepsy	Toxicity	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	irinotecan	UGT1A1	UGT1A1*1, UGT1A1*28			Dosage	P22309	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7				
pharmgkb	desflurane	CACNA1S	R1086H		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	42113.0	C(C(F)(F)F)(OC(F)F)F	1	201060815.0	C	W
pharmgkb	desflurane	CACNA1S	R174W		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	42113.0	C(C(F)(F)F)(OC(F)F)F	1	201091993.0	G	A
pharmgkb	trimipramine	CYP2C19	CYP2C19*1, CYP2C19*2			Metabolism/PK	P33261	Drug	5584.0	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C				
pharmgkb	desipramine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6		Depressive Disorder,Depressive Disorder, Major	Toxicity	P10635	Drug, Metabolite	2995.0	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R328W		Malignant Hyperthermia	Toxicity	P21817				19	38448673.0	C	W
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R401C		Malignant Hyperthermia	Toxicity	P21817				19	38451842.0	C	K
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R533C		Malignant Hyperthermia	Toxicity	P21817				19	38455471.0	C	D
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	I4893T		Malignant Hyperthermia	Toxicity	P21817				19	38584989.0	T	C
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	G341R		Malignant Hyperthermia	Toxicity	P21817				19	38448712.0	G	M
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R44C		Malignant Hyperthermia	Toxicity	P21817				19	38440829.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	T4821I		Malignant Hyperthermia	Toxicity	P21817				19	38580094.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2458L		Malignant Hyperthermia	Toxicity	P21817				19	38500655.0	G	W
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2163H		Malignant Hyperthermia	Toxicity	P21817				19	38494565.0	G	M
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2458C		Malignant Hyperthermia	Toxicity	P21817				19	38500654.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	Y522S		Malignant Hyperthermia	Toxicity	P21817				19	38455359.0	A	S
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2435L		Malignant Hyperthermia	Toxicity	P21817				19	38499997.0	G	W
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R614C		Malignant Hyperthermia	Toxicity	P21817				19	38457545.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	G2434R		Malignant Hyperthermia	Toxicity	P21817				19	38499993.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2163C		Malignant Hyperthermia	Toxicity	P21817				19	38494564.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	H4833Y		Malignant Hyperthermia	Toxicity	P21817				19	38580114.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	C35R		Malignant Hyperthermia	Toxicity	P21817				19	38440802.0	T	C
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R4861H		Malignant Hyperthermia	Toxicity	P21817				19	38580440.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R552W		Malignant Hyperthermia	Toxicity	P21817				19	38455528.0	C	T
pharmgkb	enflurane	CACNA1S	R174W		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	3226.0	C(C(OC(F)F)(F)F)(F)Cl	1	201091993.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	I403M		Malignant Hyperthermia	Toxicity	P21817				19	38451850.0	C	K
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	G2375A		Malignant Hyperthermia	Toxicity	P21817				19	38499731.0	G	C
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	G248R		Malignant Hyperthermia	Toxicity	P21817				19	38446710.0	G	H
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R614H		Malignant Hyperthermia	Toxicity	P21817				19	38457546.0	G	W
pharmgkb	enflurane	CACNA1S	R1086H		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	3226.0	C(C(OC(F)F)(F)F)(F)Cl	1	201060815.0	C	W
pharmgkb	halothane	CACNA1S	R1086H		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	3562.0	C(C(F)(F)F)(Cl)Br	1	201060815.0	C	W
pharmgkb	isoflurane	CACNA1S	R1086H		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	3763.0	C(C(F)(F)F)(OC(F)F)Cl	1	201060815.0	C	W
pharmgkb	halothane	CACNA1S	R174W		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	3562.0	C(C(F)(F)F)(Cl)Br	1	201091993.0	G	A
pharmgkb	isoflurane	CACNA1S	R174W		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	3763.0	C(C(F)(F)F)(OC(F)F)Cl	1	201091993.0	G	A
pharmgkb	sevoflurane	CACNA1S	R1086H		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	1	201060815.0	C	W
pharmgkb	methoxyflurane	CACNA1S	R1086H			Toxicity	Q6ZMT1	Drug	4116.0	COC(C(Cl)Cl)(F)F	1	201060815.0	C	W
pharmgkb	methoxyflurane	CACNA1S	R174W		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	4116.0	COC(C(Cl)Cl)(F)F	1	201091993.0	G	A
pharmgkb	sevoflurane	CACNA1S	R174W		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	1	201091993.0	G	A
pharmgkb	succinylcholine	CACNA1S	R1086H		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	1	201060815.0	C	W
pharmgkb	succinylcholine	CACNA1S	R174W		Malignant Hyperthermia	Toxicity	Q6ZMT1	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	1	201091993.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	E3104K		Malignant Hyperthermia	Toxicity	P21817				19	38512321.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R163C		Malignant Hyperthermia	Toxicity	P21817							
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	V2168M		Malignant Hyperthermia	Toxicity	P21817				19	38494579.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	V4849I		Malignant Hyperthermia	Toxicity	P21817				19	38580403.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	G3990V		Malignant Hyperthermia	Toxicity	P21817				19	38543832.0	G	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	rs121918596		Malignant Hyperthermia	Toxicity	P21817				19	38499646.0	GAG	-
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	T2206M		Malignant Hyperthermia	Toxicity	P21817				19	38496283.0	C	K
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	Y4791C		Malignant Hyperthermia	Toxicity	P21817				19	38580004.0	A	G
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2336H		Malignant Hyperthermia	Toxicity	P21817				19	38499223.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	A2428T		Malignant Hyperthermia	Toxicity	P21817				19	38499975.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	L4833V		Malignant Hyperthermia	Toxicity	P21817				19	38580370.0	C	G
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2355W		Malignant Hyperthermia	Toxicity	P21817				19	38499670.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2452W		Malignant Hyperthermia	Toxicity	P21817				19	38500636.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2508G		Malignant Hyperthermia	Toxicity	P21817				19	38500898.0	C	K
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2508H		Malignant Hyperthermia	Toxicity	P21817				19	38500899.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R163H		Malignant Hyperthermia	Toxicity	P21817				19	38444212.0	G	W
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	A2350T		Malignant Hyperthermia	Toxicity	P21817				19	38499655.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2454C		Malignant Hyperthermia	Toxicity	P21817				19	38500642.0	C	T
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R2454H		Malignant Hyperthermia	Toxicity	P21817				19	38500643.0	G	A
pharmgkb	fluorouracil	DPYD	R592W		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97450190.0	G	A
pharmgkb	azathioprine	NUDT15	R139C		Inflammatory Bowel Diseases,Myelosuppression	Toxicity	Q9NV35	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	13	48045719.0	C	T
pharmgkb	efavirenz	CYP2B6	CYP2B6*1, CYP2B6*2, CYP2B6*6, CYP2B6*18, CYP2B6*38		HIV Infections	Toxicity	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F				
pharmgkb	warfarin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11		Hemorrhage	Toxicity	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	abacavir	HLA-B	HLA-B*57:01		Drug Hypersensitivity,HIV Infections	Toxicity	P01889	Drug	441300.0	C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N				
pharmgkb	acenocoumarol	VKORC1	rs9923231			Dosage	Q8N0U8	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	efavirenz	CYP2B6	Q172H		HIV Infections	Toxicity	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	41006936.0	G	W
pharmgkb	allopurinol	HLA-B	HLA-B*58:01		Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	ivacaftor	CFTR	S1255P		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117642483.0	T	M
pharmgkb	ivacaftor	CFTR	G178R		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117534318.0	G	A
pharmgkb	ivacaftor	CFTR	G551S		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117587805.0	G	A
pharmgkb	ivacaftor	CFTR	E56K		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117509035.0	G	A
pharmgkb	ivacaftor	CFTR	S549N		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117587800.0	G	W
pharmgkb	ivacaftor	CFTR	G1349D		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117664770.0	G	A
pharmgkb	ivacaftor	CFTR	R352Q		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117540285.0	G	A
pharmgkb	ivacaftor	CFTR	A455E		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117548795.0	C	W
pharmgkb	ivacaftor	CFTR	D579A		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117590409.0	A	S
pharmgkb	ivacaftor	CFTR	S945L		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117603708.0	C	T
pharmgkb	ivacaftor	CFTR	F1052L		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117611595.0	T	S
pharmgkb	ivacaftor	CFTR	K1060T		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117611620.0	A	C
pharmgkb	ivacaftor	CFTR	A1067P		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117611640.0	G	M
pharmgkb	ivacaftor	CFTR	G551D		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117587806.0	G	A
pharmgkb	ivacaftor	CFTR	R347L		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117540270.0	G	H
pharmgkb	ivacaftor	CFTR	F1074L		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117611663.0	T	A
pharmgkb	ivacaftor	CFTR	S549R		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117587801.0	T	S
pharmgkb	ivacaftor	CFTR	D1152H		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117614699.0	G	C
pharmgkb	ivacaftor	CFTR	D1270N		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117642528.0	G	W
pharmgkb	ivacaftor	CFTR	S549R		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117587799.0	A	C
pharmgkb	efavirenz	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9, CYP2B6*18, CYP2B6*28		HIV Infections	Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F				
pharmgkb	ivacaftor	CFTR	R117H		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117530975.0	G	H
pharmgkb	efavirenz	CYP2B6	CYP2B6*1, CYP2B6*6, CYP2B6*26		HIV Infections	Dosage	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F				
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,telaprevir	IFNL3	rs12979860		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs12979860		Hepatitis C	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	boceprevir,peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs12979860		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	fluorouracil	DPYD	M166V		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97699535.0	T	C
pharmgkb	FOLFIRI,irinotecan	UGT1A1	UGT1A1*1, UGT1A1*28		Neutropenia	Toxicity	P22309							
pharmgkb	fluvoxamine	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14		Depressive Disorder	Metabolism/PK	P10635	Drug	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F				
pharmgkb	amitriptyline	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41		Depressive Disorder	Toxicity	P10635	Drug	2160.0	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	amitriptyline	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41		Depressive Disorder,Mental Disorders	Metabolism/PK	P10635	Drug	2160.0	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	clomipramine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6		Depressive Disorder, Major	Toxicity	P10635	Drug	2801.0	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl				
pharmgkb	clomipramine	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41		Depressive Disorder, Major,Mental Disorders	Metabolism/PK	P10635	Drug	2801.0	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl				
pharmgkb	imipramine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6		Depressive Disorder	Toxicity	P10635	Drug	3696.0	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	imipramine	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*4, CYP2D6*5		Depressive Disorder	Dosage	P10635	Drug	3696.0	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	codeine	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN		Pain	Toxicity	P10635	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O				
pharmgkb	doxepin	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41			Metabolism/PK	P10635	Drug	667477.0	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31				
pharmgkb	imipramine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5		Depressive Disorder, Major,Mental Disorders	Metabolism/PK	P10635	Drug	3696.0	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	nortriptyline	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10		Depressive Disorder	Toxicity	P10635	Drug	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	nortriptyline	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17		Depressive Disorder, Major	Metabolism/PK	P10635	Drug	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	voriconazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17			Metabolism/PK	P33261	Drug	71616.0	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O				
pharmgkb	lansoprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9, CYP2C19*17		Gastroesophageal Reflux	Metabolism/PK	P33261	Drug	3883.0	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F				
pharmgkb	clopidogrel	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17		Cardiovascular Diseases	Efficacy	P33261	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3				
pharmgkb	pantoprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17			Metabolism/PK	P33261	Drug	4679.0	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC				
pharmgkb	atomoxetine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6		Attention Deficit Disorder with Hyperactivity	Toxicity	P10635	Drug	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2				
pharmgkb	atomoxetine	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*92, CYP2D6*96		Attention Deficit Disorder with Hyperactivity	Metabolism/PK	P10635	Drug	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2				
pharmgkb	flecainide	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36		Arrhythmias, Cardiac	Metabolism/PK	P10635	Drug	3356.0	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F				
pharmgkb	paroxetine	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*41			Metabolism/PK	P10635	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4				
pharmgkb	tamoxifen	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*10x2, CYP2D6*11, CYP2D6*17, CYP2D6*21, CYP2D6*36, CYP2D6*41		Breast Neoplasms	Efficacy	P10635	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3				
pharmgkb	tramadol	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN		cardiotoxicity,Respiratory Insufficiency	Toxicity	P10635	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O				
pharmgkb	metoprolol	CYP2D6	CYP2D6*1, CYP2D6*4		Heart Failure	Dosage	P10635	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O				
pharmgkb	metoprolol	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*31, CYP2D6*35, CYP2D6*41		Hypertension	Metabolism/PK	P10635	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O				
pharmgkb	haloperidol	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17		Schizophrenia	Metabolism/PK	P10635	Drug	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F				
pharmgkb	propafenone	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36		Arrhythmias, Cardiac,Tachycardia	Metabolism/PK	P10635	Drug	4932.0	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O				
pharmgkb	risperidone	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14		Psychotic Disorders,Schizophrenia	Metabolism/PK	P10635	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F				
pharmgkb	clomipramine	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17		Mental Disorders	Metabolism/PK	P33261	Drug	2801.0	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl				
pharmgkb	escitalopram	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17		Depressive Disorder, Major,Mental Disorders	Metabolism/PK	P33261	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	imipramine	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17		Depressive Disorder,Depressive Disorder, Major	Metabolism/PK	P33261	Drug	3696.0	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	omeprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Esophagitis,Gastroesophageal Reflux,Helicobacter Infections,Peptic Ulcer	Efficacy	P33261	Drug	4594.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC				
pharmgkb	omeprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*9, CYP2C19*10, CYP2C19*17, CYP2C19*24, CYP2C19*26		Gastroesophageal Reflux	Metabolism/PK	P33261	Drug	4594.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC				
pharmgkb	lansoprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Gastroesophageal Reflux,Helicobacter Infections	Efficacy	P33261	Drug	3883.0	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F				
pharmgkb	pantoprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Helicobacter Infections,Ulcer	Efficacy	P33261	Drug	4679.0	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC				
pharmgkb	zuclopenthixol	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4		Schizophrenia	Metabolism/PK	P10635	Drug	5311507.0	C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO				
pharmgkb	clopidogrel	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*10, CYP2C19*17, CYP2C19*19, CYP2C19*25, CYP2C19*26			Metabolism/PK	P33261	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3				
pharmgkb	fluorouracil	DPYD	D949V			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97082391.0	T	A
pharmgkb	fluorouracil	DPYD	D949V		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97082391.0	T	A
pharmgkb	tegafur	DPYD	D949V		Neoplasms	Toxicity	Q12882	Prodrug	5386.0		1	97082391.0	T	A
pharmgkb	capecitabine	DPYD	D949V		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97082391.0	T	A
pharmgkb	capecitabine	DPYD	rs3918290		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97450058.0	C	K
pharmgkb	tegafur	DPYD	rs3918290		Neoplasms	Toxicity	Q12882	Prodrug	5386.0		1	97450058.0	C	K
pharmgkb	fluorouracil	DPYD	rs3918290		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97450058.0	C	K
pharmgkb	fluorouracil	DPYD	rs3918290			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97450058.0	C	K
pharmgkb	fluorouracil	DPYD	I560N			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97515787.0	A	Y
pharmgkb	capecitabine	DPYD	I560N		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97515787.0	A	Y
pharmgkb	fluorouracil	DPYD	I560N		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97515787.0	A	Y
pharmgkb	tegafur	DPYD	I560N		Neoplasms	Toxicity	Q12882	Prodrug	5386.0		1	97515787.0	A	Y
pharmgkb	fluorouracil	DPYD	V515I			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97515923.0	C	T
pharmgkb	fluorouracil	DPYD	T768K			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97234991.0	G	T
pharmgkb	mercaptopurine	NUDT15	NUDT15*1, NUDT15*2, NUDT15*3		Leukopenia,Neutropenia	Toxicity	Q9NV35	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	mercaptopurine	NUDT15	NUDT15*1, NUDT15*2, NUDT15*3		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage	Q9NV35	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	mercaptopurine	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*9		dose reduction	Dosage	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	tobramycin	MT-RNR1	rs267606617		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	36294.0	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N				
pharmgkb	amikacin	MT-RNR1	rs267606617		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	37768.0	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N				
pharmgkb	gentamicin	MT-ND1	rs267606617		Ototoxicity	Toxicity	P03886	Drug	3467.0	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC				
pharmgkb	aminoglycoside antibacterials	MT-RNR1	rs267606617		Ototoxicity	Toxicity	A0A0C5B5G6	Drug Class						
pharmgkb	streptomycin	MT-RNR1	rs267606617		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O				
pharmgkb	kanamycin	MT-RNR1	rs267606617		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	6032.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N				
pharmgkb	kanamycin	MT-RNR1	rs267606619		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	6032.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N				
pharmgkb	streptomycin	MT-RNR1	rs267606619		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O				
pharmgkb	gentamicin	MT-RNR1	rs267606619		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	3467.0	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC				
pharmgkb	tobramycin	MT-RNR1	rs267606619		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	36294.0	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N				
pharmgkb	aminoglycoside antibacterials	MT-RNR1	rs267606619		Ototoxicity	Toxicity	A0A0C5B5G6	Drug Class						
pharmgkb	aminoglycoside antibacterials	MT-RNR1	rs267606618		Ototoxicity	Toxicity	A0A0C5B5G6	Drug Class						
pharmgkb	gentamicin	MT-RNR1	rs267606618		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	3467.0	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC				
pharmgkb	kanamycin	MT-RNR1	rs267606618		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	6032.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N				
pharmgkb	streptomycin	MT-RNR1	rs267606618		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O				
pharmgkb	ondansetron	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35xN		Vomiting	Efficacy	P10635	Drug	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C				
pharmgkb	warfarin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*4, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11		Cardiovascular Diseases	Dosage	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	phenytoin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11, CYP2C9*13, CYP2C9*14, CYP2C9*16, CYP2C9*29, CYP2C9*31, CYP2C9*33, CYP2C9*37, CYP2C9*39, CYP2C9*42, CYP2C9*43, CYP2C9*45, CYP2C9*50, CYP2C9*52, CYP2C9*55		Epilepsy	Metabolism/PK	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	aripiprazole	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41		Psychotic Disorders,schizoaffective disorder,Schizophrenia	Metabolism/PK	P10635	Drug	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl				
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7		heart transplantation,hemopoietic stem cell transplant,Kidney Transplantation,liver transplantation,lung transplantation	Dosage	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	tramadol	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41			Metabolism/PK	P10635	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O				
pharmgkb	codeine	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*36, CYP2D6*41			Metabolism/PK	P10635	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O				
pharmgkb	warfarin	VKORC1	rs9923231			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	codeine	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*17, CYP2D6*40		Pain	Efficacy	P10635	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O				
pharmgkb	hydrocodone	CYP2D6	CYP2D6*5, CYP2D6*17		Pain	Efficacy	P10635	Drug	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4				
pharmgkb	tramadol	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17		Pain,Pain, Postoperative	Efficacy	P10635	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O				
pharmgkb	clopidogrel	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17		Acute coronary syndrome,Cardiovascular Diseases,Ischemic Attack, Transient,Stroke	Efficacy,Toxicity	P33261	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3				
pharmgkb	fluvastatin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Metabolism/PK	P11712	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F				
pharmgkb	simvastatin,simvastatin acid	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6				12	21178615.0	T	C
pharmgkb	lovastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15		statin-related myopathy	Toxicity	Q9Y6L6	Drug	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C				
pharmgkb	simvastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15		statin-related myopathy	Toxicity	Q9Y6L6	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C				
pharmgkb	atorvastatin	SLCO1B1	V174A		statin-related myopathy	Toxicity	Q9Y6L6	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	12	21178615.0	T	C
pharmgkb	lovastatin	SLCO1B1	V174A		statin-related myopathy	Toxicity	Q9Y6L6	Drug	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	12	21178615.0	T	C
pharmgkb	lovastatin,lovastatin acid	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6				12	21178615.0	T	C
pharmgkb	lovastatin,lovastatin acid	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15			Metabolism/PK	Q9Y6L6							
pharmgkb	rosuvastatin	SLCO1B1	V174A		Hypercholesterolemia	Metabolism/PK	Q9Y6L6	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	12	21178615.0	T	C
pharmgkb	pitavastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37			Metabolism/PK	Q9Y6L6	Drug	5282452.0					
pharmgkb	pitavastatin	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6	Drug	5282452.0		12	21178615.0	T	C
pharmgkb	rosuvastatin	SLCO1B1	V174A		statin-related myopathy	Toxicity	Q9Y6L6	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	12	21178615.0	T	C
pharmgkb	pravastatin	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	12	21178615.0	T	C
pharmgkb	pravastatin	SLCO1B1	V174A		statin-related myopathy	Toxicity	Q9Y6L6	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	12	21178615.0	T	C
pharmgkb	pravastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15		statin-related myopathy	Toxicity	Q9Y6L6	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O				
pharmgkb	fluvastatin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Toxicity	P11712	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F				
pharmgkb	rosuvastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37			Metabolism/PK	Q9Y6L6	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C				
pharmgkb	simvastatin,simvastatin acid	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15			Metabolism/PK	Q9Y6L6							
pharmgkb	simvastatin	SLCO1B1	V174A		statin-related myopathy	Toxicity	Q9Y6L6	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	12	21178615.0	T	C
pharmgkb	rosuvastatin	ABCG2	Q141K			Metabolism/PK	Q9UNQ0	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	4	88131171.0	G	Y
pharmgkb	fluvastatin	SLCO1B1	V174A		statin-related myopathy	Toxicity	Q9Y6L6	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	12	21178615.0	T	C
pharmgkb	fluvastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15		statin-related myopathy	Toxicity	Q9Y6L6	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F				
pharmgkb	fluvastatin	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	12	21178615.0	T	C
pharmgkb	atorvastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37			Metabolism/PK	Q9Y6L6	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4				
pharmgkb	fluvastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15			Metabolism/PK	Q9Y6L6	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F				
pharmgkb	pravastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15			Metabolism/PK	Q9Y6L6	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O				
pharmgkb	rosuvastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15		statin-related myopathy	Toxicity	Q9Y6L6	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C				
pharmgkb	oxcarbazepine	HLA-B	HLA-B*15:02		Stevens-Johnson Syndrome	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	carbamazepine	HLA-A	HLA-A*31:01		Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,Stevens-Johnson Syndrome	Toxicity	P04439	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7		heart transplantation,hematopoietic stem cell transplantation,Kidney Transplantation,lung transplantation	Metabolism/PK	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	citalopram	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17		Depressive Disorder,Depressive Disorder, Major	Metabolism/PK	P33261	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	citalopram	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4		Depressive Disorder	Toxicity	P33261	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	quetiapine	CYP3A4	CYP3A4*1, CYP3A4*20, CYP3A4*22			Metabolism/PK	P08684	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42				
pharmgkb	mercaptopurine	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*4, TPMT*6, TPMT*9, TPMT*12			Toxicity	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	phenytoin	HLA-B	HLA-B*15:02		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	carbamazepine	HLA-B	HLA-B*15:02, HLA-B*15:11		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	lamotrigine	HLA-B	HLA-B*15:02		Epidermal Necrolysis, Toxic,Epilepsy,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N				
pharmgkb	atorvastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15			Toxicity	Q9Y6L6	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4				
pharmgkb	capecitabine	DPYD	rs56038477		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97573863.0	C	T
pharmgkb	fluorouracil	DPYD	rs56038477		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97573863.0	C	T
pharmgkb	fluorouracil	DPYD	rs75017182			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97579893.0	G	Y
pharmgkb	capecitabine	DPYD	rs75017182		Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97579893.0	G	Y
pharmgkb	fluorouracil	DPYD	rs75017182		Neoplasms	Toxicity	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97579893.0	G	Y
pharmgkb	vortioxetine	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*10			Metabolism/PK	P10635	Drug	9966051.0	CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C				
pharmgkb	sertraline	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17		Mental Disorders	Metabolism/PK	P33261	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl				
pharmgkb	sertraline	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9			Metabolism/PK	P20813	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl				
pharmgkb	venlafaxine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10		Depressive Disorder,Obsessive-Compulsive Disorder	Metabolism/PK	P10635	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O				
pharmgkb	venlafaxine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*81		agitation,Alcohol-Related Disorders,cardiotoxicity,Depression,Depressive Disorder,Depressive Disorder, Major,Drug Toxicity,dysphoria,Edema,Nausea,Obsessive-Compulsive Disorder,Tachycardia,Vomiting	Toxicity	P10635	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O				
pharmgkb	tamoxifen	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41		Breast Neoplasms	Metabolism/PK	P10635	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3				
pharmgkb	azathioprine	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*6		Leukopenia,Myelosuppression	Toxicity	P51580	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]				
pharmgkb	doxepin	CYP2C19	CYP2C19*1, CYP2C19*2			Metabolism/PK	P33261	Drug	667477.0	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31				
pharmgkb	amitriptyline	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17		Depressive Disorder, Major,Mental Disorders	Metabolism/PK	P33261	Drug	2160.0	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	atorvastatin	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	12	21178615.0	T	C
pharmgkb	warfarin	VKORC1	rs9923231		over-anticoagulation	Toxicity	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	FOLFIRI,irinotecan	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28		Diarrhea	Toxicity	P22309							
pharmgkb	FOLFIRI,irinotecan	UGT1A1	UGT1A1*1, UGT1A1*6		Neutropenia	Toxicity	P22309							
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		liver transplantation	Metabolism/PK	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		liver transplantation	Metabolism/PK	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL4	rs11322783		Hepatitis C, Chronic	Efficacy	K9M1U5				19	39248514.0	T	-
pharmgkb	interferons,peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs8099917		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39252525.0	T	G
pharmgkb	acenocoumarol	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3		over-anticoagulation	Toxicity	P11712	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	acenocoumarol	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Dosage	P11712	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	warfarin	VKORC1	rs8050894			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31093188.0	C	K
pharmgkb	warfarin	VKORC1	rs9934438			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31093557.0	G	M
pharmgkb	warfarin	VKORC1	rs2359612			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31092475.0	A	G
pharmgkb	warfarin	VKORC1	rs7294			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31091000.0	C	T
pharmgkb	Drugs For Treatment Of Tuberculosis,isoniazid	NAT2	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5D, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*12A, NAT2*13A, NAT2*14A		drug-induced liver injury,Hepatitis, Toxic,Toxic liver disease,Tuberculosis	Toxicity	Q6N069							
pharmgkb	nicotine	CYP2A6	CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*12, CYP2A6*13, CYP2A6*14, CYP2A6*15, CYP2A6*17, CYP2A6*19, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*38, CYP2A6*46		Tobacco Use Disorder	Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2				
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs11881222		Hepatitis C,HIV Infections	Efficacy	Q8IZI9				19	39244283.0	A	G
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,telaprevir	IFNL3	rs8099917		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39252525.0	T	G
pharmgkb	warfarin	VKORC1	rs9923231		time to therapeutic inr	Efficacy	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	warfarin	VKORC1	rs9923231		time in therapeutic range	Efficacy	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	methotrexate	SLC19A1	H27R		Arthritis, Rheumatoid	Efficacy	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45537880.0	T	S
pharmgkb	dapsone	HLA-B	HLA-B*13:01		Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Leprosy,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N				
pharmgkb	nevirapine	CYP2B6	Q172H		HIV Infections	Metabolism/PK	P20813	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	19	41006936.0	G	W
pharmgkb	SN-38	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28			Metabolism/PK	P22309	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O				
pharmgkb	rosuvastatin	ABCG2	Q141K		Hypercholesterolemia,Myocardial Infarction	Efficacy	Q9UNQ0	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	4	88131171.0	G	Y
pharmgkb	irinotecan	UGT1A1	rs10929302		Neutropenia	Toxicity	P22309	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	2	233757136.0	G	A
pharmgkb	tacrolimus	CYP3A4	rs4646437		Kidney Transplantation,liver transplantation,Proteinuria	Metabolism/PK	P08684	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99767460.0	G	A
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		liver transplantation	Dosage	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	methazolamide	HLA-B	HLA-B*59:01		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4100.0	CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C				
pharmgkb	warfarin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13, CYP2C9*14		Atrial Fibrillation,heart valve replacement	Efficacy	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	phenprocoumon	VKORC1	rs9934438			Dosage	Q8N0U8	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31093557.0	G	M
pharmgkb	warfarin	VKORC1	rs9923231		Hemorrhage	Toxicity	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	acenocoumarol	VKORC1	rs9934438			Dosage	Q8N0U8	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	16	31093557.0	G	M
pharmgkb	tramadol	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10		Pain	Dosage	P10635	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O				
pharmgkb	warfarin	VKORC1	rs2884737			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31094233.0	A	C
pharmgkb	acenocoumarol	CYP4F2	V433M		Atrial Fibrillation	Dosage	P78329	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	19	15879621.0	C	T
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		liver transplantation	Dosage	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	salmeterol	ADRB2	R16G		Asthma	Efficacy	P07550	Drug	5152.0	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O	5	148826877.0	G	A
pharmgkb	nevirapine	CYP2B6	I328T		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P20813	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	19	41012316.0	T	C
pharmgkb	phenprocoumon	VKORC1	rs9923231		Hemorrhage,over-anticoagulation,time above therapeutic range	Toxicity	Q8N0U8	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	hmg coa reductase inhibitors	SLCO1B1	V174A		statin-related myopathy	Toxicity	Q9Y6L6	Drug Class			12	21178615.0	T	C
pharmgkb	captopril	ACE	rs1799752		Diabetes Mellitus, Type 2,Heart Failure,Pulmonary Disease, Chronic Obstructive	Efficacy	P12821	Drug	44093.0	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	bupropion	CYP2B6	CYP2B6*1, CYP2B6*2, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22, CYP2B6*30			Metabolism/PK	P20813	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C				
pharmgkb	mirtazapine	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6			Metabolism/PK	P10635	Drug	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4				
pharmgkb	rabeprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3			Metabolism/PK	P33261	Drug	5029.0	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC				
pharmgkb	methadone	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*18		Heroin Dependence,Opioid-Related Disorders	Metabolism/PK	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	acenocoumarol	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3		Hemorrhage	Toxicity	P11712	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	tacrolimus	CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22		Kidney Transplantation,Organ Transplantation	Dosage	P08684	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	warfarin	VKORC1	D36Y			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31094624.0	C	W
pharmgkb	carbamazepine	HLA-B	HLA-B*40:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	oxycodone	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7		Pain	Metabolism/PK	P10635	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O				
pharmgkb	methotrexate	MTHFR	A222V		Drug Toxicity,hematotoxicity,Leukopenia,Lymphoma,mucositis,Neoplasms,Neutropenia,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma,primary central nervous system lymphoma,Thrombocytopenia,Toxic liver disease	Toxicity	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11796321.0	G	A
pharmgkb	methotrexate	MTHFR	A222V		Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Arthritis, Rheumatoid,Drug Toxicity	Toxicity	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11796321.0	G	A
pharmgkb	sulfamethoxazole / trimethoprim	HLA-B	HLA-B*13:01, HLA-B*15:02, HLA-B*38:02		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	358641.0					
pharmgkb	isoniazid	NAT2	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6A, NAT2*6B, NAT2*6J, NAT2*6O, NAT2*7A, NAT2*7B, NAT2*7G, NAT2*12A, NAT2*13A, NAT2*14A		Tuberculosis	Metabolism/PK	Q6N069	Drug	3767.0	C1=CN=CC=C1C(=O)NN				
pharmgkb	antiepileptics	HLA-B	HLA-B*15:02		Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug Class						
pharmgkb	fentanyl	CYP3A4	rs2242480		Pain, Postoperative	Dosage	P08684	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	99763843.0	C	T
pharmgkb	tacrolimus	CYP3A4	CYP3A4*1, CYP3A4*18, CYP3A4*20, CYP3A4*22		Kidney Transplantation,laparoscopic sleeve gastrectomy,liver transplantation,lung transplantation	Metabolism/PK	P08684	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	tacrolimus	CYP3A4	rs2242480		Kidney Transplantation,liver transplantation	Metabolism/PK	P08684	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99763843.0	C	T
pharmgkb	methazolamide	HLA-C	HLA-C*01:02		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	4100.0	CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C				
pharmgkb	clopidogrel	CES1	G144E			Efficacy	Q9NZK5	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	16	55823658.0	C	T
pharmgkb	clopidogrel	CES1	G144E			Metabolism/PK	Q9NZK5	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	16	55823658.0	C	T
pharmgkb	carbamazepine	SCN1A	rs3812718		Epilepsy	Dosage	P35498	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	2	166053034.0	C	T
pharmgkb	allopurinol	HLA-C	HLA-C*03:02		Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	methotrexate	ATIC	rs4673993		Arthritis, Rheumatoid	Efficacy	P31939	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	2	215347616.0	T	M
pharmgkb	etanercept	TNF	rs1800629		Arthritis, Psoriatic,Arthritis, Rheumatoid,Crohn Disease,Inflammation,Psoriasis,Spondylitis, Ankylosing	Efficacy	Q9UNG2	Drug			6	31575254.0	G	A
pharmgkb	nevirapine	HLA-DRB1	HLA-DRB1*01:01			Toxicity	P01911	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	Platinum compounds	XRCC1	Q399R		Neoplasms	Efficacy	P18887	Drug Class			19	43551574.0	T	C
pharmgkb	erlotinib	EGFR	T790M		Adenocarcinoma,Carcinoma, Non-Small-Cell Lung,Drug Resistance,Lung Neoplasms	Efficacy	P00533	Drug	176870.0	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	7	55181378.0	C	T
pharmgkb	nicotine	CHRNA5	D398N		Tobacco Use Disorder	Toxicity	P30532	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78590583.0	G	A
pharmgkb	nevirapine	HLA-C	HLA-C*04:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Exanthema,Hypersensitivity,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	ethanol	ALDH2	E457K		Alcoholism	Toxicity	P05091	Drug	702.0	CCO	12	111803962.0	G	A
pharmgkb	aspirin	HLA-DPB1	HLA-DPB1*03:01		Asthma	Toxicity	P04440	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O				
pharmgkb	atorvastatin	APOE	R176C		Coronary Disease,Hyperlipidemias	Efficacy	P02649	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	19	44908822.0	C	T
pharmgkb	peginterferon alfa-2b,ribavirin	ITPA	P32T		Anemia,Hepatitis C, Chronic	Toxicity	Q9BY32				20	3213196.0	C	R
pharmgkb	Ace Inhibitors, Plain	XPNPEP2	rs3788853		Angioedema	Toxicity	O43895	Drug Class			X	129736814.0	C	A
pharmgkb	hydrochlorothiazide	ADD1	G460W		Essential hypertension,Hypertension	Efficacy	P35611	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	4	2904980.0	G	W
pharmgkb	gefitinib	EGFR	T790M		Carcinoma, Non-Small-Cell Lung,Drug Resistance	Efficacy	P00533	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	7	55181378.0	C	T
pharmgkb	peginterferon alfa-2b,ribavirin	ITPA	rs7270101		Anemia,Hepatitis C, Chronic	Toxicity	Q9BY32				20	3213247.0	A	C
pharmgkb	rituximab	FCGR3A	F175V		Arthritis, Rheumatoid,Neuromyelitis Optica	Efficacy	P20963	Drug			1	161544752.0	A	B
pharmgkb	pravastatin	KIF6	W170R		Coronary Disease,Myocardial Infarction	Efficacy	Q6ZMV9	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	6	39357302.0	A	G
pharmgkb	sulfamethoxazole / trimethoprim	HLA-C	HLA-C*06:02, HLA-C*07:27, HLA-C*08:01		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	358641.0					
pharmgkb	allopurinol	HLA-A	HLA-A*33:03		Drug Hypersensitivity,Stevens-Johnson Syndrome	Toxicity	P04439	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	sorafenib	EPAS1	rs7557402		Drug Toxicity	Toxicity	Q99814	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	2	46376532.0	C	R
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	CSRP3	rs983332		Arthritis, Rheumatoid	Efficacy	P50461	Drug Class			1	87666697.0	G	T
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	ARAP2	rs437943		Arthritis, Rheumatoid	Efficacy	Q96P48	Drug Class			4	35370476.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	CST5	rs6138150		Arthritis, Rheumatoid	Efficacy	P28325	Drug Class			20	23866372.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	MAFB	rs6028945		Arthritis, Rheumatoid	Efficacy	Q9Y5Q3	Drug Class			20	40192165.0	G	W
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	MAFB	rs6071980		Arthritis, Rheumatoid	Efficacy	Q9Y5Q3	Drug Class			20	40239936.0	T	C
pharmgkb	mephenytoin	CYP2C19	rs11188072			Dosage	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	10	94759304.0	C	T
pharmgkb	diuretics	ADD1	G460W		Hypertension,Myocardial Infarction	Efficacy	P35611	Drug Class			4	2904980.0	G	W
pharmgkb	clozapine	DRD3	G9S		Schizophrenia	Efficacy	P35462	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	3	114171968.0	C	T
pharmgkb	valproic acid	UGT1A10	S7A		Epilepsy	Dosage	Q9HAW8	Drug	3121.0	CCCC(CCC)C(=O)O	2	233693023.0	T	G
pharmgkb	methotrexate	SLC19A1	rs9977268		Arthritis, Rheumatoid	Efficacy	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45487373.0	C	T
pharmgkb	aspirin	PTGS2	rs20417		Coronary Artery Disease	Efficacy	P35354	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	186681189.0	C	K
pharmgkb	phenytoin	ABCB1	I1145M			Dosage	P08183	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	7	87509329.0	A	K
pharmgkb	dexamethasone,doxorubicin,vincristine	ABCB1	I1145M		Multiple Myeloma	Efficacy	P08183				7	87509329.0	A	K
pharmgkb	dicloxacillin	ABCB1	I1145M			Other	P08183	Drug	18381.0	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	7	87509329.0	A	K
pharmgkb	capecitabine	ABCB1	I1145M		Neoplasms	Toxicity	P08183	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	7	87509329.0	A	K
pharmgkb	tenofovir	ABCC2	V1188E		HIV Infections	Toxicity	Q5T2W1	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	10	99836239.0	T	A
pharmgkb	phenytoin	ABCB1	rs1128503			Other	P08183	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	7	87550285.0	A	G
pharmgkb	cisplatin,cyclophosphamide	ERCC1	rs11615		Ovarian Neoplasms	Toxicity	P07992				19	45420395.0	A	G
pharmgkb	cisplatin,cyclophosphamide	GSTP1	I105V		Ovarian Neoplasms	Efficacy	P09211				11	67585218.0	A	G
pharmgkb	fluorouracil,leucovorin,oxaliplatin	ERCC2	rs13181		Colorectal Neoplasms	Efficacy,Toxicity	P18074				19	45351661.0	T	R
pharmgkb	dexamethasone,doxorubicin,vincristine	ABCB1	S893A		Multiple Myeloma	Efficacy	P08183				7	87531302.0	A	Y
pharmgkb	doxorubicin	ABCB1	S893A		Breast Neoplasms	Other	P08183	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	7	87531302.0	A	Y
pharmgkb	digoxin	ABCB1	S893A			Other	P08183	Drug	30322.0	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	7	87531302.0	A	Y
pharmgkb	Ace Inhibitors, Plain	PTGER3	rs11209716		Cough,Hypertension	Toxicity	P43115	Drug Class			1	70911967.0	T	C
pharmgkb	Antivirals for treatment of HIV infections, combinations,ritonavir	APOE	R176C		HIV Infections,Hypertriglyceridemia	Toxicity	P02649				19	44908822.0	C	T
pharmgkb	docetaxel	SLCO1B3	rs11045585		Neoplasms	Toxicity	F5H094	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	12	20892760.0	A	G
pharmgkb	Ace Inhibitors, Plain	MME	rs2016848		Cough,Hypertension	Toxicity	P39900	Drug Class			3	155140896.0	G	A
pharmgkb	risperidone	DRD2	rs1799978			Toxicity	P14416	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	11	113475629.0	T	C
pharmgkb	tamoxifen	ESR2	rs4986938			Toxicity	Q92731	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	14	64233098.0	C	T
pharmgkb	Ace Inhibitors, Plain	BDKRB2	rs8012552		Cough,Hypertension	Toxicity	P30411	Drug Class			14	96222430.0	C	T
pharmgkb	warfarin	STX4	rs10871454			Dosage	Q12846	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31036758.0	C	T
pharmgkb	trastuzumab	ERBB2	I655V		Breast Neoplasms,Drug Toxicity	Toxicity	P04626	Drug			17	39723335.0	A	K
pharmgkb	warfarin	VKORC1	V29L			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31094645.0	C	A
pharmgkb	warfarin	VKORC1	V45A			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31094596.0	A	G
pharmgkb	warfarin	VKORC1	R58G			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31094558.0	T	C
pharmgkb	warfarin	VKORC1	L128R			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31091243.0	A	C
pharmgkb	paclitaxel	ABCB1	S400N			Other	P08183	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	7	87550493.0	C	W
pharmgkb	nevirapine	HLA-C	rs9461684		HIV Infections	Toxicity	P10321	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	6	31285667.0	C	T
pharmgkb	fluvastatin	SLCO1B1	P155T		Hypercholesterolemia	Efficacy	Q9Y6L6	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	12	21176879.0	C	W
pharmgkb	tamoxifen	ESR1	rs9340799			Toxicity	P03372	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	6	151842246.0	A	G
pharmgkb	antidepressants,mirtazapine,venlafaxine	TPH2	rs10879346		Depressive Disorder, Major	Efficacy	Q8IWU9				12	71958055.0	C	T
pharmgkb	methotrexate	ADORA2A	rs5760410		Arthritis, Rheumatoid	Toxicity	P29274	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	22	24419438.0	G	M
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	MOB3B	rs868856		Arthritis, Rheumatoid	Efficacy	Q86TA1	Drug Class			9	27489253.0	A	G
pharmgkb	Platinum compounds,taxanes	ABCB1	S893A		Ovarian Neoplasms	Toxicity	P08183				7	87531302.0	A	Y
pharmgkb	topoisomerase I inhibitors	EGFR	rs712829		Neoplasms	Efficacy	P00533	Drug Class			7	55019062.0	G	Y
pharmgkb	geldanamycin	EGFR	rs712829		Neoplasms	Efficacy	P00533	Drug	46936377.0	C[C@@H]1C[C@H]([C@@H]([C@@H](/C=C(\[C@H]([C@@H](/C=C\C=C(/C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)\C)OC)OC(=O)N)/C)C)O)OC	7	55019062.0	G	Y
pharmgkb	methamphetamine	DTNBP1	rs2619538		Psychotic Disorders	Toxicity	Q96EV8	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	6	15664978.0	A	T
pharmgkb	montelukast	ALOX5	rs2115819		Asthma	Efficacy	P09917	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	10	45405641.0	A	G
pharmgkb	montelukast	LTA4H	rs2660845		Asthma	Efficacy	P09960	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	12	96044775.0	G	M
pharmgkb	olanzapine,risperidone	HTR2A	rs6313		Alzheimer Disease	Efficacy	P28223				13	46895805.0	G	A
pharmgkb	olanzapine	ADRB3	W64R		Schizophrenia,Weight gain	Toxicity	P13945	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	8	37966280.0	A	G
pharmgkb	olanzapine,perphenazine	RGS4	rs2842030		Schizophrenia	Efficacy	P49798				1	163070705.0	G	W
pharmgkb	risperidone	RGS4	rs2842030		Schizophrenia	Efficacy	P49798	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	1	163070705.0	G	W
pharmgkb	olanzapine	LEP	rs4731426		Schizophrenia	Toxicity	P41159	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	7	128242017.0	G	H
pharmgkb	Platinum compounds,taxanes	ABCB1	S893A		Ovarian Neoplasms	Toxicity	P08183				7	87531302.0	A	Y
pharmgkb	cetuximab	CCND1	rs9344		Colorectal Neoplasms	Efficacy	P24385	Drug			11	69648142.0	G	A
pharmgkb	clozapine	DTNBP1	rs742105		Schizophrenia	Efficacy	Q96EV8	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	6	15572843.0	C	T
pharmgkb	cyclosporine	ABCB1	S893A		Colitis, Ulcerative	Efficacy	P08183	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	87531302.0	A	Y
pharmgkb	risperidone	ABCB1	rs1128503		Autistic Disorder	Efficacy	P08183	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	7	87550285.0	A	G
pharmgkb	amiodarone	KCNH2	R444G		Torsades de Pointes	Toxicity	Q12809	Drug	2157.0	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	7	150950216.0	G	M
pharmgkb	methotrexate	GGH	T151I		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q92820	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	8	63026205.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	C9orf72	rs774359		Arthritis, Rheumatoid	Efficacy	Q96LT7	Drug Class			9	27561051.0	T	C
pharmgkb	doxorubicin	CBR3	C4S		Breast Neoplasms,Neutropenia	Efficacy,Toxicity	O75828	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	21	36135203.0	G	M
pharmgkb	daunorubicin	NRP2	rs10932125		Drug Toxicity	Other	O60462	Drug	30323.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O	2	205787576.0	C	G
pharmgkb	paclitaxel	CYP3A	T185S		Carcinoma, Non-Small-Cell Lung,Neoplasms	Dosage	Q9HB55	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	7	99768470.0	G	C
pharmgkb	risperidone	RGS4	rs951439		Schizophrenia	Efficacy	P49798	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	1	163063901.0	C	K
pharmgkb	antipsychotics,olanzapine,perphenazine,quetiapine,ziprasidone	RGS4	rs951439		Schizophrenia	Efficacy	P49798				1	163063901.0	C	K
pharmgkb	propofol	UGT1A9	D256N			Toxicity	O60656	Drug	4943.0	CC(C)C1=C(C(=CC=C1)C(C)C)O	2	233672700.0	G	A
pharmgkb	prednisone,tacrolimus	ABCB1	I1145M		Organ Transplantation,Transplantation	Other	P08183				7	87509329.0	A	K
pharmgkb	carbamazepine	BAG6	rs750332			Toxicity	P46379	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	6	31639273.0	C	T
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	C9orf72	rs3849942		Arthritis, Rheumatoid	Efficacy	Q96LT7	Drug Class			9	27543283.0	T	M
pharmgkb	erlotinib	EGFR	rs712829		Neoplasms	Efficacy	P00533	Drug	176870.0	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	7	55019062.0	G	Y
pharmgkb	rofecoxib	PTGS2	rs20417			Efficacy	P35354	Drug	5090.0	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3	1	186681189.0	C	K
pharmgkb	sildenafil	ACE	rs4343		Erectile Dysfunction	Efficacy	P12821	Drug	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	17	63488670.0	G	A
pharmgkb	acenocoumarol	CYP2C9	rs4086116			Dosage	P11712	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	10	94947445.0	C	T
pharmgkb	amlodipine,chlorthalidone	NPPA	rs5065		Cardiovascular Diseases,Coronary Disease,Stroke	Efficacy	Q5BKX8				1	11846011.0	A	G
pharmgkb	Beta Blocking Agents	PPARA	rs4253778		Coronary Disease	Efficacy	Q07869	Drug Class			22	46234737.0	G	Y
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	MOB3B	rs2814707		Arthritis, Rheumatoid	Efficacy	Q86TA1	Drug Class			9	27536399.0	C	K
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	GBP6	rs928655		Arthritis, Rheumatoid	Efficacy	Q6ZN66	Drug Class			1	89384015.0	G	M
pharmgkb	anthracyclines and related substances	CAT	rs10836235		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P04040	Drug Class			11	34439157.0	C	K
pharmgkb	repaglinide	SLCO1B1	N130H			Other	Q9Y6L6	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	12	21176804.0	A	K
pharmgkb	paclitaxel	CYP2C8	R139K			Other	P10632	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	10	95067273.0	C	W
pharmgkb	paclitaxel	CYP2C8	K297R			Other	P10632	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	10	95038992.0	T	C
pharmgkb	fluvoxamine,milnacipran,paroxetine	HTR1A	rs10042486		Depressive Disorder, Major	Efficacy	P08908				5	63965502.0	C	T
pharmgkb	haloperidol	DTNBP1	rs909706		Schizophrenia	Efficacy	Q96EV8	Drug	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	6	15660640.0	T	C
pharmgkb	iloperidone	NRG3	rs4933824		Acquired Long QT Syndrome (aLQTS)	Toxicity	P56975	Drug	71360.0		10	82059369.0	T	G
pharmgkb	iloperidone	NUBPL	rs7142881		Acquired Long QT Syndrome (aLQTS)	Toxicity	Q8TB37	Drug	71360.0		14	31624342.0	G	A
pharmgkb	iloperidone	CELF4	rs4799915		Acquired Long QT Syndrome (aLQTS)	Toxicity	Q9BZC1	Drug	71360.0		18	37348676.0	C	T
pharmgkb	iloperidone	CERKL	rs993648		Acquired Long QT Syndrome (aLQTS)	Toxicity	Q49MI3	Drug	71360.0		2	181591267.0	C	T
pharmgkb	verapamil	NOS1AP	rs10918594		Acquired Long QT Syndrome (aLQTS)	Toxicity	O75052	Drug	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	1	162060898.0	C	G
pharmgkb	verapamil	NOS1AP	rs10494366		Acquired Long QT Syndrome (aLQTS)	Toxicity	O75052	Drug	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	1	162115895.0	G	T
pharmgkb	Measles vaccines	TLR3	L412V			Efficacy	O15455	Drug Class			4	186082920.0	C	K
pharmgkb	methamphetamine	PICK1	rs2076369		Psychotic Disorders,Substance-Related Disorders	Toxicity	Q9NRD5	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	22	38067645.0	T	R
pharmgkb	methamphetamine	DTNBP1	rs3213207		Psychotic Disorders	Toxicity	Q96EV8	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	6	15627871.0	T	C
pharmgkb	docetaxel,thalidomide	CHST3	rs4148945		Prostatic Neoplasms	Efficacy,Toxicity	Q7LGC8				10	72009832.0	C	T
pharmgkb	docetaxel,thalidomide	CHST3	rs4148943		Prostatic Neoplasms	Efficacy	Q7LGC8				10	72009749.0	C	T
pharmgkb	docetaxel	PIK3CA	rs870995		Carcinoma, Non-Small-Cell Lung	Dosage	P42336	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	3	179195218.0	C	A
pharmgkb	antipsychotics	CLCN6	A222V		Schizophrenia	Toxicity	P51797	Drug Class			1	11796321.0	G	A
pharmgkb	Bisphosphonates,clodronate,etidronic acid,risedronate,tiludronate	IL1B	rs16944		Osteitis Deformans	Efficacy	P01584				2	112837290.0	A	G
pharmgkb	cyclophosphamide	CYP2B6	K262R		Transplantation	Toxicity	P20813	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	19	41009358.0	A	G
pharmgkb	risperidone	DRD3	G9S		Autistic Disorder	Efficacy	P35462	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3	114171968.0	C	T
pharmgkb	risperidone	HTR2A	rs6311		Autistic Disorder	Efficacy	P28223	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	13	46897343.0	C	T
pharmgkb	methotrexate	TYMS	rs2853539		Arthritis, Rheumatoid	Efficacy	P04818	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	18	659829.0	A	K
pharmgkb	risperidone	DRD3	rs167771		Bipolar Disorder,Schizophrenia	Toxicity	P35462	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3	114157428.0	G	W
pharmgkb	fluorouracil	GSTP1	I105V		Rectal Neoplasms	Toxicity	P09211	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	11	67585218.0	A	G
pharmgkb	carboplatin,paclitaxel	DSCAM	rs9981861		Carcinoma, Non-Small-Cell Lung,Neoplasms	Efficacy	O60469				21	40043117.0	T	C
pharmgkb	doxorubicin	ABCC2	C1515Y		Lymphoma, Non-Hodgkin	Toxicity	Q5T2W1	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	10	99851537.0	G	A
pharmgkb	docetaxel,thalidomide	CHST3	rs730720		Prostatic Neoplasms	Efficacy	Q7LGC8				10	72013004.0	C	T
pharmgkb	docetaxel,thalidomide	PPARD	rs6922548		Prostatic Neoplasms	Efficacy	Q03181				6	35385746.0	A	G
pharmgkb	docetaxel,thalidomide	ABCC6	R1268Q		Prostatic Neoplasms	Toxicity	O95255				16	16157742.0	C	T
pharmgkb	docetaxel,thalidomide	PPARD	rs1883322		Prostatic Neoplasms	Efficacy	Q03181				6	35402029.0	C	W
pharmgkb	docetaxel,thalidomide	CHST3	rs12418		Prostatic Neoplasms	Efficacy	Q7LGC8				10	72013256.0	G	A
pharmgkb	Platinum compounds	CD3EAP	Q506K		Ovarian Neoplasms	Efficacy	O15446	Drug Class			19	45409478.0	C	D
pharmgkb	antidepressants,citalopram,fluoxetine	SERPINE1	rs2227631		Depressive Disorder, Major	Efficacy	Q8NC51				7	101126257.0	A	G
pharmgkb	cyclophosphamide	CYP3A4	rs2740574		Breast Neoplasms	Toxicity	P08684	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	7	99784473.0	C	T
pharmgkb	pramipexole	DRD3	G9S		Parkinson Disease	Efficacy	P35462	Drug	59868.0	CCCN[C@@H]1CCC2=C(C1)SC(=N2)N	3	114171968.0	C	T
pharmgkb	rifampin	NR1I2	rs2472677			Other	O75469	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	3	119799570.0	C	T
pharmgkb	risperidone	COMT	rs165599		Schizophrenia	Efficacy	P21964	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	22	19969258.0	G	A
pharmgkb	risperidone	GRM3	rs724226		Schizophrenia	Efficacy	Q14832	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	7	86696058.0	A	B
pharmgkb	ritonavir	APOC3	rs5128		HIV Infections,Hyperlipidemias	Toxicity	P02656	Drug	392622.0	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	11	116832924.0	G	C
pharmgkb	rosiglitazone	LPIN1	rs10192566		Diabetes Mellitus, Type 2	Efficacy	Q14693	Drug	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	2	11750302.0	C	G
pharmgkb	sulfonamides, urea derivatives	TCF7L2	rs12255372		Diabetes Mellitus, Type 2	Efficacy	P35222	Drug Class			10	113049143.0	G	W
pharmgkb	montelukast	ABCC1	rs119774		Asthma	Efficacy	P33527	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	16	15992976.0	C	T
pharmgkb	methotrexate	ABCC1	T1337A		Psoriasis	Efficacy	P33527	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	16	16134392.0	A	G
pharmgkb	methotrexate	ABCC1	rs2238476		Psoriasis	Efficacy,Toxicity	P33527	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	16	16120015.0	G	A
pharmgkb	methotrexate	ABCG2	rs17731538		Psoriasis	Efficacy	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88134227.0	G	A
pharmgkb	methotrexate	ABCC1	rs246240		Drug Toxicity,Psoriasis	Toxicity	P33527	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	16	16025167.0	A	G
pharmgkb	methotrexate	ABCG2	rs13120400		Psoriasis	Efficacy	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88112375.0	T	C
pharmgkb	irbesartan	APOB	T98I		Hypertension	Efficacy	P04114	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	2	21041028.0	G	A
pharmgkb	atorvastatin,pravastatin,simvastatin	HTR3B	rs2276307		Myalgia unspecified	Toxicity	O95264				11	113933165.0	A	G
pharmgkb	caffeine	CYP1A2	rs762551		Myocardial Infarction	Toxicity	P05177	Drug	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	15	74749576.0	C	A
pharmgkb	mephenytoin	CYP2C19	rs12248560			Dosage	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	10	94761900.0	C	W
pharmgkb	methotrexate	FPGS	rs1544105		Arthritis, Rheumatoid	Efficacy	Q05932	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	9	127800446.0	C	T
pharmgkb	nitrous oxide	MTHFR	A222V			Toxicity	P42898	Drug			1	11796321.0	G	A
pharmgkb	paclitaxel	CYP2C8	rs1113129			Toxicity	P10632	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	10	95051288.0	G	M
pharmgkb	atorvastatin,hmg coa reductase inhibitors,pravastatin,simvastatin	HTR7	rs1935349		Myalgia unspecified	Toxicity	P34969				10	90834586.0	C	T
pharmgkb	methotrexate	NALCN	rs7992226		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Other	Q8IZF0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	13	101145489.0	A	G
pharmgkb	methotrexate	ARID5B	rs10821936		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Other	Q14865	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	61963818.0	C	T
pharmgkb	methotrexate	MTHFR	F435L		Arthritis, Rheumatoid,Drug Toxicity	Toxicity	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11794400.0	G	A
pharmgkb	methotrexate	GGH	C6R		Arthritis, Rheumatoid	Efficacy	Q92820	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	8	63038753.0	A	G
pharmgkb	antipsychotics,clozapine,olanzapine	DRD2	rs1079598		Schizophrenia	Toxicity	P14416				11	113425552.0	A	G
pharmgkb	Antihypertensives And Diuretics In Combination	NOS3	rs2070744			Efficacy	P29474	Drug Class			7	150992991.0	C	T
pharmgkb	antidepressants,desipramine,fluoxetine	BDNF	rs61888800		Depression,Depressive Disorder, Major	Efficacy	P23560				11	27700731.0	G	T
pharmgkb	repaglinide	TCF7L2	rs290487		Diabetes Mellitus, Type 2	Efficacy	P35222	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	10	113149972.0	C	T
pharmgkb	doxorubicin	ABCC2	V1188E		Arrhythmias, Cardiac,Drug Toxicity,Lymphoma, Non-Hodgkin	Toxicity	Q5T2W1	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	10	99836239.0	T	A
pharmgkb	doxorubicin	ABCC1	G671V		Arrhythmias, Cardiac,Drug Toxicity,Lymphoma, Non-Hodgkin	Toxicity	P33527	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	16	16079375.0	G	T
pharmgkb	phenytoin	EPHX1	Y113H		Congenital Abnormalities,Craniofacial Abnormalities	Toxicity	P07099	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	1	225831932.0	T	C
pharmgkb	phenytoin	EPHX1	H139R		Congenital Abnormalities,Craniofacial Abnormalities	Toxicity	P07099	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	1	225838705.0	A	K
pharmgkb	etoposide	SLIT1	rs2784917			Toxicity	O75093	Drug	36462.0	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	10	97169185.0	A	G
pharmgkb	fexofenadine	ABCB1	I1145M			Dosage	P08183	Drug	3348.0	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O	7	87509329.0	A	K
pharmgkb	docetaxel,thalidomide	PPARD	rs7769719		Prostatic Neoplasms	Efficacy	Q03181				6	35394748.0	G	M
pharmgkb	docetaxel,thalidomide	CYP4B1	R10W		Prostatic Neoplasms	Toxicity	P13584				1	46813503.0	C	T
pharmgkb	docetaxel,thalidomide	CHST3	rs4148950		Prostatic Neoplasms	Efficacy,Toxicity	Q7LGC8				10	72011948.0	G	A
pharmgkb	docetaxel,thalidomide	CHST3	rs4148947		Prostatic Neoplasms	Efficacy	Q7LGC8				10	72010359.0	T	C
pharmgkb	docetaxel,thalidomide	PPARD	rs3734254		Prostatic Neoplasms	Efficacy	Q03181				6	35427233.0	C	T
pharmgkb	docetaxel,thalidomide	SLC10A2	rs2301159		Prostatic Neoplasms	Toxicity	Q12908				13	103045378.0	G	A
pharmgkb	docetaxel,thalidomide	SPG7	T503A		Prostatic Neoplasms	Toxicity	Q9UQ90				16	89546715.0	A	G
pharmgkb	docetaxel,thalidomide	ATP7A	V767L		Prostatic Neoplasms	Toxicity	Q04656				X	78013005.0	G	C
pharmgkb	docetaxel,thalidomide	PPARD	rs2016520		Prostatic Neoplasms	Efficacy	Q03181				6	35411001.0	C	T
pharmgkb	docetaxel,thalidomide	NAT2	G286E		Prostatic Neoplasms	Toxicity	Q6N069				8	18400860.0	G	A
pharmgkb	docetaxel,thalidomide	SULT1C4	D5E		Prostatic Neoplasms	Efficacy	O75897				2	108378352.0	C	G
pharmgkb	docetaxel,thalidomide	RPL13	R688Q		Prostatic Neoplasms	Toxicity	P26373				16	89553920.0	G	A
pharmgkb	docetaxel	PRDX4	rs518329		Carcinoma, Non-Small-Cell Lung	Dosage	Q13162	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	X	23677119.0	T	C
pharmgkb	docetaxel	EPHX1	H139R		Carcinoma, Non-Small-Cell Lung	Dosage	P07099	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	1	225838705.0	A	K
pharmgkb	docetaxel	XRCC4	rs1382368		Carcinoma, Non-Small-Cell Lung	Dosage	Q13426	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	5	83155256.0	C	T
pharmgkb	paroxetine	ADM	rs11042725		Depressive Disorder, Major	Efficacy	Q7Z4H4	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	11	10303778.0	C	A
pharmgkb	antidepressants,citalopram,fluoxetine	SERPINE1	rs1799889		Depressive Disorder, Major	Efficacy	Q8NC51				7	101126430.0	A	G
pharmgkb	clodronate	VDR	rs731236		Osteitis Deformans	Efficacy	P11473	Drug	25419.0	C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl	12	47844974.0	A	G
pharmgkb	methotrexate	ADORA2A	rs3761422		Arthritis, Rheumatoid	Toxicity	P29274	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	22	24430704.0	T	C
pharmgkb	methotrexate	ADORA2A	rs2267076		Arthritis, Rheumatoid	Toxicity	P29274	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	22	24434627.0	T	C
pharmgkb	cyclophosphamide	CYP2B6	R22C		Cystitis,Transplantation	Toxicity	P20813	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	19	40991369.0	C	T
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil,methotrexate	NOS3	rs2070744		Breast Neoplasms	Efficacy	P29474				7	150992991.0	C	T
pharmgkb	azathioprine	DDRGK1	P32T		Inflammatory Bowel Diseases	Efficacy	O94874	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	20	3213196.0	C	R
pharmgkb	erlotinib	EGFR	rs712829		Neoplasms	Toxicity	P00533	Drug	176870.0	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	7	55019062.0	G	Y
pharmgkb	budesonide,flunisolide,fluticasone propionate,glucocorticoids,nedocromil,triamcinolone	GLCCI1	rs37973		Asthma	Efficacy	Q6P1L5				7	7968245.0	G	M
pharmgkb	verapamil	KCNIP1	E65K		Hypertension	Efficacy	Q9NZI2	Drug	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	5	170383792.0	C	T
pharmgkb	duloxetine	DRD3	rs963468		Anxiety Disorders	Efficacy	P35462	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	114144040.0	G	A
pharmgkb	leflunomide	ESR1	rs9340799		Arthritis, Rheumatoid	Efficacy	P03372	Drug	3899.0	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	6	151842246.0	A	G
pharmgkb	conjugated estrogens,medroxyprogesterone	ESR1	rs9340799			Efficacy	P03372				6	151842246.0	A	G
pharmgkb	atenolol,verapamil	CACNA1C	rs1051375		Coronary Artery Disease,Hypertension	Efficacy	P54284				12	2679713.0	G	A
pharmgkb	metoprolol	GRK4	A142V		Hypertension,Kidney Diseases,Nephrosclerosis	Efficacy	P32298	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	4	3004316.0	C	D
pharmgkb	tenofovir	ABCC10	rs9349256			Toxicity	Q5T3U5	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	6	43436773.0	G	A
pharmgkb	interferon alfa-2a, recombinant,peginterferon alfa-2b	IDO1	rs9657182		Hepatitis C, Chronic	Toxicity	P14902				8	39908329.0	C	K
pharmgkb	interferon beta-1a,interferon beta-1b	HLA-DQA1	rs9272105			Efficacy	P01909				6	32632222.0	G	A
pharmgkb	Antiinflammatory agents, non-steroids	AGT	rs943580		Acute coronary syndrome	Toxicity	Q9BYV1	Drug Class			1	230701298.0	G	A
pharmgkb	amoxicillin,clavulanate	HLA-DQB1	F41Y		Drug Toxicity	Toxicity	P01920				6	32665055.0	A	Y
pharmgkb	coumarin	CYP2A6	L160H			Other	P11509	Drug			19	40848628.0	A	T
pharmgkb	nicotine	CYP2A6	rs28399433			Other	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40850474.0	A	B
pharmgkb	valproic acid	UGT1A10	T181A		Epilepsy	Dosage	Q9HAW8	Drug	3121.0	CCCC(CCC)C(=O)O	2	233693545.0	A	G
pharmgkb	antipsychotics	COMT	V158M		tardive dyskinesia	Toxicity	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	coumarin	CYP2A6	rs28399433			Other	P11509	Drug			19	40850474.0	A	B
pharmgkb	cyclophosphamide,doxorubicin	CYP2B6	Q172H		Breast Neoplasms	Dosage	P20813				19	41006936.0	G	W
pharmgkb	nicotine	CYP2A6	R485L			Other	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40843827.0	C	R
pharmgkb	Antihypertensives,Antihypertensives And Diuretics In Combination,diuretics	NOS3	rs2070744		Hypertension	Efficacy	P29474				7	150992991.0	C	T
pharmgkb	cyclophosphamide	CYP2B6	Q172H		Hepatic Veno-Occlusive Disease,Transplantation	Toxicity	P20813	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	19	41006936.0	G	W
pharmgkb	methotrexate	GGH	rs3758149		Arthritis, Rheumatoid	Efficacy	Q92820	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	8	63039169.0	G	A
pharmgkb	antipsychotics	COMT	V158M		Schizophrenia	Other	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	efavirenz	CYP3A	rs2740574		HIV Infections	Other	Q9HB55	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	7	99784473.0	C	T
pharmgkb	repaglinide	CYP2C8	K297R			Other	P10632	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	10	95038992.0	T	C
pharmgkb	atorvastatin,hmg coa reductase inhibitors,rosuvastatin	COQ2	rs6535454		Muscular Diseases	Toxicity	Q96H96				4	83269878.0	A	G
pharmgkb	cerivastatin	RYR2	rs2819742		Rhabdomyolysis	Toxicity	Q92736	Drug	446156.0	CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC	1	237826822.0	A	K
pharmgkb	amiodarone	NOS1AP	rs10919035		Long QT Syndrome	Toxicity	O75052	Drug	2157.0	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	1	162274222.0	C	T
pharmgkb	methotrexate	SHMT1	L474F		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P34896	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	17	18328782.0	G	A
pharmgkb	calcium channel blockers,nitrendipine	KCNH2	rs1137617		Essential hypertension	Efficacy	Q12809				7	150951110.0	A	B
pharmgkb	repaglinide	CYP2C8	R139K			Dosage	P10632	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	10	95067273.0	C	W
pharmgkb	venlafaxine	GABRQ	I478L		Depressive Disorder, Major	Efficacy	Q9UN88	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	X	152652814.0	A	Y
pharmgkb	metoprolol	CYP2D6	rs5030655			Efficacy	P10635	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	22	42129084.0	A	-
pharmgkb	mirtazapine,venlafaxine	TPH2	rs1487278		Depression	Efficacy	Q8IWU9				12	72007071.0	T	C
pharmgkb	citalopram,fluoxetine	GSK3B	rs334558		Depressive Disorder, Major	Efficacy	P49841				3	120094435.0	A	G
pharmgkb	lithium	CACNG2	rs2284017		Bipolar Disorder	Efficacy	Q9Y698	Drug	28486.0	[Li+]	22	36700882.0	T	C
pharmgkb	metoprolol	CYP2D6	rs3892097			Efficacy	P10635	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	22	42128945.0	C	T
pharmgkb	antidepressants	FKBP5	rs3800373		Depression	Efficacy	Q13451	Drug Class			6	35574699.0	C	A
pharmgkb	zoledronate	FDPS	rs2297480		Neoplasms,Osteonecrosis	Toxicity	P14324	Drug	68740.0	C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O	1	155309691.0	T	G
pharmgkb	antidepressants,Selective serotonin reuptake inhibitors,venlafaxine	GABRA6	rs1992647		Depressive Disorder, Major	Efficacy	Q16445				5	161684168.0	G	A
pharmgkb	antidepressants,Selective serotonin reuptake inhibitors,venlafaxine	GABRP	L7V		Depressive Disorder, Major	Efficacy	O00591				5	170788634.0	T	C
pharmgkb	antidepressants,Selective serotonin reuptake inhibitors,venlafaxine	GRIA3	rs3761555		Depressive Disorder, Major	Efficacy	P42263				X	123182584.0	T	C
pharmgkb	antidepressants,Selective serotonin reuptake inhibitors,venlafaxine	GRIA3	rs3761554		Depressive Disorder, Major	Efficacy	P42263				X	123183391.0	T	C
pharmgkb	antidepressants,Selective serotonin reuptake inhibitors,venlafaxine	GRIA3	rs502434		Depressive Disorder, Major	Efficacy	P42263				X	123403426.0	T	C
pharmgkb	antidepressants,benzodiazepine derivatives,mirtazapine,Selective serotonin reuptake inhibitors	GAL	rs948854		Depressive Disorder, Major	Efficacy	P07902				11	68682735.0	C	T
pharmgkb	escitalopram,nortriptyline	BDNF	rs962369		Depressive Disorder, Major	Toxicity	P23560				11	27712873.0	T	C
pharmgkb	cangrelor	P2RY12	rs9859552			Efficacy	Q9H244	Drug	9854012.0	CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F	3	151373208.0	G	W
pharmgkb	hydroxyurea	MAP3K5	rs9376230		Thalassemia	Efficacy	Q99683	Drug	3657.0	C(=O)(N)NO	6	136781227.0	C	A
pharmgkb	hydroxyurea	MAP3K5	rs9483947		Thalassemia	Efficacy	Q99683	Drug	3657.0	C(=O)(N)NO	6	136784262.0	C	T
pharmgkb	lithium	CRY1	rs8192440		Bipolar Disorder	Efficacy	Q16526	Drug	28486.0	[Li+]	12	107001328.0	A	K
pharmgkb	amitriptyline,citalopram,paroxetine,venlafaxine	ABCB1	rs7787082		Depressive Disorder	Efficacy	P08183				7	87527735.0	G	A
pharmgkb	lithium	DRD1	rs4532		Bipolar Disorder	Efficacy	P21728	Drug	28486.0	[Li+]	5	175443147.0	C	T
pharmgkb	lithium	GSK3B	rs334558		Bipolar Disorder	Efficacy	P49841	Drug	28486.0	[Li+]	3	120094435.0	A	G
pharmgkb	lithium	OR52J2P	rs2499984		Bipolar Disorder	Efficacy		Drug	28486.0	[Li+]	11	5040311.0	A	G
pharmgkb	lithium	CACNG2	rs2284018		Bipolar Disorder	Efficacy	Q9Y698	Drug	28486.0	[Li+]	22	36701519.0	C	K
pharmgkb	cisplatin,cyclophosphamide	GSTM3	rs1799735		Ovarian Neoplasms	Toxicity	P21266							
pharmgkb	mycophenolate mofetil	IL12A	rs568408		Kidney Transplantation	Toxicity	P29459	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	3	159995680.0	G	A
pharmgkb	pitrakinra	IL4R	rs8832		Asthma	Efficacy	P24394	Drug			16	27364466.0	A	G
pharmgkb	methadone	BDNF	rs7934165		Heroin Dependence,Opioid-Related Disorders	Dosage	P23560	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	11	27710436.0	G	A
pharmgkb	methadone	BDNF	rs1491850		Heroin Dependence,Opioid-Related Disorders	Dosage	P23560	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	11	27728178.0	T	C
pharmgkb	lithium	NR1D1	rs2314339		Bipolar Disorder	Efficacy	P20393	Drug	28486.0	[Li+]	17	40096959.0	C	T
pharmgkb	mycophenolate mofetil	IMPDH1	rs2278294		Kidney Transplantation,Organ Transplantation	Efficacy	P20839	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	7	128400645.0	C	T
pharmgkb	methadone	NTRK2	rs2120266		Heroin Dependence,Opioid-Related Disorders	Dosage	Q16620	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	9	84841436.0	G	A
pharmgkb	artesunate,primaquine,pyrimethamine,sulfadoxine	G6PD	V68M			Toxicity	P11413				X	154536002.0	C	T
pharmgkb	methadone	NTRK2	rs2289658		Heroin Dependence,Opioid-Related Disorders	Dosage	Q16620	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	9	84948455.0	T	C
pharmgkb	mycophenolate mofetil	IMPDH1	rs2278294		Leukopenia	Toxicity	P20839	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	7	128400645.0	C	T
pharmgkb	methadone	NTRK2	rs4358872		Heroin Dependence,Opioid-Related Disorders	Dosage	Q16620	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	9	84986054.0	T	G
pharmgkb	methadone	NTRK2	rs1948308		Heroin Dependence,Opioid-Related Disorders	Dosage	Q16620	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	9	85001342.0	G	A
pharmgkb	methadone	NTRK2	rs2378676		Heroin Dependence,Opioid-Related Disorders	Dosage	Q16620	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	9	85004508.0	A	Y
pharmgkb	methadone	NTRK2	rs4877900		Heroin Dependence,Opioid-Related Disorders	Dosage	Q16620	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	9	85017403.0	C	K
pharmgkb	methadone	ANKK1	A239T		Heroin Dependence,Opioid-Related Disorders	Dosage	Q8NFD2	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	11	113396099.0	G	A
pharmgkb	methadone	DRD2	rs2283265		Heroin Dependence,Opioid-Related Disorders	Dosage	P14416	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	11	113414814.0	C	A
pharmgkb	methadone	NGF	rs2239622		Heroin Dependence,Opioid-Related Disorders	Dosage	P01138	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	1	115295088.0	A	K
pharmgkb	methadone	BDNF	rs10835210		Heroin Dependence,Opioid-Related Disorders	Dosage	P23560	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	11	27674363.0	C	R
pharmgkb	lithium	GSK3B	rs6438552		Bipolar Disorder	Efficacy	P49841	Drug	28486.0	[Li+]	3	119912967.0	A	G
pharmgkb	lithium	TPH1	rs1800532		Bipolar Disorder	Efficacy	P17752	Drug	28486.0	[Li+]	11	18026269.0	G	T
pharmgkb	cytarabine	CDA	rs532545		Leukemia, Myeloid, Acute,Neoplasms	Efficacy	Q96GN5	Drug	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	1	20588679.0	C	W
pharmgkb	cytarabine	CDA	rs532545		Leukemia, Myeloid	Toxicity	Q96GN5	Drug	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	1	20588679.0	C	W
pharmgkb	cytarabine	CDA	rs602950			Toxicity	Q96GN5	Drug	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	1	20589038.0	A	G
pharmgkb	cytarabine	CDA	rs3215400			Toxicity	Q96GN5	Drug	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	1	20589097.0	C	-
pharmgkb	nicotine	CHRNA4	rs2236196		Tobacco Use Disorder	Other	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63346204.0	G	M
pharmgkb	muraglitazar	ADRB1	G389R		Diabetes Mellitus,Edema,Hyperlipidemias	Toxicity	P08588	Drug			10	114045297.0	G	C
pharmgkb	olanzapine	GNB3	rs5443		Schizophrenia,Weight gain	Toxicity	P16520	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	12	6845711.0	C	T
pharmgkb	olanzapine	HTR2A	rs6313		Schizophrenia,Weight gain	Toxicity	P28223	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	13	46895805.0	G	A
pharmgkb	nortriptyline	ABCB1	I1145M		Depression,Depressive Disorder,Depressive Disorder, Major,Hypotension	Toxicity	P08183	Drug	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	7	87509329.0	A	K
pharmgkb	verapamil	KCNIP1	V110L		Coronary Artery Disease,Hypertension	Efficacy	Q9NZI2	Drug	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	5	170378952.0	C	K
pharmgkb	olanzapine	DRD3	G9S		Schizophrenia	Efficacy	P35462	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	3	114171968.0	C	T
pharmgkb	oxaliplatin	ABCB1	I1145M		Colorectal Neoplasms	Efficacy	P08183	Drug	6857599.0	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	7	87509329.0	A	K
pharmgkb	oxaliplatin	ABCB1	rs1128503		Colorectal Neoplasms	Efficacy	P08183	Drug	6857599.0	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	7	87550285.0	A	G
pharmgkb	nitroprusside	ACE	rs1799752			Efficacy	P12821	Drug	11963622.0	[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+4]	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	acetylcholine	ACE	rs1799752			Efficacy	P12821	Drug	187.0	CC(=O)OCC[N+](C)(C)C	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	nifedipine	SLC14A2	V750F		Hypertension	Efficacy	Q15849	Drug	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	18	45672918.0	G	W
pharmgkb	nifedipine	SLC14A2	A880T		Hypertension	Efficacy	Q15849	Drug	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	18	45682394.0	G	A
pharmgkb	nicotine	CHRNA4	S543R		Tobacco Use Disorder	Other	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63349782.0	G	M
pharmgkb	olanzapine	CYP1A2	rs762551			Efficacy	P05177	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	15	74749576.0	C	A
pharmgkb	olanzapine	HTR2A	rs7997012			Toxicity	P28223	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	13	46837850.0	A	G
pharmgkb	midazolam	CYP3A4	T185S			Other	P08684	Drug	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F	7	99768470.0	G	C
pharmgkb	nemonapride	ANKK1	E713K		Schizophrenia	Toxicity	Q8NFD2	Drug			11	113400106.0	G	A
pharmgkb	warfarin	VKORC1	rs17880887			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31099180.0	G	T
pharmgkb	nitrous oxide	MTHFR	E429A			Toxicity	P42898	Drug			1	11794419.0	T	G
pharmgkb	verapamil	ABCB1	I1145M			Other	P08183	Drug	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	7	87509329.0	A	K
pharmgkb	spironolactone	ACE	rs1799752		Heart Failure	Efficacy	P12821	Drug	5833.0	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	spironolactone	ACE	rs4343			Efficacy	P12821	Drug	5833.0	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C	17	63488670.0	G	A
pharmgkb	sumatriptan	GNB3	rs5443		Cluster Headache	Efficacy	P16520	Drug	5358.0	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C	12	6845711.0	C	T
pharmgkb	cisplatin,cyclophosphamide,doxorubicin,methotrexate,vincristine	ABCC3	rs4148416		Osteosarcoma	Efficacy	O15438				17	50676062.0	C	T
pharmgkb	paroxetine	CYP1A2	rs762551		Depressive Disorder, Major	Dosage,Toxicity	P05177	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	15	74749576.0	C	A
pharmgkb	paroxetine	BDNF	V66M		Depressive Disorder, Major	Efficacy	P23560	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	11	27658369.0	C	T
pharmgkb	prasugrel	CYP2C19	rs4244285		Acute coronary syndrome	Efficacy	P33261	Drug	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	10	94781859.0	G	M
pharmgkb	cyclosporine,mycophenolate mofetil	ABCB1	S893A		Kidney Transplantation	Efficacy	P08183				7	87531302.0	A	Y
pharmgkb	fluorouracil	WNT5B	rs2010851		Colonic Neoplasms	Other	Q9H1J7	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	12	1647476.0	C	A
pharmgkb	repaglinide	NEUROD1	T45S		Diabetes Mellitus	Efficacy	Q13562	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	2	181678728.0	T	C
pharmgkb	repaglinide	PAX4	R129W		Diabetes Mellitus	Efficacy	O43316	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	7	127614533.0	G	W
pharmgkb	bucindolol	ADRA2C	rs61767072		Heart Failure	Efficacy	P18825	Drug	51045.0	CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O	4	3767570.0	GGGGCGGGGCCG	-
pharmgkb	sulfamethoxazole	GCLC	rs761142		HIV Infections	Toxicity	P48506	Drug	5329.0	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	6	53527310.0	A	C
pharmgkb	Alkylating Agents	EGFR	rs712829		Neoplasms	Efficacy	P00533	Drug Class			7	55019062.0	G	Y
pharmgkb	paclitaxel	ABCB1	N21H			Other	P08183	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	7	87600124.0	T	C
pharmgkb	paclitaxel	ABCB1	A999S			Other	P08183	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	7	87516598.0	C	W
pharmgkb	atenolol	LDLR	rs688		Hypertension	Efficacy	P01130	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	19	11116926.0	C	T
pharmgkb	docetaxel,thalidomide	CHST3	rs1871450		Prostatic Neoplasms	Efficacy,Toxicity	Q7LGC8				10	72012256.0	G	H
pharmgkb	antipsychotics,clozapine,olanzapine	DRD2	rs6277		Schizophrenia	Toxicity	P14416				11	113412737.0	G	A
pharmgkb	tolbutamide	CYP2C9	P489S			Other	P11712	Drug	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C	10	94989020.0	C	T
pharmgkb	verapamil	ABCB1	S893A			Other	P08183	Drug	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	7	87531302.0	A	Y
pharmgkb	losartan	CYP2C9	I359L			Efficacy	P11712	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	10	94981296.0	A	S
pharmgkb	muraglitazar	REN	rs2368564		Diabetes Mellitus,Edema,Hyperlipidemias	Toxicity	P00797	Drug			1	204155737.0	C	K
pharmgkb	muraglitazar	EDN1	K198N		Diabetes Mellitus,Edema,Hyperlipidemias	Toxicity	P05305	Drug			6	12296022.0	G	T
pharmgkb	aspirin	P2RY1	rs1065776		Myocardial Infarction	Efficacy	P47900	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	3	152835839.0	C	T
pharmgkb	clomipramine,lithium,nefazodone,paroxetine,venlafaxine	ABCB1	S893A		Depression	Toxicity	P08183				7	87531302.0	A	Y
pharmgkb	lithium	NR1D1	rs2071427		Bipolar Disorder	Efficacy	P20393	Drug	28486.0	[Li+]	17	40098239.0	C	T
pharmgkb	aspirin	FSIP1	rs7179742		Asthma	Toxicity	Q8NA03	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	15	39770852.0	A	G
pharmgkb	aspirin	CEP68	G74S		Asthma	Toxicity	Q76N32	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	2	65069664.0	G	A
pharmgkb	aspirin	PPARG	rs3856806		Asthma	Toxicity	P37231	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	3	12434058.0	C	T
pharmgkb	aspirin	IL4	rs2243250		Asthma	Toxicity	P05112	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	5	132673462.0	C	T
pharmgkb	aspirin	ADORA1	rs2228079		Asthma	Toxicity	P30542	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	203129147.0	T	G
pharmgkb	aspirin	GP6	P219A		Coronary Artery Disease	Efficacy	Q86SQ4	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	19	55025227.0	G	A
pharmgkb	aspirin	FCER1G	rs11587213		Asthma	Toxicity	P30273	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	161215085.0	A	G
pharmgkb	aspirin	IL1B	rs1143627			Toxicity	P01584	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	2	112836810.0	G	A
pharmgkb	aspirin	TBXA2R	rs1131882		Asthma	Toxicity	P21731	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	19	3595925.0	G	A
pharmgkb	aspirin	ITGA2	rs1062535		Myocardial Infarction	Efficacy	P17301	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	5	53055583.0	G	A
pharmgkb	aspirin	NTRK1	rs2768759			Efficacy	P04629	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	156882671.0	A	S
pharmgkb	aspirin	HNMT	rs1050891			Toxicity	P50135	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	2	138014190.0	A	G
pharmgkb	warfarin	CYP2C9	rs9332096			Dosage	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94937118.0	C	T
pharmgkb	sunitinib	VEGFA	rs833061			Toxicity	P15692	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	6	43769749.0	C	K
pharmgkb	erythromycin	ABCC2	rs717620			Other	Q5T2W1	Drug	12560.0	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	10	99782821.0	C	T
pharmgkb	raloxifene,tamoxifen	ZNF423	rs8060157		Breast Neoplasms	Efficacy	Q2M1K9				16	49796293.0	A	G
pharmgkb	calcium	VDR	rs731236			Efficacy	P11473	Drug, Ion	271.0	[Ca+2]	12	47844974.0	A	G
pharmgkb	aspirin	F13A1	V35L			Efficacy	P50502	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	6	6318562.0	C	W
pharmgkb	citalopram,escitalopram	FKBP5	rs9380524		Depressive Disorder, Major	Efficacy	Q13451				6	35621293.0	C	W
pharmgkb	clopidogrel	CYP2B6	CYP2B6*1, CYP2B6*5			Efficacy	P20813	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3				
pharmgkb	desipramine	MC1R	V92M		Depressive Disorder, Major	Efficacy	Q01726	Drug, Metabolite	2995.0	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	16	89919532.0	G	M
pharmgkb	desipramine	MC1R	rs2228478		Depressive Disorder, Major	Efficacy	Q01726	Drug, Metabolite	2995.0	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	16	89920200.0	A	G
pharmgkb	mycophenolate mofetil	UGT1A9	M33T		Kidney Transplantation	Toxicity	O60656	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	2	233672032.0	T	M
pharmgkb	doxepin	CYP2C9	CYP2C9*1, CYP2C9*3			Efficacy	P11712	Drug	667477.0	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31				
pharmgkb	fenofibrate	PPARA	rs135543			Efficacy	Q07869	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	22	46159422.0	C	T
pharmgkb	fenofibrate	PPARA	rs135550			Efficacy	Q07869	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	22	46157339.0	T	C
pharmgkb	fluvoxamine,milnacipran,paroxetine	HTR1A	rs1364043		Depressive Disorder, Major	Efficacy	P08908				5	63955024.0	T	G
pharmgkb	antidepressants	GRIK4	rs12800734		Depressive Disorder	Efficacy	Q16099	Drug Class			11	120966045.0	G	A
pharmgkb	hydrochlorothiazide	KCNJ1	rs12795437		Diabetes Mellitus,Hypertension	Toxicity	P48048	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	11	128860981.0	G	C
pharmgkb	phenytoin	CYP2C9	rs12782374		Epilepsy	Dosage	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	10	94935594.0	G	A
pharmgkb	fluoxetine	CRHR1	rs242941		Anxiety Disorders,Depressive Disorder, Major	Efficacy	P34998	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	17	45815154.0	A	C
pharmgkb	fluvoxamine	COMT	V158M		Depressive Disorder, Major	Efficacy	P21964	Drug	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	22	19963748.0	G	A
pharmgkb	cyclosporine,mycophenolate mofetil	IL10	rs1800872		Kidney Transplantation	Efficacy	P22301				1	206773062.0	T	G
pharmgkb	mycophenolate mofetil	SLCO1B3	M233I		Kidney Transplantation	Other	F5H094	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	12	20862826.0	G	A
pharmgkb	lovastatin	CETP	rs708272			Efficacy	P11597	Drug	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	16	56962376.0	G	A
pharmgkb	pravastatin	ACE	rs1799752			Efficacy	P12821	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	fluvastatin	ACE	rs1799752		Coronary Artery Disease	Efficacy	P12821	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	atorvastatin,quinapril	ACE	rs1799752		Coronary Artery Disease	Efficacy	P12821				17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	cyclophosphamide,doxorubicin	CYP2B6	R487S		Breast Neoplasms	Toxicity	P20813				19	41016810.0	C	D
pharmgkb	olanzapine	FMO1	rs12720462			Other	Q01740	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	1	171248552.0	C	A
pharmgkb	olanzapine	FMO3	E308G			Other	P31513	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	1	171114102.0	A	G
pharmgkb	olanzapine	FMO1	rs7877			Other	Q01740	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	1	171285751.0	C	T
pharmgkb	thalidomide	ERCC1	K261R		Multiple Myeloma	Efficacy	P07992	Drug	5426.0	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	19	45408744.0	A	C
pharmgkb	thalidomide	XRCC5	rs1051685		Multiple Myeloma	Efficacy	P13010	Drug	5426.0	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	2	216205653.0	A	G
pharmgkb	warfarin	CYP2C9	rs10509680			Dosage	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94974582.0	G	T
pharmgkb	warfarin	PRSS53	rs17886199			Dosage	Q2L4Q9	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31093126.0	A	G
pharmgkb	thalidomide	GSTT1	rs4630		Multiple Myeloma	Toxicity	P30711	Drug	5426.0	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O				
pharmgkb	warfarin	CYP2C9	rs4918758			Dosage	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94937495.0	T	C
pharmgkb	warfarin	VKORC1	rs61162043			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31102913.0	A	G
pharmgkb	fluvastatin	SREBF1	rs60282872			Efficacy	P36956	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	17	17836851.0	C	-
pharmgkb	simvastatin	SCAP	V798F		Hypercholesterolemia	Efficacy	Q12770	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	3	47418189.0	C	T
pharmgkb	ABT-751	UGT1A4	P24T		Neoplasms	Other	P22310	Drug			2	233718890.0	C	W
pharmgkb	Ace Inhibitors, Plain	BDKRB2	rs8016905		Cough	Toxicity	P30411	Drug Class			14	96209596.0	A	B
pharmgkb	pravastatin	TLR4	D99G		Coronary Artery Disease	Efficacy	O00206	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	9	117713024.0	A	K
pharmgkb	folic acid,methotrexate	TLR4	D99G		Arthritis, Rheumatoid	Toxicity	O00206				9	117713024.0	A	K
pharmgkb	Ace Inhibitors, Plain	AGTR1	rs5186		Coronary Artery Disease	Efficacy,Toxicity	P30556	Drug Class			3	148742201.0	A	C
pharmgkb	pitavastatin	SLCO1B1	N130H			Other	Q9Y6L6	Drug	5282452.0		12	21176804.0	A	K
pharmgkb	Ace Inhibitors, Plain	ABO	rs495828			Toxicity	P16442	Drug Class			9	133279294.0	T	G
pharmgkb	Alkylating Agents,cisplatin	ESR1	rs2207396		Neoplasms	Toxicity	P03372				6	152061247.0	G	A
pharmgkb	amphetamine	OPRM1	rs510769			Efficacy	P35372	Drug	3007.0	C[C@@H](CC1=CC=CC=C1)N	6	154040884.0	C	T
pharmgkb	amphetamine	OPRM1	rs2281617			Other	P35372	Drug	3007.0	C[C@@H](CC1=CC=CC=C1)N	6	154166286.0	C	T
pharmgkb	antipsychotics	CYP2D6	rs5030655			Toxicity	P10635	Drug Class			22	42129084.0	A	-
pharmgkb	antipsychotics	RGS2	rs4606		Schizophrenia	Toxicity	P41220	Drug Class			1	192812042.0	C	K
pharmgkb	atenolol,verapamil	NR1H3	rs11039149		Coronary Artery Disease,Hypertension	Toxicity	Q13133				11	47255124.0	A	G
pharmgkb	atorvastatin	UGT1A3	UGT1A3*1, UGT1A3*2			Efficacy	P35503	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4				
pharmgkb	azathioprine	AOX1	N1135S		Inflammatory Bowel Diseases	Efficacy	Q06278	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	2	200661607.0	A	G
pharmgkb	bevacizumab,fluorouracil,irinotecan,leucovorin	SHMT1	L474F		Colorectal Neoplasms	Efficacy	P34896				17	18328782.0	G	A
pharmgkb	bortezomib,dexamethasone,melphalan,prednisone	CTLA4	rs4553808			Toxicity	P16410				2	203866282.0	A	G
pharmgkb	bupropion,nicotine	DRD1	rs2168631			Efficacy	P21728				5	175448999.0	G	W
pharmgkb	pravastatin	MTTP	rs1800591		Coronary Artery Disease	Efficacy	P55157	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	4	99574331.0	G	T
pharmgkb	atorvastatin	MTTP	rs1800591		Hyperlipoproteinemia Type II	Efficacy	P55157	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	4	99574331.0	G	T
pharmgkb	bupropion,nicotine	DRD1	rs11749035			Efficacy	P21728				5	175456049.0	C	T
pharmgkb	bupropion,nicotine	DRD1	rs11746641			Efficacy	P21728				5	175439088.0	T	G
pharmgkb	nortriptyline	UST	rs2500535		Depressive Disorder, Major	Efficacy	Q9Y2C2	Drug	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	6	149008131.0	A	K
pharmgkb	zidovudine	UGT2B7	rs28365062			Other	P16662	Prodrug	35370.0	CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]	4	69098553.0	A	K
pharmgkb	zidovudine	ABCC4	rs11568695		HIV Infections	Other	O15439	Prodrug	35370.0	CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]	13	95044286.0	C	T
pharmgkb	simvastatin	ABCB1	I1145M		Hypercholesterolemia,Myalgia unspecified	Toxicity	P08183	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	87509329.0	A	K
pharmgkb	atorvastatin	ABCB1	I1145M		Coronary Artery Disease,Myalgia unspecified	Toxicity	P08183	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	87509329.0	A	K
pharmgkb	losartan	AGTR1	A192T			Efficacy	P30556	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	3	148741522.0	G	A
pharmgkb	corticosteroids	DCAF4	rs7160796		Asthma	Efficacy	Q8WV16	Drug Class			14	72927906.0	G	C
pharmgkb	corticosteroids	FKBP5	rs4713916		Crohn Disease	Efficacy	Q13451	Drug Class			6	35702206.0	A	B
pharmgkb	cisplatin,cyclophosphamide	CYP2E1	rs6413432		Ovarian Neoplasms	Efficacy	P05181				10	133535040.0	T	A
pharmgkb	cisplatin,cyclophosphamide	CYP2E1	rs2070676		Ovarian Neoplasms	Efficacy,Toxicity	P05181				10	133537633.0	G	C
pharmgkb	simvastatin	ABCB1	S893A		Hypercholesterolemia,Myalgia unspecified	Toxicity	P08183	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	87531302.0	A	Y
pharmgkb	clozapine	CYP1A2	R456H			Other	P05177	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	15	74754904.0	G	A
pharmgkb	clozapine	CYP1A2	I386V			Other	P05177	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	15	74752237.0	A	K
pharmgkb	clozapine	HTR3A	rs1150226		Schizophrenia	Efficacy	P46098	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	11	113974819.0	A	G
pharmgkb	rosuvastatin	SLCO1B1	rs4149081		Coronary Disease	Efficacy	Q9Y6L6	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	12	21225087.0	G	A
pharmgkb	dexmedetomidine	PRKCB	rs9922316			Other	P05771	Drug	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	16	23898631.0	T	R
pharmgkb	dexmedetomidine	ADRA2A	rs1800544			Other	P08913	Drug	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	10	111076745.0	G	C
pharmgkb	disulfiram	DRD2	rs2283265		Cocaine-Related Disorders	Efficacy	P14416	Drug	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	11	113414814.0	C	A
pharmgkb	disulfiram	ANKK1	E713K		Cocaine-Related Disorders	Efficacy	Q8NFD2	Drug	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	11	113400106.0	G	A
pharmgkb	diuretics	PDE4D	rs702553		Nephrosclerosis	Efficacy	Q08499	Drug Class			5	60440946.0	A	T
pharmgkb	dolasetron,granisetron	NOS1AP	rs10494366			Toxicity	O75052				1	162115895.0	G	T
pharmgkb	calcein,lopinavir	ABCC2	C1515Y			Other	Q5T2W1				10	99851537.0	G	A
pharmgkb	lopinavir	ABCC2	C1515Y		HIV Infections	Efficacy	Q5T2W1	Drug	92727.0	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	10	99851537.0	G	A
pharmgkb	folic acid,vitamin b-complex, plain	MTRR	I49M		Migraine with Aura	Efficacy	Q9UBK8				5	7870860.0	A	G
pharmgkb	mitotane	CYP2B6	Q172H		Adrenocortical Carcinoma	Other	P20813	Drug	4211.0	C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl	19	41006936.0	G	W
pharmgkb	atorvastatin	ABCG8	D19N		Coronary Artery Disease,Hypercholesterolemia	Efficacy	Q9H221	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	2	43839108.0	G	M
pharmgkb	midazolam	POR	A503V			Other	Q9Y277	Drug	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F	7	75985688.0	C	T
pharmgkb	atorvastatin	CYP3A5	CYP3A5*1, CYP3A5*3		Myalgia unspecified	Efficacy,Toxicity	P20815	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4				
pharmgkb	carboplatin,paclitaxel	MAD1L1	R466H		Ovarian Neoplasms	Efficacy	Q13257				7	1936821.0	C	T
pharmgkb	simvastatin	CYP3A4	CYP3A4*1, CYP3A4*4		Hyperlipidemias	Efficacy	P08684	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C				
pharmgkb	simvastatin	CYBA	Y72N		Hypercholesterolemia	Other	Q8NFA2	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	16	88646828.0	A	K
pharmgkb	haloperidol	SLC6A5	rs2298826		Schizophrenia	Toxicity	Q9Y345	Drug	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	11	20638211.0	G	A
pharmgkb	fluvastatin	CETP	rs4783961		Hypercholesterolemia	Efficacy	P11597	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	16	56960982.0	G	A
pharmgkb	fluvastatin	ABCB1	rs1922242		Hypercholesterolemia	Efficacy	P08183	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	7	87544351.0	A	T
pharmgkb	fluvastatin	CETP	V422I		Hypercholesterolemia	Efficacy	P11597	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	16	56982180.0	G	M
pharmgkb	simvastatin	CETP	V422I		Hypercholesterolemia	Efficacy	P11597	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	16	56982180.0	G	M
pharmgkb	pravastatin	HMGCR	rs17238540			Efficacy	P04035	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	5	75359673.0	T	G
pharmgkb	simvastatin	HMGCR	rs17238540			Efficacy	P04035	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	5	75359673.0	T	G
pharmgkb	atorvastatin,fluvastatin,hmg coa reductase inhibitors,lovastatin,pravastatin,simvastatin	HMGCR	rs17238540			Efficacy	P04035				5	75359673.0	T	G
pharmgkb	simvastatin	HMGCR	rs17244841			Efficacy	P04035	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	5	75347030.0	A	T
pharmgkb	pravastatin	HMGCR	rs17244841			Efficacy	P04035	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	5	75347030.0	A	T
pharmgkb	pravastatin	MTHFR	A222V		Coronary Artery Disease,Myocardial Infarction	Efficacy	P42898	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	1	11796321.0	G	A
pharmgkb	hmg coa reductase inhibitors	CXCL5	rs352046		Acute coronary syndrome	Efficacy	P42830	Drug Class			4	73998833.0	G	H
pharmgkb	atorvastatin	TNF	rs1800629		Acute coronary syndrome	Other	Q9UNG2	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	6	31575254.0	G	A
pharmgkb	simvastatin	F3	rs3917643		Myocardial Ischemia	Efficacy	Q13275	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	1	94536311.0	T	C
pharmgkb	pravastatin	ABCA1	R219K		Coronary Disease	Efficacy	O95477	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	9	104858586.0	C	T
pharmgkb	pravastatin	NPC1L1	rs17655652		Diabetes Mellitus,Hypertension,Vascular Diseases	Efficacy	Q9UHC9	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	7	44541392.0	T	C
pharmgkb	atorvastatin,pravastatin,simvastatin	ABCA1	rs12003906		Hyperlipidemias	Efficacy	O95477				9	104883196.0	G	T
pharmgkb	atorvastatin	SCARB1	rs5888		Hypercholesterolemia	Efficacy	Q8WTV0	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	12	124800202.0	A	K
pharmgkb	hmg coa reductase inhibitors	HMGCR	rs12654264		Colonic Neoplasms	Other	P04035	Drug Class			5	75352778.0	A	T
pharmgkb	pravastatin	LPL	rs328			Efficacy	P06858	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	8	19962213.0	C	G
pharmgkb	fenofibrate	APOA1	rs964184		Hypertriglyceridemia	Efficacy	P02647	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	11	116778201.0	G	C
pharmgkb	docetaxel,gemcitabine,paclitaxel,Platinum compounds,vinorelbine	CASP7	T19N		Carcinoma, Non-Small-Cell Lung	Efficacy	P55210				10	113679810.0	C	K
pharmgkb	clozapine	ABCB1	rs7787082		Schizophrenia	Efficacy	P08183	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	7	87527735.0	G	A
pharmgkb	candesartan	AGTR1	rs5186		Heart Failure	Efficacy	P30556	Drug	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	3	148742201.0	A	C
pharmgkb	atenolol,irbesartan	EDN1	K198N		Essential hypertension	Efficacy	P05305				6	12296022.0	G	T
pharmgkb	atenolol	AGT	rs5051		Hypertension	Efficacy	Q9BYV1	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	1	230714126.0	C	K
pharmgkb	amlodipine,chlorthalidone,lisinopril	ACE	rs4291		Hypertension	Efficacy	P12821				17	63476833.0	T	M
pharmgkb	fenofibrate	SCARB1	G2S		Hypertriglyceridemia	Efficacy	Q8WTV0	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	12	124863717.0	C	T
pharmgkb	irinotecan	SLCO1B1	rs4149015		Carcinoma, Non-Small-Cell Lung	Toxicity	Q9Y6L6	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	12	21130388.0	G	M
pharmgkb	irinotecan	ABCC2	I1324M		Carcinoma, Non-Small-Cell Lung	Toxicity	Q5T2W1	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	10	99844450.0	C	K
pharmgkb	fenofibrate	CRP	rs3091244		Metabolic Syndrome	Efficacy	P02741	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	1	159714875.0	G	W
pharmgkb	bupropion	SACM1L	rs2742435		Depressive Disorder, Major	Toxicity	Q9NTJ5	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	3	45699371.0	G	A
pharmgkb	bupropion	SACM1L	rs2742423		Depressive Disorder, Major	Toxicity	Q9NTJ5	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	3	45691938.0	A	K
pharmgkb	bupropion	SACM1L	rs2742421		Depressive Disorder, Major	Toxicity	Q9NTJ5	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	3	45691023.0	T	G
pharmgkb	bupropion	SACM1L	rs2742417		Depressive Disorder, Major	Toxicity	Q9NTJ5	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	3	45689959.0	C	T
pharmgkb	bupropion	SACM1L	rs2742390		Depressive Disorder, Major	Toxicity	Q9NTJ5	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	3	45715230.0	G	A
pharmgkb	olanzapine	DRD2	rs2440390		Mental Disorders	Toxicity	P14416	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	113416156.0	T	C
pharmgkb	carbamazepine	GABRA1	rs2290732		Epilepsy	Efficacy	P14867	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	5	161897892.0	A	K
pharmgkb	bupropion	SACM1L	rs2251954		Depressive Disorder, Major	Toxicity	Q9NTJ5	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	3	45690292.0	T	C
pharmgkb	bupropion	SACM1L	rs2245705		Depressive Disorder, Major	Toxicity	Q9NTJ5	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	3	45708230.0	T	C
pharmgkb	repaglinide	KCNQ1	rs2237895		Diabetes Mellitus, Type 2	Efficacy	P51787	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	11	2835964.0	A	Y
pharmgkb	repaglinide	KCNQ1	rs2237892		Diabetes Mellitus, Type 2	Efficacy	P51787	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	11	2818521.0	C	T
pharmgkb	irinotecan	ABCG2	V12M		Carcinoma, Non-Small-Cell Lung	Toxicity	Q9UNQ0	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	4	88139962.0	C	T
pharmgkb	fenofibrate	ABCA1	K1587R		Hypertriglyceridemia	Efficacy	O95477	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	9	104800523.0	T	C
pharmgkb	fenofibrate	ABCA1	R219K		Hypertriglyceridemia	Efficacy	O95477	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	9	104858586.0	C	T
pharmgkb	docetaxel,gemcitabine,paclitaxel,Platinum compounds,vinorelbine	CASP7	T244S		Carcinoma, Non-Small-Cell Lung	Efficacy	P55210				10	113729393.0	C	G
pharmgkb	captopril	ACE2	rs2106809		Hypertension	Efficacy	Q9BYF1	Drug	44093.0	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	X	15599938.0	A	G
pharmgkb	bupropion	SACM1L	rs1969624		Depressive Disorder, Major	Toxicity	Q9NTJ5	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	3	45693326.0	T	C
pharmgkb	benazepril	MTR	D919G		Essential hypertension	Efficacy	Q13613	Drug	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	1	236885200.0	A	G
pharmgkb	irbesartan	APOB	R3638Q		Hypertrophy, Left Ventricular	Efficacy	P04114	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	2	21005955.0	C	T
pharmgkb	dobutamine	ADRB1	G389R			Efficacy	P08588	Drug	36811.0	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O	10	114045297.0	G	C
pharmgkb	disulfiram	MTHFR	A222V		Cocaine-Related Disorders	Efficacy	P42898	Drug	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	1	11796321.0	G	A
pharmgkb	Enzymes	F12	rs1801020		Stroke	Efficacy	Q96EY5	Drug Class			5	177409531.0	A	G
pharmgkb	atenolol	ADRA2A	rs1800545		Hypertrophy, Left Ventricular	Efficacy	P08913	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	10	111077780.0	G	A
pharmgkb	fentanyl,morphine,opioids,oxycodone	RHBDF2	rs12948783		Neoplasms	Efficacy	P78536				17	76503318.0	G	H
pharmgkb	citalopram	COL26A1	rs17135437		Depressive Disorder, Major	Toxicity	Q96A83	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	7	101472713.0	C	T
pharmgkb	fenofibrate	CRP	rs1417938		Metabolic Syndrome	Efficacy	P02741	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	1	159714396.0	T	M
pharmgkb	docetaxel,gemcitabine,paclitaxel,Platinum compounds,vinorelbine	CASP7	rs12415607		Carcinoma, Non-Small-Cell Lung	Efficacy	P55210				10	113678445.0	C	A
pharmgkb	docetaxel,gemcitabine,paclitaxel,Platinum compounds,vinorelbine	CASP7	rs4353229		Carcinoma, Non-Small-Cell Lung	Efficacy	P55210				10	113729830.0	T	C
pharmgkb	efavirenz	HTR2A	rs6313		HIV Infections	Toxicity	P28223	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	13	46895805.0	G	A
pharmgkb	efavirenz	ABCG2	Q141K		HIV Infections	Toxicity	Q9UNQ0	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	4	88131171.0	G	Y
pharmgkb	sirolimus	ABCB1	rs1128503		Kidney Transplantation	Toxicity	P08183	Drug	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	7	87550285.0	A	G
pharmgkb	gemcitabine,Platinum compounds	CASP7	rs1127687		Carcinoma, Non-Small-Cell Lung	Efficacy	P55210				10	113730350.0	G	A
pharmgkb	paclitaxel,Platinum compounds	CASP7	rs1127687		Carcinoma, Non-Small-Cell Lung	Efficacy	P55210				10	113730350.0	G	A
pharmgkb	acetaminophen	UGT1A	rs10929303			Other	Q9HAW7	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	2	233772770.0	T	C
pharmgkb	acetaminophen	UGT1A	rs10929303		Liver Failure, Acute	Toxicity	Q9HAW7	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	2	233772770.0	T	C
pharmgkb	iloperidone	CYP2D6	P34A		Schizophrenia	Toxicity	P10635	Drug	71360.0		22	42130692.0	G	A
pharmgkb	capecitabine,docetaxel	CYP1A1	I462L		Breast Neoplasms	Efficacy	P11511				15	74720644.0	T	C
pharmgkb	sirolimus	ABCB1	I1145M		Kidney Transplantation	Toxicity	P08183	Drug	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	7	87509329.0	A	K
pharmgkb	acetaminophen	UGT1A	rs1042640			Other	Q9HAW7	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	2	233772898.0	G	H
pharmgkb	acetaminophen	UGT1A	rs1042640		Liver Failure, Acute	Toxicity	Q9HAW7	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	2	233772898.0	G	H
pharmgkb	acetaminophen	UGT1A	rs8330			Other	Q9HAW7	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	2	233772999.0	G	C
pharmgkb	mirtazapine	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7		Depression	Other	P20813	Drug	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4				
pharmgkb	mirtazapine	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7		Depression	Efficacy	P20813	Drug	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4				
pharmgkb	olanzapine	HTR2C	rs1414334		Mental Disorders	Toxicity	P28335	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	X	114903581.0	C	G
pharmgkb	irinotecan	SLCO1B1	V174A		Neoplasms	Toxicity	Q9Y6L6	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	12	21178615.0	T	C
pharmgkb	irinotecan	ABCC2	V417I		Colorectal Neoplasms	Other	Q5T2W1	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	10	99804058.0	G	A
pharmgkb	imatinib	ABCC4	rs9561765		Gastrointestinal Stromal Tumors	Efficacy	O15439	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	13	95030989.0	G	A
pharmgkb	adalimumab,etanercept,infliximab	TNFRSF1A	rs767455		Arthritis, Psoriatic	Efficacy	Q15628				12	6341779.0	T	C
pharmgkb	tacrolimus	NOD2	R675W		Kidney Transplantation	Efficacy	Q9HC29	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	16	50712015.0	C	T
pharmgkb	tacrolimus	CYP2C19	CYP2C19*1, CYP2C19*2		Kidney Transplantation	Efficacy	P33261	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	digoxin	ABCB1	rs1128503			Other	P08183	Drug	30322.0	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	7	87550285.0	A	G
pharmgkb	Enzymes	A2M	I1000V		Stroke	Efficacy	Q9Y6Q5	Drug Class			12	9079672.0	T	C
pharmgkb	benazepril	PRCP	E133D		Hypertension	Efficacy	P42785	Drug	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	11	82853252.0	T	R
pharmgkb	prasugrel	PEAR1	rs12407843			Efficacy	Q5VY43	Drug	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	1	156903935.0	G	M
pharmgkb	prasugrel	PEAR1	rs77235035			Efficacy	Q5VY43	Drug	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	1	156908005.0	C	W
pharmgkb	paroxetine	HTR1B	rs130058		Depression	Other	P28222	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	6	77463564.0	T	R
pharmgkb	antidepressants,citalopram,fluvoxamine,paroxetine,sertraline,venlafaxine	ABCB1	rs2235040			Toxicity	P08183				7	87536434.0	C	T
pharmgkb	paroxetine	CYP1A2	rs2470890		Depressive Disorder, Major	Efficacy	P05177	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	15	74755085.0	T	C
pharmgkb	paroxetine	CYP1A2	rs2472304		Depressive Disorder, Major	Efficacy	P05177	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	15	74751897.0	G	A
pharmgkb	paroxetine	CYP1A2	rs4646425		Depressive Disorder, Major	Efficacy	P05177	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	15	74750940.0	C	T
pharmgkb	paroxetine	CYP1A2	rs4646427		Depressive Disorder, Major	Efficacy	P05177	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	15	74753351.0	T	C
pharmgkb	tramadol	SLC22A1	G401S			Other	O15245	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	6	160139792.0	G	A
pharmgkb	tramadol	SLC22A1	rs35167514			Other	O15245	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	6	160139849.0	A	-
pharmgkb	antidepressants,fluvoxamine,paroxetine,Selective serotonin reuptake inhibitors,sertraline	HTR1A	rs6295		Depressive Disorder,Depressive Disorder, Major	Efficacy	P08908				5	63962738.0	C	G
pharmgkb	amitriptyline,citalopram,paroxetine,venlafaxine	ABCB1	rs10280101		Depression	Efficacy	P08183				7	87524269.0	A	S
pharmgkb	amitriptyline,citalopram,paroxetine,venlafaxine	ABCB1	rs10248420		Depression	Efficacy	P08183				7	87535670.0	A	K
pharmgkb	amitriptyline,citalopram,paroxetine,venlafaxine	ABCB1	rs11983225		Depression	Efficacy	P08183				7	87532204.0	T	C
pharmgkb	amitriptyline,citalopram,paroxetine,venlafaxine	ABCB1	rs12720067		Depression	Efficacy	P08183				7	87540040.0	C	T
pharmgkb	amitriptyline,citalopram,paroxetine,venlafaxine	ABCB1	rs2235040		Depression	Efficacy	P08183				7	87536434.0	C	T
pharmgkb	paroxetine	DRD3	G9S		Depressive Disorder, Major	Efficacy	P35462	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	3	114171968.0	C	T
pharmgkb	citalopram,fluoxetine,paroxetine,sertraline	SRP19	rs495794		Depressive Disorder, Major	Efficacy	P09132				5	112865397.0	A	S
pharmgkb	citalopram,fluoxetine,paroxetine,sertraline	REEP5	rs153560		Depressive Disorder, Major	Efficacy	Q00765				5	112918680.0	G	W
pharmgkb	citalopram,fluoxetine,paroxetine,sertraline	REEP5	rs153549		Depressive Disorder, Major	Efficacy	Q00765				5	112900600.0	A	G
pharmgkb	tacrolimus	CYP2C19	CYP2C19*1, CYP2C19*2		Kidney Transplantation	Dosage	P33261	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	amodiaquine,pyrimethamine,sulfadoxine	G6PD	V68M		Malaria,Malaria, Falciparum	Toxicity	P11413				X	154536002.0	C	T
pharmgkb	trimipramine	CYP2C9	CYP2C9*1, CYP2C9*3			Other	P11712	Drug	5584.0	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C				
pharmgkb	prasugrel	PEAR1	rs3737224			Efficacy	Q5VY43	Drug	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	1	156909788.0	C	T
pharmgkb	prasugrel	PEAR1	rs41273215			Efficacy	Q5VY43	Drug	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	1	156912167.0	C	T
pharmgkb	prasugrel	PEAR1	rs822441			Efficacy	Q5VY43	Drug	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	1	156913204.0	G	H
pharmgkb	prasugrel	PEAR1	N848K			Efficacy	Q5VY43	Drug	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	1	156913423.0	C	W
pharmgkb	escitalopram	CYP1A2	rs2069526		Depressive Disorder, Major	Toxicity	P05177	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	15	74749000.0	T	G
pharmgkb	escitalopram	CYP1A2	rs4646425		Depressive Disorder, Major	Toxicity	P05177	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	15	74750940.0	C	T
pharmgkb	escitalopram	CYP1A2	rs4646427		Depressive Disorder, Major	Toxicity	P05177	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	15	74753351.0	T	C
pharmgkb	duloxetine	DRD3	rs324026		Anxiety Disorders	Efficacy	P35462	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	114172195.0	C	T
pharmgkb	duloxetine	DRD3	rs324023		Anxiety Disorders	Efficacy	P35462	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	114166548.0	T	C
pharmgkb	duloxetine	DRD3	rs167770		Anxiety Disorders	Efficacy	P35462	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	114160715.0	G	A
pharmgkb	clomipramine,liothyronine,lithium,nefazodone,venlafaxine	HTR1B	rs130058		Depression	Toxicity	P28222				6	77463564.0	T	R
pharmgkb	amitriptyline,citalopram,paroxetine,venlafaxine	ABCB1	rs4148740		Depressive Disorder, Major	Efficacy	P08183				7	87522787.0	A	G
pharmgkb	amitriptyline,citalopram,paroxetine,venlafaxine	ABCB1	rs2235067		Depressive Disorder, Major	Efficacy	P08183				7	87520606.0	C	T
pharmgkb	quetiapine	GRIN2B	rs1806201		Drug Toxicity	Toxicity	Q8TB68	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	12	13564574.0	G	A
pharmgkb	risperidone	GRIN2B	rs1806201		Drug Toxicity	Toxicity	Q8TB68	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	12	13564574.0	G	A
pharmgkb	risperidone	HTR2A	rs6313		Drug Toxicity	Toxicity	P28223	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	13	46895805.0	G	A
pharmgkb	clomipramine,nefazodone,paroxetine,venlafaxine	FKBP5	rs1360780		Depression	Toxicity	Q13451				6	35639794.0	T	M
pharmgkb	carboplatin,cisplatin	AKT1	rs1130214		Lung Neoplasms	Efficacy	P31749				14	104793397.0	C	A
pharmgkb	carboplatin,cisplatin,fluorouracil	SLC19A1	rs12659		Uterine Cervical Neoplasms	Efficacy	P41440				21	45531642.0	A	G
pharmgkb	cisplatin	GSTM1	GSTM1 non-null, GSTM1 null		Deafness,Ototoxicity,Testicular Neoplasms	Toxicity	P09488	Drug	441203.0	N.N.Cl[Pt+2]Cl				
pharmgkb	dobutamine	GNAS	rs62205366			Efficacy	O95467	Drug	36811.0	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O	20	58903138.0	T	C
pharmgkb	captopril	AGTR1	rs5186		Diabetes Mellitus, Type 2	Efficacy	P30556	Drug	44093.0	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	3	148742201.0	A	C
pharmgkb	amisulpride,antipsychotics,olanzapine,quetiapine,risperidone	HTR1A	rs10042486		Schizophrenia	Efficacy	P08908				5	63965502.0	C	T
pharmgkb	antidepressants	TGFBR3	rs12082710		Depression	Efficacy	Q03167	Drug Class			1	91689780.0	T	M
pharmgkb	antipsychotics	ZNF804A	rs1344706		Schizophrenia	Efficacy	Q7Z570	Drug Class			2	184913701.0	A	Y
pharmgkb	enalapril	ADRB2	Q27E		Hypertrophy, Left Ventricular	Efficacy	P07550	Drug	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	5	148826910.0	G	Y
pharmgkb	benazepril,imidapril	CYP11B2	rs1799998		Essential hypertension	Efficacy	P19099				8	142918184.0	A	G
pharmgkb	benazepril	AGT	rs7079		Hypertension	Efficacy	Q9BYV1	Drug	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	1	230702585.0	G	T
pharmgkb	bevacizumab,ranibizumab	VEGFA	rs3025000		Macular Degeneration	Efficacy	P15692				6	43778432.0	C	T
pharmgkb	candesartan	CYP11B2	rs1799998		Hypertension	Efficacy	P19099	Drug	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	8	142918184.0	A	G
pharmgkb	carboplatin,cisplatin	EIF3A	rs3740556		Lung Neoplasms	Efficacy	Q14152				10	119080683.0	G	A
pharmgkb	cytarabine	CDA	A70T			Other	Q96GN5	Drug	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	1	20604981.0	G	A
pharmgkb	clozapine	ABCB1	rs10248420		Schizophrenia	Efficacy	P08183	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	7	87535670.0	A	K
pharmgkb	clozapine	HTR3A	rs1062613		Schizophrenia	Efficacy	P46098	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	11	113975284.0	T	C
pharmgkb	clozapine	HTR3A	rs2276302		Schizophrenia	Efficacy	P46098	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	11	113979418.0	G	A
pharmgkb	fenofibrate	PPARA	rs4253778		Diabetes Mellitus	Efficacy	Q07869	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	22	46234737.0	G	Y
pharmgkb	flunisolide	TBXT	G177D		Asthma	Efficacy	O15178	Drug	82153.0	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O	6	166165782.0	C	T
pharmgkb	gemcitabine	DCK	I24F			Other	P27707	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	4	70993905.0	A	K
pharmgkb	pitrakinra	IL4R	rs1110470		Asthma	Efficacy	P24394	Drug			16	27325106.0	G	A
pharmgkb	pitrakinra	IL4R	rs3024530		Asthma	Efficacy	P24394	Drug			16	27339366.0	A	G
pharmgkb	pitrakinra	IL4R	I75L		Asthma	Efficacy	P24394	Drug			16	27344882.0	A	B
pharmgkb	pitrakinra	IL4R	rs2239347		Asthma	Efficacy	P24394	Drug			16	27347700.0	A	C
pharmgkb	pitrakinra	IL4R	rs1029489		Asthma	Efficacy	P24394	Drug			16	27364896.0	A	G
pharmgkb	rituximab	TGFB1	R25Q		Arthritis, Rheumatoid	Efficacy	P01137	Drug			19	41352971.0	C	K
pharmgkb	SN-38	SLCO1B1	V174A		Carcinoma, Non-Small-Cell Lung	Dosage	Q9Y6L6	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	12	21178615.0	T	C
pharmgkb	olanzapine	SV2C	rs11960832		Schizophrenia	Efficacy	Q496J9	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	5	76219161.0	C	T
pharmgkb	l-tryptophan	SLC22A2	S270A			Other	O15244	Drug, Biological Intermediate	6305.0	C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N	6	160249250.0	A	C
pharmgkb	memantine	NR1I2	rs1523130		Dementia	Other	O75469	Drug	4054.0	CC12CC3CC(C1)(CC(C3)(C2)N)C	3	119780660.0	T	C
pharmgkb	simvastatin	PPARA	rs4823613			Efficacy	Q07869	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	22	46202410.0	A	G
pharmgkb	simvastatin	PPARA	rs4253728			Efficacy	Q07869	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	22	46214170.0	G	A
pharmgkb	talinolol	ABCB1	I1145M			Other	P08183	Drug			7	87509329.0	A	K
pharmgkb	carboplatin,docetaxel,paclitaxel	OPRM1	rs544093		Ovarian Neoplasms	Toxicity	P35372				6	154136358.0	G	T
pharmgkb	carboplatin,docetaxel,paclitaxel	BCL2	rs2849380		Ovarian Neoplasms	Toxicity	P10415				18	63312127.0	C	T
pharmgkb	carboplatin,docetaxel,paclitaxel	SOX10	rs139887		Ovarian Neoplasms	Toxicity	P56693				22	37975389.0	G	Y
pharmgkb	citalopram,escitalopram	GRK5	rs915120		Depressive Disorder	Efficacy	P34947				10	119430601.0	T	C
pharmgkb	citalopram,escitalopram	RFK	rs11144870		Depressive Disorder	Efficacy	Q969G6				9	76389297.0	C	T
pharmgkb	hydrochlorothiazide	WNK1	rs880054		Hypertension	Efficacy	Q9H4A3	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	12	879392.0	C	T
pharmgkb	antipsychotics	HSPG2	rs878949		Schizophrenia	Toxicity	P98160	Drug Class			1	21900598.0	T	C
pharmgkb	antipsychotics	HSPG2	rs2445142		Schizophrenia	Toxicity	P98160	Drug Class			1	21899250.0	G	M
pharmgkb	antipsychotics	GABRG3	rs2061051		Schizophrenia	Toxicity	Q99928	Drug Class			15	27275664.0	G	A
pharmgkb	risperidone	ADRB2	R16G		Schizophrenia	Toxicity	P07550	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	5	148826877.0	G	A
pharmgkb	anthracyclines and related substances,taxanes	ABCB1	I1145M		Breast Neoplasms	Efficacy	P08183				7	87509329.0	A	K
pharmgkb	hydrochlorothiazide	PRKCA	rs4791040		Hypertension	Efficacy	Q9NRD5	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	17	66791455.0	T	C
pharmgkb	antipsychotics,chlorpromazine,fluphenazine,thioridazine,trifluoperazine	CYP1A2	rs762551		Schizophrenia	Toxicity	P05177				15	74749576.0	C	A
pharmgkb	sorafenib	UGT1A9	rs17868320		Neoplasms	Toxicity	O60656	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	2	233669782.0	C	T
pharmgkb	Bisphosphonates	MEX3C	rs17751934		Osteonecrosis	Toxicity	Q5U5Q3	Drug Class						
pharmgkb	fluorouracil,oxaliplatin	PARD3B	rs17626122		Colorectal Neoplasms,Drug Toxicity	Toxicity	Q9BYG5				2	205609288.0	T	C
pharmgkb	antineoplastic agents	DPYD	rs1760217		Pancreatic Neoplasms	Efficacy	Q12882	Drug Class			1	97137438.0	A	G
pharmgkb	cisplatin,irinotecan	DCBLD1	rs17574269		Carcinoma, Small Cell	Efficacy	Q8N8Z6				6	117494965.0	A	G
pharmgkb	antineoplastic agents	SERPINA3	rs17091162		Pancreatic Neoplasms	Efficacy	P01011	Drug Class			14	94622895.0	C	A
pharmgkb	nortriptyline	SLC39A14	rs17060812		Depression	Efficacy	Q15043	Drug	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	8	22371315.0	C	T
pharmgkb	Bisphosphonates	RBMS3	rs17024608		Osteonecrosis	Efficacy	Q6XE24	Drug Class			3	29913199.0	A	G
pharmgkb	cisplatin,irinotecan	ABCC4	rs16950650		Carcinoma, Small Cell	Efficacy	O15439				13	95123178.0	C	T
pharmgkb	Bisphosphonates	ABCC4	rs1678387		Osteonecrosis	Toxicity	O15439	Drug Class			13	95065652.0	T	C
pharmgkb	Bisphosphonates	CSRNP3	rs7588295		Osteonecrosis	Toxicity	Q8WYN3	Drug Class			2	165551001.0	A	G
pharmgkb	Bisphosphonates	ALDH1A2	rs12903202		Osteonecrosis	Efficacy	O94788	Drug Class			15	58014595.0	A	K
pharmgkb	lansoprazole,omeprazole,rabeprazole	IL1B	rs16944		Helicobacter Infections	Efficacy	P01584				2	112837290.0	A	G
pharmgkb	salbutamol	CLOCK	rs1522113		Asthma	Efficacy	O15516	Drug	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	4	55465604.0	G	A
pharmgkb	Thiazides, plain	SLC12A3	rs13306673		Essential hypertension	Efficacy	P55017	Drug Class			16	56867019.0	C	T
pharmgkb	repaglinide	SLC30A8	R276W		Diabetes Mellitus, Type 2	Efficacy	Q8IWU4	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	8	117172544.0	C	W
pharmgkb	peginterferon alfa-2b,ribavirin	OASL	rs12819210		Hepatitis C	Efficacy	Q15646				12	121020597.0	C	T
pharmgkb	azathioprine	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C		Transplantation	Toxicity	P51580	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]				
pharmgkb	aspirin	PEAR1	rs12041331		Myocardial Infarction	Toxicity	Q5VY43	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	156899922.0	G	A
pharmgkb	cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin	SLC22A12	rs11231825		Leukemia, Myeloid, Acute	Toxicity	Q96S37				11	64592802.0	T	C
pharmgkb	cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin	CYP2E1	rs2070673		Leukemia, Myeloid, Acute	Toxicity	P05181				10	133527063.0	A	T
pharmgkb	cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin	SULT2B1	L198V		Leukemia, Myeloid, Acute	Toxicity	O00204				19	48592808.0	C	T
pharmgkb	cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin	CYP2E1	F421L		Leukemia, Myeloid, Acute	Toxicity	P05181				10	133537858.0	C	K
pharmgkb	cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin	SLCO1B1	V174A		Leukemia, Myeloid, Acute	Toxicity	Q9Y6L6				12	21178615.0	T	C
pharmgkb	citalopram,fluoxetine,paroxetine,sertraline	ABCB1	rs28401781		Depressive Disorder, Major	Efficacy	P08183				7	87519012.0	C	T
pharmgkb	amitriptyline,citalopram,fluoxetine,paroxetine,sertraline,venlafaxine	ABCB1	rs4148739		Depression,Depressive Disorder, Major	Efficacy	P08183				7	87531733.0	T	C
pharmgkb	sirolimus	CYP3A4	rs2740574		Kidney Transplantation	Other	P08684	Drug	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	7	99784473.0	C	T
pharmgkb	timolol	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5			Other	P10635	Drug	33624.0	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O				
pharmgkb	didanosine	XDH	rs1594160		HIV Infections	Toxicity	P47989	Drug	50599.0	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	2	31356103.0	A	C
pharmgkb	didanosine	XDH	rs1429376		HIV Infections	Toxicity	P47989	Drug	50599.0	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	2	31365695.0	A	Y
pharmgkb	didanosine	NT5C2	rs11191561		HIV Infections	Toxicity	P49902	Drug	50599.0	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	10	103109774.0	C	G
pharmgkb	didanosine	NT5C2	rs11598702		HIV Infections	Toxicity	P49902	Drug	50599.0	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	10	103138228.0	T	S
pharmgkb	olanzapine	DRD2	rs1124493			Other	P14416	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	113411573.0	T	G
pharmgkb	lovastatin	CYP2D6	CYP2D6*1, CYP2D6*5, CYP2D6*10			Other	P10635	Drug	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C				
pharmgkb	irinotecan	SLC19A1	H27R		Colorectal Neoplasms	Efficacy	P41440	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	21	45537880.0	T	S
pharmgkb	irinotecan	SLCO1B1	N130H		Colorectal Neoplasms	Efficacy	Q9Y6L6	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	12	21176804.0	A	K
pharmgkb	capecitabine	CDA	rs602950		Neoplasms	Toxicity	Q96GN5	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	20589038.0	A	G
pharmgkb	tamoxifen	ABCB1	I1145M		Breast Neoplasms	Efficacy	P08183	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	7	87509329.0	A	K
pharmgkb	nifedipine	CYP3A5	rs776746		Pregnancy	Other	P20815	Drug	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	7	99672916.0	T	C
pharmgkb	methacholine	ADRB2	R16G		Asthma	Efficacy	P07550	Drug	1993.0	CC(C[N+](C)(C)C)OC(=O)C	5	148826877.0	G	A
pharmgkb	sipoglitazar	UGT2B15	UGT2B15*1, UGT2B15*2			Efficacy	P54855	Drug	9825652.0	CCOC1=NN(C=C1CCC(=O)O)CC2=CC=C(C=C2)OCC3=CSC(=N3)C4=CC=CC=C4				
pharmgkb	cyclosporine	CYP3A4	L292P		Kidney Transplantation	Other	P08684	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	99764003.0	A	G
pharmgkb	bumetanide,furosemide,torasemide	NPPA-AS1	V32M			Efficacy	Q9UMX0				1	11847591.0	C	T
pharmgkb	indinavir	UGT1A1	G71R		HIV Infections	Toxicity	P22309	Drug	5362440.0	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	2	233760498.0	G	A
pharmgkb	fenofibrate	IL6	rs1800795		Cardiovascular Diseases	Efficacy	P05231	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	7	22727026.0	C	G
pharmgkb	imatinib	SLC22A5	rs2631372		Gastrointestinal Stromal Tumors	Efficacy	O76082	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	5	132367886.0	G	C
pharmgkb	carvedilol	UGT1A1	G71R		Angina Pectoris,Heart Failure	Other	P22309	Drug	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	2	233760498.0	G	A
pharmgkb	carboplatin,cisplatin	AKT1	rs2494752		Carcinoma, Non-Small-Cell Lung	Efficacy	P31749				14	104797271.0	A	G
pharmgkb	cladribine,cytarabine	RRM2	rs5030743		Leukemia, Myeloid, Acute	Efficacy	Q9UI43				2	10123747.0	C	K
pharmgkb	cladribine,cytarabine	RRM2B	rs1265138		Leukemia, Myeloid, Acute	Efficacy	Q7LG56				8	102187808.0	A	G
pharmgkb	cladribine,cytarabine	RRM1	rs2898950		Leukemia, Myeloid, Acute	Efficacy	Q9UET6				11	4082830.0	A	C
pharmgkb	cladribine,cytarabine	RRM1	rs1561876		Leukemia, Myeloid, Acute	Efficacy	Q9UET6				11	4092165.0	G	H
pharmgkb	cladribine,cytarabine	RRM1	rs1042919		Leukemia, Myeloid, Acute	Efficacy	Q9UET6				11	4138534.0	A	T
pharmgkb	fluorouracil	ABCC11	rs7194667		Leukopenia,Neoplasms	Toxicity	Q96J66	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	16	48208987.0	T	G
pharmgkb	fenofibrate	PPARA	rs9626730			Efficacy	Q07869	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	22	46166284.0	T	C
pharmgkb	Drugs used in alcohol dependence	GATA4	rs13273672		Alcoholism	Efficacy	P43694	Drug Class			8	11754872.0	T	C
pharmgkb	hydrochlorothiazide	KCNJ1	rs11600347		Hypertension	Toxicity	P48048	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	11	128863419.0	C	A
pharmgkb	Bisphosphonates	SFRP5	rs11189381		Osteonecrosis	Toxicity	Q5T4F7	Drug Class			10	97803441.0	T	C
pharmgkb	methotrexate	DHFR	rs1105525		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P00374	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	80654689.0	C	K
pharmgkb	adalimumab,etanercept,infliximab,Tumor necrosis factor alpha (TNF-alpha) inhibitors	PTPRC	rs10919563		Arthritis, Rheumatoid	Efficacy	P08575				1	198731313.0	G	A
pharmgkb	amiodarone	NOS1AP	rs10800397		Long QT Syndrome	Toxicity	O75052	Drug	2157.0	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	1	162267300.0	C	K
pharmgkb	Antiinflammatory agents, non-steroids	CDKN2B-AS1	rs10757274		Acute coronary syndrome	Toxicity	Q9UM00	Drug Class			9	22096056.0	A	G
pharmgkb	debrisoquine	CYP2D6	rs1080985			Other	P10635	Drug	2966.0	C1CN(CC2=CC=CC=C21)C(=N)N	22	42132375.0	G	M
pharmgkb	cisplatin,fluorouracil,oxaliplatin	VEGFA	rs25648		Stomach Neoplasms	Efficacy	P15692				6	43771240.0	C	K
pharmgkb	zonisamide	HLA-A	HLA-A*02:07		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P04439	Drug	5734.0	C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N				
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	K70R		Hepatitis C	Efficacy	Q8IZI9				19	39244466.0	T	C
pharmgkb	antipsychotics	BDNF-AS	rs10501087		Schizophrenia	Efficacy	P23560	Drug Class			11	27648561.0	T	C
pharmgkb	antipsychotics	BDNF	V66M		Schizophrenia	Efficacy	P23560	Drug Class			11	27658369.0	C	T
pharmgkb	antipsychotics	BDNF	rs11030104		Schizophrenia	Efficacy	P23560	Drug Class			11	27662970.0	A	G
pharmgkb	cyclophosphamide	VEGFA	rs2010963		Prostatic Neoplasms	Efficacy	P15692	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	6	43770613.0	C	G
pharmgkb	montelukast	SLCO2B1	R168Q		Asthma	Efficacy	O94956	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	11	75172532.0	G	W
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	MOB3B	rs7046653		Arthritis, Rheumatoid	Efficacy	Q86TA1	Drug Class			9	27490969.0	A	K
pharmgkb	gemcitabine	SLC29A1	rs9394992		Pancreatic Neoplasms	Toxicity	Q99808	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	6	44228255.0	C	T
pharmgkb	carboplatin,cisplatin	SLC31A1	rs7851395		Carcinoma, Non-Small-Cell Lung	Efficacy	O15431				9	113240184.0	A	G
pharmgkb	Bisphosphonates	TBC1D32	rs7740004		Osteonecrosis	Toxicity	Q96NH3	Drug Class			6	120535057.0	T	A
pharmgkb	docetaxel	SLCO1B3	M233I			Other	F5H094	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	12	20862826.0	G	A
pharmgkb	carboplatin,cisplatin,docetaxel,erlotinib,gefitinib,paclitaxel	MAP3K1	rs726501			Efficacy	Q13233				5	56832039.0	G	A
pharmgkb	cyclophosphamide,doxorubicin	SLC22A16	V252A			Dosage	Q86VW1				6	110442672.0	A	G
pharmgkb	atorvastatin,simvastatin	ABCC2	rs717620			Dosage	Q5T2W1				10	99782821.0	C	T
pharmgkb	sildenafil	VEGFA	rs699947		Erectile Dysfunction	Efficacy	P15692	Drug	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	6	43768652.0	A	Y
pharmgkb	sunitinib	VEGFA	rs699947			Toxicity	P15692	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	6	43768652.0	A	Y
pharmgkb	Antiinflammatory agents, non-steroids	AGT	M268T			Toxicity	Q9BYV1	Drug Class			1	230710048.0	A	G
pharmgkb	methotrexate	TNFAIP3	rs6920220			Efficacy	Q8NFZ5	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	6	137685367.0	G	A
pharmgkb	losartan	STK39	rs6749447			Efficacy	Q9UEW8	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	2	168184876.0	T	G
pharmgkb	bupropion,nicotine	EPB41	rs6702335		Tobacco Use Disorder	Efficacy	P11171				1	29084738.0	A	G
pharmgkb	hydrochlorothiazide	KCNJ1	rs658903		Diabetes Mellitus,Hypertension	Toxicity	P48048	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	11	128858172.0	T	R
pharmgkb	antipsychotics	HTR2A	rs6311		tardive dyskinesia	Efficacy	P28223	Drug Class			13	46897343.0	C	T
pharmgkb	carboplatin,cyclophosphamide,thiotepa	ALDH1A1	rs6151031			Toxicity	P00352				9	72953468.0	-	CTGGTGAGGAGAGAACC
pharmgkb	irinotecan	TOP1	rs6072262			Toxicity	P11387	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	20	41076355.0	G	A
pharmgkb	eculizumab	C5	R891H			Efficacy	O60282	Drug			9	120997683.0	C	T
pharmgkb	glyburide	G6PD	G6PD A- 202A_376G, G6PD B (reference)		Anemia, Hemolytic	Toxicity	P11413	Drug	3488.0	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3				
pharmgkb	glyburide	G6PD	S188F		Diabetes Mellitus, Type 2	Toxicity	P11413	Drug	3488.0	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	X	154534419.0	G	A
pharmgkb	chloramphenicol	G6PD	G6PD A- 202A_376G, G6PD B (reference)		Anemia, Hemolytic,Hemolysis	Toxicity	P11413	Drug	298.0	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]				
pharmgkb	phenazopyridine	G6PD	G6PD B (reference), G6PD Mediterranean Haplotype		Anemia, Hemolytic,Hemolysis	Toxicity	P11413	Drug	4756.0	C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N				
pharmgkb	nitrofurantoin	G6PD	G6PD A- 202A_376G, G6PD B (reference)		Anemia, Hemolytic,Hemolysis	Toxicity	P11413	Drug	5353830.0	C1C(=O)NC(=O)N1/N=C\C2=CC=C(O2)[N+](=O)[O-]				
pharmgkb	morphine	ABCB1	I1145M		Pain	Efficacy	P08183	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	7	87509329.0	A	K
pharmgkb	gemcitabine	CDA	A70T		Neoplasms,Neutropenia	Toxicity	Q96GN5	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	20604981.0	G	A
pharmgkb	ondansetron	SLC6A4	rs1042173		Alcoholism	Efficacy	P31645	Drug	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	17	30197993.0	A	C
pharmgkb	clomipramine	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)			Toxicity	P31645	Drug	2801.0	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl				
pharmgkb	ondansetron	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Alcoholism	Efficacy	P31645	Drug	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C				
pharmgkb	enalapril	NR3C2	V180I		Hypertension	Efficacy	P08235	Drug	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	4	148436323.0	C	T
pharmgkb	antidepressants,antiepileptics,Beta Blocking Agents,calcium channel blockers	ACE	rs1799752		Headache Disorders,Migraine with Aura,Migraine without Aura	Other	P12821				17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	opioids	COMT	rs4633		Pain	Other	P21964	Drug Class			22	19962712.0	C	T
pharmgkb	opioids	COMT	rs6269		Pain	Other	P21964	Drug Class			22	19962429.0	A	G
pharmgkb	opioids	COMT	rs4818		Pain	Other	P21964	Drug Class			22	19963684.0	C	K
pharmgkb	cisplatin,cyclophosphamide	EPHX1	Y113H		Ovarian Neoplasms	Toxicity	P07099				1	225831932.0	T	C
pharmgkb	cisplatin,cyclophosphamide	ADH1C	I350V		Ovarian Neoplasms	Efficacy	P00326				4	99339632.0	T	M
pharmgkb	cisplatin,cyclophosphamide	TPMT	Y240C		Ovarian Neoplasms	Efficacy	P51580				6	18130687.0	T	S
pharmgkb	cisplatin,cyclophosphamide	MUTYH	V22M		Ovarian Neoplasms	Toxicity	Q9UIF7				1	45334484.0	C	T
pharmgkb	cisplatin,cyclophosphamide	NAT2	I114T		Ovarian Neoplasms	Toxicity	Q6N069				8	18400344.0	T	C
pharmgkb	platinum	ERCC5	D1104H		Ovarian Neoplasms	Efficacy	P28715	Drug			13	102875652.0	G	C
pharmgkb	cisplatin,cyclophosphamide	LIG3	rs1052536		Ovarian Neoplasms	Toxicity	P49916				17	35004556.0	C	T
pharmgkb	clozapine,olanzapine	GCG	rs13429709		Schizophrenia	Other	Q9BUX1				2	162141450.0	T	C
pharmgkb	rhodamine 123	ABCB1	I1145M			Other	P08183	Drug			7	87509329.0	A	K
pharmgkb	gemcitabine	DCK	rs4694362		Pancreatic Neoplasms	Toxicity	P27707	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	4	71028147.0	C	T
pharmgkb	anastrozole,letrozole	ESR1	rs2234693		Neoplasms	Toxicity	P03372				6	151842200.0	T	C
pharmgkb	gemcitabine	SLC28A3	rs7867504		Neoplasms	Other	Q9HAS3	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	9	84305321.0	T	M
pharmgkb	cytarabine,idarubicin	DCK	rs80143932		Leukemia, Myeloid, Acute	Efficacy	P27707				4	70993476.0	C	D
pharmgkb	asparaginase,cyclophosphamide,cytarabine,daunorubicin,dexamethasone,doxorubicin,leucovorin,mercaptopurine,methotrexate,pegaspargase,prednisone,thioguanine,vincristine	GATA3	rs3824662			Efficacy	P23771				10	8062245.0	C	W
pharmgkb	warfarin	FPGS	rs7856096			Dosage	Q05932	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	9	127804260.0	A	G
pharmgkb	escitalopram	BMP5	rs41271330		Depressive Disorder, Major	Efficacy	P22003	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	6	55774230.0	G	A
pharmgkb	diltiazem	PLCD3	rs12946454		Hypertension	Efficacy	Q8N3E9	Drug	39186.0	CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC	17	45130754.0	A	T
pharmgkb	radiotherapy	TANC1	rs264663		Prostatic Neoplasms	Toxicity	Q9C0D5	Drug Class			2	159053694.0	T	S
pharmgkb	heroin	GRM3	rs274618		Heroin Dependence	Other	Q14832	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	7	86642700.0	T	M
pharmgkb	heroin	GRM3	rs1990040		Heroin Dependence	Other	Q14832	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	7	86683758.0	A	G
pharmgkb	heroin	GRM3	rs13242038		Heroin Dependence	Other	Q14832	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	7	86685104.0	C	T
pharmgkb	heroin	GRM3	rs724226		Heroin Dependence	Other	Q14832	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	7	86696058.0	A	B
pharmgkb	heroin	GRM3	rs2189814		Heroin Dependence	Other	Q14832	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	7	86702440.0	T	M
pharmgkb	dimercaprol	G6PD	G6PD A- 202A_376G, G6PD B (reference)		Hemolysis,Lead Poisoning, Nervous System, Childhood	Toxicity	P11413	Drug	3080.0	C(C(CS)S)O				
pharmgkb	ciprofloxacin	G6PD	G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham		Anemia, Hemolytic	Toxicity	P11413	Drug	2764.0	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O				
pharmgkb	aspirin	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham		Hemolysis	Toxicity	P11413	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O				
pharmgkb	sulfadoxine	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham		Hemolysis	Toxicity	P11413	Drug	17134.0	COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N				
pharmgkb	sulfasalazine	G6PD	G6PD A- 202A_376G, G6PD B (reference)		Hemolysis	Toxicity	P11413	Drug	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O				
pharmgkb	allopurinol	HLA-DRB1	HLA-DRB1*14:01		Drug Hypersensitivity	Toxicity	P01911	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	allopurinol	HLA-DRB1	HLA-DRB1*09:01		Drug Hypersensitivity	Toxicity	P01911	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	atorvastatin	MYLIP	N342I		Hypercholesterolemia	Efficacy	Q8WY64	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	6	16145094.0	A	G
pharmgkb	methotrexate	MTHFR	rs1476413		Arthritis, Rheumatoid	Efficacy	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11792243.0	C	T
pharmgkb	methotrexate	MTHFR	rs17421511		Arthritis, Rheumatoid	Efficacy	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11797731.0	G	A
pharmgkb	methotrexate	ATIC	rs16853826		Arthritis, Rheumatoid	Toxicity	P31939	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	2	215340444.0	G	A
pharmgkb	methotrexate	ATIC	rs10197559		Arthritis, Rheumatoid	Toxicity	P31939	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	2	215321102.0	C	T
pharmgkb	methotrexate	DHFR	rs1643650		Arthritis, Rheumatoid	Efficacy	P00374	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	80644324.0	T	C
pharmgkb	gemcitabine,paclitaxel	SLC29A1	rs747199		Breast Neoplasms	Efficacy	Q99808				6	44226608.0	G	C
pharmgkb	vincristine	CAPG	rs3770102		Drug Toxicity,Neurotoxicity Syndromes	Toxicity	P40121	Drug	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	2	85410714.0	G	H
pharmgkb	vincristine	ABCB1	rs4728709		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P08183	Drug	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	7	87604286.0	G	A
pharmgkb	vincristine	ABCB1	I1145M		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P08183	Drug	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	7	87509329.0	A	K
pharmgkb	vincristine	ACTG1	rs1135989		Neurotoxicity Syndromes	Toxicity	P63261	Drug	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	17	81510981.0	G	A
pharmgkb	allopurinol	HLA-DRB1	HLA-DRB1*03:01		severe cutaneous adverse reactions	Toxicity	P01911	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	debrisoquine,dextromethorphan	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*15			Other	P10635							
pharmgkb	debrisoquine,sparteine	CYP2D6	CYP2D6*1, CYP2D6*5, CYP2D6*8			Other	P10635							
pharmgkb	debrisoquine	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*38			Other	P10635	Drug	2966.0	C1CN(CC2=CC=CC=C21)C(=N)N				
pharmgkb	allopurinol	HLA-C	HLA-C*03:02		Exanthema	Toxicity	P10321	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	allopurinol	HLA-DRB1	HLA-DRB1*15:02		severe cutaneous adverse reactions	Toxicity	P01911	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	allopurinol	HLA-DRB1	HLA-DRB1*13:02		severe cutaneous adverse reactions	Toxicity	P01911	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	allopurinol	PSORS1C3	rs3094188		Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity		Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31174468.0	C	A
pharmgkb	allopurinol	POU5F1	rs3130501		Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	Q01860	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31168676.0	A	G
pharmgkb	allopurinol	POU5F1	rs3130931		Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	Q01860	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31167111.0	T	M
pharmgkb	debrisoquine,dextromethorphan,sparteine	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*44			Other	P10635							
pharmgkb	sparteine	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*7, CYP2D6*8, CYP2D6*11, CYP2D6*12, CYP2D6*41, CYP2D6*59, CYP2D6*62			Other	P10635	Drug						
pharmgkb	irinotecan	KCNQ5	rs9351963		Neoplasms	Toxicity	Q9NR82	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	6	73040138.0	A	C
pharmgkb	imatinib	BCL2L11	rs724710		Neoplasms	Efficacy	O43521	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	2	111150114.0	T	M
pharmgkb	tacrolimus	PPARA	rs4823613		Organ Transplantation	Other	Q07869	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	22	46202410.0	A	G
pharmgkb	Platinum compounds	ATP7B	rs9535828		Lung Neoplasms	Efficacy	P35670	Drug Class			13	51999286.0	G	H
pharmgkb	Platinum compounds	ATP7B	rs9535826		Lung Neoplasms	Efficacy	P35670	Drug Class			13	51991990.0	T	S
pharmgkb	repaglinide	NR1I2	rs2276706			Other	O75469	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	3	119782460.0	G	A
pharmgkb	repaglinide	NR1I2	rs3814058			Other	O75469	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	3	119818444.0	T	C
pharmgkb	opioids	OPRD1	rs2236861		Opioid-Related Disorders	Other	P41143	Drug Class			1	28813244.0	G	A
pharmgkb	opioids	GAL	rs948854		Opioid-Related Disorders	Other	P07902	Drug Class			11	68682735.0	C	T
pharmgkb	opioids	OPRM1	rs9479757		Opioid-Related Disorders	Other	P35372	Drug Class			6	154090209.0	G	A
pharmgkb	atenolol	PTGS2	rs4648287		Hypertension	Toxicity	P35354	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	1	186674818.0	A	G
pharmgkb	atenolol	PLA2G4A	rs10157410		Hypertension	Toxicity	P47712	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	1	186978092.0	G	C
pharmgkb	atenolol	GALNT2	rs2144297		Hypertension	Toxicity	P98088	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	1	230128097.0	T	S
pharmgkb	atenolol	GALNT2	rs2144300		Hypertension	Other	P98088	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	1	230159169.0	C	T
pharmgkb	atenolol	ABCB1	rs3213619		Hypertension	Toxicity	P08183	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	7	87600877.0	A	G
pharmgkb	atenolol	ABCB1	rs10267099		Hypertension	Toxicity	P08183	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	7	87649444.0	G	A
pharmgkb	atenolol	FTO	rs12595985		Hypertension	Toxicity	Q9C0B1	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	16	53842839.0	C	W
pharmgkb	atenolol	FTO	rs9940629		Hypertension	Toxicity	Q9C0B1	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	16	53970899.0	A	G
pharmgkb	Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan	HTR2A	rs6305			Toxicity	P28223				13	46892487.0	G	A
pharmgkb	Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan	DBH	rs1611115		Substance Withdrawal Syndrome	Other	Q6UVY6				9	133635393.0	T	C
pharmgkb	Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan	BDNF	V66M			Other	P23560				11	27658369.0	C	T
pharmgkb	Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan	DRD2	rs6275			Other	P14416				11	113412755.0	A	G
pharmgkb	allopurinol	HLA-A	HLA-A*02:01		severe cutaneous adverse reactions	Toxicity	P04439	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	itopride	FMO3	E95K			Other	P31513	Drug			1	171107825.0	G	A
pharmgkb	itopride	FMO3	E308G			Other	P31513	Drug			1	171114102.0	A	G
pharmgkb	hmg coa reductase inhibitors	HLA-G	rs1063320		Asthma	Efficacy	P17693	Drug Class			6	29830972.0	C	K
pharmgkb	dextromethorphan	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*13, CYP2D6*31, CYP2D6*69, CYP2D6*100, CYP2D6*101			Other	P10635	Drug	5360696.0	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC				
pharmgkb	allopurinol	HLA-B	HLA-B*48:01		Drug Hypersensitivity	Toxicity	P01889	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	allopurinol	HLA-C	HLA-C*08:01		Drug Hypersensitivity,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	azathioprine,mercaptopurine	HLA-DRB1	HLA-DRB1*07:01		Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis	Toxicity	P01911							
pharmgkb	azathioprine,mercaptopurine	HLA-DQA1	HLA-DQA1*02:01		Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis	Toxicity	P01909							
pharmgkb	clopidogrel	ITGB3	L59P		Coronary Artery Disease,Myocardial Infarction	Efficacy	P05106	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	17	47283364.0	T	C
pharmgkb	trichloroethylene	HLA-B	HLA-B*13:01		Drug Hypersensitivity	Toxicity	P01889	Drug	6575.0	C(=C(Cl)Cl)Cl				
pharmgkb	oxcarbazepine	HLA-B	HLA-B*13:02		Maculopapular Exanthema	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	carbamazepine	HLA-B	HLA-B*15:18		Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	oxcarbazepine	HLA-B	HLA-B*15:19		Maculopapular Exanthema	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	oxcarbazepine	HLA-B	HLA-B*15:27		Maculopapular Exanthema	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	oxcarbazepine	HLA-B	HLA-B*27:09		Maculopapular Exanthema	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	oxcarbazepine	HLA-B	HLA-B*38:02		Maculopapular Exanthema	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	HLA-B	HLA-B*38:01		Hepatitis C	Efficacy	P01889							
pharmgkb	oxcarbazepine	HLA-B	HLA-B*48:04		Maculopapular Exanthema	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	antiepileptics	HLA-B	HLA-B*58:01		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug Class						
pharmgkb	acetazolamide	HLA-B	HLA-B*59:01		Stevens-Johnson Syndrome	Toxicity	P01889	Drug	1986.0	CC(=O)NC1=NN=C(S1)S(=O)(=O)N				
pharmgkb	carbamazepine	HLA-B	HLA-B*59:01		Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	morphine	ABCB1	I1145M		Pain	Other	P08183	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	7	87509329.0	A	K
pharmgkb	carbamazepine	ABCC2	V417I		Epilepsy	Toxicity	Q5T2W1	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	10	99804058.0	G	A
pharmgkb	warfarin	VKORC1	P83L			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31091268.0	G	A
pharmgkb	acenocoumarol	VKORC1	P83L			Dosage	Q8N0U8	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	16	31091268.0	G	A
pharmgkb	acenocoumarol	VKORC1	D36Y			Dosage	Q8N0U8	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	16	31094624.0	C	W
pharmgkb	acenocoumarol	VKORC1	rs55894764			Dosage	Q8N0U8	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	16	31094694.0	C	W
pharmgkb	acenocoumarol	VKORC1	rs17878544			Dosage	Q8N0U8	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	16	31096606.0	T	C
pharmgkb	amoxicillin,clavulanate	HLA-B	HLA-B*18:01			Toxicity	P01889							
pharmgkb	sulfasalazine	HLA-B	HLA-B*39:01		drug reaction with eosinophilia and systemic symptoms	Toxicity	P01889	Drug	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O				
pharmgkb	sulfasalazine	HLA-B	HLA-B*13:01		drug reaction with eosinophilia and systemic symptoms	Toxicity	P01889	Drug	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O				
pharmgkb	sulfasalazine	HLA-B	HLA-B*15:05		drug reaction with eosinophilia and systemic symptoms	Toxicity	P01889	Drug	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O				
pharmgkb	phenprocoumon	PPARA	rs4253728			Dosage	Q07869	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	22	46214170.0	G	A
pharmgkb	simvastatin	UGT1A9	rs2003569			Efficacy	O60656	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	2	233759291.0	G	A
pharmgkb	cocaine	CNR1	rs6454674		Cocaine-Related Disorders	Other	P21554	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	6	88163211.0	T	G
pharmgkb	cocaine	CNR1	rs806368		Cocaine-Related Disorders	Other	P21554	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	6	88140381.0	T	C
pharmgkb	risperidone	NR1I2	rs7643645		Psychotic Disorders	Metabolism/PK	O75469	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3	119806650.0	A	G
pharmgkb	bevacizumab	CFH	H402Y		Macular Degeneration	Dosage	P08603	Drug			1	196690107.0	C	T
pharmgkb	tamoxifen	E2F7	rs310786			Efficacy	Q96AV8	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	12	77042368.0	C	T
pharmgkb	tamoxifen	E2F7	rs310786		Breast Neoplasms	Toxicity	Q96AV8	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	12	77042368.0	C	T
pharmgkb	antidepressants	CREB1	rs889895		Depressive Disorder, Major	Efficacy	P16220	Drug Class			2	207534205.0	A	G
pharmgkb	olanzapine	GSTM3	rs1799735			Metabolism/PK	P21266	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C				
pharmgkb	olanzapine	ANKK1	E713K			Metabolism/PK	Q8NFD2	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	113400106.0	G	A
pharmgkb	olanzapine	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6		Hypotension	Toxicity	P11712	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C				
pharmgkb	olanzapine	TPMT	TPMT*1, TPMT*3A, TPMT*3C		Fatigue	Toxicity	P51580	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C				
pharmgkb	olanzapine	UGT1A1	UGT1A1*1, UGT1A1*28		Fatigue	Toxicity	P22309	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C				
pharmgkb	galantamine	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41		Dementia	Metabolism/PK	P10635	Drug	9651.0	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O				
pharmgkb	metformin	SLC22A1	M408V		Diabetes Mellitus, Type 2	Efficacy	O15245	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160139813.0	A	S
pharmgkb	Platinum compounds	XBP1	rs2269577		Carcinoma, Non-Small-Cell Lung	Efficacy,Toxicity	P17861	Drug Class			22	28800769.0	G	C
pharmgkb	nevirapine	CYP2B6	rs58425034		HIV Infections	Other	P20813	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	19	41009060.0	G	C
pharmgkb	fluoxetine	HTR1A	rs6295		Depressive Disorder, Major	Efficacy	P08908	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	5	63962738.0	C	G
pharmgkb	docetaxel	ABCC2	rs12762549			Toxicity,Metabolism/PK	Q5T2W1	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	10	99861014.0	C	K
pharmgkb	deferiprone	UGT1A6	S7A		beta-Thalassemia	Efficacy,Toxicity	P19224	Drug	2972.0	CC1=C(C(=O)C=CN1C)O	2	233693023.0	T	G
pharmgkb	clozapine,olanzapine	TBC1D1	rs9852		Schizophrenia	Toxicity	Q86TI0				4	38137403.0	C	T
pharmgkb	ethanol	ADH1B	H48R			Metabolism/PK	P00325	Drug	702.0	CCO	4	99318162.0	T	S
pharmgkb	metformin	SLC22A1	rs72552763			Metabolism/PK	O15245	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160139851.0	GAT	-
pharmgkb	pemetrexed	DHFR	rs442767		Carcinoma, Non-Small-Cell Lung	Toxicity	P00374	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	5	80655677.0	G	T
pharmgkb	mycophenolate mofetil	SLCO1B1	V174A		Kidney Transplantation	Toxicity	Q9Y6L6	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	12	21178615.0	T	C
pharmgkb	atomoxetine	SLC6A2	rs3785143		Attention Deficit Disorder with Hyperactivity	Efficacy	P23975	Drug	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	16	55661194.0	C	T
pharmgkb	olanzapine	ABCB1	I1145M		Psychotic Disorders	Other	P08183	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	7	87509329.0	A	K
pharmgkb	aspirin	TBXA2R	rs4523			Efficacy	P21731	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	19	3595796.0	A	G
pharmgkb	bevacizumab	CXCL8	rs4073		Macular Degeneration	Efficacy	P98066	Drug			4	73740307.0	A	T
pharmgkb	mycophenolate mofetil	CYP2C8	rs11572076		Kidney Transplantation	Toxicity	P10632	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	10	95067393.0	C	T
pharmgkb	gemcitabine	DAPK1	rs11141915		Neoplasms	Toxicity	P53355	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	9	87620879.0	A	C
pharmgkb	rituximab	IL2	rs6822844		Lupus Erythematosus, Systemic	Efficacy	P60568	Drug			4	122588266.0	G	T
pharmgkb	cyclophosphamide	CYP2B6	CYP2B6*1, CYP2B6*6		Leukemia, Lymphocytic, Chronic, B-Cell	Efficacy,Toxicity	P20813	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl				
pharmgkb	citalopram	BDNF	rs7124442		Depressive Disorder, Major	Efficacy	P23560	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	11	27655494.0	C	K
pharmgkb	efavirenz,nelfinavir	ABCB1	I1145M		HIV Infections	Efficacy,Toxicity	P08183				7	87509329.0	A	K
pharmgkb	doxorubicin	GSTA1	rs3957357		Sarcoma	Efficacy	P08263	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	6	52803889.0	A	G
pharmgkb	bevacizumab,pegaptanib,ranibizumab	VEGFA	rs2010963		Choroidal Neovascularization	Efficacy	P15692				6	43770613.0	C	G
pharmgkb	ustekinumab	HLA-C	HLA-C*06:02		Psoriasis	Efficacy	P10321	Drug						
pharmgkb	capecitabine	DPYD	rs76387818		Colorectal Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97073844.0	G	A
pharmgkb	capecitabine	DPYD	rs12022243		Colorectal Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97397224.0	C	T
pharmgkb	capecitabine	ENOSF1	rs2741171		Colorectal Neoplasms	Toxicity	Q7L5Y1	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	18	700687.0	T	S
pharmgkb	methamphetamine	GRIN1	rs1126442		Psychotic Disorders	Toxicity	Q7Z2K8	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	9	137156924.0	G	A
pharmgkb	dextroamphetamine,methylphenidate	DRD1	rs4532		Attention Deficit Disorder with Hyperactivity	Toxicity	P21728				5	175443147.0	C	T
pharmgkb	fluticasone propionate,montelukast	CA10	rs967676		Asthma	Efficacy	Q5TGZ0				17	51882949.0	T	C
pharmgkb	escitalopram	IL11	rs1126757		Depression	Efficacy	P20809	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	19	55368504.0	C	K
pharmgkb	fluorouracil	EGFR	rs2293347		Stomach Neoplasms	Efficacy	P00533	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	7	55201223.0	C	T
pharmgkb	methylphenidate	DRD3	G9S		Autism Spectrum Disorder	Efficacy	P35462	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	3	114171968.0	C	T
pharmgkb	egfr inhibitors	EGFR	R521K		Carcinoma, Non-Small-Cell Lung,Colorectal Neoplasms,Neoplasms,Pancreatic Neoplasms	Toxicity	P00533	Drug Class			7	55161562.0	G	H
pharmgkb	cetuximab,irinotecan,panitumumab	AREG	rs1353295		Colorectal Neoplasms	Efficacy	P15514				4	74463405.0	G	A
pharmgkb	cetuximab,irinotecan,panitumumab	AREG	rs13104811		Colorectal Neoplasms	Efficacy	P15514				4	74529595.0	G	A
pharmgkb	cetuximab,irinotecan,panitumumab	AREG	rs9996584		Colorectal Neoplasms	Efficacy	P15514				4	74556244.0	A	G
pharmgkb	cetuximab,irinotecan,panitumumab	AREG	rs11942466		Colorectal Neoplasms	Efficacy	P15514				4	74556361.0	C	A
pharmgkb	cetuximab,irinotecan,panitumumab	EGFR	rs712829		Colorectal Neoplasms	Efficacy	P00533				7	55019062.0	G	Y
pharmgkb	irinotecan	UGT1A1	UGT1A1*60		Neoplasms	Efficacy	P22309	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7				
pharmgkb	sunitinib	CYP3A5	rs776746		Carcinoma, Renal Cell	Dosage,Toxicity	P20815	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	7	99672916.0	T	C
pharmgkb	aspirin	HLA-DPB1	HLA-DPB1*04:01		Asthma	Toxicity	P04440	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O				
pharmgkb	Antiinflammatory agents, non-steroids	HLA-DRB1	HLA-DRB1*11:01		anaphylactoid reaction	Toxicity	P01911	Drug Class						
pharmgkb	tiotropium	ADRB2	R16G		Asthma	Efficacy	P07550	Drug	5487426.0	C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]	5	148826877.0	G	A
pharmgkb	topiramate	GRIK1	rs2832407		Alcohol-Related Disorders	Efficacy,Metabolism/PK	P39086	Drug	5284627.0	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C	21	29595188.0	C	W
pharmgkb	docetaxel	ORM2	S1184P		Prostatic Neoplasms	Metabolism/PK	P19652	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	9	114341693.0	A	K
pharmgkb	sulfonamides, urea derivatives	KCNJ11	K23Q		Diabetes Mellitus, Type 2	Efficacy	Q14654	Drug Class			11	17388025.0	T	M
pharmgkb	benazepril,imidapril	AGT	rs5051		Hypertension	Efficacy	Q9BYV1				1	230714126.0	C	K
pharmgkb	deferasirox	ABCC2	V417I		beta-Thalassemia	Metabolism/PK	Q5T2W1	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	10	99804058.0	G	A
pharmgkb	Platinum compounds	ERCC3	rs3738948		Carcinoma, Non-Small-Cell Lung	Efficacy	P19447	Drug Class			2	127260487.0	A	S
pharmgkb	Platinum compounds	XPA	rs1800975		Carcinoma, Non-Small-Cell Lung	Efficacy	P23025	Drug Class			9	97697296.0	T	S
pharmgkb	Platinum compounds	ERCC4	rs1799801		Carcinoma, Non-Small-Cell Lung	Efficacy	Q92889	Drug Class			16	13948101.0	T	C
pharmgkb	Platinum compounds	APLF	rs3213239		Carcinoma, Non-Small-Cell Lung	Efficacy	Q8IW19	Drug Class			19	43576908.0	-	GGCC
pharmgkb	Platinum compounds	ERCC2	rs13181		Carcinoma, Non-Small-Cell Lung	Toxicity	P18074	Drug Class			19	45351661.0	T	R
pharmgkb	Platinum compounds	CXXC4	rs4413407		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9H2H0	Drug Class			4	104472204.0	A	K
pharmgkb	Platinum compounds	WNT5B	rs12819505		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9H1J7	Drug Class			12	1647499.0	A	G
pharmgkb	Platinum compounds	WIF1	rs10878232		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9Y5W5	Drug Class			12	65128867.0	T	V
pharmgkb	Platinum compounds	AXIN2	rs11868547		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9Y2T1	Drug Class			17	65527485.0	G	H
pharmgkb	Platinum compounds	AXIN2	rs4541111		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9Y2T1	Drug Class			17	65538420.0	C	A
pharmgkb	methotrexate	MTR	rs3768142		Agranulocytosis	Toxicity	Q13613	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	236865264.0	G	T
pharmgkb	antidepressants	CRHR1	rs28364032		Depressive Disorder, Major	Efficacy	P34998	Drug Class			17	45834976.0	G	A
pharmgkb	citalopram	NEDD4L	rs520210		Depression	Efficacy	Q96PU5	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	18	58140841.0	G	A
pharmgkb	rosiglitazone	PAX4	rs6467136		Diabetes Mellitus, Type 2	Efficacy	O43316	Drug	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	7	127524904.0	A	K
pharmgkb	pemetrexed	DHFR	I79L		Carcinoma, Non-Small-Cell Lung,Mesothelioma	Toxicity	P00374	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	5	80654962.0	A	K
pharmgkb	pemetrexed	GGH	T151I		Carcinoma, Non-Small-Cell Lung	Toxicity	Q92820	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	8	63026205.0	G	A
pharmgkb	pemetrexed	FOLR3	R98C		Carcinoma, Non-Small-Cell Lung,Mesothelioma	Efficacy	P41439	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	11	72139084.0	C	T
pharmgkb	pemetrexed	SLC19A1	rs3788189		Carcinoma, Non-Small-Cell Lung,Mesothelioma	Efficacy	P41440	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	21	45516669.0	T	G
pharmgkb	pemetrexed	SLC19A1	rs914232		Carcinoma, Non-Small-Cell Lung,Mesothelioma	Efficacy	P41440	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	21	45532836.0	T	C
pharmgkb	risperidone	ABCB1	I1145M		Schizophrenia	Toxicity	P08183	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	7	87509329.0	A	K
pharmgkb	Platinum compounds	ERCC2	rs1052555		Carcinoma, Non-Small-Cell Lung	Efficacy	P18074	Drug Class			19	45352266.0	G	A
pharmgkb	carbamazepine	HLA-B	HLA-B*51:01		Drug Hypersensitivity	Toxicity	P01889	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	aspirin	CYP2D6	rs28360521			Toxicity	P10635	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	22	42132969.0	C	T
pharmgkb	capecitabine,fluorouracil	EXO1	E589Q		Neoplasm Metastasis	Efficacy	Q9UQ84				1	241878999.0	G	A
pharmgkb	capecitabine,fluorouracil	UMPS	rs2291078		Neoplasm Metastasis	Efficacy	P11172				3	124740091.0	T	A
pharmgkb	capecitabine,fluorouracil	UMPS	I446V		Neoplasm Metastasis	Efficacy	P11172				3	124743977.0	A	G
pharmgkb	capecitabine,fluorouracil	UMPS	rs3772810		Neoplasm Metastasis	Efficacy	P11172				3	124744112.0	A	G
pharmgkb	capecitabine,fluorouracil	REV3L	R2684Q		Neoplasm Metastasis	Efficacy	O60673				6	111322635.0	C	T
pharmgkb	carvedilol	ADRB2	Q27E		Heart Failure	Efficacy	P07550	Drug	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	5	148826910.0	G	Y
pharmgkb	capecitabine,fluorouracil	ABCB1	rs17160359		Neoplasm Metastasis	Efficacy	P08183				7	87717503.0	G	W
pharmgkb	capecitabine,fluorouracil	DLG5	P1481Q		Neoplasm Metastasis	Efficacy	Q8TDM6				10	77811115.0	G	H
pharmgkb	capecitabine,fluorouracil	PTEN	rs17431184		Neoplasm Metastasis	Efficacy	P60484				10	87960494.0	T	C
pharmgkb	capecitabine,fluorouracil	CYP19A1	W39R		Neoplasm Metastasis	Efficacy	P11511				15	51242798.0	A	G
pharmgkb	aspirin	CHIA	G102R		aspirin-induced asthma	Toxicity	Q9BZP6	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	111314586.0	G	M
pharmgkb	acetaminophen	UGT1A	rs8330		Liver Failure, Acute	Toxicity	Q9HAW7	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	2	233772999.0	G	C
pharmgkb	aspirin	SLC30A9	M50L		aspirin-induced asthma	Toxicity	Q6PML9	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	4	42001654.0	A	S
pharmgkb	aspirin	HLA-DPB1	rs3097671		aspirin-induced asthma	Toxicity	P04440	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	6	33079835.0	G	C
pharmgkb	aspirin	HLA-DPB1	I94L		aspirin-induced asthma,Asthma	Toxicity	P04440	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	6	33080851.0	A	Y
pharmgkb	aspirin	HLA-DPB1	M105V		aspirin-induced asthma,Asthma	Toxicity	P04440	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	6	33080884.0	A	G
pharmgkb	aspirin	HLA-DPB2	rs3129294		aspirin-induced asthma,Asthma	Toxicity		Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	6	33116894.0	A	C
pharmgkb	aspirin	TSC1	rs7862221		aspirin-induced asthma,Asthma	Toxicity	Q92574	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	9	132906834.0	T	C
pharmgkb	aspirin	THRA	rs11819745		aspirin-induced asthma,Asthma	Toxicity	Q9Y6Q9	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	10	37501484.0	G	W
pharmgkb	metformin	CAPN10	rs3792269		Diabetes Mellitus	Efficacy	Q9HC96	Drug	4091.0	CN(C)C(=N)N=C(N)N	2	240592062.0	A	G
pharmgkb	latanoprost	PTGS1	rs10306114		Glaucoma, Open-Angle	Efficacy	P23219	Drug	5282380.0	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	9	122370243.0	A	G
pharmgkb	latanoprost	ABCC4	G187W		Glaucoma, Open-Angle	Efficacy	O15439	Drug	5282380.0	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	13	95210754.0	C	A
pharmgkb	pioglitazone	ADIPOQ	rs2241766		Diabetes Mellitus	Efficacy	Q86V24	Drug	4829.0	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	3	186853103.0	T	S
pharmgkb	valproic acid	SOD2	V16A		Epilepsy	Toxicity	P04179	Drug	3121.0	CCCC(CCC)C(=O)O	6	159692840.0	A	G
pharmgkb	imatinib	SLC22A4	L503F		Gastrointestinal Stromal Tumors,Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	Q9H015	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	5	132340627.0	C	T
pharmgkb	metformin	SP1	rs2683511		Diabetes Mellitus	Efficacy,Metabolism/PK	P08047	Drug	4091.0	CN(C)C(=N)N=C(N)N	12	53410706.0	C	T
pharmgkb	metformin	PPARA	rs149711321		Diabetes Mellitus	Efficacy,Metabolism/PK	Q07869	Drug	4091.0	CN(C)C(=N)N=C(N)N	22	46198138.0	T	C
pharmgkb	hmg coa reductase inhibitors	CELSR2	rs646776			Efficacy	Q9HCU4	Drug Class			1	109275908.0	C	T
pharmgkb	hmg coa reductase inhibitors	SLCO1B1	rs2900478			Efficacy	Q9Y6L6	Drug Class			12	21215863.0	T	A
pharmgkb	insulin recombinant,zinc acetate	SLC30A8	R276W			Efficacy	Q8IWU4				8	117172544.0	C	W
pharmgkb	interferon alfa-2a, recombinant,interferon alfa-2b, recombinant,ribavirin	FTO	rs9939609		Hepatitis C, Chronic,HIV Infections	Efficacy	Q9C0B1				16	53786615.0	T	A
pharmgkb	caffeine	CYP1A2	CYP1A2*1A, CYP1A2*1F		Abortion, Spontaneous	Toxicity	P05177	Drug	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C				
pharmgkb	clonidine	GNB3	rs5443		Liver Cirrhosis	Efficacy	P16520	Drug	2803.0	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	12	6845711.0	C	T
pharmgkb	imatinib	GSTT1	GSTT1 non-null, GSTT1 null		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	P30711	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5				
pharmgkb	Antihypertensives,Beta Blocking Agents	GRK5	Q41L		Heart Diseases	Efficacy	P34947				10	119326585.0	A	T
pharmgkb	nevirapine	CYP2B6	rs2054675		HIV Infections	Toxicity	P20813	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	19	40989850.0	T	C
pharmgkb	nevirapine	CYP2B6	rs3786547		HIV Infections	Toxicity	P20813	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	19	41000286.0	T	C
pharmgkb	risperidone	HRH3	rs3787430		Schizophrenia	Efficacy	Q9Y5N1	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	20	62216366.0	C	K
pharmgkb	rituximab	TGFB1	P10R		Arthritis, Rheumatoid	Efficacy	P01137	Drug			19	41353016.0	G	M
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNFRSF10A	R209T		Arthritis	Efficacy	O00220	Drug Class			8	23201811.0	C	G
pharmgkb	imatinib	SLC22A5	rs2631367		Gastrointestinal Stromal Tumors	Efficacy	O76082	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	5	132369766.0	C	G
pharmgkb	irinotecan	UGT1A6	T181A		Colorectal Neoplasms	Toxicity	P19224	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	2	233693545.0	A	G
pharmgkb	haloperidol	COMT	V158M		Schizophrenia	Toxicity	P21964	Drug	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	22	19963748.0	G	A
pharmgkb	lamivudine,lopinavir,ritonavir,zidovudine	ABCC1	rs212091		HIV Infections	Efficacy	P33527				16	16142793.0	T	M
pharmgkb	eculizumab	CR1	H1658R		paroxysmal nocturnal hemoglobinuria	Efficacy	P17927	Drug			1	207580276.0	A	G
pharmgkb	docetaxel	VEGFA	rs35864111		Breast Neoplasms	Efficacy	P15692	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	6	43768801.0	-	G
pharmgkb	docetaxel	VEGFA	rs13207351		Breast Neoplasms	Efficacy	P15692	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	6	43770057.0	A	K
pharmgkb	imatinib	ABCG2	rs12505410		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	Q9UNQ0	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	4	88109689.0	T	S
pharmgkb	imatinib	ABCG2	rs13120400		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	Q9UNQ0	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	4	88112375.0	T	C
pharmgkb	imatinib	ABCG2	rs2725252		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	Q9UNQ0	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	4	88140758.0	C	W
pharmgkb	levodopa	HOMER1	rs4704559		Parkinson Disease	Toxicity	Q86YM7	Drug, Biological Intermediate	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	5	79517086.0	A	G
pharmgkb	warfarin	GGCX	rs2592551		Atrial Fibrillation	Dosage	P38435	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	85553008.0	G	A
pharmgkb	busulfan	CYP2C19	rs12248560		hemopoietic stem cell transplant	Metabolism/PK	P33261	Drug	2478.0	CS(=O)(=O)OCCCCOS(=O)(=O)C	10	94761900.0	C	W
pharmgkb	busulfan	CYP2C9	R144C		hemopoietic stem cell transplant	Metabolism/PK	P11712	Drug	2478.0	CS(=O)(=O)OCCCCOS(=O)(=O)C	10	94942290.0	C	T
pharmgkb	imatinib	CYP2B6	Q172H		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy,Toxicity	P20813	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	19	41006936.0	G	W
pharmgkb	corticosteroids	HDAC1	rs1741981		Asthma	Efficacy	Q13547	Drug Class			1	32290838.0	T	M
pharmgkb	sulfasalazine	ABCG2	Q141K		Arthritis, Rheumatoid	Efficacy	Q9UNQ0	Drug	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	4	88131171.0	G	Y
pharmgkb	imatinib	SLC22A1	L160F		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy,Metabolism/PK	O15245	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	6	160130172.0	G	H
pharmgkb	SN-38	UGT1A9	rs3806598			Metabolism/PK	O60656	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	2	233671246.0	A	C
pharmgkb	SN-38	UGT1A9	rs2741049			Metabolism/PK	O60656	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	2	233673188.0	T	C
pharmgkb	donepezil,galantamine,rivastigmine	CHRNA7	rs6494223		Alzheimer Disease	Efficacy	P36544				15	32104256.0	C	T
pharmgkb	cyclosporine	CYP3A4	rs4646437		Kidney Transplantation	Efficacy,Metabolism/PK	P08684	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	99767460.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IL1B	rs4848306		Colitis, Ulcerative,Inflammatory Bowel Diseases	Efficacy	P01584	Drug Class			2	112840530.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IL1RN	rs4251961		Colitis, Ulcerative	Efficacy	P18510	Drug Class			2	113116890.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TLR9	rs352139		Crohn Disease,Inflammatory Bowel Diseases	Efficacy	Q9NR96	Drug Class			3	52224356.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TLR2	rs4696480		Colitis, Ulcerative	Efficacy	O60603	Drug Class			4	153685974.0	T	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TLR2	rs1816702		Crohn Disease	Efficacy	O60603	Drug Class			4	153688371.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TLR2	rs3804099		Inflammatory Bowel Diseases	Efficacy	O60603	Drug Class			4	153703504.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	CD14	rs2569190		Colitis, Ulcerative	Efficacy	P08571	Drug Class			5	140633331.0	A	G
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IL17A	rs2275913		Colitis, Ulcerative,Inflammatory Bowel Diseases	Efficacy	Q16552	Drug Class			6	52186235.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNFAIP3	rs6927172		Colitis, Ulcerative,Inflammatory Bowel Diseases	Efficacy	Q8NFZ5	Drug Class			6	137681038.0	C	D
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IL6	rs10499563		Colitis, Ulcerative,Inflammatory Bowel Diseases	Efficacy	P05231	Drug Class			7	22720869.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TLR4	rs5030728		Inflammatory Bowel Diseases	Efficacy	O00206	Drug Class			9	117712004.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	CNPY4	rs1554973		Inflammatory Bowel Diseases	Efficacy	Q8N129	Drug Class			9	117718534.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNFRSF1A	rs4149570		Crohn Disease,Inflammatory Bowel Diseases	Efficacy	Q15628	Drug Class			12	6342424.0	A	B
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IFNG	rs2430561		Crohn Disease,Inflammatory Bowel Diseases	Efficacy	P01579	Drug Class			12	68158742.0	T	A
pharmgkb	tacrolimus	KCNQ1	rs2237895		Kidney Transplantation	Toxicity	P51787	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	11	2835964.0	A	Y
pharmgkb	tacrolimus	IL10	rs1800896		liver transplantation	Dosage	P22301	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	206773552.0	T	C
pharmgkb	tacrolimus	IL10	rs1800872		liver transplantation	Dosage	P22301	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	206773062.0	T	G
pharmgkb	tacrolimus	IL10	rs1800871		liver transplantation	Dosage	P22301	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	206773289.0	A	G
pharmgkb	tacrolimus	ABCB1	I1145M		Kidney Transplantation	Toxicity	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87509329.0	A	K
pharmgkb	gemcitabine	CMPK1	rs11211524		Neoplasms	Efficacy	P30085	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	47367541.0	A	C
pharmgkb	hmg coa reductase inhibitors	ABCB1	I1145M			Other	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	methylphenobarbital	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*16			Metabolism/PK	P33261	Drug	8271.0	CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2				
pharmgkb	gemcitabine	CDA	rs1048977		Neoplasms	Other	Q96GN5	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	20618562.0	C	T
pharmgkb	vitamin e	CYP4F2	V433M			Metabolism/PK	P78329	Drug	14985.0	CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O	19	15879621.0	C	T
pharmgkb	succinylcholine	BCHE	T271M			Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165830222.0	G	A
pharmgkb	isoproterenol	ADRB2	R16G			Other	P07550	Drug	3779.0	CC(C)NCC(C1=CC(=C(C=C1)O)O)O	5	148826877.0	G	A
pharmgkb	clozapine	NTRK2	rs10465180		Schizophrenia	Efficacy	Q16620	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	9	84777667.0	C	T
pharmgkb	clozapine	NTRK2	rs1778929		Schizophrenia	Efficacy	Q16620	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	9	84707625.0	T	C
pharmgkb	clozapine	FKBP5	rs1360780		Schizophrenia	Efficacy	Q13451	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	6	35639794.0	T	M
pharmgkb	nevirapine	TRAF3IP2	rs76228616		HIV Infections	Toxicity	O43734	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	6	111601300.0	G	C
pharmgkb	aspirin	TAPBP	rs1059288		Asthma	Toxicity	O15533	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	6	33299895.0	A	G
pharmgkb	aspirin	TAPBP	T260R		Asthma	Toxicity	O15533	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	6	33305078.0	G	C
pharmgkb	dasatinib,imatinib	ABCG2	A528T			Other	Q9UNQ0				4	88097518.0	C	T
pharmgkb	dasatinib,imatinib	ABCG2	L525R			Other	Q9UNQ0				4	88097526.0	A	C
pharmgkb	dasatinib,imatinib,nilotinib	ABCG2	D296H			Other	Q9UNQ0				4	88115014.0	C	G
pharmgkb	dasatinib,imatinib,nilotinib	ABCG2	F208S			Other	Q9UNQ0				4	88121701.0	A	G
pharmgkb	imatinib	ABCG2	Q141K			Metabolism/PK	Q9UNQ0	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	4	88131171.0	G	Y
pharmgkb	dasatinib,imatinib,nilotinib	ABCG2	V12M			Other	Q9UNQ0				4	88139962.0	C	T
pharmgkb	phenprocoumon	STX4	rs10871454			Dosage	Q12846	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31036758.0	C	T
pharmgkb	phenprocoumon	CYP2C9	rs4086116			Dosage	P11712	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94947445.0	C	T
pharmgkb	nicotine	FMO1	M1T			Other	Q01740	Drug	942.0	CN1CCCC1C2=CN=CC=C2	1	171258077.0	T	C
pharmgkb	nicotine	FMO1	rs7877			Other	Q01740	Drug	942.0	CN1CCCC1C2=CN=CC=C2	1	171285751.0	C	T
pharmgkb	XK469	AOX1	rs10931910			Metabolism/PK	Q06278	Drug	148183.0	CC(C(=O)O)OC1=CC=C(C=C1)OC2=CN=C3C=CC(=CC3=N2)Cl	2	200659013.0	A	K
pharmgkb	tamoxifen	RRAS2	rs11023197		Breast Neoplasms	Efficacy	P62070	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	11	14359452.0	G	A
pharmgkb	gemcitabine,Platinum compounds	RRM1	rs11030918		Mesothelioma	Toxicity	Q9UET6				11	4094257.0	T	C
pharmgkb	celecoxib	ALOX12	rs11078659		Colorectal Neoplasms	Efficacy,Toxicity	P18054	Drug	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	17	7000625.0	G	M
pharmgkb	nicotine	UGT2B10	N481D			Metabolism/PK	P36537	Drug	942.0	CN1CCCC1C2=CN=CC=C2	4	68830733.0	A	G
pharmgkb	aspirin	PTGIR	rs1126510		Asthma	Toxicity	P43119	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	19	46620526.0	A	G
pharmgkb	tenofovir	OCRL	rs113165732		HIV Infections	Other	Q01968	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	X	129576236.0	C	K
pharmgkb	escitalopram	HTR1B	rs11568817		Anxiety Disorders	Toxicity	P28222	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	6	77463665.0	A	C
pharmgkb	citalopram	PAPLN	rs11628713		Depressive Disorder, Major	Toxicity	O95428	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	14	73255067.0	C	T
pharmgkb	verapamil	NR1H3	rs12221497		Hypertension	Toxicity	Q13133	Drug	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	11	47259102.0	G	A
pharmgkb	nevirapine	CYP2C19	rs12768009		HIV Infections	Metabolism/PK	P33261	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	10	94766108.0	G	A
pharmgkb	gemcitabine,Platinum compounds	RRM1	rs12806698		Mesothelioma	Toxicity	Q9UET6				11	4094744.0	C	A
pharmgkb	hmg coa reductase inhibitors	CFAP44	rs13064411			Efficacy	Q96MT7	Drug Class			3	113327793.0	A	G
pharmgkb	aspirin	PTGER2	rs1353411		Asthma	Toxicity	P35408	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	14	52314383.0	G	A
pharmgkb	nicotine	CYP2A6	E390Q			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40844766.0	C	K
pharmgkb	nicotine	CYP2A6	R265Q			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40846912.0	C	K
pharmgkb	nicotine	CYP2A6	V68M			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40849959.0	C	T
pharmgkb	peginterferon alfa-2a,ribavirin	VDR	rs1544410		Hepatitis C	Toxicity	P11473				12	47846052.0	C	D
pharmgkb	levodopa	DBH	rs1611115		Cocaine-Related Disorders	Efficacy	Q6UVY6	Drug, Biological Intermediate	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	9	133635393.0	T	C
pharmgkb	methotrexate	ABCC4	rs9516519		Leukemia, B-Cell, Acute	Toxicity	O15439	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	13	95020203.0	T	S
pharmgkb	quetiapine	CYP3A5	rs776746			Metabolism/PK	P20815	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	7	99672916.0	T	C
pharmgkb	Antiinflammatory agents, non-steroids	PTGS1	rs10306135		Acute coronary syndrome	Toxicity	P23219	Drug Class			9	122375416.0	A	T
pharmgkb	warfarin	THBD	rs1042580			Toxicity	P07204	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	20	23046984.0	T	C
pharmgkb	radiotherapy	CDK1	rs10711		pneumonitis	Toxicity	P06493	Drug Class			10	60794716.0	T	G
pharmgkb	paclitaxel	FGD4	rs10771973			Toxicity	Q96M96	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	12	32640040.0	G	A
pharmgkb	radiotherapy	PRKCE	rs11125035			Toxicity	Q02156	Drug Class			2	45828910.0	T	A
pharmgkb	Ace Inhibitors, Plain,Angiotensin II Antagonists,Beta Blocking Agents,digoxin,diuretics,spironolactone	NOS3	D298E		Heart Failure	Efficacy	P29474				7	150999023.0	T	R
pharmgkb	enalapril	BDKRB2	rs1799722			Efficacy	P30411	Drug	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	14	96204802.0	C	T
pharmgkb	enalapril,imidapril,lisinopril	BDKRB2	rs1799722		Cough,Essential hypertension	Toxicity	P30411				14	96204802.0	C	T
pharmgkb	Bisphosphonates	KCNT2	rs1886629		Osteonecrosis	Toxicity	Q6UVM3	Drug Class			1	196185768.0	C	T
pharmgkb	sildenafil	NOS3	rs2070744		Erectile Dysfunction	Efficacy	P29474	Drug	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	7	150992991.0	C	T
pharmgkb	adalimumab,etanercept,infliximab,Tumor necrosis factor alpha (TNF-alpha) inhibitors	TRAF1	rs3761847		Arthritis, Rheumatoid	Efficacy	Q13077				9	120927961.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNF	rs1799964		Spondylitis, Ankylosing	Efficacy	Q9UNG2	Drug Class			6	31574531.0	T	C
pharmgkb	methadone	ALDH5A1	H180Y		Opioid-Related Disorders	Efficacy	P51649	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	6	24503362.0	C	T
pharmgkb	risperidone	CCL2	rs2857657		Schizophrenia	Efficacy	P13500	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	17	34256113.0	G	C
pharmgkb	phenobarbital	ABCB1	I1145M		Epilepsy	Efficacy	P08183	Drug	4763.0	CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2	7	87509329.0	A	K
pharmgkb	venlafaxine	CYP2C19	rs4244285		Depression	Toxicity	P33261	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	10	94781859.0	G	M
pharmgkb	etravirine	CYP2C19	rs4244285		HIV Infections	Metabolism/PK	P33261	Drug	193962.0	CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N	10	94781859.0	G	M
pharmgkb	atomoxetine	SLC6A2	rs12708954		Attention Deficit Disorder with Hyperactivity	Efficacy	P23975	Drug	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	16	55697687.0	C	A
pharmgkb	gemcitabine	ALG10	rs1705772			Toxicity	Q5BKT4	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	12	34021821.0	G	A
pharmgkb	rosuvastatin	FMO3	V194M			Efficacy	P31513	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	1	171110939.0	G	A
pharmgkb	Ace Inhibitors, Plain	ACE	rs1799752			Toxicity	P12821	Drug Class			17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	olanzapine,risperidone	DRD2	rs1799978		Schizophrenia	Efficacy	P14416				11	113475629.0	T	C
pharmgkb	interferons,ribavirin	BCL2	A43T		Hepatitis C	Efficacy	P10415				18	63318540.0	C	T
pharmgkb	adalimumab,etanercept,infliximab	IL6	rs1800795		Arthritis, Rheumatoid	Efficacy	P05231				7	22727026.0	C	G
pharmgkb	timolol	ADRB1	S49G			Efficacy	P08588	Drug	33624.0	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O	10	114044277.0	A	G
pharmgkb	warfarin	EPHX1	rs1877724			Dosage	P07099	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	1	225825654.0	C	T
pharmgkb	fluoxetine	ABCB1	S893A		Depressive Disorder	Efficacy	P08183	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	7	87531302.0	A	Y
pharmgkb	aspirin	PTGER2	rs2075797		Asthma	Toxicity	P35408	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	14	52313933.0	C	G
pharmgkb	paroxetine	GDNF	rs2216711		Depressive Disorder, Major	Efficacy	P39905	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	5	37828742.0	G	M
pharmgkb	tenofovir	ABCC2	rs8187707		HIV Infections	Toxicity	Q5T2W1	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	10	99850776.0	C	T
pharmgkb	vardenafil	CYP3A5	rs776746			Metabolism/PK	P20815	Drug	110634.0	CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C	7	99672916.0	T	C
pharmgkb	aspirin	PTGER3	rs7551789		Asthma	Toxicity	P43115	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	71049286.0	A	T
pharmgkb	aspirin	ACE	rs4292		Asthma	Toxicity	P12821	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	17	63476980.0	C	T
pharmgkb	aspirin	ACE	rs4291		Asthma	Toxicity	P12821	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	17	63476833.0	T	M
pharmgkb	aspirin	TLR3	L412V		Asthma	Toxicity	O15455	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	4	186082920.0	C	K
pharmgkb	aspirin	AGT	rs5050			Toxicity	Q9BYV1	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	230714140.0	T	S
pharmgkb	olanzapine,quetiapine,risperidone,ziprasidone	EIF2AK4	rs2412459		Schizophrenia	Efficacy	Q9P2K8				15	40003758.0	C	T
pharmgkb	haloperidol	EIF2AK4	rs2412459		Schizophrenia	Efficacy	Q9P2K8	Drug	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	15	40003758.0	C	T
pharmgkb	celecoxib	IL23R	rs7518660		Colorectal Neoplasms	Toxicity	Q5VWK5	Drug	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	1	67219760.0	G	A
pharmgkb	mycophenolate mofetil	UGT2B7	rs7438135		Kidney Transplantation	Toxicity	P16662	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	4	69095621.0	G	A
pharmgkb	methotrexate	SLC16A7	T445S		Arthritis, Juvenile Rheumatoid	Efficacy	O60669	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	59779575.0	A	K
pharmgkb	metformin	SLC47A2	rs34834489			Metabolism/PK	Q86VL8	Drug	4091.0	CN(C)C(=N)N=C(N)N	17	19716951.0	G	A
pharmgkb	metformin	SLC22A1	rs36056065		Diabetes Mellitus, Type 2	Toxicity	O15245	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160139876.0	GTAAGTTG	-
pharmgkb	sunitinib	FLT4	T494A		Carcinoma, Renal Cell	Efficacy	P35916	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	5	180624003.0	T	M
pharmgkb	sunitinib	FLT4	R1324L		Carcinoma, Renal Cell	Efficacy	P35916	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	5	180603313.0	C	D
pharmgkb	simvastatin	SLCO1B1	rs4149081		Coronary Disease	Efficacy	Q9Y6L6	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	12	21225087.0	G	A
pharmgkb	topiramate,zonisamide	CA12	rs4984241			Other	P02458				15	63331264.0	A	G
pharmgkb	cytarabine,idarubicin	NT5C3A	rs3750117		Leukemia, Myeloid, Acute	Efficacy	Q9H0P0				7	33021334.0	A	G
pharmgkb	topiramate,zonisamide	CA12	rs2306719			Other	P02458				15	63341039.0	T	C
pharmgkb	Selective serotonin reuptake inhibitors	DRD2	rs2734833		Depressive Disorder, Major	Efficacy	P14416	Drug Class			11	113422198.0	G	A
pharmgkb	verapamil	NR1H3	S99R		Coronary Artery Disease,Hypertension	Toxicity	Q13133	Drug	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	11	47260473.0	C	T
pharmgkb	celecoxib	PTGES	rs2302821		Colorectal Neoplasms	Toxicity	O14684	Drug	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	9	129739602.0	A	C
pharmgkb	fexofenadine	SLCO2B1	S464F			Metabolism/PK	O94956	Drug	3348.0	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O	11	75196537.0	C	T
pharmgkb	paroxetine	GDNF	rs2973049		Depressive Disorder, Major	Efficacy	P39905	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	5	37818037.0	T	C
pharmgkb	warfarin	HNF4A	rs3212198			Dosage	P41235	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	20	44415722.0	C	K
pharmgkb	olanzapine	AHR	rs4410790		Psychotic Disorders	Metabolism/PK	P35869	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	7	17244953.0	T	C
pharmgkb	citalopram	TPH2	rs4570625		Depressive Disorder	Efficacy	Q8IWU9	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	12	71938143.0	G	T
pharmgkb	thiazolidinediones	AQP2	rs296766		Diabetes Mellitus, Type 2	Toxicity	P41181	Drug Class			12	49957170.0	T	C
pharmgkb	hmg coa reductase inhibitors	ADAMTS1	rs402007			Efficacy	Q9UHI8	Drug Class			21	26845001.0	C	K
pharmgkb	hydrochlorothiazide	TCF7L2	rs4132670		Hypertension	Toxicity	P35222	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	10	113008012.0	G	A
pharmgkb	celecoxib	PTGER4	rs4133101		Colorectal Neoplasms	Toxicity	P35408	Drug	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	5	40679465.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNFRSF1B	rs3397		Arthritis, Rheumatoid	Efficacy	Q12933	Drug Class			1	12207235.0	C	T
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNFRSF1B	rs1061631		Arthritis, Rheumatoid	Efficacy	Q12933	Drug Class			1	12208442.0	G	A
pharmgkb	hydrochlorothiazide	TCF7L2	rs4506565		Hypertension	Toxicity	P35222	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	10	112996282.0	A	K
pharmgkb	naltrexone	OPRD1	rs4654327		Alcoholism	Efficacy	P41143	Drug	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	1	28863626.0	G	A
pharmgkb	entacapone	COMT	V158M		Parkinson Disease	Efficacy	P21964	Drug	5281081.0	CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N	22	19963748.0	G	A
pharmgkb	citalopram	CACNA1C	rs1006737		Depressive Disorder, Major	Toxicity	P54284	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	12	2236129.0	G	A
pharmgkb	nicotine	GRIN3A	rs10121600		Tobacco Use Disorder	Other	Q8TCU5	Drug	942.0	CN1CCCC1C2=CN=CC=C2	9	101615721.0	C	T
pharmgkb	aspirin	COL26A1	rs10279545			Toxicity	Q96A83	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	7	101527747.0	T	C
pharmgkb	methamphetamine	ARRB2	rs1045280		Substance-Related Disorders	Other	P32121	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	17	4719343.0	C	T
pharmgkb	nicotine	CHRNA4	rs1044397		Tobacco Use Disorder	Other	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63349752.0	C	T
pharmgkb	methylprednisolone,prednisolone	ABCB1	I1145M		Kidney Transplantation	Toxicity	P08183				7	87509329.0	A	K
pharmgkb	etoposide	ABCB1	I1145M		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	P08183	Drug	36462.0	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	7	87509329.0	A	K
pharmgkb	carbamazepine	ABCC2	I1324M		Epilepsy	Metabolism/PK	Q5T2W1	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	10	99844450.0	C	K
pharmgkb	imatinib	SLCO1A2	rs3764043		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Metabolism/PK	P46721	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	12	21335070.0	C	T
pharmgkb	hydrochlorothiazide	GPR83	rs3758785		Essential hypertension	Efficacy	Q9NYM4	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	11	94398973.0	A	G
pharmgkb	candesartan	GPR83	rs3758785		Essential hypertension	Efficacy	Q9NYM4	Drug	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	11	94398973.0	A	G
pharmgkb	Ace Inhibitors, Plain	AGTR1	rs5182		Hypertension	Toxicity	P30556	Drug Class			3	148741608.0	C	T
pharmgkb	citalopram	RORA	rs809736		Depressive Disorder, Major	Efficacy	P35398	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	15	61037589.0	A	G
pharmgkb	citalopram	DTNBP1	rs760761		Depressive Disorder, Major	Efficacy	Q96EV8	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	6	15650901.0	G	A
pharmgkb	citalopram	CACNA1C	rs10848635		Depressive Disorder, Major	Toxicity	P54284	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	12	2207029.0	T	A
pharmgkb	citalopram,escitalopram	GLDC	rs10975641		Depressive Disorder, Major	Efficacy	P23378				9	6556839.0	C	K
pharmgkb	citalopram	CRHR2	rs2270007		Depressive Disorder, Major	Efficacy	P55089	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	7	30660356.0	G	C
pharmgkb	pravastatin	IL1B	rs16944			Efficacy	P01584	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	2	112837290.0	A	G
pharmgkb	tacrolimus	CYP3A5	rs776746		Hyperlipidemias	Toxicity	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99672916.0	T	C
pharmgkb	tacrolimus	CYP3A5	rs776746		Toxic liver disease	Toxicity	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99672916.0	T	C
pharmgkb	paclitaxel	ABCB1	S893A		Breast Neoplasms,Ovarian Neoplasms	Efficacy	P08183	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	7	87531302.0	A	Y
pharmgkb	simvastatin	LEPR	Q223R		Coronary Disease	Efficacy	P48357	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	1	65592830.0	A	G
pharmgkb	simvastatin	LEPR	Q223R		Hyperlipidemias	Efficacy	P48357	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	1	65592830.0	A	G
pharmgkb	cyclosporine	ABCB1	I1145M		Transplantation	Metabolism/PK	P08183	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	87509329.0	A	K
pharmgkb	methotrexate	SLCO1B1	rs11045872		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21219410.0	A	K
pharmgkb	methotrexate	SLCO1B1	rs11045821		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21179489.0	G	A
pharmgkb	lovastatin	SLCO1B1	rs2291073			Efficacy	Q9Y6L6	Drug	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	12	21172880.0	T	G
pharmgkb	rifampin	SLCO1B1	rs4149032		Tuberculosis	Metabolism/PK	Q9Y6L6	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	12	21164857.0	C	T
pharmgkb	atorvastatin	SLCO1B1	rs4149036			Efficacy	Q9Y6L6	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	12	21174806.0	C	A
pharmgkb	paroxetine	COMT	V158M		Depressive Disorder, Major	Efficacy	P21964	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	22	19963748.0	G	A
pharmgkb	Selective serotonin reuptake inhibitors	SLC1A1	rs301434		Obsessive-Compulsive Disorder	Efficacy	P43005	Drug Class			9	4582082.0	C	K
pharmgkb	Selective serotonin reuptake inhibitors	SLC1A1	rs301435		Obsessive-Compulsive Disorder	Efficacy	P43005	Drug Class			9	4582843.0	T	C
pharmgkb	Selective serotonin reuptake inhibitors	SLC1A1	rs3087879		Obsessive-Compulsive Disorder	Efficacy	P43005	Drug Class			9	4586808.0	G	C
pharmgkb	olanzapine	CHAT	D7N		Schizophrenia	Efficacy	P28329	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	10	49616071.0	G	A
pharmgkb	olanzapine	DRD2	rs2734841			Toxicity	P14416	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	113411054.0	A	B
pharmgkb	olanzapine	DRD2	rs2734842			Toxicity	P14416	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	113409552.0	G	C
pharmgkb	olanzapine	CHAT	A120T		Schizophrenia	Efficacy	P28329	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	10	49616573.0	G	A
pharmgkb	clozapine,olanzapine,risperidone	DRD2	rs4436578		Schizophrenia	Toxicity	P14416				11	113436043.0	C	T
pharmgkb	olanzapine	CYP3A43	rs472660		Schizophrenia	Metabolism/PK	Q9HB55	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	7	99862484.0	G	A
pharmgkb	Influenza vaccines	HLA-DQB1	HLA-DQB1*06:02		Narcolepsy	Toxicity	P01920	Drug Class						
pharmgkb	clozapine	HLA-DRB3	HLA-DRB3*02:02		Schizophrenia	Toxicity	P79483	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl				
pharmgkb	ticlopidine	HLA-B	HLA-B*44:03			Toxicity	P01889	Drug	5472.0	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl				
pharmgkb	methylene blue	G6PD	G6PD A- 202A_376G, G6PD B (reference)		Anemia, Hemolytic,Hemolysis,Protein Deficiency	Efficacy,Toxicity	P11413	Drug	6099.0					
pharmgkb	ticlopidine	HLA-C	HLA-C*14:03		Toxic liver disease	Toxicity	P10321	Drug	5472.0	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl				
pharmgkb	pazopanib	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*37		Carcinoma, Renal Cell	Toxicity	P22309	Drug	11525740.0					
pharmgkb	methotrexate	SLC22A11	rs11231809		Arthritis, Rheumatoid	Efficacy	Q9NSA0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	11	64535478.0	T	A
pharmgkb	methotrexate	ABCC1	rs246240		Arthritis, Rheumatoid	Efficacy	P33527	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	16	16025167.0	A	G
pharmgkb	methotrexate	ABCC1	rs3784864		Arthritis, Rheumatoid	Efficacy	P33527	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	16	16031468.0	G	A
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	MICB	rs3828913		Hepatitis C, Chronic	Efficacy	Q29980				6	31498018.0	C	A
pharmgkb	deleobuvir,faldaprevir	IFNL3	rs12979860		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	gemcitabine	SLC29A1	rs760370		Neoplasms	Efficacy	Q99808	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	6	44233216.0	A	G
pharmgkb	hydrochlorothiazide	TCF7L2	rs7917983		Hypertension	Toxicity	P35222	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	10	112973123.0	T	C
pharmgkb	propofol	CYP2B6	Q172H			Dosage	P20813	Drug	4943.0	CC(C)C1=C(C(=CC=C1)C(C)C)O	19	41006936.0	G	W
pharmgkb	antithymocyte globulin	FCGR3A	F175V		Kidney Transplantation	Other	P20963	Drug			1	161544752.0	A	B
pharmgkb	warfarin	CYP2C9	CYP2C9*1, CYP2C9*59			Dosage	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	Pertussis vaccines	TLR4	rs2770150			Efficacy	O00206	Drug Class			9	117700861.0	A	G
pharmgkb	Pertussis vaccines	TLR4	D99G			Efficacy	O00206	Drug Class			9	117713024.0	A	K
pharmgkb	daunorubicin	NOS3	D298E		Leukemia, Myeloid, Acute	Efficacy	P29474	Drug	30323.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O	7	150999023.0	T	R
pharmgkb	melphalan	SLC7A5	rs4240803		Multiple Myeloma	Toxicity	P08195	Drug	4053.0	C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl	16	87855597.0	G	H
pharmgkb	naltrexone	DBH	rs1611115		Alcoholism	Efficacy	Q6UVY6	Drug	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	9	133635393.0	T	C
pharmgkb	clozapine,olanzapine	MTHFR	E429A		schizoaffective disorder,Schizophrenia	Toxicity	P42898				1	11794419.0	T	G
pharmgkb	salvianolic acid b	NOS3	D298E		Coronary Disease	Efficacy	P29474	Drug	6441188.0	C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=C3[C@H]([C@@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O	7	150999023.0	T	R
pharmgkb	capecitabine,radiotherapy	AREG	rs11942466		Rectal Neoplasms	Efficacy	P15514				4	74556361.0	C	A
pharmgkb	capecitabine,radiotherapy	ERCC1	rs11615		Rectal Neoplasms	Efficacy	P07992				19	45420395.0	A	G
pharmgkb	antipsychotics	COMT	V158M			Toxicity	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	antipsychotics	COMT	V158M			Toxicity	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	cotinine	NAT1	rs13253389			Metabolism/PK	P18440	Metabolite	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	8	18214398.0	A	B
pharmgkb	rocuronium	SLCO1B1	N130H			Efficacy	Q9Y6L6	Drug	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C	12	21176804.0	A	K
pharmgkb	morphine	ABCB1	N21H			Toxicity	P08183	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	7	87600124.0	T	C
pharmgkb	methotrexate	ABCC4	rs7317112		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	O15439	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	13	95271269.0	A	G
pharmgkb	adalimumab	ATG16L1	rs10210302		Crohn Disease	Efficacy	Q676U5	Drug			2	233250193.0	C	W
pharmgkb	valproic acid	LEPR	Q223R		Epilepsy	Toxicity	P48357	Drug	3121.0	CCCC(CCC)C(=O)O	1	65592830.0	A	G
pharmgkb	valproic acid	ANKK1	E713K		Epilepsy	Toxicity	Q8NFD2	Drug	3121.0	CCCC(CCC)C(=O)O	11	113400106.0	G	A
pharmgkb	bilirubin	UGT1A	rs11563250		Colorectal Neoplasms	Metabolism/PK	Q9HAW7	Biological Intermediate	5280352.0	CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C\4/C(=C(C(=O)N4)C=C)C	2	233774704.0	A	G
pharmgkb	irinotecan	UGT1A	rs11563250		Colorectal Neoplasms	Toxicity	Q9HAW7	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	2	233774704.0	A	G
pharmgkb	phenytoin	CYP2C9	rs1934969		Epilepsy	Metabolism/PK	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	10	94988738.0	A	T
pharmgkb	paclitaxel	SOD2	V16A		Breast Neoplasms	Toxicity	P04179	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	6	159692840.0	A	G
pharmgkb	paclitaxel	CYP2C8	rs1113129		Breast Neoplasms	Toxicity	P10632	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	10	95051288.0	G	M
pharmgkb	paclitaxel	ERCC1	Q506K		Breast Neoplasms	Toxicity	P07992	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	19	45409478.0	C	D
pharmgkb	docetaxel	ERCC1	rs11615		Breast Neoplasms	Toxicity	P07992	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	19	45420395.0	A	G
pharmgkb	atorvastatin	POR	A503V		familial hypercholesterolemia	Efficacy	Q9Y277	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	75985688.0	C	T
pharmgkb	clozapine	HTR1A	rs6295		Schizophrenia	Efficacy	P08908	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	5	63962738.0	C	G
pharmgkb	clozapine	COMT	V158M		Schizophrenia	Efficacy	P21964	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	22	19963748.0	G	A
pharmgkb	tacrolimus	HSD11B1	rs846908		Kidney Transplantation	Metabolism/PK	P28845	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	209685108.0	A	G
pharmgkb	tacrolimus	HSD11B1	rs4844880		Kidney Transplantation	Metabolism/PK	P28845	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	209697571.0	A	T
pharmgkb	tacrolimus	HSD11B1	rs846910		Kidney Transplantation	Metabolism/PK	P28845	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	209701909.0	A	G
pharmgkb	haloperidol	ABCB5	T131N		Psychotic Disorders	Toxicity	Q2M3G0	Drug	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	7	20643261.0	C	T
pharmgkb	interferon beta-1a,interferon beta-1b	CD58	rs12044852		Multiple Sclerosis	Efficacy	P19256				1	116545157.0	C	A
pharmgkb	cisplatin	GSTP1	A114V		Neoplasms	Efficacy	P09211	Drug	441203.0	N.N.Cl[Pt+2]Cl	11	67586108.0	C	T
pharmgkb	anastrozole	UGT1A4	rs3732219			Other	P22310	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	2	233718602.0	C	T
pharmgkb	anastrozole	UGT1A4	rs3732218			Other	P22310	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	2	233718658.0	G	A
pharmgkb	bupropion	CYP2C19	CYP2C19*1, CYP2C19*2			Other	P33261	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C				
pharmgkb	benazepril	MTHFR	A222V		Hypertension	Efficacy	P42898	Drug	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	1	11796321.0	G	A
pharmgkb	docetaxel	VEGFA	rs1570360		Breast Neoplasms	Efficacy	P15692	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	6	43770093.0	A	G
pharmgkb	daptomycin	ABCB1	I1145M			Metabolism/PK	P08183	Drug	16129629.0	CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C	7	87509329.0	A	K
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNFRSF1A	rs767455		Arthritis, Rheumatoid	Efficacy	Q15628	Drug Class			12	6341779.0	T	C
pharmgkb	hydrochlorothiazide	ILKAP	rs113095083		Essential hypertension	Efficacy	Q9H0C8	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	2	238197074.0	T	C
pharmgkb	hydrochlorothiazide	TET2	rs12505746		Essential hypertension	Efficacy	Q6N021	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	4	105192914.0	A	K
pharmgkb	hydrochlorothiazide	FBXL17	rs7706429		Essential hypertension	Efficacy	Q9UF56	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	5	108251082.0	A	G
pharmgkb	hydrochlorothiazide	FBXL17	rs4431329		Essential hypertension	Efficacy	Q9UF56	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	5	108253257.0	A	T
pharmgkb	hydrochlorothiazide	CSMD1	rs11993031		Essential hypertension	Efficacy	Q96PZ7	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	8	2952059.0	T	A
pharmgkb	hydrochlorothiazide	CSMD1	rs7387065		Essential hypertension	Efficacy	Q96PZ7	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	8	3045498.0	A	K
pharmgkb	hydrochlorothiazide	SLIT1	rs11189015		Essential hypertension	Efficacy	O75093	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	10	97152179.0	G	M
pharmgkb	hydrochlorothiazide	DIAPH3	rs77876672		Essential hypertension	Efficacy	Q9NSV4	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	13	59744885.0	C	T
pharmgkb	hydrochlorothiazide	UGGT2	rs9590353		Essential hypertension	Efficacy	Q9NYU1	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	13	95978967.0	T	G
pharmgkb	hydrochlorothiazide	ANKFN1	rs9915451		Essential hypertension	Efficacy	Q8N957	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	17	56355850.0	A	G
pharmgkb	metformin	SLC22A3	rs2076828			Efficacy	O75751	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160451754.0	C	G
pharmgkb	epirubicin,fluorouracil,oxaliplatin	PON1	Q192P		Neoplasms,Stomach Neoplasms	Efficacy	P27169				7	95308134.0	T	C
pharmgkb	anthracyclines and related substances,cyclophosphamide,doxorubicin,epirubicin,fluorouracil,methotrexate,oxaliplatin,Platinum compounds	NOS3	D298E		Neoplasms,Ovarian Neoplasms,Stomach Neoplasms	Efficacy	P29474				7	150999023.0	T	R
pharmgkb	erlotinib	CYP1A2	rs2472304			Metabolism/PK	P05177	Drug	176870.0	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	15	74751897.0	G	A
pharmgkb	olanzapine	BDNF	V66M		Schizophrenia	Efficacy	P23560	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	27658369.0	C	T
pharmgkb	antipsychotics	IL1B	rs16944		Schizophrenia	Toxicity	P01584	Drug Class			2	112837290.0	A	G
pharmgkb	antipsychotics	IL1B	rs1143634		Schizophrenia	Toxicity	P01584	Drug Class			2	112832813.0	G	A
pharmgkb	antipsychotics	BDNF	V66M		Schizophrenia	Toxicity	P23560	Drug Class			11	27658369.0	C	T
pharmgkb	dextromethorphan	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*36, CYP2D6*40, CYP2D6*42, CYP2D6*56			Other	P10635	Drug	5360696.0	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC				
pharmgkb	fentanyl	KCNJ6	rs2835859		Pain, Postoperative	Dosage	P48051	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	21	37645860.0	T	C
pharmgkb	valproic acid	POLG	Q1236H		Toxic liver disease	Toxicity	P54098	Drug	3121.0	CCCC(CCC)C(=O)O	15	89316763.0	C	A
pharmgkb	bevacizumab,capecitabine,fluorouracil,irinotecan,leucovorin,oxaliplatin	VEGFA	rs699947		Colorectal Neoplasms	Efficacy	P15692				6	43768652.0	A	Y
pharmgkb	montelukast	GALNT17	rs7794356		Asthma	Efficacy	Q49A17	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	7	71273743.0	G	A
pharmgkb	montelukast	MLLT3	rs6475448		Asthma	Efficacy	P42568	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	9	20497144.0	G	A
pharmgkb	anastrozole,letrozole	TNFSF11	rs7984870		Breast Neoplasms	Efficacy	O00300				13	42572346.0	G	C
pharmgkb	anastrozole,letrozole	TNFRSF11B	N3K		Breast Neoplasms	Toxicity	O00300				8	118951813.0	G	C
pharmgkb	cytarabine	ABCB1	rs1128503		Leukemia, Myeloid, Acute	Efficacy	P08183	Drug	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	7	87550285.0	A	G
pharmgkb	liraglutide	GLP1R	P7L		Obesity,Polycystic Ovary Syndrome	Efficacy	P43220	Drug	44147092.0	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N	6	39048860.0	C	T
pharmgkb	liraglutide	GLP1R	G168S		Obesity,Polycystic Ovary Syndrome	Efficacy	P43220	Drug	44147092.0	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N	6	39066296.0	G	M
pharmgkb	metformin	SLC22A2	S270A			Other	O15244	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160249250.0	A	C
pharmgkb	bupropion	CYP2B6	R487S		Tobacco Use Disorder	Efficacy	P20813	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	19	41016810.0	C	D
pharmgkb	aripiprazole,clozapine,haloperidol,olanzapine,quetiapine,risperidone	FAAH	P129T		Psychotic Disorders	Toxicity	O00519				1	46405089.0	C	A
pharmgkb	aripiprazole,clozapine,haloperidol,olanzapine,quetiapine,risperidone	CNR1	rs1049353		Autism Spectrum Disorder,Psychotic Disorders,Schizophrenia	Toxicity	P21554				6	88143916.0	C	T
pharmgkb	clozapine,olanzapine,risperidone	CNR1	rs806378		Autism Spectrum Disorder,Schizophrenia	Toxicity	P21554				6	88149832.0	C	T
pharmgkb	maprotiline,opipramol	CYP2D6	CYP2D6*1, CYP2D6*4		Depression	Dosage,Toxicity	P10635							
pharmgkb	ketamine	CYP2B6	CYP2B6*1, CYP2B6*6		Neoplasms,Pain	Metabolism/PK	P20813	Drug	3821.0	CNC1(CCCCC1=O)C2=CC=CC=C2Cl				
pharmgkb	anthracyclines and related substances	ECT2L	rs11155012		Breast Neoplasms	Efficacy	Q008S8	Drug Class			6	138830647.0	G	W
pharmgkb	asparaginase	HLA-DRB1	R54L		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P01911	Drug			6	32584318.0	C	T
pharmgkb	asparaginase	NFATC2	rs6021191		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q13469	Drug			20	51419700.0	A	T
pharmgkb	Ace Inhibitors, Plain	KCNIP4	rs6838116			Toxicity	Q6PIL6	Drug Class			4	21354260.0	A	C
pharmgkb	carboplatin,taxanes	GSR	rs3594		Ovarian Neoplasms	Toxicity	P00390				8	30678143.0	C	A
pharmgkb	carboplatin,taxanes	ATP7B	V933A		Ovarian Neoplasms	Toxicity	P35670				13	51941218.0	A	K
pharmgkb	carboplatin,taxanes	SCN10A	rs9825762		Ovarian Neoplasms	Toxicity	Q9Y5Y9				3	38724847.0	T	C
pharmgkb	carboplatin,taxanes	ATP7B	K670R		Ovarian Neoplasms	Toxicity	P35670				13	51950352.0	T	S
pharmgkb	Drugs used in nicotine dependence,nicotine,varenicline	CHRNA5	rs588765		Tobacco Use Disorder	Efficacy	P30532				15	78573083.0	T	M
pharmgkb	sunitinib	CXCL8	rs1126647		Carcinoma, Renal Cell	Toxicity	P98066	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	4	73743328.0	A	T
pharmgkb	sunitinib	IL13	rs1800925		Carcinoma, Renal Cell	Toxicity	P35225	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	5	132657117.0	C	K
pharmgkb	trandolapril,verapamil	PTPRD	rs4742610		Hypertension	Efficacy	P23468				9	9687487.0	C	K
pharmgkb	codeine	UGT2B7	Y268H			Dosage	P16662	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	4	69098620.0	T	C
pharmgkb	sunitinib	NR1I2	rs6785049		Neoplasms	Toxicity	O75469	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	3	119814886.0	G	A
pharmgkb	fluorouracil	LGR5	V594A		Colonic Neoplasms	Efficacy	O75473	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	12	71584007.0	T	C
pharmgkb	metformin	FMO5	rs7541245		Diabetes Mellitus	Efficacy	P49326	Drug	4091.0	CN(C)C(=N)N=C(N)N	1	147209857.0	C	A
pharmgkb	deferasirox	ABCC2	C1515Y		beta-Thalassemia	Toxicity	Q5T2W1	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	10	99851537.0	G	A
pharmgkb	deferasirox	ABCC2	rs717620		beta-Thalassemia	Toxicity	Q5T2W1	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	10	99782821.0	C	T
pharmgkb	atorvastatin	FDPS	rs2297480		Coronary Disease	Other	P14324	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	1	155309691.0	T	G
pharmgkb	carbamazepine	NR1I2	rs4688040		Epilepsy	Metabolism/PK	O75469	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	3	119805244.0	G	Y
pharmgkb	citalopram	GRIA3	rs4825476		Depression,suicide	Toxicity	P42263	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	X	123307628.0	G	M
pharmgkb	Beta Blocking Agents	GNB3	rs5443			Other	P16520	Drug Class			12	6845711.0	C	T
pharmgkb	follitropin beta,thyrotropin alfa,urofollitropin	FSHR	S680N		Infertility, Female,Ovarian hyperstimulation syndrome	Efficacy	P23945				2	48962782.0	C	T
pharmgkb	efavirenz	CYP2B6	R22C			Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	40991369.0	C	T
pharmgkb	farglitazar,glyburide	SCNN1B	rs889299		Diabetes Mellitus, Type 2	Toxicity	P51168				16	23370593.0	G	A
pharmgkb	calcium channel blockers	TANC2	rs2429427		Hypertension	Efficacy	Q9HCD6	Drug Class			17	63316455.0	G	A
pharmgkb	methadone	CYP3A4	rs2242480		Heroin Dependence	Toxicity	P08684	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	99763843.0	C	T
pharmgkb	capecitabine	ABCB1	S893A		Colorectal Neoplasms,hand-foot syndrome	Toxicity	P08183	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	7	87531302.0	A	Y
pharmgkb	efavirenz	IL10	rs1800896		HIV Infections	Toxicity	P22301	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	1	206773552.0	T	C
pharmgkb	cilostazol	CYP3A5	CYP3A5*1, CYP3A5*3			Metabolism/PK	P20815	Drug	2754.0	C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4				
pharmgkb	cyclophosphamide	CYP2C19	rs4244285		Lupus Erythematosus, Systemic	Toxicity	P33261	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	10	94781859.0	G	M
pharmgkb	cyclophosphamide	CYP2B6	rs4802101		Lupus erythematosus	Toxicity,Metabolism/PK	P20813	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	19	40990556.0	T	C
pharmgkb	varenicline	CHRNA4	S543R		Tobacco Use Disorder	Efficacy	P43681	Drug	5310966.0	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	20	63349782.0	G	M
pharmgkb	Opium alkaloids and derivatives	CHRNA3	rs1051730		Pain	Toxicity	P32297	Drug Class			15	78601997.0	G	A
pharmgkb	fluorouracil,irinotecan,leucovorin	ABCC5	rs10937158		Colorectal Neoplasms	Toxicity	O15440				3	183990651.0	T	C
pharmgkb	fluorouracil,irinotecan,leucovorin	ABCG1	rs225440		Colorectal Neoplasms	Toxicity	P45844				21	42232943.0	C	T
pharmgkb	amlodipine,chlorthalidone,lisinopril	AGT	rs11122576			Efficacy	Q9BYV1				1	230710933.0	T	C
pharmgkb	amlodipine,chlorthalidone,lisinopril	AGT	rs11122576			Efficacy	Q9BYV1				1	230710933.0	T	C
pharmgkb	fluorouracil,irinotecan,leucovorin	ABCC5	rs3749438		Colorectal Neoplasms	Toxicity	O15440				3	183987396.0	G	A
pharmgkb	acetaminophen,aspirin,diclofenac,propionic acid derivatives,Pyrazolones	PLA2G4A	rs12746200			Toxicity	P47712				1	186880054.0	A	G
pharmgkb	acetaminophen,aspirin,diclofenac,propionic acid derivatives,Pyrazolones	TNFRSF11A	A192V			Toxicity	Q9Y6Q6				18	62360008.0	C	T
pharmgkb	acetaminophen,aspirin,diclofenac,propionic acid derivatives,Pyrazolones	PLCG1	S279G			Toxicity	P19174				20	41163423.0	A	G
pharmgkb	amodiaquine	CYP2C8	R139K			Toxicity	P10632	Drug	2165.0	CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O	10	95067273.0	C	W
pharmgkb	amodiaquine	CYP2C8	K297R			Toxicity	P10632	Drug	2165.0	CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O	10	95038992.0	T	C
pharmgkb	antidepressants,citalopram,clomipramine,lithium,nefazodone,paroxetine,venlafaxine	FKBP5	rs1360780		Depression	Efficacy	Q13451				6	35639794.0	T	M
pharmgkb	clopidogrel	CYP1A2	rs762551			Efficacy	P05177	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	15	74749576.0	C	A
pharmgkb	clopidogrel	P2RY12	rs6809699		Coronary Artery Disease	Efficacy	Q9H244	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	3	151338810.0	A	C
pharmgkb	aspirin,Beta Blocking Agents,clopidogrel,hmg coa reductase inhibitors	NOS3	D298E		Coronary Artery Disease	Toxicity	P29474				7	150999023.0	T	R
pharmgkb	aspirin,clopidogrel	ITGA2	F253L		Coronary Artery Disease,Coronary Disease,Myocardial Infarction	Efficacy	P17301				5	53051539.0	C	T
pharmgkb	clopidogrel	P2RY12	rs6787801			Efficacy	Q9H244	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	3	151381953.0	A	G
pharmgkb	aspirin,clopidogrel	ITGA2	rs1062535			Efficacy	P17301				5	53055583.0	G	A
pharmgkb	aspirin,clopidogrel	PTGS1	rs10306114		Myocardial Infarction	Efficacy	P23219				9	122370243.0	A	G
pharmgkb	aspirin,clopidogrel	PEAR1	rs12041331			Efficacy,Toxicity	Q5VY43				1	156899922.0	G	A
pharmgkb	clopidogrel	CES1P1	rs3785161		Coronary Disease	Efficacy	Q9UKY3	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	16	55759783.0	A	C
pharmgkb	aspirin,clopidogrel	CYP4F2	V433M		Acute coronary syndrome	Other	P78329				19	15879621.0	C	T
pharmgkb	warfarin	VKORC1	rs9934438			Efficacy	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31093557.0	G	M
pharmgkb	midazolam	CYP3A4	rs35599367		Neoplasms	Other	P08684	Drug	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F	7	99768693.0	G	A
pharmgkb	capecitabine,fluorouracil	HLA-G	rs371194629		Colorectal Neoplasms	Efficacy	P17693				6	29830805.0	-	ATTTGT/ATTTGTTCATGCCT
pharmgkb	capecitabine,fluorouracil	HLA-G	rs9380142		Colorectal Neoplasms	Efficacy	P17693				6	29831017.0	A	G
pharmgkb	capecitabine,fluorouracil	HLA-G	rs17179108		Colorectal Neoplasms	Efficacy	P17693				6	29830865.0	C	T
pharmgkb	letrozole	CYP19A1	rs3759811		Breast Neoplasms,Menopause	Other	P11511	Drug	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	15	51237068.0	T	C
pharmgkb	letrozole	CYP19A1	rs4775936		Breast Neoplasms,Menopause	Other	P11511	Drug	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	15	51243825.0	C	T
pharmgkb	letrozole	CYP19A1	rs749292		Breast Neoplasms,Menopause	Other	P11511	Drug	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	15	51266534.0	G	A
pharmgkb	letrozole	CYP19A1	rs700518		Breast Neoplasms,Menopause	Other	P11511	Drug	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	15	51236915.0	T	C
pharmgkb	hmg coa reductase inhibitors,letrozole	CYP19A1	rs1062033		Breast Neoplasms,Menopause	Other	P11511				15	51255741.0	C	G
pharmgkb	warfarin	NQO1	P187S			Dosage	P15559	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	69711242.0	G	A
pharmgkb	tenofovir	ABCC4	rs1059751		HIV Infections	Toxicity	O15439	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	13	95020696.0	A	G
pharmgkb	sorafenib	VEGFA	rs1570360		Carcinoma, Renal Cell	Efficacy	P15692	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	6	43770093.0	A	G
pharmgkb	sorafenib	KDR	rs2239702		Carcinoma, Renal Cell	Efficacy	P35968	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	4	55125972.0	C	T
pharmgkb	sorafenib	VEGFA	rs2010963		Carcinoma, Renal Cell,hand-foot syndrome	Toxicity	P15692	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	6	43770613.0	C	G
pharmgkb	sorafenib	ABCB1	I1145M		Carcinoma, Renal Cell,Hypertension	Toxicity	P08183	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	7	87509329.0	A	K
pharmgkb	donepezil,galantamine,rivastigmine	CHAT	rs3793790		Alzheimer Disease	Efficacy	P28329				10	49632690.0	G	M
pharmgkb	desloratadine,mizolastine	FCER1A	S101N		Urticaria	Efficacy	P12319				1	159304153.0	G	A
pharmgkb	efavirenz	ABCC2	rs717620		HIV Infections	Metabolism/PK	Q5T2W1	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	10	99782821.0	C	T
pharmgkb	capecitabine,fluorouracil,leucovorin,oxaliplatin	SELE	rs3917412		Colonic Neoplasms	Efficacy	Q14242				1	169731361.0	T	V
pharmgkb	exemestane,letrozole	ESR1	rs9322335		Breast Neoplasms	Toxicity	P03372				6	151878994.0	T	C
pharmgkb	letrozole	ESR1	rs4870061		Breast Neoplasms	Toxicity	P03372	Drug	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	6	151916333.0	T	C
pharmgkb	agomelatine	ABCB1	I1145M		Depressive Disorder	Efficacy	P08183	Drug	82148.0	CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC	7	87509329.0	A	K
pharmgkb	venlafaxine	ABCB1	I1145M		Depressive Disorder,Narcolepsy	Efficacy	P08183	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	7	87509329.0	A	K
pharmgkb	Selective serotonin reuptake inhibitors	ABCB1	I1145M		Depressive Disorder	Efficacy	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	atenolol	LRRC15	rs11313667		Hypertension	Efficacy	Q8TF66	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	3	194361433.0	C	-
pharmgkb	metoprolol	LRRC15	rs11313667		Hypertension	Efficacy	Q8TF66	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	3	194361433.0	C	-
pharmgkb	hydrochlorothiazide	LRRC15	rs11313667		Hypertension	Efficacy	Q8TF66	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	3	194361433.0	C	-
pharmgkb	rivastigmine	CHAT	rs2177370		Alzheimer Disease	Efficacy	P28329	Drug	77991.0	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	10	49630828.0	A	G
pharmgkb	galantamine	CHAT	rs2177370		Alzheimer Disease	Efficacy	P28329	Drug	9651.0	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O	10	49630828.0	A	G
pharmgkb	donepezil	CHAT	rs2177370		Alzheimer Disease	Efficacy	P28329	Drug	3152.0	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	10	49630828.0	A	G
pharmgkb	telmisartan	GNB3	rs5443		Essential hypertension	Efficacy	P16520	Drug	65999.0	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C	12	6845711.0	C	T
pharmgkb	quetiapine	DRD3	G9S			Metabolism/PK	P35462	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	3	114171968.0	C	T
pharmgkb	modafinil	ABCB1	I1145M		Narcolepsy	Efficacy	P08183	Drug	4236.0	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	7	87509329.0	A	K
pharmgkb	silibinin	ABCB1	I1145M			Metabolism/PK	P08183	Drug	31553.0	COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O	7	87509329.0	A	K
pharmgkb	olanzapine	DRD2	rs1076560		Schizophrenia	Efficacy	P14416	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	113412966.0	C	A
pharmgkb	modafinil	ABCB1	rs1128503		Narcolepsy	Efficacy	P08183	Drug	4236.0	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	7	87550285.0	A	G
pharmgkb	amisulpride	DRD2	rs1079597		Schizophrenia	Efficacy	P14416	Drug	2159.0	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	11	113425564.0	C	T
pharmgkb	corticosteroids	ST13	rs138335		Asthma	Efficacy	P50502	Drug Class			22	40831082.0	C	R
pharmgkb	corticosteroids	ST13	rs138337		Asthma	Efficacy	P50502	Drug Class			22	40835049.0	A	G
pharmgkb	fluvoxamine	FGF2	rs1449683		Depressive Disorder	Efficacy	P09038	Drug	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	4	122826931.0	C	K
pharmgkb	antipsychotics	ADCY2	rs1544938		Schizophrenia	Efficacy	Q08462	Drug Class			5	7634119.0	G	H
pharmgkb	antipsychotics	NRG1	rs17716295		Schizophrenia	Efficacy	Q02297	Drug Class			8	32460401.0	C	A
pharmgkb	cyclosporine,mycophenolate mofetil,sirolimus,tacrolimus	UGT1A8	A173G		Kidney Transplantation	Toxicity	Q9HAW9				2	233618225.0	C	K
pharmgkb	adalimumab,infliximab	FCGR2A	H166P		Arthritis, Rheumatoid	Efficacy	P08631				1	161509955.0	A	S
pharmgkb	cyclophosphamide	CYP2B6	CYP2B6*1, CYP2B6*6		Lymphoma, B-Cell	Metabolism/PK	P20813	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl				
pharmgkb	infliximab	FCGR3A	F175V		Arthritis, Rheumatoid	Efficacy	P20963	Drug			1	161544752.0	A	B
pharmgkb	sunitinib	ABCB1	I1145M		Carcinoma, Renal Cell	Toxicity	P08183	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	7	87509329.0	A	K
pharmgkb	Antihypertensives	ATP2B1	rs12817819		Coronary Artery Disease,Hypertension	Efficacy	P20020	Drug Class			12	89645549.0	C	T
pharmgkb	antipsychotics	GRM3	rs6465084		Schizophrenia	Efficacy	Q14832	Drug Class			7	86774159.0	A	G
pharmgkb	antipsychotics	GRM3	rs1468412		Schizophrenia	Toxicity	Q14832	Drug Class			7	86804135.0	A	T
pharmgkb	antipsychotics	NRXN1	rs12467557		Schizophrenia	Efficacy	P58400	Drug Class			2	51015132.0	A	G
pharmgkb	antipsychotics	NRXN1	rs10490162		Schizophrenia	Efficacy	P58400	Drug Class			2	51020519.0	T	C
pharmgkb	atorvastatin	HMGCR	rs17671591		Hypercholesterolemia	Efficacy	P04035	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	5	75319196.0	C	T
pharmgkb	bevacizumab	ARMS2	A69S		Macular Degeneration	Efficacy	P0C7Q2	Drug			10	122454932.0	G	T
pharmgkb	Drugs For Treatment Of Tuberculosis	CYP2E1	CYP2E1*1A, CYP2E1*5B		Tuberculosis	Toxicity	P05181	Drug Class						
pharmgkb	ethanol	CAT	rs1001179		Alcoholism	Other	P04040	Drug	702.0	CCO	11	34438684.0	C	T
pharmgkb	Hepatitis vaccines	IL13	rs1295686			Efficacy	P35225	Drug Class			5	132660151.0	T	M
pharmgkb	Hepatitis vaccines	IL4R	S488P			Efficacy	P24394	Drug Class			16	27362859.0	T	C
pharmgkb	imiquimod	TLR7	Q11P		Carcinoma, Basal Cell	Efficacy	Q9NYK1	Drug	57469.0	CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N	X	12885540.0	A	T
pharmgkb	infliximab	TNF	rs361525			Efficacy	Q9UNG2	Drug			6	31575324.0	G	A
pharmgkb	voriconazole	CYP3A4	rs4646437		Mycoses	Metabolism/PK	P08684	Drug	71616.0	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	7	99767460.0	G	A
pharmgkb	regadenoson	AMPD1	Q45K			Toxicity	P23109	Drug	219024.0	CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	1	114693436.0	G	W
pharmgkb	methotrexate	ABCG2	rs2231135		Osteosarcoma	Toxicity	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88158842.0	A	G
pharmgkb	methotrexate	DHFR	rs1650723		Osteosarcoma	Toxicity	P00374	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	80626211.0	C	T
pharmgkb	methotrexate	DHFR	rs1053129		Osteosarcoma	Efficacy	P00374	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	80626901.0	C	W
pharmgkb	pegloticase	G6PD	G6PD A- 202A_376G		Hemolysis,Methemoglobinemia	Toxicity	P11413	Drug						
pharmgkb	tacrolimus	CYP3A5	rs776746		Kidney Failure	Toxicity	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99672916.0	T	C
pharmgkb	atorvastatin,rifampin	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6				12	21178615.0	T	C
pharmgkb	atorvastatin	CYP3A5	rs776746			Efficacy	P20815	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	99672916.0	T	C
pharmgkb	lovastatin	CYP3A5	rs776746		Arteriosclerosis	Efficacy	P20815	Drug	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	99672916.0	T	C
pharmgkb	pravastatin	ADAMTS1	A227S		Coronary Disease,Myocardial Infarction	Efficacy	Q9UHI8	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	21	26844276.0	C	G
pharmgkb	peginterferon alfa-2b	HLA-DPA1	rs3077		Hepatitis B, Chronic	Efficacy	P20036	Drug	71306834.0		6	33065245.0	A	G
pharmgkb	phenytoin	HLA-B	HLA-B*15:13		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	tacrolimus	ABCB1	I1145M		Kidney Transplantation	Toxicity	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87509329.0	A	K
pharmgkb	selective beta-2-adrenoreceptor agonists	VDR	rs1540339		Asthma	Efficacy	P11473	Drug Class			12	47863543.0	C	T
pharmgkb	selective beta-2-adrenoreceptor agonists	VDR	rs2239179		Asthma	Efficacy	P11473	Drug Class			12	47863983.0	T	C
pharmgkb	adalimumab,certolizumab pegol,etanercept,glucocorticoids,infliximab,methotrexate	ATP5F1E	rs1059150		Arthritis, Rheumatoid	Efficacy	P56381				20	59030384.0	T	C
pharmgkb	clozapine	GRIN2B	rs1072388		Schizophrenia	Efficacy	Q8TB68	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	12	13785842.0	G	A
pharmgkb	adalimumab,certolizumab pegol,etanercept,glucocorticoids,infliximab,methotrexate	HLA-E	G128R		Arthritis, Rheumatoid	Efficacy	P13747				6	30490287.0	G	W
pharmgkb	Selective serotonin reuptake inhibitors	PLCB1	rs6108160		Depression	Efficacy	Q9NQ66	Drug Class			20	8591578.0	G	A
pharmgkb	olanzapine	GIPR	rs10423928		Schizophrenia	Toxicity	P48546	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	19	45679046.0	T	A
pharmgkb	capecitabine,fluorouracil,tegafur	TYMS	rs183205964		Neoplasms	Toxicity	P04818				18	657657.0	G	C
pharmgkb	risperidone	CCL2	rs4586		Schizophrenia	Efficacy	P13500	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	17	34256250.0	T	C
pharmgkb	exemestane,letrozole	CYP19A1	rs6493497		Breast Neoplasms	Toxicity	P11511				15	51338638.0	G	A
pharmgkb	olanzapine	HTR2A	H452Y		Schizophrenia	Efficacy	P28223	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	13	46834899.0	G	A
pharmgkb	Platinum compounds	HOTAIR	rs7958904		Lung Neoplasms	Efficacy		Drug Class			12	53963768.0	C	R
pharmgkb	enalapril	SLCO1B1	V174A		Essential hypertension	Toxicity	Q9Y6L6	Drug	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	12	21178615.0	T	C
pharmgkb	atorvastatin	SLCO1B1	N130H		Hypercholesterolemia	Efficacy	Q9Y6L6	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	12	21176804.0	A	K
pharmgkb	Platinum compounds	MALAT1	rs619586		Lung Neoplasms	Efficacy	Q86W50	Drug Class			11	65498698.0	A	G
pharmgkb	Platinum compounds	H19	rs2839698		Lung Neoplasms	Efficacy	P60008	Drug Class			11	1997623.0	G	A
pharmgkb	milnacipran	ADRA2A	rs1800544		Depressive Disorder	Efficacy	P08913	Drug	65833.0	CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	10	111076745.0	G	C
pharmgkb	atorvastatin	CYP7A1	rs3808607			Efficacy	P05093	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	8	58500365.0	G	T
pharmgkb	antipsychotics,risperidone	LEP	rs7799039		Autism Spectrum Disorder,Mood Disorders	Toxicity	P41159				7	128238730.0	G	M
pharmgkb	modafinil	ABCB1	S893A		Narcolepsy	Efficacy	P08183	Drug	4236.0	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	7	87531302.0	A	Y
pharmgkb	exemestane	ESR1	rs2813543		Breast Neoplasms	Toxicity	P03372	Drug	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	6	152103343.0	A	G
pharmgkb	cisplatin	REV3L	T1146I		Osteosarcoma	Efficacy	O60673	Drug	441203.0	N.N.Cl[Pt+2]Cl	6	111374684.0	G	A
pharmgkb	cyclophosphamide	GSTA1	rs3957356		Lupus Nephritis	Efficacy	P08263	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	6	52803872.0	T	C
pharmgkb	milnacipran	HTR1A	rs6295		Depressive Disorder	Efficacy	P08908	Drug	65833.0	CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	5	63962738.0	C	G
pharmgkb	risperidone	GRID2	rs1875705			Efficacy	O43424	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	4	93221348.0	G	A
pharmgkb	cyclophosphamide,dexamethasone,lenalidomide,thalidomide	CTNNB1	rs4135385		Multiple Myeloma	Efficacy,Toxicity	P35222				3	41237949.0	A	G
pharmgkb	lenalidomide,thalidomide	CTNNB1	rs4533622		Multiple Myeloma	Efficacy,Toxicity	P35222				3	41200847.0	C	W
pharmgkb	risperidone	GRM7	rs2069062			Efficacy	Q14831	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3	6992862.0	G	Y
pharmgkb	cisplatin	REV1	V138M		Osteosarcoma	Efficacy	Q9UBZ9	Drug	441203.0	N.N.Cl[Pt+2]Cl	2	99442408.0	C	T
pharmgkb	clopidogrel	IRS1	rs13431554		Coronary Artery Disease,Diabetes Mellitus, Type 2	Efficacy	P35568	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	2	226732872.0	A	G
pharmgkb	infliximab,Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNFRSF1B	M196R		Arthritis, Rheumatoid	Efficacy	Q12933				1	12192898.0	T	G
pharmgkb	asparaginase	SOD2	V16A		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P04179	Drug			6	159692840.0	A	G
pharmgkb	interferon beta-1a,interferon beta-1b	FHIT	rs760316		Multiple Sclerosis	Efficacy	P49789				3	60113241.0	C	T
pharmgkb	interferon beta-1a,interferon beta-1b	GAPVD1	rs10819043		Multiple Sclerosis	Efficacy	Q14C86				9	125274966.0	C	T
pharmgkb	Ace Inhibitors, Plain,Angiotensin II Antagonists,Beta Blocking Agents,digoxin,diuretics,spironolactone	ADRB2	R16G		Heart Failure	Efficacy	P07550				5	148826877.0	G	A
pharmgkb	terbutaline	ADRB2	Q27E			Efficacy	P07550	Drug	5403.0	CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O	5	148826910.0	G	Y
pharmgkb	atenolol,metoprolol	ADRB2	Q27E		Hypertension	Toxicity	P07550				5	148826910.0	G	Y
pharmgkb	Platinum compounds	ABCB1	I1145M		Carcinoma, Non-Small-Cell Lung	Efficacy	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	voriconazole	ABCB1	I1145M			Metabolism/PK	P08183	Drug	71616.0	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	7	87509329.0	A	K
pharmgkb	nifedipine	ADRA1A	C347R		Hypertension	Efficacy	P35348	Drug	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	8	26770511.0	A	G
pharmgkb	phenprocoumon	EPHX1	Y113H			Efficacy	P07099	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	1	225831932.0	T	C
pharmgkb	gemcitabine	SLC28A2	S75R		Neoplasms	Efficacy,Toxicity	O43868	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	15	45262069.0	C	A
pharmgkb	carboplatin,cisplatin,gemcitabine	NRAS	rs1065634		Carcinoma, Non-Small-Cell Lung	Efficacy	P01111				1	114717147.0	T	C
pharmgkb	infliximab	IL1B	rs1143634		Crohn Disease	Efficacy	P01584	Drug			2	112832813.0	G	A
pharmgkb	carboplatin,cisplatin,docetaxel,gemcitabine,paclitaxel	RAF1	rs11710163		Carcinoma, Non-Small-Cell Lung	Efficacy	P04049				3	12654789.0	A	G
pharmgkb	carboplatin,cisplatin,docetaxel,paclitaxel	MAP3K1	rs16886403		Carcinoma, Non-Small-Cell Lung	Efficacy	Q13233				5	56843419.0	T	C
pharmgkb	carboplatin,cisplatin,docetaxel,gemcitabine,paclitaxel	ACSS2	rs17309872		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9NR19				20	34927985.0	A	B
pharmgkb	carboplatin,cisplatin,gemcitabine	GPX5	rs451774		Carcinoma, Non-Small-Cell Lung	Efficacy	O75715				6	28534773.0	A	G
pharmgkb	phenprocoumon	PROC	rs1799808			Dosage	P04070	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	127418286.0	C	T
pharmgkb	catecholamines	ADRB1	G389R		Coronary Artery Disease	Dosage	P08588	Drug Class			10	114045297.0	G	C
pharmgkb	gemcitabine	RRM1	rs183484		Neoplasms	Efficacy	Q9UET6	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	11	4119902.0	C	A
pharmgkb	enalapril	NOS3	rs2070744		Hypertension	Efficacy	P29474	Drug	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	7	150992991.0	C	T
pharmgkb	gemcitabine	SLC28A1	D521N		Carcinoma, Non-Small-Cell Lung	Toxicity	O00337	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	15	84935498.0	G	W
pharmgkb	tamoxifen	ABCC2	rs3740065		Breast Neoplasms	Efficacy	Q5T2W1	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	10	99845936.0	A	G
pharmgkb	ramipril	ACE	rs4344		Hypertension	Efficacy	P12821	Drug	5362129.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O	17	63489363.0	G	M
pharmgkb	ramipril	ACE	rs4359		Hypertension	Efficacy	P12821	Drug	5362129.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O	17	63494982.0	T	C
pharmgkb	methotrexate	GGH	rs719235		Arthritis, Rheumatoid	Toxicity	Q92820	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	8	63039122.0	C	A
pharmgkb	nitrendipine	AGTR1	rs5186		Hypertension	Efficacy	P30556	Drug	4507.0	CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C	3	148742201.0	A	C
pharmgkb	losartan	AGTR1	rs5186			Efficacy	P30556	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	3	148742201.0	A	C
pharmgkb	angiotensin II	AGTR1	rs5186			Efficacy	P30556	Biological Intermediate	65143.0	CC[C@H](C)C(C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N	3	148742201.0	A	C
pharmgkb	perindopril	AGTR1	rs5186		Hypertension	Efficacy	P30556	Drug	107807.0	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	3	148742201.0	A	C
pharmgkb	losartan	AGTR1	rs5186		Liver Cirrhosis	Efficacy	P30556	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	3	148742201.0	A	C
pharmgkb	quinapril	AGT	M268T		Coronary Artery Disease	Efficacy	Q9BYV1	Drug	54892.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O	1	230710048.0	A	G
pharmgkb	icotinib	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3			Other	P33261	Drug	22024915.0	C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4				
pharmgkb	nevirapine	ABCC10	I920T		HIV Infections	Metabolism/PK	Q5T3U5	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	6	43445127.0	T	C
pharmgkb	nevirapine	CCHCR1	rs1265112		HIV Infections	Toxicity	Q8TD31	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	6	31150242.0	T	C
pharmgkb	nevirapine	CCHCR1	R716Q		HIV Infections	Toxicity	Q8TD31	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	6	31144707.0	C	T
pharmgkb	nevirapine	TCF19	P241L		HIV Infections	Toxicity	Q9Y242	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	6	31161930.0	C	T
pharmgkb	nevirapine	POLR3G	rs2562519		HIV Infections	Toxicity	Q9BUI4	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	5	90485154.0	C	T
pharmgkb	pemetrexed	SLC19A1	rs1051298		Carcinoma, Non-Small-Cell Lung,Mesothelioma	Efficacy	P41440	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	21	45514912.0	G	A
pharmgkb	bevacizumab,pemetrexed	GGH	rs3780126		Carcinoma, Non-Small-Cell Lung	Efficacy	Q92820				8	63037353.0	G	A
pharmgkb	tipifarnib	ABCB1	rs1128503		Neoplasms	Metabolism/PK	P08183	Drug			7	87550285.0	A	G
pharmgkb	bupropion	DRD2	rs1799732		Tobacco Use Disorder	Efficacy	P14416	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	11	113475530.0	-	R
pharmgkb	nicotine	DRD2	rs1799732		Tobacco Use Disorder	Efficacy	P14416	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113475530.0	-	R
pharmgkb	valproic acid	GRIN2B	rs1019385		Epilepsy	Dosage	Q8TB68	Drug	3121.0	CCCC(CCC)C(=O)O	12	13981909.0	C	A
pharmgkb	gefitinib	EGFR	rs2293347		Carcinoma, Non-Small-Cell Lung	Efficacy	P00533	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	7	55201223.0	C	T
pharmgkb	cetuximab,irinotecan,leucovorin,tegafur	EGFR	rs712830		Colorectal Neoplasms	Toxicity	P00533				7	55019087.0	A	C
pharmgkb	efavirenz	CYP2B6	rs8192719		HIV Infections	Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	41012868.0	C	T
pharmgkb	gefitinib	EGFR	rs712829		Neoplasms	Efficacy	P00533	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	7	55019062.0	G	Y
pharmgkb	methamphetamine	DAOA	rs778293		Psychotic Disorders	Toxicity	P59103	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	13	105516850.0	C	W
pharmgkb	salbutamol	DUSP1	rs881152		Asthma	Efficacy	P28562	Drug	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	5	172771552.0	G	M
pharmgkb	methamphetamine	HTR1A	rs878567		Substance-Related Disorders	Toxicity	P08908	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	5	63960164.0	A	S
pharmgkb	ethanol	TAS2R16	N172K		Alcoholism	Toxicity	Q9NYV7	Drug	702.0	CCO	7	122995119.0	A	C
pharmgkb	catecholamines,metformin	SLC22A3	T400N			Metabolism/PK	O75751				6	160437122.0	C	W
pharmgkb	nicotine	POR	A503V			Metabolism/PK	Q9Y277	Drug	942.0	CN1CCCC1C2=CN=CC=C2	7	75985688.0	C	T
pharmgkb	atenolol	PROX1	rs340874		Hypertension	Toxicity	Q92786	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	1	213985913.0	T	C
pharmgkb	conjugated estrogens,medroxyprogesterone	VDR	rs1544410			Efficacy	P11473				12	47846052.0	C	D
pharmgkb	irinotecan	UGT1A9	W208R		Colorectal Neoplasms	Toxicity	O60656	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	2	233682559.0	T	C
pharmgkb	SN-38	UGT1A9	L233R			Metabolism/PK	O60656	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	2	233760985.0	T	G
pharmgkb	SN-38	UGT1A9	Y218D			Metabolism/PK	O60656	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	2	233772413.0	T	V
pharmgkb	SN-38	UGT1A9	P229L			Metabolism/PK	O60656	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	2	233760973.0	C	W
pharmgkb	fluvastatin	CYP3A4	M445T			Efficacy	P08684	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	7	99760901.0	A	G
pharmgkb	fluvastatin,simvastatin	LIPC	rs1800588			Efficacy	P11150				15	58431476.0	C	K
pharmgkb	pravastatin	LIPC	rs1800588			Efficacy	P11150	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	15	58431476.0	C	K
pharmgkb	pravastatin	ACE	rs4341			Efficacy	P12821	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	17	63488629.0	G	C
pharmgkb	lovastatin	LDLR	rs688			Efficacy	P01130	Drug	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	19	11116926.0	C	T
pharmgkb	lovastatin	LDLR	rs5925			Efficacy	P01130	Drug	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	19	11120205.0	T	C
pharmgkb	atorvastatin,simvastatin	PON1	Q192P		Hypercholesterolemia	Efficacy	P27169				7	95308134.0	T	C
pharmgkb	atorvastatin,simvastatin	PON1	rs705379		Hypercholesterolemia	Efficacy	P27169				7	95324583.0	G	H
pharmgkb	simvastatin	ABCB1	rs1128503		Hypercholesterolemia	Efficacy	P08183	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	87550285.0	A	G
pharmgkb	simvastatin	ABCB1	rs1128503		Hypercholesterolemia	Toxicity	P08183	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	87550285.0	A	G
pharmgkb	pravastatin	ABCC2	rs113646094			Metabolism/PK	Q5T2W1	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	10	99804255.0	C	K
pharmgkb	nelfinavir	CYP2C19	rs4244285		HIV Infections,Pancreatic Neoplasms	Metabolism/PK	P33261	Drug	64143.0	CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O	10	94781859.0	G	M
pharmgkb	efavirenz	CYP2B6	CYP2B6*27, CYP2B6*28			Other	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F				
pharmgkb	atorvastatin	LEPR	K656N		Acute coronary syndrome	Efficacy	P48357	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	1	65610269.0	G	Y
pharmgkb	gemcitabine	FKBP5	rs73748206			Other	Q13451	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	6	35640178.0	C	T
pharmgkb	cefotaxime	SLC22A8	I214F			Metabolism/PK	Q8TCC7	Drug	456256.0	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O	11	62995792.0	T	A
pharmgkb	hydrochlorothiazide	NEDD4L	rs292449			Efficacy	Q96PU5	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	18	58227849.0	G	C
pharmgkb	cocaine	DRD2	rs2283265		Cocaine-Related Disorders	Toxicity	P14416	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	11	113414814.0	C	A
pharmgkb	pravastatin,simvastatin	RHOA	rs11716445		Hypercholesterolemia	Efficacy	P61586				3	49368662.0	G	A
pharmgkb	asparaginase,dexamethasone,methotrexate	PYGL	rs7142143		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P06737				14	50936813.0	T	C
pharmgkb	mephenytoin	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*5, CYP2C19*6, CYP2C19*7, CYP2C19*8			Metabolism/PK	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2				
pharmgkb	Ace Inhibitors, Plain	AGT	M268T		Hypertension	Efficacy	Q9BYV1	Drug Class			1	230710048.0	A	G
pharmgkb	imatinib	ULK3	rs2290573		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	Q6PHR2	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	15	74837253.0	G	W
pharmgkb	corticosteroids	TBX21	H33Q		Asthma	Efficacy	Q9UL17	Drug Class			17	47733553.0	C	G
pharmgkb	flupirtine	HLA-DRB1	HLA-DRB1*16:01		drug-induced liver injury	Toxicity	P01911	Drug	53276.0	CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N				
pharmgkb	allopurinol	HLA-DQB1	HLA-DQB1*05:02		Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01920	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1				
pharmgkb	flupirtine	HLA-DQB1	HLA-DQB1*05:02		drug-induced liver injury	Toxicity	P01920	Drug	53276.0	CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N				
pharmgkb	nicotine	DDC	rs12718541		Tobacco Use Disorder	Toxicity	P20711	Drug	942.0	CN1CCCC1C2=CN=CC=C2	7	50482446.0	A	G
pharmgkb	clozapine	DRD1	rs265976		Schizophrenia	Efficacy	P21728	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	5	175435417.0	G	T
pharmgkb	methamphetamine	ARRB2	rs2036657		Substance-Related Disorders	Toxicity	P32121	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	17	4721864.0	G	A
pharmgkb	cannabinoids	FAAH	P129T		Substance-Related Disorders	Toxicity	O00519	Drug Class			1	46405089.0	C	A
pharmgkb	tamoxifen	CYP3A4	rs2740574		Breast Neoplasms	Toxicity	P08684	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	7	99784473.0	C	T
pharmgkb	gemcitabine	RRM1	rs9937		Neoplasms	Efficacy,Toxicity	Q9UET6	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	11	4138227.0	A	G
pharmgkb	cyclosporine	ABCB1	S893A			Dosage	P08183	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	87531302.0	A	Y
pharmgkb	cyclosporine	ABCB1	rs1128503		Kidney Transplantation,Myasthenia Gravis	Dosage	P08183	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	87550285.0	A	G
pharmgkb	metoprolol	GRK4	V454A		hypertensive nephrosclerosis	Efficacy	P32298	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	4	3037423.0	T	S
pharmgkb	fenofibrate	APOA1	rs2727786		Hypertriglyceridemia	Efficacy	P02647	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	11	116837807.0	C	G
pharmgkb	fenofibrate	LPL	rs320		Hypertriglyceridemia	Efficacy	P06858	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	8	19961566.0	T	R
pharmgkb	Thiazides, plain	ACE	rs4341		Diabetes Mellitus	Toxicity	P12821	Drug Class			17	63488629.0	G	C
pharmgkb	Thiazides, plain	AGTR1	rs5186			Toxicity	P30556	Drug Class			3	148742201.0	A	C
pharmgkb	Thiazides, plain	GNB3	rs5443		Diabetes Mellitus	Toxicity	P16520	Drug Class			12	6845711.0	C	T
pharmgkb	antiepileptics,carbamazepine	ABCB1	S893A		Epilepsy	Dosage,Efficacy	P08183				7	87531302.0	A	Y
pharmgkb	antiepileptics	ABCB1	rs3789243		Epilepsy	Efficacy	P08183	Drug Class			7	87591570.0	A	G
pharmgkb	olanzapine	PPARG	P12A		Schizophrenia	Toxicity	P37231	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	3	12351626.0	C	G
pharmgkb	efavirenz	CYP2B6	rs36118214		HIV Infections	Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	41013401.0	G	W
pharmgkb	atorvastatin,simvastatin	CYP3A4	rs2740574			Dosage	P08684				7	99784473.0	C	T
pharmgkb	ethambutol,isoniazid,pyrazinamide,rifampin	NAT2	rs4646244		Tuberculosis	Toxicity,Metabolism/PK	Q6N069				8	18390208.0	T	A
pharmgkb	atorvastatin	PON1	rs705379		Hypercholesterolemia	Efficacy	P27169	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	95324583.0	G	H
pharmgkb	methylphenidate	ADGRL3	rs1947275		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9HAR2	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	4	61878827.0	T	C
pharmgkb	methylphenidate	ADGRL3	rs6813183		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9HAR2	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	4	61903413.0	G	C
pharmgkb	methylphenidate	ADGRL3	rs1355368		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9HAR2	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	4	61914104.0	A	K
pharmgkb	methylphenidate	ADGRL3	N693K		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9HAR2	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	4	61935010.0	T	M
pharmgkb	aspirin	NAT2	rs4271002		Asthma	Toxicity	Q6N069	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	8	18390758.0	G	C
pharmgkb	fluorouracil	IGFBP3	rs2854744		Stomach Neoplasms	Efficacy	P17936	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	7	45921476.0	G	T
pharmgkb	perindopril	AGTR1	rs275651		Coronary Artery Disease	Efficacy	P30556	Drug	107807.0	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	3	148697100.0	T	A
pharmgkb	tamoxifen	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17		Breast Neoplasms	Efficacy,Metabolism/PK	P33261	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3				
pharmgkb	perindopril	BDKRB1	rs12050217		Coronary Artery Disease	Efficacy	P46663	Drug	107807.0	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	14	96262416.0	A	G
pharmgkb	capecitabine	ABCB1	rs1128503		Colorectal Neoplasms	Toxicity	P08183	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	7	87550285.0	A	G
pharmgkb	leflunomide	ESR1	rs2234693		Arthritis, Rheumatoid	Efficacy	P03372	Drug	3899.0	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	6	151842200.0	T	C
pharmgkb	aspirin	TBXAS1	rs6962291		Asthma	Toxicity	P24557	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	7	139971318.0	T	A
pharmgkb	antipsychotics	LEPR	Q223R			Toxicity	P48357	Drug Class			1	65592830.0	A	G
pharmgkb	sorafenib	VEGFA	rs2010963		Carcinoma, Hepatocellular	Efficacy	P15692	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	6	43770613.0	C	G
pharmgkb	sorafenib	NOS3	rs2070744		Carcinoma, Hepatocellular	Efficacy	P29474	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	7	150992991.0	C	T
pharmgkb	sorafenib	NOS3	D298E		Carcinoma, Hepatocellular	Efficacy	P29474	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	7	150999023.0	T	R
pharmgkb	tegafur	CYP2A6	rs8192725			Other	P11509	Prodrug	5386.0		19	40848807.0	A	G
pharmgkb	tegafur	CYP2A6	rs28399433			Other	P11509	Prodrug	5386.0		19	40850474.0	A	B
pharmgkb	tegafur	CYP2A6	L8V			Other	P11509	Prodrug	5386.0		19	40850405.0	G	A
pharmgkb	methadone	DRD2	rs1799978		Heroin Dependence	Dosage	P14416	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	11	113475629.0	T	C
pharmgkb	methadone	CYP3A4	rs3735451		Heroin Dependence	Toxicity	P08684	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	99758352.0	T	C
pharmgkb	methadone	CYP3A4	rs4646440		Heroin Dependence	Toxicity	P08684	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	99763247.0	G	A
pharmgkb	methadone	CYP3A4	rs4646437		Heroin Dependence	Toxicity	P08684	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	99767460.0	G	A
pharmgkb	methadone	CYP3A4	rs2246709		Heroin Dependence	Toxicity	P08684	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	99768096.0	A	G
pharmgkb	lithium	OR52E2	N5S		Bipolar Disorder	Efficacy	Q8NGJ4	Drug	28486.0	[Li+]	11	5059614.0	T	C
pharmgkb	lithium	ASIC2	rs11869731		Bipolar Disorder	Efficacy	Q16515	Drug	28486.0	[Li+]	17	34011852.0	G	Y
pharmgkb	somatropin recombinant	COL1A1	rs1800012			Dosage	P02452	Drug			17	50200388.0	C	A
pharmgkb	testosterone	UGT1A4	UGT1A4*1a, UGT1A4*3a			Metabolism/PK	P22310	Drug, Biological Intermediate	6013.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C				
pharmgkb	nevirapine	CYP2D6	T107N		HIV Infections	Metabolism/PK	P10635	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	22	42129770.0	G	W
pharmgkb	metformin	SLC22A1	rs594709		Diabetes Mellitus, Type 2	Efficacy	O15245	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160134722.0	G	A
pharmgkb	bevacizumab	CFH	V62I			Efficacy	P08603	Drug			1	196673103.0	G	A
pharmgkb	methadone	UGT2B7	rs6600879		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69094669.0	C	G
pharmgkb	methadone	UGT2B7	rs6600880		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69094762.0	T	A
pharmgkb	methadone	UGT2B7	rs4554144		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69094837.0	C	T
pharmgkb	methadone	UGT2B7	rs11940316		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69095409.0	T	C
pharmgkb	methadone	UGT2B7	rs7438135		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69095621.0	G	A
pharmgkb	methadone	UGT2B7	rs7662029		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69096194.0	A	K
pharmgkb	methadone	UGT2B7	Y268H		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69098620.0	T	C
pharmgkb	methadone	UGT2B7	rs4292394		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69107231.0	C	G
pharmgkb	methadone	UGT2B7	rs6600893		Opioid-Related Disorders	Efficacy,Toxicity	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69113183.0	T	C
pharmgkb	topotecan	ABCG2	rs4148157		Brain Neoplasms	Metabolism/PK	Q9UNQ0	Drug	60700.0	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O	4	88099782.0	G	A
pharmgkb	difluorodeoxyuridine	CDA	rs4655226		Neoplasms	Metabolism/PK	Q96GN5	Metabolite			1	20601791.0	C	T
pharmgkb	gemcitabine	CMPK1	rs1044457		Neoplasms	Efficacy	P30085	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	47377105.0	C	T
pharmgkb	gemcitabine	NT5C3A	rs3750117		Neoplasms	Metabolism/PK	Q9H0P0	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	7	33021334.0	A	G
pharmgkb	gemcitabine	SH2D5	rs10916852		Pancreatic Neoplasms	Efficacy	Q6ZV89	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	20726200.0	G	T
pharmgkb	gemcitabine	CMPK1	G8W		Pancreatic Neoplasms	Efficacy	P30085	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	47333967.0	G	H
pharmgkb	gemcitabine	TENT4A	rs274713		Pancreatic Neoplasms	Efficacy	Q5XG87	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	5	6723447.0	T	G
pharmgkb	gemcitabine	CMPK1	Q80H		Pancreatic Neoplasms	Efficacy	P30085	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	47368537.0	G	T
pharmgkb	gemcitabine	DCTD	rs12507552		Pancreatic Neoplasms	Efficacy	P32321	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	4	182892272.0	C	T
pharmgkb	gemcitabine	TENT4A	rs274717		Pancreatic Neoplasms	Efficacy	Q5XG87	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	5	6720954.0	A	G
pharmgkb	gemcitabine	CDC5L	rs992160		Pancreatic Neoplasms	Efficacy	Q99459	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	6	44386904.0	C	T
pharmgkb	exemestane	AKR1C3	R258C			Metabolism/PK	P42330	Drug	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	10	5102576.0	C	T
pharmgkb	exemestane	AKR1C4	G135E			Metabolism/PK	P17516	Drug	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	10	5205791.0	G	M
pharmgkb	corticosteroids	TAAR6	rs7772821		Asthma	Efficacy	Q96RI8	Drug Class			6	132571367.0	T	S
pharmgkb	bufuralol,dextromethorphan	CYP2D6	R293Q			Metabolism/PK	P10635				22	42127589.0	C	T
pharmgkb	bufuralol,dextromethorphan	CYP2D6	R440C			Metabolism/PK	P10635				22	42126750.0	G	A
pharmgkb	bufuralol,dextromethorphan	CYP2D6	V342M			Metabolism/PK	P10635				22	42127596.0	C	W
pharmgkb	bufuralol,dextromethorphan	CYP2D6	D336N			Metabolism/PK	P10635				22	42127614.0	C	T
pharmgkb	carboplatin,paclitaxel	SLCO1B3	M233I		Carcinoma, Non-Small-Cell Lung	Toxicity	F5H094				12	20862826.0	G	A
pharmgkb	atazanavir,lopinavir,ritonavir,tenofovir	ABCC2	rs717620			Toxicity	Q5T2W1				10	99782821.0	C	T
pharmgkb	bufuralol,dextromethorphan	CYP2D6	E164K			Metabolism/PK	P10635				22	42128807.0	C	T
pharmgkb	carboplatin,paclitaxel	SLCO1B3	S112P		Lung Neoplasms	Toxicity	F5H094				12	20858546.0	T	S
pharmgkb	bufuralol,dextromethorphan	CYP2D6	F168S			Metabolism/PK	P10635				22	42128794.0	A	G
pharmgkb	bufuralol,dextromethorphan	CYP2D6	R25Q			Metabolism/PK	P10635				22	42130718.0	C	T
pharmgkb	cladribine,fluorouracil,gemcitabine	NT5C1A	L254P			Other	Q9BXI3				1	39659467.0	A	G
pharmgkb	cladribine,fluorouracil,gemcitabine	NT5C1A	rs374150125			Other	Q9BXI3				1	39663330.0	G	M
pharmgkb	dimethyl fumarate	GSTP1	I105V		Psoriasis	Efficacy	P09211	Drug	637568.0	COC(=O)/C=C/C(=O)OC	11	67585218.0	A	G
pharmgkb	valproic acid	COL1A1	rs1800012		Epilepsy	Toxicity	P02452	Drug	3121.0	CCCC(CCC)C(=O)O	17	50200388.0	C	A
pharmgkb	ranibizumab	NRP1	rs2070296		Macular Degeneration	Efficacy	O14786	Drug			10	33263767.0	C	T
pharmgkb	topiramate	INSR	rs2396185			Efficacy	P06213	Drug	5284627.0	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C	19	7246650.0	A	S
pharmgkb	cladribine,fluorouracil,gemcitabine	NT5C1A	A214T			Other	Q9BXI3				1	39661180.0	C	K
pharmgkb	asparaginase	CPA2	rs199695765		Pancreatitis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P48052	Drug			7	130269008.0	C	T
pharmgkb	antipsychotics	ABCB1	I1145M		Schizophrenia	Dosage	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	tolperisone	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5			Metabolism/PK	P10635	Drug	5511.0	CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2				
pharmgkb	carbamazepine	CYP1A2	rs762551		Epilepsy	Metabolism/PK	P05177	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	15	74749576.0	C	A
pharmgkb	antipsychotics	ABCB1	S893A		Schizophrenia	Dosage	P08183	Drug Class			7	87531302.0	A	Y
pharmgkb	phenobarbital	HLA-B	HLA-B*51:01		Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4763.0	CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2				
pharmgkb	cotinine	PSMA4	rs57064725		Tobacco Use Disorder	Metabolism/PK	P25789	Metabolite	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	15	78540694.0	C	A
pharmgkb	cotinine	CHRNA3	rs7170068		Tobacco Use Disorder	Metabolism/PK	P32297	Metabolite	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	15	78620601.0	G	M
pharmgkb	atenolol	PRKCB	rs11649514		Hyperglycemia	Toxicity	P05771	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	16	24175240.0	G	T
pharmgkb	sulfinpyrazone	UGT1A9	M33T			Metabolism/PK	O60656	Drug	5342.0	C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4	2	233672032.0	T	M
pharmgkb	efavirenz	NR1I3	rs2307424		HIV Infections	Metabolism/PK	Q14994	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	1	161232815.0	G	A
pharmgkb	efavirenz	NR1I3	rs3003596		HIV Infections	Metabolism/PK	Q14994	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	1	161234427.0	A	G
pharmgkb	carbamazepine	NR1I2	rs3814055		Epilepsy	Metabolism/PK	O75469	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	3	119781188.0	C	T
pharmgkb	carbamazepine	NR1I2	rs2461817		Epilepsy	Metabolism/PK	O75469	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	3	119805804.0	A	C
pharmgkb	carbamazepine	NR1I2	rs7643645		Epilepsy	Metabolism/PK	O75469	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	3	119806650.0	A	G
pharmgkb	carbamazepine	UGT2B7	R124S		Epilepsy	Metabolism/PK	P16662	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	4	69096892.0	A	K
pharmgkb	carbamazepine	ABCB1	rs4148740		Epilepsy	Metabolism/PK	P08183	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	87522787.0	A	G
pharmgkb	carbamazepine	ABCB1	rs4148739		Epilepsy	Metabolism/PK	P08183	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	87531733.0	T	C
pharmgkb	carbamazepine	CYP3A4	rs2740574		Epilepsy	Metabolism/PK	P08684	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	99784473.0	C	T
pharmgkb	bupropion,Drugs used in nicotine dependence	CYP2A6	rs4803381		Tobacco Use Disorder	Efficacy	P11509				19	40851439.0	T	C
pharmgkb	Dipeptidyl peptidase 4 (DPP-4) inhibitors	CDKAL1	rs7756992		Diabetes Mellitus	Efficacy	Q5VV42	Drug Class			6	20679478.0	A	K
pharmgkb	citalopram,escitalopram	ERICH3	L1056V		Depressive Disorder	Efficacy	Q5RHP9				1	74572544.0	A	C
pharmgkb	docetaxel	VAC14	rs875858		Prostatic Neoplasms	Toxicity	Q08AM6	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	16	70741552.0	C	W
pharmgkb	capecitabine	DPYD	rs12132152		Colorectal Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97057448.0	G	M
pharmgkb	fluorouracil	DPYD	rs115632870			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97828265.0	C	T
pharmgkb	fluorouracil	DPYD	rs72728438			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97382318.0	T	C
pharmgkb	fluorouracil	TYMS	rs2847153		Pancreatic Neoplasms	Efficacy	P04818	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	18	661647.0	G	A
pharmgkb	rivastigmine	BCHE	A567T		Alzheimer Disease,Lewy Body Disease	Efficacy	P06276	Drug	77991.0	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	3	165773492.0	C	T
pharmgkb	donepezil	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6		Alzheimer Disease	Other	P10635	Drug	3152.0	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC				
pharmgkb	irbesartan	CYP2C9	I359L		Essential hypertension	Efficacy,Metabolism/PK	P11712	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	10	94981296.0	A	S
pharmgkb	rivastigmine	ACHE	rs2571598		Alzheimer Disease	Efficacy	Q04844	Drug	77991.0	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	7	100892018.0	C	K
pharmgkb	ritonavir	ABCB1	S893A		HIV Infections	Metabolism/PK	P08183	Drug	392622.0	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	7	87531302.0	A	Y
pharmgkb	irbesartan	CYP2C9	L90P			Metabolism/PK	P11712	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	10	94941958.0	T	C
pharmgkb	heroin	GRM3	rs274622		Heroin Dependence	Other	Q14832	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	7	86643624.0	C	T
pharmgkb	cyclophosphamide,cytarabine,daunorubicin,mercaptopurine,methotrexate,prednisone,vincristine	DROSHA	rs639174		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9NRR4				5	31433540.0	C	T
pharmgkb	anastrozole,exemestane	MAP4K4	rs4550690		Breast Neoplasms	Toxicity	Q8WXF7				2	101806532.0	T	C
pharmgkb	mycophenolate mofetil	UGT1A9	rs3832043		Kidney Transplantation	Other	O60656	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	2	233671808.0	T	-
pharmgkb	antineoplastic agents	RBFOX1	rs6500843		Breast Neoplasms	Efficacy	Q9NWB1	Drug Class			16	6820854.0	A	K
pharmgkb	enalapril	VEGFA	rs699947		Hypertension	Efficacy	P15692	Drug	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	6	43768652.0	A	Y
pharmgkb	bevacizumab,capecitabine,oxaliplatin	MGAT4A	rs885036		Colorectal Neoplasms	Efficacy	Q9UM21				2	98688331.0	A	G
pharmgkb	bevacizumab,capecitabine,cetuximab,oxaliplatin	MGAT4A	rs885036		Colorectal Neoplasms	Efficacy	Q9UM21				2	98688331.0	A	G
pharmgkb	citalopram,escitalopram	ERICH3	rs696692		Depressive Disorder	Efficacy	Q5RHP9				1	74591902.0	T	M
pharmgkb	brivaracetam	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3			Metabolism/PK	P33261	Drug	9837243.0	CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N				
pharmgkb	succinylcholine,volatile anesthetics	RYR1	A612P		Malignant Hyperthermia	Toxicity	P21817				19	38457539.0	G	A
pharmgkb	tamoxifen	ABCC2	rs717620		Breast Neoplasms	Efficacy	Q5T2W1	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	10	99782821.0	C	T
pharmgkb	irinotecan	NR1I2	rs10934498		Colonic Neoplasms	Metabolism/PK	O75469	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	3	119785534.0	G	H
pharmgkb	vitamin e	CYP4F2	W12G			Metabolism/PK	P78329	Drug	14985.0	CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O	19	15897578.0	A	C
pharmgkb	cisplatin,gemcitabine	CMPK1	rs4492666		Carcinoma, Non-Small-Cell Lung	Efficacy	P30085				1	47335173.0	A	C
pharmgkb	cisplatin,gemcitabine	RRM1	rs2284449		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9UET6				11	4099619.0	T	C
pharmgkb	cisplatin,gemcitabine	RRM1	rs720106		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9UET6				11	4118748.0	T	C
pharmgkb	cisplatin,gemcitabine	RRM1	rs232043		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9UET6				11	4117895.0	G	A
pharmgkb	mycophenolic acid	UGT1A9	rs3832043		Kidney Transplantation	Metabolism/PK	O60656	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	2	233671808.0	T	-
pharmgkb	docetaxel	NR1I2	rs3732360		Anemia,Nasopharyngeal Neoplasms	Toxicity	O75469	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	3	119817734.0	C	K
pharmgkb	docetaxel	RXRA	rs62576288		Nasopharyngeal Neoplasms	Toxicity	P19793	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	9	134324891.0	G	A
pharmgkb	docetaxel	RXRA	rs1536475		Nasopharyngeal Neoplasms	Toxicity	P19793	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	9	134429310.0	A	G
pharmgkb	carbamazepine	ABCC2	rs4148386		Epilepsy	Metabolism/PK	Q5T2W1	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	10	99788711.0	G	A
pharmgkb	cisplatin	LRP2	A2872T		Neoplasms	Toxicity	P98164	Drug	441203.0	N.N.Cl[Pt+2]Cl	2	169196995.0	C	D
pharmgkb	busulfan	GSTA1	rs3957357		Transplantation	Metabolism/PK	P08263	Drug	2478.0	CS(=O)(=O)OCCCCOS(=O)(=O)C	6	52803889.0	A	G
pharmgkb	calcium channel blockers	NUMA1	rs10898815		Hypertension	Efficacy	Q14980	Drug Class			11	72028377.0	G	A
pharmgkb	calcium channel blockers	PICALM	rs588076		Hypertension	Efficacy	Q9BSJ6	Drug Class			11	85980619.0	G	M
pharmgkb	hmg coa reductase inhibitors	SREBF1	rs11868035		Schizophrenia	Toxicity	P36956	Drug Class			17	17811787.0	G	A
pharmgkb	rifampin	SLCO1B1	P155T			Metabolism/PK	Q9Y6L6	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	12	21176879.0	C	W
pharmgkb	rifampin	SLCO1B1	N130H			Metabolism/PK	Q9Y6L6	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	12	21176804.0	A	K
pharmgkb	docetaxel	HNF4A	rs2273618		Anemia,Nasopharyngeal Neoplasms	Toxicity	P41235	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	20	44423930.0	T	C
pharmgkb	docetaxel	HNF4A	rs3746574		Anemia,Nasopharyngeal Neoplasms	Toxicity	P41235	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	20	44429378.0	T	C
pharmgkb	docetaxel	RXRA	rs6413517		Anemia,Nasopharyngeal Neoplasms	Toxicity	P19793	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	9	134429410.0	T	G
pharmgkb	docetaxel	HNF4A	rs6130615		Anemia,Nasopharyngeal Neoplasms	Toxicity	P41235	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	20	44430797.0	C	T
pharmgkb	docetaxel	NR1I3	rs9725457		Anemia,Nasopharyngeal Neoplasms	Toxicity	Q14994	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	1	161231784.0	G	A
pharmgkb	docetaxel	NR1I3	rs2502815		Anemia,Nasopharyngeal Neoplasms	Toxicity	Q14994	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	1	161233437.0	G	A
pharmgkb	docetaxel	NR1I3	rs2501873		Anemia,Nasopharyngeal Neoplasms	Toxicity	Q14994	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	1	161234748.0	C	T
pharmgkb	docetaxel	NR1I3	rs10538494		Anemia,Nasopharyngeal Neoplasms	Toxicity	Q14994	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O				
pharmgkb	docetaxel	NR1I3	rs75114882		Nasopharyngeal Neoplasms,Neutropenia	Toxicity	Q14994	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	1	161237587.0	A	K
pharmgkb	docetaxel	NR1I2	rs3732359		Anemia,Nasopharyngeal Neoplasms	Toxicity	O75469	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	3	119817582.0	G	A
pharmgkb	indinavir	CYP3A4	rs2740574		HIV Infections	Other	P08684	Drug	5362440.0	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	7	99784473.0	C	T
pharmgkb	lansoprazole,tacrolimus	ABCB1	I1145M		Gastroesophageal Reflux,Transplantation	Metabolism/PK	P08183				7	87509329.0	A	K
pharmgkb	paclitaxel	CYP2C8	R139K		Drug Toxicity,Neurotoxicity Syndromes	Toxicity	P10632	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	10	95067273.0	C	W
pharmgkb	metformin	SLC22A1	rs622342		Diabetes Mellitus	Efficacy	O15245	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160151834.0	C	A
pharmgkb	docetaxel	NR1I2	rs3814058		Anemia,Nasopharyngeal Neoplasms	Toxicity	O75469	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	3	119818444.0	T	C
pharmgkb	risperidone	RGS4	rs2661319		Schizophrenia	Efficacy	P49798	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	1	163069987.0	T	C
pharmgkb	docetaxel	RXRA	rs2234753		Anemia,Nasopharyngeal Neoplasms	Toxicity	P19793	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	9	134401915.0	G	A
pharmgkb	sulfasalazine	ABCG2	rs72552713			Metabolism/PK	Q9UNQ0	Drug	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	4	88131805.0	G	A
pharmgkb	cytarabine,daunorubicin,etoposide,mitoxantrone	SLCO1B1	rs2291075		Leukemia, Myeloid, Acute	Efficacy	Q9Y6L6				12	21178691.0	C	T
pharmgkb	cytarabine,daunorubicin,etoposide,mitoxantrone	SLCO1B1	rs2291075		Leukemia, Myeloid, Acute	Efficacy	Q9Y6L6				12	21178691.0	C	T
pharmgkb	doxorubicin,doxorubicinol	SLC22A16	H49R		Breast Neoplasms	Other	Q86VW1				6	110456925.0	T	C
pharmgkb	cytarabine	CDA	K27Q		Leukemia,Lymphoma	Toxicity	Q96GN5	Drug	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	1	20589208.0	A	C
pharmgkb	opioids	COMT	V158M		Pain	Other	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	antipsychotics	DRD2	rs1799732		Psychotic Disorders	Toxicity	P14416	Drug Class			11	113475530.0	-	R
pharmgkb	antidepressants	HTR2A	H452Y		Depressive Disorder, Major	Efficacy	P28223	Drug Class			13	46834899.0	G	A
pharmgkb	alemtuzumab,chlorambucil,cyclophosphamide,fludarabine,prednisone,rituximab,vincristine	CXCL12	rs1801157		Leukemia, Lymphocytic, Chronic, B-Cell	Efficacy	P61073				10	44372809.0	C	T
pharmgkb	Photodynamic therapy	F13A1	V35L		Choroidal Neovascularization	Efficacy	P50502	Drug Class			6	6318562.0	C	W
pharmgkb	mycophenolate mofetil	SLCO1B3	S112P		Kidney Transplantation	Dosage,Toxicity	F5H094	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	12	20858546.0	T	S
pharmgkb	interferons	STAT3	rs4796793		Carcinoma, Renal Cell	Efficacy	P40763	Drug Class			17	42390192.0	G	C
pharmgkb	methamphetamine	PICK1	rs713729		Substance-Related Disorders	Other	Q9NRD5	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	22	38059462.0	T	A
pharmgkb	cyclosporine	CTLA4	T17S		Kidney Transplantation	Toxicity	P16410	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	2	203867991.0	A	K
pharmgkb	antidepressants	FHIT	rs49411		Depressive Disorder, Major	Efficacy	P49789	Drug Class			3	59771849.0	T	C
pharmgkb	antidepressants	MTRF1L	rs766127		Depressive Disorder, Major	Efficacy	Q9Y5R4	Drug Class			6	152992697.0	G	W
pharmgkb	antidepressants	RGS17	rs672170		Depressive Disorder, Major	Efficacy	Q9UGC6	Drug Class			6	153024050.0	A	G
pharmgkb	antidepressants	PON2	rs2299267		Depressive Disorder, Major	Efficacy	Q15165	Drug Class			7	95432609.0	A	G
pharmgkb	antidepressants	CTNNA3	rs10997242		Depressive Disorder, Major	Efficacy	Q9UI47	Drug Class			10	66576537.0	T	C
pharmgkb	antidepressants	CACNA1A	rs2112460		Depressive Disorder, Major	Efficacy	O00555	Drug Class			19	13479598.0	G	A
pharmgkb	nicotine	DRD1	rs4532		Tobacco Use Disorder	Other	P21728	Drug	942.0	CN1CCCC1C2=CN=CC=C2	5	175443147.0	C	T
pharmgkb	nicotine	DRD1	rs686		Tobacco Use Disorder	Other	P21728	Drug	942.0	CN1CCCC1C2=CN=CC=C2	5	175441697.0	G	H
pharmgkb	adalimumab	HFE	rs2071303		Crohn Disease	Efficacy	Q30201	Drug			6	26091108.0	T	C
pharmgkb	pravastatin	LDLR	rs1433099		Vascular Diseases	Efficacy	P01130	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	19	11131982.0	T	M
pharmgkb	adalimumab	TF	L247M		Crohn Disease	Efficacy	P13726	Drug			3	133756878.0	C	T
pharmgkb	pravastatin	LDLR	rs2738466		Vascular Diseases	Efficacy	P01130	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	19	11132089.0	A	G
pharmgkb	dexamethasone	SERPINE1	A15T		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q8NC51	Drug	5743.0	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	7	101128436.0	G	A
pharmgkb	ticagrelor	UGT2B7	L46P		Acute coronary syndrome	Metabolism/PK	P16662	Drug	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	4	69096657.0	T	C
pharmgkb	ticagrelor	CYP3A4	G56D		Acute coronary syndrome	Metabolism/PK	P08684	Drug	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	7	99778079.0	C	T
pharmgkb	ticagrelor	SLCO1B1	V174A		Acute coronary syndrome	Metabolism/PK	Q9Y6L6	Drug	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	12	21178615.0	T	C
pharmgkb	mercaptopurine	TPMT	rs12201199			Other	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	6	18139571.0	A	T
pharmgkb	mercaptopurine	TPMT	rs17839843			Other	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	6	18143623.0	G	A
pharmgkb	mercaptopurine	TPMT	rs3931660			Other	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	6	18148874.0	A	T
pharmgkb	chlorpromazine,clozapine,haloperidol,olanzapine,quetiapine,risperidone,trifluoperazine	EPM2A	rs1415744		Schizophrenia	Efficacy	O95278				6	145701395.0	T	C
pharmgkb	adalimumab	CRP	rs1130864			Efficacy	P02741	Drug			1	159713301.0	G	A
pharmgkb	adalimumab	ATG5	rs510432		Inflammatory Bowel Diseases	Efficacy	Q9H1Y0	Drug			6	106326155.0	T	C
pharmgkb	rasagiline	DRD2	rs1076560		Parkinson Disease	Efficacy	P14416	Drug	3052776.0	C#CCN[C@@H]1CCC2=CC=CC=C12	11	113412966.0	C	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	CERS6	rs13393173		Arthritis, Rheumatoid	Efficacy	Q6ZMG9	Drug Class			2	168532581.0	G	A
pharmgkb	rasagiline	DRD2	rs2283265		Parkinson Disease	Efficacy	P14416	Drug	3052776.0	C#CCN[C@@H]1CCC2=CC=CC=C12	11	113414814.0	C	A
pharmgkb	telaprevir	CYP24A1	rs2585428		Hepatitis C	Metabolism/PK	Q07973	Drug	3010818.0	CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5	20	54170358.0	C	T
pharmgkb	sitagliptin,vildagliptin	GLP1R	G168S		Diabetes Mellitus, Type 2	Efficacy	P43220				6	39066296.0	G	M
pharmgkb	bisoprolol	ACY3	rs2514036		Hypertension	Efficacy	Q96HD9	Drug	2405.0	CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O	11	67647583.0	C	T
pharmgkb	losartan	NPHS1	rs3814995		Hypertension	Efficacy	O60500	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	19	35851310.0	C	K
pharmgkb	mycophenolic acid	ABCC2	I1324M		Organ Transplantation	Metabolism/PK	Q5T2W1	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	10	99844450.0	C	K
pharmgkb	mycophenolic acid	SLCO1B1	N130H		Kidney Transplantation	Metabolism/PK	Q9Y6L6	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	12	21176804.0	A	K
pharmgkb	tamoxifen	NCOA1	P1272S		Breast Neoplasms	Toxicity	Q15788	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	2	24752089.0	C	T
pharmgkb	tamoxifen	LRMDA	rs10509373		Breast Neoplasms	Efficacy	Q9H2I8	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	10	76397814.0	T	C
pharmgkb	bupropion	GALR1	rs2717162		Tobacco Use Disorder	Efficacy	P47211	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	18	77256371.0	T	C
pharmgkb	nicotine	GALR1	rs2717162		Tobacco Use Disorder	Efficacy	P47211	Drug	942.0	CN1CCCC1C2=CN=CC=C2	18	77256371.0	T	C
pharmgkb	codeine	ABCB1	rs1128503		Pain	Toxicity	P08183	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	7	87550285.0	A	G
pharmgkb	hydrochlorothiazide	DOT1L	rs2269879		Hypertension	Efficacy	Q8TEK3	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	19	2194897.0	T	C
pharmgkb	midazolam	VDR	rs1544410			Metabolism/PK	P11473	Drug	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F	12	47846052.0	C	D
pharmgkb	midazolam	VDR	rs4516035			Metabolism/PK	P11473	Drug	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F	12	47906043.0	T	C
pharmgkb	nicotine	CHRM2	rs324650		Tobacco Use Disorder	Other	P08172	Drug	942.0	CN1CCCC1C2=CN=CC=C2	7	137008914.0	T	A
pharmgkb	methotrexate	ARID5B	rs10994982		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q14865	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	61950345.0	A	G
pharmgkb	dabigatran	ABCB1	rs4148738		Atrial Fibrillation	Metabolism/PK	P08183	Drug			7	87533733.0	C	T
pharmgkb	dabigatran	CES1	rs2244613		Atrial Fibrillation	Toxicity	Q9NZK5	Drug			16	55810697.0	G	W
pharmgkb	dabigatran	CES1	rs8192935		Atrial Fibrillation	Metabolism/PK	Q9NZK5	Drug			16	55827882.0	A	G
pharmgkb	aspirin	SLC6A12	C10R		Asthma	Toxicity	P48065	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	12	209959.0	A	G
pharmgkb	mycophenolate mofetil	IMPDH1	rs2228075		Organ Transplantation	Toxicity	P20839	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	7	128394575.0	C	D
pharmgkb	amantadine,Anticholinergics,Dopamine agonists,levodopa,selegiline	SLC22A1	rs622342		Parkinson Disease	Dosage,Toxicity	O15245				6	160151834.0	C	A
pharmgkb	fenofibrate	APOB	P2739Q		Hypertriglyceridemia	Efficacy	P04114	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	2	21008652.0	G	W
pharmgkb	cotinine	CHRNA5	D398N		Tobacco Use Disorder	Metabolism/PK	P30532	Metabolite	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	15	78590583.0	G	A
pharmgkb	Opium alkaloids and derivatives	CHRNA5	D398N		Pain	Toxicity	P30532	Drug Class			15	78590583.0	G	A
pharmgkb	nicotine,Opium alkaloids and derivatives	CHRNA5	rs660652		Pain,Tobacco Use Disorder	Toxicity	P30532				15	78595490.0	A	K
pharmgkb	nicotine	CHRNB2	rs2072660		Tobacco Use Disorder	Toxicity	P17787	Drug	942.0	CN1CCCC1C2=CN=CC=C2	1	154576245.0	T	S
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	SLC29A1	rs760370		Hepatitis C, Chronic	Efficacy	Q99808				6	44233216.0	A	G
pharmgkb	nicotine	CHRNB2	rs2072658		Tobacco Use Disorder	Other	P17787	Drug	942.0	CN1CCCC1C2=CN=CC=C2	1	154567749.0	G	A
pharmgkb	nicotine	CHRNA4	rs2229959		Tobacco Use Disorder	Other	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63350202.0	C	W
pharmgkb	stavudine	TNF	rs1799964		HIV Infections	Toxicity	Q9UNG2	Drug	18283.0	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO	6	31574531.0	T	C
pharmgkb	nicotine	CHRNB4	rs3813567		Tobacco Use Disorder	Toxicity	P30926	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78642209.0	G	A
pharmgkb	nicotine	CHRNA3	rs3743078		Tobacco Use Disorder	Toxicity	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78602417.0	C	R
pharmgkb	nicotine	CHRNA5	rs637137		Tobacco Use Disorder	Toxicity	P30532	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78581634.0	T	A
pharmgkb	nicotine	CHRNA5	rs684513		Tobacco Use Disorder	Toxicity	P30532	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78566058.0	C	K
pharmgkb	deferasirox	CYP1A2	rs2470890		beta-Thalassemia	Metabolism/PK	P05177	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	15	74755085.0	T	C
pharmgkb	deferasirox	CYP1A1	rs2606345		beta-Thalassemia	Metabolism/PK	P11511	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	15	74724835.0	C	A
pharmgkb	deferasirox	CYP1A2	rs762551		beta-Thalassemia	Metabolism/PK	P05177	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	15	74749576.0	C	A
pharmgkb	berberine,coptisine	CYP2D6	CYP2D6*1, CYP2D6*10			Metabolism/PK	P10635							
pharmgkb	amiodarone,Antibiotics,antipsychotics,diuretics,quinidine,sotalol	KCNE1	D85N			Toxicity	P15382				21	34449382.0	C	T
pharmgkb	methamphetamine	DRD3	G9S		HIV Infections	Toxicity	P35462	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	3	114171968.0	C	T
pharmgkb	fluoxetine,sertraline	ACE	rs1799752		Depressive Disorder	Efficacy	P12821				17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs4803219		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39245279.0	C	T
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs28416813		Hepatitis C, Chronic,HIV Infections	Efficacy	Q8IZI9				19	39245004.0	C	G
pharmgkb	bumetanide,furosemide,torasemide	GNB3	rs5443			Efficacy	P16520				12	6845711.0	C	T
pharmgkb	bumetanide,furosemide,torasemide	ADD1	G460W			Efficacy	P35611				4	2904980.0	G	W
pharmgkb	fluorouracil,leucovorin,oxaliplatin	ABCC2	rs717620		Colonic Neoplasms	Toxicity	Q5T2W1				10	99782821.0	C	T
pharmgkb	fluorouracil,leucovorin,oxaliplatin	ABCC2	rs717620		Colorectal Neoplasms	Toxicity	Q5T2W1				10	99782821.0	C	T
pharmgkb	carboplatin,cisplatin	PIK3CA	rs2699887		Carcinoma, Non-Small-Cell Lung	Toxicity	P42336				3	179148620.0	C	T
pharmgkb	carboplatin,cisplatin	PTEN	rs2299939		Carcinoma, Non-Small-Cell Lung	Toxicity	P60484				10	87897393.0	C	W
pharmgkb	bleomycin,dacarbazine,doxorubicin,vinblastine	GSTM1	GSTM1 non-null, GSTM1 null			Efficacy,Toxicity	P09488							
pharmgkb	irinotecan,oxaliplatin,tegafur / gimeracil / oteracil	UGT1A7	UGT1A7*3		Colorectal Neoplasms	Toxicity	Q9HAW7							
pharmgkb	irinotecan,oxaliplatin,tegafur / gimeracil / oteracil	UGT1A6	UGT1A6*2a		Colorectal Neoplasms	Toxicity	P19224							
pharmgkb	peginterferon alfa-2b,ribavirin	CYP27B1	rs10877012		Hepatitis C, Chronic	Efficacy	O15528				12	57768302.0	G	Y
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs4803217		Hepatitis C,HIV Infections	Efficacy	Q8IZI9				19	39243580.0	C	A
pharmgkb	docetaxel,epirubicin	MDM4	rs1563828		Breast Neoplasms	Efficacy	O15151				1	204547449.0	A	K
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	CYP1B1	L432V		Breast Neoplasms	Efficacy	Q16678				2	38071060.0	G	C
pharmgkb	bevacizumab,fluorouracil,irinotecan,leucovorin	RGS5	rs1056515		Colorectal Neoplasms	Efficacy	O15539				1	163143470.0	G	T
pharmgkb	cyclophosphamide,docetaxel	VEGFA	rs1570360		Prostatic Neoplasms	Efficacy	P15692				6	43770093.0	A	G
pharmgkb	peginterferon alfa-2b,protease inhibitors,ribavirin	SLC28A2	P22L		Hepatitis C	Toxicity	O43868				15	45253280.0	C	T
pharmgkb	doxorubicin,methotrexate,prednisolone,vincristine	ABCB1	S400N		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P08183				7	87550493.0	C	W
pharmgkb	cyclophosphamide,epirubicin,paclitaxel	CYP1B1	L432V		Breast Neoplasms	Toxicity	Q16678				2	38071060.0	G	C
pharmgkb	bleomycin,cyclophosphamide,doxorubicin,prednisone,rituximab,vincristine,vindesine	ABCB1	S400N		Lymphoma, Non-Hodgkin	Toxicity	P08183				7	87550493.0	C	W
pharmgkb	interferons,ribavirin	IL18	rs1946518		Hepatitis C, Chronic	Efficacy	Q14116				11	112164735.0	T	G
pharmgkb	interferons,ribavirin	IL18	rs187238		Hepatitis C, Chronic	Efficacy	Q14116				11	112164265.0	C	R
pharmgkb	mercaptopurine,methotrexate	PACSIN2	rs2413739		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9UNF0				22	43001030.0	C	T
pharmgkb	peginterferon alfa-2b,ribavirin	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Hepatitis C, Chronic	Toxicity	P31645							
pharmgkb	peginterferon alfa-2b,ribavirin	IL6	rs1800795		Hepatitis C, Chronic	Toxicity	P05231				7	22727026.0	C	G
pharmgkb	cisplatin,fluorouracil,mitoxantrone	GALNT14	rs12613732		Carcinoma, Hepatocellular	Efficacy	Q96FL9				2	31026561.0	T	R
pharmgkb	mercaptopurine,methotrexate	FOLH1	H460Y		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q04609				11	49164722.0	G	A
pharmgkb	Antivirals for treatment of HIV infections, combinations,Drugs For Treatment Of Tuberculosis	CYP2B6	Q172H		HIV Infections,Tuberculosis	Toxicity	P20813				19	41006936.0	G	W
pharmgkb	Antivirals for treatment of HIV infections, combinations,Drugs For Treatment Of Tuberculosis	ABCB1	I1145M		HIV Infections,Tuberculosis	Toxicity	P08183				7	87509329.0	A	K
pharmgkb	cyclosporine,dicloxacillin	ABCB1	S893A		Cystic Fibrosis	Metabolism/PK	P08183				7	87531302.0	A	Y
pharmgkb	cyclophosphamide,fluorouracil,methotrexate	FGFR4	G388R		Breast Neoplasms	Efficacy	P22455				5	177093242.0	G	A
pharmgkb	Dihydropyridine derivatives	NOS1AP	rs10494366			Toxicity	O75052	Drug Class			1	162115895.0	G	T
pharmgkb	ethanol	CHRNA3	rs1051730		Alcoholism	Other	P32297	Drug	702.0	CCO	15	78601997.0	G	A
pharmgkb	capecitabine,oxaliplatin	PTGS2	rs5275		Colorectal Neoplasms	Efficacy	P35354				1	186673926.0	A	K
pharmgkb	methadone	GNB3	rs5443		Opioid-Related Disorders	Toxicity	P16520	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	12	6845711.0	C	T
pharmgkb	methamphetamine	ESR1	rs2234693		Psychotic Disorders	Toxicity	P03372	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	6	151842200.0	T	C
pharmgkb	amphetamine	DRD2	rs12364283			Other	P14416	Drug	3007.0	C[C@@H](CC1=CC=CC=C1)N	11	113476233.0	A	G
pharmgkb	nicotine	GRIN3A	rs11788456		Tobacco Use Disorder	Other	Q8TCU5	Drug	942.0	CN1CCCC1C2=CN=CC=C2	9	101585868.0	G	A
pharmgkb	methadone	KCNJ6	rs2070995		Heroin Dependence	Other	P48051	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	21	37714662.0	T	C
pharmgkb	Analgesics	KCNJ6	rs2070995		Pain	Efficacy	P48051	Drug Class			21	37714662.0	T	C
pharmgkb	flucloxacillin	NR1I2	rs3814055		Toxic liver disease	Toxicity	O75469	Drug	21319.0	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	3	119781188.0	C	T
pharmgkb	repaglinide	NOS1AP	rs10494366		Diabetes Mellitus, Type 2	Efficacy	O75052	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	1	162115895.0	G	T
pharmgkb	ethanol	CHRNA3	rs578776		Alcoholism	Other	P32297	Drug	702.0	CCO	15	78596058.0	G	A
pharmgkb	ethanol	CHRNA5	rs615470		Alcoholism	Other	P30532	Drug	702.0	CCO	15	78593646.0	T	C
pharmgkb	cocaine	CHRNA5	rs684513		Cocaine-Related Disorders	Other	P30532	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	15	78566058.0	C	K
pharmgkb	repaglinide	IGF2BP2	rs4402960		Diabetes Mellitus, Type 2	Efficacy	Q9Y6M1	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	3	185793899.0	G	T
pharmgkb	repaglinide	IGF2BP2	rs1470579		Diabetes Mellitus, Type 2	Efficacy	Q9Y6M1	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	3	185811292.0	A	C
pharmgkb	clozapine	SLC6A3	rs2975226		Schizophrenia	Efficacy	Q01959	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	5	1445501.0	A	T
pharmgkb	rosuvastatin	CRP	rs1205		Coronary Disease	Efficacy	P02741	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	1	159712443.0	C	T
pharmgkb	cocaine	DRD2	rs1125394		Cocaine-Related Disorders	Other	P14416	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	11	113426463.0	T	C
pharmgkb	olanzapine	DRD2	rs6279		Bipolar Disorder,Depression	Other	P14416	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	113410351.0	G	C
pharmgkb	olanzapine	DRD2	rs6275		Bipolar Disorder,Depression	Other	P14416	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	113412755.0	A	G
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	LDLR	rs14158		Hepatitis C, Chronic,HIV Infections	Efficacy	P01130				19	11131368.0	G	A
pharmgkb	ritonavir	APOC3	rs2854116		HIV Infections,Hyperlipidemias	Toxicity	P02656	Drug	392622.0	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	11	116829453.0	C	T
pharmgkb	ritonavir	APOC3	rs2854117		HIV Infections,Hyperlipidemias	Toxicity	P02656	Drug	392622.0	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	11	116829426.0	T	M
pharmgkb	capecitabine,oxaliplatin	VEGFA	rs2010963		Colorectal Neoplasms	Efficacy	P15692				6	43770613.0	C	G
pharmgkb	atorvastatin	ABCB1	S893A			Toxicity	P08183	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	87531302.0	A	Y
pharmgkb	antidepressants,citalopram	CREB1	rs7569963		Depression	Efficacy,Toxicity	P16220				2	207608460.0	G	A
pharmgkb	doxorubicin,doxorubicinol	CBR1	rs20572		Breast Neoplasms	Metabolism/PK	P16152				21	36072675.0	C	T
pharmgkb	doxorubicin	CBR1	rs9024		Breast Neoplasms	Dosage,Metabolism/PK	P16152	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	21	36073015.0	G	A
pharmgkb	carbamazepine	HSPA1A	I74M			Toxicity	P0DMV8	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	6	31815978.0	T	S
pharmgkb	phenytoin	CYP2C9	rs71486745			Dosage	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	10	94936019.0	GT	-
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs12980275		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39241143.0	A	G
pharmgkb	gemcitabine	ESR2	rs944050		Pancreatic Neoplasms	Efficacy	Q92731	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	14	64233327.0	T	C
pharmgkb	rosuvastatin	ABCG2	rs2199939			Efficacy	Q9UNQ0	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	8	40053975.0	C	T
pharmgkb	perindopril	AGTR1	rs5182		Coronary Artery Disease	Efficacy	P30556	Drug	107807.0	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	3	148741608.0	C	T
pharmgkb	repaglinide	KCNJ11	K23Q		Diabetes Mellitus, Type 2	Efficacy	Q14654	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	11	17388025.0	T	M
pharmgkb	bumetanide,furosemide,torasemide	SLC12A3	G263A			Efficacy	P55017				16	56870675.0	C	G
pharmgkb	tacrolimus	CAPN10	rs5030952		Kidney Transplantation	Toxicity	Q9HC96	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	2	240603286.0	C	K
pharmgkb	risperidone	CCL2	rs4795893		Schizophrenia	Efficacy	P13500	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	17	34247429.0	G	A
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,simeprevir	IFNL3	rs8099917		Hepatitis C	Efficacy	Q8IZI9				19	39252525.0	T	G
pharmgkb	atorvastatin,Bisphosphonates	FDPS	rs11264359		Coronary Disease,Osteoporosis	Efficacy	P14324				1	155313038.0	A	G
pharmgkb	alendronate	MVK	rs10161126		Bone Diseases	Efficacy	Q03426	Drug	2088.0	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN	12	109604543.0	A	G
pharmgkb	docetaxel	ERCC1	Q506K		Breast Neoplasms	Toxicity	P07992	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	19	45409478.0	C	D
pharmgkb	antipsychotics	IL1B	rs4849127		Schizophrenia	Toxicity	P01584	Drug Class			2	112844982.0	A	G
pharmgkb	interferon beta-1a,interferon beta-1b	ZNF697	rs10494227		Multiple Sclerosis	Efficacy	Q5TEC3				1	119594822.0	A	G
pharmgkb	interferon beta-1a,interferon beta-1b	GAPVD1	rs2291858		Multiple Sclerosis	Efficacy	Q14C86				9	125366503.0	A	G
pharmgkb	interferon beta-1a,interferon beta-1b	GAPVD1	rs10760397		Multiple Sclerosis	Efficacy	Q14C86				9	125370928.0	T	C
pharmgkb	anastrozole,exemestane	TUBB1	rs10485828		Breast Neoplasms	Other	Q9H4B7				20	59025600.0	G	C
pharmgkb	atazanavir,ritonavir	UGT1A1	rs1042640		HIV Infections,nephrolithiasis	Toxicity	P22309				2	233772898.0	G	H
pharmgkb	aspirin	ZBTB22	T310A		aspirin-induced asthma,Asthma	Toxicity	O15209	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	6	33315989.0	T	C
pharmgkb	carboplatin,taxanes	VEGFA	rs6900017		Ovarian Neoplasms	Toxicity	P15692				6	43790748.0	C	T
pharmgkb	carboplatin,taxanes	VEGFA	rs9369421		Ovarian Neoplasms	Efficacy	P15692				6	43794385.0	T	C
pharmgkb	carboplatin,taxanes	VEGFA	rs879825		Ovarian Neoplasms	Toxicity	P15692				6	43796077.0	A	G
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b	CXCL10	rs56061981		Hepatitis C, Chronic	Efficacy	P02778				4	76023632.0	C	T
pharmgkb	carboplatin,lonafarnib,paclitaxel	FNTB	rs11623866		Ovarian Neoplasms	Efficacy	P49356				14	64986345.0	G	C
pharmgkb	cyclophosphamide	CYP2B6	rs7254579		Lupus erythematosus	Metabolism/PK	P20813	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	19	40988986.0	T	C
pharmgkb	cotinine	CHRNB4	rs10851907		Tobacco Use Disorder	Metabolism/PK	P30926	Metabolite	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	15	78623522.0	G	A
pharmgkb	atazanavir,ritonavir	UGT1A7	rs7586110		HIV Infections,Hyperbilirubinemia	Toxicity	Q9HAW7				2	233681881.0	T	R
pharmgkb	atazanavir,ritonavir	UGT1A7	N129K		HIV Infections,Hyperbilirubinemia	Toxicity	Q9HAW7				2	233682324.0	T	R
pharmgkb	atazanavir,ritonavir	UGT1A7	R131G		HIV Infections,Hyperbilirubinemia	Toxicity	Q9HAW7				2	233682328.0	C	D
pharmgkb	atazanavir,ritonavir	UGT1A3	rs3806596		HIV Infections,Hyperbilirubinemia	Toxicity	P35503				2	233729061.0	T	C
pharmgkb	docetaxel	RXRA	rs11185647		Anemia,Nasopharyngeal Neoplasms,Neutropenia	Toxicity	P19793	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	9	134323982.0	G	A
pharmgkb	cyclophosphamide,cytarabine,daunorubicin,dexamethasone,doxorubicin,methotrexate,pegaspargase,prednisone,thioguanine,vincristine	DOK5	rs117532069		Osteonecrosis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9P104				20	54684529.0	G	A
pharmgkb	cyclophosphamide,cytarabine,daunorubicin,dexamethasone,doxorubicin,methotrexate,pegaspargase,prednisone,thioguanine,vincristine	BMP7	rs79085477		Osteonecrosis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P18075				20	57126159.0	C	T
pharmgkb	cyclophosphamide,cytarabine,daunorubicin,dexamethasone,doxorubicin,methotrexate,pegaspargase,prednisone,thioguanine,vincristine	LINC00251	rs141059755		Osteonecrosis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity					8	65195370.0	A	G
pharmgkb	letrozole	ESR2	rs10140457		Breast Neoplasms	Toxicity	Q92731	Drug	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	14	64249975.0	A	C
pharmgkb	efavirenz	HNF4A	rs1884613		HIV Infections	Metabolism/PK	P41235	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	20	44351775.0	C	D
pharmgkb	Platinum compounds	EIF3A	rs7091672		Carcinoma, Non-Small-Cell Lung	Toxicity	Q14152	Drug Class			10	118836909.0	T	V
pharmgkb	Platinum compounds	EIF3A	rs4752219		Carcinoma, Non-Small-Cell Lung	Toxicity	Q14152	Drug Class			10	118856049.0	C	T
pharmgkb	Platinum compounds	EIF3A	rs4752220		Carcinoma, Non-Small-Cell Lung	Toxicity	Q14152	Drug Class			10	118856097.0	A	G
pharmgkb	Platinum compounds	EIF3A	rs1409314		Carcinoma, Non-Small-Cell Lung	Toxicity	Q14152	Drug Class			10	118856240.0	A	K
pharmgkb	Platinum compounds	EIF3A	rs10510050		Carcinoma, Non-Small-Cell Lung	Toxicity	Q14152	Drug Class			10	118867050.0	A	G
pharmgkb	antidepressants	RAPGEF5	rs16873129		Depressive Disorder, Major	Efficacy	Q92565	Drug Class			7	22105466.0	T	C
pharmgkb	antidepressants	CRH	rs4737771		Depressive Disorder, Major	Efficacy	P34998	Drug Class			8	66280144.0	T	C
pharmgkb	antidepressants	PARP11	rs2532560		Depressive Disorder, Major	Efficacy	Q9NR21	Drug Class			12	4052705.0	G	A
pharmgkb	antidepressants	NBEA	rs9315310		Depressive Disorder, Major	Efficacy	Q8NFP9	Drug Class			13	34777294.0	T	M
pharmgkb	ticagrelor	CYP3A43	rs62471956		Acute coronary syndrome	Metabolism/PK	Q9HB55	Drug	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	7	99823462.0	G	A
pharmgkb	ticagrelor	SLCO1B1	rs113681054		Acute coronary syndrome	Metabolism/PK	Q9Y6L6	Drug	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	12	21250045.0	T	C
pharmgkb	antipsychotics,aripiprazole,risperidone	ANKK1	E713K		Schizophrenia	Efficacy	Q8NFD2				11	113400106.0	G	A
pharmgkb	nicotine	CHRNB4	rs2869950		Tobacco Use Disorder	Toxicity	P30926	Drug	942.0	CN1CCCC1C2=CN=CC=C2	4	88821613.0	C	W
pharmgkb	busulfan	GSTM1	rs3754446		Leukemia, Myeloid, Acute	Metabolism/PK	P09488	Drug	2478.0	CS(=O)(=O)OCCCCOS(=O)(=O)C	1	109710619.0	A	C
pharmgkb	methamphetamine	ARRB2	rs4790694		Substance-Related Disorders	Toxicity	P32121	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	17	4723059.0	A	C
pharmgkb	olanzapine	PMCH	rs7973796		Schizophrenia	Toxicity	P20382	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	12	102202345.0	G	A
pharmgkb	anastrozole,exemestane,letrozole	CYP19A1	rs6493497		Breast Neoplasms	Efficacy	P11511				15	51338638.0	G	A
pharmgkb	exemestane	CYP19A1	rs7176005		Breast Neoplasms	Toxicity	P11511	Drug	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	15	51339082.0	C	T
pharmgkb	antipsychotics	INSIG2	rs17587100		Schizophrenia	Toxicity	Q9Y5U4	Drug Class			2	118080834.0	A	C
pharmgkb	midazolam	VDR	rs11568820			Metabolism/PK	P11473	Drug	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F	12	47908762.0	C	T
pharmgkb	asparaginase	GRIA1	rs4958381		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P42261	Drug			5	154651307.0	T	C
pharmgkb	aspirin	PTGS2	rs12042763		Prostatic Neoplasms	Efficacy	P35354	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	186682744.0	G	H
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs7248668		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39253181.0	G	A
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs8105790		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39241861.0	T	C
pharmgkb	ethanol	CHRNA5	D398N		Alcoholism	Other	P30532	Drug	702.0	CCO	15	78590583.0	G	A
pharmgkb	aripiprazole	TAAR6	rs4305746		Schizophrenia	Efficacy	Q96RI8	Drug	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	6	132572626.0	G	A
pharmgkb	aspirin	ADORA1	rs16851030		Asthma	Toxicity	P30542	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	1	203166324.0	C	T
pharmgkb	cyclosporine,mycophenolate mofetil	TNF	rs1800629		Kidney Transplantation	Efficacy	Q9UNG2				6	31575254.0	G	A
pharmgkb	nevirapine	CYP2B6	rs12721646		HIV Infections	Other	P20813	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	19	41009202.0	C	K
pharmgkb	triamcinolone	HCG22	rs3873352		Retinal Diseases	Toxicity	E2RYF7	Drug	31307.0	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O	6	31054336.0	C	D
pharmgkb	Selective serotonin reuptake inhibitors	DRD2	rs4460839		Depressive Disorder, Major	Efficacy	P14416	Drug Class			11	113451074.0	C	T
pharmgkb	aspirin	TGFB1	rs1800469			Toxicity	P01137	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	19	41354391.0	A	G
pharmgkb	tenofovir	ABCC2	rs7917432		HIV Infections	Toxicity	Q5T2W1	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	10	68399112.0	T	C
pharmgkb	tenofovir	OCRL	rs757639		HIV Infections	Toxicity	Q01968	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	7	34111163.0	T	C
pharmgkb	peginterferon alfa-2a,ribavirin	ITPA	rs6051702		Hepatitis C	Toxicity	Q9BY32				20	3271278.0	A	C
pharmgkb	olanzapine	CYP1A1	rs2472297		Psychotic Disorders	Metabolism/PK	P11511	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	15	74735539.0	C	T
pharmgkb	olanzapine	IL1A	rs11677416		Schizophrenia	Efficacy	P01583	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	2	112771663.0	T	C
pharmgkb	montelukast	LTC4S	rs730012		Asthma	Efficacy	Q16873	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	5	179793637.0	A	Y
pharmgkb	triamcinolone	HCG22	rs2523864		Retinal Diseases	Toxicity	E2RYF7	Drug	31307.0	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O	6	31050769.0	C	T
pharmgkb	valproic acid	UGT1A6	R184S		Epilepsy	Dosage	P19224	Drug	3121.0	CCCC(CCC)C(=O)O	2	233693556.0	A	C
pharmgkb	rosuvastatin	CYP3A5	rs776746		Myocardial Infarction	Efficacy	P20815	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	7	99672916.0	T	C
pharmgkb	carbamazepine	LTA	rs1800629		Hypersensitivity	Toxicity	P01374	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	6	31575254.0	G	A
pharmgkb	leflunomide	DHODH	rs3213422		Arthritis, Rheumatoid	Efficacy	Q02127	Drug	3899.0	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	16	72008783.0	A	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	PON1	rs854547		Arthritis, Rheumatoid	Efficacy	P27169	Drug Class			7	95294544.0	G	H
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	PON1	rs854548		Arthritis, Rheumatoid	Efficacy	P27169	Drug Class			7	95296508.0	A	G
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	PON1	rs854555		Arthritis, Rheumatoid	Efficacy	P27169	Drug Class			7	95301079.0	A	C
pharmgkb	azathioprine,purine analogues	ITPA	P32T		Lupus Erythematosus, Systemic	Efficacy	Q9BY32				20	3213196.0	C	R
pharmgkb	warfarin	VKORC1	rs9934438			Efficacy	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31093557.0	G	M
pharmgkb	erythromycin	CYP3A4	rs35599367		Neoplasms	Other	P08684	Drug	12560.0	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	7	99768693.0	G	A
pharmgkb	methotrexate	MTHFR	E429A		Arthritis, Rheumatoid	Efficacy	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11794419.0	T	G
pharmgkb	carbamazepine	HSPA1L	T493M		Epilepsy	Toxicity	P34931	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	6	31810495.0	G	H
pharmgkb	selective beta-2-adrenoreceptor agonists	ARG1	rs2781659		Asthma	Efficacy	Q8N6T3	Drug Class			6	131570680.0	A	G
pharmgkb	bupropion	COMT	rs165599		Tobacco Use Disorder	Efficacy	P21964	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	22	19969258.0	G	A
pharmgkb	cisplatin,cyclophosphamide	GSTA1	rs3957357		Anemia,Ovarian Neoplasms	Toxicity	P08263				6	52803889.0	A	G
pharmgkb	cisplatin,irinotecan	UBE2I	rs9597		Carcinoma, Non-Small-Cell Lung	Efficacy	P63279				16	1324950.0	C	K
pharmgkb	abacavir	LST1	rs3093726		Drug Hypersensitivity	Toxicity	O00453	Drug	441300.0	C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N	6	31579012.0	T	C
pharmgkb	citalopram	HTR1B	rs6296		Anxiety Disorders,Depressive Disorder, Major	Toxicity	P28222	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	6	77462543.0	C	G
pharmgkb	latanoprost	PTGFR	rs3766355		Glaucoma, Open-Angle	Efficacy	P43088	Drug	5282380.0	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	1	78491756.0	C	W
pharmgkb	cyclophosphamide,docetaxel,doxorubicin,epirubicin,fluorouracil	SLCO1B1	V174A		Breast Neoplasms	Toxicity	Q9Y6L6				12	21178615.0	T	C
pharmgkb	tamoxifen	UGT1A4	L48M		Breast Neoplasms	Metabolism/PK	P22310	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	2	233718962.0	T	R
pharmgkb	tocilizumab	CD69	rs11052877		Arthritis, Rheumatoid	Efficacy	Q07108	Drug			12	9753094.0	A	G
pharmgkb	tocilizumab	GALNT18	rs4910008		Arthritis, Rheumatoid	Efficacy	Q6P9A2	Drug			11	11458319.0	C	T
pharmgkb	cisplatin	CSNK2A3	rs7937567		Urinary Bladder Neoplasms	Efficacy	Q8NEV1	Drug	441203.0	N.N.Cl[Pt+2]Cl	11	11354027.0	G	A
pharmgkb	cisplatin	MLLT3	rs10964552		Urinary Bladder Neoplasms	Efficacy	P42568	Drug	441203.0	N.N.Cl[Pt+2]Cl	9	20405632.0	C	A
pharmgkb	cisplatin	RARS	rs244898		Urinary Bladder Neoplasms	Efficacy	P54136	Drug	441203.0	N.N.Cl[Pt+2]Cl	5	168491921.0	T	M
pharmgkb	allopurinol	CYCSP5	rs9469003		Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity		Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31440051.0	T	C
pharmgkb	carboplatin,taxanes	VEGFA	rs9369421			Toxicity	P15692				6	43794385.0	T	C
pharmgkb	warfarin	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Atrial Fibrillation	Dosage	P33261	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	zafirlukast	CYP2C9	CYP2C9*1, CYP2C9*3, CYP2C9*13			Metabolism/PK	P11712	Drug	5717.0	CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC				
pharmgkb	clozapine	ITIH3	rs2535629		Schizophrenia	Efficacy	Q06033	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	3	52799203.0	G	M
pharmgkb	methotrexate	ADORA2A	rs2298383		Hematologic Neoplasms	Toxicity	P29274	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	22	24429543.0	C	W
pharmgkb	valganciclovir	ABCC4	G187W		Kidney Transplantation	Toxicity	O15439	Drug	64147.0	CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N	13	95210754.0	C	A
pharmgkb	valganciclovir	ABCB1	S400N		Kidney Transplantation	Toxicity	P08183	Drug	64147.0	CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N	7	87550493.0	C	W
pharmgkb	axitinib,sorafenib	HIF1A	P582S			Efficacy	Q16665				14	61740839.0	C	T
pharmgkb	imatinib	CYP3A5	rs776746		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Metabolism/PK	P20815	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	7	99672916.0	T	C
pharmgkb	dalcetrapib	ADCY9	rs1967309		Acute coronary syndrome	Efficacy,Toxicity	O60503	Drug	6918540.0	CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C	16	4015582.0	A	G
pharmgkb	sorafenib	KDR	Q472H		Carcinoma, Hepatocellular	Efficacy	P35968	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	4	55106807.0	T	A
pharmgkb	capecitabine,fluorouracil	MIR27A	rs895819		Neoplasms	Toxicity					19	13836478.0	T	C
pharmgkb	tacrolimus	CYP3A5	rs776746		Infection	Toxicity	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99672916.0	T	C
pharmgkb	mercaptopurine	GNMT	rs10948059		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q14749	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	6	42960723.0	C	K
pharmgkb	metformin	SLC2A2	rs8192675		Diabetes Mellitus	Efficacy	P11168	Drug	4091.0	CN(C)C(=N)N=C(N)N	3	171007094.0	T	C
pharmgkb	sorafenib	UGT1A9	rs7574296		Carcinoma, Hepatocellular,hand-foot syndrome	Toxicity	O60656	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	2	233729603.0	A	G
pharmgkb	sorafenib	VEGFA	rs3025040		Carcinoma, Hepatocellular,hand-foot syndrome	Toxicity	P15692	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	6	43785314.0	C	T
pharmgkb	Platinum compounds	ERCC2	D312N		Carcinoma, Non-Small-Cell Lung	Toxicity	P18074	Drug Class			19	45364001.0	C	W
pharmgkb	Platinum compounds	ERCC2	rs50872		Carcinoma, Non-Small-Cell Lung	Toxicity	P18074	Drug Class			19	45359191.0	A	K
pharmgkb	Platinum compounds	IL16	rs7170924		Carcinoma, Non-Small-Cell Lung	Toxicity	Q14005	Drug Class			15	81290798.0	G	T
pharmgkb	Platinum compounds	ABCB1	rs1128503		Carcinoma, Non-Small-Cell Lung	Toxicity	P08183	Drug Class			7	87550285.0	A	G
pharmgkb	Platinum compounds	IL1B	rs12621220		Carcinoma, Non-Small-Cell Lung	Toxicity	P01584	Drug Class			2	112840678.0	C	T
pharmgkb	Platinum compounds	IL1B	rs1143623		Carcinoma, Non-Small-Cell Lung	Toxicity	P01584	Drug Class			2	112838252.0	C	G
pharmgkb	warfarin	POR	rs41301394			Dosage	Q9Y277	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	7	75983485.0	C	T
pharmgkb	warfarin	DDHD1	rs17126068			Dosage	Q8NEL9	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	14	53033179.0	A	G
pharmgkb	warfarin	NEDD4	rs2288344			Dosage	P46934	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	15	55830149.0	T	G
pharmgkb	warfarin	ASPH	rs4379440			Efficacy	Q12797	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	8	61553255.0	G	T
pharmgkb	sorafenib	SLCO1B1	N130H		Diarrhea	Toxicity	Q9Y6L6	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	12	21176804.0	A	K
pharmgkb	sorafenib	SLCO1B1	V174A		Thrombocytopenia	Toxicity	Q9Y6L6	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	12	21178615.0	T	C
pharmgkb	sorafenib	ABCC2	rs717620		Exanthema	Toxicity	Q5T2W1	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	10	99782821.0	C	T
pharmgkb	sorafenib	KDR	Q472H		hand-foot syndrome,Hypertension	Toxicity	P35968	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	4	55106807.0	T	A
pharmgkb	captopril	ACE	rs4291		Alzheimer Disease	Efficacy	P12821	Drug	44093.0	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	17	63476833.0	T	M
pharmgkb	raloxifene	ESR1	rs11543791		Menopause,Schizophrenia	Efficacy	P03372	Drug	5035.0	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	7	110448995.0	T	C
pharmgkb	raloxifene	UGT1A8	A173G		Menopause,Schizophrenia	Efficacy	Q9HAW9	Drug	5035.0	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	2	233618225.0	C	K
pharmgkb	clindamycin	HLA-B	HLA-B*51:01			Toxicity	P01889	Drug	29029.0	CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl				
pharmgkb	clindamycin	HLA-B	HLA-B*15:27			Toxicity	P01889	Drug	29029.0	CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl				
pharmgkb	atazanavir,ritonavir	UGT1A1	rs10929303		HIV Infections,nephrolithiasis	Toxicity	P22309				2	233772770.0	T	C
pharmgkb	clopidogrel	B4GALT2	I303M			Efficacy	O60909	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	1	43985562.0	C	D
pharmgkb	warfarin	CYP4F2	V433M			Efficacy	P78329	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	19	15879621.0	C	T
pharmgkb	warfarin	GGCX	rs11676382			Efficacy	P38435	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	85550510.0	C	G
pharmgkb	warfarin	GGCX	R325Q			Efficacy	P38435	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	85553413.0	C	T
pharmgkb	warfarin	GGCX	rs11676382			Efficacy	P38435	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	85550510.0	C	G
pharmgkb	ephedrine,phenylephrine	ADRB2	R16G			Dosage	P07550				5	148826877.0	G	A
pharmgkb	fentanyl,propofol,remifentanil,sevoflurane	ADRB2	R175W		Hypotension	Toxicity	P07550				5	148827354.0	C	W
pharmgkb	docetaxel	CYP3A4	rs2740574		Neoplasms	Toxicity,Metabolism/PK	P08684	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	7	99784473.0	C	T
pharmgkb	peginterferon alfa-2a,ribavirin	SCARB1	rs10846744		Hepatitis C, Chronic	Efficacy	Q8WTV0				12	124827879.0	G	C
pharmgkb	oxcarbazepine	HLA-B	HLA-B*40:02		Epilepsy	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	oxcarbazepine	HLA-B	HLA-B*15:01		Epilepsy	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	oxcarbazepine	HLA-DRB1	HLA-DRB1*04:03		Epilepsy	Toxicity	P01911	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,simeprevir	IFNL4	rs11322783		Hepatitis C, Chronic	Efficacy	K9M1U5				19	39248514.0	T	-
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs117648444		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39247938.0	G	A
pharmgkb	Antibiotics	LGALS3	Q201H		Hypersensitivity	Toxicity	Q08380	Drug Class			14	55145121.0	A	T
pharmgkb	etanercept	CD84	rs6427528		Arthritis, Rheumatoid,Psoriasis	Efficacy	Q9UIB8	Drug			1	160546518.0	A	G
pharmgkb	ustekinumab	IL12B	rs3213094		Psoriasis	Efficacy	P29460	Drug			5	159323761.0	C	T
pharmgkb	rifampin	CUX2	rs7958375		Tuberculosis	Toxicity	O14529	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	12	111202213.0	G	A
pharmgkb	rifampin	RIPOR2	rs10946739		Tuberculosis	Toxicity	Q9Y4F9	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	6	24992899.0	C	K
pharmgkb	rifampin	AGBL4	rs320003		Tuberculosis	Toxicity	Q5VU57	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	1	48661106.0	G	A
pharmgkb	rifampin	AGBL4	rs319952		Tuberculosis	Toxicity	Q5VU57	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	1	48647950.0	A	K
pharmgkb	rifampin	AGBL4	rs393994		Tuberculosis	Toxicity	Q5VU57	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	1	48643073.0	A	G
pharmgkb	risperidone	CYP3A4	rs35599367		Bipolar Disorder,Depression,Substance-Related Disorders	Metabolism/PK	P08684	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	7	99768693.0	G	A
pharmgkb	risperidone	NR1I2	rs1523130		Bipolar Disorder,Depression,Substance-Related Disorders	Metabolism/PK	O75469	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3	119780660.0	T	C
pharmgkb	risperidone	NR1I2	rs2276707		Bipolar Disorder,Depression,Substance-Related Disorders	Metabolism/PK	O75469	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3	119815306.0	C	K
pharmgkb	adalimumab,certolizumab pegol,etanercept,glucocorticoids,infliximab,methotrexate	KLRD1	rs2302489		Arthritis, Rheumatoid	Efficacy	Q13241				12	10307944.0	A	K
pharmgkb	adalimumab,certolizumab pegol,etanercept,glucocorticoids,infliximab,methotrexate	KLRC1	rs7301582		Arthritis, Rheumatoid	Efficacy	P26715				12	10449091.0	C	T
pharmgkb	carbamazepine	CYP3A4	rs2242480		Epilepsy	Metabolism/PK	P08684	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	99763843.0	C	T
pharmgkb	carbamazepine	CYP3A5	rs776746		Epilepsy	Dosage,Metabolism/PK	P20815	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	99672916.0	T	C
pharmgkb	carbamazepine	CYP3A5	rs15524		Epilepsy	Metabolism/PK	P20815	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	99648291.0	A	G
pharmgkb	warfarin	NQO1	rs10517			Dosage	P15559	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	69709857.0	A	K
pharmgkb	warfarin	STX1B	rs72800847		heart valve replacement	Dosage	P61266	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31011318.0	G	A
pharmgkb	warfarin	CYP1A1	rs3826041		heart valve replacement	Dosage	P11511	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	15	74726549.0	A	C
pharmgkb	warfarin	DNMT3A	rs2304429		heart valve replacement	Dosage	Q9Y6K1	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	25235677.0	C	T
pharmgkb	azathioprine,mercaptopurine	ABCC4	E757K		Inflammatory Bowel Diseases	Toxicity	O15439				13	95163161.0	C	T
pharmgkb	azathioprine,mercaptopurine	FTO	A134T		Irritable Bowel Syndrome,Leukopenia	Toxicity	Q9C0B1				16	53826140.0	G	A
pharmgkb	rosiglitazone	SLCO1B1	V174A		Diabetes Mellitus, Type 2	Efficacy	Q9Y6L6	Drug	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	12	21178615.0	T	C
pharmgkb	amitriptyline,antidepressants,citalopram,paroxetine,venlafaxine	ABCB1	rs2235015		Depression,Depressive Disorder,Depressive Disorder, Major	Efficacy	P08183				7	87570248.0	C	A
pharmgkb	amitriptyline,antidepressants,citalopram,fluvoxamine,paroxetine,sertraline,venlafaxine	ABCB1	rs2032583		Depression,Depressive Disorder,Depressive Disorder, Major	Efficacy	P08183				7	87531245.0	A	G
pharmgkb	irinotecan	TGFB1	rs1800469		Colorectal Neoplasms	Toxicity	P01137	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	19	41354391.0	A	G
pharmgkb	irinotecan	TGFBR2	rs3087465		Colorectal Neoplasms	Toxicity	P36897	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	3	30605668.0	A	G
pharmgkb	zileuton	PRORP	rs12436663		Asthma	Efficacy	O15091	Drug	60490.0	CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O	14	35169914.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IL23R	R381Q		Psoriasis	Toxicity	Q5VWK5	Drug Class			1	67240275.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	CTLA4	rs3087243		Psoriasis	Toxicity	P16410	Drug Class			2	203874196.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	SLC12A8	rs651630		Psoriasis	Toxicity	A0AV02	Drug Class			3	125092470.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	FBXL19	rs10782001		Psoriasis	Toxicity	Q6PCT2	Drug Class			16	30931304.0	G	A
pharmgkb	quetiapine	COMT	rs5993883		Schizophrenia	Efficacy	P21964	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	22	19950115.0	T	G
pharmgkb	quetiapine	COMT	rs6269		Schizophrenia	Efficacy	P21964	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	22	19962429.0	A	G
pharmgkb	quetiapine	COMT	rs4818		Schizophrenia	Efficacy	P21964	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	22	19963684.0	C	K
pharmgkb	furosemide	ABCC4	rs17268282		Heart Failure	Efficacy	O15439	Drug	3440.0	C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl	13	95273060.0	G	T
pharmgkb	carbamazepine,phenobarbital,phenytoin,valproic acid	CYP1A1	rs2606345		Epilepsy	Efficacy	P11511				15	74724835.0	C	A
pharmgkb	granisetron	CYP3A5	CYP3A5*1, CYP3A5*3			Metabolism/PK	P20815	Drug	3510.0	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C				
pharmgkb	granisetron	CYP1A1	CYP1A1*1, CYP1A1*2A			Metabolism/PK	P11511	Drug	3510.0	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C				
pharmgkb	interferon beta-1a	HLA-DRB1	HLA-DRB1*04:01		Multiple Sclerosis	Efficacy	P01911	Drug						
pharmgkb	interferon beta-1a	HLA-B	HLA-B*15:01		Multiple Sclerosis	Efficacy	P01889	Drug						
pharmgkb	adalimumab,etanercept,infliximab	FCGR3A	F175V		Psoriasis	Efficacy	P20963				1	161544752.0	A	B
pharmgkb	gefitinib	ABCB1	rs1128503		Carcinoma, Non-Small-Cell Lung	Toxicity	P08183	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	7	87550285.0	A	G
pharmgkb	bevacizumab	EDN1	K198N		Breast Neoplasms	Efficacy	P05305	Drug			6	12296022.0	G	T
pharmgkb	bevacizumab	VEGFA	rs3025039		Breast Neoplasms	Efficacy	P15692	Drug			6	43784799.0	C	T
pharmgkb	clozapine	ABCB1	I1145M			Toxicity	P08183	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	7	87509329.0	A	K
pharmgkb	clozapine	GSTM1	GSTM1 non-null, GSTM1 null			Toxicity	P09488	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl				
pharmgkb	clozapine	GSTT1	GSTT1 non-null, GSTT1 null			Toxicity	P30711	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl				
pharmgkb	antidepressants	NTRK2	rs1439050		Depressive Disorder, Major	Toxicity	Q16620	Drug Class			9	84673278.0	G	W
pharmgkb	antipsychotics	GRIK3	rs1334802		Psychotic Disorders	Toxicity	Q13003	Drug Class			1	36930738.0	C	T
pharmgkb	antipsychotics	SLC18A2	rs363341		Psychotic Disorders	Toxicity	Q05940	Drug Class			10	117250954.0	C	T
pharmgkb	antipsychotics	DRD2	rs1124491		Psychotic Disorders	Toxicity	P14416	Drug Class			11	113411368.0	G	A
pharmgkb	antipsychotics	HTR2A	rs9567733		Psychotic Disorders	Toxicity	P28223	Drug Class			13	46827200.0	A	G
pharmgkb	allopurinol,febuxostat	UGT1A1	rs34650714		Gout	Dosage	P22309				2	233767183.0	C	T
pharmgkb	allopurinol,febuxostat	AOX1	rs75995567		Gout	Dosage	Q06278				2	200604661.0	T	C
pharmgkb	allopurinol,febuxostat	AOX1	H1297R		Gout	Dosage	Q06278				2	200669666.0	A	G
pharmgkb	bevacizumab	CXCR4	rs2228014		Colorectal Neoplasms	Efficacy	P61073	Drug			2	136115514.0	G	A
pharmgkb	exemestane	CYP3A4	CYP3A4*1, CYP3A4*22		Breast Neoplasms	Metabolism/PK	P08684	Drug	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C				
pharmgkb	fluorouracil,leucovorin,oxaliplatin	ERCC1	rs11615		Colonic Neoplasms	Toxicity	P07992				19	45420395.0	A	G
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	PGLYRP4	rs2916205		Psoriasis	Efficacy	Q96LB8	Drug Class			1	153348279.0	C	T
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	CTNNA2	rs11126740		Psoriasis	Efficacy	P26232	Drug Class			2	79673969.0	A	G
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	MAP3K1	rs96844		Psoriasis	Efficacy	Q13233	Drug Class			5	56900777.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IL12B	rs2546890		Psoriasis	Efficacy	P29460	Drug Class			5	159332892.0	A	G
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	CDKAL1	rs6908425		Psoriasis	Efficacy	Q5VV42	Drug Class			6	20728500.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	HLA-C	rs12191877		Psoriasis	Efficacy	P10321	Drug Class			6	31285148.0	C	T
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	ZNF816	rs9304742		Psoriasis	Efficacy	Q0VGE8	Drug Class			19	52948038.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IL17RA	rs4819554		Psoriasis	Efficacy	Q96F46	Drug Class			22	17084145.0	G	A
pharmgkb	levodopa	DRD2	rs1799732		Parkinson Disease	Toxicity	P14416	Drug, Biological Intermediate	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	11	113475530.0	-	R
pharmgkb	busulfan,cyclophosphamide	CTH	S403I		hemopoietic stem cell transplant	Toxicity	P32929				1	70439117.0	G	T
pharmgkb	lamotrigine	HLA-B	HLA-B*38:01		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N				
pharmgkb	carbamazepine	HLA-A	HLA-A*11:01		Drug Hypersensitivity,Epidermal Necrolysis, Toxic,erythema exudativum multiforme,Maculopapular Exanthema,Stevens-Johnson Syndrome	Toxicity	P04439	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	carbamazepine	HLA-C	HLA-C*08:01		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	phenytoin	HLA-C	HLA-C*08:01		Epidermal Necrolysis, Toxic,Maculopapular Exanthema,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	tocilizumab	IL6R	rs12083537		Arthritis, Rheumatoid	Efficacy	P08887	Drug			1	154408627.0	A	G
pharmgkb	tocilizumab	IL6R	rs11265618		Arthritis, Rheumatoid	Efficacy	P08887	Drug			1	154457616.0	C	T
pharmgkb	tacrolimus	FOXP3	rs3761548		Kidney Transplantation	Toxicity	Q9BZS1	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	X	49261784.0	G	W
pharmgkb	SN-38	ABCC1	rs6498588		Colorectal Neoplasms	Metabolism/PK	P33527	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	16	15938949.0	A	T
pharmgkb	irinotecan	ABCC1	rs17501331		Colorectal Neoplasms,Neutropenia	Toxicity	P33527	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	16	15995584.0	A	G
pharmgkb	SN-38	ABCC1	rs35621		Colorectal Neoplasms	Metabolism/PK	P33527	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	16	16074751.0	C	T
pharmgkb	irinotecan	ABCC1	rs3743527		Colorectal Neoplasms	Toxicity	P33527	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	16	16141824.0	C	T
pharmgkb	ticagrelor	PEAR1	rs12041331			Efficacy	Q5VY43	Drug	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	1	156899922.0	G	A
pharmgkb	ticagrelor	PEAR1	rs4661012			Efficacy	Q5VY43	Drug	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	1	156915699.0	T	G
pharmgkb	morphine	UGT2B7	rs7438135			Metabolism/PK	P16662	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	4	69095621.0	G	A
pharmgkb	dabigatran	ABCB1	I1145M			Metabolism/PK	P08183	Drug			7	87509329.0	A	K
pharmgkb	rivaroxaban	ABCB1	I1145M			Metabolism/PK	P08183	Drug	9875401.0		7	87509329.0	A	K
pharmgkb	dabigatran	ABCB1	S893A			Metabolism/PK	P08183	Drug			7	87531302.0	A	Y
pharmgkb	rivaroxaban	ABCB1	S893A			Metabolism/PK	P08183	Drug	9875401.0		7	87531302.0	A	Y
pharmgkb	ledipasvir,sofosbuvir	IFNL3	rs12979860		Hepatitis C, Chronic,Recurrence	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	ledipasvir,sofosbuvir	IFNL3	rs8099917		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39252525.0	T	G
pharmgkb	sirolimus	POR	A503V		Kidney Transplantation	Metabolism/PK	Q9Y277	Drug	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	7	75985688.0	C	T
pharmgkb	sirolimus	IL10	rs1800896		Kidney Transplantation	Metabolism/PK	P22301	Drug	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	1	206773552.0	T	C
pharmgkb	hydrochlorothiazide	VASP	rs10995		Hypertension	Efficacy	P50552	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	19	45526896.0	G	M
pharmgkb	cetuximab	EGFR	R521K		Head and Neck Neoplasms	Efficacy	P00533	Drug			7	55161562.0	G	H
pharmgkb	Platinum compounds	GSTP1	I105V		Neoplasms	Efficacy	P09211	Drug Class			11	67585218.0	A	G
pharmgkb	capecitabine	ENOSF1	rs2612091		Neoplasms	Toxicity	Q7L5Y1	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	18	683607.0	C	T
pharmgkb	warfarin	STX1B	rs4889606			Efficacy	P61266	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	30999862.0	A	G
pharmgkb	3,4-methylenedioxymethamphetamine	CYP2B6	Q172H			Metabolism/PK	P20813	Drug	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC	19	41006936.0	G	W
pharmgkb	tacrolimus	CYP3A5	rs776746		Colitis, Ulcerative	Efficacy	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99672916.0	T	C
pharmgkb	tacrolimus	ABCB1	rs1128503		Colitis, Ulcerative	Efficacy	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87550285.0	A	G
pharmgkb	tacrolimus	ABCB1	S893A		Colitis, Ulcerative,Kidney Transplantation	Efficacy	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87531302.0	A	Y
pharmgkb	tacrolimus	ABCB1	I1145M		Colitis, Ulcerative	Efficacy	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87509329.0	A	K
pharmgkb	metformin	SLC22A1	P341L			Metabolism/PK	O15245	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160136611.0	C	K
pharmgkb	ivacaftor	SLC26A9	rs7512462		Cystic Fibrosis	Efficacy	Q7LBE3	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	1	205930467.0	T	C
pharmgkb	clopidogrel	P2RY12	rs3732759		Coronary Disease	Efficacy	Q9H244	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	3	151357137.0	A	G
pharmgkb	venlafaxine	SLC6A2	rs2242446		Depressive Disorder, Major	Efficacy	P23975	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	16	55656513.0	C	W
pharmgkb	cotinine	UGT2B10	rs2942857		Tobacco Use Disorder	Metabolism/PK	P36537	Metabolite	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	4	68822269.0	A	B
pharmgkb	fluoxetine	HTR1B	rs9361233		Depressive Disorder, Major	Efficacy	P28222	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	6	77460345.0	T	C
pharmgkb	atenolol,verapamil	PLEKHH2	rs11124945		Diabetes Mellitus,Hypertension	Toxicity	Q8IVE3				2	43650017.0	A	G
pharmgkb	atenolol	DPYS	rs2669429		Hyperglycemia,Hypertension	Toxicity	Q14117	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	8	104451462.0	A	K
pharmgkb	capecitabine	CES1	rs3217164		Drug Toxicity	Toxicity	Q9NZK5	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	16	55821239.0	G	-
pharmgkb	capecitabine	CES1	rs2244614		Drug Toxicity	Toxicity	Q9NZK5	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	16	55810705.0	G	A
pharmgkb	capecitabine	CES1P1	rs11861118		Drug Toxicity	Toxicity	Q9UKY3	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	16	55759367.0	A	G
pharmgkb	capecitabine	CES1P1	rs7187684		Drug Toxicity	Toxicity	Q9UKY3	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	16	55761039.0	T	C
pharmgkb	peginterferon alfa-2b,ribavirin	CYP2R1	rs10741657		Hepatitis C, Chronic	Efficacy	Q6VVX0				11	14893332.0	A	G
pharmgkb	opioids	FAAH	rs2295632			Toxicity	O00519	Drug Class			1	46413890.0	T	G
pharmgkb	morphine	FAAH	rs2295632			Toxicity	O00519	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	1	46413890.0	T	G
pharmgkb	morphine	FAAH	rs4141964			Toxicity	O00519	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	1	46399368.0	T	C
pharmgkb	morphine	FAAH	rs3766246			Toxicity	O00519	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	1	46399999.0	A	S
pharmgkb	tacrolimus	IL18	rs1946518		Kidney Transplantation,lung transplantation	Metabolism/PK	Q14116	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	11	112164735.0	T	G
pharmgkb	tacrolimus	IL18	rs5744247		Transplantation	Metabolism/PK	Q14116	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	11	112155433.0	G	C
pharmgkb	clozapine	C3	rs2277984		Metabolic Syndrome	Toxicity	Q9Y5Q9	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	19	6679500.0	C	T
pharmgkb	oxcarbazepine	UGT1A10	rs2741049		Epilepsy,Seizures	Efficacy	Q9HAW8	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	2	233673188.0	T	C
pharmgkb	lenalidomide,thalidomide	FGF2	rs308395		Multiple Myeloma	Efficacy	P09038				4	122825787.0	C	R
pharmgkb	Antihypertensives	CLNK	rs13144136		Hypertension	Efficacy	Q7Z7G1	Drug Class			4	10665285.0	G	T
pharmgkb	Selective serotonin reuptake inhibitors	ADRA2A	rs1800544		Depressive Disorder, Major	Efficacy	P08913	Drug Class			10	111076745.0	G	C
pharmgkb	sulfasalazine	ABCG2	Q141K			Metabolism/PK	Q9UNQ0	Drug	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	4	88131171.0	G	Y
pharmgkb	amisulpride	ANKS1B	rs7968606		Schizophrenia	Efficacy	P38432	Drug	2159.0	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	12	99423064.0	C	T
pharmgkb	sulindac	FMO3	E95K			Metabolism/PK	P31513	Drug	5352.0	CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O	1	171107825.0	G	A
pharmgkb	sulindac	FMO3	E308G			Metabolism/PK	P31513	Drug	5352.0	CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O	1	171114102.0	A	G
pharmgkb	atorvastatin,fluvastatin,hmg coa reductase inhibitors,pravastatin,rosuvastatin,simvastatin	HLA-DRB1	HLA-DRB1*01:01, HLA-DRB1*04:06			Toxicity	P01911							
pharmgkb	tacrolimus	CTLA4	rs4553808		Kidney Transplantation	Metabolism/PK	P16410	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	2	203866282.0	A	G
pharmgkb	tacrolimus	IL3	rs181781		Kidney Transplantation	Metabolism/PK	P08700	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	5	132059422.0	G	A
pharmgkb	clopidogrel	PEAR1	rs41273215			Efficacy	Q5VY43	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	1	156912167.0	C	T
pharmgkb	clopidogrel	PEAR1	rs57731889			Efficacy	Q5VY43	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	1	156912469.0	C	T
pharmgkb	rocuronium	SLCO1A2	rs3834939			Metabolism/PK	P46721	Drug	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C	12	21334836.0	-	T
pharmgkb	anastrozole	ABCB1	I1145M		Arthralgia,Breast Neoplasms	Toxicity	P08183	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	7	87509329.0	A	K
pharmgkb	anastrozole	ABCB1	S893A		Breast Neoplasms	Metabolism/PK	P08183	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	7	87531302.0	A	Y
pharmgkb	anastrozole	CYP19A1	rs727479		Breast Neoplasms	Efficacy	P11511	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	15	51242350.0	C	W
pharmgkb	hmg coa reductase inhibitors,letrozole	CYP19A1	rs1008805		Breast Neoplasms,Menopause	Other	P11511				15	51257402.0	G	A
pharmgkb	phenytoin	CYP2C19	rs4986893			Toxicity	P33261	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	10	94780653.0	G	A
pharmgkb	phenytoin	HLA-B	HLA-B*13:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	cisplatin	TPMT	TPMT*1, TPMT*3A		Ototoxicity	Toxicity	P51580	Drug	441203.0	N.N.Cl[Pt+2]Cl				
pharmgkb	cisplatin	TPMT	A154T		Neoplasms	Toxicity	P51580	Drug	441203.0	N.N.Cl[Pt+2]Cl	6	18138997.0	C	T
pharmgkb	cisplatin	SLC31A1	rs10981694		Carcinoma, Non-Small-Cell Lung	Toxicity	O15431	Drug	441203.0	N.N.Cl[Pt+2]Cl	9	113224129.0	T	G
pharmgkb	methotrexate	FOXP3	rs3761548		Psoriasis	Efficacy	Q9BZS1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	X	49261784.0	G	W
pharmgkb	capecitabine	UMPS	rs4678145		Asthenia,Neoplasms	Toxicity	P11172	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	3	124731234.0	G	C
pharmgkb	capecitabine	SLC22A7	rs2270860		Drug Toxicity,Neoplasms	Toxicity	Q9Y694	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	6	43302413.0	C	T
pharmgkb	capecitabine	SLC22A7	rs4149178		Diarrhea,Neoplasms	Toxicity	Q9Y694	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	6	43304450.0	A	G
pharmgkb	capecitabine	TYMS	rs2853741		Diarrhea,Neoplasms	Toxicity	P04818	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	18	657352.0	T	S
pharmgkb	capecitabine	CDA	rs1048977		Hyperbilirubinemia,Neoplasms	Toxicity	Q96GN5	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	20618562.0	C	T
pharmgkb	capecitabine	DPYD	rs12119882		Hyperbilirubinemia,Neoplasms	Toxicity	Q12882	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	97696806.0	A	G
pharmgkb	capecitabine	UMPS	rs2279199		Nausea,Vomiting	Toxicity	P11172	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	3	124730405.0	T	S
pharmgkb	gemcitabine,Platinum compounds	RRM1	rs1042927		Mesothelioma	Efficacy	Q9UET6				11	4138699.0	C	A
pharmgkb	atazanavir	ABCB1	S893A		HIV Infections	Toxicity	P08183	Drug	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	7	87531302.0	A	Y
pharmgkb	aspirin	TBXA2R	rs1131882		Diabetes Mellitus, Type 2	Efficacy,Toxicity	P21731	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	19	3595925.0	G	A
pharmgkb	atazanavir	CYP3A	rs2740574			Metabolism/PK	Q9HB55	Drug	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	7	99784473.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIGB	rs12050587		Breast Neoplasms,Leukopenia,Neutropenia	Toxicity	Q92521				15	55335330.0	A	G
pharmgkb	gemtuzumab ozogamicin	CD33	G304R		Leukemia, Myeloid, Acute	Efficacy	P20138	Drug			19	51235662.0	G	A
pharmgkb	ethambutol,isoniazid,pyrazinamide,rifampin	CYP2B6	CYP2B6*1, CYP2B6*6		Tuberculosis	Toxicity	P20813							
pharmgkb	warfarin	CYP4F2	rs2189784			Dosage	P78329	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	19	15848390.0	G	H
pharmgkb	warfarin	CYP4F11	rs1060467			Dosage	Q9HBI6	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	19	15913728.0	A	G
pharmgkb	cisplatin	COMT	rs4646316		Drug Toxicity,Neoplasms,Ototoxicity	Toxicity	P21964	Drug	441203.0	N.N.Cl[Pt+2]Cl	22	19964609.0	C	K
pharmgkb	cisplatin	COMT	rs9332377		Drug Toxicity,Neoplasms,Ototoxicity	Toxicity	P21964	Drug	441203.0	N.N.Cl[Pt+2]Cl	22	19968169.0	C	W
pharmgkb	cisplatin	COMT	rs4646316		Neoplasms,nephrotoxicity	Toxicity	P21964	Drug	441203.0	N.N.Cl[Pt+2]Cl	22	19964609.0	C	K
pharmgkb	cisplatin	COMT	rs9332377		Neoplasms,nephrotoxicity	Toxicity	P21964	Drug	441203.0	N.N.Cl[Pt+2]Cl	22	19968169.0	C	W
pharmgkb	clopidogrel	ABCB1	S893A		Coronary Artery Disease	Toxicity	P08183	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	7	87531302.0	A	Y
pharmgkb	cyclosporine,mycophenolic acid	ABCC2	rs717620		Kidney Transplantation	Metabolism/PK	Q5T2W1				10	99782821.0	C	T
pharmgkb	Beta Blocking Agents	ADRB1	S49G		major adverse cardiac events (mace)	Toxicity	P08588	Drug Class			10	114044277.0	A	G
pharmgkb	salbutamol,selective beta-2-adrenoreceptor agonists	CRHR2	rs2267715		Asthma	Efficacy	P55089				7	30676471.0	G	M
pharmgkb	valproic acid	UGT1A6	UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8		Epilepsy	Dosage	P19224	Drug	3121.0	CCCC(CCC)C(=O)O				
pharmgkb	mercaptopurine	NUDT15	R34T		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage,Toxicity	Q9NV35	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	13	48037847.0	G	M
pharmgkb	mercaptopurine	NUDT15	rs746071566		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage,Toxicity	Q9NV35	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	13	48037783.0	GGAGTC	-
pharmgkb	nevirapine	GSTM1	GSTM1 non-null, GSTM1 null		Epidermal Necrolysis, Toxic,HIV Infections,Stevens-Johnson Syndrome	Toxicity	P09488	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	heparin	HLA-DRB3	HLA-DRB3*01:01		heparin-induced thrombocytopenia	Toxicity	P79483	Drug	772.0	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O				
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	EGFR	rs11506105		Hepatitis C, Chronic	Efficacy	P00533				7	55152484.0	A	G
pharmgkb	everolimus	ABCB1	S893A		Breast Neoplasms,Lymphopenia	Toxicity	P08183	Drug	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	7	87531302.0	A	Y
pharmgkb	everolimus	ABCB1	I1145M		Breast Neoplasms,mucositis	Toxicity	P08183	Drug	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	7	87509329.0	A	K
pharmgkb	everolimus	FGFR4	G388R		discontinuation	Efficacy	P22455	Drug	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	5	177093242.0	G	A
pharmgkb	everolimus	PIK3R1	rs10515074		Breast Neoplasms,Hyperglycemia,Leukopenia	Toxicity	Q15303	Drug	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	5	68270365.0	A	K
pharmgkb	venlafaxine	COMT	V158M		Anxiety Disorders,Depressive Disorder	Efficacy	P21964	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	22	19963748.0	G	A
pharmgkb	fluorouracil	TPMT	TPMT*1, TPMT*3B, TPMT*3C		Neoplasms	Efficacy	P51580	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F				
pharmgkb	tacrolimus	C6	rs9200		liver transplantation	Metabolism/PK	Q9H0N0	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	5	41142504.0	C	W
pharmgkb	tacrolimus	C6	rs10052999		liver transplantation	Metabolism/PK	Q9H0N0	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	5	41165642.0	C	T
pharmgkb	tenofovir	ABCG2	Q141K		HIV Infections	Metabolism/PK	Q9UNQ0	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	4	88131171.0	G	Y
pharmgkb	mephenytoin	CYP2C19	M1L			Metabolism/PK	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	10	94762706.0	A	K
pharmgkb	dolutegravir	ABCG2	Q141K		HIV Infections	Metabolism/PK	Q9UNQ0	Drug	54726191.0	C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	4	88131171.0	G	Y
pharmgkb	valproic acid	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3		Bipolar Disorder,Psychotic Disorders	Dosage,Metabolism/PK	P11712	Drug	3121.0	CCCC(CCC)C(=O)O				
pharmgkb	efavirenz	CYP2B6	M46L		HIV Infections	Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	40991441.0	A	G
pharmgkb	hormonal contraceptives for systemic use	F2	rs1799963		Stroke,Venous Thrombosis	Toxicity	Q14209	Drug Class			11	46739505.0	G	A
pharmgkb	cytarabine,idarubicin	DCK	rs2306744		Leukemia, Myeloid, Acute	Efficacy	P27707				4	70993635.0	C	D
pharmgkb	cladribine,cytarabine	RRM2	S59A		Leukemia, Myeloid, Acute	Efficacy	Q9UI43				2	10122793.0	T	S
pharmgkb	hmg coa reductase inhibitors	SLCO1B1	N130H		Coronary Artery Disease,Diabetes Mellitus,Hypercholesterolemia	Toxicity	Q9Y6L6	Drug Class			12	21176804.0	A	K
pharmgkb	codeine,dextromethorphan,n-desmethyltamoxifen	CYP2D6	CYP2D6*1, CYP2D6*24			Metabolism/PK	P10635							
pharmgkb	cyclophosphamide,doxorubicin	SLC22A16	M409T		Breast Neoplasms	Toxicity	Q86VW1				6	110438805.0	A	G
pharmgkb	Drugs For Treatment Of Tuberculosis,isoniazid	ABCB1	I1145M		Tuberculosis	Toxicity	P08183				7	87509329.0	A	K
pharmgkb	Drugs For Treatment Of Tuberculosis	NAT2	rs1799929		Tuberculosis	Toxicity	Q6N069	Drug Class			8	18400484.0	C	T
pharmgkb	ethambutol,isoniazid,pyrazinamide,rifampin	TNF	rs1800629		Toxic liver disease,Tuberculosis	Toxicity	Q9UNG2				6	31575254.0	G	A
pharmgkb	oseltamivir	CES1	E220G			Metabolism/PK	Q9NZK5	Drug	65028.0	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC	16	55821399.0	T	C
pharmgkb	hormonal contraceptives for systemic use	F11	rs2289252			Toxicity	Q6ZWK6	Drug Class			4	186286227.0	C	T
pharmgkb	hormonal contraceptives for systemic use	KNG1	I581T			Toxicity	P01042	Drug Class			3	186742138.0	T	C
pharmgkb	hormonal contraceptives for systemic use	SUGCT	rs4379368			Toxicity	Q9HAC7	Drug Class			7	40426601.0	C	T
pharmgkb	hormonal contraceptives for systemic use	ABO	rs56392308			Toxicity	P16442	Drug Class			9	133255670.0	G	-
pharmgkb	hormonal contraceptives for systemic use	ABO	rs8176719			Toxicity	P16442	Drug Class			9	133257522.0	-	C
pharmgkb	hormonal contraceptives for systemic use	CYP2C9	R144C			Toxicity	P11712	Drug Class			10	94942290.0	C	T
pharmgkb	ethanol	SLC6A3	N38K			Toxicity	Q01959	Drug	702.0	CCO	5	1443084.0	G	M
pharmgkb	methadone	CDH2	rs8094439			Efficacy	P19022	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	18	28132643.0	G	A
pharmgkb	methadone	CDH2	rs17446819			Efficacy	P19022	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	18	28136925.0	A	C
pharmgkb	peginterferon alfa-2b,ribavirin	HLA-C	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01		Hepatitis C	Efficacy	P10321							
pharmgkb	etanercept	STAT4	rs7574865		Arthritis, Rheumatoid	Efficacy	Q14765	Drug			2	191099907.0	T	G
pharmgkb	etanercept	PSORS1C1	rs2233945		Arthritis, Rheumatoid	Efficacy	Q9UIG5	Drug			6	31139584.0	C	A
pharmgkb	Antithyroid Preparations	FOXF2	rs199564443		Agranulocytosis	Toxicity	Q12947	Drug Class			6	1388744.0	TTTT	-
pharmgkb	Antithyroid Preparations	HLA-B	Y91S		Agranulocytosis	Toxicity	P01889	Drug Class			6	31356759.0	T	V
pharmgkb	Antithyroid Preparations	EHMT2	rs652888		Agranulocytosis	Toxicity	Q96KQ7	Drug Class			6	31883457.0	A	G
pharmgkb	Antithyroid Preparations	HLA-B	HLA-B*08:01		Agranulocytosis	Toxicity	P01889	Drug Class						
pharmgkb	Antithyroid Preparations	HLA-B	HLA-B*27:05		Agranulocytosis	Toxicity	P01889	Drug Class						
pharmgkb	clopidogrel	ABCB1	rs1128503			Efficacy	P08183	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	7	87550285.0	A	G
pharmgkb	isoniazid	BACH1	rs2070401		drug-induced liver injury,Toxic liver disease	Toxicity	O14867	Drug	3767.0	C1=CN=CC=C1C(=O)NN	21	29343164.0	A	G
pharmgkb	salbutamol	ADRB2	T164I			Other	P07550	Drug	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	5	148827322.0	C	T
pharmgkb	isoniazid	XPO1	rs11125883		drug-induced liver injury,Toxic liver disease	Toxicity	O14980	Drug	3767.0	C1=CN=CC=C1C(=O)NN	2	61483438.0	A	C
pharmgkb	isoniazid	MAFK	rs4720833		drug-induced liver injury,Toxic liver disease	Toxicity	O60675	Drug	3767.0	C1=CN=CC=C1C(=O)NN	7	1534767.0	A	S
pharmgkb	clopidogrel	ABCB1	I1145M		Acute coronary syndrome,Myocardial Infarction	Efficacy,Toxicity,Metabolism/PK	P08183	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	7	87509329.0	A	K
pharmgkb	clopidogrel	CES1	S75N		Acute coronary syndrome	Efficacy	Q9NZK5	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	16	55828800.0	C	T
pharmgkb	valproic acid	UGT1A10	Q6R		Epilepsy	Metabolism/PK	Q9HAW8	Drug	3121.0	CCCC(CCC)C(=O)O	2	233729143.0	A	G
pharmgkb	oxcarbazepine	UGT2B7	Y268H		Epilepsy	Efficacy	P16662	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	4	69098620.0	T	C
pharmgkb	cisplatin,gemcitabine	CD3EAP	Q506K		Mesothelioma	Efficacy	O15446				19	45409478.0	C	D
pharmgkb	cisplatin,pemetrexed	ABCC2	V417I		Mesothelioma	Efficacy	Q5T2W1				10	99804058.0	G	A
pharmgkb	cisplatin,gemcitabine	ERCC2	rs13181		Mesothelioma	Efficacy	P18074				19	45351661.0	T	R
pharmgkb	methotrexate	SLC19A1	rs2838958		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45528653.0	G	A
pharmgkb	lumefantrine	CYP3A5	rs10264272		Malaria	Metabolism/PK	P20815	Drug	6437380.0	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	7	99665212.0	C	T
pharmgkb	lumefantrine	CYP3A	rs776746		Malaria	Metabolism/PK	Q9HB55	Drug	6437380.0	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	7	99672916.0	T	C
pharmgkb	lumefantrine	CYP3A4	rs2740574		Malaria	Efficacy,Metabolism/PK	P08684	Drug	6437380.0	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	7	99784473.0	C	T
pharmgkb	warfarin	VKORC1L1	rs4072879			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	7	65908864.0	A	S
pharmgkb	midazolam	CYP3A5	CYP3A5*1, CYP3A5*3			Metabolism/PK	P20815	Drug	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F				
pharmgkb	amisulpride,aripiprazole,clozapine,lithium,mirtazapine,olanzapine,paliperidone,quetiapine,risperidone,valproic acid	SH2B1	rs3888190		Bipolar Disorder,Depressive Disorder,Psychotic Disorders,schizoaffective disorder	Toxicity	Q9NRF2				16	28878165.0	C	A
pharmgkb	amisulpride,aripiprazole,clozapine,lithium,mirtazapine,olanzapine,paliperidone,quetiapine,risperidone,valproic acid	RABEP1	rs1000940		Bipolar Disorder,Depressive Disorder,Psychotic Disorders,schizoaffective disorder	Other	O43747				17	5379957.0	A	G
pharmgkb	bupropion	CYP2B6	K262R		Tobacco Use Disorder	Efficacy	P20813	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	19	41009358.0	A	G
pharmgkb	remifentanil,sevoflurane	ABCB1	rs1128503		tonsillectomy	Efficacy,Toxicity	P08183				7	87550285.0	A	G
pharmgkb	imatinib	ABCB1	I1145M		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	P08183	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	7	87509329.0	A	K
pharmgkb	imatinib	ABCB1	rs1128503		Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	P08183	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	7	87550285.0	A	G
pharmgkb	sirolimus,temsirolimus	NR1I2	rs3814055		adverse events,gastrointestinal toxicity,Myelosuppression,Urinary Bladder Neoplasms	Toxicity,Metabolism/PK	O75469				3	119781188.0	C	T
pharmgkb	sirolimus,temsirolimus	NR1I2	rs6785049		gastrointestinal toxicity,Myelosuppression,Urinary Bladder Neoplasms	Toxicity,Metabolism/PK	O75469				3	119814886.0	G	A
pharmgkb	sirolimus,temsirolimus	ABCB1	S893A		hematopoietic stem cell transplantation,Kidney Transplantation,Urinary Bladder Neoplasms	Metabolism/PK	P08183				7	87531302.0	A	Y
pharmgkb	sirolimus,temsirolimus	ABCB1	rs1128503		Urinary Bladder Neoplasms	Metabolism/PK	P08183				7	87550285.0	A	G
pharmgkb	antipsychotics,aripiprazole,bromperidol,chlorpromazine,clozapine,nemonapride,olanzapine,risperidone	DRD2	rs1799732		Schizophrenia	Efficacy	P14416				11	113475530.0	-	R
pharmgkb	Thiazides, plain	SLCO2A1	A396T		Hypernatremia,Hypertension	Toxicity	Q92959	Drug Class			3	133947365.0	C	K
pharmgkb	lithium	EPHX2	rs59724122		Bipolar Disorder	Efficacy	P34913	Drug	28486.0	[Li+]	8	27567179.0	C	T
pharmgkb	lithium	GRAMD1B	rs61123830		Bipolar Disorder	Efficacy	Q3KR37	Drug	28486.0	[Li+]	11	123522138.0	G	A
pharmgkb	lithium	MYO1H	rs7959663		Bipolar Disorder	Efficacy	Q8N1T3	Drug	28486.0	[Li+]	12	109446562.0	G	M
pharmgkb	lithium	FAM178B	rs6728642		Bipolar Disorder	Efficacy	Q8IXR5	Drug	28486.0	[Li+]	2	96941334.0	A	G
pharmgkb	lithium	ZNF804A	rs62200793		Bipolar Disorder	Efficacy	Q7Z570	Drug	28486.0	[Li+]	2	184885915.0	T	C
pharmgkb	lithium	ADCY1	rs1521470		Bipolar Disorder	Efficacy	Q08828	Drug	28486.0	[Li+]	7	45607253.0	A	G
pharmgkb	lithium	FAM177A1	rs79403677		Bipolar Disorder	Efficacy	Q8N128	Drug	28486.0	[Li+]	14	35069925.0	T	G
pharmgkb	fluorouracil,Platinum compounds,radiotherapy	ERCC1	rs2298881		Stomach Neoplasms	Efficacy	P07992				19	45423658.0	C	W
pharmgkb	Platinum compounds	XPC	A499V		Carcinoma, Non-Small-Cell Lung,gastrointestinal toxicity,Hematologic Diseases,Leukopenia	Toxicity	Q01831	Drug Class			3	14158387.0	G	A
pharmgkb	tipiracil hydrochloride,trifluridine	SLC29A1	rs760370		Colorectal Neoplasms	Efficacy	Q99808				6	44233216.0	A	G
pharmgkb	sulfonamides, urea derivatives	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3		Diabetes Mellitus, Type 2	Toxicity	P11712	Drug Class						
pharmgkb	sofosbuvir,velpatasvir,voxilaprevir	IFNL3	rs12979860		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	metformin	SLC47A1	rs2252281		Diabetes Mellitus, Type 2,Polycystic Ovary Syndrome	Efficacy	Q96FL8	Drug	4091.0	CN(C)C(=N)N=C(N)N	17	19533874.0	T	C
pharmgkb	metformin	SLC47A2	rs12943590			Metabolism/PK	Q86VL8	Drug	4091.0	CN(C)C(=N)N=C(N)N	17	19716685.0	G	A
pharmgkb	metformin	SLC47A1	rs2289669		Diabetes Mellitus, Type 2,Polycystic Ovary Syndrome	Efficacy	Q96FL8	Drug	4091.0	CN(C)C(=N)N=C(N)N	17	19560030.0	G	A
pharmgkb	metformin	SLC47A2	rs12943590		Diabetes Mellitus	Efficacy	Q86VL8	Drug	4091.0	CN(C)C(=N)N=C(N)N	17	19716685.0	G	A
pharmgkb	atazanavir,ritonavir	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7		HIV Infections	Metabolism/PK	P20815							
pharmgkb	atazanavir	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7			Metabolism/PK	P20815	Drug	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC				
pharmgkb	capecitabine	TYMS	rs699517		Asthenia,Nausea,Neoplasms,Vomiting	Toxicity	P04818	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	18	673016.0	C	T
pharmgkb	hdl cholesterol,letrozole,triglycerides	CYP19A1	rs2289105		Breast Neoplasms,Menopause	Other	P11511				15	51215311.0	T	C
pharmgkb	hdl cholesterol,letrozole,triglycerides	CYP19A1	rs10046		Breast Neoplasms,Menopause	Other	P11511				15	51210789.0	G	A
pharmgkb	metformin,sulfonamides, urea derivatives	KCNJ11	K23Q		Diabetes Mellitus, Type 2	Efficacy	Q14654				11	17388025.0	T	M
pharmgkb	carbamazepine,phenytoin,valproic acid	GABRA1	rs2279020		Epilepsy	Efficacy	P14867				5	161895883.0	G	A
pharmgkb	sunitinib	POR	A503V		Gastrointestinal Stromal Tumors	Efficacy	Q9Y277	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	7	75985688.0	C	T
pharmgkb	sunitinib	SLCO1B3	S112P		Gastrointestinal Stromal Tumors	Efficacy	F5H094	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	12	20858546.0	T	S
pharmgkb	cocaine	BCHE	A567T		Cocaine-Related Disorders	Other	P06276	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	3	165773492.0	C	T
pharmgkb	ustekinumab	TIRAP	S180L		Psoriasis	Efficacy	P58753	Drug			11	126292948.0	C	T
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TLR2	rs11938228		Inflammatory Bowel Diseases,Psoriasis	Efficacy	O60603	Drug Class			4	153700794.0	C	W
pharmgkb	ustekinumab	TLR5	F616L		Psoriasis	Efficacy	O60602	Drug			1	223111186.0	A	G
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors,ustekinumab	IL1B	rs1143627		Psoriasis	Efficacy	P01584				2	112836810.0	G	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors,ustekinumab	IL1B	rs1143623		Psoriasis	Efficacy	P01584				2	112838252.0	C	G
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TLR9	rs352139		Psoriasis	Efficacy	Q9NR96	Drug Class			3	52224356.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TLR2	rs4696480		Psoriasis	Efficacy	O60603	Drug Class			4	153685974.0	T	A
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	LY96	rs11465996		Psoriasis	Efficacy	Q9Y6Y9	Drug Class			8	73989727.0	C	G
pharmgkb	simvastatin	CYP3A4	CYP3A4*1, CYP3A4*22		Hypercholesterolemia	Metabolism/PK	P08684	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C				
pharmgkb	fluorouracil,Platinum compounds,radiotherapy	XRCC4	rs10040363		Stomach Neoplasms	Efficacy	Q13426				5	83177826.0	A	G
pharmgkb	Platinum compounds,radiotherapy	MEG3	rs10132552		Anemia,Dermatitis,Leukopenia,mucositis,Myelosuppression,Neutropenia,Thrombocytopenia	Toxicity					14	100834675.0	T	C
pharmgkb	ritodrine	CACNA1C	M1821V		adverse events,Premature Birth	Toxicity	P54284	Drug	33572.0	C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O	12	2681966.0	A	S
pharmgkb	nevirapine	HLA-B	HLA-B*35:05		Exanthema	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*39:10		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*51:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*51:02		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*54:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*55:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*55:02		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*56:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*56:06		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	bupropion,nicotine,varenicline	CHRNA5	rs503464		Tobacco Use Disorder	Efficacy,Toxicity	P30532				15	78565554.0	T	A
pharmgkb	nicotine	CHRNA4	rs2236196		Tobacco Use Disorder	Other	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63346204.0	G	M
pharmgkb	nicotine	CHRNA5	rs55781567		Tobacco Use Disorder	Toxicity	P30532	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78565644.0	C	G
pharmgkb	nevirapine	HLA-B	HLA-B*78:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*13:02		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*38:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*39:05		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*39:06		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*39:09		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*15:12		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*15:24		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*15:25		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*15:27		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*15:32		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*15:35		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*52:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*35:10		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-C	HLA-C*04:03		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-DRB1	HLA-DRB1*01:02		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01911	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-DRB1	HLA-DRB1*10:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01911	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-DRB1	HLA-DRB1*08:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01911	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-DRB1	HLA-DRB1*04:04		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01911	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-DRB1	HLA-DRB1*01:03		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01911	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-C	HLA-C*04:06		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-C	HLA-C*04:07		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-C	HLA-C*05:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-C	HLA-C*05:09		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-C	HLA-C*18:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P10321	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	sunitinib	ABCB1	rs1128503		Carcinoma, Renal Cell	Toxicity	P08183	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	7	87550285.0	A	G
pharmgkb	capecitabine,fluorouracil	TYMP	S471L		Neoplasms	Toxicity	P19971				22	50525807.0	G	H
pharmgkb	gemcitabine,Platinum compounds	RRM1	rs12806698		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9UET6				11	4094744.0	C	A
pharmgkb	deferasirox	ABCG2	rs13120400		beta-Thalassemia	Efficacy,Metabolism/PK	Q9UNQ0	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	4	88112375.0	T	C
pharmgkb	Ace Inhibitors, Plain	KCNIP4	rs145489027			Toxicity	Q6PIL6	Drug Class			4	21389571.0	G	A
pharmgkb	Ace Inhibitors, Plain	KCNIP4	rs1495509			Toxicity	Q6PIL6	Drug Class			4	21391993.0	T	C
pharmgkb	isoniazid,rifampin	GSTP1	I105V		drug-induced liver injury,Tuberculosis	Toxicity	P09211				11	67585218.0	A	G
pharmgkb	sunitinib	ABCB1	S893A		Carcinoma, Renal Cell,Neutropenia	Toxicity	P08183	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	7	87531302.0	A	Y
pharmgkb	sunitinib	ABCB1	S893A		Carcinoma, Renal Cell	Efficacy	P08183	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	7	87531302.0	A	Y
pharmgkb	fluorouracil,Platinum compounds,radiotherapy	TMEM167A	rs2075685		Stomach Neoplasms	Efficacy	Q8TBQ9				5	83076846.0	G	W
pharmgkb	cyclosporine,mycophenolic acid	ABCC2	V417I		Kidney Transplantation	Metabolism/PK	Q5T2W1				10	99804058.0	G	A
pharmgkb	atazanavir	NR1I2	rs2472677		Acquired Immunodeficiency Syndrome,HIV Infections,nephrolithiasis	Metabolism/PK	O75469	Drug	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	3	119799570.0	C	T
pharmgkb	atorvastatin,simvastatin	RYR2	rs2819742		Cardiovascular Diseases	Toxicity	Q92736				1	237826822.0	A	K
pharmgkb	bevacizumab	VEGFA	rs3025039		Breast Neoplasms,Colorectal Neoplasms	Efficacy	P15692	Drug			6	43784799.0	C	T
pharmgkb	pazopanib	KDR	C482R		Kidney Neoplasms	Efficacy,Metabolism/PK	P35968	Drug	11525740.0		4	55106779.0	A	G
pharmgkb	tipiracil hydrochloride,trifluridine	SLC29A1	rs9394992		Colorectal Neoplasms	Efficacy	Q99808				6	44228255.0	C	T
pharmgkb	deferasirox	UGT1A3	rs3806596		beta-Thalassemia	Efficacy,Metabolism/PK	P35503	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	2	233729061.0	T	C
pharmgkb	opioids	DBH	rs1611131		Opioid-Related Disorders	Toxicity	Q6UVY6	Drug Class			9	133657065.0	A	G
pharmgkb	letrozole	CYP19A1	rs4646		Breast Neoplasms,Menopause	Other	P11511	Drug	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	15	51210647.0	A	C
pharmgkb	cyclosporine	CYP3A5	rs776746		liver transplantation	Dosage,Metabolism/PK	P20815	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	99672916.0	T	C
pharmgkb	atazanavir,ritonavir	UGT1A1	rs8330		HIV Infections,nephrolithiasis	Toxicity	P22309				2	233772999.0	G	C
pharmgkb	Platinum compounds	XRCC3	T241M		Carcinoma, Non-Small-Cell Lung	Efficacy	O43542	Drug Class			14	103699416.0	G	A
pharmgkb	buprenorphine	OPRD1	rs529520		Opioid-Related Disorders	Efficacy	P41143	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	1	28848434.0	A	S
pharmgkb	irbesartan	CYP2C9	R144C			Efficacy	P11712	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	10	94942290.0	C	T
pharmgkb	ethanol	DRD2	E713K		Alcoholism,Death	Toxicity	P14416	Drug	702.0	CCO	11	113400106.0	G	A
pharmgkb	allopurinol	NOTCH4	rs367398		severe cutaneous adverse reactions	Toxicity	Q99466	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	32223953.0	G	A
pharmgkb	nicotine	FMO3	E308G		Tobacco Use Disorder	Metabolism/PK	P31513	Drug	942.0	CN1CCCC1C2=CN=CC=C2	1	171114102.0	A	G
pharmgkb	deferasirox	CYP24A1	rs927650		beta-Thalassemia	Metabolism/PK	Q07973	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	20	54156202.0	T	M
pharmgkb	deferasirox	CYP24A1	rs2585428		beta-Thalassemia	Metabolism/PK	Q07973	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	20	54170358.0	C	T
pharmgkb	deferasirox	CYP24A1	rs2248359		beta-Thalassemia	Metabolism/PK	Q07973	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	20	54174979.0	C	T
pharmgkb	aripiprazole	DRD2	rs6277		Schizophrenia	Efficacy	P14416	Drug	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	11	113412737.0	G	A
pharmgkb	Antiinflammatory agents, non-steroids	IL10	rs1800896			Toxicity	P22301	Drug Class			1	206773552.0	T	C
pharmgkb	Antiinflammatory agents, non-steroids	CTLA4	T17S			Toxicity	P16410	Drug Class			2	203867991.0	A	K
pharmgkb	tramadol	ABCB1	rs1128503			Metabolism/PK	P08183	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	7	87550285.0	A	G
pharmgkb	corticosteroids	BCL2L11	rs724710		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	O43521	Drug Class			2	111150114.0	T	M
pharmgkb	corticosteroids	BCL2L11	rs2241843		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	O43521	Drug Class			2	111121804.0	C	D
pharmgkb	caffeine	CYP1A2	rs2069514			Metabolism/PK	P05177	Drug	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	15	74745879.0	G	A
pharmgkb	caffeine	CYP1A2	rs762551			Metabolism/PK	P05177	Drug	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	15	74749576.0	C	A
pharmgkb	warfarin	GATA4	rs2645400			Dosage	P43694	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	8	11751907.0	T	G
pharmgkb	warfarin	GATA4	rs4841588			Dosage	P43694	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	8	11756716.0	G	T
pharmgkb	warfarin	VDR	rs11168292			Dosage	P11473	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	12	47899822.0	C	R
pharmgkb	warfarin	VDR	rs11168293			Dosage	P11473	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	12	47899933.0	G	W
pharmgkb	warfarin	VDR	rs4760658			Dosage	P11473	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	12	47902703.0	A	G
pharmgkb	sildenafil	CYP3A4	CYP3A4*1, CYP3A4*22		Heart Failure	Metabolism/PK	P08684	Drug	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C				
pharmgkb	somatropin recombinant	CDK4	rs2069502		Turner Syndrome	Other	P11802	Drug			12	57750882.0	C	T
pharmgkb	somatropin recombinant	CDK4	rs2270777			Other	P11802	Drug			12	57751373.0	C	K
pharmgkb	doxorubicin,idarubicin	CYBA	Y72N		Neoplasms	Toxicity	Q8NFA2				16	88646828.0	A	K
pharmgkb	doxorubicin,idarubicin	CYBA	Y72N		Neoplasms	Efficacy,Toxicity	Q8NFA2				16	88646828.0	A	K
pharmgkb	doxorubicin,idarubicin	NCF4	rs1883112		Neoplasms	Toxicity	Q15080				22	36860804.0	G	A
pharmgkb	doxorubicin,idarubicin	RAC2	rs13058338		Neoplasms	Toxicity	P15153				22	37236730.0	T	R
pharmgkb	idarubicin	NCF4	rs1883112		Leukemia, Myeloid, Acute	Efficacy	Q15080	Drug	42890.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	22	36860804.0	G	A
pharmgkb	idarubicin	RAC2	rs13058338		Leukemia, Myeloid, Acute	Efficacy	P15153	Drug	42890.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	22	37236730.0	T	R
pharmgkb	Drugs Used In Diabetes	IRS1	G971R		Diabetes Mellitus, Type 2	Efficacy	P35568	Drug Class			2	226795828.0	C	K
pharmgkb	imatinib	SLC22A1	L160F		Gastrointestinal Stromal Tumors	Toxicity	O15245	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	6	160130172.0	G	H
pharmgkb	imatinib	SLC22A5	rs274558		Gastrointestinal Stromal Tumors	Toxicity	O76082	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	5	132385482.0	A	G
pharmgkb	imatinib	EGFR	rs10258429		Gastrointestinal Stromal Tumors	Toxicity	P00533	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	7	55170394.0	C	T
pharmgkb	imatinib	ABCB1	rs2235040		Gastrointestinal Stromal Tumors	Toxicity	P08183	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	7	87536434.0	C	T
pharmgkb	3,4-methylenedioxymethamphetamine	SLC6A2	rs2242446			Other	P23975	Drug	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC	16	55656513.0	C	W
pharmgkb	3,4-methylenedioxymethamphetamine	SLC6A2	rs36029			Other	P23975	Drug	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC	16	55662844.0	A	G
pharmgkb	3,4-methylenedioxymethamphetamine	SLC6A2	rs1861647			Other	P23975	Drug	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC	16	55694494.0	G	M
pharmgkb	methotrexate	ABCG2	Q141K		Arthritis, Rheumatoid	Toxicity	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88131171.0	G	Y
pharmgkb	metformin	SLC22A1	R61C			Metabolism/PK	O15245	Drug	4091.0	CN(C)C(=N)N=C(N)N	6	160122116.0	C	T
pharmgkb	cetuximab,panitumumab	KRAS	rs61764370		Neoplasms	Efficacy	P01116				12	25207290.0	A	C
pharmgkb	cyclosporine	POR	A503V		Kidney Transplantation	Metabolism/PK	Q9Y277	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	75985688.0	C	T
pharmgkb	cyclosporine	CYP3A4	rs35599367		Organ Transplantation	Other	P08684	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	99768693.0	G	A
pharmgkb	tacrolimus	SUMO4	V55L		liver transplantation	Metabolism/PK	Q6EEV6	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	6	149400554.0	G	A
pharmgkb	omeprazole	ABCB1	I1145M		Gastroesophageal Reflux	Efficacy,Metabolism/PK	P08183	Drug	4594.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	7	87509329.0	A	K
pharmgkb	dapoxetine	CYP2D6	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98			Metabolism/PK	P10635	Drug	71353.0	CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3				
pharmgkb	caffeine,chlorocresol	RYR1	T84R		Malignant Hyperthermia	Other	P21817				19	38442434.0	C	K
pharmgkb	tacrolimus	TLR4	rs1927907		Organ Transplantation	Other	O00206	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	9	117710486.0	C	T
pharmgkb	allopurinol	PSORS1C1	rs3131003		severe cutaneous adverse reactions	Toxicity	Q9UIG5	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31125705.0	G	A
pharmgkb	methotrexate	DHFR	rs408626		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy,Toxicity	P00374	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	80655314.0	T	C
pharmgkb	methotrexate	DHFR	rs442767		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P00374	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	80655677.0	G	T
pharmgkb	nicotine	CYP2A6	rs4803381			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40851439.0	T	C
pharmgkb	nicotine	CYP2A6	rs56113850		Tobacco Use Disorder	Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40847202.0	T	C
pharmgkb	metformin	SP1	rs784888		Diabetes Mellitus, Type 2	Efficacy,Metabolism/PK	P08047	Drug	4091.0	CN(C)C(=N)N=C(N)N	12	53430724.0	G	C
pharmgkb	metformin	AMHR2	rs784892		Diabetes Mellitus	Efficacy,Metabolism/PK	Q16671	Drug	4091.0	CN(C)C(=N)N=C(N)N	12	53429100.0	G	A
pharmgkb	opioids	OPRL1	rs6090041		Opioid-Related Disorders	Toxicity	P41146	Drug Class			20	64081323.0	G	A
pharmgkb	opioids	LKAAEAR1	rs6090043		Opioid-Related Disorders	Toxicity	Q7Z3Y8	Drug Class			20	64086577.0	C	T
pharmgkb	capecitabine	CDA	K27Q		Neoplasms	Toxicity	Q96GN5	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	20589208.0	A	C
pharmgkb	methylphenidate	PEBP4	rs17685420		Attention Deficit Disorder with Hyperactivity	Efficacy	Q96S96	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	8	22927888.0	C	T
pharmgkb	methylphenidate	ZDHHC7	rs3210967		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9NXF8	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	16	84975857.0	T	C
pharmgkb	methylphenidate	ZNF134	A46S		Attention Deficit Disorder with Hyperactivity	Efficacy	P52741	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	19	57620255.0	G	W
pharmgkb	methylphenidate	ARSA	N352S		Attention Deficit Disorder with Hyperactivity	Efficacy	P15289	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	22	50625988.0	T	C
pharmgkb	methylphenidate	SPSB2	rs12302749		Attention Deficit Disorder with Hyperactivity	Efficacy	Q99619	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	12	6867132.0	C	T
pharmgkb	methylphenidate	ZNF211	rs10420097		Attention Deficit Disorder with Hyperactivity	Efficacy	Q13398	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	19	57633193.0	A	S
pharmgkb	methylphenidate	CORO7	E384V		Attention Deficit Disorder with Hyperactivity	Efficacy	P57737	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	16	4382028.0	A	Y
pharmgkb	methylphenidate	FXR2	A350T		Attention Deficit Disorder with Hyperactivity	Efficacy	P51116	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	17	7581494.0	G	A
pharmgkb	methylphenidate	ZNF565	I188S		Attention Deficit Disorder with Hyperactivity	Efficacy	Q8N9K5	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	19	36183403.0	A	G
pharmgkb	methylphenidate	ELP5	V197E		Attention Deficit Disorder with Hyperactivity	Efficacy	Q8TE02	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	17	7260420.0	A	G
pharmgkb	methylphenidate	CDH23	V1675I		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9H251	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	10	71777857.0	G	A
pharmgkb	methylphenidate	ARHGAP12	rs2799018		Attention Deficit Disorder with Hyperactivity	Efficacy	Q8IWW6	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	10	31913141.0	C	K
pharmgkb	methylphenidate	PIGM	F365L		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9H3S5	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	1	160030645.0	A	T
pharmgkb	methylphenidate	CHURC1	rs4902333		Attention Deficit Disorder with Hyperactivity	Efficacy	Q8WUH1	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	14	64909368.0	C	T
pharmgkb	methylphenidate	TRIB3	Q84R		Attention Deficit Disorder with Hyperactivity	Efficacy	Q96RU7	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	20	388261.0	A	K
pharmgkb	methylphenidate	CMTM8	rs4627790		Attention Deficit Disorder with Hyperactivity	Efficacy	Q8IZV2	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	3	32259860.0	T	C
pharmgkb	methylphenidate	PDIA2	P502T		Attention Deficit Disorder with Hyperactivity	Efficacy	Q13087	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	16	286916.0	C	W
pharmgkb	methylphenidate	OPCML	rs751655		Attention Deficit Disorder with Hyperactivity	Efficacy	Q14982	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	11	132623600.0	C	T
pharmgkb	methylphenidate	ETFDH	T31I		Attention Deficit Disorder with Hyperactivity	Efficacy	Q16134	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	4	158680524.0	C	T
pharmgkb	methylphenidate	NFIB	rs7858		Attention Deficit Disorder with Hyperactivity	Efficacy	O00712	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	9	14087770.0	C	T
pharmgkb	methylphenidate	ARHGEF28	rs929740		Attention Deficit Disorder with Hyperactivity	Efficacy	Q8N1W1	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	5	73621913.0	G	A
pharmgkb	methylphenidate	SENP3	G67R		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9H4L4	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	17	7559238.0	G	M
pharmgkb	methylphenidate	ESYT2	rs1061735		Attention Deficit Disorder with Hyperactivity	Efficacy	A0FGR8	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	7	158733764.0	G	W
pharmgkb	methylphenidate	RRP7A	V88L		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9Y3A4	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	22	42516091.0	C	K
pharmgkb	methylphenidate	HTT	V2788F		Attention Deficit Disorder with Hyperactivity	Efficacy	P42858	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	4	3233253.0	G	W
pharmgkb	methylphenidate	FARP2	T260I		Attention Deficit Disorder with Hyperactivity	Efficacy	O94887	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	2	241431686.0	C	W
pharmgkb	methylphenidate	GGH	rs17279558		Attention Deficit Disorder with Hyperactivity	Efficacy	Q92820	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	8	63015187.0	T	C
pharmgkb	methylphenidate	PURA	rs2013169		Attention Deficit Disorder with Hyperactivity	Efficacy	Q00577	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	5	140118020.0	T	A
pharmgkb	duloxetine	NRXN1	rs4971678		Depressive Disorder, Major	Efficacy	P58400	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	2	50438029.0	T	A
pharmgkb	duloxetine	ZNF385D	rs9873889		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21753431.0	C	K
pharmgkb	duloxetine	ZNF385D	rs9879065		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21754288.0	C	K
pharmgkb	duloxetine	ZNF385D	rs9310658		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21756084.0	C	T
pharmgkb	duloxetine	ZNF385D	rs7616119		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21756203.0	G	H
pharmgkb	duloxetine	ZNF385D	rs7653345		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21756949.0	A	G
pharmgkb	duloxetine	ZNF385D	rs9819548		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21757051.0	G	W
pharmgkb	duloxetine	ZNF385D	rs13093500		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21757155.0	T	V
pharmgkb	duloxetine	ZNF385D	rs12630569		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21757421.0	G	M
pharmgkb	duloxetine	ZNF385D	rs9824595		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21757835.0	G	H
pharmgkb	duloxetine	ZNF385D	rs4334661		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21757936.0	T	C
pharmgkb	duloxetine	TTC37	rs12657120		Depressive Disorder, Major	Efficacy	Q6PGP7	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	5	95466585.0	G	M
pharmgkb	duloxetine	TTC37	rs4639250		Depressive Disorder, Major	Efficacy	Q6PGP7	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	5	95481198.0	C	G
pharmgkb	duloxetine	TREML4	rs13204353		Depressive Disorder, Major	Efficacy	Q6UXN2	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	6	41237497.0	G	M
pharmgkb	duloxetine	INVS	rs10123866		Depressive Disorder, Major	Efficacy	Q9Y283	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	9	100301363.0	G	M
pharmgkb	duloxetine	TEX10	F911L		Depressive Disorder, Major	Efficacy	Q9NXF1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	9	100302248.0	G	A
pharmgkb	duloxetine	TEX10	rs10124893		Depressive Disorder, Major	Efficacy	Q9NXF1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	9	100302983.0	G	A
pharmgkb	duloxetine	TEX10	rs6479008		Depressive Disorder, Major	Efficacy	Q9NXF1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	9	100311309.0	C	A
pharmgkb	duloxetine	TEX10	rs10989064		Depressive Disorder, Major	Efficacy	Q9NXF1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	9	100349683.0	C	T
pharmgkb	duloxetine	FCN2	rs3124955		Depressive Disorder, Major	Efficacy	Q15485	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	9	134882699.0	T	C
pharmgkb	duloxetine	FCN2	rs3128624		Depressive Disorder, Major	Efficacy	Q15485	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	9	134883293.0	A	G
pharmgkb	duloxetine	ANO2	rs61908402		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5915594.0	T	C
pharmgkb	duloxetine	ANO2	rs61908403		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5915639.0	G	A
pharmgkb	duloxetine	ANO2	rs61908404		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5916105.0	C	T
pharmgkb	duloxetine	ANO2	rs61908405		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5916164.0	C	A
pharmgkb	duloxetine	ANO2	rs17724452		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5916322.0	C	A
pharmgkb	duloxetine	ANO2	rs17724464		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5916418.0	G	C
pharmgkb	duloxetine	ANO2	rs17786394		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5916924.0	T	C
pharmgkb	duloxetine	ANO2	rs17786400		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5916985.0	A	K
pharmgkb	duloxetine	ANO2	rs61908406		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5917081.0	G	A
pharmgkb	duloxetine	ANO2	rs17786412		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5917148.0	G	W
pharmgkb	duloxetine	ANO2	rs61908407		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5917207.0	A	G
pharmgkb	duloxetine	ANO2	rs61908408		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5917289.0	A	G
pharmgkb	duloxetine	ANO2	rs61908409		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5917405.0	C	G
pharmgkb	duloxetine	ANO2	rs61908410		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5917412.0	T	A
pharmgkb	duloxetine	ANO2	rs78482393		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5917824.0	G	A
pharmgkb	duloxetine	ANO2	rs78615940		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5917867.0	A	C
pharmgkb	duloxetine	ANO2	rs17724494		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5918126.0	C	T
pharmgkb	duloxetine	ANO2	rs61908411		Depressive Disorder, Major	Efficacy	Q9NQ90	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	12	5918478.0	C	T
pharmgkb	duloxetine	ATP10A	rs12595802		Depressive Disorder, Major	Efficacy	O60312	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	15	25806438.0	G	M
pharmgkb	duloxetine	MIEF2	rs3889402		Depressive Disorder, Major	Efficacy	O00429	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	17	18264083.0	G	W
pharmgkb	duloxetine	MIEF2	G324E		Depressive Disorder, Major	Efficacy	O00429	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	17	18264370.0	G	A
pharmgkb	duloxetine	MIEF2	rs56355515		Depressive Disorder, Major	Efficacy	O00429	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	17	18265930.0	G	W
pharmgkb	duloxetine	ZNF385D	rs9310657		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21756083.0	T	G
pharmgkb	duloxetine	TREML4	rs9369266		Depressive Disorder, Major	Efficacy	Q6UXN2	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	6	41232816.0	A	G
pharmgkb	duloxetine	TEX10	rs7035619		Depressive Disorder, Major	Efficacy	Q9NXF1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	9	100309102.0	A	T
pharmgkb	valproic acid	UGT2B7	rs7668258		Epilepsy	Metabolism/PK	P16662	Drug	3121.0	CCCC(CCC)C(=O)O	4	69096360.0	T	C
pharmgkb	valproic acid	UGT2B7	A71T		Epilepsy	Metabolism/PK	P16662	Drug	3121.0	CCCC(CCC)C(=O)O	4	69096731.0	G	H
pharmgkb	clopidogrel	CYP2C19	rs11568732		Hemorrhage,Myocardial Infarction	Toxicity	P33261	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	10	94761817.0	T	S
pharmgkb	atorvastatin	AGTR1	rs5186			Metabolism/PK	P30556	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	3	148742201.0	A	C
pharmgkb	atorvastatin	BDKRB2	rs1799722			Metabolism/PK	P30411	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	14	96204802.0	C	T
pharmgkb	aspirin	UGT1A6	R184S		Colonic Neoplasms	Efficacy	P19224	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	2	233693556.0	A	C
pharmgkb	aspirin	UGT1A6	T181A		Colonic Neoplasms	Efficacy	P19224	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	2	233693545.0	A	G
pharmgkb	atorvastatin	ABCC2	rs717620		Hypercholesterolemia	Efficacy	Q5T2W1	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	10	99782821.0	C	T
pharmgkb	lamotrigine	HLA-A	HLA-A*02:07		Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P04439	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N				
pharmgkb	lamotrigine	HLA-A	HLA-A*33:03		Maculopapular Exanthema	Toxicity	P04439	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N				
pharmgkb	allopurinol	PSORS1C1	R37H		drug reaction with eosinophilia and systemic symptoms,Stevens-Johnson Syndrome	Toxicity	Q9UIG5	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31138722.0	G	A
pharmgkb	allopurinol	CYCSP5	rs3099844		drug reaction with eosinophilia and systemic symptoms,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity		Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31481199.0	C	A
pharmgkb	granisetron,palonosetron	ERCC1	Q506K		Nausea,Neoplasms,Vomiting	Efficacy	P07992				19	45409478.0	C	D
pharmgkb	granisetron	ABCB1	I1145M		Neoplasms	Efficacy	P08183	Drug	3510.0	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C	7	87509329.0	A	K
pharmgkb	dexamethasone,lenalidomide	ABCB1	S400N		Multiple Myeloma,progression-free survival	Efficacy	P08183				7	87550493.0	C	W
pharmgkb	methadone	CYP2B6	R22C			Metabolism/PK	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	19	40991369.0	C	T
pharmgkb	methadone	CYP2B6	R487S			Metabolism/PK	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	19	41016810.0	C	D
pharmgkb	heroin	SOD2	rs5746136		Heroin Dependence	Toxicity	P04179	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	159682052.0	C	T
pharmgkb	tacrolimus	CYP3A7	CYP3A7*1A, CYP3A7*1C		Kidney Transplantation	Metabolism/PK	P24462	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	tacrolimus	CYP2J2	rs890293		Kidney Transplantation	Toxicity	P51589	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	59926822.0	C	A
pharmgkb	tacrolimus	ABCC2	I1324M		Kidney Transplantation	Metabolism/PK	Q5T2W1	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	10	99844450.0	C	K
pharmgkb	tacrolimus	CYP2C8	CYP2C8*1, CYP2C8*3		Kidney Transplantation	Metabolism/PK	P10632	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	tacrolimus	CYP2C8	CYP2C8*1, CYP2C8*3		Kidney Transplantation	Toxicity	P10632	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	tacrolimus	PPARA	rs4253728		Kidney Transplantation	Toxicity	Q07869	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	22	46214170.0	G	A
pharmgkb	fluvoxamine,milnacipran,paroxetine	MDGA2	rs1160351		Depressive Disorder, Major	Toxicity	Q7Z553				14	47546779.0	A	C
pharmgkb	acenocoumarol	CALU	rs1043550			Dosage	O43852	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	7	128769171.0	A	G
pharmgkb	acenocoumarol	VKORC1	rs7294			Other	Q8N0U8	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	16	31091000.0	C	T
pharmgkb	cotinine,nicotine	OPRM1	rs6912029			Metabolism/PK	P35372				6	154039373.0	G	T
pharmgkb	cotinine,nicotine	OPRM1	rs1074287			Metabolism/PK	P35372				6	154027674.0	A	G
pharmgkb	cotinine,nicotine	OPRM1	N40D			Metabolism/PK	P35372				6	154039662.0	A	G
pharmgkb	cotinine,nicotine	OPRM1	rs12209447			Metabolism/PK	P35372				6	154039913.0	C	T
pharmgkb	cotinine,nicotine	OPRM1	rs510769			Metabolism/PK	P35372				6	154040884.0	C	T
pharmgkb	cotinine,nicotine	OPRM1	rs3798676			Metabolism/PK	P35372				6	154043004.0	C	T
pharmgkb	cotinine,nicotine	OPRM1	rs553202			Metabolism/PK	P35372				6	154043682.0	C	T
pharmgkb	cotinine,nicotine	OPRM1	rs7748401			Metabolism/PK	P35372				6	154059015.0	T	G
pharmgkb	cotinine,nicotine	OPRM1	rs495491			Metabolism/PK	P35372				6	154061407.0	A	G
pharmgkb	cotinine,nicotine	OPRM1	rs10457090			Metabolism/PK	P35372				6	154069938.0	A	K
pharmgkb	cotinine,nicotine	OPRM1	rs589046			Metabolism/PK	P35372				6	154072003.0	C	T
pharmgkb	cotinine,nicotine	OPRM1	rs3778152			Metabolism/PK	P35372				6	154072696.0	A	G
pharmgkb	cotinine,nicotine	OPRM1	rs563649			Metabolism/PK	P35372				6	154086832.0	C	T
pharmgkb	cotinine,nicotine	OPRM1	rs2075572			Metabolism/PK	P35372				6	154090869.0	G	C
pharmgkb	chlorothiazide,hydrochlorothiazide	HMGCS2	rs9943291		Hyperglycemia,Hypertension	Toxicity	P54868				1	119749667.0	T	G
pharmgkb	antineoplastic agents	ABCB1	I1145M		Neoplasms	Toxicity	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	cocaine,heroin	OPRM1	C192F		Cocaine-Related Disorders,Heroin Dependence	Toxicity	P35372				6	154090110.0	G	T
pharmgkb	irinotecan	ABCB1	rs12720066		Colorectal Neoplasms,Neutropenia	Toxicity	P08183	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	7	87540386.0	A	C
pharmgkb	ivacaftor	CFTR	G970R		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117603782.0	G	M
pharmgkb	(R)-methadone,methadone,S-EDDP	UGT2B7	Y268H		Opioid-Related Disorders	Metabolism/PK	P16662				4	69098620.0	T	C
pharmgkb	methadone	ABCB1	N21H		Opioid-Related Disorders	Metabolism/PK	P08183	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	87600124.0	T	C
pharmgkb	oxycodone	UGT2B7	Y268H		Pain	Efficacy	P16662	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	4	69098620.0	T	C
pharmgkb	clopidogrel	ABCB1	I1145M		Coronary Disease,Hemorrhage	Toxicity	P08183	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	7	87509329.0	A	K
pharmgkb	Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan	OPRM1	N40D		Substance Withdrawal Syndrome	Other	P35372				6	154039662.0	A	G
pharmgkb	apixaban	ABCG2	Q141K		Atrial Fibrillation	Metabolism/PK	Q9UNQ0	Drug	10182969.0	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N	4	88131171.0	G	Y
pharmgkb	apixaban	CYP3A5	rs776746		Atrial Fibrillation	Metabolism/PK	P20815	Drug	10182969.0	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N	7	99672916.0	T	C
pharmgkb	acenocoumarol,warfarin	APOE	C130R		Hemorrhage,venous thromboembolism	Toxicity	P02649				19	44908684.0	T	C
pharmgkb	Vitamin K	CYP4F2	V433M			Metabolism/PK	P78329	Drug Class			19	15879621.0	C	T
pharmgkb	ethanol	KLB	rs11940694		Alcoholism	Dosage	Q86Z14	Drug	702.0	CCO	4	39413373.0	A	G
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	IRS1	rs115457081		Breast Neoplasms,Neutropenia	Toxicity	P35568				2	226804325.0	G	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	GNL3	rs112242273		Breast Neoplasms,Neutropenia	Toxicity	Q9BVP2				3	52741044.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	HMMR	rs299293		Breast Neoplasms,Neutropenia	Toxicity	O75330				5	163482208.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	HMMR	rs299313		Breast Neoplasms,Neutropenia	Toxicity	O75330				5	163486945.0	G	M
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PERP	rs117101815		Breast Neoplasms,Neutropenia	Toxicity	Q96FX8				6	138131313.0	G	W
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PERP	rs78428806		Breast Neoplasms,Neutropenia	Toxicity	Q96FX8				6	138114070.0	G	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PPP2R5D	rs3805945		Breast Neoplasms,Neutropenia	Toxicity	Q14738				6	43039244.0	T	C
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	HMMR	rs299314		Breast Neoplasms,Neutropenia	Toxicity	O75330				5	163487994.0	T	C
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PERP	rs9402944		Breast Neoplasms,Neutropenia	Toxicity	Q96FX8				6	138132382.0	G	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PERP	rs9389568		Breast Neoplasms,Neutropenia	Toxicity	Q96FX8				6	138145853.0	T	C
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	CYP2C8	rs117458836		Breast Neoplasms,Neutropenia	Toxicity	P10632				10	95013625.0	G	W
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	TP53AIP1	rs118088833		Breast Neoplasms,Neutropenia	Toxicity	Q9HCN2				11	128937143.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	NOS1	rs149212925		Breast Neoplasms,Neutropenia	Toxicity	P29475				12	117191508.0	A	G
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	FOXO1	rs144991623		Breast Neoplasms,Neutropenia	Toxicity	Q12778				13	40694197.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	CCNK	rs77769901		Breast Neoplasms,Neutropenia	Toxicity	O75909				14	99447319.0	A	G
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	TP53	rs4968187		Breast Neoplasms,Neutropenia	Toxicity	Q12888				17	7669124.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	TOP2A	rs181501757		Breast Neoplasms,Neutropenia	Toxicity	P11388				17	40398140.0	G	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	INSR	rs142244113		Breast Neoplasms,Neutropenia	Toxicity	P06213				19	7164496.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	INSR	rs41412545		Breast Neoplasms,Neutropenia	Toxicity	P06213				19	7172515.0	C	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs118129530		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18120913.0	G	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	T196M		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18123979.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs117341846		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18125871.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs117951771		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18129161.0	C	W
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs148235907		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18129545.0	G	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs138602176		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18131325.0	G	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs150688309		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18131482.0	C	G
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs79430272		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18132742.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs55633228		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18134954.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs148013902		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18137528.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs145623321		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18145130.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs58695150		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18151561.0	C	T
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	PIK3R2	rs8110364		Breast Neoplasms,Neutropenia	Toxicity	P30530				19	18162822.0	G	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	CBR3	rs74743371		Breast Neoplasms,Neutropenia	Toxicity	O75828				21	36183667.0	G	H
pharmgkb	buprenorphine,methadone	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Opioid-Related Disorders	Efficacy	P31645							
pharmgkb	cocaine,ethanol,nicotine	OPRM1	A6V		Substance-Related Disorders	Toxicity	P35372				6	154039561.0	C	D
pharmgkb	morphine	UGT2B7	rs7668282		Anemia, Sickle Cell	Metabolism/PK	P16662	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	4	69096396.0	T	C
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	RBX1	rs141084494		Breast Neoplasms,Neutropenia	Toxicity	P62877				22	40972293.0	G	A
pharmgkb	caffeine	CYP1A2	rs762551		insomnia	Toxicity	P05177	Drug	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	15	74749576.0	C	A
pharmgkb	metformin	CPA6	rs2162145		Diabetes Mellitus, Type 2	Efficacy	P11509	Drug	4091.0	CN(C)C(=N)N=C(N)N	8	67747912.0	T	S
pharmgkb	metformin	NBEA	rs57081354		Diabetes Mellitus, Type 2	Efficacy	Q8NFP9	Drug	4091.0	CN(C)C(=N)N=C(N)N	13	35202457.0	T	C
pharmgkb	metformin	PRPF31	rs254271		Diabetes Mellitus, Type 2	Efficacy	P55769	Drug	4091.0	CN(C)C(=N)N=C(N)N	19	54127382.0	C	R
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		Nephrotic Syndrome	Metabolism/PK	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan	COMT	V158M			Other	P21964				22	19963748.0	G	A
pharmgkb	diuretics,hydrochlorothiazide,Thiazides, plain	NELFCD	rs2273359		Hypertension	Efficacy	Q8IXH7				20	58987047.0	C	K
pharmgkb	mercaptopurine,methotrexate	SLCO1B1	V174A		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage	Q9Y6L6				12	21178615.0	T	C
pharmgkb	mercaptopurine	TPMT	Y240C		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage,Toxicity	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	6	18130687.0	T	S
pharmgkb	repaglinide	SLCO1B1	V174A			Efficacy	Q9Y6L6	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	12	21178615.0	T	C
pharmgkb	propofol,remifentanil	ABCB1	rs1128503			Efficacy	P08183				7	87550285.0	A	G
pharmgkb	bevacizumab	HSP90AB1	rs3734704		Hypertension	Toxicity	P08238	Drug			6	44234210.0	A	Y
pharmgkb	bevacizumab	HSP90AB1	rs6929249		Hypertension	Toxicity	P08238	Drug			6	44235246.0	A	G
pharmgkb	bevacizumab	HSP90AB1	rs834576		Hypertension	Toxicity	P08238	Drug			6	44238042.0	C	A
pharmgkb	bevacizumab	PRKCA	rs9381299		Hypertension	Toxicity	Q9NRD5	Drug			6	44244130.0	T	C
pharmgkb	mercaptopurine,methotrexate	ITPA	rs7270101		Leukopenia,Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage,Toxicity	Q9BY32				20	3213247.0	A	C
pharmgkb	acenocoumarol,phenprocoumon	VKORC1	rs7294			Dosage	Q8N0U8				16	31091000.0	C	T
pharmgkb	donepezil	BCHE	A567T		Alzheimer Disease,cognitive dysfunction	Efficacy	P06276	Drug	3152.0	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	3	165773492.0	C	T
pharmgkb	antidepressants,citalopram,paroxetine	BDNF	V66M		Depressive Disorder	Efficacy	P23560				11	27658369.0	C	T
pharmgkb	gemcitabine	ABCG2	Q141K		Carcinoma, Non-Small-Cell Lung	Efficacy,Toxicity	Q9UNQ0	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	4	88131171.0	G	Y
pharmgkb	gemcitabine	POLR2A	N764K		Carcinoma, Non-Small-Cell Lung	Toxicity	Q6P1J9	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	17	7501672.0	T	C
pharmgkb	methotrexate	ABCC1	rs35592		Arthritis, Rheumatoid,Psoriasis	Efficacy	P33527	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	16	16047966.0	T	C
pharmgkb	warfarin	UGT1A1	rs887829		heart valve replacement	Dosage	P22309	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	233759924.0	C	T
pharmgkb	phenytoin	CYP2C9	L294F		Drug Toxicity	Toxicity	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	10	94972166.0	G	W
pharmgkb	phenytoin	CYP2C9	R307K		Drug Toxicity	Toxicity	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	10	94972204.0	G	A
pharmgkb	phenytoin	HLA-A	HLA-A*24:02		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P04439	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	Platinum compounds	SLC31A1	rs4979223		overall survival,Thrombocytopenia	Efficacy,Toxicity	O15431	Drug Class			9	113219836.0	A	C
pharmgkb	Platinum compounds	SLC31A1	rs4978536		Thrombocytopenia	Toxicity	O15431	Drug Class			9	113220123.0	A	G
pharmgkb	Platinum compounds	SLC31A1	rs2233914		Drug Toxicity,overall survival	Efficacy,Toxicity	O15431	Drug Class			9	113221260.0	G	A
pharmgkb	Platinum compounds	SLC31A1	rs10817464		Anemia,Leukopenia,Nausea,Neutropenia,Thrombocytopenia,Vomiting	Toxicity	O15431	Drug Class			9	113230217.0	T	M
pharmgkb	fluorouracil	DPYD	N893S			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97098577.0	T	C
pharmgkb	fluorouracil	DPYD	H807R			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97234874.0	T	S
pharmgkb	fluorouracil	DPYD	V434L			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97573799.0	C	R
pharmgkb	fluorouracil	DPYD	rs1184321568			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97593251.0	T	-
pharmgkb	fluorouracil	DPYD	T298M			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97595124.0	G	W
pharmgkb	fluorouracil	DPYD	Y109N			Other	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97721668.0	A	T
pharmgkb	pemetrexed	MTHFR	A222V		Carcinoma, Non-Small-Cell Lung,Mesothelioma	Efficacy	P42898	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	1	11796321.0	G	A
pharmgkb	atenolol,hydrochlorothiazide	ALDH1A2	rs261316		Hypertension	Efficacy	O94788				15	58341621.0	C	T
pharmgkb	montelukast	UGT1A3	rs7604115		Asthma	Metabolism/PK	P35503	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	2	233749470.0	C	T
pharmgkb	montelukast	UGT1A3	UGT1A3*1, UGT1A3*2		Asthma	Metabolism/PK	P35503	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O				
pharmgkb	montelukast	ABCC9	rs704212		Asthma	Metabolism/PK	O60706	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	12	21891410.0	C	T
pharmgkb	montelukast	CYP2C8	CYP2C8*1, CYP2C8*3, CYP2C8*4		Asthma	Metabolism/PK	P10632	Drug	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O				
pharmgkb	HMG CoA reductase inhibitors, other combinations	EYS	rs9342288		Cardiovascular Diseases,Rhabdomyolysis	Toxicity	Q5T1H1	Drug Class			6	64477153.0	G	A
pharmgkb	hmg coa reductase inhibitors	EYS	rs1337512		Rhabdomyolysis	Toxicity	Q5T1H1	Drug Class			6	64483927.0	T	G
pharmgkb	hmg coa reductase inhibitors	EYS	rs3857532		Rhabdomyolysis	Toxicity	Q5T1H1	Drug Class			6	64523772.0	G	A
pharmgkb	cyclophosphamide,doxorubicin	NQO2	L47I		Breast Neoplasms	Efficacy	P16083				6	3010156.0	C	T
pharmgkb	cyclophosphamide,doxorubicin,prednisone,rituximab,vincristine	GSTA1	rs3957357		Lymphoma, Large B-Cell, Diffuse	Efficacy	P08263				6	52803889.0	A	G
pharmgkb	cisplatin,cyclophosphamide,doxorubicin,methotrexate,vincristine	ABCB1	rs4148737		Osteosarcoma	Efficacy	P08183				7	87541836.0	T	C
pharmgkb	cisplatin,cyclophosphamide,doxorubicin,methotrexate,vincristine	ABCB1	rs1128503		Osteosarcoma	Efficacy	P08183				7	87550285.0	A	G
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil,methotrexate	NOS3	D298E		Breast Neoplasms	Efficacy	P29474				7	150999023.0	T	R
pharmgkb	cyclophosphamide,doxorubicin	ALDH1A1	rs6151031		Breast Neoplasms	Efficacy	P00352				9	72953468.0	-	CTGGTGAGGAGAGAACC
pharmgkb	cyclophosphamide,doxorubicin	CYP2C19	rs4244285		Breast Neoplasms	Efficacy	P33261				10	94781859.0	G	M
pharmgkb	cyclophosphamide,doxorubicin	CYP2B6	K139E		Breast Neoplasms	Efficacy	P20813				19	41004377.0	A	G
pharmgkb	acetaminophen	SULT1A3	S8P			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	29461407.0	T	C
pharmgkb	morphine	SULT1A3	S8P			Metabolism/PK	P0DMM9	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	16	29461407.0	T	C
pharmgkb	tapentadol	SULT1A3	S8P			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	29461407.0	T	C
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	S8P			Metabolism/PK	P0DMM9				16	29461407.0	T	C
pharmgkb	acetaminophen	SULT1A3	P10R			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	29461414.0	C	K
pharmgkb	morphine	SULT1A3	P10R			Metabolism/PK	P0DMM9	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	16	29461414.0	C	K
pharmgkb	tapentadol	SULT1A3	P10R			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	29461414.0	C	K
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	P10R			Metabolism/PK	P0DMM9				16	29461414.0	C	K
pharmgkb	acetaminophen	SULT1A3	T7P			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	30200747.0	A	C
pharmgkb	tapentadol	SULT1A3	T7P			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	30200747.0	A	C
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	T7P			Metabolism/PK	P0DMM9				16	30200747.0	A	C
pharmgkb	acetaminophen	SULT1A3	R9C			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	30200753.0	C	T
pharmgkb	morphine	SULT1A3	R9C			Metabolism/PK	P0DMM9	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	16	30200753.0	C	T
pharmgkb	tapentadol	SULT1A3	R9C			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	30200753.0	C	T
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	R9C			Metabolism/PK	P0DMM9				16	30200753.0	C	T
pharmgkb	acetaminophen	SULT1A3	V15M			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	30200771.0	G	A
pharmgkb	tapentadol	SULT1A3	V15M			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	30200771.0	G	A
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	V15M			Metabolism/PK	P0DMM9				16	30200771.0	G	A
pharmgkb	acetaminophen	SULT1A3	V18F			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	30200780.0	G	T
pharmgkb	morphine	SULT1A3	V18F			Metabolism/PK	P0DMM9	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	16	30200780.0	G	T
pharmgkb	tapentadol	SULT1A3	V18F			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	30200780.0	G	T
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	V18F			Metabolism/PK	P0DMM9				16	30200780.0	G	T
pharmgkb	acetaminophen	SULT1A3	P101L			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	30201223.0	C	W
pharmgkb	morphine	SULT1A3	P101L			Metabolism/PK	P0DMM9	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	16	30201223.0	C	W
pharmgkb	tapentadol	SULT1A3	P101L			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	30201223.0	C	W
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	P101L			Metabolism/PK	P0DMM9				16	30201223.0	C	W
pharmgkb	acetaminophen	SULT1A3	R144C			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	30202747.0	C	T
pharmgkb	morphine	SULT1A3	R144C			Metabolism/PK	P0DMM9	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	16	30202747.0	C	T
pharmgkb	tapentadol	SULT1A3	R144C			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	30202747.0	C	T
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	R144C			Metabolism/PK	P0DMM9				16	30202747.0	C	T
pharmgkb	acetaminophen	SULT1A3	K234N			Metabolism/PK	P0DMM9	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	30203612.0	G	W
pharmgkb	morphine	SULT1A3	K234N			Metabolism/PK	P0DMM9	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	16	30203612.0	G	W
pharmgkb	tapentadol	SULT1A3	K234N			Metabolism/PK	P0DMM9	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	30203612.0	G	W
pharmgkb	o-desmethyltramadol,tramadol	SULT1A3	K234N			Metabolism/PK	P0DMM9				16	30203612.0	G	W
pharmgkb	oxcarbazepine	ABCB1	I1145M		Epilepsy	Efficacy,Metabolism/PK	P08183	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	7	87509329.0	A	K
pharmgkb	levetiracetam	HLA-A	HLA-A*11:01		adverse events,Epilepsy	Toxicity	P04439	Drug	441341.0	CC[C@H](C(=O)N)N1CCCC1=O				
pharmgkb	bupropion	ANKK1	E713K		Tobacco Use Disorder	Efficacy	Q8NFD2	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	11	113400106.0	G	A
pharmgkb	interferon beta-1a,interferon beta-1b	IRF6	rs2205986		drug-induced liver injury,Multiple Sclerosis	Toxicity	O14896				1	209942767.0	G	A
pharmgkb	losartan	ABCB1	I1145M		Hypertension	Efficacy	P08183	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	7	87509329.0	A	K
pharmgkb	pioglitazone	CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3			Other	P10632	Drug	4829.0	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3				
pharmgkb	carboplatin,docetaxel,trastuzumab	BARD1	rs2070096		Breast Neoplasms	Efficacy	Q99728				2	214780821.0	C	D
pharmgkb	fluorouracil,irinotecan,leucovorin	ABCG2	rs7699188		Colorectal Neoplasms	Efficacy,Toxicity	Q9UNQ0				4	88174909.0	G	M
pharmgkb	carboplatin,docetaxel,trastuzumab	ERBB3	rs2229046		Breast Neoplasms	Efficacy	P21860				12	56093417.0	T	C
pharmgkb	carboplatin,docetaxel,trastuzumab	RNF8	rs2284922		Breast Neoplasms	Efficacy	O76064				6	37381257.0	G	A
pharmgkb	carboplatin,docetaxel,trastuzumab	ERBB3	S1119C		Breast Neoplasms	Efficacy	P21860				12	56101214.0	A	T
pharmgkb	carboplatin,docetaxel,trastuzumab	ERBB2	I655V		Breast Neoplasms	Efficacy	P04626				17	39723335.0	A	K
pharmgkb	etanercept	TNFRSF1B	M196R		Spondylitis, Ankylosing	Efficacy	Q12933	Drug			1	12192898.0	T	G
pharmgkb	fentanyl	UGT2B7	rs4587017		Pain, Postoperative	Efficacy	P16662	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	4	69081680.0	T	G
pharmgkb	fentanyl	UGT2B7	rs10028494		Pain, Postoperative	Efficacy	P16662	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	4	69105219.0	A	C
pharmgkb	fentanyl	ABCB1	I1145M		Pain, Postoperative,Respiratory Insufficiency	Toxicity	P08183	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	87509329.0	A	K
pharmgkb	fentanyl	ABCB1	S893A		Pain, Postoperative,Respiratory Insufficiency	Toxicity	P08183	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	87531302.0	A	Y
pharmgkb	fentanyl	ABCB1	rs1128503		Pain, Postoperative,Respiratory Insufficiency	Toxicity	P08183	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	87550285.0	A	G
pharmgkb	fentanyl	ATF2	rs7583431		Pain, Postoperative	Efficacy	P15336	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	2	175057654.0	A	C
pharmgkb	opioids	IL17A	rs2275913		Pain, Postoperative	Dosage	Q16552	Drug Class			6	52186235.0	G	A
pharmgkb	fentanyl	ABCB1	S893A		Neoplasms,Pain	Toxicity	P08183	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	87531302.0	A	Y
pharmgkb	anastrozole,letrozole	ESR1	rs9340799		Neoplasms	Toxicity	P03372				6	151842246.0	A	G
pharmgkb	acetylcysteine	TOLLIP	rs3750920		Pulmonary Fibrosis	Efficacy	Q9H0E2	Drug	12035.0	CC(=O)N[C@@H](CS)C(=O)O	11	1288726.0	C	T
pharmgkb	cangrelor	P2RY12	rs6787801			Efficacy	Q9H244	Drug	9854012.0	CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F	3	151381953.0	A	G
pharmgkb	Opioid anesthetics,Other general anesthetics,volatile anesthetics	OPRM1	N40D			Efficacy	P35372				6	154039662.0	A	G
pharmgkb	Opioid anesthetics,Other general anesthetics,volatile anesthetics	ABCG2	Q141K			Efficacy	Q9UNQ0				4	88131171.0	G	Y
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	CYP1B1	L432V		Breast Neoplasms	Toxicity	Q16678				2	38071060.0	G	C
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ABCG2	Q141K		Breast Neoplasms	Toxicity	Q9UNQ0				4	88131171.0	G	Y
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	SLC22A16	rs6907567		Breast Neoplasms	Efficacy,Toxicity	Q86VW1				6	110456759.0	A	G
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	SLC22A16	H49R		Breast Neoplasms	Efficacy,Toxicity	Q86VW1				6	110456925.0	T	C
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	CYP2C19	rs12248560		Breast Neoplasms	Toxicity	P33261				10	94761900.0	C	W
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	CYP2C19	rs4244285		Breast Neoplasms	Toxicity	P33261				10	94781859.0	G	M
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ABCC2	V417I		Breast Neoplasms	Toxicity	Q5T2W1				10	99804058.0	G	A
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ABCC2	I1324M		Breast Neoplasms	Toxicity	Q5T2W1				10	99844450.0	C	K
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ATM	D1853N		Breast Neoplasms	Toxicity	Q13315				11	108304735.0	G	A
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ALDH3A1	P329S		Breast Neoplasms	Toxicity	P30838				17	19739639.0	G	C
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ERCC1	Q506K		Breast Neoplasms	Toxicity	P07992				19	45409478.0	C	D
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ERCC1	rs11615		Breast Neoplasms	Toxicity	P07992				19	45420395.0	A	G
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	CBR1	rs20572		Breast Neoplasms	Toxicity	P16152				21	36072675.0	C	T
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	XRCC1	Q399R		Breast Neoplasms	Toxicity	P18887				19	43551574.0	T	C
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	GSTP1	I105V		Breast Neoplasms	Toxicity	P09211				11	67585218.0	A	G
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ABCB1	I1145M		Breast Neoplasms	Toxicity	P08183				7	87509329.0	A	K
pharmgkb	lamotrigine	HLA-B	HLA-B*44:03		Maculopapular Exanthema	Toxicity	P01889	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N				
pharmgkb	stavudine	SAMHD1	rs8124728		HIV Infections,Peripheral Nervous System Diseases	Toxicity	Q9Y3Z3	Drug	18283.0	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO	20	36892303.0	G	A
pharmgkb	tacrolimus	CYP3A5	rs15524		Kidney Transplantation,liver transplantation	Metabolism/PK	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99648291.0	A	G
pharmgkb	tacrolimus	CYP3A5	rs4646450		Kidney Transplantation,liver transplantation	Metabolism/PK	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99668695.0	G	A
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		Kidney Transplantation	Toxicity	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	simvastatin	KIF6	W170R		Hypercholesterolemia	Efficacy	Q6ZMV9	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	6	39357302.0	A	G
pharmgkb	rosuvastatin	KIF6	W170R		Hypercholesterolemia	Efficacy	Q6ZMV9	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	6	39357302.0	A	G
pharmgkb	tacrolimus	ABCB1	N21H		Kidney Transplantation,lung transplantation	Metabolism/PK	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87600124.0	T	C
pharmgkb	tacrolimus	ABCB1	S400N		Kidney Transplantation	Efficacy	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87550493.0	C	W
pharmgkb	tacrolimus	NR1I2	rs2276707		Kidney Transplantation	Metabolism/PK	O75469	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	3	119815306.0	C	K
pharmgkb	tacrolimus	NR1I2	rs3814055			Metabolism/PK	O75469	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	3	119781188.0	C	T
pharmgkb	cetuximab	RASSF1	rs2236947		Colorectal Neoplasms	Efficacy	Q9NS23	Drug			3	50334001.0	C	A
pharmgkb	duloxetine	ZNF385D	rs4261893		Depressive Disorder, Major	Efficacy	Q9H6B1	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	3	21753382.0	C	K
pharmgkb	duloxetine	KMT2E	G999C		Depressive Disorder, Major	Efficacy	Q8IZD2	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	7	105107452.0	G	T
pharmgkb	duloxetine	NCAM1	rs2303377		Depressive Disorder, Major	Efficacy	P13591	Drug	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	11	113240779.0	T	C
pharmgkb	phenazepam	CYP2C19	rs12248560		Alcoholism	Efficacy	P33261	Drug	40113.0	C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3Cl	10	94761900.0	C	W
pharmgkb	atorvastatin	CYP3A5	rs17161788		Hypercholesterolemia	Efficacy	P20815	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	99648286.0	T	C
pharmgkb	codeine	ABCB1	I1145M			Toxicity	P08183	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	7	87509329.0	A	K
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	IL6	rs1800795		Psoriasis	Efficacy	P05231	Drug Class			7	22727026.0	C	G
pharmgkb	methotrexate	ATIC	T116S		Arthritis, Rheumatoid	Efficacy	P31939	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	2	215325297.0	C	G
pharmgkb	methotrexate	ITPA	P32T		Arthritis, Rheumatoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy,Toxicity	Q9BY32	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	20	3213196.0	C	R
pharmgkb	cetuximab	FCGR2A	H166P		Colorectal Neoplasms,Head and Neck Neoplasms	Efficacy	P08631	Drug			1	161509955.0	A	S
pharmgkb	cetuximab	FCGR3A	F175V		Neoplasms	Efficacy	P20963	Drug			1	161544752.0	A	B
pharmgkb	bevacizumab,carboplatin,cisplatin,cyanocobalamin,folic acid,pemetrexed	MTHFR	E429A		Neoplasms	Efficacy	P42898				1	11794419.0	T	G
pharmgkb	carboplatin,cisplatin	MTR	D919G		Neoplasms	Efficacy,Toxicity	Q13613				1	236885200.0	A	G
pharmgkb	Platinum compounds	MDM2	rs1690924		Carcinoma, Non-Small-Cell Lung	Efficacy	Q00987	Drug Class			12	68811541.0	T	C
pharmgkb	Platinum compounds	XRCC1	R194W		Carcinoma, Non-Small-Cell Lung	Efficacy	P18887	Drug Class			19	43553422.0	G	A
pharmgkb	Platinum compounds	SLC19A1	H27R		Carcinoma, Non-Small-Cell Lung	Efficacy	P41440	Drug Class			21	45537880.0	T	S
pharmgkb	oxaliplatin	PIN1	rs2233678		Colorectal Neoplasms	Efficacy	Q13526	Drug	6857599.0	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	19	9834503.0	G	M
pharmgkb	irinotecan	PIN1	rs2233678		Colorectal Neoplasms	Efficacy	Q13526	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	19	9834503.0	G	M
pharmgkb	dapsone	HLA-DRB1	M171L		Drug Hypersensitivity	Toxicity	P01911	Drug	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	6	32581698.0	T	C
pharmgkb	dapsone	HLA-DRB1	S133L		Drug Hypersensitivity	Toxicity	P01911	Drug	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	6	32581811.0	G	A
pharmgkb	dapsone	HLA-DRB1	rs17211071		Drug Hypersensitivity	Toxicity	P01911	Drug	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	6	32589759.0	G	A
pharmgkb	dapsone	HLA-DRB1	HLA-DRB1*15:01, HLA-DRB1*16:02		Drug Hypersensitivity	Toxicity	P01911	Drug	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N				
pharmgkb	dapsone	HLA-A	HLA-A*24:02		Drug Hypersensitivity	Toxicity	P04439	Drug	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N				
pharmgkb	risperidone	UGT1A1	rs10929302		Hyperprolactinemia	Toxicity	P22309	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	2	233757136.0	G	A
pharmgkb	risperidone	UGT1A1	rs1976391		Hyperprolactinemia	Toxicity	P22309	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	2	233757337.0	A	G
pharmgkb	risperidone	UGT1A1	rs887829		Hyperprolactinemia	Toxicity	P22309	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	2	233759924.0	C	T
pharmgkb	hydrochlorothiazide	NEDD4L	rs4149601		Hypertension	Efficacy	Q96PU5	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	18	58149559.0	G	A
pharmgkb	fluorouracil	XRCC1	Q399R		Colonic Neoplasms,Colorectal Neoplasms,Neoplasms,Rectal Neoplasms,Uterine Cervical Neoplasms	Efficacy	P18887	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	19	43551574.0	T	C
pharmgkb	fluorouracil,leucovorin,oxaliplatin	ERCC1	rs11615		Colorectal Neoplasms	Efficacy	P07992				19	45420395.0	A	G
pharmgkb	bumetanide,furosemide,torasemide	ACE	rs1799752			Efficacy	P12821				17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	clonidine	ADRA2C	rs11269124		Liver Cirrhosis	Efficacy	P18825	Drug	2803.0	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	4	3768063.0	-	GGGGAGCTTTCCCAGAGACCC
pharmgkb	docetaxel	VEGFA	rs144854329		Breast Neoplasms	Efficacy	P15692	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	6	43768679.0	GGTCCCACTCTTCCCACA	-
pharmgkb	benazepril,perindopril	ACE	rs1799752		Diabetes Mellitus	Efficacy	P12821				17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	thioridazine	CYP2D6	rs1080985			Other	P10635	Drug	5452.0	CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC	22	42132375.0	G	M
pharmgkb	antipsychotics	CYP2D6	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*14		Dystonia	Toxicity	P10635	Drug Class						
pharmgkb	chlorthalidone,lisinopril	MMP3	rs35068180		Hypertension	Efficacy	P08254				11	102845217.0	-	M
pharmgkb	pravastatin	MMP3	rs35068180		Coronary Artery Disease	Efficacy	P08254	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	11	102845217.0	-	M
pharmgkb	ceftriaxone	ABCG2	rs13120400		Central Nervous System Infections	Metabolism/PK	Q9UNQ0	Drug	5479530.0	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O	4	88112375.0	T	C
pharmgkb	ceftriaxone	ABCC2	V417I		Central Nervous System Infections	Metabolism/PK	Q5T2W1	Drug	5479530.0	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O	10	99804058.0	G	A
pharmgkb	methotrexate	UGT1A1	rs4148324		Osteosarcoma	Metabolism/PK	P22309	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	2	233764076.0	T	G
pharmgkb	methotrexate	ABCG2	rs12505410		Osteosarcoma	Metabolism/PK	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88109689.0	T	S
pharmgkb	methotrexate	ABCG2	rs13120400		Osteosarcoma	Metabolism/PK	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88112375.0	T	C
pharmgkb	methotrexate	ABCG2	rs13137622		Osteosarcoma	Metabolism/PK	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88141361.0	G	T
pharmgkb	ethanol	DRD2	E713K		Alcoholism,Substance-Related Disorders	Toxicity	P14416	Drug	702.0	CCO	11	113400106.0	G	A
pharmgkb	nevirapine	CYCSP5	rs3099844		Acquired Immunodeficiency Syndrome	Toxicity		Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	6	31481199.0	C	A
pharmgkb	ondansetron	CYP3A5	rs776746			Other	P20815	Drug	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	7	99672916.0	T	C
pharmgkb	tacrolimus	ABCB1	S893A		Nephrotic Syndrome	Efficacy	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87531302.0	A	Y
pharmgkb	tacrolimus	ABCB1	rs1128503		Nephrotic Syndrome	Efficacy	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87550285.0	A	G
pharmgkb	acamprosate	GRIN2B	rs2058878		Alcoholism	Efficacy	Q8TB68	Drug	71158.0	CC(=O)NCCCS(=O)(=O)O	12	13800184.0	T	M
pharmgkb	tocilizumab	FCGR3A	F175V		Arthritis, Rheumatoid	Efficacy	P20963	Drug			1	161544752.0	A	B
pharmgkb	rituximab	FCGR2A	H166P		Arthritis, Rheumatoid	Efficacy	P08631	Drug			1	161509955.0	A	S
pharmgkb	maraviroc	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7		HIV Infections	Efficacy,Metabolism/PK	P20815	Drug	3002977.0	CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C				
pharmgkb	Drugs For Treatment Of Tuberculosis,rifampin	RIPOR2	rs10946737		Tuberculosis	Toxicity	Q9Y4F9				6	24967012.0	G	A
pharmgkb	levodopa	SLC6A3	rs3836790		Parkinson Disease	Efficacy	Q01959	Drug, Biological Intermediate	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	5	1411741.0	-	
pharmgkb	methadone	OPRM1	V214I		Heroin Dependence	Efficacy	P35372	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	6	152994560.0	C	T
pharmgkb	morphine	IL1B	rs1143634		Pain, Postoperative	Dosage,Efficacy	P01584	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	2	112832813.0	G	A
pharmgkb	morphine	IL1B	rs1143634		Pain, Postoperative	Dosage,Efficacy	P01584	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	2	112832813.0	G	A
pharmgkb	imatinib	UGT2A1	rs11249454		Gastrointestinal Stromal Tumors	Toxicity	P0DTE4	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	4	69633516.0	T	C
pharmgkb	imatinib	ABCB4	rs1202283		Gastrointestinal Stromal Tumors	Efficacy	P21439	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	7	87452976.0	G	A
pharmgkb	imatinib	ABCC2	V417I		Gastrointestinal Stromal Tumors	Efficacy	Q5T2W1	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	10	99804058.0	G	A
pharmgkb	imatinib	CHST1	rs9787901		Gastrointestinal Stromal Tumors	Toxicity	O43916	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	11	45674603.0	G	M
pharmgkb	imatinib	NQO1	rs10517		Gastrointestinal Stromal Tumors	Efficacy	P15559	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	16	69709857.0	A	K
pharmgkb	imatinib	CYP2F1	rs305968		Gastrointestinal Stromal Tumors	Toxicity	P24903	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	19	41116284.0	G	W
pharmgkb	imatinib	SLC19A1	rs12659		Gastrointestinal Stromal Tumors	Toxicity	P41440	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	21	45531642.0	A	G
pharmgkb	imatinib	SLC19A1	H27R		Gastrointestinal Stromal Tumors	Toxicity	P41440	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	21	45537880.0	T	S
pharmgkb	gemcitabine	CDA	rs471760		Neutropenia,Pancreatic Neoplasms	Toxicity	Q96GN5	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	20590713.0	G	A
pharmgkb	gemcitabine	SLC28A1	rs3825876		Neutropenia,Pancreatic Neoplasms	Toxicity	O00337	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	15	84892637.0	G	A
pharmgkb	gemcitabine	SLC28A1	rs12148896		Neutropenia,Pancreatic Neoplasms	Toxicity	O00337	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	15	84891963.0	G	A
pharmgkb	morphine	KCNJ6	rs6517442		Pain	Efficacy	P48051	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	21	37917643.0	C	T
pharmgkb	acetaminophen	TRPV1	T469I		Pain	Efficacy	Q8NER1	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	17	3583408.0	G	A
pharmgkb	acetaminophen	UGT2B15	Y85D		Pain	Efficacy	P54855	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	4	68670366.0	A	C
pharmgkb	methylphenidate	ABCB1	S893A		Attention Deficit Disorder with Hyperactivity	Toxicity	P08183	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	7	87531302.0	A	Y
pharmgkb	methylphenidate	TH	rs2070762		Attention Deficit Disorder with Hyperactivity	Efficacy	P07101	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	11	2165105.0	A	G
pharmgkb	methylphenidate	DRD2	rs2283265		Attention Deficit Disorder with Hyperactivity	Toxicity	P14416	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	11	113414814.0	C	A
pharmgkb	bleomycin,cisplatin,etoposide	ABCB1	I1145M		Testicular Neoplasms,Vomiting	Toxicity	P08183				7	87509329.0	A	K
pharmgkb	bleomycin,cisplatin,etoposide	CYP3A	rs2740574		Alopecia,Testicular Neoplasms	Toxicity	Q9HB55				7	99784473.0	C	T
pharmgkb	bleomycin,cisplatin,etoposide	GSTP1	I105V		Infection,Nausea,Testicular Neoplasms	Toxicity	P09211				11	67585218.0	A	G
pharmgkb	bleomycin,cisplatin,etoposide	BLMH	I443V		Alopecia,Pain,Testicular Neoplasms	Toxicity	Q13867				17	30249058.0	T	C
pharmgkb	bleomycin,cisplatin,etoposide	ERCC2	rs13181		Alopecia,Testicular Neoplasms	Toxicity	P18074				19	45351661.0	T	R
pharmgkb	bleomycin,cisplatin,etoposide	ERCC2	D312N		Anemia,Testicular Neoplasms	Toxicity	P18074				19	45364001.0	C	W
pharmgkb	bleomycin,cisplatin,etoposide	ERCC2	rs238406		Leukopenia,Testicular Neoplasms	Toxicity	P18074				19	45365051.0	T	G
pharmgkb	bleomycin,cisplatin,etoposide	ERCC1	Q506K		Testicular Neoplasms,Vomiting	Toxicity	P07992				19	45409478.0	C	D
pharmgkb	bleomycin,cisplatin,etoposide	ERCC1	rs11615		febrile neutropenia,Testicular Neoplasms	Toxicity	P07992				19	45420395.0	A	G
pharmgkb	tramadol	ABCB1	I1145M			Metabolism/PK	P08183	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	7	87509329.0	A	K
pharmgkb	tramadol	ABCB1	S893A			Metabolism/PK	P08183	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	7	87531302.0	A	Y
pharmgkb	allopurinol	NTNG1	rs61816456			Efficacy	Q9Y2I2	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	1	105853440.0	G	A
pharmgkb	allopurinol	GREM2	rs77567654			Efficacy	Q9H772	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	1	240549089.0	A	G
pharmgkb	allopurinol	GREM2	rs10802887			Efficacy	Q9H772	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	1	240550730.0	A	G
pharmgkb	allopurinol	GREM2	rs1934341			Efficacy	Q9H772	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	1	240558252.0	C	K
pharmgkb	allopurinol	GREM2	rs4659982			Efficacy	Q9H772	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	1	240566955.0	T	M
pharmgkb	allopurinol	MYT1L	rs79663562			Efficacy	Q9UL68	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	2	2269048.0	T	C
pharmgkb	allopurinol	TRIB2	rs10193126			Efficacy	Q92519	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	2	14177682.0	T	C
pharmgkb	allopurinol	TBL1XR1	rs57449396			Efficacy	Q9BZK7	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	3	176534890.0	C	T
pharmgkb	allopurinol	PKD2	rs2725215			Efficacy	Q13563	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	4	88040419.0	C	T
pharmgkb	allopurinol	ABCG2	rs4148157			Efficacy	Q9UNQ0	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	4	88099782.0	G	A
pharmgkb	allopurinol	ABCG2	rs76979899			Efficacy	Q9UNQ0	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	4	88104089.0	C	T
pharmgkb	allopurinol	ABCG2	rs4148155			Efficacy	Q9UNQ0	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	4	88133515.0	A	G
pharmgkb	allopurinol	HLA-C	rs9366772			Efficacy	P10321	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31261561.0	G	A
pharmgkb	morphine	TAOK3	rs795484		Pain, Postoperative	Dosage,Efficacy	Q9H2K8	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	12	118152057.0	T	C
pharmgkb	morphine	TAOK3	rs1277441		Pain, Postoperative	Dosage,Efficacy	Q9H2K8	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	12	118168184.0	G	M
pharmgkb	tacrolimus	KCNJ11	K23Q		Diabetes Mellitus, Type 2	Toxicity	Q14654	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	11	17388025.0	T	M
pharmgkb	phenytoin	CFHR4	rs78239784		Maculopapular Exanthema	Toxicity	Q92496	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	1	196899970.0	T	G
pharmgkb	methylphenidate	SLC6A2	rs28386840		Attention Deficit Disorder with Hyperactivity	Efficacy	P23975	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	16	55652906.0	T	M
pharmgkb	isoniazid,phenytoin	NAT2	rs1041983		Drug interaction with drug,Drug Toxicity	Toxicity	Q6N069				8	18400285.0	C	T
pharmgkb	isoniazid,phenytoin	NAT2	I114T		Drug interaction with drug,Drug Toxicity	Toxicity	Q6N069				8	18400344.0	T	C
pharmgkb	isoniazid,phenytoin	NAT2	rs1799929		Drug interaction with drug,Drug Toxicity	Toxicity	Q6N069				8	18400484.0	C	T
pharmgkb	isoniazid,phenytoin	NAT2	R197Q		Drug interaction with drug,Drug Toxicity	Toxicity	Q6N069				8	18400593.0	G	A
pharmgkb	isoniazid,phenytoin	NAT2	R268I		Drug interaction with drug,Drug Toxicity	Toxicity	Q6N069				8	18400806.0	G	W
pharmgkb	isoniazid,phenytoin	NAT2	G286E		Drug interaction with drug,Drug Toxicity	Toxicity	Q6N069				8	18400860.0	G	A
pharmgkb	cyclosporine,sirolimus,tacrolimus	TCF7L2	rs7903146		Kidney Transplantation,liver transplantation	Toxicity	P35222				10	112998590.0	C	K
pharmgkb	tacrolimus	TCF7L2	rs290487		liver transplantation	Toxicity	P35222	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	10	113149972.0	C	T
pharmgkb	nevirapine	HLA-B	HLA-B*57:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	sulfonamides, urea derivatives	ABCC8	A1369S		Diabetes Mellitus	Efficacy	Q09428	Drug Class			11	17396930.0	C	W
pharmgkb	heroin	OPRM1	rs2075572		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154090869.0	G	C
pharmgkb	nicotine	COMT	V158M		Tobacco Use Disorder	Toxicity	P21964	Drug	942.0	CN1CCCC1C2=CN=CC=C2	22	19963748.0	G	A
pharmgkb	heroin	OPRM1	rs9479757		Heroin Dependence	Dosage	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154090209.0	G	A
pharmgkb	nicotine	DRD2	E713K		Tobacco Use Disorder	Toxicity	P14416	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113400106.0	G	A
pharmgkb	sibutramine	GNB3	rs5443		Obesity	Efficacy	P16520	Drug	5210.0	CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C	12	6845711.0	C	T
pharmgkb	methamphetamine	OPRM1	rs2075572		methamphetamine dependence	Toxicity	P35372	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	6	154090869.0	G	C
pharmgkb	ethanol	OPRM1	rs511435		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154047412.0	C	K
pharmgkb	ethanol	OPRM1	rs524731		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154053957.0	C	A
pharmgkb	cocaine	OPRM1	rs524731		Cocaine-Related Disorders	Toxicity	P35372	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	6	154053957.0	C	A
pharmgkb	ethanol	OPRM1	rs3823010		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154058017.0	G	A
pharmgkb	cocaine	OPRM1	rs3823010		Cocaine-Related Disorders	Toxicity	P35372	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	6	154058017.0	G	A
pharmgkb	ethanol	OPRM1	rs3778156		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154083178.0	A	G
pharmgkb	opioids	OPRM1	rs3778156		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154083178.0	A	G
pharmgkb	opioids	OPRM1	rs609148		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154109880.0	G	A
pharmgkb	cocaine	OPRM1	rs495491		Cocaine-Related Disorders	Toxicity	P35372	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	6	154061407.0	A	G
pharmgkb	opioids	OPRM1	rs548646		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154097012.0	T	C
pharmgkb	opioids	OPRM1	rs648893		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154117494.0	A	G
pharmgkb	disopyramide	KCNH2	N588K		short qt syndrome 1	Efficacy	Q12809	Drug	3114.0	CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C	7	150951629.0	G	Y
pharmgkb	quinidine	KCNH2	N588K		short qt syndrome 1	Efficacy	Q12809	Drug	441074.0	COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	7	150951629.0	G	Y
pharmgkb	ethanol	CYP2E1	rs2031920		Alcoholism	Toxicity	P05181	Drug	702.0	CCO	10	133526341.0	C	T
pharmgkb	ethanol	CHRNA4	C226W		Alcoholism	Toxicity	P43681	Drug	702.0	CCO	20	63350733.0	A	G
pharmgkb	nicotine	OPRM1	N40D		Tobacco Use Disorder	Efficacy	P35372	Drug	942.0	CN1CCCC1C2=CN=CC=C2	6	154039662.0	A	G
pharmgkb	bupropion	CYP2B6	CYP2B6*1, CYP2B6*6		Tobacco Use Disorder	Efficacy	P20813	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C				
pharmgkb	heroin	OPRK1	rs1051660		Heroin Dependence	Toxicity	P41145	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	8	53251002.0	C	W
pharmgkb	nicotine	CYP2B6	K262R		Tobacco Use Disorder	Metabolism/PK	P20813	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	41009358.0	A	G
pharmgkb	cotinine,nicotine	CYP2B6	CYP2B6*1, CYP2B6*6		Tobacco Use Disorder	Metabolism/PK	P20813							
pharmgkb	ethanol	OPRM1	rs553202			Efficacy	P35372	Drug	702.0	CCO	6	154043682.0	C	T
pharmgkb	ethanol	OPRM1	rs524731			Efficacy	P35372	Drug	702.0	CCO	6	154053957.0	C	A
pharmgkb	ethanol	OPRM1	rs548646			Efficacy	P35372	Drug	702.0	CCO	6	154097012.0	T	C
pharmgkb	ethanol	OPRM1	rs648007			Efficacy	P35372	Drug	702.0	CCO	6	154101476.0	A	G
pharmgkb	ethanol	OPRM1	rs3778148			Efficacy	P35372	Drug	702.0	CCO	6	154059877.0	G	T
pharmgkb	ethanol	OPRM1	rs1461773			Efficacy	P35372	Drug	702.0	CCO	6	154070234.0	G	A
pharmgkb	ethanol	OPRM1	rs2075572			Efficacy	P35372	Drug	702.0	CCO	6	154090869.0	G	C
pharmgkb	ethanol	OPRM1	rs681243			Efficacy	P35372	Drug	702.0	CCO	6	154106606.0	T	C
pharmgkb	heroin	GAL	rs694066		Heroin Dependence	Toxicity	P07902	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	11	68685517.0	G	A
pharmgkb	heroin	HTR3B	rs3758987		Heroin Dependence	Toxicity	O95264	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	11	113904553.0	T	C
pharmgkb	heroin	OPRK1	rs6473797		Heroin Dependence	Toxicity	P41145	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	8	53240422.0	T	C
pharmgkb	heroin	CSNK1E	rs1534891		Heroin Dependence	Toxicity	P49674	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	22	38299094.0	T	C
pharmgkb	nicotine	DRD2	rs6277			Efficacy	P14416	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113412737.0	G	A
pharmgkb	nimodipine	CYP3A5	CYP3A5*1, CYP3A5*3			Metabolism/PK	P20815	Drug	4497.0	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC				
pharmgkb	nimodipine	CACNA1C	rs2239128			Efficacy	P54284	Drug	4497.0	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC	12	2648603.0	T	C
pharmgkb	dextropropoxyphene	CYP3A5	CYP3A5*1, CYP3A5*3			Metabolism/PK	P20815	Drug	441275.0					
pharmgkb	nicotine	CHRNA7	rs2337980			Efficacy	P36544	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	32151995.0	C	T
pharmgkb	ethanol	CRHBP	rs10055255		Alcoholism	Toxicity	P24387	Drug	702.0	CCO	5	76968168.0	A	T
pharmgkb	bupropion	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Tobacco Use Disorder	Efficacy	P31645	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C				
pharmgkb	nicotine	ANKK1	E713K		Tobacco Use Disorder	Toxicity	Q8NFD2	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113400106.0	G	A
pharmgkb	nicotine	CYP2A13	rs1709083		Tobacco Use Disorder	Toxicity	Q16696	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	41095991.0	C	D
pharmgkb	nicotine	CYP2A13	rs72552266		Tobacco Use Disorder	Toxicity	Q16696	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	41089049.0	C	K
pharmgkb	nicotine	CYP2A6	rs28399433		Tobacco Use Disorder	Toxicity	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40850474.0	A	B
pharmgkb	nicotine	CYP2B6	CYP2B6*1, CYP2B6*4		Tobacco Use Disorder	Toxicity	P20813	Drug	942.0	CN1CCCC1C2=CN=CC=C2				
pharmgkb	nicotine	HTR3B	rs3758987		Tobacco Use Disorder	Toxicity	O95264	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113904553.0	T	C
pharmgkb	nicotine	HTR3B	rs11606194		Tobacco Use Disorder	Toxicity	O95264	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113910259.0	T	C
pharmgkb	bupropion	CYP2B6	rs8109525		Tobacco Use Disorder	Efficacy	P20813	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	19	40986013.0	A	G
pharmgkb	varenicline	HYKK	rs7164594		Tobacco Use Disorder	Efficacy	A2RU49	Drug	5310966.0	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	15	78510715.0	C	T
pharmgkb	methamphetamine	BDNF	V66M		methamphetamine dependence	Toxicity	P23560	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	11	27658369.0	C	T
pharmgkb	modafinil	COMT	V158M		methamphetamine dependence	Efficacy	P21964	Drug	4236.0	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	22	19963748.0	G	A
pharmgkb	highly active antiretroviral therapy (haart)	OPRM1	rs671531		HIV Infections	Efficacy	P35372	Drug Class			6	154119607.0	A	K
pharmgkb	l-methylfolate,Vitamin B-complex, Incl. Combinations	MTHFR	E429A		Depressive Disorder, Major	Efficacy	P42898				1	11794419.0	T	G
pharmgkb	l-methylfolate,Vitamin B-complex, Incl. Combinations	MTHFR	A222V		Depressive Disorder, Major	Efficacy	P42898				1	11796321.0	G	A
pharmgkb	ethanol	DRD2	E713K			Dosage	P14416	Drug	702.0	CCO	11	113400106.0	G	A
pharmgkb	cocaine	OPRM1	rs2236256		Cocaine-Related Disorders	Toxicity	P35372	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	6	154157305.0	C	A
pharmgkb	cocaine	GABRA2	rs11503014		Cocaine-Related Disorders	Toxicity	P47869	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	4	46388848.0	C	G
pharmgkb	bupropion	ACE	rs8075924		Depressive Disorder, Major	Efficacy	P12821	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	17	63505531.0	C	T
pharmgkb	bupropion	HTR2A	rs2770296		Depressive Disorder, Major	Efficacy	P28223	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	13	46866425.0	C	T
pharmgkb	bupropion	DBH	rs2873804		Depressive Disorder, Major	Efficacy	Q6UVY6	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	9	133640522.0	T	C
pharmgkb	bupropion	SLC18A2	rs363225		Depressive Disorder, Major	Efficacy	Q05940	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	10	117264991.0	C	W
pharmgkb	bupropion	SLC18A2	rs363226		Depressive Disorder, Major	Efficacy	Q05940	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	10	117265701.0	G	Y
pharmgkb	bupropion	FKBP5	rs17614642		Depressive Disorder, Major	Efficacy	Q13451	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	6	35654144.0	T	C
pharmgkb	pitavastatin	ABCC2	rs717620			Metabolism/PK	Q5T2W1	Drug	5282452.0		10	99782821.0	C	T
pharmgkb	pioglitazone	PPARG	P12A		Diabetes Mellitus, Type 2	Efficacy	P37231	Drug	4829.0	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	3	12351626.0	C	G
pharmgkb	pioglitazone	PTPRD	rs17584499		Diabetes Mellitus, Type 2	Efficacy	P23468	Drug	4829.0	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	9	8879118.0	C	T
pharmgkb	risperidone	PPA2	rs2636697		Schizophrenia	Efficacy	Q9H2U2	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	4	105376356.0	G	M
pharmgkb	risperidone	TJP1	rs813676		Schizophrenia	Efficacy	Q07157	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	15	29901113.0	T	M
pharmgkb	olanzapine	ATP1A2	rs6688363		Schizophrenia	Efficacy	P50993	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	1	160108064.0	C	T
pharmgkb	olanzapine	SPOPL	rs10170310		Schizophrenia	Efficacy	Q6IQ16	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	2	138521352.0	G	M
pharmgkb	risperidone	TNFRSF11A	rs2980976		Schizophrenia	Efficacy	Q9Y6Q6	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	18	62412879.0	G	A
pharmgkb	quetiapine	PDE4D	rs17382202		Schizophrenia	Efficacy	Q08499	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	5	59684120.0	C	T
pharmgkb	quetiapine	MIR582	rs17742120		Schizophrenia	Efficacy		Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	5	59703216.0	A	G
pharmgkb	risperidone	TJP1	rs711355		Schizophrenia	Efficacy	Q07157	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	15	29901265.0	T	C
pharmgkb	risperidone	TJP1	rs785423		Schizophrenia	Efficacy	Q07157	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	15	29882173.0	A	G
pharmgkb	risperidone	PPA2	rs2636719		Schizophrenia	Efficacy	Q9H2U2	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	4	105432212.0	A	C
pharmgkb	everolimus	RPTOR	rs9906827		pneumonitis,progression-free survival	Efficacy,Toxicity	Q8N122	Drug	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	17	80691605.0	C	W
pharmgkb	prochlorperazine	ANKK1	E713K		Nausea	Efficacy	Q8NFD2	Drug	4917.0	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	11	113400106.0	G	A
pharmgkb	prochlorperazine	DRD2	rs1079597		Nausea	Efficacy	P14416	Drug	4917.0	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	11	113425564.0	C	T
pharmgkb	nicotine	CHRNA4	rs6090378		Tobacco Use Disorder	Toxicity	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63344026.0	A	G
pharmgkb	nicotine	CHRNA4	rs3787138		Tobacco Use Disorder	Toxicity	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63347872.0	G	A
pharmgkb	nicotine	CHRNA4	rs3787140		Tobacco Use Disorder	Toxicity	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63357759.0	T	C
pharmgkb	amiloride,spironolactone	CYP4A11	F402S		Hypertension	Efficacy	Q02928				1	46932824.0	A	G
pharmgkb	spironolactone	CYP4A11	rs3890011		Hypertension	Efficacy	Q02928	Drug	5833.0	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C	1	46933071.0	G	C
pharmgkb	heroin	OPRM1	rs9479757		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154090209.0	G	A
pharmgkb	fluorouracil	TYMS	rs11280056		Colorectal Neoplasms	Efficacy	P04818	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	18	673447.0	AAGTTA	-
pharmgkb	pemetrexed	TYMS	rs11280056		Mesothelioma	Efficacy	P04818	Drug	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	18	673447.0	AAGTTA	-
pharmgkb	heroin	OPRM1	N40D		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154039662.0	A	G
pharmgkb	heroin	OPRD1	rs2298897		Heroin Dependence	Toxicity	P41143	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	1	28839325.0	C	G
pharmgkb	heroin	OPRD1	rs2236855		Heroin Dependence	Toxicity	P41143	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	1	28835487.0	C	R
pharmgkb	cocaine	OPRD1	rs678849		Cocaine-Related Disorders	Toxicity	P41143	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	1	28818676.0	C	T
pharmgkb	rifampin	SLCO1B1	SLCO1B1*1, SLCO1B1*15		drug-induced liver injury	Toxicity	Q9Y6L6	Drug	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C				
pharmgkb	antidepressants,antipsychotics,benzodiazepine derivatives,opioids,Sympathomimetics	OPRM1	N40D		Heart Arrest,Overdose,Respiratory Insufficiency	Toxicity	P35372				6	154039662.0	A	G
pharmgkb	opioids	ABCB1	I1145M		Opioid-Related Disorders	Other	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	opioids	ANKK1	E713K		Opioid-Related Disorders	Toxicity	Q8NFD2	Drug Class			11	113400106.0	G	A
pharmgkb	nicotine	HINT1	rs3852209		cessation,Tobacco Use Disorder	Other	P49773	Drug	942.0	CN1CCCC1C2=CN=CC=C2	5	131160322.0	C	T
pharmgkb	nicotine	HINT1	rs3852209		Tobacco Use Disorder	Efficacy	P49773	Drug	942.0	CN1CCCC1C2=CN=CC=C2	5	131160322.0	C	T
pharmgkb	heroin	OPRM1	rs3778150		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154062523.0	T	C
pharmgkb	heroin	OPRM1	L445M		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154093438.0	C	T
pharmgkb	heroin,opioids	OPRM1	rs3823010		Heroin Dependence,Opioid-Related Disorders	Toxicity	P35372				6	154058017.0	G	A
pharmgkb	heroin,opioids	OPRM1	rs524731		Heroin Dependence,Opioid-Related Disorders	Toxicity	P35372				6	154053957.0	C	A
pharmgkb	heroin,opioids	OPRM1	rs511435		Heroin Dependence,Opioid-Related Disorders	Toxicity	P35372				6	154047412.0	C	K
pharmgkb	Drugs used in nicotine dependence,nicotine	CHRNA3	rs1051730		Tobacco Use Disorder	Dosage	P32297				15	78601997.0	G	A
pharmgkb	nicotine	OPRM1	rs10485057		Tobacco Use Disorder	Toxicity	P35372	Drug	942.0	CN1CCCC1C2=CN=CC=C2	6	154092120.0	A	G
pharmgkb	ethanol	OPRM1	rs10485057			Dosage	P35372	Drug	702.0	CCO	6	154092120.0	A	G
pharmgkb	nicotine	OPRM1	rs10485057			Dosage	P35372	Drug	942.0	CN1CCCC1C2=CN=CC=C2	6	154092120.0	A	G
pharmgkb	ethanol	OPRM1	rs10485057		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154092120.0	A	G
pharmgkb	nicotine	CHRNA3	D398N			Dosage,Efficacy	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78590583.0	G	A
pharmgkb	amphetamine,cannabinoids,cocaine,opioids	KAT2B	rs9829896		Substance-Related Disorders	Toxicity	Q92831				3	20135980.0	C	W
pharmgkb	aripiprazole,risperidone	DRD2	rs2514218		Psychotic Disorders,schizoaffective disorder,Schizophrenia	Efficacy	P14416				11	113522272.0	C	T
pharmgkb	aripiprazole	DRD2	rs2514218		Psychomotor Agitation	Toxicity	P14416	Drug	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	11	113522272.0	C	T
pharmgkb	cannabinoids	OPRM1	N40D		Marijuana Abuse	Toxicity	P35372	Drug Class			6	154039662.0	A	G
pharmgkb	nicotine	ANKK1	E713K			Toxicity	Q8NFD2	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113400106.0	G	A
pharmgkb	nicotine	DRD2	E713K			Toxicity	P14416	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113400106.0	G	A
pharmgkb	nicotine	OPRM1	N40D		Tobacco Use Disorder	Toxicity	P35372	Drug	942.0	CN1CCCC1C2=CN=CC=C2	6	154039662.0	A	G
pharmgkb	ethanol	OPRM1	rs3778150			Efficacy	P35372	Drug	702.0	CCO	6	154062523.0	T	C
pharmgkb	ethanol	OPRM1	rs3778150			Dosage	P35372	Drug	702.0	CCO	6	154062523.0	T	C
pharmgkb	oxazepam	UGT2B15	Y85D			Metabolism/PK	P54855	Drug	4616.0	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O	4	68670366.0	A	C
pharmgkb	lorazepam	UGT2B15	Y85D			Metabolism/PK	P54855	Drug	3958.0	C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl	4	68670366.0	A	C
pharmgkb	ethanol	SLC6A3	rs28363170			Other	Q01959	Drug	702.0	CCO	5	1393748.0	-	GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT
pharmgkb	ethanol	SLC6A3	rs28363170			Other	Q01959	Drug	702.0	CCO	5	1393748.0	-	GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT
pharmgkb	fentanyl	ABCB1	rs1128503		Pain,Pain, Postoperative	Dosage,Efficacy	P08183	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	87550285.0	A	G
pharmgkb	ethanol	ACSS2	rs6088638		Alcoholism	Toxicity	Q9NR19	Drug	702.0	CCO	20	34882711.0	T	C
pharmgkb	risperidone	HTT	rs362306		Schizophrenia	Efficacy	P42858	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	4	3240373.0	G	A
pharmgkb	risperidone	HRH3	rs3787429		Schizophrenia	Efficacy	Q9Y5N1	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	20	62216348.0	C	K
pharmgkb	risperidone	CYP1B1	A119S		Schizophrenia	Efficacy	Q16678	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	2	38075034.0	C	A
pharmgkb	risperidone	UGT1A10	E27D		Schizophrenia	Efficacy	Q9HAW8	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	2	233729207.0	G	A
pharmgkb	risperidone	CYP1B1	R48G		Schizophrenia	Efficacy	Q16678	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	2	38075247.0	G	C
pharmgkb	risperidone	HTT	rs362267		Schizophrenia	Efficacy	P42858	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	4	3241491.0	C	T
pharmgkb	risperidone	CYP2E1	F421L		Schizophrenia	Efficacy	P05181	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	10	133537858.0	C	K
pharmgkb	risperidone	COMT	rs4818		Schizophrenia	Efficacy	P21964	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	22	19963684.0	C	K
pharmgkb	risperidone	AKT1	rs3803300		Schizophrenia	Efficacy	P31749	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	14	104803442.0	T	M
pharmgkb	risperidone	HRH4	rs4483927		Schizophrenia	Efficacy	Q9H3N8	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	18	24464436.0	G	T
pharmgkb	risperidone	DRD3	G9S		Schizophrenia	Efficacy	P35462	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	3	114171968.0	C	T
pharmgkb	risperidone	AKT1	rs2494732		Schizophrenia	Efficacy	P31749	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	14	104772855.0	T	C
pharmgkb	aspirin,prasugrel	NTRK1	rs2768759			Efficacy	P04629				1	156882671.0	A	S
pharmgkb	ethanol	OPRM1	N40D			Dosage	P35372	Drug	702.0	CCO	6	154039662.0	A	G
pharmgkb	varenicline	CHRNA5	rs2036527		Tobacco Use Disorder	Efficacy	P30532	Drug	5310966.0	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	15	78559273.0	G	A
pharmgkb	bupropion	CHRNA5	rs2036527		Tobacco Use Disorder	Efficacy	P30532	Drug	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	15	78559273.0	G	A
pharmgkb	nicotine	CHRNA5	rs2036527		Tobacco Use Disorder	Efficacy	P30532	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78559273.0	G	A
pharmgkb	bupropion,Drugs used in nicotine dependence,nicotine,varenicline	CHRNA5	D398N		Tobacco Use Disorder	Efficacy	P30532				15	78590583.0	G	A
pharmgkb	opioids	TAOK3	rs1277441		Pain	Efficacy	Q9H2K8	Drug Class			12	118168184.0	G	M
pharmgkb	opioids	TAOK3	rs1277441		Pain	Dosage	Q9H2K8	Drug Class			12	118168184.0	G	M
pharmgkb	opioids	TAOK3	rs795484		Pain	Efficacy	Q9H2K8	Drug Class			12	118152057.0	T	C
pharmgkb	opioids	TAOK3	rs795484		Pain	Dosage	Q9H2K8	Drug Class			12	118152057.0	T	C
pharmgkb	Drugs used in nicotine dependence,nicotine	CHRNA3	rs1051730		Tobacco Use Disorder	Efficacy	P32297				15	78601997.0	G	A
pharmgkb	nicotine	CHRNA3	rs1051730		Pregnancy	Other	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78601997.0	G	A
pharmgkb	Drugs used in nicotine dependence,nicotine	CHRNA3	rs1051730		Tobacco Use Disorder	Other	P32297				15	78601997.0	G	A
pharmgkb	nicotine	CHRNA3	rs1051730			Toxicity	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78601997.0	G	A
pharmgkb	opioids	ABCB1	I1145M		Pain,Pain, Postoperative	Dosage	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	oxycodone	ABCB1	I1145M		Pain	Dosage	P08183	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	7	87509329.0	A	K
pharmgkb	heroin	OPRD1	rs508448		Heroin Dependence	Other	P41143	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	1	28855013.0	A	G
pharmgkb	heroin	OPRM1	rs3778151		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154072545.0	T	C
pharmgkb	heroin	BDNF	rs16917234		Heroin Dependence	Other	P23560	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	11	27676827.0	T	M
pharmgkb	heroin	OPRD1	rs4654327		Heroin Dependence	Toxicity	P41143	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	1	28863626.0	G	A
pharmgkb	atenolol	XIRP2	rs7606603		Hypertension	Efficacy	A4UGR9	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	2	167134845.0	C	W
pharmgkb	hydrochlorothiazide	TXNDC11	rs3784921		Hypertension	Efficacy	Q6PKC3	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	16	11680345.0	G	T
pharmgkb	nicotine	CHRNA3	K97N		Tobacco Use Disorder	Toxicity	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78617110.0	T	M
pharmgkb	nicotine	CHRNB4	rs7178270		Tobacco Use Disorder	Toxicity	P30926	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78628735.0	C	K
pharmgkb	nicotine	CHRNB4	rs1948		Tobacco Use Disorder	Toxicity	P30926	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78625057.0	A	K
pharmgkb	ethanol	PIP5K1C	rs2074957		Alcoholism	Toxicity	Q9Y5X3	Drug	702.0	CCO	19	3653527.0	C	W
pharmgkb	ethanol	PIP5K1C	rs4807493		Alcoholism	Toxicity	Q9Y5X3	Drug	702.0	CCO	19	3631038.0	A	G
pharmgkb	ethanol	PIP5K1C	rs10432303		Alcoholism	Toxicity	Q9Y5X3	Drug	702.0	CCO	19	3656654.0	G	A
pharmgkb	ethanol	PIP5K1C	rs8109485		Alcoholism	Toxicity	Q9Y5X3	Drug	702.0	CCO	19	3664096.0	A	G
pharmgkb	ethanol	PIP5K1C	rs4432372		Alcoholism	Toxicity	Q9Y5X3	Drug	702.0	CCO	19	3698844.0	A	K
pharmgkb	ethanol	PIP5K1C	rs10405681		Alcoholism	Toxicity	Q9Y5X3	Drug	702.0	CCO	19	3634021.0	C	W
pharmgkb	ethanol	PIP5K1C	rs1476592		Alcoholism	Toxicity	Q9Y5X3	Drug	702.0	CCO	19	3679742.0	A	K
pharmgkb	ethanol	PIP5K1C	rs10419980		Alcoholism	Toxicity	Q9Y5X3	Drug	702.0	CCO	19	3685118.0	C	T
pharmgkb	ethanol	PNPLA3	I148M		Alcoholism	Toxicity	Q9NST1	Drug	702.0	CCO	22	43928847.0	C	G
pharmgkb	fentanyl	ADRB2	R175W			Other	P07550	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	5	148827354.0	C	W
pharmgkb	fentanyl	CYP3A5	CYP3A5*1, CYP3A5*3		Neoplasms,Pain	Toxicity	P20815	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3				
pharmgkb	sertraline	GNB3	rs5441		Depressive Disorder, Major	Efficacy	P16520	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	12	6839862.0	A	K
pharmgkb	fentanyl	CYP3A4	rs2242480		Pain, Postoperative	Efficacy	P08684	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	99763843.0	C	T
pharmgkb	ethambutol,isoniazid,pyrazinamide,rifampin	CYP2C9	rs9332096		Maculopapular Exanthema,Tuberculosis	Toxicity	P11712				10	94937118.0	C	T
pharmgkb	ethambutol,isoniazid,pyrazinamide,rifampin	CYP2C19	rs4986893		Maculopapular Exanthema,Tuberculosis	Toxicity	P33261				10	94780653.0	G	A
pharmgkb	fluorouracil,leucovorin,oxaliplatin	MTHFR	A222V		Colonic Neoplasms	Efficacy	P42898				1	11796321.0	G	A
pharmgkb	capecitabine,fluorouracil,leucovorin,oxaliplatin	MTHFR	E429A		Neoplasms	Toxicity	P42898				1	11794419.0	T	G
pharmgkb	capecitabine,fluorouracil,leucovorin,oxaliplatin	MTHFR	E429A		Neoplasms	Efficacy	P42898				1	11794419.0	T	G
pharmgkb	buprenorphine,fentanyl,tramadol	OPRD1	rs2234918		Opioid-Related Disorders,Sexual Dysfunctions, Psychological	Toxicity	P41143				1	28863085.0	C	T
pharmgkb	buprenorphine,fentanyl,tramadol	ARRB2	rs1045280		adverse events,Opioid-Related Disorders	Toxicity	P32121				17	4719343.0	C	T
pharmgkb	deferasirox	CYP27B1	rs10877012		beta-Thalassemia	Efficacy	O15528	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	12	57768302.0	G	Y
pharmgkb	deferasirox	UGT1A1	rs887829		beta-Thalassemia	Efficacy	P22309	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	2	233759924.0	C	T
pharmgkb	deferasirox	GC	D432E		beta-Thalassemia	Efficacy	P02774	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	4	71752617.0	A	Y
pharmgkb	deferasirox	UGT1A3	rs1983023		beta-Thalassemia	Efficacy	P35503	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	2	233728376.0	T	C
pharmgkb	deferasirox	VDR	rs731236		beta-Thalassemia	Efficacy	P11473	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	12	47844974.0	A	G
pharmgkb	deferasirox	VDR	rs1544410		beta-Thalassemia	Efficacy	P11473	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	12	47846052.0	C	D
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNFAIP3	rs610604		Arthritis, Psoriatic,Psoriasis	Efficacy	Q8NFZ5	Drug Class			6	137878280.0	G	T
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	SH3BP2	rs6920220		Arthritis, Psoriatic,Psoriasis	Efficacy	P78314	Drug Class			6	137685367.0	G	A
pharmgkb	ethanol	MAP2K4	rs2159140		Alcoholism,Attention Deficit Disorder with Hyperactivity	Toxicity	P45985	Drug	702.0	CCO	17	12073183.0	T	C
pharmgkb	nicotine	ADGRL3	rs2271339		Tobacco Use Disorder	Toxicity	Q9HAR2	Drug	942.0	CN1CCCC1C2=CN=CC=C2	4	61996667.0	A	G
pharmgkb	nicotine	ADGRL3	rs1456862		Tobacco Use Disorder	Toxicity	Q9HAR2	Drug	942.0	CN1CCCC1C2=CN=CC=C2	4	61380610.0	A	T
pharmgkb	imatinib	SLC22A1	M408V		Neoplasms	Efficacy,Toxicity,Metabolism/PK	O15245	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	6	160139813.0	A	S
pharmgkb	imatinib	CYP1A2	rs762551		Gastrointestinal Stromal Tumors	Dosage	P05177	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	15	74749576.0	C	A
pharmgkb	imatinib	ABCG2	V12M		Drug Toxicity,Gastrointestinal Stromal Tumors	Dosage	Q9UNQ0	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	4	88139962.0	C	T
pharmgkb	imatinib	ABCB1	rs28656907		Drug Toxicity,Gastrointestinal Stromal Tumors	Dosage	P08183	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	7	87714706.0	T	M
pharmgkb	mexiletine	SCN4A	I1310N		Myotonic Disorders	Efficacy	P35499	Drug	4178.0	CC1=C(C(=CC=C1)C)OCC(C)N				
pharmgkb	mexiletine	SCN4A	N1297K		Myotonic Disorders	Efficacy	P35499	Drug	4178.0	CC1=C(C(=CC=C1)C)OCC(C)N	17	63944694.0	G	T
pharmgkb	flecainide	SCN4A	I1310N		Myotonic Disorders	Efficacy	P35499	Drug	3356.0	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F				
pharmgkb	mexiletine	SCN4A	F1298C		Myotonic Disorders	Efficacy	P35499	Drug	4178.0	CC1=C(C(=CC=C1)C)OCC(C)N	17	63944692.0	A	S
pharmgkb	flecainide,mexiletine	SCN4A	G1306V		Myotonia	Efficacy	P35499				17	63943846.0	C	D
pharmgkb	mexiletine	SCN4A	T1313M		Myotonic Disorders	Efficacy	P35499	Drug	4178.0	CC1=C(C(=CC=C1)C)OCC(C)N	17	63943825.0	G	A
pharmgkb	flecainide	SCN4A	T1313M		Myotonic Disorders	Efficacy	P35499	Drug	3356.0	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	17	63943825.0	G	A
pharmgkb	rocuronium	ABCB1	rs1128503			Efficacy	P08183	Drug	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C	7	87550285.0	A	G
pharmgkb	migalastat	GLA	D33G		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101407806.0	T	C
pharmgkb	migalastat	GLA	A156T		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101401713.0	C	T
pharmgkb	migalastat	GLA	G85A		Fabry Disease	Efficacy	P06280	Drug	176077.0					
pharmgkb	migalastat	GLA	G183D		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101400757.0	C	A
pharmgkb	migalastat	GLA	R356W		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398033.0	G	A
pharmgkb	migalastat	GLA	R112H		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101403845.0	C	W
pharmgkb	migalastat	GLA	M187I		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101400744.0	C	T
pharmgkb	migalastat	GLA	P205T		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101400692.0	G	Y
pharmgkb	migalastat	GLA	L300P		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398470.0	A	G
pharmgkb	migalastat	GLA	D313Y		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398432.0	C	W
pharmgkb	migalastat	GLA	L36W		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101407797.0	A	C
pharmgkb	migalastat	GLA	Y216C		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398939.0	T	C
pharmgkb	migalastat	GLA	L243F		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398857.0	C	K
pharmgkb	migalastat	GLA	I253T		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398828.0	A	G
pharmgkb	migalastat	GLA	P259L		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398810.0	G	M
pharmgkb	migalastat	GLA	R301L		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398467.0	C	W
pharmgkb	migalastat	GLA	D322E		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398403.0	G	Y
pharmgkb	migalastat	GLA	G373S		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101397982.0	C	T
pharmgkb	migalastat	GLA	D264N		Fabry Disease	Efficacy	P06280	Drug	176077.0		X	101398796.0	C	A
pharmgkb	azathioprine,mercaptopurine	NUDT15	rs746071566		Pancytopenia,Thrombocytopenia	Toxicity	Q9NV35				13	48037783.0	GGAGTC	-
pharmgkb	azathioprine,mercaptopurine	NUDT15	R139C		Pancytopenia,Thrombocytopenia	Toxicity	Q9NV35				13	48045719.0	C	T
pharmgkb	fentanyl	P2RX7	rs1718125		Pain, Postoperative	Dosage	Q99572	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	12	121155216.0	C	T
pharmgkb	tianeptine	OPRM1	N40D		Depressive Disorder, Major,suicidal ideation	Toxicity	P35372	Drug	68870.0		6	154039662.0	A	G
pharmgkb	ibuprofen	CYP2C8	CYP2C8*1, CYP2C8*3			Dosage	P10632	Drug	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O				
pharmgkb	mephenytoin	CYP2C19	CYP2C19*1, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*9, CYP2C19*10, CYP2C19*11, CYP2C19*13, CYP2C19*14, CYP2C19*15, CYP2C19*16, CYP2C19*18, CYP2C19*19, CYP2C19*22, CYP2C19*23, CYP2C19*24, CYP2C19*25, CYP2C19*26			Metabolism/PK	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2				
pharmgkb	tolbutamide	CYP2C9	P73L			Metabolism/PK	P11712	Drug	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C	10	94941907.0	C	T
pharmgkb	tolbutamide	CYP2C9	I264S			Metabolism/PK	P11712	Drug	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C	10	94949256.0	T	S
pharmgkb	mephenytoin	CYP2C19	A173D			Metabolism/PK	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	10	94780535.0	C	W
pharmgkb	mephenytoin	CYP2C19	V113I			Metabolism/PK	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	10	94775395.0	G	A
pharmgkb	mephenytoin	CYP2C19	Q193R			Metabolism/PK	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	10	94780595.0	A	G
pharmgkb	mephenytoin	CYP2C19	Q22R			Metabolism/PK	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	10	94762770.0	A	G
pharmgkb	Drugs For Treatment Of Tuberculosis	XPO1	rs4430924		Drug Toxicity,Tuberculosis	Toxicity	O14980	Drug Class			2	61476721.0	A	S
pharmgkb	desmethylnaproxen	SULT1A1	M77I			Metabolism/PK	P50225	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28608521.0	C	T
pharmgkb	acetaminophen	SULT1A1	M77I			Metabolism/PK	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28608521.0	C	T
pharmgkb	tapentadol	NPIPB8	F247L			Metabolism/PK	E9PQR5	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	28606092.0	A	S
pharmgkb	desmethylnaproxen	NPIPB8	F247L			Metabolism/PK	E9PQR5	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28606092.0	A	S
pharmgkb	acetaminophen	NPIPB8	F247L			Metabolism/PK	E9PQR5	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28606092.0	A	S
pharmgkb	tapentadol	SULT1A1	R135H			Metabolism/PK	P50225	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	28606193.0	C	T
pharmgkb	desmethylnaproxen	SULT1A1	R135H			Metabolism/PK	P50225	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28606193.0	C	T
pharmgkb	acetaminophen	SULT1A1	R135H			Metabolism/PK	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28606193.0	C	T
pharmgkb	acetaminophen	SULT1A1	R37L			Metabolism/PK	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28608746.0	C	W
pharmgkb	desmethylnaproxen	SULT1A1	R37L			Metabolism/PK	P50225	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28608746.0	C	W
pharmgkb	tapentadol	SULT1A1	R37L			Metabolism/PK	P50225	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	28608746.0	C	W
pharmgkb	acetaminophen	SULT1A1	H71Y			Metabolism/PK	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28607005.0	G	A
pharmgkb	tapentadol	SULT1A1	H71Y			Metabolism/PK	P50225	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	28607005.0	G	A
pharmgkb	desmethylnaproxen	SULT1A1	H71Y			Metabolism/PK	P50225	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28607005.0	G	A
pharmgkb	acetaminophen	SULT1A1	Y91D			Metabolism/PK	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28606850.0	A	C
pharmgkb	tapentadol	SULT1A1	Y91D			Metabolism/PK	P50225	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	28606850.0	A	C
pharmgkb	desmethylnaproxen	SULT1A1	Y91D			Metabolism/PK	P50225	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28606850.0	A	C
pharmgkb	desmethylnaproxen	SULT1A1	V165A			Metabolism/PK	P50225	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28606103.0	A	K
pharmgkb	tapentadol	SULT1A1	V165A			Metabolism/PK	P50225	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	28606103.0	A	K
pharmgkb	acetaminophen	SULT1A1	V165A			Metabolism/PK	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28606103.0	A	K
pharmgkb	acetaminophen	SULT1A1	P47S			Metabolism/PK	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28608717.0	G	A
pharmgkb	desmethylnaproxen	SULT1A1	P47S			Metabolism/PK	P50225	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28608717.0	G	A
pharmgkb	tapentadol	SULT1A1	P47S			Metabolism/PK	P50225	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	28608717.0	G	A
pharmgkb	tapentadol	SULT1A1	T149P			Metabolism/PK	P50225	Drug	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C	16	28606152.0	T	G
pharmgkb	acetaminophen	SULT1A1	T149P			Metabolism/PK	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28606152.0	T	G
pharmgkb	desmethylnaproxen	SULT1A1	T149P			Metabolism/PK	P50225	Metabolite	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O	16	28606152.0	T	G
pharmgkb	conjugated estrogens	SULT1A1	R135H		Endometrial Neoplasms	Toxicity	P50225	Drug, Biological Intermediate	23667301.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]	16	28606193.0	C	T
pharmgkb	acetaminophen	SULT1A1	R135H		Pain	Efficacy	P50225	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O	16	28606193.0	C	T
pharmgkb	cisplatin	AQP1	rs1049305		Mesothelioma,Thrombocytopenia	Toxicity	P29972	Drug	441203.0	N.N.Cl[Pt+2]Cl	7	30924207.0	G	C
pharmgkb	cisplatin	AQP1	G165D		Thrombocytopenia	Toxicity	P29972	Drug	441203.0	N.N.Cl[Pt+2]Cl	7	30922175.0	G	A
pharmgkb	cisplatin	AQP1	rs1049305		Alopecia,Mesothelioma	Toxicity	P29972	Drug	441203.0	N.N.Cl[Pt+2]Cl	7	30924207.0	G	C
pharmgkb	cisplatin	AQP1	rs1049305		Anemia,Mesothelioma	Toxicity	P29972	Drug	441203.0	N.N.Cl[Pt+2]Cl	7	30924207.0	G	C
pharmgkb	cisplatin	AQP1	rs1049305		Leukopenia,Mesothelioma	Toxicity	P29972	Drug	441203.0	N.N.Cl[Pt+2]Cl	7	30924207.0	G	C
pharmgkb	ethanol	SRPRB	rs17376019			Metabolism/PK	Q9Y5M8	Drug	702.0	CCO	3	133822039.0	C	T
pharmgkb	acetaldehyde	ADH1A	rs1229976			Metabolism/PK	P07327	Metabolite	177.0		4	99280921.0	C	W
pharmgkb	ABT-751	UGT1A8	rs6431558		Neoplasms	Other	Q9HAW9	Drug			2	233620997.0	C	T
pharmgkb	Beta Blocking Agents	KL	rs36217263			Efficacy	Q9UEF7	Drug Class			13	33015697.0	A	-
pharmgkb	calcium channel blockers	CACNA1C	rs2238032		Hypertension	Efficacy	P54284	Drug Class			12	2113566.0	T	S
pharmgkb	cyclosporine	ABCB1	rs1128503		hematopoietic stem cell transplantation,Neurotoxicity Syndromes	Toxicity	P08183	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	87550285.0	A	G
pharmgkb	metoprolol	ADRB1	S49G		Hypertension	Efficacy	P08588	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	10	114044277.0	A	G
pharmgkb	glucocorticoids	HSD3B1	T367I		Asthma	Efficacy	P14060	Drug Class			1	119514623.0	C	A
pharmgkb	fluorouracil,irinotecan,leucovorin	KLC1	T241M		Colorectal Neoplasms	Efficacy	Q07866				14	103699416.0	G	A
pharmgkb	isoniazid,rifampin	NOS2	rs11080344		Toxic liver disease,Tuberculosis	Toxicity	P35228				17	27777485.0	T	C
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b	IFNL3	rs12979860		Myeloproliferative Disorders	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	caffeine	ADORA2A	rs3761422		Anxiety Disorders	Toxicity	P29274	Drug	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	22	24430704.0	T	C
pharmgkb	sorafenib	SLC15A2	L350V		Carcinoma, Hepatocellular	Efficacy	Q16348	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	3	121924957.0	C	K
pharmgkb	simvastatin	HMGCR	rs3846662		Cardiovascular Diseases	Other	P04035	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	5	75355259.0	A	G
pharmgkb	calcium channel blockers	CACNA1C	rs2239128		Hypertension	Efficacy	P54284	Drug Class			12	2648603.0	T	C
pharmgkb	calcium channel blockers	CACNA1C	rs2239050			Efficacy	P54284	Drug Class			12	2338248.0	G	M
pharmgkb	aspirin,clopidogrel,prasugrel	PEAR1	rs12041331			Efficacy	Q5VY43				1	156899922.0	G	A
pharmgkb	rosiglitazone	PLIN1	rs894160		Diabetes Mellitus, Type 2,Weight gain	Toxicity	O60240	Drug	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	15	89668592.0	C	T
pharmgkb	acetaldehyde	ADH1B	H48R			Metabolism/PK	P00325	Metabolite	177.0		4	99318162.0	T	S
pharmgkb	methadone	CCL11	A23P		Opioid-Related Disorders	Toxicity	P51671	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	17	34285875.0	G	H
pharmgkb	methadone	OPRD1	rs678849		Opioid-Related Disorders	Efficacy	P41143	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	1	28818676.0	C	T
pharmgkb	fentanyl	MYD88	rs6853			Toxicity	Q99836	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	3	38142879.0	A	G
pharmgkb	methylphenidate	ALDH1L1	V330L		Attention Deficit Disorder with Hyperactivity	Efficacy	O75891	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	3	126146923.0	C	A
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	CBR3	rs112783657		Breast Neoplasms,Neutropenia	Toxicity	O75828				21	36183988.0	C	T
pharmgkb	ethanol	DRD2	rs1799732		Alcoholism	Toxicity	P14416	Drug	702.0	CCO	11	113475530.0	-	R
pharmgkb	fentanyl	CACNA1E	rs3845446		Pain, Postoperative	Dosage	Q5JVL4	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	1	181797301.0	T	C
pharmgkb	quetiapine	PDE4D	rs2164660		Schizophrenia	Efficacy	Q08499	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	5	59715681.0	G	A
pharmgkb	cisplatin	SLC22A2	S270A		Neoplasms	Toxicity	O15244	Drug	441203.0	N.N.Cl[Pt+2]Cl	6	160249250.0	A	C
pharmgkb	l-phenylalanine	PAH	R158P			Metabolism/PK	P00439	Drug	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N	12	102866632.0	C	K
pharmgkb	carbocisteine	PAH	I65S			Metabolism/PK	P00439	Drug	193653.0		12	102894893.0	A	B
pharmgkb	carbocisteine	PAH	R158P			Metabolism/PK	P00439	Drug	193653.0		12	102866632.0	C	K
pharmgkb	carbocisteine	PAH	R68S			Metabolism/PK	P00439	Drug	193653.0		12	102894883.0	T	A
pharmgkb	l-phenylalanine	PAH	I174N			Metabolism/PK	P00439	Drug	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N	12	102855321.0	A	K
pharmgkb	carbocisteine	PAH	I174N			Metabolism/PK	P00439	Drug	193653.0		12	102855321.0	A	K
pharmgkb	l-phenylalanine	PAH	R261Q			Metabolism/PK	P00439	Drug	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N	12	102852875.0	C	K
pharmgkb	carbocisteine	PAH	R261Q			Metabolism/PK	P00439	Drug	193653.0		12	102852875.0	C	K
pharmgkb	carbocisteine	PAH	V388L			Metabolism/PK	P00439	Drug	193653.0		12	102843683.0	C	K
pharmgkb	l-phenylalanine	PAH	V388L			Metabolism/PK	P00439	Drug	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N	12	102843683.0	C	K
pharmgkb	l-phenylalanine	PAH	R408W			Metabolism/PK	P00439	Drug	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N	12	102840493.0	G	A
pharmgkb	carbocisteine	PAH	R408W			Metabolism/PK	P00439	Drug	193653.0		12	102840493.0	G	A
pharmgkb	carbocisteine	PAH	Y414C			Metabolism/PK	P00439	Drug	193653.0		12	102840474.0	T	C
pharmgkb	l-phenylalanine	PAH	Y414C			Metabolism/PK	P00439	Drug	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N	12	102840474.0	T	C
pharmgkb	l-phenylalanine	PAH	R68S			Metabolism/PK	P00439	Drug	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N	12	102894883.0	T	A
pharmgkb	Platinum compounds	ERCC2	D312N		Carcinoma, Non-Small-Cell Lung,pneumonitis	Toxicity	P18074	Drug Class			19	45364001.0	C	W
pharmgkb	Platinum compounds	ERCC2	D312N		adverse events,Carcinoma, Non-Small-Cell Lung	Toxicity	P18074	Drug Class			19	45364001.0	C	W
pharmgkb	atenolol,hydrochlorothiazide,metoprolol	SLC25A31	rs201279313		Hypertension	Efficacy	Q9H0C2				4	127735886.0	TTA	-
pharmgkb	antipsychotics	NRG1	rs13250975		Schizophrenia	Efficacy	Q02297	Drug Class			8	32535292.0	A	G
pharmgkb	atenolol	ZMAT4	rs1367094		Hypertension	Efficacy	Q9H898	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	8	40544855.0	C	T
pharmgkb	methylphenidate	ADGRL3	rs6551665		Attention Deficit Disorder with Hyperactivity	Efficacy	Q9HAR2	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	4	61873823.0	G	A
pharmgkb	adalimumab	ATG5	rs9373839		Inflammatory Bowel Diseases	Efficacy	Q9H1Y0	Drug			6	106207742.0	T	C
pharmgkb	Platinum compounds	SLC22A2	S270A		Carcinoma, Non-Small-Cell Lung	Toxicity	O15244	Drug Class			6	160249250.0	A	C
pharmgkb	clopidogrel	CES1	rs8192950		Constriction, Pathologic,Ischemic Attack, Transient,Stroke	Efficacy	Q9NZK5	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	16	55808492.0	T	G
pharmgkb	ticagrelor	PEAR1	rs12566888			Efficacy	Q5VY43	Drug	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	1	156899255.0	G	T
pharmgkb	3,4-methylenedioxymethamphetamine	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17			Toxicity	P33261	Drug	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC				
pharmgkb	3,4-methylenedioxymethamphetamine	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17			Metabolism/PK	P33261	Drug	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC				
pharmgkb	tolterodine	CYP2D6	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98			Metabolism/PK	P10635	Drug	60774.0	CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2				
pharmgkb	Antivirals for treatment of HIV infections, combinations,ritonavir	APOE	C130R		HIV Infections,Hyperlipidemias	Toxicity	P02649				19	44908684.0	T	C
pharmgkb	Antivirals for treatment of HIV infections, combinations,ritonavir	APOE	R176C		HIV Infections,Hyperlipidemias,Hypertriglyceridemia	Toxicity	P02649				19	44908822.0	C	T
pharmgkb	hmg coa reductase inhibitors	APOE	C130R		Alzheimer Disease	Efficacy	P02649	Drug Class			19	44908684.0	T	C
pharmgkb	pravastatin	APOE	R176C			Efficacy	P02649	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	19	44908822.0	C	T
pharmgkb	fluvastatin	APOE	R176C			Efficacy	P02649	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	19	44908822.0	C	T
pharmgkb	fenofibrate	APOE	R176C		Hypertriglyceridemia	Efficacy	P02649	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	19	44908822.0	C	T
pharmgkb	warfarin	APOE	R176C			Efficacy	P02649	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	19	44908822.0	C	T
pharmgkb	warfarin	APOE	C130R			Efficacy	P02649	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	19	44908684.0	T	C
pharmgkb	simvastatin	APOE	C130R		Myocardial Infarction	Efficacy	P02649	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	19	44908684.0	T	C
pharmgkb	atorvastatin	ABCB1	I1145M		Coronary Artery Disease	Efficacy	P08183	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	87509329.0	A	K
pharmgkb	cytarabine,daunorubicin,dexrazoxane,idarubicin	ABCB1	S893A		Leukemia, Myeloid, Acute	Efficacy	P08183				7	87531302.0	A	Y
pharmgkb	propranolol	ADRB2	R16G		Liver Cirrhosis	Efficacy	P07550	Drug	4946.0	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O	5	148826877.0	G	A
pharmgkb	Antihypertensives	PTPRD	rs324498		Hypertension	Efficacy	P23468	Drug Class			9	9059545.0	G	A
pharmgkb	fentanyl	CYP2D6	CYP2D6*1, CYP2D6*9, CYP2D6*29			Metabolism/PK	P10635	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3				
pharmgkb	o-desmethyltramadol,tramadol	RGL4	L90Q			Metabolism/PK	Q8IZJ4				22	23692424.0	T	A
pharmgkb	o-desmethyltramadol,tramadol	ICA1	rs62435418			Metabolism/PK	P05362				7	8148016.0	G	W
pharmgkb	o-desmethyltramadol,tramadol	HCN1	rs79983226			Metabolism/PK	O60741				5	45595553.0	G	C
pharmgkb	o-desmethyltramadol,tramadol	RFPL4B	rs9384825			Metabolism/PK	Q6ZWI9				6	112346991.0	C	T
pharmgkb	acetaldehyde	PGM1	rs4643			Metabolism/PK	P36871	Metabolite	177.0		1	63659768.0	A	C
pharmgkb	mycophenolic acid	SLCO1B3	S112P		lung transplantation,overall survival	Efficacy	F5H094	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	12	20858546.0	T	S
pharmgkb	mycophenolic acid	SLCO1B3	S112P		chronic lung allograft dysfunction,lung transplantation	Efficacy	F5H094	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	12	20858546.0	T	S
pharmgkb	mycophenolic acid	SLCO1B3	M233I		lung transplantation,overall survival	Efficacy	F5H094	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	12	20862826.0	G	A
pharmgkb	mycophenolic acid	SLCO1B3	S112P		lung transplantation,transplant rejection	Efficacy	F5H094	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	12	20858546.0	T	S
pharmgkb	mycophenolic acid	SLCO1B3	M233I		lung transplantation,transplant rejection	Efficacy	F5H094	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	12	20862826.0	G	A
pharmgkb	mycophenolic acid	SLCO1B3	M233I		chronic lung allograft dysfunction,lung transplantation	Efficacy	F5H094	Drug	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	12	20862826.0	G	A
pharmgkb	ethanol	OPRK1	rs6473797		Alcoholism	Toxicity	P41145	Drug	702.0	CCO	8	53240422.0	T	C
pharmgkb	ethanol	OPRM1	rs495491		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154061407.0	A	G
pharmgkb	botulinum toxin type a	TRPV1	P91S		Migraine NOS	Efficacy	Q8NER1	Drug			17	3592080.0	G	A
pharmgkb	botulinum toxin type a	CALCA	rs3781719		Migraine NOS	Efficacy	P06881	Drug			11	14972978.0	A	G
pharmgkb	letermovir	SLCO1B1	rs4149032			Metabolism/PK	Q9Y6L6	Drug	45138674.0		12	21164857.0	C	T
pharmgkb	letermovir	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6	Drug	45138674.0		12	21178615.0	T	C
pharmgkb	letermovir	UGT1A1	G71R			Metabolism/PK	P22309	Drug	45138674.0		2	233760498.0	G	A
pharmgkb	heroin	DRD2	rs12364283		Heroin Dependence	Toxicity	P14416	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	11	113476233.0	A	G
pharmgkb	opioids	DRD2	rs1076560		Heroin Dependence,Opioid-Related Disorders	Other	P14416	Drug Class			11	113412966.0	C	A
pharmgkb	atenolol,metoprolol	SLC4A1	rs45545233		Hypertension	Efficacy	P02730				17	44260984.0	T	C
pharmgkb	cocaine	SYT1	rs2251214		Cocaine-Related Disorders	Toxicity	P21579	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	12	79430071.0	A	K
pharmgkb	disulfiram	SLC6A3	rs28363170		Cocaine-Related Disorders	Efficacy	Q01959	Drug	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	5	1393748.0	-	GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT
pharmgkb	atenolol,metoprolol	ADRB2	R16G		Tachycardia	Efficacy	P07550				5	148826877.0	G	A
pharmgkb	atenolol,metoprolol	ADRB2	Q27E		Tachycardia	Efficacy	P07550				5	148826910.0	G	Y
pharmgkb	ethanol	RABGAP1L	rs61826952		Alcoholism	Toxicity	Q5R372	Drug	702.0	CCO	1	174668799.0	A	G
pharmgkb	methotrexate	SLC19A1	rs2838956		adverse events,Arthritis, Rheumatoid	Toxicity	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45525110.0	A	G
pharmgkb	atazanavir	SORCS2	rs73208473		HIV Infections	Metabolism/PK	Q96PQ0	Drug	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	4	7322869.0	C	W
pharmgkb	Vitamin K1	CYP4F2	CYP4F2*1, CYP4F2*3			Metabolism/PK	P78329	Drug	5284607.0					
pharmgkb	warfarin	APOB	A618V		heart valve replacement,Hemorrhage	Toxicity	P04114	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	21028042.0	G	A
pharmgkb	warfarin	APOB	T98I		heart valve replacement,Hemorrhage	Toxicity	P04114	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	21041028.0	G	A
pharmgkb	lopinavir	CYP3A	rs776746		HIV Infections	Metabolism/PK	Q9HB55	Drug	92727.0	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	7	99672916.0	T	C
pharmgkb	amprenavir	SLCO1B1	V174A		HIV Infections	Metabolism/PK	Q9Y6L6	Drug	65016.0	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N	12	21178615.0	T	C
pharmgkb	lopinavir	CYP3A4	CYP3A4*1, CYP3A4*22		HIV Infections	Metabolism/PK	P08684	Drug	92727.0	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O				
pharmgkb	hydrochlorothiazide	NUCB2	Q338E		Hypertension	Efficacy	P80303	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	11	17330136.0	C	G
pharmgkb	atenolol	RRP1B	L436P		Hypertension	Efficacy	Q14684	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	21	43687681.0	T	C
pharmgkb	candesartan	SH2B3	W262G		Hypertension	Efficacy	Q9UQQ2	Drug	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	12	111446804.0	T	V
pharmgkb	hydrochlorothiazide	C5orf56	rs12521868		Hypertension	Efficacy	Q8N8D9	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	5	132448701.0	G	T
pharmgkb	candesartan	KCNK3	rs1275988		Hypertension	Efficacy	O14649	Drug	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	2	26691496.0	C	T
pharmgkb	hydrochlorothiazide	CSK	rs1378942		Hypertension	Efficacy	P41240	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	15	74785026.0	C	W
pharmgkb	hydrochlorothiazide	PDE3A	rs12579720		Hypertension	Efficacy	Q14432	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	12	20020830.0	C	D
pharmgkb	candesartan	SULT1C3	M194T		Hypertension	Efficacy	Q6IMI6	Drug	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	2	108258788.0	T	C
pharmgkb	atenolol	STN1	rs4387287		Hypertension	Efficacy	Q9H668	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	10	103918139.0	A	C
pharmgkb	atenolol	TBX2	rs8068318		Hypertension	Efficacy	Q13207	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	17	61406405.0	C	T
pharmgkb	hydrochlorothiazide	PLCE1	rs932764		Hypertension	Efficacy	Q9P212	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	10	94136183.0	A	G
pharmgkb	hydrochlorothiazide	ADO	P39A		Hypertension	Efficacy	Q96SZ5	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	10	62805174.0	C	G
pharmgkb	hydrochlorothiazide	PRKAG2	rs10224002		Hypertension	Efficacy	Q9UGJ0	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	7	151717955.0	A	G
pharmgkb	candesartan	DOT1L	rs740406		Hypertension	Efficacy	Q8TEK3	Drug	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	19	2232222.0	A	K
pharmgkb	remifentanil	ABCB1	I1145M			Dosage	P08183	Drug	60815.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC	7	87509329.0	A	K
pharmgkb	remifentanil	ABCB1	I1145M			Efficacy	P08183	Drug	60815.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC	7	87509329.0	A	K
pharmgkb	opioids	MCOLN1	rs114077267		Overdose	Toxicity	Q9GZU1	Drug Class			19	7522131.0	C	W
pharmgkb	opioids	MCOLN1	rs115208233		Overdose	Toxicity	Q9GZU1	Drug Class			19	7524175.0	C	G
pharmgkb	opioids	MCOLN1	rs116181528		Overdose	Toxicity	Q9GZU1	Drug Class			19	7529361.0	C	W
pharmgkb	docetaxel,FEC100,gemcitabine,trastuzumab,zoledronate	PPCDC	rs147451859		Amenorrhea	Toxicity	Q96CD2				15	75039102.0	C	G
pharmgkb	phenobarbital,phenytoin	MTHFR	A222V		Epilepsy,Psychotic Disorders	Toxicity	P42898				1	11796321.0	G	A
pharmgkb	nicotine	CHRNA3	rs578776			Toxicity	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78596058.0	G	A
pharmgkb	nicotine	CHRNA4	S543R			Toxicity	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63349782.0	G	M
pharmgkb	nicotine	CHRNA4	rs2229959			Toxicity	P43681	Drug	942.0	CN1CCCC1C2=CN=CC=C2	20	63350202.0	C	W
pharmgkb	Beta blocking agents, selective	BST1	rs28404156		Hypertension	Efficacy	Q10588	Drug Class			4	15736109.0	G	A
pharmgkb	antipsychotics	DGKB	rs1525085		Weight gain	Toxicity	Q9Y6T7	Drug Class			7	14600073.0	G	A
pharmgkb	ethanol	ANKS1B	rs2133896		Alcoholism	Toxicity	P38432	Drug	702.0	CCO	12	99455122.0	G	T
pharmgkb	heroin	ANKS1B	rs2133896		Heroin Dependence	Toxicity	P38432	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	12	99455122.0	G	T
pharmgkb	methamphetamine	ANKS1B	rs2133896		methamphetamine dependence	Toxicity	P38432	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	12	99455122.0	G	T
pharmgkb	oxycodone	OPRD1	rs581111			Efficacy	P41143	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	1	28848861.0	A	G
pharmgkb	cisplatin	ERCC1	rs11615		Drug Toxicity	Toxicity	P07992	Drug	441203.0	N.N.Cl[Pt+2]Cl	19	45420395.0	A	G
pharmgkb	opioids	PDYN	rs910080		Opioid-Related Disorders	Toxicity	P01213	Drug Class			20	1979580.0	A	G
pharmgkb	opioids	PDYN	rs1997794		Opioid-Related Disorders	Toxicity	P01213	Drug Class			20	1994212.0	T	C
pharmgkb	artemether	CYP2B6	CYP2B6*1, CYP2B6*6			Metabolism/PK	P20813	Drug	9796294.0	C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)OC)C				
pharmgkb	opioids	PDYN	rs1022563		Opioid-Related Disorders	Toxicity	P01213	Drug Class			20	1973693.0	C	K
pharmgkb	clopidogrel	CES1	rs778068631			Metabolism/PK	Q9NZK5	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	16	55820390.0	A	-
pharmgkb	ethanol	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Alcoholism	Toxicity	P31645	Drug	702.0	CCO				
pharmgkb	ethanol	SLC6A4	rs2066713		Alcoholism	Toxicity	P31645	Drug	702.0	CCO	17	30224647.0	G	A
pharmgkb	ethanol	SLC6A4	rs25531		Alcoholism	Toxicity	P31645	Drug	702.0	CCO	17	30237328.0	T	C
pharmgkb	ethanol	SLC6A4	rs4251417		Alcoholism	Toxicity	P31645	Drug	702.0	CCO	17	30224840.0	C	T
pharmgkb	morphine	UGT2B7	Y268H		Pain	Efficacy	P16662	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	4	69098620.0	T	C
pharmgkb	morphine	UGT2B7	Y268H			Metabolism/PK	P16662	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	4	69098620.0	T	C
pharmgkb	cisplatin,fluorouracil	GALNT14	rs9679162		Liver Neoplasms	Efficacy	Q96FL9				2	31024648.0	G	T
pharmgkb	sorafenib	GALNT14	rs9679162		Hepatitis C,Liver Neoplasms	Efficacy	Q96FL9	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	2	31024648.0	G	T
pharmgkb	thioguanine	TPMT	TPMT*1, TPMT*3A, TPMT*3C		Crohn Disease	Metabolism/PK	P51580	Drug	2723601.0	C1=NC2=C(N1)C(=S)N=C(N2)N				
pharmgkb	carboplatin,gemcitabine	C6orf15	rs2233980		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q6UXA7				6	31111867.0	G	A
pharmgkb	carboplatin,gemcitabine	SERPINC1	rs5877		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P01008				1	173909724.0	T	M
pharmgkb	carboplatin,gemcitabine	ATAT1	rs9262132		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q5SQI0				6	30643573.0	C	W
pharmgkb	carboplatin,gemcitabine	PPP1R18	G339R		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q6NYC8				6	30685004.0	C	K
pharmgkb	carboplatin,gemcitabine	CDSN	rs3130985		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q15517				6	31117579.0	C	T
pharmgkb	carboplatin,gemcitabine	HLA-C	rs1049709		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P10321				6	31269077.0	T	C
pharmgkb	carboplatin,gemcitabine	MUCL3	rs3094086		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q3MIW9				6	30951614.0	G	A
pharmgkb	carboplatin,gemcitabine	HCP5	rs3130907		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q6MZN7				6	31464036.0	A	G
pharmgkb	carboplatin,gemcitabine	PRRC2A	rs11229		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P48634				6	31635993.0	A	G
pharmgkb	carboplatin,gemcitabine	TNF	rs1800629		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q9UNG2				6	31575254.0	G	A
pharmgkb	carboplatin,gemcitabine	PRRC2A	P2006S		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P48634				6	31636814.0	C	T
pharmgkb	carboplatin,gemcitabine	MSH5	rs3115672		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	O43196				6	31760120.0	C	T
pharmgkb	carboplatin,gemcitabine	DOCK8	rs10491684		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q8NF50				9	449798.0	G	A
pharmgkb	carboplatin,gemcitabine	CYP2C8	rs1058932		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P10632				10	95037104.0	G	A
pharmgkb	carboplatin,gemcitabine	CYP2C8	rs11572078		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P10632				10	95067363.0	-	AA/A
pharmgkb	carboplatin,gemcitabine	SERPINA5	K105E		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P05154				14	94587675.0	A	G
pharmgkb	carboplatin,gemcitabine	XYLT2	T801I		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	Q9H1B5				17	50360095.0	C	K
pharmgkb	carboplatin,gemcitabine	SERPINA5	rs6113		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P05154				14	94587512.0	T	C
pharmgkb	carboplatin,gemcitabine	SERPINA5	A55V		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P05154				14	94587526.0	C	T
pharmgkb	carboplatin,gemcitabine	ETS2	A19T		Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	Toxicity	P15036				21	38805401.0	G	A
pharmgkb	tenofovir disoproxil fumarate	SLC28A2	P22L		HIV Infections,nephrotoxicity	Toxicity	O43868	Drug	6398764.0		15	45253280.0	C	T
pharmgkb	tenofovir disoproxil fumarate	CYP24A1	rs2248359		HIV Infections,nephrotoxicity	Toxicity	Q07973	Drug	6398764.0		20	54174979.0	C	T
pharmgkb	tenofovir disoproxil fumarate	CYP27B1	rs4646536		HIV Infections,nephrotoxicity	Toxicity	O15528	Drug	6398764.0		12	57764205.0	A	G
pharmgkb	tenofovir	ABCC2	rs717620		HIV Infections	Toxicity	Q5T2W1	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	10	99782821.0	C	T
pharmgkb	temozolomide	ABCB1	S400N		Glioma	Efficacy	P08183	Drug	5394.0	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	7	87550493.0	C	W
pharmgkb	creatine	MOBP	rs616147		Amyotrophic Lateral Sclerosis	Efficacy	Q13875	Drug	586.0	CN(CC(=O)O)C(=N)N	3	39492990.0	A	G
pharmgkb	desloratadine	HRH1	rs901865		sedation,Urticaria	Toxicity	P35367	Drug	124087.0	C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4	3	11259021.0	T	C
pharmgkb	cisplatin	OTOS	rs2291767		Neoplasms	Toxicity	Q8NHW6	Drug	441203.0	N.N.Cl[Pt+2]Cl	2	240140715.0	T	C
pharmgkb	cisplatin	TPMT	rs12201199		Neoplasms	Toxicity	P51580	Drug	441203.0	N.N.Cl[Pt+2]Cl	6	18139571.0	A	T
pharmgkb	cisplatin	SLC22A2	S270A		Ototoxicity	Toxicity	O15244	Drug	441203.0	N.N.Cl[Pt+2]Cl	6	160249250.0	A	C
pharmgkb	cisplatin	ABCC3	rs1051640		Drug Toxicity,Neoplasms,Ototoxicity	Toxicity	O15438	Drug	441203.0	N.N.Cl[Pt+2]Cl	17	50691125.0	A	G
pharmgkb	cisplatin	SLC16A5	L41M		Neoplasms,Ototoxicity,Testicular Neoplasms	Toxicity	O15375	Drug	441203.0	N.N.Cl[Pt+2]Cl	17	75093757.0	T	C
pharmgkb	efavirenz	ABCB1	rs3842		HIV Infections	Other	P08183	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	7	87504050.0	T	C
pharmgkb	efavirenz	ABCB1	I1145M		HIV Infections	Other	P08183	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	7	87509329.0	A	K
pharmgkb	efavirenz	CYP2A6	rs28399433		HIV Infections	Other	P11509	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	40850474.0	A	B
pharmgkb	ethanol	CACNA1C	rs1034936		Alcoholism,Bipolar Disorder	Toxicity	P54284	Drug	702.0	CCO	12	2551994.0	C	T
pharmgkb	lurasidone	HTR1A	rs6295		Schizophrenia	Efficacy	P08908	Drug	213046.0	C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O	5	63962738.0	C	G
pharmgkb	Drugs For Treatment Of Tuberculosis	ABCC2	rs3740065		Toxic liver disease,Tuberculosis	Toxicity	Q5T2W1	Drug Class			10	99845936.0	A	G
pharmgkb	interferon beta-1a	RORA	rs4774388		Multiple Sclerosis	Efficacy	P35398	Drug			15	61174799.0	C	T
pharmgkb	gefitinib	RELA	rs11227247		Carcinoma, Non-Small-Cell Lung,Toxic liver disease	Toxicity	Q8WUF5	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	11	65655382.0	A	C
pharmgkb	gefitinib	IKBKB	rs2272733		Carcinoma, Non-Small-Cell Lung,Exanthema	Efficacy	Q96Q05	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	8	42300384.0	T	C
pharmgkb	gefitinib	IKBKE	rs2151222		Carcinoma, Non-Small-Cell Lung,Diarrhea	Toxicity	Q9BRV8	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	1	206480926.0	A	G
pharmgkb	gefitinib	IKBKE	rs12142086		Carcinoma, Non-Small-Cell Lung,Exanthema	Toxicity	Q9BRV8	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	1	206484465.0	T	S
pharmgkb	gefitinib	NFKBIA	rs2233406		Carcinoma, Non-Small-Cell Lung,Diarrhea	Toxicity	P25963	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	14	35405593.0	G	A
pharmgkb	gefitinib	NFKBIA	rs2233407		Carcinoma, Non-Small-Cell Lung,Toxic liver disease	Toxicity	P25963	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	14	35405317.0	T	M
pharmgkb	gefitinib	IKBKB	rs9694958		Carcinoma, Non-Small-Cell Lung,Exanthema	Toxicity	Q96Q05	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	8	42298528.0	A	G
pharmgkb	gefitinib	IKBKE	P713L		Carcinoma, Non-Small-Cell Lung,Exanthema	Toxicity	Q9BRV8	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	1	206496132.0	C	T
pharmgkb	gefitinib	NFKBIA	rs2233409		Carcinoma, Non-Small-Cell Lung,Diarrhea	Toxicity	P25963	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	14	35405064.0	G	A
pharmgkb	gefitinib	NFKBIB	rs2053071		Toxic liver disease	Toxicity	Q9NYS0	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	19	38900291.0	C	G
pharmgkb	gefitinib	NR1H2	rs2695121		Carcinoma, Non-Small-Cell Lung,Diarrhea	Toxicity	P55055	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	19	50377484.0	T	C
pharmgkb	gefitinib	TAB2	rs577001		Diarrhea	Toxicity	Q9NYJ8	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	6	149325172.0	C	T
pharmgkb	gefitinib	NFKBIA	rs8904		Carcinoma, Non-Small-Cell Lung,Exanthema	Toxicity	P25963	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	14	35402011.0	G	H
pharmgkb	progesterone	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17			Metabolism/PK	P33261	Drug	5994.0	CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C				
pharmgkb	ethanol	ANKK1	E713K		Alcoholism	Toxicity	Q8NFD2	Drug	702.0	CCO	11	113400106.0	G	A
pharmgkb	opioids	COMT	rs4633		Dizziness	Toxicity	P21964	Drug Class			22	19962712.0	C	T
pharmgkb	opioids	COMT	rs4633		Sexual Dysfunctions, Psychological	Toxicity	P21964	Drug Class			22	19962712.0	C	T
pharmgkb	oxycodone	CYP3A5	CYP3A5*1, CYP3A5*3			Dosage	P20815	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O				
pharmgkb	sufentanil	CYP3A5	CYP3A5*1, CYP3A5*3			Dosage	P20815	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC				
pharmgkb	sufentanil	ABCB1	rs1128503			Dosage	P08183	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	7	87550285.0	A	G
pharmgkb	methamphetamine	FAAH	P129T		Substance-Related Disorders	Other	O00519	Drug	10836.0	C[C@@H](CC1=CC=CC=C1)NC	1	46405089.0	C	A
pharmgkb	opioids	ADGRV1	rs2366929		Opioid-Related Disorders	Toxicity	Q8WXG9	Drug Class			5	90730817.0	T	C
pharmgkb	diclofenac	CYP2C8	CYP2C8*1, CYP2C8*3, CYP2C8*4			Metabolism/PK	P10632	Drug	3033.0	C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl				
pharmgkb	opioids	OPRM1	rs10457090		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154069938.0	A	K
pharmgkb	opioids	OPRM1	rs589046		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154072003.0	C	T
pharmgkb	hydralazine / isosorbide dinitrate	GNB3	rs5443		Heart Failure	Efficacy	P16520	Drug	9954530.0		12	6845711.0	C	T
pharmgkb	methadone	GAD1	rs3749034		Heroin Dependence	Dosage	Q99259	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	2	170816965.0	G	W
pharmgkb	methadone	GAD1	rs3762556		Heroin Dependence	Dosage	Q99259	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	2	170815568.0	C	R
pharmgkb	methadone	GAD1	H37Q		Heroin Dependence	Dosage	Q99259	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	2	170822115.0	T	C
pharmgkb	methadone	OPRD1	rs204047			Dosage	P41143	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	1	28818612.0	G	Y
pharmgkb	methadone	OPRD1	rs797397			Metabolism/PK	P41143	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	1	28824671.0	G	A
pharmgkb	methadone	OPRD1	rs204047			Metabolism/PK	P41143	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	1	28818612.0	G	Y
pharmgkb	methadone	OPRK1	rs3802279		Heroin Dependence	Dosage	P41145	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	8	53228388.0	C	T
pharmgkb	methadone	OPRK1	rs3802281		Heroin Dependence	Dosage	P41145	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	8	53228603.0	T	C
pharmgkb	methadone	OPRK1	rs963549		Heroin Dependence	Dosage	P41145	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	8	53229264.0	C	T
pharmgkb	dipyrone	CYP2C19	CYP2C19*1, CYP2C19*2			Metabolism/PK	P33261	Drug	522325.0	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]				
pharmgkb	dipyrone	CYP2C9	CYP2C9*1, CYP2C9*3			Metabolism/PK	P11712	Drug	522325.0	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]				
pharmgkb	dipyrone	NAT2	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14			Metabolism/PK	Q6N069	Drug	522325.0	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]				
pharmgkb	opioids	CRYBG2	S902Y		Nausea,Vomiting	Toxicity	Q8N1P7	Drug Class			1	26343953.0	G	T
pharmgkb	opioids	CLCC1	S318R		Nausea,Vomiting	Toxicity	Q96S66	Drug Class			1	108937356.0	G	T
pharmgkb	opioids	POM121L2	A967P		Nausea,Vomiting	Toxicity	Q96KW2	Drug Class			6	27309272.0	C	K
pharmgkb	opioids	ZNF165	rs9393888		Nausea,Vomiting	Toxicity	P49910	Drug Class			6	28091439.0	G	Y
pharmgkb	opioids	MUC16	V8969M		Nausea,Vomiting	Toxicity	Q8WXI7	Drug Class			19	8949865.0	C	T
pharmgkb	opioids	PDE3A	D12N		Nausea,Vomiting	Toxicity	Q14432	Drug Class			12	20369318.0	G	A
pharmgkb	opioids	ZNF568	Y488D		Nausea,Vomiting	Toxicity	Q3ZCX4	Drug Class			19	36997153.0	T	G
pharmgkb	cytarabine	ABCB1	I1145M		Leukemia, Myeloid, Acute	Efficacy	P08183	Drug	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	7	87509329.0	A	K
pharmgkb	hydralazine	NAT2	NAT2*5, NAT2*6, NAT2*7, NAT2*14		Hypertension	Toxicity	Q6N069	Drug	3637.0	C1=CC=C2C(=C1)C=NN=C2NN				
pharmgkb	morphine	ABCC3	rs4793665		Pain	Other	O15438	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	17	50634726.0	C	W
pharmgkb	cisplatin	ERCC1	Q506K		Neoplasms	Toxicity	P07992	Drug	441203.0	N.N.Cl[Pt+2]Cl	19	45409478.0	C	D
pharmgkb	alprazolam	CYP3A	rs35599367			Metabolism/PK	Q9HB55	Drug	2118.0	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	7	99768693.0	G	A
pharmgkb	cocaine	CHRNA5	rs588765		Cocaine-Related Disorders	Toxicity	P30532	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	15	78573083.0	T	M
pharmgkb	cocaine	CHRNA3	D398N		Cocaine-Related Disorders	Toxicity	P32297	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	15	78590583.0	G	A
pharmgkb	opioids	TH	rs2070762		Opioid-Related Disorders	Toxicity	P07101	Drug Class			11	2165105.0	A	G
pharmgkb	opioids	TH	rs10770141		Opioid-Related Disorders	Toxicity	P07101	Drug Class			11	2172610.0	A	S
pharmgkb	opioids	TH	rs10770140		Opioid-Related Disorders	Toxicity	P07101	Drug Class			11	2172367.0	C	T
pharmgkb	dexmedetomidine	ADRA2A	N266K		Pain, Postoperative	Efficacy	P08913	Drug	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	10	111078794.0	C	K
pharmgkb	dexmedetomidine	ADRA2A	R3C		Pain, Postoperative	Efficacy	P08913	Drug	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	10	111078003.0	C	T
pharmgkb	dexmedetomidine	ADRA2A	P15L		Pain, Postoperative	Efficacy	P08913	Drug	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	10	111078040.0	C	T
pharmgkb	imatinib	CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22			Metabolism/PK	P08684	Drug	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5				
pharmgkb	amlodipine	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7			Metabolism/PK	P20815	Drug	2162.0	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN				
pharmgkb	fesoterodine	CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22			Metabolism/PK	P08684	Drug	6918558.0	CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2				
pharmgkb	fentanyl	UGT2B7	Y268H		Pain, Postoperative	Efficacy	P16662	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	4	69098620.0	T	C
pharmgkb	methadone	COMT	rs933271		Opioid-Related Disorders	Efficacy	P21964	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	22	19943884.0	T	M
pharmgkb	opioids	COMT	V158M		Hyperalgesia	Toxicity	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	phenytoin	CYP2C9	N218I			Metabolism/PK	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	10	94949118.0	A	T
pharmgkb	warfarin	CYP2C9	N218I			Metabolism/PK	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94949118.0	A	T
pharmgkb	warfarin	CYP2C9	CYP2C9*1, CYP2C9*29			Metabolism/PK	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	morphine	SLC6A4	rs1042173		Pain	Dosage	P31645	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	17	30197993.0	A	C
pharmgkb	vancomycin	HLA-A	HLA-A*32:01		drug reaction with eosinophilia and systemic symptoms	Toxicity	P04439	Drug	14969.0	C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O				
pharmgkb	ethanol	PDE4B	rs6421482		Alcoholism	Toxicity	Q07343	Drug	702.0	CCO	1	65954222.0	A	K
pharmgkb	ethanol	GCKR	L446R		Alcoholism	Toxicity	Q14397	Drug	702.0	CCO	2	27508073.0	T	C
pharmgkb	ethanol	THSD7B	rs13382553		Alcoholism	Toxicity	Q9C0I4	Drug	702.0	CCO	2	137506661.0	A	G
pharmgkb	ethanol	CADM2	rs62250713		Alcoholism	Toxicity	Q8N3J6	Drug	702.0	CCO	3	85464643.0	A	G
pharmgkb	ethanol	ADH1B	R370H		Alcoholism	Toxicity	P00325	Drug	702.0	CCO	4	99307859.0	C	T
pharmgkb	ethanol	ADH1B	H48R		Alcoholism	Toxicity	P00325	Drug	702.0	CCO	4	99318162.0	T	S
pharmgkb	ethanol	ADH1C	rs13125415		Alcoholism	Toxicity	P00326	Drug	702.0	CCO	4	99349295.0	A	G
pharmgkb	ethanol	SLC39A8	rs13135092		Alcoholism	Toxicity	Q9C0K1	Drug	702.0	CCO	4	102276925.0	A	G
pharmgkb	antineoplastic agents	TP53	P33H		Drug Toxicity	Toxicity	Q12888	Drug Class			17	7676154.0	G	Y
pharmgkb	ethanol	DPP6	rs2533200		Alcoholism	Toxicity	P42658	Drug	702.0	CCO	7	153791989.0	C	G
pharmgkb	ethanol	MED19	rs576859		Alcoholism	Toxicity	A0JLT2	Drug	702.0	CCO	11	57713151.0	C	R
pharmgkb	ethanol	SLC4A8	rs12296477		Alcoholism	Toxicity	Q2Y0W8	Drug	702.0	CCO	12	51510076.0	C	G
pharmgkb	ethanol	ARID4A	rs61974485		Alcoholism	Toxicity	P29374	Drug	702.0	CCO	14	58299185.0	T	C
pharmgkb	ethanol	TNRC6A	rs72768626		Alcoholism	Toxicity	Q8NDV7	Drug	702.0	CCO	16	24681727.0	A	G
pharmgkb	ethanol	FTO	rs9937709		Alcoholism	Toxicity	Q9C0B1	Drug	702.0	CCO	16	53786901.0	A	G
pharmgkb	ethanol	FUT2	rs492602		Alcoholism	Toxicity	Q10981	Drug	702.0	CCO	19	48703160.0	A	G
pharmgkb	phenytoin	ABCB1	I1145M		Epilepsy	Efficacy	P08183	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	7	87509329.0	A	K
pharmgkb	risperidone	HTR2A	rs6313		Schizophrenia	Efficacy	P28223	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	13	46895805.0	G	A
pharmgkb	olanzapine	HTR2A	rs6313		Schizophrenia	Efficacy	P28223	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	13	46895805.0	G	A
pharmgkb	ethylmorphine	CYP2D6	CYP2D6*1, CYP2D6*4			Metabolism/PK	P10635	Drug	5359271.0					
pharmgkb	hydrocodone	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4		Opioid-Related Disorders	Toxicity	P10635	Drug	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4				
pharmgkb	codeine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4		Opioid-Related Disorders	Toxicity	P10635	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O				
pharmgkb	dihydrocodeine	CYP2D6	CYP2D6*1, CYP2D6*4			Metabolism/PK	P10635	Drug, Metabolite	5284543.0					
pharmgkb	hydrocodone	CYP2D6	CYP2D6*1, CYP2D6*2xN		Drug Toxicity	Toxicity	P10635	Drug	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4				
pharmgkb	cisplatin,cyclophosphamide	GSTM3	rs36120609		Drug Toxicity	Toxicity	P21266				1	109737631.0	TCC	-
pharmgkb	olanzapine	GSTM3	rs36120609			Metabolism/PK	P21266	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	1	109737631.0	TCC	-
pharmgkb	methotrexate	HLA-G	rs371194629		Arthritis, Rheumatoid	Efficacy	P17693	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	6	29830805.0	-	ATTTGT/ATTTGTTCATGCCT
pharmgkb	ethanol	OPRM1	N40D		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154039662.0	A	G
pharmgkb	clozapine	UGT1A1	UGT1A1*1, UGT1A1*28			Metabolism/PK	P22309	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl				
pharmgkb	raloxifene	UGT1A1	UGT1A1*1, UGT1A1*28		bone density	Efficacy	P22309	Drug	5035.0	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O				
pharmgkb	raloxifene	UGT1A1	UGT1A1*1, UGT1A1*28		Osteoporosis	Metabolism/PK	P22309	Drug	5035.0	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O				
pharmgkb	metronidazole	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17			Metabolism/PK	P11509	Drug	4173.0	CC1=NC=C(N1CCO)[N+](=O)[O-]				
pharmgkb	tranilast	UGT1A1	UGT1A1*1, UGT1A1*28		Hyperbilirubinemia	Toxicity	P22309	Drug	5282230.0					
pharmgkb	nilotinib	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28		Hyperbilirubinemia	Toxicity	P22309	Drug	644241.0	CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5				
pharmgkb	oxcarbazepine	HLA-A	HLA-A*31:01		drug reaction with eosinophilia and systemic symptoms	Toxicity	P04439	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	morphine	ABCB1	rs1128503			Metabolism/PK	P08183	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	7	87550285.0	A	G
pharmgkb	dabigatran	CYP3A5	CYP3A5*1, CYP3A5*3			Metabolism/PK	P20815	Drug						
pharmgkb	fentanyl	CYP2D6	CYP2D6*1, CYP2D6*10			Dosage	P10635	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3				
pharmgkb	ketoprofen,tramadol	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41			Toxicity	P10635							
pharmgkb	opioids	ABCB1	N21H		Death,Opioid-Related Disorders	Toxicity	P08183	Drug Class			7	87600124.0	T	C
pharmgkb	opioids	COMT	V158M		Death,Opioid-Related Disorders	Toxicity	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	indinavir	UGT1A1	UGT1A1*1, UGT1A1*28		HIV Infections	Toxicity	P22309	Drug	5362440.0	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5				
pharmgkb	peginterferon alfa-2a	IFNL3	rs12979860		Hepatitis B, Chronic	Efficacy	Q8IZI9	Drug			19	39248147.0	C	T
pharmgkb	sofosbuvir	IFNL3	rs12979860		Hepatitis C, Chronic	Efficacy	Q8IZI9	Drug	45375808.0	C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	19	39248147.0	C	T
pharmgkb	interferons	IFNL3	rs12979860		Hepatitis C	Efficacy	Q8IZI9	Drug Class			19	39248147.0	C	T
pharmgkb	methadone	CYP2B6	K262R		Neonatal Abstinence Syndrome	Toxicity	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	19	41009358.0	A	G
pharmgkb	buprenorphine	PNOC	rs351776		Neonatal Abstinence Syndrome	Toxicity	Q13519	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	8	28333789.0	A	C
pharmgkb	methadone	PNOC	rs351776		Neonatal Abstinence Syndrome	Toxicity	Q13519	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	8	28333789.0	A	C
pharmgkb	methadone	CYP2A7P1	Q172H		Neonatal Abstinence Syndrome	Toxicity		Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	19	41006936.0	G	W
pharmgkb	methadone	COMT	V158M		Neonatal Abstinence Syndrome	Toxicity	P21964	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	22	19963748.0	G	A
pharmgkb	buprenorphine	PNOC	rs4732636		Neonatal Abstinence Syndrome	Toxicity	Q13519	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	8	28310063.0	C	A
pharmgkb	methadone	PNOC	rs4732636		Neonatal Abstinence Syndrome	Toxicity	Q13519	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	8	28310063.0	C	A
pharmgkb	methadone	COMT	rs740603		Neonatal Abstinence Syndrome	Toxicity	P21964	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	22	19957654.0	A	G
pharmgkb	carboplatin,cisplatin,oxaliplatin,platinum,Platinum compounds	ERCC1	rs11615		Neoplasms	Toxicity	P07992				19	45420395.0	A	G
pharmgkb	Platinum compounds	SLC31A1	rs10759637		overall survival,Thrombocytopenia	Efficacy	O15431	Drug Class			9	113262744.0	A	C
pharmgkb	gemcitabine	SLC28A2	P22L		Carcinoma, Non-Small-Cell Lung	Efficacy	O43868	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	15	45253280.0	C	T
pharmgkb	nevirapine	CYP2B6	I328T		HIV Infections	Metabolism/PK	P20813	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	19	41012316.0	T	C
pharmgkb	methadone	CYP2B6	CYP2B6*1, CYP2B6*6			Toxicity	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	methadone	CYP2B6	CYP2B6*1, CYP2B6*6			Efficacy	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	losartan	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*13, CYP2C9*59, CYP2C9*62			Metabolism/PK	P11712	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl				
pharmgkb	atazanavir	UGT1A1	rs887829		HIV Infections	Other	P22309	Drug	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	2	233759924.0	C	T
pharmgkb	antidepressants	HTR7	rs7905446		Depression	Efficacy	P34969	Drug Class			10	90859404.0	T	R
pharmgkb	Selective serotonin reuptake inhibitors	HTR7	rs7905446		Depression	Efficacy	P34969	Drug Class			10	90859404.0	T	R
pharmgkb	paroxetine	HTR7	rs7905446		Bipolar Disorder	Efficacy	P34969	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	10	90859404.0	T	R
pharmgkb	escitalopram	HTR7	rs7905446		Depression	Efficacy	P34969	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	10	90859404.0	T	R
pharmgkb	heroin	OPRM1	rs495491		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154061407.0	A	G
pharmgkb	opioids	OPRM1	rs495491		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154061407.0	A	G
pharmgkb	cisplatin,oxaliplatin,platinum,Platinum compounds	ERCC2	rs13181		Colorectal Neoplasms,Esophageal Neoplasms,Osteosarcoma,Ovarian Neoplasms,Pancreatic Neoplasms	Efficacy	P18074				19	45351661.0	T	R
pharmgkb	Platinum compounds	TP53	P33H		overall survival	Efficacy	Q12888	Drug Class			17	7676154.0	G	Y
pharmgkb	corticosteroids	CRHR1	rs1876828		Asthma	Efficacy	P34998	Drug Class			17	45834159.0	C	T
pharmgkb	capecitabine	CDA	rs3215400		hand-foot syndrome,Neoplasms	Toxicity	Q96GN5	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	1	20589097.0	C	-
pharmgkb	cisplatin	XPC	Q939E		Neoplasms,Osteosarcoma,Ototoxicity,Testicular Neoplasms	Toxicity	Q01831	Drug	441203.0	N.N.Cl[Pt+2]Cl	3	14145949.0	G	T
pharmgkb	cisplatin	TMEM43	Q939E		Neutropenia,Urinary Bladder Neoplasms	Toxicity	Q9BTV4	Drug	441203.0	N.N.Cl[Pt+2]Cl	3	14145949.0	G	T
pharmgkb	cisplatin	TMEM43	Q939E		Drug Toxicity,Urinary Bladder Neoplasms	Toxicity	Q9BTV4	Drug	441203.0	N.N.Cl[Pt+2]Cl	3	14145949.0	G	T
pharmgkb	dapsone	HLA-B	HLA-B*15:02		severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N				
pharmgkb	sunitinib	ABCG2	Q141K		Neoplasms	Toxicity	Q9UNQ0	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	4	88131171.0	G	Y
pharmgkb	sorafenib	UGT1A1	UGT1A1*1, UGT1A1*28		Carcinoma, Hepatocellular,Hyperbilirubinemia	Toxicity	P22309	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F				
pharmgkb	methotrexate	ABCC3	rs9895420		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	O15438	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	17	50634677.0	T	A
pharmgkb	omeprazole	CYP2C19	CYP2C19*1, CYP2C19*23, CYP2C19*29, CYP2C19*30, CYP2C19*31, CYP2C19*33			Metabolism/PK	P33261	Drug	4594.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC				
pharmgkb	acenocoumarol	VKORC1	rs9923231		Hemorrhage	Toxicity	Q8N0U8	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	16	31096368.0	C	D
pharmgkb	pravastatin,simvastatin	HMGCR	rs17244841			Efficacy	P04035				5	75347030.0	A	T
pharmgkb	simvastatin	HMGCR	rs17244841			Efficacy	P04035	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	5	75347030.0	A	T
pharmgkb	lovastatin acid	SLCO1B1	V174A			Metabolism/PK	Q9Y6L6	Metabolite	64727.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C	12	21178615.0	T	C
pharmgkb	risperidone	ANKK1	E713K		Hyperprolactinemia,Schizophrenia	Toxicity	Q8NFD2	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	11	113400106.0	G	A
pharmgkb	clobazam	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Epilepsy	Metabolism/PK	P33261	Drug	2789.0	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3				
pharmgkb	clobazam	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Epilepsy	Efficacy	P33261	Drug	2789.0	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3				
pharmgkb	clobazam	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Epilepsy	Dosage	P33261	Drug	2789.0	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3				
pharmgkb	corticosteroids	ADRB2	R16G		Asthma	Efficacy	P07550	Drug Class			5	148826877.0	G	A
pharmgkb	corticosteroids,selective beta-2-adrenoreceptor agonists	ADRB2	R16G		Asthma	Efficacy	P07550				5	148826877.0	G	A
pharmgkb	rosuvastatin	LPA	rs10455872			Efficacy	O75334	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	6	160589086.0	A	G
pharmgkb	nicotine	COMT	V158M		Tobacco Use Disorder	Efficacy	P21964	Drug	942.0	CN1CCCC1C2=CN=CC=C2	22	19963748.0	G	A
pharmgkb	nicotine	COMT	V158M		Tobacco Use Disorder	Toxicity	P21964	Drug	942.0	CN1CCCC1C2=CN=CC=C2	22	19963748.0	G	A
pharmgkb	enalapril	ACE	rs1799752		Arteriosclerosis,Coronary Disease,Essential hypertension,glomerular disease,Glomerulonephritis, IGA,Kidney Diseases	Efficacy	P12821	Drug	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	gemcitabine	CDA	K27Q		Carcinoma, Non-Small-Cell Lung,Mesothelioma,Pancreatic Neoplasms	Toxicity	Q96GN5	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	1	20589208.0	A	C
pharmgkb	caffeine	ADORA2A	rs5751876		Anxiety Disorders	Toxicity	P29274	Drug	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	22	24441333.0	T	C
pharmgkb	debrisoquine,dextromethorphan	CYP2D6	CYP2D6*1, CYP2D6*29			Other	P10635							
pharmgkb	gefitinib	EGFR	rs11568315		Carcinoma, Non-Small-Cell Lung	Efficacy	P00533	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4				
pharmgkb	venlafaxine	CYP2C19	CYP2C19*2		Depression	Metabolism/PK	P33261	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O				
pharmgkb	carbamazepine	EPHX1	Y113H		Epilepsy	Metabolism/PK	P07099	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	1	225831932.0	T	C
pharmgkb	carbamazepine	EPHX1	Y113H		Epilepsy	Dosage	P07099	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	1	225831932.0	T	C
pharmgkb	lapatinib	HLA-DRB1	HLA-DRB1*07:01		Toxic liver disease	Toxicity	P01911	Drug	208908.0	CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl				
pharmgkb	tegafur	UMPS	G213A		Drug Toxicity	Toxicity	P11172	Prodrug	5386.0		3	124737895.0	G	M
pharmgkb	cisplatin,oxaliplatin,Platinum compounds	MTHFR	A222V		Neoplasms	Toxicity	P42898				1	11796321.0	G	A
pharmgkb	lopinavir	SLCO1B1	V174A		HIV Infections	Metabolism/PK	Q9Y6L6	Drug	92727.0	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	12	21178615.0	T	C
pharmgkb	interferon alfa-2b, recombinant,ribavirin	ITPA	P32T		Hepatitis C, Chronic	Dosage	Q9BY32				20	3213196.0	C	R
pharmgkb	fluorouracil,FOLFOX	TYMS	rs11280056		Neoplasms	Toxicity	P04818				18	673447.0	AAGTTA	-
pharmgkb	allopurinol	ABCG2	Q141K		Gout	Efficacy	Q9UNQ0	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	4	88131171.0	G	Y
pharmgkb	cisplatin,oxaliplatin,Platinum compounds	GSTP1	I105V		Carcinoma, Non-Small-Cell Lung,Colorectal Neoplasms,Gastrointestinal Neoplasms,Ovarian Neoplasms	Toxicity	P09211				11	67585218.0	A	G
pharmgkb	nicotine	ANKK1	E713K		Tobacco Use Disorder	Efficacy	Q8NFD2	Drug	942.0	CN1CCCC1C2=CN=CC=C2	11	113400106.0	G	A
pharmgkb	risperidone	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Drug Toxicity	Toxicity	P31645	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F				
pharmgkb	carbamazepine	SCN1A	rs3812718		Epilepsy	Efficacy	P35498	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	2	166053034.0	C	T
pharmgkb	warfarin	CALU	rs339097			Dosage	O43852	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	7	128759170.0	A	G
pharmgkb	phenprocoumon	CYP4F2	V433M			Dosage	P78329	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	19	15879621.0	C	T
pharmgkb	carbamazepine	EPHX1	H139R		Epilepsy	Dosage	P07099	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	1	225838705.0	A	K
pharmgkb	diuretics,hydrochlorothiazide	NEDD4L	rs4149601		Hypertension	Efficacy	Q96PU5				18	58149559.0	G	A
pharmgkb	phenytoin	CYP2C9	CYP2C9*1, CYP2C9*19, CYP2C9*27, CYP2C9*36, CYP2C9*40, CYP2C9*41, CYP2C9*47, CYP2C9*49, CYP2C9*51, CYP2C9*53, CYP2C9*54, CYP2C9*56			Metabolism/PK	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	nevirapine	CCHCR1	rs746647		HIV Infections	Toxicity	Q8TD31	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	6	31146405.0	A	G
pharmgkb	hmg coa reductase inhibitors	CETP	rs1532624		Hyperlipidemias	Efficacy	P11597	Drug Class			16	56971567.0	C	A
pharmgkb	nicotine	CHRNB2	rs2072661		Tobacco Use Disorder	Efficacy,Toxicity	P17787	Drug	942.0	CN1CCCC1C2=CN=CC=C2	1	154576404.0	G	A
pharmgkb	digoxin	ABCB1	I1145M			Metabolism/PK	P08183	Drug	30322.0	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	7	87509329.0	A	K
pharmgkb	nicotine	UGT2B10	D67Y			Metabolism/PK	P36537	Drug	942.0	CN1CCCC1C2=CN=CC=C2	4	68816218.0	G	W
pharmgkb	cyclophosphamide	SOD2	V16A		Breast Neoplasms	Efficacy	P04179	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	6	159692840.0	A	G
pharmgkb	tacrolimus	POR	A503V		Transplantation	Metabolism/PK	Q9Y277	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	75985688.0	C	T
pharmgkb	rosiglitazone	CYP2C8	CYP2C8*1, CYP2C8*3			Metabolism/PK	P10632	Drug	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3				
pharmgkb	rosiglitazone	CYP2C8	CYP2C8*1, CYP2C8*3			Toxicity	P10632	Drug	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3				
pharmgkb	sunitinib	FLT3	T227M		Leukopenia,Myelosuppression,Neutropenia,Thrombocytopenia	Toxicity	P36888	Drug	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	13	28050157.0	G	A
pharmgkb	methotrexate	MTRR	I49M		Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	Efficacy	Q9UBK8	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	7870860.0	A	G
pharmgkb	warfarin	VKORC1	rs7196161			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31099660.0	G	M
pharmgkb	Bisphosphonates	FDPS	rs2297480		Osteoporosis,Osteoporosis, Postmenopausal	Efficacy	P14324	Drug Class			1	155309691.0	T	G
pharmgkb	salbutamol	CRHR2	rs7793837		Asthma	Efficacy	P55089	Drug	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	7	30687161.0	A	Y
pharmgkb	etoposide,Platinum compounds	DYNC2H1	rs716274			Efficacy	Q8NCM8				11	103547430.0	A	G
pharmgkb	cisplatin,oxaliplatin,Platinum compounds	GSTM1	GSTM1 non-null, GSTM1 null		Neoplasms	Efficacy	P09488							
pharmgkb	hydrochlorothiazide	ACE	rs1799752		Essential hypertension	Efficacy	P12821	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	nortriptyline	GNB3	rs5443		Depressive Disorder, Major	Efficacy	P16520	Drug	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	12	6845711.0	C	T
pharmgkb	mirtazapine	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Depressive Disorder, Major	Toxicity	P31645	Drug	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4				
pharmgkb	antidepressants,Selective serotonin reuptake inhibitors	FKBP5	rs4713916		Depressive Disorder,Mood Disorders	Efficacy	Q13451				6	35702206.0	A	B
pharmgkb	fluindione	VKORC1	rs9934438		Thromboembolism	Efficacy	Q8N0U8	Drug			16	31093557.0	G	M
pharmgkb	warfarin	EPHA7	rs78132896		Hemorrhage	Toxicity	Q15375	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	6	93420339.0	T	C
pharmgkb	anastrozole	CYP19A1	rs1008805		Breast Neoplasms	Toxicity	P11511	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	15	51257402.0	G	A
pharmgkb	radiotherapy	TANC1	rs10497203		Prostatic Neoplasms	Toxicity	Q9C0D5	Drug Class			2	158994911.0	A	C
pharmgkb	anthracyclines and related substances	CBR3	V244M		Heart Failure,Neoplasms	Toxicity	O75828	Drug Class			21	36146408.0	G	A
pharmgkb	anthracyclines and related substances	CBR1	rs9024		Cardiomyopathies,Neoplasms	Toxicity	P16152	Drug Class			21	36073015.0	G	A
pharmgkb	esomeprazole	STAT6	rs1059513		eosinophilic esophagitis	Efficacy	P42226	Drug	9568614.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	12	57095926.0	T	C
pharmgkb	antipsychotics	HTR2C	rs3813929		Mental Disorders	Toxicity	P28335	Drug Class			X	114584047.0	C	K
pharmgkb	olanzapine	HTR2C	rs3813929		Mental Disorders,Schizophrenia	Toxicity	P28335	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	X	114584047.0	C	K
pharmgkb	risperidone	HTR2C	rs3813929		Mental Disorders,Schizophrenia	Toxicity	P28335	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	X	114584047.0	C	K
pharmgkb	clozapine	HTR2C	rs3813929		Mental Disorders,Schizophrenia	Toxicity	P28335	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	X	114584047.0	C	K
pharmgkb	clozapine	HTR2C	rs1414334		Metabolic Syndrome,Schizophrenia	Toxicity	P28335	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	X	114903581.0	C	G
pharmgkb	risperidone	HTR2C	rs1414334		Metabolic Syndrome	Toxicity	P28335	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	X	114903581.0	C	G
pharmgkb	olanzapine	HTR2C	rs518147		Schizophrenia,Weight gain	Toxicity	P28335	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	X	114584109.0	C	R
pharmgkb	risperidone	HTR2C	C23S		Schizophrenia,Weight gain	Toxicity	P28335	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	X	114731326.0	C	K
pharmgkb	escitalopram	HTR2C	C23S		neuropathic pain	Efficacy	P28335	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	X	114731326.0	C	K
pharmgkb	olanzapine	HTR2C	rs2497538		Weight gain	Toxicity	P28335	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	X	114733932.0	A	C
pharmgkb	tamoxifen	CYP19A1	rs4646		Breast Neoplasms,Menopause	Efficacy	P11511	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	15	51210647.0	A	C
pharmgkb	tamoxifen	CYP19A1	rs4646		Breast Neoplasms	Efficacy	P11511	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	15	51210647.0	A	C
pharmgkb	amitriptyline	CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98			Metabolism/PK	P10635	Drug	2160.0	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31				
pharmgkb	clopidogrel	CYP2C19	CYP2C19*1, CYP2C19*14, CYP2C19*23			Metabolism/PK	P33261	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3				
pharmgkb	nicotine	CHRNA3	rs1051730		Tobacco Use Disorder	Toxicity	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78601997.0	G	A
pharmgkb	nicotine	CHRNA3	rs1051730		Tobacco Use Disorder	Dosage	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78601997.0	G	A
pharmgkb	gemcitabine	NT5C2	rs11598702		Neoplasms	Metabolism/PK	P49902	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	10	103138228.0	T	S
pharmgkb	radiotherapy	TANC1	rs7582141		Prostatic Neoplasms	Toxicity	Q9C0D5	Drug Class			2	159042977.0	G	T
pharmgkb	radiotherapy	TANC1	rs6432512		Prostatic Neoplasms	Toxicity	Q9C0D5	Drug Class			2	159043401.0	C	T
pharmgkb	radiotherapy	TANC1	rs264631		Prostatic Neoplasms	Toxicity	Q9C0D5	Drug Class			2	159094353.0	C	G
pharmgkb	radiotherapy	TANC1	rs264588		Prostatic Neoplasms	Toxicity	Q9C0D5	Drug Class			2	159079879.0	C	W
pharmgkb	hydrochlorothiazide	PRKCA	rs16960228		Hypertension	Efficacy	Q9NRD5	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	17	66792709.0	G	A
pharmgkb	salbutamol	COL22A1	rs6988229		Asthma	Efficacy	Q8NFW1	Drug	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	8	138872266.0	C	T
pharmgkb	radiotherapy	TANC1	rs264651		Prostatic Neoplasms	Toxicity	Q9C0D5	Drug Class			2	159072919.0	A	G
pharmgkb	cisplatin	ACYP2	rs1872328		Brain Neoplasms,Deafness,Ototoxicity	Toxicity	P14621	Drug	441203.0	N.N.Cl[Pt+2]Cl	2	54168122.0	G	A
pharmgkb	furosemide,spironolactone	ADD1	G460W		Liver Cirrhosis	Efficacy	P35611				4	2904980.0	G	W
pharmgkb	caffeine	ADORA2A	rs2298383			Toxicity	P29274	Drug	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	22	24429543.0	C	W
pharmgkb	cerivastatin	SLCO1B1	V174A		Rhabdomyolysis	Toxicity	Q9Y6L6	Drug	446156.0	CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC	12	21178615.0	T	C
pharmgkb	clodronate	VDR	rs1544410			Efficacy	P11473	Drug	25419.0	C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl	12	47846052.0	C	D
pharmgkb	sirolimus	CYP3A5	CYP3A5*1, CYP3A5*3		Transplantation	Metabolism/PK	P20815	Drug	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC				
pharmgkb	sirolimus	CYP3A5	CYP3A5*1, CYP3A5*3			Dosage	P20815	Drug	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC				
pharmgkb	metoprolol	ADRB1	G389R			Efficacy	P08588	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	10	114045297.0	G	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	SLCO1C1	rs3794271		Arthritis, Psoriatic,Arthritis, Rheumatoid	Efficacy	Q9NYB5	Drug Class			12	20707159.0	G	A
pharmgkb	cyclosporine,tacrolimus	CRTC2	rs8450		Transplantation	Toxicity	Q53ET0				1	153947810.0	G	A
pharmgkb	Selective serotonin reuptake inhibitors	CYP2D6	CYP2D6*1, CYP2D6*4		Depression	Dosage	P10635	Drug Class						
pharmgkb	peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,simeprevir	IFNL3	rs12979860		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	daclatasvir,peginterferon alfa-2a,peginterferon alfa-2b,ribavirin	IFNL3	rs12979860		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	sulfonamides, urea derivatives	TCF7L2	rs7903146			Efficacy	P35222	Drug Class			10	112998590.0	C	K
pharmgkb	trastuzumab	FCGR3A	F175V		Breast Neoplasms	Efficacy	P20963	Drug			1	161544752.0	A	B
pharmgkb	anthracyclines and related substances	HAS3	rs2232228		Cardiomyopathies	Toxicity	O00219	Drug Class			16	69109674.0	A	S
pharmgkb	trastuzumab	FCGR2A	H166P		Breast Neoplasms	Efficacy	P08631	Drug			1	161509955.0	A	S
pharmgkb	asparaginase,cyclophosphamide,daunorubicin,prednisolone,vincristine	PNPLA3	I148M		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9NST1				22	43928847.0	C	G
pharmgkb	azathioprine,mercaptopurine,thioguanine	NUDT15	rs746071566		Inflammatory Bowel Diseases,Myelosuppression	Toxicity	Q9NV35				13	48037783.0	GGAGTC	-
pharmgkb	Selective serotonin reuptake inhibitors	COMT	rs13306278		Depressive Disorder, Major	Efficacy	P21964	Drug Class			22	19941504.0	C	T
pharmgkb	warfarin	CYP2C9	rs7089580			Dosage	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94945466.0	A	K
pharmgkb	pravastatin	SLCO1B1	rs4149015			Metabolism/PK	Q9Y6L6	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	12	21130388.0	G	M
pharmgkb	atorvastatin,hmg coa reductase inhibitors,rosuvastatin	COQ2	rs4693075		Muscular Diseases	Toxicity	Q96H96				4	83271015.0	G	H
pharmgkb	warfarin	GGCX	rs11676382			Dosage	P38435	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	85550510.0	C	G
pharmgkb	simvastatin	ABCB1	S893A		Hypercholesterolemia	Efficacy	P08183	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	87531302.0	A	Y
pharmgkb	anthracyclines and related substances	SLC28A3	rs885004		Neoplasms	Toxicity	Q9HAS3	Drug Class			9	84294635.0	G	A
pharmgkb	anthracyclines and related substances	SLC28A3	rs7853758		Neoplasms	Toxicity	Q9HAS3	Drug Class			9	84286011.0	G	A
pharmgkb	ibuprofen	CYP2C8	CYP2C8*1, CYP2C8*3			Metabolism/PK	P10632	Drug	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O				
pharmgkb	peginterferon alfa-2b,ribavirin	VDR	M51T		Hepatitis C, Chronic	Efficacy	P11473				12	47879112.0	A	B
pharmgkb	irinotecan	SEMA3C	rs7779029		Carcinoma, Non-Small-Cell Lung	Toxicity	Q99985	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	7	80902796.0	T	C
pharmgkb	phenytoin	SCN1A	rs3812718		Epilepsy	Dosage	P35498	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	2	166053034.0	C	T
pharmgkb	sildenafil	GNB3	rs5443		Erectile Dysfunction	Efficacy	P16520	Drug	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	12	6845711.0	C	T
pharmgkb	rituximab	FCGR3A	F175V			Efficacy	P20963	Drug			1	161544752.0	A	B
pharmgkb	naloxone	OPRM1	N40D			Efficacy	P35372	Drug	5284596.0	C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O	6	154039662.0	A	G
pharmgkb	irinotecan	C8orf34	rs1517114		Carcinoma, Non-Small-Cell Lung	Toxicity	Q49A92	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	8	68476982.0	C	D
pharmgkb	lamotrigine	HLA-B	HLA-B*58:01		severe cutaneous adverse reactions	Toxicity	P01889	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N				
pharmgkb	warfarin	CYP2C19	rs3814637			Dosage	P33261	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94761288.0	C	D
pharmgkb	warfarin	CYP2C19	rs3814637			Toxicity	P33261	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94761288.0	C	D
pharmgkb	gliclazide	KCNJ11	K23Q		Diabetes Mellitus	Efficacy	Q14654	Drug	3475.0	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2	11	17388025.0	T	M
pharmgkb	sulfonamides, urea derivatives	KCNJ11	K23Q		Diabetes Mellitus	Efficacy	Q14654	Drug Class			11	17388025.0	T	M
pharmgkb	atenolol	GNB3	rs5443		Essential hypertension	Efficacy	P16520	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	12	6845711.0	C	T
pharmgkb	pravastatin	CETP	rs708272		Coronary Artery Disease	Efficacy	P11597	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	16	56962376.0	G	A
pharmgkb	efavirenz	CYP2B6	rs4803419		HIV Infections	Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	41006887.0	C	T
pharmgkb	alfentanil	OPRM1	N40D		Pain	Efficacy	P35372	Drug	51263.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	6	154039662.0	A	G
pharmgkb	alfentanil	OPRM1	N40D			Toxicity	P35372	Drug	51263.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	6	154039662.0	A	G
pharmgkb	alfentanil	OPRM1	N40D		Pain	Metabolism/PK	P35372	Drug	51263.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	6	154039662.0	A	G
pharmgkb	alfentanil	OPRM1	N40D		Pain	Dosage	P35372	Drug	51263.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	6	154039662.0	A	G
pharmgkb	buprenorphine,fentanyl,tramadol	OPRM1	N40D		adverse events,Opioid-Related Disorders	Toxicity	P35372				6	154039662.0	A	G
pharmgkb	fentanyl	OPRM1	N40D		somnolence	Toxicity	P35372	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	6	154039662.0	A	G
pharmgkb	fentanyl	OPRM1	Q402H		Vomiting	Toxicity	P35372	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	6	154093311.0	A	Y
pharmgkb	fentanyl	OPRM1	rs9397685		Nausea,Pain, Postoperative,Vomiting	Toxicity	P35372	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	6	154112099.0	A	G
pharmgkb	fentanyl	OPRM1	N40D		Pain	Efficacy	P35372	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	6	154039662.0	A	G
pharmgkb	fentanyl	OPRM1	N40D		Pain,Pain, Postoperative	Dosage	P35372	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	6	154039662.0	A	G
pharmgkb	hydrocodone	OPRM1	N40D		Constipation,dry mouth,Respiratory Insufficiency	Toxicity	P35372	Drug	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	6	154039662.0	A	G
pharmgkb	morphine	OPRM1	N40D		Neonatal Abstinence Syndrome	Toxicity	P35372	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	6	154039662.0	A	G
pharmgkb	codeine	OPRM1	N40D			Dosage	P35372	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	6	154039662.0	A	G
pharmgkb	sufentanil	OPRM1	rs1323040			Dosage	P35372	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	6	154010889.0	A	G
pharmgkb	acetaminophen,tramadol	OPRM1	N40D		neuropathic pain	Efficacy	P35372				6	154039662.0	A	G
pharmgkb	buprenorphine,fentanyl,tramadol	COMT	V158M		Exanthema,Opioid-Related Disorders	Toxicity	P21964				22	19963748.0	G	A
pharmgkb	buprenorphine	COMT	V158M		Neonatal Abstinence Syndrome	Toxicity	P21964	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	22	19963748.0	G	A
pharmgkb	buprenorphine	COMT	V158M		Neonatal Abstinence Syndrome	Toxicity	P21964	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	22	19963748.0	G	A
pharmgkb	buprenorphine	COMT	rs740603		Neonatal Abstinence Syndrome	Toxicity	P21964	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	22	19957654.0	A	G
pharmgkb	fentanyl	COMT	V158M		Pain	Efficacy	P21964	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	22	19963748.0	G	A
pharmgkb	fentanyl	COMT	V158M		somnolence	Toxicity	P21964	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	22	19963748.0	G	A
pharmgkb	morphine	COMT	V158M		Pain,Pain, Postoperative	Dosage	P21964	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	22	19963748.0	G	A
pharmgkb	remifentanil	COMT	V158M		Pain	Efficacy	P21964	Drug	60815.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC	22	19963748.0	G	A
pharmgkb	opioids	COMT	V158M		Pain	Efficacy	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	oxycodone	COMT	V158M			Efficacy	P21964	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	22	19963748.0	G	A
pharmgkb	opioids	OPRM1	N40D		adverse events,Nausea,Vomiting	Toxicity	P35372	Drug Class			6	154039662.0	A	G
pharmgkb	opioids	OPRM1	N40D		Pain, Postoperative	Efficacy	P35372	Drug Class			6	154039662.0	A	G
pharmgkb	oxycodone	OPRM1	N40D			Efficacy	P35372	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	6	154039662.0	A	G
pharmgkb	methadone	OPRM1	rs2075572		Opioid-Related Disorders	Toxicity	P35372	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	6	154090869.0	G	C
pharmgkb	methadone	OPRM1	N40D		Opioid-Related Disorders,Sleep Disorders	Toxicity	P35372	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	6	154039662.0	A	G
pharmgkb	methadone	OPRM1	rs558025		Heroin Dependence,Opioid-Related Disorders	Dosage	P35372	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	6	154120830.0	A	G
pharmgkb	methadone	OPRM1	N40D		Neonatal Abstinence Syndrome	Toxicity	P35372	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	6	154039662.0	A	G
pharmgkb	methadone	COMT	V158M		Neonatal Abstinence Syndrome	Toxicity	P21964	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	22	19963748.0	G	A
pharmgkb	methadone	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6		Heroin Dependence,Opioid-Related Disorders	Efficacy	P10635	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	methadone	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*6			Metabolism/PK	P10635	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	methadone	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6		Heroin Dependence,Opioid-Related Disorders	Dosage	P10635	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	warfarin	CYP2C9	rs4917639			Dosage	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	10	94965778.0	A	Y
pharmgkb	fluorouracil,FOLFIRI,FOLFOX	TYMS	rs45445694		overall survival,progression-free survival	Efficacy	P04818							
pharmgkb	fluorouracil	TYMS	rs45445694		Drug Toxicity	Toxicity	P04818	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F				
pharmgkb	acetaldehyde	ALDH2	E457K			Metabolism/PK	P05091	Metabolite	177.0		12	111803962.0	G	A
pharmgkb	ethanol	ALDH2	E457K			Metabolism/PK	P05091	Drug	702.0	CCO	12	111803962.0	G	A
pharmgkb	ivacaftor / lumacaftor	CFTR	rs113993960		Cystic Fibrosis	Toxicity	P13569	Drug	71494926.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117559592.0	CTT	-
pharmgkb	ivacaftor / lumacaftor	CFTR	A455E		Cystic Fibrosis	Efficacy	P13569	Drug	71494926.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117548795.0	C	W
pharmgkb	ivacaftor / lumacaftor	CFTR	R334W		Cystic Fibrosis	Efficacy	P13569	Drug	71494926.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117540230.0	C	T
pharmgkb	esomeprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3			Metabolism/PK	P33261	Drug	9568614.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC				
pharmgkb	Platinum compounds	NQO1	P187S		Neoplasms	Efficacy	P15559	Drug Class			16	69711242.0	G	A
pharmgkb	cyclosporine	CYP3A5	CYP3A5*1, CYP3A5*3		Kidney Transplantation	Dosage	P20815	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C				
pharmgkb	cyclosporine	CYP3A5	CYP3A5*1, CYP3A5*3		Kidney Transplantation	Metabolism/PK	P20815	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C				
pharmgkb	antidepressants	GRIK4	rs1954787		Depressive Disorder	Efficacy	Q16099	Drug Class			11	120792654.0	T	C
pharmgkb	aspirin	GP1BA	T161M			Efficacy	P07359	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	17	4933086.0	C	T
pharmgkb	hmg coa reductase inhibitors	LPA	rs10455872		Coronary Artery Disease	Efficacy	O75334	Drug Class			6	160589086.0	A	G
pharmgkb	hmg coa reductase inhibitors	LPA	rs10455872		Coronary Artery Disease	Toxicity	O75334	Drug Class			6	160589086.0	A	G
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNF	rs1800629			Efficacy	Q9UNG2	Drug Class			6	31575254.0	G	A
pharmgkb	lapatinib	HLA-DQA1	HLA-DQA1*02:01		Toxic liver disease	Toxicity	P01909	Drug	208908.0	CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl				
pharmgkb	cetuximab	EGF	rs4444903		Colorectal Neoplasms,Rectal Neoplasms	Efficacy	P01133	Drug			4	109912954.0	A	G
pharmgkb	cisplatin	GSTP1	I105V		Medulloblastoma,Neoplasms,Ototoxicity,Testicular Neoplasms	Toxicity	P09211	Drug	441203.0	N.N.Cl[Pt+2]Cl	11	67585218.0	A	G
pharmgkb	antipsychotics	MC4R	rs17782313		Weight gain	Toxicity	P32245	Drug Class			18	60183864.0	T	C
pharmgkb	antipsychotics	MC4R	rs489693		Weight gain	Toxicity	P32245	Drug Class			18	60215554.0	C	W
pharmgkb	aspirin	LTC4S	rs730012		Urticaria	Toxicity	Q16873	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	5	179793637.0	A	Y
pharmgkb	aspirin	PTGS1	rs10306114		Coronary Artery Disease,Myocardial Infarction	Efficacy	P23219	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	9	122370243.0	A	G
pharmgkb	carbimazole,methimazole	HLA-B	HLA-B*38:02		Graves Disease	Toxicity	P01889							
pharmgkb	cocaine	DRD2	rs1076560		Cocaine-Related Disorders	Toxicity	P14416	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	11	113412966.0	C	A
pharmgkb	cyclophosphamide	GSTP1	I105V		Neoplasms	Efficacy	P09211	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	11	67585218.0	A	G
pharmgkb	irinotecan	UGT1A1	UGT1A1*1, UGT1A1*6			Dosage	P22309	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7				
pharmgkb	fentanyl	ABCB1	I1145M		Pain,Pain, Postoperative	Dosage	P08183	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	87509329.0	A	K
pharmgkb	heroin	OPRD1	rs2236857		Heroin Dependence	Toxicity	P41143	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	1	28835097.0	T	C
pharmgkb	nevirapine	HLA-B	HLA-B*35:01		Drug Hypersensitivity	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	heroin	OPRM1	rs510769		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154040884.0	C	T
pharmgkb	heroin	OPRD1	rs3766951		Heroin Dependence	Toxicity	P41143	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	1	28843047.0	T	C
pharmgkb	tolterodine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10			Metabolism/PK	P10635	Drug	60774.0	CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2				
pharmgkb	SN-38	UGT1A9	rs3832043		Carcinoma, Non-Small-Cell Lung	Metabolism/PK	O60656	Metabolite	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	2	233671808.0	T	-
pharmgkb	ondansetron	ABCB1	I1145M		Postoperative Nausea and Vomiting,Vomiting	Efficacy	P08183	Drug	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	7	87509329.0	A	K
pharmgkb	ondansetron	ABCB1	S893A		Postoperative Nausea and Vomiting,Vomiting	Efficacy	P08183	Drug	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	7	87531302.0	A	Y
pharmgkb	opioids	OPRM1	N40D		Pain,Pain, Postoperative	Dosage	P35372	Drug Class			6	154039662.0	A	G
pharmgkb	nicotine	CHRNA3	rs578776		Tobacco Use Disorder	Efficacy,Toxicity	P32297	Drug	942.0	CN1CCCC1C2=CN=CC=C2	15	78596058.0	G	A
pharmgkb	hydrochlorothiazide	YEATS4	rs7297610		Essential hypertension,Hypertension	Efficacy	O95619	Drug	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	12	69430244.0	C	T
pharmgkb	latanoprost	PTGFR	rs3753380		Glaucoma, Open-Angle	Efficacy	P43088	Drug	5282380.0	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	1	78490747.0	T	C
pharmgkb	propafenone	CYP2D6	CYP2D6*1, CYP2D6*10		Arrhythmias, Cardiac	Efficacy	P10635	Drug	4932.0	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O				
pharmgkb	lamotrigine	UGT1A4	L48M		Epilepsy	Metabolism/PK	P22310	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	2	233718962.0	T	R
pharmgkb	paroxetine	HTR1A	rs6295		Panic Disorder	Efficacy	P08908	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	5	63962738.0	C	G
pharmgkb	nevirapine	ABCB1	I1145M		HIV Infections,Toxic liver disease	Toxicity	P08183	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	7	87509329.0	A	K
pharmgkb	hydralazine	NAT2	NAT2*4, NAT2*5, NAT2*6, NAT2*7			Metabolism/PK	Q6N069	Drug	3637.0	C1=CC=C2C(=C1)C=NN=C2NN				
pharmgkb	olanzapine	SLC22A1	G465R			Metabolism/PK	O15245	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	6	160154805.0	G	A
pharmgkb	olanzapine	ABCB1	rs3842			Metabolism/PK	P08183	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	7	87504050.0	T	C
pharmgkb	olanzapine	ABCB1	rs10248420		somnolence	Toxicity	P08183	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	7	87535670.0	A	K
pharmgkb	olanzapine	CYP3A5	CYP3A5*1, CYP3A5*3		somnolence	Toxicity	P20815	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C				
pharmgkb	olanzapine	APOC3	rs5128			Metabolism/PK	P02656	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	11	116832924.0	G	C
pharmgkb	olanzapine	ABCB1	rs4728709		Asthenia	Toxicity	P08183	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	7	87604286.0	G	A
pharmgkb	olanzapine	ABCB1	rs3842		Arrhythmias, Cardiac	Toxicity	P08183	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	7	87504050.0	T	C
pharmgkb	tamoxifen	CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*95, CYP2D6*98			Metabolism/PK	P10635	Drug	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3				
pharmgkb	atomoxetine	CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98			Metabolism/PK	P10635	Drug	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2				
pharmgkb	atorvastatin,lovastatin,simvastatin	APOA5	rs662799		Hyperlipidemias	Efficacy	Q6Q788				11	116792991.0	G	A
pharmgkb	sulfonamides, urea derivatives	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3		Diabetes Mellitus	Efficacy	P11712	Drug Class						
pharmgkb	sorafenib	KDR	rs2071559		Carcinoma, Hepatocellular,Carcinoma, Renal Cell	Efficacy	P35968	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	4	55126199.0	A	G
pharmgkb	Platinum compounds	GSTP1	I105V		Neoplasms	Toxicity	P09211	Drug Class			11	67585218.0	A	G
pharmgkb	atorvastatin	ABCB1	S893A		Hypercholesterolemia	Efficacy	P08183	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	87531302.0	A	Y
pharmgkb	alendronate	VDR	rs1544410		Osteoporosis	Efficacy	P11473	Drug	2088.0	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN	12	47846052.0	C	D
pharmgkb	cisplatin,fluorouracil,mitoxantrone	GALNT14	rs9679162		Carcinoma, Hepatocellular,Liver Neoplasms	Efficacy	Q96FL9				2	31024648.0	G	T
pharmgkb	ethambutol,isoniazid,pyrazinamide,rifampin	NAT2	rs1041983		Toxic liver disease,Tuberculosis	Toxicity	Q6N069				8	18400285.0	C	T
pharmgkb	isoniazid,pyrazinamide,rifampin	NAT2	rs1041983		Toxic liver disease,Tuberculosis	Toxicity	Q6N069				8	18400285.0	C	T
pharmgkb	paclitaxel	EPHA5	rs7349683		Breast Neoplasms,Ovarian Neoplasms,Peripheral Nervous System Diseases	Toxicity	P54756	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	4	65332086.0	C	W
pharmgkb	Platinum compounds	HSPA5	rs430397		Carcinoma, Non-Small-Cell Lung	Efficacy	Q24JP5	Drug Class			9	125238840.0	C	T
pharmgkb	direct acting antivirals	IFNL4	rs11322783		sustained virological response (svr)	Efficacy	K9M1U5	Drug Class			19	39248514.0	T	-
pharmgkb	telmisartan	UGT1A3	UGT1A3*1, UGT1A3*2, UGT1A3*3			Metabolism/PK	P35503	Drug	65999.0	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C				
pharmgkb	telmisartan	SLCO1B3	G256A			Metabolism/PK	F5H094	Drug	65999.0	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C	12	20875274.0	G	C
pharmgkb	efavirenz	CYP2B6	rs2279345		HIV Infections,Tuberculosis	Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	41009797.0	T	M
pharmgkb	cysteamine	CFTR	rs113993960		Cystic Fibrosis	Efficacy	P13569	Drug	6058.0	C(CS)N	7	117559592.0	CTT	-
pharmgkb	lumacaftor	CFTR	rs113993960		Cystic Fibrosis	Efficacy	P13569	Drug	16678941.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O	7	117559592.0	CTT	-
pharmgkb	methylphenidate	CES1	G144E			Metabolism/PK	Q9NZK5	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	16	55823658.0	C	T
pharmgkb	methylphenidate	CES1	G144E		Attention Deficit Disorder with Hyperactivity	Dosage	Q9NZK5	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	16	55823658.0	C	T
pharmgkb	methotrexate	C18orf56	rs45445694		Arthritis, Rheumatoid	Efficacy	Q8TAI1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O				
pharmgkb	indomethacin	CYP2C9	CYP2C9*1, CYP2C9*3			Toxicity	P11712	Drug	3715.0	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O				
pharmgkb	Antiinflammatory agents, non-steroids,celecoxib,diclofenac	CYP2C9	I359L			Toxicity	P11712				10	94981296.0	A	S
pharmgkb	naproxen	CYP2C9	N218I			Metabolism/PK	P11712	Drug	1302.0	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	10	94949118.0	A	T
pharmgkb	irinotecan,raltitrexed	TYMS	rs45445694		Colorectal Neoplasms	Toxicity	P04818							
pharmgkb	cavosonstat	CFTR	rs113993960		Cystic Fibrosis	Efficacy	P13569	Drug	56960912.0	C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O	7	117559592.0	CTT	-
pharmgkb	heroin	ALDH2	E457K		Heroin Dependence	Other	P05091	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	12	111803962.0	G	A
pharmgkb	ivacaftor,tezacaftor	CFTR	G551D		Cystic Fibrosis	Efficacy	P13569				7	117587806.0	G	A
pharmgkb	lumacaftor	CFTR	A561E		Cystic Fibrosis	Efficacy	P13569	Drug	16678941.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O	7	117590355.0	C	A
pharmgkb	enalapril	CES1	G144E			Metabolism/PK	Q9NZK5	Drug	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	16	55823658.0	C	T
pharmgkb	ivacaftor	CFTR	R334W		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117540230.0	C	T
pharmgkb	ivacaftor	CFTR	rs77010898		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117642566.0	G	M
pharmgkb	ivacaftor	CFTR	G1249R		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117642465.0	G	A
pharmgkb	heroin	CES1	G144E			Metabolism/PK	Q9NZK5	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	16	55823658.0	C	T
pharmgkb	ivacaftor	CFTR	R668C		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117592169.0	C	T
pharmgkb	ivacaftor	CFTR	L997F		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117610521.0	G	C
pharmgkb	ivacaftor	CFTR	M1V		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117480095.0	A	G
pharmgkb	ivacaftor	CFTR	R1066L		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117611638.0	G	W
pharmgkb	ivacaftor	CFTR	H1054D		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117611601.0	C	K
pharmgkb	ivacaftor	CFTR	E92K		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117530899.0	G	W
pharmgkb	ivacaftor	CFTR	I336K		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117540237.0	T	M
pharmgkb	ivacaftor	CFTR	S1235R		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117627758.0	T	G
pharmgkb	ivacaftor	CFTR	T338I		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117540243.0	C	T
pharmgkb	ivacaftor	CFTR	L927P		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117603654.0	T	M
pharmgkb	ivacaftor	CFTR	A561E		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117590355.0	C	A
pharmgkb	hmg coa reductase inhibitors	RYR1	R614C		Muscular Diseases	Toxicity	P21817	Drug Class			19	38457545.0	C	T
pharmgkb	curcumin,ivacaftor	CFTR	rs77010898		Cystic Fibrosis	Efficacy	P13569				7	117642566.0	G	M
pharmgkb	penicillin g,penicillin v	HLA-B	HLA-B*55:01		Drug Hypersensitivity	Toxicity	P01889							
pharmgkb	morphine	OPRM1	N40D		Sleep Apnea Syndromes	Toxicity	P35372	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	6	154039662.0	A	G
pharmgkb	opioids	COMT	V158M		Pain,Pain, Postoperative	Dosage	P21964	Drug Class			22	19963748.0	G	A
pharmgkb	opioids	OPRM1	N40D		Sleep Disorders	Toxicity	P35372	Drug Class			6	154039662.0	A	G
pharmgkb	fentanyl	OPRM1	R181C			Efficacy	P35372	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	6	154090076.0	C	T
pharmgkb	remifentanil	OPRM1	R181C			Efficacy	P35372	Drug	60815.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC	6	154090076.0	C	T
pharmgkb	sofosbuvir	IFNL4	rs11322783		Hepatitis C, Chronic	Efficacy	K9M1U5	Drug	45375808.0	C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	19	39248514.0	T	-
pharmgkb	opioids	KCNJ6	rs6517442		Low Back Pain	Dosage	P48051	Drug Class			21	37917643.0	C	T
pharmgkb	opioids	ABCB1	I1145M		Low Back Pain	Toxicity	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	sufentanil	OPRM1	N40D		Pain,Pain, Postoperative	Dosage	P35372	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	6	154039662.0	A	G
pharmgkb	sufentanil	ABCB1	S893A		Pain, Postoperative	Dosage	P08183	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	7	87531302.0	A	Y
pharmgkb	warfarin	VKORC1	V66M			Dosage,Efficacy	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31093399.0	C	T
pharmgkb	methadone	CNR1	rs806368		Heroin Dependence	Dosage	P21554	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	6	88140381.0	T	C
pharmgkb	methadone	TPH2	rs1386493		Heroin Dependence	Dosage	Q8IWU9	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	12	71961399.0	A	G
pharmgkb	methadone	OPRL1	rs2229205		Heroin Dependence	Dosage	P41146	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	20	64098078.0	C	T
pharmgkb	methadone	CYP2B6	rs16974799		Heroin Dependence	Dosage	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	19	40998172.0	C	K
pharmgkb	clozapine	NFIB	rs28379954		Schizophrenia	Metabolism/PK	O00712	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	9	14163908.0	T	C
pharmgkb	methadone	NECTIN4	rs11265549		Opioid-Related Disorders,Pruritus	Toxicity	Q96NY8	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	1	161081736.0	A	G
pharmgkb	methadone	NECTIN4	rs11265549		Opioid-Related Disorders	Dosage	Q96NY8	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	1	161081736.0	A	G
pharmgkb	methadone	NECTIN4	rs11265549		Opioid-Related Disorders	Metabolism/PK	Q96NY8	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	1	161081736.0	A	G
pharmgkb	ethanol	OPRM1	N40D			Toxicity	P35372	Drug	702.0	CCO	6	154039662.0	A	G
pharmgkb	simvastatin	SLCO1B1	V174A			Efficacy	Q9Y6L6	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	12	21178615.0	T	C
pharmgkb	sufentanil	NFKBIA	rs696		Pain, Postoperative	Dosage	P25963	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	14	35401887.0	C	T
pharmgkb	anastrozole	CSMD1	rs6990851		Breast Neoplasms	Efficacy	Q96PZ7	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	8	3269991.0	A	G
pharmgkb	anastrozole	DLG2	rs2449598		Breast Neoplasms	Efficacy	Q14168	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	11	83983729.0	T	R
pharmgkb	anastrozole	CSMD1	rs6981827		Breast Neoplasms	Efficacy	Q96PZ7	Drug	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	8	3217516.0	C	W
pharmgkb	heroin	DBH	rs1611114		Heroin Dependence,Memory Disorders	Toxicity	Q6UVY6	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	9	133635081.0	C	T
pharmgkb	propranolol	COMT	V158M		Temporomandibular joint-pain-dysfunction syndrome	Efficacy	P21964	Drug	4946.0	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O	22	19963748.0	G	A
pharmgkb	cyclophosphamide	ABCC4	rs9561778		Breast Neoplasms,Drug Toxicity	Toxicity	O15439	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	13	95061461.0	G	W
pharmgkb	atenolol	GNB3	rs2301339		Essential hypertension	Efficacy	P16520	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	12	6845460.0	G	W
pharmgkb	atenolol	GNB3	rs11064426		Essential hypertension	Efficacy	P16520	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	12	6844093.0	A	B
pharmgkb	clopidogrel	CYP2C19	CYP2C19*1, CYP2C19*17		Acute coronary syndrome,Coronary Artery Disease,Hemorrhage,Myocardial Infarction	Toxicity	P33261	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3				
pharmgkb	risperidone	HTR2C	rs3813928		Autistic Disorder	Efficacy	P28335	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	X	114583809.0	G	A
pharmgkb	methylphenidate	STRBP	rs9032		Attention Deficit Disorder with Hyperactivity	Efficacy	Q96SI9	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	9	123104493.0	C	K
pharmgkb	methylphenidate	PYROXD2	rs1061115		Attention Deficit Disorder with Hyperactivity	Efficacy	Q8N2H3	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	10	98417292.0	G	A
pharmgkb	cyclophosphamide,doxorubicin	ABCB1	S893A		Breast Neoplasms	Efficacy	P08183				7	87531302.0	A	Y
pharmgkb	deferasirox	UGT1A1	rs4124874		Drug Toxicity,Thalassemia	Toxicity	P22309	Drug	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	2	233757013.0	T	R
pharmgkb	pregabalin	SLC7A5	rs4240803		adverse events,neuropathic pain	Toxicity	P08195	Drug	5486971.0	CC(C)C[C@@H](CC(=O)O)CN	16	87855597.0	G	H
pharmgkb	gabapentin	SLC7A5	rs4240803		adverse events,neuropathic pain	Toxicity	P08195	Drug	3446.0	C1CCC(CC1)(CC(=O)O)CN	16	87855597.0	G	H
pharmgkb	gabapentin	SLC7A5	rs4240803		neuropathic pain	Efficacy	P08195	Drug	3446.0	C1CCC(CC1)(CC(=O)O)CN	16	87855597.0	G	H
pharmgkb	gabapentin	SLC7A5	rs4240803		neuropathic pain	Dosage	P08195	Drug	3446.0	C1CCC(CC1)(CC(=O)O)CN	16	87855597.0	G	H
pharmgkb	pregabalin	SLC7A5	rs4240803		neuropathic pain	Efficacy	P08195	Drug	5486971.0	CC(C)C[C@@H](CC(=O)O)CN	16	87855597.0	G	H
pharmgkb	propylthiouracil	HLA-B	HLA-B*38:02		Agranulocytosis,Graves Disease	Toxicity	P01889	Drug	657298.0	CCCC1=CC(=O)NC(=S)N1				
pharmgkb	carvedilol	ADRB1	S49G			Efficacy	P08588	Drug	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	10	114044277.0	A	G
pharmgkb	carvedilol	ADRB1	G389R		Heart Failure	Dosage	P08588	Drug	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	10	114045297.0	G	C
pharmgkb	fluoxetine	FKBP5	rs4713916		Mood Disorders	Efficacy	Q13451	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	6	35702206.0	A	B
pharmgkb	mirtazapine	FKBP5	rs4713916		Mood Disorders	Efficacy	Q13451	Drug	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	6	35702206.0	A	B
pharmgkb	cyclophosphamide,epirubicin	GSTP1	I105V		Breast Neoplasms,Drug Toxicity	Toxicity	P09211				11	67585218.0	A	G
pharmgkb	cyclophosphamide,epirubicin	GSTP1	I105V		Breast Neoplasms,Neutropenia	Toxicity	P09211				11	67585218.0	A	G
pharmgkb	capecitabine,epirubicin,platinum	GSTP1	I105V		Colorectal Neoplasms	Efficacy	P09211				11	67585218.0	A	G
pharmgkb	cyclophosphamide,epirubicin	GSTP1	I105V		Breast Neoplasms	Efficacy	P09211				11	67585218.0	A	G
pharmgkb	epirubicin,fluorouracil,oxaliplatin	NQO1	P187S		Neoplasm Metastasis,Stomach Neoplasms	Efficacy	P15559				16	69711242.0	G	A
pharmgkb	bucindolol	ADRB1	G389R		Heart Failure	Efficacy	P08588	Drug	51045.0	CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O	10	114045297.0	G	C
pharmgkb	paliperidone	MC4R	rs489693		Weight gain	Efficacy	P32245	Drug, Metabolite	115237.0	CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	18	60215554.0	C	W
pharmgkb	paliperidone	MC4R	rs17782313		Weight gain	Toxicity	P32245	Drug, Metabolite	115237.0	CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	18	60183864.0	T	C
pharmgkb	cyclophosphamide,epirubicin,fluorouracil	NQO1	P187S		Breast Neoplasms	Efficacy	P15559				16	69711242.0	G	A
pharmgkb	haloperidol	MC4R	rs489693		Hypertriglyceridemia,schizoaffective disorder,Schizophrenia,Weight gain	Toxicity	P32245	Drug	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	18	60215554.0	C	W
pharmgkb	quetiapine	MC4R	rs489693		Hypertriglyceridemia,schizoaffective disorder,Schizophrenia,Weight gain	Toxicity	P32245	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	18	60215554.0	C	W
pharmgkb	quetiapine	MC4R	rs17782313		Weight gain	Toxicity	P32245	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	18	60183864.0	T	C
pharmgkb	risperidone	MC4R	rs489693		Weight gain	Toxicity	P32245	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	18	60215554.0	C	W
pharmgkb	risperidone	MC4R	rs17782313		Weight gain	Toxicity	P32245	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	18	60183864.0	T	C
pharmgkb	amisulpride	MC4R	rs489693		Hypertriglyceridemia,Weight gain	Toxicity	P32245	Drug	2159.0	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	18	60215554.0	C	W
pharmgkb	amisulpride	MC4R	rs17782313		Weight gain	Toxicity	P32245	Drug	2159.0	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	18	60183864.0	T	C
pharmgkb	aripiprazole	MC4R	rs489693		Weight gain	Toxicity	P32245	Drug	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	18	60215554.0	C	W
pharmgkb	ataluren	CFTR	rs77010898		Cystic Fibrosis	Other	P13569	Drug	11219835.0	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	7	117642566.0	G	M
pharmgkb	ataluren	CFTR	rs75039782		Cystic Fibrosis	Other	P13569	Drug	11219835.0	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	7	117639961.0	C	K
pharmgkb	ataluren	CFTR	G542R		Cystic Fibrosis	Other	P13569	Drug	11219835.0	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	7	117587778.0	G	W
pharmgkb	cetuximab	KRAS	G13V		Colorectal Neoplasms	Efficacy	P01116	Drug						
pharmgkb	fenofibrate	APOA5	S19L		Hypertriglyceridemia	Efficacy	Q6Q788	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	11	116791691.0	G	M
pharmgkb	methotrexate	SLCO1B1	rs4149081		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21225087.0	G	A
pharmgkb	methadone	ABCB1	I1145M		Opioid-Related Disorders	Metabolism/PK	P08183	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	87509329.0	A	K
pharmgkb	opioids	BDNF-AS	rs11030096		Opioid-Related Disorders	Toxicity	P23560	Drug Class			11	27643996.0	T	M
pharmgkb	opioids	GABRB3	rs4906902		Opioid-Related Disorders	Toxicity	P28472	Drug Class			15	26774621.0	A	G
pharmgkb	opioids	DRD2	rs1079596		Opioid-Related Disorders	Toxicity	P14416	Drug Class			11	113425897.0	C	W
pharmgkb	opioids	DRD3	rs2654754		Opioid-Related Disorders	Toxicity	P35462	Drug Class			3	114136949.0	G	A
pharmgkb	opioids	DRD2	rs1125394		Opioid-Related Disorders	Toxicity	P14416	Drug Class			11	113426463.0	T	C
pharmgkb	opioids	DRD3	rs9288993		Opioid-Related Disorders	Toxicity	P35462	Drug Class			3	114140326.0	A	G
pharmgkb	opioids	TACR1	rs735668		Opioid-Related Disorders	Toxicity	P25103	Drug Class			2	75135918.0	A	S
pharmgkb	opioids	ZNF804A	rs7597593		Opioid-Related Disorders	Toxicity	Q7Z570	Drug Class			2	184668853.0	T	C
pharmgkb	opioids	CNR1	rs2023239		Opioid-Related Disorders	Toxicity	P21554	Drug Class			6	88150763.0	T	C
pharmgkb	opioids	OPRM1	rs510769		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154040884.0	C	T
pharmgkb	opioids	CNR1	rs6928499		Opioid-Related Disorders	Toxicity	P21554	Drug Class			6	88151570.0	G	C
pharmgkb	opioids	CYP2A7P1	Q172H		Opioid-Related Disorders	Toxicity		Drug Class			19	41006936.0	G	W
pharmgkb	opioids	DRD3	G9S		Opioid-Related Disorders	Toxicity	P35462	Drug Class			3	114171968.0	C	T
pharmgkb	opioids	CYP2D6	P34A		Opioid-Related Disorders	Toxicity	P10635	Drug Class			22	42130692.0	G	A
pharmgkb	opioids	DRD3	rs324029		Opioid-Related Disorders	Toxicity	P35462	Drug Class			3	114162776.0	A	G
pharmgkb	opioids	EXOC4	rs718656		Opioid-Related Disorders	Toxicity	Q96A65	Drug Class			7	133436098.0	C	K
pharmgkb	opioids	TACR3	rs1384401		Opioid-Related Disorders	Toxicity	P29371	Drug Class			4	103643921.0	G	A
pharmgkb	rocuronium	SLCO1A2	rs7967354			Dosage	P46721	Drug	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C	12	21271069.0	T	C
pharmgkb	rocuronium	IAPP	rs11045995			Dosage	P10997	Drug	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C	12	21355244.0	T	C
pharmgkb	tramadol	ABCB1	I1145M		Fractures, Bone,Pain,Pain, Postoperative	Efficacy	P08183	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	7	87509329.0	A	K
pharmgkb	tramadol	OPRM1	N40D		Pain, Postoperative	Efficacy	P35372	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	6	154039662.0	A	G
pharmgkb	ibuprofen	PTGS2	rs20417			Efficacy	P35354	Drug	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	1	186681189.0	C	K
pharmgkb	tramadol	ABCB1	S893A		Fractures, Bone,Pain,Pain, Postoperative	Efficacy	P08183	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	7	87531302.0	A	Y
pharmgkb	mercaptopurine	FTO	rs16952570		Colitis, Ulcerative,Crohn Disease,Irritable Bowel Syndrome,Leukopenia,Neutropenia	Toxicity	Q9C0B1	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	16	53831818.0	T	C
pharmgkb	azathioprine	FTO	rs16952570		Colitis, Ulcerative,Crohn Disease,Irritable Bowel Syndrome,Leukopenia,Neutropenia	Toxicity	Q9C0B1	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	16	53831818.0	T	C
pharmgkb	morphine	OPRK1	rs1051660		Neoplasms,Pain	Dosage	P41145	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	8	53251002.0	C	W
pharmgkb	morphine	COMT	V158M		Pain	Efficacy	P21964	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	22	19963748.0	G	A
pharmgkb	morphine	OPRM1	N40D		Pain,Pain, Postoperative	Efficacy	P35372	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	6	154039662.0	A	G
pharmgkb	butorphanol	OPRK1	rs702764			Efficacy	P41145	Drug	5361092.0	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O	8	53229597.0	T	S
pharmgkb	morphine	COMT	rs6269			Efficacy	P21964	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	22	19962429.0	A	G
pharmgkb	butorphanol	COMT	rs4633			Efficacy	P21964	Drug	5361092.0	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O	22	19962712.0	C	T
pharmgkb	butorphanol	COMT	rs6269			Efficacy	P21964	Drug	5361092.0	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O	22	19962429.0	A	G
pharmgkb	atorvastatin	ABCA1	R219K			Efficacy	O95477	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	9	104858586.0	C	T
pharmgkb	rosuvastatin	ABCA1	R219K			Efficacy	O95477	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	9	104858586.0	C	T
pharmgkb	simvastatin	ABCA1	R219K			Efficacy	O95477	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	9	104858586.0	C	T
pharmgkb	atorvastatin	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4			Efficacy	P10635	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4				
pharmgkb	simvastatin	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4			Efficacy	P10635	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C				
pharmgkb	rosuvastatin	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4			Efficacy	P10635	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C				
pharmgkb	fluvastatin	CYP2D6	CYP2D6*1, CYP2D6*4			Efficacy	P10635	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F				
pharmgkb	rosuvastatin	CETP	rs708272			Efficacy	P11597	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	16	56962376.0	G	A
pharmgkb	rosuvastatin	CETP	V422I			Efficacy	P11597	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	16	56982180.0	G	M
pharmgkb	cotinine glucuronide	UGT1A9	rs12471326			Metabolism/PK	O60656	Metabolite	178540.0		2	233767812.0	T	C
pharmgkb	nicotine	CYP2A6	rs145014075			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40843881.0	G	T
pharmgkb	everolimus	CYP3A5	CYP3A5*1, CYP3A5*3		Breast Neoplasms,heart transplantation,Kidney Neoplasms,Kidney Transplantation,lung transplantation,Neuroendocrine Tumors	Metabolism/PK	P20815	Drug	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC				
pharmgkb	everolimus	MTOR	rs2024627		Breast Neoplasms,Kidney Neoplasms,Neuroendocrine Tumors	Efficacy	P42345	Drug	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	1	11238733.0	T	C
pharmgkb	infliximab	HLA-B	HLA-B*08:01, HLA-B*39:01		drug-induced liver injury	Toxicity	P01889	Drug						
pharmgkb	infliximab	HLA-C	HLA-C*12:03		drug-induced liver injury	Toxicity	P10321	Drug						
pharmgkb	infliximab	HLA-DQB1	HLA-DQB1*02:01		drug-induced liver injury	Toxicity	P01920	Drug						
pharmgkb	infliximab	HLA-DPB1	HLA-DPB1*10:01		drug-induced liver injury	Toxicity	P04440	Drug						
pharmgkb	infliximab	HLA-DRB1	HLA-DRB1*03:01, HLA-DRB1*04:04		drug-induced liver injury	Toxicity	P01911	Drug						
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	MICA	V152M		Arthritis, Rheumatoid	Efficacy	Q29983	Drug Class			6	31411200.0	G	A
pharmgkb	Ace Inhibitors, Plain	KCNMA1	rs2253201		Angioedema	Toxicity	Q86W47	Drug Class			10	77596639.0	G	A
pharmgkb	voriconazole	SLCO2B1	rs3781727			Metabolism/PK	O94956	Drug	71616.0	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	11	75204976.0	T	C
pharmgkb	methotrexate	ADORA2A	rs2236624		adverse events,Arthritis, Rheumatoid	Toxicity	P29274	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	22	24440056.0	T	C
pharmgkb	methotrexate	ADORA2A	rs2298383		Arthritis, Rheumatoid	Toxicity	P29274	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	22	24429543.0	C	W
pharmgkb	methotrexate	ADORA2A-AS1	rs17004921		Arthritis, Rheumatoid	Efficacy	P86434	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	22	24444708.0	C	T
pharmgkb	cisplatin,fluorouracil,radiotherapy	APEX1	rs1760944		Carcinoma, Squamous Cell,overall survival	Efficacy	P27695				14	20454990.0	T	S
pharmgkb	cisplatin,fluorouracil,radiotherapy	XRCC1	R194W		Carcinoma, Squamous Cell,overall survival	Efficacy	P18887				19	43553422.0	G	A
pharmgkb	cisplatin,fluorouracil,radiotherapy	MUTYH	Q335H		Carcinoma, Squamous Cell,progression-free survival	Efficacy	Q9UIF7				1	45331833.0	C	G
pharmgkb	glyburide	NOS1AP	rs10494366		Diabetes Mellitus, Type 2,Hypoglycemia	Toxicity	O75052	Drug	3488.0	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	1	162115895.0	G	T
pharmgkb	glimepiride	NOS1AP	rs10494366		Diabetes Mellitus, Type 2,Hypoglycemia	Toxicity	O75052	Drug	3476.0	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	1	162115895.0	G	T
pharmgkb	glipizide	NOS1AP	rs10494366		Diabetes Mellitus, Type 2,Hypoglycemia	Toxicity	O75052	Drug	3478.0	CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	1	162115895.0	G	T
pharmgkb	oseltamivir	ABCB1	I1145M			Toxicity	P08183	Drug	65028.0	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC	7	87509329.0	A	K
pharmgkb	lamotrigine	ABCG2	rs3114020		Epilepsy	Metabolism/PK	Q9UNQ0	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	4	88162514.0	T	C
pharmgkb	lamotrigine	ABCG2	Q141K		Epilepsy	Metabolism/PK	Q9UNQ0	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	4	88131171.0	G	Y
pharmgkb	lamotrigine	SLC22A1	M408V		Epilepsy	Metabolism/PK	O15245	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	6	160139813.0	A	S
pharmgkb	lamotrigine	UGT1A4	UGT1A4*1a, UGT1A4*1b, UGT1A4*2		Epilepsy	Metabolism/PK	P22310	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N				
pharmgkb	lamotrigine	UGT2B7	rs7668258		Epilepsy	Dosage	P16662	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	4	69096360.0	T	C
pharmgkb	Antithyroid Preparations	HLA-DRB1	HLA-DRB1*08:03		Agranulocytosis,Graves Disease	Toxicity	P01911	Drug Class						
pharmgkb	Antithyroid Preparations	HLA-B	HLA-B*39:01		Agranulocytosis,Graves Disease	Toxicity	P01889	Drug Class						
pharmgkb	Antithyroid Preparations	HLA-DQB1	HLA-DQB1*06:01		Agranulocytosis,Graves Disease	Toxicity	P01920	Drug Class						
pharmgkb	Antithyroid Preparations	HLA-DQA1	HLA-DQA1*01:03		Agranulocytosis,Graves Disease	Toxicity	P01909	Drug Class						
pharmgkb	succinylcholine	BCHE	R414C		Apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165829794.0	G	A
pharmgkb	succinylcholine	BCHE	D98G		postanesthesia apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165830741.0	T	C
pharmgkb	succinylcholine	BCHE	A567T		postanesthesia apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165773492.0	C	T
pharmgkb	antidepressants	HTR2A	rs6313		adverse events,Bipolar Disorder,Depression,Depressive Disorder, Major	Toxicity	P28223	Drug Class			13	46895805.0	G	A
pharmgkb	antidepressants	HTR2A	rs6311		adverse events,Bipolar Disorder,Depression,Depressive Disorder, Major	Toxicity	P28223	Drug Class			13	46897343.0	C	T
pharmgkb	antidepressants	HTR2A	rs7997012		Bipolar Disorder,Depression,Depressive Disorder, Major	Efficacy	P28223	Drug Class			13	46837850.0	A	G
pharmgkb	FOLFIRINOX	UGT1A1	UGT1A1*1, UGT1A1*28		Pancreatic Neoplasms,Thrombocytopenia	Toxicity	P22309	Drug						
pharmgkb	gemcitabine,paclitaxel	CDA	K27Q		Nausea,Pancreatic Neoplasms	Toxicity	Q96GN5				1	20589208.0	A	C
pharmgkb	temozolomide	ABCB1	rs1128503		Glioma	Metabolism/PK	P08183	Drug	5394.0	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	7	87550285.0	A	G
pharmgkb	carvedilol	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10		Heart Diseases	Metabolism/PK	P10635	Drug	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O				
pharmgkb	carvedilol	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*10		Heart Failure	Dosage	P10635	Drug	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O				
pharmgkb	citalopram	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*10			Metabolism/PK	P10635	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	citalopram	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN			Efficacy	P10635	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	citalopram	CYP2D6	CYP2D6*1, CYP2D6*4			Dosage	P10635	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	fluoxetine	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17		Depressive Disorder, Major,Mental Disorders	Metabolism/PK	P10635	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F				
pharmgkb	gefitinib	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10		Adenocarcinoma,Carcinoma, Non-Small-Cell Lung,Drug Toxicity,Exanthema,Toxic liver disease	Toxicity	P10635	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4				
pharmgkb	methylphenidate	CYP2D6	CYP2D6*2, CYP2D6*10		Attention Deficit Disorder with Hyperactivity	Toxicity	P10635	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2				
pharmgkb	atomoxetine,methylphenidate	CYP2D6	CYP2D6*4, CYP2D6*5			Metabolism/PK	P10635							
pharmgkb	olanzapine	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4		Schizophrenia,Weight gain	Toxicity	P10635	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C				
pharmgkb	oxycodone	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4		Opioid-Related Disorders	Toxicity	P10635	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O				
pharmgkb	sertraline	CYP2D6	CYP2D6*1, CYP2D6*4		Depression	Dosage	P10635	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl				
pharmgkb	metoprolol	CYP2D6	CYP2D6*1, CYP2D6*45, CYP2D6*46		Hypertension	Metabolism/PK	P10635	Drug	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O				
pharmgkb	risperidone	CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98			Metabolism/PK	P10635	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F				
pharmgkb	venlafaxine	CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98			Metabolism/PK	P10635	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O				
pharmgkb	phenytoin	HLA-B	HLA-B*56:02		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	isepamicin	MT-ND1	rs267606617		Ototoxicity	Toxicity	P03886	Drug	3037209.0					
pharmgkb	micronomicin	MT-ND1	rs267606619		Ototoxicity	Toxicity	P03886	Drug	3037206.0					
pharmgkb	aminoglycoside antibacterials	MT-RNR1	rs1556422499		Ototoxicity	Toxicity	A0A0C5B5G6	Drug Class						
pharmgkb	aminoglycoside antibacterials	MT-ND1	rs1603218569		Ototoxicity	Toxicity	P03886	Drug Class						
pharmgkb	dihydrostreptomycin	MT-RNR1	rs1556422499		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	439369.0					
pharmgkb	cyclosporine	CYP3A4	rs2740574		Kidney Transplantation	Metabolism/PK	P08684	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	7	99784473.0	C	T
pharmgkb	streptomycin	MT-RNR1	rs28358569		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O				
pharmgkb	gentamicin	MT-RNR1	rs28358569		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	3467.0	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC				
pharmgkb	neomycin	MT-ND1	rs267606617		Ototoxicity	Toxicity	P03886	Drug	8378.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N				
pharmgkb	streptomycin	MT-RNR1	rs1556422499		Ototoxicity	Toxicity	A0A0C5B5G6	Drug	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O				
pharmgkb	cyclosporine,tacrolimus	CYP3A	rs2740574		Kidney Transplantation,transplant rejection	Toxicity	Q9HB55				7	99784473.0	C	T
pharmgkb	buprenorphine	CYP3A4	rs2740574		Opioid-Related Disorders	Dosage	P08684	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	7	99784473.0	C	T
pharmgkb	fentanyl	CYP3A	rs2740574			Metabolism/PK	Q9HB55	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	99784473.0	C	T
pharmgkb	tolbutamide	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*62			Metabolism/PK	P11712	Drug	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C				
pharmgkb	sufentanil	COMT	V158M			Dosage	P21964	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	22	19963748.0	G	A
pharmgkb	rosuvastatin	SLCO2B1	R168Q			Efficacy	O94956	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	11	75172532.0	G	W
pharmgkb	mercaptopurine	PACSIN2	rs2413739		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9UNF0	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	22	43001030.0	C	T
pharmgkb	azathioprine	PACSIN2	rs2413739		Irritable Bowel Syndrome	Efficacy	Q9UNF0	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	22	43001030.0	C	T
pharmgkb	mercaptopurine	NUDT15	NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6		Leukopenia	Toxicity	Q9NV35	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	mercaptopurine	NUDT15	NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6			Dosage	Q9NV35	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	mercaptopurine	NUDT15	NUDT15*1, NUDT15*6		Neutropenia	Toxicity	Q9NV35	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	pravastatin	SLCO1B1	V174A			Efficacy	Q9Y6L6	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	12	21178615.0	T	C
pharmgkb	hmg coa reductase inhibitors	CETP	rs708272		Coronary Artery Disease	Efficacy	P11597	Drug Class			16	56962376.0	G	A
pharmgkb	hmg coa reductase inhibitors	ABCB1	rs1128503			Other	P08183	Drug Class			7	87550285.0	A	G
pharmgkb	hmg coa reductase inhibitors	GNB3	rs5443		Hypercholesterolemia,Myocardial Infarction	Efficacy	P16520	Drug Class			12	6845711.0	C	T
pharmgkb	methotrexate	ARID5B	rs4948496		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q14865	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	62045858.0	T	C
pharmgkb	methotrexate	ARID5B	rs4948496		Leukopenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q14865	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	62045858.0	T	C
pharmgkb	methotrexate	SLCO1B1	rs11045879		Neoplasms	Metabolism/PK	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21229685.0	T	C
pharmgkb	Ace Inhibitors, Plain,Angiotensin II Antagonists,Beta Blocking Agents,digoxin,diuretics,spironolactone	ADRB1	G389R		Heart Failure	Efficacy	P08588				10	114045297.0	G	C
pharmgkb	cisplatin,doxorubicin,methotrexate	MTHFD1	R653Q		Osteosarcoma	Efficacy	P11586				14	64442127.0	G	A
pharmgkb	cisplatin,doxorubicin,methotrexate	ABCC2	rs717620		Osteosarcoma	Efficacy	Q5T2W1				10	99782821.0	C	T
pharmgkb	cisplatin,doxorubicin,methotrexate	GSTP1	I105V		Osteosarcoma	Efficacy	P09211				11	67585218.0	A	G
pharmgkb	cisplatin,doxorubicin,methotrexate	GSTT1	GSTT1 non-null, GSTT1 null		Osteosarcoma	Efficacy	P30711							
pharmgkb	cisplatin,doxorubicin,methotrexate	CCND1	rs9344		Osteosarcoma	Efficacy	P24385				11	69648142.0	G	A
pharmgkb	methotrexate	ABCC2	V1188E		Leukopenia,Osteosarcoma	Toxicity	Q5T2W1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	99836239.0	T	A
pharmgkb	cisplatin,doxorubicin	ERCC1	rs11615		mucositis,Osteosarcoma	Toxicity	P07992				19	45420395.0	A	G
pharmgkb	cisplatin,doxorubicin	CYBA	Y72N		Anemia,mucositis,Osteosarcoma	Toxicity	Q8NFA2				16	88646828.0	A	K
pharmgkb	cisplatin,doxorubicin,methotrexate	GSTP1	I105V		cardiotoxicity,Osteosarcoma	Toxicity	P09211				11	67585218.0	A	G
pharmgkb	doxorubicin	GSTP1	I105V		Leukopenia,Osteosarcoma	Toxicity	P09211	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	11	67585218.0	A	G
pharmgkb	cisplatin,doxorubicin,methotrexate	CLCN6	A222V		nephrotoxicity,Osteosarcoma	Toxicity	P51797				1	11796321.0	G	A
pharmgkb	cisplatin,doxorubicin,methotrexate	ERCC2	rs13181		nephrotoxicity,Osteosarcoma	Toxicity	P18074				19	45351661.0	T	R
pharmgkb	methotrexate	SOD2	V16A			Other	P04179	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	6	159692840.0	A	G
pharmgkb	heroin	OPRD1	rs2236861		Heroin Dependence	Toxicity	P41143	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	1	28813244.0	G	A
pharmgkb	irbesartan	AGT	T207M		Hypertension,Hypertrophy, Left Ventricular	Efficacy	Q9BYV1	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	1	230710231.0	G	A
pharmgkb	irbesartan	AGT	M268T		Hypertension,Hypertrophy, Left Ventricular	Efficacy	Q9BYV1	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	1	230710048.0	A	G
pharmgkb	atenolol	AGT	M268T		Hypertension,Hypertrophy, Left Ventricular	Efficacy	Q9BYV1	Drug	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	1	230710048.0	A	G
pharmgkb	irbesartan	AGTR1	rs5186		Hypertension,Hypertrophy, Left Ventricular	Efficacy	P30556	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	3	148742201.0	A	C
pharmgkb	irbesartan	ACE	rs1799752		Hypertension,Hypertrophy, Left Ventricular	Efficacy	P12821	Drug	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	diazepam	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3			Metabolism/PK	P33261	Drug	3016.0	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3				
pharmgkb	heroin	SOD2	rs2758339		Heroin Dependence	Toxicity	P04179	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	159691552.0	A	Y
pharmgkb	sulfamethoxazole	G6PD	G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like		Hemolysis	Toxicity	P11413	Drug	5329.0	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N				
pharmgkb	succinylcholine	BCHE	rs774072493		Apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165830599.0	-	C
pharmgkb	succinylcholine	BCHE	rs568724445		Apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165830419.0	C	W
pharmgkb	succinylcholine	BCHE	L222R		Apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165830369.0	A	B
pharmgkb	succinylcholine	BCHE	E469Q		Apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C				
pharmgkb	succinylcholine	BCHE	F56I		Apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165830868.0	A	T
pharmgkb	succinylcholine	BCHE	G143D		Apnea	Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165830606.0	C	T
pharmgkb	succinylcholine	BCHE	G418A			Toxicity	P06276	Drug	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	3	165829781.0	C	D
pharmgkb	methotrexate	MTHFD1	R653Q		Mesothelioma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P11586	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	14	64442127.0	G	A
pharmgkb	methotrexate	TYMS	rs45445694		Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P04818	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O				
pharmgkb	methotrexate	SLCO1B1	V174A		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21178615.0	T	C
pharmgkb	rivaroxaban	ABCB1	I1145M			Toxicity	P08183	Drug	9875401.0		7	87509329.0	A	K
pharmgkb	apixaban	ABCB1	rs4148738			Toxicity	P08183	Drug	10182969.0	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N	7	87533733.0	C	T
pharmgkb	pegaspargase	ARHGAP28	rs9958628			Toxicity	Q9P2N2	Drug			18	6739625.0	A	T
pharmgkb	pegaspargase	HLA-DQB1	HLA-DQB1*02:02			Toxicity	P01920	Drug						
pharmgkb	pegaspargase	HLA-DRB1	HLA-DRB1*07:01			Toxicity	P01911	Drug						
pharmgkb	methotrexate	GGH	rs3758149		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q92820	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	8	63039169.0	G	A
pharmgkb	methotrexate	SLC19A1	rs1051296		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45514947.0	A	C
pharmgkb	phenprocoumon	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Dosage	P11712	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	phenprocoumon	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Metabolism/PK	P11712	Drug	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	conjugated estrogens	SLCO1B1	SLCO1B1*1, SLCO1B1*12, SLCO1B1*13			Metabolism/PK	Q9Y6L6	Drug, Biological Intermediate	23667301.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]				
pharmgkb	fluvastatin	SLCO1B1	SLCO1B1*1, SLCO1B1*14		Hypercholesterolemia	Efficacy	Q9Y6L6	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F				
pharmgkb	olmesartan	SLCO1B1	SLCO1B1*15, SLCO1B1*37			Metabolism/PK	Q9Y6L6	Drug	130881.0	CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O				
pharmgkb	repaglinide	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37			Metabolism/PK	Q9Y6L6	Drug	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O				
pharmgkb	atrasentan	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37			Metabolism/PK	Q9Y6L6	Drug						
pharmgkb	opioids	CNIH3	rs10799590		Opioid-Related Disorders	Toxicity	Q8TBE1	Drug Class			1	224634780.0	G	A
pharmgkb	methotrexate	FPGS	rs1544105		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	Q05932	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	9	127800446.0	C	T
pharmgkb	methotrexate	DHFR	rs70991108		drug-induced liver injury,Leukopenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	Toxicity	P00374	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	80654345.0	-	TGGCGCGTCCCGCCCAGGT
pharmgkb	methotrexate	ENOSF1	rs11280056		gastrointestinal toxicity,mucositis,Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q7L5Y1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	18	673447.0	AAGTTA	-
pharmgkb	methotrexate	ENOSF1	rs11280056		Arthritis, Rheumatoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	Q7L5Y1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	18	673447.0	AAGTTA	-
pharmgkb	morphine	TLR2	rs3804100		Pain, Postoperative	Dosage	O60603	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	4	153704257.0	T	C
pharmgkb	cisplatin	ERCC1	rs11615		Esophageal Neoplasms,Ovarian Neoplasms,Stomach Neoplasms	Efficacy	P07992	Drug	441203.0	N.N.Cl[Pt+2]Cl	19	45420395.0	A	G
pharmgkb	cisplatin,gemcitabine	ERCC1	rs11615		Carcinoma, Non-Small-Cell Lung	Efficacy	P07992				19	45420395.0	A	G
pharmgkb	cisplatin	ERCC1	rs11615		Pancreatic Neoplasms	Efficacy	P07992	Drug	441203.0	N.N.Cl[Pt+2]Cl	19	45420395.0	A	G
pharmgkb	cisplatin	ERCC1	D396N		Ovarian Neoplasms	Efficacy	P07992	Drug	441203.0	N.N.Cl[Pt+2]Cl	19	45409148.0	G	A
pharmgkb	methotrexate	GGH	rs3758149		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	Q92820	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	8	63039169.0	G	A
pharmgkb	methotrexate	GGH	A31S		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	Q92820	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	8	63038678.0	C	W
pharmgkb	methotrexate	GGH	rs11545076		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	Q92820	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	8	63038892.0	A	C
pharmgkb	tramadol	CYP2A7P1	Q172H			Metabolism/PK		Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	19	41006936.0	G	W
pharmgkb	methotrexate	TYMS	rs45445694		Lymphoma, Non-Hodgkin,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P04818	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O				
pharmgkb	salbutamol	ADRB2	R16G		Asthma	Efficacy	P07550	Drug	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	5	148826877.0	G	A
pharmgkb	bupropion,naltrexone	ANKK1	E713K		Obesity	Efficacy	Q8NFD2				11	113400106.0	G	A
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R533H		Malignant Hyperthermia	Toxicity	P21817				19	38455472.0	G	A
pharmgkb	methadone	UGT2B7	rs7668258		Opioid-Related Disorders	Efficacy	P16662	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	4	69096360.0	T	C
pharmgkb	lamotrigine	UGT2B7	rs7668258		Epilepsy	Metabolism/PK	P16662	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	4	69096360.0	T	C
pharmgkb	desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine	RYR1	R530H		Malignant Hyperthermia	Toxicity	P21817				19	38455463.0	G	W
pharmgkb	methadone	ABCB1	S893A		Opioid-Related Disorders	Metabolism/PK	P08183	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	87531302.0	A	Y
pharmgkb	fentanyl	ASTN2	rs7858836		Pain, Postoperative	Dosage	O75129	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	9	117194009.0	T	C
pharmgkb	fentanyl	ASTN2	rs958804		Pain, Postoperative	Dosage	O75129	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	9	117196574.0	T	C
pharmgkb	antiepileptics	SCN2A	rs2304016		Epilepsy	Efficacy	Q99250	Drug Class			2	165311993.0	A	G
pharmgkb	carbamazepine	SCN2A	rs2304016		Epilepsy	Efficacy	Q99250	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	2	165311993.0	A	G
pharmgkb	lamotrigine	SCN2A	rs2304016		Epilepsy	Efficacy	Q99250	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	2	165311993.0	A	G
pharmgkb	oxcarbazepine	SCN2A	rs2304016		Epilepsy	Efficacy	Q99250	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	2	165311993.0	A	G
pharmgkb	phenytoin	SCN2A	rs2304016		Epilepsy	Efficacy	Q99250	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	2	165311993.0	A	G
pharmgkb	topiramate	SCN2A	rs2304016		Epilepsy	Efficacy	Q99250	Drug	5284627.0	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C	2	165311993.0	A	G
pharmgkb	nevirapine	HLA-B	HLA-B*67:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	morphine,nortriptyline	ABCB1	I1145M		Pain	Efficacy	P08183				7	87509329.0	A	K
pharmgkb	irinotecan	VDR	rs11574077		Colorectal Neoplasms	Metabolism/PK	P11473	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	12	47859144.0	T	C
pharmgkb	ledipasvir,sofosbuvir	IFNL3	rs12979860		Hepatitis C, Chronic	Efficacy	Q8IZI9				19	39248147.0	C	T
pharmgkb	interferons	IFNL3	rs12979860		Hepatitis C	Efficacy	Q8IZI9	Drug Class			19	39248147.0	C	T
pharmgkb	flurbiprofen	CYP2C9	N218I			Metabolism/PK	P11712	Drug	3394.0	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O	10	94949118.0	A	T
pharmgkb	methadone	GAD1	rs3762555		Heroin Dependence	Dosage	Q99259	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	2	170815885.0	C	R
pharmgkb	rosiglitazone	CYP2C8	CYP2C8*1, CYP2C8*3			Efficacy	P10632	Drug	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3				
pharmgkb	talinolol	ABCC2	V417I			Metabolism/PK	Q5T2W1	Drug			10	99804058.0	G	A
pharmgkb	thiotepa	GSTP1	A114V		Neoplasms	Metabolism/PK	P09211	Drug			11	67586108.0	C	T
pharmgkb	risperidone	COMT	rs9606186		Schizophrenia	Efficacy	P21964	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	22	19932836.0	C	G
pharmgkb	warfarin	VKORC1	Q30R			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31087690.0	T	C
pharmgkb	fluorouracil	CCND1	rs9344		Colonic Neoplasms	Efficacy	P24385	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	11	69648142.0	G	A
pharmgkb	pravastatin	ABCB1	S893A		Acute coronary syndrome,Hyperlipoproteinemia Type II	Efficacy	P08183	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	7	87531302.0	A	Y
pharmgkb	tramadol	SLC22A1	R61C			Metabolism/PK	O15245	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	6	160122116.0	C	T
pharmgkb	clozapine	MC4R	rs11872992		Schizophrenia	Toxicity	P32245	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	18	60373354.0	G	A
pharmgkb	olanzapine	MC4R	rs11872992		Schizophrenia,Weight gain	Toxicity	P32245	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	18	60373354.0	G	A
pharmgkb	clozapine	GLP1R	rs2268639		Schizophrenia,Weight gain	Toxicity	P43220	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	6	39082846.0	T	A
pharmgkb	olanzapine	GLP1R	rs2268639		Schizophrenia,Weight gain	Toxicity	P43220	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	6	39082846.0	T	A
pharmgkb	warfarin	NQO1	P187S		Thrombosis	Efficacy	P15559	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	69711242.0	G	A
pharmgkb	Dipeptidyl peptidase 4 (DPP-4) inhibitors	CDKAL1	rs7754840		Diabetes Mellitus	Efficacy	Q5VV42	Drug Class			6	20661019.0	G	H
pharmgkb	ethanol	OPRM1	rs1381376		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154072123.0	C	D
pharmgkb	cocaine	OPRM1	rs3778156		Cocaine-Related Disorders	Toxicity	P35372	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	6	154083178.0	A	G
pharmgkb	tolbutamide	CYP2C9	S115R			Metabolism/PK	P11712	Drug	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C	10	94942203.0	A	C
pharmgkb	mephenytoin	CYP2C19	R186C			Metabolism/PK	P33261	Drug	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2	10	94780573.0	C	T
pharmgkb	docetaxel,doxorubicin	AKR1C3	rs1937840		Breast Neoplasms	Efficacy	P42330				10	5099115.0	C	G
pharmgkb	doxorubicin	AKR1C3	rs1937840		Breast Neoplasms	Other	P42330	Drug	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	10	5099115.0	C	G
pharmgkb	nicotine	OPRM1	N40D			Other	P35372	Drug	942.0	CN1CCCC1C2=CN=CC=C2	6	154039662.0	A	G
pharmgkb	cyclophosphamide,doxorubicin,fluorouracil	ABCC4	rs9561778		Breast Neoplasms,Neoplasms	Toxicity	O15439				13	95061461.0	G	W
pharmgkb	levodopa	DRD3	G9S		gastrointestinal toxicity,Hallucinations,Parkinson Disease	Toxicity	P35462	Drug, Biological Intermediate	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	3	114171968.0	C	T
pharmgkb	methadone	DRD2	rs6275		Heroin Dependence	Dosage	P14416	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	11	113412755.0	A	G
pharmgkb	methotrexate	ABCB1	I1145M		Burkitt Lymphoma,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	P08183	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	7	87509329.0	A	K
pharmgkb	methotrexate	ABCC2	rs3740065		Carcinoma, Non-Small-Cell Lung,Drug Toxicity,Leukemia, B-Cell, Acute	Toxicity	Q5T2W1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	99845936.0	A	G
pharmgkb	methotrexate	SLCO1B1	V174A		Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21178615.0	T	C
pharmgkb	methotrexate	SLCO1B1	rs4149081		Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21225087.0	G	A
pharmgkb	methotrexate	SLCO1B1	N130H		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21176804.0	A	K
pharmgkb	methotrexate	SLCO1A2	rs4149009		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	P46721	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21267537.0	C	T
pharmgkb	methotrexate	FPGS	rs1544105		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q05932	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	9	127800446.0	C	T
pharmgkb	methotrexate	ABCB1	I1145M		Arthritis, Rheumatoid	Efficacy,Toxicity	P08183	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	7	87509329.0	A	K
pharmgkb	methotrexate	SLC19A1	H27R		Arthritis, Rheumatoid,Drug Toxicity	Toxicity	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45537880.0	T	S
pharmgkb	methotrexate	MTHFR	E429A		Arthritis, Rheumatoid	Toxicity	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11794419.0	T	G
pharmgkb	methotrexate	ABCB1	rs1128503		Lymphoma,mucositis,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P08183	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	7	87550285.0	A	G
pharmgkb	methotrexate	ABCB1	I1145M		Burkitt Lymphoma,Drug Toxicity,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P08183	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	7	87509329.0	A	K
pharmgkb	folic acid,hydroxychloroquine,methotrexate,sulfasalazine	MTR	D919G		Arthritis, Rheumatoid	Efficacy	Q13613				1	236885200.0	A	G
pharmgkb	methotrexate	MTR	D919G		Arthritis, Rheumatoid	Efficacy	Q13613	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	236885200.0	A	G
pharmgkb	methotrexate	MTR	D919G		Arthritis, Rheumatoid	Toxicity	Q13613	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	236885200.0	A	G
pharmgkb	methotrexate	ABCC2	rs717620		Leukemia,Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q5T2W1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	99782821.0	C	T
pharmgkb	methotrexate	CCND1	rs9344		Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P24385	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	11	69648142.0	G	A
pharmgkb	methotrexate	CCND1	rs9344		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P24385	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	11	69648142.0	G	A
pharmgkb	cisplatin,doxorubicin,methotrexate	CCND1	rs9344		Osteosarcoma	Efficacy	P24385				11	69648142.0	G	A
pharmgkb	methotrexate	MTHFD1	R653Q		Anemia,Leukopenia,Lymphoma, Non-Hodgkin,mucositis,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia,Toxic liver disease	Toxicity	P11586	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	14	64442127.0	G	A
pharmgkb	mercaptopurine,methotrexate	GSTP1	I105V		Drug Toxicity,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P09211				11	67585218.0	A	G
pharmgkb	methotrexate	MTRR	I49M		Drug Toxicity,Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9UBK8	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	7870860.0	A	G
pharmgkb	disulfiram	OPRD1	rs678849		Cocaine-Related Disorders	Efficacy	P41143	Drug	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	1	28818676.0	C	T
pharmgkb	mercaptopurine	SLCO1B1	rs11045879		gastrointestinal toxicity,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9Y6L6	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	12	21229685.0	T	C
pharmgkb	codeine	WBP2NL	rs9620007		adverse events	Toxicity	Q6ICG8	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	22	42009653.0	C	G
pharmgkb	hydrocodone	OPRM1	rs62436463		adverse events	Toxicity	P35372	Drug	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	6	154069472.0	C	T
pharmgkb	oxycodone	OPRM1	rs62436463		adverse events	Toxicity	P35372	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	6	154069472.0	C	T
pharmgkb	meperidine	FIP1L1	rs113100019		adverse events	Toxicity	Q6UN15	Drug	4058.0	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2	4	53421530.0	T	G
pharmgkb	tramadol	OPRM1	rs62436463		adverse events	Toxicity	P35372	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	6	154069472.0	C	T
pharmgkb	codeine	SEPTIN3	rs739296		adverse events	Toxicity	Q9UH03	Prodrug	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	22	41993944.0	G	A
pharmgkb	oxycodone	SEPTIN3	rs739296		adverse events	Toxicity	Q9UH03	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	22	41993944.0	G	A
pharmgkb	hydrocodone	SEPTIN3	rs739296		adverse events	Toxicity	Q9UH03	Drug	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	22	41993944.0	G	A
pharmgkb	tramadol	SEPTIN3	rs739296		adverse events	Toxicity	Q9UH03	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	22	41993944.0	G	A
pharmgkb	meperidine	SERINC5	rs185462714		adverse events	Toxicity	Q86VE9	Drug	4058.0	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2	5	80184547.0	A	C
pharmgkb	ketorolac	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3		Pain, Postoperative	Efficacy	P11712	Drug	3826.0	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O				
pharmgkb	paclitaxel	ABCB1	rs1128503		Breast Neoplasms,Peripheral Nervous System Diseases	Toxicity	P08183	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	7	87550285.0	A	G
pharmgkb	carbamazepine	HLA-B	HLA-B*46:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	carbamazepine	HLA-B	HLA-B*15:21		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	carbamazepine	HLA-A	HLA-A*24:02		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P04439	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	methadone	CYP2B6	K262R		Heroin Dependence	Dosage	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	19	41009358.0	A	G
pharmgkb	methadone	ABCB1	I1145M		Pain	Dosage	P08183	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	87509329.0	A	K
pharmgkb	methadone	DRD1	rs5326		Heroin Dependence	Dosage	P21728	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	5	175443193.0	C	T
pharmgkb	oxycodone	CYP3A4	CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*7, CYP3A4*8, CYP3A4*9, CYP3A4*10, CYP3A4*11, CYP3A4*12, CYP3A4*13, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*18, CYP3A4*19, CYP3A4*20, CYP3A4*21, CYP3A4*22, CYP3A4*23, CYP3A4*24, CYP3A4*26, CYP3A4*28, CYP3A4*29, CYP3A4*30, CYP3A4*31, CYP3A4*32, CYP3A4*33, CYP3A4*34			Metabolism/PK	P08684	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O				
pharmgkb	buprenorphine	ADAMTSL2	rs756770		Opioid-Related Disorders	Efficacy	Q86TH1	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	9	133533736.0	C	A
pharmgkb	naltrexone	ADH1C	I350V		Alcoholism	Efficacy	P00326	Drug	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	4	99339632.0	T	M
pharmgkb	naltrexone	ADH1B	R370C		Alcoholism	Efficacy	P00325	Drug	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	4	99307860.0	G	A
pharmgkb	naltrexone	ALDH2	E457K		Alcoholism	Efficacy	P05091	Drug	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	12	111803962.0	G	A
pharmgkb	morphine	OPRM1	N40D		Pain,Pain, Postoperative	Dosage	P35372	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	6	154039662.0	A	G
pharmgkb	naltrexone	AKR1C4	L311V			Metabolism/PK	P17516	Drug	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	10	5218719.0	C	G
pharmgkb	naltrexone	AKR1C4	S145Y			Metabolism/PK	P17516	Drug	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	10	5205821.0	C	G
pharmgkb	cocaine	OPRK1	rs997917		Cocaine-Related Disorders	Toxicity	P41145	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	8	53239818.0	T	C
pharmgkb	opioids	OPRK1	rs997917		Opioid-Related Disorders	Toxicity	P41145	Drug Class			8	53239818.0	T	C
pharmgkb	aspirin	EYA1	rs12678747		Peptic Ulcer	Toxicity	Q99502	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	8	71202541.0	A	T
pharmgkb	nicotine	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46		Tobacco Use Disorder	Toxicity	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2				
pharmgkb	nicotine	CYP2A6	V110I			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40849833.0	C	D
pharmgkb	nicotine	CYP2A6	R64S			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40849971.0	G	W
pharmgkb	nicotine	CYP2A6	R190H			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40848304.0	C	W
pharmgkb	nicotine	CYP2A6	rs61605570			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40845458.0	T	A
pharmgkb	nicotine	CYP2A6	E419K			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40844679.0	C	T
pharmgkb	nicotine	CYP2A6	I434V			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40844634.0	T	C
pharmgkb	nicotine	CYP2A6	M275I			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40846881.0	C	A
pharmgkb	nicotine	CYP2A6	E330D			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40845465.0	C	A
pharmgkb	nicotine	CYP2A6	T378I			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40845322.0	G	W
pharmgkb	nicotine	CYP2A6	I61F			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40849980.0	T	R
pharmgkb	nicotine	CYP2A6	M368I			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40845351.0	C	G
pharmgkb	nicotine	CYP2A6	G115D			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40848763.0	C	T
pharmgkb	nicotine	CYP2A6	R257C			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40846937.0	G	H
pharmgkb	nicotine	CYP2A6	I300T			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40846030.0	A	K
pharmgkb	nicotine	CYP2A6	V323M			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40845962.0	C	T
pharmgkb	nicotine	CYP2A6	F362S			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40845370.0	A	S
pharmgkb	nicotine	CYP2A6	R64H			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40849970.0	C	T
pharmgkb	nicotine	CYP2A6	V140A			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40848688.0	A	G
pharmgkb	nicotine	CYP2A6	E97K			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40849872.0	C	T
pharmgkb	nicotine	CYP2A6	I471T			Metabolism/PK	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2	19	40843869.0	A	G
pharmgkb	buprenorphine	OPRD1	rs678849		Opioid-Related Disorders	Efficacy	P41143	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	1	28818676.0	C	T
pharmgkb	morphine	FAAH	P129T		Constipation,Delirium,Lung Neoplasms,Nausea,Pain,Postoperative Nausea and Vomiting,Pruritus,Respiratory Insufficiency,somnolence,Urinary Retention	Toxicity	O00519	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	1	46405089.0	C	A
pharmgkb	morphine	OPRM1	N40D		adverse events,Constipation,Delirium,Dizziness,Nausea,Pain, Postoperative,Postoperative Nausea and Vomiting,Pruritus,Respiratory Insufficiency,somnolence,Urinary Retention,Vomiting	Toxicity	P35372	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	6	154039662.0	A	G
pharmgkb	oxycodone	OPRM1	N40D		Pain,Pain, Postoperative	Dosage	P35372	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	6	154039662.0	A	G
pharmgkb	fentanyl	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6		Pain,Pain, Postoperative	Metabolism/PK	P20815	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3				
pharmgkb	methadone	CYP2B6	Q172H		Heroin Dependence,Opioid-Related Disorders	Dosage	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	19	41006936.0	G	W
pharmgkb	methadone	OPRM1	rs10485058		Opioid-Related Disorders	Efficacy	P35372	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	6	154124080.0	A	G
pharmgkb	methadone	DAO	rs55944529		Heroin Dependence	Metabolism/PK	P14920	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	12	108898654.0	C	T
pharmgkb	methadone	DAO	rs55944529		Heroin Dependence	Dosage	P14920	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	12	108898654.0	C	T
pharmgkb	abiraterone	SRD5A2	L89I		Prostatic Neoplasms	Efficacy	P31213	Drug	132971.0	C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O	2	31580636.0	G	H
pharmgkb	abiraterone,prednisolone	DSE	P62T		Prostatic Neoplasms	Efficacy	Q9UL01				6	116279647.0	G	W
pharmgkb	atorvastatin	ABCG2	Q141K			Other	Q9UNQ0	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	4	88131171.0	G	Y
pharmgkb	simvastatin	ABCG2	Q141K			Metabolism/PK	Q9UNQ0	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	4	88131171.0	G	Y
pharmgkb	fluvastatin	ABCG2	Q141K			Metabolism/PK	Q9UNQ0	Drug	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	4	88131171.0	G	Y
pharmgkb	methotrexate	MTHFR	A222V		Burkitt Lymphoma,Leukemia,Lymphoma,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11796321.0	G	A
pharmgkb	folic acid,vitamin b-complex, plain	MTHFR	A222V			Efficacy	P42898				1	11796321.0	G	A
pharmgkb	folic acid	MTHFR	A222V			Metabolism/PK	P42898	Drug	6037.0	C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N	1	11796321.0	G	A
pharmgkb	methotrexate	MTHFR	A222V		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11796321.0	G	A
pharmgkb	methotrexate	MTHFR	A222V		Graft vs Host Disease,Leukemia,Leukemia, Myelogenous, Chronic, BCR-ABL Positive	Efficacy	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11796321.0	G	A
pharmgkb	interferon alfa-2a, recombinant,ribavirin	HLA-B	HLA-B*44:02		Hepatitis C	Efficacy	P01889							
pharmgkb	sacubitril	CES1	G144E			Metabolism/PK	Q9NZK5	Prodrug			16	55823658.0	C	T
pharmgkb	sulfamethoxazole / trimethoprim	HLA-B	HLA-B*07:02		Respiratory Insufficiency	Toxicity	P01889	Drug	358641.0					
pharmgkb	sulfamethoxazole / trimethoprim	HLA-C	HLA-C*07:02		Respiratory Insufficiency	Toxicity	P10321	Drug	358641.0					
pharmgkb	sulfamethoxazole / trimethoprim	GSTM1	GSTM1 non-null, GSTM1 null		Acquired Immunodeficiency Syndrome	Toxicity	P09488	Drug	358641.0					
pharmgkb	sulfamethoxazole / trimethoprim	NAT2	G286E		adverse events,Hypersensitivity	Toxicity	Q6N069	Drug	358641.0		8	18400860.0	G	A
pharmgkb	sulfamethoxazole / trimethoprim	NAT2	R197Q		adverse events,Hypersensitivity	Toxicity	Q6N069	Drug	358641.0		8	18400593.0	G	A
pharmgkb	Glucarpidase	INSRR	rs10908521		nephrotoxicity	Toxicity	P14616	Drug			1	156843858.0	T	C
pharmgkb	Glucarpidase	GATA3	rs3824662		nephrotoxicity	Toxicity	P23771	Drug			10	8062245.0	C	W
pharmgkb	clozapine	CYP1A2	CYP1A2*1A, CYP1A2*1C, CYP1A2*1F		Confusion,Drug Toxicity,Headache,Muscle Rigidity,Schizophrenia,sedation,Seizures,Tachycardia	Toxicity	P05177	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl				
pharmgkb	quetiapine	CYP3A4	CYP3A4*1, CYP3A4*3			Metabolism/PK	P08684	Drug	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42				
pharmgkb	alprazolam	CYP3A4	CYP3A4*1, CYP3A4*22		adverse events,Alcoholism,Anxiety Disorders	Toxicity	P08684	Drug	2118.0	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4				
pharmgkb	paclitaxel	CYP3A5	CYP3A5*1, CYP3A5*3		Neoplasms,Neurotoxicity Syndromes	Toxicity	P20815	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C				
pharmgkb	paclitaxel	CYP3A4	CYP3A4*1, CYP3A4*8, CYP3A4*20, CYP3A4*22		Breast Neoplasms,Ovarian Neoplasms	Toxicity	P08684	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C				
pharmgkb	aspirin,clopidogrel	JMJD8	rs11640115		Acute coronary syndrome,major adverse cardiac events (mace)	Efficacy	Q96S16				16	685794.0	A	G
pharmgkb	aspirin,clopidogrel	EFR3A	rs4736529		Acute coronary syndrome,major adverse cardiac events (mace)	Efficacy	Q14156				8	132010916.0	G	Y
pharmgkb	aspirin,clopidogrel	NECAB1	rs74569896		Acute coronary syndrome,major adverse cardiac events (mace)	Efficacy	Q8N987				8	90925381.0	A	G
pharmgkb	aspirin,clopidogrel	AGAP3	rs75750968		Acute coronary syndrome,major adverse cardiac events (mace)	Efficacy	Q96P47				7	151128719.0	T	M
pharmgkb	aspirin,clopidogrel	ECHS1	rs140410716		Acute coronary syndrome,major adverse cardiac events (mace)	Efficacy	P30084				10	133368948.0	C	T
pharmgkb	diclofenac	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8, CYP2C9*13, CYP2C9*36, CYP2C9*37, CYP2C9*38, CYP2C9*39, CYP2C9*40, CYP2C9*42, CYP2C9*43, CYP2C9*44, CYP2C9*45, CYP2C9*46, CYP2C9*47, CYP2C9*48, CYP2C9*50, CYP2C9*52, CYP2C9*53, CYP2C9*54, CYP2C9*55, CYP2C9*59, CYP2C9*60, CYP2C9*62			Metabolism/PK	P11712	Drug	3033.0	C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl				
pharmgkb	atorvastatin	KIF6	W170R		Coronary Disease,Hypercholesterolemia,Myocardial Infarction	Efficacy	Q6ZMV9	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	6	39357302.0	A	G
pharmgkb	aspirin,clopidogrel	MYOM2	rs17064642		Acute coronary syndrome,major adverse cardiac events (mace)	Efficacy	P54296				8	2069296.0	T	C
pharmgkb	acetaminophen	HLA-DQB1	HLA-DQB1*02:02		severe cutaneous adverse reactions	Toxicity	P01920	Drug	1983.0	CC(=O)NC1=CC=C(C=C1)O				
pharmgkb	mercaptopurine	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34		Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	Toxicity	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	thioguanine	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34		Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	Toxicity	P51580	Drug	2723601.0	C1=NC2=C(N1)C(=S)N=C(N2)N				
pharmgkb	mercaptopurine	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	thioguanine	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage	P51580	Drug	2723601.0	C1=NC2=C(N1)C(=S)N=C(N2)N				
pharmgkb	thioguanine	TPMT	TPMT*1, TPMT*19, TPMT*20, TPMT*21, TPMT*22, TPMT*30, TPMT*32, TPMT*33, TPMT*34			Metabolism/PK	P51580	Drug	2723601.0	C1=NC2=C(N1)C(=S)N=C(N2)N				
pharmgkb	mercaptopurine	TPMT	TPMT*1, TPMT*21, TPMT*24, TPMT*25, TPMT*32, TPMT*33, TPMT*34, TPMT*37		Lupus Erythematosus, Systemic,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	P51580	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2				
pharmgkb	clozapine	CYP1A2	CYP1A2*1A, CYP1A2*1F		schizoaffective disorder,Schizophrenia	Metabolism/PK	P05177	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl				
pharmgkb	tenofovir	ABCC4	rs3742106		HIV Infections	Metabolism/PK	O15439	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	13	95021537.0	A	C
pharmgkb	tenofovir	ABCC4	K1116N		HIV Infections	Metabolism/PK	O15439	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	13	95062722.0	C	K
pharmgkb	tenofovir disoproxil fumarate	ABCC10	rs9349256		HIV Infections,nephrotoxicity	Toxicity	Q5T3U5	Drug	6398764.0		6	43436773.0	G	A
pharmgkb	tenofovir disoproxil fumarate	ABCC4	rs3742106		HIV Infections,nephrotoxicity	Toxicity	O15439	Drug	6398764.0		13	95021537.0	A	C
pharmgkb	digoxin	NOS1AP	rs10494366		Shortened QT interval	Toxicity	O75052	Drug	30322.0	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	1	162115895.0	G	T
pharmgkb	highly active antiretroviral therapy (haart)	ABCB1	I1145M		HIV Infections	Efficacy	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	Antivirals for treatment of HIV infections, combinations,Drugs For Treatment Of Tuberculosis	NAT2	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*12, NAT2*13		drug-induced liver injury,HIV Infections,Tuberculosis	Toxicity	Q6N069							
pharmgkb	sulfamethoxazole / trimethoprim	NAT2	NAT2*4, NAT2*5A, NAT2*5B, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*14A, NAT2*14B		adverse events,Hypersensitivity,severe cutaneous adverse reactions	Toxicity	Q6N069	Drug	358641.0					
pharmgkb	carboplatin,paclitaxel	CYP3A5	CYP3A5*1, CYP3A5*3		Leukopenia,Neutropenia,Ovarian Neoplasms	Toxicity	P20815							
pharmgkb	methotrexate	AHRR	P185A		Arthritis, Rheumatoid	Efficacy	A9YTQ3	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	422840.0	C	K
pharmgkb	phenytoin	CYP2C9	CYP2C9*1, CYP2C9*3		Stevens-Johnson Syndrome	Toxicity	P11712	Drug	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3				
pharmgkb	ketoprofen	CYP2C9	CYP2C9*1, CYP2C9*2		Dyspepsia,Pain, Postoperative	Toxicity	P11712	Drug	3825.0	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O				
pharmgkb	ketoprofen	CYP2C9	CYP2C9*1, CYP2C9*3		Pain, Postoperative	Efficacy	P11712	Drug	3825.0	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O				
pharmgkb	methoxsalen	CYP2A6	CYP2A6*1, CYP2A6*15, CYP2A6*21, CYP2A6*22			Metabolism/PK	P11509	Drug	4114.0	COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2				
pharmgkb	nicotine	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*46		Tobacco Use Disorder	Dosage	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2				
pharmgkb	nicotine	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12		Tobacco Use Disorder	Toxicity	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2				
pharmgkb	naloxone,oxycodone	OPRM1	N40D		Erythema	Toxicity	P35372				6	154039662.0	A	G
pharmgkb	naloxone,oxycodone	COMT	V158M		Vomiting	Toxicity	P21964				22	19963748.0	G	A
pharmgkb	naloxone,oxycodone	COMT	V158M		Erythema	Toxicity	P21964				22	19963748.0	G	A
pharmgkb	hydralazine	NAT2	NAT2*4, NAT2*5D, NAT2*6B, NAT2*7A, NAT2*12A, NAT2*13A, NAT2*14A		Hypertension	Efficacy	Q6N069	Drug	3637.0	C1=CC=C2C(=C1)C=NN=C2NN				
pharmgkb	tegafur	CYP2A6	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*18, CYP2A6*19, CYP2A6*46		Neoplasms	Metabolism/PK	P11509	Prodrug	5386.0					
pharmgkb	letrozole	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35, CYP2A6*46		Breast Neoplasms	Metabolism/PK	P11509	Drug	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3				
pharmgkb	coumarin	CYP2A6	CYP2A6*1, CYP2A6*4, CYP2A6*5, CYP2A6*6, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*12, CYP2A6*17, CYP2A6*18, CYP2A6*19, CYP2A6*20			Metabolism/PK	P11509	Drug						
pharmgkb	nicotine	CYP2A6	CYP2A6*1, CYP2A6*1x2, CYP2A6*2		Tobacco Use Disorder	Toxicity	P11509	Drug	942.0	CN1CCCC1C2=CN=CC=C2				
pharmgkb	buprenorphine / naloxone	UGT2B7	rs7662029		Opioid-Related Disorders	Metabolism/PK	P16662	Drug			4	69096194.0	A	K
pharmgkb	buprenorphine,fentanyl,tramadol	COMT	V158M		adverse events,Opioid-Related Disorders	Toxicity	P21964				22	19963748.0	G	A
pharmgkb	buprenorphine / naloxone	UGT2B7	Y268H		Opioid-Related Disorders	Metabolism/PK	P16662	Drug			4	69098620.0	T	C
pharmgkb	tramadol	ABCB1	I1145M		Opioid-Related Disorders	Toxicity	P08183	Drug	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	7	87509329.0	A	K
pharmgkb	nifedipine	CYP3A4	CYP3A4*1, CYP3A4*17			Metabolism/PK	P08684	Drug	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC				
pharmgkb	clopidogrel	N6AMT1	rs2254638		major adverse cardiac events (mace)	Efficacy	Q9Y5N5	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	21	28883961.0	A	S
pharmgkb	clopidogrel	P2RY12	rs2046934		major adverse cardiac events (mace)	Efficacy	Q9H244	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	3	151339854.0	G	M
pharmgkb	clopidogrel	PTGS1	rs1330344		major adverse cardiac events (mace)	Efficacy	P23219	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	9	122369409.0	C	T
pharmgkb	nimodipine	CACNA1C	rs2239050			Efficacy	P54284	Drug	4497.0	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC	12	2338248.0	G	M
pharmgkb	Beta Blocking Agents	ADRA2C	rs61767072		Cardiomyopathy, Dilated,Death	Efficacy	P18825	Drug Class			4	3767570.0	GGGGCGGGGCCG	-
pharmgkb	Beta Blocking Agents	GRK5	rs10787959		Coronary Artery Disease	Efficacy	P34947	Drug Class			10	119371801.0	A	G
pharmgkb	Beta Blocking Agents	GRK5	rs3740563		Coronary Artery Disease	Efficacy	P34947	Drug Class			10	119335888.0	A	C
pharmgkb	Beta Blocking Agents	GRK5	rs11198893		Coronary Artery Disease	Efficacy	P34947	Drug Class			10	119348388.0	G	M
pharmgkb	Beta Blocking Agents	GRK5	rs4752292		Coronary Artery Disease	Efficacy	P34947	Drug Class			10	119340641.0	T	G
pharmgkb	sorafenib	TNF	rs1800629		Carcinoma, Hepatocellular,hand-foot syndrome	Toxicity	Q9UNG2	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	6	31575254.0	G	A
pharmgkb	Glucarpidase	SLCO1B1	V174A		nephrotoxicity	Toxicity	Q9Y6L6	Drug			12	21178615.0	T	C
pharmgkb	Glucarpidase	ABCC4	rs7317112		nephrotoxicity	Toxicity	O15439	Drug			13	95271269.0	A	G
pharmgkb	atenolol,verapamil	GRK4	A142V		Coronary Artery Disease,Hypertension	Toxicity	P32298				4	3004316.0	C	D
pharmgkb	alprazolam	CYP3A4	CYP3A4*1, CYP3A4*22		Alcoholism,Anxiety Disorders	Efficacy	P08684	Drug	2118.0	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4				
pharmgkb	buprenorphine	CYP3A4	rs2740574		Pain	Efficacy	P08684	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	7	99784473.0	C	T
pharmgkb	losartan	CYP2C9	rs1934969			Other	P11712	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	10	94988738.0	A	T
pharmgkb	sulfonamides, urea derivatives	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Diabetes Mellitus, Type 2	Efficacy	P33261	Drug Class						
pharmgkb	clozapine	HLA-DRB1	HLA-DRB1*04:02		Agranulocytosis	Toxicity	P01911	Drug	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl				
pharmgkb	carbamazepine	HLA-DRB1	HLA-DRB1*03:01		Maculopapular Exanthema	Toxicity	P01911	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	sorafenib	PIK3R5	rs444904		Hypertension	Toxicity	P48736	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	17	8900750.0	C	T
pharmgkb	sorafenib	EGFR	rs917881		Diarrhea	Toxicity	P00533	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	7	55094612.0	A	G
pharmgkb	sorafenib	VEGFB	D136E		Drug Toxicity	Toxicity	P49765	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	11	64237220.0	C	K
pharmgkb	sorafenib	EPAS1	rs4035887		Drug Toxicity	Toxicity	Q99814	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	2	46340088.0	A	K
pharmgkb	sorafenib	KDR	rs4864950		Drug Toxicity	Toxicity	P35968	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	4	55080735.0	T	A
pharmgkb	regorafenib	KDR	rs4864950		Drug Toxicity	Toxicity	P35968	Drug			4	55080735.0	T	A
pharmgkb	sorafenib	EPAS1	rs1868089		Drug Toxicity	Toxicity	Q99814	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	2	46327507.0	C	T
pharmgkb	sorafenib	PRKCE	rs11125039		Hypertension	Toxicity	Q02156	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	2	45869545.0	A	G
pharmgkb	sorafenib	ADAMTS18	rs1346563		Hypertension	Toxicity	Q8TE60	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	16	77402386.0	G	A
pharmgkb	sorafenib	EGFR	rs2330951		Hypertension	Toxicity	P00533	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	7	55106649.0	C	A
pharmgkb	sorafenib	MAP2K6	rs11651488		Diarrhea	Toxicity	P52564	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	17	69478057.0	T	C
pharmgkb	sorafenib	CDH13	rs17682789		Diarrhea	Toxicity	P55290	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	16	82981129.0	T	C
pharmgkb	sorafenib	WWOX	rs9927200		Diarrhea	Toxicity	Q9NZC7	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	16	78170090.0	A	C
pharmgkb	sorafenib	EGFR	rs917881		Diarrhea	Toxicity	P00533	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	7	55094612.0	A	G
pharmgkb	sorafenib	MAP2K6	rs12948059		Drug Toxicity	Toxicity	P52564	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	17	69498353.0	A	G
pharmgkb	sorafenib	EPAS1	rs9973653		Drug Toxicity	Toxicity	Q99814	Drug	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	2	46320970.0	G	T
pharmgkb	losartan	CAMK1D	rs10737062		Essential hypertension	Efficacy	Q8IU85	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	10	12690744.0	G	M
pharmgkb	losartan	CAMK1D	rs10752271		Essential hypertension	Efficacy	Q8IU85	Drug	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	10	12662192.0	G	A
pharmgkb	tacrolimus	IL10	rs1800871		Kidney Transplantation	Metabolism/PK	P22301	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	206773289.0	A	G
pharmgkb	rivaroxaban	ABCB1	I1145M			Metabolism/PK	P08183	Drug	9875401.0		7	87509329.0	A	K
pharmgkb	sufentanil	CYP3A4	rs2242480		Respiratory Insufficiency	Toxicity	P08684	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	7	99763843.0	C	T
pharmgkb	sufentanil	CYP3A4	rs2242480		Pain	Dosage	P08684	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	7	99763843.0	C	T
pharmgkb	sufentanil	CYP3A4	rs2242480			Efficacy	P08684	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	7	99763843.0	C	T
pharmgkb	sufentanil	CYP3A4	rs2242480			Metabolism/PK	P08684	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	7	99763843.0	C	T
pharmgkb	tacrolimus	CYP3A4	rs2242480		liver transplantation	Toxicity	P08684	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99763843.0	C	T
pharmgkb	atorvastatin	CYP3A4	rs2242480		Hyperlipidemias	Efficacy	P08684	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	7	99763843.0	C	T
pharmgkb	fentanyl	CYP3A4	rs2242480			Metabolism/PK	P08684	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	99763843.0	C	T
pharmgkb	fentanyl	CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22			Metabolism/PK	P08684	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3				
pharmgkb	sevoflurane	FASTKD3	I49M		sedation	Efficacy	Q14CZ7	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	5	7870860.0	A	G
pharmgkb	sevoflurane	FASTKD3	I49M			Other	Q14CZ7	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	5	7870860.0	A	G
pharmgkb	sevoflurane	GABRA2	K132N			Other	P47869	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	4	46312576.0	T	C
pharmgkb	sevoflurane	FASTKD3	rs2307116			Other	Q14CZ7	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	5	7861872.0	G	A
pharmgkb	sevoflurane	KCNK3	rs1275988			Other	O14649	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	2	26691496.0	C	T
pharmgkb	sevoflurane	CYP2E1	rs2031920			Other	P05181	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	10	133526341.0	C	T
pharmgkb	sevoflurane	CYP2E1	rs3813867			Other	P05181	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	10	133526101.0	G	M
pharmgkb	sevoflurane	KCNK2	rs6686529		sedation	Efficacy	O95069	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	1	215236763.0	G	Y
pharmgkb	sevoflurane	GRIN2B	rs1806201			Other	Q8TB68	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	12	13564574.0	G	A
pharmgkb	sevoflurane	FASTKD3	rs3733784			Efficacy	Q14CZ7	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	5	7862813.0	T	C
pharmgkb	sevoflurane	FASTKD3	rs2307116			Efficacy	Q14CZ7	Drug	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	5	7861872.0	G	A
pharmgkb	nevirapine	HLA-B	HLA-B*39:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	oxcarbazepine	HLA-B	HLA-B*15:18, HLA-B*40:01		Stevens-Johnson Syndrome	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	methotrexate	HLA-C	HLA-C*06:02		Psoriasis	Efficacy	P10321	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O				
pharmgkb	nevirapine	HLA-DQB1	HLA-DQB1*05:01		Drug Hypersensitivity	Toxicity	P01920	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	nevirapine	HLA-B	HLA-B*15:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	minocycline	HLA-B	HLA-B*35:02		drug-induced liver injury	Toxicity	P01889	Drug	5281021.0	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)/C(=C(/N)\O)/C1=O)O)O)O)N(C)C				
pharmgkb	azathioprine	ITPA	P32T		liver transplantation,transplant rejection	Efficacy	Q9BY32	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	20	3213196.0	C	R
pharmgkb	aspirin,clopidogrel	ZDHHC3	rs3749187		Acute coronary syndrome,major adverse cardiac events (mace)	Efficacy	Q9NYG2				3	44945082.0	G	A
pharmgkb	capecitabine	CES1	rs2244613		Drug Toxicity	Toxicity	Q9NZK5	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	16	55810697.0	G	W
pharmgkb	cyclosporine	CALM1	rs12885713		Psoriasis	Efficacy	P0DP23	Drug	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	14	90397013.0	C	D
pharmgkb	cisplatin	TPMT	Y240C		Drug Toxicity,Neoplasms,Ototoxicity	Toxicity	P51580	Drug	441203.0	N.N.Cl[Pt+2]Cl	6	18130687.0	T	S
pharmgkb	citalopram	HTR2A	rs7997012		Depression,Depressive Disorder	Efficacy	P28223	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46837850.0	A	G
pharmgkb	venlafaxine	HTR2A	rs7997012		Anxiety Disorders	Efficacy	P28223	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	13	46837850.0	A	G
pharmgkb	citalopram	HTR2A	rs6311		Depressive Disorder, Major,Nausea,Vomiting	Toxicity	P28223	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46897343.0	C	T
pharmgkb	escitalopram	HTR2A	rs6311		Anxiety Disorders,Depressive Disorder, Major	Toxicity	P28223	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46897343.0	C	T
pharmgkb	paroxetine	HTR2A	rs6311		Depression,Depressive Disorder, Major	Toxicity	P28223	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	13	46897343.0	C	T
pharmgkb	citalopram	HTR2A	rs6313		Depressive Disorder, Major,Sexual Dysfunctions, Psychological	Toxicity	P28223	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46895805.0	G	A
pharmgkb	paroxetine	HTR2A	rs6313		Depression	Toxicity	P28223	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	13	46895805.0	G	A
pharmgkb	escitalopram	HTR2A	rs9316233		Depressive Disorder	Efficacy	P28223	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46859220.0	C	K
pharmgkb	Selective serotonin reuptake inhibitors	HTR2A	rs6311		ability to concentrate,Depressive Disorder, Major,Diarrhea,Dizziness,Tremor	Toxicity	P28223	Drug Class			13	46897343.0	C	T
pharmgkb	fluvoxamine	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Depressive Disorder, Major	Efficacy	P31645	Drug	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F				
pharmgkb	paroxetine	SLC6A4	rs57098334		Depression	Efficacy	P31645	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4				
pharmgkb	paroxetine	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Depressive Disorder, Major,Mood Disorders,Panic Disorder	Efficacy	P31645	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4				
pharmgkb	fluoxetine	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Depressive Disorder, Major	Toxicity	P31645	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F				
pharmgkb	fluoxetine	SLC6A4	rs57098334		Depression,Depressive Disorder, Major	Efficacy	P31645	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F				
pharmgkb	antidepressants	SLC6A4	rs57098334		Depression	Toxicity	P31645	Drug Class						
pharmgkb	Selective serotonin reuptake inhibitors	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)			Toxicity	P31645	Drug Class						
pharmgkb	escitalopram	CYP2D6	P34A		Depressive Disorder, Major	Efficacy	P10635	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	22	42130692.0	G	A
pharmgkb	vincristine	CEP72	rs924607		Peripheral Nervous System Diseases	Toxicity	Q9P209	Drug	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	5	609978.0	C	T
pharmgkb	mianserin	CYP2D6	CYP2D6*1, CYP2D6*5, CYP2D6*10		Depression	Metabolism/PK	P10635	Drug	4184.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42				
pharmgkb	rabeprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Gastroesophageal Reflux,Helicobacter Infections,Peptic Ulcer	Efficacy	P33261	Drug	5029.0	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC				
pharmgkb	esomeprazole	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Gastroesophageal Reflux,Helicobacter Infections	Efficacy	P33261	Drug	9568614.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC				
pharmgkb	prasugrel	CYP2C19	CYP2C19*1, CYP2C19*17		Acute coronary syndrome	Toxicity	P33261	Drug	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4				
pharmgkb	anthracyclines and related substances,daunorubicin,doxorubicin	RARG	S416L		cardiotoxicity,Neoplasms	Toxicity	P13631				12	53211761.0	G	A
pharmgkb	atorvastatin	ABCG2	Q141K			Toxicity	Q9UNQ0	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	4	88131171.0	G	Y
pharmgkb	Glucarpidase	ARID5B	rs10821936		nephrotoxicity	Toxicity	Q14865	Drug			10	61963818.0	C	T
pharmgkb	bufuralol,dextromethorphan	CYP2D6	CYP2D6*1, CYP2D6*7, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*27, CYP2D6*29, CYP2D6*36, CYP2D6*37, CYP2D6*39, CYP2D6*40, CYP2D6*47, CYP2D6*48, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*53, CYP2D6*54, CYP2D6*55, CYP2D6*62, CYP2D6*71, CYP2D6*72, CYP2D6*75, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98, CYP2D6*114			Other	P10635							
pharmgkb	n-desmethyltamoxifen	CYP2D6	CYP2D6*1, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*22, CYP2D6*23, CYP2D6*24, CYP2D6*25, CYP2D6*26, CYP2D6*27, CYP2D6*28, CYP2D6*29, CYP2D6*30, CYP2D6*31, CYP2D6*32, CYP2D6*33, CYP2D6*36, CYP2D6*37, CYP2D6*40, CYP2D6*43, CYP2D6*45, CYP2D6*46, CYP2D6*47, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*52, CYP2D6*54, CYP2D6*55, CYP2D6*61, CYP2D6*62, CYP2D6*63, CYP2D6*64, CYP2D6*65, CYP2D6*70, CYP2D6*71, CYP2D6*114			Metabolism/PK	P10635	Metabolite	3032890.0	CC/C(=C(/C1=CC=CC=C1)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3				
pharmgkb	nevirapine	CYP3A5	rs776746		HIV Infections	Other	P20815	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	7	99672916.0	T	C
pharmgkb	mercaptopurine	MTHFR	A222V		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P42898	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	1	11796321.0	G	A
pharmgkb	antiepileptics	ABCB1	S893A		Epilepsy	Efficacy	P08183	Drug Class			7	87531302.0	A	Y
pharmgkb	cyclophosphamide	XRCC1	Q399R		Neoplasms,Ovarian Neoplasms	Efficacy,Toxicity	P18887	Prodrug	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	19	43551574.0	T	C
pharmgkb	paclitaxel	CYP2C8	I199F			Dosage	P10632	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	10	95058349.0	T	A
pharmgkb	Bisphosphonates,pamidronate,zoledronate	CYP2C8	rs1934951		Multiple Myeloma,Osteonecrosis	Toxicity	P10632				10	95038791.0	C	T
pharmgkb	leflunomide	CYP1A2	rs762551		Arthritis, Rheumatoid	Toxicity	P05177	Drug	3899.0	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	15	74749576.0	C	A
pharmgkb	antipsychotics	CYP1A2	rs2069514		Schizophrenia	Toxicity	P05177	Drug Class			15	74745879.0	G	A
pharmgkb	warfarin	EPHX1	rs1131873			Dosage	P07099	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	1	225831952.0	G	A
pharmgkb	lithium	CLOCK	rs1801260		Bipolar Disorder	Toxicity	O15516	Drug	28486.0	[Li+]	4	55435202.0	A	G
pharmgkb	mycophenolate mofetil,mycophenolic acid	IMPDH2	rs11706052		Kidney Transplantation	Efficacy,Toxicity	P12268				3	49026677.0	A	G
pharmgkb	mycophenolate mofetil	UGT1A9	rs17868320		Kidney Transplantation	Efficacy	O60656	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	2	233669782.0	C	T
pharmgkb	antidepressants	GNB3	rs5443		Depressive Disorder, Major	Efficacy	P16520	Drug Class			12	6845711.0	C	T
pharmgkb	atorvastatin	SCAP	V798F			Other	Q12770	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	3	47418189.0	C	T
pharmgkb	pravastatin	SLCO1B1	N130H			Efficacy	Q9Y6L6	Drug	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	12	21176804.0	A	K
pharmgkb	amlodipine	CYP3A4	rs2740574		Hypertension	Efficacy	P08684	Drug	2162.0	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	7	99784473.0	C	T
pharmgkb	fenofibrate	FABP1	T94A		Hypertriglyceridemia	Efficacy	P07148	Drug	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	2	88124547.0	T	C
pharmgkb	fluoxetine	BDNF	V66M		Depressive Disorder, Major	Toxicity	P23560	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	11	27658369.0	C	T
pharmgkb	gemcitabine	RRM1	rs1042858		Breast Neoplasms	Efficacy	Q9UET6	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	11	4138236.0	G	W
pharmgkb	benazepril	ADRB2	R16G		Essential hypertension	Efficacy	P07550	Drug	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	5	148826877.0	G	A
pharmgkb	ranibizumab	VEGFA	rs833069		Macular Degeneration	Efficacy	P15692	Drug			6	43774842.0	T	S
pharmgkb	propranolol	CYP2D6	CYP2D6*1, CYP2D6*10			Other	P10635	Drug	4946.0	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O				
pharmgkb	mefloquine	G6PD	G6PD A- 202A_376G, G6PD B (reference)		Malaria	Toxicity	P11413	Drug	4046.0	C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O				
pharmgkb	cisplatin,cyclophosphamide	RAD52	rs11226		Ovarian Neoplasms	Toxicity	P43351				12	912647.0	G	A
pharmgkb	irinotecan	UGT1A9	rs3832043		Carcinoma, Non-Small-Cell Lung	Toxicity	O60656	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	2	233671808.0	T	-
pharmgkb	chloroquine	G6PD	G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham		Anemia, Hemolytic	Toxicity	P11413	Drug	2719.0	CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl				
pharmgkb	antiepileptics,carbamazepine,phenobarbital,phenytoin,valproic acid	SCN2A	R19K		Epilepsy	Efficacy	Q99250				2	165295879.0	G	A
pharmgkb	antiepileptics	ABCC2	I1324M		Epilepsy	Efficacy	Q5T2W1	Drug Class			10	99844450.0	C	K
pharmgkb	paroxetine	HTR3B	Y129S		Mental Disorders	Toxicity	O95264	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	11	113932306.0	A	C
pharmgkb	ranibizumab	VEGFA	rs699947		Macular Degeneration	Efficacy	P15692	Drug			6	43768652.0	A	Y
pharmgkb	antiepileptics,carbamazepine,oxcarbazepine	ABCC2	V417I		Epilepsy	Toxicity	Q5T2W1				10	99804058.0	G	A
pharmgkb	carbamazepine,phenytoin,valproic acid	ABCB1	S893A		Epilepsy	Efficacy	P08183				7	87531302.0	A	Y
pharmgkb	capecitabine	ADCY2	rs4702484		Colorectal Neoplasms	Efficacy	Q08462	Prodrug	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	5	7649747.0	C	T
pharmgkb	tacrolimus	CYP3A5	rs776746		Hypertension	Toxicity	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99672916.0	T	C
pharmgkb	simvastatin	SLCO1B1	rs4363657		Muscular Diseases	Toxicity	Q9Y6L6	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	12	21215788.0	T	C
pharmgkb	carisoprodol	CYP2C19	CYP2C19*1, CYP2C19*2			Metabolism/PK	P33261	Drug	2576.0	CCCC(C)(COC(=O)N)COC(=O)NC(C)C				
pharmgkb	cyclosporine,mycophenolate mofetil	IMPDH2	rs11706052		Kidney Transplantation	Efficacy	P12268				3	49026677.0	A	G
pharmgkb	clopidogrel	PON1	Q192P		Angina Pectoris,Coronary Artery Disease,Myocardial Infarction,Myocardial Ischemia,Thrombosis	Efficacy,Toxicity	P27169	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	7	95308134.0	T	C
pharmgkb	clopidogrel	P2RY12	N6K			Efficacy,Toxicity	Q9H244	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	3	151338828.0	G	W
pharmgkb	carbamazepine	ABCB1	I1145M		Epilepsy	Efficacy	P08183	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	87509329.0	A	K
pharmgkb	cisplatin	GSTT1	GSTT1 non-null, GSTT1 null		Deafness,Neoplasms,Ototoxicity	Toxicity	P30711	Drug	441203.0	N.N.Cl[Pt+2]Cl				
pharmgkb	tenofovir	ABCC2	V417I		HIV Infections,Kidney Diseases	Toxicity	Q5T2W1	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	10	99804058.0	G	A
pharmgkb	docetaxel	VEGFA	rs699947		Breast Neoplasms	Efficacy	P15692	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	6	43768652.0	A	Y
pharmgkb	efavirenz	UGT2B7	Y268H		HIV Infections	Other	P16662	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	4	69098620.0	T	C
pharmgkb	Drugs For Treatment Of Tuberculosis,ethambutol,isoniazid,pyrazinamide,rifampin,streptomycin	GSTM1	GSTM1 non-null, GSTM1 null		Tuberculosis	Toxicity	P09488							
pharmgkb	Drugs For Treatment Of Tuberculosis,ethambutol,isoniazid,pyrazinamide,rifampin,streptomycin	GSTT1	GSTT1 non-null, GSTT1 null		Tuberculosis	Toxicity	P30711							
pharmgkb	tacrolimus	CYP3A5	rs776746		Neurotoxicity Syndromes	Toxicity	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99672916.0	T	C
pharmgkb	atorvastatin	CETP	rs708272			Efficacy,Toxicity	P11597	Drug	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	16	56962376.0	G	A
pharmgkb	simvastatin	CETP	rs708272		Hypercholesterolemia,Hyperlipoproteinemia Type II	Efficacy	P11597	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	16	56962376.0	G	A
pharmgkb	efavirenz	CYP2A6	rs8192726		HIV Infections	Other	P11509	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	40848591.0	C	A
pharmgkb	efavirenz	CYP2A6	V365M		HIV Infections	Other	P11509	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	40845362.0	C	T
pharmgkb	Photodynamic therapy	CFH	H402Y		Macular Degeneration	Efficacy	P08603	Drug Class			1	196690107.0	C	T
pharmgkb	gefitinib	ABCG2	Q141K		Lung Neoplasms	Toxicity	Q9UNQ0	Drug	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	4	88131171.0	G	Y
pharmgkb	antiepileptics	ABCB1	rs1128503		Epilepsy	Efficacy	P08183	Drug Class			7	87550285.0	A	G
pharmgkb	bevacizumab,ranibizumab	HTRA1	rs11200638		Macular Degeneration	Efficacy	Q92743				10	122461028.0	G	A
pharmgkb	efavirenz	UGT2B7	rs28365062		HIV Infections	Metabolism/PK	P16662	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	4	69098553.0	A	K
pharmgkb	dolasetron,granisetron	CYP2D6	CYP2D6*1, CYP2D6*1xN		Postoperative Nausea and Vomiting	Efficacy	P10635							
pharmgkb	simvastatin	CYP3A5	rs776746		Hypercholesterolemia,Myalgia unspecified	Other	P20815	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	99672916.0	T	C
pharmgkb	methadone	DRD2	rs6277		Substance-Related Disorders	Efficacy	P14416	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	11	113412737.0	G	A
pharmgkb	bevacizumab,ranibizumab	CFH	H402Y		Macular Degeneration	Efficacy	P08603				1	196690107.0	C	T
pharmgkb	mycophenolate mofetil	IMPDH1	rs2278293			Toxicity	P20839	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	7	128400698.0	C	T
pharmgkb	efavirenz	ABCB1	S893A		HIV Infections	Efficacy	P08183	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	7	87531302.0	A	Y
pharmgkb	citalopram,escitalopram	TSPAN5	rs11947402		Depressive Disorder	Other	P62079				4	98680790.0	A	G
pharmgkb	hmg coa reductase inhibitors,simvastatin	GATM	rs9806699		Myocardial Infarction	Toxicity	P50440				15	45448194.0	G	A
pharmgkb	mycophenolate mofetil	UGT1A9	rs6714486		Kidney Transplantation	Efficacy	O60656	Drug	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	2	233671659.0	T	A
pharmgkb	lithium	NTRK2	rs1387923		Bipolar Disorder	Efficacy	Q16620	Drug	28486.0	[Li+]	9	85025721.0	A	G
pharmgkb	efavirenz	CYP3A5	rs776746		HIV Infections	Other	P20815	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	7	99672916.0	T	C
pharmgkb	anthracyclines and related substances	FMO3	V194M		Neoplasms	Toxicity	P31513	Drug Class			1	171110939.0	G	A
pharmgkb	anthracyclines and related substances	HNMT	rs17583889		Neoplasms	Toxicity	P50135	Drug Class			2	137988469.0	C	A
pharmgkb	anthracyclines and related substances	UGT1A6	rs4261716		Neoplasms	Toxicity	P19224	Drug Class			2	233684471.0	G	T
pharmgkb	anthracyclines and related substances	UGT1A6	S7A			Toxicity	P19224	Drug Class			2	233693023.0	T	G
pharmgkb	anthracyclines and related substances	UGT1A6	rs17863783		Neoplasms	Toxicity	P19224	Drug Class			2	233693631.0	G	T
pharmgkb	anthracyclines and related substances	ADH7	rs729147			Toxicity	P40394	Drug Class			4	99412110.0	G	A
pharmgkb	anthracyclines and related substances	SLC22A2	S270A		Neoplasms	Toxicity	O15244	Drug Class			6	160249250.0	A	C
pharmgkb	anthracyclines and related substances	ABCB4	rs1149222		Neoplasms	Toxicity	P21439	Drug Class			7	87444459.0	G	T
pharmgkb	anthracyclines and related substances	ABCB4	rs4148808		Neoplasms	Toxicity	P21439	Drug Class			7	87476479.0	T	C
pharmgkb	anthracyclines and related substances	ABCB1	rs2235047		Neoplasms	Toxicity	P08183	Drug Class			7	87509216.0	A	S
pharmgkb	anthracyclines and related substances	SLC28A3	rs4877847		Neoplasms	Toxicity	Q9HAS3	Drug Class			9	84331502.0	A	C
pharmgkb	anthracyclines and related substances	SLC10A2	rs9514091		Neoplasms	Toxicity	Q12908	Drug Class			13	103061904.0	G	A
pharmgkb	anthracyclines and related substances	SLC10A2	rs7319981		Neoplasms	Toxicity	Q12908	Drug Class			13	103071372.0	G	A
pharmgkb	anthracyclines and related substances	SLC28A1	rs2290271			Toxicity	O00337	Drug Class			15	84904404.0	A	C
pharmgkb	anthracyclines and related substances	ABCC1	rs4148350		Neoplasms	Toxicity	P33527	Drug Class			16	16076620.0	G	T
pharmgkb	anthracyclines and related substances	SLC28A1	rs2305364		Neoplasms	Toxicity	O00337	Drug Class			15	84909044.0	T	C
pharmgkb	anthracyclines and related substances	SPG7	rs2019604		Neoplasms	Toxicity	Q9UQ90	Drug Class			16	89549357.0	T	R
pharmgkb	anthracyclines and related substances	CYP4F2	rs2108623		Neoplasms	Toxicity	P78329	Drug Class			19	15906196.0	G	A
pharmgkb	anthracyclines and related substances	SULT2B1	rs10426377		Neoplasms	Toxicity	O00204	Drug Class			19	48588977.0	C	A
pharmgkb	lamotrigine	HNF4A	rs2071197		Epilepsy	Efficacy,Metabolism/PK	P41235	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	20	44401795.0	G	A
pharmgkb	paclitaxel	CYP2C8	rs1934951		Breast Neoplasms	Toxicity	P10632	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	10	95038791.0	C	T
pharmgkb	docetaxel	ERCC2	rs13181		Breast Neoplasms	Toxicity	P18074	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	19	45351661.0	T	R
pharmgkb	ustekinumab	TNFAIP3	rs610604		Psoriasis	Efficacy	Q8NFZ5	Drug			6	137878280.0	G	T
pharmgkb	carbamazepine	ABCB1	rs1128503		Epilepsy	Metabolism/PK	P08183	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	87550285.0	A	G
pharmgkb	carbamazepine	ABCB1	I1145M		Epilepsy	Dosage,Metabolism/PK	P08183	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	7	87509329.0	A	K
pharmgkb	antiepileptics	ABCC2	rs717620		Epilepsy	Efficacy	Q5T2W1	Drug Class			10	99782821.0	C	T
pharmgkb	adalimumab,etanercept,infliximab	FCGR2A	H166P		Psoriasis	Efficacy	P08631				1	161509955.0	A	S
pharmgkb	irinotecan	SLCO1B1	N130H		Neoplasms	Toxicity	Q9Y6L6	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	12	21176804.0	A	K
pharmgkb	capecitabine,fluorouracil,leucovorin,oxaliplatin	ABCG2	Q141K		Colorectal Neoplasms	Efficacy	Q9UNQ0				4	88131171.0	G	Y
pharmgkb	fluorouracil	ABCB1	I1145M		Colorectal Neoplasms	Toxicity	P08183	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	7	87509329.0	A	K
pharmgkb	cisplatin,fluorouracil	ABCB1	I1145M		Esophageal Neoplasms	Efficacy	P08183				7	87509329.0	A	K
pharmgkb	tocilizumab	IL6R	rs4329505		Arthritis, Rheumatoid	Efficacy	P08887	Drug			1	154459944.0	T	C
pharmgkb	sirolimus	CYP3A4	CYP3A4*1, CYP3A4*22			Metabolism/PK	P08684	Drug	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC				
pharmgkb	propofol	CYP2B6	K262R			Metabolism/PK	P20813	Drug	4943.0	CC(C)C1=C(C(=CC=C1)C(C)C)O	19	41009358.0	A	G
pharmgkb	clopidogrel	P2RY12	rs2046934		Acute coronary syndrome,Angina Pectoris	Efficacy	Q9H244	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	3	151339854.0	G	M
pharmgkb	tacrolimus	IL10	rs1800896		Transplantation	Metabolism/PK	P22301	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	1	206773552.0	T	C
pharmgkb	simvastatin	CYP3A4	rs35599367		Chronic Disease	Efficacy	P08684	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	99768693.0	G	A
pharmgkb	salbutamol,selective beta-2-adrenoreceptor agonists	CRHR2	rs255100		Asthma	Efficacy	P55089				7	30689292.0	A	K
pharmgkb	salbutamol,selective beta-2-adrenoreceptor agonists	CRHR2	rs2284220		Asthma	Efficacy	P55089				7	30678487.0	G	A
pharmgkb	carbamazepine	HNF4A	rs2071197		Epilepsy	Metabolism/PK	P41235	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	20	44401795.0	G	A
pharmgkb	methotrexate	SLCO1B1	rs10841753		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21168436.0	T	C
pharmgkb	lumefantrine	CYP3A5	rs41303343		Malaria	Metabolism/PK	P20815	Drug	6437380.0	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	7	99652771.0	-	A
pharmgkb	carbamazepine,oxcarbazepine	SCN1A	A1056P		Epilepsy	Efficacy	P35498				2	166036278.0	C	T
pharmgkb	carbamazepine,clobazam,ethosuximide,lamotrigine,levetiracetam,oxcarbazepine,valproic acid	SCN1A	A1056P		Epilepsy	Efficacy	P35498				2	166036278.0	C	T
pharmgkb	atazanavir,ritonavir	ABCB1	I1145M		HIV Infections	Other	P08183				7	87509329.0	A	K
pharmgkb	nevirapine	HLA-B	HLA-B*38:02		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4				
pharmgkb	Ace Inhibitors, Plain	KCNIP4	rs16870989			Toxicity	Q6PIL6	Drug Class			4	21385141.0	T	A
pharmgkb	nevirapine	CYP2B6	Q172H		drug reaction with eosinophilia and systemic symptoms,HIV Infections,Stevens-Johnson Syndrome,Toxic liver disease	Toxicity	P20813	Drug	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	19	41006936.0	G	W
pharmgkb	Ace Inhibitors, Plain	KCNIP4	rs7661530			Toxicity	Q6PIL6	Drug Class			4	21349637.0	T	C
pharmgkb	Ace Inhibitors, Plain	KCNIP4	rs7675300			Toxicity	Q6PIL6	Drug Class			4	21383914.0	C	A
pharmgkb	buprenorphine	OPRD1	rs581111		Opioid-Related Disorders	Efficacy	P41143	Drug	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	1	28848861.0	A	G
pharmgkb	allopurinol	PSORS1C1	rs3815087		Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	Q9UIG5	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	6	31125810.0	G	A
pharmgkb	warfarin	NR1I3	rs2501873			Dosage	Q14994	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	1	161234748.0	C	T
pharmgkb	capecitabine,fluorouracil	MTHFR	A222V		Neoplasms	Toxicity	P42898				1	11796321.0	G	A
pharmgkb	tacrolimus	ABCB1	S893A		Kidney Transplantation,liver transplantation	Dosage,Metabolism/PK	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87531302.0	A	Y
pharmgkb	tacrolimus	ABCB1	rs1128503		Transplantation	Dosage,Metabolism/PK	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87550285.0	A	G
pharmgkb	cyclosporine,tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		Kidney Transplantation,transplant rejection	Toxicity	P20815							
pharmgkb	clopidogrel	ABCB1	I1145M		platelet reactivity	Efficacy	P08183	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	7	87509329.0	A	K
pharmgkb	acenocoumarol	GGCX	rs11676382			Dosage	P38435	Drug	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	2	85550510.0	C	G
pharmgkb	warfarin	GGCX	rs12714145			Dosage	P38435	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	85560218.0	C	T
pharmgkb	warfarin	GGCX	R325Q			Dosage	P38435	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	2	85553413.0	C	T
pharmgkb	citalopram	BDNF	rs7103411		Depressive Disorder, Major	Efficacy	P23560	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	11	27678578.0	C	T
pharmgkb	gemcitabine	SLC29A3	S158F		Carcinoma, Non-Small-Cell Lung	Efficacy	Q9BZD2	Prodrug	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	10	71351651.0	C	T
pharmgkb	methotrexate	PTPRM	rs6506569		Arthritis, Rheumatoid	Efficacy	P28827	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	18	8275859.0	T	C
pharmgkb	warfarin	ABCB1	I1145M			Dosage	P08183	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	7	87509329.0	A	K
pharmgkb	tacrolimus	CYP3A5	rs776746		transplant rejection	Efficacy	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	99672916.0	T	C
pharmgkb	tacrolimus	ABCB1	I1145M		Kidney Transplantation	Toxicity	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87509329.0	A	K
pharmgkb	methotrexate	AMPD1	Q45K		Arthritis, Rheumatoid	Efficacy,Toxicity	P23109	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	114693436.0	G	W
pharmgkb	Platinum compounds	ERCC2	D312N		Neoplasms	Efficacy,Toxicity	P18074	Drug Class			19	45364001.0	C	W
pharmgkb	adefovir dipivoxil,cidofovir,tenofovir	SLC22A6	R50H			Other	Q4U2R8				11	62984542.0	C	D
pharmgkb	adefovir dipivoxil	SLC22A6	R454Q			Other	Q4U2R8	Prodrug	60871.0	CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C	11	62979488.0	C	T
pharmgkb	lisinopril	ACE	rs1799752		Diabetes Mellitus, Type 1,Heart Failure	Efficacy	P12821	Drug	5362119.0	C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O	17	63488530.0	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G
pharmgkb	risperidone	ABCB1	I1145M		Bipolar Disorder,Depression,Psychotic Disorders,Schizophrenia,Substance-Related Disorders	Metabolism/PK	P08183	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	7	87509329.0	A	K
pharmgkb	allopurinol	ABCG2	rs10011796			Efficacy	Q9UNQ0	Drug	2094.0	C1=C2C(=NC=NC2=O)NN1	4	88169725.0	T	S
pharmgkb	methylphenidate	SLC6A2	rs5569		Attention Deficit Disorder with Hyperactivity	Efficacy	P23975	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	16	55697923.0	G	M
pharmgkb	opioids	OPRM1	A6V		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154039561.0	C	D
pharmgkb	cocaine	OPRM1	N40D		Cocaine-Related Disorders	Toxicity	P35372	Drug	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	6	154039662.0	A	G
pharmgkb	nicotine	OPRM1	N40D		Tobacco Use Disorder	Toxicity	P35372	Drug	942.0	CN1CCCC1C2=CN=CC=C2	6	154039662.0	A	G
pharmgkb	clopidogrel	CYP3A4	rs2242480		Coronary Artery Disease	Efficacy	P08684	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	7	99763843.0	C	T
pharmgkb	risperidone	COMT	rs4633		Schizophrenia	Efficacy	P21964	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	22	19962712.0	C	T
pharmgkb	risperidone	COMT	V158M		Schizophrenia	Efficacy	P21964	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	22	19963748.0	G	A
pharmgkb	risperidone	ANKK1	E713K		Schizophrenia	Efficacy	Q8NFD2	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	11	113400106.0	G	A
pharmgkb	fentanyl	ABCB1	I1145M		Pain	Efficacy	P08183	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	7	87509329.0	A	K
pharmgkb	morphine	ABCB1	I1145M		Pain,Pain, Postoperative	Dosage	P08183	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	7	87509329.0	A	K
pharmgkb	heroin	OPRM1	N40D		Heroin Dependence	Toxicity	P35372	Drug	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	6	154039662.0	A	G
pharmgkb	heroin,methamphetamine	BDNF	V66M		Substance-Related Disorders	Other	P23560				11	27658369.0	C	T
pharmgkb	Drugs For Treatment Of Tuberculosis	CYP2E1	rs2031920		Tuberculosis	Toxicity	P05181	Drug Class			10	133526341.0	C	T
pharmgkb	amlodipine	CYP3A4	rs2246709		Hypertension	Efficacy	P08684	Drug	2162.0	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	7	99768096.0	A	G
pharmgkb	tacrolimus	ABCB1	I1145M		Organ Transplantation	Dosage,Metabolism/PK	P08183	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	87509329.0	A	K
pharmgkb	warfarin	CYP4F2	V433M		over-anticoagulation	Other	P78329	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	19	15879621.0	C	T
pharmgkb	valproic acid	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3		Epilepsy	Toxicity	P33261	Drug	3121.0	CCCC(CCC)C(=O)O				
pharmgkb	simvastatin	ABCB1	I1145M			Efficacy	P08183	Drug	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	7	87509329.0	A	K
pharmgkb	morphine	UGT2B7	Y268H			Dosage	P16662	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	4	69098620.0	T	C
pharmgkb	cisplatin	LRP2	rs2075252		Neoplasms	Toxicity	P98164	Drug	441203.0	N.N.Cl[Pt+2]Cl	2	169154475.0	T	M
pharmgkb	efavirenz	ABCB1	rs1128503		HIV Infections	Metabolism/PK	P08183	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	7	87550285.0	A	G
pharmgkb	efavirenz	CYP2B6	R487S			Metabolism/PK	P20813	Drug	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	19	41016810.0	C	D
pharmgkb	antidepressants,citalopram,escitalopram,fluoxetine,paroxetine	TPH1	rs1800532		Depressive Disorder, Major	Efficacy	P17752				11	18026269.0	G	T
pharmgkb	carvedilol	UGT1A1	UGT1A1*1, UGT1A1*28			Metabolism/PK	P22309	Drug	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O				
pharmgkb	methadone	CYP2B6	CYP2B6*1, CYP2B6*6		Opioid-Related Disorders	Dosage	P20813	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	methadone	CYP3A5	CYP3A5*1, CYP3A5*3			Metabolism/PK	P20815	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	methadone	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Metabolism/PK	P11712	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	methadone	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3			Metabolism/PK	P33261	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	artesunate,chlorproguanil,dapsone	G6PD	V68M		Malaria	Toxicity	P11413				X	154536002.0	C	T
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		hematopoietic stem cell transplantation,Kidney Transplantation,transplant rejection	Efficacy	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	venlafaxine	CYP2C19	CYP2C19*1, CYP2C19*2			Efficacy	P33261	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O				
pharmgkb	oxaliplatin	GSTP1	I105V			Efficacy	P09211	Drug	6857599.0	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	11	67585218.0	A	G
pharmgkb	methylphenidate	ADRA2A	rs1800544		Attention Deficit Disorder with Hyperactivity	Efficacy	P08913	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	10	111076745.0	G	C
pharmgkb	tacrolimus	POR	A503V		Kidney Transplantation	Toxicity	Q9Y277	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	7	75985688.0	C	T
pharmgkb	Platinum compounds	ERCC1	Q506K		Carcinoma, Non-Small-Cell Lung,Ovarian Neoplasms	Efficacy	P07992	Drug Class			19	45409478.0	C	D
pharmgkb	Drugs used in nicotine dependence,nicotine	OPRM1	N40D		Tobacco Use Disorder	Efficacy	P35372				6	154039662.0	A	G
pharmgkb	clopidogrel	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3		Acute coronary syndrome,Coronary Artery Disease	Efficacy	P11712	Prodrug	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3				
pharmgkb	azathioprine	ITPA	rs7270101		Inflammatory Bowel Diseases	Toxicity	Q9BY32	Drug	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	20	3213247.0	A	C
pharmgkb	aspirin	ITGB3	L59P		Acute coronary syndrome,Coronary Artery Disease	Efficacy	P05106	Drug	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	17	47283364.0	T	C
pharmgkb	Tumor necrosis factor alpha (TNF-alpha) inhibitors	TNF	rs1799724		Arthritis, Rheumatoid,Crohn Disease,Psoriasis,Spondylitis, Ankylosing	Efficacy	Q9UNG2	Drug Class			6	31574705.0	C	T
pharmgkb	mercaptopurine	ITPA	P32T		Myelosuppression,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9BY32	Drug, Metabolite	667490.0	C1=NC2=C(N1)C(=S)N=CN2	20	3213196.0	C	R
pharmgkb	metformin	ATM	rs11212617		Diabetes Mellitus, Type 2	Efficacy	Q13315	Drug	4091.0	CN(C)C(=N)N=C(N)N	11	108412434.0	C	A
pharmgkb	tacrolimus	CYP3A5	CYP3A5*1, CYP3A5*3		nephrotoxicity	Toxicity	P20815	Drug	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC				
pharmgkb	risperidone	DRD2	rs1799978		Schizophrenia	Efficacy	P14416	Drug	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	11	113475629.0	T	C
pharmgkb	methadone	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*87, CYP2D6*89, CYP2D6*90, CYP2D6*93, CYP2D6*95, CYP2D6*97, CYP2D6*98			Metabolism/PK	P10635	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2				
pharmgkb	olanzapine	CYP3A5	CYP3A5*1, CYP3A5*3			Metabolism/PK	P20815	Drug	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C				
pharmgkb	antiepileptics	ABCB1	I1145M		Epilepsies, Partial,Epilepsy,Epilepsy, Generalized	Efficacy	P08183	Drug Class			7	87509329.0	A	K
pharmgkb	naproxen	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29			Metabolism/PK	P11712	Drug	1302.0	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O				
pharmgkb	fluorouracil	DPYD	rs3918290		Neoplasms	Efficacy	Q12882	Drug	3385.0	C1=C(C(=O)NC(=O)N1)F	1	97450058.0	C	K
pharmgkb	ivacaftor	CFTR	rs113993960		Cystic Fibrosis	Efficacy	P13569	Drug	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	7	117559592.0	CTT	-
pharmgkb	tenofovir	ABCC2	C1515Y		Fanconi Syndrome,HIV Infections	Toxicity	Q5T2W1	Prodrug	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	10	99851537.0	G	A
pharmgkb	ethanol	OPRM1	N40D		Alcoholism	Toxicity	P35372	Drug	702.0	CCO	6	154039662.0	A	G
pharmgkb	sufentanil	OPRM1	N40D		adverse events,Pain, Postoperative	Toxicity	P35372	Drug	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	6	154039662.0	A	G
pharmgkb	naltrexone	OPRM1	N40D		Alcoholism,hypersexuality state,Tobacco Use Disorder	Efficacy	P35372	Drug	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	6	154039662.0	A	G
pharmgkb	rosuvastatin	SLCO1B1	V174A			Efficacy	Q9Y6L6	Drug	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	12	21178615.0	T	C
pharmgkb	cannabinoids,cocaine,ethanol,nicotine,opioids	OPRM1	N40D		Substance-Related Disorders	Toxicity	P35372				6	154039662.0	A	G
pharmgkb	opioids	OPRM1	N40D		Opioid-Related Disorders	Toxicity	P35372	Drug Class			6	154039662.0	A	G
pharmgkb	ibuprofen	CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4		Pain, Postoperative	Efficacy	P10632	Drug	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O				
pharmgkb	morphine	COMT	rs6269		Neoplasms,Pain,Pain, Postoperative	Dosage	P21964	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	22	19962429.0	A	G
pharmgkb	everolimus	CYP3A4	CYP3A4*1, CYP3A4*22		Breast Neoplasms,Kidney Neoplasms,Kidney Transplantation,Neuroendocrine Tumors	Metabolism/PK	P08684	Drug	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC				
pharmgkb	morphine	OPRM1	N40D			Metabolism/PK	P35372	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	6	154039662.0	A	G
pharmgkb	pantoprazole	ABCB1	I1145M		Helicobacter Infections	Efficacy	P08183	Drug	4679.0	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC	7	87509329.0	A	K
pharmgkb	lamotrigine	UGT2B7	R124S		Epilepsy	Metabolism/PK	P16662	Drug	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	4	69096892.0	A	K
pharmgkb	oxycodone	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6		cns depression,Drug Toxicity	Toxicity	P10635	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O				
pharmgkb	citalopram	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41		Depressive Disorder, Major	Toxicity	P10635	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	warfarin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Efficacy	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	warfarin	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3			Efficacy	P11712	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O				
pharmgkb	methotrexate	MTHFR	E429A		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Dosage	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11794419.0	T	G
pharmgkb	irinotecan	UGT1A1	rs4124874		Lymphoma,Neoplasms	Toxicity	P22309	Prodrug	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	2	233757013.0	T	R
pharmgkb	sulfamethoxazole / trimethoprim	G6PD	G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like		Anemia, Hemolytic,Hemolysis	Toxicity	P11413	Drug	358641.0					
pharmgkb	sulfametopyrazine	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham		Hemolysis	Toxicity	P11413	Drug	9047.0	COC1=NC=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N				
pharmgkb	methotrexate	SLC19A1	H27R		Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45537880.0	T	S
pharmgkb	methotrexate	MTHFR	E429A		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11794419.0	T	G
pharmgkb	cisplatin	ERCC1	Q506K		Esophageal Neoplasms,Ovarian Neoplasms,Stomach Neoplasms	Efficacy	P07992	Drug	441203.0	N.N.Cl[Pt+2]Cl	19	45409478.0	C	D
pharmgkb	methotrexate	C18orf56	rs45445694		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q8TAI1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O				
pharmgkb	methotrexate	ABCB1	I1145M		Precursor Cell Lymphoblastic Leukemia-Lymphoma	Efficacy	P08183	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	7	87509329.0	A	K
pharmgkb	methotrexate	SLC19A1	H27R		Neoplasms	Toxicity	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45537880.0	T	S
pharmgkb	warfarin	VKORC1	rs17708472			Dosage	Q8N0U8	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	31094032.0	G	A
pharmgkb	oxcarbazepine	HLA-B	HLA-B*15:02		Maculopapular Exanthema	Toxicity	P01889	Drug	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N				
pharmgkb	methotrexate	TYMS	rs11280056		Arthritis, Rheumatoid,Drug Toxicity,hematopoietic stem cell transplantation,Psoriasis,Toxic liver disease	Toxicity	P04818	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	18	673447.0	AAGTTA	-
pharmgkb	warfarin	NQO1	P187S			Dosage	P15559	Drug	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	16	69711242.0	G	A
pharmgkb	nicotine	OPRM1	N40D			Dosage	P35372	Drug	942.0	CN1CCCC1C2=CN=CC=C2	6	154039662.0	A	G
pharmgkb	valproic acid	UGT2B7	Y268H		Epilepsy	Metabolism/PK	P16662	Drug	3121.0	CCCC(CCC)C(=O)O	4	69098620.0	T	C
pharmgkb	methotrexate	ABCG2	Q141K		Burkitt Lymphoma,Lymphoma, T-Cell,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88131171.0	G	Y
pharmgkb	methotrexate	ABCC2	rs717620		Leukemia, Lymphoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q5T2W1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	99782821.0	C	T
pharmgkb	methotrexate	ABCC2	rs3740065		Leukemia, B-Cell, Acute,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	Q5T2W1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	99845936.0	A	G
pharmgkb	methotrexate	SLC19A1	H27R		Burkitt Lymphoma,Leukemia,Lymphoma, T-Cell,Neoplasms,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Metabolism/PK	P41440	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	21	45537880.0	T	S
pharmgkb	methotrexate	ABCC2	V417I		Arthritis, Rheumatoid	Toxicity	Q5T2W1	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	10	99804058.0	G	A
pharmgkb	methotrexate	ABCB1	rs1128503		Arthritis, Rheumatoid	Toxicity	P08183	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	7	87550285.0	A	G
pharmgkb	methotrexate	ABCB1	I1145M		Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	Efficacy	P08183	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	7	87509329.0	A	K
pharmgkb	methotrexate	MTR	D919G		Brain Diseases,Drug Toxicity,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q13613	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	236885200.0	A	G
pharmgkb	methotrexate	FASTKD3	I49M		Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	Toxicity	Q14CZ7	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	5	7870860.0	A	G
pharmgkb	methotrexate	ABCG2	Q141K		Burkitt Lymphoma,Drug Toxicity,Lymphoma, T-Cell,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9UNQ0	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	4	88131171.0	G	Y
pharmgkb	methotrexate	SLCO1B1	rs11045879		Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	Q9Y6L6	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	12	21229685.0	T	C
pharmgkb	methotrexate	MTHFR	E429A		Burkitt Lymphoma,Lymphoma, Non-Hodgkin,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	Toxicity	P42898	Drug	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	1	11794419.0	T	G
pharmgkb	carbamazepine	HLA-B	HLA-B*58:01		drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P01889	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	methadone	ABCB1	rs1128503		Heroin Dependence,Opioid-Related Disorders	Dosage	P08183	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	87550285.0	A	G
pharmgkb	methadone	ABCB1	I1145M		Heroin Dependence,Opioid-Related Disorders	Dosage	P08183	Drug	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	7	87509329.0	A	K
pharmgkb	oxycodone	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6		Pain	Efficacy	P10635	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O				
pharmgkb	oxycodone	OPRM1	N40D		adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	Toxicity	P35372	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	6	154039662.0	A	G
pharmgkb	morphine	COMT	V158M		adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	Toxicity	P21964	Drug, Metabolite	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	22	19963748.0	G	A
pharmgkb	oxycodone	COMT	V158M		adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	Toxicity	P21964	Drug	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	22	19963748.0	G	A
pharmgkb	methylphenidate	COMT	V158M		Attention Deficit Disorder with Hyperactivity	Efficacy	P21964	Drug	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	22	19963748.0	G	A
pharmgkb	citalopram	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17		Depressive Disorder, Major,Obsessive-Compulsive Disorder	Efficacy	P33261	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	paclitaxel	ABCB1	I1145M		Breast Neoplasms,Neoplasms	Efficacy	P08183	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	7	87509329.0	A	K
pharmgkb	docetaxel	ABCB1	I1145M		Breast Neoplasms,Neoplasms	Efficacy	P08183	Drug	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	7	87509329.0	A	K
pharmgkb	paclitaxel	ABCB1	I1145M		Drug Toxicity,Neoplasms,Neutropenia,Peripheral Nervous System Diseases	Toxicity	P08183	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	7	87509329.0	A	K
pharmgkb	paclitaxel	CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4		Drug Toxicity,Neutropenia,Peripheral Nervous System Diseases,Toxic liver disease	Toxicity	P10632	Drug	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C				
pharmgkb	Beta Blocking Agents	ADRB1	G389R		Cardiomyopathy, Dilated,Heart Failure	Efficacy	P08588	Drug Class			10	114045297.0	G	C
pharmgkb	Beta Blocking Agents	GRK5	Q41L		Heart Failure	Efficacy	P34947	Drug Class			10	119326585.0	A	T
pharmgkb	Beta Blocking Agents	ADRB2	R16G		Cardiomyopathy, Dilated,Heart Failure	Efficacy	P07550	Drug Class			5	148826877.0	G	A
pharmgkb	carbamazepine	HLA-A	HLA-A*02:01		Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	Toxicity	P04439	Drug	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N				
pharmgkb	fentanyl	CYP3A4	CYP3A4*1, CYP3A4*18		Pain, Postoperative	Dosage	P08684	Drug	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3				
pharmgkb	fluoxetine	HTR2A	rs6313			Efficacy	P28223	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	13	46895805.0	G	A
pharmgkb	fluoxetine	HTR2A	rs6311			Efficacy	P28223	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	13	46897343.0	C	T
pharmgkb	antidepressants	HTR2A	rs6311		Bipolar Disorder,Depression,Depressive Disorder, Major	Efficacy	P28223	Drug Class			13	46897343.0	C	T
pharmgkb	antidepressants	HTR2A	rs6313		Bipolar Disorder,Depression,Depressive Disorder, Major	Efficacy	P28223	Drug Class			13	46895805.0	G	A
pharmgkb	sertraline	HTR2A	rs6313		Anxiety Disorders,Depression	Efficacy	P28223	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	13	46895805.0	G	A
pharmgkb	venlafaxine	HTR2A	rs6313		Depressive Disorder, Major	Efficacy	P28223	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	13	46895805.0	G	A
pharmgkb	venlafaxine	HTR2A	rs6311		Depressive Disorder, Major	Efficacy	P28223	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	13	46897343.0	C	T
pharmgkb	fluvoxamine	HTR2A	rs6313		Depressive Disorder, Major	Efficacy	P28223	Drug	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	13	46895805.0	G	A
pharmgkb	paroxetine	HTR2A	rs6313		Depressive Disorder, Major	Efficacy	P28223	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	13	46895805.0	G	A
pharmgkb	paroxetine	HTR2A	rs6311		Depressive Disorder, Major,Obsessive-Compulsive Disorder	Efficacy	P28223	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	13	46897343.0	C	T
pharmgkb	escitalopram	HTR2A	rs6313		Depressive Disorder, Major	Efficacy	P28223	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46895805.0	G	A
pharmgkb	escitalopram	HTR2A	rs6311		Depressive Disorder, Major	Efficacy	P28223	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46897343.0	C	T
pharmgkb	citalopram	HTR2A	rs6311		Depressive Disorder, Major	Efficacy	P28223	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46897343.0	C	T
pharmgkb	citalopram	HTR2A	rs6313		Depressive Disorder, Major	Efficacy	P28223	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46895805.0	G	A
pharmgkb	venlafaxine	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Anxiety Disorders,Depression	Efficacy	P31645	Drug	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O				
pharmgkb	escitalopram	HTR2A	rs7997012		Depressive Disorder, Major	Efficacy	P28223	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	13	46837850.0	A	G
pharmgkb	fluoxetine	HTR2A	rs7997012		Depressive Disorder, Major	Efficacy	P28223	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	13	46837850.0	A	G
pharmgkb	fluvoxamine	HTR2A	rs6311		Depressive Disorder, Major	Toxicity	P28223	Drug	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	13	46897343.0	C	T
pharmgkb	fluvoxamine	HTR2A	rs6311		Depressive Disorder, Major	Efficacy	P28223	Drug	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	13	46897343.0	C	T
pharmgkb	fluoxetine	HTR2A	rs6311		Depressive Disorder, Major	Toxicity	P28223	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	13	46897343.0	C	T
pharmgkb	sertraline	HTR2A	rs6311		Depressive Disorder, Major,Sexual Dysfunctions, Psychological	Toxicity	P28223	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	13	46897343.0	C	T
pharmgkb	sertraline	HTR2A	rs6311		Depressive Disorder, Major	Efficacy	P28223	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	13	46897343.0	C	T
pharmgkb	sertraline	HTR2A	rs6313		Depressive Disorder, Major,Sexual Dysfunctions, Psychological	Toxicity	P28223	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	13	46895805.0	G	A
pharmgkb	paroxetine	HTR2A	rs7997012		Depressive Disorder, Major	Efficacy	P28223	Drug	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	13	46837850.0	A	G
pharmgkb	sertraline	HTR2A	rs7997012		Anxiety Disorders,Depression	Efficacy	P28223	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	13	46837850.0	A	G
pharmgkb	citalopram	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Depressive Disorder, Major	Efficacy	P31645	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	citalopram	SLC6A4	rs25531			Efficacy	P31645	Drug	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	17	30237328.0	T	C
pharmgkb	escitalopram	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Depression,Depressive Disorder	Efficacy	P31645	Drug	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F				
pharmgkb	sertraline	SLC6A4	rs57098334		Depressive Disorder, Major,Panic Disorder	Efficacy	P31645	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl				
pharmgkb	sertraline	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Depressive Disorder, Major,Panic Disorder	Efficacy	P31645	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl				
pharmgkb	sertraline	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Anxiety Disorders,Depressive Disorder, Major	Toxicity	P31645	Drug	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl				
pharmgkb	fluoxetine	SLC6A4	rs25531		Depressive Disorder, Major	Efficacy	P31645	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	17	30237328.0	T	C
pharmgkb	fluoxetine	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)		Depressive Disorder, Major,Obsessive-Compulsive Disorder	Efficacy	P31645	Drug	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F				
pharmgkb	Ace Inhibitors, Plain	BDKRB2	rs1799722		Cough	Toxicity	P30411	Drug Class			14	96204802.0	C	T
ret	Cabozantinib	RET	L730I	1.496993433			P07949							
ret	Cabozantinib	RET	L730V	1.364533191			P07949							
ret	Cabozantinib	RET	L730V/V804M	2.040557866			P07949							
ret	Cabozantinib	RET	E732K	0.933646966			P07949							
ret	Cabozantinib	RET	V738A	0.959006724			P07949							
ret	Cabozantinib	RET	V804L	1.547160501			P07949							
ret	Cabozantinib	RET	V804M	1.713935672			P07949							
ret	Cabozantinib	RET	Y806N	1.780063812			P07949							
ret	Cabozantinib	RET	A807V	0.515421162			P07949							
ret	Cabozantinib	RET	G810A	-0.05184698			P07949							
ret	Cabozantinib	RET	G810S	0.879440123			P07949							
ret	Cabozantinib	RET	V871I	0.890683181			P07949							
ret	Cabozantinib	RET	F998V	0.670950003			P07949							
ret	Cabozantinib	RET	M918T	1.119147697			P07949							
ret	Lenvatinib	RET	L730I	1.02988595			P07949							
ret	Lenvatinib	RET	L730V	0.11384301			P07949							
ret	Lenvatinib	RET	L730V/V804M	2.325363222			P07949							
ret	Lenvatinib	RET	E732K	-0.102399447			P07949							
ret	Lenvatinib	RET	V738A	1.498686231			P07949							
ret	Lenvatinib	RET	V804L	2.396319377			P07949							
ret	Lenvatinib	RET	V804M	1.996638466			P07949							
ret	Lenvatinib	RET	Y806N	1.38136332			P07949							
ret	Lenvatinib	RET	A807V	0.622407199			P07949							
ret	Lenvatinib	RET	G810A	-0.325665927			P07949							
ret	Lenvatinib	RET	G810S	0.7509402540000001			P07949							
ret	Lenvatinib	RET	V871I	0.599919082			P07949							
ret	Lenvatinib	RET	F998V	0.906589265			P07949							
ret	Lenvatinib	RET	M918T	1.19851451			P07949							
ret	Vandetanib	RET	L730I	0.90561003			P07949							
ret	Vandetanib	RET	L730V	0.568262907			P07949							
ret	Vandetanib	RET	L730V/V804M	1.4912139080000002			P07949							
ret	Vandetanib	RET	E732K	0.091852899			P07949							
ret	Vandetanib	RET	V738A	0.545985009			P07949							
ret	Vandetanib	RET	V804L	1.594407555			P07949							
ret	Vandetanib	RET	V804M	1.56743172			P07949							
ret	Vandetanib	RET	Y806N	1.570490055			P07949							
ret	Vandetanib	RET	A807V	0.545985009			P07949							
ret	Vandetanib	RET	G810A	1.121852487			P07949							
ret	Vandetanib	RET	G810S	1.5294522869999998			P07949							
ret	Vandetanib	RET	V871I	0.516912688			P07949							
ret	Vandetanib	RET	F998V	0.361174735			P07949							
ret	Vandetanib	RET	M918T	0.877003047			P07949							
ret	Nintedanib	RET	L730I	1.067645645			P07949							
ret	Nintedanib	RET	L730V	1.038573324			P07949							
ret	Nintedanib	RET	L730V/V804M	1.444099791			P07949							
ret	Nintedanib	RET	E732K	0.115690653			P07949							
ret	Nintedanib	RET	V738A	1.121852487			P07949							
ret	Nintedanib	RET	V804L	0.846953098			P07949							
ret	Nintedanib	RET	V804M	1.08166663			P07949							
ret	Nintedanib	RET	Y806N	1.115340244			P07949							
ret	Nintedanib	RET	A807V	-0.091852899			P07949							
ret	Nintedanib	RET	G810A	-0.044158301			P07949							
ret	Nintedanib	RET	G810S	0.82604343			P07949							
ret	Nintedanib	RET	V871I	0.149749316			P07949							
ret	Nintedanib	RET	F998V	0.0			P07949							
ret	Nintedanib	RET	M918T	0.321168816			P07949							
